PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wu, MT; Wu, CF; Chen, BH; Chen, EK; Chen, YL; Shiea, J; Lee, WT; Chao, MC; Wu, JR				Wu, Ming-Tsang; Wu, Chia-Fang; Chen, Bai-Hsiun; Chen, Eric K.; Chen, Yi-Ling; Shiea, Jentaie; Lee, Wei-Te; Chao, Mei-Chyn; Wu, Jiunn-Ren			Intake of Phthalate-Tainted Foods Alters Thyroid Functions in Taiwanese Children	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BISPHENOL-A; EXPOSURE; HEALTH; LESSONS	Background: On April-May, 2011, two Taiwan chemical companies were found to have intentionally added phthalates, Di-(2-ethylhexyl) phthalate (DEHP) and/or Di-isononyl phthalate, as a substitute of emulsifier to many foodstuffs. This study aimed to investigate whether exposure to these foods altered endocrine functions in children aged <= 10 years and, if so, whether those changes could be reversed by stopping exposure. Methods: One Phthalates Clinic for Children was established in southern Taiwan between May 31 and June 17, 2011. All eligible children had their exposure information, blood and/or urine specimens collected. Endocrine functions were assessed in serum. The exposure groups were categorized into three (High, >500 ppm, Low, 1-500 ppm, and No, <1 ppm of DEHP). After six months, some children were followed up for the selected endocrine hormones. Results: Sixty children were eligible in this study; all were Tanner stage 1 with no pubic hair. Compared to non-exposed group, both high and low exposure groups had significantly lower serum thyroid-stimulating hormone (TSH) levels (P = 0.001 and 0.024). At six months follow-up, serum triiodothyronine (T3) levels was significantly changed (P = 0.034) in high exposure group (n = 13). For serum estradiol (E2), the detectable rate (>= 8 pg/mL) decreased from 76.9% (10/13) to 30.8% (4/13) (P = 0.070). Conclusions: This study shows that serum TSH levels can be altered when children were exposed to high concentrations of phthalate-tainted foodstuffs. Serum E2 and T3 may be partially recovered after stopping exposure.	[Wu, Ming-Tsang; Wu, Chia-Fang] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Municipal Hsiaokang Hosp, Ctr Environm & Occupat Med, Kaohsiung, Taiwan; [Chen, Bai-Hsiun; Chao, Mei-Chyn; Wu, Jiunn-Ren] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Eric K.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Superintendants Off, Kaohsiung, Taiwan; [Chen, Eric K.] Kaohsiung Med Univ, Ctr Gen Educ, Kaohsiung, Taiwan; [Chen, Yi-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Shiea, Jentaie] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan; [Lee, Wei-Te] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Pediat, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wu, MT (corresponding author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan.	960021@ms.kmuh.org.tw; jirewu@cc.kmu.edu.tw	Wu, Ming-Tsang/G-5637-2012; Chen, Yi/HIR-2608-2022	Wu, Ming-Tsang/0000-0001-7307-7816; Chen, Bai Hsiun/0000-0001-9496-553X; Wu, Meiye/0000-0003-3712-1554	Taiwan National Science Council [NSC 101-2314-B-037-037-MY3]; Kaohsiung Medical University Hospital [KMUH100-0R55, KMUH101-1I04]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This work was supported by the Taiwan National Science Council (NSC 101-2314-B-037-037-MY3) and Kaohsiung Medical University Hospital (KMUH100-0R55 and KMUH101-1I04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Chiang YL, 2011, J FORMOS MED ASSOC, V110, P551, DOI 10.1016/j.jfma.2011.07.001; Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712; Environmental Protection Agency (EPA) USA, DI 2 ETH PHTH DEHP C; European Food Safety Authority (EFSA), OP SCI PAN FOOD ADD; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Ishihara A, 2003, MOL CELL ENDOCRINOL, V199, P105, DOI 10.1016/S0303-7207(02)00302-7; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079; Lu JY, 2011, J FORMOS MED ASSOC, V110, P553, DOI 10.1016/j.jfma.2011.07.002; Meeker JD, 2012, ARCH PEDIAT ADOLESC, V4, P1; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582; Pak VM, 2011, AAOHN J, V59, P228, DOI 10.3928/08910162-20110426-01; Presu JL, 2010, ENV HLTH PERSPECT, V118, P1748; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Shimada N, 2004, J ENDOCRINOL, V183, P627, DOI 10.1677/joe.1.05893; Tai SSC, 2005, ANAL CHEM, V77, P6359, DOI 10.1021/ac050837i; Wu MT, 2012, ENVIRON INT, V44, P75, DOI 10.1016/j.envint.2012.01.014; Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002	22	127	128	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55005	10.1371/journal.pone.0055005	http://dx.doi.org/10.1371/journal.pone.0055005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383031	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800101
J	Sun, ZZ; Dragon, S; Becker, A; Gounni, AS				Sun, Zhizhi; Dragon, Stephane; Becker, Allan; Gounni, Abdelilah S.			Leptin Inhibits Neutrophil Apoptosis in Children via ERK/NF-kappa B-Dependent Pathways	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; COLONY-STIMULATING FACTOR; HUMAN DENDRITIC CELLS; PROTEIN-KINASE; ADIPOSE-TISSUE; DEFICIENT MICE; SURVIVAL; ACTIVATION; RECEPTOR; OBESITY	Introduction and Rationale: Previous studies have shown that delayed neutrophil apoptosis is associated with chronic airway diseases. Leptin is an adipocyte-derived hormone that acts as a regulator of energy homeostasis and food intake. Emerging evidence suggests that leptin can regulate immune responses including the release of proinflammatory cytokines and protection of inflammatory cells from apoptosis. Serum leptin is increased during allergic reactions in the airways. However, the expression and function of leptin receptor in neutrophils isolated from children is not known. Methods: Flow cytometry was used to detect leptin receptor expression in neutrophils isolated from allergic asthmatic (n = 14), allergic non asthmatic (n = 21), non allergic asthmatic (n = 7) and healthy children (n = 23); confocal laser scanning microscopy combined with immunofluorescence was performed to detect intracellular pool of leptin receptor; Annexin-V/PI staining and caspase 3 activity was used to determine neutrophil survival. Pharmacological inhibitors were utilized to understand the role of MAPK and NF-kB pathway in leptin-induced neutrophil survival. Results and Conclusion: A heterogeneous leptin receptor expression was observed on neutrophils isolated from children. Neutrophils isolated from healthy children expressed more leptin receptor than those from allergic asthmatic (P<0.05) but not allergic non-asthmatic (P>0.05) or non-allergic asthmatic children (n = 7, P>0.05). Neutrophils isolated from children express an intracellular pool of leptin receptor that was mobilized to the cell surface upon GM-CSF stimulation. Finally, leptin exhibited anti-apoptotic properties on neutrophils via NF-kappa B and MEK1/2 MAPK pathway. Collectively, our data suggest that leptin may enhance airway inflammation by promoting neutrophil survival.	[Sun, Zhizhi; Dragon, Stephane; Becker, Allan; Gounni, Abdelilah S.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Becker, Allan; Gounni, Abdelilah S.] Univ Manitoba, GREAT ICE, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Gounni, AS (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	gounni@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Kim, Do-Gyoon/0000-0001-7673-1254; Gounni, Abdelilah/0000-0003-1265-6560; DRAGON, Stephane/0000-0002-4999-5307; Soussi Gounni, Abdelilah/0000-0002-7282-0388	Canadian Institutes of Health Research (CIHR) [ROP:88714]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR grant number ROP:88714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Kristensson M, 2001, FASEB J, V15, P129, DOI 10.1096/fj.01-0817fje; Aoshiba K, 1999, J IMMUNOL, V162, P1692; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Beuther DA, 2006, AM J RESP CRIT CARE, V174, P112, DOI 10.1164/rccm.200602-231PP; Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280; BRACH MA, 1992, BLOOD, V80, P2920; Bruno A, 2005, EUR RESPIR J, V26, P398, DOI 10.1183/09031936.05.00092404; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; Bruno A, 2009, J ALLERGY CLIN IMMUN, V124, P230, DOI 10.1016/j.jaci.2009.04.032; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Caldefie-Chezet F, 2003, FREE RADICAL RES, V37, P809, DOI 10.1080/1071576031000097526; Caldefie-Chezet F, 2001, J LEUKOCYTE BIOL, V69, P414; COLOTTA F, 1992, BLOOD, V80, P2012; Conus S, 2005, J ALLERGY CLIN IMMUN, V116, P1228, DOI 10.1016/j.jaci.2005.09.003; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fernandez-Riejos P, 2008, CLIN EXP IMMUNOL, V151, P505, DOI 10.1111/j.1365-2249.2007.03563.x; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Girard D, 1997, BIOCHEM J, V325, P147, DOI 10.1042/bj3250147; Gorska E, 2010, EUR J MED RES, V15, P50; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; KLEBANOFF SJ, 1992, BLOOD, V80, P225; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; Lam QLK, 2007, J BIOL CHEM, V282, P27587, DOI 10.1074/jbc.M704579200; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lo CKC, 2009, CELL MOL IMMUNOL, V6, P353, DOI 10.1038/cmi.2009.46; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Mancuso P, 2011, J IMMUNOL, V186, P1081, DOI 10.4049/jimmunol.1001470; Martin-Romero C, 2001, CELL IMMUNOL, V212, P83, DOI 10.1006/cimm.2001.1851; Matarese G, 2000, EUR CYTOKINE NETW, V11, P7; Mattioli B, 2005, J IMMUNOL, V174, P6820, DOI 10.4049/jimmunol.174.11.6820; Mattioli B, 2009, FEBS LETT, V583, P1102, DOI 10.1016/j.febslet.2009.02.029; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Moore SI, 2003, INFECT IMMUN, V71, P4182, DOI 10.1128/IAI.71.7.4182-4185.2003; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; O'Donnell CP, 2000, RESP PHYSIOL, V119, P163, DOI 10.1016/S0034-5687(99)00111-5; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Procaccini C, 2009, CURR SIGNAL TRANSD T, V4, P22, DOI 10.2174/157436209787048711; Raso GM, 2006, NEUROSCI LETT, V396, P121, DOI 10.1016/j.neulet.2005.11.022; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Saffar AS, 2008, J ALLERGY CLIN IMMUN, V121, P492, DOI 10.1016/j.jaci.2007.10.003; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P103, DOI 10.1016/j.jaci.2004.10.007; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Suzukawa M, 2011, J IMMUNOL, V186, P5254, DOI 10.4049/jimmunol.1004054; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; THOMAS EL, 1988, REV INFECT DIS, V10, pS450; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Wong CK, 2007, EUR J IMMUNOL, V37, P2337, DOI 10.1002/eji.200636866	58	171	183	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55249	10.1371/journal.pone.0055249	http://dx.doi.org/10.1371/journal.pone.0055249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383125	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600080
J	Sun, ZK; Fu, Q; Cao, LX; Jin, W; Cheng, LL; Li, ZL				Sun, Zikai; Fu, Qiang; Cao, Longxing; Jin, Wen; Cheng, LingLing; Li, Zhiliang			Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; RENAL-FUNCTION; SODIUM-BICARBONATE; SYSTEMATIC REVIEWS; REPERFUSION INJURY; CREATININE; CYSTEINE; PLASMA; CARE; PHARMACOKINETICS	Background: Contrast-induced nephropathy (CIN) is one of the common causes of acute renal insufficiency after contrast procedures. Whether intravenous N-acetylcysteine (NAC) is beneficial for the prevention of contrast-induced nephropathy is uncertain. In this meta-analysis of randomized controlled trials, we aimed to assess the efficacy of intravenous NAC for preventing CIN after administration of intravenous contrast media. Study Design: Relevant studies published up to September 2012 that investigated the efficacy of intravenous N-acetylcysteine for preventing CIN were collected from MEDLINE, OVID, EMBASE, Web of Science, Cochrane Central Register of Controlled Trials, and the conference proceedings from major cardiology and nephrology meetings. The primary outcome was CIN. Secondary outcomes included renal failure requiring dialysis, mortality, and length of hospitalization. Data were combined using random-effects models with the performance of standard tests to assess for heterogeneity and publication bias. Meta-regression analyses were also performed. Results: Ten trials involving 1916 patients met our inclusion criteria. Trials varied in patient demographic characteristics, inclusion criteria, dosing regimens, and trial quality. The summary risk ratio for contrast-induced nephropathy was 0.68 (95% CI, 0.46 to 1.02), a nonsignificant trend towards benefit in patients treated with intravenous NAC. There was evidence of significant heterogeneity in NAC effect across studies (Q = 17.42, P = 0.04; I-2 = 48%). Meta-regression revealed no significant relation between the relative risk of CIN and identified differences in participant or study characteristics. Conclusion: This meta-analysis showed that research on intravenous N-acetylcysteine and the incidence of CIN is too inconsistent at present to warrant a conclusion on efficacy. A large, well designed trial that incorporates the evaluation of clinically relevant outcomes in participants with different underlying risks of CIN is required to more adequately assess the role for intravenous NAC in CIN prevention.	[Sun, Zikai; Fu, Qiang; Cao, Longxing; Cheng, LingLing; Li, Zhiliang] Southern Med Univ, Zhujiang Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China; [Jin, Wen] Guangdong 2 Prov Peoples Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Li, ZL (corresponding author), Southern Med Univ, Zhujiang Hosp, Cardiovasc Dept, Guangzhou, Guangdong, Peoples R China.	lizhiliang010@163.com	Gounni, Abdelilah Soussi/AAH-3456-2020	Kim, Do-Gyoon/0000-0001-7673-1254; Gounni, Abdelilah/0000-0003-1265-6560; DRAGON, Stephane/0000-0002-4999-5307; Soussi Gounni, Abdelilah/0000-0002-7282-0388				Ariarajah N, 2011, Rev Med Suisse, V7, P490; Aslanger E, 2012, CORONARY ARTERY DIS, V23, P265, DOI 10.1097/MCA.0b013e328351aacc; Baker CSR, 2003, J AM COLL CARDIOL, V41, P2114, DOI 10.1016/S0735-1097(03)00487-X; Baranska-Kosakowska A, 2007, TRANSPL P, V39, P2853, DOI 10.1016/j.transproceed.2007.08.057; BORGSTROM L, 1986, EUR J CLIN PHARMACOL, V31, P217, DOI 10.1007/BF00606662; Brautigam M, 2006, RADIOLOGY, V240, P615, DOI 10.1148/radiol.2402051532; Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016; Briguori C, 2002, J AM COLL CARDIOL, V40, P298, DOI 10.1016/S0735-1097(02)01958-7; Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; Carbonell N, 2007, INT J CARDIOL, V115, P57, DOI 10.1016/j.ijcard.2006.04.023; Carbonell N, 2010, REV ESP CARDIOL, V63, P12, DOI 10.1016/S0300-8932(10)70004-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiMari J, 1997, AM J PHYSIOL-RENAL, V272, pF292, DOI 10.1152/ajprenal.1997.272.3.F292; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Haase M, 2008, NEPHROL DIAL TRANSPL, V23, P1581, DOI 10.1093/ndt/gfm818; Hashimoto S, 2001, BRIT J PHARMACOL, V132, P270, DOI 10.1038/sj.bjp.0703787; Heyman SN, 2003, KIDNEY INT, V63, P634, DOI 10.1046/j.1523-1755.2003.00783.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoffmann U, 2004, J AM SOC NEPHROL, V15, P407, DOI 10.1097/01.ASN.0000106780.14856.55; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jaffery Z, 2012, CATHETER CARDIO INTE, V79, P921, DOI 10.1002/ccd.23157; Kefer JM, 2003, ACTA CARDIOL, V58, P555, DOI 10.2143/AC.58.6.2005321; Kiefer P, 2000, CRIT CARE MED, V28, P3935, DOI 10.1097/00003246-200012000-00037; Koc F, 2012, INT J CARDIOL, V155, P418, DOI 10.1016/j.ijcard.2010.10.041; Kotlyar Eugene, 2005, Heart Lung Circ, V14, P245, DOI 10.1016/j.hlc.2005.06.007; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moist L, 2010, AM J KIDNEY DIS, V56, P643, DOI 10.1053/j.ajkd.2010.03.028; Molitoris BA, 2007, NAT CLIN PRACT NEPHR, V3, P439, DOI 10.1038/ncpneph0551; Murphy SW, 2000, J AM SOC NEPHROL, V11, P177, DOI 10.1681/ASN.V111177; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; OLSSON B, 1988, EUR J CLIN PHARMACOL, V34, P77, DOI 10.1007/BF01061422; Parfrey P, 2005, CARDIOVASC INTER RAD, V28, pS3, DOI 10.1007/s00270-005-0196-8; Poletti PA, 2007, AM J ROENTGENOL, V189, P687, DOI 10.2214/AJR.07.2356; Quintavalle C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.38; Rashid ST, 2004, J VASC SURG, V40, P1136, DOI 10.1016/j.jvs.2004.09.026; Ratcliffe JA, 2009, INT J ANGIOL, V18, P193, DOI 10.1055/s-0031-1278353; Recio-Mayoral A, 2007, J AM COLL CARDIOL, V49, P1283, DOI 10.1016/j.jacc.2006.11.034; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Schultz MJ, 2006, CURR MED CHEM, V13, P2565, DOI 10.2174/092986706778201684; Shalansky SJ, 2005, PHARMACOTHERAPY, V25, P1095, DOI 10.1592/phco.2005.25.8.1095; Shalansky SJ, 2005, HEART, V91, P997, DOI 10.1136/hrt.2004.053579; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Trivedi H, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.01.035; Tsikas D, 1998, J CHROMATOGR B, V708, P55, DOI 10.1016/S0378-4347(97)00670-1; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Walser M, 1998, AM J KIDNEY DIS, V32, P23, DOI 10.1053/ajkd.1998.v32.pm9669420; Webb JG, 2004, AM HEART J, V148, P422, DOI 10.1016/j.ahj.2004.03.041; Weinbroum AA, 2000, TRANSPLANTATION, V69, P853; Weisbord Steven D, 2005, J Intensive Care Med, V20, P63, DOI 10.1177/0885066604273503	57	171	183	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55124	10.1371/journal.pone.0055124	http://dx.doi.org/10.1371/journal.pone.0055124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383125	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800113
J	Hamann, S; Metrailler, S; Schorderet, DF; Cottet, S				Hamann, Severine; Metrailler, Sylviane; Schorderet, Daniel F.; Cottet, Sandra			Analysis of the Cytoprotective Role of alpha-Crystallins in Cell Survival and Implication of the alpha A-Crystallin C-Terminal Extension Domain in Preventing Bax-Induced Apoptosis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; RETINAL-PIGMENT EPITHELIUM; LEBERS CONGENITAL AMAUROSIS; STAUROSPORINE-INDUCED APOPTOSIS; RPE65(-/-) MOUSE MODEL; B-CRYSTALLIN; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; MACULAR DEGENERATION; MOLECULAR CHAPERONE	alpha-Crystallins, initially described as the major structural proteins of the lens, belong to the small heat shock protein family. Apart from their function as chaperones, alpha-crystallins are involved in the regulation of intracellular apoptotic signals. alpha A- and alpha B-crystallins have been shown to interfere with the mitochondrial apoptotic pathway triggering Bax pro-apoptotic activity and downstream activation of effector caspases. Differential regulation of alpha-crystallins has been observed in several eye diseases such as age-related macular degeneration and stress-induced and inherited retinal degenerations. Although the function of alpha-crystallins in healthy and diseased retina remains poorly understood, their altered expression in pathological conditions argue in favor of a role in cellular defensive response. In the Rpe65(-/-) mouse model of Leber's congenital amaurosis, we previously observed decreased expression of alpha A- and alpha B-crystallins during disease progression, which was correlated with Bax pro-death activity and photoreceptor apoptosis. In the present study, we demonstrated that alpha-crystallins interacted with pro-apoptotic Bax and displayed cytoprotective action against Bax-triggered apoptosis, as assessed by TUNEL and caspase assays. We further observed in staurosporine-treated photoreceptor-like 661W cells stably overexpressing alpha A- or alpha B-crystallin that Bax-dependent apoptosis and caspase activation were inhibited. Finally, we reported that the C-terminal extension domain of alpha A- crystallin was sufficient to provide protection against Bax-triggered apoptosis. Altogether, these data suggest that alpha-crystallins interfere with Bax-induced apoptosis in several cell types, including the cone-derived 661W cells. They further suggest that alpha A-crystallin-derived peptides might be sufficient to promote cytoprotective action in response to apoptotic cell death.	[Hamann, Severine; Metrailler, Sylviane; Schorderet, Daniel F.; Cottet, Sandra] IRO, Sion, Switzerland; [Hamann, Severine; Schorderet, Daniel F.] Swiss Fed Inst Technol EPFL, Sch Life Sci, Lausanne, Switzerland; [Schorderet, Daniel F.; Cottet, Sandra] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Cottet, S (corresponding author), IRO, Sion, Switzerland.	sandra.cottet@irovision.ch			Swiss National Science Foundation (SNSF) [31003A-138313]; Fondation Telethon Action Suisse (FTAS)	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Fondation Telethon Action Suisse (FTAS)	This research was supported by the Swiss National Science Foundation (SNSF) Grant 31003A-138313 (www.snf.ch) and the Fondation Telethon Action Suisse (FTAS) (www.telethon.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Andley UP, 1998, J BIOL CHEM, V273, P31252, DOI 10.1074/jbc.273.47.31252; Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; Asomugha CO, 2011, MOL VIS, V17, P2356; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Cavusoglu N, 2003, MOL CELL PROTEOMICS, V2, P494, DOI 10.1074/mcp.M300029-MCP200; Cottet S, 2008, APOPTOSIS, V13, P329, DOI 10.1007/s10495-008-0180-2; Cottet S, 2006, FASEB J, V20, P2036, DOI 10.1096/fj.06-6211com; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Dou GR, 2012, FREE RADICAL BIO MED, V53, P1111, DOI 10.1016/j.freeradbiomed.2012.06.042; Dufour EM, 2003, NEUROBIOL DIS, V14, P166, DOI 10.1016/S0969-9961(03)00102-5; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Hamann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006616; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hu WF, 2012, CURR MOL MED, V12, P177, DOI 10.2174/156652412798889036; Johnson PT, 2005, INVEST OPHTH VIS SCI, V46, P4788, DOI 10.1167/iovs.05-0767; Jones SE, 1998, NEUROREPORT, V9, P4161, DOI 10.1097/00001756-199812210-00030; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kannan R, 2012, PROG RETIN IN PRESS; KANTOROW M, 1994, P NATL ACAD SCI USA, V91, P3112, DOI 10.1073/pnas.91.8.3112; Kapphahn RJ, 2003, BIOCHEMISTRY-US, V42, P15310, DOI 10.1021/bi034774e; Kashkar H, 2002, CELL DEATH DIFFER, V9, P750, DOI 10.1038/sj.cdd.4401024; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Maeda A, 1999, INVEST OPHTH VIS SCI, V40, P2788; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; McGreal RS, 2012, BBA-GEN SUBJECTS, V1820, P921, DOI 10.1016/j.bbagen.2012.04.004; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Metrailler S, 2012, EXP EYE RES, V96, P70, DOI 10.1016/j.exer.2011.12.019; Munemasa Y, 2009, INVEST OPHTH VIS SCI, V50, P3869, DOI 10.1167/iovs.08-3138; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Rao NA, 2008, INVEST OPHTH VIS SCI, V49, P1161, DOI 10.1167/iovs.07-1259; Rao NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033582; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xi JH, 2003, MOL VIS, V9, P410; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yaung J, 2007, MOL VIS, V13, P566; Ying X, 2008, J MOL NEUROSCI, V35, P253, DOI 10.1007/s12031-007-9010-1; Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	61	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55372	10.1371/journal.pone.0055372	http://dx.doi.org/10.1371/journal.pone.0055372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383327	gold, Green Published, Green Submitted			2022-12-27	WOS:000314597900034
J	Bartasun, P; Cieslinski, H; Bujacz, A; Wierzbicka-Wos, A; Kur, J				Bartasun, Paulina; Cieslinski, Hubert; Bujacz, Anna; Wierzbicka-Wos, Anna; Kur, Jozef			A Study on the Interaction of Rhodamine B with Methylthioadenosine Phosphorylase Protein Sourced from an Antarctic Soil Metagenomic Library	PLOS ONE			English	Article							5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE; FLUORESCENCE; IDENTIFICATION; LIPASE; PURIFICATION; REFINEMENT; RESOLUTION; CRYSTAL; BINDING	The presented study examines the phenomenon of the fluorescence under UV light excitation (312 nm) of E. coli cells expressing a novel metagenomic-derived putative methylthioadenosine phosphorylase gene, called rsfp, grown on LB agar supplemented with a fluorescent dye rhodamine B. For this purpose, an rsfp gene was cloned and expressed in an LMG194 E. coli strain using an arabinose promoter. The resulting RSFP protein was purified and its UV-VIS absorbance spectrum and emission spectrum were assayed. Simultaneously, the same spectroscopic studies were carried out for rhodamine B in the absence or presence of RSFP protein or native E. coli proteins, respectively. The results of the spectroscopic studies suggested that the fluorescence of E. coli cells expressing rsfp gene under UV illumination is due to the interaction of rhodamine B molecules with the RSFP protein. Finally, this interaction was proved by a crystallographic study and then by site-directed mutagenesis of rsfp gene sequence. The crystal structures of RSFP apo form (1.98 angstrom) and complex RSFP/RB (1.90 angstrom) show a trimer of RSFP molecules located on the crystallographic six fold screw axis. The RSFP complex with rhodamine B revealed the binding site for RB, in the pocket located on the interface between symmetry related monomers.	[Bartasun, Paulina; Cieslinski, Hubert; Kur, Jozef] Gdansk Univ Technol, Fac Chem, Dept Microbiol, Gdansk, Poland; [Bujacz, Anna] Lodz Univ Technol, Inst Tech Biochem, Lodz, Poland; [Wierzbicka-Wos, Anna] Univ Szczecin, Fac Biol, Dept Microbiol, Szczecin, Poland	Fahrenheit Universities; Gdansk University of Technology; Lodz University of Technology; University of Szczecin	Cieslinski, H (corresponding author), Gdansk Univ Technol, Fac Chem, Dept Microbiol, Gdansk, Poland.	hcieslin@pg.gda.pl	Wierzbicka-Woś, Anna/AAI-9544-2020; Bujacz, Anna/M-4464-2018; Wierzbicka-Woś, Anna/E-1089-2012	Wierzbicka-Woś, Anna/0000-0002-8416-5077; Bujacz, Anna/0000-0002-0808-1349; Wierzbicka-Woś, Anna/0000-0002-8416-5077; , Hubert/0000-0002-3504-2257; Cieslinski, Hubert/0000-0003-0573-0830				Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Appleby TC, 2001, J BIOL CHEM, V276, P39232, DOI 10.1074/jbc.M105694200; Appleby TC, 1999, STRUCTURE, V7, P629, DOI 10.1016/S0969-2126(99)80084-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai HH, 2010, COLLOID SURFACE A, V372, P35, DOI 10.1016/j.colsurfa.2010.09.017; Castro-Ochoa LD, 2005, ENZYME MICROB TECH, V37, P648, DOI 10.1016/j.enzmictec.2005.06.003; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; Cieslinski H, 2009, POL J MICROBIOL, V58, P199; Cieslinski H, 2009, FEMS MICROBIOL LETT, V299, P232, DOI 10.1111/j.1574-6968.2009.01756.x; Deyl Z, 1998, J CHROMATOGR LIBR, V60, P465, DOI 10.1016/S0301-4770(08)60310-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faoro H, 2011, ENV MICROBIOL REP, V3, P750, DOI 10.1111/j.1758-2229.2011.00295.x; GOLLNICK K, 1981, TETRAHEDRON LETT, V22, P4049, DOI 10.1016/S0040-4039(01)82062-1; KEMNITZ K, 1986, J PHYS CHEM-US, V90, P5094, DOI 10.1021/j100412a043; KEMNITZ K, 1983, CHEM PHYS LETT, V101, P337, DOI 10.1016/0009-2614(83)87489-2; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muthuraman G, 2009, J IND ENG CHEM, V15, P841, DOI 10.1016/j.jiec.2009.09.010; Oplatowska M, 2011, ANALYST, V136, P2403, DOI 10.1039/c0an00934b; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMETTE RW, 1956, J AM CHEM SOC, V78, P4872, DOI 10.1021/ja01600a017; SHAPIRO SH, 1988, ANN CLIN LAB SCI, V18, P451; TRUANT J P, 1962, Henry Ford Hosp Med Bull, V10, P287; VANDERAUWERAER M, 1988, LANGMUIR, V4, P583, DOI 10.1021/la00081a016; WESSELY Z, 1981, STAIN TECHNOL, V56, P169, DOI 10.3109/10520298109067305; Whitehead KA, 2009, INT J FOOD MICROBIOL, V135, P75, DOI 10.1016/j.ijfoodmicro.2009.07.003; Wierzbicka-Wos A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-108; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116; Zhang Y, 2006, J MOL BIOL, V357, P252, DOI 10.1016/j.jmb.2005.12.040; Zhao X, 2009, DYES PIGMENTS, V80, P212, DOI 10.1016/j.dyepig.2008.07.003; Zhu J, 2009, SENSOR ACTUAT B-CHEM, V138, P9, DOI 10.1016/j.snb.2009.02.054	35	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55697	10.1371/journal.pone.0055697	http://dx.doi.org/10.1371/journal.pone.0055697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383268	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600148
J	Kessler, RL; Soares, MJ; Probst, CM; Krieger, MA				Kessler, Rafael Luis; Soares, Maurilio Jose; Probst, Christian Macagnan; Krieger, Marco Aurelio			Trypanosoma cruzi Response to Sterol Biosynthesis Inhibitors: Morphophysiological Alterations Leading to Cell Death	PLOS ONE			English	Article							DELTA(24(25))-STEROL METHYL TRANSFERASE; LOVASTATIN-INDUCED APOPTOSIS; ISCHEMIC NEURONAL DEATH; SCHIZOTRYPANUM CRUZI; IN-VITRO; 3-HYDROXY-3-METHYL-GLUTARYL-COA REDUCTASE; ULTRASTRUCTURAL ALTERATIONS; CANDIDA-ALBICANS; PLASMA-MEMBRANES; SCH 56592	The protozoan parasite Trypanosoma cruzi displays similarities to fungi in terms of its sterol lipid biosynthesis, as ergosterol and other 24-alkylated sterols are its principal endogenous sterols. The sterol pathway is thus a potential drug target for the treatment of Chagas disease. We describe here a comparative study of the growth inhibition, ultrastructural and physiological changes leading to the death of T. cruzi cells following treatment with the sterol biosynthesis inhibitors (SBIs) ketoconazole and lovastatin. We first calculated the drug concentration inhibiting epimastigote growth by 50% (EC50/72 h) or killing all cells within 24 hours (EC100/24 h). Incubation with inhibitors at the EC50/72 h resulted in interesting morphological changes: intense proliferation of the inner mitochondrial membrane, which was corroborated by flow cytometry and confocal microscopy of the parasites stained with rhodamine 123, and strong swelling of the reservosomes, which was confirmed by acridine orange staining. These changes to the mitochondria and reservosomes may reflect the involvement of these organelles in ergosterol biosynthesis or the progressive autophagic process culminating in cell lysis after 6 to 7 days of treatment with SBIs at the EC50/72 h. By contrast, treatment with SBIs at the EC100/24 h resulted in rapid cell death with a necrotic phenotype: time-dependent cytosolic calcium overload, mitochondrial depolarization and reservosome membrane permeabilization (RMP), culminating in cell lysis after a few hours of drug exposure. We provide the first demonstration that RMP constitutes the "point of no return" in the cell death cascade, and propose a model for the necrotic cell death of T. cruzi. Thus, SBIs trigger cell death by different mechanisms, depending on the dose used, in T. cruzi. These findings shed new light on ergosterol biosynthesis and the mechanisms of programmed cell death in this ancient protozoan parasite.	[Kessler, Rafael Luis; Soares, Maurilio Jose; Probst, Christian Macagnan; Krieger, Marco Aurelio] Fiocruz MS, Inst Carlos Chagas, Curitiba, PR, Brazil	Fundacao Oswaldo Cruz	Krieger, MA (corresponding author), Fiocruz MS, Inst Carlos Chagas, Curitiba, PR, Brazil.	mkrieger@fiocruz.br	Soares, Maurilio J/I-4627-2016; Probst, Christian/B-8678-2009; Kessler, Rafael/E-9291-2018; Krieger, Marco/AAE-8611-2020	Soares, Maurilio J/0000-0001-9701-836X; Probst, Christian/0000-0001-9993-6375; Kessler, Rafael/0000-0002-6365-8251; Krieger, Marco Aurelio/0000-0003-0030-3952	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fiocruz	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fiocruz	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fiocruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P285; Andrade-Neto VV, 2011, ACTA TROP; BEACH DH, 1986, BIOCHEM BIOPH RES CO, V136, P851, DOI 10.1016/0006-291X(86)90410-9; Braga MV, 2005, MICROSC MICROANAL, V11, P506, DOI 10.1017/S143192760505035X; Braga MV, 2004, INT J ANTIMICROB AG, V24, P72, DOI 10.1016/j.ijantimicag.2003.12.009; BRENER Z, 1993, MEM I OSWALDO CRUZ, V88, P149, DOI 10.1590/S0074-02761993000100023; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Buckner FS, 2008, ADV EXP MED BIOL, V625, P61, DOI 10.1007/978-0-387-77570-8_6; Camargo EP, 2009, MEM I OSWALDO CRUZ, V104, P275, DOI 10.1590/S0074-02762009000900036; Concepcion JL, 1998, ARCH BIOCHEM BIOPHYS, V352, P114, DOI 10.1006/abbi.1998.0577; Contreras LM, 1997, BIOCHEM PHARMACOL, V53, P697, DOI 10.1016/S0006-2952(96)00903-3; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Cunha-e-Silva N, 2006, PARASITOL RES, V99, P325, DOI 10.1007/s00436-006-0190-3; Dantas AP, 2006, MEM I OSWALDO CRUZ, V101, P207, DOI 10.1590/S0074-02762006000200013; de Souza Wanderley, 2009, Interdiscip Perspect Infect Dis, V2009, P642502, DOI 10.1155/2009/642502; de Souza W, 2009, PROG HISTOCHEM CYTO, V44, P67, DOI 10.1016/j.proghi.2009.01.001; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Dumonteil E, 2009, INFECT GENET EVOL, V9, P1075, DOI 10.1016/j.meegid.2009.02.009; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; ENDO A, 1992, J LIPID RES, V33, P1569; Fernandes MP, 2010, J BIOENERG BIOMEMBR, V42, P69, DOI 10.1007/s10863-010-9268-9; FLORINCHRISTENSEN M, 1990, BIOCHEM BIOPH RES CO, V166, P1441, DOI 10.1016/0006-291X(90)91028-Q; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Giusti C, 2009, EXP CELL RES, V315, P26, DOI 10.1016/j.yexcr.2008.09.028; Golstein P, 2005, CELL DEATH DIFFER, V12, P1490, DOI 10.1038/sj.cdd.4401607; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Grijalba MT, 1999, BIOCHEMISTRY-US, V38, P13279, DOI 10.1021/bi9828674; Guerra-Slompo EP, 2012, BIOCH BIOPHYS RES CO; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Herman M, 2006, AUTOPHAGY, V2, P107, DOI 10.4161/auto.2.2.2369; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Ho YS, 1998, TOXICOL APPL PHARM, V153, P39, DOI 10.1006/taap.1998.8467; Hurtado-Guerrrero R, 2002, FEBS LETT, V510, P141, DOI 10.1016/S0014-5793(01)03238-0; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lamb DC, 2000, CHEM-BIOL INTERACT, V125, P165, DOI 10.1016/S0009-2797(99)00169-6; Laporte C, 2007, CELL DEATH DIFFER, V14, P266, DOI 10.1038/sj.cdd.4401994; Laverriere M, 2012, CELL DEATH DIFFER, V19, P1358, DOI 10.1038/cdd.2012.12; LAZARDI K, 1991, ANTIMICROB AGENTS CH, V35, P736, DOI 10.1128/AAC.35.4.736; LAZARDI K, 1990, ANTIMICROB AGENTS CH, V34, P2097, DOI 10.1128/AAC.34.11.2097; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Liendo A, 1998, J ANTIMICROB CHEMOTH, V41, P197, DOI 10.1093/jac/41.2.197; Liendo A, 1999, MOL BIOCHEM PARASIT, V104, P81, DOI 10.1016/S0166-6851(99)00129-2; Lin KL, 2009, TOXICOL IN VITRO, V23, P1268, DOI 10.1016/j.tiv.2009.07.025; Marcelli M, 1998, CANCER RES, V58, P76; MCCABE R, 1988, J INFECT DIS, V158, P1408, DOI 10.1093/infdis/158.6.1408; MCCABE RE, 1984, J INFECT DIS, V150, P594, DOI 10.1093/infdis/150.4.594; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Menna-Barreto RFS, 2007, PARASITOL RES, V101, P895, DOI 10.1007/s00436-007-0556-1; Minamikawa T, 1999, EXP CELL RES, V246, P26, DOI 10.1006/excr.1998.4290; Molina J, 2000, ANTIMICROB AGENTS CH, V44, P150, DOI 10.1128/AAC.44.1.150-155.2000; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Padayatty SJ, 1997, J CLIN ENDOCR METAB, V82, P1434, DOI 10.1210/jc.82.5.1434; Pena-Diaz J, 2004, MOL BIOL CELL, V15, P1356, DOI 10.1091/mbc.E03-10-0720; PEREZSALA D, 1994, BIOCHEM BIOPH RES CO, V199, P1209, DOI 10.1006/bbrc.1994.1359; Porto-Carreiro I, 2000, EUR J CELL BIOL, V79, P858, DOI 10.1078/0171-9335-00112; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; REEDQUIST KA, 1995, BIOCHEM BIOPH RES CO, V211, P665, DOI 10.1006/bbrc.1995.1863; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Rodrigues CO, 2001, J EUKARYOT MICROBIOL, V48, P588, DOI 10.1111/j.1550-7408.2001.tb00195.x; Rodrigues JCF, 2007, PROTIST, V158, P447, DOI 10.1016/j.protis.2007.05.004; Rubins JB, 1998, AM J RESP CRIT CARE, V157, P1616, DOI 10.1164/ajrccm.157.5.9709020; Sant'Anna C, 2008, HISTOCHEM CELL BIOL, V130, P1187, DOI 10.1007/s00418-008-0486-8; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; Santa-Rita RM, 2005, J ANTIMICROB CHEMOTH, V55, P780, DOI 10.1093/jac/dki087; Sanz-Rodriguez CE, 2007, J BIOL CHEM, V282, P12377, DOI 10.1074/jbc.M607286200; SOARES MJ, 1991, PARASITOL RES, V77, P461, DOI 10.1007/BF00928410; SOARES MJ, 1988, J SUBMICR CYTOL PATH, V20, P349; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Trosken ER, 2006, TOXICOLOGY, V228, P24, DOI 10.1016/j.tox.2006.08.007; URBINA JA, 1991, ANTIMICROB AGENTS CH, V35, P730, DOI 10.1128/AAC.35.4.730; URBINA JA, 1993, ANTIMICROB AGENTS CH, V37, P580, DOI 10.1128/AAC.37.3.580; URBINA JA, 1995, MOL BIOCHEM PARASIT, V73, P199, DOI 10.1016/0166-6851(95)00117-J; Urbina JA, 1996, SCIENCE, V273, P969, DOI 10.1126/science.273.5277.969; Urbina JA, 1998, ANTIMICROB AGENTS CH, V42, P1771, DOI 10.1128/AAC.42.7.1771; URBINA JA, 1988, ANTIMICROB AGENTS CH, V32, P1237, DOI 10.1128/AAC.32.8.1237; Urbina JA, 2000, ANTIMICROB AGENTS CH, V44, P2498, DOI 10.1128/AAC.44.9.2498-2502.2000; Urbina JA, 2003, INT J ANTIMICROB AG, V21, P39, DOI 10.1016/S0924-8579(02)00274-1; Urbina JA, 2003, INT J ANTIMICROB AG, V21, P27, DOI 10.1016/S0924-8579(02)00273-X; URBINA JA, 1988, MOL BIOCHEM PARASIT, V30, P185, DOI 10.1016/0166-6851(88)90111-9; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vannier-Santos MA, 2009, CURR DRUG TARGETS, V10, P246, DOI 10.2174/138945009787581168; Vivas J, 1997, INT J ANTIMICROB AG, V8, P1, DOI 10.1016/S0924-8579(96)00345-7; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Worthen C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000678; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X	97	62	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55497	10.1371/journal.pone.0055497	http://dx.doi.org/10.1371/journal.pone.0055497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383204	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600112
J	Shembekar, N; Mallajosyula, VVA; Mishra, A; Yeolekar, L; Dhere, R; Kapre, S; Varadarajan, R; Gupta, SK				Shembekar, Nachiket; Mallajosyula, Vamsee V. Aditya; Mishra, Arpita; Yeolekar, Leena; Dhere, Rajeev; Kapre, Subhash; Varadarajan, Raghavan; Gupta, Satish Kumar			Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the 'Sa' Antigenic Site	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; INFLUENZA-VIRUS; HEMAGGLUTININ; EPITOPE; IMMUNOGEN; IMMUNITY; DESIGN	Influenza virus evades host immunity through antigenic drift and shift, and continues to circulate in the human population causing periodic outbreaks including the recent 2009 pandemic. A large segment of the population was potentially susceptible to this novel strain of virus. Historically, monoclonal antibodies (MAbs) have been fundamental tools for diagnosis and epitope mapping of influenza viruses and their importance as an alternate treatment option is also being realized. The current study describes isolation of a high affinity (K-D = 2.1 +/- 0.4 pM) murine MAb, MA2077 that binds specifically to the hemagglutinin (HA) surface glycoprotein of the pandemic virus. The antibody neutralized the 2009 pandemic H1N1 virus in an in vitro microneutralization assay (IC50 = 0.08 mu g/ml). MA2077 also showed hemagglutination inhibition activity (HI titre of 0.50 mu g/ml) against the pandemic virus. In a competition ELISA, MA2077 competed with the binding site of the human MAb, 2D1 (isolated from a survivor of the 1918 Spanish flu pandemic) on pandemic H1N1 HA. Epitope mapping studies using yeast cell-surface display of a stable HA1 fragment, wherein 'Sa' and 'Sb' sites were independently mutated, localized the binding site of MA2077 within the 'Sa' antigenic site. These studies will facilitate our understanding of antigen antibody interaction in the context of neutralization of the pandemic influenza virus.	[Shembekar, Nachiket; Mishra, Arpita; Gupta, Satish Kumar] Natl Inst Immunol, Reprod Cell Biol Lab, New Delhi 110067, India; [Mallajosyula, Vamsee V. Aditya; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Yeolekar, Leena; Dhere, Rajeev; Kapre, Subhash] Serum Inst India Ltd, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore; Serum Institute of India	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in; skgupta@nii.ac.in	Gupta, Satish/B-9934-2009	Gupta, Satish/0000-0003-3717-0436; Mallajosyula, Vamsee/0000-0002-0658-3652	Department of Biotechnology, Government of India [BT/BIPP/0213/04/09]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Biotechnology, Government of India (BT/BIPP/0213/04/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WORLDWIDE H1N1 SWINE; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Burioni R, 2009, NEW MICROBIOL, V32, P319; Cabral TM, 2012, J VIROL METHODS, V183, P25, DOI 10.1016/j.jviromet.2012.03.016; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Drescher J, 1987, INTERVIROLOGY, V4, P205; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Govind CK, 2000, BIOL REPROD, V62, P67, DOI 10.1095/biolreprod62.1.67; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harlow E, 1999, USING ANTIBODIES LAB, P384; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LUBECK MD, 1981, VIROLOGY, V113, P64, DOI 10.1016/0042-6822(81)90136-7; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; Saha P, 2011, BIOCHEMISTRY-US, V50, P7891, DOI 10.1021/bi200870r; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Webster RG, 1999, P NATL ACAD SCI USA, V96, P1164, DOI 10.1073/pnas.96.4.1164; World Health Organization, 2002, WHO MAN AN INFL DIAG; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	33	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55516	10.1371/journal.pone.0055516	http://dx.doi.org/10.1371/journal.pone.0055516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383214	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000314610600118
J	Khan, R; Lee, JE; Yang, YM; Liang, FX; Sehgal, PB				Khan, Rasel; Lee, Jason E.; Yang, Yang-Ming; Liang, Feng-Xia; Sehgal, Pravin B.			Live-Cell Imaging of the Association of STAT6-GFP with Mitochondria	PLOS ONE			English	Article							PROTEIN-PROTEIN; STAT3; COLOCALIZATION; LOCALIZATION; CYTOPLASM; PY-STAT3	The transcription factor STAT3 has been previously reported to be associated with mitochondria. However, we have been unable to visualize an association of STAT3-GFP, STAT3-DsRed or STAT3-Flag with mitochondria in human Hep3B hepatocytes thus far even though an association of these molecules with other cytoplasmic organelles (endosomes) was readily demonstrable. We then addressed the broader question of a possible association of other STAT-family of proteins with mitochondria by first using immunolocalization assays in Hep3B and human pulmonary arterial endothelial and smooth muscle cells. Strong anti-STAT6-immunolocalization with mitochondria was apparent in fluorescence and electron microscopy assays of cells first washed with a digitonin-sucrose buffer to remove bulk soluble STAT proteins. In live-cell imaging studies, STAT6-GFP, but not N1-GFP, was observed to constitutively colocalize with MitoTracker-and tetramethylrhodamine ethyl ester (TMRE)-positive mitochondria, and with mitochondrial F1-ATPase when assayed by immunofluorescence after fixation. This association was Tyr-phosphorylation independent in that a STAT6 truncated protein (STAT6(1-459)-GFP) which lacked the SH2 domain (517-632) and the cytokine-activated Y641 phosphorylation site also accumulated in MitoTracker-positive mitochondria. This was consistent with the unexpected discovery that anti-STAT6-immunofluoresence also associated with mitochondria in mouse embryo fibroblasts (MEFs) from both wild-type and the STAT6(SH2-/SH2-) mouse. MEFs from the latter mouse, which had been engineered in 1996 to be deleted in the STAT6 SH2 domain (amino acids 505-584) expressed an immune-specific similar to 50 kDa protein detectable in whole cell and mitochondria-enriched fractions. Taken together, the present data provide the first definitive evidence of the association of any STAT-protein family member with mitochondria - that of STAT6.	[Khan, Rasel; Lee, Jason E.; Yang, Yang-Ming; Sehgal, Pravin B.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Liang, Feng-Xia] NYU, Sch Med, OCS Microscopy Core, New York, NY USA; [Sehgal, Pravin B.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA	New York Medical College; New York University; New York Medical College	Sehgal, PB (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	Pravin_sehgal@nymc.edu	Liang, Fenghua/HHM-3798-2022; Liang, Feng/GZK-4305-2022	LEE, JASON/0000-0001-5757-5954	National Institutes of Health [R01HL087176, F31HL107013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087176, F31HL107013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants R01HL087176 (P. B. S.) and F31HL107013 (J.E.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chapoval SP, 2011, J IMMUNOL, V186, P2571, DOI 10.4049/jimmunol.1002567; Chen HC, 2010, J IMMUNOL, V185, P64, DOI 10.4049/jimmunol.0903323; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen LY, 2012, MOL CELL, V47, P839, DOI 10.1016/j.molcel.2012.07.002; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Chueh FY, 2010, BIOCHEM BIOPH RES CO, V402, P778, DOI 10.1016/j.bbrc.2010.10.112; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; Jeong K, 2009, EXP MOL MED, V41, P226, DOI 10.3858/emm.2009.41.4.025; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Lee JE, 2013, AM J PHYSIOL-CELL PH, V304, pC312, DOI 10.1152/ajpcell.00311.2012; Lee JE, 2012, AM J PHYSIOL-CELL PH, V302, pC804, DOI 10.1152/ajpcell.00379.2011; Mukhopadhyay S, 2008, AM J PHYSIOL-LUNG C, V294, pL449, DOI 10.1152/ajplung.00377.2007; Peters PJ, 2006, CURR PROTOCOLS CELL, DOI 0.1002/0471143030.cb0407s30; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Sehgal PB, 2008, SEMIN CELL DEV BIOL, V19, P329, DOI 10.1016/j.semcdb.2008.07.003; Shah M, 2006, J BIOL CHEM, V281, P7302, DOI 10.1074/jbc.M508527200; Suzuki K, 2002, J EXP MED, V196, P27, DOI 10.1084/jem.20011682; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xu F, 2007, AM J PHYSIOL-CELL PH, V293, pC1374, DOI 10.1152/ajpcell.00220.2007; Zhou P, 2000, J IMMUNOL, V165, P5580, DOI 10.4049/jimmunol.165.10.5580	26	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55426	10.1371/journal.pone.0055426	http://dx.doi.org/10.1371/journal.pone.0055426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383189	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800154
J	Luo, SL; Christensen, S; Zhangsun, DT; Wu, Y; Hu, YY; Zhu, XP; Chhabra, S; Norton, RS; McIntosh, JM				Luo, Sulan; Christensen, Sean; Zhangsun, Dongting; Wu, Yong; Hu, Yuanyan; Zhu, Xiaopeng; Chhabra, Sandeep; Norton, Raymond S.; McIntosh, J. Michael			A Novel Inhibitor of alpha 9 alpha 10 Nicotinic Acetylcholine Receptors from Conus vexillum Delineates a New Conotoxin Superfamily	PLOS ONE			English	Article							ALPHA-D-CONOPEPTIDES; CYSTEINE PATTERN; CDNA CLONING; IN-VITRO; PEPTIDE; PROTEIN; DIVERSITY; CHANNEL; UNIQUE; SEQUENCES	Conotoxins (CTxs) selectively target a range of ion channels and receptors, making them widely used tools for probing nervous system function. Conotoxins have been previously grouped into superfamilies according to signal sequence and into families based on their cysteine framework and biological target. Here we describe the cloning and characterization of a new conotoxin, from Conus vexillum, named alpha B-conotoxin VxXXIVA. The peptide does not belong to any previously described conotoxin superfamily and its arrangement of Cys residues is unique among conopeptides. Moreover, in contrast to previously characterized conopeptide toxins, which are expressed initially as prepropeptide precursors with a signal sequence, a "pro'' region, and the toxin-encoding region, the precursor sequence of alpha B-VxXXIVA lacks a "pro'' region. The predicted 40-residue mature peptide, which contains four Cys, was synthesized in each of the three possible disulfide arrangements. Investigation of the mechanism of action of alpha B-VxXXIVA revealed that the peptide is a nicotinic acetylcholine receptor (nAChR) antagonist with greatest potency against the alpha 9 alpha 10 subtype. H-1 nuclear magnetic resonance (NMR) spectra indicated that all three alpha B-VxXXIVA isomers were poorly structured in aqueous solution. This was consistent with circular dichroism (CD) results which showed that the peptides were unstructured in buffer, but adopted partially helical conformations in aqueous trifluoroethanol (TFE) solution. The alpha 9 alpha 10 nAChR is an important target for the development of analgesics and cancer chemotherapeutics, and alpha B-VxXXIVA represents a novel ligand with which to probe the structure and function of this protein.	[Luo, Sulan; Zhangsun, Dongting; Wu, Yong; Hu, Yuanyan; Zhu, Xiaopeng] Hainan Univ, Key Lab Marine Drug Haikou, Minist Educ, Key Lab Trop Biol Resources, Haikou Hainan, Peoples R China; [Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Chhabra, Sandeep; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia	Hainan University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Monash University	Luo, SL (corresponding author), Hainan Univ, Key Lab Marine Drug Haikou, Minist Educ, Key Lab Trop Biol Resources, Haikou Hainan, Peoples R China.	luosulan2003@163.com	chhabra, sandeep/R-9942-2017; Chhabra, Sandeep/T-5468-2018	Chhabra, Sandeep/0000-0002-5225-1333; Norton, Raymond/0000-0001-8893-0584	Program for Changjiang Scholars and Innovative Research Team in University(PCSIRT) [IRT1123]; State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China [2012AA021706]; International Science & Technology Cooperation Program of China [2011DFR31210]; National Natural Science Foundation of China [81160503]; National Institute of Health [GM 48677, GM103801]; Australian National Health and Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103801, P01GM048677] Funding Source: NIH RePORTER	Program for Changjiang Scholars and Innovative Research Team in University(PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China; International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University(PCSIRT, IRT1123), State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China (2012AA021706), International Science & Technology Cooperation Program of China (2011DFR31210), and National Natural Science Foundation of China (No. 81160503). A preliminary account of some of this work was presented in the patent literature (Luo,S, et al. CN(201210117928.9)-A 2012). Support also was received from National Institute of Health Grants GM 48677 and GM103801 and RSN acknowledges fellowship support from the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Biggs JS, 2010, MOL PHYLOGENET EVOL, V56, P1, DOI 10.1016/j.ympev.2010.03.029; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Buczek O, 2008, TOXICON, V51, P218, DOI 10.1016/j.toxicon.2007.09.006; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Chen CS, 2011, BREAST CANCER RES TR, V125, P73, DOI 10.1007/s10549-010-0821-3; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Chikova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027978; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Conticello SG, 2003, J BIOL CHEM, V278, P26311, DOI 10.1074/jbc.C300141200; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Daly NL, 2009, IUBMB LIFE, V61, P144, DOI 10.1002/iub.158; Dowell C, 2003, J NEUROSCI, V23, P8445; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; England LJ, 1998, SCIENCE, V281, P575, DOI 10.1126/science.281.5376.575; Espiritu DJD, 2001, TOXICON, V39, P1899, DOI 10.1016/S0041-0101(01)00175-1; Fan CX, 2003, J BIOL CHEM, V278, P12624, DOI 10.1074/jbc.M210200200; Favreau P, 2012, BRIT J PHARMACOL, V166, P1654, DOI 10.1111/j.1476-5381.2012.01837.x; Franchini LF, 2006, MOL PHYLOGENET EVOL, V41, P622, DOI 10.1016/j.ympev.2006.05.042; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Hidaka Y, 1998, BIOCHEMISTRY-US, V37, P8498, DOI 10.1021/bi9731246; Holtman JR, 2011, EUR J PHARMACOL, V670, P500, DOI 10.1016/j.ejphar.2011.08.053; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Jakubowski JA, 2004, J MASS SPECTROM, V39, P548, DOI 10.1002/jms.624; Jimenez EC, 2007, BIOCHEMISTRY-US, V46, P8717, DOI 10.1021/bi700582m; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kauferstein S, 2009, TOXICON, V54, P295, DOI 10.1016/j.toxicon.2009.04.016; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Lee CH, 2010, JNCI-J NATL CANCER I, V102, P1322, DOI 10.1093/jnci/djq300; Lirazan MB, 2000, BIOCHEMISTRY-US, V39, P1583, DOI 10.1021/bi9923712; Lluisma AO, 2008, TOXICON, V51, P174, DOI 10.1016/j.toxicon.2007.07.009; Loughnan M, 2006, J BIOL CHEM, V281, P24745, DOI 10.1074/jbc.M603703200; Loughnan ML, 2009, BIOCHEMISTRY-US, V48, P3717, DOI 10.1021/bi9000326; Lu BS, 1999, PEPTIDES, V20, P1139; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2007, J PEPT SCI, V13, P44, DOI 10.1002/psc.802; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; McIntosh JM, 2009, BIOCHEM PHARMACOL, V78, P693, DOI 10.1016/j.bcp.2009.05.020; Mebs D, 2011, ACTA CHIM SLOV, V58, P730; Nemecz A, 2011, J BIOL CHEM, V286, P42555, DOI 10.1074/jbc.M111.286583; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Peng C, 2008, PEPTIDES, V29, P985, DOI 10.1016/j.peptides.2008.01.007; Pi CH, 2006, GENOMICS, V88, P809, DOI 10.1016/j.ygeno.2006.06.014; Plazas PV, 2005, J NEUROSCI, V25, P10905, DOI 10.1523/JNEUROSCI.3805-05.2005; PriceCarter M, 1996, BIOCHEMISTRY-US, V35, P15537, DOI 10.1021/bi961574c; Quan Ya-ru, 2005, Zhongguo Haiyang Yaowu, V24, P1; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P9581, DOI 10.1021/bi970235w; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Teichert RW, 2005, J NEUROSCI, V25, P732, DOI 10.1523/JNEUROSCI.4065-04.2005; Teichertt RW, 2005, BIOCHEMISTRY-US, V44, P7897, DOI 10.1021/bi047274+; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; WOODWARD SR, 1990, EMBO J, V9, P1015, DOI 10.1002/j.1460-2075.1990.tb08204.x; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Ye MY, 2012, J BIOL CHEM, V287, P14973, DOI 10.1074/jbc.M111.334615; Yuan DD, 2008, PEPTIDES, V29, P1521, DOI 10.1016/j.peptides.2008.05.015; Yuan DD, 2009, PEPTIDES, V30, P861, DOI 10.1016/j.peptides.2009.01.012; Zhangsun D, 2006, CHEM BIOL DRUG DES, V68, P256, DOI 10.1111/j.1747-0285.2006.00443.x; Zheng GR, 2011, BIOORG MED CHEM LETT, V21, P2476, DOI 10.1016/j.bmcl.2011.02.043	68	39	50	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54648	10.1371/journal.pone.0054648	http://dx.doi.org/10.1371/journal.pone.0054648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382933	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800060
J	McCarter, MW; Sheremeta, RM				McCarter, Matthew W.; Sheremeta, Roman M.			You Can't Put Old Wine in New Bottles: The Effect of Newcomers on Coordination in Groups	PLOS ONE			English	Article							INTERPERSONAL-TRUST; SOCIAL DILEMMAS; WORK TEAMS; IMPACT; COMMUNICATION; UNCERTAINTY; COOPERATION; EXPERIENCE; INTERDEPENDENCE; CONSEQUENCES	A common finding in social sciences is that member change hinders group functioning and performance. However, questions remain as to why member change negatively affects group performance and what are some ways to alleviate the negative effects of member change on performance? To answer these questions we conduct an experiment in which we investigate the effect of newcomers on a group's ability to coordinate efficiently. Participants play a coordination game in a four-person group for the first part of the experiment, and then two members of the group are replaced with new participants, and the newly formed group plays the game for the second part of the experiment. Our results show that the arrival of newcomers decreases trust among group members and this decrease in trust negatively affects group performance. Knowing the performance history of the arriving newcomers mitigates the negative effect of their arrival, but only when newcomers also know the oldtimers performance history. Surprisingly, in groups that performed poorly prior to the newcomers' arrival, the distrust generated by newcomers is mainly between oldtimers about each other rather than about the newcomers.	[McCarter, Matthew W.; Sheremeta, Roman M.] Chapman Univ, Argyros Sch Business & Econ, Orange, CA 92866 USA	Chapman University System; Chapman University	McCarter, MW (corresponding author), Chapman Univ, Argyros Sch Business & Econ, Orange, CA 92866 USA.	mccarter@chapman.edu	McCarter, Matthew/I-6429-2013	McCarter, Matthew/0000-0001-7308-6333	Argyros School of Business and Economics; Wang-Fradkin Research Fund	Argyros School of Business and Economics; Wang-Fradkin Research Fund	This research was made possible by the generous funding of the Argyros School of Business and Economics provided to both authors, the Wang-Fradkin Research Fund awarded to the first author, and the facilities at the Economic Science Institute at Chapman University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgun AE, 2002, J ENG TECHNOL MANAGE, V19, P263, DOI 10.1016/S0923-4748(02)00021-8; [Anonymous], 1997, ORG DECISION MAKING; ARROW H, 1995, RES ORGAN BEHAV, V17, P373; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; BETTENHAUSEN KL, 1991, ADMIN SCI QUART, V36, P20, DOI 10.2307/2393428; Bottom WP, 1998, ORGAN BEHAV HUM DEC, V76, P89, DOI 10.1006/obhd.1998.2800; Bottom WP, 2002, ORGAN SCI, V13, P497, DOI 10.1287/orsc.13.5.497.7816; Brandts J, 2003, MANAGE SCI, V49, P116, DOI 10.1287/mnsc.49.1.116.12755; Brodbeck FC, 2000, J EXP SOC PSYCHOL, V36, P621, DOI 10.1006/jesp.2000.1423; Campion MA, 1996, PERS PSYCHOL, V49, P429, DOI 10.1111/j.1744-6570.1996.tb01806.x; Cason TN, 2012, GAME ECON BEHAV, V76, P26, DOI 10.1016/j.geb.2012.05.001; Cason TN, 2012, EUR ECON REV, V56, P233, DOI 10.1016/j.euroecorev.2011.09.001; Choi HS, 2005, ORGAN BEHAV HUM DEC, V98, P121, DOI 10.1016/j.obhdp.2005.06.003; Choi HS, 2004, J EXP SOC PSYCHOL, V40, P273, DOI 10.1016/S0022-1031(03)00101-X; Colquitt JA, 2008, ACAD MANAGE J, V51, P616; Crawford V, 1998, J ECON THEORY, V78, P286, DOI 10.1006/jeth.1997.2359; Creswell J. W., 2014, RES DESIGN QUALITATI; Dineen BR, 2003, RES PERS H, V22, P1; Dirks KT, 1999, J APPL PSYCHOL, V84, P445, DOI 10.1037/0021-9010.84.3.445; Edmondson C, 2009, J PROD INNOVAT MANAG, V26, P123; Fawcett Stanley E., 2008, International Journal of Procurement Management, V1, P318, DOI 10.1504/IJPM.2008.017528; Finkel EJ, 2006, J PERS SOC PSYCHOL, V91, P456, DOI 10.1037/0022-3514.91.3.456; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; FRANK RH, 1993, J ECON PERSPECT, V7, P159, DOI 10.1257/jep.7.2.159; FRANZEN A, 1995, RATION SOC, V7, P183, DOI 10.1177/1043463195007002006; Friedman S., 1994, EXPT METHODS PRIMER, DOI 10.1017/cbo9781139174176; GOODMAN PS, 1988, J APPL PSYCHOL, V73, P81, DOI 10.1037/0021-9010.73.1.81; Gratton L, 2007, HARVARD BUS REV, V85, P100; GULATI R, 1995, ACAD MANAGE J, V38, P85, DOI 10.2307/256729; Ho TH, 2005, MANAGE SCI, V51, P519, DOI 10.1287/mnsc.1040.0350; Hogg M, 2005, SOCIAL PSYCHOL INCLU, P191; Hornsey MJ, 2007, PERS SOC PSYCHOL B, V33, P1036, DOI 10.1177/0146167207301029; Huckman RS, 2009, MANAGE SCI, V55, P85, DOI 10.1287/mnsc.1080.0921; Jarvenpaa SL, 1999, ORGAN SCI, V10, P791, DOI 10.1287/orsc.10.6.791; Jones GR, 1998, ACAD MANAGE REV, V23, P531, DOI 10.2307/259293; Kane AA, 2005, ORGAN BEHAV HUM DEC, V96, P56, DOI 10.1016/j.obhdp.2004.09.002; Kenny D.A., 1998, HDB SOCIAL PSYCHOL, V4th ed., P233; Kiffin-Petersen S., 2004, J MANAGE ORGAN, V10, P38, DOI DOI 10.5172/JM0.2004.10.1.38; Knez M, 2000, ORGAN BEHAV HUM DEC, V82, P194, DOI 10.1006/obhd.2000.2882; KNEZ M, 1994, STRATEGIC MANAGE J, V15, P101, DOI 10.1002/smj.4250150908; KOLLOCK P, 1994, AM J SOCIOL, V100, P313, DOI 10.1086/230539; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kramer RM, 1999, APP SOC RES, P145; Krishnamurthy S, 2001, MARKET LETT, V12, P315, DOI 10.1023/A:1012268221707; Lewicki RJ, 2006, J MANAGE, V32, P991, DOI 10.1177/0149206306294405; Lomborg B, 1996, AM SOCIOL REV, V61, P278, DOI 10.2307/2096335; Madsen TL, 2003, ORGAN SCI, V14, P173, DOI 10.1287/orsc.14.2.173.14997; Marks MA, 2001, ACAD MANAGE REV, V26, P356, DOI 10.5465/AMR.2001.4845785; Marques J. M., 1994, EUROPEAN REV SOCIAL, V5, P38, DOI 10.1080/14792779543000011; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P287, DOI 10.1002/ejsp.2420180308; McCarter MW, 2007, J OPER MANAG, V25, P498, DOI 10.1016/j.jom.2006.05.005; Mccarter MW, 2011, ACAD MANAGE REV, V36, P621, DOI 10.5465/amr.2009.0481; McCarter MW, 2010, ORGAN BEHAV HUM DEC, V111, P1, DOI 10.1016/j.obhdp.2009.06.003; McCarter MW, 2013, ORG MANAGEM IN PRESS; Moreland R.L., 2002, GROUP PROCESS INTERG, V5, P185, DOI [10.1177/1368430202005003001, DOI 10.1177/1368430202005003001]; Moreland R. L., 1989, PSYCHOL GROUP INFLUE, P143; Okhuysen GA, 2009, ACAD MANAG ANN, V3, P463, DOI 10.1080/19416520903047533; Olson M., 2012, CONT SOCIOLOGICAL TH; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Poppo L, 2008, ORGAN SCI, V19, P39, DOI 10.1287/orsc.1070.0281; Robinson SL, 1996, ADMIN SCI QUART, V41, P574, DOI 10.2307/2393868; SALLY D, 1995, RATION SOC, V7, P58, DOI 10.1177/1043463195007001004; SCHNAKE ME, 1991, J MANAGE, V17, P41, DOI 10.1177/014920639101700104; Schniter E, 2013, J EC BEHAV IN PRESS; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; SNIEZEK JA, 1990, ORGAN BEHAV HUM DEC, V46, P155, DOI 10.1016/0749-5978(90)90027-7; Speck Frank G., 1946, AM ANTHROPOL, V48, P355; TAYLOR M, 1982, POLIT STUD-LONDON, V30, P350, DOI 10.1111/j.1467-9248.1982.tb00545.x; van der Vegt GS, 2010, J MANAGE, V36, P1168, DOI 10.1177/0149206309344117; VANHUYCK JB, 1990, AM ECON REV, V80, P234; Weber R, 2001, ORGAN SCI, V12, P582, DOI 10.1287/orsc.12.5.582.10090; Weber RA, 2006, AM ECON REV, V96, P114, DOI 10.1257/000282806776157588; Winer B.J., 1962, STAT PRINCIPLES EXPT; ZALD MN, 1966, SOC FORCES, V44, P327, DOI 10.2307/2575833; Zellmer-Bruhn ME, 2003, MANAGE SCI, V49, P514, DOI 10.1287/mnsc.49.4.514.14423	75	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55058	10.1371/journal.pone.0055058	http://dx.doi.org/10.1371/journal.pone.0055058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383056	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800108
J	Miyagi, H; Kanemoto, S; Saito, A; Asada, R; Iwamoto, H; Izumi, S; Kido, M; Gomi, F; Nishida, K; Kiuchi, Y; Imaizumi, K				Miyagi, Hidetaka; Kanemoto, Soshi; Saito, Atsushi; Asada, Rie; Iwamoto, Hideo; Izumi, Soutarou; Kido, Miori; Gomi, Fumi; Nishida, Kohji; Kiuchi, Yoshiaki; Imaizumi, Kazunori			Transcriptional Regulation of VEGFA by the Endoplasmic Reticulum Stress Transducer OASIS in ARPE-19 Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL GROWTH-FACTOR; ER STRESS; CREB/ATF-FAMILY; ATF6; IRE1; IDENTIFICATION; ANGIOGENESIS; CLEAVAGE; PATHWAY	Background: Vascular endothelial growth factor-A (VEGFA) is the main mediator of angiogenesis. Angiogenesis plays important roles not only in many physiological processes, but also in the pathophysiology of many diseases. VEGFA is one of the therapeutic targets of treatment for ocular diseases with neovascularization. Therefore, elucidation of the regulatory mechanisms for VEGFA expression is important for the development of pharmaceutical drugs. Recent studies have demonstrated that the unfolded protein response is involved in the transcriptional regulation of VEGFA. However, the precise regulation of VEGFA in the human retina is not fully understood. Principal Findings: When human retinal pigment epithelial cells, ARPE-19, were exposed to endoplasmic reticulum stressors, VEGFA mRNA was significantly upregulated. The unfolded protein response-related transcription factors XBP1, ATF4, ATF6, and OASIS were expressed in ARPE-19 cells. To determine which transcription factors preferentially contribute to the induction of VEGFA expression after endoplasmic reticulum stress, we carried out reporter assays using an approximately 6-kbp 5'-upstream region of the human VEGFA gene. Among these transcription factors, OASIS acted most effectively on the VEGFA promoter in ARPE-19 cells. Based on data obtained for certain deleted and mutated reporter constructs, we determined that OASIS promoted VEGFA expression by acting on a cyclic AMP-responsive element-like site located at around -500 bp relative to the VEGFA transcription start site. Furthermore, we confirmed that OASIS directly bound to the promoter region containing this site by chromatin immunoprecipitation assays. Conclusions and Significance: We have demonstrated a novel regulatory mechanism for VEGFA transcription by OASIS in human retinal pigment epithelial cells. Chemical compounds that regulate the binding of OASIS to the promoter region of the VEGFA gene may have potential as therapeutic agents for ocular diseases with neovascularization.	[Miyagi, Hidetaka; Kanemoto, Soshi; Saito, Atsushi; Asada, Rie; Iwamoto, Hideo; Izumi, Soutarou; Kido, Miori; Imaizumi, Kazunori] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biochem, Hiroshima, Japan; [Miyagi, Hidetaka; Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Gomi, Fumi; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan	Hiroshima University; Hiroshima University; Osaka University	Imaizumi, K (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Biochem, Hiroshima, Japan.	imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909; Nishida, Kohji/0000-0001-9069-3610; Gomi, Fumi/0000-0003-0807-8817	Takeda Science Foundation; Naito Foundation; Senri Life Science Foundation; Hokuto Foundation for Bioscience; Japan Prize Foundation; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [25650069] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Senri Life Science Foundation; Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Japan Prize Foundation(Japan Prize Foundation); Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from the Takeda Science Foundation, Naito Foundation, Senri Life Science Foundation, Hokuto Foundation for Bioscience, Japan Prize Foundation, and Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chihara K, 2009, J NEUROCHEM, V110, P956, DOI 10.1111/j.1471-4159.2009.06188.x; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Funamoto T, 2011, BONE, V49, P724, DOI 10.1016/j.bone.2011.06.012; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2011, BONE, V48, P514, DOI 10.1016/j.bone.2010.10.176; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Nikaido T, 2001, HISTOCHEM CELL BIOL, V116, P141; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang XY, 2008, DIABETES, V57, P1026, DOI 10.2337/db07-0982; Zhong YM, 2012, DIABETES, V61, P492, DOI 10.2337/db11-0315; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	50	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55155	10.1371/journal.pone.0055155	http://dx.doi.org/10.1371/journal.pone.0055155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383089	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800123
J	Laforenza, U; Scaffino, MF; Gastaldi, G				Laforenza, Umberto; Scaffino, Manuela F.; Gastaldi, Giulia			Aquaporin-10 Represents an Alternative Pathway for Glycerol Efflux from Human Adipocytes	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; ADIPOSE GENE-EXPRESSION; WATER PERMEABILITY; MEMBRANE-VESICLES; CHANNEL; OBESITY; TISSUE; CLONING; AQP10; LOCALIZATION	Background: Glycerol outflow from adipocytes has been considered for a decade to be mediated by aquaporin-7, an aquaglyceroporin highly expressed in the adipose tissue. Its involvement in glycerol metabolism has been widely studied also in humans. Recent studies in different aquaporin-7 KO mice models pose two different questions 1) the exact localization of aquaporin-7 in human white adipose tissue; 2) the existence of other aquaglyceroporins that work with aquaporin-7 to guarantee glycerol efflux and thus a normal adiposity in humans. To this purpose we investigated the expression, the localization and the functioning of aquaglyceroporin-10 in subcutaneous white adipose tissue, in isolated and cultured differentiated adipocytes. Methodology/Principal Findings: Aquaporin-7 and -10 were expressed in the white adipose tissue both at mRNA and at protein level. Immunofluorescence revealed aquaporin-7 and -10 labelling in the human adipose tissue both to the plasma membrane and to a thin rim of cytoplasm of adipocytes. Aquaporin-7, but not aquaporin-10, colocalized with the endothelial marker CD34. Human cultured differentiated adipocytes showed an aquaporin-7 and -10 labelling mainly in the cytoplasm and in the lipid droplets with insulin reinforcing the lipid droplets staining and isoproterenol inducing its translocation to the plasma membrane compartment. Water and glycerol permeability measurements using adipocytes and adipose membrane vesicles confirmed the presence of functioning aquaglyceroporins. Aquaporin-10 silencing in human differentiated adipocytes resulted in a 50% decrease of glycerol and osmotic water permeability. Conclusions/Significance: The results indicate that aquaporin-7, differently from mice, is present in both adipocyte and capillary plasma membranes of human adipose tissue. Aquaporin-10, on the contrary, is expressed exclusively in the adipocytes. The expression of two aquaglyceroporins in human adipose tissue is particularly important for the maintenance of normal or low glycerol contents inside the adipocyte, thus protecting humans from obesity.	[Laforenza, Umberto; Scaffino, Manuela F.; Gastaldi, Giulia] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy	University of Pavia	Laforenza, U (corresponding author), Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.	lumberto@unipv.it		Laforenza, Umberto/0000-0003-2951-5983				Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceperuelo-Mallafre V, 2007, J CLIN ENDOCR METAB, V92, P3640, DOI 10.1210/jc.2007-0531; DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608; Fasshauer M, 2003, HORM METAB RES, V35, P222; Fruhbeck G, 2005, NATURE, V438, P436, DOI 10.1038/438436b; Fruhbeck G, 2006, TRENDS PHARMACOL SCI, V27, P345, DOI 10.1016/j.tips.2006.05.002; Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P15493, DOI 10.1074/jbc.C500028200; Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Ishibashi K, 2006, CELL MOL BIOL, V52, P20, DOI 10.1170/T745; Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7; Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200; Kishida K, 2001, J BIOL CHEM, V276, P48572, DOI 10.1074/jbc.M108213200; Kondo H, 2002, EUR J BIOCHEM, V269, P1814, DOI 10.1046/j.1432-1033.2002.02821.x; Kuriyama H, 1997, BIOCHEM BIOPH RES CO, V241, P53, DOI 10.1006/bbrc.1997.7769; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laforenza U, 2005, BIOL CELL, V97, P605, DOI 10.1042/BC20040090; Laforenza U, 2005, J NUTR, V135, P2329, DOI 10.1093/jn/135.10.2329; Laforenza U, 2012, MOL ASPECTS MED, V33, P642, DOI 10.1016/j.mam.2012.03.001; Laforenza U, 2010, BIOL CELL, V102, P457, DOI 10.1042/BC20100023; Li HP, 2005, BIOL CELL, V97, P823, DOI 10.1042/BC20040091; MA TH, 1993, J BIOL CHEM, V268, P22756; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Marrades MP, 2006, BIOCHEM BIOPH RES CO, V339, P785, DOI 10.1016/j.bbrc.2005.11.080; Matsumura K, 2007, MOL CELL BIOL, V27, P6026, DOI 10.1128/MCB.00384-07; Mobasheri A, 2004, HISTOCHEM CELL BIOL, V121, P463, DOI 10.1007/s00418-004-0657-1; Morinaga T, 2002, BIOCHEM BIOPH RES CO, V294, P630, DOI 10.1016/S0006-291X(02)00536-3; OKA Y, 1988, J BIOL CHEM, V263, P13432; Prudente S, 2007, DIABETES, V56, P1468, DOI 10.2337/db06-1389; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Skowronski MT, 2007, AM J PHYSIOL-RENAL, V292, pP956, DOI 10.1152/ajprenal.00314.2006; Tritto S, 2007, BIOCHEM CELL BIOL, V85, P675, DOI 10.1139/O07-142; Verkman AS, 2000, J MEMBRANE BIOL, V173, P73, DOI 10.1007/s002320001009; Walker CG, 2007, INT J OBESITY, V31, P1165, DOI 10.1038/sj.ijo.0803555; WIENER H, 1989, J MEMBRANE BIOL, V110, P147, DOI 10.1007/BF01869470; Yang BX, 2006, J BIOL CHEM, V281, P16202, DOI 10.1074/jbc.M601864200; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017	42	65	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54474	10.1371/journal.pone.0054474	http://dx.doi.org/10.1371/journal.pone.0054474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382902	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200008
J	Loeser, RF; Olex, AL; McNulty, MA; Carlson, CS; Callahan, M; Ferguson, C; Fetrow, JS				Loeser, Richard F.; Olex, Amy L.; McNulty, Margaret A.; Carlson, Cathy S.; Callahan, Michael; Ferguson, Cristin; Fetrow, Jacquelyn S.			Disease Progression and Phasic Changes in Gene Expression in a Mouse Model of Osteoarthritis	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; PROTEIN; PRELP; MICE; CHONDROGENESIS; FIBROMODULIN; COMPLEMENT; REVEALS; REPAIR; CELLS	Osteoarthritis (OA) is the most common form of arthritis and has multiple risk factors including joint injury. The purpose of this study was to characterize the histologic development of OA in a mouse model where OA is induced by destabilization of the medial meniscus (DMM model) and to identify genes regulated during different stages of the disease, using RNA isolated from the joint "organ'' and analyzed using microarrays. Histologic changes seen in OA, including articular cartilage lesions and osteophytes, were present in the medial tibial plateaus of the DMM knees beginning at the earliest (2 week) time point and became progressively more severe by 16 weeks. 427 probe sets (371 genes) from the microarrays passed consistency and significance filters. There was an initial up-regulation at 2 and 4 weeks of genes involved in morphogenesis, differentiation, and development, including growth factor and matrix genes, as well as transcription factors including Atf2, Creb3l1, and Erg. Most genes were off or down-regulated at 8 weeks with the most highly down-regulated genes involved in cell division and the cytoskeleton. Gene expression increased at 16 weeks, in particular extracellular matrix genes including Prelp, Col3a1 and fibromodulin. Immunostaining revealed the presence of these three proteins in cartilage and soft tissues including ligaments as well as in the fibrocartilage covering osteophytes. The results support a phasic development of OA with early matrix remodeling and transcriptional activity followed by a more quiescent period that is not maintained. This implies that the response to an OA intervention will depend on the timing of the intervention. The quiescent period at 8 weeks may be due to the maturation of the osteophytes which are thought to temporarily stabilize the joint.	[Loeser, Richard F.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA; [Olex, Amy L.; Fetrow, Jacquelyn S.] Wake Forest Univ, Dept Comp Sci, Winston Salem, NC 27109 USA; [McNulty, Margaret A.; Carlson, Cathy S.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Callahan, Michael; Ferguson, Cristin] Wake Forest Univ, Bowman Gray Sch Med, Dept Orthoped Surg, Winston Salem, NC USA; [Fetrow, Jacquelyn S.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Loeser, RF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA.	rloeser@wakehealth.edu		Fetrow, Jacquelyn/0000-0002-0528-2049; McNulty, Margaret/0000-0001-6638-253X	Arthritis Foundation; Wake Forest University Translational Science Institute; NIH Musculoskeletal Training Grant [T32 AR050938]; NIH Orthopaedics and Skeletal Biology Training Grant [T32 AR052272]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938, T32AR052272] Funding Source: NIH RePORTER	Arthritis Foundation; Wake Forest University Translational Science Institute; NIH Musculoskeletal Training Grant; NIH Orthopaedics and Skeletal Biology Training Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by an Innovative Research Award from the Arthritis Foundation, The Wake Forest University Translational Science Institute, NIH Musculoskeletal Training Grant (T32 AR050938) and NIH Orthopaedics and Skeletal Biology Training Grant (T32 AR052272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGNER T, 1993, J CLIN INVEST, V91, P829, DOI 10.1172/JCI116303; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1261; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Chou Jeff W., 2005, Journal of Bioinformatics and Computational Biology, V3, P225, DOI 10.1142/S0219720005001028; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Fukui N, 2008, ARTHRITIS RHEUM-US, V58, P154, DOI 10.1002/art.23175; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Grover J, 2007, MATRIX BIOL, V26, P140, DOI 10.1016/j.matbio.2006.10.005; Happonen KE, 2012, J BIOL CHEM, V287, P8092, DOI 10.1074/jbc.M111.291476; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Johnson K, 2001, ARTHRITIS RHEUM, V44, P1071, DOI 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; McNulty MA, 2012, OSTEOARTHR CARTILAGE, V20, P949, DOI 10.1016/j.joca.2012.05.001; McNulty MA, 2011, CARTILAGE, V2, P354, DOI 10.1177/1947603511402665; Neame PJ, 1999, CELL MOL LIFE SCI, V55, P1327, DOI 10.1007/s000180050373; Olex AL, 2011, BIOINFORMATICS, V27, P1330, DOI 10.1093/bioinformatics/btr115; Olex AL, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-41; POTTENGER LA, 1990, ARTHRITIS RHEUM-US, V33, P853, DOI 10.1002/art.1780330612; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; Sharif M, 2004, ARTHRITIS RHEUM, V50, P2479, DOI 10.1002/art.20365; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; WOLFF DA, 1992, J ORTHOPAED RES, V10, P49, DOI 10.1002/jor.1100100106; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Young RD, 2000, J HISTOCHEM CYTOCHEM, V48, P423, DOI 10.1177/002215540004800312	31	81	81	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54633	10.1371/journal.pone.0054633	http://dx.doi.org/10.1371/journal.pone.0054633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382930	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500021
J	Walker, ML; Farcot, E; Traas, J; Godin, C				Walker, Michael Luke; Farcot, Etienne; Traas, Jan; Godin, Christophe			The Flux-Based PIN Allocation Mechanism Can Generate Either Canalyzed or Diffuse Distribution Patterns Depending on Geometry and Boundary Conditions	PLOS ONE			English	Article							AUXIN TRANSPORT; CANALIZATION; MODEL; ENDOCYTOSIS; PHYLLOTAXIS; DYNAMICS; POLARITY; LEAVES; ABP1	Growth and morphogenesis in plants require controlled transport of the plant hormone auxin. An important participant is the auxin effluxing protein PIN, whose polarized subcellular localization allows it to effectively transport auxin large distances through tissues. The flux-based model, in which auxin flux through a wall stimulates PIN allocation to that wall, is a dominant contender among models determining where and in what quantity PIN is allocated to cell walls. In this paper we characterise the behaviour of flux-based PIN allocation models in various tissues of the shoot apical meristem. Arguing from both mathematical analysis and computer simulations, we describe the natural behaviours of this class of models under various circumstances. In particular, we demonstrate the important dichotomy between sink- and source-driven systems, and show that both diffuse and canalized PIN distributions can be generated simultaneously in the same tissue, without model hybridization or variation of PIN-related parameters. This work is performed in the context of the shoot apical and floral meristems and is applicable to the construction of a unified PIN allocation model.	[Walker, Michael Luke; Farcot, Etienne; Godin, Christophe] INRIA, UMR AGAP, Virtual Plants Project Team, Montpellier, France; [Traas, Jan] Univ Lyon 1, INRA, CNRS, ENS Lyon,Lab Reprod & Dev Plantes, F-69365 Lyon, France	Inria; Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Walker, ML (corresponding author), INRIA, UMR AGAP, Virtual Plants Project Team, Montpellier, France.	Michael.Walker@inria.fr; Christophe.Godin@inria.fr	Traas, Jan/AAZ-7004-2020; Godin, Christophe/C-1218-2008	Traas, Jan/0000-0001-5107-1472; Godin, Christophe/0000-0002-1202-8460	ANR under EU	ANR under EU(French National Research Agency (ANR))	This work was funded by ANR, partners of the ERASysBio+ initiative supported under the EU ERA-NET Plus scheme in FP7, iSAM project. It also received funding from the ANR grant GeneShape and from the Institute for Computational Biology of Montpellier (IBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Balla J, 2011, PLANT J, V65, P571, DOI 10.1111/j.1365-313X.2010.04443.x; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Feugier FG, 2005, J THEOR BIOL, V236, P366, DOI 10.1016/j.jtbi.2005.03.017; Feugier FG, 2006, GENE DEV; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; Kramer EM, 2009, TRENDS PLANT SCI, V14, P242, DOI 10.1016/j.tplants.2009.02.005; Krupinski P, 2010, COLD SPRING HARBOR P, V2; Lin DS, 2012, CURR BIOL, V22, P1319, DOI 10.1016/j.cub.2012.05.019; Merks RMH, 2007, TRENDS PLANT SCI, V12, P384, DOI 10.1016/j.tplants.2007.08.004; MITCHISON GJ, 1981, PHILOS T ROY SOC B, V295, P461, DOI 10.1098/rstb.1981.0154; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; Prusinkiewicz P, 2009, P NATL ACAD SCI USA, V106, P17431, DOI 10.1073/pnas.0906696106; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Rolland-Lagan AG, 2005, PLANT J, V44, P854, DOI 10.1111/j.1365-313X.2005.02581.x; SACHS T, 1969, ANN BOT-LONDON, V33, P263, DOI 10.1093/oxfordjournals.aob.a084281; Scarpella E, 2004, DEVELOPMENT, V131, P3445, DOI 10.1242/dev.01182; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Steinacher A, 2012, J THEOR BIOL, V296, P84, DOI 10.1016/j.jtbi.2011.11.020; Stoma S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000207; van Mourik S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028762; Wabnik K, 2012, MOL SYST BIOL, V6, P1; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003	30	12	12	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54802	10.1371/journal.pone.0054802	http://dx.doi.org/10.1371/journal.pone.0054802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382973	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500029
J	Ewald, JA; Downs, TM; Cetnar, JP; Ricke, WA				Ewald, Jonathan A.; Downs, Tracy M.; Cetnar, Jeremy P.; Ricke, William A.			Expression Microarray Meta-Analysis Identifies Genes Associated with Ras/MAPK and Related Pathways in Progression of Muscle-Invasive Bladder Transition Cell Carcinoma	PLOS ONE			English	Article							INTEGRIN REGULATION; COLLAGENS; SIGNATURE; SURVIVAL; RECEPTOR; NETWORK; SYSTEM	The effective detection and management of muscle-invasive bladder Transition Cell Carcinoma (TCC) continues to be an urgent clinical challenge. While some differences of gene expression and function in papillary (Ta), superficial (T1) and muscle-invasive (>= T2) bladder cancers have been investigated, the understanding of mechanisms involved in the progression of bladder tumors remains incomplete. Statistical methods of pathway-enrichment, cluster analysis and text-mining can extract and help interpret functional information about gene expression patterns in large sets of genomic data. The public availability of patient-derived expression microarray data allows open access and analysis of large amounts of clinical data. Using these resources, we investigated gene expression differences associated with tumor progression and muscle-invasive TCC. Gene expression was calculated relative to Ta tumors to assess progression-associated differences, revealing a network of genes related to Ras/MAPK and PI3K signaling pathways with increased expression. Further, we identified genes within this network that are similarly expressed in superficial Ta and T1 stages but altered in muscle-invasive T2 tumors, finding 7 genes (COL3A1, COL5A1, COL11A1, FN1, ErbB3, MAPK10 and CDC25C) whose expression patterns in muscle-invasive tumors are consistent in 5 to 7 independent outside microarray studies. Further, we found increased expression of the fibrillar collagen proteins COL3A1 and COL5A1 in muscle-invasive tumor samples and metastatic T24 cells. Our results suggest that increased expression of genes involved in mitogenic signaling may support the progression of muscle-invasive bladder tumors that generally lack activating mutations in these pathways, while expression changes of fibrillar collagens, fibronectin and specific signaling proteins are associated with muscle-invasive disease. These results identify potential biomarkers and targets for TCC treatments, and provide an integrated systems-level perspective of TCC pathobiology to inform future studies.	[Ewald, Jonathan A.; Downs, Tracy M.; Ricke, William A.] Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Cetnar, Jeremy P.] Univ Wisconsin, Dept Med, Hematol Oncol Unit, Sch Med & Publ Hlth, Madison, WI USA; [Ewald, Jonathan A.; Downs, Tracy M.; Cetnar, Jeremy P.; Ricke, William A.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ricke, WA (corresponding author), Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rickew@urology.wisc.edu		Ricke, William/0000-0002-9807-2090	National Institutes of Health [CA123199, DK093690, RC2ES018764]; NATIONAL CANCER INSTITUTE [R01CA123199, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health [grant numbers: CA123199, DK093690, RC2ES018764 to WAR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiadou S, 2010, TRENDS BIOTECHNOL, V28, P381, DOI 10.1016/j.tibtech.2010.04.005; Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Collier IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024029; Dietzsch J, 2006, BIOINFORMATICS, V22, P1010, DOI 10.1093/bioinformatics/btl070; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Dyrskjot L, 2007, CLIN CANCER RES, V13, P3545, DOI 10.1158/1078-0432.CCR-06-2940; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eissa S, 2010, MED ONCOL, V27, P1286, DOI 10.1007/s12032-009-9375-9; Ewald JA, 2012, TRANSL ONCOL, V5, P278, DOI 10.1593/tlo.12181; Exposito JY, 2010, INT J MOL SCI, V11, P407, DOI 10.3390/ijms11020407; Faro A, 2012, BRIEF BIOINFORM, V13, P61, DOI 10.1093/bib/bbr018; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Howlander Nea, 2012, SEER CANC STAT REV 1; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443; Knowles MA, 2001, J CLIN PATHOL-MOL PA, V54, P215, DOI 10.1136/mp.54.4.215; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008; Memon AA, 2006, BRIT J CANCER, V94, P1703, DOI 10.1038/sj.bjc.6603154; Modlich O, 2004, CLIN CANCER RES, V10, P3410, DOI 10.1158/1078-0432.CCR-03-0134; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Simon R, 2008, CURR OPIN BIOTECH, V19, P26, DOI 10.1016/j.copbio.2007.10.008; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wenstrup RJ, 2011, J BIOL CHEM, V286, P20455, DOI 10.1074/jbc.M111.223693; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200	37	40	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55414	10.1371/journal.pone.0055414	http://dx.doi.org/10.1371/journal.pone.0055414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383328	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900035
J	Scholling, M; Thurner, S; Hanel, R				Schoelling, Manuel; Thurner, Stefan; Hanel, Rudolf			Protein Complex Formation: Computational Clarification of the Sequential versus Probabilistic Recruitment Puzzle	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; RNA; INITIATION; PROMOTER	Our current view on how protein complexes assemble and disassemble at promoter sites is based on experimental data. For instance this data is provided by biochemical methods (e.g. ChIP-on-chip assays) or GFP-based assays. These two approaches suggest very different characteristics for protein recruitment processes that regulate and initiate gene transcription. Biochemical methods suggest a strictly ordered and consecutive protein recruitment while GFP-based assays draw a picture much closer to chaotic or stochastic recruitment. To understand the reason for these conflicting results, we design a generalized recruitment model (GRM) that allows to simulate all possible scenarios between strictly sequential recruitment and completely probabilistic recruitment. With this model we show that probabilistic, transient binding events that are visible in GFP experiments can not be detected by ChIP experiments. We demonstrate that sequential recruitment processes and probabilistic recruitment processes that contain "shortcuts'' exhibit periodic dynamics and are hard to distinguish with standard ChIP measurements. Therefore we propose a simple experimental method that can be used to discriminate sequential from probabilistic recruitment processes. We discuss the limitations of this method.	[Schoelling, Manuel; Thurner, Stefan; Hanel, Rudolf] Med Univ Vienna, Sect Sci Complex Syst CeMSIIS, Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA	Medical University of Vienna; The Santa Fe Institute	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst CeMSIIS, Vienna, Austria.	stefan.thurner@meduniwien.ac.at		Hanel, Rudolf/0000-0002-4045-9532	Forum Integrativmedizin; Hilde Umdasch Privatstiftung	Forum Integrativmedizin; Hilde Umdasch Privatstiftung	The project has been funded by "Forum Integrativmedizin'', an initiative of the "Hilde Umdasch Privatstiftung'' (http://www.integrativmedizin.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100007; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; D'Orsogna MR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.170603; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hanel R, 2011, PLOS ONE, V7; Hanel R, 2010, PHILOS T R SOC A, V368, P5583, DOI 10.1098/rsta.2010.0267; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Lemaire V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198102; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Stasevich TJ, 2011, CHROMOSOMA, V120, P533, DOI 10.1007/s00412-011-0340-y; Stasevich TJ, 2010, BIOPHYS J, V99, P3093, DOI 10.1016/j.bpj.2010.08.059	27	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55046	10.1371/journal.pone.0055046	http://dx.doi.org/10.1371/journal.pone.0055046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383305	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900012
J	Tironi-Farinati, C; Geoghegan, PA; Cangelosi, A; Pinto, A; Loidl, CF; Goldstein, J				Tironi-Farinati, Carla; Geoghegan, Patricia A.; Cangelosi, Adriana; Pinto, Alipio; Fabian Loidl, C.; Goldstein, Jorge			A Translational Murine Model of Sub-Lethal Intoxication with Shiga Toxin 2 Reveals Novel Ultrastructural Findings in the Brain Striatum	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI O157-H7; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; BASAL GANGLIA; NEUROLOGICAL COMPLICATIONS; MAST-CELLS; DNA FRAGMENTATION; ORAL INFECTION; PRIMATE MODEL	Infection by Shiga toxin-producing Escherichia coli causes hemorrhagic colitis, hemolytic uremic syndrome (HUS), acute renal failure, and also central nervous system complications in around 30% of the children affected. Besides, neurological deficits are one of the most unrepairable and untreatable outcomes of HUS. Study of the striatum is relevant because basal ganglia are one of the brain areas most commonly affected in patients that have suffered from HUS and since the deleterious effects of a sub-lethal dose of Shiga toxin have never been studied in the striatum, the purpose of this study was to attempt to simulate an infection by Shiga toxin-producing E. coli in a murine model. To this end, intravenous administration of a sub-lethal dose of Shiga toxin 2 (0.5 eta g per mouse) was used and the correlation between neurological manifestations and ultrastructural changes in striatal brain cells was studied in detail. Neurological manifestations included significant motor behavior abnormalities in spontaneous motor activity, gait, pelvic elevation and hind limb activity eight days after administration of the toxin. Transmission electron microscopy revealed that the toxin caused early perivascular edema two days after administration, as well as significant damage in astrocytes four days after administration and significant damage in neurons and oligodendrocytes eight days after administration. Interrupted synapses and mast cell extravasation were also found eight days after administration of the toxin. We thus conclude that the chronological order of events observed in the striatum could explain the neurological disorders found eight days after administration of the toxin.	[Tironi-Farinati, Carla; Pinto, Alipio; Goldstein, Jorge] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Neurofisiopatol, RA-1425 Buenos Aires, DF, Argentina; [Geoghegan, Patricia A.; Cangelosi, Adriana] Ctr Nacl Control Calidad Biol CNCCB ANLIS Dr Carl, Buenos Aires, DF, Argentina; [Fabian Loidl, C.] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Goldstein, J (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Neurofisiopatol, RA-1425 Buenos Aires, DF, Argentina.	jogol@fmed.uba.ar		Goldstein, Jorge/0000-0002-9488-0074	CONICET (National Research Council, Argentina) [PIP114-200801-00497]; Universidad de Buenos Aires (UBA) [UBACYT 20020090200634]	CONICET (National Research Council, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	These studies were supported by CONICET (National Research Council, Argentina) Grant PIP114-200801-00497 (http://www.conicet.gov.ar/web/conicet/inicio) and Universidad de Buenos Aires (UBA) grant UBACYT 20020090200634 (http://www.uba.ar/secyt/contenido.php?id=42&s=50) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BARNETT NDP, 1995, PEDIATR NEUROL, V12, P155, DOI 10.1016/0887-8994(94)00121-H; BARRON KD, 1990, BRAIN RES, V523, P219, DOI 10.1016/0006-8993(90)91490-8; Bast DJ, 1997, INFECT IMMUN, V65, P2019, DOI 10.1128/IAI.65.6.2019-2028.1997; Berciano MT, 1999, J NEUROPATH EXP NEUR, V58, P1234, DOI 10.1097/00005072-199912000-00004; Boccoli J, 2008, BRAIN RES, V1230, P320, DOI 10.1016/j.brainres.2008.07.052; Boyd SG, 2001, ARCH DIS CHILD, V84, P434; Bruyn GW, 1987, ACTA NEUROPATHOL, V5, P21; Burdet J, 2013, BRIT J PHARMACOL, V168, P946, DOI 10.1111/j.1476-5381.2012.02239.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Cimolai N, 1998, ACTA PAEDIATR, V87, P593, DOI 10.1080/08035259850158353; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dean-Nystrom EA, 2000, INFECT IMMUN, V68, P2356, DOI 10.1128/IAI.68.4.2356-2358.2000; DIMARIO FJ, 1987, CLIN PEDIATR, V26, P586, DOI 10.1177/000992288702601106; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Florenzano F, 2000, J COMP NEUROL, V424, P651; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; FUJII J, 1994, INFECT IMMUN, V62, P3447, DOI 10.1128/IAI.62.8.3447-3453.1994; Fujii J, 1996, INFECT IMMUN, V64, P5053, DOI 10.1128/IAI.64.12.5053-5060.1996; Garbuzova-Davis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016601; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Goldstein J, 2007, BRAIN RES, V1161, P106, DOI 10.1016/j.brainres.2007.05.067; Grundmann K, 2012, NEUROBIOL DIS, V47, P61, DOI 10.1016/j.nbd.2012.03.024; Hager A, 1999, NEUROPEDIATRICS, V30, P210, DOI 10.1055/s-2007-973492; HAHN JS, 1989, J CHILD NEUROL, V4, P108, DOI 10.1177/088307388900400206; Isogai E, 1998, INFECT IMMUN, V66, P197, DOI 10.1128/IAI.66.1.197-202.1998; JEONG YK, 1994, PEDIATR RADIOL, V24, P585, DOI 10.1007/BF02012739; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Karpman D, 1997, J INFECT DIS, V175, P611, DOI 10.1093/infdis/175.3.611; Kita E, 2000, INFECT IMMUN, V68, P1207, DOI 10.1128/IAI.68.3.1207-1214.2000; Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8; Kurioka T, 1998, INFECT IMMUN, V66, P1726, DOI 10.1128/IAI.66.4.1726-1734.1998; Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Malamud N, 1974, ATLAS NEUROPATHOLOGY, P36; Matise I, 2000, VET PATHOL, V37, P318, DOI 10.1354/vp.37-4-318; Meichtri L, 2004, INT J FOOD MICROBIOL, V96, P189, DOI 10.1016/j.ijfoodmicro.2004.03.018; Mizuguchi M, 2001, ACTA NEUROPATHOL, V102, P306; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; MURATA F, 1974, AM J ANAT, V139, P335, DOI 10.1002/aja.1001390304; Nishikawa K, 2002, P NATL ACAD SCI USA, V99, P7669, DOI 10.1073/pnas.112058999; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; O'Brien AD, 1998, ESCHERICHIA COLI O15, P1; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; Obata F, 2010, ADV APPL MICROBIOL, V71, P1, DOI 10.1016/S0065-2164(10)71001-7; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Pastor AM, 1997, NEUROSCIENCE, V81, P457, DOI 10.1016/S0306-4522(97)00200-5; PETITO CK, 1982, J NEUROPATH EXP NEUR, V41, P423, DOI 10.1097/00005072-198207000-00005; Priestley J.V., 1992, ELECT MICROSCOPIC IM, P89; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; RICHARDSON SE, 1992, INFECT IMMUN, V60, P4154, DOI 10.1128/IAI.60.10.4154-4167.1992; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; ROOS RAC, 1983, J NEUROL SCI, V61, P37, DOI 10.1016/0022-510X(83)90053-9; Ruan YW, 2003, BRAIN RES, V982, P228, DOI 10.1016/S0006-8993(03)03021-X; SHETH KJ, 1986, ANN NEUROL, V19, P90, DOI 10.1002/ana.410190120; Siegler RL, 2001, J AM SOC NEPHROL, V12, P1458, DOI 10.1681/ASN.V1271458; Signorini E, 2000, PEDIATR NEPHROL, V14, P990, DOI 10.1007/s004670050059; Steinborn M, 2004, PEDIATR RADIOL, V34, P805, DOI 10.1007/s00247-004-1289-2; Strbian D, 2006, J CEREBR BLOOD F MET, V26, P605, DOI 10.1038/sj.jcbfm.9600228; Struelens MJ, 2011, EUROSURVEILLANCE, V16, P2; Sugatani J, 2000, THROMB RES, V100, P61, DOI 10.1016/S0049-3848(00)00305-4; Taguchi H, 2002, J MED MICROBIOL, V51, P336, DOI 10.1099/0022-1317-51-4-336; Takahashi K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-11; Taylor FB, 1999, AM J PATHOL, V154, P1285, DOI 10.1016/S0002-9440(10)65380-1; Tironi-Farinati C, 2010, J NEUROIMMUNOL, V222, P48, DOI 10.1016/j.jneuroim.2010.03.001; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; TZIPORI S, 1988, J CLIN PATHOL, V41, P1099, DOI 10.1136/jcp.41.10.1099; TZIPORI S, 1995, INFECT IMMUN, V63, P3621, DOI 10.1128/IAI.63.9.3621-3627.1995; UPADHYAYA K, 1980, PEDIATRICS, V65, P115; Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7; Watanabe M, 2004, J INFECT DIS, V189, P360, DOI 10.1086/381124; WEST MO, 1990, J NEUROPHYSIOL, V64, P1233, DOI 10.1152/jn.1990.64.4.1233; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wood NI, 2007, NEUROBIOL DIS, V25, P342, DOI 10.1016/j.nbd.2006.09.015; ZOJA C, 1992, J LAB CLIN MED, V120, P229	81	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55812	10.1371/journal.pone.0055812	http://dx.doi.org/10.1371/journal.pone.0055812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383285	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600162
J	Cullen, CL; Burne, THJ; Lavidis, NA; Moritz, KM				Cullen, Carlie L.; Burne, Thomas H. J.; Lavidis, Nickolas A.; Moritz, Karen M.			Low Dose Prenatal Ethanol Exposure Induces Anxiety-Like Behaviour and Alters Dendritic Morphology in the Basolateral Amygdala of Rat Offspring	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; FEAR-POTENTIATED STARTLE; SOCIAL-INTERACTION; MODERATE LEVELS; BINGE DRINKING; CELL LOSS; STRESS; BRAIN; PREGNANCY; SPINES	Prenatal exposure to high levels of alcohol is strongly associated with poor cognitive outcomes particularly in relation to learning and memory. It is also becoming more evident that anxiety disorders and anxiety-like behaviour can be associated with prenatal alcohol exposure. This study used a rat model to determine if prenatal exposure to a relatively small amount of alcohol would result in anxiety-like behaviour and to determine if this was associated with morphological changes in the basolateral amygdala. Pregnant Sprague Dawley rats were fed a liquid diet containing either no alcohol (Control) or 6% (vol/vol) ethanol (EtOH) throughout gestation. Male and Female offspring underwent behavioural testing at 8 months (Adult) or 15 months (Aged) of age. Rats were perfusion fixed and brains were collected at the end of behavioural testing for morphological analysis of pyramidal neuron number and dendritic morphology within the basolateral amygdala. EtOH exposed offspring displayed anxiety-like behaviour in the elevated plus maze, holeboard and emergence tests. Although sexually dimorphic behaviour was apparent, sex did not impact anxiety-like behaviour induced by prenatal alcohol exposure. This increase in anxiety - like behaviour could not be attributed to a change in pyramidal cell number within the BLA but rather was associated with an increase in dendritic spines along the apical dendrite which is indicative of an increase in synaptic connectivity and activity within these neurons. This study is the first to link increases in anxiety like behaviour to structural changes within the basolateral amygdala in a model of prenatal ethanol exposure. In addition, this study has shown that exposure to even a relatively small amount of alcohol during development leads to long term alterations in anxiety-like behaviour.	[Cullen, Carlie L.; Lavidis, Nickolas A.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Moritz, KM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	k.moritz1@uq.edu.au	Moritz, Karen/G-2508-2015; Burne, Thomas H/C-5656-2009; Cullen, Carlie/H-6535-2013; Cullen, Carlie/J-7706-2014	Moritz, Karen/0000-0002-8085-0034; Burne, Thomas H/0000-0003-3502-9789; Cullen, Carlie/0000-0001-6929-6258	National Health and Medical Research Council of Australia; NHMRC; Australian post-graduate award	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian post-graduate award(Australian Government)	This work was supported by a project grant from the National Health and Medical Research Council of Australia. KMM is supported by a NH&MRC Senior Research Fellowship and CC by an Australian post-graduate award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1983, NEUROBEH TOXICOL TER, V5, P363; ABEL EL, 1995, NEUROTOXICOL TERATOL, V17, P437, DOI 10.1016/0892-0362(95)00005-C; Adamec RE, 2005, NEUROSCI BIOBEHAV R, V29, P1225, DOI 10.1016/j.neubiorev.2005.05.007; Allan AM, 2003, ALCOHOL CLIN EXP RES, V27, P2009, DOI 10.1097/01.ALC.0000100940.95053.72; Allison C, 2003, PHARMACOL THERAPEUT, V98, P171, DOI 10.1016/S0163-7258(03)00029-9; Astley SJ, 2000, ALCOHOL ALCOHOLISM, V35, P509, DOI 10.1093/alcalc/35.5.509; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; Baker S, 2009, BRAIN RES, V1302, P194, DOI 10.1016/j.brainres.2009.09.023; Barr HM, 2006, AM J PSYCHIAT, V163, P1061, DOI 10.1176/appi.ajp.163.6.1061; Barr HM, 2001, ALCOHOL CLIN EXP RES, V25, P283, DOI 10.1111/j.1530-0277.2001.tb02210.x; Berman RE, 2000, HIPPOCAMPUS, V10, P94, DOI 10.1002/(SICI)1098-1063(2000)10:1<94::AID-HIPO11>3.3.CO;2-K; Bogoch Y, 2007, J NEUROCHEM, V101, P1018, DOI 10.1111/j.1471-4159.2006.04402.x; Brocardo PS, 2012, NEUROPHARMACOLOGY, V62, P1607, DOI 10.1016/j.neuropharm.2011.10.006; BROWN RT, 1991, NEUROTOXICOL TERATOL, V13, P369, DOI 10.1016/0892-0362(91)90085-B; Burden MJ, 2011, ALCOHOL CLIN EXP RES, V35, P69, DOI 10.1111/j.1530-0277.2010.01323.x; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; Cui ZJ, 2010, ALCOHOL ALCOHOLISM, V45, P312, DOI 10.1093/alcalc/agq036; Dursun I, 2006, PHARMACOL BIOCHEM BE, V85, P345, DOI 10.1016/j.pbb.2006.09.001; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Elliott EJ, 2008, ARCH DIS CHILD, V93, P732, DOI 10.1136/adc.2007.120220; Famy C, 1998, AM J PSYCHIAT, V155, P552, DOI 10.1176/ajp.155.4.552; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Gabriel KI, 2006, PSYCHONEUROENDOCRINO, V31, P1046, DOI 10.1016/j.psyneuen.2006.06.003; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Giglia Roslyn C, 2008, Breastfeed Rev, V16, P17; Gonzalez-Burgos I, 2006, NEUROSCI RES, V56, P400, DOI 10.1016/j.neures.2006.08.007; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; HALL JL, 1994, PSYCHOBIOLOGY, V22, P181; Hamilton DA, 2010, BEHAV BRAIN RES, V207, P290, DOI 10.1016/j.bbr.2009.10.012; Hamilton GF, 2010, SYNAPSE, V64, P127, DOI 10.1002/syn.20711; Harris KR, 2003, J PAEDIATR CHILD H, V39, P528, DOI 10.1046/j.1440-1754.2003.00208.x; Hellemans KGC, 2010, ALCOHOL CLIN EXP RES, V34, P633, DOI 10.1111/j.1530-0277.2009.01132.x; Hellemans KGC, 2008, ANN NY ACAD SCI, V1144, P154, DOI 10.1196/annals.1418.016; Hofmann CE, 2005, PHARMACOL BIOCHEM BE, V82, P549, DOI 10.1016/j.pbb.2005.10.010; JONES KL, 1973, LANCET, V1, P1267; KELLY SJ, 1988, BEHAV BRAIN RES, V27, P247, DOI 10.1016/0166-4328(88)90121-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee PR, 2007, BRAIN RES, V1156, P152, DOI 10.1016/j.brainres.2007.04.042; Lee S, 1990, MOL CELLULAR NEUROSC, V1; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Maier SE, 2003, ALCOHOL, V30, P67, DOI 10.1016/S0741-8329(03)00096-X; Maier SE, 2001, ALCOHOL, V23, P49, DOI 10.1016/S0741-8329(00)00133-6; MARCUSSEN BL, 1994, ALCOHOL, V11, P147, DOI 10.1016/0741-8329(94)90056-6; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Moonat S, 2011, ADDICT BIOL, V16, P238, DOI 10.1111/j.1369-1600.2010.00275.x; Morley KC, 2001, EUR J PHARMACOL, V433, P91, DOI 10.1016/S0014-2999(01)01512-6; NAPPER RMA, 1995, J COMP NEUROL, V362, P283, DOI 10.1002/cne.903620210; Ogilvie KM, 1997, ALCOHOL CLIN EXP RES, V21, P424, DOI 10.1111/j.1530-0277.1997.tb03786.x; Osborn JA, 1998, ALCOHOL CLIN EXP RES, V22, P685, DOI 10.1097/00000374-199805000-00021; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Probyn ME, 2012, REPROD FERT DEVELOP, V24, P859, DOI 10.1071/RD11200; Rainnie DG, 2004, J NEUROSCI, V24, P3471, DOI 10.1523/JNEUROSCI.5740-03.2004; Rasmussen C, 2011, CHILD CARE HLTH DEV, V37, P711, DOI 10.1111/j.1365-2214.2010.01152.x; Rice JP, 2012, ALCOHOL, V46, P577, DOI 10.1016/j.alcohol.2011.11.008; SANDERS SK, 1995, BRAIN RES, V699, P250, DOI 10.1016/0006-8993(95)00915-D; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840; Sayal K, 2009, PEDIATRICS, V123, pE289, DOI 10.1542/peds.2008-1861; Schneider ML, 2001, ALCOHOL CLIN EXP RES, V25, P1383; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Streissguth A P, 2000, Semin Clin Neuropsychiatry, V5, P177, DOI 10.1053/scnp.2000.6729; STREISSGUTH AP, 1989, NEUROTOXICOL TERATOL, V11, P493, DOI 10.1016/0892-0362(89)90026-3; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; WEST JR, 1990, ANN MED, V22, P319, DOI 10.3109/07853899009147914; WEST JR, 1994, METAB BRAIN DIS, V9, P291, DOI 10.1007/BF02098878; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Westergren S, 1996, PHARMACOL BIOCHEM BE, V55, P515, DOI 10.1016/S0091-3057(96)00277-8; Willford JA, 2004, ALCOHOL CLIN EXP RES, V28, P497, DOI 10.1097/01.ALC.0000117868.97486.2D; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhou R, 2010, NEUROSCIENCE, V170, P749, DOI 10.1016/j.neuroscience.2010.07.055; ZIMMERBERG B, 1991, BEHAV BRAIN RES, V42, P49, DOI 10.1016/S0166-4328(05)80039-7	76	71	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54924	10.1371/journal.pone.0054924	http://dx.doi.org/10.1371/journal.pone.0054924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383000	Green Published, gold			2022-12-27	WOS:000315563800088
J	Guttman, C; Davidov, G; Shaked, H; Kolusheva, S; Bitton, R; Ganguly, A; Miller, JF; Chill, JH; Zarivach, R				Guttman, Chen; Davidov, Geula; Shaked, Hadassa; Kolusheva, Sofiya; Bitton, Ronit; Ganguly, Atish; Miller, Jeff F.; Chill, Jordan H.; Zarivach, Raz			Characterization of the N-Terminal Domain of BteA: A Bordetella Type III Secreted Cytotoxic Effector	PLOS ONE			English	Article							DIFFUSION MEASUREMENTS; FIELD GRADIENT; PSEUDOMONAS-SYRINGAE; VIRULENCE FACTORS; SYSTEM; ASSOCIATION; CHAPERONES; PREDICTION; SCREEN; MOTIF	BteA, a 69-kDa cytotoxic protein, is a type III secretion system (T3SS) effector in the classical Bordetella, the etiological agents of pertussis and related mammalian respiratory diseases. Currently there is limited information regarding the structure of BteA or its subdomains, and no insight as to the identity of its eukaryotic partners(s) and their modes of interaction with BteA. The mechanisms that lead to BteA dependent cell death also remain elusive. The N-terminal domain of BteA is multifunctional, acting as a docking platform for its cognate chaperone (BtcA) in the bacterium, and targeting the protein to lipid raft microdomains within the eukaryotic host cell. In this study we describe the biochemical and biophysical characteristics of this domain (BteA287) and determine its architecture. We characterize BteA287 as being a soluble and highly stable domain which is rich in alpha helical content. Nuclear magnetic resonance (NMR) experiments combined with size exclusion and analytical ultracentrifugation measurements confirm these observations and reveal BteA287 to be monomeric in nature with a tendency to oligomerize at concentrations above 200 mu M. Furthermore, diffusion-NMR demonstrated that the first 31 residues of BteA287 are responsible for the apparent aggregation behavior of BteA287. Light scattering analyses and small angle X-ray scattering experiments reveal a prolate ellipsoidal bi-pyramidal dumb-bell shape. Thus, our biophysical characterization is a first step towards structure determination of the BteA N-terminal domain.	[Guttman, Chen; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Guttman, Chen; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, NIBN, IL-84105 Beer Sheva, Israel; [Kolusheva, Sofiya; Bitton, Ronit] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Bitton, Ronit] Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel; [Shaked, Hadassa; Chill, Jordan H.] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [Ganguly, Atish; Miller, Jeff F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Bar Ilan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chill, JH (corresponding author), Bar Ilan Univ, Dept Chem, Ramat Gan, Israel.	Jordan.Chill@biu.ac.il; zarivach@bgu.ac.il	Chill, Jordan/W-5048-2018; ZARIVACH, RAZ/F-1671-2012	Chill, Jordan/0000-0002-9518-824X; ZARIVACH, RAZ/0000-0001-6543-0296; Bitton, Ronit/0000-0001-9601-9926; Davidov, Geula/0000-0001-5153-4940; Kolusheva, Sofiya/0000-0002-4406-2241	EU [239182, 227764]	EU(European Commission)	The research leading to these results has received funding from the EU Seventh Framework Programme (FP7/2007-2013 under grant agreement no 239182 and no 227764 (P-CUBE)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja U, BMC MICROBIOL, V12, P167; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Ambrus A, 2007, ANAL BIOCHEM, V367, P56, DOI 10.1016/j.ab.2007.04.025; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; Guinier A., 1955, SMALL ANGLE SCATTERI; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; Ilyina E, 1997, BIOCHEMISTRY-US, V36, P3383, DOI 10.1021/bi9622229; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; McDermott JE, 2011, INFECT IMMUN, V79, P23, DOI 10.1128/IAI.00537-10; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Price WS, 1999, J AM CHEM SOC, V121, P11503, DOI 10.1021/ja992265n; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; WHO, 2005, PERT VACC WHO POS PA, V44; William SP, 2006, CURRENT OPINION COLL, V11, P19; Winn MD, ACTA CRYSTALLOGR D, V67, P235; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x	39	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55650	10.1371/journal.pone.0055650	http://dx.doi.org/10.1371/journal.pone.0055650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383256	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800181
J	Haefliger, JA; Martin, D; Favre, D; Petremand, Y; Mazzolai, L; Abderrahmani, A; Meda, P; Waeber, G; Allagnat, F				Haefliger, Jacques-Antoine; Martin, David; Favre, Dimitri; Petremand, Yannick; Mazzolai, Lucia; Abderrahmani, Amar; Meda, Paolo; Waeber, Gerard; Allagnat, Florent			Reduction of Connexin36 Content by ICER-1 Contributes to Insulin- Secreting Cells Apoptosis Induced by Oxidized LDL Particles	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MOUSE; APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; DOWN-REGULATION; FATTY-ACIDS; ATHEROSCLEROSIS; MICE; EXPRESSION	Connexin36 (Cx36), a trans-membrane protein that forms gap junctions between insulin-secreting beta-cells in the Langerhans islets, contributes to the proper control of insulin secretion and beta-cell survival. Hypercholesterolemia and pro-atherogenic low density lipoproteins (LDL) contribute to beta-cell dysfunction and apoptosis in the context of Type 2 diabetes. We investigated the impact of LDL-cholesterol on Cx36 levels in beta-cells. As compared to WT mice, the Cx36 content was reduced in islets from hypercholesterolemic ApoE-/- mice. Prolonged exposure to human native (nLDL) or oxidized LDL (oxLDL) particles decreased the expression of Cx36 in insulin secreting cell-lines and isolated rodent islets. Cx36 down-regulation was associated with overexpression of the inducible cAMP early repressor (ICER-1) and the selective disruption of ICER-1 prevented the effects of oxLDL on Cx36 expression. Oil red O staining and Plin1 expression levels suggested that oxLDL were less stored as neutral lipid droplets than nLDL in INS-1E cells. The lipid beta-oxidation inhibitor etomoxir enhanced oxLDL-induced apoptosis whereas the ceramide synthesis inhibitor myriocin partially protected INS-1E cells, suggesting that oxLDL toxicity was due to impaired metabolism of the lipids. ICER-1 and Cx36 expressions were closely correlated with oxLDL toxicity. Cx36 knock-down in INS-1E cells or knock-out in primary islets sensitized beta-cells to oxLDL-induced apoptosis. In contrast, overexpression of Cx36 partially protected INS-1E cells against apoptosis. These data demonstrate that the reduction of Cx36 content in beta-cells by oxLDL particles is mediated by ICER-1 and contributes to oxLDL-induced beta-cell apoptosis.	[Haefliger, Jacques-Antoine; Martin, David; Waeber, Gerard; Allagnat, Florent] CHU Vaudois, Serv Internal Med, CH-1011 Lausanne, Switzerland; [Favre, Dimitri] Univ Lausanne, Dept Cellular Biol & Morphol, Lausanne, Switzerland; [Petremand, Yannick] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Mazzolai, Lucia] CHU Vaudois, Serv Vasc Med, CH-1011 Lausanne, Switzerland; [Abderrahmani, Amar] Univ Lille Nord France, European Genom Inst Diabet, UMR 8199, Lille, France; [Meda, Paolo] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Geneva	Allagnat, F (corresponding author), CHU Vaudois, Serv Internal Med, CH-1011 Lausanne, Switzerland.	Florent.Allagnat@chuv.ch	Allagnat, Florent/X-3772-2019; Allagnat, Florent/A-4471-2017; Abderrahmani, Amar/O-3124-2017; Allagnat, Florent/AAY-7188-2021	Allagnat, Florent/0000-0001-6528-679X; Abderrahmani, Amar/0000-0003-0752-0343; Allagnat, Florent/0000-0001-6528-679X; Waeber, Gerard/0000-0003-4193-788X; Haefliger, Jacques-Antoine/0000-0003-2732-1667	The Swiss National Science Foundation [31003A_138528/1]; Novartis Foundation; Octav and Marcella Botnar Foundation; Chair of Excellence from the French National Agency for Research [ANR-10-CEXC-005-01]; Regional Council Nord Pas de Calais; European Regional Development Fund	The Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); Octav and Marcella Botnar Foundation; Chair of Excellence from the French National Agency for Research; Regional Council Nord Pas de Calais(Region Hauts-de-France); European Regional Development Fund(European Commission)	Supported by grants from The Swiss National Science Foundation [31003A_138528/1], the Novartis Foundation; the Octav and Marcella Botnar Foundation. AA was supported by the Chair of Excellence from the French National Agency for Research NoANR-10-CEXC-005-01, the Regional Council Nord Pas de Calais and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2007, DIABETOLOGIA, V50, P1304, DOI 10.1007/s00125-007-0642-z; Abderrahmani A, 2006, EMBO J, V25, P977, DOI 10.1038/sj.emboj.7601008; Allagnat F, 2005, J CELL SCI, V118, P5335, DOI 10.1242/jcs.02600; Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; ALLAGNAT F, 2012, CELL DEATH DIFFER; Allagnat F, 2008, J BIOL CHEM, V283, P5226, DOI 10.1074/jbc.M708181200; Berneis K, 2005, METABOLISM, V54, P227, DOI 10.1016/j.metabol.2004.08.017; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cnop M, 2002, ENDOCRINOLOGY, V143, P3449, DOI 10.1210/en.2002-220273; de Souza JA, 2010, J CELL MOL MED, V14, P608, DOI 10.1111/j.1582-4934.2009.00713.x; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Favre D, 2011, DIABETOLOGIA, V54, P2337, DOI 10.1007/s00125-011-2165-x; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Hamelin R, 2009, CURR PROTEIN PEPT SC, V10, P18, DOI 10.2174/138920309787315167; Heinecke JW, 2006, J EXP MED, V203, P813, DOI 10.1084/jem.20060218; Hofker MH, 1998, ATHEROSCLEROSIS, V137, P1, DOI 10.1016/S0021-9150(97)00266-9; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; KASHYAP VS, 1995, J CLIN INVEST, V96, P1612, DOI 10.1172/JCI118200; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Le Gurun S, 2003, J BIOL CHEM, V278, P37690, DOI 10.1074/jbc.M212382200; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Lopez S, 2010, CURR OPIN LIPIDOL, V21, P15, DOI 10.1097/MOL.0b013e3283346d39; Martin Daniel, 2008, P51; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nakhjavani M, 2010, INT UROL NEPHROL, V42, P487, DOI 10.1007/s11255-009-9643-9; Nakhjavani M, 2010, LIPIDS, V45, P321, DOI 10.1007/s11745-010-3401-8; Nguidjoe E, 2011, DIABETES, V60, P2076, DOI 10.2337/db10-0924; Pellegrin M, 2007, ATHEROSCLEROSIS, V190, P35, DOI 10.1016/j.atherosclerosis.2006.02.001; Pellegrin M, 2009, HYPERTENSION, V53, P782, DOI 10.1161/HYPERTENSIONAHA.108.128165; Petremand J, 2008, CURR OPIN LIPIDOL, V19, P95, DOI 10.1097/MOL.0b013e3282f41982; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Robbesyn F, 2003, FASEB J, V17, P743, DOI 10.1096/fj.02-0240fje; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Rohrer L, 2004, CURR OPIN LIPIDOL, V15, P269, DOI 10.1097/00041433-200406000-00006; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Taskinen MR, 2003, DIABETES RES CLIN PR, V61, pS19, DOI 10.1016/S0168-8227(03)00126-8; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Veniant MM, 2008, CURR DRUG TARGETS, V9, P174; von Eckardstein A, 2011, CURR OPIN LIPIDOL, V22, P26, DOI 10.1097/MOL.0b013e3283412279; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Williams KJ, 2005, CURR OPIN CLIN NUTR, V8, P139, DOI 10.1097/00075197-200503000-00006; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	51	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55198	10.1371/journal.pone.0055198	http://dx.doi.org/10.1371/journal.pone.0055198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383107	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800128
J	Hure, AJ; Powers, JR; Chojenta, CL; Byles, JE; Loxton, D				Hure, Alexis J.; Powers, Jennifer R.; Chojenta, Catherine L.; Byles, Julie E.; Loxton, Deborah			Poor Adherence to National and International Breastfeeding Duration Targets in an Australian Longitudinal Cohort	PLOS ONE			English	Article							MATERNAL RECALL	Objectives: To report on the proportion and characteristics of Australian infants who are fed, and mothers who feed, in accordance with the national and international breastfeeding duration targets of six, 12 and 24 months. Furthermore, to examine the longitudinal breastfeeding duration patterns for women with more than one child. Methods: Breastfeeding duration data for 9773 children have been self-reported by a national sample of 5091 mothers aged 30-36 years in 2009, participating in the Australian Longitudinal Study on Women's Health. Results: Only 60% of infants received the minimum recommended 6 months of breast milk, irrespective of breastfeeding exclusivity. Less than 30% of infants received any breast milk at 12 months, and less than 3% were breastfed to the international target of 24 months. Young, less educated, unmarried or low-income women were at an increased risk of premature breastfeeding cessation. For women with three or more children, nearly 75% of women who breastfed their first child for at least six months reached this breastfeeding duration target for their next two children. Conclusion: While national breastfeeding rates are typically evaluated in relation to the infant, a novel component of our study is that we have assessed maternal adherence to breastfeeding duration targets and the longitudinal feeding practices of women with more than one child. Separate evaluations of maternal and infant breastfeeding rates are important as they differ in their implications for public health policy and practice.	[Hure, Alexis J.; Powers, Jennifer R.; Chojenta, Catherine L.; Byles, Julie E.; Loxton, Deborah] Univ Newcastle, Sch Med & Publ Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia	University of Newcastle	Hure, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia.	alexis.hure@newcastle.edu.au	Byles, Julie E/C-5062-2008; Chojenta, Catherine L/B-2521-2008; Powers, Jennifer R/A-8108-2011	Byles, Julie E/0000-0002-3984-6877; Chojenta, Catherine L/0000-0002-2541-4491; Hure, Alexis/0000-0003-2225-0986	Department of Health and Ageing; National Health and Medical Research Council	Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Australian Longitudinal Study on Women's Health is funded by the Department of Health and Ageing. AJH is a Postdoctoral Research Fellow with the Centre for Research Excellence in Women's Health in the 21st Century, funded by the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2010, 4102 0 AUSTR SOC TRE; Australian Government Department of Health and Ageing, 2009, AUSTR HLTH MIN C 200; Australian Institute of Health and Welfare, 2009, PICT AUSTR CHILDR 20; Australian Institute of Health and Welfare, 2005, PICT AUSTR CHILDR 20; Australian Institute of Health and Welfare, 2011, 2010 AUSTR NAT INF F; Blyth R, 2002, BIRTH-ISS PERINAT C, V29, P278, DOI 10.1046/j.1523-536X.2002.00202.x; Bolling K, 2007, INFANT FEEDING SURVE; Bonet M, 2012, MATERN CHILD HLTH J; Brown WJ, 1999, J WOMEN HEALTH GEN-B, V8, P681, DOI 10.1089/jwh.1.1999.8.681; Centers for Disease Control and Prevention, 2012, BREASTF US CHILDR BO; Chinese Nutrition Society, 2022, DIET GUID SCH AG CHI; Hure AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037109; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Meedya Shahla, 2010, Women Birth, V23, P135, DOI 10.1016/j.wombi.2010.02.002; Powers J, 2010, ANN EPIDEMIOL, V20, P318, DOI 10.1016/j.annepidem.2010.01.002; Promislow JHE, 2005, AM J EPIDEMIOL, V161, P289, DOI 10.1093/aje/kwi044; UNICEF, 2012, BREASTF; Webb K, 2001, NATL SYSTEM MONITORI; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED	20	11	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54409	10.1371/journal.pone.0054409	http://dx.doi.org/10.1371/journal.pone.0054409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382897	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800048
J	Monty, A; Bizoux, JP; Escarre, J; Mahy, G				Monty, Arnaud; Bizoux, Jean-Philippe; Escarre, Jose; Mahy, Gregory			Rapid Plant Invasion in Distinct Climates Involves Different Sources of Phenotypic Variation	PLOS ONE			English	Article							SENECIO-INAEQUIDENS; LOCAL ADAPTATION; GENETIC DIVERSITY; INVADED RANGE; ALPINE PLANT; PLASTICITY; WEED; DISPERSAL; EVOLUTION; TRAITS	When exotic species spread over novel environments, their phenotype will depend on a combination of different processes, including phenotypic plasticity (PP), local adaptation (LA), environmental maternal effects (EME) and genetic drift (GD). Few attempts have been made to simultaneously address the importance of those processes in plant invasion. The present study uses the well-documented invasion history of Senecio inaequidens (Asteraceae) in southern France, where it was introduced at a single wool-processing site. It gradually invaded the Mediterranean coast and the Pyrenean Mountains, which have noticeably different climates. We used seeds from Pyrenean and Mediterranean populations, as well as populations from the first introduction area, to explore the phenotypic variation related to climatic variation. A reciprocal sowing experiment was performed with gardens under Mediterranean and Pyrenean climates. We analyzed climatic phenotypic variation in germination, growth, reproduction, leaf physiology and survival. Genetic structure in the studied invasion area was characterized using AFLP. We found consistent genetic differentiation in growth traits but no home-site advantage, so weak support for LA to climate. In contrast, genetic differentiation showed a relationship with colonization history. PP in response to climate was observed for most traits, and it played an important role in leaf trait variation. EME mediated by seed mass influenced all but leaf traits in a Pyrenean climate. Heavier, earlier-germinating seeds produced larger individuals that produced more flower heads throughout the growing season. However, in the Mediterranean garden, seed mass only influenced the germination rate. The results show that phenotypic variation in response to climate depends on various ecological and evolutionary processes associated with geographical zone and life history traits. Seeing the relative importance of EME and GD, we argue that a "local adaptation vs. phenotypic plasticity" approach is therefore not sufficient to fully understand what shapes phenotypic variation and genetic architecture of invasive populations.	[Monty, Arnaud; Bizoux, Jean-Philippe; Mahy, Gregory] Univ Liege, Gembloux Agrobio Tech, Biodivers & Landscape Unit, B-5030 Gembloux, Belgium; [Escarre, Jose] Ctr Ecol Fonct & Evolut, UMR 5175, F-5000 Montpellier, France	University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Monty, A (corresponding author), Univ Liege, Gembloux Agrobio Tech, Biodivers & Landscape Unit, Passage Deportes 2, B-5030 Gembloux, Belgium.	arnaud.monty@ulg.ac.be		mahy, gregory/0000-0003-3094-8620; Monty, Arnaud/0000-0003-1910-6748	Belgian Fonds National de la Recherche Scientifique [FRFC 2.4605.06]; Belgian FONDS NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FNRS) [FRFC 2.4556.05]	Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian FONDS NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the project FRFC 2.4605.06 from the Belgian Fonds National de la Recherche Scientifique (www1.frs-fnrs.be). J-P.B. has a postdoctoral position at the Fonds National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Guy Buchet, Christian Collin and Gerard Malot's team (Office National des Forets, ONF) who provided technical assistance during the research project. Bernard Kazandjian and Jean-Luc Martin helped us find a suitable experimental site in the Pyrenean region. This research was supported by the project FRFC 2.4556.05 from the Belgian FONDS NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FNRS).	[Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Austerlitz F, 2000, GENETICS, V154, P1309; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Bossdorf O, 2008, DIVERS DISTRIB, V14, P676, DOI 10.1111/j.1472-4642.2008.00471.x; Cano L, 2008, J ECOL, V96, P468, DOI 10.1111/j.1365-2745.2008.01363.x; COTTREL V, 1998, P 6 MED S E W R S EN, P41; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dijkstra P., 1989, CAUSES CONSEQUENCES, P125; Donohue K., 1998, MATERNAL EFFECTS ADA; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Ebeling SK, 2011, J PLANT ECOL-UK, V4, P209, DOI 10.1093/jpe/rtr007; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Ernst WHO, 1998, ACTA BOT NEERL, V47, P131; Excoffier L, 2006, ARLEQUIN VER 3 01 IN; Faraway J.J., 2005, LINEAR MODELS R; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 1995, EVOLUTION, V49, P1095, DOI 10.1111/j.1558-5646.1995.tb04436.x; Garcia-Serrano H, 2004, CAN J BOT, V82, P1346, DOI [10.1139/B04-097, 10.1139/b04-097]; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Gaudeul M, 2000, MOL ECOL, V9, P1625, DOI 10.1046/j.1365-294x.2000.01063.x; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Godoy O, 2011, BIOL INVASIONS, V13, P1615, DOI 10.1007/s10530-010-9919-0; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Guillerm J. L., 1990, Biological invasions in Europe and the Mediterranean Basin., P61; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kollmann J, 2004, DIVERS DISTRIB, V10, P377, DOI 10.1111/j.1366-9516.2004.00126.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; LACEY EP, 1988, ECOLOGY, V69, P220, DOI 10.2307/1943178; Lachmuth S, 2011, NEW PHYTOL, V192, P529, DOI 10.1111/j.1469-8137.2011.03808.x; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lafuma L, 2003, PLANT SYST EVOL, V243, P59, DOI 10.1007/s00606-003-0075-0; Lafuma L, 2007, OIKOS, V116, P201, DOI 10.1111/j.0030-1299.2007.15220.x; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Lopez-Garcia MC, 2005, BIOL INVASIONS, V7, P181, DOI 10.1007/s10530-004-8978-5; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Monty A, 2009, J EVOLUTION BIOL, V22, P917, DOI 10.1111/j.1420-9101.2009.01728.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Monty A, 2008, BELG J BOT, V141, P51; Monty A, 2010, BIOTECHNOL AGRON SOC, V14, P627; Monty A, 2010, OIKOS, V119, P1563, DOI 10.1111/j.1600-0706.2010.17769.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palacio-Lopez K, 2011, OIKOS, V120, P1393, DOI 10.1111/j.1600-0706.2010.19114.x; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Paz H, 2003, ECOLOGY, V84, P439, DOI 10.1890/0012-9658(2003)084[0439:SMASPW]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; RICE KJ, 1991, OECOLOGIA, V88, P91, DOI 10.1007/BF00328408; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Ross CA, 2009, BIOL INVASIONS, V11, P441, DOI 10.1007/s10530-008-9261-y; SCHMITT J, 1992, AM NAT, V139, P451, DOI 10.1086/285338; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Senay P, 1944, B SOC BOT FRANCE, V91, P111; STRATTON DA, 1989, AM J BOT, V76, P1646, DOI 10.2307/2444402; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344	62	33	33	2	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55627	10.1371/journal.pone.0055627	http://dx.doi.org/10.1371/journal.pone.0055627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383251	Green Published, gold			2022-12-27	WOS:000315563800177
J	Rakosy, Z; Ecsedi, S; Toth, R; Vizkeleti, L; Herandez-Vargas, H; Lazar, V; Emri, G; Szatmari, I; Herceg, Z; Adany, R; Balazs, M				Rakosy, Zsuzsa; Ecsedi, Szilvia; Toth, Reka; Vizkeleti, Laura; Herandez-Vargas, Hector; Lazar, Viktoria; Emri, Gabriella; Szatmari, Istvan; Herceg, Zdenko; Adany, Roza; Balazs, Margit			Integrative Genomics Identifies Gene Signature Associated with Melanoma Ulceration	PLOS ONE			English	Article							COPY NUMBER ALTERATIONS; MALIGNANT-MELANOMA; DNA-METHYLATION; IN-SITU; MOLECULAR CLASSIFICATION; EXPRESSION SIGNATURES; SOMATIC ALTERATIONS; CUTANEOUS MELANOMA; TUMOR PROGRESSION; TRANSITION	Background: Despite the extensive research approaches applied to characterise malignant melanoma, no specific molecular markers are available that are clearly related to the progression of this disease. In this study, our aims were to define a gene expression signature associated with the clinical outcome of melanoma patients and to provide an integrative interpretation of the gene expression -, copy number alterations -, and promoter methylation patterns that contribute to clinically relevant molecular functional alterations. Methods: Gene expression profiles were determined using the Affymetrix U133 Plus2.0 array. The NimbleGen Human CGH Whole-Genome Tiling array was used to define CNAs, and the Illumina GoldenGate Methylation platform was applied to characterise the methylation patterns of overlapping genes. Results: We identified two subclasses of primary melanoma: one representing patients with better prognoses and the other being characteristic of patients with unfavourable outcomes. We assigned 1,080 genes as being significantly correlated with ulceration, 987 genes were downregulated and significantly enriched in the p53, Nf-kappaB, and WNT/beta-catenin pathways. Through integrated genome analysis, we defined 150 downregulated genes whose expression correlated with copy number losses in ulcerated samples. These genes were significantly enriched on chromosome 6q and 10q, which contained a total of 36 genes. Ten of these genes were downregulated and involved in cell-cell and cell-matrix adhesion or apoptosis. The expression and methylation patterns of additional genes exhibited an inverse correlation, suggesting that transcriptional silencing of these genes is driven by epigenetic events. Conclusion: Using an integrative genomic approach, we were able to identify functionally relevant molecular hotspots characterised by copy number losses and promoter hypermethylation in distinct molecular subtypes of melanoma that contribute to specific transcriptomic silencing and might indicate a poor clinical outcome of melanoma.	[Rakosy, Zsuzsa; Ecsedi, Szilvia; Toth, Reka; Vizkeleti, Laura; Lazar, Viktoria; Adany, Roza; Balazs, Margit] Univ Debrecen, Med & Hlth Sci Ctr, Fac Publ Hlth, Dept Prevent Med, H-4012 Debrecen, Hungary; [Rakosy, Zsuzsa; Ecsedi, Szilvia; Vizkeleti, Laura; Adany, Roza; Balazs, Margit] Univ Debrecen, Hungarian Acad Sci, Publ Hlth Res Grp, H-4012 Debrecen, Hungary; [Emri, Gabriella] Univ Debrecen, Med & Hlth Sci Ctr, Fac Med, Dept Dermatol, H-4012 Debrecen, Hungary; [Szatmari, Istvan] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Herandez-Vargas, Hector; Herceg, Zdenko] WHO, Int Agcy Res Canc, Epigenet Grp, Lyon, France	University of Debrecen; Hungarian Academy of Sciences; University of Debrecen; University of Debrecen; University of Debrecen; World Health Organization; International Agency for Research on Cancer (IARC)	Balazs, M (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Fac Publ Hlth, Dept Prevent Med, H-4012 Debrecen, Hungary.	balazs.margit@sph.unideb.hu	Toth, Reka/AAB-1695-2020; Szatmari, Istvan/B-3152-2010; Lazar, Vladimir/AAQ-2086-2020; Vizkeleti, Laura/T-4416-2017	Toth, Reka/0000-0002-6096-1052; Szatmari, Istvan/0000-0001-5260-1498; Vizkeleti, Laura/0000-0001-6870-3499; Hernandez-Vargas, Hector/0000-0001-6045-2103; Lazar, Viktoria/0000-0002-9778-941X; Zsuzsa, Rakosy/0000-0002-9852-1159	Hungarian National Research Fund [OTKA K75191]; National Research and Development Program of Hungary [NKFP1-00003/2005]; Hungarian Medical Research Council [193/09-ETT]; Hungarian Academy of Sciences [2011 TKI 473]; European Union; European Social Fund;  [TAMOP 4.2.1/B-09/1/KONV-2010-0007];  [TAMOP-4.2.2.A-11/1/KONV-2012-0031]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research and Development Program of Hungary; Hungarian Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); European Social Fund(European Social Fund (ESF)); ; 	This work was supported by the Hungarian National Research Fund (OTKA K75191), the National Research and Development Program of Hungary (NKFP1-00003/2005), the Hungarian Medical Research Council (193/09-ETT), the Hungarian Academy of Sciences (grant number 2011 TKI 473), by the TAMOP 4.2.1/B-09/1/KONV-2010-0007 and TAMOP-4.2.2.A-11/1/KONV-2012-0031 projects; the TAMOP projects are co-financed by the European Union and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Berger MF, 2009, HEMATOL ONCOL CLIN N, V23, P397, DOI 10.1016/j.hoc.2009.03.005; Berthier-Vergnes O, 2011, BRIT J CANCER, V104, P155, DOI 10.1038/sj.bjc.6605994; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blokx WAM, 2010, HISTOPATHOLOGY, V56, P121, DOI 10.1111/j.1365-2559.2009.03452.x; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Broekaert SMC, 2010, PIGM CELL MELANOMA R, V23, P763, DOI 10.1111/j.1755-148X.2010.00778.x; Buback F, 2009, EXP DERMATOL, V18, P750, DOI 10.1111/j.1600-0625.2009.00926.x; Christensen BC, 2010, CANCER RES, V70, P5686, DOI 10.1158/0008-5472.CAN-10-0190; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Conway C, 2010, GENE CHROMOSOME CANC, V49, P425, DOI 10.1002/gcc.20753; Conway C, 2009, CLIN CANCER RES, V15, P6939, DOI 10.1158/1078-0432.CCR-09-1631; Conway K, 2011, PIGM CELL MELANOMA R, V24, P352, DOI 10.1111/j.1755-148X.2011.00828.x; Daryanani D, 2006, EJSO-EUR J SURG ONC, V32, P218, DOI 10.1016/j.ejso.2005.11.011; Dietel Manfred, 2007, V176, P25; Eggermont AMM, 2012, CURR OPIN ONCOL, V24, P137, DOI 10.1097/CCO.0b013e32834fcb0d; Forschner A, 2010, CLIN DERMATOL, V28, P275, DOI 10.1016/j.clindermatol.2009.06.012; Freedman JA, 2011, AM J PATHOL, V178, P2513, DOI 10.1016/j.ajpath.2011.02.037; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Gao K, 2008, INT J ONCOL, V32, P1343; Gast A, 2010, GENE CHROMOSOME CANC, V49, P733, DOI 10.1002/gcc.20785; Gaudi Sudeep, 2011, Patholog Res Int, V2011, P159421, DOI 10.4061/2011/159421; Gerami P, 2011, J CUTAN PATHOL, V38, P329, DOI 10.1111/j.1600-0560.2010.01666.x; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Goppner D, 2011, J SKIN CANC, V2011, DOI DOI 10.1155/2011/521947; Ha LN, 2008, CELL CYCLE, V7, P1944, DOI 10.4161/cc.7.13.6230; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Howell PM, 2009, CANCER CONTROL, V16, P200, DOI 10.1177/107327480901600302; Ilmonen S, 2005, MODERN PATHOL, V18, P503, DOI 10.1038/modpathol.3800300; in't Hout FEM, 2012, ANN SURG, V255, P1165, DOI 10.1097/SLA.0b013e31824c4b0b; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; Jensen EH, 2007, ANN SURG ONCOL, V14, P1416, DOI 10.1245/s10434-006-9226-2; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Koh SS, 2009, MODERN PATHOL, V22, P538, DOI 10.1038/modpathol.2009.8; Kunz M, 2008, Curr Drug Discov Technol, V5, P9, DOI 10.2174/157016308783769423; Macdonald JB, 2011, J CANCER, V2, P538, DOI 10.7150/jca.2.538; Mandruzzato S, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-50; Martins WK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-76; Mitra A, 2010, BRIT J CANCER, V103, P1229, DOI 10.1038/sj.bjc.6605849; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Poage GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009651; Rakosy Z, 2008, CANCER GENET CYTOGEN, V182, P116, DOI 10.1016/j.cancergencyto.2008.01.008; Rakosy Z, 2007, INT J CANCER, V121, P1729, DOI 10.1002/ijc.22928; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rose AE, 2011, CANCER RES, V71, P2561, DOI 10.1158/0008-5472.CAN-10-2958; Schinke C, 2010, MELANOMA RES, V20, P253, DOI 10.1097/CMR.0b013e328338a35a; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Soong SJ, 2010, ANN SURG ONCOL, V17, P2006, DOI 10.1245/s10434-010-1050-z; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; Valsesia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018369; van de Wiel MA, 2007, CANCER INFORM, V3, P55; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yeang CH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-495; Yuan YY, 2012, IEEE ACM T COMPUT BI, V9, P947, DOI 10.1109/TCBB.2011.105	63	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54958	10.1371/journal.pone.0054958	http://dx.doi.org/10.1371/journal.pone.0054958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383013	Green Published, gold			2022-12-27	WOS:000315563800090
J	Martinez-Beamonte, R; Navarro, MA; Acin, S; Guillen, N; Barranquero, C; Arnal, C; Surra, J; Osada, J				Martinez-Beamonte, Roberto; Navarro, Maria A.; Acin, Sergio; Guillen, Natalia; Barranquero, Cristina; Arnal, Carmen; Surra, Joaquin; Osada, Jesus			Postprandial Changes in High Density Lipoproteins in Rats Subjected to Gavage Administration of Virgin Olive Oil	PLOS ONE			English	Article							APOLIPOPROTEIN-A-IV; CHOLESTERYL ESTER TRANSFER; KNOCKOUT MICE; SPHINGOMYELIN METABOLISM; PLASMA-LIPOPROTEINS; SERUM-LIPOPROTEINS; TRANSFER PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; INHIBITION	Background and Aims: The present study was designed to verify the influence of acute fat loading on high density lipoprotein (HDL) composition, and the involvement of liver and different segments of small intestine in the changes observed. Methods and Results: To address these issues, rats were administered a bolus of 5-ml of extra-virgin olive oil and sacrificed 4 and 8 hours after feeding. In these animals, lipoproteins were analyzed and gene expressions of apolipoprotein and HDL enzymes were assessed in duodenum, jejunum, ileum and liver. Using this experimental design, total plasma and HDL phospholipids increased at the 8-hour-time-point due to increased sphingomyelin content. An increase in apolipoprotein A4 was also observed mainly in lipid-poor HDL. Increased expression of intestinal Apoa1, Apoa4 and Sgms1 mRNA was accompanied by hepatic decreases in the first two genes in liver. Hepatic expression of Abcg1, Apoa1bp, Apoa2, Apoe, Ptlp, Pon1 and Scarb1 decreased significantly following fat gavage, while no changes were observed for Abca1, Lcat or Pla2g7. Significant associations were also noted for hepatic expression of apolipoproteins and Pon1. Manipulation of postprandial triglycerides using an inhibitor of microsomal transfer protein -CP-346086- or of lipoprotein lipase -tyloxapol- did not influence hepatic expression of Apoa1 or Apoa4 mRNA. Conclusion: All these data indicate that dietary fat modifies the phospholipid composition of rat HDL, suggesting a mechanism of down-regulation of hepatic HDL when intestine is the main source of those particles and a coordinated regulation of hepatic components of these lipoproteins at the mRNA level, independently of plasma postprandial triglycerides.	[Martinez-Beamonte, Roberto; Navarro, Maria A.; Acin, Sergio; Guillen, Natalia; Barranquero, Cristina; Osada, Jesus] Univ Zaragoza, Fac Vet, Dept Bioquim & Biol Mol & Celular, Inst Invest Sanitaria Aragon, Zaragoza, Spain; [Arnal, Carmen] Univ Zaragoza, Fac Vet, Dept Patol Anim, Zaragoza, Spain; [Surra, Joaquin] Escuela Politecn Super Huesca, Dept Anim Prod, Huesca, Spain; [Martinez-Beamonte, Roberto; Navarro, Maria A.; Acin, Sergio; Guillen, Natalia; Barranquero, Cristina; Arnal, Carmen; Surra, Joaquin; Osada, Jesus] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Osada, J (corresponding author), Univ Zaragoza, Fac Vet, Dept Bioquim & Biol Mol & Celular, Inst Invest Sanitaria Aragon, Zaragoza, Spain.	Josada@unizar.es	Surra, Joaquín Carlos/G-1128-2014; Acin, Sergio/S-5185-2017; Martinez Beamonte, Roberto/E-4981-2016	Surra, Joaquín Carlos/0000-0002-5841-0462; Acin, Sergio/0000-0001-7335-2865; Guillen Monzon, Natalia/0000-0001-6627-298X; Martinez Beamonte, Roberto/0000-0002-8100-5596	Ministerio de Ciencia e Inovacion-Fondo Europeo de Desarrollo Regional [SAF2010-14958]; CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon [PI025/08]; Gobierno de Aragon-Fondo Social Europeo [B-69]; Fundacion ARAID; Miguel Servet grants	Ministerio de Ciencia e Inovacion-Fondo Europeo de Desarrollo Regional; CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon(Gobierno de Aragon); Gobierno de Aragon-Fondo Social Europeo(Gobierno de Aragon); Fundacion ARAID; Miguel Servet grants	Funding provided by the Ministerio de Ciencia e Inovacion-Fondo Europeo de Desarrollo Regional SAF2010-14958 (www.micinn.es/.../Anexo_ayudas_concedidas_proyectos_2010.xls); CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon (PI025/08); Gobierno de Aragon-Fondo Social Europeo (B-69); and Fundacion ARAID 2010/2012. M.A.N. and S.A. were recipients of Miguel Servet grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APFELBAUM TF, 1987, AM J PHYSIOL, V252, pG662, DOI 10.1152/ajpgi.1987.252.5.G662; Arbones-Mainar JM, 2006, J NUTR, V136, P353, DOI 10.1093/jn/136.2.353; BAGDADE JD, 1990, DIABETES, V39, P426, DOI 10.2337/diabetes.39.4.426; Barter P, 2011, TRENDS PHARMACOL SCI, V32, P694, DOI 10.1016/j.tips.2011.07.004; Bergeron N, 1997, CURR OPIN LIPIDOL, V8, P43, DOI 10.1097/00041433-199702000-00010; Bladergroen BA, 1999, J NUTR, V129, P628, DOI 10.1093/jn/129.3.628; BORENSZTAJN J, 1976, BIOCHEM J, V156, P539, DOI 10.1042/bj1560539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Calleja L, 2000, ATHEROSCLEROSIS, V152, P69, DOI 10.1016/S0021-9150(99)00451-7; Calleja L, 1999, ARTERIOSCL THROM VAS, V19, P2368, DOI 10.1161/01.ATV.19.10.2368; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70; Cianflone K, 2008, ATHEROSCLEROSIS SUPP, V9, P63, DOI 10.1016/j.atherosclerosissup.2008.05.014; Clark RW, 2004, ARTERIOSCL THROM VAS, V24, P490, DOI 10.1161/01.ATV.0000118278.21719.17; Cozzi Jean, 2009, Methods Mol Biol, V561, P73, DOI 10.1007/978-1-60327-019-9_5; DUVERGER N, 1994, BBA-LIPID LIPID MET, V1211, P23, DOI 10.1016/0005-2760(94)90134-1; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P8242, DOI 10.1073/pnas.82.23.8242; Fournier N, 1997, ARTERIOSCL THROM VAS, V17, P2685, DOI 10.1161/01.ATV.17.11.2685; GEELEN MJH, 1995, J NUTR, V125, P2294, DOI 10.1093/jn/125.9.2294; Geelen MJH, 2000, BRIT J NUTR, V83, P541; Geelen MJH, 1999, J NUTR, V129, P2119, DOI 10.1093/jn/129.12.2119; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Glatzle J, 2004, AM J PHYSIOL-REG I, V287, pR354, DOI 10.1152/ajpregu.00705.2003; Guillen N, 2008, ATHEROSCLEROSIS, V196, P558; Guillen N, 2007, GENE, V388, P117, DOI 10.1016/j.gene.2006.10.013; He XX, 2002, ANAL BIOCHEM, V306, P115, DOI 10.1006/abio.2002.5686; Hewing B, 2012, CURR OPIN LIPIDOL; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; Hussain MM, 2001, FRONT BIOSCI, V6, pD320, DOI 10.2741/Hussain; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Kalogeris TJ, 1997, J NUTR, V127, pS537, DOI 10.1093/jn/127.3.537S; Kalogeris TJ, 1996, AM J PHYSIOL-GASTR L, V270, pG277, DOI 10.1152/ajpgi.1996.270.2.G277; KALOGERIS TJ, 1994, J LIPID RES, V35, P1141; Kannel WB, 2009, CURR OPIN CARDIOL, V24, P345, DOI 10.1097/HCO.0b013e32832c1284; KELLEY JL, 1986, METHOD ENZYMOL, V128, P170; Kusunoki J, 2000, ARTERIOSCL THROM VAS, V20, P171, DOI 10.1161/01.ATV.20.1.171; Lairon D, 2008, ATHEROSCLEROSIS SUPP, V9, P45, DOI 10.1016/j.atherosclerosissup.2008.05.006; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Lou-Bonafonte JM, 2012, CURR VASC PHARMACOL, V10, P392; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Mahley RW, 1999, J LIPID RES, V40, P1933; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Martinez-Beamonte Roberto, 2011, Front Biosci (Elite Ed), V3, P11, DOI 10.2741/e215; MERRIL CR, 1984, METHOD ENZYMOL, V104, P441; Navarro MA, 2005, CYTOKINE, V31, P52, DOI 10.1016/j.cyto.2005.03.002; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; Nuno-Ayala M, 2010, ATHEROSCLEROSIS, V212, P268, DOI 10.1016/j.atherosclerosis.2010.04.028; OSADA J, 1994, ATHEROSCLEROSIS, V108, P83, DOI 10.1016/0021-9150(94)90039-6; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; Overturf ML, 1992, CURR OPIN LIPIDOL, V3, P179, DOI DOI 10.1097/00041433-199206000-00004; Perez-Martinez P, 2008, ATHEROSCLEROSIS SUPP, V9, P49, DOI 10.1016/j.atherosclerosissup.2008.05.005; Redgrave TG, 2008, ATHEROSCLEROSIS SUPP, V9, P3, DOI 10.1016/j.atherosclerosissup.2008.05.002; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; Rodriguez MD, 1997, AM J PHYSIOL-REG I, V272, pR1170, DOI 10.1152/ajpregu.1997.272.4.R1170; RUBIN DC, 1992, AM J PHYSIOL, V263, pG853, DOI 10.1152/ajpgi.1992.263.6.G853; Sonoyama K, 2000, J NUTR, V130, P637, DOI 10.1093/jn/130.3.637; Spaulding HL, 2006, AM J PHYSIOL-CELL PH, V290, pC95, DOI 10.1152/ajpcell.00388.2005; SUBBAIAH PV, 1993, J BIOL CHEM, V268, P20156; TALL A, 1986, J CLIN INVEST, V77, P1163, DOI 10.1172/JCI112417; TERPSTRA AHM, 1981, ANAL BIOCHEM, V111, P149, DOI 10.1016/0003-2697(81)90243-8; Tso P, 2001, ANNU REV NUTR, V21, P231, DOI 10.1146/annurev.nutr.21.1.231; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Xu TT, 2009, LIPIDS, V44, P161, DOI 10.1007/s11745-008-3258-2; Young SG, 1995, J CLIN INVEST, V96, P2932, DOI 10.1172/JCI118365	67	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55231	10.1371/journal.pone.0055231	http://dx.doi.org/10.1371/journal.pone.0055231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383120	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200049
J	Pan, YB; Zhou, FL; Zhang, RH; Claret, FX				Pan, Yunbao; Zhou, Fuling; Zhang, Ronghua; Claret, Francois X.			Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							MOLECULAR TARGETS; GROWTH-FACTOR; ACTIVATION; CANCER; EXPRESSION; JAB1/CSN5; PROLIFERATION; INVASIVENESS; RESISTANCE; SURVIVAL	Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-associated malignancy most common in East Asia, Africa and Alaska. Radiotherapy and cisplatin-based chemotherapy are the main treatment options. Unfortunately, disease response to concurrent chemoradiotherapy varies among patients with NPC, and many cases are resistant to cisplatin and radiotherapy. Signal transducer and activator of transcription 3 (Stat3) has been implicated in the development and progression of various solid tumors. In this study, we assessed the activation and expression of Stat3 in NPC cells. We found that Stat3 was activated and could be blocked by the small molecule inhibitor Stattic. The inhibition of Stat3 in NPC cells by Stattic decreased the expression of cyclin D1 in a dose- and time-dependent manner. Thus, Stattic was used to target Stat3 in NPC cell lines. We found that Stattic could inhibit cell viability and proliferation in NPC cells and significantly induced apoptosis. Additionally, Stat3 transfection attenuated, whereas Stat3 knockdown enhanced, the effects of Stattic upon cell viability inhibition and apoptosis induction. Furthermore, Stattic sensitized NPC cells to cisplatin and ionizing radiation (IR) by preventing cell proliferation and inducing apoptosis. Taken together, Stattic inhibit Stat3 and display antitumor effect in NPC, and enhanced chemosensitivity and radiosensitivity in NPC. Therefore, our findings provide the base for more rational approaches to treat NPC in the clinic.	[Pan, Yunbao; Zhou, Fuling; Zhang, Ronghua; Claret, Francois X.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Pan, Yunbao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Fuling] Xi An Jiao Tong Univ, Hosp 2, Dept Clin Hematol, Xian 710049, Shanxi, Peoples R China; [Claret, Francois X.] Univ Texas Grad Sch Biomed Sci Houston, Expt Therapeut Acad Program, Houston, TX USA; [Claret, Francois X.] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; Xi'an Jiaotong University	Claret, FX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	fxclaret@mdanderson.org	Claret, Francois X/R-2104-2016; Pan, Yunbao/J-9016-2013	Claret, Francois X/0000-0003-4629-6495; Pan, Yunbao/0000-0002-6311-2945; Zhou, Fuling/0000-0003-0982-0382	China Scholarship Council [2010638087]; National Cancer Institute [RO1-CA90853]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA090853] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a fellowship from China Scholarship Council (2010638087) (YP) and a grant from National Cancer Institute (RO1-CA90853) (FXC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2012, ORAL ONCOLOGY; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bonner JA, 2009, RADIOTHER ONCOL, V92, P339, DOI 10.1016/j.radonc.2009.06.022; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Hsiao JR, 2003, BRIT J CANCER, V89, P344, DOI 10.1038/sj.bjc.6601003; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Pan Y, 2012, ONCOGENE, DOI [10.1038/onc.2012.1294, DOI 10.1038/ONC.2012.1294]; Pan YB, 2012, CANCER LETT, V326, P155, DOI 10.1016/j.canlet.2012.07.033; Pan YB, 2012, CANCER RES, V72, P1890, DOI 10.1158/0008-5472.CAN-11-3472; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Shanmugam MK, 2012, CANCER LETT, V320, P158, DOI 10.1016/j.canlet.2012.02.037; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; Tu B, 2012, CANC LETT; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; Wang ZL, 2010, EUR J CANCER, V46, P2996, DOI 10.1016/j.ejca.2010.07.008; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yip KW, 2005, CLIN CANCER RES, V11, P8131, DOI 10.1158/1078-0432.CCR-05-1266; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	41	100	103	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54565	10.1371/journal.pone.0054565	http://dx.doi.org/10.1371/journal.pone.0054565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382914	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200057
J	Agliari, E; Asti, L; Barra, A; Scrivo, R; Valesini, G; Wallis, RS				Agliari, Elena; Asti, Lorenzo; Barra, Adriano; Scrivo, Rossana; Valesini, Guido; Wallis, Robert S.			Application of a Stochastic Modeling to Assess the Evolution of Tuberculous and Non-Tuberculous Mycobacterial Infection in Patients Treated with Tumor Necrosis Factor Inhibitors	PLOS ONE			English	Article							ANNUAL RISK; TNF; MECHANISMS; NEUTRALIZATION; REACTIVATION; INFLIXIMAB; THERAPIES; DISEASE	In this manuscript we apply stochastic modeling to investigate the risk of reactivation of latent mycobacterial infections in patients undergoing treatment with tumor necrosis factor inhibitors. First, we review the perspective proposed by one of the authors in a previous work and which consists in predicting the occurrence of reactivation of latent tuberculosis infection or newly acquired tuberculosis during treatment; this is based on variational procedures on a simple set of parameters (e.g. rate of reactivation of a latent infection). Then, we develop a full analytical study of this approach through a Markov chain analysis and we find an exact solution for the temporal evolution of the number of cases of tuberculosis infection (re) activation. The analytical solution is compared with Monte Carlo simulations and with experimental data, showing overall excellent agreement. The generality of this theoretical framework allows to investigate also the case of non-tuberculous mycobacteria infections; in particular, we show that reactivation in that context plays a minor role. This may suggest that, while the screening for tuberculous is necessary prior to initiating biologics, when considering non-tuberculous mycobacteria only a watchful monitoring during the treatment is recommended. The framework outlined in this paper is quite general and could be extremely promising in further researches on drug-related adverse events.	[Agliari, Elena] Univ Parma, Dipartimento Fis, I-43100 Parma, Italy; [Agliari, Elena] Ist Nazl Fis Nucl, Grp Collegato Parma, Parma, Italy; [Asti, Lorenzo] Univ Roma La Sapienza, Dipartimento Sci Base & Applicate Ingn, Rome, Italy; [Barra, Adriano] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Scrivo, Rossana; Valesini, Guido] Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, Rome, Italy; [Wallis, Robert S.] Pfizer, Groton, CT USA	University of Parma; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Pfizer	Agliari, E (corresponding author), Univ Parma, Dipartimento Fis, Viale Sci, I-43100 Parma, Italy.	elena.agliari@fis.unipr.it	Wallis, Robert S/A-8018-2009; Agliari, Elena/AAA-2311-2021; Agliari, Elena/I-3921-2012	Wallis, Robert S/0000-0001-6152-5183; Agliari, Elena/0000-0002-5121-3511; Agliari, Elena/0000-0002-5121-3511	FIRB from Ministero dell' Instruzione Universita Ricerca [RBFR08EKEV]; Sapienza Universita di Roma	FIRB from Ministero dell' Instruzione Universita Ricerca; Sapienza Universita di Roma	This research was sponsored by the FIRB grant RBFR08EKEV from Ministero dell' Instruzione Universita Ricerca and by Sapienza Universita di Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliari E, 2012, J BIOL DYNAM, V6, P740, DOI 10.1080/17513758.2012.704083; Agliari E, 2011, J THEOR BIOL, V287, P48, DOI 10.1016/j.jtbi.2011.07.027; Bellomo N, 2008, PHYS LIFE REV, V5, P183, DOI 10.1016/j.plrev.2008.07.001; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cooper EL, 2010, PHYS LIFE REV, V7, P55, DOI 10.1016/j.plrev.2009.12.001; Daniel TM, 1997, J INFECT DIS, V175, P1535, DOI 10.1086/516495; ELLIOTT MJ, 1995, INT J IMMUNOPHARMACO, V17, P141, DOI 10.1016/0192-0561(94)00092-3; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Fallahi-Sichani M, 2012, J IMMUNOL, V188, P3169, DOI 10.4049/jimmunol.1103298; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Iliopoulos A, 2006, CLIN RHEUMATOL, V25, P121, DOI 10.1007/s10067-005-1135-4; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Liberopoulos EN, 2002, AM J MED, V113, P615, DOI 10.1016/S0002-9343(02)01205-6; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Marino S, 2007, PLOS COMPUT BIOL, V3, P1909, DOI 10.1371/journal.pcbi.0030194; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pearson RK, 1952, EXPLORING DATA ENG S; Peschon JJ, 1998, J IMMUNOL, V160, P943; Plessner HL, 2007, J INFECT DIS, V195, P1643, DOI 10.1086/517519; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; Scrivo R, 2012, J RHEUMATOL IN PRESS; Scrivo R, 2012, CLIN RHEUMATOL, V31, P1567, DOI 10.1007/s10067-012-2049-6; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; SUTHERLAND I, 1983, TUBERCLE, V64, P241, DOI 10.1016/0041-3879(83)90021-1; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Verhave JC, 2008, NETH J MED, V66, P77; Wagner D, 2003, INFECTION, V31; Wallis RS, 2008, ARTHRITIS RHEUM, V58, P947, DOI 10.1002/art.23285; Wallis RS, 2005, SEMIN ARTHRITIS RHEU, V34, P34, DOI 10.1016/j.semarthrit.2005.01.009; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; Winthrop KL, 2008, CLIN INFECT DIS, V46, P1738, DOI 10.1086/587989; Winthrop KL, 2009, EMERG INFECT DIS, V15, P1556, DOI 10.3201/eid1510.090310	38	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55017	10.1371/journal.pone.0055017	http://dx.doi.org/10.1371/journal.pone.0055017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383039	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500047
J	Rahman, M; Sohel, N; Yunus, M; Chowdhury, ME; Hore, SK; Zaman, K; Bhuiya, A; Streatfield, PK				Rahman, Mahfuzar; Sohel, Nazmul; Yunus, Mohammad; Chowdhury, Mahbub Elahi; Hore, Samar Kumar; Zaman, Khalequ; Bhuiya, Abbas; Streatfield, Peter Kim			Increased Childhood Mortality and Arsenic in Drinking Water in Matlab, Bangladesh: A Population-Based Cohort Study	PLOS ONE			English	Article							CANCER-MORTALITY; BLACKFOOT DISEASE; SODIUM ARSENITE; LUNG-CANCER; EXPOSURE; CONTAMINATION; HEALTH; CHILE; METABOLISM; GENDER	Background: Arsenic in drinking water was associated with increased risk of all-cause, cancer, and cardiovascular death in adults. However, the extent to which exposure is related to all-cause and deaths from cancer and cardiovascular condition in young age is unknown. Therefore, we prospectively assessed whether long-term and recent arsenic exposures are associated with all-cause and cancer and cardiovascular mortalities in Bangladeshi childhood population. Methods and Findings: We assembled a cohort of 58406 children aged 5-18 years from the Health and Demographic Surveillance System of icddrb in Bangladesh and followed during 2003-2010. There were 185 non-accidental deaths registered in-about 0.4 million person-years of observation. We calculated hazard ratios for cause-specific death in relation to exposure at baseline (mu g/L), time-weighted lifetime average (mg/L) and cumulative concentration (mu g-years/L). After adjusting covariates, hazard ratios (HRs) for all-cause childhood deaths comparing lifetime average exposure 10-50.0, 50.1-150.0, 150.1-300.0 and >= 300.1 mu g/L were 1.37 (95% confidence interval [CI], 0.74-2.57), 1.44 (95% CI, 0.88-2.38), 1.22 (95% CI, 0.75-1.98) and 1.88 (95% CI, 1.14-3.10) respectively. Significant increased risk was also observed for baseline (P for trend = 0.023) and cumulative exposure categories (P for trend = 0.036). Girls had higher mortality risk compared to boys (HR for girls 1.79, 1.21, 1.64, 2.31; HR for boys 0.52, 0.53, 1.14, 0.99) in relation to baseline exposure. For all cancers and cardiovascular deaths combined, multivariable adjusted HRs amounted to 1.53 (95% CI 0.51-4.57); 1.29 (95% CI 0.43-3.87); 2.18 (95% CI 1.15-4.16) for 10.0-50.0, 50.1-150.0, and >= 150.1, comparing lowest exposure as reference (P for trend = 0.009). Adolescents had higher mortality risk compared to children (HRs = 1.53, 95% CI 1.03-2.28 vs. HRs = 1.30, 95% CI 0.78-2.17). Conclusions: Arsenic exposure was associated with substantial increased risk of deaths at young age from all-cause, and cancers and cardiovascular conditions. Girls and adolescents (12-18 years) had higher risk compared to boys and child.	[Rahman, Mahfuzar; Sohel, Nazmul; Yunus, Mohammad; Chowdhury, Mahbub Elahi; Hore, Samar Kumar; Zaman, Khalequ; Bhuiya, Abbas; Streatfield, Peter Kim] Icddrb, Dhaka, Bangladesh; [Rahman, Mahfuzar] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Sohel, Nazmul] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); Columbia University; McMaster University	Rahman, M (corresponding author), Icddrb, Dhaka, Bangladesh.	mahfuzar@icddrb.org		Yunus, Mohammed/0000-0003-1116-4978	Swedish International Development Agency (Sida) [ICDDR] [GR-00123, GR-00211, GR-00212, U11 BB/1.5.5-3, 1998-05440, U11 BB/1.5.5-3/A]; World Health Organization (WHO) [ICDDR] [GR-00024, SE/01/037664]; United States of Agency for International Development (USAID) [ICDDR] [GR-00118, 388-G-00-02-00125-00]; Department for International Development (DFID) [ICDDR] [GR-00210]	Swedish International Development Agency (Sida) [ICDDR]; World Health Organization (WHO) [ICDDR]; United States of Agency for International Development (USAID) [ICDDR](United States Agency for International Development (USAID)); Department for International Development (DFID) [ICDDR]	The base study was supported by Swedish International Development Agency (Sida) [ICDDR, B ref. GR-00123, GR-00211 & GR-00212; Donor ref. U11 BB/1.5.5-3, 1998-05440 & U11 BB/1.5.5-3/A], World Health Organization (WHO) [ICDDR, B ref. GR-00024, Donor ref. SE/01/037664] and United States of Agency for International Development (USAID) [ICDDR, B ref. GR-00118, Donor ref. 388-G-00-02-00125-00]. Matlab HDSS is primarily supported by the Department for International Development (DFID) [ICDDR, B ref. GR-00210]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S A, 1999, J Prev Soc Med, V18, P35; Alam N, 2010, J HEALTH POPUL NUTR, V28, P520; Pou SA, 2011, CANCER CAUSE CONTROL, V22, P407, DOI 10.1007/s10552-010-9711-6; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; CHEN CJ, 1985, CANCER RES, V45, P5895; FALK H, 1981, CANCER, V47, P382, DOI 10.1002/1097-0142(19810115)47:2<382::AID-CNCR2820470228>3.0.CO;2-N; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Hopenhayn-Rich C, 1998, INT J EPIDEMIOL, V27, P561, DOI 10.1093/ije/27.4.561; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P1; Infante-Rivard C, 2001, EPIDEMIOLOGY, V12, P13, DOI 10.1097/00001648-200101000-00004; Jakariya M, 2005, SUSTAINABLE SAFE WAT, P319; Kadono T, 2002, INT J DERMATOL, V41, P841, DOI 10.1046/j.1365-4362.2002.01668.x; Liaw J, 2008, CANCER EPIDEM BIOMAR, V17, P1982, DOI 10.1158/1055-9965.EPI-07-2816; Lindberg AL, 2008, ENVIRON RES, V106, P110, DOI 10.1016/j.envres.2007.08.011; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; McLellan F, 2002, LANCET, V359, P1127, DOI 10.1016/S0140-6736(02)08179-5; Moore LE, 2002, ARCH ENVIRON HEALTH, V57, P201, DOI 10.1080/00039890209602937; Nahar N, 2008, J ENVIRON HEALTH, V70, P42; National Research Council (NRC), 2001, ARS DRINK WAT 2001 U; Pilsner JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037147; Rahman M, 2006, J EPIDEMIOL COMMUN H, V60, P242, DOI 10.1136/jech.2005.040212; Rahman M, 1998, AM J EPIDEMIOL, V148, P198, DOI 10.1093/oxfordjournals.aje.a009624; Ramirez P, 1997, MUTAT RES-REV MUTAT, V386, P291, DOI 10.1016/S1383-5742(97)00018-5; Razzaque A, 2002, MATLAB DEMOGRAPHIC S, V1, p[387, 287]; Rubin CS, 2007, ENVIRON HEALTH PERSP, V115, P151, DOI 10.1289/ehp.9022; Ruzicka LT, 1978, DEMOGRAPHIC SURVEILL, V2; Sampayo-Reyes A, 2010, TOXICOL SCI, V117, P63, DOI 10.1093/toxsci/kfq173; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Smith AH, 2011, AM J EPIDEMIOL, V173, P414, DOI 10.1093/aje/kwq383; Sohel N, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-53; Sohel N, 2010, J ENVIRON MONITOR, V12, P1341, DOI 10.1039/c001708f; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Sudo N, 2004, INT J FOOD SCI NUTR, V55, P499, DOI 10.1080/09637480400015844; TSENG WP, 1977, ENVIRON HEALTH PERSP, V19, P109, DOI 10.2307/3428460; Watanabe C, 2001, ENVIRON HEALTH PERSP, V109, P1265, DOI 10.2307/3454749; Yih LH, 1997, CANCER RES, V57, P5051; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; Yunus M, 2011, KAOHSIUNG J MED SCI, P1	44	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55014	10.1371/journal.pone.0055014	http://dx.doi.org/10.1371/journal.pone.0055014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383038	Green Submitted, gold, Green Published			2022-12-27	WOS:000315211500046
J	Senatore, A; Monteil, A; van Minnen, J; Smit, AB; Spafford, JD				Senatore, Adriano; Monteil, Arnaud; van Minnen, Jan; Smit, August B.; Spafford, J. David			NALCN Ion Channels Have Alternative Selectivity Filters Resembling Calcium Channels or Sodium Channels	PLOS ONE			English	Article							VOLTAGE-GATED SODIUM; CATION CHANNEL; NEURONAL EXCITABILITY; HYDROZOAN JELLYFISH; GENETIC-ANALYSIS; NERVOUS-SYSTEM; LYMNAEA; ACID; LEAK; CA2+	NALCN is a member of the family of ion channels with four homologous, repeat domains that include voltage-gated calcium and sodium channels. NALCN is a highly conserved gene from simple, extant multicellular organisms without nervous systems such as sponges and placozoans and mostly remains a single gene compared to the calcium and sodium channels which diversified into twenty genes in humans. The single NALCN gene has alternatively-spliced exons at exons 15 or exon 31 that splices in novel selectivity filter residues that resemble calcium channels (EEEE) or sodium channels (EKEE or EEKE). NALCN channels with alternative calcium, (EEEE) and sodium, (EKEE or EEKE) -selective pores are conserved in simple bilaterally symmetrical animals like flatworms to non-chordate deuterostomes. The single NALCN gene is limited as a sodium channel with a lysine (K)-containing pore in vertebrates, but originally NALCN was a calcium-like channel, and evolved to operate as both a calcium channel and sodium channel for different roles in many invertebrates. Expression patterns of NALCN-EKEE in pond snail, Lymnaea stagnalis suggest roles for NALCN in secretion, with an abundant expression in brain, and an up-regulation in secretory organs of sexually-mature adults such as albumen gland and prostate. NALCN-EEEE is equally abundant as NALCN-EKEE in snails, but is greater expressed in heart and other muscle tissue, and 50% less expressed in the brain than NALCN-EKEE. Transfected snail NALCN-EEEE and NALCN-EKEE channel isoforms express in HEK-293T cells. We were not able to distinguish potential NALCN currents from background, non-selective leak conductances in HEK293T cells. Native leak currents without expressing NALCN genes in HEK-293T cells are NMDG(+) impermeant and blockable with 10 mu M Gd3+ ions and are indistinguishable from the hallmark currents ascribed to mammalian NALCN currents expressed in vitro by Lu et al. in Cell. 2007 Apr 20;129(2):371-83.	[Senatore, Adriano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Monteil, Arnaud] CNRS, Inst Genom Fonct, Montpellier, France; [Monteil, Arnaud] INSERM, Montpellier, France; [Monteil, Arnaud] Univ Montpellier I, Montpellier, France; [Monteil, Arnaud] Univ Montpellier 2, Montpellier, France; [van Minnen, Jan] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands	University of Waterloo; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; University of Calgary; Vrije Universiteit Amsterdam	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca	Monteil, Arnaud/G-3113-2012	Monteil, Arnaud/0000-0003-1632-7318	National Sciences and Engineering Research Council of Canada (NSERC) Canada; Heart and Stroke Foundation of Canada	National Sciences and Engineering Research Council of Canada (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was funded through a National Sciences and Engineering Research Council of Canada (NSERC) Canada Discovery grant and Heart and Stroke Foundation of Canada Grant-In-Aid to JDS and an NSERC Canada Graduate Scholarship and Ontario Graduate Scholarship award to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ANDERSON PAV, 1993, P NATL ACAD SCI USA, V90, P7419, DOI 10.1073/pnas.90.15.7419; Bannister RA, 2009, J GEN PHYSIOL, V134, P35, DOI 10.1085/jgp.200910241; Bouhours M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-16; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; CAMPBELL DB, 1994, P NATL ACAD SCI USA, V91, P2135, DOI 10.1073/pnas.91.6.2135; Catterall WA, 2010, NEUROSCI LETT, V486, P107, DOI 10.1016/j.neulet.2010.08.085; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DeLange RPJ, 1997, NEUROSCIENCE, V78, P289, DOI 10.1016/S0306-4522(96)00576-3; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Grigoriev NG, 1996, J NEUROPHYSIOL, V76, P2240, DOI 10.1152/jn.1996.76.4.2240; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lipkind GM, 2008, J GEN PHYSIOL, V131, P523, DOI 10.1085/jgp.200809991; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Lu TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018745; MAROIS R, 1992, J COMP NEUROL, V322, P255, DOI 10.1002/cne.903220211; McComb C, 2005, J EXP BIOL, V208, P1459, DOI 10.1242/jeb.01544; Miller HM, 1934, DROSOPH INF SERV, V2, P9; Morgan P G, 2007, WormBook, P1; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Singaram VK, 2011, CURR BIOL, V21, P2070, DOI 10.1016/j.cub.2011.10.042; Sinke AP, 2011, PHYSIOL GENOMICS, V43, P265, DOI 10.1152/physiolgenomics.00188.2010; Snutch TP, 2007, NEURON, V54, P505, DOI 10.1016/j.neuron.2007.05.005; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Spafford JD, 1998, BIOCHEM BIOPH RES CO, V244, P772, DOI 10.1006/bbrc.1998.8332; Spafford JD, 1999, RECEPTOR CHANNEL, V6, P493; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Talavera K, 2006, CELL CALCIUM, V40, P97, DOI 10.1016/j.ceca.2006.04.013; Tikhonov DB, 2011, J BIOL CHEM, V286, P2998, DOI 10.1074/jbc.M110.175406; Wicher D, 2004, J BIOL CHEM, V279, P50410, DOI 10.1074/jbc.M405800200; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	52	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55088	10.1371/journal.pone.0055088	http://dx.doi.org/10.1371/journal.pone.0055088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383067	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500056
J	Yang, Y; Wang, Y; Shi, ZW; Zhu, DL; Gao, PJ				Yang, Yan; Wang, Yan; Shi, Zhong-wei; Zhu, Ding-liang; Gao, Ping-jin			Association of E/E' and NT-proBNP with Renal Function in Patients with Essential Hypertension	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; CHRONIC HEART-FAILURE; NATRIURETIC PEPTIDE; DOPPLER-ECHOCARDIOGRAPHY; INSUFFICIENCY; MORTALITY; VELOCITY; DISEASE; MICROALBUMINURIA; RECOMMENDATIONS	Objectives: To evaluate the association of left ventricular (LV) diastolic function and N-terminal pro-brain natriuretic peptide (NT-proBNP) with renal function in essential hypertension. Methods: LV diastolic function was estimated by the ratio of early diastolic velocities (E) from transmitral inflow to early diastolic velocities (E') of tissue Doppler at mitral annulus (septal corner); NT-proBNP was measured in 207 hypertensive patients (mean age 56 +/- 14 years). The subjects were classified into 3 groups: E/E'<= 10 group (n = 48), 10<E/E'<= 15 group (n = 109) and E/E'>15 group (n = 50). The renal function was estimated by glomerular filtration rate (GFR) with Tc-99m-DTPA. GFR from 30 to 59 ml/min/1.73 m(2) was defined as Stage 3 chronic kidney disease (CKD). GFR was also estimated using the modified MDRD equation. Albuminuria was defined by urinary albumin/creatinine ratio (UACR). Results: GFR was lower and UACR was higher in E/E'>15 group than in 10<E/E' <= 15 group or E/E' <= 10 group (p<0.0001), GFR was significantly negative and UACR was positive correlated with E/E' and NT-proBNP (p<0.0001). In multivariate stepwise linear analysis, GFR had significant correlation with age (p = 0.001), gender (p = 0.003), E/E' (p = 0.03), lgNT-proBNP (p = 0.001) and lgUACR (p = 0.01), while eGFR had no significant correlation with E/E' or lgNT-proBNP. Multivariate logistic regression analysis, adjusted for potential confounding factors, showed that participants in E/E'>15 group were more likely to have Stage 3 CKD compared with those in E/E'<= 10 group with an adjusted odds ratio of 8.31 (p = 0.0036). Conclusions: LV diastolic function, assessed with E/E' and NT-proBNP is associated with renal function in essential hypertension.	[Yang, Yan; Wang, Yan; Zhu, Ding-liang; Gao, Ping-jin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,State Key Lab Med Genom, Shanghai Inst Hypertens,Dept Hypertens,Shanghai K, Shanghai 200030, Peoples R China; [Shi, Zhong-wei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Zhu, Ding-liang; Gao, Ping-jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Vasc Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,State Key Lab Med Genom, Shanghai Inst Hypertens,Dept Hypertens,Shanghai K, Shanghai 200030, Peoples R China.	gaopingjin@yahoo.com.cn	Yang, Sophie/GQB-2082-2022		National Natural Science Foundation of China [81070261]; National Basic Research Program of China [2011CB503905]; National Hightech RD Program [2012AA02A516]; Doctor Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Hightech RD Program(National High Technology Research and Development Program of China); Doctor Innovation Fund of Shanghai Jiao Tong University School of Medicine	This study was supported financially by grants from the National Natural Science Foundation of China (81070261), National Basic Research Program of China (2011CB503905), National Hightech R&D Program (2012AA02A516) and Doctor Innovation Fund (BXJ201046) of Shanghai Jiao Tong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9; Bruch C, 2007, INT J CARDIOL, V118, P375, DOI 10.1016/j.ijcard.2006.06.066; Chinese committee on guide of hypertension prevention and treatment, 2005, CHINESE J HYPERTEN S, V134, P2; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; DeFilippi C, 2008, AM J CARDIOL, V101, p82A, DOI 10.1016/j.amjcard.2007.11.029; DEVEREUX RB, 1993, EUR HEART J, V14, P8, DOI 10.1093/eurheartj/14.suppl_D.8; Esler M, 2000, AM J HYPERTENS, V13, p99S, DOI 10.1016/S0895-7061(00)00225-9; Farias CA, 1999, J AM SOC ECHOCARDIOG, V12, P609, DOI 10.1053/je.1999.v12.a99249; Fathi R, 2003, AM J KIDNEY DIS, V41, P1016, DOI 10.1016/S0272-6386(03)00199-9; Joles JA, 2004, HYPERTENSION, V43, P699, DOI 10.1161/01.HYP.0000121881.77212.b1; Khan NA, 2006, J AM SOC NEPHROL, V17, P244, DOI 10.1681/ASN.2005030270; Lainchbury JG, 1998, CLIN SCI, V95, P547, DOI 10.1042/cs0950547; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_1.29; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mancia G, 2009, J HYPERTENSION, V27, P000; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McConnaughey MM, 1999, J CLIN PHARMACOL, V39, P547, DOI 10.1177/00912709922008155; McCullough Peter A, 2003, Rev Cardiovasc Med, V4 Suppl 4, pS13; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nardi E, 2007, J NEPHROL, V20, P320; Nardi E, 2009, J HYPERTENS, V27, P633, DOI 10.1097/HJH.0b013e3283220ecd; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Olsen MJ, 2004, J HUM HYPERTENS, V18, P453, DOI 10.1038/sj.jhh.1001711; Olsson LG, 2007, EUR J HEART FAIL, V9, P795, DOI 10.1016/j.ejheart.2007.07.010; Osranek M, 2007, AM HEART J, V154, P130, DOI 10.1016/j.ahj.2007.03.026; Otsuka T, 2009, J CARDIOL, V54, P199, DOI 10.1016/j.jjcc.2009.05.002; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; PERRONE RD, 1990, AM J KIDNEY DIS, V16, P224, DOI 10.1016/S0272-6386(12)81022-5; Prigent A, 2008, SEMIN NUCL MED, V38, P32, DOI 10.1053/j.semnuclmed.2007.09.003; RICHARDS AM, 1993, BRIT HEART J, V69, P414; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schillaci G, 2002, J AM COLL CARDIOL, V39, P2005, DOI 10.1016/S0735-1097(02)01896-X; Shah AM, 2011, J HYPERTENS, V29, P1829, DOI 10.1097/HJH.0b013e32834a4d38; Silverberg D, 2004, CURR OPIN NEPHROL HY, V13, P163, DOI 10.1097/00041552-200403000-00004; Slama M, 2002, CURR OPIN CARDIOL, V17, P368, DOI 10.1097/00001573-200207000-00008; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Svensson M, 2009, CLIN NEPHROL, V71, P380; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; van Kimmenade RRJ, 2009, J AM COLL CARDIOL, V53, P884, DOI 10.1016/j.jacc.2008.11.032; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54513	10.1371/journal.pone.0054513	http://dx.doi.org/10.1371/journal.pone.0054513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382907	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500014
J	Couldrey, C; Wells, DN				Couldrey, Christine; Wells, David N.			DNA Methylation at a Bovine Alpha Satellite I Repeat CpG Site during Development following Fertilization and Somatic Cell Nuclear Transfer	PLOS ONE			English	Article							CLONED EMBRYOS; TRANSFER BLASTOCYSTS; FETUSES; PATTERNS; CATTLE; GENE; DEMETHYLATION; ABNORMALITIES; EXPRESSION; SEQUENCES	Incomplete epigenetic reprogramming is postulated to contribute to the low developmental success following somatic cell nuclear transfer (SCNT). Here, we describe the epigenetic reprogramming of DNA methylation at an alpha satellite I CpG site (alpha satI-5) during development of cattle generated either by artificial insemination (AI) or in vitro fertilization (IVF) and SCNT. Quantitative methylation analysis identified that SCNT donor cells were highly methylated at alpha satI-5 and resulting SCNT blastocysts showed significantly more methylation than IVF blastocysts. At implantation, no difference in methylation was observed between SCNT and AI in trophoblast tissue at alpha satI-5, however, SCNT embryos were significantly hyper-methylated compared to AI controls at this time point. Following implantation, DNA methylation at alpha satI-5 decreased in AI but not SCNT placental tissues. In contrast to placenta, the proportion of methylation at alpha satI-5 remained high in adrenal, kidney and muscle tissues during development. Differences in the average proportion of methylation were smaller in somatic tissues than placental tissues but, on average, SCNT somatic tissues were hyper-methylated at alpha satI-5. Although sperm from all bulls was less methylated than somatic tissues at alpha satI-5, on average this site remained hyper-methylated in sperm from cloned bulls compared with control bulls. This developmental time course confirms that epigenetic reprogramming does occur, at least to some extent, following SCNT. However, the elevated methylation levels observed in SCNT blastocysts and cellular derivatives implies that there is either insufficient time or abundance of appropriate reprogramming factors in oocytes to ensure complete reprogramming. Incomplete reprogramming at this CpG site may be a contributing factor to low SCNT success rates, but more likely represents the tip of the iceberg in terms of incompletely reprogramming. Until protocols ensure the epigenetic signature of a differentiated somatic cell is reset to a state resembling totipotency, the efficiency of SCNT is likely to remain low.	[Couldrey, Christine; Wells, David N.] AgRes Ruakura Res Ctr, Hamilton, New Zealand	AgResearch - New Zealand	Couldrey, C (corresponding author), AgRes Ruakura Res Ctr, Hamilton, New Zealand.	Christine.Couldrey@agresearch.co.nz		Wells, David/0000-0002-8729-4958	New Zealand Foundation for Research, Science, and Technology [C10X0303]; AgResearch Curiosity Fund	New Zealand Foundation for Research, Science, and Technology(New Zealand Foundation for Research, Science and Technology); AgResearch Curiosity Fund	This work was supported by a grant from the New Zealand Foundation for Research, Science, and Technology (C10X0303) and the AgResearch Curiosity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburatani Hiroyuki, 2011, Gan To Kagaku Ryoho, V38, P1; Alonso-Gonzalez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035619; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; Cezar GG, 2003, BIOL REPROD, V68, P1009, DOI 10.1095/biolreprod.102.010181; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Chavatte-Palmer P, 2002, BIOL REPROD, V66, P1596, DOI 10.1095/biolreprod66.6.1596; Chavatte-Palmer PM, 2009, CLONING STEM CELLS, V11, P309, DOI 10.1089/clo.2008.0080; Chaves R, 2000, CHROMOSOME RES, V8, P621, DOI 10.1023/A:1009290125305; Chen T, 2005, FRONT BIOSCI-LANDMRK, V10, P3002, DOI 10.2741/1756; Chu L, 2012, J MOL CELL BIOL; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Couldrey C, 2011, CELL REPROGRAM, V13, P171, DOI 10.1089/cell.2010.0065; Couldrey C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-27; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dindot SV, 2004, BIOL REPROD, V71, P470, DOI 10.1095/biolreprod.103.025775; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Hiendleder S, 2004, BIOL REPROD, V71, P217, DOI 10.1095/biolreprod.103.026062; Hori N, 2010, ANIM REPROD SCI, V122, P303, DOI 10.1016/j.anireprosci.2010.09.008; Kaneda Masahiro, 2011, BMC Proc, V5 Suppl 4, pS3, DOI 10.1186/1753-6561-5-S4-S3; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kang YK, 2003, MOL REPROD DEV, V66, P32, DOI 10.1002/mrd.10330; Lanza RP, 2001, SCIENCE, V294, P1893, DOI 10.1126/science.1063440; Ledgard A, 2009, J REPROD DEVELOP, V55, P467, DOI 10.1262/jrd.20142; Lee RSF, 2004, BIOL REPROD, V70, P1, DOI 10.1095/biolreprod.103.020982; Lucifero D, 2006, BIOL REPROD, V75, P531, DOI 10.1095/biolreprod.106.051722; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Prada D, 2012, MUTAT RES-FUND MOL M, V729, P100, DOI 10.1016/j.mrfmmm.2011.10.007; Reik W, 2003, PHILOS T R SOC B, V358, P1403, DOI 10.1098/rstb.2003.1326; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Smith C, 2007, REPRODUCTION, V133, P231, DOI 10.1530/rep.1.0966; Somers J, 2006, REPRODUCTION, V131, P1073, DOI 10.1530/rep.1.00967; Su H, 2011, ANIM REPROD SCI, V127, P23, DOI 10.1016/j.anireprosci.2011.07.002; Suzuki T, 2002, EXP GERONTOL, V37, P1005, DOI 10.1016/S0531-5565(02)00061-X; Wilmut I, 2006, METH MOL B, V348, P307; Yamanaka K, 2011, ANIM SCI J, V82, P523, DOI 10.1111/j.1740-0929.2011.00881.x	36	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55153	10.1371/journal.pone.0055153	http://dx.doi.org/10.1371/journal.pone.0055153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383311	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900018
J	Fukusumi, H; Shofuda, T; Kanematsu, D; Yamamoto, A; Suemizu, H; Nakamura, M; Yamasaki, M; Ohgushi, M; Sasai, Y; Kanemura, Y				Fukusumi, Hayato; Shofuda, Tomoko; Kanematsu, Daisuke; Yamamoto, Atsuyo; Suemizu, Hiroshi; Nakamura, Masato; Yamasaki, Mami; Ohgushi, Masatoshi; Sasai, Yoshiki; Kanemura, Yonehiro			Feeder-Free Generation and Long-Term Culture of Human Induced Pluripotent Stem Cells Using Pericellular Matrix of Decidua Derived Mesenchymal Cells	PLOS ONE			English	Article							UNDIFFERENTIATED GROWTH; X-INACTIVATION; SELF-RENEWAL; RECOMBINANT VITRONECTIN; FORESKIN FIBROBLASTS; DEFINED CONDITIONS; GENE-EXPRESSION; LINES; DERIVATION; DIFFERENTIATION	Human ES cells (hESCs) and human induced pluripotent stem cells (hiPSCs) are usually generated and maintained on living feeder cells like mouse embryonic fibroblasts or on a cell-free substrate like Matrigel. For clinical applications, a quality-controlled, xenobiotic-free culture system is required to minimize risks from contaminating animal-derived pathogens and immunogens. We previously reported that the pericellular matrix of decidua-derived mesenchymal cells (PCM-DM) is an ideal human-derived substrate on which to maintain hiPSCs/hESCs. In this study, we examined whether PCM-DM could be used for the generation and long-term stable maintenance of hiPSCs. Decidua-derived mesenchymal cells (DMCs) were reprogrammed by the retroviral transduction of four factors (OCT4, SOX2, KLF4, c-MYC) and cultured on PCM-DM. The established hiPSC clones expressed alkaline phosphatase, hESC-specific genes and cell-surface markers, and differentiated into three germ layers in vitro and in vivo. At over 20 passages, the hiPSCs cultured on PCM-DM held the same cellular properties with genome integrity as those at early passages. Global gene expression analysis showed that the GDF3, FGF4, UTF1, and XIST expression levels varied during culture, and GATA6 was highly expressed under our culture conditions; however, these gene expressions did not affect the cells' pluripotency. PCM-DM can be conveniently prepared from DMCs, which have a high proliferative potential. Our findings indicate that PCM-DM is a versatile and practical human-derived substrate that can be used for the feeder-cell-free generation and long-term stable maintenance of hiPSCs.	[Fukusumi, Hayato; Kanematsu, Daisuke; Kanemura, Yonehiro] Natl Hosp Org, Div Regenerat Med, Inst Clin Res, Osaka Natl Hosp, Osaka, Japan; [Shofuda, Tomoko; Yamamoto, Atsuyo] Natl Hosp Org, Div Stem Cell Res, Inst Clin Res, Osaka Natl Hosp, Osaka, Japan; [Yamasaki, Mami] Natl Hosp Org, Div Mol Med, Inst Clin Res, Osaka Natl Hosp, Osaka, Japan; [Yamasaki, Mami; Kanemura, Yonehiro] Natl Hosp Org, Dept Neurosurg, Osaka Natl Hosp, Osaka, Japan; [Suemizu, Hiroshi; Nakamura, Masato] Cent Inst Expt Anim, Biomed Res Dept, Kawasaki, Kanagawa, Japan; [Nakamura, Masato] Tokai Univ, Sch Med, Dept Pathol & Regenerat Med, Isehara, Kanagawa 25911, Japan; [Ohgushi, Masatoshi] RIKEN, Unit Human Stem Cell Technol, Ctr Dev Biol, Kobe, Hyogo, Japan; [Sasai, Yoshiki] RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan; [Yamasaki, Mami] Takatsuki Gen Hosp, Dept Pediat Neurosurg, Takatsuki, Osaka, Japan	Osaka National Hospital; Osaka National Hospital; Osaka National Hospital; Osaka National Hospital; Tokai University; RIKEN; RIKEN	Kanemura, Y (corresponding author), Natl Hosp Org, Div Regenerat Med, Inst Clin Res, Osaka Natl Hosp, Osaka, Japan.	kanemura@onh.go.jp		Fukusumi, Hayato/0000-0002-5723-7506; Suemizu, Hiroshi/0000-0002-3706-2454	Project for the Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER) project from MEXT, Japan; Research on New Drug Development, Health and Labour Sciences Research Grants; Ministry of Health, Labour and Welfare (MHLW) of Japan	Project for the Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER) project from MEXT, Japan; Research on New Drug Development, Health and Labour Sciences Research Grants; Ministry of Health, Labour and Welfare (MHLW) of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Project for the Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER) project from MEXT, Japan, and the Research on New Drug Development, Health and Labour Sciences Research Grants, the Ministry of Health, Labour and Welfare (MHLW) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Caricasole AAD, 1998, ONCOGENE, V16, P95, DOI 10.1038/sj.onc.1201515; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Fu X, 2011, TISSUE ENG PART C-ME, V17, P927, DOI [10.1089/ten.tec.2010.0735, 10.1089/ten.TEC.2010.0735]; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kanematsu D, 2011, DIFFERENTIATION, V82, P77, DOI 10.1016/j.diff.2011.05.010; Kitajima H, 2010, BIOCHEM BIOPH RES CO, V396, P933, DOI 10.1016/j.bbrc.2010.05.026; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Meng GL, 2010, STEM CELLS DEV, V19, P547, DOI 10.1089/scd.2009.0303; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60; Nagase T, 2009, DEV DYNAM, V238, P1118, DOI 10.1002/dvdy.21944; Navarro-Alvarez N, 2008, CELL TRANSPLANT, V17, P27, DOI 10.3727/000000008783906900; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Pan CY, 2010, J GENET GENOMICS, V37, P241, DOI 10.1016/S1673-8527(09)60042-4; Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Shofuda T, 2013, CELL MED IN PRESS; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yap LYW, 2011, TISSUE ENG PART C-ME, V17, P193, DOI [10.1089/ten.tec.2010.0328, 10.1089/ten.TEC.2010.0328]; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	57	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55226	10.1371/journal.pone.0055226	http://dx.doi.org/10.1371/journal.pone.0055226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383118	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600078
J	Homouz, D; Kudlicki, AS				Homouz, Dirar; Kudlicki, Andrzej S.			The 3D Organization of the Yeast Genome Correlates with Co-Expression and Reflects Functional Relations between Genes	PLOS ONE			English	Article							CHROMOSOME CONFORMATION CAPTURE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-ORGANIZATION; BUDDING YEAST; TRANSCRIPTIONAL REGULATION; EXPRESSION; HYBRIDIZATION; LOCALIZATION; ARCHITECTURE; TERRITORIES	The spatial organization of eukaryotic genomes is thought to play an important role in regulating gene expression. The recent advances in experimental methods including chromatin capture techniques, as well as the large amounts of accumulated gene expression data allow studying the relationship between spatial organization of the genome and co-expression of protein-coding genes. To analyse this genome-wide relationship at a single gene resolution, we combined the interchromosomal DNA contacts in the yeast genome measured by Duan et al. with a comprehensive collection of 1,496 gene expression datasets. We find significant enhancement of co-expression among genes with contact links. The co-expression is most prominent when two gene loci fall within 1,000 base pairs from the observed contact. We also demonstrate an enrichment of inter-chromosomal links between functionally related genes, which suggests that the non random nature of the genome organization serves to facilitate coordinated transcription in groups of genes.	[Homouz, Dirar; Kudlicki, Andrzej S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Homouz, Dirar; Kudlicki, Andrzej S.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Homouz, Dirar] Khalifa Univ Sci Technol & Res, Dept Appl Math & Sci, Abu Dhabi, U Arab Emirates; [Kudlicki, Andrzej S.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Khalifa University of Science & Technology; University of Texas System; University of Texas Medical Branch Galveston	Kudlicki, AS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	askudlic@utmb.edu	Kudlicki, Andrzej/AAG-8537-2019; Homouz, Dirar/E-2922-2017	Kudlicki, Andrzej/0000-0001-8158-9600; Homouz, Dirar/0000-0002-8859-0265	March of Dimes grant [5-FY10-136]; University of Texas Medical Branch	March of Dimes grant(March of Dimes); University of Texas Medical Branch	This research was supported partly by March of Dimes grant 5-FY10-136 and partly by startup funds provided by University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2008, CURR OPIN GENET DEV, V18, P571, DOI 10.1016/j.gde.2008.10.002; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bussey H, 1997, NATURE, V387, P103, DOI 10.1038/387s103; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gehlen LR, 2012, NUCLEUS, V3, P15; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Janga SC, 2008, P NATL ACAD SCI USA, V105, P15761, DOI 10.1073/pnas.0806317105; Jin QW, 2000, J CELL SCI, V113, P1903; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; O'Sullivan JM, 2010, CURR OPIN CELL BIOL, V22, P298, DOI 10.1016/j.ceb.2010.03.008; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; Rowicka M, 2007, P NATL ACAD SCI USA, V104, P16892, DOI 10.1073/pnas.0706022104; Saez-Vasquez J, 2010, MOL PLANT, V3, P678, DOI 10.1093/mp/ssq034; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stone EM, 2000, CURR BIOL, V10, P373, DOI 10.1016/S0960-9822(00)00413-9; Taddei A, 2010, COLD SPRING HARBOR P; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tjong H, 2012, GENOME RES, V22, P1295, DOI 10.1101/gr.129437.111; Tokuda N, 2012, BIOPHYS J, V102, P296, DOI 10.1016/j.bpj.2011.12.005; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong H, 2012, CURR BIOL, V22, P1881, DOI 10.1016/j.cub.2012.07.069; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058	45	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54699	10.1371/journal.pone.0054699	http://dx.doi.org/10.1371/journal.pone.0054699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382942	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600036
J	Liu, H; Wu, R; Jia, RP; Zhong, B; Zhu, JG; Yu, P; Zhao, Y; Ge, YZ; Wu, JP				Liu, Hao; Wu, Ran; Jia, Rui-Peng; Zhong, Bing; Zhu, Jia-Geng; Yu, Peng; Zhao, Yan; Ge, Yu-Zheng; Wu, Jian-Ping			Ischemic Preconditioning Increases Endothelial Progenitor Cell Number to Attenuate Partial Nephrectomy-Induced Ischemia/Reperfusion Injury	PLOS ONE			English	Article							RENAL CORTICAL TUMORS; GROWTH-FACTOR; INFLAMMATORY RESPONSE; REPERFUSION INJURY; RAT-KIDNEY; REPAIR; TRANSPLANTATION; ANGIOGENESIS; MOBILIZATION; ACTIVATION	Objectives: The objective of this study was to investigate the role of endothelial progenitor cells (EPCs) in the modulation of ischemia-reperfusion injury (IRI) in a partial nephrectomy (PN) rat model using early-phase ischemic preconditioning (IPC). Materials and Methods: Ninety male Sprague-Dawley rats were randomly divided into three groups following right-side nephrectomy: Sham-operated rats (surgery without vascular clamping); PN rats (renal blood vessels were clamped for 40 min and PN was performed); and IPC rats (pretreated with 15 min ischemia and 10 min reperfusion). At 1, 3, 6, 12, 24 h, and 3 days after reperfusion, the pool of circulating EPCs and kidneys were harvested. The extent of renal injury was assessed, along with EPC number, cell proliferation, angiogenesis, and vascular growth factor expression. Results: Pretreated rats exhibited significant improvements in renal function and morphology. EPC numbers in the kidneys were increased at 12 h following reperfusion in the IPC group as compared to the PN or Sham groups. Cell proliferation (including endothelial and tubular epithelial cells) and angiogenesis in peritubular capillaries were markedly increased in kidneys treated with IPC. In addition, vascular endothelial growth factor-A (VEGF-A) and stromal cell-derived factor-1 alpha (SDF-1 alpha) expression in the kidneys of pretreated rats was increased compared to rats subjected to PN. Conclusions: Our investigation suggested that: (1) the early phase of IPC may attenuate renal IRI induced by PN; (2) EPCs play an important role in renal protection, involving promotion of cell proliferation and angiogenesis through release of several angiogenic factors.	[Liu, Hao; Wu, Ran; Jia, Rui-Peng; Zhong, Bing; Zhu, Jia-Geng; Yu, Peng; Zhao, Yan; Ge, Yu-Zheng; Wu, Jian-Ping] Nanjing Med Univ, Dept Urol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Jia, RP (corresponding author), Nanjing Med Univ, Dept Urol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	urologist025@sohu.com			National Natural Science Foundation of China [81070597]; Open Key Program of the Jiangsu Province Health Bureau [KF200942]; Science and Education Development Program of the Jiangsu Province Health Board [LJ201107]; Six Talent Peaks of the Jiangsu Province Health Bureau [2011-WS-093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Key Program of the Jiangsu Province Health Bureau; Science and Education Development Program of the Jiangsu Province Health Board; Six Talent Peaks of the Jiangsu Province Health Bureau	This work was supported by grants from the National Natural Science Foundation of China (81070597), the Open Key Program of the Jiangsu Province Health Bureau (KF200942), Science and Education Development Program of the Jiangsu Province Health Board (LJ201107) and Six Talent Peaks of the Jiangsu Province Health Bureau (2011-WS-093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow LJ, 2010, BJU INT, V106, P489, DOI 10.1111/j.1464-410X.2009.09147.x; Blanco Miguel, 2006, Cerebrovasc Dis, V21 Suppl 2, P38, DOI 10.1159/000091702; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Breau RH, 2010, J UROLOGY, V183, P903, DOI 10.1016/j.juro.2009.11.037; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Cao CC, 2010, AM J NEPHROL, V31, P1, DOI 10.1159/000252844; Chen L, 2010, CARDIOVASC RES, V88, P462, DOI 10.1093/cvr/cvq207; Chen X, 2009, AM J NEPHROL, V30, P287, DOI 10.1159/000225928; Czeiger D, 2011, STEM CELL REV REP, V7, P639, DOI 10.1007/s12015-011-9234-x; Desai MM, 2005, BJU INT, V95, P377, DOI 10.1111/j.1464-410X.2005.05304.x; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Goligorsky MS, 2010, J AM SOC NEPHROL, V21, P911, DOI 10.1681/ASN.2009111119; Gupta GN, 2010, J UROLOGY, V184, P59, DOI 10.1016/j.juro.2010.03.035; Henrich D, 2004, SHOCK, V21, P13, DOI 10.1097/01.shk.0000101669.49265.50; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Jefayri MK, 2000, BJU INT, V85, P1007, DOI 10.1046/j.1464-410x.2000.00678.x; Jia RP, 2009, TRANSPL P, V41, P69, DOI 10.1016/j.transproceed.2008.11.001; Jiang SH, 2007, CELL BIOCHEM FUNCT, V25, P335, DOI 10.1002/cbf.1395; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Karellas ME, 2010, BJU INT, V106, P1484, DOI 10.1111/j.1464-410X.2010.09405.x; Kim JM, 2010, KOREAN J UROL, V51, P596, DOI 10.4111/kju.2010.51.9.596; Kwon O, 2010, J HISTOCHEM CYTOCHEM, V58, P687, DOI 10.1369/jhc.2010.956011; Lane BR, 2010, J UROLOGY, V184, P1286, DOI 10.1016/j.juro.2010.06.011; Lane BR, 2010, J UROLOGY, V183, P473, DOI 10.1016/j.juro.2009.10.023; Lesage K, 2007, EUR UROL, V51, P614, DOI 10.1016/j.eururo.2006.10.040; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Patschan D, 2006, CURR OPIN PHARMACOL, V6, P176, DOI 10.1016/j.coph.2005.10.013; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Sola A, 2003, TRANSPLANTATION, V75, P744, DOI 10.1097/01.TP.0000054683.72223.2D; Sutton TA, 2003, AM J PHYSIOL-RENAL, V285, pF191, DOI 10.1152/ajprenal.00042.2003; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Torras J, 2002, KIDNEY INT, V61, P2218, DOI 10.1046/j.1523-1755.2002.00360.x; Van Poppel H, 2010, INT J UROL, V17, P314, DOI 10.1111/j.1442-2042.2010.02482.x; Weight CJ, 2010, J UROLOGY, V183, P1317, DOI 10.1016/j.juro.2009.12.030; Xu SJ, 2012, J CARDIOVASC PHARM, V59, P387, DOI 10.1097/FJC.0b013e3182440338; Yi CG, 2006, J SURG RES, V135, P100, DOI 10.1016/j.jss.2006.01.014; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049; Yu Y, 2010, BASIC RES CARDIOL, V105, P713, DOI 10.1007/s00395-010-0117-0; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	46	13	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55389	10.1371/journal.pone.0055389	http://dx.doi.org/10.1371/journal.pone.0055389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383174	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600096
J	Liu, YW; Mattila, JP; Schmid, SL				Liu, Ya-Wen; Mattila, Juha-Pekka; Schmid, Sandra L.			Dynamin-Catalyzed Membrane Fission Requires Coordinated GTP Hydrolysis	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; COATED PITS; IN-VIVO; VESICLE FORMATION; RECEPTOR; MUTANT; MECHANISM; ACTIN; CELLS	Dynamin is the most-studied membrane fission machinery and has served as a paradigm for studies of other fission GTPases; however, several critical questions regarding its function remain unresolved. In particular, because most dynamin GTPase domain mutants studied to date equally impair both basal and assembly-stimulated GTPase activities, it has been difficult to distinguish their respective roles in clathrin-mediated endocytosis (CME) or in dynamin catalyzed membrane fission. Here we compared a new dynamin mutant, Q40E, which is selectively impaired in assembly-stimulated GTPase activity with S45N, a GTP-binding mutant equally defective in both basal and assembly-stimulated GTPase activities. Both mutants potently inhibit CME and effectively recruit other endocytic accessory proteins to stalled coated pits. However, the Q40E mutant blocks at a later step than S45N, providing additional evidence that GTP binding and/or basal GTPase activities of dynamin are required throughout clathrin coated pit maturation. Importantly, using in vitro assays for assembly-stimulated GTPase activity and membrane fission, we find that the latter is much more potently inhibited by both dominant-negative mutants than the former. These studies establish that efficient fission from supported bilayers with excess membrane reservoir (SUPER) templates requires coordinated GTP hydrolysis across two rungs of an assembled dynamin collar.	[Liu, Ya-Wen; Mattila, Juha-Pekka; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), UT SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	Sandra.Schmid@UTSouthwestern.edu		LIU, YA-WEN/0000-0003-0180-4142; Schmid, Sandra/0000-0002-1690-7024	Muscular Dystrophy Association Grant [MDA-114824]; Academy of Finland;  [GM42455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER	Muscular Dystrophy Association Grant(Muscular Dystrophy Association); Academy of Finland(Academy of Finland); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y-WL was supported by Muscular Dystrophy Association Grant MDA-114824, J-PM was supported by a postdoctoral research grant from the Academy of Finland. This work was supported by GM42455 to SLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Binns DD, 2000, BIOCHEMISTRY-US, V39, P7188, DOI 10.1021/bi000033r; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Faelber K, 2012, STRUCTURE, V20, P1621, DOI 10.1016/j.str.2012.08.028; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Lee A, 1999, CURR BIOL, V9, P261, DOI 10.1016/S0960-9822(99)80115-8; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	44	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55691	10.1371/journal.pone.0055691	http://dx.doi.org/10.1371/journal.pone.0055691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383266	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600147
J	Piggott, DA; Muzaale, AD; Mehta, SH; Brown, TT; Patel, KV; Leng, SX; Kirk, GD				Piggott, Damani A.; Muzaale, Abimereki D.; Mehta, Shruti H.; Brown, Todd T.; Patel, Kushang V.; Leng, Sean X.; Kirk, Gregory D.			Frailty, HIV Infection, and Mortality in an Aging Cohort of Injection Drug Users	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CARE; INFLAMMATION; POPULATION; DISABILITY; BALTIMORE; SURVIVAL; SUPPRESSION; PREVENTION; PHENOTYPE	Background: Frailty is associated with morbidity and premature mortality among elderly HIV-uninfected adults, but the determinants and consequences of frailty in HIV-infected populations remain unclear. We evaluated the correlates of frailty, and the impact of frailty on mortality in a cohort of aging injection drug users (IDUs). Methods: Frailty was assessed using standard criteria among HIV-infected and uninfected IDUs in 6-month intervals from 2005 to 2008. Generalized linear mixed-model analyses assessed correlates of frailty. Cox proportional hazards models estimated risk for all-cause mortality. Results: Of 1230 participants at baseline, the median age was 48 years and 29% were HIV-infected; the frailty prevalence was 12.3%. In multivariable analysis of 3,365 frailty measures, HIV-infected IDUs had an increased likelihood of frailty (OR, 1.66; 95% CI, 1.24-2.21) compared to HIV-uninfected IDUs; the association was strongest (OR, 2.37; 95% CI, 1.62-3.48) among HIV-infected IDUs with advanced HIV disease (CD4<350 cells/mm3 and detectable HIV RNA). No significant association was seen with less advanced disease. Sociodemographic factors, comorbidity, depressive symptoms, and prescription drug abuse were also independently associated with frailty. Mortality risk was increased with frailty alone (HR 2.63, 95% CI, 1.23-5.66), HIV infection alone (HR 3.29, 95% CI, 1.85-5.88), and being both HIV-infected and frail (HR, 7.06; 95% CI 3.49-14.3). Conclusion: Frailty was strongly associated with advanced HIV disease, but IDUs with well-controlled HIV had a similar prevalence to HIV-uninfected IDUs. Frailty was independently associated with mortality, with a marked increase in mortality risk for IDUs with both frailty and HIV infection.	[Piggott, Damani A.; Muzaale, Abimereki D.; Brown, Todd T.; Leng, Sean X.; Kirk, Gregory D.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Piggott, Damani A.; Muzaale, Abimereki D.; Mehta, Shruti H.; Brown, Todd T.; Kirk, Gregory D.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Patel, Kushang V.] Univ Washington, Sch Med, Seattle, WA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle	Piggott, DA (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	dpiggott@jhsph.edu			National Institutes of Health [RC1-AI-086053, R01-DA-04334, R01-DA-12568]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036297, R01DA004334, R01DA012568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (grants RC1-AI-086053, R01-DA-04334, and R01-DA-12568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J GERONTOL A; Armstrong GL, 2007, ARCH INTERN MED, V167, P166, DOI 10.1001/archinte.167.2.166; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Carroll JE, 2011, BRAIN BEHAV IMMUN; Celentano DD, 1998, JAMA-J AM MED ASSOC, V280, P544, DOI 10.1001/jama.280.6.544; Crystal S, 2003, JAIDS-J ACQ IMM DEF, V33, pS76, DOI 10.1097/00126334-200306012-00004; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Desquilbet L, 2011, J GERONTOL A; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Joseph Cherian, 2005, Molecular Aspects of Medicine, V26, P181, DOI 10.1016/j.mam.2005.01.004; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; Khosla N, 2011, ADDICT BEHAV, V36, P1282, DOI 10.1016/j.addbeh.2011.07.046; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kohli R, 2005, CLIN INFECT DIS, V41, P864, DOI 10.1086/432883; Koster A, 2006, J GERONTOL A-BIOL, V61, P284, DOI 10.1093/gerona/61.3.284; Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mehta SH, 2010, CLIN INFECT DIS, V50, P1664, DOI 10.1086/652867; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; Nijhawan Ank, 2008, Curr Infect Dis Rep, V10, P432, DOI 10.1007/s11908-008-0068-x; Onen NF, 2009, J INFECTION, V59, P346, DOI 10.1016/j.jinf.2009.08.008; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Salter ML, 2011, CLIN INFECT DIS, V53, P1256, DOI 10.1093/cid/cir673; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Szanton SL, 2010, J EPIDEMIOL COMMUN H, V64, P63, DOI 10.1136/jech.2008.078428; Terzian AS, 2009, J WOMENS HEALTH, V18, P1965, DOI 10.1089/jwh.2008.1090; Vlahov D, 2005, AM J EPIDEMIOL, V161, P999, DOI 10.1093/aje/kwi133; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2005, LANCET INFECT DIS, V5, P407, DOI 10.1016/S1473-3099(05)70162-6; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009; Yao X, 2011, CLIN GERIATR MED, V27, P79, DOI 10.1016/j.cger.2010.08.002	52	116	116	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54910	10.1371/journal.pone.0054910	http://dx.doi.org/10.1371/journal.pone.0054910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23382997	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600049
J	Fonoudi, H; Yeganeh, M; Fattahi, F; Ghazizadeh, Z; Rassouli, H; Alikhani, M; Mojarad, BA; Baharvand, H; Salekdeh, GH; Aghdami, N				Fonoudi, Hananeh; Yeganeh, Meghdad; Fattahi, Faranak; Ghazizadeh, Zaniar; Rassouli, Hassan; Alikhani, Mehdi; Mojarad, Bahareh Adhami; Baharvand, Hossein; Salekdeh, Ghasem Hosseini; Aghdami, Nasser			ISL1 Protein Transduction Promotes Cardiomyocyte Differentiation from Human Embryonic Stem Cells	PLOS ONE			English	Article							SCALABLE EXPANSION; PROGENITOR CELLS; SMOOTH-MUSCLE; TAT; PEPTIDE; HEART; MANIPULATION; ENDOCYTOSIS; DELIVERY; PATHWAY	Background: Human embryonic stem cells (hESCs) have the potential to provide an unlimited source of cardiomyocytes, which are invaluable resources for drug or toxicology screening, medical research, and cell therapy. Currently a number of obstacles exist such as the insufficient efficiency of differentiation protocols, which should be overcome before hESC-derived cardiomyocytes can be used for clinical applications. Although the differentiation efficiency can be improved by the genetic manipulation of hESCs to over-express cardiac-specific transcription factors, these differentiated cells are not safe enough to be applied in cell therapy. Protein transduction has been demonstrated as an alternative approach for increasing the efficiency of hESCs differentiation toward cardiomyocytes. Methods: We present an efficient protocol for the differentiation of hESCs in suspension by direct introduction of a LIM homeodomain transcription factor, Islet1 (ISL1) recombinant protein into the cells. Results: We found that the highest beating clusters were derived by continuous treatment of hESCs with 40 mu g/ml recombinant ISL1 protein during days 1-8 after the initiation of differentiation. The treatment resulted in up to a 3-fold increase in the number of beating areas. In addition, the number of cells that expressed cardiac specific markers (cTnT, CONNEXIN 43, ACTININ, and GATA4) doubled. This protocol was also reproducible for another hESC line. Conclusions: This study has presented a new, efficient, and reproducible procedure for cardiomyocytes differentiation. Our results will pave the way for scaled up and controlled differentiation of hESCs to be used for biomedical applications in a bioreactor culture system.	[Fonoudi, Hananeh; Fattahi, Faranak; Ghazizadeh, Zaniar; Mojarad, Bahareh Adhami; Baharvand, Hossein; Aghdami, Nasser] Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Fonoudi, Hananeh; Fattahi, Faranak; Mojarad, Bahareh Adhami] Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran; [Yeganeh, Meghdad; Rassouli, Hassan; Alikhani, Mehdi; Salekdeh, Ghasem Hosseini] Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Mol Syst Biol Biol, Cell Sci Res Ctr, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Acad Ctr Educ Culture & Res, Dept Dev Biol, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran; [Aghdami, Nasser] Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Regenerat Med, Cell Sci Res Ctr, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR); University of Tehran; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Baharvand, H (corresponding author), Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran.	Baharvand@RoyanInstitute.Org; Salekdeh@RoyanInstitute.Org; Nasser.Aghdami@RoyanInstitute.Org	Alikhani, Mehdi/AAZ-7970-2020; Aghdami, Nasser/ABH-7238-2020; Salekdeh, Ghasem Hosseini/E-4198-2012	Alikhani, Mehdi/0000-0002-8808-9577; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Fonoudi, Hananeh/0000-0001-5888-9306	Royan Institute; Iranian Council of Stem Cell Research and Technology	Royan Institute; Iranian Council of Stem Cell Research and Technology	This study was funded by grants provided from Royan Institute and the Iranian Council of Stem Cell Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2011, NAT PROTOC, V6, P572, DOI 10.1038/nprot.2011.325; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Baharvand H, 2004, IN VITRO CELL DEV-AN, V40, P76, DOI 10.1290/1543-706X(2004)040<0076:CCDFEO>2.0.CO;2; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Do Kwon Y, 2005, MOL THER, V12, P28, DOI 10.1016/y.ymthe.2005.03.01; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Fijnvandraat AC, 2003, J MUSCLE RES CELL M, V24, P211, DOI 10.1023/A:1026063409656; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Moore JC, 2005, REPROD TOXICOL, V20, P377, DOI 10.1016/j.reprotox.2005.04.012; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Rezaei Larijani M, 2011, STEM CELLS DEV; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Serra M, 2009, ANN ANAT, V191, P104, DOI 10.1016/j.aanat.2008.09.005; Stock K, 2010, CELL MOL LIFE SCI, V67, P2439, DOI 10.1007/s00018-010-0347-1; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zhu Wei-Zhong, 2009, Transplant Rev (Orlando), V23, P53, DOI 10.1016/j.trre.2008.05.005; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318	35	29	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55577	10.1371/journal.pone.0055577	http://dx.doi.org/10.1371/journal.pone.0055577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383231	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800170
J	Freeman, EE; Roy-Gagnon, MH; Descovich, D; Masse, H; Lesk, MR				Freeman, Ellen E.; Roy-Gagnon, Marie-Helene; Descovich, Denise; Masse, Hugues; Lesk, Mark R.			The Heritability of Glaucoma-Related Traits Corneal Hysteresis, Central Corneal Thickness, Intraocular Pressure, and Choroidal Blood Flow Pulsatility	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GUANGZHOU TWIN EYE; TO-DISC RATIO; ASSOCIATION; PEDIGREES; NUCLEAR; CHINESE	Purpose: The purpose of this work was to investigate the heritability of potential glaucoma endophenotypes. We estimated for the first time the heritability of the pulsatility of choroidal blood flow. We also sought to confirm the heritability of corneal hysteresis, central corneal thickness, and 3 ways of measuring intraocular pressure. Methods: Measurements were performed on 96 first-degree relatives recruited from Maisonneuve-Rosemont Hospital in Montreal. Corneal hysteresis was determined using the Reichert Ocular Response Analyser. Central corneal thickness was measured with an ultrasound pachymeter. Three measures of intraocular pressure were obtained: Goldmann-correlated and corneal compensated intraocular pressure using the Ocular Response Analyser, and Pascal intraocular pressure using the Pascal Dynamic Contour Tonometer. The pulsatility of choroidal blood velocity and flow were measured in the sub-foveolar choroid using single-point laser Doppler flowmetry (Oculix). We estimated heritability using maximum-likelihood variance components methods implemented in the SOLAR software. Results: No significant heritability was detected for the pulsatility of choroidal blood flow or velocity. The Goldman-correlated, corneal compensated, and Pascal measures of intraocular pressure measures were all significantly heritable at 0.94, 0.79, and 0.53 after age and sex adjustment (p = 0.0003, p = 0.0023, p = 0.0239). Central corneal thickness was significantly heritable at 0.68 (p = 0.0078). Corneal hysteresis was highly heritable but the estimate was at the upper boundary of 1.00 preventing us from giving a precise estimate. Conclusion: Corneal hysteresis, central corneal thickness, and intraocular pressure are all heritable and may be suitable as glaucoma endophenotypes. The pulsatility of choroidal blood flow and blood velocity were not significantly heritable in this sample.	[Freeman, Ellen E.; Descovich, Denise; Lesk, Mark R.] Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada; [Freeman, Ellen E.; Lesk, Mark R.] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Roy-Gagnon, Marie-Helene; Masse, Hugues] Univ Montreal, CHU St Justine Res Ctr, Montreal, PQ, Canada; [Roy-Gagnon, Marie-Helene] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Freeman, EE (corresponding author), Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada.	eefreeman@gmail.com		Freeman, Ellen/0000-0002-1403-8427; Roy-Gagnon, Marie-Helene/0000-0001-8747-0846	Canadian Glaucoma Clinical Research Council; Canadian National Institute for the Blind; Fonds de Recherche en Ophtalmologie de l'Universite de Montreal	Canadian Glaucoma Clinical Research Council; Canadian National Institute for the Blind; Fonds de Recherche en Ophtalmologie de l'Universite de Montreal	This project was funded through a grant from the Canadian Glaucoma Clinical Research Council and the Canadian National Institute for the Blind, and also by the Fonds de Recherche en Ophtalmologie de l'Universite de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Bahrami H, 2006, OPHTHAL EPIDEMIOL, V13, P283, DOI 10.1080/09286580600681339; Carbonaro F, 2008, BRIT J OPHTHALMOL, V92, P1125, DOI 10.1136/bjo.2007.133272; Carbonaro F, 2008, OPHTHALMOLOGY, V115, P1545, DOI 10.1016/j.ophtha.2008.02.011; Chang TC, 2005, OPHTHALMOLOGY, V112, P1186, DOI 10.1016/j.ophtha.2005.03.006; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; De Moraes CGV, 2012, J GLAUCOMA, V21, P209, DOI 10.1097/IJG.0b013e3182071b92; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Goldman David, 2007, ScientificWorldJournal, V7, P124; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Kochkorov A, 2010, GRAEF ARCH CLIN EXP, V248, P833, DOI 10.1007/s00417-009-1277-1; Landers JA, 2009, INVEST OPHTH VIS SCI, V50, P4087, DOI 10.1167/iovs.08-3271; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Mangouritsas G, 2009, ACTA OPHTHALMOL, V87, P901, DOI 10.1111/j.1755-3768.2008.01370.x; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Parssinen O, 2007, OPHTHALMOLOGY, V114, P2227, DOI 10.1016/j.ophtha.2007.03.011; Polska E, 2004, BRIT J OPHTHALMOL, V88, P533, DOI 10.1136/bjo.2003.028480; Roy-Gagnon MH, 2008, ANN HUM GENET, V72, P115, DOI 10.1111/j.1469-1809.2007.00401.x; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Toh TY, 2005, INVEST OPHTH VIS SCI, V46, P3718, DOI 10.1167/iovs.04-1497; Ulmer M, 2012, INVEST OPHTH VIS SCI, V53, P4468, DOI 10.1167/iovs.12-9784; van Koolwijk LME, 2007, INVEST OPHTH VIS SCI, V48, P3669, DOI 10.1167/iovs.06-1519; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Zheng YF, 2008, INVEST OPHTH VIS SCI, V49, P4303, DOI 10.1167/iovs.08-1934; Zheng YF, 2009, INVEST OPHTH VIS SCI, V50, P2040, DOI 10.1167/iovs.08-3082	31	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55573	10.1371/journal.pone.0055573	http://dx.doi.org/10.1371/journal.pone.0055573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383229	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800168
J	Hu, LN; Wang, TG; Gocke, AR; Nath, A; Zhang, H; Margolick, JB; Whartenby, KA; Calabresi, PA				Hu, Lina; Wang, Tongguang; Gocke, Anne R.; Nath, Avindra; Zhang, Hao; Margolick, Joseph B.; Whartenby, Katharine A.; Calabresi, Peter A.			Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+T Effector Memory Lymphocytes	PLOS ONE			English	Article							CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; GATED K+ CHANNELS; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; CLONAL EXPANSIONS; PERIPHERAL-BLOOD; BINDING-SITES; IN-VIVO; CHARYBDOTOXIN	Increased expression of the voltage-gated potassium channel Kn1.3 on activated effector memory T cells (T-EM) is associated with pathology in multiple sclerosis (MS). To date, most studies of Kn1.3 channels in MS have focused on CD4+ T-EM cells. Much less is known about the functional relevance of Kv1.3 on CD8+ T-EM cells. Herein, we examined the effects of Kn1.3 blockade on CD8+ T cell proliferation, differentiation into cytotoxic effector cells, and release of granzyme B (GrB), a key effector of CD8+ T cell-mediated cytotoxicity. We confirmed the expression of Kv1.3 channels on activated human CD8+ T lymphocytes by immunofluorescent staining. To test the functional relevance of the Kv1.3 channel in CD8+ T cells, we inhibited this channel via pharmacological blockers or a lentiviral-dominant negative (Kv1.xDN) approach and determined the effects of the blockade on critical pathogenic parameters of CD8+ T cells. We found that blockade of Kv1.3 with both lentivirus and pharmacologic agents effectively inhibited cytotoxic effector memory cells' proliferation, secretion of GrB, and their ability to kill neural progenitor cells. Intriguingly, the KvDN transduced T cells exhibited arrested differentiation from central memory (T-CM) to effector memory (T-EM) states. Transduction of cells that had already differentiated into T-EM with KvDN led to their conversion into T-CM. CD8+ T-EM have a critical role in MS and other autoimmune diseases. Our present results indicate a critical role for Kv1.3 in the conversion of CD8+ T cells into potential pathogenic effector cells with cytotoxic function.	[Hu, Lina; Gocke, Anne R.; Whartenby, Katharine A.; Calabresi, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wang, Tongguang; Nath, Avindra] NINDS, Sect Infect Nervous Syst, NIH, Bethesda, MD 20892 USA; [Zhang, Hao; Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Calabresi, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	Calabresi@jhmi.edu	Calabresi, Peter A./AAF-2288-2019	Calabresi, Peter/0000-0002-7776-6472	National Institutes of Health [NS041435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003134, R01NS041435, ZIANS003130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from National Institutes of Health: NS041435 (PAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Babichuk CK, 1996, J BIOL CHEM, V271, P16485, DOI 10.1074/jbc.271.28.16485; Babichuk CK, 1997, J BIOL CHEM, V272, P18564, DOI 10.1074/jbc.272.30.18564; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Beeton C, 2005, NEUROSCIENTIST, V11, P550, DOI 10.1177/1073858405278016; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BOOSS J, 1983, J NEUROL SCI, V62, P219, DOI 10.1016/0022-510X(83)90201-0; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Calabresi PA, 2003, J NEUROIMMUNOL, V139, P58, DOI 10.1016/S0165-5728(03)00127-9; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; DEUTSCH C, 1991, J BIOL CHEM, V266, P3668; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Hu LN, 2012, J BIOL CHEM, V287, P1261, DOI 10.1074/jbc.M111.296798; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Jacobsen M, 2002, BRAIN, V125, P538, DOI 10.1093/brain/awf059; Koo GC, 1997, J IMMUNOL, V158, P5120; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mullen KM, 2006, ANN NEUROL, V60, P118, DOI 10.1002/ana.20884; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Perez-Garcia MT, 2000, J NEUROSCI, V20, P5689, DOI 10.1523/JNEUROSCI.20-15-05689.2000; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; Rock MT, 2005, J IMMUNOL, V174, P3757, DOI 10.4049/jimmunol.174.6.3757; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SANDS SB, 1989, J GEN PHYSIOL, V93, P1061, DOI 10.1085/jgp.93.6.1061; Skulina C, 2004, P NATL ACAD SCI USA, V101, P2428, DOI 10.1073/pnas.0308689100; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; TAKAYAMA H, 1987, J EXP MED, V166, P725, DOI 10.1084/jem.166.3.725; Wang T, 2006, FASEB J, V20, P1209, DOI 10.1096/fj.05-5022fje; Wang TG, 2010, J NEUROSCI, V30, P5020, DOI 10.1523/JNEUROSCI.0311-10.2010; WARGNIER A, 1995, P NATL ACAD SCI USA, V92, P6930, DOI 10.1073/pnas.92.15.6930; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120	43	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54267	10.1371/journal.pone.0054267	http://dx.doi.org/10.1371/journal.pone.0054267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382885	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800041
J	Leteneur, S; Simoneau, E; Gillet, C; Dessery, Y; Barbier, F				Leteneur, Sebastien; Simoneau, Emilie; Gillet, Christophe; Dessery, Yoann; Barbier, Franck			Trunk's Natural Inclination Influences Stance Limb Kinetics, but Not Body Kinematics, during Gait Initiation in Able Men	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; AGE-RELATED-CHANGES; MOVEMENTS; JOINT; ANKLE; YOUNG; STEP; CLASSIFICATION; ORGANIZATION; STRATEGIES	The imposing mass of the trunk in relation to the whole body has an important impact on human motion. The objective of this study is to determine the influence of trunk's natural inclination - forward (FW) or backward (BW) with respect to the vertical - on body kinematics and stance limb kinetics during gait initiation. Twenty-five healthy males were divided based on their natural trunk inclination (FW or BW) during gait initiation. Instantaneous speed was calculated at the center of mass at the first heel strike. The antero-posterior impulse was calculated by integrating the antero-posterior ground reaction force in time. Ankle, knee, hip and thoraco-lumbar (L5) moments were calculated using inverse dynamics and only peaks of the joint moments were analyzed. Among all the investigated parameters, only joint moments present significant differences between the two groups. The knee extensor moment is 1.4 times higher (P<0.001) for the BW group, before the heel contact. At the hip, although the BW group displays a flexor moment 2.4 times higher (P<0.001) before the swing limb's heel-off, the FW group displays an extensor moment 3.1 times higher (P<0.01) during the swing phase. The three L5 extensor peaks after the toe-off are respectively 1.7 (P<0.001), 1.4 (P<0.001) and 1.7 (P<0.01) times higher for the FW group. The main results support the idea that the patterns described during steady-state gait are already observable during gait initiation. This study also provides reference data to further investigate stance limb kinetics in specific or pathologic populations during gait initiation. It will be of particular interest for elderly people, knowing that this population displays atypical trunk postures and present a high risk of falling during this forward stepping.	[Leteneur, Sebastien; Simoneau, Emilie; Gillet, Christophe; Barbier, Franck] Univ Lille Nord France, Lille, France; [Leteneur, Sebastien; Simoneau, Emilie; Gillet, Christophe; Barbier, Franck] UVHC, LAMIH, Valenciennes, France; [Leteneur, Sebastien; Simoneau, Emilie; Gillet, Christophe; Barbier, Franck] CNRS, UMR 8201, Valenciennes, France; [Leteneur, Sebastien] Ctr Reeduc Fonct La Rougeville, St Saulve, France; [Dessery, Yoann] Univ Laval, Fac Med, Div Kinesiol, Quebec City, PQ G1K 7P4, Canada	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite Polytechnique Hauts-de-France; Laval University	Leteneur, S (corresponding author), Univ Lille Nord France, Lille, France.	sebastien.leteneur@univ-valenciennes.fr	Simoneau, Emilie/ABA-6405-2020	SIMONEAU-BUESSINGER, Emilie/0000-0003-2059-884X; Dessery, Yoann/0000-0001-5198-356X	International Campus on Safety and Intermodality in Transportation; Nord/Pas-de-Calais Region; European Community; Regional Delegation for Research and Technology; Ministry of Higher Education and Research; French National Research Agency; National Center for Scientific Research	International Campus on Safety and Intermodality in Transportation; Nord/Pas-de-Calais Region(Region Hauts-de-FranceEuropean Commission); European Community(European Commission); Regional Delegation for Research and Technology; Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); French National Research Agency(French National Research Agency (ANR)); National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS))	This research was supported by International Campus on Safety and Intermodality in Transportation, the Nord/Pas-de-Calais Region, the European Community, the Regional Delegation for Research and Technology, the Ministry of Higher Education and Research, the French National Research Agency and the National Center for Scientific Research. The authors gratefully acknowledge the support of these institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2007, GAIT POSTURE, V26, P526, DOI 10.1016/j.gaitpost.2006.11.203; BRENIERE Y, 1987, J BIOPHYS BIOMEC, V11, P161; BRENIERE Y, 1986, J BIOMECH, V19, P1035, DOI 10.1016/0021-9290(86)90120-X; BRENIERE Y, 1987, J MOTOR BEHAV, V19, P62, DOI 10.1080/00222895.1987.10735400; BRENIERE Y, 1981, J BIOPHYS BIOMEC, V5, P197; Brunt D, 1999, GAIT POSTURE, V10, P121, DOI 10.1016/S0966-6362(99)00020-X; Brunt D, 2000, NEUROSCI LETT, V285, P228, DOI 10.1016/S0304-3940(00)01063-6; Bruyneel A. -V., 2008, Annales de Readaptation et de Medecine Physique, V51, P630, DOI 10.1016/j.annrmp.2008.05.004; Callaghan JP, 1999, CLIN BIOMECH, V14, P203, DOI 10.1016/S0268-0033(98)00069-2; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Couillandre A, 2000, NEUROSCI LETT, V285, P150, DOI 10.1016/S0304-3940(00)01015-6; CRENNA P, 1991, J PHYSIOL-LONDON, V437, P635, DOI 10.1113/jphysiol.1991.sp018616; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dessery Y, 2011, GAIT POSTURE, V33, P550, DOI 10.1016/j.gaitpost.2011.01.008; DIETRICH G, 1994, HUM MOVEMENT SCI, V13, P195, DOI 10.1016/0167-9457(94)90036-1; ENG JJ, 1995, J BIOMECH, V28, P753, DOI 10.1016/0021-9290(94)00124-M; Engsberg JR, 2001, SPINE, V26, P2020, DOI 10.1097/00007632-200109150-00016; Gillet A, 2003, AM J PHYS MED REHAB, V82, P101, DOI 10.1097/01.PHM.0000046629.78324.28; Goh JH, 1998, CLIN BIOMECH, V13, pS26, DOI 10.1016/S0268-0033(97)00071-5; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hirose D, 2004, CLIN BIOMECH, V19, P57, DOI 10.1016/j.clinbiomech.2003.08.005; Laudani L, 2006, J ELECTROMYOGR KINES, V16, P603, DOI 10.1016/j.jelekin.2006.08.001; Leardini A, 2009, CLIN BIOMECH, V24, P542, DOI 10.1016/j.clinbiomech.2009.05.005; LEPERS R, 1995, EXP BRAIN RES, V107, P118; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Leteneur S, 2009, CLIN BIOMECH, V24, P190, DOI 10.1016/j.clinbiomech.2008.10.005; MANN RA, 1979, J BONE JOINT SURG AM, V61, P232, DOI 10.2106/00004623-197961020-00011; McGibbon CA, 2001, J NEUROPHYSIOL, V85, P1923, DOI 10.1152/jn.2001.85.5.1923; Michel V, 2002, NEUROSCI LETT, V325, P139, DOI 10.1016/S0304-3940(02)00255-0; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; Nikravesh P.E., 1988, COMPUTER AIDED ANAL; NISSAN M, 1990, J BIOMED ENG, V12, P165, DOI 10.1016/0141-5425(90)90139-E; Patchay S, 2003, GAIT POSTURE, V18, P85, DOI 10.1016/S0966-6362(02)00167-4; Polcyn AF, 1998, ARCH PHYS MED REHAB, V79, P1582, DOI 10.1016/S0003-9993(98)90425-7; Saha D, 2008, GAIT POSTURE, V27, P653, DOI 10.1016/j.gaitpost.2007.08.009; Surgeons AAOO, 1966, JOINT MOT METH MEAS; THORSTENSSON A, 1984, ACTA PHYSIOL SCAND, V121, P9, DOI 10.1111/j.1748-1716.1984.tb10452.x; Vardaxis VG, 1998, HUM MOVEMENT SCI, V17, P121, DOI 10.1016/S0167-9457(97)00024-9; Watelain E, 2000, ARCH PHYS MED REHAB, V81, P579, DOI 10.1053/mr.2000.4415; Wicart P, 2003, NEUROSCI LETT, V351, P67, DOI 10.1016/S0304-3940(03)00619-0; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	44	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55256	10.1371/journal.pone.0055256	http://dx.doi.org/10.1371/journal.pone.0055256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383128	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800137
J	Sato, A; Shibuya, H				Sato, Atsushi; Shibuya, Hiroshi			WNK Signaling Is Involved in Neural Development via Lhx8/Awh Expression	PLOS ONE			English	Article							FOREBRAIN CHOLINERGIC NEURONS; ALANINE-RICH KINASE; LIM-HOMEOBOX GENE; PROTEIN-KINASE; MONOCLONAL-ANTIBODIES; COTRANSPORTERS; HYPERTENSION; CELLS; MICE; OSR1	WNK kinase family is conserved among many species and regulates SPAK/OSR1 and ion co-transporters. Some mutations in human WNK1 or WNK4 are associated with Pseudohypoaldosteronism type II, a form of hypertension. WNK is also involved in developmental and cellular processes, but the molecular mechanisms underlying its regulation in these processes remain unknown. Here, we identify a new target gene in WNK signaling, Arrowhead and Lhx8, which is a mammalian homologue of Drosophila Arrowhead. In Drosophila, WNK was shown to genetically interact with Arrowhead. In Wnk1 knockout mice, levels of Lhx8 expression were reduced. Ectopic expression of WNK1, WNK4 or Osr1 in mammalian cells induced the expression of the Lhx8. Moreover, neural specification was inhibited by the knockdown of both Wnk1 and Wnk4 or Lhx8. Drosophila WNK mutant caused defects in axon guidance during embryogenesis. These results suggest that WNK signaling is involved in the morphological and neural development via Lhx8/Arrowhead.	[Sato, Atsushi; Shibuya, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Shibuya, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo, Japan.	shibuya.mcb@mri.tmd.ac.jp			Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan to A.S. and H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; CURTISS J, 1995, DEVELOPMENT, V121, P3819; Curtiss J, 1997, DEV BIOL, V190, P129, DOI 10.1006/dbio.1997.8659; Denaxa M, 2009, DEV BIOL, V333, P324, DOI 10.1016/j.ydbio.2009.07.001; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Fowles LF, 2003, GENESIS, V35, P73, DOI 10.1002/gene.10165; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Huang HS, 2007, J NEUROSCI, V27, P11254, DOI 10.1523/JNEUROSCI.3272-07.2007; Kahle KT, 2004, CURR OPIN NEPHROL HY, V13, P557, DOI 10.1097/00041552-200409000-00012; Lawrence P.A., 1986, P229; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Manabe T, 2005, J NEUROCHEM, V94, P723, DOI 10.1111/j.1471-4159.2005.03261.x; Matsumoto K, 1996, NEUROSCI LETT, V204, P113, DOI 10.1016/0304-3940(96)12341-7; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Ohnishi E, 2010, MOL CELL BIOL, V30, P675, DOI 10.1128/MCB.00576-09; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Sato A, 1999, DEVELOPMENT, V126, P4421; Shibaguchi T, 2003, ARCH HISTOL CYTOL, V66, P95, DOI 10.1679/aohc.66.95; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhang YP, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-29; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55301	10.1371/journal.pone.0055301	http://dx.doi.org/10.1371/journal.pone.0055301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383144	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800140
J	Benseddik, K; Sen Nkwe, N; Daou, P; Verdier-Pinard, P; Badache, A				Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali			ErbB2-Dependent Chemotaxis Requires Microtubule Capture and Stabilization Coordinated by Distinct Signaling Pathways	PLOS ONE			English	Article							CELL-MIGRATION; BREAST-CANCER; KINASE; PHOSPHORYLATION; POLARITY; NETWORK; PROTEIN; CDC42; ERBB2; ACTIVATION	Activation of the ErbB2 receptor tyrosine kinase stimulates breast cancer cell migration. Cell migration is a complex process that requires the synchronized reorganization of numerous subcellular structures including cell-to-matrix adhesions, the actin cytoskeleton and microtubules. How the multiple signaling pathways triggered by ErbB2 coordinate, in time and space, the various processes involved in cell motility, is poorly defined. We investigated the mechanism whereby ErbB2 controls microtubules and chemotaxis. We report that activation of ErbB2 increased both cell velocity and directed migration. Impairment of the Cdc42 and RhoA GTPases, but not of Rac1, prevented the chemotactic response. RhoA is a key component of the Memo/ACF7 pathway whereby ErbB2 controls microtubule capture at the leading edge. Upon Memo or ACF7 depletion, microtubules failed to reach the leading edge and cells lost their ability to follow the chemotactic gradient. Constitutive ACF7 targeting to the membrane in Memo-depleted cells reestablished directed migration. ErbB2-mediated activation of phospholipase C gamma (PLC gamma) also contributed to cell guidance. We further showed that PLC gamma signaling, via classical protein kinases C, and Memo signaling converged towards a single pathway controlling the microtubule capture complex. Finally, inhibiting the PI3K/Akt pathway did not affect microtubule capture, but disturbed microtubule stability, which also resulted in defective chemotaxis. PI3K/Akt-dependent stabilization of microtubules involved repression of GSK3 activity on the one hand and inhibition of the microtubule destabilizing protein, Stathmin, on the other hand. Thus, ErbB2 triggers distinct and complementary pathways that tightly coordinate microtubule capture and microtubule stability to control chemotaxis.	[Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali] INSERM, Ctr Rech Cancerol Marseille, U1068, F-13258 Marseille, France; [Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali] Aix Marseille Univ, Marseille, France; [Benseddik, Khedidja; Sen Nkwe, Nadine; Daou, Pascale; Verdier-Pinard, Pascal; Badache, Ali] CNRS, UMR7258, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Badache, A (corresponding author), INSERM, Ctr Rech Cancerol Marseille, U1068, F-13258 Marseille, France.	ali.badache@inserm.fr	Badache, Ali/Q-6098-2017	Badache, Ali/0000-0001-7710-2505; Verdier-Pinard, Pascal/0000-0002-6149-6578	Bourse Franco-Algerienne fellowship; Fondation pour la Recherche Medicale fellowship; GEFLUC fellowship; Association pour la Recherche sur le Cancer; Institut National du Cancer; Inserm Avenir Program	Bourse Franco-Algerienne fellowship; Fondation pour la Recherche Medicale fellowship(Fondation pour la Recherche Medicale); GEFLUC fellowship; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm))	KB was supported by Bourse Franco-Algerienne, Fondation pour la Recherche Medicale and GEFLUC fellowships. AB was supported by Association pour la Recherche sur le Cancer, Institut National du Cancer and Inserm Avenir Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Badache A, 2006, J MAMMARY GLAND BIOL, V11, P13, DOI 10.1007/s10911-006-9009-1; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Goold RG, 1999, J CELL SCI, V112, P3373; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Holmfeldt P, 2009, CELL MOL LIFE SCI, V66, P3263, DOI 10.1007/s00018-009-0084-5; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Manneville JB, 2010, J CELL BIOL, V191, P585, DOI 10.1083/jcb.201002151; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wittmann T, 2001, J CELL SCI, V114, P3795; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; ZICHA D, 1995, EXP CELL RES, V221, P526, DOI 10.1006/excr.1995.1404	40	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55211	10.1371/journal.pone.0055211	http://dx.doi.org/10.1371/journal.pone.0055211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383112	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200025
J	Sang, Q; Yan, XK; Wang, H; Feng, RZ; Fei, X; Ma, D; Xing, QH; Li, QL; Zhao, XZ; Jin, L; He, L; Li, HW; Wang, L				Sang, Qing; Yan, Xukun; Wang, Huan; Feng, Ruizhi; Fei, Xiang; Ma, Duan; Xing, Qinghe; Li, Qiaoli; Zhao, Xinzhi; Jin, Li; He, Lin; Li, Huawei; Wang, Lei			Identification and Functional Study of a New Missense Mutation in the Motor Head Domain of Myosin VIIA in a Family with Autosomal Dominant Hearing Impairment (DFNA11)	PLOS ONE			English	Article							COCHLEAR HAIR-CELLS; USHER-SYNDROME; GENE CAUSE; DEAFNESS; MYO7A; ASSOCIATION; SPECTRUM; PROTEIN; DFNB2	The MYO7A encodes a protein classified as an unconventional myosin. Here, we present a family with non-syndromic autosomal dominant hearing impairment that clinically resembles other previously published DFNA11 families. Affected members of the family present with an ascending audiogram affecting low and middle frequencies at young ages and then affecting all frequencies with increasing age. Genome-wide linkage analysis using Illumina Cyto-12 Chip mapped the disease locus to the DFNA11 interval in the family. A c.2003G -> A (p.R668H) mutation of the MYO7A, is heterozygous in all affected family members and absent in 100 healthy individuals. Arg668His is located in a region of the myosin VIIA motor domain that is highly conserved among different species. Molecular modeling predicts that the conserved R668 residue plays important structural role in linking different lobes of motor domain together. In the actin-activated ATPase activity assay, the rate of NADH oxidation was higher in the wild-type myosin VIIA, indicating that the ATPase activity in the p.R668H mutant myosin VIIA was significantly destroyed.	[Sang, Qing; Wang, Huan; Feng, Ruizhi; Jin, Li; Wang, Lei] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Sang, Qing; Wang, Huan; Feng, Ruizhi; Jin, Li; Wang, Lei] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yan, Xukun; Ma, Duan; Li, Huawei] Fudan Univ, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China; [Sang, Qing; Wang, Huan; Feng, Ruizhi; Xing, Qinghe; Li, Qiaoli; Zhao, Xinzhi; He, Lin; Wang, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Xing, Qinghe; Li, Qiaoli; Zhao, Xinzhi; He, Lin; Wang, Lei] Shanghai Jiao Tong Univ, Minist Educ, Bio X Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Yan, Xukun] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Fei, Xiang] Fudan Univ, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Chinese People's Liberation Army General Hospital; Fudan University	Li, HW (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China.	hwli@shmu.edu.cn; wangleiwanglei@fudan.edu.cn	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Ma, Duan/I-8330-2014	Jin, Li/0000-0002-4546-2415; 	National Basic Research Program of China [2011CB504502, 2011CB504506]; National High Technology Research and Development Program of China (863 Program) [2011AA02A112]; National Natural Science Foundation of China [81100467, 81270747, 81070793, 81230019]; Program for Changjiang Scholars and Innovative Research Team in Universities [IRT1010]; Innovation Programme of Major Basic Research Projects; Program of Outstanding Shanghai Academic Leaders [11XD1401300]; Program of Leading Medical Personnel in Shanghai; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601, 09DJ1400602]; China Postdoctoral Science Foundation [2012M512064]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovation Programme of Major Basic Research Projects; Program of Outstanding Shanghai Academic Leaders; Program of Leading Medical Personnel in Shanghai; Shanghai Municipal Commission of Science and Technology Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by a grant from the National Basic Research Program of China (2011CB504502, 2011CB504506), the National High Technology Research and Development Program of China (863 Program) 2011AA02A112), the National Natural Science Foundation of China (81100467, 81270747, 81070793, 81230019), the Program for Changjiang Scholars and Innovative Research Team in Universities (IRT1010), the Innovation Programme of Major Basic Research Projects, the Program of Outstanding Shanghai Academic Leaders (11XD1401300) and the Program of Leading Medical Personnel in Shanghai, the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601, 09DJ1400602) and the General Financial Grant from the China Postdoctoral Science Foundation (2012M512064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Bolz Hanno, 2004, Hum Mutat, V24, P274, DOI 10.1002/humu.9272; Di Leva F, 2006, AUDIOL NEURO-OTOL, V11, P157, DOI 10.1159/000091199; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; Houdusse A, 2001, CURR OPIN STRUC BIOL, V11, P182, DOI 10.1016/S0959-440X(00)00188-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Liu XZ, 2002, ADV OTO-RHINO-LARYNG, V61, P120; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Luijendijk MWJ, 2004, HUM GENET, V115, P149, DOI 10.1007/s00439-004-1137-3; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Self T, 1998, DEVELOPMENT, V125, P557; Street VA, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013557; Sun Y, 2011, J HUM GENET, V56, P64, DOI 10.1038/jhg.2010.147; Tamagawa Y, 2000, ADV OTO-RHINO-LARYNG, V56, P103; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	25	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55178	10.1371/journal.pone.0055178	http://dx.doi.org/10.1371/journal.pone.0055178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383098	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200035
J	Suginta, W; Chumjan, W; Mahendran, KR; Janning, P; Schulte, A; Winterhalter, M				Suginta, Wipa; Chumjan, Watcharin; Mahendran, Kozhinjampara R.; Janning, Petra; Schulte, Albert; Winterhalter, Mathias			Molecular Uptake of Chitooligosaccharides through Chitoporin from the Marine Bacterium Vibrio harveyi	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CHITIN CATABOLIC CASCADE; LAMB MALTOPORIN CHANNEL; CENTRAL CONSTRICTION SITE; ESCHERICHIA-COLI; OUTER-MEMBRANE; SUGAR-TRANSPORT; PSEUDOMONAS-AERUGINOSA; ENZYMATIC-PROPERTIES; SINGLE-CHANNEL	Background: Chitin is the most abundant biopolymer in marine ecosystems. However, there is no accumulation of chitin in the ocean-floor sediments, since marine bacteria Vibrios are mainly responsible for a rapid turnover of chitin biomaterials. The catabolic pathway of chitin by Vibrios is a multi-step process that involves chitin attachment and degradation, followed by chitooligosaccharide uptake across the bacterial membranes, and catabolism of the transport products to fructose-6-phosphate, acetate and NH3. Principal Findings: This study reports the isolation of the gene corresponding to an outer membrane chitoporin from the genome of Vibrio harveyi. This porin, expressed in E. coli, (so called VhChiP) was found to be a SDS-resistant, heat-sensitive trimer. Immunoblotting using anti-ChiP polyclonal antibody confirmed the expression of the recombinant ChiP, as well as endogenous expression of the native protein in the V. harveyi cells. The specific function of VhChiP was investigated using planar lipid membrane reconstitution technique. VhChiP nicely inserted into artificial membranes and formed stable, trimeric channels with average single conductance of 1.8 +/- 0.13 nS. Single channel recordings at microsecond-time resolution resolved translocation of chitooligosaccharides, with the greatest rate being observed for chitohexaose. Liposome swelling assays showed no permeation of other oligosaccharides, including maltose, sucrose, maltopentaose, maltohexaose and raffinose, indicating that VhChiP is a highly-specific channel for chitooligosaccharides. Conclusion/Significance: We provide the first evidence that chitoporin from V. harveyi is a chitooligosaccharide specific channel. The results obtained from this study help to establish the fundamental role of VhChiP in the chitin catabolic cascade as the molecular gateway that Vibrios employ for chitooligosaccharide uptake for energy production.	[Suginta, Wipa; Chumjan, Watcharin; Schulte, Albert] Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Sch Chem, Nakhon Ratchasima, Thailand; [Suginta, Wipa; Chumjan, Watcharin; Schulte, Albert] Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Sch Biochem, Nakhon Ratchasima, Thailand; [Mahendran, Kozhinjampara R.; Winterhalter, Mathias] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany; [Janning, Petra] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany	Suranaree University of Technology; Suranaree University of Technology; University of Bremen; Max Planck Society	Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Sch Chem, Nakhon Ratchasima, Thailand.	wipa@sut.ac.th		Winterhalter, Mathias/0000-0002-1604-3318	Thailand Research Fund [RMU5380055]; Alexander von Humboldt Foundation, Germany; Commission of Higher Education, Ministry of University Affairs (MUA), Thailand through a CHE-PHD-SW [60/2550]; Deutsche Forschungsgemeinschaft (DFG) [WI 2278/18-1]	Thailand Research Fund(Thailand Research Fund (TRF)); Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation); Commission of Higher Education, Ministry of University Affairs (MUA), Thailand through a CHE-PHD-SW; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work is financially supported by the Thailand Research Fund (contract no. RMU5380055). WS was a Humboldt fellow under the Alexander von Humboldt Fellowship for Experienced Researchers, The Alexander von Humboldt Foundation, Germany. WC was funded by the Commission of Higher Education, Ministry of University Affairs (MUA), Thailand through a CHE-PHD-SW scholarship (contract no 60/2550). MW acknowledges funding through WI 2278/18-1 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1991, J BIOL CHEM, V266, P24268; Bezrukov SM, 2000, FEBS LETT, V476, P224, DOI 10.1016/S0014-5793(00)01753-1; Bouma CL, 1996, J BIOL CHEM, V271, P33457, DOI 10.1074/jbc.271.52.33457; Bouma CL, 1996, J BIOL CHEM, V271, P33468, DOI 10.1074/jbc.271.52.33468; CLEMENT JM, 1981, CELL, V27, P507, DOI 10.1016/0092-8674(81)90392-5; Dando RT, 1990, NCIMB CATALOGUE STRA, P172; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; Denker K, 2005, J MOL BIOL, V352, P534, DOI 10.1016/j.jmb.2005.07.025; Dumas F, 2000, J BIOL CHEM, V275, P19747, DOI 10.1074/jbc.M000268200; Dutzler R, 2002, STRUCTURE, V10, P1273, DOI 10.1016/S0969-2126(02)00811-0; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; JEUNIAUX C, 1991, BIOCHEM SYST ECOL, V19, P347, DOI 10.1016/0305-1978(91)90051-Z; Jung BO, 2008, MACROMOL RES, V16, P1, DOI 10.1007/BF03218953; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Keyhani NO, 1996, J BIOL CHEM, V271, P33425, DOI 10.1074/jbc.271.52.33425; Keyhani NO, 1996, J BIOL CHEM, V271, P33414, DOI 10.1074/jbc.271.52.33414; Keyhani NO, 1996, J BIOL CHEM, V271, P33409, DOI 10.1074/jbc.271.52.33409; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; LUCKEY M, 1980, BIOCHEM BIOPH RES CO, V93, P166, DOI 10.1016/S0006-291X(80)80261-0; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; Mahendran KR, 2009, EUR BIOPHYS J BIOPHY, V38, P1141, DOI 10.1007/s00249-009-0495-0; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Orlik F, 2002, BIOPHYS J, V82, P2466, DOI 10.1016/S0006-3495(02)75589-6; Orlik F, 2002, BIOPHYS J, V83, P309, DOI 10.1016/S0006-3495(02)75171-0; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; Park JK, 2002, J BIOL CHEM, V277, P15573, DOI 10.1074/jbc.M107953200; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Suginta W, 2005, FEBS J, V272, P3376, DOI 10.1111/j.1742-4658.2005.04753.x; Suginta W, 2004, ARCH BIOCHEM BIOPHYS, V424, P171, DOI 10.1016/j.abb.2004.01.017; Suginta W, 2000, J APPL MICROBIOL, V89, P76, DOI 10.1046/j.1365-2672.2000.01076.x; Suginta W, 2007, BBA-GEN SUBJECTS, V1770, P1151, DOI 10.1016/j.bbagen.2007.03.012; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; TRIAS J, 1988, BIOCHIM BIOPHYS ACTA, V938, P493, DOI 10.1016/0005-2736(88)90148-4; Van Gelder P, 2000, BIOPHYS CHEM, V85, P153, DOI 10.1016/S0301-4622(99)00153-2; WYLIE JL, 1994, EUR J BIOCHEM, V220, P505, DOI 10.1111/j.1432-1033.1994.tb18649.x; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; YU C, 1991, J BIOL CHEM, V266, P24260; Zeth K, 2000, STRUCTURE, V8, P981, DOI 10.1016/S0969-2126(00)00189-1; Zobell CE, 1938, J BACTERIOL, V35, P275, DOI 10.1128/JB.35.3.275-287.1938	52	33	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55126	10.1371/journal.pone.0055126	http://dx.doi.org/10.1371/journal.pone.0055126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383078	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200043
J	Da, H; Jia, SJ; Meng, GL; Cheng, JH; Zhou, W; Xiong, Z; Mu, YJ; Liu, J				Da, Hu; Jia, Shuai-Jun; Meng, Guo-Lin; Cheng, Jian-Hua; Zhou, Wei; Xiong, Zhuo; Mu, Yun-Jing; Liu, Jian			The Impact of Compact Layer in Biphasic Scaffold on Osteochondral Tissue Engineering	PLOS ONE			English	Article							ARTICULAR-CARTILAGE REPAIR; IN-VITRO; CONSTRUCTS; DEFECTS; BONE; COMPOSITE; CHONDROCYTES; MORPHOLOGY; INTERFACE; HYPOXIA	The structure of an osteochondral biphasic scaffold is required to mimic native tissue, which owns a calcified layer associated with mechanical and separation function. The two phases of biphasic scaffold should possess efficient integration to provide chondrocytes and osteocytes with an independent living environment. In this study, a novel biphasic scaffold composed of a bony phase, chondral phase and compact layer was developed. The compact layer-free biphasic scaffold taken as control group was also fabricated. The purpose of current study was to evaluate the impact of the compact layer in the biphasic scaffold. Bony and chondral phases were seeded with autogeneic osteoblast-or chondrocyte-induced bone marrow stromal cells (BMSCs), respectively. The biphasic scaffolds-cells constructs were then implanted into osteochondral defects of rabbits' knees, and the regenerated osteochondral tissue was evaluated at 3 and 6 months after surgery. Anti-tensile and anti-shear properties of the compact layer-containing biphasic scaffold were significantly higher than those of the compact layer-free biphasic scaffold in vitro. Furthermore, in vivo studies revealed superior macroscopic scores, glycosaminoglycan (GAG) and collagen content, micro tomograph imaging results, and histological properties of regenerated tissue in the compact layer-containing biphasic scaffold compared to the control group. These results indicated that the compact layer could significantly enhance the biomechanical properties of biphasic scaffold in vitro and regeneration of osteochondral tissue in vivo, and thus represented a promising approach to osteochondral tissue engineering.	[Da, Hu; Meng, Guo-Lin; Liu, Jian] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Peoples R China; [Da, Hu; Cheng, Jian-Hua; Zhou, Wei] 82nd Hosp PLA, Huaian, Peoples R China; [Jia, Shuai-Jun] Shannxi Hosp Armed Police Force, Xian, Peoples R China; [Xiong, Zhuo] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China; [Mu, Yun-Jing] 309 Hosp PLA, Zhan Tan Si Clin, Beijing, Peoples R China	Air Force Military Medical University; Tsinghua University	Liu, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed & Traumatol, Xian 710032, Peoples R China.	jianliufmmu@sina.com			National Natural Science Foundation of China [31070860]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	work was supported by the National Natural Science Foundation of China (Grant No. 31070860, http://nsfc.pubmed.cn/f9fe39817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan KS, 2007, TISSUE ENG, V13, P167, DOI 10.1089/ten.2006.0081; Beris AE, 2005, INJURY, V36, pS14, DOI 10.1016/j.injury.2005.10.007; BULLOUGH PG, 1983, J BONE JOINT SURG BR, V65, P72, DOI 10.1302/0301-620X.65B1.6337169; Cao T, 2003, TISSUE ENG, V9, pS103, DOI 10.1089/10763270360697012; Chang CH, 2004, J BIOMED MATER RES B, V71B, P313, DOI 10.1002/jbm.b.30090; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187; Ghosh S, 2008, MAT SCI ENG C-BIO S, V28, P80, DOI 10.1016/j.msec.2006.12.012; Hughes L C, 2005, Eur Cell Mater, V9, P68; Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS182; Hunziker EB, 1999, CLIN ORTHOP RELAT R, pS135; Hwang YS, 2010, TISSUE ENG PT A, V16, P3033, DOI [10.1089/ten.tea.2010.0045, 10.1089/ten.TEA.2010.0045]; Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009; Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442; Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005; Khanarian NT, 2012, BIOMATERIALS, V33, P5247, DOI 10.1016/j.biomaterials.2012.03.076; Koh JL, 2004, AM J SPORT MED, V32, P317, DOI 10.1177/0363546503261730; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lima EG, 2008, BIOMATERIALS, V29, P4292, DOI 10.1016/j.biomaterials.2008.07.018; Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H; Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007; Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008; Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309; Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1; Oegema TR, 1997, MICROSC RES TECHNIQ, V37, P324, DOI 10.1002/(SICI)1097-0029(19970515)37:4<324::AID-JEMT7>3.0.CO;2-K; Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; REDLER I, 1975, CLIN ORTHOP RELAT R, P357; Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7; Schaefer D, 2002, ARTHRITIS RHEUM-US, V46, P2524, DOI 10.1002/art.10493; Schek RM, 2004, ORTHOD CRANIOFAC RES, V8, P313; Scotti C, 2010, BIOMATERIALS, V31, P2252, DOI 10.1016/j.biomaterials.2009.11.110; Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040; Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5; Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Sun Xiao-tang, 2006, Chin J Traumatol, V9, P381; Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008; Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169; Urrutia J, 2010, J CLIN NEUROSCI, V17, P481, DOI 10.1016/j.jocn.2009.06.024; Wang CJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/579141; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Yang F, 2006, BIOMATERIALS, V27, P4923, DOI 10.1016/j.biomaterials.2006.05.028; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	51	49	56	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54838	10.1371/journal.pone.0054838	http://dx.doi.org/10.1371/journal.pone.0054838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382984	Green Submitted, gold, Green Published			2022-12-27	WOS:000315211500034
J	Nosyk, B; Colley, G; Yip, B; Chan, K; Heath, K; Lima, VD; Gilbert, M; Hogg, RS; Harrigan, PR; Montaner, JSG				Nosyk, Bohdan; Colley, Guillaume; Yip, Benita; Chan, Keith; Heath, Katherine; Lima, Viviane D.; Gilbert, Mark; Hogg, Robert S.; Harrigan, P. Richard; Montaner, Julio S. G.		STOP HIV AIDS Study Grp	Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada	PLOS ONE			English	Article							PREVALENCE; VERIFICATION; PREVENTION; PEOPLE; CARE	Objective: To define a population-level cohort of individuals infected with the human immunodeficiency virus (HIV) in the province of British Columbia from available registries and administrative datasets using a validated case-finding algorithm. Methods: Individuals were identified for possible cohort inclusion from the BC Centre for Excellence in HIV/AIDS (CfE) drug treatment program (antiretroviral therapy) and laboratory testing datasets (plasma viral load (pVL) and CD4 diagnostic test results), the BC Centre for Disease Control (CDC) provincial HIV surveillance database (positive HIV tests), as well as databases held by the BC Ministry of Health (MoH); the Discharge Abstract Database (hospitalizations), the Medical Services Plan (physician billing) and PharmaNet databases (additional HIV-related medications). A validated case-finding algorithm was applied to distinguish true HIV cases from those likely to have been misclassified. The sensitivity of the algorithms was assessed as the proportion of confirmed cases (those with records in the CfE, CDC and MoH databases) positively identified by each algorithm. A priori hypotheses were generated and tested to verify excluded cases. Results: A total of 25,673 individuals were identified as having at least one HIV-related health record. Among 9,454 unconfirmed cases, the selected case-finding algorithm identified 849 individuals believed to be HIV-positive. The sensitivity of this algorithm among confirmed cases was 88%. Those excluded from the cohort were more likely to be female (44.4% vs. 22.5%; p<0.01), had a lower mortality rate (2.18 per 100 person years (100PY) vs. 3.14/100PY; p<0.01), and had lower median rates of health service utilization (days of medications dispensed: 9745/100PY vs. 10266/100PY; p<0.01; days of inpatient care: 29/100PY vs. 98/100PY; p<0.01; physician billings: 602/100PY vs. 2,056/100PY; p<0.01). Conclusions: The application of validated case-finding algorithms and subsequent hypothesis testing provided a strong framework for defining a population-level cohort of HIV infected people in BC using administrative databases.	[Nosyk, Bohdan; Colley, Guillaume; Yip, Benita; Chan, Keith; Heath, Katherine; Lima, Viviane D.; Hogg, Robert S.; Harrigan, P. Richard; Montaner, Julio S. G.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane D.; Harrigan, P. Richard; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Div Aids, Vancouver, BC V5Z 1M9, Canada; [Gilbert, Mark] BC Ctr Dis Control, Clin Prevent Serv, Vancouver, BC, Canada; [Gilbert, Mark] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; Simon Fraser University	Montaner, JSG (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	jmontaner@cfenet.ubc.ca		Hogg, Robert/0000-0003-3463-5488	BC Ministry of Health-funded 'Seek and treat for optimal prevention of HIV & AIDS' pilot project; Abbott; Biolytical; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Janssen; Merck; ViiV Healthcare; Ministry of Health Services; Ministry of Healthy Living and Sport; Province of British Columbia; National Institute of Drug Abuse, at the US National Institutes of Health [1DP1DA026182]; International AIDS Society; United Nations AIDS Program; World Health Organization; National Institute on Drug Abuse; National Institutes of Health Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); Bill & Melinda Gates Foundation; French National Agency for Research on AIDS & Viral Hepatitis (ANRS); Public Health Agency of Canada; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033851, R01DA036307, R01DA032551] Funding Source: NIH RePORTER	BC Ministry of Health-funded 'Seek and treat for optimal prevention of HIV & AIDS' pilot project; Abbott(Abbott Laboratories); Biolytical; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); ViiV Healthcare; Ministry of Health Services; Ministry of Healthy Living and Sport; Province of British Columbia; National Institute of Drug Abuse, at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health Research-Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); French National Agency for Research on AIDS & Viral Hepatitis (ANRS); Public Health Agency of Canada; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the BC Ministry of Health-funded 'Seek and treat for optimal prevention of HIV & AIDS' pilot project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. JSGM has received grants from Abbott, Biolytical, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. He is also supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); and through an Avant-Garde Award (No. 1DP1DA026182) from the National Institute of Drug Abuse, at the US National Institutes of Health. He has also received support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institute on Drug Abuse, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), Bill & Melinda Gates Foundation, French National Agency for Research on AIDS & Viral Hepatitis (ANRS), Public Health Agency of Canada. These do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1999, EPIDEMIOLOGIC METHOD; Antoniou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021748; BC Centre for Disease Control, 2012, BRIT COL HIV PREV IN; BC Centre for Excellence in HIV/AIDS, 2010, STOP HIV AIDS PIL PR; BC Ministry of Health, EL ENR; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Burns DN, 2010, CLIN INFECT DIS, V51, P725, DOI 10.1086/655889; Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5; Cohen MS, 2011, NEW ENGL J MED, DOI [10.1056/NEJMoa1105243, DOI 10.1056/NEJMOAL105243]; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Guttmann A, 2010, PEDIATR DIABETES, V11, P122, DOI 10.1111/j.1399-5448.2009.00539.x; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; KEYES M, 1991, J ACQ IMMUN DEF SYND, V4, P1015; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Lima VD, 2010, CAN J PUBLIC HEALTH, V101, P44, DOI 10.1007/BF03405561; Lix L, 2006, DEFINING VALIDATING; Manuel DG, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-174; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; WHO, 2012, M REP FRAM METR SUPP; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	26	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54416	10.1371/journal.pone.0054416	http://dx.doi.org/10.1371/journal.pone.0054416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382898	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500012
J	Schultke, E; Trippel, M; Brauer-Krisch, E; Renier, M; Bartzsch, S; Requardt, H; Dobrossy, MD; Nikkhah, G				Schueltke, Elisabeth; Trippel, Michael; Braeuer-Krisch, Elke; Renier, Michel; Bartzsch, Stefan; Requardt, Herwig; Doebroessy, Mate D.; Nikkhah, Guido			Pencilbeam Irradiation Technique for Whole Brain Radiotherapy: Technical and Biological Challenges in a Small Animal Model	PLOS ONE			English	Article							MICROBEAM RADIATION-THERAPY; X-RAY-BEAMS; 9L GLIOSARCOMA; SYNCHROTRON	We have conducted the first in-vivo experiments in pencilbeam irradiation, a new synchrotron radiation technique based on the principle of microbeam irradiation, a concept of spatially fractionated high-dose irradiation. In an animal model of adult C57 BL/6J mice we have determined technical and physiological limitations with the present technical setup of the technique. Fifty-eight animals were distributed in eleven experimental groups, ten groups receiving whole brain radiotherapy with arrays of 50 mu m wide beams. We have tested peak doses ranging between 172 Gy and 2,298 Gy at 3 mm depth. Animals in five groups received whole brain radiotherapy with a center-to-center (ctc) distance of 200 mu m and a peak-to-valley ratio (PVDR) of similar to 100, in the other five groups the ctc was 400 mm (PVDR similar to 400). Motor and memory abilities were assessed during a six months observation period following irradiation. The lower dose limit, determined by the technical equipment, was at 172 Gy. The LD50 was about 1,164 Gy for a ctc of 200 mu m and higher than 2,298 Gy for a ctc of 400 mu m. Age-dependent loss in motor and memory performance was seen in all groups. Better overall performance (close to that of healthy controls) was seen in the groups irradiated with a ctc of 400 mu m.	[Schueltke, Elisabeth; Trippel, Michael; Doebroessy, Mate D.; Nikkhah, Guido] Univ Freiburg, Med Ctr, Div Stereotact & Funct Neurosurg, Hugstetter Str 55, D-79106 Freiburg, Germany; [Braeuer-Krisch, Elke; Renier, Michel; Requardt, Herwig] ESRF, Grenoble, France; [Bartzsch, Stefan] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany	University of Freiburg; European Synchrotron Radiation Facility (ESRF); Helmholtz Association; German Cancer Research Center (DKFZ)	Schultke, E (corresponding author), Univ Freiburg, Med Ctr, Div Stereotact & Funct Neurosurg, Hugstetter Str 55, D-79106 Freiburg, Germany.	elisabeth.schueltke@uniklinik-freiburg.de	Schultke, Elisabeth/M-3959-2013; Dobrossy, Mate/AAL-7897-2021; Brauer-Krisch, Elke/O-6026-2017	Dobrossy, Mate/0000-0002-0187-2252; Bartzsch, Stefan/0000-0001-9550-9122; Brauer-Krisch, Elke/0000-0003-4587-1160	FP 7 Programme of the European Union [PIRG07-GA-2010]; Research Commission of the Faculty of Medicine at the Albert-Ludwigs-University Freiburg	FP 7 Programme of the European Union; Research Commission of the Faculty of Medicine at the Albert-Ludwigs-University Freiburg	Dr. Schultke holds a Marie-Curie-Reintegration Grant from the FP 7 Programme of the European Union (PIRG07-GA-2010; http://cordis.europa.eu/fp7/dc/index.cfm?fuseaction = UserSite.peopleDetailsCallPage&call_id = 168). Drs. Schultke and Trippel received funding from the Research Commission of the Faculty of Medicine at the Albert-Ludwigs-University Freiburg (no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ISP EBT PRODUCT BRIE; [Anonymous], GAFCHR HD 810 RAD DO; Bouchet A, 2010, INT J RADIAT ONCOL, V78, P1503, DOI 10.1016/j.ijrobp.2010.06.021; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Brauer-Krisch E, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3170035; Brauer-Krisch E, 2009, IFMBE P, V25, P174, DOI [10.1007/978-3-642-03902-7-49, DOI 10.1007/978-3-642-03902-7-49]; D'Ambrosio DJ, 2007, J NEURO-ONCOL, V85, P77, DOI 10.1007/s11060-007-9384-5; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Kerklaan JP, 2011, J NEUROL, V258, P1098, DOI 10.1007/s00415-010-5892-x; Laissue JA, 2001, P SOC PHOTO-OPT INS, V4508, P65, DOI 10.1117/12.450774; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Martinez-Rovira I, 2012, MED PHYS, V39, P119, DOI 10.1118/1.3665768; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Qiu D, 2007, INT J RADIAT ONCOL, V69, P846, DOI 10.1016/j.ijrobp.2007.04.041; Regnard P, 2008, PHYS MED BIOL, V53, P861, DOI 10.1088/0031-9155/53/4/003; Schultke E, 2008, EUR J RADIOL, V68, pS142, DOI 10.1016/j.ejrad.2008.04.051; Serduc R, 2009, PHYS MED BIOL, V54, P6711, DOI 10.1088/0031-9155/54/21/017; Shi L, 2009, J NEUROL SCI, V285, P178, DOI 10.1016/j.jns.2009.06.031; Szerlip N, 2011, J NEURO-ONCOL, V103, P111, DOI 10.1007/s11060-010-0358-7; Uyama A, 2011, J SYNCHROTRON RADIAT, V18, P1	21	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54960	10.1371/journal.pone.0054960	http://dx.doi.org/10.1371/journal.pone.0054960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383014	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500040
J	Brenna, O; Furnes, MW; Drozdov, I; Granlund, AV; Flatberg, A; Sandvik, AK; Zwiggelaar, RTM; Marvik, R; Nordrum, IS; Kidd, M; Gustafsson, BI				Brenna, Oystein; Furnes, Marianne W.; Drozdov, Ignat; Granlund, Atle van Beelen; Flatberg, Arnar; Sandvik, Arne K.; Zwiggelaar, Rosalie T. M.; Marvik, Ronald; Nordrum, Ivar S.; Kidd, Mark; Gustafsson, Bjorn I.			Relevance of TNBS-Colitis in Rats: A Methodological Study with Endoscopic, Historical and Transcripttomic Characterization and Correlation to IBD	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACTIVATED RECEPTOR-GAMMA; TRINITROBENZENE SULFONIC-ACID; CELLULAR PRION PROTEIN; TOLL-LIKE RECEPTORS; GENE-EXPRESSION; INTESTINAL EPITHELIUM; ULCERATIVE-COLITIS; BINDING PROTEIN; CROHNS-DISEASE	Background: Rectal instillation of trinitrobenzene sulphonic acid (TNBS) in ethanol is an established model for inflammatory bowel disease (IBD). We aimed to 1) set up a TNBS-colitis protocol resulting in an endoscopic and histologic picture resembling IBD, 2) study the correlation between endoscopic, histologic and gene expression alterations at different time points after colitis induction, and 3) compare rat and human IBD mucosal transcriptomic data to evaluate whether TNBS-colitis is an appropriate model of IBD. Methodology/Principal Findings: Five female Sprague Daley rats received TNBS diluted in 50% ethanol (18 mg/0.6 ml) rectally. The rats underwent colonoscopy with biopsy at different time points. RNA was extracted from rat biopsies and microarray was performed. PCR and in situ hybridization (ISH) were done for validation of microarray results. Rat microarray profiles were compared to human IBD expression profiles (25 ulcerative colitis Endoscopic score demonstrated mild to moderate colitis after three and seven days, but declined after twelve days. Histologic changes corresponded with the endoscopic appearance. Over-represented Gene Ontology Biological Processes included: Cell Adhesion, Immune Response, Lipid Metabolic Process, and Tissue Regeneration. IL-1 alpha, IL-1 beta, TLR2, TLR4, PRNP were all significantly up-regulated, while PPAR gamma was significantly down-regulated. Among genes with highest fold change (FC) were SPINK4, LBP, ADA, RETNLB and IL-1 alpha. The highest concordance in differential expression between TNBS and IBD transcriptomes was three days after colitis induction. ISH and PCR results corresponded with the microarray data. The most concordantly expressed biologically relevant pathways included TNF signaling, Cell junction organization, and Interleukin-1 processing. Conclusions/Significance: Endoscopy with biopsies in TNBS-colitis is useful to follow temporal changes of inflammation visually and histologically, and to acquire tissue for gene expression analyses. TNBS-colitis is an appropriate model to study specific biological processes in IBD.	[Brenna, Oystein; Sandvik, Arne K.; Gustafsson, Bjorn I.] Univ Trondheim Hosp, St Olavs Hosp, Dept Gastroenterol & Hepatol, Trondheim, Norway; [Brenna, Oystein; Furnes, Marianne W.; Granlund, Atle van Beelen; Flatberg, Arnar; Sandvik, Arne K.; Zwiggelaar, Rosalie T. M.; Marvik, Ronald; Nordrum, Ivar S.; Gustafsson, Bjorn I.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Drozdov, Ignat] Bering Ltd, Richmond, Surrey, England; [Marvik, Ronald] Univ Trondheim Hosp, St Olavs Hosp, Dept Gastrointestinal Surg, Trondheim, Norway; [Nordrum, Ivar S.] Univ Trondheim Hosp, St Olavs Hosp, Dept Pathol & Med Genet, Trondheim, Norway; [Kidd, Mark] Yale Univ, Sch Med, Dept Surg, Gastroenterol Sect, New Haven, CT 06510 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Yale University	Brenna, O (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Gastroenterol & Hepatol, Trondheim, Norway.	Oystein.Brenna@stolav.no	Brenna, Øystein/AAH-2774-2020	Granlund, Atle van Beelen/0000-0001-8117-2637; Drozdov, Ignat/0000-0001-6727-4688	NIH [DK080871]; National Technology Microarray Platform (Norwegian Microarray Consortium); DMF/NTNU [96990]; Kontaktutvalget, St. Olavs Hospital, Trondheim University Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Technology Microarray Platform (Norwegian Microarray Consortium); DMF/NTNU; Kontaktutvalget, St. Olavs Hospital, Trondheim University Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Kontaktutvalget, St. Olavs Hospital, Trondheim University Hospital and DMF/NTNU (Project number 96990)(BIG); MK is supported by NIH DK080871; The microarray work was carried out with support from the National Technology Microarray Platform (Norwegian Microarray Consortium) funded the Functional Genomics Programme (FUGE) of the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Akcan A, 2008, WORLD J GASTROENTERO, V14, P918, DOI 10.3748/wjg.14.918; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Antonioli L, 2007, J PHARMACOL EXP THER, V322, P435, DOI 10.1124/jpet.107.122762; Antonioli L, 2010, J PHARMACOL EXP THER, V335, P434, DOI 10.1124/jpet.110.171223; Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Brinkman BM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.101; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Celinski K, 2011, MED SCI MONITOR, V17, pBR116, DOI 10.12659/MSM.881712; Chen Y, 2009, J GASTROEN HEPATOL, V24, P912, DOI 10.1111/j.1440-1746.2008.05721.x; Cominelli F, 1996, ALIMENT PHARM THERAP, V10, P49, DOI 10.1046/j.1365-2036.1996.22164020.x; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; Dooley TP, 2004, INFLAMM BOWEL DIS, V10, P1, DOI 10.1097/00054725-200401000-00001; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Drozdov Ignat, 2011, BMC Res Notes, V4, P462, DOI 10.1186/1756-0500-4-462; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Fang K, 2011, PHYSIOL GENOMICS, V43, P43, DOI 10.1152/physiolgenomics.00138.2010; FERRETTI M, 1994, J CLIN INVEST, V94, P449, DOI 10.1172/JCI117345; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; Gollamudi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036191; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Granlund AV, 2011, SCAND J GASTROENTERO, V46, P1316, DOI 10.3109/00365521.2011.605463; Guarner F, 2003, BEST PRACT RES CL GA, V17, P793, DOI 10.1016/S1521-6918(03)00068-4; Hasler R, 2012, GENOME RES, V22, P2130, DOI 10.1101/gr.138347.112; Hammer HF, 2011, DIGEST DIS, V29, P550, DOI 10.1159/000332981; Heimerl S, 2006, BBA-MOL BASIS DIS, V1762, P341, DOI 10.1016/j.bbadis.2005.12.006; Hogan SP, 2006, J ALLERGY CLIN IMMUN, V118, P257, DOI 10.1016/j.jaci.2006.04.039; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Hugot JP, 2005, GASTROENTEROLOGY, V128, P500, DOI 10.1053/j.gastro.2004.12.041; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim I, 2009, PHARM RES-DORDR, V26, P415, DOI 10.1007/s11095-008-9758-1; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Knollmann FD, 2002, J MAGN RESON IMAGING, V15, P165, DOI 10.1002/jmri.10054; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lakatos PL, 2011, INFLAMM BOWEL DIS, V17, P767, DOI 10.1002/ibd.21402; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee J, 2008, SEMIN IMMUNOPATHOL, V30, P3, DOI 10.1007/s00281-007-0099-7; Lee J, 2006, ANN NY ACAD SCI, V1072, P351, DOI 10.1196/annals.1326.022; Lehrke M, 2008, SCAND J GASTROENTERO, V43, P283, DOI 10.1080/00365520701679249; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; MacDonald TT, 2012, INFLAMM BOWEL DIS, V18, P2180, DOI 10.1002/ibd.22967; Marcos Z, 2004, J HISTOCHEM CYTOCHEM, V52, P1357, DOI 10.1369/jhc.4A6321.2004; Martin GR, 2011, AM J PATHOL, V179, P2290, DOI 10.1016/j.ajpath.2011.07.025; Martinez-Augustin O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-490; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mitsuyama K, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/26875; Mizoguchi A, 2012, PROG MOL BIOL TRANSL, V105, P263, DOI 10.1016/B978-0-12-394596-9.00009-3; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Ohta N, 2003, NUTR RES, V23, P279, DOI 10.1016/S0271-5317(02)00511-0; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ostvik AE, 2012, INFLAMM BOWEL DIS; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Pan XQ, 2010, EXP NEUROL, V225, P262, DOI 10.1016/j.expneurol.2010.05.012; Pastorelli Luca, 2011, Therap Adv Gastroenterol, V4, P311, DOI 10.1177/1756283X11410770; Petit CS, 2012, GASTROENTEROLOGY, V143, P122; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Pohlmann A, 2009, INFLAMM BOWEL DIS, V15, P534, DOI 10.1002/ibd.20800; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rieder F, 2008, CURR OPIN GASTROEN, V24, P462, DOI 10.1097/MOG.0b013e3282ff8b36; Sanchez-Hidalgo M, 2007, EUR J PHARMACOL, V562, P247, DOI 10.1016/j.ejphar.2007.01.047; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Shen C, 2007, INFLAMM BOWEL DIS, V13, P308, DOI 10.1002/ibd.20005; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; SHIBATA Y, 1993, GASTROENTEROL JPN, V28, P518; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Sugawara K, 2005, GASTROENTEROLOGY, V128, P351, DOI 10.1053/j.gastro.2004.11.001; Uza N, 2011, GUT, V60, P1494, DOI 10.1136/gut.2010.221879; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; Vermeulen W, 2011, ACTA GASTRO-ENT BELG, V74, P304; WALLACE JL, 1995, J PHARMACOL TOXICOL, V33, P237, DOI 10.1016/1056-8719(95)00001-X; Wang DZ, 2010, GASTROENTEROL CLIN N, V39, P697, DOI 10.1016/j.gtc.2010.08.014; Wapenaar MC, 2007, IMMUNOGENETICS, V59, P349, DOI 10.1007/s00251-007-0199-5; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898	105	50	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54543	10.1371/journal.pone.0054543	http://dx.doi.org/10.1371/journal.pone.0054543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382912	Green Published, Green Accepted, gold			2022-12-27	WOS:000314610600030
J	Freling, HG; Pieper, PG; Vermeulen, KM; van Swieten, JM; Sijens, PE; van Veldhuisen, DJ; Willems, TP				Freling, Hendrik G.; Pieper, Petronella G.; Vermeulen, Karin M.; van Swieten, Jeroen M.; Sijens, Paul E.; van Veldhuisen, Dirk J.; Willems, Tineke P.			Improved Cardiac MRI Volume Measurements in Patients with Tetralogy of Fallot by Independent End-Systolic and End-Diastolic Phase Selection	PLOS ONE			English	Article							PULMONARY VALVE-REPLACEMENT; CARDIOVASCULAR MAGNETIC-RESONANCE; CONGENITAL HEART-DISEASE; REPAIRED TETRALOGY; AGE; ECHOCARDIOGRAPHY; DYSSYNCHRONY; DYSFUNCTION; GUIDELINES; MANAGEMENT	Objectives: To investigate to what extent cardiac MRI derived measurements of right ventricular (RV) volumes using the left ventricular (LV) end-systolic and end-diastolic frame misrepresent RV end-systolic and end-diastolic volumes in patients with tetralogy of Fallot (ToF) and a right bundle branch block. Methods: Sixty-five cardiac MRI scans of patients with ToF and a right bundle branch block, and 50 cardiac MRI scans of control subjects were analyzed. RV volumes and function using the end-systolic and end-diastolic frame of the RV were compared to using the end-systolic and end-diastolic frame of the LV. Results: Timing of the RV end-systolic frame was delayed compared to the LV end-systolic frame in 94% of patients with ToF and in 50% of control subjects. RV end-systolic volume using the RV end-systolic instead of LV end-systolic frame was smaller in ToF (median -3.3 ml/m(2), interquartile range -1.9 to 25.6 ml/m(2); p<0.001) and close to unchanged in control subjects. Using the RV instead of LV end-systolic and end-diastolic frame hardly affected RV end-diastolic volumes in both groups and ejection fraction in control subjects (54 +/- 4%, both methods), while increasing ejection fraction from 45 +/- 7% to 48 +/- 7% for patients with ToF (p<0.001). QRS duration correlated positively with the changes in the RV end-systolic volume (p<0.001) and RV ejection fraction obtained in ToF patients when using the RV instead of the LV end-systolic and end-diastolic frame (p=0.004). Conclusion: For clinical decision making in ToF patients RV volumes derived from cardiac MRI should be measured in the end-systolic frame of the RV instead of the LV.	[Freling, Hendrik G.; van Swieten, Jeroen M.; Sijens, Paul E.; Willems, Tineke P.] Univ Groningen, Dept Radiol, Groningen, Netherlands; [Freling, Hendrik G.; Pieper, Petronella G.; Vermeulen, Karin M.; van Swieten, Jeroen M.; Sijens, Paul E.; van Veldhuisen, Dirk J.; Willems, Tineke P.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Pieper, Petronella G.; van Veldhuisen, Dirk J.] Univ Groningen, Dept Cardiol, Groningen, Netherlands; [Vermeulen, Karin M.] Univ Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Willems, TP (corresponding author), Univ Groningen, Dept Radiol, Groningen, Netherlands.	t.p.willems@umcg.nl	van Veldhuisen, Dirk Jan/E-8967-2014		radiology department University of Groningen	radiology department University of Groningen	This study was supported by the radiology department University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfakih K, 2003, J MAGN RESON IMAGING, V17, P323, DOI 10.1002/jmri.10262; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Buechel ERV, 2005, EUR HEART J, V26, P2721, DOI 10.1093/eurheartj/ehi581; Clarke CJ, 2012, JACC-CARDIOVASC IMAG, V5, P28, DOI 10.1016/j.jcmg.2011.05.007; CULLEN S, 1995, CIRCULATION, V91, P1782, DOI 10.1161/01.CIR.91.6.1782; D'Andrea A, 2004, Eur J Echocardiogr, V5, P123, DOI 10.1016/S1525-2167(03)00053-2; Edwards R, 2009, INT J CARDIOVAS IMAG, V25, P791, DOI 10.1007/s10554-009-9496-4; Frigiola A, 2004, CIRCULATION, V110, pII153, DOI 10.1161/01.CIR.0000138397.60956.c2; Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825; GELBAND H, 1971, CIRCULATION, V44, P1022, DOI 10.1161/01.CIR.44.6.1022; Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9; Maceira AM, 2006, EUR HEART J, V27, P2879, DOI 10.1093/eurheartj/ehl336; Mirvis DM, 2011, BRAUNWALDS HEART DIS, P126; Mueller M, 2010, EUR J ECHOCARDIOGR, V11, P786, DOI 10.1093/ejechocard/jeq067; Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664; Sun AM, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-43; Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037; van den Berg J, 2007, RADIOLOGY, V243, P212, DOI 10.1148/radiol.2431060213; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Yu CM, 2003, ECHOCARDIOGR-J CARD, V20, P19, DOI 10.1046/j.1540-8175.2003.00003.x	20	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55462	10.1371/journal.pone.0055462	http://dx.doi.org/10.1371/journal.pone.0055462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383197	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600106
J	Jiang, LL; Song, LB; Wu, JH; Yang, Y; Zhu, X; Hu, B; Cheng, SY; Li, MF				Jiang, Lili; Song, Libing; Wu, Jueheng; Yang, Yi; Zhu, Xun; Hu, Bo; Cheng, Shi-Yuan; Li, Mengfeng			Bmi-1 Promotes Glioma Angiogenesis by Activating NF-kappa B Signaling	PLOS ONE			English	Article							CELL-PROLIFERATION; TUMOR ANGIOGENESIS; STEM-CELLS; EXPRESSION; GROWTH; CANCER; LOCUS; GLIOMAGENESIS; PROGRESSION; METASTASIS	Angiogenesis in glioma is associated with the poor prognosis of the disease and closely correlates with the highly invasive phenotype of glioma cells, which represents the most challenging impediment against the currently glioma treatments. Bmi-1, an onco-protein, has been implicated in the progression of various human cancers, including gliomas, whereas its role in glioma angiogenesis remains unclear. Our current study examined the effects of Bmi-1 on glioma angiogenesis in vitro as well as in vivo. We found that overexpression of Bmi-1 enhanced, whereas knockdown of Bmi-1 diminished, the capability of glioma cells to induce tubule formation and migration of endothelial cells and neovascularization in chicken chorioallantoic membrane. In vivo, Bmi-1 overexpression and knockdown, respectively, promoted and inhibited angiogenesis in orthotopically transplanted human gliomas. Furthermore, NF-kappa B activity and VEGF-C expression was induced by Bmi-1 overexpression, whereas Bmi-1 knockdown attenuated NF-kappa B signaling and decreased VEGF-C expression. Additionally suppression of NF-kappa B activity using a specific chemical inhibitor abrogated the NF-kappa B activation and the pro-angiogenic activities of glioma cells. Together, our data suggest that Bmi-1 plays an important role in glioma angiogenesis and therefore could represent a potential target for anti-angiogenic therapy against the disease.	[Jiang, Lili] Guangzhou Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Song, Libing] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jueheng; Zhu, Xun; Li, Mengfeng] Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yi] Sun Yat Sen Univ, Dept Pharmacol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jueheng; Yang, Yi; Zhu, Xun; Li, Mengfeng] Sun Yat Sen Univ, Chinese Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Bo; Cheng, Shi-Yuan] Northwestern Univ, Dept Neurol, NW Brain Tumor Inst, Ctr Genet Med,Feinberg Sch Med, Chicago, IL 60611 USA; [Hu, Bo; Cheng, Shi-Yuan] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Li, MF (corresponding author), Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	limf@mail.sysu.edu.cn	Song, LB/AAL-1968-2020; meng, li/GVT-2063-2022		Natural Science Foundation of China [81071762, 81071780, 81101680]; National Science and Technique Major Project [201005022-2, 2012ZX09102101-017, 2012ZX10004213, 311030]; Key Science and Technique Research Project of Guangdong Province [2010B030600003, 2009010058]; Science and Technology Department of Guangdong Province, China [S2011020002757]; NATIONAL CANCER INSTITUTE [R01CA159811, R01CA130966] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technique Major Project; Key Science and Technique Research Project of Guangdong Province; Science and Technology Department of Guangdong Province, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Natural Science Foundation of China (81071762, 81071780, 81101680); National Science and Technique Major Project (201005022-2, 2012ZX09102101-017, 2012ZX10004213, 311030); The Key Science and Technique Research Project of Guangdong Province (2010B030600003, 2009010058); The Science and Technology Department of Guangdong Province, China (No. S2011020002757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Birlik B, 2006, NEUROPATH APPL NEURO, V32, P532, DOI 10.1111/j.1365-2990.2006.00763.x; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cea Valentina, 2012, J Signal Transduct, V2012, P483040, DOI 10.1155/2012/483040; Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176; Chowdhury M, 2007, LEUKEMIA, V21, P1116, DOI 10.1038/sj.leu.2404623; Clarke J, 2006, ARCH NEUROL-CHICAGO, V67, P279; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Guo BH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-10; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Hong TM, 2009, J NEURO-ONCOL, V93, P289, DOI 10.1007/s11060-008-9786-z; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jiang LL, 2012, J CLIN INVEST, V122, P33, DOI 10.1172/JCI58849; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Jiang LL, 2009, ACTA BIOCH BIOPH SIN, V41, P527, DOI 10.1093/abbs/gmp040; Leon SP, 1996, CANCER-AM CANCER SOC, V77, P362, DOI 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Lindstrom MS, 2001, ONCOGENE, V20, P2171, DOI 10.1038/sj.onc.1204303; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Meng X, 2012, LUNG CANC; Miyagami Mitsusuke, 2005, Medical Molecular Morphology, V38, P36, DOI 10.1007/s00795-004-0273-0; Orpana A, 2002, LEUKEMIA LYMPHOMA, V43, P219, DOI 10.1080/10428190290005964; Ribatti D, 2008, GENES NUTR, V3, P29, DOI 10.1007/s12263-008-0076-3; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor LP, 2010, NEUROLOGY, V75, pS28, DOI 10.1212/WNL.0b013e3181fb3661; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Yan CH, 2004, FASEB J, V18, P540, DOI 10.1096/fj.03-0960fje; Yu Q, 2000, GENE DEV, V14, P163; Zhang FB, 2008, BRIT J BIOMED SCI, V65, P172, DOI 10.1080/09674845.2008.11732824; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	44	34	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55527	10.1371/journal.pone.0055527	http://dx.doi.org/10.1371/journal.pone.0055527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383216	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600120
J	Parthsarathy, V; McClean, PL; Holscher, C; Taylor, M; Tinker, C; Jones, G; Kolosov, O; Salvati, E; Gregori, M; Masserini, M; Allsop, D				Parthsarathy, Vadivel; McClean, Paula L.; Hoelscher, Christian; Taylor, Mark; Tinker, Claire; Jones, Glynn; Kolosov, Oleg; Salvati, Elisa; Gregori, Maria; Masserini, Massimo; Allsop, David			A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							BETA-SHEET CONFORMATION; LONG-TERM POTENTIATION; FIBRIL FORMATION; IN-VIVO; OLIGOMERS; PROTEIN; AGGREGATION; CURCUMIN; FIBRILLOGENESIS; THERAPEUTICS	Previously, we have developed a retro-inverso peptide inhibitor (RI-OR2, rGffvlkGr) that blocks the in vitro formation and toxicity of the Ab oligomers which are thought to be a cause of neurodegeneration and memory loss in Alzheimer's disease. We have now attached a retro-inverted version of the HIV protein transduction domain 'TAT' to RI-OR2 to target this new inhibitor (RI-OR2-TAT, Ac-rGffvlkGrrrrqrrkkrGy-NH2) into the brain. Following its peripheral injection, a fluorescein-labelled version of RI-OR2-TAT was found to cross the blood brain barrier and bind to the amyloid plaques and activated microglial cells present in the cerebral cortex of 17-months-old APPswe/PS1 Delta E9 transgenic mice. Daily intraperitoneal injection of RI-OR2- TAT (at 100 nmol/kg) for 21 days into 10-months-old APPswe/PS1 Delta E9 mice resulted in a 25% reduction (p<0.01) in the cerebral cortex of A beta oligomer levels, a 32% reduction (p<0.0001) of beta-amyloid plaque count, a 44% reduction (p<0.0001) in the numbers of activated microglial cells, and a 25% reduction (p<0.0001) in oxidative damage, while the number of young neurons in the dentate gyrus was increased by 210% (p<0.0001), all compared to control APPswe/PS1 Delta E9 mice injected with vehicle (saline) alone. Our data suggest that oxidative damage, inflammation, and inhibition of neurogenesis are all a downstream consequence of A beta aggregation, and identify a novel brain-penetrant retro-inverso peptide inhibitor of A beta oligomer formation for further testing in humans as a potential disease-modifying treatment for Alzheimer's disease.	[Parthsarathy, Vadivel; McClean, Paula L.; Hoelscher, Christian] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Co Londonderry, North Ireland; [Taylor, Mark; Tinker, Claire; Jones, Glynn; Allsop, David] Univ Lancaster, Div Biomed & Life Sci, Lancaster, England; [Kolosov, Oleg] Univ Lancaster, Dept Phys, Lancaster, England; [Salvati, Elisa; Gregori, Maria; Masserini, Massimo] Univ Milano Bicocca, Dept Expt Med, Milan, Italy	Ulster University; Lancaster University; Lancaster University; University of Milano-Bicocca	Allsop, D (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Lancaster, England.	d.allsop@lancaster.ac.uk	Kolosov, Oleg V/D-3815-2013; Allsop, David/B-9725-2008	Kolosov, Oleg V/0000-0003-3278-9643; Allsop, David/0000-0002-0513-5575; Tinker-Mill, Claire/0000-0002-1981-3111; Parthsarathy, Vadivel/0000-0002-2037-7804; Holscher, Christian/0000-0002-8159-3260; McClean, Paula/0000-0002-3906-1172	Alzheimer's Research UK; EPSRC [EP/K023373/1] Funding Source: UKRI; Alzheimers Research UK [ART-ESG2009-4] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1064552, EP/K023373/1] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of this work was funded by a grant from Alzheimer's Research UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aguilar MI, 2005, NEUROTOX RES, V7, P17, DOI 10.1007/BF03033773; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Chafekar SM, 2007, CHEMBIOCHEM, V8, P1857, DOI 10.1002/cbic.200700338; Chen SY, 2011, BIOORGAN MED CHEM, V19, P5596, DOI 10.1016/j.bmc.2011.07.033; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cunningham C, 2012, J NEUROIMMUNE PHARM, V7, P60, DOI 10.1007/s11481-011-9312-5; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Findeis MA, 1999, BIOCHEMISTRY-US, V38, P6791, DOI 10.1021/bi982824n; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gordon DJ, 2001, BIOCHEMISTRY-US, V40, P8237, DOI 10.1021/bi002416v; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Holscher C, 1998, NEUROBIOL DIS, V5, P129, DOI 10.1006/nbdi.1998.0193; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Howlett DR, 2011, HISTOL HISTOPATHOL, V26, P1611, DOI 10.14670/HH-26.1611; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kagan BL, 2010, ADV EXP MED BIOL, V677, P150; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Klaver DW, 2010, BIOL CHEM, V391, P849, DOI 10.1515/BC.2010.089; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nunomura A, 2012, J NEUROPATH EXP NEUR, V71, P233, DOI 10.1097/NEN.0b013e318248e614; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.3.CO;2-5; Ramanathan S, 2009, MOL PHAR, V6, P836; Repici M, 2001, PHARM RES, V18, P950; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Taylor M, 2011, NANOMED-NANOTECHNOL, V7, P541, DOI 10.1016/j.nano.2011.06.015; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wolfe MS, 2008, NEUROTHERAPEUTICS, V5, P391, DOI 10.1016/j.nurt.2008.05.010; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhang GB, 2003, BIOCONJUGATE CHEM, V14, P86, DOI 10.1021/bc025526i; Zhang X, 2007, NEUROSCIENCE, V150, P950, DOI 10.1016/j.neuroscience.2007.09.059; Zhang Y, 2011, J ALZHEIMERS DIS, V23, P551, DOI 10.3233/JAD-2010-091195	55	63	66	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54769	10.1371/journal.pone.0054769	http://dx.doi.org/10.1371/journal.pone.0054769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382963	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600040
J	Geary, DC; Hoard, MK; Nugent, L; Bailey, DH				Geary, David C.; Hoard, Mary K.; Nugent, Lara; Bailey, Drew H.			Adolescents' Functional Numeracy Is Predicted by Their School Entry Number System Knowledge	PLOS ONE			English	Article							MATHEMATICAL LEARNING-DISABILITY; INDIVIDUAL-DIFFERENCES; NUMERICAL ESTIMATION; FRACTION SKILLS; YOUNG-CHILDREN; UNITED-STATES; ACHIEVEMENT; COMPETENCE; DEFICITS; COMPUTATION	One in five adults in the United States is functionally innumerate; they do not possess the mathematical competencies needed for many modern jobs. We administered functional numeracy measures used in studies of young adults' employability and wages to 180 thirteen-year-olds. The adolescents began the study in kindergarten and participated in multiple assessments of intelligence, working memory, mathematical cognition, achievement, and in-class attentive behavior. Their number system knowledge at the beginning of first grade was defined by measures that assessed knowledge of the systematic relations among Arabic numerals and skill at using this knowledge to solve arithmetic problems. Early number system knowledge predicted functional numeracy more than six years later (beta = 0.195, p = .0014) controlling for intelligence, working memory, in-class attentive behavior, mathematical achievement, demographic and other factors, but skill at using counting procedures to solve arithmetic problems did not. In all, we identified specific beginning of schooling numerical knowledge that contributes to individual differences in adolescents' functional numeracy and demonstrated that performance on mathematical achievement tests underestimates the importance of this early knowledge.	[Geary, David C.; Hoard, Mary K.; Nugent, Lara] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; [Geary, David C.] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA; [Bailey, Drew H.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Carnegie Mellon University	Geary, DC (corresponding author), Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA.	GearyD@Missouri.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [R37 HD045914]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045914] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by grant R37 HD045914 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DH, 2012, J EXP CHILD PSYCHOL, V113, P447, DOI 10.1016/j.jecp.2012.06.004; Berlin G., 1988, MORE PERFECT UNION B; Booth JL, 2006, DEV PSYCHOL, V42, P189, DOI 10.1037/0012-1649.41.6.189; Budgen S, 2011, COGN, V118, P32; Bynner JM, 1997, CAREER DEV Q, V45, P305, DOI 10.1002/j.2161-0045.1997.tb00536.x; Clements DH, 2011, J RES MATH EDUC, V42, P127; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Dyson NI, J LEARN DIS IN PRESS; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fuchs LS, 2006, J EDUC PSYCHOL, V98, P29, DOI 10.1037/0022-0663.98.1.29; Fuchs LS, 2010, DEV PSYCHOL, V46, P1731, DOI 10.1037/a0020662; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Geary D.C., 2010, BRIT J ED PSYCHOL 2, V7, P31, DOI [https://doi.org/10.1348/97818543370009X12583699332410, DOI 10.1348/97818543370009X12583699332410]; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Geary DC, 2012, J LEARN DISABIL-US, V45, P291, DOI 10.1177/0022219410392046; Geary DC, 2012, J EDUC PSYCHOL, V104, P206, DOI 10.1037/a0025398; Geary DC, 2011, DEV PSYCHOL, V47, P1539, DOI 10.1037/a0025510; Geary DC, 2009, J PSYCHOEDUC ASSESS, V27, P265, DOI 10.1177/0734282908330592; GEARY DC, 1990, J EXP CHILD PSYCHOL, V49, P363, DOI 10.1016/0022-0965(90)90065-G; Geary DC, 1997, PSYCHON B REV, V4, P425, DOI 10.3758/BF03210805; Gorsuch R., 1983, FACTOR ANAL; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Hecht SA, 2003, J EXP CHILD PSYCHOL, V86, P277, DOI 10.1016/j.jecp.2003.08.003; Hecht SA, 1998, J EDUC PSYCHOL, V90, P545, DOI 10.1037/0022-0663.90.3.545; Hudson C., 2009, LONG TERM COSTS NUME; Jordan NC, 2009, DEV PSYCHOL, V45, P850, DOI 10.1037/a0014939; LeFevre JA, 2010, CHILD DEV, V81, P1753, DOI 10.1111/j.1467-8624.2010.01508.x; Lyons IM, 2011, COGNITION, V121, P256, DOI 10.1016/j.cognition.2011.07.009; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Nunez Rafael, 2009, Biology Theory, V4, P68, DOI 10.1162/biot.2009.4.1.68; Parsons S., 1997, ED TRAIN, V39, P43, DOI 10.1108/00400919710164125; Pickering S., 2001, WORKING MEMORY TEST; Raven J. C, 1993, MANUAL RAVENS PROGRE; RIVERABATIZ FL, 1992, J HUM RESOUR, V27, P313, DOI 10.2307/145737; SAS Institute, 2004, STAT AN SYST 7 5; Siegler RS, 2012, PSYCHOL SCI, V23, P691, DOI 10.1177/0956797612440101; Siegler RS, 2004, CHILD DEV, V75, P428, DOI 10.1111/j.1467-8624.2004.00684.x; SIEGLER RS, 1987, J EXP PSYCHOL GEN, V116, P250, DOI DOI 10.1037/0096-3445.116.3.250; Swanson J. M., 2008, CATEGORICAL DIMENSIO; United States Center for Educational Statistics, 2007, 2007064 NCES US CTR; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2001, WECHSLER INDIVIDUAL, Vsecond	46	148	152	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54651	10.1371/journal.pone.0054651	http://dx.doi.org/10.1371/journal.pone.0054651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382934	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800061
J	Kang, JH; Yun, SI; Park, MH; Park, JH; Jeong, SY; Park, HO				Kang, Ji-Hee; Yun, Sung-Il; Park, Mi-Hee; Park, Jun-Hong; Jeong, So-Young; Park, Han-Oh			Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; LOW-PROTEIN; ADIPOCYTE SIZE; LINOLEIC-ACID; LIPID-CONTENT; BODY-WEIGHT; PROBIOTICS; EXPRESSION; INCREASES; CHOLESTEROL	Previously, we reported that Lactobacillus gasseri BNR17 (BNR17), a probiotic strain isolated from human breast milk, inhibited increases in body weight and adipocyte tissue weight in high-sucrose diet-fed Sprague-Dawley (SD) rats and reduced glucose levels in type 2 diabetes mice. In the current study, we conducted further experiments to extend these observations and elucidate the mechanism involved. C57BL/6J mice received a normal diet, high-sucrose diet or high-sucrose diet containing L. gasseri BNR17 (10(9) or 10(10) CFU) for 10 weeks. The administration of L. gasseri BNR17 significantly reduced the body weight and white adipose tissue weight regardless of the dose administered. In BNR17-fed groups, mRNA levels of fatty acid oxidation-related genes (ACO, CPT1, PPAR alpha, PPAR delta) were significantly higher and those of fatty acid synthesis-related genes (SREBP-1c, ACC) were lower compared to the high-sucrose-diet group. The expression of GLUT4, main glucose transporter-4, was elevated in BNR17-fed groups. L. gasseri BNR17 also reduced the levels of leptin and insulin in serum. These results suggest that the anti-obesity actions of L. gasseri BNR17 can be attributed to elevated expression of fatty acid oxidation-related genes and reduced levels of leptin. Additionally, data suggested the anti-diabetes activity of L. gasseri BNR17 may be to due elevated GLUT4 and reduced insulin levels.	[Kang, Ji-Hee; Yun, Sung-Il; Park, Mi-Hee; Park, Jun-Hong; Jeong, So-Young; Park, Han-Oh] Bioneer Corp, R&D Ctr, Taejon, South Korea		Kang, JH (corresponding author), Bioneer Corp, R&D Ctr, Taejon, South Korea.	arachnoa@pknu.ac.kr		Park, Jun hong/0000-0001-8905-4125	High Value-Added Food Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	High Value-Added Food Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by High Value-Added Food Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2007, J INTERN MED, V262, P184, DOI 10.1111/j.1365-2796.2007.01825.x; Ali AA, 2005, J NUTR BIOCHEM, V16, P693, DOI 10.1016/j.jnutbio.2005.03.011; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Blaut M, 2010, ANN NUTR METAB, V57, P20, DOI 10.1159/000309079; Buzelle SL, 2010, CAN J PHYSIOL PHARM, V88, P1157, DOI 10.1139/Y10-096; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Choi H, 2012, NUTR RES, V32, P100, DOI 10.1016/j.nutres.2011.12.013; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; de Franca SA, 2009, NUTRITION, V25, P1186, DOI 10.1016/j.nut.2009.03.011; dos Santos MP, 2012, LIPIDS, V47, P279, DOI 10.1007/s11745-011-3648-8; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fukuchi S, 2004, EXP BIOL MED, V229, P486, DOI 10.1177/153537020422900606; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gill H, 2008, ADV EXP MED BIOL, V606, P423, DOI 10.1007/978-0-387-74087-4_17; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; Ikarashi N, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep241; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392; Kouidhi S, 2011, ACTA DIABET IN PRESS; Kumar M, 2010, INT J FOOD SCI NUTR, V61, P473, DOI 10.3109/09637480903455971; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; Lee K, 2007, J APPL MICROBIOL, V103, P1140, DOI 10.1111/j.1365-2672.2007.03336.x; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Mennigen R, 2009, ANN NY ACAD SCI, V1165, P183, DOI 10.1111/j.1749-6632.2009.04059.x; Park DY, 2011, J MED FOOD, V14, P670, DOI 10.1089/jmf.2010.1355; Shin HS, 2010, ARCH PHARM RES, V33, P1425, DOI 10.1007/s12272-010-0917-7; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Sousa R, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-5; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Takemura N, 2010, EXP BIOL MED, V235, P849, DOI 10.1258/ebm.2010.009377; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wickelgren I, 1998, SCIENCE, V280, P1364, DOI 10.1126/science.280.5368.1364; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Xie N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-53; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x; Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x	41	114	121	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54617	10.1371/journal.pone.0054617	http://dx.doi.org/10.1371/journal.pone.0054617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382926	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800058
J	Mitchell, KM; Cox, AP; Mabey, D; Tucker, JD; Peeling, RW; Vickerman, P				Mitchell, Kate M.; Cox, Andrew P.; Mabey, David; Tucker, Joseph D.; Peeling, Rosanna W.; Vickerman, Peter			The Impact of Syphilis Screening among Female Sex Workers in China: A Modelling Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; CONDOM USE; TRANSMISSION DYNAMICS; COST-EFFECTIVENESS; MASS TREATMENT; HIGH-RISK; HIV; TESTS; INFECTIONS; CLIENTS	Background: In China, female sex workers (FSWs) are at high risk of syphilis infection, but are hard to reach for interventions. Point-of-care testing introduces opportunities for expanding syphilis control measures. Modelling is used to estimate the impact of using rapid tests to screen FSWs for syphilis. In other settings, modelling has predicted large rebounds in infectious syphilis following screening, which may undermine any impact achieved. Methods: A deterministic syphilis transmission model among FSWs and clients was fitted to data from Yunnan Province (FSW syphilis prevalence = 7.5%), and used to estimate the impact of rapid syphilis testing and treatment for FSWs. Impact projections were compared for different model structures that included risk heterogeneity amongst FSWs, incoming syphilis infections amongst new FSWs and clients and re-infection from FSWs' regular non-commercial partners. The rebound in syphilis prevalence after screening ceased was explored. Results: All model structures suggest yearly syphilis screening could substantially reduce (by 72-88%) syphilis prevalence amongst FSWs in this setting over five years. However, incoming syphilis infections amongst new FSWs and clients or re-infections from regular non-commercial partners of FSWs can considerably reduce (>30%) the proportion of infections averted. Including heterogeneity in risk amongst FSWs had little effect upon the proportion of infections averted. In this setting, the rebound in syphilis prevalence after screening ceased is predicted to be slight, but it could be large in high prevalence settings. Conclusions: Rapid test screening could dramatically reduce syphilis prevalence amongst hard-to-reach groups, but strategies to reduce re-infection from regular non-commercial partners are needed to maximise impact.	[Mitchell, Kate M.; Vickerman, Peter] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Cox, Andrew P.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Mabey, David; Tucker, Joseph D.; Peeling, Rosanna W.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Tucker, Joseph D.] Univ N Carolina, Sch Med, Chapel Hill, NC USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mitchell, KM (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	Kate.Mitchell@lshtm.ac.uk	Mitchell, Kate/ABE-5796-2020	Tucker, Joseph/0000-0003-2804-1181; Mabey, David/0000-0002-0031-8276; Vickerman, Peter/0000-0002-8291-5890	Bill and Melinda Gates Foundation [OPP47697]; FOGARTY INTERNATIONAL CENTER [K01TW008200] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Bill and Melinda Gates Foundation (www.gatesfoundation.org), grant number OPP47697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Briggs A, 2006, DECISION MODELLING H; Bruusgaard E, 1929, ARCH DERMATOL SYPH-G, V157, P309, DOI 10.1007/BF01959543; CDC, 1968, SYPH A SYN; Chen XS, 2011, SEX TRANSM INFECT, V87, pA2, DOI 10.1136/sextrans-2011-050102.7; China Centre for Disease Prevention and Control, 2004, NAT EP REP SEX TRANS; CLARK E G, 1955, J Chronic Dis, V2, P311, DOI 10.1016/0021-9681(55)90139-9; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Foss AM, 2009, SEX TRANSM INFECT, V85, P276, DOI 10.1136/sti.2008.032458; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; Herring A, 2006, NAT REV MICROBIOL, pS33, DOI 10.1038/nrmicro1563; Indian Council of Medical Research & Family Health International, 2007, NAT INT SUMM REP IND; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Lau JTF, 2009, SEX TRANSM INFECT, V85, P376, DOI 10.1136/sti.2008.035162; Lau JTF, 2002, AIDS CARE, V14, P219, DOI 10.1080/09540120220104721; Lin CC, 2006, SEX TRANSM DIS, V33, P726, DOI 10.1097/01.olq.0000222703.12018.58; LIU Dalin, 1997, SEXUAL BEHAV MODERN; Lowndes CM, 2000, AIDS, V14, P2523, DOI 10.1097/00002030-200011100-00015; Lukehart SA, 2008, SEXUALLY TRANSMITTED, P648; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; MAGNUSON HJ, 1956, MEDICINE, V35, P33, DOI 10.1097/00005792-195602000-00002; Mandell, 2005, PRINCIPLES PRACTICE; Mishra S, 2010, SEX TRANSM INFECT, V86, P193, DOI 10.1136/sti.2009.038778; MOORE MB, 1963, PUBLIC HEALTH REP, V78, P966, DOI 10.2307/4591989; Mukenge-Tshibaka L, 2002, SEX TRANSM DIS, V29, P324, DOI 10.1097/00007435-200206000-00003; Myer L, 2003, SEX TRANSM INFECT, V79, P208, DOI 10.1136/sti.79.3.208; Pirkle C, 2007, SEX TRANSM DIS, V34, P695, DOI 10.1097/01.olq.0000260989.70866.94; Pourbohloul B, 2003, SEX TRANSM DIS, V30, P297, DOI 10.1097/00007435-200304000-00005; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; SCHROETER AL, 1972, J AMER MED ASSOC, V221, P471, DOI 10.1001/jama.221.5.471; Sparling PF., 2008, SEX TRANSM DIS, V4th ed, pp. 661; The Sexually Transmitted Diseases Diagnostics Initiative (SDI) Special Programme for Research and Training in Tropical Diseases (TDR), 2006, US RAP SYPH TESTS; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824; Vickerman P, 2006, SEX TRANSM INFECT, V82, P403, DOI 10.1136/sti.2006.020107; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; Vickerman P, 2010, SEX TRANSM INFECT, V86, P163, DOI 10.1136/sti.2008.034678; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; West B, 2002, SEX TRANSM INFECT, V78, P282, DOI 10.1136/sti.78.4.282; Williams JR, 2006, SEX TRANSM INFECT, V82, P372, DOI 10.1136/sti.2006.020875; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yang HM, 2005, SEX TRANSM DIS, V32, P572, DOI 10.1097/01.olq.0000175418.48665.95; Zhong N, 2002, CHIN TROPICAL MED, P2100	51	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55622	10.1371/journal.pone.0055622	http://dx.doi.org/10.1371/journal.pone.0055622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383249	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000315563800176
J	Nguyen, TT; Calvano, SE; Lowry, SF; Androulakis, IP				Nguyen, Tung T.; Calvano, Steve E.; Lowry, Stephen F.; Androulakis, Ioannis P.			An Agent-Based Model of Cellular Dynamics and Circadian Variability in Human Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; GENE-EXPRESSION; IMMUNE-RESPONSE; TNF-ALPHA; JAK-STAT; ANTIINFLAMMATORY CYTOKINES; SYSTEMIC INFLAMMATION; PINEAL MELATONIN; PROTEIN	As cellular variability and circadian rhythmicity play critical roles in immune and inflammatory responses, we present in this study an agent-based model of human endotoxemia to examine the interplay between circadian controls, cellular variability and stochastic dynamics of inflammatory cytokines. The model is qualitatively validated by its ability to reproduce circadian dynamics of inflammatory mediators and critical inflammatory responses after endotoxin administration in vivo. Novel computational concepts are proposed to characterize the cellular variability and synchronization of inflammatory cytokines in a population of heterogeneous leukocytes. Our results suggest that there is a decrease in cell-to-cell variability of inflammatory cytokines while their synchronization is increased after endotoxin challenge. Model parameters that are responsible for I kappa B production stimulated by NF kappa B activation and for the production of anti-inflammatory cytokines have large impacts on system behaviors. Additionally, examining time-dependent systemic responses revealed that the system is least vulnerable to endotoxin in the early morning and most vulnerable around midnight. Although much remains to be explored, proposed computational concepts and the model we have pioneered will provide important insights for future investigations and extensions, especially for single-cell studies to discover how cellular variability contributes to clinical implications.	[Nguyen, Tung T.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ USA; [Androulakis, Ioannis P.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA; [Calvano, Steve E.; Lowry, Stephen F.; Androulakis, Ioannis P.] UMDNJ, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Androulakis, IP (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	yannis@rci.rutgers.edu			National Institutes of Health (NIH) [GM082974]; NIH [GM34695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034695, R01GM082974, R37GM034695] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TTN and IPA acknowledge support from National Institutes of Health (NIH) GM082974. SEC and SFL are supported, in part, from NIH GM34695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An G, 2004, CRIT CARE MED, V32, P2050, DOI 10.1097/01.CCM.0000139707.13729.7D; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; An G, 2009, MATH BIOSCI, V217, P43, DOI 10.1016/j.mbs.2008.10.001; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; An GC, 2009, MATH BIOSCI, V217, P53, DOI 10.1016/j.mbs.2008.08.013; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Bahcall OG, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100020; Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; BROWN GC, 1991, J THEOR BIOL, V153, P195, DOI 10.1016/S0022-5193(05)80422-9; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; Chavali AK, 2008, TRENDS IMMUNOL, V29, P589, DOI 10.1016/j.it.2008.08.006; Coogan AN, 2008, BRAIN RES, V1232, P104, DOI 10.1016/j.brainres.2008.07.087; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Cutolo M, 2003, ANN RHEUM DIS, V62, P593, DOI 10.1136/ard.62.7.593; Fernandes PACM, 2009, J NEUROENDOCRINOL, V21, P90, DOI 10.1111/j.1365-2826.2008.01817.x; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; Foteinou PT, 2009, MATH BIOSCI, V217, P27, DOI 10.1016/j.mbs.2008.09.003; Foteinou PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004706; Gori AM, 2009, ATHEROSCLEROSIS, V202, P255, DOI 10.1016/j.atherosclerosis.2008.04.001; Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335; Hermann C, 2006, EUR J IMMUNOL, V36, P371, DOI 10.1002/eji.200535470; Hermida Ramon C, 2007, Ther Clin Risk Manag, V3, P119, DOI 10.2147/tcrm.2007.3.1.119; Hermida RC, 2005, CURR OPIN NEPHROL HY, V14, P453, DOI 10.1097/01.mnh.0000174144.07174.74; Hess A, 2001, ATMOS ENVIRON, V35, P5211, DOI 10.1016/S1352-2310(01)00342-9; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Ihekwaba A. E. C., 2004, Systems Biology, V1, P93, DOI 10.1049/sb:20045009; Jerin A, 2003, CLIN CHEM LAB MED, V41, P899, DOI 10.1515/CCLM.2003.136; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kilfoil ML, 2009, HFSP J, V3, P379, DOI 10.2976/1.3223356; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lissoni P, 1998, NAT IMMUN, V16, P1, DOI 10.1159/000069464; Lowry SF, 2005, SHOCK, V24, P94, DOI 10.1097/01.shk.0000191340.23907.a1; Mager DE, 2003, DRUG METAB DISPOS, V31, P510, DOI 10.1124/dmd.31.5.510; MAH RSH, 1995, COMPUT CHEM ENG, V19, P129, DOI 10.1016/0098-1354(94)E0042-L; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meier-Schellersheim M, 2006, PLOS COMPUT BIOL, V2, P710, DOI 10.1371/journal.pcbi.0020082; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nguyen TT, 2009, OMICS, V13, P219, DOI 10.1089/omi.2008.0074; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Paramalingam SS, 2007, ANN ACAD MED SINGAP, V36, P96; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Pontes GN, 2007, J PINEAL RES, V43, P365, DOI 10.1111/j.1600-079X.2007.00487.x; Prabhakar U, 2005, DNA CELL BIOL, V24, P410, DOI 10.1089/dna.2005.24.410; Rankin James A, 2004, AACN Clin Issues, V15, P3, DOI 10.1097/00044067-200401000-00002; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rausenberger J, 2008, BIOPHYS J, V95, P4523, DOI 10.1529/biophysj.107.127035; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rothman S, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-25; Scheff JD, 2010, J THEOR BIOL, V264, P1068, DOI 10.1016/j.jtbi.2010.03.026; Schooley K, 2003, BIOCHEM J, V369, P331, DOI 10.1042/BJ20020253; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Skwarlo-Sonta K, 2003, CAN J PHYSIOL PHARM, V81, P342, DOI 10.1139/Y03-026; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tetta C, 2005, Crit Care Resusc, V7, P32; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; VELDHUIS J D, 1989, American Journal of Physiology, V257, pE6; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Warrender C, 2006, B MATH BIOL, V68, P2233, DOI 10.1007/s11538-006-9103-y; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009	96	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55550	10.1371/journal.pone.0055550	http://dx.doi.org/10.1371/journal.pone.0055550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383223	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800165
J	Sakthiswary, R; Raymond, AA				Sakthiswary, Rajalingham; Raymond, Azman Ali			The Clinical Significance of Vitamin D in Systemic Lupus Erythematosus: A Systematic Review	PLOS ONE			English	Review							GENE BSMI POLYMORPHISMS; DISEASE-ACTIVITY; D DEFICIENCY; CHINESE PATIENTS; SERUM CONCENTRATIONS; 25-HYDROXYVITAMIN D; RISK-FACTORS; ASSOCIATION; SLE; FATIGUE	Background: Vitamin D deficiency is more prevalent among SLE patients than the general population. Over the past decade, many studies across the globe have been carried out to investigate the role of vitamin D in SLE from various clinical angles. Therefore, the aim of this systematic review is to summarise and evaluate the evidence from the published literature; focusing on the clinical significance of vitamin D in SLE. Methods: The following databases were searched: MEDLINE, Scopus, Web of Knowledge and CINAHL, using the terms "lupus'', "systemic lupus erythematosus'', "SLE and "vitamin D''. We included only adult human studies published in the English language between 2000 and 2012. The reference lists of included studies were thoroughly reviewed in search for other relevant studies. Results: A total of 22 studies met the selection criteria. The majority of the studies were observational (95.5%) and cross sectional (90.9%). Out of the 15 studies which looked into the association between vitamin D and SLE disease activity, 10 studies (including the 3 largest studies in this series) revealed a statistically significant inverse relationship. For disease damage, on the other hand, 5 out of 6 studies failed to demonstrate any association with vitamin D levels. Cardiovascular risk factors such as insulin resistance, hypertension and hypercholesterolaemia were related to vitamin D deficiency, according to 3 of the studies. Conclusion: There is convincing evidence to support the association between vitamin D levels and SLE disease activity. There is paucity of data in other clinical aspects to make firm conclusions.	[Sakthiswary, Rajalingham; Raymond, Azman Ali] Univ Kebangsaan Malaysia, Dept Med, Med Ctr, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia	Sakthiswary, R (corresponding author), Univ Kebangsaan Malaysia, Dept Med, Med Ctr, Kuala Lumpur, Malaysia.	sakthis5@hotmail.com	Sakthiswary, Rajalingham/E-8565-2017	Raymond, Ali Azman/0000-0001-6066-5168				Abbasi M, 2010, RHEUMATOL INT, V30, P1537, DOI 10.1007/s00296-010-1504-4; Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Amital H, 2010, ANN RHEUM DIS, V69, P1155, DOI 10.1136/ard.2009.120329; Bogaczewicz J, 2012, LUPUS, V21, P477, DOI 10.1177/0961203311427549; Bonakdar ZS, 2011, LUPUS, V20, P1155, DOI 10.1177/0961203311405703; Borba VZC, 2009, OSTEOPOROSIS INT, V20, P427, DOI 10.1007/s00198-008-0676-1; Brunner HI, 2008, ARTHRITIS RHEUM-US, V58, P556, DOI 10.1002/art.23204; Fragoso TS, 2012, REV BRAS REUMATOL, V52, P55; Giles BM, 2012, IMMUNOL RES; Hamza RT, 2011, MED SCI MONITOR, V17, pCR711, DOI 10.12659/MSM.882131; Huang CM, 2002, J RHEUMATOL, V29, P1211; Huang CM, 2002, LUPUS, V11, P31, DOI 10.1191/0961203302lu143oa; Kamen Diane L, 2008, Curr Rheumatol Rep, V10, P273, DOI 10.1007/s11926-008-0044-3; Kamen DL, 2006, AUTOIMMUN REV, V5, P114, DOI 10.1016/j.autrev.2005.05.009; Kim HA, 2011, RHEUMATOL INT, V31, P1189, DOI 10.1007/s00296-010-1442-1; Lopez R, 2012, RHEUMATOLOGY, V51, P491, DOI 10.1093/rheumatology/ker368; Mok CC, 2012, LUPUS, V21, P36, DOI 10.1177/0961203311422094; Mok CC, 2012, RHEUMATOLOGY, V51, P644, DOI 10.1093/rheumatology/ker212; MULLER K, 1995, CLIN RHEUMATOL, V14, P397, DOI 10.1007/BF02207671; Munoz-Ortego J, 2012, SCANDINAVIAN J RHEUM; Pradhan V, 2012, INDIAN PEDIAT; Ravenell RL, 2012, AM J MED SCI, V344, P268, DOI 10.1097/MAJ.0b013e31823fa7d9; Reynolds JA, 2012, RHEUMATOLOGY, V51, P544, DOI 10.1093/rheumatology/ker352; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Ruiz-Irastorza G, 2008, RHEUMATOLOGY, V47, P920, DOI 10.1093/rheumatology/ken121; Ruiz-Irastorza G, 2010, ARTHRIT CARE RES, V62, P1160, DOI 10.1002/acr.20186; Stockton KA, 2012, LUPUS, V21, P271, DOI 10.1177/0961203311425530; Szodoray P, 2011, SCAND J RHEUMATOL, V40, P122, DOI 10.3109/03009742.2010.507220; Thudi A, 2008, AM J MED SCI, V335, P99, DOI 10.1097/MAJ.0b013e318134eeb6; Toloza SMA, 2010, LUPUS, V19, P13, DOI 10.1177/0961203309345775; Wu PW, 2009, ARTHRIT CARE RES, V61, P1387, DOI 10.1002/art.24785; Yeap SS, 2012, INT J RHEUM DIS, V15, P17, DOI 10.1111/j.1756-185X.2011.01653.x	32	32	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55275	10.1371/journal.pone.0055275	http://dx.doi.org/10.1371/journal.pone.0055275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383135	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800138
J	Silvius, D; Pitstick, R; Ahn, M; Meishery, D; Oehler, A; Barsh, GS; DeArmond, SJ; Carlson, GA; Gunn, TM				Silvius, Derek; Pitstick, Rose; Ahn, Misol; Meishery, Delisha; Oehler, Abby; Barsh, Gregory S.; DeArmond, Stephen J.; Carlson, George A.; Gunn, Teresa M.			Levels of the Mahogunin Ring Finger 1 E3 Ubiquitin Ligase Do Not Influence Prion Disease	PLOS ONE			English	Article							CELL-DEATH; PROTEIN; NEURODEGENERATION; DEGENERATION; EXPRESSION; PRP	Prion diseases are rare but invariably fatal neurodegenerative disorders. They are associated with spongiform encephalopathy, a histopathology characterized by the presence of large, membrane-bound vacuolar structures in the neuropil of the brain. While the primary cause is recognized as conversion of the normal form of prion protein (PrPC) to a conformationally distinct, pathogenic form (PrPSc), the cellular pathways and mechanisms that lead to spongiform change, neuronal dysfunction and death are not known. Mice lacking the Mahogunin Ring Finger 1 (MGRN1) E3 ubiquitin ligase develop spongiform encephalopathy by 9 months of age but do not become ill. In cell culture, PrP aberrantly present in the cytosol was reported to interact with and sequester MGRN1. This caused endo-lysosomal trafficking defects similar to those observed when Mgrn1 expression is knocked down, implicating disrupted MGRN1-dependent trafficking in the pathogenesis of prion disease. As these defects were rescued by over-expression of MGRN1, we investigated whether reduced or elevated Mgrn1 expression influences the onset, progression or pathology of disease in mice inoculated with PrPSc. No differences were observed, indicating that disruption of MGRN1-dependent pathways does not play a significant role in the pathogenesis of transmissible spongiform encephalopathy.	[Silvius, Derek; Pitstick, Rose; Meishery, Delisha; Carlson, George A.; Gunn, Teresa M.] McLaughlin Res Inst, Great Falls, MT USA; [Ahn, Misol; Oehler, Abby; DeArmond, Stephen J.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Ahn, Misol; Oehler, Abby; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	McLaughlin Research Institute for Biomedical Sciences, Inc.; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Gunn, TM (corresponding author), McLaughlin Res Inst, Great Falls, MT USA.	tmg@mri.montana.edu		Ahn, Misol/0000-0002-6088-8481; Gunn, Teresa/0000-0003-2688-6420	National Institutes of Health [NS41997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health program project grant NS41997. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Azouz A, 2007, EXP CELL RES, V313, P761, DOI 10.1016/j.yexcr.2006.11.018; Bajsarowicz K, 2012, J NEUROPATH EXP NEUR, V71, P449, DOI 10.1097/NEN.0b013e3182544680; Bouzamondo-Bernstein E, 2004, J NEUROPATH EXP NEUR, V63, P882, DOI 10.1093/jnen/63.8.882; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; DEARMOND SJ, 1993, P NATL ACAD SCI USA, V90, P6449, DOI 10.1073/pnas.90.14.6449; DeArmond SJ, 1996, COLD SPRING HARB SYM, V61, P531; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Giese A, 1998, BRAIN PATHOL, V8, P449; Gunn TM, 2001, GENETICS, V158, P1683; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Imran M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-559; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Jiao J, 2009, BBA-MOL BASIS DIS, V1792, P1027, DOI 10.1016/j.bbadis.2009.08.009; Jiao J, 2009, GENESIS, V47, P524, DOI 10.1002/dvg.20529; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; LAMPERT P, 1971, ACTA NEUROPATHOL, V19, P81, DOI 10.1007/BF00688486; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Miesbauer M, 2010, CURR ISSUES MOL BIOL, V12, P109; Norstrom EM, 2007, J VIROL, V81, P2831, DOI 10.1128/JVI.02157-06; Restelli E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013725; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Wong K, 1996, NEUROLOGY, V47, P741, DOI 10.1212/WNL.47.3.741	31	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55575	10.1371/journal.pone.0055575	http://dx.doi.org/10.1371/journal.pone.0055575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383230	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800169
J	Muchero, W; Sewell, MM; Ranjan, P; Gunter, LE; Tschaplinski, TJ; Yin, TM; Tuskan, GA				Muchero, Wellington; Sewell, Mitchell M.; Ranjan, Priya; Gunter, Lee E.; Tschaplinski, Timothy J.; Yin, Tongming; Tuskan, Gerald A.			Genome Anchored QTLs for Biomass Productivity in Hybrid Populus Grown under Contrasting Environments	PLOS ONE			English	Article							MOLECULAR-GENETICS; PHENOTYPIC VARIATION; SHORT-ROTATION; IDENTIFICATION; TRAITS; YIELD; L.	Traits related to biomass production were analyzed for the presence of quantitative trait loci (QTLs) in a Populus trichocarpa x P. deltoides F-2 population. A genetic linkage map composed of 841 SSR, AFLP, and RAPD markers and phenotypic data from 310 progeny were used to identify genomic regions harboring biomass QTLs. Twelve intervals were identified, of which BM-1, BM-2, and BM-7 were identified in all three years for both height and diameter. One putative QTL, BM-7, and one suggestive QTL exhibited significant evidence of over-dominance in all three years for both traits. Conversely, QTLs BM-4 and BM-6 exhibited evidence of under-dominance in both environments for height and diameter. Seven of the nine QTLs were successfully anchored, and QTL peak positions were estimated for each one on the P. trichocarpa genome assembly using flanking SSR markers with known physical positions. Of the 3,031 genes located in genome-anchored QTL intervals, 1,892 had PFAM annotations. Of these, 1,313, representing 255 unique annotations, had at least one duplicate copy in a QTL interval identified on a separate scaffold. This observation suggests that some QTLs identified in this study may have shared the same ancestral sequence prior to the salicoid genome duplication in Populus.	[Muchero, Wellington; Sewell, Mitchell M.; Ranjan, Priya; Gunter, Lee E.; Tschaplinski, Timothy J.; Yin, Tongming; Tuskan, Gerald A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA; [Muchero, Wellington; Ranjan, Priya; Gunter, Lee E.; Tschaplinski, Timothy J.; Tuskan, Gerald A.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Muchero, W (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.	mucherow@ornl.gov	Gunter, Lee E/L-3480-2016; Tuskan, Gerald/A-6225-2011; Tschaplinski, Timothy/D-6382-2018	Gunter, Lee E/0000-0003-1211-7532; Tuskan, Gerald/0000-0003-0106-1289; Tschaplinski, Timothy/0000-0002-9540-6622; muchero, wellington/0000-0002-0200-9856; Ranjan, Priya/0000-0002-0357-1939	Biomass Feedstock Development Program, United States Department of Energy; Office of Industrial Technology, Energy Efficiency Renewable Energy, United States Department of Energy; Office of Science, Biological, and Environmental Research, United States Department of Energy; Department of Energy, Office of Science, Biological and Environmental Research of the Plant Microbe Interfaces Scientific Focus Area; BioEnergy Science Center; United States Department of Energy [DE-AC05-00OR22725]	Biomass Feedstock Development Program, United States Department of Energy; Office of Industrial Technology, Energy Efficiency Renewable Energy, United States Department of Energy; Office of Science, Biological, and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); Department of Energy, Office of Science, Biological and Environmental Research of the Plant Microbe Interfaces Scientific Focus Area; BioEnergy Science Center; United States Department of Energy(United States Department of Energy (DOE))	This research was supported, in part, by the Biomass Feedstock Development Program, United States Department of Energy; by the Office of Industrial Technology, Energy Efficiency Renewable Energy, United States Department of Energy; by the Office of Science, Biological, and Environmental Research, United States Department of Energy; by the Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area and by the BioEnergy Science Center. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the United States Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1991, SCIENCE, V252, P1469, DOI 10.1126/science.252.5012.1469; BRADSHAW HD, 1995, GENETICS, V139, P963; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P167, DOI 10.1007/BF00225137; Brown GR, 2003, GENETICS, V164, P1537; CHURCHILL GA, 1994, GENETICS, V138, P963; Eckenwalder J.E., 2001, POPLAR CULTURE N AM, P331; GAUCH HG, 1988, BIOMETRICS, V44, P705, DOI 10.2307/2531585; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Muchero W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-8; Muchero W, 2010, THEOR APPL GENET, V120, P509, DOI 10.1007/s00122-009-1171-6; Novaes E, 2009, NEW PHYTOL, V182, P878, DOI 10.1111/j.1469-8137.2009.02785.x; Rae AM, 2008, TREE GENET GENOMES, V4, P97, DOI 10.1007/s11295-007-0091-3; Ranjan P, 2010, BIOENERG RES, V3, P172, DOI 10.1007/s12155-009-9060-z; RANNEY JW, 1987, J FOREST, V85, P17; ScarasciaMugnozza GE, 1997, CAN J FOREST RES, V27, P285, DOI 10.1139/x96-180; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Stettler RF, 1996, BIOL POPULUS ITS IMP, P87; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Tschaplinski TJ, 2006, TREE PHYSIOL, V26, P595, DOI 10.1093/treephys/26.5.595; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 1998, BIOMASS BIOENERG, V14, P307, DOI 10.1016/S0961-9534(97)10065-4; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wu R, 1997, AM J BOT, V84, P143, DOI 10.2307/2446076; Wu R, 1997, HEREDITY, V78, P124; Wu RL, 1997, THEOR APPL GENET, V94, P104, DOI 10.1007/s001220050388; Wullschleger S, 2005, CAN J FOREST RES, V35, P1779, DOI 10.1139/x05-101; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; Yin TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014021; Zhuang Y, 2007, GENETICS, V177, P1987, DOI 10.1534/genetics.107.080325; Zsuffa L., 1996, P515	31	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54468	10.1371/journal.pone.0054468	http://dx.doi.org/10.1371/journal.pone.0054468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382900	Green Submitted, Green Published, gold			2022-12-27	WOS:000315483200030
J	Wang, GH; Wang, F; Ding, WF; Wang, JC; Jing, RR; Li, HQ; Wang, XD; Wang, YG; Ju, SQ; Wang, HM				Wang, Guihua; Wang, Feng; Ding, Weifeng; Wang, Jingchun; Jing, Rongrong; Li, Haiquan; Wang, Xudong; Wang, Yueguo; Ju, Shaoqing; Wang, Huimin			APRIL Induces Tumorigenesis and Metastasis of Colorectal Cancer Cells via Activation of the PI3K/Akt Pathway	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; KAPPA-B; PHOSPHOINOSITIDE 3-KINASE; UP-REGULATION; MEMBER APRIL; C-MYC; PROLIFERATION; EXPRESSION; MATRIX-METALLOPROTEINASE-9; INHIBITION	A proliferation-inducing ligand (APRIL) is highly expressed in colorectal cancer (CRC) tissues and cell lines. However, the biological functions and precise signals elicited by APRIL in CRC have not been fully understood. Here, we used small interfering RNA to selectively deplete APRIL and to determine its tumorigenic effects in a CRC cell line SW480 both in vitro and in vivo. Knockdown of APRIL in SW480 cells was associated with modulation of cell proliferation as well as reduction of cell migration and invasion in vitro. Moreover APRIL-knockdown SW480 cells displayed markedly inhibited tumor growth and decreased metastasis to the liver in immunodeficient mice upon subcutaneous injection. Importantly, we observed that downregulation of APRIL in SW480 cells resulted in greatly decreased activity of phosphoinositide 3-kinase (PI3K)/Akt pathway. In addition, we observed that recombinant human APRIL mediated activation of the PI3K/Akt pathway in CRC cells resulting in induced expression of important cell cycle proteins and matrix metalloproteinases in a PI3K/Akt dependent manner. This was concurrent with marked cell growth viability as well as increased cell migration and invasion. Together, these compelling data suggest that APRIL-induced tumorigenesis and metastasis of CRC cells may be accomplished through activation of the PI3K/Akt pathway. These findings may lead to a better understanding of the biological effects of APRIL and may provide clues for identifying novel therapeutic and preventive molecular markers for CRC.	[Wang, Guihua; Wang, Feng; Ding, Weifeng; Wang, Jingchun; Jing, Rongrong; Li, Haiquan; Wang, Xudong; Wang, Yueguo; Ju, Shaoqing; Wang, Huimin] Nantong Univ, Sch Publ Hlth, Affiliated Hosp, Dept Clin Lab Ctr, Nantong, Jiangsu, Peoples R China	Nantong University	Wang, HM (corresponding author), Nantong Univ, Sch Publ Hlth, Affiliated Hosp, Dept Clin Lab Ctr, Nantong, Jiangsu, Peoples R China.	onehuimin@gmail.com	Wang, Feng/F-2653-2015; wang, huimin/HDM-8421-2022		National Natural Science Foundation of China [81201351, 81201350]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (numbers 81201351 and 81201350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Chen X, 2011, PATHOL ONCOL RES, V17, P257, DOI 10.1007/s12253-010-9307-1; Chu DK, 2012, ANN SURG ONCOL, V19, P318, DOI 10.1245/s10434-011-1686-3; Ding WF, 2009, PATHOL ONCOL RES, V15, P693, DOI 10.1007/s12253-009-9172-y; Ding WF, 2009, CLIN BIOCHEM, V42, P1694, DOI 10.1016/j.clinbiochem.2009.06.019; Dragutinovic VV, 2011, MOL CELL BIOCHEM, V355, P173, DOI 10.1007/s11010-011-0851-0; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gupta M, 2009, BLOOD, V113, P5206, DOI 10.1182/blood-2008-09-179762; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Hwang MK, 2009, INT J BIOCHEM CELL B, V41, P1592, DOI 10.1016/j.biocel.2009.01.014; Ispanovic E, 2006, AM J PHYSIOL-CELL PH, V291, pC579, DOI 10.1152/ajpcell.00300.2005; Kumar A, 2006, MOL CELL BIOL, V26, P9116, DOI 10.1128/MCB.00783-06; Lascano V, 2012, CELL DEATH DIFFER, V19, P1826, DOI 10.1038/cdd.2012.68; Lu YB, 2005, J LEUKOCYTE BIOL, V78, P259, DOI 10.1189/jlb.0904498; Mhawech-Fauceglia P, 2006, J LEUKOCYTE BIOL, V80, P697, DOI 10.1189/jlb.1105655; Planelles L, 2007, HAEMATOLOGICA, V92, P1284, DOI 10.3324/haematol.10317; Quinn J, 2011, BLOOD, V117, P890, DOI 10.1182/blood-2010-01-264424; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tanaka H, 2005, J BIOL CHEM, V280, P40965, DOI 10.1074/jbc.M506235200; Wang CG, 2011, CELL CYCLE, V10, P57, DOI 10.4161/cc.10.1.14449; Wang F, 2011, CANCER GENE THER, V18, P500, DOI 10.1038/cgt.2011.19; Wang F, 2008, ONCOL REP, V20, P135; Wang F, 2011, CLIN CHEM LAB MED, V49, P1715, DOI 10.1515/CCLM.2011.608; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang HH, 2009, INT J CANCER, V125, P297, DOI 10.1002/ijc.24289	34	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55298	10.1371/journal.pone.0055298	http://dx.doi.org/10.1371/journal.pone.0055298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383143	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200007
J	Herbert, BS; Grimes, BR; Xu, WM; Werner, M; Ward, C; Rossetti, S; Harris, P; Bello-Reuss, E; Ward, HH; Miller, C; Gattone, VH; Phillips, CL; Wandinger-Ness, A; Bacallao, RL				Herbert, Brittney-Shea; Grimes, Brenda R.; Xu, Wei Min; Werner, Michael; Ward, Christopher; Rossetti, Sandro; Harris, Peter; Bello-Reuss, Elsa; Ward, Heather H.; Miller, Caroline; Gattone, Vincent H., II; Phillips, Carrie L.; Wandinger-Ness, Angela; Bacallao, Robert L.			A Telomerase Immortalized Human Proximal Tubule Cell Line with a Truncation Mutation (Q4004X) in Polycystin-1	PLOS ONE			English	Article							CYST EPITHELIAL-CELLS; KIDNEY-DISEASE; CYCLIC-AMP; PKD1 GENE; IN-VITRO; EXPRESSION; GROWTH; CHANNEL; PROTEIN; ADPKD	Autosomal dominant polycystic kidney disease (ADPKD) is associated with a variety of cellular phenotypes in renal epithelial cells. Cystic epithelia are secretory as opposed to absorptive, have higher proliferation rates in cell culture and have some characteristics of epithelial to mesenchymal transitions [1,2]. In this communication we describe a telomerase immortalized cell line that expresses proximal tubule markers and is derived from renal cysts of an ADPKD kidney. These cells have a single detectable truncating mutation (Q4004X) in polycystin-1. These cells make normal appearing but shorter cilia and fail to assemble polycystin-1 in the cilia, and less uncleaved polycystin-1 in membrane fractions. This cell line has been maintained in continuous passage for over 35 passages without going into senescence. Nephron segment specific markers suggest a proximal tubule origin for these cells and the cell line will be useful to study mechanistic details of cyst formation in proximal tubule cells.	[Herbert, Brittney-Shea; Grimes, Brenda R.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Ward, Christopher; Rossetti, Sandro; Harris, Peter] Mayo Clin, Div Nephrol, Rochester, MN USA; [Miller, Caroline; Gattone, Vincent H., II] Indiana Univ, Dept Anat & Cell Biol, Indianapolis, IN 46204 USA; [Ward, Heather H.; Wandinger-Ness, Angela] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Phillips, Carrie L.] Indiana Univ, Dept Pathol, Indianapolis, IN 46204 USA; [Bello-Reuss, Elsa] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Div Nephrol & Hypertens, Lubbock, TX 79430 USA; [Xu, Wei Min; Werner, Michael; Bacallao, Robert L.] Richard L Roudebush VAMC, Div Nephrol, Indianapolis, IN USA; [Xu, Wei Min; Werner, Michael; Bacallao, Robert L.] Indiana Univ, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Mayo Clinic; Indiana University System; Indiana University-Purdue University Indianapolis; University of New Mexico; Indiana University System; Indiana University-Purdue University Indianapolis; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Bacallao, RL (corresponding author), Richard L Roudebush VAMC, Div Nephrol, Indianapolis, IN USA.	rbacalla@iupui.edu	Ward, Heather/R-7785-2016; Wandinger-Ness, Angela/J-9104-2012	Ward, Heather/0000-0002-8502-3679; Wandinger-Ness, Angela/0000-0003-0613-3157; Herbert, Brittney-Shea/0000-0003-3192-2203; Bacallao, Robert/0000-0002-5703-5701; Phillips, Carrie/0000-0002-0256-0736	National Institutes of Health/NIDDK [R21DK067246, R01DK050141, RO1 DK58816]; Indiana Genomics Initiative (INGEN); Lilly Endowment Inc.; PKD Foundation; NIH [DK59597, DK065056, DK090726]; IUSM Cytogenetics division; Department of Medicine at Indiana University; Mayo Translational Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050141, R21DK067246, R01DK059597, R01DK065056, R01DK058816] Funding Source: NIH RePORTER	National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indiana Genomics Initiative (INGEN); Lilly Endowment Inc.; PKD Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IUSM Cytogenetics division; Department of Medicine at Indiana University; Mayo Translational Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/NIDDK grants R21DK067246, R01DK050141 to RLB and AWN respectively, and the Indiana Genomics Initiative (INGEN) to BH and BG. INGEN of Indiana University is supported in part by Lilly Endowment Inc. Electron microscopy work was supported by a generous center grant from the PKD Foundation to VG. CW is supported by NIH R01 R01 grants DK59597, DK065056 grants. PH is supported by RO1 DK58816 grant from the NIH/NIDDK. BRG received funding support from the PKD Foundation and the IUSM Cytogenetics division. RLB has received funding support from the Department of Medicine at Indiana University. Mutation analysis was supported by the Mayo Translational Core which is supported by NIH P30 grant DK090726. URLs: www.niddk.nih.gov; www.pkdcure.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belibi FA, 2004, KIDNEY INT, V66, P964, DOI 10.1111/j.1523-1755.2004.00843.x; Boucher C, 2004, EUR J HUM GENET, V12, P347, DOI 10.1038/sj.ejhg.5201162; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; CARONE FA, 1993, LAB INVEST, V68, P413; CARONE FA, 1989, KIDNEY INT, V35, P1351, DOI 10.1038/ki.1989.134; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Cotsiki M, 2004, P NATL ACAD SCI USA, V101, P947, DOI 10.1073/pnas.0308006100; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; Germino GG, 1997, HOSP PRACT, V32, P81, DOI 10.1080/21548331.1997.11443444; Glasspool RM, 2005, NEOPLASIA, V7, P614, DOI 10.1593/neo.04766; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Hackmann K, 2005, HUM MOL GENET, V14, P3249, DOI 10.1093/hmg/ddi356; Hein J, 2009, J VIROL, V83, P117, DOI 10.1128/JVI.01515-08; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Kher R, 2011, AM J PHYSIOL-CELL PH, V301, pC99, DOI 10.1152/ajpcell.00151.2010; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Lewis CM, 2006, BREAST CANCER RES TR, V99, P103, DOI 10.1007/s10549-006-9189-9; Li NF, 2009, ONCOGENE, V28, P773, DOI 10.1038/onc.2008.412; Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002; MACKAY K, 1987, KIDNEY INT, V32, P827, DOI 10.1038/ki.1987.283; MANGOOKARIM R, 1989, FASEB J, V3, P2629, DOI 10.1096/fasebj.3.14.2480260; Maunsbach AB, 1997, J AM SOC NEPHROL, V8, P1; MCATEER JA, 1987, ANAT REC, V217, P229, DOI 10.1002/ar.1092170303; Montesano R, 1997, J CELL PHYSIOL, V173, P152, DOI 10.1002/(SICI)1097-4652(199711)173:2<152::AID-JCP14>3.0.CO;2-I; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Takakura A, 2008, J AM SOC NEPHROL, V19, P2351, DOI 10.1681/ASN.2007101139; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Watnick T, 1999, SEMIN NEPHROL, V19, P327; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WILSON PD, 1991, KIDNEY INT, V39, P450, DOI 10.1038/ki.1991.56; Xu C, 2007, AM J PHYSIOL-RENAL, V292, pF930, DOI 10.1152/ajprenal.00285.2006; Xu C, 2009, AM J PHYSIOL-RENAL, V296, pF1464, DOI 10.1152/ajprenal.90542.2008; Xu GM, 2003, J BIOL CHEM, V278, P1457, DOI 10.1074/jbc.M209996200	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55191	10.1371/journal.pone.0055191	http://dx.doi.org/10.1371/journal.pone.0055191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383103	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500063
J	Hsiao, JR; Ou, CY; Lo, HI; Huang, CC; Lee, WT; Huang, JS; Chen, KC; Wong, TY; Tsai, ST; Yen, CJ; Wu, YH; Hsueh, WT; Yang, MW; Wu, SY; Chang, JY; Chang, KY; Lin, CL; Wang, FT; Wang, YH; Weng, YL; Yang, HC; Chang, JS				Hsiao, Jenn-Ren; Ou, Chun-Yen; Lo, Hung-I; Huang, Cheng-Chih; Lee, Wei-Ting; Huang, Jehn-Shyun; Chen, Ken-Chung; Wong, Tung-Yiu; Tsai, Sen-Tien; Yen, Chia-Jui; Wu, Yuan-Hua; Hsueh, Wei-Ting; Yang, Ming-Wei; Wu, Shang-Yin; Chang, Jang-Yang; Chang, Kwang-Yu; Lin, Chen-Lin; Wang, Fang-Ting; Wang, Yi-Hui; Weng, Ya-Ling; Yang, Han-Chien; Chang, Jeffrey S.			Allergies and Risk of Head and Neck Cancer: An Original Study plus Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ASSOCIATION; TOBACCO; EPIDEMIOLOGY; ALCOHOL; ASTHMA; IGE; POLYMORPHISM; MORTALITY; DISEASES	Background: Although the relationship between allergy and cancer has been investigated extensively, the role of allergy in head and neck cancer (HNC) appears less consistent. It is not clear whether allergies can independently influence the risk of HNC in the presence of known strong environmental risk factors, including consumption of alcohol, betel quid, and cigarette. Methods: The current paper reports results from: 1) an original hospital-based case-control study, which included 252 incident cases of HNC and 236 controls frequency-matched to cases on sex and age; and 2) a meta-analysis combining the results of the current case-control study and 13 previously published studies (9 cohort studies with 727,569 subjects and 550 HNC outcomes and 5 case-control studies with 4,017 HNC cases and 10,928 controls). Results: In the original case-control study, we observed a strong inverse association between allergies and HNC [odds ratio = 0.41, 95% confidence interval (CI): 0.27-0.62]. The meta-analysis also indicated a statistically significant inverse association between HNC and allergies [meta-relative risk (RR) = 0.76, 95% CI: 0.63-0.91], particularly strong for allergic rhinitis (meta-RR = 0.55, 95% CI: 0.40-0.76). In addition, the inverse association between allergies and HNC was observed only among men (meta-RR = 0.67, 95% CI: 0.54-0.84) but not among women (meta-RR = 0.98, 95% CI: 0.81-1.18). Conclusions: These findings suggest that immunity plays an influential role in the risk of HNC. Future studies investigating immune biomarkers, including cytokine profiles and genetic polymorphisms, are warranted to further delineate the relationship between allergies and HNC. Understanding the relationship between allergies and HNC may help devise effective strategies to reduce and treat HNC.	[Hsiao, Jenn-Ren; Ou, Chun-Yen; Lo, Hung-I; Huang, Cheng-Chih; Lee, Wei-Ting; Tsai, Sen-Tien; Wang, Fang-Ting] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Otolaryngol, Tainan 70101, Taiwan; [Huang, Jehn-Shyun; Chen, Ken-Chung; Wong, Tung-Yiu] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Stomatol, Tainan 70101, Taiwan; [Yen, Chia-Jui; Wu, Shang-Yin; Chang, Jang-Yang; Chang, Kwang-Yu] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Hematol Oncol,Dept Internal Med, Tainan 70101, Taiwan; [Wu, Yuan-Hua; Hsueh, Wei-Ting; Yang, Ming-Wei] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Radiat Oncol, Tainan 70101, Taiwan; [Chang, Jang-Yang; Chang, Kwang-Yu; Wang, Yi-Hui; Weng, Ya-Ling; Yang, Han-Chien; Chang, Jeffrey S.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Lin, Chen-Lin] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Nursing, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital	Chang, JS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jeffreychang@nhri.org.tw	Chang, Kwang-Yu/G-9161-2011; Chang, Jang-Yang/D-2099-2010; Chang, Jeffrey Shu-Ming/B-1092-2010; Chang, Jeffrey Shu-Ming/AAR-4161-2020	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205; WU, SHANG-YIN/0000-0003-2914-510X	National Health Research Institutes [CA-101-PP-07]; National Research Program for Biopharmaceuticals [100CAP1015-6, NSC100-2325-B-400-013]; National Science Council [NSC99-2314-B-006-018-MY3, NSC101-2325-B-006-009]; Establishment of Cancer Research System Excellence Program; Department of Health, Executive Yuan, Taiwan [DOH101-TD-C-111-003, DOH101-TD-C-111-004]	National Health Research Institutes(National Health Research Institutes, Japan); National Research Program for Biopharmaceuticals; National Science Council(Ministry of Science and Technology, Taiwan); Establishment of Cancer Research System Excellence Program; Department of Health, Executive Yuan, Taiwan	This work was funded by the National Health Research Institutes (CA-101-PP-07), the National Research Program for Biopharmaceuticals (100CAP1015-6, NSC100-2325-B-400-013), the National Science Council (NSC99-2314-B-006-018-MY3, NSC101-2325-B-006-009) and the Establishment of Cancer Research System Excellence Program funded by the Department of Health, Executive Yuan (DOH101-TD-C-111-003, DOH101-TD-C-111-004), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman D, 2011, ORAL ONCOL, V47, P725, DOI 10.1016/j.oraloncology.2011.05.004; BLOT WJ, 1988, CANCER RES, V48, P3282; Bosetti C, 2004, EUR J CANCER PREV, V13, P173, DOI 10.1097/01.cej.0000130016.85687.cf; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Boyle P, 2008, WORLD CANC REPORT; De Andrade M, 1998, ANN HUM GENET, V62, P505, DOI 10.1017/S0003480099007204; de Guia RM, 2010, INT J MOL EPIDEMIOL, V1, P67; Department of Health, 2009, ANN CANC REP; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Durham SR, 2000, AM J RHINOL, V14, P305, DOI 10.2500/105065800781329492; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engkilde K, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000084; Eriksson NE, 2005, J INVEST ALLERG CLIN, V15, P161; ERIKSSON NE, 1995, ALLERGY, V50, P718, DOI 10.1111/j.1398-9995.1995.tb01212.x; Freedman ND, 2007, CANCER, V110, P1593, DOI 10.1002/cncr.22957; Gandini S, 2005, CANCER EPIDEM BIOMAR, V14, P1908, DOI 10.1158/1055-9965.EPI-05-0119; Gaur P, 2011, ORAL DIS, V17, P720, DOI 10.1111/j.1601-0825.2011.01831.x; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Guha N, 2007, AM J EPIDEMIOL, V166, P1159, DOI 10.1093/aje/kwm193; Hagstromer L, 2005, ARCH DERMATOL, V141, P1123, DOI 10.1001/archderm.141.9.1123; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoddeson EK, 2010, OTOLARYNG CLIN N AM, V43, P503, DOI 10.1016/j.otc.2010.02.009; Hwang CY, 2012, INT J CANCER, V130, P1160, DOI 10.1002/ijc.26105; Jensen-Jarolim E, 2008, ALLERGY, V63, P1255, DOI 10.1111/j.1398-9995.2008.01768.x; Ji J, 2009, BRIT J CANCER, V100, P829, DOI 10.1038/sj.bjc.6604890; KALLEN B, 1993, EUR RESPIR J, V6, P694; Kay AB, 2000, BRIT MED BULL, V56, P843, DOI 10.1258/0007142001903481; Linos E, 2007, JNCI-J NATL CANCER I, V99, P1544, DOI 10.1093/jnci/djm170; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Merrill RM, 2007, ANN ALLERG ASTHMA IM, V99, P102, DOI 10.1016/S1081-1206(10)60632-1; Michaud DS, 2012, CANCER CAUSE CONTROL, V23, P1317, DOI 10.1007/s10552-012-0009-8; NEUCHRIST C, 1994, INT ARCH ALLERGY IMM, V104, P97, DOI 10.1159/000236714; PETROIANU A, 1995, J INT MED RES, V23, P358, DOI 10.1177/030006059502300505; POLEDNAK AP, 1975, LANCET, V2, P1147; ROBINETTE CD, 1978, J CHRON DIS, V31, P619, DOI 10.1016/0021-9681(78)90022-X; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Sherman PW, 2008, Q REV BIOL, V83, P339, DOI 10.1086/592850; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sterne J. A. C., 2005, SYSTEMATIC REV HLTH, P285; Tsai MH, 2005, J CLIN LAB ANAL, V19, P93, DOI 10.1002/jcla.20060; Turner MC, 2006, INT J CANCER, V118, P3124, DOI 10.1002/ijc.21752; Vairaktaris E, 2007, ORAL SURG ORAL MED O, V104, P796, DOI 10.1016/j.tripleo.2006.12.029; VENA JE, 1985, AM J EPIDEMIOL, V122, P66, DOI 10.1093/oxfordjournals.aje.a114087; VESTERINEN E, 1993, INT J EPIDEMIOL, V22, P976, DOI 10.1093/ije/22.6.976; Wang H, 2005, ALLERGY, V60, P1098, DOI 10.1111/j.1398-9995.2005.00813.x	48	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55138	10.1371/journal.pone.0055138	http://dx.doi.org/10.1371/journal.pone.0055138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383309	Green Submitted, gold, Green Published			2022-12-27	WOS:000314597900016
J	Chua, GL; Patra, AT; Tan, SM; Bhattacharjya, S				Chua, Geok-Lin; Patra, Alok Tanala; Tan, Suet-Mien; Bhattacharjya, Surajit			NMR Structure of Integrin alpha 4 Cytosolic Tail and Its Interactions with Paxillin	PLOS ONE			English	Article							CYTOPLASMIC DOMAIN; ADHESION; BINDING; ACTIVATION; REGION; VLA-4; SITE; PHOSPHORYLATION; RECOGNITION; ASSOCIATION	Background: Integrins are a group of transmembrane signaling proteins that are important in biological processes such as cell adhesion, proliferation and migration. Integrins are alpha/beta hetero-dimers and there are 24 different integrins formed by specific combinations of 18 alpha and 8 beta subunits in humans. Generally, each of these subunits has a large extracellular domain, a single pass transmembrane segment and a cytosolic tail (CT). CTs of integrins are important in bidirectional signal transduction and they associate with a large number of intracellular proteins. Principal Findings: Using NMR spectroscopy, we determined the 3-D structure of the full-length alpha 4 CT (Lys968-Asp999) and characterize its interactions with the adaptor protein paxillin. The alpha 4 CT assumes an overall helical structure with a kink in its membrane proximal region. Residues Gln981-Asn997 formed a continuous helical conformation that may be sustained by potential ionic and/or hydrogen bond interactions and packing of aromatic-aliphatic side-chains. N-15-H-1 HSQC NMR experiments reveal interactions of the alpha 4 CT C-terminal region with a fragment of paxillin (residues G139-K277) that encompassed LD2-LD4 repeats. Residues of these LD repeats including their adjoining linkers showed alpha 4 CT binding-induced chemical shift changes. Furthermore, NMR studies using LD-containing peptides showed predominant interactions between LD3 and LD4 of paxillin and alpha 4 CT. Docked structures of the alpha 4 CT with these LD repeats suggest possible polar and/or salt-bridge and non-polar packing interactions. Significance: The current study provides molecular insights into the structural diversity of alpha CTs of integrins and interactions of integrin alpha 4 CT with the adaptor protein paxillin.	[Chua, Geok-Lin; Patra, Alok Tanala; Tan, Suet-Mien; Bhattacharjya, Surajit] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	smtan@ntu.edu.sg; surajit@ntu.edu.sg	PATRA, ALOK/HCH-9797-2022; Tan, Suet/A-2224-2011	PATRA, ALOK/0000-0001-6983-911X; Tan, Suet-Mien/0000-0003-2371-8739	Ministry of Education (MOE) Singapore [ARC4/11, RG34/08]	Ministry of Education (MOE) Singapore(Ministry of Education, Singapore)	This work was supported by the Ministry of Education (MOE) Singapore to SB (ARC4/11) and to SMT (RG34/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Boettiger D, 2012, CURRENT OPINION CELL; Briskin M, 1997, AM J PATHOL, V151, P97; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; Chua GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041924; Chua GL, 2011, J BIOL CHEM, V286, P43842, DOI 10.1074/jbc.M111.280164; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KASSNER PD, 1995, MOL BIOL CELL, V6, P661, DOI 10.1091/mbc.6.6.661; Kummer C, 2010, J BIOL CHEM, V285, P9462, DOI 10.1074/jbc.M109.066993; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2002, J BIOL CHEM, V277, P20887, DOI 10.1074/jbc.M110928200; Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; May AE, 2000, BLOOD, V96, P506; MOULD AP, 1991, J BIOL CHEM, V266, P3579; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Rose DM, 2006, EXP MOL MED, V38, P191, DOI 10.1038/emm.2006.23; Sandborn WJ, 2003, AM J GASTROENTEROL, V98, P2372, DOI 10.1016/j.amjgastroenterol.2003.08.009; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; YANG JT, 1995, DEVELOPMENT, V121, P549; Young BA, 2001, MOL BIOL CELL, V12, P3214, DOI 10.1091/mbc.12.10.3214; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	49	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55184	10.1371/journal.pone.0055184	http://dx.doi.org/10.1371/journal.pone.0055184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383101	Green Published, gold			2022-12-27	WOS:000314610600073
J	Wu, MT; Huang, PY; Yen, CT; Chen, CC; Lee, MJ				Wu, Min-Tzu; Huang, Po-Yuan; Yen, Chen-Tung; Chen, Chih-Cheng; Lee, Ming-Jen			A Novel SCN9A Mutation Responsible for Primary Erythromelalgia and Is Resistant to the Treatment of Sodium Channel Blockers	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL PROPERTIES; PRIMARY ERYTHERMALGIA; STATE INACTIVATION; SENSORY NEURONS; ALPHA-SUBUNIT; PAIN; IDENTIFICATION; ONSET; GENE; PN1	Primary erythromelalgia (PE) is an autosomal dominant neurological disorder characterized by severe burning pain and erythema in the extremities upon heat stimuli or exercise. Mutations in human SCN9A gene, encoding the alpha-subunit of the voltage-gated sodium channel, Na(v)1.7, were found to be responsible for PE. Three missense mutations of SCN9A gene have recently been identified in Taiwanese patients including a familial (I136V) and two sporadic mutations (I848T, V1316A). V1316A is a novel mutation and has not been characterized yet. Topologically, I136V is located in DI/S1 segment and both I848T and V1316A are located in S4-S5 linker region of DII and DIII domains, respectively. To characterize the elelctrophysiological manifestations, the channel conductance with whole-cell patch clamp was recorded on the over-expressed Chinese hamster overy cells. As compared with wild type, the mutant channels showed a significant hyperpolarizing shift in voltage dependent activation and a depolarizing shift in steady-state fast inactivation. The recovery time from channel inactivation is faster in the mutant than in the wild type channels. Since warmth can trigger and exacerbate symptoms, we then examine the influence of tempearture on the sodium channel conduction. At 35 degrees C, I136V and V1316A mutant channels exhibit a further hyperpolarizing shift at activation as compared with wild type channel, even though wild type channel also produced a significant hyperpolarizing shift compared to that of 25 degrees C. High temperature caused a significant depolarizing shift in steady-state fast inactivation in all three mutant channels. These findings may confer to the hyperexcitability of sensory neurons, especially at high temperature. In order to identifying an effective treatment, we tested the IC50 values of selective sodium channel blockers, lidocaine and mexiletine. The IC50 for mexiletine is lower for I848T mutant channel as compared to that of the wild type and other two mutants which is comparable to the clinical observations.	[Wu, Min-Tzu; Huang, Po-Yuan; Yen, Chen-Tung] Natl Taiwan Univ, Grad Inst Zool, Coll Life Sci, Taipei 10764, Taiwan; [Chen, Chih-Cheng] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Ming-Jen] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chen, CC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	chih@ibms.sinica.edu.tw; mjlee@ntu.edu.tw	Chen, Chih-Cheng/AAT-1062-2021; Chen, Chih-Cheng/S-7015-2018	Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660; Lee, Ming-Jen/0000-0001-8732-2448; Yen, Chen-Tung/0000-0002-0076-4487	Institute of Biomedical Sciecnes, Academia Sinica of Taiwanese Government [IBMS-CRC96-P03]; National Science Council of Taiwanese Government [NSC-99-3112-B-002-012]	Institute of Biomedical Sciecnes, Academia Sinica of Taiwanese Government; National Science Council of Taiwanese Government	This work was supported by a grant from Institute of Biomedical Sciecnes, Academia Sinica (IBMS-CRC96-P03) and National Science Council (NSC-99-3112-B-002-012) of Taiwanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn H-S, 2010, EUROPEAN J PAIN, P1; BABB RR, 1964, CIRCULATION, V29, P136, DOI 10.1161/01.CIR.29.1.136; Cheng XD, 2011, PROG MOL BIOL TRANSL, V101, P1, DOI 10.1016/B978-0-12-387685-0.00001-9; Cheng XY, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-24; Cheng XY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-1; Choi J-S, 2010, NATURE PUBLISHING GR, V7, P51; Choi JS, 2006, NEUROLOGY, V67, P1563, DOI 10.1212/01.wnl.0000231514.33603.1e; Choi JS, 2009, EXP NEUROL, V216, P383, DOI 10.1016/j.expneurol.2008.12.012; Cox JJ, 2010, HUM MUTAT, V31, pE1670, DOI 10.1002/humu.21325; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Davis MDP, 2000, ARCH DERMATOL, V136, P330, DOI 10.1001/archderm.136.3.330; Dib-Hajj S. D., 2006, DRUG DISCOV TODAY, V3, P343; Djouhri L, 2003, J PHYSIOL-LONDON, V546, P565, DOI 10.1113/jphysiol.2002.026559; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; DRENTH JPH, 1994, ANGIOLOGY, V45, P451, DOI 10.1177/000331979404500606; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Drenth JPH, 2001, AM J HUM GENET, V68, P1277, DOI 10.1086/320107; Estacion M, 2010, J PHYSIOL-LONDON, V588, P1915, DOI 10.1113/jphysiol.2009.186114; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2006, J NEUROL NEUROSUR PS, V77, P1294, DOI 10.1136/jnnp.2006.089664; Fischer TZ, 2009, ANN NEUROL, V65, P733, DOI 10.1002/ana.21678; Han CY, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-3; Han CY, 2009, BRAIN, V132, P1711, DOI 10.1093/brain/awp078; Harty TP, 2006, J NEUROSCI, V26, P12566, DOI 10.1523/JNEUROSCI.3424-06.2006; Lampert A, 2006, J BIOL CHEM, V281, P36029, DOI 10.1074/jbc.M607637200; Lampert A, 2009, BIOCHEM BIOPH RES CO, V390, P319, DOI 10.1016/j.bbrc.2009.09.121; Lee MJ, 2007, J NEUROL, V254, P210, DOI 10.1007/s00415-006-0328-3; Lin YW, 2008, NEUROSCIENCE, V151, P544, DOI 10.1016/j.neuroscience.2007.10.020; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Mitchell WS, 1878, AM J MED SCI, V151, P17; Natkunarajah J, 2009, CLIN EXP DERMATOL, V34, pE640, DOI 10.1111/j.1365-2230.2009.03355.x; Rogers M, 2006, SEMIN CELL DEV BIOL, V17, P571, DOI 10.1016/j.semcdb.2006.10.009; THOMPSON GH, 1979, CLIN ORTHOP RELAT R, P249; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Waxman SG, 2005, TRENDS MOL MED, V11, P555, DOI 10.1016/j.molmed.2005.10.004; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109	38	42	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55212	10.1371/journal.pone.0055212	http://dx.doi.org/10.1371/journal.pone.0055212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383113	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600075
J	Fraser, B; DuVal, MG; Wang, H; Allison, WT				Fraser, Brittany; DuVal, Michele G.; Wang, Hao; Allison, W. Ted			Regeneration of Cone Photoreceptors when Cell Ablation Is Primarily Restricted to a Particular Cone Subtype	PLOS ONE			English	Article							RETINAL STEM-CELLS; TROUT ONCORHYNCHUS-MYKISS; OPSIN GENE-EXPRESSION; ZEBRAFISH RETINA; RAINBOW-TROUT; MULLER GLIA; PATTERN-FORMATION; NEURONAL PROGENITORS; REARRANGEMENT MODEL; ROD PHOTORECEPTORS	We sought to characterize the regenerated cells, if any, when photoreceptor ablation was mostly limited to a particular cone subtype. This allowed us to uniquely assess whether the remaining cells influence specification of regenerating photoreceptors. The ability to replace lost photoreceptors via stem cell therapy holds promise for treating many retinal degenerative diseases. Zebrafish are potent for modelling this because they have robust regenerative capacity emanating from endogenous stem cells, and abundant cone photoreceptors including multiple spectral subtypes similar to human fovea. We ablated the homolog of the human S-cones, the ultraviolet-sensitive (UV) cones, and tested the hypothesis that the photoreceptors regenerating in their place take on identities matching those expected from normal cone mosaic development. We created transgenic fish wherein UV cones can be ablated by addition of a prodrug. Thus photoreceptors developed normally and only the UV cones expressed nitroreductase; the latter converts the prodrug metronidazole to a cell-autonomous neurotoxin. A significant increase in proliferation of progenitor cell populations (p<0.01) was observed when cell ablation was primarily limited to UV cones. In control fish, we found that BrdU primarily incorporated into rod photoreceptors, as expected. However the majority of regenerating photoreceptors became cones when retinal cell ablation was predominantly restricted to UV cones: a 2-fold increase in the relative abundance of cones (p = 0.008) was mirrored by a 35% decrease in rods. By primarily ablating only a single photoreceptor type, we show that the subsequent regeneration is biased towards restoring the cognate photoreceptor type. We discuss the hypothesis that, after cone death, the microenvironment formed by the remaining retinal cells may be influential in determining the identity of regenerating photoreceptors, though other interpretations are plausible. Our novel animal model provides control of ablation that will assist in identifying mechanisms required to replace cone photoreceptors clinically to restore daytime vision.	[Fraser, Brittany; DuVal, Michele G.; Wang, Hao; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Ctr Pr & Prot Folding Dis, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/A-2612-2014; Allison, W. Ted/K-5228-2012	Allison, W. Ted/0000-0002-8461-4864; DuVal, Michele/0000-0001-6975-8117	NSERC; CIHR	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	NSERC (www.nserc-crsng.gc.ca) Discovery Grant to WTA, and Studentships from NSERC and CIHR (www.cihr-irsc.gc.ca) to BF and MGD, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake CM, 2011, DEV BIOL, V352, P191, DOI 10.1016/j.ydbio.2011.01.002; Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Allison WT, 2006, MOL VIS, V12, P655; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Allison WT, 2006, VISUAL NEUROSCI, V23, P25, DOI 10.1017/S0952523806231031; Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Allison WT, 2004, THESIS U VICTORIA VI; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Ariga Junko, 2010, J Vis Exp, DOI 10.3791/2093; BEAUDET L, 1993, VISION RES, V33, P1739, DOI 10.1016/0042-6989(93)90164-R; Beaudet L., 1999, P413; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bernardos RL, 2004, J COMP NEUR IN PRESS; Bernardos RL, 2005, INVEST OPHTHALMOL, V46, P5327; Bhatia B, 2011, EXP EYE RES, V93, P852, DOI 10.1016/j.exer.2011.09.015; BROWMAN HI, 1992, VISION RES, V32, P2303, DOI 10.1016/0042-6989(92)90094-Y; CAMERON DA, 1995, J NEUROSCI, V15, P2255, DOI 10.1523/JNEUROSCI.15-03-02255.1995; Cameron DA, 2000, J COMP NEUROL, V416, P356; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; DuVal MG, 2012, MOL VISION IN PRESS; Easter SS, 2000, NEUROSCIENTIST, V6, P454, DOI 10.1177/107385840000600608; EASTER SS, 1992, J NEUROSCI, V12, P2381; EDWARDS DI, 1993, J ANTIMICROB CHEMOTH, V31, P201, DOI 10.1093/jac/31.2.201; Eglen SJ, 2000, NETWORK-COMP NEURAL, V11, P103, DOI 10.1088/0954-898X/11/1/306; Eglen SJ, 2002, DEVELOPMENT, V129, P5399, DOI 10.1242/dev.00118; Eglen SJ, 2008, VISUAL NEUROSCI, V25, P209, DOI 10.1017/S0952523808080176; Eglen SJ, 2006, RETINAL DEVELOPMENT, P193, DOI 10.1017/CBO9780511541629.012; ENGSTROM KJELL, 1960, ACTA ZOOL [STOCKHOLM], V41, P277; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; FERNALD RD, 1990, J EXP ZOOL, P167; Flamarique IN, 1996, J EXP BIOL, V199, P869; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Giannelli SG, 2011, STEM CELLS, V29, P344, DOI 10.1002/stem.579; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; Gust J, 2011, INVEST OPHTH VIS SCI, V52, P5266, DOI 10.1167/iovs.10-6329; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; Inoue T, 2010, STEM CELLS, V28, P489, DOI 10.1002/stem.279; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; Jomary C, 2008, INVEST OPHTH VIS SCI, V49, P429, DOI 10.1167/iovs.07-0812; Jomary C, 2010, INVEST OPHTH VIS SCI, V51, P1181, DOI 10.1167/iovs.09-4385; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lamba DA, 2009, PROG BRAIN RES, V175, P23, DOI 10.1016/S0079-6123(09)17502-7; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; LYALL AH, 1957, Q J MICROSC SCI, V98, P101; LYALL AH, 1957, Q J MICROSC SCI, V98, P189; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mochizuki A, 2002, J THEOR BIOL, V215, P345, DOI 10.1006/jtbi.2001.2508; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Perron M, 2000, BIOESSAYS, V22, P685, DOI 10.1002/1521-1878(200008)22:8<685::AID-BIES1>3.0.CO;2-C; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Ramachandran R, 2010, J COMP NEUROL, V518, P4196, DOI 10.1002/cne.22448; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; RAYMOND PA, 1991, CIBA F SYMP, V160, P171; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1988, J NEUROBIOL, V19, P431, DOI 10.1002/neu.480190504; Raymond PA, 1991, CIBA F SYMP, V160, P186; REH TA, 1992, J NEUROBIOL, V23, P1067, DOI 10.1002/neu.480230811; REH TA, 1994, PERSPECT DEV NEUROBI, V2, P183; Rister J, 2011, DEV NEUROBIOL, V71, P1212, DOI 10.1002/dneu.20905; Stenkamp DL, 2002, MOL VIS, V8, P280; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Temple SE, 2008, J EXP BIOL, V211, P3879, DOI 10.1242/jeb.020289; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Togashi H, 2011, SCIENCE, V333, P1144, DOI 10.1126/science.1208467; Tohya S, 1999, J THEOR BIOL, V200, P231, DOI 10.1006/jtbi.1999.0990; Tohya S, 2003, J THEOR BIOL, V221, P289, DOI 10.1006/jtbi.2003.3192; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; Veldhoen K, 2006, VISUAL NEUROSCI, V23, P169, DOI 10.1017/S0952523806232139; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; West EL, 2012, STEM CELLS; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhao XF, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-107	83	46	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55410	10.1371/journal.pone.0055410	http://dx.doi.org/10.1371/journal.pone.0055410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383182	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800151
J	Maulik, M; Thinakaran, G; Kar, S				Maulik, Mahua; Thinakaran, Gopal; Kar, Satyabrata			Alterations in Gene Expression in Mutant Amyloid Precursor Protein Transgenic Mice Lacking Niemann-Pick Type C1 Protein	PLOS ONE			English	Article							BETA-DEGRADING ENZYMES; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; MOUSE MODEL; A-BETA; CHOLESTEROL ACCUMULATION; TRAFFICKING; PATHOGENESIS; NEURODEGENERATION; HOMEOSTASIS	Niemann-Pick type C (NPC) disease, a rare autosomal recessive disorder caused mostly by mutation in NPC1 gene, is pathologically characterized by the accumulation of free cholesterol in brain and other tissues. This is accompanied by gliosis and loss of neurons in selected brain regions, including the cerebellum. Recent studies have shown that NPC disease exhibits intriguing parallels with Alzheimer's disease, including the presence of neurofibrillary tangles and increased levels of amyloid precursor protein (APP)-derived beta-amyloid (A beta) peptides in vulnerable brain neurons. To evaluate the role of A beta in NPC disease, we determined the gene expression profile in selected brain regions of our recently developed bigenic ANPC mice, generated by crossing APP transgenic (Tg) mice with heterozygous Npc1-deficient mice. The ANPC mice exhibited exacerbated neuronal and glial pathology compared to other genotypes [i.e., APP-Tg, double heterozygous (Dhet), Npc1-null and wild-type mice]. Analysis of expression profiles of 86 selected genes using real-time RT-PCR arrays showed a wide-spectrum of alterations in the four genotypes compared to wild-type controls. The changes observed in APP-Tg and Dhet mice are limited to only few genes involved mostly in the regulation of cholesterol metabolism, whereas Npc1-null and ANPC mice showed alterations in the expression profiles of a number of genes regulating cholesterol homeostasis, APP metabolism, vesicular trafficking and cell death mechanism in both hippocampus and cerebellum compared to wild-type mice. Intriguingly, ANPC and Npc1-null mice, with some exceptions, exhibited similar changes, although more genes were differentially expressed in the affected cerebellum than the relatively spared hippocampus. The altered gene profiles were found to match with the corresponding protein levels. These results suggest that lack of Npc1 protein can alter the expression profile of selected transcripts as well as proteins, and APP overexpression influences cerebral pathology by enhancing changes triggered by Npc1 deficiency in the bigenic line.	[Maulik, Mahua; Kar, Satyabrata] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Maulik, Mahua; Kar, Satyabrata] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kar, Satyabrata] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada; [Kar, Satyabrata] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Chicago; University of Chicago; University of Chicago; University of Alberta; University of Alberta	Kar, S (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	skar@ualberta.ca		Maulik, Mahua/0000-0002-9046-3716	Canadian Institutes of Health Research; National Institutes of Health, United States of America [AG021495, AG019070]; University of Alberta; Alberta Innovates Health Solutions (AIHS); Canada Research Chair (Tier-II) in Neurodegenerative Diseases; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alberta(University of Alberta); Alberta Innovates Health Solutions (AIHS); Canada Research Chair (Tier-II) in Neurodegenerative Diseases; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from Canadian Institutes of Health Research (SK). GT is supported by grants AG021495 and AG019070 from the National Institutes of Health, United States of America. MM is a recipient of President's International Doctoral Award from the University of Alberta and a studentship award from the Alberta Innovates Health Solutions (AIHS). SK is a recipient of Canada Research Chair (Tier-II) in Neurodegenerative Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalbert R, 2009, BRAIN, V132, P402, DOI 10.1093/brain/awn312; Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; AUER IA, 1995, ACTA NEUROPATHOL, V90, P547; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Canevari L, 2007, NEUROCHEM RES, V32, P739, DOI 10.1007/s11064-006-9200-1; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; German DC, 2001, J COMP NEUROL, V433, P415, DOI 10.1002/cne.1149; Hartmann T, 2001, TRENDS NEUROSCI, V24, pS45, DOI 10.1016/S0166-2236(00)01990-1; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kodam A, 2010, GLIA, V58, P1267, DOI 10.1002/glia.21001; Lai A. Y., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/548380; Li GP, 2011, CURR DRUG TARGETS, V12, P1188, DOI 10.2174/138945011795906561; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Mattsson N, 2011, NEUROLOGY, V76, P366, DOI 10.1212/WNL.0b013e318208f4ab; Maulik M, 2012, MOL NEUROBI IN PRESS; Maulik M, 2012, HUM MOL GENET, V21, P4857, DOI 10.1093/hmg/dds322; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Ohm TG, 2003, PHARMACOPSYCHIATRY, V36, pS120; Pacheco Chris D., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800080X; Pacheco CD, 2009, HUM MOL GENET, V18, P956, DOI 10.1093/hmg/ddn423; Paul CA, 2004, BBA-MOL CELL BIOL L, V1685, P63, DOI 10.1016/j.bbalip.2004.08.012; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Poirier J, 2003, TRENDS MOL MED, V9, P94, DOI 10.1016/S1471-4914(03)00007-8; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Saito Y, 2002, ANN NEUROL, V52, P351, DOI 10.1002/ana.10266; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Vanier MT, 1998, BRAIN PATHOL, V8, P163; Wu YP, 2005, MOL GENET METAB, V84, P9, DOI 10.1016/j.ymgme.2004.08.017; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	51	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54605	10.1371/journal.pone.0054605	http://dx.doi.org/10.1371/journal.pone.0054605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382922	Green Submitted, Green Published, gold			2022-12-27	WOS:000315483200005
J	Richter, S; Gorny, X; Machts, J; Behnisch, G; Wustenberg, T; Herbort, MC; Munte, TF; Seidenbecher, CI; Schott, BH				Richter, Sylvia; Gorny, Xenia; Machts, Judith; Behnisch, Gusalija; Wuestenberg, Torsten; Herbort, Maike C.; Muente, Thomas F.; Seidenbecher, Constanze I.; Schott, Bjoern H.			Effects of AKAP5 Pro100Leu Genotype on Working Memory for Emotional Stimuli	PLOS ONE			English	Article							GENETIC-VARIATION; SEROTONIN TRANSPORTER; NEURAL MECHANISMS; AMYGDALA RESPONSIVENESS; REPETITION SUPPRESSION; INDIVIDUAL-DIFFERENCES; FACIAL EXPRESSIONS; BRAIN ACTIVATION; FACES; RESPONSES	Recent investigations addressing the role of the synaptic multiadaptor molecule AKAP5 in human emotion and behavior suggest that the AKAP5 Pro100Leu polymorphism (rs2230491) contributes to individual differences in affective control. Carriers of the less common Leu allele show a higher control of anger as indicated by behavioral measures and dACC brain response on emotional distracters when compared to Pro homozygotes. In the current fMRI study we used an emotional working memory task according to the n-back scheme with neutral and negative emotional faces as target stimuli. Pro homozygotes showed a performance advantage at the behavioral level and exhibited enhanced activation of the amygdala and fusiform face area during working memory for emotional faces. On the other hand, Leu carriers exhibited increased activation of the dACC during performance of the 2-back condition. Our results suggest that AKAP5 Pro100Leu effects on emotion processing might be task-dependent with Pro homozygotes showing lower control of emotional interference, but more efficient processing of task-relevant emotional stimuli.	[Richter, Sylvia] Salzburg Univ, Dept Clin Psychol, A-5020 Salzburg, Austria; [Richter, Sylvia; Gorny, Xenia; Behnisch, Gusalija; Herbort, Maike C.; Seidenbecher, Constanze I.; Schott, Bjoern H.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Machts, Judith; Schott, Bjoern H.] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [Wuestenberg, Torsten; Herbort, Maike C.; Schott, Bjoern H.] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Muente, Thomas F.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	Salzburg University; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck	Schott, BH (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	bschott@neuro2.med.uni-magdeburg.de	Schott, Björn H/U-5626-2017; Münte, Thomas/C-2077-2014; Machts, Judith/J-2508-2019	Schott, Björn H/0000-0002-8237-4481; Machts, Judith/0000-0002-8660-095X; Seidenbecher, Constanze/0000-0002-7433-2716; Wustenberg, Torsten/0000-0001-8408-2864	Deutsche Forschungsgemeinschaft [SFB 779]; Leibniz Society (Leibniz Graduate School Synaptogenetics); State of Saxony-Anhalt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Society (Leibniz Graduate School Synaptogenetics); State of Saxony-Anhalt	The present project is supported by the Deutsche Forschungsgemeinschaft (SFB 779, TP A8), the "Pakt fur Forschung und Innovation" of the Leibniz Society (Leibniz Graduate School Synaptogenetics), and the State of Saxony-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia-Klein N, 2009, EMOTION, V9, P385, DOI 10.1037/a0015904; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Buckholtz JW, 2008, TRENDS NEUROSCI, V31, P120, DOI 10.1016/j.tins.2007.12.006; Calder AJ, 2011, PHILOS T R SOC B, V366, P1684, DOI 10.1098/rstb.2010.0362; Canli T, 2009, NEUROSCIENCE, V164, P43, DOI 10.1016/j.neuroscience.2009.06.049; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; De Martino B, 2008, PSYCHOPHARMACOLOGY, V197, P127, DOI 10.1007/s00213-007-1015-5; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; Dekowska M, 2008, ACTA NEUROBIOL EXP, V68, P229; Domschke K, 2012, NEUROIMAGE, V60, P2222, DOI 10.1016/j.neuroimage.2012.02.039; Druzgal TJ, 2001, COGNITIVE BRAIN RES, V10, P355, DOI 10.1016/S0926-6410(00)00056-2; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Erk S, 2007, NEUROIMAGE, V37, P623, DOI 10.1016/j.neuroimage.2007.05.006; Erk S, 2006, EUR J NEUROSCI, V24, P1227, DOI 10.1111/j.1460-9568.2006.04976.x; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Furmark T, 2009, J PSYCHIATR NEUROSCI, V34, P30; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Greene CM, 2008, BIOL PSYCHOL, V79, P30, DOI 10.1016/j.biopsycho.2007.11.009; Haas BW, 2009, J NEUROSCI, V29, P1132, DOI 10.1523/JNEUROSCI.5324-08.2009; Hariri AR, 2009, ANNU REV NEUROSCI, V32, P225, DOI 10.1146/annurev.neuro.051508.135335; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Heinz A, 2006, REV NEUROSCIENCE, V17, P359; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kienast T, 2008, NAT NEUROSCI, V11, P1381, DOI 10.1038/nn.2222; Kilpatrick LA, 2011, GASTROENTEROLOGY, V140, P1943, DOI 10.1053/j.gastro.2011.03.011; Ladouceur CD, 2009, EMOTION, V9, P855, DOI 10.1037/a0017747; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Liu LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009790; Lonsdorf TB, 2011, BIOL PSYCHOL, V87, P106, DOI 10.1016/j.biopsycho.2011.02.014; Lundqvist D., 1998, KAROLINSKA DIRECTED; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; O'Nions EJP, 2011, J COGNITIVE NEUROSCI, V23, P3681, DOI 10.1162/jocn_a_00055; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001; Richter S, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00175; Said CP, 2010, NEUROPSYCHOLOGIA, V48, P3596, DOI 10.1016/j.neuropsychologia.2010.08.009; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Schardt DM, 2010, NEUROIMAGE, V53, P943, DOI 10.1016/j.neuroimage.2009.11.078; Schott BH, 2011, HUM BRAIN MAPP; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schubert R, 2008, CEREB CORTEX, V18, P2686, DOI 10.1093/cercor/bhn029; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Sharpe JP, 2001, PERS INDIV DIFFER, V31, P505, DOI 10.1016/S0191-8869(00)00155-0; Shin LM, 2011, AM J PSYCHIAT, V168, P979, DOI 10.1176/appi.ajp.2011.09121812; Sik A, 2000, EUR J NEUROSCI, V12, P1155, DOI 10.1046/j.1460-9568.2000.00002.x; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010; Strange BA, 2003, P NATL ACAD SCI USA, V100, P13626, DOI 10.1073/pnas.1635116100; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Ulfig N, 1999, MICROSC RES TECHNIQ, V46, P48, DOI 10.1002/(SICI)1097-0029(19990701)46:1<48::AID-JEMT4>3.0.CO;2-1; Ulfig N, 2001, CELLS TISSUES ORGANS, V168, P319, DOI 10.1159/000047848; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wager TD, 2009, NEUROIMAGE, V47, P836, DOI 10.1016/j.neuroimage.2009.05.044; Walter H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006726; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Wolfensberger SPA, 2008, NEUROIMAGE, V41, P544, DOI 10.1016/j.neuroimage.2008.01.053; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009; Zweynert S, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00144	82	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55613	10.1371/journal.pone.0055613	http://dx.doi.org/10.1371/journal.pone.0055613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383244	Green Submitted, gold, Green Published			2022-12-27	WOS:000315483200023
J	Cherubini, P; Humbel, T; Beeckman, H; Gartner, H; Mannes, D; Pearson, C; Schoch, W; Tognetti, R; Lev-Yadun, S				Cherubini, Paolo; Humbel, Turi; Beeckman, Hans; Gaertner, Holger; Mannes, David; Pearson, Charlotte; Schoch, Werner; Tognetti, Roberto; Lev-Yadun, Simcha			Olive Tree-Ring Problematic Dating: A Comparative Analysis on Santorini (Greece)	PLOS ONE			English	Article							X-RAY-FLUORESCENCE; EASTERN SPAIN; WOOD; ANATOMY; GROWTH; AGE	Olive trees are a classic component of Mediterranean environments and some of them are known historically to be very old. In order to evaluate the possibility to use olive tree-rings for dendrochronology, we examined by various methods the reliability of olive tree-rings identification. Dendrochronological analyses of olive trees growing on the Aegean island Santorini (Greece) show that the determination of the number of tree-rings is impossible because of intra-annual wood density fluctuations, variability in tree-ring boundary structure, and restriction of its cambial activity to shifting sectors of the circumference, causing the tree-ring sequences along radii of the same cross section to differ.	[Cherubini, Paolo; Humbel, Turi; Gaertner, Holger; Schoch, Werner] WSL Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland; [Humbel, Turi] Univ Zurich, Dept Geog, Zurich, Switzerland; [Beeckman, Hans] Royal Museum Cent Africa, Lab Wood Biol & Xylarium, Tervuren, Belgium; [Mannes, David] Paul Scherrer Inst, Villigen, Switzerland; [Pearson, Charlotte] Cornell Univ, Malcolm & Carolyn Wiener Lab Aegean & Near Easter, Ithaca, NY USA; [Pearson, Charlotte] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [Tognetti, Roberto] Univ Molise, Dept Biosci & Terr, Pesche, Italy; [Lev-Yadun, Simcha] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Oranim, Tivon, Israel	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Zurich; Royal Museum for Central Africa; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Cornell University; University of Arizona; University of Molise; University of Haifa	Cherubini, P (corresponding author), WSL Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland.	paolo.cherubini@wsl.ch	Pearson, Charlotte/AAP-3087-2020; Beeckman, Hans/I-7653-2019; Tognetti, Roberto/C-4962-2008; Cherubini, Paolo/AAC-3121-2021; Cherubini, Paolo/N-9702-2013; Gärtner, Holger W/J-7887-2013	Pearson, Charlotte/0000-0002-3594-3194; Beeckman, Hans/0000-0001-8954-6277; Tognetti, Roberto/0000-0002-7771-6176; Cherubini, Paolo/0000-0002-9809-250X; Cherubini, Paolo/0000-0002-9809-250X; Gärtner, Holger W/0000-0001-6243-9578; Mannes, David/0000-0003-4028-7504	Institute for Aegean Prehistory (INSTAP); Division Of Behavioral and Cognitive Sci [1236981] Funding Source: National Science Foundation	Institute for Aegean Prehistory (INSTAP); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Institute for Aegean Prehistory (INSTAP) funded the sampling work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battipaglia G, 2010, NEW PHYTOL, V188, P1099, DOI 10.1111/j.1469-8137.2010.03443.x; BORMANN F.H., 1981, AGE GROWTH RATE TROP; Cherubini P, 2003, BIOL REV, V78, P119, DOI 10.1017/S1464793102006000; Copenheaver CA, 2010, BOTANY, V88, P545, DOI 10.1139/B10-029; De Micco V, 2007, IAWA J, V28, P61, DOI 10.1163/22941932-90001619; Fritts H. C., 1976, TREE RINGS CLIMATE; GOURLAY ID, 1995, J TROP ECOL, V11, P121, DOI 10.1017/S0266467400008488; Keunecke D., 2011, WOOD RES, V55, P49; Krzyszkowska, 2010, CRETAN OFFERINGS STU, P367; LIPHSCHITZ N, 1986, IAWA BULL, V7, P145, DOI 10.1163/22941932-90000978; Mannes D, 2007, TREES-STRUCT FUNCT, V21, P605, DOI 10.1007/s00468-007-0149-8; Martin RR, 2001, X-RAY SPECTROM, V30, P338, DOI 10.1002/xrs.507; McLaughlin SB, 1999, NEW PHYTOL, V142, P373, DOI 10.1046/j.1469-8137.1999.00420.x; Pearson CL, 2011, FOREST ECOL MANAG, V262, P1258, DOI 10.1016/j.foreco.2011.06.023; Poussart PM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026929; Schweingruber F. H., 1988, TREE RINGS BASICS AP; STUIVER M, 1986, RADIOCARBON, V28, P969, DOI 10.1017/S0033822200060252; Terral JF, 1996, QUATERNARY RES, V46, P176, DOI 10.1006/qres.1996.0057; Terral JF, 1999, PALAEOGEOGR PALAEOCL, V153, P71, DOI 10.1016/S0031-0182(99)00079-6; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; Zohary M, 1973, GEOBOTANICAL FDN MID	21	46	46	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54730	10.1371/journal.pone.0054730	http://dx.doi.org/10.1371/journal.pone.0054730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382949	Green Published, gold, Green Accepted			2022-12-27	WOS:000315211500023
J	O'Donnell, RK; Goldstein, WE; Perruzzi, C; Benjamin, LE; Aird, W				O'Donnell, Rebekah K.; Goldstein, Whitney E.; Perruzzi, Carole; Benjamin, Laura E.; Aird, William			Overexpression of MyrAkt1 in Endothelial Cells Leads to Erythropoietin- and BMP4-Independent Splenic Erythropoiesis in Mice	PLOS ONE			English	Article							BMP4-DEPENDENT STRESS ERYTHROPOIESIS; ERYTHROID PROGENITORS; REQUIRES; EXPRESSION; EXPANSION; ANEMIA; MOUSE; MODEL	Under steady state conditions, erythropoiesis occurs in the bone marrow. However, in mice, stress or tissue hypoxia results in increased erythropoiesis in the spleen. There is increasing evidence that the hematopoietic microenvironment, including endothelial cells, plays an important role in regulating erythropoiesis. Here, we show that short-term expression of constitutively active Akt in the endothelium of mice results in non-anemic stress erythropoiesis in the spleen. The initiation of this stress response was independent of erythropoietin and BMP4, and was observed in endothelial myrAkt1 mice reconstituted with wild-type bone marrow. Together, these data suggest that endothelial cell hyperactivation is a potentially novel pathway of inducing red cell production under stress.	[O'Donnell, Rebekah K.; Goldstein, Whitney E.; Perruzzi, Carole; Benjamin, Laura E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [O'Donnell, Rebekah K.; Goldstein, Whitney E.; Perruzzi, Carole; Benjamin, Laura E.; Aird, William] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Aird, William] Beth Israel Deaconess Med Ctr, Dept Med, Div Mol & Vasc Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	O'Donnell, RK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	rebekah.k.odonnell@gmail.com		O'Donnell, Rebekah/0000-0001-5878-7510	National Institutes of Health [CA131152]; NATIONAL CANCER INSTITUTE [R01CA131152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (grant CA131152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cancro MP, 2009, NAT REV IMMUNOL, V9, P657, DOI 10.1038/nri2621; Casola S, 2007, CURR OPIN IMMUNOL, V19, P143, DOI 10.1016/j.coi.2007.02.010; Eckardt KU, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01525.x; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kim HS, 2005, FASEB J, V19, P1042, DOI 10.1096/fj.04-2841fje; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lenox LE, 2009, EXP HEMATOL, V37, P549, DOI 10.1016/j.exphem.2009.01.004; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liesveld J, 2005, HEMATOLOGY, V10; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Ohneda O, 1997, BRIT J HAEMATOL, V98, P798, DOI 10.1046/j.1365-2141.1997.3163133.x; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Perry JM, 2009, BLOOD, V113, P911, DOI 10.1182/blood-2008-03-147892; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Porayette P, 2008, DEV BIOL, V317, P24, DOI 10.1016/j.ydbio.2008.01.047; Sheng Y, 2008, IMMUNOL LETT, V121, P33, DOI 10.1016/j.imlet.2008.08.001; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Wen XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026536; Yamashita T, 2008, BLOOD, V112, P1482, DOI 10.1182/blood-2007-11-122648	28	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55095	10.1371/journal.pone.0055095	http://dx.doi.org/10.1371/journal.pone.0055095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383068	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500057
J	Carmona-Catot, G; Magellan, K; Garcia-Berthou, E				Carmona-Catot, Gerard; Magellan, Kit; Garcia-Berthou, Emili			Temperature-Specific Competition between Invasive Mosquitofish and an Endangered Cyprinodontid Fish	PLOS ONE			English	Article							CLIMATE-CHANGE; LIFE-HISTORY; APHANIUS-IBERUS; SWIMMING PERFORMANCE; TRINIDADIAN GUPPY; ABIOTIC FACTORS; COEXISTENCE; BEHAVIOR; PISCES; COSTS	Condition-specific competition is widespread in nature. Species inhabiting heterogeneous environments tend to differ in competitive abilities depending on environmental stressors. Interactions between these factors can allow coexistence of competing species, which may be particularly important between invasive and native species. Here, we examine the effects of temperature on competitive interactions between invasive mosquitofish, Gambusia holbrooki, and an endemic Iberian toothcarp, Aphanius iberus. We compare the tendency to approach heterospecifics and food capture rates between these two species, and examine differences between sexes and species in aggressive interactions, at three different temperatures (19, 24 and 29 degrees C) in three laboratory experiments. Mosquitofish exhibit much more aggression than toothcarp. We show that mosquitofish have the capacity to competitively displace toothcarp through interference competition and this outcome is more likely at higher temperatures. We also show a reversal in the competitive hierarchy through reduced food capture rate by mosquitofish at lower temperatures and suggest that these two types of competition may act synergistically to deprive toothcarp of food at higher temperatures. Males of both species carry out more overtly aggressive acts than females, which is probably related to the marked sexual dimorphism and associated mating systems of these two species. Mosquitofish may thus impact heavily on toothcarp, and competition from mosquitofish, especially in warmer summer months, may lead to changes in abundance of the native species and displacement to non-preferred habitats. Globally increasing temperatures mean that highly invasive, warm-water mosquitofish may be able to colonize environments from which they are currently excluded through reduced physiological tolerance to low temperatures. Research into the effects of temperature on interactions between native and invasive species is thus of fundamental importance.	[Carmona-Catot, Gerard; Magellan, Kit; Garcia-Berthou, Emili] Univ Girona, Inst Aquat Ecol, Girona, Catalonia, Spain	Universitat de Girona	Carmona-Catot, G (corresponding author), Univ Girona, Inst Aquat Ecol, Girona, Catalonia, Spain.	carmona.catot@gmail.com	Magellan, Kit/B-5528-2012; García-Berthou, Emili/A-5392-2008	García-Berthou, Emili/0000-0001-8412-741X; Magellan, Kit/0000-0002-0860-5931	University of Girona [BR2010/10]; Spanish Ministry of Science [CGL2009-12877-C02-01, CSD2009-00065]	University of Girona; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Gerard Carmona-Catot held a doctoral fellowship (BR2010/10) from the University of Girona during the preparation of the manuscript. Financial support was provided by the Spanish Ministry of Science (projects CGL2009-12877-C02-01 and Consolider-Ingenio 2010 CSD2009-00065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 2008, OECOLOGIA, V155, P205, DOI 10.1007/s00442-007-0899-4; Alcaraz C, 2007, ENVIRON BIOL FISH, V78, P193, DOI 10.1007/s10641-006-0018-0; Andersson Malte, 1994; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Ashley PJ, 2007, APPL ANIM BEHAV SCI, V104, P199, DOI 10.1016/j.applanim.2006.09.001; Benejam L, 2009, BIOL INVASIONS, V11, P2265, DOI 10.1007/s10530-008-9413-0; Botham MS, 2006, NATURWISSENSCHAFTEN, V93, P431, DOI 10.1007/s00114-006-0131-0; Caiola N, 2005, J APPL ICHTHYOL, V21, P358, DOI 10.1111/j.1439-0426.2005.00684.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Carmona-Catot G, 2011, DIVERS DISTRIB, V17, P214, DOI 10.1111/j.1472-4642.2011.00743.x; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Cote IM, 2012, CURR ZOOL, V58, P1; DESTASO J, 1994, T AM FISH SOC, V123, P289, DOI 10.1577/1548-8659(1994)123<0289:IOWTOI>2.3.CO;2; Doadrio I., 2002, ATLAS LIBRO ROJO PEC; DUNSON WA, 1994, ESTUARIES, V17, P102, DOI 10.2307/1352338; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; Fobert E, 2011, J FISH BIOL, V79, P1592, DOI 10.1111/j.1095-8649.2011.03083.x; Freyhof J, 2011, EUROPEAN RED LIST FR; Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Hernandez M, 2002, AQUAC RES, V33, P933, DOI 10.1046/j.1365-2109.2002.00744.x; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Huntingford F.A., 1987, ANIMAL CONFLICT; JOHANSEN PH, 1980, CAN J ZOOL, V58, P586, DOI 10.1139/z80-082; Karplus I, 2007, J FISH BIOL, V71, P1023, DOI 10.1111/j.1095-8649.2007.01568.x; Krassoi FR, 2008, J ANIM ECOL, V77, P5, DOI 10.1111/j.1365-2656.2007.01316.x; La Peyre MKG, 2001, ECOLOGY, V82, P62, DOI 10.2307/2680086; Laha M, 2006, BIOL INVASIONS, V8, P719, DOI 10.1007/s10530-005-3426-8; Lang B, 2012, J ANIM ECOL, V81, P516, DOI 10.1111/j.1365-2656.2011.01931.x; Lapointe NWR, 2012, DIVERS DISTRIB, V18, P282, DOI 10.1111/j.1472-4642.2011.00858.x; Lowe S., 2000, ENCY BIOL INVASIONS; Magellan K, 2005, BEHAV ECOL SOCIOBIOL, V58, P366, DOI 10.1007/s00265-005-0950-6; Magellan K, 2006, ANIM BEHAV, V72, P75, DOI 10.1016/j.anbehav.2005.09.022; Magellan K, 2010, AFR ZOOL, V45, P18, DOI 10.3377/004.045.0115; Magurran AE, 2000, J FISH BIOL, V57, P839, DOI [10.1006/jfbi.2000.1391, 10.1111/j.1095-8649.2000.tb02196.x]; Meffe GK, 1989, ECOLOGY EVOLUTION LI; Moreno-Amich R, 1999, EFECTO REGULACION HI, P115; Navarro AR, 2012, MUSEO NACL CIENCIAS; Neat FC, 1998, ANIM BEHAV, V55, P875, DOI 10.1006/anbe.1997.0668; Oliva Paterna FJ, 2008, FARTET REGION MURCIA; Oliva-Paterna FJ, 2006, ENVIRON BIOL FISH, V75, P307, DOI 10.1007/s10641-006-0016-2; Oltra R, 2000, ENVIRON BIOL FISH, V57, P113, DOI 10.1023/A:1007579527064; Oyugi DO, 2012, REV FISH BIOL FISHER, V22, P499, DOI 10.1007/s11160-011-9243-5; Pilastro A, 2003, ANIM BEHAV, V65, P1161, DOI 10.1006/anbe.2003.2118; Portz DE, 2006, REV FISH BIOL FISHER, V16, P125, DOI 10.1007/s11160-006-9012-z; Priddis E, 2009, DIVERS DISTRIB, V15, P682, DOI 10.1111/j.1472-4642.2009.00573.x; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Reddon AR, 2011, ANIM BEHAV, V82, P93, DOI 10.1016/j.anbehav.2011.04.003; Rincon PA, 2002, J FISH BIOL, V61, P1560, DOI 10.1006/jfbi.2002.2175; Rowe DK, 2007, J APPL ICHTHYOL, V23, P668, DOI 10.1111/j.1439-0426.2007.00912.x; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Seda JB, 2012, ETHOLOGY, V118, P411, DOI 10.1111/j.1439-0310.2012.02025.x; Sinclair ELE, 2011, J ZOOL, V283, P243, DOI 10.1111/j.1469-7998.2010.00776.x; Smith CC, 2006, ANIM BEHAV, V71, P401, DOI 10.1016/j.anbehav.2005.06.003; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Taniguchi Y, 2000, ECOLOGY, V81, P2027, DOI 10.2307/177290; Vargas MJ, 1997, NETH J ZOOL, V47, P143; Vargas MJ, 1996, HYDROBIOLOGIA, V341, P215, DOI 10.1007/BF00014686; Vidal O, 2010, BIOL INVASIONS, V12, P841, DOI 10.1007/s10530-009-9505-5; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; WARNER SC, 1993, ECOLOGY, V74, P183, DOI 10.2307/1939513; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wilson RS, 2005, ANIM BEHAV, V70, P1387, DOI 10.1016/j.anbehav.2004.12.024	65	57	58	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54734	10.1371/journal.pone.0054734	http://dx.doi.org/10.1371/journal.pone.0054734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23382951	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500118
J	Ali, BH; Al-Husseni, I; Beegam, S; Al-Shukaili, A; Nemmar, A; Schierling, S; Queisser, N; Schupp, N				Ali, Badreldin H.; Al-Husseni, Isehaq; Beegam, Sumyia; Al-Shukaili, Ahmed; Nemmar, Abderrahim; Schierling, Simone; Queisser, Nina; Schupp, Nicole			Effect of Gum Arabic on Oxidative Stress and Inflammation in Adenine-Induced Chronic Renal Failure in Rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ACACIA GUM; INDUCED NEPHROTOXICITY; MULTIPLE-ANTIOXIDANTS; NITROGEN-EXCRETION; HYPERTENSION; OXYGEN; BIOMARKERS; UREMIA; CANCER	Inflammation and oxidative stress are known to be involved in the pathogenesis of chronic kidney disease in humans, and in chronic renal failure (CRF) in rats. The aim of this work was to study the role of inflammation and oxidative stress in adenine-induced CRF and the effect thereon of the purported nephroprotective agent gum arabic (GA). Rats were divided into four groups and treated for 4 weeks as follows: control, adenine in feed (0.75%, w/w), GA in drinking water (15%, w/v) and adenine+GA, as before. Urine, blood and kidneys were collected from the rats at the end of the treatment for analysis of conventional renal function tests (plasma creatinine and urea concentration). In addition, the concentrations of the pro-inflammatory cytokine TNF-alpha and the oxidative stress markers glutathione and superoxide dismutase, renal apoptosis, superoxide formation and DNA double strand break frequency, detected by immunohistochemistry for gamma-H2AX, were measured. Adenine significantly increased the concentrations of urea and creatinine in plasma, significantly decreased the creatinine clearance and induced significant increases in the concentration of the measured inflammatory mediators. Further, it caused oxidative stress and DNA damage. Treatment with GA significantly ameliorated these actions. The mechanism of the reported salutary effect of GA in adenine-induced CRF is associated with mitigation of the adenine-induced inflammation and generation of free radicals.	[Ali, Badreldin H.; Beegam, Sumyia] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Pharmacol & Clin Pharm, Muscat, Oman; [Al-Husseni, Isehaq] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Physiol, Muscat, Oman; [Al-Shukaili, Ahmed] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman; [Nemmar, Abderrahim] UAE Univ, Dept Physiol, Fac Med, Al Ain, U Arab Emirates; [Schierling, Simone; Queisser, Nina; Schupp, Nicole] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany	Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University; United Arab Emirates University; University of Wurzburg	Schupp, N (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	nicole.schupp@toxi.uni-wuerzburg.de	Alhusseni, Isehaq/C-6160-2013	Alhusseni, Isehaq/0000-0002-6037-3146; Schupp, Nicole/0000-0002-1836-6348; Al-Shukaili, Ahmed/0000-0002-4476-2395	Research Council of Oman [RC/Med/Phar/10/01]; Sultan Qaboos University (SQU); Deutsche Forschungsgemeinschaft [SCHU 2367/1-2]; University of Wurzburg; German Research Foundation (DFG)	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Sultan Qaboos University (SQU); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was financially supported by a grant from the Research Council of Oman (RC/Med/Phar/10/01), and the Sultan Qaboos University (SQU), by the Deutsche Forschungsgemeinschaft, grant SCHU 2367/1-2 und the University of Wurzburg. The publication of this work was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mosawi AJ, 2007, J TROP PEDIATRICS, V53, P362, DOI 10.1093/tropej/fmm033; Al-Majed AA, 2003, J BIOCHEM MOL TOXIC, V17, P146, DOI 10.1002/jbt.10072; Al-Majed AA, 2002, PHARMACOL RES, V46, P445, DOI 10.1016/S1043661802001251; Al-Yahya AA, 2009, OXID MED CELL LONGEV, V2, P207, DOI 10.4161/oxim.2.4.8878; Ali AA, 2008, NAT PROD RES, V22, P12, DOI 10.1080/14786410500463544; Ali BH, 2013, PHYSIOL RES, V62, P47, DOI 10.33549/physiolres.932383; Ali BH, 2011, PHYTOMEDICINE, V18, P1176, DOI 10.1016/j.phymed.2011.03.005; Ali BH, 2011, EXP BIOL MED, V236, P107, DOI 10.1258/ebm.2010.010163; Ali BH, 2010, EXP BIOL MED, V235, P373, DOI 10.1258/ebm.2009.009214; Ali BH, 2009, FOOD CHEM TOXICOL, V47, P1, DOI 10.1016/j.fct.2008.07.001; Ali BH, 2003, RENAL FAILURE, V25, P15, DOI 10.1081/JDI-120017439; Annuk M, 2001, J AM SOC NEPHROL, V12, P2747, DOI 10.1681/ASN.V12122747; Aviles-Gomez R, 2006, ETHNIC DIS, V16; Bassaganya-Riera J, 2011, J NUTR, V141, P1318, DOI 10.3945/jn.111.139022; Batista ML, 2009, ARQ BRAS CARDIOL, V93, P692, DOI 10.1590/S0066-782X2009001200021; Bliss DZ, 1996, AM J CLIN NUTR, V63, P392, DOI 10.1093/ajcn/63.3.392; Bolton CH, 2001, NEPHROL DIAL TRANSPL, V16, P1189, DOI 10.1093/ndt/16.6.1189; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Cheung WW, 2010, PEDIATR NEPHROL, V25, P711, DOI 10.1007/s00467-009-1427-z; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015; DUARTE CG, 1993, CLIN LAB MED, V13, P33, DOI 10.1016/S0272-2712(18)30459-1; ELDIN AMG, 2003, PHARM RES, V48, P631; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; Goux A, 2011, FREE RADICAL RES, V45, P454, DOI 10.3109/10715762.2010.541455; Himmelfarb J, 2004, SEMIN DIALYSIS, V17, P449, DOI 10.1111/j.0894-0959.2004.17605.x; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Kim HJ, 2010, CLIN EXP NEPHROL, V14, P536, DOI 10.1007/s10157-010-0340-x; Kinugasa E, CONTRIB NEPHROL, V168, P134; Korish AA, 2010, RENAL FAILURE, V32, P203, DOI 10.3109/08860221003592820; Korish AA, 2009, SAUDI MED J, V30, P1150; Locatelli F, 2006, J NEPHROL, V19, P6; Mahmoud MF, 2012, RENAL FAILURE, V34, P73, DOI 10.3109/0886022X.2011.623563; Manning RD, 2005, AM J NEPHROL, V25, P311, DOI 10.1159/000086411; Matsumoto N, 2006, KIDNEY INT, V69, P257, DOI 10.1038/sj.ki.5000028; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; ORMROD D, 1980, NEPHRON, V26, P249, DOI 10.1159/000181994; Perazella MA, 2010, SEMIN NEPHROL, V30, P570, DOI 10.1016/j.semnephrol.2010.09.005; Pradeep AR, 2010, AUST DENT J, V55, P65, DOI 10.1111/j.1834-7819.2009.01180.x; Schupp N, 2011, FASEB J, V25, P968, DOI 10.1096/fj.10-173286; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sener G, 2007, PROSTAG OTH LIPID M, V83, P257, DOI 10.1016/j.prostaglandins.2007.01.013; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI [10.1586/eri.10.154, 10.1586/ERI.10.154]; Suliman S. M., 2000, SUD ASS PHYS 17 C KH; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Tyler V.B., 1977, PHARMACOGNOSY, P64; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Welch WJ, 2006, CLIN EXP PHARMACOL P, V33, P1002, DOI 10.1111/j.1440-1681.2006.04478.x; Westhoff JH, 2008, HYPERTENSION, V52, P123, DOI 10.1161/HYPERTENSIONAHA.107.099432; Winchester JF, 2010, J AM SOC NEPHROL, V21, P209, DOI 10.1681/ASN.2008080899; Xuan NT, 2010, CELL PHYSIOL BIOCHEM, V25, P641, DOI 10.1159/000315083; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; YOUNES H, 1995, J NUTR, V125, P1010; Zhao MM, 2011, KIDNEY INT, V79, P1071, DOI 10.1038/ki.2011.18	59	92	93	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55242	10.1371/journal.pone.0055242	http://dx.doi.org/10.1371/journal.pone.0055242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383316	Green Published, gold			2022-12-27	WOS:000314597900023
J	Feng, Y; Liu, SJ; Wang, QG; Wang, L; Tang, SW; Wang, JM; Lu, W				Feng, Yan; Liu, Sijun; Wang, Qungang; Wang, Liang; Tang, Shaowen; Wang, Jianming; Lu, Wei			Rapid Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol Using Genotype MTBDRsl Assay: A Meta-Analysis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS STRAINS; GENE-MUTATIONS; 2ND-LINE; SUSCEPTIBILITY; GYRA; PERFORMANCE; EMERGENCE; MECHANISM; FUTURE; TB	Background: There are urgent needs for rapid and accurate drug susceptibility testing of M. tuberculosis. GenoType MTBDRsl is a new molecular kit designed for rapid identification of the resistance to the second-line antituberculosis drugs with a single strip. In recent years, it has been evaluated in many settings, but with varied results. The aim of this meta-analysis was to synthesize the latest data on the diagnostic accuracy of GenoType MTBDRsl in detecting drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol, in comparison with the phenotypic drug susceptibility test. Methods: This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The search terms of "MTBDRsl" and "tuberculosis" were used on PubMed, EMBASE, and Web of Science. QUADAS-2 was used to assess the quality of included studies. Data were analyzed by Meta-Disc 1.4. We calculated the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and corresponding 95% confidence interval (CI) for each study. From these calculations, forest plots and summary receiver operating characteristic (SROC) curves were produced. Results: Patient selection bias as well as flow and timing bias were observed in most studies. The summarized sensitivity (95% CI) was 0.874(0.845-0.899), 0.826(0.777-0.869), 0.820(0.772-0.862), 0.444(0.396-0.492), and 0.679(0.652-0.706) for fluoroquinolones, amikacin, capreomycin, kanamycin, and ethambutol, respectively. The specificity (95% CI) was 0.971(0.961-0.980), 0.995(0.987-0.998), 0.973(0.963-0.981), 0.993(0.985-0.997), and 0.799(0.773-0.823), respectively. The AUC (standard error) were 0.9754(0.0203), 0.9300(0.0598), 0.9885(0.0038), 0.9689(0.0359), and 0.6846(0.0550), respectively. Conclusion: Genotype MTBDRsl showed good accuracy for detecting drug resistance to fluoroquinolones, amikacin and capreomycin, but it may not be an appropriate choice for kanamycin and ethambutol. The lack of data did not allow for proper evaluation of the test on clinical specimens. Further systematic assessment of diagnostic performance should be carried out on direct clinical samples.	[Feng, Yan; Liu, Sijun; Tang, Shaowen; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Liu, Sijun] Nanjing Med Univ, Dept Epidemiol, Kangda Coll, Nanjing, Jiangsu, Peoples R China; [Wang, Qungang] Zhangjiagang Ctr Dis Prevent & Control, Dept TB, Zhangjiagang, Peoples R China; [Wang, Liang] E Tennessee State Univ, Coll Publ Hlth, Dept Epidemiol & Biostat, Johnson City, TN 37614 USA; [Lu, Wei] Jiangsu Prov Ctr Dis Prevent & Control, Dept Chron Infect Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; East Tennessee State University	Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	merry21st@yahoo.com.cn; weiluxx@163.com		Tang, Shaowen/0000-0001-5879-8594; Wang, Jianming/0000-0002-9151-284X	National Natural Science Foundation of China [81072351]; Jiangsu Science Supported Planning/Social Development Foundation [BE2011841]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science Supported Planning/Social Development Foundation; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study is partly supported by National Natural Science Foundation of China (81072351), Jiangsu Science Supported Planning/Social Development Foundation (BE2011841), and Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2007, TUBERCULOSIS, V87, P123, DOI 10.1016/j.tube.2006.05.004; Alangaden GJ, 1998, ANTIMICROB AGENTS CH, V42, P1295, DOI 10.1128/AAC.42.5.1295; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Cheng AFB, 2004, ANTIMICROB AGENTS CH, V48, P596, DOI 10.1128/AAC.48.2.596-601.2004; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; Drlica K, 1999, CURR OPIN MICROBIOL, V2, P504, DOI 10.1016/S1369-5274(99)00008-9; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Garrigo M, 2007, J CLIN MICROBIOL, V45, P1766, DOI 10.1128/JCM.02162-06; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Gikalo MB, 2012, J ANTIMICROB CHEMOTH, V67, P2107, DOI 10.1093/jac/dks178; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Hazbon MH, 2005, ANTIMICROB AGENTS CH, V49, P3794, DOI 10.1128/AAC.49.9.3794-3802.2005; Heysell SK, 2012, EXPERT REV MOL DIAGN, V12, P395, DOI [10.1586/ERM.12.25, 10.1586/erm.12.25]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Huang WL, 2011, J CLIN MICROBIOL, V49, P2502, DOI 10.1128/JCM.00197-11; Ignatyeva O, 2012, J CLIN MICROBIOL, V50, P1593, DOI 10.1128/JCM.00039-12; Isola D, 2005, J MICROBIOL METH, V62, P113, DOI 10.1016/j.mimet.2005.02.004; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kontsevaya I, 2011, J CLIN MICROBIOL, V49, P2832, DOI 10.1128/JCM.01889-10; Kruuner A, 2003, ANTIMICROB AGENTS CH, V47, P2971, DOI 10.1128/AAC.47.9.2971-2973.2003; Lacoma A, 2012, J CLIN MICROBIOL, V50, P30, DOI 10.1128/JCM.05274-11; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Migliori GB, 2007, EUROSURVEILLANCE, V12, P5, DOI DOI 10.2807/ESW.12.20.03194-EN; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Miotto P, 2012, EUR RESPIR J, V40, P690, DOI 10.1183/09031936.00164111; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muyoyeta M, 2009, INT J TUBERC LUNG D, V13, P460; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Palomino JC, 2012, FUTURE MICROBIOL, V7, P59, DOI [10.2217/fmb.11.133, 10.2217/FMB.11.133]; Plinke C, 2009, TUBERCULOSIS, V89, P448, DOI 10.1016/j.tube.2009.09.001; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Said HM, 2012, INT J TUBERC LUNG D, V16, P104, DOI 10.5588/ijtld.10.0600; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shamputa IC, 2004, APMIS, V112, P728, DOI 10.1111/j.1600-0463.2004.apm11211-1203.x; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; Sun ZG, 2008, INT J ANTIMICROB AG, V31, P115, DOI 10.1016/j.ijantimicag.2007.10.014; Suzuki Y, 1998, J CLIN MICROBIOL, V36, P1220, DOI 10.1128/JCM.36.5.1220-1225.1998; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Tessema B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-37; Van Deun A, 2011, INT J TUBERC LUNG D, V15, P116; van Ingen J, 2010, J CLIN MICROBIOL, V48, P2749, DOI 10.1128/JCM.00652-10; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Vo SK, 2010, J CLIN MICROBIOL, V48, P2934, DOI 10.1128/JCM.00201-10; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2010, POL FRAM IMPL NEW TU; WHO, 2011, TUB MDR TB XDR TB 20; World Health Organisation, 2006, EM XDR TB; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	57	53	57	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55292	10.1371/journal.pone.0055292	http://dx.doi.org/10.1371/journal.pone.0055292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383320	Green Published, gold			2022-12-27	WOS:000314597900027
J	Tsao, N; Cheng, MH; Yang, HC; Wang, YC; Liu, YL; Kuo, CF				Tsao, Nina; Cheng, Miao-Hui; Yang, Hsiu-Chen; Wang, Yu-Chieh; Liu, Yi-Ling; Kuo, Chih-Feng			Determining Antibody-Binding Site of Streptococcal Pyrogenic Exotoxin B to Protect Mice from Group A Streptococcus Infection	PLOS ONE			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; MEDIATED OPSONOPHAGOCYTOSIS; IMMUNOGLOBULIN-G; RHEUMATIC-FEVER; GLOBAL BURDEN; PYOGENES; SPEB; PROTEINASE; ACTIVATION; CLEAVAGE	Streptococcal pyrogenic exotoxin B (SPE B), a cysteine protease, is an important virulence factor in group A streptococcal (GAS) infection. SPE B binds and cleaves antibody isotypes and further impairs the immune system by inhibiting complement activation. In this study, we examined the antibody-binding site of SPE B and used it to block SPE B actions during GAS infection. We constructed different segments of the spe B gene and induced them to express different recombinant fragments of SPE B. Using an enzyme-linked immunosorbent assay (ELISA), we found that residues 345-398 of the C-terminal domain of SPE B (rSPE B345-398), but not the N-terminal domain, was the major binding site for antibody isotypes. Using a competitive ELISA, we also found that rSPE B345-398 bound to the Fc portion of IgG. The in vitro functional assays indicate that rSPE B345-398 not only interfered with cleavage of antibody isotypes but also interfered with SPE B-induced inhibition of complement activation. Immunization of BALB/c mice using rSPE B345-398 was able to induce production of a high titer of anti-rSPE B345-398 antibodies and efficiently protected mice from GAS-induced death. These findings suggest that SPE B uses its C-terminal domain to bind the Fc portion of IgG and that immunization of mice with this binding domain (rSPE B345-398) could protect mice from GAS infection.	[Tsao, Nina; Cheng, Miao-Hui; Yang, Hsiu-Chen; Wang, Yu-Chieh] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Liu, Yi-Ling; Kuo, Chih-Feng] I Shou Univ, Dept Nursing, Kaohsiung, Taiwan	I Shou University; I Shou University	Kuo, CF (corresponding author), I Shou Univ, Dept Nursing, Kaohsiung, Taiwan.	kuo@isu.edu.tw			I-Shou University [ISU101-04-02]; National Science Council, Taiwan [NSC97-2320-B214-001-MY3, NSC100-2320-B-214-007, NSC101-2320-B-214-004]	I-Shou University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants ISU101-04-02 from I-Shou University and NSC97-2320-B214-001-MY3, NSC100-2320-B-214-007 as well as NSC101-2320-B-214-004 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Chiang-Ni C, 2006, MED MICROBIOL IMMUN, V195, P55, DOI 10.1007/s00430-005-0001-y; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Dale JB, 2008, ADV EXP MED BIOL, V609, P53, DOI 10.1007/978-0-387-73960-1_5; Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003; Eriksson BKG, 1999, J INFECT DIS, V180, P410, DOI 10.1086/314872; Herwald H, 1996, J EXP MED, V184, P665, DOI 10.1084/jem.184.2.665; Hung CH, 2012, MED MICROBIOL IMMUN, V201, P357, DOI 10.1007/s00430-012-0241-6; Jackson SJ, 2011, TROP MED INT HEALTH, V16, P2, DOI 10.1111/j.1365-3156.2010.02670.x; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kuo CF, 2004, MICROB PATHOGENESIS, V36, P273, DOI 10.1016/j.micpath.2004.01.003; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Kuo CF, 2008, INFECT IMMUN, V76, P1163, DOI 10.1128/IAI.01116-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Luo YH, 2010, LAB INVEST, V90, P1492, DOI 10.1038/labinvest.2010.93; Matsuka YV, 1999, INFECT IMMUN, V67, P4326, DOI 10.1128/IAI.67.9.4326-4333.1999; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Nilsson M, 2005, EUR J IMMUNOL, V35, P1472, DOI 10.1002/eji.200424850; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; Steer AC, 2012, DRUGS, V72, P1213, DOI 10.2165/11634180-000000000-00000; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Uchiyama S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002736; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Wang CC, 2009, J BIOL CHEM, V284, P10957, DOI 10.1074/jbc.M807624200; WOLF BB, 1994, J BIOL CHEM, V269, P30682	39	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55028	10.1371/journal.pone.0055028	http://dx.doi.org/10.1371/journal.pone.0055028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383045	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600058
J	Bal, PM; Veltkamp, M				Bal, P. Matthijs; Veltkamp, Martijn			How Does Fiction Reading Influence Empathy? An Experimental Investigation on the Role of Emotional Transportation	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; COMPREHENSION; NONFICTION; INCUBATION; PERSUASION; REGRESSION; MODELS	The current study investigated whether fiction experiences change empathy of the reader. Based on transportation theory, it was predicted that when people read fiction, and they are emotionally transported into the story, they become more empathic. Two experiments showed that empathy was influenced over a period of one week for people who read a fictional story, but only when they were emotionally transported into the story. No transportation led to lower empathy in both studies, while study 1 showed that high transportation led to higher empathy among fiction readers. These effects were not found for people in the control condition where people read non-fiction. The study showed that fiction influences empathy of the reader, but only under the condition of low or high emotional transportation into the story.	[Bal, P. Matthijs] Vrije Univ Amsterdam, Dept Management & Org, Amsterdam, Netherlands; [Veltkamp, Martijn] FrieslandCampina, Deventer, Netherlands	Vrije Universiteit Amsterdam	Bal, PM (corresponding author), Vrije Univ Amsterdam, Dept Management & Org, Amsterdam, Netherlands.	p.m.bal@vu.nl		Veltkamp, Martijn/0000-0003-1300-0715; Bal, P. Matthijs/0000-0002-6955-2837				Aiken L. S., 1991, MULTIPLE REGRESSION; Appel M, 2008, J COMMUN, V58, P62, DOI 10.1111/j.1460-2466.2007.00374.x; Appel M, 2007, MEDIA PSYCHOL, V10, P113; Appel M, 2010, MEDIA PSYCHOL, V13, P101, DOI 10.1080/15213261003799847; Argo JJ, 2008, J CONSUM RES, V34, P614, DOI 10.1086/521907; Bal PM, 2011, REV GEN PSYCHOL, V15, P361, DOI 10.1037/a0025416; Bolt D, 2007, EXPLICATOR, V66, P44, DOI 10.3200/EXPL.66.1.44-47; Brock TC, 2002, NARRATIVE IMPACT: SOCIAL AND COGNITIVE FOUNDATIONS, P1; Bruner J. S., 1986, ACTUAL MINDS POSSIBL, DOI DOI 10.4159/9780674029019; Busselle R, 2008, COMMUN THEOR, V18, P255, DOI 10.1111/j.1468-2885.2008.00322.x; Busselle R, 2009, MEDIA PSYCHOL, V12, P321, DOI 10.1080/15213260903287259; Christensen BT, 2005, CREATIVITY RES J, V17, P207, DOI 10.1207/s15326934crj1702&3_7; Coplan A, 2004, J AESTHET ART CRITIC, V62, P141, DOI 10.1111/j.1540-594X.2004.00147.x; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Djikic M, 2009, CREATIVITY RES J, V21, P24, DOI 10.1080/10400410802633392; Doyle AC, 1905, TERUGKEER SHERLOCK H; Doyle AC, 2004, TERUGKEER SHERLOCK H; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; EVANS MG, 1985, ORGAN BEHAV HUM DEC, V36, P305, DOI 10.1016/0749-5978(85)90002-0; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Gerdes KE, 2010, BRIT J SOC WORK, V40, P2326, DOI 10.1093/bjsw/bcq048; Gerrig RJ, 2009, J MEM LANG, V60, P144, DOI 10.1016/j.jml.2008.08.004; Gerrig Richard J., 1993, EXPERIENCING NARRATI; GERRIG RJ, 1991, PSYCHOL SCI, V2, P336, DOI 10.1111/j.1467-9280.1991.tb00162.x; GERRIG RJ, 1994, PERS SOC PSYCHOL B, V20, P712, DOI 10.1177/0146167294206009; GINZBURG C, 1980, HIST WORKSHOP, P6; Goldstein TR, 2009, PSYCHOL AESTHET CREA, V3, P232, DOI 10.1037/a0015343; Grant AM, 2008, J APPL PSYCHOL, V93, P48, DOI 10.1037/0021-9010.93.1.48; Grant AM, 2011, ACAD MANAGE J, V54, P73, DOI 10.5465/AMJ.2011.59215085; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Green MC, 2004, DISCOURSE PROCESS, V38, P247, DOI 10.1207/s15326950dp3802_5; Hovland CI, 1951, PUBLIC OPIN QUART, V15, P635, DOI 10.1086/266350; Kohn N, 2009, J CREATIVE BEHAV, V43, P102, DOI 10.1002/j.2162-6057.2009.tb01309.x; Kumkale GT, 2004, PSYCHOL BULL, V130, P143, DOI 10.1037/0033-2909.130.1.143; Mar RA, 2006, J RES PERS, V40, P694, DOI 10.1016/j.jrp.2005.08.002; Mar RA, 2011, COGNITION EMOTION, V25, P818, DOI 10.1080/02699931.2010.515151; Mar RA, 2009, COMMUNICATIONS-GER, V34, P407, DOI 10.1515/COMM.2009.025; Marsh EJ, 2003, J MEM LANG, V49, P519, DOI 10.1016/S0749-596X(03)00092-5; Marsh EJ, 2006, MEM COGNITION, V34, P1140, DOI 10.3758/BF03193260; Miall DS, 2002, POETICS, V30, P221, DOI 10.1016/S0304-422X(02)00011-6; Nell V., 1988, LOST BOOK PSYCHOL RE; Oatley K, 2002, NARRATIVE IMPACT: SOCIAL AND COGNITIVE FOUNDATIONS, P39; Oatley K., 1999, REV GEN PSYCHOL, V3, P101, DOI [10.1037/1089-2680.3.2.101, DOI 10.1037/1089-2680.3.2.101]; Paluck EL, 2009, J PERS SOC PSYCHOL, V96, P574, DOI 10.1037/a0011989; Pelowski M, 2011, NEW IDEAS PSYCHOL, V29, P80, DOI 10.1016/j.newideapsych.2010.04.001; Petty R. E., 1986, COMMUN PERSUATION, P1; Poulson C, 2005, RES EMOTION ORGAN, V1, P211; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Prentice DA, 1997, PSYCHON B REV, V4, P416, DOI 10.3758/BF03210803; Rapp DN, 2001, J MEM LANG, V45, P737, DOI 10.1006/jmla.2000.2789; Saramago J, 1995, BLINDNESS; Saramago J, 1998, STAD BLINDEN; Schank RC, 1995, ADV SOCIAL COGNITION, P287; Shuman A, 2006, NARRAT INQ, V16, P148, DOI 10.1075/ni.16.1.19shu; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Stocks EL, 2009, EUR J SOC PSYCHOL, V39, P649, DOI 10.1002/ejsp.561; Weisberg DS, 2009, J COGN CULT, V9, P69, DOI 10.1163/156853709X414647; Wheeler SC, 1999, PSYCHON B REV, V6, P136; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	62	196	198	21	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55341	10.1371/journal.pone.0055341	http://dx.doi.org/10.1371/journal.pone.0055341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383160	gold, Green Accepted, Green Published			2022-12-27	WOS:000315563800143
J	Khunti, K; Morris, DH; Weston, CL; Gray, LJ; Webb, DR; Davies, MJ				Khunti, Kamlesh; Morris, Danielle H.; Weston, Claire L.; Gray, Laura J.; Webb, David R.; Davies, Melanie J.			Joint Prevalence of Diabetes, Impaired Glucose Regulation, Cardiovascular Disease Risk and Chronic Kidney Disease in South Asians and White Europeans	PLOS ONE			English	Article							ADULTS	Background: Multiple vascular risk factors may confer very high risk, but the degree of commonality between risk factors is unclear, particularly among ethnic minorities. Furthermore, it is unknown what impact this commonality will have on the UK-based NHS Health Check Programme; a vascular disease prevention programme that screens individuals aged 40-74 years. We estimated the joint prevalence of diabetes, impaired glucose regulation (IGR), high cardiovascular disease (CVD) risk and chronic kidney disease (CKD) among White Europeans and South Asians who would be eligible for the Programme. Methods: Cross-sectional data were analysed for 3707 participants (23.6% South Asian) in a screening study set in Leicestershire, UK. Diabetes and IGR were screen-detected. CKD may have been diagnosed previously. IGR was defined as impaired fasting glucose and/or impaired glucose tolerance, and high CVD risk as 10 year risk greater than 20%. Results: Among males, South Asians had higher prevalence than White Europeans of diabetes (9.0% vs. 3.9%, respectively, p<0.001), IGR (12.5% vs. 9.2%, p = 0.06), and high CVD risk (39.1% vs. 33.1%, p = 0.03), but lower prevalence of CKD (1.5% vs. 4.6%, p<0.01). Among females, South Asians had higher prevalence than White Europeans of diabetes (7.4% vs. 3.3%, p<0.001), but lower prevalence of CKD (3.7% vs. 13.0%, p<0.001) and CVD risk (2.4% vs. 4.6%, p = 0.03), and a nonsignificant difference in IGR prevalence. At least one risk factor was diagnosed in 34% of participants, and all of them in 0.4%, suggesting that 723,589-734,589 more individuals each year will require monitoring following implementation of the Health Check Programme. Conclusions: The collective prevalence of risk factors for vascular disease in this population was high, but there was little overlap between the risk factors, and prevalence differed by ethnicity. This has implications for service delivery and resources, and should be considered when planning screening and intervention programmes.	[Khunti, Kamlesh; Weston, Claire L.; Gray, Laura J.] Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester Diabet Ctr, Leicester, Leics, England; [Morris, Danielle H.; Webb, David R.; Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester Gen Hosp, Leicester Diabet Ctr, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Khunti, K (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester Diabet Ctr, Leicester, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099; Webb, David/0000-0002-3932-3339; Davies, Melanie/0000-0002-9987-9371; Gray, Laura/0000-0002-9284-9321	Department of Health; University Hospitals of Leicester Diabetes Research Fund; Diabetes UK; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire; Northamptonshire and Rutland (NIHR CLAHRC - LNR); NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, University Hospitals of Leicester NHS Trust; Loughborough University; University of Leicester; National Institute for Health Research [RP-PG-0606-1272, RP-DG-1210-10183] Funding Source: researchfish	Department of Health; University Hospitals of Leicester Diabetes Research Fund; Diabetes UK(Diabetes UK); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire; Northamptonshire and Rutland (NIHR CLAHRC - LNR); NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, University Hospitals of Leicester NHS Trust; Loughborough University; University of Leicester; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by funding from the Department of Health (www.dh.gov.uk), the University Hospitals of Leicester Diabetes Research Fund (www.leicestershospitals.nhs.uk) and Diabetes UK (www.diabetes.org.uk) and was conducted as part of activities supported by the National Institute for Health Research (www.nihr.ac.uk) Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR) and The NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Audit Commission, 2000, TEST TIM REV DIAB SE; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brindle P, 2006, HEART, V92, P1595, DOI 10.1136/hrt.2006.092346; Dalton ARH, 2011, J PUBLIC HEALTH-UK, V33, P422, DOI 10.1093/pubmed/fdr034; Dalton AR, 2011, EUR J CARDIOVASC PRE; DH Renal NSF Team, 2005, NAT SERV FRAM REN SE; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; Khunti K, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c6312; Middleton RJ, 2006, NEPHROL DIAL TRANSPL, V21, P88, DOI 10.1093/ndt/gfi163; NHS Diabetes and Kidney Care, 2010, NHS HLTH CHECK FREQ; NHS The Information Centre for Health and Social Care, 2011, DIS PREV QUAL OUTC F; Office for National Statistics, 2011, PEEG CURR EST POP ES; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Sandbaek A, 2008, DIABETOLOGIA, V51, P1127, DOI 10.1007/s00125-008-1013-0; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Stevens LA, 2005, J AM SOC NEPHROL, V16, P2439, DOI 10.1681/ASN.2005020192; Vascular Checks Programme, 2008, VASC CHECKS RISK ASS; Webb DR, 2011, DIABETOLOGIA, V54, P2237, DOI 10.1007/s00125-011-2189-2; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	25	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55580	10.1371/journal.pone.0055580	http://dx.doi.org/10.1371/journal.pone.0055580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383233	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800171
J	Sasaki, Y; Hagiwara, K; Kakisaka, M; Yamada, K; Murakami, T; Aida, Y				Sasaki, Yutaka; Hagiwara, Kyoji; Kakisaka, Michinori; Yamada, Kazunori; Murakami, Tomoyuki; Aida, Yoko			Importin alpha 3/Qip1 Is Involved in Multiplication of Mutant Influenza Virus with Alanine Mutation at Amino Acid 9 Independently of Nuclear Transport Function	PLOS ONE			English	Article							A VIRUS; LOCALIZATION SIGNAL; POLYMERASE PROTEINS; ALPHA FAMILY; NUCLEOPROTEIN; REPLICATION; CELLS; RNA; MEMBRANE; RIBONUCLEOPROTEINS	The nucleoprotein (NP) of influenza A virus is transported into the nucleus via the classical importin alpha/beta pathway, and proceeds via nuclear localization signals (NLSs) recognized by importin a molecules. Although NP binds to importin a isoforms Rch1, Qip1 and NPI-1, the role of each individual isoform during the nuclear transport of NP and replication of the influenza virus remains unknown. In this study, we examined the contribution of importin a isoforms for nuclear localization of NP and viral growth using a panel of NP mutants containing serial alanine replacements within an unconventional NLS of NP. Alanine mutation at amino acid 8 (R8A) caused a significant reduction in the nuclear localization and binding to the three importin isoforms. The R8A NP mutant virus did not generate by reverse-genetics approach. This indicates that position 8 is the main site that mediates nuclear localization via interactions with Rch1, Qip1 and NPI-1, and subsequent viral production. This was confirmed by the finding that the conservation of amino acid 8 in human-and avian-origin influenza virus NP was necessary for virus propagation. By contrast, another mutant, S9A NP, which localized in the nucleus, caused a reduction in viral growth and vRNA transcription, suggesting that the unconventional NLS within NP may be associated with nuclear transport, vRNA transcription and viral replication through independent pathways. Interestingly, the N-terminal 110-amino acid region, which contained the unconventional NLS with S9A mutation, mainly bound to Qip1. Furthermore, activities of vRNA transcription and replication of S9A NP mutants were decreased by silencing Qip1 in without changing nuclear localization, indicating that Qip1 involves in multiplication of S9A mutant virus independently of nuclear transport function. Collectively, our results demonstrate the unconventional NLS within NP might have the additional ability to regulate the viral replication that is independent of nuclear localization activity via interactions with Qip1.	[Sasaki, Yutaka; Hagiwara, Kyoji; Kakisaka, Michinori; Yamada, Kazunori; Murakami, Tomoyuki; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Yamada, Kazunori; Murakami, Tomoyuki; Aida, Yoko] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Viral Infect Dis, Wako, Saitama, Japan	RIKEN; University of Tokyo	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp			RIKEN Program for Drug Discovery and Medical Technology Platforms	RIKEN Program for Drug Discovery and Medical Technology Platforms	This study was supported in part by a RIKEN Program for Drug Discovery and Medical Technology Platforms. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AKKINA RK, 1987, J VIROL, V61, P2217, DOI 10.1128/JVI.61.7.2217-2224.1987; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2005.00263.x; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V394, P721, DOI 10.1016/j.bbrc.2010.03.058; HERZ C, 1981, CELL, V26, P391, DOI 10.1016/0092-8674(81)90208-7; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 1997, THESIS JUSTUS LIEBIG; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; JONES IM, 1986, EMBO J, V5, P2371, DOI 10.1002/j.1460-2075.1986.tb04506.x; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Ketha KMV, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-22; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Kohler M, 2001, VIROLOGY, V289, P186, DOI 10.1006/viro.2001.1151; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Sieczkarski SB, 2005, ARCH VIROL, V150, P1783, DOI 10.1007/s00705-005-0558-1; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Takeda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027815; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; Zhang J, 1996, VIROLOGY, V225, P255, DOI 10.1006/viro.1996.0599	43	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55765	10.1371/journal.pone.0055765	http://dx.doi.org/10.1371/journal.pone.0055765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383277	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800186
J	Shao, M; Yue, Y; Sun, GY; You, QH; Wang, N; Zhang, D				Shao, Min; Yue, Yang; Sun, Geng-Yun; You, Qing-Hai; Wang, Nan; Zhang, Dan			Caveolin-1 Regulates Rac1 Activation and Rat Pulmonary Microvascular Endothelial Hyperpermeability Induced by TNF-alpha	PLOS ONE			English	Article							NF-KAPPA-B; RHO-GTPASES; INTRACELLULAR CA2+; CELL POLARIZATION; BARRIER INTEGRITY; REACTIVE OXYGEN; SMOOTH-MUSCLE; NITRIC-OXIDE; PERMEABILITY; KINASE	A multiplicity of vital cellular and tissue level functions are controlled by caveolin-1 and it is considered to be an important candidate for targeted therapeutics. Rac1-cortactin signaling plays an important role in maintaining the functions of the endothelial barrier in microvascular endothelial cells. The activity of Rac1 has been shown to be regulated by caveolin-1. Therefore, the present study investigated the consequences of down-regulating caveolin-1 and the subsequent changes in activity of Rac1 and the endothelial barrier functions in primary rat pulmonary microvascular endothelial cells (RPMVECs). RPMVECs were transfected with a small hairpin RNA duplex to down-regulate caveolin-1 expression. This procedure significantly increased the activity of Rac1. Moreover, down-regulation of caveolin-1 attenuated TNF-alpha-induced decrease in TER, increase in the flux of FITC-BSA and the disappearance of cortactin from the cell periphery in RPMVEC. Rac1 inhibitors significantly abolished this barrier-protective effect induced by down-regulation of caveolin-1 in response to TNF-alpha in RPMVECs. In conclusion, our data suggest a mechanism for the regulation of Rac1 activity by caveolin-1, with consequences for activation of endothelial cells in response to TNF-alpha.	[Shao, Min; Yue, Yang; Sun, Geng-Yun; You, Qing-Hai; Wang, Nan; Zhang, Dan] Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China; [Shao, Min] Anhui Med Univ, Dept Crit Care Med, Anhui Prov Hosp, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Sun, GY (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Resp Med, Hefei, Anhui, Peoples R China.	sungengyun@yahoo.com.cn			National Natural Science Foundation of China [81070054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This was a research article and the work supported by a grant from the National Natural Science Foundation of China (No. 81070054)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2010, CARDIOVASC RES, V88, P344, DOI 10.1093/cvr/cvq184; Aggarwal BB, 2000, ANN RHEUM DIS, V59, P6; Armstrong SM, 2012, AM J PATHOL, V180, P1308, DOI 10.1016/j.ajpath.2011.12.002; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Fiedler LR, 2009, CELL ADHES MIGR, V3, P143, DOI 10.4161/cam.3.2.8279; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Jacobson JR, 2006, AM J PHYSIOL-LUNG C, V291, pL289, DOI 10.1152/ajplung.00343.2005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; May JM, 2011, BIOCHEM BIOPH RES CO, V404, P701, DOI 10.1016/j.bbrc.2010.12.046; Mehta D, 2005, J BIOL CHEM, V280, P17320, DOI 10.1074/jbc.M411674200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Nasarre P, 2003, NEOPLASIA, V5, P83, DOI 10.1016/S1476-5586(03)80020-9; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Sathish V, 2011, AM J PHYSIOL-LUNG C, V301, pL607, DOI 10.1152/ajplung.00019.2011; Schlegel N, 2009, MICROCIRCULATION, V16, P521, DOI 10.1080/10739680902967427; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Sukumaran SK, 2002, J BIOL CHEM, V277, P50716, DOI 10.1074/jbc.M208830200; Sumida GM, 2010, INVEST OPHTH VIS SCI, V51, P6633, DOI 10.1167/iovs.10-5391; Sun XH, 2009, FEBS LETT, V583, P3681, DOI 10.1016/j.febslet.2009.10.055; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tyml K, 2011, MICROCIRCULATION, V18, P152, DOI 10.1111/j.1549-8719.2010.00080.x; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; Vouret-Craviari V, 2002, J CELL SCI, V115, P2475; Wang L, 2008, METABOLISM, V57, P1328, DOI 10.1016/j.metabol.2008.01.036; Waschke J, 2006, HISTOCHEM CELL BIOL, V125, P397, DOI 10.1007/s00418-005-0080-2; Weed SA, 1998, J CELL SCI, V111, P2433; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Wojciak-Stothard B, 2009, MOL BIOL CELL, V20, P33, DOI 10.1091/mbc.E08-04-0395; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; You QH, 2010, INFLAMM RES, V59, P949, DOI 10.1007/s00011-010-0207-3; You QH, 2010, J SURG RES, V162, P110, DOI 10.1016/j.jss.2009.01.019; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	60	13	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55213	10.1371/journal.pone.0055213	http://dx.doi.org/10.1371/journal.pone.0055213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383114	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800132
J	Sawada, M; Kawayama, T; Imaoka, H; Sakazaki, Y; Oda, H; Takenaka, S; Kaku, Y; Azuma, K; Tajiri, M; Edakuni, N; Okamoto, M; Kato, S; Hoshino, T				Sawada, Masanori; Kawayama, Tomotaka; Imaoka, Haruki; Sakazaki, Yuki; Oda, Hanako; Takenaka, Shin-ichi; Kaku, Yoichiro; Azuma, Koichi; Tajiri, Morihiro; Edakuni, Nobutaka; Okamoto, Masaki; Kato, Seiya; Hoshino, Tomoaki			IL-18 Induces Airway Hyperresponsiveness and Pulmonary Inflammation via CD4(+) T Cell and IL-13	PLOS ONE			English	Article							IFN-GAMMA; ALLERGIC-ASTHMA; POTENTIAL ROLE; INTERLEUKIN-18; EXPRESSION; CYTOKINES; MICE; EMPHYSEMA; RECEPTOR; TH1	IL-18 plays a key role in the pathogenesis of pulmonary inflammatory diseases including pulmonary infection, pulmonary fibrosis, lung injury and chronic obstructive pulmonary disease (COPD). However, it is unknown whether IL-18 plays any role in the pathogenesis of asthma. We hypothesized that overexpression of mature IL-18 protein in the lungs may exacerbate disease activities of asthma. We established lung-specific IL-18 transgenic mice on a Balb/c genetic background. Female mice sensitized-and challenged-with antigen (ovalbumin) were used as a mouse asthma model. Pulmonary inflammation and emphysema were not observed in the lungs of naive transgenic mice. However, airway hyperresponsiveness and airway inflammatory cells accompanied with CD4(+) T cells, CD8(+) T cells, eosinophils, neutrophils, and macrophages were significantly increased in ovalbumin-sensitized and challenged transgenic mice, as compared to wild type Balb/c mice. We also demonstrate that IL-18 induces IFN-gamma, IL-13, and eotaxin in the lungs of ovalbumin-sensitized and challenged transgenic mice along with an increase in IL-13 producing CD4(+) T cells. Treatment with anti-CD4 monoclonal antibody or deletion of the IL-13 gene improves ovalbumin-induced airway hyperresponsiveness and reduces airway inflammatory cells in transgenic mice. Overexpressing the IL-18 protein in the lungs induces type 1 and type 2 cytokines and airway inflammation, and results in increasing airway hyperresponsiveness via CD4(+) T cells and IL-13 in asthma.	[Sawada, Masanori; Kawayama, Tomotaka; Imaoka, Haruki; Sakazaki, Yuki; Oda, Hanako; Takenaka, Shin-ichi; Kaku, Yoichiro; Azuma, Koichi; Tajiri, Morihiro; Edakuni, Nobutaka; Okamoto, Masaki; Hoshino, Tomoaki] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Med 1, Fukuoka, Japan; [Kato, Seiya] Univ Ryukyus, Grad Sch, Div Pathol & Cell Biol, Nishihara, Okinawa 90301, Japan; [Kato, Seiya] Univ Ryukyus, Fac Med, Nishihara, Okinawa 90301, Japan	Kurume University; University of the Ryukyus; University of the Ryukyus	Hoshino, T (corresponding author), Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Med 1, Fukuoka, Japan.	hoshino@med.kurume-u.ac.jp			Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Science, Sports, and Culture of Japan [21590977]; Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan); Kaibara Morikazu Medical Science Promotion Foundation; Allergy Foundation; Takeda Science Foundation	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan); Kaibara Morikazu Medical Science Promotion Foundation(Kaibara Morikazu Medical Science Promotion Foundation); Allergy Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan, a Grant-in-Aid for Scientific Research (C) (no. 21590977: TH) from the Ministry of Education, Science, Sports, and Culture of Japan, Kato Memorial Fund for Incurable Diseases Research (Tokyo, Japan) (TH), Kaibara Morikazu Medical Science Promotion Foundation (HI), Allergy Foundation (HI) and Takeda Science Foundation (HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Harada M, 2009, AM J RESP CRIT CARE, V180, P1048, DOI 10.1164/rccm.200905-0652OC; Hashino T, 1999, J IMMUNOL, V162, P51; Hoshino T, 1999, J IMMUNOL, V162, P5070; Hoshino T, 2001, J IMMUNOL, V166, P7014, DOI 10.4049/jimmunol.166.12.7014; Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Ichiki H, 2005, BIOCHEM BIOPH RES CO, V334, P1141, DOI 10.1016/j.bbrc.2005.07.007; Imaoka H, 2008, EUR RESPIR J, V31, P287, DOI 10.1183/09031936.00019207; Imaoka H, 2011, EUR RESPIR J, V38, P981, DOI 10.1183/09031936.00033811; Imaoka H, 2007, BIOCHEM BIOPH RES CO, V360, P525, DOI 10.1016/j.bbrc.2007.06.019; Izuhara K, 2009, CURR MED CHEM, V16, P2867, DOI 10.2174/092986709788803196; Kang MJ, 2012, AM J RESP CRIT CARE, V185, P1205, DOI 10.1164/rccm.201108-1545OC; Kawase Y, 2003, J INVEST DERMATOL, V121, P502, DOI 10.1046/j.1523-1747.2003.12407.x; Kitasato Y, 2004, AM J RESP CELL MOL, V31, P619, DOI 10.1165/rcmb.2003-0306OC; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Moorman Jeanne E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakanishi Kenji, 2010, Allergology International, V59, P137, DOI 10.2332/allergolint.10-RAI-0208; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Okamoto M, 2002, BLOOD, V99, P1289, DOI 10.1182/blood.V99.4.1289; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Sakai A, 2008, J IMMUNOL, V181, P2898, DOI 10.4049/jimmunol.181.4.2898; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takei S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3295; Tanaka H, 2001, J ALLERGY CLIN IMMUN, V107, P331, DOI 10.1067/mai.2001.112275; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zhu GH, 2008, EUR J HUM GENET, V16, P1083, DOI 10.1038/ejhg.2008.67	37	39	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54623	10.1371/journal.pone.0054623	http://dx.doi.org/10.1371/journal.pone.0054623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382928	Green Submitted, gold, Green Published			2022-12-27	WOS:000315483200037
J	Bouwman, LI; Niewold, P; van Putten, JPM				Bouwman, Lieneke I.; Niewold, Paula; van Putten, Jos P. M.			Basolateral Invasion and Trafficking of Campylobacter jejuni in Polarized Epithelial Cells	PLOS ONE			English	Article							ENTEROINVASIVE PATHOGENS; INTRACELLULAR SURVIVAL; CACO-2 CELLS; HEP-2 CELLS; INFECTION; TRANSLOCATION; MECHANISMS; PROTEIN; ENTRY; CYTOSKELETON	Campylobacter jejuni is a major cause of bacterial diarrheal disease. Most enteropathogenic bacteria including C. jejuni can invade cultured eukaryotic cells via an actin-and/or microtubule-dependent and an energy-consuming uptake process. Recently, we identified a novel highly efficient C. jejuni invasion pathway that involves bacterial migration into the subcellular space of non-polarized epithelial cells (termed subvasion) followed by invasion from the cell basis. Here we report cellular requirements of this entry mechanism and the subsequent intracellular trafficking route of C. jejuni in polarized islands of Caco-2 intestinal epithelial cells. Advanced microscopy on infected cells revealed that C. jejuni invades the polarized intestinal cells via the subcellular invasion pathway. Remarkably, invasion was not blocked by the inhibitors of microtubule dynamics colchicine or paclitaxel, and was even enhanced after disruption of host cell actin filaments by cytochalasin D. Invasion also continued after dinitrophenol-induced cellular depletion of ATP, whereas this compound effectively inhibited the uptake of invasive Escherichia coli. Confocal microscopy demonstrated that intracellular C. jejuni resided in membrane-bound CD63-positive cellular compartments for up to 24 h. Establishment of a novel luciferase reporter-based bacterial viability assay, developed to overcome the limitations of the classical bacterial recovery assay, demonstrated that a subset of C. jejuni survived intracellularly for up to 48 h. Taken together, our results indicate that C. jejuni is able to actively invade polarized intestinal epithelial cells via a novel actin-and microtubule-independent mechanism and remains metabolically active in the intracellular niche for up to 48 hours.	[Bouwman, Lieneke I.; Niewold, Paula; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	van Putten, JPM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	j.vanputten@uu.nl		Bouwman, Lieneke/0000-0002-4949-3892; Niewold, Paula/0000-0002-9614-4601; van Putten, Jos/0000-0002-4126-8172	Utrecht University, The Netherlands	Utrecht University, The Netherlands(Netherlands Government)	This research received financial support from Utrecht University, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; BARROW PA, 1989, J MED MICROBIOL, V28, P59, DOI 10.1099/00222615-28-1-59; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Bouwman LI, 2012, FOODBORNE AND WATERBORNE BACTERIAL PATHOGENS: EPIDEMIOLOGY, EVOLUTION AND MOLECULAR BIOLOGY, P231; Bras AM, 1999, FEMS MICROBIOL LETT, V179, P209, DOI 10.1016/S0378-1097(99)00413-9; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; DEMELO MA, 1989, INFECT IMMUN, V57, P2214, DOI 10.1128/IAI.57.7.2214-2222.1989; Dersch P, 1999, EMBO J; Duncan MJ, 2002, CELL MICROBIOL, V4, P783, DOI 10.1046/j.1462-5822.2002.00230.x; FERRERO RL, 1988, J GEN MICROBIOL, V134, P53; Friis LM, 2005, J MICROBIOL METH, V61, P145, DOI 10.1016/j.mimet.2004.12.003; Girard MP, 2006, VACCINE, V24, P2732, DOI 10.1016/j.vaccine.2005.10.014; Grassme HUC, 1996, INFECT IMMUN, V64, P1621; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Ham H, 2011, NAT REV MICROBIOL, V9, P635, DOI 10.1038/nrmicro2602; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Hu L, 2006, MICROB PATHOGENESIS, V40, P91, DOI 10.1016/j.micpath.2005.11.004; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Hu L, 2008, CAMPYLOBACTER, 3RD EDITION, P297; Kalischuk LD, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-2; Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921; KONKEL ME, 1992, MICROB PATHOGENESIS, V13, P357, DOI 10.1016/0882-4010(92)90079-4; KONKEL ME, 1992, J INFECT DIS, V166, P308, DOI 10.1093/infdis/166.2.308; Kopecko DJ, 2001, TRENDS MICROBIOL, V9, P389, DOI 10.1016/S0966-842X(01)02107-2; Krause-Gruszczynska M, 2007, CELL MICROBIOL, V9, P2431, DOI 10.1111/j.1462-5822.2007.00971.x; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; Liu XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002562; Louwen R, 2012, INFECT IMMUN, V80, P3307, DOI 10.1128/IAI.06270-11; MacCallum A, 2005, MICROBIOL-SGM, V151, P2451, DOI 10.1099/mic.0.27950-0; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Monteville MR, 2002, INFECT IMMUN, V70, P6665, DOI 10.1128/IAI.70.12.6665-6671.2002; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Pryjma M, 2012, J BACTERIOL, V194, P3803, DOI 10.1128/JB.06665-11; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Rodriguez MS, 1996, ONCOGENE, V12, P2425; RUSSELL RG, 1994, INFECT IMMUN, V62, P3773, DOI 10.1128/IAI.62.9.3773-3779.1994; Sansonetti P, 2002, GUT, V50, P2; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; van Alphen LB, 2008, CELL MICROBIOL, V10, P53, DOI 10.1111/j.1462-5822.2007.01014.x; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; van Putten JPM, 2009, CURR TOP MICROBIOL, V337, P197, DOI 10.1007/978-3-642-01846-6_7; van Putten JPM, 1998, MOL MICROBIOL, V29, P369, DOI 10.1046/j.1365-2958.1998.00951.x; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; WALKER RI, 1988, CAN J MICROBIOL, V34, P1142, DOI 10.1139/m88-201; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; Young KT, 2007, NATURE REV MICROBIOL, P5665	53	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54759	10.1371/journal.pone.0054759	http://dx.doi.org/10.1371/journal.pone.0054759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382959	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500024
J	Fantin, YS; Neverov, AD; Favorov, AV; Alvarez-Figueroa, MV; Braslavskaya, SI; Gordukova, MA; Karandashova, IV; Kuleshov, KV; Myznikova, AI; Polishchuk, MS; Reshetov, DA; Voiciehovskaya, YA; Mironov, AA; Chulanov, VP				Fantin, Yuri S.; Neverov, Alexey D.; Favorov, Alexander V.; Alvarez-Figueroa, Maria V.; Braslavskaya, Svetlana I.; Gordukova, Maria A.; Karandashova, Inga V.; Kuleshov, Konstantin V.; Myznikova, Anna I.; Polishchuk, Maya S.; Reshetov, Denis A.; Voiciehovskaya, Yana A.; Mironov, Andrei A.; Chulanov, Vladimir P.			Base-Calling Algorithm with Vocabulary (BCV) Method for Analyzing Population Sequencing Chromatograms	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RIBOSOMAL-RNA SEQUENCES; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; PNCA MUTATIONS; DNA; PYRAZINAMIDE; HIV; DATABASE; DETECT	Sanger sequencing is a common method of reading DNA sequences. It is less expensive than high-throughput methods, and it is appropriate for numerous applications including molecular diagnostics. However, sequencing mixtures of similar DNA of pathogens with this method is challenging. This is important because most clinical samples contain such mixtures, rather than pure single strains. The traditional solution is to sequence selected clones of PCR products, a complicated, time-consuming, and expensive procedure. Here, we propose the base-calling with vocabulary (BCV) method that computationally deciphers Sanger chromatograms obtained from mixed DNA samples. The inputs to the BCV algorithm are a chromatogram and a dictionary of sequences that are similar to those we expect to obtain. We apply the base-calling function on a test dataset of chromatograms without ambiguous positions, as well as one with 3-14% sequence degeneracy. Furthermore, we use BCV to assemble a consensus sequence for an HIV genome fragment in a sample containing a mixture of viral DNA variants and to determine the positions of the indels. Finally, we detect drug-resistant Mycobacterium tuberculosis strains carrying frameshift mutations mixed with wild-type bacteria in the pncA gene, and roughly characterize bacterial communities in clinical samples by direct 16S rRNA sequencing.	[Fantin, Yuri S.; Neverov, Alexey D.; Alvarez-Figueroa, Maria V.; Braslavskaya, Svetlana I.; Gordukova, Maria A.; Karandashova, Inga V.; Kuleshov, Konstantin V.; Myznikova, Anna I.; Voiciehovskaya, Yana A.; Chulanov, Vladimir P.] Minist Publ Hlth Russia, Cent Res Inst Epidemiol, Fed State Inst Sci, Moscow, Russia; [Neverov, Alexey D.; Reshetov, Denis A.; Mironov, Andrei A.] Lomonosov Moscow State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Favorov, Alexander V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Favorov, Alexander V.] State Res Inst Genet & Select Ind Microorganisms, Moscow, Russia; [Favorov, Alexander V.; Reshetov, Denis A.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Polishchuk, Maya S.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Polishchuk, Maya S.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Mironov, Andrei A.] Kharkevich Inst, Inst Informat Transmiss Problems, Moscow, Russia	Lomonosov Moscow State University; Johns Hopkins University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of California System; University of California Berkeley; Kharkevich Institute for Information Transmission Problems of the RAS	Neverov, AD (corresponding author), Minist Publ Hlth Russia, Cent Res Inst Epidemiol, Fed State Inst Sci, Moscow, Russia.	neva_2000@mail.ru	Gordukova, Maria A/S-7654-2018; Kuleshov, Konstantin V/U-5294-2018; Chulanov, Vladimir/S-4708-2016; Kuznetsova, Anna/AAJ-6484-2021; Chulanov, Vladimir/AAY-7277-2020; Favorov, Alexander V/K-2699-2018	Gordukova, Maria A/0000-0002-3948-8491; Kuleshov, Konstantin V/0000-0002-5238-7900; Chulanov, Vladimir/0000-0001-6303-9293; Chulanov, Vladimir/0000-0001-6303-9293; Favorov, Alexander V/0000-0003-2595-1091; Kuznetsova (Myznikova), Anna/0000-0001-5299-3081	Russian Foundation of Basic Research [11-04-02016-a, 10-04-92663-IND a, 11-04-02051-a]; State Contract of Russian Ministry of Education and Science [07.514.11.4007, 11.G34.31.0008]; Presidium of Russian Academy of Science; National Institutes of Health Core Grant [P30 CA006973]; Johns Hopkins University; Commonwealth Foundation; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); State Contract of Russian Ministry of Education and Science; Presidium of Russian Academy of Science(Russian Academy of Sciences); National Institutes of Health Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); Commonwealth Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by Russian Foundation of Basic Research [grant numbers 11-04-02016-a, 10-04-92663-IND a and 11-04-02051-a]; State Contract of Russian Ministry of Education and Science [grant numbers 07.514.11.4007, 11.G34.31.0008]; Programs 6 and 17 of the Presidium of Russian Academy of Science; by the National Institutes of Health Core Grant P30 CA006973, the Johns Hopkins University Framework for the Future and by the Commonwealth Foundation. Funding for open access charge: State Contract of Russian Ministry of Education and Science [grant numbers 07.514.11.4007, 11.G34.31.0008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade-Cetto L, 2005, MACHINE LEARN SIGN P, P369, DOI 10.1109/MLSP.2005.1532931; Andrade-Cetto L, 2002, WORKSH GEN SIGN PROC, P1; Applied Biosystems, 2009, SEQ CAP EL APPL BIOS, P201; Barco P, 2006, J ANTIMICROB CHEMOTH, V58, P930, DOI 10.1093/jac/dkl363; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bhangale TR, 2006, NAT GENET, V38, P1457, DOI 10.1038/ng1925; BICHKO VV, 1982, GENE, V20, P481, DOI 10.1016/0378-1119(82)90218-9; Bushman FD, 2008, AIDS, V22, P1411, DOI 10.1097/QAD.0b013e3282fc972e; Celera Diagnostics, 2002, VIROSEQ HIV 1 GENOTY, P48; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Denisov GA, 2004, US Patent, Patent No. 6681186; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dicks E, 2007, BIOINFORMATICS, V23, P1689, DOI 10.1093/bioinformatics/btm152; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gajer P, 2004, NUCLEIC ACIDS RES, V32, P562, DOI 10.1093/nar/gkh216; Hagemann TL, 1999, MOL BIOTECHNOL, V13, P137, DOI 10.1385/MB:13:2:137; Halvas EK, 2006, J CLIN MICROBIOL, V44, P2612, DOI 10.1128/JCM.00449-06; Karp R.M., 1972, REDUCIBILITY COMBINA, P85, DOI DOI 10.1007/978-1-4684-2001-29; Kommedal O, 2008, J CLIN MICROBIOL, V46, P3766, DOI 10.1128/JCM.00213-08; Kwong Ann D, 2011, Gastroenterology, V140, P755, DOI 10.1053/j.gastro.2011.01.029; LEITNER T, 1993, BIOTECHNIQUES, V15, P120; Lemaitre N, 1999, ANTIMICROB AGENTS CH, V43, P1761, DOI 10.1128/AAC.43.7.1761; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Manaster C, 2005, HUM MUTAT, V26, P11, DOI 10.1002/humu.20188; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Mascolini M, 2011, ANTIVIR THER, V16, P263, DOI 10.3851/IMP1761; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2210, DOI 10.1128/AAC.49.6.2210-2217.2005; McIlroy SJ, 2011, ENVIRON MICROBIOL, V13, P33, DOI 10.1111/j.1462-2920.2010.02306.x; Morlock GP, 2000, ANTIMICROB AGENTS CH, V44, P2291, DOI 10.1128/AAC.44.9.2291-2295.2000; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nomenclature Committee for the International Union of Biochemistry (NC- IUB), 1986, MOL BIOL EVOL, V3, P99; Pacold M, 2010, AIDS RES HUM RETROV, V26, P1291, DOI 10.1089/aid.2010.0042; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pozhitkov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-281; PUMPEN PP, 1981, DOKL AKAD NAUK SSSR+, V260, P1022; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Seroussi E, 2002, BIOINFORMATICS, V18, P1137, DOI 10.1093/bioinformatics/18.8.1137; Seroussi Y, 2007, BIOTECHNIQUES, V43, P452, DOI 10.2144/000112552; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Shafer RW, 2001, HIV SEQUENCE COMPEND, P83; Shaw T, 2006, J HEPATOL, V44, P593, DOI 10.1016/j.jhep.2006.01.001; Shin-I T, 2008, HEPATOL RES, V38, P234, DOI 10.1111/j.1872-034X.2007.00262.x; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trosvik P, 2007, APPL ENVIRON MICROB, V73, P4975, DOI 10.1128/AEM.00128-07; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wildenberg A, 2003, J COMPUT BIOL, V10, P635, DOI 10.1089/10665270360688237; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhidkov I, 2011, NUCLEIC ACIDS RES, V39, pE47, DOI 10.1093/nar/gkq1354; Zimhony O, 2007, ANTIMICROB AGENTS CH, V51, P752, DOI 10.1128/AAC.01369-06	67	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54835	10.1371/journal.pone.0054835	http://dx.doi.org/10.1371/journal.pone.0054835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382983	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500033
J	Garcia, RA; Search, DJ; Lupisella, JA; Ostrowski, J; Guan, B; Chen, J; Yang, WP; Truong, A; He, AQ; Zhang, RG; Yan, MJ; Hellings, SE; Gargalovic, PS; Ryan, CS; Watson, LM; Langish, RA; Shipkova, PA; Carson, NL; Taylor, JR; Yang, R; Psaltis, GC; Harrity, TW; Robl, JA; Gordon, DA				Garcia, Ricardo A.; Search, Debra J.; Lupisella, John A.; Ostrowski, Jacek; Guan, Bo; Chen, Jian; Yang, Wen-Pin; Amy Truong; He, Aiqing; Zhang, Rongan; Yan, Mujing; Hellings, Samuel E.; Gargalovic, Peter S.; Ryan, Carol S.; Watson, Linda M.; Langish, Robert A.; Shipkova, Petia A.; Carson, Nancy L.; Taylor, Joseph R.; Yang, Richard; Psaltis, George C.; Harrity, Thomas W.; Robl, Jeffrey A.; Gordon, David A.			11 beta-Hydroxysteroid Dehydrogenase Type 1 Gene Knockout Attenuates Atherosclerosis and In Vivo Foam Cell Formation in Hyperlipidemic apoE(-/-) Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTOR-4; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; VISCERAL OBESITY; OXIDIZED LDL; MACROPHAGES; INHIBITION; ACCUMULATION; APOPTOSIS	Background: Chronic glucocorticoid excess has been linked to increased atherosclerosis and general cardiovascular risk in humans. The enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta HSD1) increases active glucocorticoid levels within tissues by catalyzing the conversion of cortisone to cortisol. Pharmacological inhibition of 11 beta HSD1 has been shown to reduce atherosclerosis in murine models. However, the cellular and molecular details for this effect have not been elucidated. Methodology/Principal Findings: To examine the role of 11 beta HSD1 in atherogenesis, 11 beta HSD1 knockout mice were created on the pro-atherogenic apoE(-/-) background. Following 14 weeks of Western diet, aortic cholesterol levels were reduced 50% in 11 beta HSD1(-/-)/apoE(-/-) mice vs. 11 beta HSD1(+/+)/apoE(-/-) mice without changes in plasma cholesterol. Aortic 7-ketocholesterol content was reduced 40% in 11 beta HSD1(-/-)/apoE(-/-) mice vs. control. In the aortic root, plaque size, necrotic core area and macrophage content were reduced similar to 30% in 11 beta HSD1(-/-)/apoE(-/-) mice. Bone marrow transplantation from 11 beta HSD1(-/-)/apoE(-/-) mice into apoE(-/-) recipients reduced plaque area 39-46% in the thoracic aorta. In vivo foam cell formation was evaluated in thioglycollate-elicited peritoneal macrophages from 11 beta HSD1(+/+)/apoE(-/-) and 11 beta HSD1(-/-)/apoE(-/-) mice fed a Western diet for similar to 5 weeks. Foam cell cholesterol levels were reduced 48% in 11 beta HSD1(-/-)/apoE(-/-) mice vs. control. Microarray profiling of peritoneal macrophages revealed differential expression of genes involved in inflammation, stress response and energy metabolism. Several toll-like receptors (TLRs) were downregulated in 11 beta HSD1(-/-)/apoE(-/-) mice including TLR 1, 3 and 4. Cytokine release from 11 beta HSD1(-/-)/apoE(-/-)-derived peritoneal foam cells was attenuated following challenge with oxidized LDL. Conclusions: These findings suggest that 11 beta HSD1 inhibition may have the potential to limit plaque development at the vessel wall and regulate foam cell formation independent of changes in plasma lipids. The diminished cytokine response to oxidized LDL stimulation is consistent with the reduction in TLR expression and suggests involvement of 11 beta HSD1 in modulating binding of pro-atherogenic TLR ligands.	[Garcia, Ricardo A.; Search, Debra J.; Lupisella, John A.; Ostrowski, Jacek; Zhang, Rongan; Yan, Mujing; Hellings, Samuel E.; Gargalovic, Peter S.; Ryan, Carol S.; Carson, Nancy L.; Yang, Richard; Harrity, Thomas W.; Gordon, David A.] Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ 08534 USA; [Guan, Bo; Chen, Jian; Yang, Wen-Pin; Amy Truong; He, Aiqing] Bristol Myers Squibb Co, Appl Genom, Pennington, NJ USA; [Watson, Linda M.] Bristol Myers Squibb Co, Pharmaceut Compound Optimizat Discovery Toxicol, Lawrenceville, NJ USA; [Langish, Robert A.; Shipkova, Petia A.] Bristol Myers Squibb Co, Pharmaceut Compound Optimizat Discovery Analyt Sc, Pennington, NJ USA; [Taylor, Joseph R.] Bristol Myers Squibb Co, Metab Dis, Pennington, NJ USA; [Psaltis, George C.] Bristol Myers Squibb Co, Vet Sci, Pennington, NJ USA; [Robl, Jeffrey A.] Bristol Myers Squibb Co, Discovery Chem, Pennington, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Gordon, DA (corresponding author), Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ 08534 USA.	david.gordon@bms.com		Lupisella, John/0000-0003-1343-6412	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	Studies described in this report were funded by Bristol-Myers Squibb Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker L, 2010, CELL METAB, V11, P125, DOI 10.1016/j.cmet.2010.01.003; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1997, J LIPID RES, V38, P1730; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Deuchar GA, 2011, ENDOCRINOLOGY, V152, P236, DOI 10.1210/en.2010-0925; Du Q, 2012, J SURG RES, V173, P354, DOI 10.1016/j.jss.2010.10.016; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Fantidis P, 2010, CURR VASC PHARMACOL, V8, P517, DOI 10.2174/157016110791330889; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Garedew A, 2008, J CELL SCI, V121, P3468, DOI 10.1242/jcs.034660; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Hadoke PWF, 2009, BRIT J PHARMACOL, V156, P689, DOI 10.1111/j.1476-5381.2008.00047.x; Hadoke PWF, 2001, CIRCULATION, V104, P2832, DOI 10.1161/hc4801.100077; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Howell KW, 2011, J SURG RES, V171, pE27, DOI 10.1016/j.jss.2011.06.033; Hult M, 2004, CELL MOL LIFE SCI, V61, P992, DOI 10.1007/s00018-003-3476-y; Jaffe IZ, 2010, J CLIN INVEST, V120, P3891, DOI 10.1172/JCI40205; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Miller YI, 2009, TRENDS CARDIOVAS MED, V19, P227, DOI 10.1016/j.tcm.2010.02.001; Morgan SA, 2010, EXPERT OPIN INV DRUG, V19, P1067, DOI 10.1517/13543784.2010.504713; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Preusch MR, 2008, ARTERIOSCL THROM VAS, V28, P2158, DOI 10.1161/ATVBAHA.108.174128; Rickard AJ, 2009, J MOL ENDOCRINOL, V42, P449, DOI 10.1677/JME-08-0144; Salvayre R, 2002, BBA-MOL CELL BIOL L, V1585, P213, DOI 10.1016/S1388-1981(02)00343-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Thieringer R, 2001, J IMMUNOL, V167, P30, DOI 10.4049/jimmunol.167.1.30; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Tsukamoto Kayo, 2002, J Atheroscler Thromb, V9, P57; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wake DJ, 2006, ENDOCRINE, V29, P101, DOI 10.1385/ENDO:29:1:101; Wamil M, 2008, ENDOCRINOLOGY, V149, P5909, DOI 10.1210/en.2008-0420; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200	48	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e53192	10.1371/journal.pone.0053192	http://dx.doi.org/10.1371/journal.pone.0053192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383297	gold, Green Published, Green Submitted			2022-12-27	WOS:000314597900004
J	Sims, JT; Ganguly, SS; Bennett, H; Friend, JW; Tepe, J; Plattner, R				Sims, Jonathan T.; Ganguly, Sourik S.; Bennett, Holly; Friend, J. Woodrow; Tepe, Jessica; Plattner, Rina			Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-kappa B and HSP27/p38/AKT Pathways and by Inhibiting ABCB1	PLOS ONE			English	Article							BREAST-CANCER CELLS; MULTIDRUG-RESISTANCE; ABCG2 BCRP; C-ABL; TYROSINE KINASE; GENE-EXPRESSION; MELANOMA-CELLS; PROTEIN-KINASE; MESYLATE; TRANSCRIPTION	Despite advances in cancer detection and prevention, a diagnosis of metastatic disease remains a death sentence due to the fact that many cancers are either resistant to chemotherapy (conventional or targeted) or develop resistance during treatment, and residual chemoresistant cells are highly metastatic. Metastatic cancer cells resist the effects of chemotherapeutic agents by upregulating drug transporters, which efflux the drugs, and by activating proliferation and survival signaling pathways. Previously, we found that c-Abl and Arg non-receptor tyrosine kinases are activated in breast cancer, melanoma, and glioblastoma cells, and promote cancer progression. In this report, we demonstrate that the c-Abl/Arg inhibitor, imatinib (imatinib mesylate, STI571, Gleevec), reverses intrinsic and acquired resistance to the anthracycline, doxorubicin, by inducing G2/M arrest and promoting apoptosis in cancer cells expressing highly active c-Abl and Arg. Significantly, imatinib prevents intrinsic resistance by promoting doxorubicin-mediated NF-kappa B/p65 nuclear localization and repression of NF-kappa B targets in a STAT3-dependent manner, and by preventing activation of a novel STAT3/HSP27/p38/Akt survival pathway. In contrast, imatinib prevents acquired resistance by inhibiting upregulation of the ABC drug transporter, ABCB1, directly inhibiting ABCB1 function, and abrogating survival signaling. Thus, imatinib inhibits multiple novel chemoresistance pathways, which indicates that it may be effective in reversing intrinsic and acquired resistance in cancers containing highly active c-Abl and Arg, a critical step in effectively treating metastatic disease. Furthermore, since imatinib converts a master survival regulator, NF-kappa B, from a pro-survival into a pro-apoptotic factor, our data suggest that NF-kappa B inhibitors may be ineffective in sensitizing tumors containing activated c-Abl/Arg to anthracyclines, and instead might antagonize anthracycline-induced apoptosis.	[Sims, Jonathan T.; Ganguly, Sourik S.; Bennett, Holly; Friend, J. Woodrow; Tepe, Jessica; Plattner, Rina] Univ Kentucky, Sch Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA	University of Kentucky	Plattner, R (corresponding author), Univ Kentucky, Sch Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	rplat2@uky.edu			NIH/NCI [R01CA116784]; NATIONAL CANCER INSTITUTE [R01CA116784] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by NIH/NCI R01CA116784. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Ashikawa K, 2004, BIOCHEM PHARMACOL, V67, P353, DOI 10.1016/j.bcp.2003.08.039; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Burger H, 2005, CANCER BIOL THER, V4, P747, DOI 10.4161/cbt.4.7.1826; Burger H, 2004, CELL CYCLE, V3, P1502, DOI 10.4161/cc.3.12.1331; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dahlman JM, 2009, J CELL BIOCHEM, V106, P42, DOI 10.1002/jcb.21976; Deininger MW, 2008, CLIN CANCER RES, V14, P4027, DOI 10.1158/1078-0432.CCR-07-5015; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gangadharan C, 2009, J CELL BIOCHEM, V107, P203, DOI 10.1002/jcb.22115; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hafsi S, 2012, INT J ONCOL, V40, P639, DOI 10.3892/ijo.2011.1312; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Houghton PJ, 2004, CANCER RES, V64, P2333, DOI 10.1158/0008-5472.CAN-03-3344; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Kanagasabai R, 2011, J BIOL CHEM, V286, P33289, DOI 10.1074/jbc.M111.249102; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; LEE JS, 1994, MOL PHARMACOL, V46, P627; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Mersin H, 2008, BREAST, V17, P341, DOI 10.1016/j.breast.2007.11.031; Mouawad R, 2010, CRIT REV ONCOL HEMAT, V74, P27, DOI 10.1016/j.critrevonc.2009.08.005; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485, DOI 10.1124/mol.65.6.1485; Paumi CM, 2003, BIOCHEMISTRY-US, V42, P5429, DOI 10.1021/bi027347u; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Pletz N, 2012, EXP DERMATOL, V21, P301, DOI 10.1111/j.1600-0625.2012.01440.x; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Ricci C, 2002, CANCER RES, V62, P5995; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Sims JT, 2009, CANCER CHEMOTH PHARM, V64, P629, DOI 10.1007/s00280-009-1004-y; Sims JT, 2009, BIOCHEM PHARMACOL, V78, P249, DOI 10.1016/j.bcp.2009.04.007; Sissung TM, 2010, MOL BIOTECHNOL, V44, P152, DOI 10.1007/s12033-009-9220-6; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Tapia MA, 2007, CELL CYCLE, V6, P2284, DOI 10.4161/cc.6.18.4721; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Walsh N, 2010, BRIT J CANCER, V102, P1157, DOI 10.1038/sj.bjc.6605590; Zhao HJ, 2010, NEOPLASIA, V12, P214, DOI 10.1593/neo.91576	59	81	86	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55509	10.1371/journal.pone.0055509	http://dx.doi.org/10.1371/journal.pone.0055509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383209	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600115
J	Solberg, MF; Skaala, O; Nilsen, F; Glover, KA				Solberg, Monica Favneboe; Skaala, Oystein; Nilsen, Frank; Glover, Kevin Alan			Does Domestication Cause Changes in Growth Reaction Norms? A Study of Farmed, Wild and Hybrid Atlantic Salmon Families Exposed to Environmental Stress	PLOS ONE			English	Article							HISTOCOMPATIBILITY CLASS-II; SALAR L.; RAINBOW-TROUT; PHENOTYPIC PLASTICITY; GENETIC-DIFFERENCES; PLASMA-CORTISOL; ONCORHYNCHUS-MYKISS; LOCAL ADAPTATION; RED JUNGLEFOWL; SELECTION	One of the most important traits linked with the successful domestication of animals is reducing their sensitivity to environmental stressors in the human controlled environment. In order to examine whether domestication selection in Atlantic salmon Salmo salar L., over approximately ten generations, has inadvertently selected for reduced responsiveness to stress, we compared the growth reaction norms of 29 wild, hybrid and domesticated families reared together under standard hatchery conditions (control) and in the presence of a stressor (reduced water level twice daily). The experiment was conducted for a 14 week period. Farmed salmon outgrew wild salmon 1:2.93 in the control tanks, and no overlap in mean weight was displayed between families representing the three groups. Thus, the elevation of the reaction norms differed among the groups. Overall, growth was approximately 25% lower in the stressed tanksl; however, farmed salmon outgrew wild salmon 1:3.42 under these conditions. That farmed salmon maintained a relatively higher growth rate than the wild salmon in the stressed tanks demonstrates a lower responsiveness to stress in the farmed salmon. Thus, flatter reaction norm slopes were displayed in the farmed salmon, demonstrating reduced plasticity for this trait under these specific experimental conditions. For all growth measurements, hybrid salmon displayed intermediate values. Wild salmon displayed higher heritability estimates for body weight than the hybrid and farmed salmon in both environments. This suggests reduced genetic variation for body weight in the farmed contra wild salmon studied here. While these results may be linked to the specific families and stocks investigated, and verification in other stocks and traits is needed, these data are consistent with the theoretical predictions of domestication.	[Solberg, Monica Favneboe; Skaala, Oystein; Glover, Kevin Alan] Inst Marine Res, Sect Populat Genet & Ecol, N-5024 Bergen, Norway; [Solberg, Monica Favneboe; Nilsen, Frank] Univ Bergen, Dept Biol, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen	Glover, KA (corresponding author), Inst Marine Res, Sect Populat Genet & Ecol, POB 1870, N-5024 Bergen, Norway.	Kevin.Glover@imr.no		Solberg, Monica Favneboe/0000-0002-5844-9498	INTERACT [13159]; Research Council of Norway	INTERACT; Research Council of Norway(Research Council of Norway)	The project was conducted within the project INTERACT 13159 funded by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Awata S, 2011, AQUACULTURE, V314, P115, DOI 10.1016/j.aquaculture.2011.01.024; Bate D, 2012, LME4 LINEAR MIXED EF; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; Besnier F, 2011, AQUACULT ENV INTERAC, V2, P75, DOI 10.3354/aei00032; Bidau CJ, 2009, GAYANA, V73, P55; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; BRONSON FH, 1984, BIOL REPROD, V31, P83, DOI 10.1095/biolreprod31.1.83; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; Clifford SL, 1998, CAN J FISH AQUAT SCI, V55, P358, DOI 10.1139/cjfas-55-2-358; Clifford SL, 1998, J FISH BIOL, V52, P118, DOI 10.1111/j.1095-8649.1998.tb01557.x; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Crozier WW, 2000, FISHERIES MANAG ECOL, V7, P437, DOI 10.1046/j.1365-2400.2000.00219.x; CROZIER WW, 1993, AQUACULTURE, V113, P19, DOI 10.1016/0044-8486(93)90337-X; Darwish TL, 2009, CAN J FISH AQUAT SCI, V66, P83, DOI 10.1139/F08-185; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; FEVOLDEN SE, 1991, AQUACULTURE, V95, P53, DOI 10.1016/0044-8486(91)90072-F; Fevolden SE, 2002, AQUACULTURE, V205, P61, DOI 10.1016/S0044-8486(01)00660-3; FEVOLDEN SE, 1993, J FISH BIOL, V43, P919, DOI 10.1111/j.1095-8649.1993.tb01166.x; Fevolden SE, 1999, J FISH BIOL, V54, P900, DOI 10.1111/j.1095-8649.1999.tb02040.x; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 1997, BEHAV ECOL, V8, P470, DOI 10.1093/beheco/8.5.470; Fleming IA, 1997, ICES J MAR SCI, V54, P1051, DOI 10.1006/jmsc.1997.0289; Fleming IA, 2002, CAN J FISH AQUAT SCI, V59, P1323, DOI 10.1139/F02-082; Fox J., 2011, COMPANION APPL REGRE; Fraser DJ, 2008, EVOL APPL, V1, P501, DOI 10.1111/j.1752-4571.2008.00037.x; Fritts AL, 2007, CAN J FISH AQUAT SCI, V64, P813, DOI 10.1139/F07-057; GAVRILETS S, 1993, J EVOLUTION BIOL, V6, P49, DOI 10.1046/j.1420-9101.1993.6010049.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; GJEDREM T, 1975, AQUACULTURE, V6, P23, DOI 10.1016/0044-8486(75)90087-3; GJEDREM T, 1979, Z TIERZ ZUCHTUNGSBIO, V96, P56; Gjedrem T, 2006, DEV AQUATIC ANIMAL G, P22; GJERDE B, 1984, AQUACULTURE, V36, P97, DOI 10.1016/0044-8486(84)90057-7; GJERDE B, 1986, AQUACULTURE, V57, P37, DOI 10.1016/0044-8486(86)90179-1; Glover KA, 2008, ICES J MAR SCI, V65, P912, DOI 10.1093/icesjms/fsn056; Glover KA, 2006, AQUACULTURE, V254, P72, DOI 10.1016/j.aquaculture.2005.10.040; Glover KA, 2004, J FISH BIOL, V64, P1168, DOI 10.1111/j.0022-1112.2004.00376.x; Glover KA, 2004, AQUACULTURE, V232, P41, DOI 10.1016/S0044-8486(03)00454-X; Glover KA, 2001, J FISH BIOL, V59, P105, DOI 10.1111/j.1095-8649.2001.tb02341.x; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Glover KA, 2009, AQUACULTURE, V286, P203, DOI 10.1016/j.aquaculture.2008.09.023; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Gross MR, 1998, CAN J FISH AQUAT SCI, V55, P131, DOI 10.1139/cjfas-55-S1-131; Gulevich RG, 2004, PHYSIOL BEHAV, V82, P513, DOI 10.1016/j.physbeh.2004.04.062; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; Hansen SW, 1996, APPL ANIM BEHAV SCI, V49, P137, DOI 10.1016/0168-1591(96)01045-3; Herbinger CM, 1999, AQUACULTURE, V173, P105, DOI 10.1016/S0044-8486(98)00479-7; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Houde ALS, 2010, ICES J MAR SCI, V67, P657, DOI 10.1093/icesjms/fsp272; Houde ALS, 2010, CONSERV GENET, V11, P785, DOI 10.1007/s10592-009-9892-2; Jensen P, 2006, APPL ANIM BEHAV SCI, V97, P3, DOI 10.1016/j.applanim.2005.11.015; Jentoft S, 2005, COMP BIOCHEM PHYS A, V141, P353, DOI 10.1016/j.cbpb.2005.06.006; Karlsson S, 2011, MOL ECOL RESOUR, V11, P247, DOI 10.1111/j.1755-0998.2010.02959.x; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Kostow KE, 2004, CAN J FISH AQUAT SCI, V61, P577, DOI [10.1139/f04-019, 10.1139/F04-019]; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kunzl C, 1999, HORM BEHAV, V35, P28, DOI 10.1006/hbeh.1998.1493; Lankin V, 1997, GENET SEL EVOL, V29, P73, DOI 10.1051/gse:19970105; Lankin VS, 1997, GENETIKA+, V33, P1119; Lankin VS, 2000, ZH VYSSH NERV DEYAT+, V50, P1016; Lindqvist C, 2009, BEHAV PROCESS, V81, P80, DOI 10.1016/j.beproc.2009.02.005; Lund RA, 1989, RES REPORT NORWEGIAN, V1, P1; Marchetti MP, 2003, ENVIRON BIOL FISH, V66, P9, DOI 10.1023/A:1023269221678; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1016/S1054-3139(97)80004-5; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Mignon-Grasteau S, 2005, LIVEST PROD SCI, V93, P3, DOI 10.1016/j.livprodsci.2004.11.001; Mirkena T, 2010, LIVEST SCI, V132, P1, DOI 10.1016/j.livsci.2010.05.003; Mjolnerod IB, 1997, HEREDITAS, V127, P239, DOI 10.1111/j.1601-5223.1997.t01-1-00239.x; Morris MRJ, 2011, EVOL APPL, V4, P444, DOI 10.1111/j.1752-4571.2010.00159.x; Norris AT, 1999, AQUACULTURE, V180, P247, DOI 10.1016/S0044-8486(99)00212-4; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Ottera H, 2004, REPORT I MARINE RES, V3, P1; PICKERING AD, 1993, AQUACULTURE, V111, P51, DOI 10.1016/0044-8486(93)90024-S; Pottinger TG, 1999, AQUACULTURE, V175, P351, DOI 10.1016/S0044-8486(99)00107-6; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reilly A, 1999, AQUACULTURE, V173, P459, DOI 10.1016/S0044-8486(98)00476-1; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; Sanchez JA, 1996, HEREDITY, V77, P423, DOI 10.1038/hdy.1996.162; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Skaala O, 2005, J FISH BIOL, V67, P118, DOI 10.1111/j.0022-1112.2005.00843.x; Skaala O, 2004, AQUACULTURE, V240, P131, DOI 10.1016/j.aquaculture.2004.07.009; Skaala O, 2006, ICES J MAR SCI, V63, P1224, DOI 10.1016/j.icesjms.2006.04.005; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; SLETTAN A, 1995, ANIM GENET, V26, P281, DOI 10.1111/j.1365-2052.1995.tb03262.x; Solberg Monica F., 2012, BMC Research Notes, V5, P672, DOI 10.1186/1756-0500-5-672; Stet RJM, 2002, IMMUNOGENETICS, V54, P320, DOI 10.1007/s00251-002-0477-1; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Taggart JB, 2007, MOL ECOL NOTES, V7, P412, DOI 10.1111/j.1471-8286.2006.01616.x; Tanck MWT, 2002, AQUACULTURE, V204, P419, DOI 10.1016/S0044-8486(01)00828-6; Thodesen J, 1999, AQUACULTURE, V180, P237, DOI 10.1016/S0044-8486(99)00204-5; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; van den Brandt J, 2000, CLIN EXP PHARMACOL P, V27, P793, DOI 10.1046/j.1440-1681.2000.03336.x; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; WOODWARD CC, 1987, T AM FISH SOC, V116, P574, DOI 10.1577/1548-8659(1987)116<574:PSRIWA>2.0.CO;2; Wynne JW, 2007, J FISH BIOL, V70, P45, DOI 10.1111/j.1095-8649.2007.01364.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	111	88	88	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54469	10.1371/journal.pone.0054469	http://dx.doi.org/10.1371/journal.pone.0054469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382901	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600028
J	Zhang, JQ; Tao, R; You, ZL; Dai, YM; Fan, Y; Cui, JG; Mao, Q; Wang, J				Zhang, Jiuquan; Tao, Ran; You, Zhonglan; Dai, Yongming; Fan, Yi; Cui, Jinguo; Mao, Qing; Wang, Jian			Gamna-Gandy Bodies of the Spleen Detected with Susceptibility Weighted Imaging: Maybe a New Potential Non-Invasive Marker of Esophageal Varices	PLOS ONE			English	Article							CHARACTERIZING IRON DEPOSITION; PORTAL-HYPERTENSION; SIDEROTIC NODULES; LIVER-CIRRHOSIS; MR; PRESSURE; PREVENTION; DIAGNOSIS	Background/Objectives: Portal hypertension (PH) is a clinical sequelae of liver cirrhosis, and bleeding from esophageal varices (EV) is a serious complication of PH with significant morbidity and mortality. The aims of this study were to assess the ability of 2D multislice breath-hold susceptibility weighted imaging (SWI) to detect Gamna-Gandy bodies (GGBs) in the spleens of patients with PH and to evaluate the potential role of GGB number as a non-invasive marker of PH and EV. Materials and Methods: T1-, T2- and T2* - weighted imaging and SWI were performed on 135 patients with PH and on 37 control individuals. Platelet counts were collected from all PH patients. Two radiologists analyzed all magnetic resonance imaging (MRI) data, and measured the portal vein diameter, splenic index (SI), and platelet count/spleen diameter ratio. The numbers of patients with GGBs in the spleen were determined, and the numbers of GGB were counted in the four MRI sequences in GGB-positive patients. The portal vein diameter, SI, platelet count, and platelet count/spleen diameter ratio of control individuals were compared with those of GGB-negative and GGB-positive patients on SWI images. The correlations among GGB numbers, the portal vein diameter, the SI, the platelet count, and the platelet count/spleen diameter ratio were analyzed. Results: The GGB detection rate and the detected GGB number by using SWI were significantly greater than those by using T1-, T2-, and T2* -weighted images. The number of GGBs in the SWI images correlated positively with the portal vein diameter and SI and correlated negatively with the platelet count and platelet count/spleen diameter ratio. Conclusion: SWI provided more accurate information of GGBs in patients with PH. The number of GGB may be a non-invasive predictor of improving the selection for endoscopic screening of PH patients at risk of EV.	[Zhang, Jiuquan; Tao, Ran; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Dai, Yongming] Siemens Healthcare, MR Collaborat NE Asia, Shanghai, Peoples R China; [You, Zhonglan; Fan, Yi; Mao, Qing] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Tao, Ran; Cui, Jinguo] Peoples Liberty Army, Dept Radiol, Bethune Int Peace Hosp, Shijiazhuang, Peoples R China	Army Medical University; Siemens AG; Army Medical University	Mao, Q (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China.	qingmao@yahoo.com; wangjian_811@yahoo.com	ZHANG, JIUQUAN/X-8389-2019					Berzigotti A, 2008, CLIN GASTROENTEROL H, V6, P1129, DOI 10.1016/j.cgh.2008.05.004; Bhatt S, 2006, J ULTRAS MED, V25, P1625, DOI 10.7863/jum.2006.25.12.1625; Bosch J, 2003, LANCET, V361, P952, DOI 10.1016/S0140-6736(03)12778-X; BOYER TD, 1977, GASTROENTEROLOGY, V72, P584; Cheng YCN, 2001, NMR BIOMED, V14, P468, DOI 10.1002/nbm.727; D'Amico G, 1999, SEMIN LIVER DIS, V19, P475, DOI 10.1055/s-2007-1007133; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; de Franchis R, 2008, DIGEST LIVER DIS, V40, P312, DOI 10.1016/j.dld.2007.12.007; Dib N, 2005, GASTROEN CLIN BIOL, V29, P975, DOI 10.1016/S0399-8320(05)88170-9; Dobritz M, 2001, MAGN RESON IMAGING, V19, P1249, DOI 10.1016/S0730-725X(01)00451-9; Elsayes KM, 2005, RADIOGRAPHICS, V25, P967, DOI 10.1148/rg.254045154; FEU F, 1995, LANCET, V346, P1056, DOI 10.1016/S0140-6736(95)91740-3; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; GIBSON PR, 1990, AUST NZ J MED, V20, P771, DOI 10.1111/j.1445-5994.1990.tb00421.x; Gluud LL, 2007, AM J GASTROENTEROL, V102, P2842, DOI 10.1111/j.1572-0241.2007.01564.x; Groszmann RJ, 2005, J CLIN GASTROENTEROL, V39, pS125, DOI 10.1097/01.mcg.0000155552.14396.3d; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haag K, 1999, AM J ROENTGENOL, V172, P631, DOI 10.2214/ajr.172.3.10063849; Laurent O, 2011, J RADIOL, V92, P909, DOI 10.1016/j.jradio.2011.05.010; Luo T Y, 1998, Radiat Med, V16, P473; MINAMI M, 1989, RADIOLOGY, V172, P681, DOI 10.1148/radiology.172.3.2672092; Robinson RJ, 2011, J NEUROIMAGING; SAGOH T, 1989, RADIOLOGY, V172, P685, DOI 10.1148/radiology.172.3.2672093; Schepis F, 2001, HEPATOLOGY, V33, P333, DOI 10.1053/jhep.2001.21410; Sharma SK, 2007, J GASTROEN HEPATOL, V22, P1909, DOI 10.1111/j.1440-1746.2006.04501.x; Thomopoulos KC, 2003, DIGEST LIVER DIS, V35, P473, DOI 10.1016/S1590-8658(03)00219-6; Unsal Nuray Haliloglu, 2006, Diagn Interv Radiol, V12, P125; Watanabe S, 2000, J COMPUT ASSIST TOMO, V24, P788, DOI 10.1097/00004728-200009000-00022; WITTE CL, 1983, LYMPHOLOGY, V16, P60; Yilmaz S, 2007, J GASTROEN HEPATOL, V22, P758, DOI 10.1111/j.1440-1746.2007.04965.x; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036	33	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55626	10.1371/journal.pone.0055626	http://dx.doi.org/10.1371/journal.pone.0055626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383250	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600139
J	Liu, WH; Liu, JJ; Wu, J; Zhang, LL; Liu, F; Yin, L; Zhang, MM; Yu, B				Liu, Wen-hua; Liu, Jing-jin; Wu, Jian; Zhang, Lu-lu; Liu, Fang; Yin, Li; Zhang, Mao-mao; Yu, Bo			RETRACTED: Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling Pathway (Retracted article. See vol. 13, art no E0194455, 2018)	PLOS ONE			English	Article; Retracted Publication							ANTIGEN-PRESENTING CELLS; BLOOD MONOCYTES; IFN-GAMMA; T-CELLS; IL-10; DIFFERENTIATION; ACTIVATION; SUPPRESSOR; NAIVE	Mesenchymal stem cells (MSCs) can suppress dendritic cells (DCs) maturation and function, mediated by soluble factors, such as indoleamine 2,3-dioxygenase (IDO), prostaglandin E-2 (PGE(2)), and nitric oxide (NO). Interleukin-10 (IL-10) is a common immunosuppressive cytokine, and the downstream signaling of the JAK-STAT pathway has been shown to be involved with DCs differentiation and maturation in the context of cancer. Whether IL-10 and/or the JAK-STAT pathway play a role in the inhibitory effect of MSCs on DCs maturation remains controversial. In our study, we cultured MSCs and DCs derived from rat bone marrow under different culturing conditions. Using Transwell plates, we detected by ELISA that the level of IL-10 significantly increased in the supernatants of MSC-DC co-cultures at 48 hours. The cell immunofluorescence assay suggested that the MSCs secreted more IL-10 than the DCs in the co-cultures. Adding exogenous IL-10 to the DCs monoculture or MSC-DC co-cultures stimulated IL-10 and led to a decrease in IL-12, and lower expression of the DCs surface markers CD80, CD86, OX62, MHC-II and CD11b/c. Supplementing the culture with an IL-10 neutralizing antibody (IL-10NA) showed precisely the opposite effect of adding IL-10. Moreover, we demonstrated that the JAK-STAT signaling pathway is involved in inhibiting DCs maturation. Both JAK1 and STAT3 expression and IL-10 secretion decreased markedly after adding a JAK inhibitor (AG490) to the co-culture plate. We propose that there is an IL-10 positive feedback loop, which may explain our observations of elevated IL-10 and enhanced JAK1 and STAT3 expression. Overall, we demonstrated that MSCs inhibit the maturation of DCs through the stimulation of IL-10 secretion, and by activating the JAK1 and STAT3 signaling pathway.	[Liu, Wen-hua] Harbin Med Univ, Affiliated Hosp 2, Intens Care Unit ICU Dept, Harbin, Province Heilon, Peoples R China; [Liu, Jing-jin; Wu, Jian; Zhang, Lu-lu; Liu, Fang; Yin, Li; Zhang, Mao-mao; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Province Heilon, Peoples R China	Harbin Medical University; Harbin Medical University	Yu, B (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Province Heilon, Peoples R China.	yubodr@163.com			Heilongjiang Provincial Health Department [2011-087]; Heilongjiang Provincial Education Department (12521265), China	Heilongjiang Provincial Health Department; Heilongjiang Provincial Education Department (12521265), China	This project was supported by research grants from Heilongjiang Provincial Health Department issued in 2011 (2011-087), Heilongjiang Provincial Education Department issued in 2012 (12521265), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci A, 2010, J IMMUNOL, V185, P5102, DOI 10.4049/jimmunol.1001332; Bishopric NH, 2008, CIRC RES, V103, P125, DOI 10.1161/CIRCRESAHA.108.180596; Chen L, 2007, STEM CELLS DEV, V16, P719, DOI 10.1089/scd.2007.0065; Conzelmann M, 2010, BIOCHEM PHARMACOL, V80, P2074, DOI 10.1016/j.bcp.2010.07.040; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Groux H, 2003, J AUTOIMMUN, V20, P281, DOI 10.1016/S0896-8411(03)00044-1; Hirata N, 2009, CELL IMMUNOL, V258, P9, DOI 10.1016/j.cellimm.2009.03.006; Kamdje AHN, 2011, BLOOD, V118, P380, DOI 10.1182/blood-2010-12-326694; Kim YH, 2011, MOL MED, V17, P697, DOI 10.2119/molmed.2010.00098; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kronsteiner B, 2011, CELL IMMUNOL, V267, P30, DOI 10.1016/j.cellimm.2010.11.001; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee Eun Byul, 2010, Immune Netw, V10, P219, DOI 10.4110/in.2010.10.6.219; Li H, 2008, STEM CELLS, V26, P2531, DOI 10.1634/stemcells.2008-0146; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; Manuzak J, 2012, CLIN VACCINE IMMUNOL, V19, P1207, DOI 10.1128/CVI.00282-12; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nefedova Y, 2007, CURR CANCER DRUG TAR, V7, P71, DOI 10.2174/156800907780006887; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Szade K, 2011, MOL CELLS, V31, P497, DOI 10.1007/s10059-011-2176-y; Wang XL, 2006, STEM CELLS, V24, P482, DOI 10.1634/stemcells.2005-0219; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138; Zhang MM, 2011, J IMMUNOL, V187, P1674, DOI 10.4049/jimmunol.1001937; Zhao ZG, 2012, IMMUNOL INVEST, V41, P183, DOI 10.3109/08820139.2011.607877; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	35	71	74	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55487	10.1371/journal.pone.0055487	http://dx.doi.org/10.1371/journal.pone.0055487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383203	Green Published, gold			2022-12-27	WOS:000315563800159
J	Neogi, U; Heylen, E; Shet, A; Chandy, S; Shamsunder, R; Sonnerborg, A; Ekstrand, ML				Neogi, Ujjwal; Heylen, Elsa; Shet, Anita; Chandy, Sara; Shamsunder, Ranjani; Soennerborg, Anders; Ekstrand, Maria L.			Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study	PLOS ONE			English	Article							DRUG-RESISTANCE; VIROLOGICAL FAILURE; INFECTED PATIENTS; ADHERENCE; METAANALYSIS; SUPPRESSION; MUTATIONS; SETTINGS; PROGRAMS; OPTIONS	Background: Short term efficacy of combination antiretroviral therapy (cART) in resource-constrained settings is comparable to that found in western studies. However, long term data are limited. India has the third largest HIV infected population in the world but the long-term outcome of first line therapy according to the national guidelines has not been evaluated yet. Therefore, we conducted a long-term longitudinal analysis of the efficacy of the national first-line therapy in India from an observational cohort of Indian patients in two different clinical settings. Methodology/Principal Findings: A total 323 patients who had been on ART for a median of 23 months and achieved virological suppression <100 copies/ml by their study baseline visit, were included and followed for two years. Blood samples were collected every six months for viral load and CD4 count. Drug resistance genotyping was performed when the viral load was >2000 copies/mL. Adherence and treatment interruptions (>48 h) were assessed via self-report. In the studied patients, the median duration of viral suppression was 44 months; 15.8% of patients showed viral rebound, and 2.8% viral failure. Viral rebound or failure was significantly negatively related to perfect adherence (100% adherence and no treatment interruption >48 hrs). Virological re-suppression in the subsequent visit was observed in three patients without any change in therapy despite the presence of key mutations. Conclusion/Significance: Our study reports for the first time, a good long-term response to the first line therapy for a median of nearly four years although a less than perfect adherence increases the risk for treatment failure and subsequent drug resistance development. The empirical findings in this study also indicate the overall success of the Indian ART program in two different settings which likely are representative of other clinics that operate under the national guidelines.	[Neogi, Ujjwal; Soennerborg, Anders] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Neogi, Ujjwal; Shamsunder, Ranjani] St Johns Med Coll, Dept Microbiol, Div Clin Virol, Bangalore, Karnataka, India; [Heylen, Elsa; Ekstrand, Maria L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Shet, Anita] St Johns Med Coll Hosp, Dept Paediat, Bangalore, Karnataka, India; [Chandy, Sara] St Johns Med Coll Hosp, Dept Med, Bangalore, Karnataka, India	Karolinska Institutet; St. John's National Academy of Health Sciences; St. John's Medical College; University of California System; University of California San Francisco; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Medical College	Neogi, U (corresponding author), Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden.	ujjwal.neogi@ki.se	Sönnerborg, Anders/W-2011-2019; Neogi, Ujjwal/E-4274-2012; Neogi, Ujjwal/ABF-1172-2021	Sönnerborg, Anders/0000-0001-8928-3374; Neogi, Ujjwal/0000-0002-0844-3338; Shet, Anita/0000-0002-7204-8164	National Institute of Mental Health (NIMH) (Bethesda, MD, USA) [R01MH067513]; Swedish Physicians against AIDS fund [FOa2011-0014]; EU FP7 CHAIN grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067513, R01MH095659] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH) (Bethesda, MD, USA); Swedish Physicians against AIDS fund; EU FP7 CHAIN grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grant R01MH067513 from the National Institute of Mental Health (NIMH) (Bethesda, MD, USA) to MLE and the Swedish Physicians against AIDS fund (FOa2011-0014) to UN. A Sonnerborg acknowledges the support received from EU FP7 CHAIN grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous JL, 2009, CURR OPIN HIV AIDS, V4, P459, DOI 10.1097/COH.0b013e328331dea5; Aleman S, 2002, AIDS, V16, P1039, DOI 10.1097/00002030-200205030-00010; [Anonymous], PAT AL ANT THER; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Ekstrand ML, 2011, INT HEALTH, V3, P27, DOI 10.1016/j.inhe.2010.11.003; Ekstrand ML, 2010, JAIDS-J ACQ IMM DEF, V53, P415, DOI 10.1097/QAI.0b013e3181ba3e4e; Ekstrand MLCS, 2008, AIDS 2008 17 INT AID, P361; El-Khatib Ziad, 2011, J AIDS Clin Res, V2; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Innes CCS, 2008, AIDS 2008 17 INT AID; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Konate I, 2011, JAIDS-J ACQ IMM DEF, V57, pS50, DOI 10.1097/QAI.0b013e3182207a3f; Kumarasamy N, 2005, AIDS, V19, P625, DOI 10.1097/01.aids.0000163940.85940.03; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Neogi U, 2011, AIDS, V25, P1123, DOI 10.1097/QAD.0b013e328346269f; Neogi U, 2010, AIDS RES HUM RETROV, V26, P1097, DOI 10.1089/aid.2010.0092; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Orrell C, 2007, ANTIVIR THER, V12, P83; Rashbaum Victoria, 2010, 2009 2010 ANN REPORT; Roge BT, 2004, HIV MED, V5, P344, DOI 10.1111/j.1468-1293.2004.00233.x; Saravanan S, 2009, J VIROL METHODS, V159, P211, DOI 10.1016/j.jviromet.2009.03.021; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shet A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-277; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Verhofstede C, 2007, J MED VIROL, V79, P1254, DOI 10.1002/jmv.20950; World Health Organization, 2010, ATR ITS MET DRINK WA, P1	31	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55421	10.1371/journal.pone.0055421	http://dx.doi.org/10.1371/journal.pone.0055421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383185	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800153
J	Nesnidal, MP; Helmkampf, M; Bruchhaus, I; El-Matbouli, M; Hausdorf, B				Nesnidal, Maximilian P.; Helmkampf, Martin; Bruchhaus, Iris; El-Matbouli, Mansour; Hausdorf, Bernhard			Agent of Whirling Disease Meets Orphan Worm: Phylogenomic Analyses Firmly Place Myxozoa in Cnidaria	PLOS ONE			English	Article							COMPOSITIONAL HETEROGENEITY; SEQUENCE ALIGNMENTS; ORIGIN; TREE; BUDDENBROCKIA; POSITION; RANDOMNESS; PROTISTS; METAZOA; PHYLUM	Myxozoa are microscopic obligate endoparasites with complex live cycles. Representatives are Myxobolus cerebralis, the causative agent of whirling disease in salmonids, and the enigmatic "orphan worm'' Buddenbrockia plumatellae parasitizing in Bryozoa. Originally, Myxozoa were classified as protists, but later several metazoan characteristics were reported. However, their phylogenetic relationships remained doubtful. Some molecular phylogenetic analyses placed them as sister group to or even within Bilateria, whereas the possession of polar capsules that are similar to nematocysts of Cnidaria and of minicollagen genes suggest a close relationship between Myxozoa and Cnidaria. EST data of Buddenbrockia also indicated a cnidarian origin of Myxozoa, but were not sufficient to reject a closer relationship to bilaterians. Phylogenomic analyses of new genomic sequences of Myxobolus cerebralis firmly place Myxozoa as sister group to Medusozoa within Cnidaria. Based on the new dataset, the alternative hypothesis that Myxozoa form a clade with Bilateria can be rejected using topology tests. Sensitivity analyses indicate that this result is not affected by long branch attraction artifacts or compositional bias.	[Nesnidal, Maximilian P.; Helmkampf, Martin; Hausdorf, Bernhard] Univ Hamburg, Zool Museum, Hamburg, Germany; [Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [El-Matbouli, Mansour] Univ Vet Med, Clin Div Fish Med, Vienna, Austria	University of Hamburg; Bernhard Nocht Institut fur Tropenmedizin; University of Veterinary Medicine Vienna	Hausdorf, B (corresponding author), Univ Hamburg, Zool Museum, Hamburg, Germany.	hausdorf@zoologie.uni-hamburg.de	Helmkampf, Martin/ABD-8649-2020; Hausdorf, Bernhard/E-9829-2016	Hausdorf, Bernhard/0000-0002-1604-1689; El-Matbouli, Mansour/0000-0001-8148-0218	Deutsche Forschungsgemeinschaft [HA 2763/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the priority program "Deep Metazoan Phylogeny'' of the Deutsche Forschungsgemeinschaft (http://www.dfg.de; grant number: HA 2763/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 1998, NATURE, V392, P346, DOI 10.1038/32801; Canning EU, 2004, ADV PARASIT, V56, P43, DOI 10.1016/S0065-308X(03)56002-X; CavalierSmith T, 1996, CAN J ZOOL, V74, P2031, DOI 10.1139/z96-231; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; El-Matbouli M, 2006, PARASITOLOGY, V132, P467, DOI 10.1017/S0031182005009522; Evans NM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-139; Evans NM, 2010, MOL BIOL EVOL, V27, P2733, DOI 10.1093/molbev/msq159; Grabner DS, 2010, PARASITOLOGY, V137, P629, DOI 10.1017/S0031182009991429; Hanelt B, 1996, MOL BIOL EVOL, V13, P1187, DOI 10.1093/oxfordjournals.molbev.a025683; Holland JW, 2011, P ROY SOC B-BIOL SCI, V278, P546, DOI 10.1098/rspb.2010.1301; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kent ML, 2001, J EUKARYOT MICROBIOL, V48, P395, DOI 10.1111/j.1550-7408.2001.tb00173.x; Kim JH, 1999, MOL BIOL EVOL, V16, P423, DOI 10.1093/oxfordjournals.molbev.a026124; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lom J., 1990, P36; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Lom J, 1997, ACTA PROTOZOOL, V36, P83; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Monteiro AS, 2002, MOL BIOL EVOL, V19, P968, DOI 10.1093/oxfordjournals.molbev.a004155; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Okamura B, 2002, PARASITOLOGY, V124, P215, DOI 10.1017/S0031182001001184; Ott M, 2007, P ACM IEEE C SUP 200; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roure B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-17; Schlegel M, 1996, ARCH PROTISTENKD, V147, P1; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siddall ME, 1999, CLADISTICS, V15, P9, DOI 10.1111/j.1096-0031.1999.tb00391.x; Siddall ME, 1995, J PARASITOL, V81, P961, DOI 10.2307/3284049; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SMOTHERS JF, 1994, SCIENCE, V265, P1719, DOI 10.1126/science.8085160; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tops S, 2004, DIS AQUAT ORGAN, V60, P109, DOI 10.3354/dao060109; Zrzavy J, 1998, CLADISTICS, V14, P249, DOI 10.1111/j.1096-0031.1998.tb00338.x; Zrzavy J, 2003, CLADISTICS, V19, P164, DOI 10.1016/S0748-3007(03)00007-0	48	46	46	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54576	10.1371/journal.pone.0054576	http://dx.doi.org/10.1371/journal.pone.0054576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382916	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800054
J	Gill, JK; Chatzidaki, A; Ursu, D; Sher, E; Millar, NS				Gill, JasKiran K.; Chatzidaki, Anna; Ursu, Daniel; Sher, Emanuele; Millar, Neil S.			Contrasting Properties of alpha 7-Selective Orthosteric and Allosteric Agonists Examined on Native Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							TRANSMEMBRANE SITE; ION CHANNELS; IN-VITRO; ALPHA-7; MODULATORS; SUBUNIT; BINDING; RAT; POTENTIATION; ACTIVATION	Subtype-selective ligands are important tools for the pharmacological characterisation of neurotransmitter receptors. This is particularly the case for nicotinic acetylcholine receptors (nAChRs), given the heterogeneity of their subunit composition. In addition to agonists and antagonists that interact with the extracellular orthosteric nAChR binding site, a series of nAChR allosteric modulators have been identified that interact with a distinct transmembrane site. Here we report studies conducted with three pharmacologically distinct nicotinic ligands, an orthosteric agonist (compound B), a positive allosteric modulator (TQS) and an allosteric agonist (4BP-TQS). The primary focus of the work described in this study is to examine the suitability of these compounds for the characterisation of native neuronal receptors (both rat and human). However, initial experiments were conducted on recombinant nAChRs demonstrating the selectivity of these three compounds for alpha 7 nAChRs. In patch-clamp recordings on rat primary hippocampal neurons we found that all these compounds displayed pharmacological properties that mimicked closely those observed on recombinant alpha 7 nAChRs. However, it was not possible to detect functional responses with compound B, an orthosteric agonist, using a fluorescent intracellular calcium assay on either rat hippocampal neurons or with human induced pluripotent stem cell-derived neurons (iCell neurons). This is, presumably, due to the rapid desensitisation of alpha 7 nAChR that is induced by orthosteric agonists. In contrast, clear agonist-evoked responses were observed in fluorescence-based assays with the non-desensitising allosteric agonist 4BP-TQS and also when compound B was co-applied with the non-desensitising positive allosteric modulator TQS. In summary, we have demonstrated the suitability of subtype-selective orthosteric and allosteric ligands for the pharmacological identification and characterisation of native nAChRs and the usefulness of ligands that minimise receptor desensitisation for the characterisation of alpha 7 nAChRs in fluorescence-based assays.	[Gill, JasKiran K.; Chatzidaki, Anna; Millar, Neil S.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Ursu, Daniel; Sher, Emanuele] Eli Lilly & Co Ltd, Lilly Res Ctr, Windlesham, Surrey, England	University of London; University College London; Eli Lilly	Millar, NS (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	n.millar@ucl.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F017146/1]; Eli Lilly Co. Ltd.	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eli Lilly Co. Ltd.(Eli Lilly)	The work was supported by PhD studentship awarded by the Biotechnology and Biological Sciences Research Council (BBSRC; BB/F017146/1)) with additional financial support from Eli Lilly & Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Cilia J, 2005, PSYCHOPHARMACOLOGY, V182, P214, DOI 10.1007/s00213-005-0069-5; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Croxen R, 2001, BRAIN, V124, P1362, DOI 10.1093/brain/124.7.1362; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; De Filippi G, 2002, SOC NEUR ABSTR, V137, P135; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dickinson JA, 2007, J NEUROCHEM, V100, P1089, DOI 10.1111/j.1471-4159.2006.04273.x; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; Dunlop J, 2009, J PHARMACOL EXP THER, V328, P766, DOI 10.1124/jpet.108.146514; Elliott KJ, 1996, J MOL NEUROSCI, V7, P217, DOI 10.1007/BF02736842; Faghih R, 2008, J MED CHEM, V51, P701, DOI 10.1021/jm070256g; Gill JK, 2012, MOL PHARMACOL, V81, P710, DOI 10.1124/mol.111.076026; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Hogg RC, 2005, BIOCHEM PHARMACOL, V70, P1267, DOI 10.1016/j.bcp.2005.06.010; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jindrichova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032073; Lansdell SJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-73; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Malysz J, 2009, J PHARMACOL EXP THER, V330, P257, DOI 10.1124/jpet.109.151886; Mazurov AA, 2011, J MED CHEM, V54, P7943, DOI 10.1021/jm2007672; Medhurst SJ, 2008, J PAIN, V9, P580, DOI 10.1016/j.jpain.2008.01.336; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; O'Neill MJ, 2002, SOC NEUR ABSTR, V137, P136; Palczynska MM, 2012, MOL PHARM, DOI [10.1124/mol.1112.080259, DOI 10.1124/MOL.1112.080259]; Phillips E, 2001, PCT International Application, Patent No. [0160821, WO 01/60821 A1]; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Visanji NP, 2006, NEUROPHARMACOLOGY, V51, P506, DOI 10.1016/j.neuropharm.2006.04.015; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809	41	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55047	10.1371/journal.pone.0055047	http://dx.doi.org/10.1371/journal.pone.0055047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383051	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200016
J	Raykov, Z; Grekova, SP; Horlein, R; Leuchs, B; Giese, T; Giese, NA; Rommelaere, J; Zawatzky, R; Daeffler, L				Raykov, Zahari; Grekova, Svitlana P.; Hoerlein, Rita; Leuchs, Barbara; Giese, Thomas; Giese, Nathalia A.; Rommelaere, Jean; Zawatzky, Rainer; Daeffler, Laurent			TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NONSTRUCTURAL PROTEINS NS2; INTERFERON-PRODUCING CELLS; MINUTE VIRUS; RIG-I; CPG MOTIFS; KILHAM RAT; ACTIVATION; INFECTION; EXPRESSION	The oncotropism of Minute Virus of Mice (MVMp) is partially related to the stimulation of an antiviral response mediated by type-I interferons (IFNs) in normal but not in transformed mouse cells. The present work was undertaken to assess whether the oncotropism displayed against human cells by MVMp and its rat homolog H-1PV also depends on antiviral mechanisms and to identify the pattern recognition receptor (PRR) involved. Despite their low proliferation rate which represents a drawback for parvovirus multiplication, we used human peripheral blood mononuclear cells (hPBMCs) as normal model specifically because all known PRRs are functional in this mixed cell population and moreover because some of its subsets are among the main IFN producers upon infections in mammals. Human transformed models consisted in lines and tumor cells more or less permissive to both parvoviruses. Our results show that irrespective of their permissiveness, transformed cells do not produce IFNs nor develop an antiviral response upon parvovirus infection. However, MVMp- or H-1PV-infected hPBMCs trigger such defense mechanisms despite an absence of parvovirus replication and protein expression, pointing to the viral genome as the activating element. Substantial reduction of an inhibitory oligodeoxynucleotide (iODN) of the latter IFN production identified TLR-9 as a potential PRR for parvoviruses in hPBMCs. However, neither the iODN treatment nor an antibody-induced neutralization of the IFN-triggered effects restored parvovirus multiplication in these cells as expected by their weak proliferation in culture. Finally, given that a TLR-9 activation could also not be observed in parvovirus-infected human lines reported to be endowed with a functional TLR-9 pathway (Namalwa, Raji, and HEK293-TLR9(+/+)), our data suggest that transformed human cells do not sense MVMp or H-1PV either because of an absence of PRR expression or an intrinsic, or virus-driven defect in the endosomal sensing of the parvovirus genomes by TLR-9.	[Raykov, Zahari; Grekova, Svitlana P.; Hoerlein, Rita; Leuchs, Barbara; Rommelaere, Jean; Daeffler, Laurent] German Canc Res Ctr, Div F010, Infect & Canc Program, Heidelberg, Germany; [Raykov, Zahari; Grekova, Svitlana P.; Hoerlein, Rita; Leuchs, Barbara; Rommelaere, Jean; Daeffler, Laurent] German Canc Res Ctr, INSERM, U701, Heidelberg, Germany; [Zawatzky, Rainer] German Canc Res Ctr, Div F030, Infect & Canc Program, Dept Viral Transformat Mech, Heidelberg, Germany; [Giese, Thomas] Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany; [Giese, Nathalia A.] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Daeffler, L (corresponding author), German Canc Res Ctr, Div F010, Infect & Canc Program, Heidelberg, Germany.	l.daeffler@dkfz.de	Daeffler, Laurent/M-8914-2017; Daeffler, Laurent/S-6395-2019	Daeffler, laurent/0000-0001-5871-5082	DFG [RA 1891/2]; French Institut National de la Sante et de la Recherche Medicale (INSERM); German Cancer Research Center (DKFZ, Heidelberg)	DFG(German Research Foundation (DFG)); French Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); German Cancer Research Center (DKFZ, Heidelberg)	This work was supported by DFG grants RA 1891/2 to Z. Raykov and by funds provided by the French Institut National de la Sante et de la Recherche Medicale (INSERM) and the German Cancer Research Center (DKFZ, Heidelberg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelova AL, 2009, MOL THER; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ashman RF, 2011, INT IMMUNOL, V23, P203, DOI 10.1093/intimm/dxq473; Bartel M, 2008, J PATHOL, V215, P195, DOI 10.1002/path.2348; Berns KI, 1996, CURR TOP MICROBIOL, V218, P1; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bodendorf U, 1999, J VIROL, V73, P7769, DOI 10.1128/JVI.73.9.7769-7779.1999; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Brockhaus K, 1996, J VIROL, V70, P7527, DOI 10.1128/JVI.70.11.7527-7534.1996; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Chiang CY, 2012, CELL HOST MICROBE, V11, P306, DOI 10.1016/j.chom.2012.02.002; Daeffler L, 2003, J VIROL, V77, P12466, DOI 10.1128/JVI.77.23.12466-12478.2003; Deleu L, 1999, J VIROL, V73, P3877, DOI 10.1128/JVI.73.5.3877-3885.1999; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Fiola C, 2006, INT J CANCER, V119, P328, DOI 10.1002/ijc.21821; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Geletneky K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-99; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Grekova SP, 2012, CANC GENE THER; Grekova S, 2010, CANCER BIOL THER, V10, P1280, DOI 10.4161/cbt.10.12.13455; Grekova S, 2010, J VIROL, V84, P516, DOI 10.1128/JVI.01618-09; Grieger JC, 2012, METHOD ENZYMOL, V507, P229, DOI 10.1016/B978-0-12-386509-0.00012-0; Haller O, 2007, CURR TOP MICROBIOL, V316, P315; Hanten JA, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-39; Henault M, 2005, J IMMUNOL METHODS, V300, P93, DOI 10.1016/j.jim.2005.02.012; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kim Y, 2012, IMMUNOL CELL BIOL, V90, P655, DOI 10.1038/icb.2011.85; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Laredj LN, 2011, J VIROL, V85, P13133, DOI 10.1128/JVI.05407-11; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Malerba M, 2003, J VIROL, V77, P6683, DOI 10.1128/JVI.77.12.6683-6691.2003; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; Mohr A, 2012, EUR J CELL BIOL, V91, P524, DOI 10.1016/j.ejcb.2011.09.005; Morales O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032197; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Nayak R, 2007, J VIROL, V81, P11908, DOI 10.1128/JVI.01132-07; Nuesch JP, 2012, CLIN CANC RES; Peng WM, 2007, HUM IMMUNOL, V68, P879, DOI 10.1016/j.humimm.2007.10.008; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Raykov Z, 2004, INT J CANCER, V109, P742, DOI 10.1002/ijc.20013; Raykov Z, 2008, INT J CANCER, V122, P2880, DOI 10.1002/ijc.23472; Rommelaere J, 2001, AUTONOMOUS PARVOVIRU; Rommelaere J, 2010, CYTOKINE GROWTH F R, V21, P185, DOI 10.1016/j.cytogfr.2010.02.011; Satomi H, 2002, CYTOKINE, V18, P108, DOI 10.1006/cyto.2002.1028; Schirrmacher V, 2005, CANCER IMMUNOL IMMUN, V54, P587, DOI 10.1007/s00262-004-0602-0; SCHLEHOFER JR, 1992, MED MICROBIOL IMMUN, V181, P153; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Wang LL, 1999, P NATL ACAD SCI USA, V96, P3906, DOI 10.1073/pnas.96.7.3906; Weitzman MD, 2011, METHODS MOL BIOL, V807, P1, DOI 10.1007/978-1-61779-370-7_1; Weng YJ, 2011, J HUAZHONG U SCI-MED, V31, P550, DOI 10.1007/s11596-011-0488-y; Wilden H, 2009, INT J ONCOL, V34, P971, DOI 10.3892/ijo_00000223; Younesi V, 2010, MICROBIOL IMMUNOL, V54, P534, DOI 10.1111/j.1348-0421.2010.00248.x; Yu SL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3803; Zaiss AK, 2008, GENE THER, V15, P808, DOI 10.1038/gt.2008.54; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zipris D, 2005, J IMMUNOL, V174, P131, DOI 10.4049/jimmunol.174.1.131; Zipris D, 2007, J IMMUNOL, V178, P693, DOI 10.4049/jimmunol.178.2.693; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	74	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55086	10.1371/journal.pone.0055086	http://dx.doi.org/10.1371/journal.pone.0055086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383065	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200061
J	Martinez-Poveda, B; Garcia-Vilas, JA; Cardenas, C; Melgarejo, E; Quesada, AR; Medina, MA				Martinez-Poveda, Beatriz; Garcia-Vilas, Javier A.; Cardenas, Casimiro; Melgarejo, Esther; Quesada, Ana R.; Medina, Miguel A.			The Brominated Compound Aeroplysinin-1 Inhibits Proliferation and the Expression of Key Pro-Inflammatory Molecules in Human Endothelial and Monocyte Cells	PLOS ONE			English	Article							SPONGE VERONGIA-AEROPHOBA; IN-VITRO; ANGIOGENESIS ASSAYS; APLYSINA-AEROPHOBA; CHEMICAL DEFENSE; RECEPTOR; MMP-1; VIVO; MEMBRANE; DISEASE	Aeroplysinin-1 is a brominated antibiotic used by some sponges for defense against bacterial pathogen invasion. Aeroplysinin-1 has a wide spectrum of anti-tumoral action and behaves as a potent anti-angiogenic compound for bovine aortic endothelial cells. In this study, we demonstrate anti-angiogenic effects of aeroplysinin-1 on human endothelial cells. Furthermore, the response of angiogenesis related genes to aeroplysinin-1 treatment was studied in human endothelial cells by using gene arrays. The major changes were observed in thrombospondin 1 (TSP-1) and monocyte chemoattractant protein-1 (MCP-1), both of which were down-regulated. These inhibitory effects of aeroplysinin-1 were confirmed by using independent experimental approaches. To have a deeper insight on the anti-inflammatory effects of aeroplysinin-1 in endothelial cells, cytokine arrays were also used. This experimental approach confirmed effects on MCP-1 and TSP-1 and showed down-regulation of several other cytokines. Western blotting experiments confirmed down-regulation of ELTD1 (EGF, latrophilin and seven transmembrane domain-containing protein 1), interleukin 1 alpha and matrix metalloproteinase 1 (MMP-1). These results along with our observation of a dramatic inhibitory effect of aeroplysinin-1 on cyclooxygenase-2 protein expression levels in endothelial cells and a human monocyte cell line suggest that aeroplysinin-1 could be a novel anti-inflammatory compound with potential pharmacological interest.	[Martinez-Poveda, Beatriz; Garcia-Vilas, Javier A.; Cardenas, Casimiro; Melgarejo, Esther; Quesada, Ana R.; Medina, Miguel A.] Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, Malaga, Spain; [Quesada, Ana R.; Medina, Miguel A.] CIBER Enfermedades Raras CIBERER, Malaga, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Medina, MA (corresponding author), Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, Malaga, Spain.	medina@uma.es	Medina, Miguel Ángel/K-1763-2014; Cardenas, Casimiro/L-1051-2014; Martinez-Poveda, Beatriz/T-6973-2017	Medina, Miguel Ángel/0000-0001-7275-6462; Cardenas, Casimiro/0000-0001-6259-8296; Martinez-Poveda, Beatriz/0000-0003-3927-3877; Rodriguez Quesada, Ana Maria/0000-0002-6419-8867	Spanish Ministry of Science and Innovation, ISCIII and FEDER [PS09/02216]; group BIO-267 Andalusian Government;  [PIE P08-CTS-3759];  [PIE CVI-6585]	Spanish Ministry of Science and Innovation, ISCIII and FEDER; group BIO-267 Andalusian Government; ; 	The authors' experimental work is supported by grants PS09/02216 (Spanish Ministry of Science and Innovation, ISCIII and FEDER), and PIE P08-CTS-3759, CVI-6585 and funds from group BIO-267 (Andalusian Government). The "CIBER de Enfermedades Raras" is an initiative from the ISCIII (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Cardenas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023407; Chapman PT, 1997, ARTHRITIS RHEUM, V40, P955, DOI 10.1002/art.1780400525; Cipollone F, 2006, J CARDIOVASC PHARM, V47, pS26, DOI 10.1097/00005344-200605001-00006; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; CYBULSKY M I, 1987, Annales de l'Institut Pasteur Immunology, V138, P505; Debitus C, 1998, J MAR BIOTECHNOL, V6, P136; Fattorusso E, 1972, J Chem Soc Perkin 1, V1, P16; Forslow A, 2007, CELL MOL LIFE SCI, V64, P66, DOI 10.1007/s00018-006-6255-8; Garcia-Caballero M, 2011, J INVEST DERMATOL, V131, P1347, DOI 10.1038/jid.2010.416; Herouy Y, 2001, J DERMATOL SCI, V25, P198, DOI 10.1016/S0923-1811(00)00128-6; Hinterding K, 1998, BIOORGAN MED CHEM, V6, P1153, DOI 10.1016/S0968-0896(98)00070-4; Ikeda U, 2002, CLIN CARDIOL, V25, P143, DOI 10.1002/clc.4960250403; Koulman A, 1996, J NAT PROD, V59, P591, DOI 10.1021/np960167z; KREUTER MH, 1989, Z NATURFORSCH C, V44, P680; KREUTER MH, 1990, COMP BIOCHEM PHYS B, V97, P151, DOI 10.1016/0305-0491(90)90194-X; KREUTER MH, 1992, COMP BIOCHEM PHYS C, V101, P183, DOI 10.1016/0742-8413(92)90217-U; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; LEE WY, 1994, FASEB J, V8, P1081, DOI 10.1096/fasebj.8.13.7926375; Li DY, 2002, AM J PHYSIOL-HEART C, V283, pH1795, DOI 10.1152/ajpheart.00382.2002; Maes M, 2011, J AFFECT DISORD; Melgarejo E, 2007, CELL MOL LIFE SCI, V64, P2690, DOI 10.1007/s00018-007-7331-4; Melgarejo E, 2009, BRIT J PHARMACOL, V158, P1705, DOI 10.1111/j.1476-5381.2009.00452.x; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; NIEDER M, 1985, ARCH BIOCHEM BIOPHYS, V240, P121, DOI 10.1016/0003-9861(85)90014-1; Niu QX, 2008, CLIN EXP PHARMACOL P, V35, P89, DOI 10.1111/j.1440-1681.2007.04755.x; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Neto LRP, 2011, ANIM GENET, V42, P50, DOI 10.1111/j.1365-2052.2010.02120.x; Ray A, 2005, BBA-GENE STRUCT EXPR, V1732, P53, DOI 10.1016/j.bbaexp.2005.11.004; Rodriguez-Nieto S, 2001, FASEB J, V15, P261, DOI 10.1096/fj.01-0427fje; Scarborough Robert M., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P73, DOI 10.2174/1568016033356698; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; TEEYAPANT R, 1993, Z NATURFORSCH C, V48, P939; Thoms C, 2006, J CHEM ECOL, V32, P97, DOI 10.1007/s10886-006-9355-x; Thoms C, 2004, Z NATURFORSCH C, V59, P113; van Beijnum JR, 2008, EXP CELL RES, V314, P264, DOI 10.1016/j.yexcr.2007.08.013; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573; Zhou XY, 2004, THROMB RES, V113, P181, DOI 10.1016/j.thromres.2004.02.016	43	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55203	10.1371/journal.pone.0055203	http://dx.doi.org/10.1371/journal.pone.0055203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383109	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500065
J	Zavan, B; Ferroni, L; Giorgi, C; Calo, G; Brun, P; Cortivo, R; Abatangelo, G; Pinton, P				Zavan, Barbara; Ferroni, Letizia; Giorgi, Carlotta; Calo, Girolamo; Brun, Paola; Cortivo, Roberta; Abatangelo, Giovanni; Pinton, Paolo			Hyaluronic Acid Induces Activation of the kappa-Opioid Receptor	PLOS ONE			English	Article							KNEE; OSTEOARTHRITIS; VISCOSUPPLEMENTATION; MECHANISMS; EXPRESSION; AGONIST; CALCIUM; TRANSFORMATION; ANALGESIA; ARTHRITIS	Introduction: Nociceptive pain is one of the most common types of pain that originates from an injury involving nociceptors. Approximately 60% of the knee joint innervations are classified as nociceptive. The specific biological mechanism underlying the regulation of nociceptors is relevant for the treatment of symptoms affecting the knee joint. Intra-articular administration of exogenous hyaluronic acid (HA) in patients with osteoarthritis (OA) appears to be particularly effective in reducing pain and improving patient function. Methods: We performed an in vitro study conducted in CHO cells that expressed a panel of opioid receptors and in primary rat dorsal root ganglion (DRG) neurons to determine if HA induces the activation of opioid peptide receptors (OPr) using both aequorin and the fluorescent dye Fura-2/AM. Results: Selective agonists and antagonists for each OPr expressed on CHO cells were used to test the efficacy of our in vitro model followed by stimulation with HA. The results showed that HA induces stimulatory effects on the kappa receptor (KOP). These effects of HA were also confirmed in rat DRG neurons, which express endogenously the OPr. Conclusions: HA activates the KOP receptor in a concentration dependent manner, with a pEC(50) value of 7.57.	[Zavan, Barbara; Ferroni, Letizia; Brun, Paola; Cortivo, Roberta; Abatangelo, Giovanni] Univ Padua, Dept Biomed Sci, Padua, Italy; [Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Dept Expt & Clin Med, Pharmacol Sect, I-44100 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Neurosci Ctr, I-44100 Ferrara, Italy	University of Padua; University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Zavan, B (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	barbara.zavan@unipd.it; pnp@unife.it	Brun, Paola/K-5729-2016; Pinton, Paolo/J-8025-2012; Giorgi, Carlotta/K-4649-2016	Pinton, Paolo/0000-0001-7108-6508; Giorgi, Carlotta/0000-0002-2494-7405; Brun, Paola/0000-0002-4204-3549; Ferroni, Letizia/0000-0002-5457-0338	University of Padova; University of Ferrara; Italian Ministry of Education, University and Research (COFIN); Italian Ministry of Health; Italian Association for Cancer Research (AIRC), Telethon	University of Padova; University of Ferrara; Italian Ministry of Education, University and Research (COFIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC), Telethon(Fondazione AIRC per la ricerca sul cancroFondazione Telethon)	This research was supported by local funds from the University of Padova to RC and GA. PP lab is supported by local funds from the University of Ferrara, Italian Association for Cancer Research (AIRC), Telethon, the Italian Ministry of Education, University and Research (COFIN) and Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2008, UPSALA J MED SCI, V113, P261, DOI 10.3109/2000-1967-233; Anelli T, 2012, ANTIOXID REDOX SIGN, V16, P1077, DOI 10.1089/ars.2011.4004; Bannuru RR, 2011, OSTEOARTHR CARTILAGE, V19, P611, DOI 10.1016/j.joca.2010.09.014; Barron MC, 2007, J AM OSTEOPATH ASSOC, V107, pES21; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Bellamy N, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321; Bezzerri V, 2011, J IMMUNOL, V186, P4946, DOI 10.4049/jimmunol.1003535; Binder W, 1998, BRIT J PHARMACOL, V124, P647, DOI 10.1038/sj.bjp.0701874; Boettger MK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3394; Bot PT, 2008, CURR MED CHEM, V15, P786, DOI 10.2174/092986708783955554; Brough SJ, 2009, METHODS MOL BIOL, V552, P181, DOI 10.1007/978-1-60327-317-6_13; BUTTON D, 1993, CELL CALCIUM, V14, P663, DOI 10.1016/0143-4160(93)90091-J; Camarda Valeria, 2013, Methods Mol Biol, V937, P293; Camarda V, 2009, N-S ARCH PHARMACOL, V379, P599, DOI 10.1007/s00210-009-0396-x; Connor-Ballard PA, 2009, AM J NURS, V109, P48, DOI 10.1097/01.NAJ.0000348604.47231.68; Das A, 2009, J FAM PRACTICE, V58; De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92; Demaria M, 2012, CELL DEATH DIFFER, V19, P1390, DOI 10.1038/cdd.2012.20; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; FRIEDMAN MJ, 1977, PSYCHOSOM MED, V39, P134, DOI 10.1097/00006842-197703000-00008; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Giorgi C, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-27; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gomis A, 2009, OSTEOARTHR CARTILAGE, V17, P798, DOI 10.1016/j.joca.2008.11.013; Grigg P, 2001, CELLS TISSUES ORGANS, V169, P218, DOI 10.1159/000047885; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kieffer BL, 2009, NEUROPHARMACOLOGY, V56, P205, DOI 10.1016/j.neuropharm.2008.07.033; Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073; Kim KS, 2011, ACTA BIOMATER, V7, P666, DOI 10.1016/j.actbio.2010.09.030; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; LAWRENCE AJ, 1992, EUR J CLIN PHARMACOL, V43, P351, DOI 10.1007/BF02220608; Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45; McCall J, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00011; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; Peng JS, 2012, DRUG ALCOHOL DEPEN, V124, P223, DOI 10.1016/j.drugalcdep.2012.01.013; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Riedel W, 2001, Z RHEUMATOL, V60, P404, DOI 10.1007/s003930170003; Shen H, 2005, ARTHRITIS RHEUM-US, V52, P1402, DOI 10.1002/art.21141; Snyder SH, 2003, TRENDS PHARMACOL SCI, V24, P198, DOI 10.1016/S0165-6147(03)00066-X; Sorrentino G, 2012, CELL DEATH DIFFER; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; STEIN C, 1993, LANCET, V342, P321, DOI 10.1016/0140-6736(93)91471-W; Stein C, 1996, J CLIN INVEST, V98, P793, DOI 10.1172/JCI118852; Verkaar F, 2008, BIOTECHNOL ANN REV, V14, P253, DOI 10.1016/S1387-2656(08)00010-0; Waddell DD, 2007, DRUG AGING, V24, P629, DOI 10.2165/00002512-200724080-00002; Wilson JL, 1996, BRIT J PHARMACOL, V118, P1754, DOI 10.1111/j.1476-5381.1996.tb15601.x; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293	53	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55510	10.1371/journal.pone.0055510	http://dx.doi.org/10.1371/journal.pone.0055510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383210	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500077
J	Maasoumy, B; Port, K; Markova, AA; Serrano, BC; Rogalska-Taranta, M; Sollik, L; Mix, C; Kirschner, J; Manns, MP; Wedemeyer, H; Cornberg, M				Maasoumy, Benjamin; Port, Kerstin; Markova, Antoaneta Angelova; Serrano, Beatriz Calle; Rogalska-Taranta, Magdalena; Sollik, Lisa; Mix, Carola; Kirschner, Janina; Manns, Michael P.; Wedemeyer, Heiner; Cornberg, Markus			Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting	PLOS ONE			English	Article							BOCEPREVIR; TELAPREVIR; EPIDEMIOLOGY; COMBINATION; MANAGEMENT; RIBAVIRIN	Background: HCV protease inhibitors (PIs) boceprevir and telaprevir in combination with PEG-Interferon alfa and Ribavirin (P/R) is the new standard of care in the treatment of chronic HCV genotype 1 (GT1) infection. However, not every HCV GT1 infected patient is eligible for P/R/PI therapy. Furthermore phase III studies did not necessarily reflect real world as patients with advanced liver disease or comorbidities were underrepresented. The aim of our study was to analyze the eligibility and safety of P/R/PI treatment in a real world setting of a tertiary referral center. Methods: All consecutive HCV GT1 infected patients who were referred to our hepatitis treatment unit between June and November 2011 were included. Patients were evaluated for P/R/PI according to their individual risk/benefit ratio based on 4 factors: Treatment-associated safety concerns, chance for SVR, treatment urgency and nonmedical patient related reasons. On treatment data were analyzed until week 12. Results: 208 patients were included (F3/F4 64%, mean platelet count 169/nl, 40% treatment-naive). Treatment was not initiated in 103 patients most frequently due to safety concerns. 19 patients were treated in phase II/III trials or by local centers and a triple therapy concept was initiated at our unit in 86 patients. Hospitalization was required in 16 patients; one patient died due to a gastrointestinal infection possibly related to treatment. A platelet count of <110/nl was associated with hospitalization as well as treatment failure. Overall, 128 patients were either not eligible for therapy or experienced a treatment failure at week 12. Conclusions: P/R/PI therapies are complex, time-consuming and sometimes dangerous in a real world setting, especially in patients with advanced liver disease. A careful patient selection plays a crucial role to improve safety of PI based therapies. A significant number of patients are not eligible for P/R/PI, emphasizing the need for alternative therapeutic options.	[Maasoumy, Benjamin; Port, Kerstin; Markova, Antoaneta Angelova; Serrano, Beatriz Calle; Rogalska-Taranta, Magdalena; Sollik, Lisa; Mix, Carola; Kirschner, Janina; Manns, Michael P.; Wedemeyer, Heiner; Cornberg, Markus] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Hannover Medical School	Cornberg, M (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Cornberg.Markus@mh-hannover.de	Rogalska-Taranta, Magdalena/W-5799-2019; Cornberg, Markus/AAN-6939-2021	Rogalska-Taranta, Magdalena/0000-0003-3539-3679; Cornberg, Markus/0000-0002-9141-8001; Maasoumy, Benjamin/0000-0002-3250-3177	Integrated Research and Treatment Center Transplantation (IFB-Tx); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung; BMBF); Merck; Janssen-Cilag; Roche	Integrated Research and Treatment Center Transplantation (IFB-Tx); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung; BMBF)(Federal Ministry of Education & Research (BMBF)); Merck(Merck & Company); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding)	BM was supported by the Integrated Research and Treatment Center Transplantation (IFB-Tx) funded by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung; BMBF). Publication costs were covered by the DFG (Deutsche Forschungsgemeinschaft)-Project "Open Access Publizieren". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and declare the following conflicts concerning Peg-Interferon alpha-2a (Roche), Peg-Interferon alpha-2b (Merck), Ribavirin (Roche, Merck), Boceprevir (Merck), Telaprevir (Janssen-Cilag): BM received travel grants from Merck and Janssen-Cilag, KP received lecture fees from Roche and Janssen-Cilag, AM declares no conflict, BCS received lecture fees from Merck, MRT declares no conflict, LS declares no conflict, JK declares no conflict, CM declares no conflict, MPM received grants, lectural fees and/or consult fees from Roche, Merck and Janssen-Cilag, HW received grants, lectural fees and/or consult fees from Roche, Merck and Janssen-Cilag. HW is also Academic Editor of PLOS ONE. MC received grants, lectural fees and/or consult fees from Roche, Merck and Janssen-Cilag. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Davis GL, 1998, NEW ENGL J MED, V339, P1493, DOI 10.1056/NEJM199811193392102; de Ledinghen V, 2008, GASTROEN CLIN BIOL, V32, P58, DOI 10.1016/S0399-8320(08)73994-0; Deuffic-Burban S, 2012, GASTROENTEROLOGY, V143, P974, DOI 10.1053/j.gastro.2012.05.054; Dusheiko G, 2012, GUT; Foster GR, 2011, J HEPATOL, V54, pS3, DOI 10.1016/S0168-8278(11)60008-1; Hezode C, 2012, J HEPATOL, V56, pS4, DOI 10.1016/S0168-8278(12)60022-1; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Poordad F, 2012, GASTROENTEROLOGY; Poordad FF, 2012, J HEPATOL, V56, pS559, DOI 10.1016/S0168-8278(12)61430-5; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	21	87	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55285	10.1371/journal.pone.0055285	http://dx.doi.org/10.1371/journal.pone.0055285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383319	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900026
J	Baudoin, JP; Jerome, WG; Kubel, C; de Jonge, N				Baudoin, Jean-Pierre; Jerome, W. Gray; Kuebel, Christian; de Jonge, Niels			Whole-Cell Analysis of Low-Density Lipoprotein Uptake by Macrophages Using STEM Tomography	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; NANOPARTICLE UPTAKE; OXIDIZED LDL; CHOLESTEROL; LYSOSOMES; FLUORESCENCE; PROTEINS; FUSION	Nanoparticles of heavy materials such as gold can be used as markers in quantitative electron microscopic studies of protein distributions in cells with nanometer spatial resolution. Studying nanoparticles within the context of cells is also relevant for nanotoxicological research. Here, we report a method to quantify the locations and the number of nanoparticles, and of clusters of nanoparticles inside whole eukaryotic cells in three dimensions using scanning transmission electron microscopy (STEM) tomography. Whole-mount fixed cellular samples were prepared, avoiding sectioning or slicing. The level of membrane staining was kept much lower than is common practice in transmission electron microscopy (TEM),such that the nanoparticles could be detected throughout the entire cellular thickness. Tilt-series were recorded with a limited tilt-range of 80 degrees thereby preventing excessive beam broadening occurring at higher tilt angles. The 3D locations of the nanoparticles were nevertheless determined with high precision using computation. The obtained information differed from that obtained with conventional TEM tomography data since the nanoparticles were highlighted while only faint contrast was obtained on the cellular material. Similar as in fluorescence microscopy, a particular set of labels can be studied. This method was applied to study the fate of sequentially up-taken low-density lipoprotein (LDL) conjugated to gold nanoparticles in macrophages. Analysis of a 3D reconstruction revealed that newly up-taken LDL-gold was delivered to lysosomes containing previously up-taken LDL-gold thereby forming onion-like clusters.	[Baudoin, Jean-Pierre; de Jonge, Niels] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Jerome, W. Gray] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Kuebel, Christian] Karlsruhe Inst Technol, Inst Nanotechnol INT, Eggenstein Leopoldshaffe, Germany; [Kuebel, Christian] Karlsruhe Inst Technol, KNMF, Eggenstein Leopoldshaffe, Germany; [de Jonge, Niels] INM Leibniz Inst New Mat, Saarbrucken, Germany	Vanderbilt University; Vanderbilt University; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Leibniz Institut fur Neue Materialien (INM)	de Jonge, N (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	niels.dejonge@inm-gmbh.de	Kübel, Christian/A-1720-2009; de Jonge, Niels/B-5677-2008	Kübel, Christian/0000-0001-5701-4006; de Jonge, Niels/0000-0002-3969-6821; BAUDOIN, Jean-Pierre/0000-0001-7361-5653	Office of Basic Energy Sciences, U.S. Department of Energy; Karlsruhe Nano Micro Facility, a Helmholtz research infrastructure at the Karlsruhe Institute of Technology; Vanderbilt Cell Imaging Shared Resource; National Institutes of Health [R01-GM081801]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081801] Funding Source: NIH RePORTER	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Karlsruhe Nano Micro Facility, a Helmholtz research infrastructure at the Karlsruhe Institute of Technology; Vanderbilt Cell Imaging Shared Resource; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Microscopy at the SHaRE user facility at Oak Ridge National Laboratory, sponsored by the Office of Basic Energy Sciences, U.S. Department of Energy, and at the Karlsruhe Nano Micro Facility, a Helmholtz research infrastructure at the Karlsruhe Institute of Technology, and at the Vanderbilt Cell Imaging Shared Resource. Research supported by National Institutes of Health grant R01-GM081801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2008, ULTRAMICROSCOPY, V109, P70, DOI 10.1016/j.ultramic.2008.08.005; Bright NA, 1997, J CELL SCI, V110, P2027; Bushby AJ, 2011, NAT PROTOC, V6, P845, DOI 10.1038/nprot.2011.332; Chithrani DB, 2010, NANOMED-NANOTECHNOL, V6, P161, DOI 10.1016/j.nano.2009.04.009; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; de Jonge N, 2010, ULTRAMICROSCOPY, V110, P1114, DOI 10.1016/j.ultramic.2010.04.001; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Dukes MJ, 2011, J STRUCT BIOL, V174, P552, DOI 10.1016/j.jsb.2011.03.013; Elsaesser A, 2010, NANOMEDICINE-UK, V5, P1447, DOI [10.2217/nnm.10.118, 10.2217/NNM.10.118]; Free P, 2009, CHEM COMMUN, P5009, DOI 10.1039/b910657j; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; GUSNARD D, 1977, J MICROSC-OXFORD, V110, P51, DOI 10.1111/j.1365-2818.1977.tb00012.x; Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Hohn K, 2011, HISTOCHEM CELL BIOL, V135, P1, DOI 10.1007/s00418-010-0765-z; Hoenger A, 2009, CURR OPIN CELL BIOL, V21, P89, DOI 10.1016/j.ceb.2008.12.003; Hohmann-Marriott MF, 2009, NAT METHODS, V6, P729, DOI [10.1038/NMETH.1367, 10.1038/nmeth.1367]; Jerome WG, 2008, MICROSC MICROANAL, V14, P138, DOI 10.1017/S1431927608080069; Jerome WG, 2010, CLIN LIPIDOL, V5, P853, DOI 10.2217/CLP.10.70; Jerome WG, 2003, MICROSC MICROANAL, V9, P54, DOI 10.1017/S1431927603030010; Klein R M, 1992, Biotechnology, V24, P384; KLINKNER AM, 1995, J HISTOCHEM CYTOCHEM, V43, P1071, DOI 10.1177/43.10.7560885; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leis A, 2009, TRENDS BIOCHEM SCI, V34, P60, DOI 10.1016/j.tibs.2008.10.011; Levy R, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.4889; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lippincott-Schwartz J, 2009, NAT METHODS, V6, P21, DOI [10.1038/NMETH.F.233, 10.1038/nmeth.f.233]; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2000, J CELL SCI, V113, P1515; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Noske AB, 2008, J STRUCT BIOL, V161, P298, DOI 10.1016/j.jsb.2007.09.015; Peckys DB, 2011, NANO LETT, V11, P1733, DOI 10.1021/nl200285r; Pierson J, 2009, HISTOCHEM CELL BIOL, V132, P253, DOI 10.1007/s00418-009-0622-0; Radermacher M., 1980, P 7 EUR C EL MICR, P132; Ring EA, 2011, J MICROSC-OXFORD, V243, P273, DOI 10.1111/j.1365-2818.2011.03501.x; Risco C, 2012, STRUCTURE, V20, P759, DOI 10.1016/j.str.2012.04.001; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Soman NR, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/18/185102; Sousa AA, 2007, J STRUCT BIOL, V159, P507, DOI 10.1016/j.jsb.2007.06.006; Tantra R, 2011, NANOTOXICOLOGY, V5, P381, DOI 10.3109/17435390.2010.512987; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; Walling MA, 2009, INT J MOL SCI, V10, P441, DOI 10.3390/ijms10020441; Yakushevska AE, 2007, J STRUCT BIOL, V159, P381, DOI 10.1016/j.jsb.2007.04.006; Yancey PG, 2002, MICROSC MICROANAL, V8, P81, DOI 10.1017/S1431927601020013; Zhang Y, 2008, BIOESSAYS, V30, P606, DOI 10.1002/bies.20759	53	13	13	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55022	10.1371/journal.pone.0055022	http://dx.doi.org/10.1371/journal.pone.0055022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383042	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600057
J	Biino, G; Santimone, I; Minelli, C; Sorice, R; Frongia, B; Traglia, M; Ulivi, S; Di Castelnuovo, A; Gogele, M; Nutile, T; Francavilla, M; Sala, C; Pirastu, N; Cerletti, C; Iacoviello, L; Gasparini, P; Toniolo, D; Ciullo, M; Pramstaller, P; Pirastu, M; de Gaetano, G; Balduini, CL				Biino, Ginevra; Santimone, Iolanda; Minelli, Cosetta; Sorice, Rossella; Frongia, Bruno; Traglia, Michela; Ulivi, Sheila; Di Castelnuovo, Augusto; Goegele, Martin; Nutile, Teresa; Francavilla, Marcella; Sala, Cinzia; Pirastu, Nicola; Cerletti, Chiara; Iacoviello, Licia; Gasparini, Paolo; Toniolo, Daniela; Ciullo, Marina; Pramstaller, Peter; Pirastu, Mario; de Gaetano, Giovanni; Balduini, Carlo L.			Age- And Sex-Related Variations in Platelet Count in Italy: A Proposal of Reference Ranges Based on 40987 Subjects' Data	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; ISOLATED POPULATION; CELL COUNT; THROMBOCYTOPENIA; PARAMETERS; ETHNICITY; ISOLATE; TRAITS; LOCI	Background and Objectives: Although several studies demonstrated that platelet count is higher in women, decreases with age, and is influenced by genetic background, most clinical laboratories still use the reference interval 150-400 x 10(9) platelets/L for all subjects. The present study was to identify age- and sex-specific reference intervals for platelet count. Methods: We analysed electronic records of subjects enrolled in three population-based studies that investigated inhabitants of seven Italian areas including six geographic isolates. After exclusion of patients with malignancies, liver diseases, or inherited thrombocytopenias, which could affect platelet count, reference intervals were estimated from 40,987 subjects with the non parametric method computing the 2.5 degrees and 97.5 degrees percentiles. Results: Platelet count was similar in men and women until the age of 14, but subsequently women had steadily more platelets than men. The number of platelets decreases quickly in childhood, stabilizes in adulthood, and further decreases in oldness. The final result of this phenomenon is that platelet count in old age was reduced by 35% in men and by 25% in women compared with early infancy. Based on these findings, we estimated reference intervals for platelet count x 10(9)/L in children (176-452), adult men (141-362), adult women (156-405), old men (122-350) and, old women (140-379). Moreover, we calculated an "extended'' reference interval that takes into account the differences in platelet count observed in different geographic areas. Conclusions: The age-, sex-, and origin-related variability of platelet count is very wide, and the patient-adapted reference intervals we propose change the thresholds for diagnosing both thrombocytopenia and thrombocytosis in Italy.	[Biino, Ginevra] Natl Res Council Italy, Inst Mol Genet, Pavia, Italy; [Biino, Ginevra; Frongia, Bruno; Francavilla, Marcella; Pirastu, Mario] Natl Res Council Italy, Inst Populat Genet, Sassari, Italy; [Santimone, Iolanda; Di Castelnuovo, Augusto; Iacoviello, Licia] Univ Cattolica, Fdn Ric & Cura Giovanni Paolo II, Res Labs, Lab Genet & Environm Epidemiol, Campobasso, Italy; [Minelli, Cosetta; Goegele, Martin; Pramstaller, Peter] EURAC Res, Inst Med Genet, Bolzano, Italy; [Sorice, Rossella; Nutile, Teresa; Ciullo, Marina] Natl Res Council Italy, Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Traglia, Michela; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Ulivi, Sheila; Pirastu, Nicola; Gasparini, Paolo] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Pirastu, Nicola; Gasparini, Paolo] Univ Trieste, Dept Reprod Sci, Trieste, Italy; [Cerletti, Chiara] Univ Cattolica, Fdn Ric & Cura Giovanni Paolo II, Res Labs, Lab Cell Biol & Pharmacol Thrombosis, Campobasso, Italy; [Pirastu, Mario] Shardna Life Sci, Cagliari, Italy; [de Gaetano, Giovanni] Univ Cattolica, Fdn Ric & Cura Giovanni Paolo II, Res Labs, Campobasso, Italy; [Balduini, Carlo L.] Univ Pavia, IRCCS, Fdn Policlin S Matteo, Dept Internal Med, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Consiglio Nazionale delle Ricerche (CNR); Catholic University of the Sacred Heart; IRCCS Istituto Tumori Bari Giovanni Paolo II; European Academy of Bozen-Bolzano; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Burlo Garofolo; University of Trieste; Catholic University of the Sacred Heart; IRCCS Istituto Tumori Bari Giovanni Paolo II; Catholic University of the Sacred Heart; IRCCS Istituto Tumori Bari Giovanni Paolo II; IRCCS Fondazione San Matteo; University of Pavia	Biino, G (corresponding author), Natl Res Council Italy, Inst Mol Genet, Pavia, Italy.	biino@igm.cnr.it	Ulivi, Sheila/H-3700-2013; Pramstaller, Peter P/C-2357-2008; Traglia, Michela/AAX-5816-2020; Francavilla, Matteo/L-6146-2013; Cerletti, Chiara/K-6447-2016; Siani, Alfonso/B-7925-2015; Di Castelnuovo, Augusto Filippo/AAC-2436-2022; Iacoviello, Licia/AGX-7071-2022; Pirastu, Nicola/G-4358-2011; Toniolo, Daniela/AAE-2969-2019; Iacoviello, Licia/K-4676-2016; Biino, Ginevra/B-5334-2013; Sala, Cinzia Felicita/AAN-1900-2020; Pirastu, Nicola/AHB-6226-2022; Ciullo, Marina/AAE-3041-2020; Gasparini, Paolo/B-6173-2014; Balduini, Carlo L/D-9299-2015	Ulivi, Sheila/0000-0003-3606-835X; Cerletti, Chiara/0000-0002-4759-3179; Di Castelnuovo, Augusto Filippo/0000-0001-9767-7998; Iacoviello, Licia/0000-0003-0514-5885; Toniolo, Daniela/0000-0001-9545-6032; Iacoviello, Licia/0000-0003-0514-5885; Biino, Ginevra/0000-0002-9936-946X; Ciullo, Marina/0000-0002-9621-9984; Balduini, Carlo L/0000-0001-6121-9311; Pramstaller, Peter P/0000-0002-9831-8302; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Pirastu, Nicola/0000-0002-5363-3886; s, hema/0000-0002-3440-9475; Gasparini, Paolo/0000-0002-0859-0856; NUTILE, TERESA/0000-0001-7062-8352; Gogele, Martin/0000-0003-4785-4348	Italian Ministry of Education, University and Research (MIUR) [5571/DSPAR/2002]; MIUR-Programma Triennale di Ricerca [D. 1588]; Pfizer Foundation, Rome; Instrumentation laboratory; Milan (Moli-sani Project); MIUR-FIRB [RBIN064YAT]; Assessorato Ricerca Regione Campania; Fondazione Banco di Napoli (Cilento National Park); Compagnia di San Paolo, Torino; Fondazione Cariplo; Ministry of Health; Ricerca Finalizzata; Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bozen/Bolzano; South Tyrolean Sparkasse Foundation (South Tyrol); FVG Regional government; Fondo Trieste; Ministry of Health (FVG); Ministry of Health (Carlantino)	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); MIUR-Programma Triennale di Ricerca; Pfizer Foundation, Rome(Pfizer); Instrumentation laboratory; Milan (Moli-sani Project); MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Assessorato Ricerca Regione Campania(Regione Campania); Fondazione Banco di Napoli (Cilento National Park); Compagnia di San Paolo, Torino(Compagnia di San Paolo); Fondazione Cariplo(Fondazione Cariplo); Ministry of Health; Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bozen/Bolzano; South Tyrolean Sparkasse Foundation (South Tyrol); FVG Regional government; Fondo Trieste; Ministry of Health (FVG); Ministry of Health (Carlantino)	This study was supported by grants from: Italian Ministry of Education, University and Research (MIUR) no: 5571/DSPAR/2002 (Ogliastra Genetic Park); MIUR-Programma Triennale di Ricerca (D. 1588), Pfizer Foundation, Rome and, "Instrumentation laboratory'', Milan (Moli-sani Project); MIUR-FIRB (RBIN064YAT), Assessorato Ricerca Regione Campania and Fondazione Banco di Napoli to MC (Cilento National Park); Compagnia di San Paolo, Torino, Fondazione Cariplo and, Ministry of Health, Ricerca Finalizzata 2008 to DT (INGI-VB); Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bozen/Bolzano and the South Tyrolean Sparkasse Foundation (South Tyrol); FVG Regional government, Fondo Trieste and the Ministry of Health (FVG and Carlantino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi P, 2007, INT J LAB HEMATOL, V29, P195, DOI 10.1111/j.1751-553X.2006.00843.x; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Beguin Y, 1999, HAEMATOLOGICA, V84, P541; Biino G, 2012, BRIT J HAEMATOL, V157, P384, DOI 10.1111/j.1365-2141.2011.08981.x; Biino G, 2011, HAEMATOL-HEMATOL J, V96, P96, DOI 10.3324/haematol.2010.029934; Buckley MF, 2000, THROMB HAEMOSTASIS, V83, P480; Cheng Calvino Ka-Wing, 2004, Lab Hematol, V10, P42, DOI 10.1532/LH96.04010; Colonna V, 2007, HUM HERED, V64, P123, DOI 10.1159/000101964; Colonna V, 2009, EUR J HUM GENET, V17, P1635, DOI 10.1038/ejhg.2009.97; Dacie J., 1991, PRACTICAL HEMATOLOGY, V7th; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; GILES C, 1981, BRIT J HAEMATOL, V48, P31; Girotto G, 2011, J MED GENET, V48, P369, DOI 10.1136/jmg.2010.088310; GRAHAM SS, 1987, AM J CLIN PATHOL, V87, P365, DOI 10.1093/ajcp/87.3.365; Ishiguro A, 1999, BRIT J HAEMATOL, V106, P884, DOI 10.1046/j.1365-2141.1999.01641.x; Kadikoylu G, 2006, J NATL MED ASSOC, V98, P398; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Nagata Y, 2003, GENE DEV, V17, P2864, DOI 10.1101/gad.1128003; National Committee for Clinical Laboratory Standards, 1990, PROC HANDL PROC BLOO; National Committee for Clinical Laboratory Standards, 1995, C28A NCCLS; National Committee for Clinical Laboratory Standards, 1991, PROC COLL DIAGN BLOO; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Peng LM, 2004, THROMB HAEMOSTASIS, V91, P367, DOI 10.1160/TH03-05-0276; PIRRIE R, 1952, J CLIN PATHOL, V5, P10, DOI 10.1136/jcp.5.1.10; Pistis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004654; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; REED AH, 1971, CLIN CHEM, V17, P275; Sandhaus LM, 2002, AM J CLIN PATHOL, V118, P235; Santimone I, 2011, HAEMATOL-HEMATOL J, V96, P1180, DOI 10.3324/haematol.2011.043042; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Solberg HE, 2004, CLIN CHEM LAB MED, V42, P710, DOI 10.1515/CCLM.2004.121; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stasi R, 2006, PLOS MED, V3, P388, DOI 10.1371/journal.pmed.0030024; STEVENS RF, 1977, BRIT J HAEMATOL, V37, P295, DOI 10.1111/j.1365-2141.1977.tb06847.x; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Traglia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007554; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999	37	148	153	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54289	10.1371/journal.pone.0054289	http://dx.doi.org/10.1371/journal.pone.0054289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382888	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600027
J	Foster, BA; Gangavarapu, KJ; Mathew, G; Azabdaftari, G; Morrison, CD; Miller, A; Huss, WJ				Foster, Barbara A.; Gangavarapu, Kalyan J.; Mathew, Grinu; Azabdaftari, Gissou; Morrison, Carl D.; Miller, Austin; Huss, Wendy J.			Human Prostate Side Population Cells Demonstrate Stem Cell Properties in Recombination with Urogenital Sinus Mesenchyme	PLOS ONE			English	Article							IN-VIVO; MALIGNANT PROSTATE; EPITHELIAL-CELLS; GENE-EXPRESSION; BENIGN; BASAL; MICE; ADENOCARCINOMA; PHENOTYPE; EFFLUX	Stem cell enrichment provides a tool to examine prostate stem cells obtained from benign and malignant tissue. Functional assays can enrich stem cells based on common stem cell phenotypes, such as high ATP binding cassette (ABC) transporter mediated efflux of Hoechst substrates (side population assay). This functional assay is based upon mechanisms that protect cells from environmental insult thus contributing to the survival and protection of the stem cell population. We have isolated and analyzed cells digested from twelve clinical prostate specimens based on the side population assay. Prostate stem cell properties of the isolated cells were tested by serial recombination with rat urogenital mesenchyme. Recombinants with side population cells demonstrate an increase in the frequency of human ductal growth and the number of glands per recombinant when compared to recombinants with non-side population cells. Isolated cells were capable of prostatic growth for up to three generations in the recombination assay with as little as 125 sorted prostate cells. The ability to reproducibly use cells isolated by fluorescence activated cell sorting from human prostate tissue is an essential step to a better understanding of human prostate stem cell biology. ABC transporter G2 (ABCG2) was expressed in recombinants from side population cells indicating the side population cells have self-renewal properties. Epithelial cell differentiation of recombinants was determined by immunohistochemical analysis for expression of the basal, luminal, and neuroendocrine markers, p63, androgen receptor, prostate specific antigen, and chromogranin A, respectively. Thus, the ABCG2 expressing side population demonstrates multipotency and self-renewal properties indicating stem cells are within this population.	[Foster, Barbara A.; Gangavarapu, Kalyan J.; Huss, Wendy J.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Mathew, Grinu] Indiana Univ Sch Med, IUPUI, Indianapolis, IN USA; [Azabdaftari, Gissou; Morrison, Carl D.] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Miller, Austin] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Huss, Wendy J.] Roswell Pk Canc Inst, Dept Urol Oncol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Huss, WJ (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	wendy.huss@roswellpark.org			NYSTEM [CO24292]; National Institutes of Health (NIH) [R01DK091240]; NIH [R01CA095367]; NCI Cancer Center Support Grant [CA016056]; NATIONAL CANCER INSTITUTE [R01CA095367, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091240] Funding Source: NIH RePORTER	NYSTEM; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NYSTEM (CO24292) and National Institutes of Health (NIH) (R01DK091240) to WJH; NIH (R01CA095367) to BAF; the NCI Cancer Center Support Grant (CA016056) to RPCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt RI, 2003, CYTOM PART A, V54A, P89, DOI 10.1002/cyto.a.10058; Brown MD, 2007, PROSTATE, V67, P1384, DOI 10.1002/pros.20620; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Collins AT, 2001, J CELL SCI, V114, P3865; Foster BA, 2002, JACKS LAB BAR HARB M; Gangavarpu KJ, 2011, CURR PROTOC TOXICOL; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; GRIMWOOD RE, 1986, J INVEST DERMATOL, V87, P42, DOI 10.1111/1523-1747.ep12523552; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Haughney PC, 1998, BIOL REPROD, V59, P93, DOI 10.1095/biolreprod59.1.93; HAYASHI N, 1990, CANCER RES, V50, P4747; HAYASHI N, 1991, CANCER RES, V51, P4924; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Hayward SW, 2001, CANCER RES, V61, P8135; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Jiang M, 2010, STEM CELLS, V28, P344, DOI 10.1002/stem.284; Jonker JW, 2005, STEM CELLS, V23, P1059, DOI 10.1634/stemcells.2005-0150; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Mathew G, 2009, CELL CYCLE, V8, P1053, DOI 10.4161/cc.8.7.8043; Morrison C, 2009, PROSTATE, V69, P770, DOI 10.1002/pros.20925; Oates JE, 2009, STEM CELLS DEV, V18, P1515, DOI 10.1089/scd.2008.0302; Pascal Laura E, 2007, BMC Urol, V7, P6, DOI 10.1186/1471-2490-7-6; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roh M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002572; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Toivanen R, 2011, STEM CELLS, V29, P1310, DOI 10.1002/stem.668; Vander Griend DJ, 2009, PROSTATE, V69, P1557, DOI 10.1002/pros.21001; WONG YC, 1992, ACTA ANAT, V143, P139; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	37	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55062	10.1371/journal.pone.0055062	http://dx.doi.org/10.1371/journal.pone.0055062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383057	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600062
J	Shionome, Y; Yan, L; Liu, S; Saeki, T; Ouchi, T				Shionome, Yoshimi; Yan, Li; Liu, Song; Saeki, Toshiaki; Ouchi, Toru			Integrity of p53 Associated Pathways Determines Induction of Apoptosis of Tumor Cells Resistant to Aurora-A Kinase Inhibitors	PLOS ONE			English	Article							CANCER-CELLS; OVARIAN-CANCER; OVEREXPRESSION; TRANSFORMATION; ACTIVATION; CARCINOMA; DISEASE	We have previously shown that mammary tumorigenesis in MMTV-Aurora-A mice is further enhanced when p53 is inactivated, demonstrating that integrity of p53 pathway determines phenotypes induced by this oncogenic kinase. In this study, we investigated the roles of genes involved in p53 pathway (p53, Puma, p21, Bax, and Chk2) in response to Aurora-A inhibitors, VX680 and MK-8745, and explored whether chemoresistant tumor cells would further undergo apoptosis with other therapeutic agents. Isogenic HCT116 cell lines were treated with VX680 or MK-8745. Cell cycle analysis, apoptosis, and tumorigenesity were studied. Chemoresistant cells were recovered from xenograft, and further induction of apoptosis was studied. Induction of apoptosis and aneuploidy with VX680 is much stronger than MK-8745. Xenograft assay indicates that tumor growth of HCT116 and HCT116 p53(-) cells are strongly inhibited by VX680, while that of other cell types are similarly inhibited by two compounds. Among the established cell lines recovered from xenografts, MK-8745-resistant clones contain elevated phosphorylation of mTOR and Akt. When further treated with inhibitors of both mTOR and Akt, those cells undergo apoptosis. These results indicate that p53-associated pathway plays a crucial role in regulating growth inhibition of tumor cells when treated with Aurora-A inhibitors. Combined treatment with Akt/mTOR inhibitors can further induce apoptosis of Aurora-A tumors.	[Shionome, Yoshimi; Ouchi, Toru] Univ Chicago, Dept Med, Natl Univ Hlth Sci, Pritzker Sch Med, Evanston, IL 60201 USA; [Yan, Li; Liu, Song] Roswell Pk Canc Inst, Dept Biostat & Bioinformat, Buffalo, NY 14263 USA; [Saeki, Toshiaki] Saitama Int Med Ctr, Dept Breast Oncol, Saitama, Japan; [Ouchi, Toru] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of Chicago; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Ouchi, T (corresponding author), Univ Chicago, Dept Med, Natl Univ Hlth Sci, Pritzker Sch Med, Evanston, IL 60201 USA.	Toru.Ouchi@RoswellPark.org			National Institutes of Health [R01CA79892, R01CA9063]; Breast Cancer Research Grant from Susan Komen Foundation;  [5P30CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA079892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Grant from Susan Komen Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants R01CA79892 and R01CA9063 from the National Institutes of Health, and a Breast Cancer Research Grant from Susan Komen Foundation (T.O.), and 5P30CA16056 (T.O. and S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cheung CHA, 2009, EXPERT OPIN INV DRUG, V18, P379, DOI [10.1517/13543780902806392 , 10.1517/13543780902806392]; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Green MR, 2011, EXPERT OPIN DRUG DIS, V6, P291, DOI 10.1517/17460441.2011.555395; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Iqbal J, 2011, LEUKEMIA, V25, P348, DOI 10.1038/leu.2010.255; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li DH, 2003, CLIN CANCER RES, V9, P991; Meulenbeld HJ, 2012, EXPERT OPIN INV DRUG, V21, P383, DOI 10.1517/13543784.2012.652303; Nair JS, 2012, CELL CYCLE, V11, P807, DOI 10.4161/cc.11.4.19323; Pihan GA, 2001, CANCER RES, V61, P2212; Sanhaji M, 2011, ONCOTARGET, V2, P935; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Taga M, 2009, INT J BIOL SCI, V5, P444, DOI 10.7150/ijbs.5.444; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Tanaka T, 1999, CANCER RES, V59, P2041; Uitdehaag JCM, 2012, BRIT J PHARMACOL, V166, P858, DOI 10.1111/j.1476-5381.2012.01859.x; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Yan AX, 2011, DRUG DISCOV TODAY, V16, P260, DOI 10.1016/j.drudis.2010.12.003; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55457	10.1371/journal.pone.0055457	http://dx.doi.org/10.1371/journal.pone.0055457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383195	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600105
J	Srour, N; LeBlanc, C; King, J; McKim, DA				Srour, Nadim; LeBlanc, Carole; King, Judy; McKim, Douglas A.			Lung Volume Recruitment in Multiple Sclerosis	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; RESPIRATORY MUSCLE FUNCTION; PULMONARY-FUNCTION; NEUROMUSCULAR WEAKNESS; COUGH; VENTILATION; DYSFUNCTION; EXTUBATION; DISABILITY; CLEARANCE	Introduction: Pulmonary function abnormalities have been described in multiple sclerosis including reductions in forced vital capacity (FVC) and cough but the time course of this impairment is unknown. Peak cough flow (PCF) is an important parameter for patients with respiratory muscle weakness and a reduced PCF has a direct impact on airway clearance and may therefore increase the risk of respiratory tract infections. Lung volume recruitment is a technique that improves PCF by inflating the lungs to their maximal insufflation capacity. Objectives: Our goals were to describe the rate of decline of pulmonary function and PCF in patients with multiple sclerosis and describe the use of lung volume recruitment in this population. Methods: We reviewed all patients with multiple sclerosis referred to a respiratory neuromuscular rehabilitation clinic from February 1999 until December 2010. Lung volume recruitment was attempted in patients with FVC<80% predicted. Regular twice daily lung volume recruitment was prescribed if it resulted in a significant improvement in the laboratory. Results: There were 79 patients included, 35 of whom were seen more than once. A baseline FVC,80% predicted was present in 82% of patients and 80% of patients had a PCF insufficient for airway clearance. There was a significant decline in FVC (122.6 mL/y, 95% CI 54.9-190.3) and PCF (192 mL/s/y, 95% 72-311) over a median follow-up time of 13.4 months. Lung volume recruitment was associated with a slower decline in FVC (p<0.0001) and PCF (p=0.042). Conclusion: Pulmonary function and cough decline significantly over time in selected patients with multiple sclerosis and lung volume recruitment is associated with a slower rate of decline in lung function and peak cough flow. Given design limitations, additional studies are needed to assess the role of lung volume recruitment in patients with multiple sclerosis.	[Srour, Nadim; McKim, Douglas A.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [McKim, Douglas A.] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [King, Judy; McKim, Douglas A.] Univ Ottawa, Ottawa, ON, Canada; [LeBlanc, Carole; McKim, Douglas A.] Ottawa Hosp Rehabil Ctr, CANVent Program Canadian Alternat Noninvas Ventil, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Srour, N (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	nsrour@ohri.ca	King, Judy/L-1070-2018	King, Judy/0000-0003-4530-9987				Aiello M, 2008, RESPIRATION, V76, P311, DOI 10.1159/000119641; Altintas A, 2007, CLIN NEUROL NEUROSUR, V109, P242, DOI 10.1016/j.clineuro.2006.09.004; Bach JR, 2007, AM J PHYS MED REHAB, V86, P295, DOI 10.1097/PHM.0b013e318038d1ce; Bach JR, 2010, CHEST, V137, P1033, DOI 10.1378/chest.09-2144; Bach JR, 1997, CHEST, V112, P1024, DOI 10.1378/chest.112.4.1024; Bach JR, 2000, CHEST, V117, P301, DOI 10.1378/chest.117.2.301; Bach JR, 1996, CHEST, V110, P1566, DOI 10.1378/chest.110.6.1566; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; Buyse B, 1997, EUR RESPIR J, V10, P139, DOI 10.1183/09031936.97.10010139; Chiara T, 2006, ARCH PHYS MED REHAB, V87, P468, DOI 10.1016/j.apmr.2005.12.035; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; Finder JD, 2004, AM J RESP CRIT CARE, V170, P456, DOI 10.1164/rccm.200307-885ST; FOGLIO K, 1994, EUR RESPIR J, V7, P23, DOI 10.1183/09031936.94.07010023; Fry Donna K, 2007, J Neurol Phys Ther, V31, P162, DOI 10.1097/NPT.0b013e31815ce136; Gauld LM, 2009, DEV MED CHILD NEUROL, V51, P350, DOI 10.1111/j.1469-8749.2008.03260.x; Gosselink R, 1999, EUR RESPIR J, V13, P449, DOI 10.1183/09031936.99.13244999; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Kang SW, 2000, CHEST, V118, P61, DOI 10.1378/chest.118.1.61; KING M, 1985, J APPL PHYSIOL, V58, P1776, DOI 10.1152/jappl.1985.58.6.1776; McKim DA, 2012, ARCH PHYS MED REHABI; McKim DA, 2011, CAN RESPIR J, V18, P197, DOI 10.1155/2011/139769; Misuri G, 2000, CHEST, V117, P447, DOI 10.1378/chest.117.2.447; Mutluay FK, 2005, CLIN REHABIL, V19, P426, DOI 10.1191/0269215505cr782oa; Sancho J, 2007, AM J RESP CRIT CARE, V175, P1266, DOI 10.1164/rccm.200612-1841OC; SMELTZER SC, 1992, CHEST, V101, P479, DOI 10.1378/chest.101.2.479; SMELTZER SC, 1988, ARCH NEUROL-CHICAGO, V45, P1245, DOI 10.1001/archneur.1988.00520350083020	26	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e56676	10.1371/journal.pone.0056676	http://dx.doi.org/10.1371/journal.pone.0056676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383293	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600168
J	Cazares-Garcia, SV; Vazquez-Garciduenas, MS; Vazquez-Marrufo, G				Viridiana Cazares-Garcia, Saila; Soledad Vazquez-Garciduenas, Ma.; Vazquez-Marrufo, Gerardo			Structural and Phylogenetic Analysis of Laccases from Trichoderma: A Bioinformatic Approach	PLOS ONE			English	Article							MELANOCARPUS-ALBOMYCES LACCASE; MULTICOPPER OXIDASE GENES; CHESTNUT BLIGHT FUNGUS; MOLECULAR ANALYSIS; CRYSTAL-STRUCTURE; COPRINOPSIS-CINEREA; MULTIGENE FAMILY; EXPRESSION; COPPER; IDENTIFICATION	The genus Trichoderma includes species of great biotechnological value, both for their mycoparasitic activities and for their ability to produce extracellular hydrolytic enzymes. Although activity of extracellular laccase has previously been reported in Trichoderma spp., the possible number of isoenzymes is still unknown, as are the structural and functional characteristics of both the genes and the putative proteins. In this study, the system of laccases sensu stricto in the Trichoderma species, the genomes of which are publicly available, were analyzed using bioinformatic tools. The intron/exon structure of the genes and the identification of specific motifs in the sequence of amino acids of the proteins generated in silico allow for clear differentiation between extracellular and intracellular enzymes. Phylogenetic analysis suggests that the common ancestor of the genus possessed a functional gene for each one of these enzymes, which is a characteristic preserved in T. atroviride and T. virens. This analysis also reveals that T. harzianum and T. reesei only retained the intracellular activity, whereas T. asperellum added an extracellular isoenzyme acquired through horizontal gene transfer during the mycoparasitic process. The evolutionary analysis shows that in general, extracellular laccases are subjected to purifying selection, and intracellular laccases show neutral evolution. The data provided by the present study will enable the generation of experimental approximations to better understand the physiological role of laccases in the genus Trichoderma and to increase their biotechnological potential.	[Viridiana Cazares-Garcia, Saila; Vazquez-Marrufo, Gerardo] Univ Michoacana, Ctr Multidisciplinario Estudios Biotecnol, Fac Med Vet & Zootecnia, Morelia, Michoacan, Mexico; [Soledad Vazquez-Garciduenas, Ma.] Univ Michoacana, Div Estudios Posgrad, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo	Vazquez-Marrufo, G (corresponding author), Univ Michoacana, Ctr Multidisciplinario Estudios Biotecnol, Fac Med Vet & Zootecnia, Morelia, Michoacan, Mexico.	gvazquezmarrufo@yahoo.com.mx	Marrufo, Gerardo Vázquez-/AEN-6859-2022; Marrufo, Gerardo Vázquez-/ENE-8739-2022	Marrufo, Gerardo Vázquez-/0000-0003-4683-699X; Marrufo, Gerardo Vázquez-/0000-0003-4683-699X	Coordinacion de la Investigacion Cientifica-Universidad Michoacana de San Nicolas de Hidalgo (CIC-UMSNH), Research Support Program; CONACYT-Mexico	Coordinacion de la Investigacion Cientifica-Universidad Michoacana de San Nicolas de Hidalgo (CIC-UMSNH), Research Support Program; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors are grateful for the support of the Coordinacion de la Investigacion Cientifica-Universidad Michoacana de San Nicolas de Hidalgo (CIC-UMSNH), Research Support Program 2012. SVCG acknowledges a scholarship from CONACYT-Mexico for doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andberg M, 2009, FEBS J, V276, P6285, DOI 10.1111/j.1742-4658.2009.07336.x; ASSAVANIG A, 1992, APPL MICROBIOL BIOT, V38, P198, DOI 10.1007/BF00174468; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Ben-Menachem R, 2011, PROTEOMICS, V11, P4468, DOI 10.1002/pmic.201100199; Brandhorst T, 2000, J BIOL CHEM, V275, P7925, DOI 10.1074/jbc.275.11.7925; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; Byun-McKay SA, 2007, TRENDS ECOL EVOL, V22, P338, DOI 10.1016/j.tree.2007.05.002; Canero DC, 2008, PHYTOPATHOLOGY, V98, P509, DOI 10.1094/PHYTO-98-5-0509; Catalano V, 2011, CURR GENET, V57, P13, DOI 10.1007/s00294-010-0322-2; Chakroun H, 2010, PROCESS BIOCHEM, V45, P507, DOI 10.1016/j.procbio.2009.11.009; CHOI GH, 1992, MOL PLANT MICROBE IN, V5, P119, DOI 10.1094/MPMI-5-119; Chung HJ, 2008, MOL PLANT MICROBE IN, V21, P1582, DOI 10.1094/MPMI-21-12-1582; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Courty PE, 2009, NEW PHYTOL, V182, P736, DOI 10.1111/j.1469-8137.2009.02774.x; Eggert C, 1998, APPL ENVIRON MICROB, V64, P1766; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FernandezLarrea J, 1996, MOL GEN GENET, V252, P539, DOI 10.1007/s004380050261; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; Ge HH, 2010, ACTA CRYSTALLOGR F, V66, P254, DOI 10.1107/S1744309110000084; GERMANN UA, 1988, J BIOL CHEM, V263, P885; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gochev V. K., 2007, Bulgarian Journal of Agricultural Science, V13, P171; Hakulinen N, 2008, J STRUCT BIOL, V162, P29, DOI 10.1016/j.jsb.2007.12.003; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Hoegger PJ, 2004, CURR GENET, V45, P9, DOI 10.1007/s00294-003-0452-x; Holker U, 2002, FOLIA MICROBIOL, V47, P423, DOI 10.1007/BF02818702; Hoshida H, 2001, J BIOSCI BIOENG, V92, P372, DOI 10.1263/jbb.92.372; Kallio JP, 2009, J MOL BIOL, V392, P895, DOI 10.1016/j.jmb.2009.06.053; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Krastanov A. I., 2007, Bulgarian Journal of Agricultural Science, V13, P349; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Lettera V, 2010, FUNGAL BIOL-UK, V114, P724, DOI 10.1016/j.funbio.2010.06.004; Levasseur A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-32; Li H, 2004, J AM CHEM SOC, V126, P8010, DOI 10.1021/ja049345y; Litvintseva AP, 2002, APPL ENVIRON MICROB, V68, P1305, DOI 10.1128/AEM.68.3.1305-1311.2002; Martin C, 2007, APPL MICROBIOL BIOT, V77, P613, DOI 10.1007/s00253-007-1207-2; Martin F, 1999, FUNGAL GENET BIOL, V27, P161, DOI 10.1006/fgbi.1999.1138; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Mate D, 2011, CURR GENOMICS, V12, P113, DOI 10.2174/138920211795564322; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oda K, 2006, APPL ENVIRON MICROB, V72, P3448, DOI 10.1128/AEM.72.5.3448-3457.2006; Pardo I, 2012, BIOTECHNOL BIOENG, V109, P2978, DOI 10.1002/bit.24588; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Poggeler S, 2011, CURR GENOMICS, V12, P95, DOI 10.2174/138920211795564368; Pokorny R, 2005, J BASIC MICROB, V45, P219, DOI 10.1002/jobm.200410354; Quintanar L, 2007, ACCOUNTS CHEM RES, V40, P445, DOI 10.1021/ar600051a; Ramos JAT, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-78; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Sadhasivam S, 2009, WORLD J MICROB BIOT, V25, P1733, DOI 10.1007/s11274-009-0069-4; Schouten A, 2002, MOL MICROBIOL, V43, P883, DOI 10.1046/j.1365-2958.2002.02801.x; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shraddha, 2011, Enzyme Res, V2011, P217861, DOI 10.4061/2011/217861; Soragni E, 2001, EMBO J, V20, P5079, DOI 10.1093/emboj/20.18.5079; Sprockett DD, 2011, GENE, V479, P29, DOI 10.1016/j.gene.2011.02.009; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Tetsch L, 2006, ANTON LEEUW INT J G, V90, P183, DOI 10.1007/s10482-006-9064-z; Vanhee C, 2011, J EXP BOT, V62, P497, DOI 10.1093/jxb/erq283; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	68	31	36	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55295	10.1371/journal.pone.0055295	http://dx.doi.org/10.1371/journal.pone.0055295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383142	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600084
J	Vital, C; Martins, EP				Vital, Cuauhcihuatl; Martins, Emilia P.			Socially-Central Zebrafish Influence Group Behavior More than Those on the Social Periphery	PLOS ONE			English	Article							BROWN-HEADED COWBIRDS; DANIO-RERIO; INFORMATION; EVOLUTION; CONSTRUCTION; RECOGNITION; ATTENTION; RESPONSES; NETWORKS; PREDATOR	Certain individuals are more effective than others at using individual experience to impact group behavior. Here, we tested whether pre-training of zebrafish that are at the focal central of social group dynamics ("Key" fish) has a stronger positive impact on group performance than does pre-training of less central ("Non-Key") fish. We used very short observation periods and social network statistics to identify Key and Non-Key individuals, trained these fish to respond to an aversive stimulus, and then measured group performance after returning these now-experienced fish to a social setting. Although Key and Non-Key fish evaded the stimulus equally quickly as individuals, groups with experienced Key fish escaped the aversive stimulus more quickly than did groups with experienced Non-Key fish. The impact depended on genetic background: PN zebrafish on the social extremes (more often males) influenced the group's baseline response to the aversive stimulus, whereas experienced Scientific Hatcheries' zebrafish (both males and females) influenced the change in response over repeated trials. These results suggest that social roles are an important feature of information transfer across a group, and set the stage for future research into the genetic and evolutionary basis of social learning.	[Vital, Cuauhcihuatl] Univ Autonoma Ciudad Juarez, Dept Vet Sci & Anim Husb, Ciudad Juarez, Chihuahua, Mexico; [Martins, Emilia P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Martins, Emilia P.] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN USA	Universidad Autonoma de Ciudad Juarez; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Vital, C (corresponding author), Univ Autonoma Ciudad Juarez, Dept Vet Sci & Anim Husb, Ciudad Juarez, Chihuahua, Mexico.	cuauvital@gmail.com	Vital, Cuau/AAQ-8145-2020	Vital Garcia, Cuauhcihuatl/0000-0002-3634-2964; Martins, Emilia/0000-0002-8952-3240	National Science Foundation award [IOB-0543491]	National Science Foundation award(National Science Foundation (NSF))	This research was supported in part by a National Science Foundation award to EPM (IOB-0543491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barcellos LJG, 2010, J FISH BIOL, V76, P1032, DOI 10.1111/j.1095-8649.2010.02542.x; Barzilai-Nahon K, 2008, J AM SOC INF SCI TEC, V59, P1493, DOI 10.1002/asi.20857; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; Bode NWF, 2011, ANIM BEHAV, V82, P29, DOI 10.1016/j.anbehav.2011.04.011; BOYD R, 1995, ETHOL SOCIOBIOL, V16, P125, DOI 10.1016/0162-3095(94)00073-G; Brown C, 2011, SOCIAL LEARNING FISH, P240; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Croft DP, 2003, FISH FISH, V4, P138, DOI 10.1046/j.1467-2979.2003.00113.x; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Fichtel C, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P37, DOI 10.1007/978-3-642-15355-6_3; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Forsman JT, 2011, ANIM BEHAV, V81, P879, DOI 10.1016/j.anbehav.2011.01.029; Gerlai Robert, 2012, Curr Top Behav Neurosci, V12, P3, DOI 10.1007/7854_2011_180; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Horner V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010625; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Katz M, 2003, ANIMAL COGNITION, V6, P5; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Kiflawi M, 2006, ENVIRON BIOL FISH, V76, P19, DOI 10.1007/s10641-006-9003-x; King AJ, 2009, COMMUNICATIVE INTEGR, V2, P3; King AP, 2003, ANIM BEHAV, V66, P817, DOI 10.1006/anbe.2003.2280; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; Laland KN, 2004, LEARN BEHAV, V32, P4; Lindeyer CM, 2010, ANIM BEHAV, V79, P827, DOI 10.1016/j.anbehav.2009.12.024; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Manassa RP, 2012, ANIM COGN, V15, P559, DOI 10.1007/s10071-012-0484-z; McClure MM, 2006, J FISH BIOL, V69, P553, DOI 10.1111/j.1095-8649.2006.01125.x; Miller JL, 2008, ANIM BEHAV, V76, P931, DOI 10.1016/j.anbehav.2008.05.011; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Moretz JA, 2007, BEHAV ECOL, V18, P556, DOI 10.1093/beheco/arm011; Morrell LJ, 2008, ANIM BEHAV, V76, P855, DOI 10.1016/j.anbehav.2008.02.015; Oswald M, 2008, CAN J ZOOL, V86, P1085, DOI 10.1139/Z08-085; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Reader SM, 2000, ANIM BEHAV, V60, P175, DOI 10.1006/anbe.2000.1450; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Saltz JB, 2011, AM NAT, V177, P645, DOI 10.1086/659631; [SAS Institute S], 2009, SAS WIND; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Scheid C, 2007, J COMP PSYCHOL, V121, P380, DOI 10.1037/0735-7036.121.4.380; Schwab C, 2008, ANIM BEHAV, V75, P501, DOI 10.1016/j.anbehav.2007.06.006; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Stewart A, 2012, NEUROPHARMACOLOGY, V62, P135, DOI 10.1016/j.neuropharm.2011.07.037; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; Vital C, 2011, J COMP PSYCHOL, V125, P278, DOI 10.1037/a0023906; Vital C, 2009, ETHOLOGY, V115, P347, DOI 10.1111/j.1439-0310.2009.01613.x; Voelkl B, 2008, J THEOR BIOL, V252, P77, DOI 10.1016/j.jtbi.2008.02.002; Wolf JBW, 2011, AM NAT, V177, P135, DOI 10.1086/657442	56	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55503	10.1371/journal.pone.0055503	http://dx.doi.org/10.1371/journal.pone.0055503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383208	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600114
J	Hendrix, CW; Chen, BA; Guddera, V; Hoesley, C; Justman, J; Nakabiito, C; Salata, R; Soto-Torres, L; Patterson, K; Minnis, AM; Gandham, S; Gomez, K; Richardson, BA; Bumpus, NN				Hendrix, Craig W.; Chen, Beatrice A.; Guddera, Vijayanand; Hoesley, Craig; Justman, Jessica; Nakabiito, Clemensia; Salata, Robert; Soto-Torres, Lydia; Patterson, Karen; Minnis, Alexandra M.; Gandham, Sharavi; Gomez, Kailazarid; Richardson, Barbra A.; Bumpus, Namandje N.			MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS ACTIVITY; DISOPROXIL FUMARATE; DILUTION ASSESSMENT; NUCLEOSIDE; PREEXPOSURE; DIPHOSPHATE; METABOLISM; ACTIVATION; LAMIVUDINE; CELLS	Background: Oral and vaginal preparations of tenofovir as pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection have demonstrated variable efficacy in men and women prompting assessment of variation in drug concentration as an explanation. Knowledge of tenofovir concentration and its active form, tenofovir diphosphate, at the putative vaginal and rectal site of action and its relationship to concentrations at multiple other anatomic locations may provide key information for both interpreting PrEP study outcomes and planning future PrEP drug development. Objective: MTN-001 was designed to directly compare oral to vaginal steady-state tenofovir pharmacokinetics in blood, vaginal tissue, and vaginal and rectal fluid in a paired cross-over design. Methods and Findings: We enrolled 144 HIV-uninfected women at 4 US and 3 African clinical research sites in an open label, 3-period crossover study of three different daily tenofovir regimens, each for 6 weeks (oral 300 mg tenofovir disoproxil fumarate, vaginal 1% tenofovir gel [40 mg], or both). Serum concentrations after vaginal dosing were 56-fold lower than after oral dosing (p < 0.001). Vaginal tissue tenofovir diphosphate was quantifiable in >= 90% of women with vaginal dosing and only 19% of women with oral dosing. Vaginal tissue tenofovir diphosphate was >= 130-fold higher with vaginal compared to oral dosing (p < 0.001). Rectal fluid tenofovir concentrations in vaginal dosing periods were higher than concentrations measured in the oral only dosing period (p < 0.03). Conclusions: Compared to oral dosing, vaginal dosing achieved much lower serum concentrations and much higher vaginal tissue concentrations. Even allowing for 100-fold concentration differences due to poor adherence or less frequent prescribed dosing, vaginal dosing of tenofovir should provide higher active site concentrations and theoretically greater PrEP efficacy than oral dosing; randomized topical dosing PrEP trials to the contrary indicates that factors beyond tenofovir's antiviral effect substantially influence PrEP efficacy.	[Hendrix, Craig W.; Bumpus, Namandje N.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Chen, Beatrice A.] Univ Pittsburgh, Ctr Family Planning Res, Pittsburgh, PA USA; [Chen, Beatrice A.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA USA; [Guddera, Vijayanand] South African Med Res Council, Durban, South Africa; [Hoesley, Craig] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Justman, Jessica] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Nakabiito, Clemensia] MU JHU Res Collaborat, Kampala, Uganda; [Salata, Robert] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Soto-Torres, Lydia] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Patterson, Karen; Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Minnis, Alexandra M.] RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA; [Minnis, Alexandra M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Gandham, Sharavi] SCHARP, Seattle, WA USA; [Gomez, Kailazarid] FHI 360, Res Triangle Pk, NC USA	Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; South African Medical Research Council; University of Alabama System; University of Alabama Birmingham; Columbia University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Research Triangle Institute; University of California System; University of California Berkeley; Fred Hutchinson Cancer Center; FHI 360	Hendrix, CW (corresponding author), Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA.	chendrix@jhmi.edu	Justman, Jessica/AAA-3572-2020; Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Minnis, Alexandra/0000-0002-2943-2005	Microbicide Trials Network (MTN); National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development a component of the U.S. National Institutes of Health; National Institute of Mental Health, a component of the U.S. National Institutes of Health [5UM1AI068633]; NIH [UM1AI068615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068633, UM1AI068615] Funding Source: NIH RePORTER	Microbicide Trials Network (MTN); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development a component of the U.S. National Institutes of Health; National Institute of Mental Health, a component of the U.S. National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Microbicide Trials Network (MTN) grant, an HIV/AIDS clinical trials network funded by the National Institute of Allergy and Infectious Diseases with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (5UM1AI068633). This cooperative agreement involved the active collaboration of the sponsor, NIH, with the grant recipients within the MTN. SCHARP received funding under a separate NIH cooperative grant (UM1AI068615). NIH and the Statistical Center for HIV/AIDS Research & Prevention (SCHARP) employees are authors on this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; [Anonymous], 18 C RETR OPP INF FE; Baeten JM, 2012, NEW ENGL J MED; Balzarini J, 2002, AIDS, V16, P2159, DOI 10.1097/00002030-200211080-00008; Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Donnell D, 2012, MICROBICIDES SYNDNEY, P2012; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; GAO WY, 1994, J BIOL CHEM, V269, P12633; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; King T, 2006, J CHROMATOGR B, V843, P147, DOI 10.1016/j.jchromb.2006.05.043; Louissaint N, 2011, KEYST S PROT HIV TAR; Microbicide Trials Network (MTN), 2011, MTN STAT DEC DISC US; Minnis AM, 2012, AIDS BEHAV IN PRESS; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; Mohamed AS, 1997, CLIN DIAGN LAB IMMUN, V4, P624, DOI 10.1128/CDLI.4.5.624-626.1997; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Nuttall J, 2012, ANTIMICROB AGENTS CH, V56, P103, DOI 10.1128/AAC.00597-11; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Pruvost A, 2009, ANTIMICROB AGENTS CH, V53, P1937, DOI 10.1128/AAC.01064-08; REAGAN JW, 1957, LAB INVEST, V6, P241; REAGAN JW, 1961, ACTA CYTOL, V5, P17; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; Robbins BL, 2003, PHARMACOTHERAPY, V23, P695, DOI 10.1592/phco.23.6.695.32189; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Simiele M, 2011, ANTIMICROB AGENTS CH, V55, P2976, DOI 10.1128/AAC.01236-10; Thigpen MC, 2012, N ENGL J MED; Van Damme L, 2012, N ENGL J MED	34	154	156	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55013	10.1371/journal.pone.0055013	http://dx.doi.org/10.1371/journal.pone.0055013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383037	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000315563800104
J	Weiss, K; Hilkenmeier, F; Scharlau, I				Weiss, Katharina; Hilkenmeier, Frederic; Scharlau, Ingrid			Attention and the Speed of Information Processing: Posterior Entry for Unattended Stimuli Instead of Prior Entry for Attended Stimuli	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENTS; AUDITORY INFORMATION; EFFECT SIZE; PERCEPTION; SIMULTANEITY; STATISTICS; DEFICIT	Why are nearly simultaneous stimuli frequently perceived in reversed order? The origin of errors in temporal judgments is a question older than experimental psychology itself. One of the earliest suspects is attention. According to the concept of prior entry, attention accelerates attended stimuli; thus they have "prior entry'' to perceptive processing stages, including consciousness. Although latency advantages for attended stimuli have been revealed in psychophysical studies many times, these measures (e.g. temporal order judgments, simultaneity judgments) cannot test the prior-entry hypothesis completely. Since they assess latency differences between an attended and an unattended stimulus, they cannot distinguish between faster processing of attended stimuli and slower processing of unattended stimuli. Therefore, we present a novel paradigm providing separate estimates for processing advantages respectively disadvantages of attended and unattended stimuli. We found that deceleration of unattended stimuli contributes more strongly to the prior-entry illusion than acceleration of attended stimuli. Thus, in the temporal domain, attention fulfills its selective function primarily by deceleration of unattended stimuli. That means it is actually posterior entry, not prior entry which accounts for the largest part of the effect.	[Weiss, Katharina] Leuphana Univ Luneburg, Dept Psychol, Luneburg, Germany; [Hilkenmeier, Frederic] Univ Paderborn, Dept Cultural Sci, D-33098 Paderborn, Germany; [Scharlau, Ingrid] Leuphana Univ Luneburg, Inkubator, Luneburg, Germany	Leuphana University Luneburg; University of Paderborn; Leuphana University Luneburg	Weiss, K (corresponding author), Leuphana Univ Luneburg, Dept Psychol, Luneburg, Germany.	kweiss@leuphana.de	Scharlau, Ingrid/AAF-7777-2021		DFG within the ECRP II Programme of the European Science Foundation [SCHA 1515/1-1, SCHA 1515/1-2]; DFG [1515/1-3]	DFG within the ECRP II Programme of the European Science Foundation; DFG(German Research Foundation (DFG))	This research was funded by DFG (http://www.dfg.de/index.jsp) grants SCHA 1515/1-1, 1-2 within the ECRP II Programme of the European Science Foundation and SCHA 1515/1-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bessel FW, 1822, ASTRONOMISCHE BEOBAC; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brans DF, 2003, SCHIZOPHR RES, V60, P12; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Carlson TA, 2006, J VISION, V6, P1406, DOI 10.1167/6.12.6; Dosher BA, 2000, PSYCHOL SCI, V11, P139, DOI 10.1111/1467-9280.00229; Exner S, 1873, EXPT UNTERSUCHUNGEN, V7, P601; Exner S., 1875, PFLUGERS ARCH GESAMT, V11, P403, DOI [10.1007/BF01659311, DOI 10.1007/BF01659311]; Finney D.J., 1971, PROBIT ANAL; Fraisse P, 1963, PSYCHOL TIME; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; Frohlich FW, 1929, EMPFINDUNGSZEIT BEIT; GIBSON BS, 1994, PERCEPT PSYCHOPHYS, V56, P669, DOI 10.3758/BF03208360; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Haggard P, 2007, CONSCIOUS COGN, V16, P211, DOI 10.1016/j.concog.2006.07.002; Hilkenmeier F, 2012, VIS COGN, V20, P48, DOI 10.1080/13506285.2011.631507; Hogendoorn H, 2011, J VIS, V11, P1; Hogendoorn H, 2010, ATTEN PERCEPT PSYCHO, V72, P2059, DOI 10.3758/APP.72.8.2059; Hogendoorn H, 2007, J VISION, V7, DOI 10.1167/7.14.2; Jaskowski P, 2008, PSYCHOL RES-PSYCH FO, V72, P65, DOI 10.1007/s00426-006-0093-z; Kanai K, 2007, PSYCHOL RES-PSYCH FO, V71, P418, DOI 10.1007/s00426-005-0024-4; Keetels M, 2011, J EXP PSYCHOL HUMAN, V37, P699, DOI 10.1037/a0020564; Kerzel D, 2002, VISION RES, V42, P181, DOI 10.1016/S0042-6989(01)00271-1; Kerzel D, 2010, SPACE TIME PERCEPTIO, P321, DOI [10.1017/CBO9780511750540.019, DOI 10.1017/CBO9780511750540.019]; KING AJ, 1985, EXP BRAIN RES, V60, P492; Kirschfeld K, 1999, VISION RES, V39, P3702, DOI 10.1016/S0042-6989(99)00089-9; Mollon JD, 1996, NATURE, V380, P101, DOI 10.1038/380101a0; Musseler J, 1998, PERCEPT PSYCHOPHYS, V60, P683, DOI 10.3758/BF03206055; Neumann O, 1990, PSYCHOPHYSICAL EXPLO, P445; Neumann O, 2007, PSYCHOL RES-PSYCH FO, V71, P667, DOI 10.1007/s00426-006-0055-5; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Rorden C, 1997, NEUROPSYCHOLOGIA, V35, P421, DOI 10.1016/S0028-3932(96)00093-0; SANFORD AJ, 1974, J EXP PSYCHOL, V102, P443, DOI 10.1037/h0035871; Sanford E. C., 1888, AM J PSYCHOL, V2, P3; Santangelo V, 2009, EXP BRAIN RES, V194, P577, DOI 10.1007/s00221-009-1734-4; Scharlau Ingrid, 2008, Adv Cogn Psychol, V3, P241, DOI 10.2478/v10053-008-0028-x; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Seifried T, 2010, Q J EXP PSYCHOL, V63, P2432, DOI 10.1080/17470218.2010.485354; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Shui L, 1994, J EXP PSYCHOL HUMAN, V20, P1037; Smith A, 2002, J CHILD PSYCHOL PSYC, V43, P529, DOI 10.1111/1469-7610.00043; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C, 2010, ATTENTION TIME, P89; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; STELMACH LB, 1991, J EXP PSYCHOL HUMAN, V17, P539, DOI 10.1037/0096-1523.17.2.539; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Stone SA, 1926, AM J PSYCHOL, V37, P284, DOI 10.2307/1413699; Titchener EB, 1908, LECT ELEMENTARY PSYC; ULRICH R, 1987, PERCEPT PSYCHOPHYS, V42, P224, DOI 10.3758/BF03203074; von Steinbuchel N, 1999, NEUROSCI LETT, V264, P168, DOI 10.1016/S0304-3940(99)00204-9; Weiss K, 2012, ACTA PSYCHOL, V139, P54, DOI 10.1016/j.actpsy.2011.10.007; Weiss K, 2011, Q J EXP PSYCHOL, V64, P394, DOI 10.1080/17470218.2010.495783; Krekelberg B, 2000, Science, V289, P1107; Wundt W, 1887, GRUNDZUGE PHYSL PSYH; Yates MJ, 2011, ATTEN PERCEPT PSYCHO, V73, P1586, DOI 10.3758/s13414-011-0117-7; Yates MJ, 2009, ATTEN PERCEPT PSYCHO, V71, P847, DOI 10.3758/APP.71.4.847; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2007, NEUROSCI LETT, V414, P75, DOI 10.1016/j.neulet.2006.12.006	62	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54257	10.1371/journal.pone.0054257	http://dx.doi.org/10.1371/journal.pone.0054257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382884	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800040
J	Ono, N; Suzuki, S; Furusawa, C; Shimizu, H; Yomo, T				Ono, Naoaki; Suzuki, Shingo; Furusawa, Chikara; Shimizu, Hiroshi; Yomo, Tetsuya			Development of a Physical Model-Based Algorithm for the Detection of Single-Nucleotide Substitutions by Using Tiling Microarrays	PLOS ONE			English	Article							DENSITY OLIGONUCLEOTIDE MICROARRAYS; PROBE LEVEL DATA; DNA MICROARRAY; HYBRIDIZATION; SUMMARIES; SOFTWARE; ARRAYS; SNPS	High-density DNA microarrays are useful tools for analyzing sequence changes in DNA samples. Although microarray analysis provides informative signals from a large number of probes, the analysis and interpretation of these signals have certain inherent limitations, namely, complex dependency of signals on the probe sequences and the existence of false signals arising from non-specific binding between probe and target. In this study, we have developed a novel algorithm to detect the single-base substitutions by using microarray data based on a thermodynamic model of hybridization. We modified the thermodynamic model by introducing a penalty for mismatches that represent the effects of substitutions on hybridization affinity. This penalty results in significantly higher detection accuracy than other methods, indicating that the incorporation of hybridization free energy can improve the analysis of sequence variants by using microarray data.	[Ono, Naoaki] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan; [Suzuki, Shingo; Furusawa, Chikara] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan; [Shimizu, Hiroshi; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Yomo, Tetsuya] JST, ERATO, Suita, Osaka, Japan	Nara Institute of Science & Technology; RIKEN; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Furusawa, C (corresponding author), RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan.	chikara.furusawa@riken.jp	Furusawa, Chikara/ABB-6516-2021; Suzuki, Shingo/O-3651-2014; Furusawa, Chikara/N-6103-2015; Shimizu, Hiroshi/C-3688-2017	Furusawa, Chikara/0000-0003-3554-4975; Suzuki, Shingo/0000-0003-1332-3194; Furusawa, Chikara/0000-0003-3554-4975; Shimizu, Hiroshi/0000-0002-8986-0861; ONO, Naoaki/0000-0002-7722-055X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Global COE Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Binder H, 2005, LANGMUIR, V21, P9287, DOI 10.1021/la051231s; Furusawa C, 2009, BIOINFORMATICS, V25, P36, DOI 10.1093/bioinformatics/btn570; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hacia JG, 1999, J MED GENET, V36, P730, DOI 10.1136/jmg.36.10.730; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karaman MW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni034; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Ono N, 2008, BIOINFORMATICS, V24, P1278, DOI 10.1093/bioinformatics/btn109; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Wu CL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni082; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	25	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54571	10.1371/journal.pone.0054571	http://dx.doi.org/10.1371/journal.pone.0054571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382915	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500017
J	Ou, DB; Zeng, D; Jin, Y; Liu, XT; Teng, JW; Guo, WG; Wang, HT; Su, FF; He, Y; Zheng, QS				Ou, Dong-Bo; Zeng, Di; Jin, Yan; Liu, Xiong-Tao; Teng, Ji-Wei; Guo, Wan-Gang; Wang, Hong-Tao; Su, Fei-Fei; He, Yong; Zheng, Qiang-Sun			The Long-Term Differentiation of Embryonic Stem Cells into Cardiomyocytes: An Indirect Co-Culture Model	PLOS ONE			English	Article							GROWTH-FACTOR; IN-VITRO; PACEMAKER; ESTABLISHMENT; RESISTANCE; CULTURES; HEART; LINES; ACID	Background: Embryonic Stem Cells (ESCs) can differentiate into cardiomyocytes (CMs) in vitro but the differentiation level from ESCs is low. Here we describe a simple co-culture model by commercially available Millicell (TM) hanging cell culture inserts to control the long-term differentiation of ESCs into CMs. Methodology/Principal Findings: Mouse ESCs were cultured in hanging drops to form embryoid bodies (EBs) and treated with 0.1 mmol/L ascorbic acid to induce the differentiation of ESCs into CMs. In the indirect co-culture system, EBs were co-cultured with epidermal keratinocytes (EKs) or neonatal CMs (NCMs) by the hanging cell culture inserts (PET membranes with 1 mm pores). The molecular expressions and functional properties of ESC-derived CMs in prolonged culture course were evaluated. During time course of ESC differentiation, the percentages of EBs with contracting areas in NCMs co-culture were significantly higher than that without co-culture or in EKs co-culture. The functional maintenance of ESC-derived CMs were more prominent in NCMs co-culture model. Conclusions/Significance: These results indicate that NCMs co-culture promote ESC differentiation and has a further effect on cell growth and differentiation. We assume that the improvement of the differentiating efficiency of ESCs into CMs in the co-culture system do not result from the effect of co-culture directly on cell differentiation, but rather by signaling effects that influence the cells in proliferation and long-term function maintenance.	[Ou, Dong-Bo; Zeng, Di; Liu, Xiong-Tao; Teng, Ji-Wei; Guo, Wan-Gang; Wang, Hong-Tao; Su, Fei-Fei; He, Yong; Zheng, Qiang-Sun] Fourth Mil Med Univ, Dept Cardiol, Tangdu Hosp, Xian 710032, Peoples R China; [Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zheng, QS (corresponding author), Fourth Mil Med Univ, Dept Cardiol, Tangdu Hosp, Xian 710032, Peoples R China.	qiangsunzheng@gmail.com	Jin, Yan/I-4204-2013		National Natural Science Foundation of China [31271039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (no. 31271039). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; David R, 2009, CARDIOVASC RES, V84, P263, DOI 10.1093/cvr/cvp211; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Fahrenbach JP, 2007, J PHYSIOL-LONDON, V585, P565, DOI 10.1113/jphysiol.2007.144121; Gassanov N, 2004, FASEB J, V18, P1710, DOI 10.1096/fj.04-1619fje; GIBSON FM, 1995, BRIT J HAEMATOL, V90, P518, DOI 10.1111/j.1365-2141.1995.tb05578.x; Graichen R, 2008, DIFFERENTIATION, V76, P357, DOI 10.1111/j.1432-0436.2007.00236.x; Hatami L, 2007, INT J CARDIOL, V117, P80, DOI 10.1016/j.ijcard.2006.04.054; HOFLAND LJ, 1995, INT J CANCER, V60, P93, DOI 10.1002/ijc.2910600114; Houweling AC, 2002, ANAT RECORD, V266, P93, DOI 10.1002/ar.10042; Igelmund P, 1999, PFLUG ARCH EUR J PHY, V437, P669, DOI 10.1007/s004240050831; Kaichi S, 2010, CARDIOVASC RES, V88, P314, DOI 10.1093/cvr/cvq189; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Maltsev VA, 1999, CIRC RES, V84, P136, DOI 10.1161/01.RES.84.2.136; Martinez EC, 2010, TISSUE ENG PT A, V16, P1349, DOI [10.1089/ten.tea.2009.0399, 10.1089/ten.TEA.2009.0399]; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ou DB, 2011, J CELL BIOCHEM, V112, P3555, DOI 10.1002/jcb.23283; Ou DB, 2009, BIOESSAYS, V31, P246, DOI 10.1002/bies.200800179; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Roggia C, 2007, EXP CELL RES, V313, P921, DOI 10.1016/j.yexcr.2006.12.009; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x; Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x; Yoon J, 2005, ANN HEMATOL, V84, P715, DOI 10.1007/s00277-005-1068-7; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	34	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55233	10.1371/journal.pone.0055233	http://dx.doi.org/10.1371/journal.pone.0055233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383121	gold, Green Submitted, Green Published			2022-12-27	WOS:000315211500067
J	Watzlawik, JO; Warrington, AE; Rodriguez, M				Watzlawik, Jens O.; Warrington, Arthur E.; Rodriguez, Moses			PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; LYSOLECITHIN-INDUCED DEMYELINATION; TYROSINE KINASE LYN; SRC FAMILY KINASES; SPINAL-CORD; SCHWANN-CELLS; RAT-BRAIN; IN-VIVO; MONOCLONAL AUTOANTIBODY	Background: Promotion of remyelination is a major goal in treating demyelinating diseases such as multiple sclerosis (MS). The recombinant human monoclonal IgM, rHIgM22, targets myelin and oligodendrocytes (OLs) and promotes remyelination in animal models of MS. It is unclear whether rHIgM22-mediated stimulation of lesion repair is due to promotion of oligodendrocyte progenitor cell (OPC) proliferation and survival, OPC differentiation into myelinating OLs or protection of mature OLs. It is also unknown whether astrocytes or microglia play a functional role in IgM-mediated lesion repair. Methods: We assessed the effect of rHIgM22 on cell proliferation in mixed CNS glial and OPC cultures by tritiated-thymidine uptake and by double-label immunocytochemistry using the proliferation marker, Ki-67. Antibody-mediated signaling events, OPC differentiation and OPC survival were investigated and quantified by Western blots. Results: rHIgM22 stimulates OPC proliferation in mixed glial cultures but not in purified OPCs. There is no proliferative response in astrocytes or microglia. rHIgM22 activates PDGF alpha R in OPCs in mixed glial cultures. Blocking PDGFR-kinase inhibits rHIgM22-mediated OPC proliferation in mixed glia. We confirm in isolated OPCs that rHIgM22-mediated antiapoptotic signaling and inhibition of OPC differentiation requires PDGF and FGF-2. We observed no IgM-mediated effect in mature OLs in the absence of PDGF and FGF-2. Conclusion: Stimulation of OPC proliferation by rHIgM22 depends on co-stimulatory astrocytic and/or microglial factors. We demonstrate that rHIgM22-mediated activation of PDGF alpha R is required for stimulation of OPC proliferation. We propose that rHIgM22 lowers the PDGF threshold required for OPC proliferation and protection, which can result in remyelination of CNS lesions.	Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA; [Rodriguez, Moses] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Rodriguez, M (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.	rodriguez.moses@mayo.edu		Rodriguez, Moses/0000-0001-6328-6497; Watzlawik, Jens/0000-0003-0610-0267	National Institutes of Health (NIH) [R01 GM092993, R01 NS024180, R01 NS032129, R01 NS048357, R21 NS073684]; National Multiple Sclerosis Society [CA 1060A11]; NIH CTSA (Center for Translational Science Activities - HIPFA); Applebaum; Hilton; Peterson Foundations; Minnesota Partnership Award for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024180, R01NS032129, R01NS048357, R21NS073684] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH CTSA (Center for Translational Science Activities - HIPFA); Applebaum; Hilton; Peterson Foundations; Minnesota Partnership Award for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) (R01 GM092993, R01 NS024180, R01 NS032129, R01 NS048357 and R21 NS073684) and the National Multiple Sclerosis Society (CA 1060A11). This work was also supported by a grant from the NIH CTSA (Center for Translational Science Activities - HIPFA). The authors also acknowledge with thanks support from the Applebaum, Hilton and Peterson Foundations, the Minnesota Partnership Award for Biotechnology and Medical Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO DM, 1992, J NEUROSCI, V12, P1668; Asakura K, 1996, J NEUROSCI RES, V43, P273, DOI 10.1002/(SICI)1097-4547(19960201)43:3<273::AID-JNR2>3.0.CO;2-G; Asakura K, 1996, J NEUROIMMUNOL, V65, P11, DOI 10.1016/0165-5728(95)00175-1; Asakura K, 1998, J NEUROSCI, V18, P7700; BALACI L, 1994, NEUROREPORT, V6, P197, DOI 10.1097/00001756-199412300-00050; Bansal R, 1997, J NEUROSCI RES, V50, P215; Bansal R, 1999, J NEUROSCI, V19, P7913; Bansal R, 2003, J NEUROSCI RES, V74, P486, DOI 10.1002/jnr.10773; Bansal R, 1997, ADV EXP MED BIOL, V429, P69; Bansal R, 1996, MOL CELL NEUROSCI, V7, P263, DOI 10.1006/mcne.1996.0020; BANSAL R, 1994, DEV BIOL, V162, P511, DOI 10.1006/dbio.1994.1105; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; Baron W, 2002, EMBO J, V21, P1957, DOI 10.1093/emboj/21.8.1957; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; Becker-Catania SG, ASN NEURO, V3; Bieber AJ, 2002, GLIA, V37, P241, DOI 10.1002/glia.10033; BLAKEMORE WF, 1985, J NEUROL SCI, V70, P207, DOI 10.1016/0022-510X(85)90088-7; BLAKEMORE WF, 1984, J NEUROL SCI, V64, P265, DOI 10.1016/0022-510X(84)90175-8; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BOTTENSTEIN JE, 1986, P NATL ACAD SCI USA, V83, P1955, DOI 10.1073/pnas.83.6.1955; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CARROLL WM, 1994, BRAIN, V117, P563, DOI 10.1093/brain/117.3.563; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Decker L, 2004, BIOCHEM SOC T, V32, P426, DOI 10.1042/BST0320426; FANTL WJ, 1989, MOL CELL BIOL, V9, P4473, DOI 10.1128/MCB.9.10.4473; FERRARA N, 1988, BRAIN RES, V462, P223, DOI 10.1016/0006-8993(88)90550-1; Frost EE, 1999, CURR BIOL, V9, P1251, DOI 10.1016/S0960-9822(99)80506-5; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Gamas P, 2009, LEUKEMIA, V23, P1500, DOI 10.1038/leu.2009.60; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Guan H, 2008, MOL CANCER THER, V7, P1807, DOI 10.1158/1535-7163.MCT-08-0058; Hammang JP, 1997, EXP NEUROL, V147, P84, DOI 10.1006/exnr.1997.6592; HART IK, 1989, DEVELOPMENT, V105, P595; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Honmou O, 1996, J NEUROSCI, V16, P3199; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jiang FJ, 2001, DEV BIOL, V232, P414, DOI 10.1006/dbio.2001.0208; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Luciano F, 2003, FASEB J, V17, P711, DOI 10.1096/fj.02-0716fje; MAYER M, 1993, GLIA, V8, P12, DOI 10.1002/glia.440080103; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; MILLER DJ, 1994, J NEUROSCI, V14, P6230; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Osterhout DJ, 1997, J NEUROSCI, V17, P9122; Pavelko KD, 1998, J NEUROSCI, V18, P2498; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; Pirko I, 2004, FASEB J, V18, P1577, DOI 10.1096/fj.04-2026fje; PRESTA M, 1995, INT J DEV NEUROSCI, V13, P29, DOI 10.1016/0736-5748(94)00065-B; PRINGLE N, 1989, EMBO J, V8, P1049, DOI 10.1002/j.1460-2075.1989.tb03472.x; Pul R, 2002, CLIN NEUROPHARMACOL, V25, P254, DOI 10.1097/00002826-200209000-00005; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Robinson S, 1998, J NEUROSCI, V18, P10457; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; SHIMOJO M, 1991, NEUROSCI LETT, V123, P229, DOI 10.1016/0304-3940(91)90937-O; Silberstein FC, 1996, J NEUROCHEM, V66, P1409; Soldan MMP, 2003, MOL CELL NEUROSCI, V22, P14, DOI 10.1016/S1044-7431(02)00018-0; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Stangel M, 2003, J NEUROIMMUNOL, V138, P25, DOI 10.1016/S0165-5728(03)00087-0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; UMEMORI H, 1992, MOL BRAIN RES, V16, P303, DOI 10.1016/0169-328X(92)90239-8; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Vana AC, 2007, J NEUROPATH EXP NEUR, V66, P975, DOI 10.1097/NEN.0b013e3181587d46; Warrington AE, 2000, P NATL ACAD SCI USA, V97, P6820, DOI 10.1073/pnas.97.12.6820; Warrington AE, 2007, J NEUROSCI RES, V85, P967, DOI 10.1002/jnr.21217; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Watzlawik J, 2010, GLIA, V58, P1782, DOI 10.1002/glia.21048; Wei S, 1996, J IMMUNOL, V157, P5155; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Yim SH, 2001, J NEUROCHEM, V76, P1925, DOI 10.1046/j.1471-4159.2001.00199.x; Zhang SC, 1999, P NATL ACAD SCI USA, V96, P4089, DOI 10.1073/pnas.96.7.4089	92	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55149	10.1371/journal.pone.0055149	http://dx.doi.org/10.1371/journal.pone.0055149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383310	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900017
J	Ying, J; Rahbar, MH; Hallman, DM; Hernandez, LM; Spitz, MR; Forman, MR; Gorlova, OY				Ying, Jun; Rahbar, Mohammad H.; Hallman, D. Michael; Hernandez, Ladia M.; Spitz, Margret R.; Forman, Michele R.; Gorlova, Olga Y.			Associations between Dietary Intake of Choline and Betaine and Lung Cancer Risk	PLOS ONE			English	Article							DNA METHYLATION; FOLATE INTAKE; PROMOTER HYPERMETHYLATION; BREAST-CANCER; SMOKING; METABOLISM; METHIONINE; SMOKERS; HEALTH; HYPOMETHYLATION	Evidence from human and animal research indicates that choline metabolic pathways may be activated during a variety of diseases, including cancer. We report results of a case-control study of 2821 lung cancer cases and 2923 controls that assessed associations of choline and betaine dietary intakes with lung cancer. Using multivariable logistic regression analyses, we report a significant association between higher betaine intake and lower lung cancer risk that varied by smoking status. Specifically, no significant association was observed between betaine intake and lung cancer among never-smokers. However, higher betaine intake was significantly associated with reduced lung cancer risk among smokers, and the protective effect was more evident among current than former smokers: for former and current smokers, the ORs (95% CI) of lung cancer for individuals with highest as compared to lowest quartiles of intake were 0.70(0.55-0.88) and 0.51(0.39-0.66) respectively. Significant linear trend of higher betaine intake and lower lung cancer risk was observed among both former (p(trend)=0.002) and current (p(trend)<0.0001) smokers. A similar protective effect was also observed with choline intake both in overall analysis as well as among current smokers, with p-values for chi-square tests being 0.001 and 0.004 respectively, but the effect was less evident, as no linear trend was observed. Our results suggest that choline and betaine intake, especially higher betaine intake, may be protective against lung cancer through mitigating the adverse effect of smoking.	[Ying, Jun; Gorlova, Olga Y.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Rahbar, Mohammad H.; Hallman, D. Michael] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol, Houston, TX USA; [Hernandez, Ladia M.; Forman, Michele R.] Univ Texas Austin, Dell Pediat Res Inst, Coll Nat Sci, Dept Nutr Sci, Austin, TX 78712 USA; [Spitz, Margret R.] Baylor Coll Med, Duncan Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Austin; Baylor College of Medicine	Ying, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	jying@mdanderson.org			NIH [RO1 CA149462, RO1 CA55769, RO1 CA127219]; NIH Centers for Translational Science Award (NIH CTSA) by the National Center for Research Resources (NCRR) [UL1 RR024148]; NATIONAL CANCER INSTITUTE [R01CA127219, R01CA149462, R01CA055769] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Centers for Translational Science Award (NIH CTSA) by the National Center for Research Resources (NCRR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported in part by the NIH RO1 CA149462 and FAMRI Young Clinical Scientist Award (YCSA) to OYG and RO1 CA55769 and CA127219 to MRS, as well as by the NIH Centers for Translational Science Award (NIH CTSA) grant (UL1 RR024148), awarded to the University of Texas Health Science Center at Houston in 2006 by the National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BARAK AJ, 1993, ALCOHOL CLIN EXP RES, V17, P552, DOI 10.1111/j.1530-0277.1993.tb00798.x; Barak AJ, 1996, ALCOHOL, V13, P483, DOI 10.1016/0741-8329(96)00040-7; BLOCK G, 1992, J AM DIET ASSOC, V92, P686; BLOCK G, 1994, AM J EPIDEMIOL, V139, P1190, DOI 10.1093/oxfordjournals.aje.a116965; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Cho E, 2007, JNCI-J NATL CANCER I, V99, P1224, DOI 10.1093/jnci/djm082; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de Vogel S, 2011, CANCER CAUSE CONTROL, V22, P1, DOI 10.1007/s10552-010-9659-6; Dueck DA, 1996, MOL CELL BIOCHEM, V162, P97; Enokida H, 2006, CANCER-AM CANCER SOC, V106, P79, DOI 10.1002/cncr.21577; Esteller M, 1999, CANCER RES, V59, P67; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Henning SM, 1996, ADV EXP MED BIOL, V399, P143; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Hudmon KS, 1997, CANCER EPIDEM BIOMAR, V6, P565; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Katz-Brull R, 2002, CANCER RES, V62, P1966; KIM YI, 1994, J NUTR, V124, P2197, DOI 10.1093/jn/124.11.2197; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Kondo Y, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001559; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Kotsopoulos J, 2010, EUR J CLIN NUTR, V64, P111, DOI 10.1038/ejcn.2009.109; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mar M-H., 2004, USDA DATABASE CHOLIN; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Osler M, 1998, PREV MED, V27, P438, DOI 10.1006/pmed.1998.0289; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; Patterson KY, 2008, USDA DATABASE CHOLIN; PIERETTI M, 1995, HUM PATHOL, V26, P398, DOI 10.1016/0046-8177(95)90140-X; Schabath MB, 2005, AM J EPIDEMIOL, V161, P412, DOI 10.1093/aje/kwi063; Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264; Schwartz AG, 2009, J THORAC ONCOL, V4, P1195, DOI 10.1097/JTO.0b013e3181b244ef; Shao CB, 2011, CLIN CANCER RES, V17, P4320, DOI 10.1158/1078-0432.CCR-10-2992; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Teixido N, 2005, LETT APPL MICROBIOL, V41, P248, DOI 10.1111/j.1472-765X.2005.01757.x; THORNTON A, 1994, J CLIN EPIDEMIOL, V47, P1143, DOI 10.1016/0895-4356(94)90101-5; U.S. Department of Agriculture Agricultural Research Service USDA Nutrient Data Laboratory, 2008, COMP FOODS RAW PROC; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; van der Maarel SM, 2008, ANN RHEUM DIS, V67, P97, DOI 10.1136/ard.2008.098392; VARELAMOREIRAS G, 1995, J AM COLL NUTR, V14, P480; Voorrips LE, 2000, CANCER EPIDEM BIOMAR, V9, P357; Wei QY, 2003, CANCER EPIDEM BIOMAR, V12, P963; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wu JY, 2008, ANN SURG ONCOL, V15, P3272, DOI 10.1245/s10434-008-0078-9; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Xu XR, 2009, FASEB J, V23, P4022, DOI 10.1096/fj.09-136507	55	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54561	10.1371/journal.pone.0054561	http://dx.doi.org/10.1371/journal.pone.0054561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383301	gold, Green Published, Green Submitted			2022-12-27	WOS:000314597900008
J	Bischoff, SR; Tsai, SQ; Hardison, NE; Motsinger-Reif, AA; Freking, BA; Nonneman, DJ; Rohrer, GA; Piedrahita, JA				Bischoff, Steve R.; Tsai, Shengdar Q.; Hardison, Nicholas E.; Motsinger-Reif, Alison A.; Freking, Bradley A.; Nonneman, Dan J.; Rohrer, Gary A.; Piedrahita, Jorge A.			Differences in X-Chromosome Transcriptional Activity and Cholesterol Metabolism between Placentae from Swine Breeds from Asian and Western Origins	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; OVULATION RATE; LITTER SIZE; PIGS; RNA; DNA; TRANSPORT; MEISHAN; GROWTH	To gain insight into differences in placental physiology between two swine breeds noted for their dissimilar reproductive performance, that is, the Chinese Meishan and white composite (WC), we examined gene expression profiles of placental tissues collected at 25, 45, 65, 85, and 105 days of gestation by microarrays. Using a linear mixed model, a total of 1,595 differentially expressed genes were identified between the two pig breeds using a false-discovery rate q-value <= 0.05. Among these genes, we identified breed-specific isoforms of XIST, a long non-coding RNA responsible X-chromosome dosage compensation in females. Additionally, we explored the interaction of placental gene expression and chromosomal location by DIGMAP and identified three Sus scrofa X chromosomal bands (Xq13, Xq21, Xp11) that represent transcriptionally active clusters that differ between Meishan and WC during placental development. Also, pathway analysis identified fundamental breed differences in placental cholesterol trafficking and its synthesis. Direct measurement of cholesterol confirmed that the cholesterol content was significantly higher in the Meishan versus WC placentae. Taken together, this work identifies key metabolic pathways that differ in the placentae of two swine breeds noted for differences in reproductive prolificacy.	[Bischoff, Steve R.; Tsai, Shengdar Q.; Piedrahita, Jorge A.] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Bischoff, Steve R.; Freking, Bradley A.; Nonneman, Dan J.; Rohrer, Gary A.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE USA; [Bischoff, Steve R.; Tsai, Shengdar Q.; Piedrahita, Jorge A.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Hardison, Nicholas E.; Motsinger-Reif, Alison A.] N Carolina State Univ, Dept Stat, Program Stat Genet, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Piedrahita, JA (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27695 USA.	jorge_piedrahita@ncsu.edu	Bischoff, Steve R./AAP-8924-2020; Motsinger-Reif, Alison/I-4167-2018; Tsai, Shengdar Q./G-4600-2012; Freking, Brad/M-1938-2019	Bischoff, Steve R./0000-0002-9287-7250; Motsinger-Reif, Alison/0000-0003-1346-2493; Tsai, Shengdar Q./0000-0001-9161-3993; Freking, Brad/0000-0001-5385-5692; Rohrer, Gary/0000-0002-8252-9308	National Research Initiative Grant from the the United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2005-35604-15343]; National Institutes of Health (NIH)/NIH Heart, Lung, and Blood institute (NHLBI) [HD048510]; National Science Foundation (NSF) Integrative Graduate Education and Research Traineeship (IGERT) fellowship; North Carolina State College of Veterinary Medicine; NSF Graduate Research Fellowship; National Institute of Environmental Health Sciences (NIEHS); Center for Comparative Medicine and Translational Research (CCMTR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048510] Funding Source: NIH RePORTER	National Research Initiative Grant from the the United States Department of Agriculture Cooperative State Research, Education, and Extension Service; National Institutes of Health (NIH)/NIH Heart, Lung, and Blood institute (NHLBI); National Science Foundation (NSF) Integrative Graduate Education and Research Traineeship (IGERT) fellowship(National Science Foundation (NSF)); North Carolina State College of Veterinary Medicine; NSF Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Comparative Medicine and Translational Research (CCMTR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a National Research Initiative Grant (2005-35604-15343) from the the United States Department of Agriculture Cooperative State Research, Education, and Extension Service to JP and BF, by a National Institutes of Health (NIH)/NIH Heart, Lung, and Blood institute (NHLBI) grant HD048510 to JP, by a National Science Foundation (NSF) Integrative Graduate Education and Research Traineeship (IGERT) fellowship to SB and ST, a North Carolina State College of Veterinary Medicine epigenetics doctoral fellowship to SB, NSF Graduate Research Fellowship to ST, and by a National Institute of Environmental Health Sciences (NIEHS) training grant to support NH. This work was supported in part by an initiative from the Center for Comparative Medicine and Translational Research (CCMTR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz DL, 2004, MAKING SENSE IT ALL; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Aye ILMH, 2010, BBA-MOL CELL BIOL L, V1801, P1013, DOI 10.1016/j.bbalip.2010.05.015; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bischoff S, 2010, REVISION 6 ANNOTATIO; Bischoff S R, 2009, Soc Reprod Fertil Suppl, V66, P245; Bischoff SR, 2009, BIOL REPROD, V81, P906, DOI 10.1095/biolreprod.109.078139; Bischoff SR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-252; Blomberg LA, 2005, PHYSIOL GENOMICS, V20, P188, DOI 10.1152/physiolgenomics.00157.2004; Brody JR, 2004, BIOTECHNIQUES, V37, P598, DOI 10.2144/04374ST04; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Cassady JP, 2002, J ANIM SCI, V80, P2303; Cepica S, 2007, ANIM GENET, V38, P634, DOI 10.1111/j.1365-2052.2007.01661.x; CHRISTENSON RK, 1993, J ANIM SCI, V71, P3060, DOI 10.2527/1993.71113060x; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dabney A, 2008, Q VALUE; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Distl O, 2007, REPROD DOMEST ANIM, V42, P10, DOI 10.1111/j.1439-0531.2007.00887.x; Ford SP, 1997, J REPROD FERTIL, P165; Foxcroft GR, 2007, THERIOGENOLOGY, V68, pS30, DOI 10.1016/j.theriogenology.2007.04.032; Freking BA, 2007, J ANIM SCI, V85, P2093, DOI 10.2527/jas.2006-766; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gibson G, 2003, PLOS BIOL, V1, P28, DOI 10.1371/journal.pbio.0000015; Guyot R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-3; Haas D, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-13; Haldermans P, 2007, STAT APPL GENET MOL, V6; HALEY CS, 1993, J REPROD FERTIL, P247; Herman GE, 2000, BBA-MOL CELL BIOL L, V1529, P357, DOI 10.1016/S1388-1981(00)00160-8; Hu ZL, 2005, MAMM GENOME, V16, P792, DOI 10.1007/s00335-005-0060-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huff W, 1999, GUIDE CARE USE AGR A; Humphray SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r139; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Johnson RK, 1999, J ANIM SCI, V77, P541; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-29; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kullberg M, 2006, MOL BIOL EVOL, V23, P1493, DOI 10.1093/molbev/msl027; Lazaridis EN, 2002, MATH BIOSCI, V176, P53, DOI 10.1016/S0025-5564(01)00100-6; Lee EK, 2006, BIOINFORMATICS, V22, P2305, DOI 10.1093/bioinformatics/btl367; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lindegaard ML, 2008, HUM MOL GENET, V17, P3806, DOI 10.1093/hmg/ddn278; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Ma JW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-159; Ma MC, 2005, MAMM GENOME, V16, P391, DOI 10.1007/s00335-004-2464-3; Maier H, 2005, NUCLEIC ACIDS RES, V33, pW779, DOI 10.1093/nar/gki417; McCoard SA, 2002, ANIM GENET, V33, P178, DOI 10.1046/j.1365-2052.2002.00878.x; McKay R, 2011, NATURE, V472, P298, DOI 10.1038/472298a; Mesa H, 2005, J ANIM SCI, V83, P983; Mosquera JL, 2008, NUCLEIC ACIDS RES, V36, pW368, DOI 10.1093/nar/gkn256; Murphy C, 2007, BIOCHEM BIOPH RES CO, V355, P359, DOI 10.1016/j.bbrc.2007.01.155; Nikitina L, 2011, PLACENTA, V32, P420, DOI 10.1016/j.placenta.2011.03.003; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Palinski W, 2009, CIRC RES, V104, P569, DOI 10.1161/CIRCRESAHA.109.194191; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Rhee SS, 2004, ANAL BIOCHEM, V325, P137, DOI 10.1016/j.ab.2003.10.019; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHOKNECHT PA, 1994, J NUTR, V124, P305, DOI 10.1093/jn/124.2.305; Seiki S, 2009, CARDIOL REV, V17, P70, DOI 10.1097/CRD.0b013e3181885905; Sembon S, 2008, ZYGOTE, V16, P327, DOI 10.1017/S0967199408004826; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Sibley CP, 2010, PLACENTA, V31, pS70, DOI 10.1016/j.placenta.2009.12.020; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey John D, 2003, Methods Mol Biol, V224, P149; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Tsai S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-328; Vallet J, 2009, RES UTERINE CAPACITY; Vallet J L, 2009, Soc Reprod Fertil Suppl, V66, P265; van Bakel H, 2008, TUTORIAL DNA MICROAR; Wang L, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1484; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Wilson ME, 2000, DECREASED PLACENTAL; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Woollett LA, 2008, ANNU REV NUTR, V28, P97, DOI 10.1146/annurev.nutr.26.061505.111311; Wu SP, 2009, ANIMAL, V3, P408, DOI 10.1017/S1751731108003467; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yi YJ, 2005, GENOMICS, V85, P401, DOI 10.1016/j.ygeno.2004.11.011; YOUNG LD, 1995, J ANIM SCI, V73, P711; YOUNGS CR, 1994, J ANIM SCI, V72, P725, DOI 10.2527/1994.723725x; ZHANG WC, 1983, LIVEST PROD SCI, V10, P59, DOI 10.1016/0301-6226(83)90007-6; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-337	91	15	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55345	10.1371/journal.pone.0055345	http://dx.doi.org/10.1371/journal.pone.0055345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383161	Green Published, gold			2022-12-27	WOS:000314610600089
J	Mohebbi, N; Perna, A; van der Wijst, J; Becker, HM; Capasso, G; Wagner, CA				Mohebbi, Nilufar; Perna, Angelica; van der Wijst, Jenny; Becker, Helen M.; Capasso, Giovambattista; Wagner, Carsten A.			Regulation of Two Renal Chloride Transporters, AE1 and Pendrin, by Electrolytes and Aldosterone	PLOS ONE			English	Article							ACID-BASE TRANSPORT; CL-/HCO3-EXCHANGER PENDRIN; INTERCALATED CELLS; COLLECTING DUCT; RAT-KIDNEY; MOUSE KIDNEY; MOLECULAR-MECHANISMS; METABOLIC-ACIDOSIS; H+-ATPASE; AMMONIUM-CHLORIDE	The renal handling of salt and protons and bicarbonate are intricately linked through shared transport mechanisms for sodium, chloride, protons, and bicarbonate. In the collecting duct, the regulated fine-tuning of salt and acid-base homeostasis is achieved by a series of transport proteins located in different cell types, intercalated and principal cells. Intercalated cells are considered to be of less importance for salt handling but recent evidence has suggested that the anion exchanger pendrin may participate in salt reabsorption and blood pressure regulation. Here, we examined the regulated expression of two functionally related but differentially expressed anion exchangers, AE1 and pendrin, by dietary electrolyte intake and aldosterone. Cortical expression of pendrin was regulated on mRNA and protein level. The combination of NaHCO3 and DOCA enhanced pendrin mRNA and protein levels, whereas DOCA or NaHCO3 alone had no effect. NaCl or KHCO3 increased pendrin mRNA, KCl decreased its mRNA abundance. On protein level, NH4Cl, NaCl, and KCl reduced pendrin expression, the other treatments were without effect. In contrast, AE1 mRNA or protein expression in kidney cortex was regulated by none of these treatments. In kidney medulla, NaHCO3/DOCA or NaHCO3 alone enhanced AE1 mRNA levels. AE1 protein abundance was increased by NH4Cl, NaHCO3/DOCA, and NaCl. Immunolocalization showed that during NH4Cl treatment the relative number of AE1 positive cells was increased and pendrin expressing cells reduced. Thus, pendrin and AE1 are differentially regulated with distinct mechanisms that separately affect mRNA and protein levels. Pendrin is regulated by acidosis and chloride intake, whereas AE1 is enhanced by acidosis, NaCl, and the combination of DOCA and NaHCO3.	[Mohebbi, Nilufar; Perna, Angelica; van der Wijst, Jenny; Becker, Helen M.; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Mohebbi, Nilufar; Perna, Angelica; van der Wijst, Jenny; Becker, Helen M.; Wagner, Carsten A.] Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Mohebbi, Nilufar] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Perna, Angelica; Capasso, Giovambattista] Univ Naples 2, Dept Internal Med, Chair Nephrol, Naples, Italy	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; Universita della Campania Vanvitelli	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	Wagnerca@access.uzh.ch	van der Wijst, Jenny/D-9726-2016; Perna, Angelica/S-8292-2019; van der Wijst, Jenny/T-1620-2019	van der Wijst, Jenny/0000-0002-1547-516X; Perna, Angelica/0000-0002-7853-9159; van der Wijst, Jenny/0000-0002-1547-516X; Capasso, Giovambattista/0000-0003-3469-8614	Swiss National Science Foundation [31003A-138143/1]; 7th EU Framework project EUNEFRON; Second University of Naples	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 7th EU Framework project EUNEFRON; Second University of Naples	This study was supported by a grant from the Swiss National Science Foundation (31003A-138143/1) to CA Wagner, the 7th EU Framework project EUNEFRON to G Capasso and CA Wagner, and a student fellowship from the Second University of Naples to A Perna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler L, 2008, AM J PHYSIOL-CELL PH, V294, pC1261, DOI 10.1152/ajpcell.00486.2007; Alesutan I, 2011, CELL PHYSIOL BIOCHEM, V28, P553, DOI 10.1159/000335114; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Amlal H, 2011, CELL PHYSIOL BIOCHEM, V28, P521, DOI 10.1159/000335117; BASTANI B, 1991, J CLIN INVEST, V88, P126, DOI 10.1172/JCI115268; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Bonnici B, 2004, PFLUG ARCH EUR J PHY, V448, P16, DOI 10.1007/s00424-003-1227-4; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; Christensen BM, 2004, AM J PHYSIOL-CELL PH, V286, pC952, DOI 10.1152/ajpcell.00266.2003; ELGER M, 1992, AM J PHYSIOL, V262, pF656, DOI 10.1152/ajprenal.1992.262.4.F656; Ellison DH, 2009, HYPERTENSION, V54, P196, DOI 10.1161/HYPERTENSIONAHA.109.129171; Frische S, 2003, AM J PHYSIOL-RENAL, V284, pF584, DOI 10.1152/ajprenal.00254.2002; Gao X, 2010, P NATL ACAD SCI US; Gimenez I, 2006, CURR OPIN NEPHROL HY, V15, P517, DOI 10.1097/01.mnh.0000242178.44576.b0; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hadchouel J, 2006, CELL METAB, V4, P335, DOI 10.1016/j.cmet.2006.10.007; Hadchouel J, 2011, CELL PHYSIOL BIOCHEM, V28, P505, DOI 10.1159/000335116; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Huber S, 1999, AM J PHYSIOL-RENAL, V277, pF841, DOI 10.1152/ajprenal.1999.277.6.F841; Jehle S, 2000, CLIN SCI, V99, P47, DOI 10.1042/CS19990317; Kim YH, 2007, AM J PHYSIOL-RENAL, V293, pF1314, DOI 10.1152/ajprenal.00155.2007; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loffing J, 2009, PFLUG ARCH EUR J PHY, V458, P111, DOI 10.1007/s00424-009-0656-0; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mohebbi N, 2009, AM J PHYSIOL-RENAL, V297, pF499, DOI 10.1152/ajprenal.90489.2008; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; PACHA J, 1991, AM J PHYSIOL, V261, pF696, DOI 10.1152/ajprenal.1991.261.4.F696; Palmer LG, 2007, AM J PHYSIOL-RENAL, V292, pF966, DOI 10.1152/ajprenal.00191.2006; Pech V, 2006, AM J PHYSL RENAL PHY; Petrovic S, 2003, AM J PHYSIOL-RENAL, V284, pF103, DOI 10.1152/ajprenal.00205.2002; Procino G, 2011, CELL PHYSIOL BIOCHEM, V28, P683, DOI 10.1159/000335762; Purkerson JM, 2010, KIDNEY INT, V78, P993, DOI 10.1038/ki.2010.195; Quentin F, 2004, AM J PHYSIOL-RENAL, V287, pF1179, DOI 10.1152/ajprenal.00211.2004; Reimold FR, 2011, CELL PHYSIOL BIOCHEM, V28, P435, DOI 10.1159/000335106; Rodighiero S, 2011, CELL PHYSIOL BIOCHEM, V28, P559, DOI 10.1159/000335120; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Rozenfeld J, 2011, CELL PHYSIOL BIOCHEM, V28, P385, DOI 10.1159/000335100; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; SEBASTIAN A, 1976, J CLIN INVEST, V58, P454, DOI 10.1172/JCI108490; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Stehberger PA, 2003, J AM SOC NEPHROL, V14, P3027, DOI 10.1097/01.ASN.0000099375.74789.AB; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; STONE DK, 1983, J CLIN INVEST, V72, P77, DOI 10.1172/JCI110986; STONE DK, 1983, J CLIN INVEST, V71, P1505, DOI 10.1172/JCI110905; Vallet M, 2006, J AM SOC NEPHROL, V17, P2153, DOI 10.1681/ASN.2005101054; Van Huyen JPD, 2008, J AM SOC NEPHROL, V19, P1965, DOI 10.1681/ASN.2007070781; Verlander JW, 2006, AM J PHYSIOL-RENAL, V291, pF833, DOI 10.1152/ajprenal.00474.2005; VERLANDER JW, 1994, AM J PHYSIOL, V266, pF633, DOI 10.1152/ajprenal.1994.266.4.F633; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wagner CA, 2002, KIDNEY INT, V62, P2109, DOI 10.1046/j.1523-1755.2002.00671.x; Wagner CA, 2011, CELL PHYSIOL BIOCHEM, V28, P513, DOI 10.1159/000335112; Wagner CA, 2011, CELL PHYSIOL BIOCHEM, V28, P497, DOI 10.1159/000335111; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wall SM, 2004, HYPERTENSION, V44, P982, DOI 10.1161/01.HYP.0000145863.96091.89; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Welsh-Bacic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025240; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101	60	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55286	10.1371/journal.pone.0055286	http://dx.doi.org/10.1371/journal.pone.0055286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383138	Green Published, Green Accepted, gold			2022-12-27	WOS:000314610600082
J	Suzan-Monti, M; Kouanfack, C; Boyer, S; Blanche, J; Bonono, RC; Delaporte, E; Carrieri, PM; Moatti, JP; Laurent, C; Spire, B				Suzan-Monti, Marie; Kouanfack, Charles; Boyer, Sylvie; Blanche, Jerome; Bonono, Renee Cecile; Delaporte, Eric; Carrieri, Patrizia M.; Moatti, Jean-Paul; Laurent, Christian; Spire, Bruno		Stratall ANRS 12-110 ESTHER Study	Impact of HIV Comprehensive Care and Treatment on Serostatus Disclosure among Cameroonian Patients in Rural District Hospitals	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL TREATMENT DELIVERY; QUALITY-OF-LIFE; POSITIVE MEN; SOUTH-AFRICA; EVAL SURVEY; ANRS 12-116; WOMEN; FAMILY; SEX	This work aimed to analyze the rate of disclosure to relatives and friends over time and to identify factors affecting disclosure among seropositive adults initiating antiretroviral therapy (ART) in rural district hospitals in the context of decentralized, integrated HIV care and task-shifting to nurses in Cameroon. Stratall was a 24-month, randomized, open-label trial comparing the effectiveness of clinical monitoring alone with laboratory plus clinical monitoring on treatment outcomes. It enrolled 459 HIV-infected ART-naive adults in 9 rural district hospitals in Cameroon. Participants in both groups were sometimes visited by nurses instead of physicians. Patients with complete data both at enrolment (M0) and at least at one follow-up visit were included in the present analysis. A mixed Poisson regression was used to estimate predictors of the evolution of disclosure index over 24 months (M24). The study population included 385 patients, accounting for 1733 face-to-face interviews at follow-up visits from M0 to M24. The median [IQR] number of categories of relatives and friends to whom patients had disclosed was 2 [1-3] and 3 [2-5] at M0 and M24 (p-trend<0.001), respectively. After multiple adjustments, factors associated with disclosure to a higher number of categories of relatives and friends were as follows: having revealed one's status to one's main partner, time on ART, HIV diagnosis during hospitalization, knowledge on ART and positive ratio of follow-up nurse-led to physician-led visits measuring task-shifting. ART delivered in the context of decentralized, integrated HIV care including task-shifting was associated with increased HIV serological status disclosure.	[Suzan-Monti, Marie; Boyer, Sylvie; Blanche, Jerome; Carrieri, Patrizia M.; Moatti, Jean-Paul; Spire, Bruno] INSERM, UMR912, SESSTIM, F-13258 Marseille, France; [Suzan-Monti, Marie; Boyer, Sylvie; Blanche, Jerome; Carrieri, Patrizia M.; Moatti, Jean-Paul; Spire, Bruno] Univ Aix Marseille, UMR S912, IRD, Marseille, France; [Suzan-Monti, Marie; Boyer, Sylvie; Blanche, Jerome; Carrieri, Patrizia M.; Moatti, Jean-Paul; Spire, Bruno] ORS PACA, Marseille, France; [Kouanfack, Charles] Cent Hosp, UMI 233, Yaounde, Cameroon; [Bonono, Renee Cecile] Catholic Univ Cent African States, Socioanthropol Res Inst IRSA, Yaounde, Cameroon; [Delaporte, Eric; Laurent, Christian] Univ Montpellier I, IRD, UMI 233, Montpellier, France; [Delaporte, Eric] Univ Hosp, Dept Infect & Trop Dis, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Suzan-Monti, M (corresponding author), INSERM, UMR912, SESSTIM, F-13258 Marseille, France.	marie.suzan@inserm.fr	Spire, Bruno/F-5546-2013; Delaporte, Eric/J-5397-2018	Spire, Bruno/0000-0002-3546-8020; Delaporte, Eric/0000-0002-1822-9853; Carrieri, Patrizia/0000-0002-6794-4837; AGHOKENG FOBANG, Avelin/0000-0002-1414-0237; Laurent, Christian/0000-0003-2658-7113	ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales); ESTHER (Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau	ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales)(ANRSFrench National Research Agency (ANR)); ESTHER (Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau	This work was funded by the ANRS (Agence Nationale de Recherche sur le Sida et les Hepatites Virales; http://www.anrs.fr/) and ESTHER (Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau; http://www.esther.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akani CI, 2006, TROP DOCT, V36, P87, DOI 10.1258/004947506776593378; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Arnold EM, 2008, AIDS CARE, V20, P80, DOI 10.1080/09540120701449138; Assefa Y, 2010, CURR OPIN HIV AIDS, V5, P78, DOI 10.1097/COH.0b013e328333b87a; Black BP, 2002, JOGNN, V31, P688, DOI 10.1177/0884217502239211; Boyer S, 2012, HEALTH POLICY PLANN, V27, P301, DOI 10.1093/heapol/czr039; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Crepaz N, 2003, AIDS CARE, V15, P379, DOI 10.1080/0954012031000105432; Deribe Kebede, 2009, East Afr J Public Health, V6, P248; Deribe K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-81; Do NT, 2010, AIDS RES HUM RETROV, V26, P685, DOI 10.1089/aid.2009.0222; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Kangwende R A, 2009, Cent Afr J Med, V55, P1; Kiene SM, 2010, AIDS PATIENT CARE ST, V24, P117, DOI 10.1089/apc.2009.0269; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Laurent C, 2011, J PUBLIC HEALTH POL, V32, P211, DOI 10.1057/jphp.2011.8; Loubiere S, 2009, SOC SCI MED, V69, P885, DOI 10.1016/j.socscimed.2009.05.044; Marcellin F, 2010, AIDS, V24, pS17, DOI 10.1097/01.aids.0000366079.83568.a2; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; Ministere de la Sante Publique, 2008, VERS ACC UN TRAIT PR; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Pearson CR, 2009, AIDS BEHAV, V13, P1189, DOI 10.1007/s10461-009-9596-0; Peretti-Watel P, 2006, AIDS CARE, V18, P254, DOI 10.1080/09540120500456193; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Serovich JM, 2007, AIDS PATIENT CARE ST, V21, P970, DOI 10.1089/apc.2007.0038; Serovich JM, 2007, AIDS PATIENT CARE ST, V21, P492, DOI 10.1089/apc.2005.0002; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Ssali SN, 2010, AIDS PATIENT CARE ST, V24, P675, DOI 10.1089/apc.2010.0062; Stutterheim SE, 2009, AIDS, V23, P2353, DOI 10.1097/QAD.0b013e3283320dce; Suzan-Monti M, 2011, JAIDS-J ACQ IMM DEF, V57, pS22, DOI 10.1097/QAI.0b013e31821fcfa8; Wong LH, 2009, JAIDS-J ACQ IMM DEF, V50, P215, DOI 10.1097/QAI.0b013e3181900172; World Health Organization, 2011, GLOB HLTH SECT STRAT; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034; Wouters E, 2009, AIDS PATIENT CARE ST, V23, P357, DOI 10.1089/apc.2008.0201	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55225	10.1371/journal.pone.0055225	http://dx.doi.org/10.1371/journal.pone.0055225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23383117	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600077
J	Thay, B; Wai, SN; Oscarsson, J				Thay, Bernard; Wai, Sun Nyunt; Oscarsson, Jan			Staphylococcus aureus alpha-Toxin-Dependent Induction of Host Cell Death by Membrane-Derived Vesicles	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PLASMA-MEMBRANE; HEMOLYSIN; VIRULENCE; APOPTOSIS; PROTEINS; RELEASE; PATHWAY; HEAD	Staphylococcus aureus causes a wide spectrum of infections in humans, ranging from superficial cutaneous infections, infections in the circum-oral region, to life-threatening bacteremia. It was recently demonstrated that Gram-positive organisms such as S. aureus liberate membrane-derived vesicles (MVs), which analogously to outer membrane vesicles (OMVs) of Gram-negative bacteria can play a role in delivering virulence factors to host cells. In the present study we have shown that cholesterol-dependent fusion of S. aureus MVs with the plasma membrane represents a route for delivery of a key virulence factor, alpha-toxin (alpha-hemolysin; Hla) to human cells. Most S. aureus strains produce this 33-kDa pore-forming protein, which can lyse a wide range of human cells, and induce apoptosis in T-lymphocytes. Our results revealed a tight association of biologically active alpha-toxin with membrane-derived vesicles isolated from S. aureus strain 8325-4. Concomitantly, alpha-toxin contributed to HeLa cell cytotoxicity of MVs, and was the main vesicle-associated protein responsible for erythrocyte lysis. In contrast, MVs obtained from an isogenic hla mutant were significantly attenuated with regards to both causing lysis of erythrocytes and death of HeLa cells. This is to our knowledge the first recognition of an S. aureus MV-associated factor contributing to host cell cytotoxicity.	[Thay, Bernard; Oscarsson, Jan] Umea Univ, Dept Odontol, Umea, Sweden; [Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, Umea, Sweden; [Wai, Sun Nyunt] Umea Univ, UCMR, Umea, Sweden	Umea University; Umea University; Umea University	Wai, SN (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	sun.nyunt.wai@molbiol.umu.se; jan.oscarsson@odont.umu.se		Wai, Sun Nyunt/0000-0003-4793-4671; Thay, Bernard/0000-0001-5099-6844	Swedish Research Council; Swedish Research Council Formas	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by grants from The Swedish Research Council (www.vr.se; SNW), and from the Swedish Research Council Formas (www.formas.se; JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldick T, 2009, MOL MICROBIOL, V71, P1496, DOI 10.1111/j.1365-2958.2009.06618.x; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; CROSSLEY KB, 1997, STAPHYLOCOCCI HUMAN; Dajcs JJ, 2002, DNA CELL BIOL, V21, P375, DOI 10.1089/10445490260099656; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dragneva Y, 2001, INFECT IMMUN, V69, P2630, DOI 10.1128/IAI.69.4.2630-2635.2001; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Giese B, 2009, INFECT IMMUN, V77, P3611, DOI 10.1128/IAI.01478-08; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Hong SW, 2011, ALLERGY, V66, P351, DOI 10.1111/j.1398-9995.2010.02483.x; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lindmark B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-220; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Soderblom T, 2005, CELL MICROBIOL, V7, P779, DOI 10.1111/j.1462-5822.2005.00510.x; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Valeva A, 1996, EMBO J, V15, P1857, DOI 10.1002/j.1460-2075.1996.tb00536.x; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WALEV I, 1993, INFECT IMMUN, V61, P4972, DOI 10.1128/IAI.61.12.4972-4979.1993; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x	55	90	93	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54661	10.1371/journal.pone.0054661	http://dx.doi.org/10.1371/journal.pone.0054661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382935	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600032
J	Uehara, K; Morishita, T; Kubota, S; Funase, K				Uehara, Kazumasa; Morishita, Takuya; Kubota, Shinji; Funase, Kozo			Change in the Ipsilateral Motor Cortex Excitability Is Independent from a Muscle Contraction Phase during Unilateral Repetitive Isometric Contractions	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; UNIMANUAL FORCE GENERATION; DORSAL INTEROSSEOUS MUSCLE; INTERHEMISPHERIC INHIBITION; VOLUNTARY CONTRACTION; CORTICOSPINAL EXCITABILITY; EVOKED-POTENTIALS; FINGER MOVEMENTS; HAND MUSCLES; HUMAN-BRAIN	The aim of this study was to investigate the difference in a muscle contraction phase dependence between ipsilateral (ipsi)- and contralateral (contra)-primary motor cortex (M1) excitability during repetitive isometric contractions of unilateral index finger abduction using a transcranial magnetic stimulation (TMS) technique. Ten healthy right-handed subjects participated in this study. We instructed them to perform repetitive isometric contractions of the left index finger abduction following auditory cues at 1 Hz. The force outputs were set at 10, 30, and 50% of maximal voluntary contraction (MVC). Motor evoked potentials (MEP) were obtained from the right and left first dorsal interosseous muscles (FDI). To examine the muscle contraction phase dependence, TMS of ipsi-M1 or contra-M1 was triggered at eight different intervals (0, 20, 40, 60, 80, 100, 300, or 500 ms) after electromyogram (EMG) onset when each interval had reached the setup triggering level. Furthermore, to demonstrate the relationships between the integrated EMG (iEMG) in the active left FDI and the ipsi-M1 excitability, we assessed the correlation between the iEMG in the left FDI for the 100 ms preceding TMS onset and the MEP amplitude in the resting/active FDI for each force output condition. Although contra-M1 excitability was significantly changed after the EMG onset that depends on the muscle contraction phase, the modulation of ipsi-M1 excitability did not differ in response to any muscle contraction phase at the 10% of MVC condition. Also, we found that contra-M1 excitability was significantly correlated with iEMG in all force output conditions, but ipsi-M1 excitability was not at force output levels of below 30% of MVC. Consequently, the modulation of ipsi-M1 excitability was independent from the contraction phase of unilateral repetitive isometric contractions at least low force output.	[Uehara, Kazumasa; Morishita, Takuya; Kubota, Shinji; Funase, Kozo] Hiroshima Univ, Div Human Sci, Human Motor Control Lab, Grad Sch Integrated Arts & Sci, Hiroshima, Japan; [Uehara, Kazumasa; Morishita, Takuya] Japan Soc Promot Sci, Tokyo, Japan	Hiroshima University; Japan Society for the Promotion of Science	Funase, K (corresponding author), Hiroshima Univ, Div Human Sci, Human Motor Control Lab, Grad Sch Integrated Arts & Sci, Hiroshima, Japan.	funase@hiroshima-u.ac.jp	Morishita, Takuya/GLN-4074-2022	Morishita, Takuya/0000-0003-0039-1825; Uehara, Kazumasa/0000-0003-2350-8694	Japan Society for the Promotion of Science [24-393]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for JSPS fellows, 24-393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carson RG, 2004, J PHYSIOL-LONDON, V560, P929, DOI 10.1113/jphysiol.2004.069088; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; Duque J, 2005, CEREB CORTEX, V15, P588, DOI 10.1093/cercor/bhh160; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; Funase K, 1999, NEUROSCI LETT, V271, P25, DOI 10.1016/S0304-3940(99)00467-X; Hayashi MJ, 2008, CEREB CORTEX, V18, P2932, DOI 10.1093/cercor/bhn053; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; HORE J, 1976, J NEUROPHYSIOL, V39, P484, DOI 10.1152/jn.1976.39.3.484; Howatson G, 2011, EUR J NEUROSCI, V33, P978, DOI 10.1111/j.1460-9568.2010.07567.x; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Kasai T, 1999, MUSCLE NERVE, V22, P1419, DOI 10.1002/(SICI)1097-4598(199910)22:10<1419::AID-MUS12>3.0.CO;2-K; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Liepert J, 2001, CLIN NEUROPHYSIOL, V112, P114, DOI 10.1016/S1388-2457(00)00503-4; MILLS KR, 1991, TRENDS NEUROSCI, V14, P401, DOI 10.1016/0166-2236(91)90029-T; Morishita T, 2012, J NEUROPHYSIOL, V107, P3086, DOI 10.1152/jn.00888.2011; Morishita T, 2011, BRAIN RES, V1371, P65, DOI 10.1016/j.brainres.2010.11.049; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Nirkko AC, 2001, NEUROIMAGE, V13, P825, DOI 10.1006/nimg.2000.0739; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Perez MA, 2009, CORTEX, V45, P1065, DOI 10.1016/j.cortex.2008.12.006; Post M, 2009, HUM BRAIN MAPP, V30, P1014, DOI 10.1002/hbm.20562; Rau C, 2003, CLIN NEUROPHYSIOL, V114, P1819, DOI 10.1016/S1388-2457(03)00174-3; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Sehm B, 2010, CEREB CORTEX, V20, P34, DOI 10.1093/cercor/bhp075; Sekiguchi H, 2007, EXP BRAIN RES, V178, P374, DOI 10.1007/s00221-006-0743-9; Sohn YH, 2003, EXP BRAIN RES, V148, P176, DOI 10.1007/s00221-002-1292-5; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; Steinberg O, 2002, EUR J NEUROSCI, V15, P1371, DOI 10.1046/j.1460-9568.2002.01968.x; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; THOMPSON PD, 1991, ELECTROEN CLIN NEURO, V81, P397, DOI 10.1016/0168-5597(91)90029-W; Tinazzi M, 1998, NEUROSCI LETT, V244, P121, DOI 10.1016/S0304-3940(98)00150-5; Uehara K, 2011, NEUROSCI LETT, V488, P22, DOI 10.1016/j.neulet.2010.10.073	36	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55083	10.1371/journal.pone.0055083	http://dx.doi.org/10.1371/journal.pone.0055083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383063	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600064
J	Armenteras, D; Rodriguez, N; Retana, J				Armenteras, Dolors; Rodriguez, Nelly; Retana, Javier			Landscape Dynamics in Northwestern Amazonia: An Assessment of Pastures, Fire and Illicit Crops as Drivers of Tropical Deforestation	PLOS ONE			English	Article							LAND-USE; FORESTS; CONSERVATION; PATTERNS; POLICY; MODIS; COCA	Many studies have identified drivers of deforestation throughout the tropics and, in most cases, have recognised differences in the level of threat. However, only a few have also looked at the temporal and spatial dynamics by which those drivers act, which is critical for assessing the conservation of biodiversity as well as for landscape planning. In this study, we analyse land cover change between 2000 and 2009 in north-western Colombian Amazonia to identify the interactions between the use of fire, cultivation of illicit crops and establishment of pastures, and their impacts on the loss of forest in the region. Yearly analyses were undertaken at randomly selected sample areas to quantify the average areas of transition of land cover types under different landscape compositions: forest-dominated mosaics, pasture mosaics, fire mosaics, and illicit crop mosaics. Our results indicate that despite the fact that forest areas were well-preserved, deforestation occurred at a low annual rate (0.06%). Conversion to pasture was the main factor responsible for forest loss (the area of pastures tripled within forest mosaics over 8 years), and this process was independent of the landscape matrix in which the forests were located. In fire mosaics, burning is a common tool for forest clearing and conversion to pasture. Thus, forests in fire mosaics were highly disturbed and frequently transformed from primary to secondary forests. The use of fire for illicit cropping was not detected, partly due to the small size of common illicit crops. Forest regeneration from pastures and secondary vegetation was observed in areas with large amounts of natural forest. Overall, assuming the continuation of the observed pasture conversion trend and the use of forest fire, we suggest that our results should be incorporated into a spatially explicit and integrated decision support tool to target and focus land-planning activities and policies.	[Armenteras, Dolors; Rodriguez, Nelly] Univ Nacl Colombia, Fac Ciencias, Dept Biol, Lab Ecol Paisaje & Modelac Ecosistemas, Bogota, Colombia; [Retana, Javier] Univ Autonoma Barcelona, Ctr Recerca Ecol & Aplicac Forestals, Bellaterra, Barcelona, Spain; [Retana, Javier] Univ Autonoma Barcelona, Unitat Ecol, Bellaterra, Barcelona, Spain	Universidad Nacional de Colombia; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona	Armenteras, D (corresponding author), Univ Nacl Colombia, Fac Ciencias, Dept Biol, Lab Ecol Paisaje & Modelac Ecosistemas, Bogota, Colombia.	darmenterasp@unal.edu.co	ERASO, NELLY RODRIGUEZ/AGN-6951-2022; Armenteras, Dolors/A-4000-2010; ERASO, NELLY RODRIGUEZ/AAI-8005-2021; Retana, Javier/L-1214-2014	Armenteras, Dolors/0000-0003-0922-7298; Rodriguez Eraso, Nelly/0000-0001-7616-2493; Retana, Javier/0000-0002-7505-9467				Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Arce-Nazario JA, 2007, LANDSCAPE ECOL, V22, P89, DOI 10.1007/s10980-007-9123-5; Ariza Eduardo, 1998, ATLAS CULTURAL AMAZO; Armenteras D, 2006, ECOL INDIC, V6, P353, DOI 10.1016/j.ecolind.2005.03.014; Armenteras D, 2009, BIOL CONSERV, V142, P1411, DOI 10.1016/j.biocon.2009.02.002; Armenteras-Pascual D, 2011, AGR FOREST METEOROL, V151, P279, DOI 10.1016/j.agrformet.2010.11.002; Bradley AV, 2008, ECOL SOC, V13; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 2008, AMBIO, V37, P522, DOI 10.1579/0044-7447-37.7.522; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Fearnside PM, 2007, BRAZ J ECOL, V10, P83; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Instituto Geografico Agustin Codazzi Comision Corografica, 2007, EC CONT COST MAR COL; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; Key C.H, 2006, FIREMON FIRE EFFECTS; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; Meidinger DV, 2003, 011 MIN FOR FOR SCI; Metzger JP, 2002, LANDSCAPE ECOL, V17, P419, DOI 10.1023/A:1021250306481; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; Nevle RJ, 2008, PALAEOGEOGR PALAEOCL, V264, P25, DOI 10.1016/j.palaeo.2008.03.008; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Rodriguez N, 2012, BIOTROPICA, V44, P123, DOI 10.1111/j.1744-7429.2011.00770.x; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Rudel TK, 2006, CONSERV BIOL, V20, P1604, DOI 10.1111/j.1523-1739.2006.00532.x; Soares BS, 2001, BIOSCIENCE, V51, P1059, DOI 10.1641/0006-3568(2001)051[1059:MTSTPO]2.0.CO;2; UNEP (United Nations Environment Program), 2010, LAT AM CAR ENV OUTL, V3; United Nations Office on Drugs and Crime-UNODC, 2009, COL MON CULT COC 200; UNODC, 2010, TRANSF SOC BIOF AS C; Vera-Diaz MD, 2008, ECOL ECON, V65, P420, DOI 10.1016/j.ecolecon.2007.07.015; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007	34	40	45	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54310	10.1371/journal.pone.0054310	http://dx.doi.org/10.1371/journal.pone.0054310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382890	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800044
J	Feriotti, C; Loures, FV; de Araujo, EF; da Costa, TA; Calich, VLG				Feriotti, Claudia; Loures, Flavio V.; de Araujo, Eliseu Frank; da Costa, Tania Alves; Calich, Vera L. G.			Mannosyl-Recognizing Receptors Induce an M1-Like Phenotype in Macrophages of Susceptible Mice but an M2-Like Phenotype in Mice Resistant to a Fungal Infection	PLOS ONE			English	Article							PARACOCCIDIOIDES-BRASILIENSIS CONIDIA; TOLL-LIKE RECEPTORS; C-TYPE LECTINS; NITRIC-OXIDE; CELL-WALL; ALTERNATIVE ACTIVATION; CYTOKINE PRODUCTION; IMMUNE RECOGNITION; INNATE; PHAGOCYTOSIS	In addition to alpha1,3 glucan, mannan and mannan-linked proteins are expressed in the outer layer of Paracoccidioides brasiliensis yeasts. The recognition of mannosyl residues by multiple pathogen recognition receptors, such as the mannose receptor (MR), complement receptor 3 (CR3) and toll-like receptor 4 (TLR4) on macrophage membranes can influence macrophage activation and the mechanisms of innate immunity against fungal pathogens. The aim of this study was to clarify the role of these receptors in the interaction between P. brasiliensis and macrophages from resistant (A/J) and susceptible (B10,A) mice. Therefore, the phagocytic, fungicidal and secretory abilities of macrophages were evaluated in the presence of mannan and antibodies against MR, CR3 and TLR4. We verified that mannan increased and anti-MR antibody decreased the killing ability and nitric oxide production of macrophages. The specific blockade of MR, CR3 and TLR4 by monoclonal antibodies impaired fungal recognition and modulated the production of cytokines. Mannan or P. brasiliensis induced decreased expression of MR and TLR2 on A/J macrophages, whereas CR3, TLR4 and TLR2 were reduced on B10. A cells. Importantly, both mannan and P. brasiliensis induced the production of IL-12 by B10. A macrophages, whereas TGF-beta, TNF-alpha and IL-6 were produced by A/J cells. In addition, B10. A macrophages exhibited a prevalent expression of inducible NO-synthase and SOCS3 (suppressor of cytokine signaling-3), indicating a pro-inflammatory, "M1-like" differentiation. In contrast, the elevated expression of arginase-1, found in inflammatory zone-1 (FIZZ1), YM1 (CHI313, chitinase-like lectin), and SOCS1, typical markers of alternatively activated macrophages, indicates a prevalent "M2-like" differentiation of A/J macrophages. In conclusion, our data reveal that several mannosyl-recognizing receptors coordinate the apparently paradoxical innate response to paracoccidioidomycosis, in which resistance is initially mediated by alternatively activated phagocytes and tolerance to fungal growth, whereas susceptibility is linked to classically activated macrophages and the efficient control of fungal growth.	[Feriotti, Claudia; Loures, Flavio V.; de Araujo, Eliseu Frank; da Costa, Tania Alves; Calich, Vera L. G.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Calich, VLG (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	vlcalich@icb.usp.br	Calich, Vera/G-8367-2011; Feriotti, Claudia/AGG-1092-2022; Loures, Flávio Vieira/B-6913-2012	Calich, Vera/0000-0002-2170-5099; Loures, Flávio Vieira/0000-0001-7711-4063; Feriotti, Claudia/0000-0002-5184-5359	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/14518-2, 05/55327-8]; Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) [23038.027914/2009-32]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Research Grants 04/14518-2 and 05/55327-8, and Coordenadoria de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) Grant 23038.027914/2009-32. The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Apostolopoulos V., 2001, Current Molecular Medicine (Hilversum), V1, P469, DOI 10.2174/1566524013363645; Baida H, 1999, MICROBES INFECT, V1, P273, DOI 10.1016/S1286-4579(99)80022-7; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; BONFIM CV, 2009, MED MYCOL, P1; Brandhorst TT, 2004, J IMMUNOL, V173, P7444, DOI 10.4049/jimmunol.173.12.7444; Briken V, 2011, J LEUKOCYTE BIOL, V90, P839, DOI 10.1189/jlb.0411203; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; CALICH VLG, 1979, CLIN IMMUNOL IMMUNOP, V12, P20, DOI 10.1016/0090-1229(79)90108-9; CALICH VLG, 1985, BRIT J EXP PATHOL, V66, P585; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; CANO LE, 1992, INFECT IMMUN, V60, P2096, DOI 10.1128/IAI.60.5.2096-2100.1992; CANO LE, 1994, INFECT IMMUN, V62, P1494, DOI 10.1128/IAI.62.4.1494-1496.1994; Cano LE, 1998, INFECT IMMUN, V66, P800, DOI 10.1128/IAI.66.2.800-806.1998; CANO LE, 1995, INFECT IMMUN, V63, P1777, DOI 10.1128/IAI.63.5.1777-1783.1995; CARBONELL LM, 1970, J BACTERIOL, V101, P636, DOI 10.1128/JB.101.2.636-642.1970; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Felonato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051071; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Jimenez MD, 2006, FEMS IMMUNOL MED MIC, V47, P56, DOI 10.1111/j.1574-695X.2006.00059.x; KANETSUNA F, 1972, J BACTERIOL, V110, P208, DOI 10.1128/JB.110.1.208-218.1972; KANETSUNA F, 1969, J BACTERIOL, V97, P1036, DOI 10.1128/JB.97.3.1036-1041.1969; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; KASHINO SS, 1990, MYCOPATHOLOGIA, V111, P173, DOI 10.1007/BF02282801; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Levitz SA, 2004, MICROBES INFECT, V6, P1351, DOI 10.1016/j.micinf.2004.08.014; Levitz Stuart M, 2002, Nihon Ishinkin Gakkai Zasshi, V43, P133, DOI 10.3314/jjmm.43.133; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Loures FV, 2011, INFECT IMMUN, V79, P2470, DOI 10.1128/IAI.00375-10; Loures FV, 2010, INFECT IMMUN, V78, P1078, DOI 10.1128/IAI.01198-09; Loures FV, 2009, J IMMUNOL, V183, P1279, DOI 10.4049/jimmunol.0801599; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McKenzie EJ, 2007, J IMMUNOL, V178, P4975, DOI 10.4049/jimmunol.178.8.4975; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakaira-Takahagi E, 2011, MED MYCOL, V49, P694, DOI 10.3109/13693786.2011.565485; Nascimento FRF, 2002, J IMMUNOL, V168, P4593, DOI 10.4049/jimmunol.168.9.4593; Netea MG, 2006, CURR PHARM DESIGN, V12, P4195, DOI 10.2174/138161206778743538; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netto C F, 1969, Rev Inst Med Trop Sao Paulo, V11, P177; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pina A, 2008, J LEUKOCYTE BIOL, V83, P1088, DOI 10.1189/jlb.1107738; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Puccia R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00257; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; SINGERVERMES LM, 1992, J MED VET MYCOL, V30, P261; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Toledo RG, 2010, MOL IMMUNOL, V48, P26, DOI 10.1016/j.molimm.2010.09.015; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; WRIGHT SD, 1983, J EXP MED, V158, P1338, DOI 10.1084/jem.158.4.1338; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020	69	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54845	10.1371/journal.pone.0054845	http://dx.doi.org/10.1371/journal.pone.0054845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382985	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800080
J	Kim, B; Kang, S; Kim, SJ				Kim, Byungtak; Kang, Seongeun; Kim, Sun Jung			Genome-Wide Pathway Analysis Reveals Different Signaling Pathways between Secreted Lactoferrin and Intracellular Delta-Lactoferrin	PLOS ONE			English	Article							MESSENGER-RNA; BREAST-CANCER; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; HOST-DEFENSE; HUMAN RNPS1; EXPRESSION; GENE; TARGET; STRESS	Human lactoferrin (LF) is a multifunctional protein involved in immunomodulation, cellular growth, and differentiation. In addition to its secreted form (sLF), an alternative form (Delta LF) lacking the signal sequence has been found to be downregulated in cancer. Although the signaling pathways mediated by LF have been studied in a few cell models, there have been no relevant systemic approaches. Therefore, this study was carried out to identify and compare signaling networks provoked by the two LF isoforms. For this, the two forms were overexpressed in HEK293 cells using the Flp-In T-Rex system, after which genome-wide expression analysis of 18,367 genes was conducted. Pathway analysis of the genes showing altered expression identified pathways which are responsible for cell survival and apoptosis. In addition, the pathways mediated by the two LF forms were within distantly related networks. GPCR, PI3K complex, and POU5F1, which are involved in receptor-mediated pathways, were centered in the sLF network, whereas RIF1, NOS3, and RNPS1, which are involved in intracellular signaling, were centered in the Delta LF network. These results suggest that structural differences between the LF isoforms, mainly glycosylation, determine the fate of LF signaling. Furthermore, these findings provide information relating to the role of Delta LF which is downregulated during carcinogenesis.	[Kim, Byungtak; Kang, Seongeun; Kim, Sun Jung] Dongguk Univ Seoul, Dept Life Sci, Seoul, South Korea	Dongguk University	Kim, SJ (corresponding author), Dongguk Univ Seoul, Dept Life Sci, Seoul, South Korea.	sunjungk@dongguk.edu	kim, sun jung/T-1013-2019		National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0004157]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0004157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2010, FEBS J, V277, P2051, DOI 10.1111/j.1742-4658.2010.07620.x; Benaissa M, 2005, INT J CANCER, V114, P299, DOI 10.1002/ijc.20728; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandl N, 2010, OSTEOARTHR CARTILAGE, V18, P117, DOI 10.1016/j.joca.2009.08.012; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; CROUCH SPM, 1992, BLOOD, V80, P235; de Jong Jeroen, 2006, Critical Reviews in Oncogenesis, V12, P171; Giancotti V, 2006, CANCER LETT, V243, P145, DOI 10.1016/j.canlet.2006.01.035; Hwang SA, 2009, INT IMMUNOL, V21, P1185, DOI 10.1093/intimm/dxp084; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Kamemori N, 2004, BRAIN RES, V1029, P34, DOI 10.1016/j.brainres.2004.09.015; Kang HS, 2011, MOL CANCER THER, V10, P580, DOI 10.1158/1535-7163.MCT-10-0763; Kettner S, 2007, MOL CELL BIOL, V27, P7718, DOI 10.1128/MCB.00180-07; Kobayashi D, 2011, ONCOL REP, V26, P965, DOI 10.3892/or.2011.1374; Kobayashi D, 2011, INT J ONCOL, V38, P933, DOI 10.3892/ijo.2011.929; Lee SH, 2009, MOL CELLS, V28, P37, DOI 10.1007/s10059-009-0102-3; Lee SH, 2009, BIOCHIMIE, V91, P102, DOI 10.1016/j.biochi.2008.05.004; Lee TH, 1998, MOL CELLS, V8, P530; Legrand D, 2004, BIOMETALS, V17, P225, DOI 10.1023/B:BIOM.0000027696.48707.42; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Legrand D, 2006, BIOCHEM CELL BIOL, V84, P282, DOI 10.1139/O06-045; Lin TY, 2005, BIOCHEM BIOPH RES CO, V337, P330, DOI 10.1016/j.bbrc.2005.09.056; Lu J, 2011, LEUKEMIA, V25, P1211, DOI 10.1038/leu.2011.65; Mariller C, 2007, FEBS J, V274, P2038, DOI 10.1111/j.1742-4658.2007.05747.x; Mariller C, 2012, BIOCHEM CELL BIOL, V90, P307, DOI [10.1139/O11-070, 10.1139/o11-070]; Mariller C, 2009, BIOCHIMIE, V91, P109, DOI 10.1016/j.biochi.2008.07.009; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; Oh SM, 2001, J BIOL CHEM, V276, P42575, DOI 10.1074/jbc.M107724200; Qin Y, 2011, PIGM CELL MELANOMA R, V24, P207, DOI 10.1111/j.1755-148X.2010.00781.x; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Sakashita E, 2004, MOL CELL BIOL, V24, P1174, DOI 10.1128/MCB.24.3.1174-1187.2004; Shiryaev A, 2010, CELL SIGNAL, V22, P1185, DOI 10.1016/j.cellsig.2010.03.002; Siebert PD, 1997, P NATL ACAD SCI USA, V94, P2198, DOI 10.1073/pnas.94.6.2198; Sorimachi K, 1997, BIOCHEM MOL BIOL INT, V43, P79; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; Tseng CK, 2011, RNA, V17, P145, DOI 10.1261/rna.2459611; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Wang HB, 2009, CARCINOGENESIS, V30, P1314, DOI 10.1093/carcin/bgp136; Ward PP, 2002, BIOCHEM CELL BIOL, V80, P95, DOI 10.1139/o01-214; Zajac M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021599	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55338	10.1371/journal.pone.0055338	http://dx.doi.org/10.1371/journal.pone.0055338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383159	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800142
J	Grade, S; Weng, YC; Snapyan, M; Kriz, J; Malva, JO; Saghatelyan, A				Grade, Sofia; Weng, Yuan C.; Snapyan, Marina; Kriz, Jasna; Malva, Joao O.; Saghatelyan, Armen			Brain-Derived Neurotrophic Factor Promotes Vasculature-Associated Migration of Neuronal Precursors toward the Ischemic Striatum	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ADULT OLFACTORY-BULB; CORTICAL INTERNEURON MIGRATION; TRANSIENT FOREBRAIN ISCHEMIA; CEREBRAL-ARTERY OCCLUSION; NEWLY GENERATED NEURONS; BLOOD-VESSELS FORM; SUBVENTRICULAR ZONE; NEUROBLAST MIGRATION; RAT-BRAIN	Stroke induces the recruitment of neuronal precursors from the subventricular zone (SVZ) into the ischemic striatum. In injured areas, de-routed neuroblasts use blood vessels as a physical scaffold to their migration, in a process that resembles the constitutive migration seen in the rostral migratory stream (RMS). The molecular mechanism underlying injury-induced vasculature-mediated migration of neuroblasts in the post-stroke striatum remains, however, elusive. Using adult mice we now demonstrate that endothelial cells in the ischemic striatum produce brain-derived neurotrophic factor (BDNF), a neurotrophin that promotes the vasculature-mediated migration of neuronal precursors in the RMS, and that recruited neuroblasts maintain expression of p75NTR, a low-affinity receptor for BDNF. Reactive astrocytes, which are widespread throughout the damaged area, ensheath blood vessels and express TrkB, a high-affinity receptor for BDNF. Despite the absence of BDNF mRNA, we observed strong BDNF immunolabeling in astrocytes, suggesting that these glial cells trap extracellular BDNF. Importantly, this pattern of expression is reminiscent of the adult RMS, where TrkB-expressing astrocytes bind and sequester vasculature-derived BDNF, leading to the entry of migrating cells into the stationary phase. Real-time imaging of cell migration in acute brain slices revealed a direct role for BDNF in promoting the migration of neuroblasts to ischemic areas. We also demonstrated that cells migrating in the ischemic striatum display higher exploratory behavior and longer stationary periods than cells migrating in the RMS. Our findings suggest that the mechanisms involved in the injury-induced vasculature-mediated migration of neuroblasts recapitulate, at least partially, those observed during constitutive migration in the RMS.	[Grade, Sofia; Snapyan, Marina; Saghatelyan, Armen] Inst Sante Mentale Quebec, Cellular Neurobiol Unit, Quebec City, PQ, Canada; [Grade, Sofia; Malva, Joao O.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Weng, Yuan C.; Kriz, Jasna] Univ Laval, Ctr Rech CHUL CHUQ, Quebec City, PQ, Canada; [Kriz, Jasna; Saghatelyan, Armen] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Malva, Joao O.] Univ Coimbra, Fac Med Polo 3, Ctr Res Environm Genet & Oncobiol CIMAGO, Coimbra, Portugal	Universidade de Coimbra; Laval University; Laval University; Universidade de Coimbra	Saghatelyan, A (corresponding author), Inst Sante Mentale Quebec, Cellular Neurobiol Unit, Quebec City, PQ, Canada.	armen.saghatelyan@crulrg.ulaval.ca	Grade, Sofia/Q-3967-2018; Grade, Sofia/AAM-6236-2021; Malva, Joao/L-3557-2014	Grade, Sofia/0000-0003-1873-5550; Malva, Joao/0000-0002-5438-4447; Saghatelyan, Armen/0000-0003-4962-0465	Canadian Institutes of Health Research (CIHR) [110947]; Fundacao Portuguesa para a Ciencia e a Tecnologia (FCT) [SFRH/BD/32953/2006]; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); Canada Research Chair in postnatal neurogenesis [950-218183]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fundacao Portuguesa para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); Canada Research Chair in postnatal neurogenesis	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) to A.S. (MOP #110947), and student scholarships from Fundacao Portuguesa para a Ciencia e a Tecnologia (FCT; SFRH/BD/32953/2006) and Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT; merit scholarship program for foreign students) to S.G. A.S. is the recipient of a Canada Research Chair in postnatal neurogenesis (950-218183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED S, 1995, J NEUROSCI, V15, P5765; Andsberg G, 2001, EXP NEUROL, V169, P351, DOI 10.1006/exnr.2001.7646; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Bath KG, 2012, DEV PSYCHOL IN PRESS; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; COMELLI MC, 1993, NEUROSCIENCE, V55, P473, DOI 10.1016/0306-4522(93)90517-J; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; Dougherty KD, 1999, J COMP NEUROL, V407, P77, DOI 10.1002/(SICI)1096-9861(19990428)407:1<77::AID-CNE6>3.0.CO;2-S; Engel O, 2011, JOVE-J VIS EXP, DOI 10.3791/2423; Angelo MF, 2009, J NEUROSCI RES, V87, P1892, DOI 10.1002/jnr.21993; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Garcia-Marques J, 2010, GLIA, V58, P218, DOI 10.1002/glia.20918; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Keiner S, 2009, J NEUROPATH EXP NEUR, V68, P83, DOI 10.1097/NEN.0b013e31819308e9; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kokaia Z, 1998, EXP NEUROL, V154, P289, DOI 10.1006/exnr.1998.6888; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Larsson E, 1999, J CEREBR BLOOD F MET, V19, P1220, DOI 10.1097/00004647-199911000-00006; LEE TH, 1995, J NEUROSCI RES, V41, P684, DOI 10.1002/jnr.490410515; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; Narumiya S, 1998, BRAIN RES, V797, P278, DOI 10.1016/S0006-8993(98)00385-0; Nygren J, 2006, J NEUROSCI RES, V84, P626, DOI 10.1002/jnr.20956; Oderfeld-Nowak B, 2003, NEUROSCIENCE, V120, P31, DOI 10.1016/S0306-4522(03)00289-6; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Polleux F, 2002, DEVELOPMENT, V129, P3147; Reichardt LF, 2003, NATURE, V426, P25, DOI 10.1038/426025a; Saarelainen T, 2000, MOL CELL NEUROSCI, V16, P87, DOI 10.1006/mcne.2000.0863; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; TAKEDA A, 1993, NEUROSCIENCE, V55, P23, DOI 10.1016/0306-4522(93)90451-K; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Wong JYF, 1997, EXP NEUROL, V148, P83, DOI 10.1006/exnr.1997.6670; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zermeno V, 2009, INT J BIOL SCI, V5, P118; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	65	100	109	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55039	10.1371/journal.pone.0055039	http://dx.doi.org/10.1371/journal.pone.0055039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383048	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200015
J	Xavier, GM; Panousopoulos, L; Cobourne, MT				Xavier, Guilherme M.; Panousopoulos, Leonidas; Cobourne, Martyn T.			Scube3 Is Expressed in Multiple Tissues during Development but Is Dispensable for Embryonic Survival in the Mouse	PLOS ONE			English	Article							CELL-SURFACE GLYCOPROTEIN; FACTOR-RELATED GENE; HEDGEHOG SIGNAL; PROTEIN SCUBE1; CUB DOMAIN; ZEBRAFISH; SECRETION; RANGE; MICE	The vertebrate Scube family consists of three independent members Scube1-3; which encode secreted cell surface-associated membrane glycoproteins that share a domain organization of at least five recognizable motifs and the ability to both homo-and heterodimerize. There is recent biochemical evidence to suggest that Scube2 is directly involved in Hedgehog signaling, acting co-operatively with Dispatched to mediate the release in soluble form of cholesterol and palmitate-modified Hedgehog ligand during long-range activity. Indeed, in the zebrafish myotome, all three Scube proteins can subtly promote Hedgehog signal transduction in a non-cell autonomous manner. In order to further investigate the role of Scube genes during development, we have generated mice with targeted inactivation of Scube3. Despite a dynamic developmental expression pattern, with transcripts present in neuroectoderm, endoderm and endochondral tissues, particularly within the craniofacial region; an absence of Scube3 function results in no overt embryonic phenotype in the mouse. Mutant mice are born at expected Mendelian ratios, are both viable and fertile, and seemingly retain normal Hedgehog signaling activity in craniofacial tissues. These findings suggest that in the mouse, Scube3 is dispensable for normal development; however, they do not exclude the possibility of a co-operative role for Scube3 with other Scube members during embryogenesis or a potential role in adult tissue homeostasis over the long-term.	[Xavier, Guilherme M.; Panousopoulos, Leonidas; Cobourne, Martyn T.] Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England; [Cobourne, Martyn T.] Kings Coll London, Inst Dent, Dept Orthodonticsm, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Cobourne, MT (corresponding author), Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England.	martyn.cobourne@kcl.ac.uk	Cobourne, Martyn/R-1165-2019	Cobourne, Martyn/0000-0003-2857-0315	European Union [E07D400355BR]	European Union(European Commission)	Author GMX was funded by the European Union ALBAN Programme, Contract Grant Number E07D400355BR. http://www.welcomeurope.com/european-funds/alban-409+309.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron MJ, 2010, HUM MOL GENET, V19, P1230, DOI 10.1093/hmg/ddq001; Creanga A, 2012, GENE DEV, V26, P1312, DOI 10.1101/gad.191866.112; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grimmond S, 2001, MECH DEVELOP, V102, P209, DOI 10.1016/S0925-4773(00)00586-4; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Haworth K, 2007, GENE EXPR PATTERNS, V7, P630, DOI 10.1016/j.modgep.2006.12.004; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; Tu CF, 2006, CARDIOVASC RES, V71, P486, DOI 10.1016/j.cardiores.2006.04.010; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Xavier GM, 2009, J EXP ZOOL PART B, V312B, P518, DOI 10.1002/jez.b.21260; Xavier GM, 2011, J MOL HISTOL, V42, P383, DOI 10.1007/s10735-011-9341-7; Xavier GM, 2010, GENESIS, V48, P684, DOI 10.1002/dvg.20678; Yang HY, 2007, CARDIOVASC RES, V75, P139, DOI 10.1016/j.cardiores.2007.03.014; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200	22	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55274	10.1371/journal.pone.0055274	http://dx.doi.org/10.1371/journal.pone.0055274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383134	Green Submitted, gold, Green Published			2022-12-27	WOS:000315483200018
J	Tu, CT; Chen, BS				Tu, Chien-Ta; Chen, Bor-Sen			New Measurement Methods of Network Robustness and Response Ability via Microarray Data	PLOS ONE			English	Article							H-INFINITY CONTROL; OXIDATIVE STRESS; GENE-EXPRESSION; CELLS; SYSTEMS; DESIGN; CANCER; CARCINOGENESIS; MECHANISMS; DIVERSE	"Robustness'', the network ability to maintain systematic performance in the face of intrinsic perturbations, and "response ability'', the network ability to respond to external stimuli or transduce them to downstream regulators, are two important complementary system characteristics that must be considered when discussing biological system performance. However, at present, these features cannot be measured directly for all network components in an experimental procedure. Therefore, we present two novel systematic measurement methods - Network Robustness Measurement (NRM) and Response Ability Measurement (RAM) - to estimate the network robustness and response ability of a gene regulatory network (GRN) or protein-protein interaction network (PPIN) based on the dynamic network model constructed by the corresponding microarray data. We demonstrate the efficiency of NRM and RAM in analyzing GRNs and PPINs, respectively, by considering aging- and cancer-related datasets. When applied to an aging-related GRN, our results indicate that such a network is more robust to intrinsic perturbations in the elderly than in the young, and is therefore less responsive to external stimuli. When applied to a PPIN of fibroblast and HeLa cells, we observe that the network of cancer cells possesses better robustness than that of normal cells. Moreover, the response ability of the PPIN calculated from the cancer cells is lower than that from healthy cells. Accordingly, we propose that generalized NRM and RAM methods represent effective tools for exploring and analyzing different systems-level dynamical properties via microarray data. Making use of such properties can facilitate prediction and application, providing useful information on clinical strategy, drug target selection, and design specifications of synthetic biology from a systems biology perspective.	[Tu, Chien-Ta; Chen, Bor-Sen] Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Chen, Bor-Sen/D-9114-2017		National Science Council of Taiwan [NSC 99-2745-E-007-001-ASP, NSC 100-2745-E-007-001-ASP]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan with grants NSC 99-2745-E-007-001-ASP and NSC 100-2745-E-007-001-ASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boyd SP, 1994, SOC IND APPL MATH, Vix; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen BS, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-66; Chen BS, 2004, IEEE T AUTOMAT CONTR, V49, P45, DOI 10.1109/TAC.2003.821400; CHEN BS, 1994, INT J CONTROL, V59, P439, DOI 10.1080/00207179408923085; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Doyle JC, 1992, FEEDBACK CONTROL THE; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Irmak MB, 2003, CANCER RES, V63, P6707; Johansson R., 1993, SYSTEM MODELING IDEN; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klipp E, 2005, SYSTEMS BIOLOGY IN PRACTICE: CONCEPTS, IMPLEMENTATION AND APPLICATION, P1, DOI 10.1002/3527603603; Kuo B., 2009, AUTOMATIC CONTROL SY; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; Lin CL, 2000, IEEE T NEURAL NETWOR, V11, P1078, DOI 10.1109/72.870041; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Schneider BL, 2004, CARCINOGENESIS, V25, P2033, DOI 10.1093/carcin/bgh204; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Troyanskaya OG, 2005, BRIEF BIOINFORM, V6, P34, DOI 10.1093/bib/6.1.34; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Yan J, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031909; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhang SH, 2007, PROTEOMICS, V7, P2856, DOI 10.1002/pmic.200700095; Zhang WH, 2006, SIAM J CONTROL OPTIM, V44, P1973, DOI 10.1137/S0363012903423727; Zhu DX, 2005, BIOINFORMATICS, V21, P4014, DOI 10.1093/bioinformatics/bti655	45	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55230	10.1371/journal.pone.0055230	http://dx.doi.org/10.1371/journal.pone.0055230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383119	gold, Green Submitted, Green Published			2022-12-27	WOS:000315211500066
J	Delpu, Y; Lulka, H; Sicard, F; Saint-Laurent, N; Lopez, F; Hanoun, N; Buscail, L; Cordelier, P; Torrisani, J				Delpu, Yannick; Lulka, Hubert; Sicard, Flavie; Saint-Laurent, Nathalie; Lopez, Frederic; Hanoun, Naima; Buscail, Louis; Cordelier, Pierre; Torrisani, Jerome			The Rescue of miR-148a Expression in Pancreatic Cancer: An Inappropriate Therapeutic Tool	PLOS ONE			English	Article							CELL-PROLIFERATION; GASTRIC-CANCER; TUMOR PROGRESSION; CARCINOGENESIS; MICRORNA-148A; METASTASIS; CARCINOMA	MicroRNAs are small non-coding RNAs that physiologically modulate proteins expression, and regulate numerous cellular mechanisms. Alteration of microRNA expression has been described in cancer and is associated to tumor initiation and progression. The microRNA 148a (miR-148a) is frequently down-regulated in cancer. We previously demonstrated that its down-regulation by DNA hypermethylation is an early event in pancreatic ductal adenocarcinoma (PDAC) carcinogenesis, suggesting a tumor suppressive function. Here, we investigate the potential role of miR-148a over-expression in PDAC as a therapeutic tool. We first report the consequences of miR-148a over-expression in PDAC cell lines. We demonstrate that miR-148a over-expression has no dramatic effect on cell proliferation and cell chemo-sensitivity in four well described PDAC cell lines. We also investigate the modulation of protein expression by a global proteomic approach (2D-DIGE). We show that despite its massive over-expression, miR-148a weakly modulates protein expression, thus preventing the identification of protein targets in PDAC cell lines. More importantly, in vivo data demonstrate that modulating miR-148a expression either in the epithelia tumor cells and/or in the tumor microenvironment does not impede tumor growth. Taken together, we demonstrate herein that miR-148a does not impact PDAC proliferation both in vitro and in vivo thus suggesting a weak potential as a therapeutic tool.	[Delpu, Yannick; Lulka, Hubert; Sicard, Flavie; Hanoun, Naima; Buscail, Louis; Cordelier, Pierre; Torrisani, Jerome] Univ Toulouse 3, INSERM UMR 1037, CRCT, Univ Hosp Ctr Rangeuil, F-31062 Toulouse, France; [Delpu, Yannick; Lulka, Hubert; Sicard, Flavie; Saint-Laurent, Nathalie; Lopez, Frederic; Hanoun, Naima; Buscail, Louis; Cordelier, Pierre; Torrisani, Jerome] Univ Toulouse 3, F-31062 Toulouse, France; [Buscail, Louis] Univ Hosp Ctr Rangueil Larrey, Dept Gastroenterol, Toulouse, France; [Saint-Laurent, Nathalie; Lopez, Frederic] Univ Hosp Ctr Rangueil, Basic & Clin Prote Grp, INSERM UMR 1037, Canc Res Ctr Toulouse, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Torrisani, J (corresponding author), Univ Toulouse 3, INSERM UMR 1037, CRCT, Univ Hosp Ctr Rangeuil, F-31062 Toulouse, France.	jerome.torrisani@inserm.fr	Nathalie, Saint-Laurent/G-5487-2017; Cordelier, Pierre/D-1150-2014; LULKA, Hubert/M-7382-2014; hanoun, naima NH/M-6408-2014; Torrisani, Jérôme/M-6203-2014	Cordelier, Pierre/0000-0003-2096-7967; Torrisani, Jérôme/0000-0001-6880-9357	Institut National de la Santee et de la Recherche Medicale (INSERM); Association pour la Recherche sur le Cancer (ARC); Toulouse Proteomics Infrastructure; "Association pour la Recherche sur le Cancer" (ARC-ARECA Program)	Institut National de la Santee et de la Recherche Medicale (INSERM); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Toulouse Proteomics Infrastructure; "Association pour la Recherche sur le Cancer" (ARC-ARECA Program)	This work was funded by the Institut National de la Santee et de la Recherche Medicale (INSERM, www.inserm.fr) and the Association pour la Recherche sur le Cancer (ARC, www.arc-cancer.net). Proteomics studies were supported by the Toulouse Proteomics Infrastructure with financial support of "Association pour la Recherche sur le Cancer" (ARC-ARECA Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen Y, 2010, J GASTROINTEST SURG, V14, P1170, DOI 10.1007/s11605-010-1202-2; Chung E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008316; Delpu Y, 2011, CURR GENOMICS, V12, P15, DOI 10.2174/138920211794520132; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Guo SL, 2011, INT J BIOL SCI, V7, P567, DOI 10.7150/ijbs.7.567; Hanoun N, 2010, J HEPATOL, V53, P880, DOI 10.1016/j.jhep.2010.04.038; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hummel R, 2011, J GASTROINTEST SURG, V15, P429, DOI 10.1007/s11605-011-1418-9; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kutanzi KR, 2011, CLIN EPIGENETICS, V2, P171, DOI 10.1007/s13148-011-0040-8; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Liffers ST, 2011, LAB INVEST, V91, P1472, DOI 10.1038/labinvest.2011.99; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Vincent A, 2004, LANCET, V363, P1049; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zhou X, 2012, ONCOL REP, V27, P447, DOI 10.3892/or.2011.1482	28	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55513	10.1371/journal.pone.0055513	http://dx.doi.org/10.1371/journal.pone.0055513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383211	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600116
J	Teraa, M; Sprengers, RW; Westerweel, PE; Gremmels, H; Goumans, MJTH; Teerlink, T; Moll, FL; Verhaar, MC				Teraa, Martin; Sprengers, Ralf W.; Westerweel, Peter E.; Gremmels, Hendrik; Goumans, Marie-Jose T. H.; Teerlink, Tom; Moll, Frans L.; Verhaar, Marianne C.		JUVENTAS Study Grp	Bone Marrow Alterations and Lower Endothelial Progenitor Cell Numbers in Critical Limb Ischemia Patients	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ASYMMETRIC DIMETHYLARGININE; INDUCED NEOVASCULARIZATION; THERAPEUTIC IMPLICATIONS; RHEUMATOID-ARTHRITIS; MONONUCLEAR-CELLS; RISK-FACTORS; T-CELLS; MOBILIZATION; DISEASE	Background: Critical limb ischemia (CLI) is characterized by lower extremity artery obstruction and a largely unexplained impaired ischemic neovascularization response. Bone marrow (BM) derived endothelial progenitor cells (EPC) contribute to neovascularization. We hypothesize that reduced levels and function of circulating progenitor cells and alterations in the BM contribute to impaired neovascularization in CLI. Methods: Levels of primitive (CD34(+) and CD133(+)) progenitors and CD34(+) KDR+ EPC were analyzed using flow cytometry in blood and BM from 101 CLI patients in the JUVENTAS-trial (NCT00371371) and healthy controls. Blood levels of markers for endothelial injury (sE-selectin, sICAM-1, sVCAM-1, and thrombomodulin), and progenitor cell mobilizing and inflammatory factors were assessed by conventional and multiplex ELISA. BM levels and activity of the EPC mobilizing protease MMP-9 were assessed by ELISA and zymography. Circulating angiogenic cells (CAC) were cultured and their paracrine function was assessed. Results: Endothelial injury markers were higher in CLI (P<0.01). CLI patients had higher levels of VEGF, SDF-1 alpha, SCF, G-CSF (P<0.05) and of IL-6, IL-8 and IP-10 (P<0.05). Circulating EPC and BM CD34(+) cells (P<0.05), lymphocytic expression of CXCR4 and CD26 in BM (P<0.05), and BM levels and activity of MMP-9 (P<0.01) were lower in CLI. Multivariate regression analysis showed an inverse association between IL-6 and BM CD34(+) cell levels (P = 0.007). CAC from CLI patients had reduced paracrine function (P<0.0001). Conclusion: CLI patients have reduced levels of circulating EPC, despite profound endothelial injury and an EPC mobilizing response. Moreover, CLI patients have lower BM CD34(+)-cell levels, which were inversely associated with the inflammatory marker IL-6, and lower BM MMP-9 levels and activity. The results of this study suggest that inflammation-induced BM exhaustion and a disturbed progenitor cell mobilization response due to reduced levels and activity of MMP-9 in the BM and alterations in the SDF-1 alpha/CXCR4 interaction contribute to the attenuated neovascularization in CLI patients.	[Teraa, Martin; Gremmels, Hendrik; Verhaar, Marianne C.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Teraa, Martin; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Sprengers, Ralf W.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Westerweel, Peter E.] Univ Med Ctr Utrecht, Dept Haematol, Utrecht, Netherlands; [Goumans, Marie-Jose T. H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Teerlink, Tom] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Verhaar, MC (corresponding author), Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands.	m.c.verhaar@umcutrecht.nl	Verhaar, Marianne/AAM-6788-2020; Gremmels, Hendrik/G-3185-2012; Teraa, Martin/A-2508-2012; Mali, Willem PThM/I-1123-2014; Goumans, Marie-José/AAG-4994-2021; Goumans, Marie Jose/U-1455-2019; Stefanadis, Christodoulos/ABH-2232-2020	Verhaar, Marianne/0000-0002-3276-6428; Gremmels, Hendrik/0000-0002-7818-620X; Teraa, Martin/0000-0002-6751-6752; Mali, Willem PThM/0000-0003-4391-0904; Goumans, Marie Jose/0000-0001-9344-6746; Stefanadis, Christodoulos/0000-0001-5974-6454	"Stichting Vrienden UMC Utrecht" of Dirkzwager-Assink foundation (The Netherlands) [CS 06.007]; Dutch Heart Foundation (The Netherlands) [2008B094]; the Netherlands Organisation for Scientific Research (The Netherlands) [116001026]; foundation "De Drie Lichten" (The Netherlands) [10/06]; the Netherlands Organisation for Scientific Research (NWO) (The Netherlands) [016.096.359]	"Stichting Vrienden UMC Utrecht" of Dirkzwager-Assink foundation (The Netherlands)(Netherlands Government); Dutch Heart Foundation (The Netherlands)(Netherlands Heart FoundationNetherlands Government); the Netherlands Organisation for Scientific Research (The Netherlands); foundation "De Drie Lichten" (The Netherlands)(Netherlands Government); the Netherlands Organisation for Scientific Research (NWO) (The Netherlands)	The reported work was supported by the "Stichting Vrienden UMC Utrecht" on behalf of the Dirkzwager-Assink foundation (The Netherlands, grant CS 06.007, www.vriendenumcutrecht.nl), The Dutch Heart Foundation (The Netherlands, grant 2008B094, www.hartstichting.nl), the Netherlands Organisation for Scientific Research (The Netherlands, ZonMw-TAS grant 116001026, www.zonmw.nl) and foundation "De Drie Lichten" (The Netherlands, grant 10/06). M.C. Verhaar is supported by the Netherlands Organisation for Scientific Research (NWO) (The Netherlands, Vidi grant 016.096.359, www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Belotti D, 2008, MOL CANCER RES, V6, P525, DOI 10.1158/1541-7786.MCR-07-0366; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Chen MC, 2009, DIABETIC MED, V26, P134, DOI 10.1111/j.1464-5491.2008.02649.x; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Cobellis G, 2010, CELL TRANSPLANT, V19, P1425, DOI 10.3727/096368910X509068; de Jong S, 2006, ANAL BIOCHEM, V353, P287, DOI 10.1016/j.ab.2006.03.010; de Kleijn DPV, 2001, FEBS LETT, V501, P37, DOI 10.1016/S0014-5793(01)02622-9; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fox A, 2008, BRIT J SURG, V95, P244, DOI 10.1002/bjs.5913; Grisar J, 2007, ANN RHEUM DIS, V66, P1284, DOI 10.1136/ard.2006.066605; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Herder C, 2011, ATHEROSCLEROSIS, V216, P244, DOI 10.1016/j.atherosclerosis.2011.01.041; Hirata Y, 2010, INT HEART J, V51, P1, DOI 10.1536/ihj.51.1; Hirsch AT, 2001, VASC MED, V6, P87, DOI 10.1191/135886301701568756; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Hung HS, 2009, CELL TRANSPLANT, V18, P1003, DOI 10.3727/096368909X12483162196683; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Iyer V, 2012, CANCER RES, V72, P2705, DOI 10.1158/0008-5472.CAN-11-3287; Jie KE, 2010, NEPHROL DIAL TRANSPL, V25, P1875, DOI 10.1093/ndt/gfp749; Kissel CK, 2007, J AM COLL CARDIOL, V49, P2341, DOI 10.1016/j.jacc.2007.01.095; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Morishita T, 2012, J ATHEROSCLER THROMB, V19, P149, DOI 10.5551/jat.10074; Nikolaisen C, 2008, J RHEUMATOL, V35, P380; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Oda M, 2012, HEART VESSELS, V27, P38, DOI 10.1007/s00380-011-0125-5; Palombo C, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-88; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Scheubel RJ, 2010, INT J CARDIOL, V139, P134, DOI 10.1016/j.ijcard.2008.10.009; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Sprengers RW, 2010, J VASC SURG, V51, P1564, DOI 10.1016/j.jvs.2010.02.020; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang CH, 2008, AM J PHYSIOL-REG I, V294, pR811, DOI 10.1152/ajpregu.00543.2007; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Westerweel PE, 2007, ANN RHEUM DIS, V66, P865, DOI 10.1136/ard.2006.065631; Zhu JH, 2008, RESP MED, V102, P1073, DOI 10.1016/j.rmed.2007.12.030	52	48	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55592	10.1371/journal.pone.0055592	http://dx.doi.org/10.1371/journal.pone.0055592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383236	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600131
J	Chen, J; Zhang, JG; Li, J; Pei, YF; Deng, HW				Chen, Jun; Zhang, Ji-Gang; Li, Jian; Pei, Yu-Fang; Deng, Hong-Wen			On Combining Reference Data to Improve Imputation Accuracy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HAPLOTYPE RECONSTRUCTION; GENOTYPE IMPUTATION; INFERENCE; SEQUENCE	Genotype imputation is an important tool in human genetics studies, which uses reference sets with known genotypes and prior knowledge on linkage disequilibrium and recombination rates to infer un-typed alleles for human genetic variations at a low cost. The reference sets used by current imputation approaches are based on HapMap data, and/or based on recently available next-generation sequencing (NGS) data such as data generated by the 1000 Genomes Project. However, with different coverage and call rates for different NGS data sets, how to integrate NGS data sets of different accuracy as well as previously available reference data as references in imputation is not an easy task and has not been systematically investigated. In this study, we performed a comprehensive assessment of three strategies on using NGS data and previously available reference data in genotype imputation for both simulated data and empirical data, in order to obtain guidelines for optimal reference set construction. Briefly, we considered three strategies: strategy 1 uses one NGS data as a reference; strategy 2 imputes samples by using multiple individual data sets of different accuracy as independent references and then combines the imputed samples with samples based on the high accuracy reference selected when overlapping occurs; and strategy 3 combines multiple available data sets as a single reference after imputing each other. We used three software (MACH, IMPUTE2 and BEAGLE) for assessing the performances of these three strategies. Our results show that strategy 2 and strategy 3 have higher imputation accuracy than strategy 1. Particularly, strategy 2 is the best strategy across all the conditions that we have investigated, producing the best accuracy of imputation for rare variant. Our study is helpful in guiding application of imputation methods in next generation association analyses.	[Chen, Jun; Zhang, Ji-Gang; Li, Jian; Pei, Yu-Fang; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Bioinformat & Genom, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Deng, Hong-Wen] Beijing Jiaotong Univ, Coll Life Sci & Bioengn, Beijing, Peoples R China	Tulane University; University of Shanghai for Science & Technology; Beijing Jiaotong University	Deng, HW (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Bioinformat & Genom, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA.	hdeng2@tulane.edu	Li, Jian/G-4445-2015	Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [P50AR055081, R01AG026564, R01AR050496, R01AR057049, R03TW008221]; Edward G. Schlieder Endowment; Tulane University; Shanghai Leading Academic Discipline Project [S30501]; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR059781, R01AR050496, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward G. Schlieder Endowment; Tulane University; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The investigators of this work were partially supported by grants from the National Institutes of Health (P50AR055081, R01AG026564, R01AR050496, R01AR057049, and R03TW008221), and the Edward G. Schlieder Endowment and startup funds from Tulane University. The work was also benefited by Shanghai Leading Academic Discipline Project (S30501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Johnson PLF, 2008, MOL BIOL EVOL, V25, P199, DOI 10.1093/molbev/msm239; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024945; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lynch M, 2009, GENETICS, V182, P295, DOI 10.1534/genetics.109.100479; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Wang ZM, 2012, NAT GENET, V44, P6, DOI 10.1038/ng.1044	28	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55600	10.1371/journal.pone.0055600	http://dx.doi.org/10.1371/journal.pone.0055600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383238	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800173
J	Curwin, AJ; LeBlanc, MA; Fairn, GD; McMaster, CR				Curwin, Amy J.; LeBlanc, Marissa A.; Fairn, Gregory D.; McMaster, Christopher R.			Localization of Lipid Raft Proteins to the Plasma Membrane Is a Major Function of the Phospholipid Transfer Protein Sec14	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL-TRANSFER PROTEIN; OXYSTEROL-BINDING-PROTEIN; YEAST GOLGI-COMPLEX; SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; TRANSPORT; PHOSPHATIDYLCHOLINE; SPHINGOLIPIDS; PATHWAY; HOMEOSTASIS	The Sec14 protein domain is a conserved tertiary structure that binds hydrophobic ligands. The Sec14 protein from Saccharomyces cerevisiae is essential with studies of S. cerevisiae Sec14 cellular function facilitated by a sole temperature sensitive allele, sec14(ts). The sec14(ts) allele encodes a protein with a point mutation resulting in a single amino acid change, Sec14(G266D). In this study results from a genome-wide genetic screen, and pharmacological data, provide evidence that the Sec14(G266D) protein is present at a reduced level compared to wild type Sec14 due to its being targeted to the proteosome. Increased expression of the sec14(ts) allele ameliorated growth arrest, but did not restore the defects in membrane accumulation or vesicular transport known to be defective in sec14(ts) cells. We determined that trafficking and localization of two well characterized lipid raft resident proteins, Pma1 and Fus-Mid-GFP, were aberrant in sec14(ts) cells. Localization of both lipid raft proteins was restored upon increased expression of the sec14(ts) allele. We suggest that a major function provided by Sec14 is trafficking and localization of lipid raft proteins.	[Curwin, Amy J.; LeBlanc, Marissa A.; Fairn, Gregory D.; McMaster, Christopher R.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada.	Christopher.mcmaster@dal.ca	Curwin, Amy/O-8816-2015	Curwin, Amy/0000-0003-1086-2483; Fairn, Greg/0000-0001-6508-168X; McMaster, Christopher/0000-0003-0822-5776	Canadian Institutes for Health Research [14124]; Canada Research Chairs Fund; Nova Scotia Health Research Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Fund(Canada Research Chairs); Nova Scotia Health Research Foundation	This work was supported by an operating grant (14124) from the Canadian Institutes for Health Research and the Canada Research Chairs Fund to CRM. MAL was the recipient of a Nova Scotia Health Research Foundation PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresta-Branco F, 2011, J BIOL CHEM, V286, P5043, DOI 10.1074/jbc.M110.154435; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Chang HJ, 2002, GENETICS, V162, P29; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Curwin AJ, 2009, J BIOL CHEM; Curwin AJ, 2008, FUTURE LIPIDOL, V3, P399, DOI 10.2217/17460875.3.4.399; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Dohmen RJ, 2007, BBA-MOL CELL RES, V1773, P1599, DOI 10.1016/j.bbamcr.2007.05.015; Fairn GD, 2005, METHODS, V36, P102, DOI 10.1016/j.ymeth.2004.11.005; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; Henneberry AL, 2001, MOL BIOL CELL, V12, P511, DOI 10.1091/mbc.12.3.511; Howe AG, 2007, EUKARYOT CELL, V6, P1814, DOI 10.1128/EC.00087-07; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; LeBlanc MA, 2010, J BIOL CHEM, V285, P33875, DOI 10.1074/jbc.M110.147264; LEE WC, 1992, MOL CELL BIOL, V12, P3865, DOI 10.1128/MCB.12.9.3865; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Mueller NS, 2012, MOL MEMBR BIOL, V29, P186, DOI 10.3109/09687688.2012.687461; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Ram RJ, 2002, MOL BIOL CELL, V13, P1484, DOI 10.1091/mbc.01-10-0495; Ryan MM, 2007, MOL BIOL CELL, V18, P1928, DOI 10.1091/mbc.E06-11-1024; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; SATO K, 1995, MOL BIOL CELL, V6, P1459, DOI 10.1091/mbc.6.11.1459; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stolz J, 2002, J BIOL CHEM, V277, P44801, DOI 10.1074/jbc.M208023200; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117; Zaremberg V, 2005, J BIOL CHEM, V280, P38047, DOI 10.1074/jbc.M502849200; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002	53	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55388	10.1371/journal.pone.0055388	http://dx.doi.org/10.1371/journal.pone.0055388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383173	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800146
J	dos Santos, MG; Muxel, SM; Zampieri, RA; Pomorski, TG; Floeter-Winter, LM				dos Santos, Marcos Gonzaga; Muxel, Sandra Marcia; Zampieri, Ricardo Andrade; Pomorski, Thomas Gunther; Floeter-Winter, Lucile Maria			Transbilayer Dynamics of Phospholipids in the Plasma Membrane of the Leishmania Genus	PLOS ONE			English	Article							MILTEFOSINE TRANSPORTER; DRUG-RESISTANCE; LIPID MOVEMENT; PHOSPHATIDYLSERINE; PROMASTIGOTES; TRANSLOCATION; DONOVANI; OVEREXPRESSION; TRAFFICKING; ASYMMETRY	Protozoans of the Leishmania genus are the etiological agents of a wide spectrum of diseases commonly known as leishmaniases. Lipid organization of the plasma membrane of the parasite may mimic the lipid organization of mammalian apoptotic cells and play a role in phagocytosis and parasite survival in the mammal host. Here, we analyzed the phospholipid dynamics in the plasma membrane of both the L. (Leishmania) and the L. (Viannia) subgenera. We found that the activity and substrate specificity of the inward translocation machinery varied between Leishmania species. The differences in activity of inward phospholipid transport correlated with the different sensitivities of the various species towards the alkyl-phospholipid analogue miltefosine. Furthermore, all species exhibited a phospholipid scramblase activity in their plasma membranes upon stimulation with calcium ionophores. However, binding of annexin V to the parasite surface was only detected for a subpopulation of parasites during the stationary growth phase and only marginally enhanced by scramblase activation.	[dos Santos, Marcos Gonzaga; Muxel, Sandra Marcia; Zampieri, Ricardo Andrade; Floeter-Winter, Lucile Maria] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Pomorski, Thomas Gunther] Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol, Frederiksberg, Denmark	Universidade de Sao Paulo; Danmarks Grundforskningsfond; University of Copenhagen	Pomorski, TG (corresponding author), Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol, Frederiksberg, Denmark.	tgp@life.ku.dk; lucile@ib.usp.br	Floeter-Winter, Lucile Maria/K-2618-2012; Zampieri, Ricardo/D-3706-2018; Floeter-Winter, Lucile Maria/AAE-7629-2019; Muxel, Sandra/F-7464-2012; Santos, Marcos/E-1993-2013; Pomorski, Thomas Günther/G-4804-2014	Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Muxel, Sandra/0000-0003-0118-5361; Pomorski, Thomas Günther/0000-0002-4889-0829	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Carlsberg Foundation; Deutsche Forschungsgemeinschaft	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlsberg Foundation(Carlsberg Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Carlsberg Foundation (TGP) and the Deutsche Forschungsgemeinschaft (TGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Araujo-Santos JM, 2005, BIOCHEM BIOPH RES CO, V330, P349, DOI 10.1016/j.bbrc.2005.02.176; Araujo-Santos JM, 2003, BIOCHEM BIOPH RES CO, V306, P250, DOI 10.1016/S0006-291X(03)00947-1; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; CRONIN T M, 1987, Paleontological Society Memoir, P1; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Farias LH, 2012, J INFECT DIS; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; HOWARD MK, 1991, T ROY SOC TROP MED H, V85, P477, DOI 10.1016/0035-9203(91)90226-O; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Parodi-Talice A, 2003, BBA-BIOMEMBRANES, V1612, P195, DOI 10.1016/S0005-2736(03)00131-7; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Perez-Victoria FJ, 2003, J BIOL CHEM, V278, P49965, DOI 10.1074/jbc.M308352200; Saraiva EM, 2005, EXP PARASITOL, V110, P39, DOI 10.1016/j.exppara.2005.01.004; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; SMEETS EF, 1994, BBA-BIOMEMBRANES, V1195, P281, DOI 10.1016/0005-2736(94)90268-2; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Tripathi A, 2003, MOL BIOCHEM PARASIT, V128, P1, DOI 10.1016/S0166-6851(03)00024-0; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; Weingartner A, 2011, MOL BIOCHEM PARASIT, V179, P59, DOI 10.1016/j.molbiopara.2011.05.006; Weingartner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012443; Weingartner A, 2011, MOL BIOCH PARASITOL; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zheng LA, 2010, RAPID COMMUN MASS SP, V24, P2074, DOI 10.1002/rcm.4618; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55604	10.1371/journal.pone.0055604	http://dx.doi.org/10.1371/journal.pone.0055604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383240	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800174
J	Jia, YF; Liu, DZ; Xiao, DJ; Ma, XL; Han, SY; Zheng, Y; Sun, SH; Zhang, MX; Gao, HM; Cui, X; Wang, YS				Jia, Yanfei; Liu, Dezhi; Xiao, Dongjie; Ma, Xiaoli; Han, Shuyi; Zheng, Yan; Sun, Shanhui; Zhang, Maoxiu; Gao, Hongmei; Cui, Xia; Wang, Yunshan			Expression of AFP and STAT3 Is Involved in Arsenic Trioxide-Induced Apoptosis and Inhibition of Proliferation in AFP-Producing Gastric Cancer Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ALPHA-FETOPROTEIN; SIGNALING PATHWAY; TUMOR; CARCINOMA; GROWTH; TRANSDUCER; INDUCTION; ACTIVATOR; AS2O3	Alpha-fetoprotein (AFP)-producing gastric cancer (AFPGC), represented by the production of AFP, has a more aggressive behavior than common gastric cancer. The underlying mechanisms are not well understood. Arsenic trioxide (As2O3) is used clinically to treat acute promyelocytic leukemia(APL) and has activity in vitro against several solid tumor cell lines, with induction of apoptosis and inhibition of proliferation the prime effects. Signal transducer and activator of transcription 3 (STAT3) has an important role in tumorigenesis of various primary cancers and cancer cell by upregulating cell-survival and downregulating tumor suppressor proteins. Here, we found decreased expression of AFP and STAT3 after induction of apoptosis by As2O3 in the AFPGC FU97 cells. Also, the level of the STAT3 target oncogene Bcl-2 was decreased with As2O3, and that of the tumor suppressor Bax was increased. Furthermore, STAT3 expression and depth of invasion and lymph node metastasis were associated. Survival of patients with gastric cancer was lower with AFP and STAT3 double overexpression than with overexpression of either alone. Downregulation of AFP and STAT3 expression plays an important role in As2O3-induced apoptosis of AFPGC cells, which suggests a new mechanism of As2O3-induced cell apoptosis. As2O3 may be a possible agent for AFPGC treatment.	[Jia, Yanfei; Xiao, Dongjie; Ma, Xiaoli; Han, Shuyi; Zheng, Yan; Sun, Shanhui; Zhang, Maoxiu; Gao, Hongmei; Cui, Xia; Wang, Yunshan] Shandong Univ, Cent Lab, Jinan Cent Hosp, Jinan 250100, Peoples R China; [Jia, Yanfei; Wang, Yunshan] Shandong Univ, Jinan Cent Hosp, Shandong Prov Key Lab Tumor Target Mol, Jinan 250100, Peoples R China; [Liu, Dezhi] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong Normal University	Wang, YS (corresponding author), Shandong Univ, Cent Lab, Jinan Cent Hosp, Jinan 250100, Peoples R China.	sdjnwys@163.com			National Nature Science Foundation Grant of China (NSFC) [81000869, 81272588]	National Nature Science Foundation Grant of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study is supported by National Nature Science Foundation Grant of China (NSFC, No. 81000869 and 81272588). (http://www.nsfc.gov.cn/Portal0/default166.htm.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Amin HM, 2004, ONCOGENE, V23, P5426, DOI 10.1038/sj.onc.1207703; Bowling BD, 2008, CANCER CHEMOTH PHARM, V63, P37, DOI 10.1007/s00280-008-0705-y; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dhar DK, 1999, ONCOLOGY-BASEL, V56, P122, DOI 10.1159/000011952; Dudich E, 1998, TUMOR BIOL, V19, P30, DOI 10.1159/000029972; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Florea AM, 2009, NEUROTOXICOLOGY, V30, P803, DOI 10.1016/j.neuro.2009.04.014; Gao F, 2002, WORLD J GASTROENTERO, V8, P36, DOI 10.3748/wjg.v8.i1.36; Gonda T, 1994, Gan To Kagaku Ryoho, V21, P1659; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Hamanaka W, 2008, SURG TODAY, V38, P275, DOI 10.1007/s00595-007-3610-9; Hayashi T, 2002, MOL CANCER THER, V1, P851; Hocking GR, 1995, PATHOLOGY, V27, P277, DOI 10.1080/00313029500169113; Hoshino K, 1996, Gan To Kagaku Ryoho, V23, P1197; Isonishi S, 2009, INT J CLIN ONCOL, V14, P70, DOI 10.1007/s10147-008-0800-4; Izdebska M, 2008, POSTEP HIG MED DOSW, V62, P463; Jiang Wei, 2006, ZHONG LIU JI CHU YU, V19, P21; Kataoka H, 2001, ONCOGENE, V20, P869, DOI 10.1038/sj.onc.1204160; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Kono K, 2002, DIGEST SURG, V19, P359, DOI 10.1159/000065838; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Leeman-Neill RJ, 2009, CARCINOGENESIS, V30, P1848, DOI 10.1093/carcin/bgp211; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li MS, 2009, CANCER LETT, V285, P190, DOI 10.1016/j.canlet.2009.05.014; Li MS, 2009, INT J CANCER, V124, P2845, DOI 10.1002/ijc.24272; Liu X, 2012, J SURG ONCOL, V102, P249; Nielsen M, 1999, LEUKEMIA, V13, P735, DOI 10.1038/sj.leu.2401415; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; SAITO S, 1989, CANCER, V63, P544, DOI 10.1002/1097-0142(19890201)63:3<544::AID-CNCR2820630324>3.0.CO;2-2; Lafayette TCS, 2010, J PEDIAT HEMATOL ONC, V32, P229, DOI 10.1097/MPH.0b013e3181cf7ef3; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Siu KPY, 2002, LIFE SCI, V71, P275, DOI 10.1016/S0024-3205(02)01622-3; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Sumi D, 2010, TOXICOL APPL PHARM, V244, P385, DOI 10.1016/j.taap.2010.02.012; Ueno M, 2001, BJU INT, V88, P611, DOI 10.1046/j.1464-410X.2001.02357.x; Wang XW, 1998, INT J CANCER, V75, P596, DOI 10.1002/(SICI)1097-0215(19980209)75:4<596::AID-IJC17>3.0.CO;2-7; Wang YS, 2005, WORLD J GASTROENTERO, V11, P6053, DOI 10.3748/wjg.v11.i38.6053; Wetzler M, 2006, CLIN CANCER RES, V12, P6817, DOI 10.1158/1078-0432.CCR-06-1354; Wu DD, 2010, CANC GENETICS CYTOGE, V19, P890; Yabusaki H, 2000, Gan To Kagaku Ryoho, V27, P735; Yamagata Toshiyuki, 2004, Can Respir J, V11, P504; Yedjou C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-28; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158	47	18	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54774	10.1371/journal.pone.0054774	http://dx.doi.org/10.1371/journal.pone.0054774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382965	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800076
J	Sakai, H; Sagara, A; Matsumoto, K; Hasegawa, S; Sato, K; Nishizaki, M; Shoji, T; Horie, S; Nakagawa, T; Tokuyama, S; Narita, M				Sakai, Hiroyasu; Sagara, Atsunobu; Matsumoto, Kenjiro; Hasegawa, Satoshi; Sato, Ken; Nishizaki, Maiko; Shoji, Tetsuro; Horie, Syunji; Nakagawa, Takayuki; Tokuyama, Shogo; Narita, Minoru			5-Fluorouracil Induces Diarrhea with Changes in the Expression of Inflammatory Cytokines and Aquaporins in Mouse Intestines	PLOS ONE			English	Article							WATER TRANSPORT; MUCOSITIS; COLON; MICE; CHANNELS; MODEL; MECHANISMS; FAMILY; CELLS	Although the mechanisms of 5-fluorouracil (5-FU)-induced diarrhea remain unclear, accumulating evidence has indicated that changes in the mucosal immune system and aquaporins (AQPs) may play a role in its pathogenesis. Therefore, we investigated the possible changes in the gene expression of inflammatory cytokines and AQPs in the intestines of mice with 5-FU-induced diarrhea. In the present study, the expressions of mRNAs that encode inflammatory cytokines, TNF-alpha, IL-1 beta, IL-6, Il-17A and IL-22, were significantly increased throughout the entire colon of mice that exhibited diarrhea following 5-FU administration. In contrast, the gene expression of IFN gamma was upregulated only in the distal colon. These increases were significantly reduced by the administration of etanercept. However, 5-FU-induced diarrhea was not recovered by etanercept. On the other hand, the genes for AQPs 4 and 8 were markedly present in the colon, and these expressions in the intestines were significantly decreased by treatment with 5-FU. These decreases were not reversed by etanercept. These findings suggest TNF-alpha neutralization had no effect on the acutely 5-FU-induced diarrhea and impaired AQPs but reduced dramatically several inflammatory cytokines.	[Sakai, Hiroyasu; Sagara, Atsunobu; Matsumoto, Kenjiro; Hasegawa, Satoshi; Sato, Ken; Nishizaki, Maiko; Shoji, Tetsuro; Narita, Minoru] Hoshi Univ, Dept Pharmacol, Tokyo 142, Japan; [Matsumoto, Kenjiro; Horie, Syunji] Josai Int Univ, Pharmacol Lab, Togane, Japan; [Nakagawa, Takayuki] Kyoto Univ, Dept Mol Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Tokuyama, Shogo] Kobe Gakuin Univ, Dept Clin Pharm, Sch Pharmaceut Sci, Kobe, Hyogo 65121, Japan; [Sakai, Hiroyasu; Matsumoto, Kenjiro; Nakagawa, Takayuki; Tokuyama, Shogo; Narita, Minoru] Japanese Soc Pharmaceut Palliat Care & Sci, Res Promot Comm, Tokyo, Japan	Hoshi University; Kyoto University; Kobe Gakuin University	Sakai, H (corresponding author), Hoshi Univ, Dept Pharmacol, Tokyo 142, Japan.	sakai@hoshi.ac.jp; narita@hoshi.ac.jp	Sagara, Atsunobu/AAM-5106-2020	Sakai, Hiroyasu/0000-0002-4501-2836; Nakagawa, Takayuki/0000-0003-1890-0843	KAKENHI [24790582]; Japan Society for the Promotion of Science	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	KAKENHI (24790582) and by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga E, 2012, J CLIN IMMUNOL; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Busch M, 2012, INVEST OPHTHALMOL VI; Chiba Y, 2009, AM J RESP CRIT CARE, V180, P713, DOI 10.1164/rccm.200903-0325OC; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Itoh T, 2005, BIOCHEM BIOPH RES CO, V330, P832, DOI 10.1016/j.bbrc.2005.03.046; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Laforenza U, 2012, MOL ASPECTS MED; Laforenza U, 2005, J NUTR, V135, P2329, DOI 10.1093/jn/135.10.2329; Logan R, 2009, CANCER CHEMOTH PHARM, V63, P239, DOI 10.1007/s00280-008-0732-8; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Ma TH, 2001, AM J PHYSIOL-CELL PH, V280, pC126; Ma TH, 1999, J PHYSIOL-LONDON, V517, P317, DOI 10.1111/j.1469-7793.1999.0317t.x; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Masyuk AI, 2002, GASTROENTEROLOGY, V122, P545, DOI 10.1053/gast.2002.31035; Matsuzaki Toshiyuki, 2004, Medical Electron Microscopy, V37, P71; Melo MLP, 2008, CANCER CHEMOTH PHARM, V61, P775, DOI 10.1007/s00280-007-0534-4; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Ohashi Y, 2003, AM J OPHTHALMOL, V136, P291, DOI 10.1016/S0002-9394(03)00203-4; Okada S, 2003, FEBS LETT, V540, P157, DOI 10.1016/S0014-5793(03)00256-4; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Shen Y, 2011, J CELL MOL MED, V15, P1355, DOI 10.1111/j.1582-4934.2010.01103.x; Smith CL, 2008, NUTR CANCER, V60, P757, DOI 10.1080/01635580802192841; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Thi MM, 2008, J NEUROSCI RES, V86, P448, DOI 10.1002/jnr.21496; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Tritto S, 2007, BIOCHEM CELL BIOL, V85, P675, DOI 10.1139/O07-142; Verkman AS, 2002, J ANAT, V200, P617, DOI 10.1046/j.1469-7580.2002.00058.x; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG463, DOI 10.1152/ajpgi.2000.279.2.G463; Yamamoto T, 2007, LIFE SCI, V81, P115, DOI 10.1016/j.lfs.2007.04.036; Yang BX, 2005, AM J PHYSIOL-CELL PH, V288, pC1161, DOI 10.1152/ajpcell.00564.2004	39	46	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54788	10.1371/journal.pone.0054788	http://dx.doi.org/10.1371/journal.pone.0054788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382968	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800078
J	Tripp, EA; Fatimah, S; Darbyshire, I; McDade, LA				Tripp, Erin A.; Fatimah, Siti; Darbyshire, Iain; McDade, Lucinda A.			Origin of African Physacanthus (Acanthaceae) via Wide Hybridization	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CYTOPLASMIC INHERITANCE; SENECIO-VULGARIS; GENE-TRANSFER; SEQUENCE DATA; DNA; RECOMBINATION; HYBRID; HETEROPLASMY; MECHANISMS	Gene flow between closely related species is a frequent phenomenon that is known to play important roles in organismal evolution. Less clear, however, is the importance of hybridization between distant relatives. We present molecular and morphological evidence that support origin of the plant genus Physacanthus via ``wide hybridization'' between members of two distantly related lineages in the large family Acanthaceae. These two lineages are well characterized by very different morphologies yet, remarkably, Physacanthus shares features of both. Chloroplast sequences from six loci indicate that all three species of Physacanthus contain haplotypes from both lineages, suggesting that heteroplasmy likely predated speciation in the genus. Although heteroplasmy is thought to be unstable and thus transient, multiple haplotypes have been maintained through time in Physacanthus. The most likely scenario to explain these data is that Physacanthus originated via an ancient hybridization event that involved phylogenetically distant parents. This wide hybridization has resulted in the establishment of an independently evolving clade of flowering plants.	[Tripp, Erin A.; Fatimah, Siti; McDade, Lucinda A.] Rancho Santa Ana Bot Garden, Claremont, CA USA; [Tripp, Erin A.] Univ Colorado, Boulder, CO 80309 USA; [Tripp, Erin A.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Darbyshire, Iain] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Royal Botanic Gardens, Kew	Tripp, EA (corresponding author), Rancho Santa Ana Bot Garden, Claremont, CA USA.	erin.tripp@colorado.edu	Isa, Siti Fatimah Md/P-1483-2018	Isa, Siti Fatimah Md/0000-0002-6334-8915; TRIPP, ERIN/0000-0001-9340-8723	United States National Science Foundation [DEB-0919594]	United States National Science Foundation(National Science Foundation (NSF))	Financial support was provided by a United States National Science Foundation grant to EAT & LAM (DEB-0919594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1984, P1; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Anderson E., 1949, INTROGRESSIVE HYBRID; [Anonymous], 1877, DIFFERENT FORMS FLOW; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; BREMEKAMP C. E. B., 1965, BULL BOT SURV INDIA, V7, P21; Cidade FW, 2010, AM J BOT, V97, pE107, DOI 10.3732/ajb.1000207; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Doublet V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002938; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Evans RC, 2002, AM J BOT, V89, P1478, DOI 10.3732/ajb.89.9.1478; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Frey JE, 2005, GENETICA, V123, P255, DOI 10.1007/s10709-004-3711-y; Frey JE, 1999, THEOR APPL GENET, V99, P578, DOI 10.1007/s001220051271; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Lewontin RC, 1996, EVOLUTION, V20, P215; LI LH, 1993, THEOR APPL GENET, V87, P361, DOI 10.1007/BF01184924; Lindau G., 1895, NATIIRLICHEN PFLANZE, P274, DOI DOI 10.5962/BHL.TITLE.4635; M?dus J., 1975, POLLEN SPORES, V17, P545; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; McDade LA, 2005, SYST BOT, V30, P834, DOI 10.1600/036364405775097734; McDade LA, 2008, AM J BOT, V95, P1136, DOI 10.3732/ajb.0800096; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; NEWMAN SM, 1992, GENETICS, V132, P413; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; PRAGER EM, 1975, P NATL ACAD SCI USA, V72, P200, DOI 10.1073/pnas.72.1.200; Reed SM, 2008, J AM SOC HORTIC SCI, V133, P84, DOI 10.21273/JASHS.133.1.84; Reid EM, 1926, BEMBRIDGE FLORA CATA; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Scotland R. W., 2000, Kew Bulletin, V55, P513, DOI 10.2307/4118776; SOLTIS DE, 1991, AM J BOT, V78, P1091, DOI 10.2307/2444898; Soltis DE, 2008, SYST BOT, V33, P7, DOI 10.1600/036364408783887401; Son JH, 2010, GENES GENOM, V32, P165, DOI 10.1007/s13258-009-0849-0; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tripp EA, 2007, SYST BOT, V32, P628, DOI 10.1600/036364407782250625; Tripp EA, 2010, SYST BOT, V35, P629, DOI 10.1600/036364410792495845; Weihe A, 2009, MOL GENET GENOMICS, V282, P587, DOI 10.1007/s00438-009-0488-9; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121; Zwickl D. J, 2006, GENETIC ALGORITHM AP	55	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55677	10.1371/journal.pone.0055677	http://dx.doi.org/10.1371/journal.pone.0055677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383261	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800183
J	Yu, RJ; Huang, Y				Yu, Rongjun; Huang, Yi			A Nickel Ain't Worth a Dime Anymore: The Illusion of Money and the Rapid Encoding of Its True Value	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; FEEDBACK-RELATED NEGATIVITY; BRAIN POTENTIALS; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; CINGULATE CORTEX; FINANCIAL REWARD; MONETARY REWARD; BAD OUTCOMES; RESPONSES	People often evaluate money based on its face value and overlook its real purchasing power, known as the money illusion. For example, the same 100 Chinese Yuan can buy many more goods in Tibet than in Beijing, but such difference in buying power is usually underestimated. Using event related potential combined with a gambling task, we sought to investigate the encoding of both the real value and the face value of money in the human brain. We found that the self-reported pleasantness of outcomes was modulated by both values. The feedback related negativity (FRN), which peaks around 250ms after feedback and is believed to be generated in the anterior cingulate cortex (ACC), was only modulated by the true value but not the face value of money. We conclude that the real value of money is rapidly encoded in the human brain even when participants exhibit the money illusion at the behavioral level.	[Yu, Rongjun] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Yu, RJ (corresponding author), S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China.	rongjun.yu@gmail.com	Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524; Huang, Yi/0000-0002-9356-2306	Foundation for High-level Talents in Higher Education of Guangdong [C10454]	Foundation for High-level Talents in Higher Education of Guangdong	The authors acknowledge the Foundation for High-level Talents in Higher Education of Guangdong (No. C10454) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitsuki Y, 2003, NEUROIMAGE, V19, P1674, DOI 10.1016/S1053-8119(03)00250-7; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; CEBULA RJ, 1981, REG STUD, V15, P241, DOI 10.1080/09595238100185251; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Elliott R, 2008, EUR J NEUROSCI, V27, P2213, DOI 10.1111/j.1460-9568.2008.06202.x; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Foti D, 2011, HUM BRAIN MAPP, V32, P2207, DOI 10.1002/hbm.21182; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Harris A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021074; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Luu P, 2009, BRAIN RES, V1247, P100, DOI 10.1016/j.brainres.2008.09.084; Marco-Pallares J, 2008, NEUROPSYCHOLOGIA, V46, P241, DOI 10.1016/j.neuropsychologia.2007.07.016; Martin LE, 2009, NEUROREPORT, V20, P1140, DOI 10.1097/WNR.0b013e32832f0dca; Mayer ML, 2000, SOC SCI MED, V51, P395, DOI 10.1016/S0277-9536(99)00472-4; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Reinhardt U E, 1986, Mod Healthc, V16, P138; San Martin R, 2010, NEUROIMAGE, V51, P1194, DOI 10.1016/j.neuroimage.2010.03.031; Sato A, 2005, NEUROREPORT, V16, P407, DOI 10.1097/00001756-200503150-00020; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Taylor SF, 2006, J NEUROSCI, V26, P4063, DOI 10.1523/JNEUROSCI.4709-05.2006; TOBIN J, 1972, AM ECON REV, V62, P1; Tyran JR, 2007, SCIENCE, V317, P1042, DOI 10.1126/science.1143917; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; Weber B, 2009, P NATL ACAD SCI USA, V106, P5025, DOI 10.1073/pnas.0901490106; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yellen JL, 2006, ECON INQ, V44, P1, DOI 10.1093/ei/cbj002; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255	45	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55025	10.1371/journal.pone.0055025	http://dx.doi.org/10.1371/journal.pone.0055025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383044	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800106
J	Zu, HL; Wang, F; Ma, Y; Xue, YW				Zu, Hongliang; Wang, Feng; Ma, Yan; Xue, Yingwei			Stage-Stratified Analysis of Prognostic Significance of Tumor Size in Patients with Gastric Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; BORRMANN TYPE-IV; SURGICAL-TREATMENT; SURVIVAL; CARCINOMA; INDICATOR	Background: The prognostic significance of tumor size in gastric cancer is not well defined. The objective of this study was to identify the prognostic value of tumor size in patients with gastric cancer. Methods: We retrospectively reviewed a total of 1800 patients with gastric cancer admitted to our hospital between 1997 and 2007. These patients were divided into two groups according to tumor size: small size group (SSG, tumor <= 5 cm) and large size group (LSG, tumor >5 cm). We compared clinico-pathologic features of the two groups and investigated the prognostic factors by performing univariate, multivariate, and stage- stratified analyses according to tumor size. Results: LSG had more aggressive clinico-pathologic features than SSG. Tumor size was an independent prognostic indicator in patients with gastric cancer. In a stratified-pT, pN, and pTNM analysis, survival of patients with LSG was significantly worse than that of patients with SSG and advanced stage. Tumor size was not a significant predictor of survival in patients with early stage tumors. Large tumor size was associated with shorter survival in patients with stages N0, N1, N2, and N3, and stages I, II, III, and IV. Conclusions: Tumor size is a simple and practical prognostic factor in patients with gastric cancer. Tumor size could supplement clinical staging in the future.	[Zu, Hongliang; Wang, Feng; Ma, Yan; Xue, Yingwei] Harbin Med Univ, Affiliated Hosp 3, Dept Surg Gastroenterol, Harbin, Peoples R China	Harbin Medical University	Xue, YW (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Surg Gastroenterol, Harbin, Peoples R China.	xyw801@163.com			Heilongjiang province of Natural Science Foundation	Heilongjiang province of Natural Science Foundation	This study was aided by Heilongjiang province of Natural Science Foundation Major Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 1997, ANN SURG ONCOL, V4, P137, DOI 10.1007/BF02303796; Aoyama T, 2011, GASTRIC CANCER, V14, P274, DOI 10.1007/s10120-011-0038-0; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Giuliani A, 2003, J EXP CLIN CANC RES, V22, P531; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kikuchi S, 2004, LANGENBECK ARCH SURG, V389, P69, DOI 10.1007/s00423-004-0462-2; Kikuchi Youichi, 1999, Gastric Cancer, V2, P173, DOI 10.1007/s101200050042; Kim DY, 2007, LANGENBECK ARCH SURG, V392, P131, DOI 10.1007/s00423-006-0114-9; Kim DY, 2006, WORLD J GASTROENTERO, V12, P1182, DOI 10.3748/wjg.v12.i8.1182; Kim DY, 2004, ACTA CHIR BELG, V104, P677, DOI 10.1080/00015458.2004.11679642; KITAMURA K, 1995, J SURG ONCOL, V58, P112, DOI 10.1002/jso.2930580208; Li C, 2009, J GASTROINTEST SURG, V13, P881, DOI 10.1007/s11605-009-0800-3; Liu XW, 2009, ANN SURG ONCOL, V16, P1875, DOI 10.1245/s10434-009-0449-x; Maehara Y, 1997, SURGERY, V121, P633, DOI 10.1016/S0039-6060(97)90051-9; MAEHARA Y, 1992, SURG GYNECOL OBSTET, V175, P13; MAEHARA Y, 1992, CANCER, V70, P392, DOI 10.1002/1097-0142(19920715)70:2<392::AID-CNCR2820700204>3.0.CO;2-P; Saito H, 2006, AM J SURG, V192, P296, DOI 10.1016/j.amjsurg.2006.03.004; Saito H, 2010, J SURG ONCOL, V101, P622, DOI 10.1002/jso.21562; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Smith DD, 2005, J CLIN ONCOL, V23, P7114, DOI 10.1200/JCO.2005.14.621; Wang X, 2008, J SURG ONCOL, V97, P236, DOI 10.1002/jso.20951; WU CW, 1994, CANCER, V73, P2059, DOI 10.1002/1097-0142(19940415)73:8<2059::AID-CNCR2820730808>3.0.CO;2-G; Yokota T, 2004, SCAND J GASTROENTERO, V39, P380, DOI 10.1080/00365520310008629; Yokota T, 2002, ANTICANCER RES, V22, P3673; Zhang M, 2010, J SURG ONCOL, V102, P64, DOI 10.1002/jso.21533	27	42	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54502	10.1371/journal.pone.0054502	http://dx.doi.org/10.1371/journal.pone.0054502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382906	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800051
J	Drain, PK; Losina, E; Parker, G; Giddy, J; Ross, D; Katz, JN; Coleman, SM; Bogart, LM; Freedberg, KA; Walensky, RP; Bassett, IV				Drain, Paul K.; Losina, Elena; Parker, Gary; Giddy, Janet; Ross, Douglas; Katz, Jeffrey N.; Coleman, Sharon M.; Bogart, Laura M.; Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.			Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MEDICAL-CARE; COLLABORATIVE ANALYSIS; FOOD INSECURITY; MORTALITY; INFECTION; ADULTS; AIDS; ERA; CONSEQUENCES	Background: After observing persistently low CD4 counts at initial HIV diagnosis in South Africa, we sought to determine risk factors for late-stage HIV disease presentation among adults. Methods: We surveyed adults prior to HIV testing at four outpatient clinics in Durban from August 2010 to November 2011. All HIV-infected adults were offered CD4 testing, and late-stage HIV disease was defined as a CD4 count<100 cells/mm(3). We used multivariate regression models to determine the effects of sex, emotional health, social support, distance from clinic, employment, perceived barriers to receiving healthcare, and foregoing healthcare to use money for food, clothing, or housing ("competing needs to healthcare'') on presentation with late-stage HIV disease. Results: Among 3,669 adults screened, 830 were enrolled, newly-diagnosed with HIV and obtained a CD4 result. Among those, 279 (33.6%) presented with late-stage HIV disease. In multivariate analyses, participants who lived >= 5 kilometers from the test site [adjusted odds ratio (AOR) 2.8, 95% CI 1.7-4.7], reported competing needs to healthcare (AOR 1.7, 95% CI 1.2-2.4), were male (AOR 1.7, 95% CI 1.2-2.3), worked outside the home (AOR 1.5, 95% CI 1.1-2.1), perceived health service delivery barriers (AOR 1.5, 95% CI 1.1-2.1), and/or had poor emotional health (AOR 1.4, 95% CI 1.0-1.9) had higher odds of late-stage HIV disease presentation. Conclusions: Independent risk factors for late-stage HIV disease presentation were from diverse domains, including geographic, economic, demographic, social, and psychosocial. These findings can inform various interventions, such as mobile testing or financial assistance, to reduce the risk of presentation with late-stage HIV disease.	[Drain, Paul K.; Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Losina, Elena; Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Drain, Paul K.; Losina, Elena; Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Drain, Paul K.; Losina, Elena; Walensky, Rochelle P.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; [Freedberg, Kenneth A.; Walensky, Rochelle P.; Bassett, Ingrid V.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Bogart, Laura M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Katz, Jeffrey N.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Katz, Jeffrey N.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Coleman, Sharon M.; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Coleman, Sharon M.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Bogart, Laura M.] Boston Childrens Hosp, Boston, MA USA; [Parker, Gary; Giddy, Janet] McCord Hosp, Dept Med, Durban, South Africa; [Ross, Douglas] St Marys Hosp, Dept Med, Durban, South Africa	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Boston University; Boston University; Harvard University; Boston Children's Hospital	Drain, PK (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	pdrain@partners.org	Bassett, Ingrid V./ABI-7674-2020	Bassett, Ingrid V./0000-0001-6920-6080; Drain, Paul/0000-0003-3300-3817; Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle P./0000-0002-8795-379X	Harvard Institute for Global Health; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; National Institute of Mental Health [R01 MH090326, R01 MH073445]; National Institute of Allergy and Infectious Disease [K24 AI062476]; Harvard University Center for AIDS Research [P30 AI060354]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24 AR057827]; National Center for Research Resources [UL1 RR 025758]; Burke Global Health Fellowship; Claflin Distinguished Scholar Award; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, K24AI062476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073445, R01MH090326] Funding Source: NIH RePORTER	Harvard Institute for Global Health; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Burke Global Health Fellowship; Claflin Distinguished Scholar Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Harvard Institute for Global Health (PKD); the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University R24 TW007988 (PKD); the National Institute of Mental Health R01 MH090326 (IVB) and R01 MH073445 (RPW); the National Institute of Allergy and Infectious Disease K24 AI062476 (KAF); the Harvard University Center for AIDS Research P30 AI060354; the National Institute of Arthritis and Musculoskeletal and Skin Diseases K24 AR057827 (EL); the National Center for Research Resources (the Harvard Catalyst UL1 RR 025758); the Burke Global Health Fellowship (IVB); and the Claflin Distinguished Scholar Award (IVB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Craw JA, 2008, JAIDS-J ACQ IMM DEF, V47, P597, DOI 10.1097/QAI.0b013e3181684c51; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Joint United Nations Programme on HIV/AIDS, 2011, UNAIDS DAT TABL 2011; Joint United Nations Programme on HIV/AIDS, 2011, UNAIDS GLOB REP 2010; Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P39; Mascolini M, 2011, S AFRICA RAISES THRE; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mills EJ, 2012, CLIN INFECT DIS, V54, P282, DOI 10.1093/cid/cir812; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nagata JM, 2012, AIDS CARE, V24, P728, DOI 10.1080/09540121.2011.630358; National Department of Health Republic of South Africa, 2010, NAT HIV COUNS TEST H; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Ramirez-Avila L, 2012, AIDS BEHAV; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Samet JH, 1998, ARCH INTERN MED, V158, P734, DOI 10.1001/archinte.158.7.734; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; South Africa Department of Health, 2011, COMPR CAR MAN TREATM; Tadios Yonas, 2006, Ethiop Med J, V44, P237; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; Wachira J, 2012, CLIN INFECT DIS, V54, P275, DOI 10.1093/cid/cir789; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	49	52	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55305	10.1371/journal.pone.0055305	http://dx.doi.org/10.1371/journal.pone.0055305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383147	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500074
J	Najaf-Zadeh, A; Dubos, F; Hue, V; Pruvost, I; Bennour, A; Martinot, A				Najaf-Zadeh, Abolfazl; Dubos, Francois; Hue, Valerie; Pruvost, Isabelle; Bennour, Ania; Martinot, Alain			Risk of Bacterial Meningitis in Young Children with a First Seizure in the Context of Fever: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SIMPLE FEBRILE SEIZURES; LUMBAR PUNCTURE; CONVULSIONS; DISEASE; INFECTIONS; DECLINE	Background: Of major concern in any febrile child presenting with a seizure is the possibility of bacterial meningitis (BM). We did a systematic review to estimate the risk of BM among various subgroups of young children with a first seizure in the context of fever, and to assess the utility of routine lumbar puncture (LP) in children with an apparent first FS. Methods/Principal Findings: MEDLINE, INIST, and the COCHRANE Library databases were searched from inception to December 2011 for published studies, supplemented by manual searches of bibliographies of potentially relevant articles and review articles. Studies reporting the prevalence of BM in young children presenting to emergency care with a first: i) "seizure and fever'', ii) apparent simple FS, and iii) apparent complex FS were included. Fourteen studies met the inclusion criteria. In children with a first "seizure and fever'', the pooled prevalence of BM was 2.6% (95% CI 0.9-5.1); the diagnosis of BM might be suspected from clinical examination in 95% of children >6 months. In children with an apparent simple FS, the average prevalence of BM was 0.2% (range 0 to 1%). The pooled prevalence of BM among children with an apparent complex FS was 0.6% (95% CI 0.2-1.4). The utility of routine LP for diagnosis of CNS infections requiring immediate treatment in children with an apparent first FS was low: the number of patients needed to test to identify one case of such infections was 1109 in children with an apparent first simple FS, and 180 in those with an apparent first complex FS. Conclusion: The values provided from this study provide a basis for an evidence-based approach to the management of different subgroups of children presenting to emergency care with a first seizure in the context of fever.	[Najaf-Zadeh, Abolfazl; Dubos, Francois; Hue, Valerie; Pruvost, Isabelle; Bennour, Ania; Martinot, Alain] Univ Lille Nord de France, UDSL, Lille, France; [Najaf-Zadeh, Abolfazl; Dubos, Francois; Hue, Valerie; Pruvost, Isabelle; Bennour, Ania; Martinot, Alain] CHRU, Paediat Emergency & Infect Dis Unit, Lille, France; [Dubos, Francois; Martinot, Alain] EA2694, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Martinot, A (corresponding author), Univ Lille Nord de France, UDSL, Lille, France.	alain.martinot@chru-lille.fr	Dubos, Francois/AGD-5638-2022; Martinot, Alain/M-6780-2016	Martinot, Alain/0000-0002-2146-8273; dubos, francois/0000-0003-2151-1638				ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; AlEissa YA, 1995, PEDIATR EMERG CARE, V11, P347, DOI 10.1097/00006565-199512000-00004; ANDERSON A B, 1989, Pediatric Emergency Care, V5, P12, DOI 10.1097/00006565-198903000-00004; Armon K, 2003, EMERG MED J, V20, P13, DOI 10.1136/emj.20.1.13; Armon K, 2001, ARCH DIS CHILD, V84, P390, DOI 10.1136/adc.84.5.390; Atabaki S, 1999, ARCH PEDIAT ADOL MED, V153, P770, DOI 10.1001/archpedi.153.7.770; Australian Government Department of Human Services, 2007, CURR IMM SCHED NAT I; Baumann RJ, 1996, PEDIATRICS, V97, P773; Carroll W, 2002, ARCH DIS CHILD, V87, P238, DOI 10.1136/adc.87.3.238; Dawson K P, 1994, J Qual Clin Pract, V14, P111; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dubos F, 2008, J PEDIATR-US, V152, P378, DOI 10.1016/j.jpeds.2007.07.012; European Center for Disease Prevention and Control, 2012, VACC SCHED; Fetveit A, 2008, EUR J PEDIATR, V167, P17, DOI 10.1007/s00431-007-0577-x; FISCHER GW, 1975, AM J DIS CHILD, V129, P590, DOI 10.1001/archpedi.1975.02120420038014; GERBER MA, 1981, AM J DIS CHILD, V135, P431, DOI 10.1001/archpedi.1981.02130290029011; HEIJBEL J, 1980, NEUROPADIATRIE, V11, P45, DOI 10.1055/s-2008-1071374; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hom J, 2011, ACAD EMERG MED, V18, P1114, DOI 10.1111/j.1553-2712.2011.01216.x; HOPKINS A, 1991, BRIT MED J, V303, P634; JAFFE M, 1981, PEDIATRICS, V67, P729; JOFFE A, 1983, AM J DIS CHILD, V137, P1153, DOI 10.1001/archpedi.1983.02140380013005; Joshi BR, 2008, J NEPAL MED ASSOC, V47, P109; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kimia A, 2010, PEDIATRICS, V126, P62, DOI 10.1542/peds.2009-2741; Kimia AA, 2009, PEDIATRICS, V123, P6, DOI 10.1542/peds.2007-3424; KINSELLA JB, 1995, INT J PEDIATR OTORHI, V32, P153, DOI 10.1016/0165-5876(95)01166-9; Laman M, 2010, CLIN INFECT DIS, V51, P534, DOI 10.1086/655679; LEARY PM, 1993, J TROP PEDIATRICS, V39, P176, DOI 10.1093/tropej/39.3.176; LEE P, 1991, ARCH DIS CHILD, V66, P1287, DOI 10.1136/adc.66.11.1287; LORBER J, 1980, LANCET, V1, P785; MCINTYRE PB, 1990, MED J AUSTRALIA, V152, P183; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nigrovic LE, 2008, PEDIATRICS, V122, P726, DOI 10.1542/peds.2007-3275; OFFRINGA M, 1992, CLIN PEDIATR, V31, P514, DOI 10.1177/000992289203100901; Offringa M, 2001, WESTERN J MED, V175, P254, DOI 10.1136/ewjm.175.4.254; Pallin DJ, 2008, INT J EMERG MED, V1, P97, DOI 10.1007/s12245-008-0024-4; RATCLIFFE JC, 1977, ANN NEUROL, V1, P285, DOI 10.1002/ana.410010316; Richardson WS, 1999, JAMA-J AM MED ASSOC, V281, P1214, DOI 10.1001/jama.281.13.1214; ROSSI LN, 1986, HELV PAEDIATR ACTA, V41, P19; RUTTER N, 1977, ARCH DIS CHILD, V52, P188, DOI 10.1136/adc.52.3.188; SAMSON JH, 1969, J AMER MED ASSOC, V210, P1918, DOI 10.1001/jama.210.10.1918; Seltz LB, 2009, PEDIATR EMERG CARE, V25, P494, DOI 10.1097/PEC.0b013e3181b0a095; Shaked O, 2009, PEDIATR EMERG CARE, V25, P8, DOI 10.1097/PEC.0b013e318191da93; Shinnar S, 2002, J CHILD NEUROL, V17, pS44, DOI 10.1177/08830738020170010601; Silber E, 1999, J NEUROL SCI, V162, P20, DOI 10.1016/S0022-510X(98)00259-7; Stuart A, 1994, KENDALLS ADV THEORY; Subcommittee on Febrile Seizures, 2011, Pediatrics, V127, P389, DOI 10.1542/peds.2010-3318; SURPURE JS, 1980, CLIN PEDIATR, V19, P361, DOI 10.1177/000992288001900510; Teach SJ, 1999, PEDIATR EMERG CARE, V15, P9, DOI 10.1097/00006565-199902000-00003; Trainor JL, 2001, ACAD EMERG MED, V8, P781, DOI 10.1111/j.1553-2712.2001.tb00207.x; van Stuijvenberg M, 1998, J PEDIATR-US, V133, P557, DOI 10.1016/S0022-3476(98)70068-X; VERBURGH ME, 1992, NEUROEPIDEMIOLOGY, V11, P169, DOI 10.1159/000110928; Waruiru C, 2004, ARCH DIS CHILD, V89, P751, DOI 10.1136/adc.2003.028449; Wears R L, 1986, Pediatr Emerg Care, V2, P191, DOI 10.1097/00006565-198609000-00011; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; WHO, 2012, IMM SURV ASS MON; WHO, 1997, ANT SUPP THER BACT M	58	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55270	10.1371/journal.pone.0055270	http://dx.doi.org/10.1371/journal.pone.0055270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383133	gold, Green Submitted, Green Published			2022-12-27	WOS:000315211500070
J	Pickett, LA; Yourshaw, M; Albornoz, V; Chen, ZJ; Solorzano-Vargas, RS; Nelson, SF; Martin, MG; Lindberg, I				Pickett, Lindsay A.; Yourshaw, Michael; Albornoz, Valeria; Chen, Zijun; Solorzano-Vargas, R. Sergio; Nelson, Stanley F.; Martin, Martin G.; Lindberg, Iris			Functional Consequences of a Novel Variant of PCSK1	PLOS ONE			English	Article							PROHORMONE CONVERTASE-1; PROPROTEIN CONVERTASES; PROTEIN FUNCTION; HUMAN GENOME; PC1; OBESITY; PROPEPTIDE; CLEAVAGE; FURIN; CELLS	Background: Common single nucleotide polymorphisms (SNPs) in proprotein convertase subtilisin/kexin type 1 with modest effects on PC1/3 in vitro have been associated with obesity in five genome-wide association studies and with diabetes in one genome-wide association study. We here present a novel SNP and compare its biosynthesis, secretion and catalytic activity to wild-type enzyme and to SNPs that have been linked to obesity. Methodology/Principal Findings: A novel PC1/3 variant introducing an Arg to Gln amino acid substitution at residue 80 (within the secondary cleavage site of the prodomain) (rs1799904) was studied. This novel variant was selected for analysis from the 1000 Genomes sequencing project based on its predicted deleterious effect on enzyme function and its comparatively more frequent allele frequency. The actual existence of the R80Q (rs1799904) variant was verified by Sanger sequencing. The effects of this novel variant on the biosynthesis, secretion, and catalytic activity were determined; the previously-described obesity risk SNPs N221D (rs6232), Q665E/S690T (rs6234/rs6235), and the Q665E and S690T SNPs (analyzed separately) were included for comparative purposes. The novel R80Q (rs1799904) variant described in this study resulted in significantly detrimental effects on both the maturation and in vitro catalytic activity of PC1/3. Conclusion/Significance: Our findings that this novel R80Q (rs1799904) variant both exhibits adverse effects on PC1/3 activity and is prevalent in the population suggests that further biochemical and genetic analysis to assess its contribution to the risk of metabolic disease within the general population is warranted.	[Yourshaw, Michael; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Chen, Zijun; Solorzano-Vargas, R. Sergio; Martin, Martin G.] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA 90095 USA; [Chen, Zijun; Solorzano-Vargas, R. Sergio; Martin, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pickett, Lindsay A.; Albornoz, Valeria; Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lindberg, I (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	ilind001@umaryland.edu	Lindberg, Iris/Q-3825-2019; Nelson, Stanley F/D-4771-2009; Solorzano-Vargas, R Sergio/D-4869-2016; Martín, María/HDL-9512-2022; Yourshaw, Michael/F-9807-2015	Nelson, Stanley F/0000-0002-2082-3114; Yourshaw, Michael/0000-0001-7612-0437	National Institute of Diabetes and Digestive and Kidney Diseases [DK083762]; California Institute of Regenerative Medicine (CIRM) [RT2-01985]; National Institute of Drug Abuse [DA05084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005084, R56DA005084] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (#DK083762) and the California Institute of Regenerative Medicine (CIRM), RT2-01985 to MGM; and a grant from the National Institute of Drug Abuse (#DA05084) to IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bernard N, 2003, J NEUROCHEM, V85, P1592, DOI 10.1046/j.1471-4159.2003.01823.x; Bissonnette L, 2004, BIOCHEM J, V379, P757, DOI 10.1042/BJ20031902; Brakch N, 1997, BIOCHEMISTRY-US, V36, P16309, DOI 10.1021/bi9714767; Braman J, 1996, Methods Mol Biol, V57, P31; Coates LC, 1998, J NEUROCHEM, V70, P1670; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; Dong WJ, 1997, J NEUROSCI, V17, P563; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; GOODMAN LJ, 1994, BIOCHEM BIOPH RES CO, V201, P795, DOI 10.1006/bbrc.1994.1771; Heni M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-86; Hoshino A., 2012, C SERIES NEUROPEPTID, V1, P1; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee SN, 2004, J ENDOCRINOL, V182, P353, DOI 10.1677/joe.0.1820353; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; MAINS RE, 1995, MOL ENDOCRINOL, V9, P3, DOI 10.1210/me.9.1.3; Mbikay M, 2011, MOL GENET METAB, V104, P682, DOI 10.1016/j.ymgme.2011.09.027; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muller L, 2000, J BIOL CHEM, V275, P39213, DOI 10.1074/jbc.M003547200; NG CP, 2003, NUCLEIC ACIDS RES, V31, P3812; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; NHLBI Exome Sequencing Project, 2011, EX VAR SERV; NIEHS Environmental Genome Project, 2011, NIEHS EX VAR SERV; Rabah N, 2006, J BIOL CHEM, V281, P7556, DOI 10.1074/jbc.M510607200; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rouille Y, 1997, J BIOL CHEM, V272, P32810, DOI 10.1074/jbc.272.52.32810; SCHAFER MKH, 1993, J NEUROSCI, V13, P1258; SEIDAH NG, 1991, GENOMICS, V11, P103, DOI 10.1016/0888-7543(91)90106-O; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; VINDROLA O, 1992, MOL ENDOCRINOL, V6, P1088, DOI 10.1210/me.6.7.1088; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; ZHOU A, 1994, J BIOL CHEM, V269, P17440; ZHOU Y, 1995, J BIOL CHEM, V270, P24702, DOI 10.1074/jbc.270.42.24702; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599; 2004, NATURE, V431, P931	54	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55065	10.1371/journal.pone.0055065	http://dx.doi.org/10.1371/journal.pone.0055065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383060	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500053
J	Strom, TS				Strom, Ted S.			A Numerical Analysis Model for the Interpretation of In Vivo Platelet Consumption Data	PLOS ONE			English	Article							WISKOTT-ALDRICH-SYNDROME; PRIMARY IMMUNE THROMBOCYTOPENIA; LONG-TERM; LIFE-SPAN; SPLENECTOMY; KINETICS; MICE; SURVIVAL; PURPURA; RECOVERY	Unlike anemias, most thrombocytopenias cannot be separated into those due to impaired production and those due to accelerated consumption. While rapid clearance of labeled platelets from the bloodstream can be followed in thrombocytopenic individuals, no model exists for quantitatively inferring from autologous or allogeneic platelet consumption data what changes in random consumption, lifespan dependent consumption, and platelet production rate may have caused the thrombocytopenia. Here we describe a numerical analysis model which resolves these issues. The model applies three parameter values (a random consumption rate constant, a lognormally-distributed platelet lifespan, and the standard deviation of the latter) to a matrix comprising a series of platelet cohorts which are sequentially produced and fractionally consumed in a series of time intervals. The cohort platelet counts achieved after equilibration of production and consumption both enumerate the population age distribution and sum to the population platelet count. Continued platelet consumption after production is halted then serves to model in vivo platelet consumption data, with consumption rate in the first such interval defining the equilibrium platelet production rate. We use a least squares fitting procedure to find parameter values which best fit observed platelet consumption data obtained in WT and thrombocytopenic WASP(-) mice. Equilibrium platelet age distributions are then 'grafted' into the matrix to allow modeling of the consumption of WT platelets in WASP(-) recipients, and vice versa. The optimal parameter values obtained indicate that random WT platelet consumption accounts for a larger fraction of platelet turnover than was previously suspected. Platelet WASP deficiency accelerates random consumption, and a trans effect of recipient WASP deficiency contributes to this. Application of the model to clinical data will allow distinctions to be made between thrombocytopenias due primarily to impaired platelet production and those due to acceleration of random or lifespan-dependent platelet consumption.	[Strom, Ted S.] Memphis Vet Adm Med Ctr, Dept Pathol & Lab Med, Memphis, TN USA; [Strom, Ted S.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center	Strom, TS (corresponding author), Memphis Vet Adm Med Ctr, Dept Pathol & Lab Med, Memphis, TN USA.	tstrom@uthsc.edu			NIAID [1R21AI079757-01A1]; Department of Veterans Affairs;  [R01AI071163]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071163, R21AI079757] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	TS was supported by R01AI071163 (David J. Rawlings, Principal Investigator), by NIAID 1R21AI079757-01A1 (TS), and by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Andreansky S, 2005, EXP HEMATOL, V33, P443, DOI 10.1016/j.exphem.2004.12.006; Arnold DM, 2006, TRANSFUSION, V46, P257, DOI 10.1111/j.1537-2995.2006.00709.x; AuBuchon JP, 2005, TRANSFUSION, V45, P1143, DOI 10.1111/j.1537-2995.2005.00177.x; BALDINI MG, 1972, ANN NY ACAD SCI, V201, P437, DOI 10.1111/j.1749-6632.1972.tb16316.x; Chapman LM, 2012, J IMMUNOL, V189, P916, DOI 10.4049/jimmunol.1200580; DORNHORST AC, 1951, BLOOD, V6, P1284, DOI 10.1182/blood.V6.12.1284.1284; Dowling MR, 2010, BLOOD, V116, P1776, DOI 10.1182/blood-2009-12-259663; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Falet H, 2009, BLOOD, V114, P4729, DOI 10.1182/blood-2009-02-202721; FENAUX P, 1989, EUR J HAEMATOL, V42, P259; GROTTUM KA, 1969, BRIT J HAEMATOL, V17, P373, DOI 10.1111/j.1365-2141.1969.tb01383.x; Grozovsky R, 2010, CURR OPIN HEMATOL, V17, P585, DOI 10.1097/MOH.0b013e32833e7561; HANSON SR, 1985, BLOOD, V66, P1105; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; HEYNS AD, 1986, BLOOD, V67, P86; HILLZOBEL RL, 1986, AM J HEMATOL, V23, P231, DOI 10.1002/ajh.2830230307; Kajiwara M, 1999, BRIT J HAEMATOL, V107, P254, DOI 10.1046/j.1365-2141.1999.01694.x; Kauppi M, 2008, BLOOD, V112, P3148, DOI 10.1182/blood-2007-10-119677; Levin J, 2001, BLOOD, V98, P1019, DOI 10.1182/blood.V98.4.1019; LOTTER MG, 1986, J NUCL MED, V27, P1192; Marathe BM, 2009, EXP HEMATOL, V37, P1353, DOI 10.1016/j.exphem.2009.08.007; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Meyer O, 2012, TRANSFUS MED HEMOTH, V39, P5, DOI 10.1159/000335553; Mills J, 1946, J PHYSL SOC, V105; Mintz PD, 2005, TRANSFUSION, V45, p72S, DOI 10.1111/j.1537-2995.2005.00537.x; MULLEN CA, 1993, BLOOD, V82, P2961; MURPHY EA, 1971, THROMB DIATH HAEMOST, V26, P431, DOI 10.1055/s-0038-1653696; NAJEAN Y, 1991, BRIT J HAEMATOL, V79, P271, DOI 10.1111/j.1365-2141.1991.tb04532.x; OCHS HD, 1980, BLOOD, V55, P243; Panel on Diagnostic Application of Radioisotopes in Hematology International Committee for Standardization in Hematology, 1977, BLOOD, V50, P1137; Pons I, 2010, EUR J HAEMATOL, V85, P158, DOI 10.1111/j.1600-0609.2010.01468.x; Prislovsky A, 2012, PLATELETS; Prislovsky A, 2008, EXP HEMATOL, V36, P906; Roca M, 2011, AM J HEMATOL, V86, P909, DOI 10.1002/ajh.22147; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sarpatwari A, 2010, BRIT J HAEMATOL, V151, P477, DOI 10.1111/j.1365-2141.2010.08377.x; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; SHAO J, 1989, ANN STAT, V17, P1176, DOI 10.1214/aos/1176347263; Shcherbina A, 1999, BRIT J HAEMATOL, V106, P875, DOI 10.1046/j.1365-2141.1999.01637.x; Slichter SJ, 2004, TRANSFUS MED REV, V18, P153, DOI 10.1016/j.tmrv.2004.03.003; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Snyder E, 2004, TRANSFUSION, V44, P1732, DOI 10.1111/j.0041-1132.2004.04145.x; Strom TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026657; TOMER A, 1991, J LAB CLIN MED, V118, P546; Wandall HH, 2008, BLOOD, V111, P3249, DOI 10.1182/blood-2007-06-097295	47	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55087	10.1371/journal.pone.0055087	http://dx.doi.org/10.1371/journal.pone.0055087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383066	Green Submitted, gold, Green Published			2022-12-27	WOS:000315211500055
J	Vesterbacka, J; Nowak, P; Barqasho, B; Abdurahman, S; Nystrom, J; Nilsson, S; Funaoka, H; Kanda, T; Andersson, LM; Gisslen, M; Sonnerborg, A				Vesterbacka, Jan; Nowak, Piotr; Barqasho, Babilonia; Abdurahman, Samir; Nystrom, Jessica; Nilsson, Staffan; Funaoka, Hiroyuki; Kanda, Tatsuo; Andersson, Lars-Magnus; Gisslen, Magnus; Sonnerborg, Anders			Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy	PLOS ONE			English	Article							HIV PROTEASE INHIBITORS; ACID-BINDING PROTEIN; LONG-TERM IMPACTS; IMMUNE ACTIVATION; VIRAL LOAD; RESIDUAL VIREMIA; DISEASE PROGRESSION; PLASMA-LEVELS; SOLUBLE CD14; I-FABP	Objectives: We investigated whether there are differences in the effects on microbial translocation (MT) and enterocyte damage by different antiretroviral therapy (ART) regimens after 1.5 years and whether antibiotic use has impact on MT. In a randomized clinical trial (NCT01445223) on first line ART, patients started either lopinavir/r (LPV/r) (n = 34) or efavirenz (EFV) containing ART (n = 37). Lipopolysaccharide (LPS), sCD14, anti-flagellin antibodies and intestinal fatty acid binding protein (I-FABP) levels were determined in plasma at baseline (BL) and week 72 (w72). Results: The levels of LPS and sCD14 were reduced from BL to w72 (157.5 pg/ml vs. 140.0 pg/ml, p = 0.0003; 3.13 ug/ml vs. 2.85 ug/ml, p = 0.005, respectively). The levels of anti-flagellin antibodies had decreased at w72 (0.35 vs 0.31 [OD]; p<0.0004), although significantly only in the LPV/r arm. I-FABP levels increased at w72 (2.26 ng/ml vs 3.13 ng/ml; p<0.0001), although significantly in EFV treated patients only. Patients given antibiotics at BL had lower sCD14 levels at w72 as revealed by ANCOVA compared to those who did not receive (Delta = -0.47 mu g/ml; p = 0.015). Conclusions: Markers of MT and enterocyte damage are elevated in untreated HIV-1 infected patients. Long-term ART reduces the levels, except for I-FABP which role as a marker of MT is questionable in ART-experienced patients. Why the enterocyte damage seems to persist remains to be established. Also antibiotic usage may influence the kinetics of the markers of MT.	[Vesterbacka, Jan; Nowak, Piotr; Abdurahman, Samir; Sonnerborg, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden; [Nowak, Piotr; Barqasho, Babilonia; Nystrom, Jessica; Sonnerborg, Anders] Karolinska Univ Hosp, Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Nilsson, Staffan] Chalmers Univ Technol, Dept Math Stat, S-41296 Gothenburg, Sweden; [Funaoka, Hiroyuki] DS Pharma Biomed Co Ltd, Osaka, Japan; [Kanda, Tatsuo] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Niigata, Japan; [Andersson, Lars-Magnus; Gisslen, Magnus] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Chalmers University of Technology; Niigata University; University of Gothenburg	Vesterbacka, J (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden.	jan.vesterbacka@karolinska.se	Sönnerborg, Anders/W-2011-2019; Gisslen, Magnus/D-7454-2015	Sönnerborg, Anders/0000-0001-8928-3374; Gisslen, Magnus/0000-0002-2357-1020; Nowak, Piotr/0000-0003-2747-0734; Abdurahman, Samir/0000-0003-0902-508X; Nystrom, Jessica/0000-0002-1185-2511; Nilsson, Staffan/0000-0003-4748-0446	Swedish Research Council; Stockholm County Council; Swedish Physicians against AIDS; Swedish Medical Society (SLS); Swedish Society for Medical Research (SSMF for Piotr Nowak); Sahlgrenska Academy at University of Gothenburg; Health & Medical Care Committee of the Region Vastra Gotaland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Physicians against AIDS; Swedish Medical Society (SLS); Swedish Society for Medical Research (SSMF for Piotr Nowak); Sahlgrenska Academy at University of Gothenburg; Health & Medical Care Committee of the Region Vastra Gotaland	This work was supported by the Swedish Research Council, Stockholm County Council, Swedish Physicians against AIDS, Swedish Medical Society (SLS), Swedish Society for Medical Research (SSMF for Piotr Nowak), Sahlgrenska Academy at University of Gothenburg and The Health & Medical Care Committee of the Region Vastra Gotaland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2011, CROI 2011; Anas A, 2010, CRIT CARE, V14, DOI 10.1186/cc8850; Ayaslioglu E, 2012, J MICROBIOL IMMUNOL; Badley AD, 2005, CELL DEATH DIFFER, V12, P924, DOI 10.1038/sj.cdd.4401580; Blas-Garcia A, 2011, CURR MED CHEM, V18, P2186, DOI 10.2174/092986711795656180; Boccara F, 2008, AIDS, V22, pS19, DOI 10.1097/01.aids.0000327512.76126.6e; Bonora S, 2009, J MED VIROL, V81, P400, DOI 10.1002/jmv.21405; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Campbell JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018688; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Eden A, 2007, J INFECT DIS, V196, P1779, DOI 10.1086/523648; Eden A, 2010, AIDS RES HUM RETROV, V26, P533, DOI 10.1089/aid.2009.0177; Funaoka H, 2011, IMMUNOL INVEST, V40, P223, DOI 10.3109/08820139.2010.534216; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Josephson F, 2010, EUR J CLIN PHARMACOL, V66, P349, DOI 10.1007/s00228-009-0763-z; Kalambokis GN, 2012, HEPATOLOGY, V55, P655, DOI 10.1002/hep.24751; Kanda T, 2011, J GASTROENTEROL, V46, P492, DOI 10.1007/s00535-011-0373-2; Karlsson AC, 1999, J VIROL, V73, P6191, DOI 10.1128/JVI.73.7.6191-6196.1999; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Lindkvist Annica, 2009, AIDS Res Ther, V6, P15, DOI 10.1186/1742-6405-6-15; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Marchetti G, 2012, CURR HIV RES; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Martinez E, 2009, CURR OPIN INFECT DIS, V22, P28, DOI 10.1097/QCO.0b013e328320a849; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Nicastri E, 2008, CURR HIV RES, V6, P261, DOI 10.2174/157016208784325010; Nowak P, 2012, INT J MICROBIOL, V2012; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Palmisano L, 2005, AIDS, V19, P1843, DOI 10.1097/01.aids.0000188426.87538.ed; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Pilon AA, 2002, ANTIMICROB AGENTS CH, V46, P2687, DOI 10.1128/AAC.46.8.2687-2691.2002; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Rizza SA, 2008, MED CHEM, V4, P75, DOI 10.2174/157340608783331443; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; Wiercinska-Drapalo A, 2008, REGUL PEPTIDES, V147, P25, DOI 10.1016/j.regpep.2007.12.002; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722	46	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55038	10.1371/journal.pone.0055038	http://dx.doi.org/10.1371/journal.pone.0055038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383047	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500050
J	Yeh, TM; Liu, SH; Lin, KC; Kuo, C; Kuo, SY; Huang, TY; Yen, YR; Wen, RK; Chen, LC; Fu, TF				Yeh, Trai-Ming; Liu, Shu-Hsiang; Lin, Kao-Chang; Kuo, Chieh; Kuo, Shu-Yun; Huang, Tzuu-Yuan; Yen, Yong-Ren; Wen, Rong-Kun; Chen, Lien-Cheng; Fu, Tsai-Feng			Dengue Virus Enhances Thrombomodulin and ICAM-1 Expression through the Macrophage Migration Inhibitory Factor Induction of the MAPK and PI3K Signaling Pathways	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; HEMORRHAGIC-FEVER; SHOCK-SYNDROME; GROWTH-FACTOR; FACTOR MIF; TNF-ALPHA; IN-VITRO; KAPPA-B; COAGULATION; ACTIVATION	Dengue virus (DV) infections cause mild dengue fever (DF) or severe life-threatening dengue hemorrhagic fever (DHF). The mechanisms that cause hemorrhage in DV infections remain poorly understood. Thrombomodulin (TM) is a glycoprotein expressed on the surface of vascular endothelial cells that plays an important role in the thrombin-mediated activation of protein C. Prior studies have shown that the serum levels of soluble TM (sTM) and macrophage migration inhibitory factor (MIF) are significantly increased in DHF patients compared to levels in DF patients or normal controls. In this study, we investigated how MIF and sTM concentrations are enhanced in the plasma of DHF patients and the potential effect of MIF on coagulation through its influence on two factors: thrombomodulin (TM) and intercellular adhesion molecule-1 (ICAM-1) in endothelial cells and monocytes. Recombinant human macrophage migration inhibitory factor (rMIF) was used to treat monocytic THP-1 cells and endothelial HMEC-1 cells or primary HUVEC cells. The subsequent expression of TM and ICAM-1 was assessed by immunofluorescent staining and flow cytometry analysis. Additionally, the co-incubation of THP-1 cells with various cell signaling pathway inhibitors was used to determine the pathways through which MIF mediated its effect. The data provided evidence that severe DV infections induce MIF expression, which in turn stimulates monocytes or endothelial cells to express TM and ICAM-1 via the Erk, JNK MAPK and the PI3K signaling pathways, supporting the idea that MIF may play an important role as a regulator of coagulation.	[Yeh, Trai-Ming] Natl Cheng Kung Univ Hosp, Dept Med Technol, Tainan, Taiwan; [Liu, Shu-Hsiang] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Liu, Shu-Hsiang] Natl Taipei Univ Nursing & Hlth Sci, Ctr Gen Educ, Taipei, Taiwan; [Lin, Kao-Chang] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Lin, Kao-Chang] So Taiwan Univ, Dept Biotechnol, Tainan, Taiwan; [Kuo, Chieh] Sin Lau Christian Hosp, Dept Cardiol, Tainan, Taiwan; [Kuo, Shu-Yun; Fu, Tsai-Feng] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou, Taiwan; [Huang, Tzuu-Yuan] Sin Lau Christian Hosp, Dept Neurosurg, Tainan, Taiwan; [Yen, Yong-Ren] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Kuo, Shu-Yun; Wen, Rong-Kun; Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan; [Chen, Lien-Cheng] Chung Hwa Univ Med Technol, Dept Med Technol, Tainan, Taiwan; [Chen, Lien-Cheng] Chung Hwa Univ Med Technol, Grad Inst Biol Sci & Technol, Tainan, Taiwan; [Chen, Lien-Cheng] Sin Lau Christian Hosp, Med Educ & Res Ctr, Tainan, Taiwan; [Chen, Lien-Cheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Chen, Lien-Cheng] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Mackay Memorial Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Chi Nan University; Chung Shan Medical University; National Chi Nan University; Chung Hua University; Chung Hua University; Taipei Medical University; Chung Shan Medical University	Chen, LC (corresponding author), Chung Hwa Univ Med Technol, Dept Med Technol, Tainan, Taiwan.	clctcell@yahoo.com.tw; tffu@ncnu.edu.tw	Yeh, Trai-Ming/C-7193-2011	Yeh, Trai-Ming/0000-0003-3172-7432; Fu, Tsai-Feng/0000-0002-0343-3018	National Science Council Grant [101-2311-B-260-002, 101-2627-M-260-001-, 98-2311-B-260-001-MY3]; Taichung Veterans General Hospital/National Chi Nan University Joint Research Program [TCVGH-NCNU1017904]	National Science Council Grant; Taichung Veterans General Hospital/National Chi Nan University Joint Research Program	This work was supported by National Science Council Grant 101-2311-B-260-002, 101-2627-M-260-001- and 98-2311-B-260-001-MY3 (to T.-F.F) and grant from the Taichung Veterans General Hospital/National Chi Nan University Joint Research Program TCVGH-NCNU1017904 (to T.-F. F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2006, BLOOD, V107, P2252, DOI 10.1182/blood-2005-05-2011; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Baugh JA, 2002, CRIT CARE MED, V30, pS27, DOI 10.1097/00003246-200201001-00004; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bunyaratvej A, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 3, P32; Butthep P, 2006, PEDIATR INFECT DIS J, V25, P894, DOI 10.1097/01.inf.0000237918.85330.b9; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2003, J INFECT DIS, V187, pS385, DOI 10.1086/374752; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; Charrad RS, 2002, BLOOD, V99, P290, DOI 10.1182/blood.V99.1.290; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; Chen LC, 2009, J INFECTION, V58, P368, DOI 10.1016/j.jinf.2009.02.018; de Jong D, 2001, FERTIL STERIL, V75, P688, DOI 10.1016/S0015-0282(00)01789-1; DITTMAN WA, 1989, P NATL ACAD SCI USA, V86, P7179, DOI 10.1073/pnas.86.18.7179; Grey ST, 1998, INT J HEMATOL, V67, P53; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Huang YH, 2003, J MED VIROL, V70, P610, DOI 10.1002/jmv.10438; Huang YH, 2001, J MED VIROL, V63, P247, DOI 10.1002/1096-9071(200103)63:3&lt;247::AID-JMV1008&gt;3.0.CO;2-F; Huang YH, 2000, AM J TROP MED HYG, V63, P71, DOI 10.4269/ajtmh.2000.63.71; Ishii H, 2003, BLOOD, V101, P4765, DOI 10.1182/blood-2002-08-2428; ISHII H, 1985, J CLIN INVEST, V76, P2178, DOI 10.1172/JCI112225; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kim HK, 2007, BLOOD COAGUL FIBRIN, V18, P157, DOI 10.1097/MBC.0b013e32801481cb; Krishnamurti C, 2002, AM J TROP MED HYG, V66, P435, DOI 10.4269/ajtmh.2002.66.435; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lin SJ, 2007, J CELL BIOCHEM, V101, P642, DOI 10.1002/jcb.21206; Mairuhu ATA, 2003, LANCET INFECT DIS, V3, P33, DOI 10.1016/S1473-3099(03)00487-0; MALEK AM, 1994, CIRC RES, V74, P852, DOI 10.1161/01.RES.74.5.852; Masamura K, 2003, ARTERIOSCL THROM VAS, V23, P512, DOI 10.1161/01.ATV.0000060461.64771.F0; Nan BC, 2005, THROMB RES, V115, P417, DOI 10.1016/j.thromres.2004.10.010; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; OHJI T, 1995, THROMB HAEMOSTASIS, V73, P812; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shyu LY, 2012, THROMB RES, V129, P43, DOI 10.1016/j.thromres.2011.08.011; Sohn RH, 2005, BLOOD, V105, P3910, DOI 10.1182/blood-2004-03-0928; Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42, DOI 10.1055/s-0037-1612941; Uehara S, 2001, THROMB RES, V104, P325, DOI 10.1016/S0049-3848(01)00358-9; Van de Wouwer M, 2004, CRIT CARE MED, V32, pS254, DOI 10.1097/01.CCM.0000128036.64448.9e; van Gorp ECM, 2002, J MED VIROL, V67, P549, DOI 10.1002/jmv.10137; van Gorp ECM, 2001, BRIT J HAEMATOL, V113, P94, DOI 10.1046/j.1365-2141.2001.02710.x; Wakabayashi K, 2012, MOD RHEUMATOL, V22, P59, DOI 10.1007/s10165-011-0466-z; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd	47	23	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55018	10.1371/journal.pone.0055018	http://dx.doi.org/10.1371/journal.pone.0055018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383040	gold, Green Submitted, Green Published			2022-12-27	WOS:000315211500048
J	Zhang, XY; Yao, DX; Wang, QH; Xu, WY; Wei, Q; Wang, CC; Liu, CL; Zhang, CJ; Yan, H; Ling, Y; Su, Z; Li, FG				Zhang, Xueyan; Yao, Dongxia; Wang, Qianhua; Xu, Wenying; Wei, Qiang; Wang, Chunchao; Liu, Chuanliang; Zhang, Chaojun; Yan, Hong; Ling, Yi; Su, Zhen; Li, Fuguang			mRNA-seq Analysis of the Gossypium arboreum transcriptome Reveals Tissue Selective Signaling in Response to Water Stress during Seedling Stage	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE RESOLUTION; GENE-EXPRESSION PROFILES; ABSCISIC-ACID; SALT-STRESS; COTTON PLANTS; HIGH SALINITY; OSMOTIC ADJUSTMENT; ARABIDOPSIS ROOTS; ION HOMEOSTASIS; ABIOTIC STRESS	The cotton diploid species, Gossypium arboreum, shows important properties of stress tolerance and good genetic stability. In this study, through mRNA-seq, we de novo assembled the unigenes of multiple samples with 3h H2O, NaCl, or PEG treatments in leaf, stem and root tissues and successfully obtained 123,579 transcripts of G. arboreum, 89,128 of which were with hits through BLAST against known cotton ESTs and draft genome of G. raimondii. About 36,961 transcripts (including 1,958 possible transcription factor members) were identified with differential expression under water stresses. Principal component analysis of differential expression levels in multiple samples suggested tissue selective signalling responding to water stresses. Venn diagram analysis showed the specificity and intersection of transcripts' response to NaCl and PEG treatments in different tissues. Self-organized mapping and hierarchical cluster analysis of the data also revealed strong tissue selectivity of transcripts under salt and osmotic stresses. In addition, the enriched gene ontology (GO) terms for the selected tissue groups were differed, including some unique enriched GO terms such as photosynthesis and tetrapyrrole binding only in leaf tissues, while the stem-specific genes showed unique GO terms related to plant-type cell wall biogenesis, and root-specific genes showed unique GO terms such as monooxygenase activity. Furthermore, there were multiple hormone cross-talks in response to osmotic and salt stress. In summary, our multidimensional mRNA sequencing revealed tissue selective signalling and hormone crosstalk in response to salt and osmotic stresses in G. arboreum. To our knowledge, this is the first such report of spatial resolution of transcriptome analysis in G. arboreum. Our study will potentially advance understanding of possible transcriptional networks associated with water stress in cotton and other crop species.	[Zhang, Xueyan; Wang, Qianhua; Liu, Chuanliang; Zhang, Chaojun; Li, Fuguang] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Yao, Dongxia; Xu, Wenying; Wei, Qiang; Wang, Chunchao; Yan, Hong; Ling, Yi; Su, Zhen] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; China Agricultural University	Su, Z (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	zhensu@cau.edu.cn; aylifug@hotmail.com			National Science Fund for Distinguished Young Scholars [31125020]; National Natural Science Foundation of China [31171276, 90817006]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Scientists and Technicians Troop Construction Projects of Henan Province	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (31125020), the National Natural Science Foundation of China (31171276 and 90817006), and the Innovation Scientists and Technicians Troop Construction Projects of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; ACKERSON RC, 1982, PLANT PHYSIOL, V69, P609, DOI 10.1104/pp.69.3.609; ACKERSON RC, 1981, PLANT PHYSIOL, V67, P489, DOI 10.1104/pp.67.3.489; Akhtar J, 2010, PAK J BOT, V42, P2857; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barozai MYK, 2012, MOL BIOL REP, V39, P1011, DOI 10.1007/s11033-011-0826-y; BERLIN J, 1982, PLANT PHYSIOL, V70, P238, DOI 10.1104/pp.70.1.238; Bharambe P. R., 1980, Journal of Maharashtra Agricultural Universities, V5, P201; BOYER JS, 1965, PLANT PHYSIOL, V40, P229, DOI 10.1104/pp.40.2.229; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Chao DY, 2005, CELL RES, V15, P796, DOI 10.1038/sj.cr.7290349; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Deyholos MK, 2010, PLANT CELL ENVIRON, V33, P648, DOI 10.1111/j.1365-3040.2009.02092.x; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Dinneny JR, 2010, PLANT CELL ENVIRON, V33, P543, DOI 10.1111/j.1365-3040.2009.02055.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL; Galvan-Ampudia SC, 2011, CURR OPIN PLANT BIOL, V14, P1; Gomez-Cadenas A, 1998, PHYSIOL PLANTARUM, V103, P475, DOI 10.1034/j.1399-3054.1998.1030405.x; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hossain MA, 2011, PLANT PHYSIOL, V156, P430, DOI 10.1104/pp.111.172254; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; JORDAN WR, 1975, PLANT PHYSIOL, V56, P595, DOI 10.1104/pp.56.5.595; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin H, 1997, CROP SCI, V37, P190, DOI 10.2135/cropsci1997.0011183X003700010032x; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Maqbool A, 2010, BIOTECHNOL PROGR, V26, P21, DOI 10.1002/btpr.306; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; OOSTERHUIS DM, 1987, PLANT PHYSIOL, V84, P1154, DOI 10.1104/pp.84.4.1154; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; RADIN JW, 1984, PLANT PHYSIOL, V76, P392, DOI 10.1104/pp.76.2.392; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; RK B.O, 2009, J PLANT ENV SCI, P16; Rodriguez-Uribe L, 2011, PLANT SCI, V180, P461, DOI 10.1016/j.plantsci.2010.10.009; Saavedra X, 2010, PLANT PHYSIOL, V152, P133, DOI 10.1104/pp.109.146381; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Sattar S, 2010, J ANIM PLANT SCI, V20, P87; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; SEXTON PD, 1982, AGRON J, V74, P699, DOI 10.2134/agronj1982.00021962007400040025x; Shinozaki K, 1999, Tanpakushitsu Kakusan Koso, V44, P2186; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; TIMPA JD, 1986, PLANT PHYSIOL, V82, P724, DOI 10.1104/pp.82.3.724; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Ueda A, 2006, THEOR APPL GENET, V112, P1286, DOI 10.1007/s00122-006-0231-4; VIEIRADASILVA J, 1974, P NATL ACAD SCI USA, V71, P3243; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wee CW, 2010, BIOTECHNOL LETT, V32, P1361, DOI 10.1007/s10529-010-0307-8; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilhelm BT, 2010, NAT PROTOC, V5, P255, DOI 10.1038/nprot.2009.229; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Yang HX, 2011, PLANT J, V65, P503, DOI 10.1111/j.1365-313X.2010.04439.x; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang Ling, 2009, BMC Res Notes, V2, P120, DOI 10.1186/1756-0500-2-120; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	85	15	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54762	10.1371/journal.pone.0054762	http://dx.doi.org/10.1371/journal.pone.0054762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382961	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500025
J	Lin, WT; Hsieh, CH; Miki, T				Lin, Wei-Ting; Hsieh, Chih-hao; Miki, Takeshi			Difference Inadaptive Dispersal Ability Can Promote Species Coexistence in Fluctuating Environments	PLOS ONE			English	Article							IDEAL-FREE DISTRIBUTION; COLONIZATION TRADE-OFF; SPATIAL HETEROGENEITY; POPULATION-DYNAMICS; HABITAT SELECTION; COMPETITION; MOVEMENT; PREY; METACOMMUNITY; CONSEQUENCES	Theories and empirical evidence suggest that random dispersal of organisms promotes species coexistence in spatially structured environments. However, directed dispersal, where movement is adjusted with fitness-related cues, is less explored in studies of dispersal-mediated coexistence. Here, we present a metacommunity model of two consumers exhibiting directed dispersal and competing for a single resource. Our results indicated that directed dispersal promotes coexistence through two distinct mechanisms, depending on the adaptiveness of dispersal. Maladaptive directed dispersal may promote coexistence similar to random dispersal. More importantly, directed dispersal is adaptive when dispersers track patches of increased resources in fluctuating environments. Coexistence is promoted under increased adaptive dispersal ability of the inferior competitor relative to the superior competitor. This newly described dispersal-mediated coexistence mechanism is likely favored by natural selection under the trade-off between competitive and adaptive dispersal abilities.	[Lin, Wei-Ting; Hsieh, Chih-hao; Miki, Takeshi] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Miki, T (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	tksmiki@ntu.edu.tw	Hsieh, Chih-hao/B-3797-2008; Miki, Takeshi/F-8189-2010	Hsieh, Chih-hao/0000-0001-5935-7272; Miki, Takeshi/0000-0002-2452-8681	National Science Council, Taiwan [NSC 100-2611-M-002-010]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	TM was supported by National Science Council (NSC 100-2611-M-002-010), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, ECOLOGY, V81, P2902, DOI 10.2307/177350; Abrams PA, 2004, ECOL LETT, V7, P929, DOI 10.1111/j.1461-0248.2004.00644.x; Abrams PA, 2007, AM NAT, V169, P581, DOI 10.1086/512688; Abrams PA, 2012, ECOLOGY, V93, P281, DOI 10.1890/11-0011.1; Abrams PA, 2011, J THEOR BIOL, V277, P99, DOI 10.1016/j.jtbi.2011.02.019; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Amarasekare P, 2010, J ANIM ECOL, V79, P282, DOI 10.1111/j.1365-2656.2009.01607.x; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; Armsworth PR, 2005, AM NAT, V165, P449, DOI 10.1086/428595; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Byers JE, 2000, J EXP MAR BIOL ECOL, V248, P133, DOI 10.1016/S0022-0981(00)00163-5; Cadotte MW, 2006, OECOLOGIA, V149, P150, DOI 10.1007/s00442-006-0426-z; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; CAMPBELL CAM, 1993, J CHEM ECOL, V19, P1569, DOI 10.1007/BF00984897; Cantrell RS, 2008, J DIFFER EQUATIONS, V245, P3687, DOI 10.1016/j.jde.2008.07.024; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Cosner C, 2005, THEOR POPUL BIOL, V67, P101, DOI 10.1016/j.tpb.2004.09.002; Cote J, 2007, ECOL LETT, V10, P411, DOI 10.1111/j.1461-0248.2007.01032.x; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Flaxman SM, 2011, THEOR ECOL-NETH, V4, P255, DOI 10.1007/s12080-011-0120-6; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; GURNEY WSC, 1975, J THEOR BIOL, V52, P441, DOI 10.1016/0022-5193(75)90011-9; HANSKI I, 1983, ECOLOGY, V64, P493, DOI 10.2307/1939969; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; Holt RD, 1997, EVOL ECOL, V11, P723, DOI 10.1023/A:1018438403047; HSU SB, 1978, SIAM J APPL MATH, V35, P617, DOI 10.1137/0135051; HSU SB, 1978, ECOL MONOGR, V48, P337, DOI 10.2307/2937235; Jansen VAA, 1998, P NATL ACAD SCI USA, V95, P3696, DOI 10.1073/pnas.95.7.3696; Jansen VAA, 1999, ECOL LETT, V2, P379; KISHIMOTO K, 1990, THEOR POPUL BIOL, V38, P149, DOI 10.1016/0040-5809(90)90008-J; Kostal V, 1996, PHYSIOL ENTOMOL, V21, P123, DOI 10.1111/j.1365-3032.1996.tb00844.x; Krug PJ, 2000, J EXP BIOL, V203, P1741; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; Levine JM, 2002, AM NAT, V160, P452, DOI 10.1086/342073; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Mouquet N, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P237; Namba T, 2004, THEOR POPUL BIOL, V66, P53, DOI 10.1016/j.tpb.2004.03.003; NAMBA T, 1989, J MATH BIOL, V27, P1, DOI 10.1007/BF00276077; NAMBA T, 1980, J THEOR BIOL, V86, P351, DOI 10.1016/0022-5193(80)90011-9; Nieminen M, 1996, OECOLOGIA, V108, P643, DOI 10.1007/BF00329038; Ostman O, 2006, OIKOS, V114, P360, DOI 10.1111/j.2006.0030-1299.14521.x; Pillai P, 2012, AM NAT, V179, P204, DOI 10.1086/663674; Poethke HJ, 2010, AM NAT, V175, P577, DOI 10.1086/651595; Powers SP, 2000, LIMNOL OCEANOGR, V45, P727, DOI 10.4319/lo.2000.45.3.0727; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; RICHARDSON JS, 1991, ECOLOGY, V72, P873, DOI 10.2307/1940589; Ruokolainen L, 2011, J THEOR BIOL, V291, P76, DOI 10.1016/j.jtbi.2011.09.004; Saglam IK, 2008, J EVOLUTION BIOL, V21, P997, DOI 10.1111/j.1420-9101.2008.01548.x; Salomon Y, 2010, ECOL LETT, V13, P432, DOI 10.1111/j.1461-0248.2009.01436.x; Schaefer J, 2001, FRESHWATER BIOL, V46, P379, DOI 10.1046/j.1365-2427.2001.00685.x; SHIGESADA N, 1979, J THEOR BIOL, V79, P83, DOI 10.1016/0022-5193(79)90258-3; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Snider SB, 2008, ECOLOGY, V89, P1961, DOI 10.1890/07-0715.1; TAKEUCHI Y, 1989, MATH BIOSCI, V95, P65, DOI 10.1016/0025-5564(89)90052-7; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1982, Monographs in Population Biology, pi; Wang WD, 2009, J THEOR BIOL, V258, P603, DOI 10.1016/j.jtbi.2009.02.014; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Yu DW, 2001, AM NAT, V158, P49, DOI 10.1086/320865; Zhao LQ, 2010, ENTOMOL EXP APPL, V135, P288, DOI 10.1111/j.1570-7458.2010.00989.x	68	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55218	10.1371/journal.pone.0055218	http://dx.doi.org/10.1371/journal.pone.0055218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383314	Green Submitted, Green Published, gold			2022-12-27	WOS:000314597900021
J	Baez, MV; Oberholzer, MV; Cercato, MC; Snitcofsky, M; Aguirre, AI; Jerusalinsky, DA				Veronica Baez, Maria; Victoria Oberholzer, Maria; Cecilia Cercato, Magali; Snitcofsky, Marina; Ines Aguirre, Alejandra; Alicia Jerusalinsky, Diana			NMDA Receptor Subunits in the Adult Rat Hippocampus Undergo Similar Changes after 5 Minutes in an Open Field and after LTP Induction	PLOS ONE			English	Article							LONG-TERM DEPRESSION; ER RETENTION SIGNAL; SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; MEMORY FORMATION; CRITICAL PERIOD; WORKING-MEMORY; NR2B SUBUNIT; LATE-PHASE; EXPRESSION	NMDA receptor subunits change during development and their synaptic expression is modified rapidly after synaptic plasticity induction in hippocampal slices. However, there is scarce information on subunits expression after synaptic plasticity induction or memory acquisition, particularly in adults. GluN1, GluN2A and GluN2B NMDA receptor subunits were assessed by western blot in 1) adult rats that had explored an open field (OF) for 5 minutes, a time sufficient to induce habituation, 2) mature rat hippocampal neuron cultures depolarized by KCl and 3) hippocampal slices from adult rats where long term potentiation (LTP) was induced by theta-burst stimulation (TBS). GluN1 and GluN2A, though not GluN2B, were significantly higher 70 minutes -but not 30 minutes-after a 5 minutes session in an OF. GluN1 and GluN2A total immunofluorescence and puncta in neurites increased in cultures, as evaluated 70 minutes after KCl stimulation. Similar changes were found in hippocampal slices 70 minutes after LTP induction. To start to explore underlying mechanisms, hippocampal slices were treated either with cycloheximide (a translation inhibitor) or actinomycin D (a transcription inhibitor) during electrophysiological assays. It was corroborated that translation was necessary for LTP induction and expression. The rise in GluN1 depends on transcription and translation, while the increase in GluN2A appears to mainly depend on translation, though a contribution of some remaining transcriptional activity during actinomycin D treatment could not be rouled out. LTP effective induction was required for the subunits to increase. Although in the three models same subunits suffered modifications in the same direction, within an apparently similar temporal course, further investigation is required to reveal if they are related processes and to find out whether they are causally related with synaptic plasticity, learning and memory.	[Veronica Baez, Maria; Victoria Oberholzer, Maria; Cecilia Cercato, Magali; Snitcofsky, Marina; Ines Aguirre, Alejandra; Alicia Jerusalinsky, Diana] Univ Buenos Aires, Fac Med, CONICET, Inst Biol Celular & Neurociencia IBCN Prof Eduard, Buenos Aires, DF, Argentina; [Alicia Jerusalinsky, Diana] Univ Buenos Aires, CBC, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Jerusalinsky, DA (corresponding author), Univ Buenos Aires, Fac Med, CONICET, Inst Biol Celular & Neurociencia IBCN Prof Eduard, Buenos Aires, DF, Argentina.	djerusal@gmail.com	Baez, Veronica/ABF-9940-2021	Baez, Maria Veronica/0000-0001-5105-2888	Univesity of Buenos Aires (UBA); CONICET (LIA)	Univesity of Buenos Aires (UBA); CONICET (LIA)	This work has been supported by: Univesity of Buenos Aires (UBA) and CONICET (LIA). MVB has been awarded with a posdoctoral fellowship by Bunge&Born foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; DAVIS M, 1993, BRAZ J MED BIOL RES, V26, P235; Dravid SM, 2007, J PHYSIOL-LONDON, V581, P107, DOI 10.1113/jphysiol.2006.124958; Flint AC, 1997, J NEUROSCI, V17, P2469; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Guscott MR, 2003, EUR J PHARMACOL, V476, P193, DOI 10.1016/S0014-2999(03)02182-4; Henderson AK, 2012, NEUROSCIENCE, V215, P98, DOI 10.1016/j.neuroscience.2012.04.040; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; IZQUIERDO I, 1992, BEHAV NEURAL BIOL, V58, P16, DOI 10.1016/0163-1047(92)90847-W; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kamphuis PJGH, 2003, FASEB J, V17, P911, DOI 10.1096/fj.02-0333fje; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; KRUGERS HJ, 1993, NEUROSCI LETT, V154, P73, DOI 10.1016/0304-3940(93)90174-J; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Packard MG, 1997, NEUROBIOL LEARN MEM, V68, P42, DOI 10.1006/nlme.1996.3762; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; STEELE RJ, 1995, BRAIN RES, V674, P352, DOI 10.1016/0006-8993(95)00014-H; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tse YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027215; Baez MV, 2011, J CELL BIOL, V195, P1141, DOI 10.1083/jcb.201108159; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wang S, 2009, J NEUROSCI, V29, P15232, DOI 10.1523/JNEUROSCI.3809-09.2009; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049	64	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55244	10.1371/journal.pone.0055244	http://dx.doi.org/10.1371/journal.pone.0055244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383317	gold, Green Submitted, Green Published			2022-12-27	WOS:000314597900024
J	Chen, T; Zhu, J; Zhang, C; Huo, K; Fei, Z; Jiang, XF				Chen, Tao; Zhu, Jie; Zhang, Chi; Huo, Kai; Fei, Zhou; Jiang, Xiao-fan			Protective Effects of SKF-96365, a Non-Specific Inhibitor of SOCE, against MPP+-Induced Cytotoxicity in PC12 Cells: Potential Role of Homer1	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; ENDOPLASMIC-RETICULUM STRESS; PROTEIN-KINASE CASCADE; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; CALCIUM-CHANNELS; IP3 RECEPTORS; BINDS; ENTRY; BRAIN	Parkinson's disease (PD) is the most common neurodegenerative movement disorder, characterized by loss of dopominergic (DA) neurons in substantia nigra pars compacta (SNpc), and can be experimentally mimicked by the neurotoxin MPP+ in vitro models. In this study, we investigated the potential protective effect of SKF-96365, a non-specific inhibitor of SOCE (store-operated calcium entry), on MPP+ induced cytotoxicity in PC12 cells. We found that pretreatment with SKF-96365 (10 mu M and 50 mu M) 30 min before injury significantly increased cell viability, decreased LDH release, prevented nuclear damage, and inhibited apoptotic cell death in MPP+ stressed PC12 cells. The results of calcium image using the ratiometric calcium indicator Fura-2-AM also showed that SKF-96365 reduced the intracellular calcium overload induced by MPP+ in PC12 cells. In addition, SKF-96365 decreased the expression of Homer1, a more recently discovered postsynaptic scaffolding protein with calcium modulating function, following MPP+ administration in PC12 cells, while had no statistically significant effects on endoplasmic reticulum (ER) calcium concentration. Furthermore, overexpression of Homer1 by using recombinant lentivirus partly reversed protective effects of SKF-96365 against MPP+ injury. The ER Ca2+ release was further amplified and ER calcium recovery was delayed by Homer1 upregulation in PC12 cells following MPP+ insult. Taken together, these data suggest that SKF-96365 protects PC12 cells against MPP+ induced cytotoxicity, and this protection may be at least in part on the inhibition of intracellular calcium overload and suppression of Homer1-mediated ER Ca2+ release.	[Chen, Tao; Zhu, Jie; Zhang, Chi; Huo, Kai; Fei, Zhou; Jiang, Xiao-fan] Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Chen, Tao] PLA, Hosp 123, Dept Neurosurg, Bengbu, Anhui, Peoples R China	Air Force Military Medical University	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.	fmmuzhoufei@163.com; fmmujiangxiaofan@163.com			National Natural Science Foundation of China [81071034, 30930093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 81071034 and No. 30930093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ango F, 2002, MOL CELL NEUROSCI, V20, P323, DOI 10.1006/mcne.2002.1100; Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brandt SK, 2011, NEUROSCIENCE, V172, P387, DOI 10.1016/j.neuroscience.2010.10.071; Cali T, 2011, BIOFACTORS, V37, P228, DOI 10.1002/biof.159; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Ding J, 2012, NEUROSCI BULL, V28, P173, DOI 10.1007/s12264-012-1213-y; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Harper JL, 2003, BIOCHEM PHARMACOL, V65, P329, DOI 10.1016/S0006-2952(02)01488-0; Ilijic E, 2011, NEUROBIOL DIS, V43, P364, DOI 10.1016/j.nbd.2011.04.007; Jellinger KA, 2001, ADV NEUROL, V86, P55; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Luo P, 2012, APOPTOSIS; Mekahli D, 2011, COLD SPRING HARB PER, V3; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Panariello F, 2012, J CELL PHYSIOL, V227, P1485, DOI 10.1002/jcp.22864; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peng L, 2011, INT J MOL MED, V28, P161, DOI 10.3892/ijmm.2011.684; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; ROSS WN, 1989, ANNU REV PHYSIOL, V51, P491, DOI 10.1146/annurev.physiol.51.1.491; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Schapira AHV, 2004, JAMA-J AM MED ASSOC, V291, P358, DOI 10.1001/jama.291.3.358; Sethi K, 2008, MOVEMENT DISORD, V23, pS521, DOI 10.1002/mds.22049; Shin DM, 2003, J CELL BIOL, V162, P293, DOI 10.1083/jcb.200210109; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Soldner F, 1999, EXP CELL RES, V250, P75, DOI 10.1006/excr.1999.4504; Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045; Szikra T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006723; TAKASHIMA A, 1985, BIOCHIM BIOPHYS ACTA, V847, P101, DOI 10.1016/0167-4889(85)90159-4; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang Y, 2012, NEUROSCI LETT, V515, P44, DOI 10.1016/j.neulet.2012.03.016; Weiner WJ, 2008, NEUROLOGY, V71, P470, DOI 10.1212/01.wnl.0000324860.70391.25; Wilhelmus MMM, 2011, FREE RADICAL BIO MED, V50, P469, DOI 10.1016/j.freeradbiomed.2010.11.033; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	44	56	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55601	10.1371/journal.pone.0055601	http://dx.doi.org/10.1371/journal.pone.0055601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383239	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600132
J	Liu, SF; Jia, XF; Li, CS; Han, XF; Yan, WH; Xing, Y				Liu, Sufang; Jia, Xiaofeng; Li, Changsheng; Han, Xuefei; Yan, Wenhai; Xing, Ying			CXCR7 Silencing Attenuates Cell Adaptive Response to Stromal Cell Derived Factor 1 alpha after Hypoxia	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; RECEPTOR CXCR7; IN-VITRO; MIGRATION; EXPRESSION; FACTOR-1-ALPHA; ANGIOGENESIS; ACTIVATION; SURVIVAL; BRAIN	Previous studies have shown that chemotactic factor stromal-cell derived factor 1 alpha (SDF1 alpha) promotes cell recovery from hypoxic injury via its main receptor C-X-C chemokine receptor type (CXCR) 4. However, the role of its new receptor CXCR7 on cell repair against hypoxia and cell response to SDF1 alpha remains largely unknown. In this study, neurons induced from hippocampal progenitor cells were pre-conditioned in hypoxia for 4h and subsequently monitored to investigate the function of SDF1 alpha on cell repair after hypoxia. Neurons were assessed for their cell morphology, actin filament polymerization and migration capability. SDF1 alpha protein levels increased significantly 1 h after hypoxia compared to control (P<0.01), and it reached a peak at 24 h after hypoxia. Moreover, addition of SDF1 alpha promoted neurite outgrowth and actin filament polymerization both in normoxic and hypoxic cells compared to untreated cells. Cell migration showed a time-dependent increase with SDF1 alpha stimulation in both groups, and hypoxic cells illustrated a significant augment at 0.5 h, 1 h and 12 h after SDF1 alpha application compared to normoxic cells (P<0.01). CXCR7 expression also increased with time dependence after hypoxia and demonstrated a two-fold upregulation compared to control at 24 h after hypoxia. With CXCR7 silencing, axon elongation and actin filament polymerization induced by SDF1 alpha were inhibited sharply both in normoxic and hypoxic cells. CXCR7 silencing also leads to reduced hypoxic cell migration at 0.5 h, 1 h, 12 h, 24 h and 36 h after SDF1 alpha application (P<0.01), but it failed to reduce normoxic cell migration induced by SDF1 alpha at 0.5 h, 1 h and 12 h (P>0.05). 24 h SDF1 alpha stimulation led to higher ERK1/2 phosphorylation compared to control, and ERK1/2 phosphorylation increased more in hypoxic cells than that in normoxic cells. This study suggested that CXCR7 plays an important role on cell repair processing induced by SDF1 alpha, and CXCR7 silencing attenuates cell adaptive response to acute SDF1 alpha stimulation (<= 12 h) after hypoxia.	[Liu, Sufang; Han, Xuefei; Yan, Wenhai; Xing, Ying] Zhengzhou Univ, Dept Physiol, Sch Med, Zhengzhou, Henan Province, Peoples R China; [Liu, Sufang; Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Jia, Xiaofeng] Johns Hopkins Univ, Dept Phys Med & Rehabil, Sch Med, Baltimore, MD USA; [Jia, Xiaofeng; Li, Changsheng] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Li, Changsheng] Henan Anticanc Hosp, Dept Anesthesiol, Zhengzhou, Henan Province, Peoples R China	Zhengzhou University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Xing, Y (corresponding author), Zhengzhou Univ, Dept Physiol, Sch Med, Zhengzhou, Henan Province, Peoples R China.	xingyingprofessor@gmail.com	Liu, Sufang/Q-9869-2018; Jia, Xiaofeng/B-2145-2008; Liu, Sufang/AAF-7275-2021	Liu, Sufang/0000-0003-2677-1295; Jia, Xiaofeng/0000-0003-1445-8525; 	State Natural Science Funds Commission	State Natural Science Funds Commission	The authors appreciate State Natural Science Funds Commission for their funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ortega JA, 2010, CEREB CORTEX, V20, P2132, DOI 10.1093/cercor/bhp275; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bakondi B, 2011, STEM CELLS DEV, V20, P1021, DOI 10.1089/scd.2010.0198; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Biswas I, 2012, BLOOD CELL MOL DIS, V49, P92, DOI 10.1016/j.bcmd.2012.05.001; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; Feast A, 2012, EPILEPSIA, V53, P1349, DOI 10.1111/j.1528-1167.2012.03591.x; Gillard SE, 2002, J NEUROIMMUNOL, V124, P16, DOI 10.1016/S0165-5728(02)00005-X; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Hota KB, 2012, HIPPOCAMPUS, V22, P723, DOI 10.1002/hipo.20934; Kremer KN, 2011, J IMMUNOL, V187, P1440, DOI 10.4049/jimmunol.1100820; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li Q, 2008, J NEUROSCI RES, V86, P1227, DOI 10.1002/jnr.21597; Lin SC, 2012, J CLIN ENDOCR METAB, V97, pE1515, DOI 10.1210/jc.2012-1450; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Lysko DE, 2011, J NEUROSCI, V31, P1739, DOI 10.1523/JNEUROSCI.3118-10.2011; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Opatz J, 2009, MOL CELL NEUROSCI, V40, P293, DOI 10.1016/j.mcn.2008.11.002; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rempel SA, 2000, CLIN CANCER RES, V6, P102; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Schneider C, 2012, BRAIN DEV-JPN, V34, P261, DOI 10.1016/j.braindev.2011.07.006; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Shimizu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020680; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Timotijevic G, 2012, INT J BIOCHEM CELL B, V44, P838, DOI 10.1016/j.biocel.2012.03.014; Tiveron MC, 2010, J NEUROIMMUNOL; WANG FZ, 1995, ACTA PHARM SINIC, V16, P419; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Wang YT, 2012, CURR DRUG TARGETS, V13, P166, DOI 10.2174/138945012799201603; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P624, DOI 10.1111/j.1440-1681.2007.04619.x; Yang K, 2012, BRAIN STRUCT FUNCT; Yu T, 2010, J NEUROSCI RES, V88, P2775, DOI 10.1002/jnr.22454; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482	43	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55290	10.1371/journal.pone.0055290	http://dx.doi.org/10.1371/journal.pone.0055290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383139	Green Published, gold			2022-12-27	WOS:000314610600083
J	Mannaerts, I; Eysackers, N; Onyema, OO; Van Beneden, K; Valente, S; Mai, A; Odenthal, M; van Grunsven, LA				Mannaerts, Inge; Eysackers, Nathalie; Onyema, Oscar O.; Van Beneden, Katrien; Valente, Sergio; Mai, Antonello; Odenthal, Margarete; van Grunsven, Leo A.			Class II HDAC Inhibition Hampers Hepatic Stellate Cell Activation by Induction of MicroRNA-29	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; MATRIX METALLOPROTEINASES; TRICHOSTATIN-A; EXPRESSION; GENE; FIBROSIS; TARGET; TRANSDIFFERENTIATION; DIFFERENTIATION; TGF-BETA-1	Background: The conversion of a quiescent vitamin A storing hepatic stellate cell (HSC) to a matrix producing, contractile myofibroblast-like activated HSC is a key event in the onset of liver disease following injury of any aetiology. Previous studies have shown that class I histone deacetylases (HDACs) are involved in the phenotypical changes occurring during stellate cell activation in liver and pancreas. Aims: In the current study we investigate the role of class II HDACs during HSC activation. Methods: We characterized the expression of the class II HDACs freshly isolated mouse HSCs. We inhibited HDAC activity by selective pharmacological inhibition with MC1568, and by repressing class II HDAC gene expression using specific siRNAs. Results: Inhibition of HDAC activity leads to a strong reduction of HSC activation markers alpha-SMA, lysyl oxidase and collagens as well as an inhibition of cell proliferation. Knock down experiments showed that HDAC4 contributes to HSC activation by regulating lysyl oxidase expression. In addition, we observed a strong up regulation of miR-29, a well-known anti-fibrotic miR, upon treatment with MC1568. Our in vivo work suggests that a successful inhibition of class II HDACs could be promising for development of future anti-fibrotic compounds. Conclusions: In conclusion, the use of MC1568 has enabled us to identify a role for class II HDACs regulating miR-29 during HSC activation.	[Mannaerts, Inge; Eysackers, Nathalie; Onyema, Oscar O.; van Grunsven, Leo A.] Vrije Univ Brussel, Dept Cell Biol, Liver Cell Biol Lab, Brussels, Belgium; [Van Beneden, Katrien] Vrije Univ Brussel, Dept Human Anat, Liver Cell Biol Lab, Brussels, Belgium; [Valente, Sergio; Mai, Antonello] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Odenthal, Margarete] Univ Hosp Cologne, Inst Pathol, Cologne, Germany	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Cologne	van Grunsven, LA (corresponding author), Vrije Univ Brussel, Dept Cell Biol, Liver Cell Biol Lab, Brussels, Belgium.	leo.van.grunsven@vub.ac.be	Mannaerts, Inge/AAC-5487-2019; Mannaerts, Inge/F-2181-2015; van Grunsven, Leo/E-5839-2010; Mai, Antonello/AAC-2144-2019; Valente, Sergio/K-2198-2016	Mannaerts, Inge/0000-0002-2235-2555; Mannaerts, Inge/0000-0002-2235-2555; van Grunsven, Leo/0000-0002-0990-7034; Valente, Sergio/0000-0002-2241-607X; Mai, Antonello/0000-0001-9176-2382	Vrije Universiteit Brussel [GOA48, GOA78, OZR1930]; Fund for Scientific Research Flanders (FWO-V) [G.0260.09]; Vrije Universiteit Brussel through an Onderzoeksraad project [OZR1428, OZR1796]	Vrije Universiteit Brussel; Fund for Scientific Research Flanders (FWO-V)(FWO); Vrije Universiteit Brussel through an Onderzoeksraad project	I. Mannaerts and L. A. van Grunsven are supported by the Vrije Universiteit Brussel (GOA48, GOA78, OZR1930) and by the Fund for Scientific Research Flanders (FWO-V, http://www.fwo.be/) (G.0260.09). K. Van Beneden is supported by the Vrije Universiteit Brussel through an Onderzoeksraad project (OZR1428 and OZR1796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bechmann LP, 2009, HEPATOL RES, V39, P601, DOI 10.1111/j.1872-034X.2008.00485.x; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Borbone E, 2010, ONCOGENE, V29, P105, DOI 10.1038/onc.2009.306; Bulow R, 2007, BIOCHEM PHARMACOL, V74, P1747, DOI 10.1016/j.bcp.2007.08.023; Bush EW, 2010, CIRC RES, V106, P272, DOI 10.1161/CIRCRESAHA.109.209338; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Du SL, 2007, J PHARMACOL EXP THER, V322, P560, DOI 10.1124/jpet.107.122481; Fallowfield JA, 2011, AM J PHYSIOL-GASTR L, V300, pG709, DOI 10.1152/ajpgi.00451.2010; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Haughton EL, 2006, GASTROENTEROLOGY, V131, P194, DOI 10.1053/j.gastro.2006.04.012; Horie S, 2000, PATHOL INT, V50, P937, DOI 10.1046/j.1440-1827.2000.01146.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kee HJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/928326; Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Lavelle D, 2001, AM J HEMATOL, V68, P170, DOI 10.1002/ajh.1174; Lenoir O, 2011, DIABETES, V60, P2861, DOI 10.2337/db11-0440; Li F, 2012, J CONTROL RELEASE, V159, P261, DOI 10.1016/j.jconrel.2011.12.023; Liu XJ, 2006, PHARM RES-DORDR, V23, P82, DOI 10.1007/s11095-005-9043-5; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Naldi M, 2009, PROTEOMICS, V9, P5437, DOI 10.1002/pmic.200800866; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Ogawa T, 2010, BIOCHEM BIOPH RES CO, V391, P316, DOI 10.1016/j.bbrc.2009.11.056; Olsen AL, 2011, AM J PHYSL GASTROINT; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Poelstra K, 2011, J HEPATOL, V55, P726, DOI 10.1016/j.jhep.2011.04.008; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Qin L, 2010, AM J PATHOL, V177, P1915, DOI 10.2353/ajpath.2010.100011; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rombouts K, 2002, J HEPATOL, V37, P788, DOI 10.1016/S0168-8278(02)00275-1; Rombouts K, 2001, ACTA GASTRO-ENT BELG, V64, P239; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Shi YF, 2006, BBA-GEN SUBJECTS, V1760, P1587, DOI 10.1016/j.bbagen.2006.09.012; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Wendtner CM, 2012, BLOOD, V119, P1095, DOI 10.1182/blood-2011-12-394494; Xiao F, 2010, DIGEST DIS SCI, V55, P261, DOI 10.1007/s10620-009-0743-2; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	58	52	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55786	10.1371/journal.pone.0055786	http://dx.doi.org/10.1371/journal.pone.0055786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383282	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600159
J	Paustian, C; Taylor, P; Johnson, T; Xu, M; Ramirez, N; Rosenthal, KS; Shu, SY; Cohen, PA; Czerniecki, BJ; Koski, GK				Paustian, Christopher; Taylor, Patricia; Johnson, Terrence; Xu, Min; Ramirez, Nancy; Rosenthal, Kenneth S.; Shu, Suyu; Cohen, Peter A.; Czerniecki, Brian J.; Koski, Gary K.			Extracellular ATP and Toll-Like Receptor 2 Agonists Trigger in Human Monocytes an Activation Program That Favors T Helper 17	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; SERUM-FREE CONDITIONS; GROWTH-FACTOR-BETA; TH17 CELLS; IN-VIVO; ADAPTIVE IMMUNITY; CD14(+) MONOCYTES; CALCIUM IONOPHORE; IL-12 PRODUCTION; HOST-DEFENSE	Strategically-paired Toll-like receptor (TLR) ligands induce a unique dendritic cell (DC) phenotype that polarizes Th1 responses. We therefore investigated pairing single TLR ligands with a non TLR-mediated danger signal to cooperatively induce distinct DC properties from cultured human monocytes. Adenosine triphosphate (ATP) and the TLR2 ligand lipoteichoic acid (LTA) selectively and synergistically induced expression of IL-23 and IL-1 beta from cultured monocytes as determined by ELISA assays. Flow cytometric analysis revealed that a sizable sub-population of treated cells acquired DC-like properties including activated surface phenotype with trans-well assays showing enhanced migration towards CCR7 ligands. Such activated cells also preferentially deviated, in an IL-23 and IL-1-dependent manner, CD4(pos) T lymphocyte responses toward the IL-22(hi), IL-17(hi)/IFN-gamma(lo) Th17 phenotype in standard in vitro allogeneic sensitization assays. Although pharmacological activation of either ionotropic or cAMP-dependent pathways acted in synergy with LTA to enhance IL-23, only inhibition of the cAMP-dependent pathway antagonized ATP-enhanced cytokine production. ATP plus atypical lipopolysaccharide from P. gingivalis (signaling through TLR2) was slightly superior to E. coli-derived LPS (TLR4 ligand) for inducing the high IL-23-secreting DC-like phenotype, but greatly inferior for inducing IL-12 p70 production when paired with IFN-gamma, a distinction reflected in activated DCs' ability to deviate lymphocytes toward Th1. Collectively, our data suggest TLR2 ligands encountered by innate immune cells in an environment with physiologically-relevant levels of extracellular ATP can induce a distinct activation state favoring IL-23- and IL-1 beta-dependent Th17 type response.	[Paustian, Christopher; Johnson, Terrence; Ramirez, Nancy; Koski, Gary K.] Kent State Univ, Dept Biol Sci, Program Biomed Sci, Kent, OH 44242 USA; [Taylor, Patricia; Rosenthal, Kenneth S.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA; [Xu, Min; Czerniecki, Brian J.] Univ Penn, Harrison Dept Surg Res, Philadelphia, PA 19104 USA; [Shu, Suyu; Cohen, Peter A.] Cleveland Clin, Dept Immunol, Lerner Res Inst, Cleveland, OH 44106 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Northeast Ohio Medical University (NEOMED); University of Pennsylvania; Cleveland Clinic Foundation	Koski, GK (corresponding author), Kent State Univ, Dept Biol Sci, Program Biomed Sci, Kent, OH 44242 USA.	dendritic_cell@hotmail.com			NIH [R01 CA100163]; National Institutes of Health/National Center for Research Resources Cleveland Clinical and Translational Science Award [1RR024989]; American Cancer Society (ACS) Research Scholars Grant [RSG-09-187-01-LIB]; NATIONAL CANCER INSTITUTE [R01CA100163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Research Resources Cleveland Clinical and Translational Science Award; American Cancer Society (ACS) Research Scholars Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH R01 CA100163 (G.K.) and in part by the National Institutes of Health/National Center for Research Resources Cleveland Clinical and Translational Science Award 1RR024989 and the American Cancer Society (ACS) Research Scholars Grant # RSG-09-187-01-LIB (G.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Berchtold S, 1999, FEBS LETT, V458, P424, DOI 10.1016/S0014-5793(99)01197-7; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Czerniecki BJ, 2007, CANCER RES, V67, P1842, DOI 10.1158/0008-5472.CAN-06-4038; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Duraisingham SS, 2009, J IMMUNOL, V183, P2242, DOI 10.4049/jimmunol.0900474; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; FORBES GM, 1994, LANCET, V343, P258, DOI 10.1016/S0140-6736(94)91111-8; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Islander U, 2010, INFECT IMMUN, V78, P381, DOI 10.1128/IAI.00724-09; Iwase T, 2010, J CLIN MICROBIOL, V48, P1949, DOI 10.1128/JCM.01941-09; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kapsenberg ML, 1999, CLIN EXP ALLERGY, V29, P33, DOI 10.1046/j.1365-2222.1999.00006.x-i2; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Koski GK, 2001, EUR J IMMUNOL, V31, P3773, DOI 10.1002/1521-4141(200112)31:12<3773::AID-IMMU3773>3.0.CO;2-W; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Liu FL, 2007, RHEUMATOLOGY, V46, P1266, DOI 10.1093/rheumatology/kem055; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Lyakh LA, 2000, J IMMUNOL, V165, P3647, DOI 10.4049/jimmunol.165.7.3647; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Maio EA, 2006, NAT IMMUNOL, V6, P569; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Martin-Orozco N, 2009, CURR OPIN INVEST DR, V10, P543; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park AY, 2002, J IMMUNOL, V168, P5771, DOI 10.4049/jimmunol.168.11.5771; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Rachmilewitz Jacob, 2010, Self Nonself, V1, P250; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tokudome Shinkan, 2006, Asian Pac J Cancer Prev, V7, P163; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xu SW, 2006, SURGERY, V140, P170, DOI 10.1016/j.surg.2006.03.006; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060	72	18	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54804	10.1371/journal.pone.0054804	http://dx.doi.org/10.1371/journal.pone.0054804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382974	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600043
J	Chang, ZY; Yeh, MK; Chiang, CH; Chen, YH; Lu, DW				Chang, Zhi-Yang; Yeh, Ming-Kung; Chiang, Chiao-Hsi; Chen, Yi-Hao; Lu, Da-Wen			Erythropoietin Protects Adult Retinal Ganglion Cells against NMDA-, Trophic Factor Withdrawal-, and TNF-alpha-Induced Damage	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; OPTIC-NERVE FIBERS; EXPERIMENTAL GLAUCOMA; INDUCED APOPTOSIS; IN-VITRO; MEDIATED NEUROPROTECTION; NEUROTROPHIC FACTOR; AXONAL-TRANSPORT; VITREOUS FLUID; MOUSE MODEL	Purpose: This study aimed to evaluate the neuroprotective effect of EPO in the presence of N-methyl-D-aspartate (NMDA)-, trophic factor withdrawal (TFW)-, and tumor necrosis factor-alpha (TNF-alpha)-induced toxicity on total, small, and large retinal ganglion cells (RGCs). Methods: Retinal cells from adult rats were cultured in a medium containing brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), basic fibroblast growth factor (bFGF), and forskolin. Expression of RGC markers and EPOR was examined using immunocytochemistry. RGCs were classified according to their morphological properties. Cytotoxicity was induced by NMDA, TFW, or TNF-alpha. RGC survival was assessed by counting thy-1 and neurofilament-L double-positive cells. Results: EPO offered dose-dependent (EC50 = 5.7 ng/mL) protection against NMDA toxicity for small RGCs; protection was not significant for large RGCs. Time-course analysis showed that the presence of EPO either before or after NMDA exposure gave effective protection. For both small and large RGCs undergoing trophic factor withdrawal, EPO at concentrations of 1, 10, or 100 ng/mL improved survival. However, EPO had to be administered soon after the onset of injury to provide effective protection. For TNF-alpha-induced toxicity, survival of small RGCs was seen only for the highest examined concentration (100 ng/mL) of EPO, whereas large RGCs were protected at concentrations of 1, 10, or 100 ng/mL of EPO. Time-course analysis showed that pretreatment with EPO provided protection only for large RGCs; early post-treatment with EPO protected both small and large RGCs. Inhibitors of signal transduction and activators of transcription such as (STAT)-5, mitogen-activated protein kinases (MAPK)/extracellular-regulated kinase (ERK), and phosphatidyl inositol-3 kinase (PI3K)/Akt impaired the protective effect of EPO on RGCs exposed to different insults. Conclusion: EPO provided neuroprotection to cultured adult rat RGCs; however, the degree of protection varied with the type of toxic insult, RGC subtype, and timing of EPO treatment.	[Chang, Zhi-Yang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yeh, Ming-Kung] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Chiang, Chiao-Hsi] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Chen, Yi-Hao; Lu, Da-Wen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Lu, DW (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan.	p310849@ms23.hinet.net	Chiang, Chiao-Hsi/AAS-9777-2021		National Science Council [NSC98-2314-B016-006-MY3, NSC98-2320-B016-003-MY3]; Tri-service General Hospital [TSGH-C99-086]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-service General Hospital	This work was supported by grants from the National Science Council (NSC98-2314-B016-006-MY3 and NSC98-2320-B016-003-MY3) and a grant from the Tri-service General Hospital (TSGH-C99-086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Brooks Dennis E., 1999, Veterinary Ophthalmology, V2, P3; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.01146.x; Chang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033983; Chang ZY, 2008, EXPERT OPIN DRUG DEL, V5, P1313, DOI 10.1517/17425240802544159 ; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dong CJ, 2008, INVEST OPHTH VIS SCI, V49, P4515, DOI 10.1167/iovs.08-2078; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; Garcia M, 2003, INVEST OPHTH VIS SCI, V44, P4532, DOI 10.1167/iovs.03-0419; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Heidinger V, 1997, BRAIN RES, V767, P279, DOI 10.1016/S0006-8993(97)00605-7; Hernandez C, 2006, DIABETES CARE, V29, P2028, DOI 10.2337/dc06-0556; Huxlin KR, 1997, J COMP NEUROL, V385, P309; Jehle T, 2009, OPHTHALMOLOGE; Kashiwagi F, 2000, INVEST OPHTH VIS SCI, V41, P2373; Katsura Y, 2005, DIABETES CARE, V28, P2252, DOI 10.2337/diacare.28.9.2252; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; Klocker N, 2000, J NEUROSCI, V20, P6962, DOI 10.1523/JNEUROSCI.20-18-06962.2000; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; Ma CHE, 2010, CELL TISSUE RES, V339, P297, DOI 10.1007/s00441-009-0897-4; Manabe S, 2003, INVEST OPHTH VIS SCI, V44, P385, DOI 10.1167/iovs.02-0187; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Osborne NN, 2009, ACTA OPHTHALMOL, V87, P450, DOI 10.1111/j.1755-3768.2008.01459.x; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Pregi N, 2009, EXP CELL RES, V315, P419, DOI 10.1016/j.yexcr.2008.11.005; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Ruiz-Ederra J, 2004, MOL VIS, V10, P83; Shen JF, 2010, INVEST OPHTH VIS SCI, V51, P35, DOI 10.1167/iovs.09-3544; Siren AL, 2001, EUR ARCH PSY CLIN N, V251, P179, DOI 10.1007/s004060170038; Sun WZ, 2002, VISUAL NEUROSCI, V19, P483, DOI 10.1017/S0952523802194107; Tsai JC, 2005, CURR EYE RES, V30, P1025, DOI 10.1080/02713680500320729; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; WATANABE M, 1995, J NEUROBIOL, V27, P189, DOI 10.1002/neu.480270206; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Zhang JF, 2008, ACTA PHARMACOL SIN, V29, P1383, DOI 10.1111/j.1745-7254.2008.00885.x; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200	53	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55291	10.1371/journal.pone.0055291	http://dx.doi.org/10.1371/journal.pone.0055291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383140	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800139
J	Jayaraman, S; Patel, A; Jayaraman, A; Patel, V; Holterman, M; Prabhakar, B				Jayaraman, Sundararajan; Patel, Akshay; Jayaraman, Arathi; Patel, Vasu; Holterman, Mark; Prabhakar, Bellur			Transcriptome Analysis of Epigenetically Modulated Genome Indicates Signature Genes in Manifestation of Type 1 Diabetes and Its Prevention in NOD Mice	PLOS ONE			English	Article							CD4(+) T-CELLS; MIGRATION-INHIBITION; MACROPHAGE-MIGRATION; NEUTROPHIL ELASTASE; TH17 CELLS; TNF-ALPHA; EXPRESSION; MOUSE; MODEL; IDENTIFICATION	Classic genetic studies implicated several genes including immune response genes in the risk of developing type 1 diabetes in humans. However, recent evidence including discordant diabetes incidence among monozygotic twins suggested a role for epigenetics in disease manifestation. NOD mice spontaneously develop type 1 diabetes like humans and serve as an excellent model system to study the mechanisms of type 1 diabetes as well as the efficacy of maneuvers to manipulate the disease. Using this preclinical model, we have recently demonstrated that pharmacological inhibition of histone deacetylases can lead to histone hyperacetylation, selective up-regulation of interferon-gamma and its transactivator Tbx21/Tbet, and amelioration of autoimmune diabetes. In the current study, we show that chromatin remodeling can render splenocytes incapable of transferring diabetes into immunodeficient NOD. scid mice. To elucidate the underlying mechanisms of drug-mediated protection against type 1 diabetes, we performed global gene expression profiling of splenocytes using high throughput microarray technology. This unbiased transcriptome analysis unraveled the exaggerated expression of a novel set of closely related inflammatory genes in splenocytes of acutely diabetic mice and their repression in mice cured of diabetes by chromatin remodeling. Analysis of gene expression by qRT-PCR using RNA derived from spleens and pancreata of cured mice validated the suppression of most of these genes, indicating an inverse correlation between the high levels of these inflammatory genes and protection against diabetes in NOD mice. In addition, higher-level expression of genes involved in insulin sensitivity, erythropoiesis, hemangioblast generation, and cellular redox control was evident in spleens of cured mice, indicating their possible contribution to protection against type 1 diabetes. Taken together, these results are consistent with the involvement of epistatic mechanisms in the manifestation of autoimmune diabetes and further indicate the utility of chromatin remodeling in curing this complex autoimmune disorder.	[Jayaraman, Sundararajan; Patel, Akshay; Jayaraman, Arathi; Patel, Vasu; Holterman, Mark] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Prabhakar, Bellur] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jayaraman, S (corresponding author), Univ Illinois, Dept Surg, Chicago, IL 60680 USA.	anue2468@uic.edu		Jayaraman, Sundararajan/0000-0002-7026-5958				Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; BAXTER AG, 1991, EUR J IMMUNOL, V21, P2051, DOI 10.1002/eji.1830210912; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; BLOOM BR, 1969, P NATL ACAD SCI USA, V64, P1176, DOI 10.1073/pnas.64.4.1176; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Cantor J, 2005, J IMMUNOL, V175, P7738, DOI 10.4049/jimmunol.175.11.7738; Chen YG, 2007, DIABETES, V56, P424, DOI 10.2337/db06-1303; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Eaves IA, 2002, GENOME RES, V12, P232, DOI 10.1101/gr.214102. Article published online before print in January 2002; Eckenrode SE, 2004, DIABETES, V53, P366, DOI 10.2337/diabetes.53.2.366; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hancock Wayne W, 2011, Handb Exp Pharmacol, V206, P103, DOI 10.1007/978-3-642-21631-2_6; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Irie J, 2008, J IMMUNOL, V180, P1071, DOI 10.4049/jimmunol.180.2.1071; JAYARAMAN S, 1979, DEV COMP IMMUNOL, V3, P67, DOI 10.1016/S0145-305X(79)80007-5; JAYARAMAN S, 1977, DEV COMP IMMUNOL, V1, P133, DOI 10.1016/S0145-305X(77)80006-2; Jayaraman S, 2012, CIRC RES, V110, P1039, DOI 10.1161/CIRCRESAHA.112.268375; Jayaraman S, 2011, EPIGENOMICS-UK, V3, P639, DOI [10.2217/EPI.11.78, 10.2217/epi.11.78]; Jayaraman S, 2010, J IMMUNOL, V184, P3008, DOI 10.4049/jimmunol.0903615; Kanagawa O, 2000, J IMMUNOL, V164, P3919, DOI 10.4049/jimmunol.164.7.3919; Kleemann R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/610479; Knip M, 2011, HORM RES PAEDIAT, V76, P57, DOI 10.1159/000329169; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lee LF, 2008, P NATL ACAD SCI USA, V105, P10107, DOI 10.1073/pnas.0803336105; Makino S, 1980, Jikken Dobutsu, V29, P1; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Marques M, 2010, EPIGENETICS-US, V5, P267, DOI 10.4161/epi.5.4.11520; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miyazaki T, 2007, CELL CYCLE, V6, P1419; Ounissi-Benkalha H, 2008, TRENDS MOL MED, V14, P268, DOI 10.1016/j.molmed.2008.04.002; Pakala SV, 1997, J EXP MED, V186, P299, DOI 10.1084/jem.186.2.299; Patel T, 2011, IMMUNOL CELL BIOL, V89, P640, DOI 10.1038/icb.2010.144; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Rajput A, 2004, J AUTOIMMUN, V23, P311, DOI 10.1016/j.jaut.2004.09.002; Regnault B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-63; Ridgway WM, 2008, ADV IMMUNOL, V100, P151, DOI 10.1016/S0065-2776(08)00806-7; ROJASESPINOSA O, 1975, BIOCHIM BIOPHYS ACTA, V403, P161, DOI 10.1016/0005-2744(75)90019-4; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Sobel DO, 2002, J AUTOIMMUN, V19, P129, DOI 10.1006/jaut.2002.0604; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Tong C, 2010, J DIABETES, V2, P267, DOI 10.1111/j.1753-0407.2010.00088.x; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Vukkadapu SS, 2005, PHYSIOL GENOMICS, V21, P201, DOI 10.1152/physiolgenomics.00173.2004; Wang CY, 2007, BLOOD, V110, P3601, DOI 10.1182/blood-2007-04-086827; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Xu HX, 2001, GENOMICS, V76, P2, DOI 10.1006/geno.2001.6600	52	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55074	10.1371/journal.pone.0055074	http://dx.doi.org/10.1371/journal.pone.0055074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383062	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800109
J	Rudolph, M; Kroll, F; Beery, M; Marinda, E; Sobiecki, JF; Douglas, G; Orr, G				Rudolph, Michael; Kroll, Florian; Beery, Moira; Marinda, Edmore; Sobiecki, Jean-Francois; Douglas, Geoffrey; Orr, Gary			A Pilot Study Assessing the Impact of a Fortified Supplementary Food on the Health and Well-Being of Creche Children and Adult TB Patients in South Africa	PLOS ONE			English	Article							VITAMIN-A; TUBERCULOSIS; MALNUTRITION; IMMUNITY; NUTRITION; DISEASES; DIETARY	The South African population faces many of the global concerns relating to micronutrient deficiency and the impact this has on health and well-being. Moreover, there is a high prevalence of HIV infection, compounded by a high level of co-infection with TB. This pilot study evaluates the impact of a fortified supplementary food on the health and well-being of a cohort of creche children, aged 3 to 6, and adult TB patients drawn from the Presidential Node of Alexandra, Johannesburg, South Africa. A further aim of this study was to evaluate the sensitivity and validity of non-invasive indicators of nutritional status in a field-based population sample. The investigational product, e'Pap, is supported by extensive anecdotal evidence that whole grain cereals with food-style nutrients constitute an effective supplementary food for those suffering from the effects of food insecurity, poor health and well-being, and coping with TB and HIV infection. The results indicate a beneficial effect of e'Pap for both study populations, and particularly for adult TB patients, whose baseline data reflected severe food insecurity and malnutrition in the majority of cases. There is evidence to suggest statistically significant improvements in key micronutrient levels, well-being and energy, hand-grip strength, the Bioelectrical Impedance Analysis (BIA) Illness Marker, and certain clinical indicators. Although Body Mass Index (BMI) and Mid Upper Arm Circumference (MUAC) are frequently used as standard measures to evaluate the efficacy of nutritional interventions, these indicators were not sufficiently sensitive in this study. Nor does weight gain necessarily indicate improved nutritional status. Hand-grip strength, lean body mass, and the BIA Illness Marker seem to be more useful indicators of change in nutritional status.	[Rudolph, Michael; Kroll, Florian; Beery, Moira] Univ Witwatersrand, Siyakhana Initiat, Hlth Consortium, Johannesburg, Gauteng, South Africa; [Marinda, Edmore] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, Gauteng, South Africa; [Sobiecki, Jean-Francois] Univ Johannesburg, Ctr Anthropol Res, Fac Humanities, Gauteng, South Africa; [Douglas, Geoffrey; Orr, Gary] Hlth Empowerment Nutr, Malvern, Worcs, England	University of Witwatersrand; University of Witwatersrand; University of Johannesburg	Douglas, G (corresponding author), Hlth Empowerment Nutr, Malvern, Worcs, England.	geoff@hetn.org			BHP Billiton; Health Empowerment Through Nutrition; South African National Tuberculosis Association; Society of St Vincent de Paul; Econocom Foods; Cytoplan (United Kingdom); FoodState (South Africa); Sportron (South Africa); Eli Lilly; Lundbeck; Astra Zeneca	BHP Billiton; Health Empowerment Through Nutrition; South African National Tuberculosis Association; Society of St Vincent de Paul; Econocom Foods; Cytoplan (United Kingdom); FoodState (South Africa); Sportron (South Africa); Eli Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Astra Zeneca(AstraZeneca)	This study was funded by BHP Billiton-www.bhpbilliton.com, Health Empowerment Through Nutrition-www.hetn.org, Econocom Foods-www.epap.co. za, South African National Tuberculosis Association-www.santa.org.za, Society of St Vincent de Paul-www.ssvpglobal.org. No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by BHP Billiton and Econocom Foods. Econocom Foods produces e'pap. GAD has received speaking grants and honoraria from Cytoplan (United Kingdom), FoodState (South Africa) and Sportron (South Africa). GO has received educational sponsorships from Eli Lilly, Lundbeck, and Astra Zeneca and was a previous employee of Bristol Myers Squibb Pharmaceuticals (United Kingdom) Ltd. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ABUL HT, 1995, MOL CELL BIOCHEM, V146, P139, DOI 10.1007/BF00944606; Academy of Science of South Africa, 2007, HIV AIDS TB NUTR; Ambrus JL, 2004, EXP BIOL MED, V229, P464, DOI 10.1177/153537020422900603; [Anonymous], 2004, HIV AIDS GUID NUTR C; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Branca F, 2002, ANN NUTR METAB, V46, P8, DOI 10.1159/000066397; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; BURK R F, 1985, American Journal of Clinical Nutrition, V41, P1091, DOI 10.1093/ajcn/41.5.1091; Chandra RK, 2004, INT J VITAM NUTR RES, V74, P144, DOI 10.1024/0300-9831.74.2.144; Committee on Food Protection Food and Nutrition Board National Research, 1973, PHYT TOX OCC NAT FOO; Cook JT, 2004, J NUTR, V134, P1432; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Erickson KL, 2000, J INFECT DIS, V182, pS5, DOI 10.1086/315922; Gorbach S., 1999, NUTR CLIN CARE, V2, P95; Hanekom WA, 1999, CLIN DIAGN LAB IMMUN, V6, P204, DOI 10.1128/CDLI.6.2.204-208.1999; Human Sciences Research Council, 2008, S AFR NAT HIV PREV H; Hurrell RF, 2003, J NUTR, V133, p2973S, DOI 10.1093/jn/133.9.2973S; Karyadi E, 2002, AM J CLIN NUTR, V75, P720, DOI 10.1093/ajcn/75.4.720; Kemp FW, 2002, NUTR RES, V22, P45, DOI 10.1016/S0271-5317(01)00373-6; Labadarios D, 2000, NATL FOOD CONSUMPTIO; Labadarios D., 2007, NATL FOOD CONSUMPTIO; Manary M, 2010, MALAWI MED J, V22, P46; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; Metcalfe N, 2005, T ROY SOC TROP MED H, V99, P115, DOI 10.1016/j.trstmh.2004.06.007; Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3; Piwoz EG, 2000, HIV AIDS NUTR REV LI; Ryan AS, 1996, CLIN DERMATOL, V14, P389, DOI 10.1016/0738-081X(96)00068-5; Seyedrezazadeh E, 2008, RESPIROLOGY, V13, P294, DOI 10.1111/j.1440-1843.2007.01200.x; Sguassero Y, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005039.pub3; Steyn NP, 2008, S AFR J CLIN NUTR, V21, P22; van Lettow M, 2003, NUTR REV, V61, P81, DOI 10.1301/nr.2003.marr.81-90; Villamor E, 2008, J INFECT DIS, V197, P1499, DOI 10.1086/587846	33	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55544	10.1371/journal.pone.0055544	http://dx.doi.org/10.1371/journal.pone.0055544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383220	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800163
J	Klein, D; Misawa, R; Bravo-Egana, V; Vargas, N; Rosero, S; Piroso, J; Ichii, H; Umland, O; Jiang, ZJ; Tsinoremas, N; Ricordi, C; Inverardi, L; Dominguez-Bendala, J; Pastori, RL				Klein, Dagmar; Misawa, Ryosuke; Bravo-Egana, Valia; Vargas, Nancy; Rosero, Samuel; Piroso, Julieta; Ichii, Hirohito; Umland, Oliver; Jiang Zhijie; Tsinoremas, Nicholas; Ricordi, Camillo; Inverardi, Luca; Dominguez-Bendala, Juan; Pastori, Ricardo L.			MicroRNA Expression in Alpha and Beta Cells of Human Pancreatic Islets	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; GENE-EXPRESSION; TRANSCRIPTION FACTORS; INSULIN-SECRETION; ANIMAL MICRORNAS; HIGH-THROUGHPUT; RAT ISLETS; C-MAF; RNA; PURIFICATION	microRNAs (miRNAs) play an important role in pancreatic development and adult beta-cell physiology. Our hypothesis is based on the assumption that each islet cell type has a specific pattern of miRNA expression. We sought to determine the profile of miRNA expression in alpha- and beta-cells, the main components of pancreatic islets, because this analysis may lead to a better understanding of islet gene regulatory pathways. Highly enriched (>98%) subsets of human alpha- and beta-cells were obtained by flow cytometric sorting after intracellular staining with c-peptide and glucagon antibody. The method of sorting based on intracellular staining is possible because miRNAs are stable after fixation. MiRNA expression levels were determined by quantitative high throughput PCR-based miRNA array platform screening. Most of the miRNAs were preferentially expressed in beta-cells. From the total of 667 miRNAs screened, the Significant Analysis of Microarray identified 141 miRNAs, of which only 7 were expressed more in alpha-cells (alpha-miRNAs) and 134 were expressed more in beta-cells (beta-miRNAs). Bioinformatic analysis identified potential targets of beta-miRNAs analyzing the Beta Cell Gene Atlas, described in the T1Dbase, the web platform, supporting the type 1 diabetes (T1D) community. cMaf, a transcription factor regulating glucagon expression expressed selectively in alpha-cells (TF alpha) is targeted by beta-miRNAs; miR-200c, miR-125b and miR-182. Min6 cells treated with inhibitors of these miRNAs show an increased expression of cMaf RNA. Conversely, over expression of miR-200c, miR-125b or miR-182 in the mouse alpha cell line alpha TC6 decreases the level of cMAF mRNA and protein. MiR-200c also inhibits the expression of Zfpm2, a TF alpha that inhibits the PI3K signaling pathway, at both RNA and protein levels. In conclusion, we identified miRNAs differentially expressed in pancreatic alpha- and beta-cells and their potential transcription factor targets that could add new insights into different aspects of islet biology and pathophysiology.	[Klein, Dagmar; Misawa, Ryosuke; Bravo-Egana, Valia; Vargas, Nancy; Rosero, Samuel; Piroso, Julieta; Ichii, Hirohito; Umland, Oliver; Ricordi, Camillo; Inverardi, Luca; Dominguez-Bendala, Juan; Pastori, Ricardo L.] Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL 33124 USA; [Jiang Zhijie; Tsinoremas, Nicholas] Univ Miami, Ctr Computat Sci, Miami, FL USA; [Tsinoremas, Nicholas; Inverardi, Luca; Pastori, Ricardo L.] Univ Miami, Leonard M Miller Sch Med, Dept Med, Miami, FL USA; [Ricordi, Camillo; Dominguez-Bendala, Juan] Univ Miami, Leonard M Miller Sch Med, Dept Surg Sci, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami	Pastori, RL (corresponding author), Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL 33124 USA.	rpastori@med.miami.edu	RICORDI, CAMILLO/AAA-4740-2019; Ichii, Hirohito/AAV-8256-2021; Dominguez-Bendala, Juan/AAE-8296-2019	Ricordi, Camillo/0000-0001-8092-7153; Ichii, Hirohito/0000-0002-3635-5773	National Institutes of Health [5U01DK070460-07]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was possible thanks to the generous support of the Diabetes Research Institute Foundation (DRIF) (www.diabetesresearch.org). The DRIF funds work conducted at the Diabetes Research Institute with the goal of achieving a cure for type 1 diabetes in the fastest, safest and most efficient way possible. Funding is internal and as such is not associated with grant numbers. This work was also supported in part by the National Institutes of Health, grant 5U01DK070460-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kalis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029166; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; Kohler M, 2012, INTEGR BIOL-UK, V4, P209, DOI 10.1039/c2ib00125j; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kredo-Russo S, 2012, EXP DIABETES RES, DOI 10.1155/2012/695214; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; PIPELEERS DG, 1981, DIABETOLOGIA, V20, P654; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Roggli E., 2012, DIABETES; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; RUSSELL TR, 1984, CYTOMETRY, V5, P539, DOI 10.1002/cyto.990050517; Schuit F, 2012, DIABETES, V61, P969, DOI 10.2337/db11-1564; Stange Geert, 2003, Methods Mol Med, V83, P15; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANDEWINKEL M, 1982, BIOCHEM BIOPH RES CO, V107, P525, DOI 10.1016/0006-291X(82)91523-6; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907	53	100	106	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55064	10.1371/journal.pone.0055064	http://dx.doi.org/10.1371/journal.pone.0055064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383059	Green Published, gold			2022-12-27	WOS:000315483200041
J	Li, O; Tormin, A; Sundberg, B; Hyllner, J; Le Blanc, K; Scheding, S				Li, Ou; Tormin, Ariane; Sundberg, Berit; Hyllner, Johan; Le Blanc, Katarina; Scheding, Stefan			Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSCs) Engraft In Vivo and Support Hematopoiesis without Suppressing Immune Function: Implications for Off-The Shelf ES-MSC Therapies	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW; IMMUNOLOGICAL-PROPERTIES; EXPRESSION; GROWTH; MICROENVIRONMENT; DIFFERENTIATION; TRAFFICKING; RECOVERY; VEHICLES	Mesenchymal stroma cells (MSCs) have a high potential for novel cell therapy approaches in clinical transplantation. Commonly used bone marrow-derived MSCs (BM-MSCs), however, have a restricted proliferative capacity and cultures are difficult to standardize. Recently developed human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) might represent an alternative and unlimited source of hMSCs. We therefore compared human ES-cell-derived MSCs (hES-MP002.5 cells) to normal human bone marrow-derived MSCs (BM-MSCs). hES-MP002.5 cells had lower yet reasonable CFU-F capacity compared with BM-MSC (8 +/- 3 versus 29 +/- 13 CFU-F per 100 cells). Both cell types showed similar immunophenotypic properties, i.e. cells were positive for CD105, CD73, CD166, HLA-ABC, CD44, CD146, CD90, and negative for CD45, CD34, CD14, CD31, CD117, CD19, CD 271, SSEA-4 and HLA-DR. hES-MP002.5 cells, like BM-MSCs, could be differentiated into adipocytes, osteoblasts and chondrocytes in vitro. Neither hES-MP002.5 cells nor BM-MSCs homed to the bone marrow of immune-deficient NSG mice following intravenous transplantation, whereas intra-femoral transplantation into NSG mice resulted in engraftment for both cell types. In vitro long-term culture-initiating cell assays and in vivo cotransplantation experiments with cord blood CD34+ hematopoietic cells demonstrated furthermore that hES-MP002.5 cells, like BM-MSCs, possess potent stroma support function. In contrast to BM-MSCs, however, hES-MP002.5 cells showed no or only little activity in mixed lymphocyte cultures and phytohemagglutinin (PHA) lymphocyte stimulation assays. In summary, ES-cell derived MSCs might be an attractive unlimited source for stroma transplantation approaches without suppressing immune function.	[Li, Ou; Tormin, Ariane; Scheding, Stefan] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Sundberg, Berit; Le Blanc, Katarina] Karolinska Univ Hosp Huddinge, Div Clin Immunol Karolinska, Stockholm, Sweden; [Hyllner, Johan] Cellartis AB, Cellectis Stem Cells, Gothenburg, Sweden; [Hyllner, Johan] Linkoping Univ, Div Biotechnol IFM, Linkoping, Sweden; [Scheding, Stefan] Skane Univ Hosp Lund, Dept Hematol, Lund, Sweden	Lund University; Karolinska Institutet; Karolinska University Hospital; Takara Bio Inc.; Cellartis; Linkoping University; Lund University; Skane University Hospital	Scheding, S (corresponding author), Lund Univ, Lund Stem Cell Ctr, Lund, Sweden.	stefan.scheding@med.lu.se	Scheding, Stefan/J-9529-2014; Le Blanc, Katarina/L-4631-2019	Scheding, Stefan/0000-0002-8005-9568	Swedish Cancer Foundation [CAN2011/708]; Swedish Childhood Cancer Foundation [PROJ08/96]; Swedish Research Council [A0329802]; Gunnar Nilsson's Cancer Foundation	Swedish Cancer Foundation; Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson's Cancer Foundation	This study was supported by funds from the Swedish Cancer Foundation, grant CAN2011/708 (http://www.cancerfonden.se), the Swedish Childhood Cancer Foundation, grant PROJ08/96 (http://www.barncancerfonden.se), the Swedish Research Council, grant A0329802 (www.vr.se), and Gunnar Nilsson's Cancer Foundation (www.cancerstiftelse.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens N, 2004, TRANSPLANTATION, V78, P925, DOI 10.1097/01.tp.0000133305.81823.2a; ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002; Bexell D, 2012, NEUROSURGERY, V70, P731, DOI 10.1227/NEU.0b013e318232dedd; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bigdeli N, 2010, TISSUE ENG PT A, V16, P3427, DOI 10.1089/ten.tea.2010.0112; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chen XD, 1999, J BONE MINER RES, V14, P362, DOI 10.1359/jbmr.1999.14.3.362; de Peppo GM, 2010, TISSUE ENG PT A, V16, P3413, DOI [10.1089/ten.tea.2010.0052, 10.1089/ten.TEA.2010.0052]; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fenno LE, 2008, CURR OPIN GENET DEV, V18, P324, DOI 10.1016/j.gde.2008.06.004; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022; Gotherstrom C, 2003, BONE MARROW TRANSPL, V32, P265, DOI 10.1038/sj.bmt.1704111; Hall B., 2007, V180, P263; Jones E, 2010, ARTHRITIS RHEUM-US, V62, P1944, DOI 10.1002/art.27451; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Karlsson C, 2009, STEM CELL RES, V3, P39, DOI 10.1016/j.scr.2009.05.002; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Li Y, 2011, ANN HEMATOL, V90, P873, DOI 10.1007/s00277-011-1156-9; Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Papathanasopoulos A, 2011, J ORTHOP RES, V29, P1327, DOI 10.1002/jor.21405; Paul D, 2009, ANTIOXID REDOX SIGN, V11, P1841, DOI [10.1089/ars.2009.2455, 10.1089/ARS.2009.2455]; Phinney DG, 2007, CELL CYCLE, V6, P2884, DOI 10.4161/cc.6.23.5095; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sensebe L, 2009, TRANSPLANTATION, V87, pS49, DOI 10.1097/TP.0b013e3181a28635; 't Anker PS, 2003, EXP HEMATOL, V31, P881, DOI 10.1016/S0301-472X(03)00202-9; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Tormin A, 2009, CYTOTHERAPY, V11, P114, DOI 10.1080/14653240802716590; Tran TC, 2011, J CELL PHYSIOL, V226, P224, DOI 10.1002/jcp.22329	50	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55319	10.1371/journal.pone.0055319	http://dx.doi.org/10.1371/journal.pone.0055319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383153	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200034
J	Berg, C; Backstrom, T; Winberg, S; Lindberg, R; Brandt, I				Berg, Cecilia; Backstrom, Tobias; Winberg, Svante; Lindberg, Richard; Brandt, Ingvar			Developmental Exposure to Fluoxetine Modulates the Serotonin System in Hypothalamus	PLOS ONE			English	Article							SEWAGE-TREATMENT PLANTS; REUPTAKE INHIBITORS; XENOPUS-TROPICALIS; IN-UTERO; BRAIN; ANTIDEPRESSANTS; MONOAMINES; PREGNANCY; BEHAVIOR; STEROIDS	The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLU, Prozac (R)) is commonly prescribed for depression in pregnant women. This results in SSRI exposure of the developing fetus. However, there are knowledge gaps regarding the impact of SSRI exposure during development. Given the role of serotonin in brain development and its cross-talk with sex hormone function, we investigated effects of developmental exposure to pharmacologically relevant concentrations of FLU (3 and 30 nM (measured)) on brain neurotransmitter levels, gonadal differentiation, aromatase activity in brain and gonads, and the thyroid system, using the Xenopus tropicalis model. Tadpoles were chronically exposed (8 weeks) until metamorphosis. At metamorphosis brains were cryosectioned and levels of serotonin, dopamine, norepinephrine, and their metabolites 5-hydroxyindoleacetic acid, 3,4-dihydroxyphenylacetic acid, and homovanillic acid were measured in discrete regions (telencephalon, hypothalamus and the reticular formation) of the cryosections using high-performance liquid chromatography. Exposure to 30 nM FLU increased the concentration of 5-hydroxyindoleacetic acid in hypothalamus compared with controls. FLU exposure did not affect survival, time to metamorphosis, thyroid histology, gonadal sex differentiation, or aromatase activity implying that the effect on the serotonergic neurotransmitter system in the hypothalamus region was specific. The FLU concentration that impacted the serotonin system is lower than the concentration measured in umbilical cord serum, suggesting that the serotonin system of the developing brain is highly sensitive to in utero exposure to FLU. To our knowledge this is the first study showing effects of developmental FLU exposure on brain neurochemistry. Given that SSRIs are present in the aquatic environment the current results warrant further investigation into the neurobehavioral effects of SSRIs in aquatic wildlife.	[Berg, Cecilia; Backstrom, Tobias; Brandt, Ingvar] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Winberg, Svante] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lindberg, Richard] Umea Univ, Dept Chem, Umea, Sweden	Uppsala University; Uppsala University; Umea University	Berg, C (corresponding author), Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden.	Cecilia.Berg@ebc.uu.se	Winberg, Svante/ABB-6458-2021; Lindberg, Richard/C-8882-2013	Winberg, Svante/0000-0003-4252-3144; Brandt, Ingvar/0000-0002-5386-2400; Backstrom, Tobias/0000-0003-1984-9533	Research Council Formas; Carl Trygger Foundation; MistraPharma; Swedish Foundation for Strategic Environmental Research (Mistra)	Research Council Formas(Swedish Research Council Formas); Carl Trygger Foundation; MistraPharma; Swedish Foundation for Strategic Environmental Research (Mistra)(Swedish Foundation for Strategic Research)	This work was funded by the Research Council Formas, the Carl Trygger Foundation and MistraPharma, a research programme supported by the Swedish Foundation for Strategic Environmental Research (Mistra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg Cecilia, 2012, Methods Mol Biol, V889, P73, DOI 10.1007/978-1-61779-867-2_6; Berg C, 2009, J TOXICOL ENV HEAL A, V72, P219, DOI 10.1080/15287390802539079; Bethea CL, 2002, FRONT NEUROENDOCRIN, V23, P41, DOI 10.1006/frne.2001.0225; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Brooks BW, 2005, ENVIRON TOXICOL CHEM, V24, P464, DOI 10.1897/04-081R.1; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; Casper RC, 2003, J PEDIATR-US, V142, P402, DOI 10.1067/mpd.2003.139; Davidson S, 2009, PEDIATR RES, V65, P236, DOI 10.1203/PDR.0b013e318193594a; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Feenstra MGP, 1996, PHARMACOL BIOCHEM BE, V55, P647, DOI 10.1016/S0091-3057(96)00276-6; Foran CM, 2004, ARCH ENVIRON CON TOX, V46, P511, DOI 10.1007/s00244-003-3042-5; Gentile S, 2011, J AFFECT DISORDERS, V128, P1, DOI 10.1016/j.jad.2010.02.125; GOLSTEIN J, 1983, EUR J PHARMACOL, V91, P239, DOI 10.1016/0014-2999(83)90471-5; Gyllenhammar I, 2009, AQUAT TOXICOL, V91, P102, DOI 10.1016/j.aquatox.2008.10.005; Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993; HILAKIVI LA, 1987, PSYCHOPHARMACOLOGY, V91, P403, DOI 10.1007/BF00216004; Hoglund E, 2000, J EXP BIOL, V203, P1711; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; KING JA, 1981, GEN COMP ENDOCR, V44, P20, DOI 10.1016/0016-6480(81)90351-8; Kloas W, 2006, J CHROMATOGR A, V1130, P16, DOI 10.1016/j.chroma.2006.04.001; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; Lister A, 2009, AQUAT TOXICOL, V95, P320, DOI 10.1016/j.aquatox.2009.04.011; Lund N, 2009, ARCH PEDIAT ADOL MED, V163, P949, DOI 10.1001/archpediatrics.2009.164; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559; Mennigen JA, 2010, AQUAT TOXICOL, V100, P354, DOI 10.1016/j.aquatox.2010.08.016; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27; Muller JC, 2012, REPROD TOXICOL, V34, P80, DOI 10.1016/j.reprotox.2012.04.001; Nielsen Rene Ernst, 2007, Ugeskr Laeger, V169, P1442; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2005, PEDIATRICS, V115, P411, DOI 10.1542/peds.2004-0420; Oberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008; OECD, 2009, TEST NO 231 AMPH MET; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Parent A, 1984, HDB CHEM NEUROANAT 1, V2; Pawluski JL, 2012, NEUROENDOCRINOLOGY, V95, P39, DOI 10.1159/000329293; Pettersson I, 2007, ENVIRON TOXICOL CHEM, V26, P1005, DOI 10.1897/06-464R.1; Pope C, 2006, DEV BIOL, V297, P172, DOI 10.1016/j.ydbio.2006.05.005; Resko JA, 1997, CELL MOL NEUROBIOL, V17, P627, DOI 10.1023/A:1022534019718; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Tsai CL, 2000, J NEUROENDOCRINOL, V12, P894, DOI 10.1046/j.1365-2826.2000.00536.x; UEDA S, 1984, ANAT EMBRYOL, V169, P219, DOI 10.1007/BF00315627; Vasskog T, 2008, J CHROMATOGR A, V1185, P194, DOI 10.1016/j.chroma.2008.01.063; Vaswani M, 2003, PROG NEURO-PSYCHOPH, V27, P85, DOI 10.1016/S0278-5846(02)00338-X; Vigh B, 1998, MICROSC RES TECHNIQ, V41, P57, DOI 10.1002/(SICI)1097-0029(19980401)41:1<57::AID-JEMT6>3.0.CO;2-R; Vijayakumar M, 1999, NEUROCHEM RES, V24, P345, DOI 10.1023/A:1020992314534; Ward RM, 2000, PEDIATRICS, V105, P880	52	27	27	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55053	10.1371/journal.pone.0055053	http://dx.doi.org/10.1371/journal.pone.0055053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383055	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500052
J	Ganesh, S; Rogal, SS; Yadav, D; Humar, A; Behari, J				Ganesh, Swaytha; Rogal, Shari S.; Yadav, Dhiraj; Humar, Abhinav; Behari, Jaideep			Risk Factors for Frequent Readmissions and Barriers to Transplantation in Patients with Cirrhosis	PLOS ONE			English	Article							QUALITY-OF-CARE; LIVER-DISEASE; HEPATIC-ENCEPHALOPATHY; DIABETES-MELLITUS; HOSPITALIZATION; SURVIVAL; MODEL; DISPARITIES; RACE	Background: Hospital readmission rate is receiving increasing regulatory scrutiny. Patients with cirrhosis have high hospital readmissions rates but the relationship between frequent readmissions and barriers to transplantation remains unexplored. The goal of this study was to determine risk factors for frequent readmissions among patients with cirrhosis and identify barriers to transplantation in this population. Methods: We retrospectively reviewed medical records of 587 patients with a confirmed diagnosis of cirrhosis admitted to a large tertiary care center between May 1, 2008 and May 1, 2009. Demographics, clinical factors, and outcomes were recorded. Multivariate logistic regression was performed to identify risk factors for high readmission rates. Transplant-related factors were assessed for patients in the high readmission group. Results: The 587 patients included in the study had 1557 admissions during the study period. A subset of 87 (15%) patients with 5 or more admissions accounted for 672 (43%) admissions. The factors associated with frequent admissions were nonwhite race (OR = 2.45, p = 0.01), diabetes (OR = 2.04, p = 0.01), higher Model for End-Stage Liver Disease (MELD) score (OR = 35.10, p<0.0001 for MELD>30) and younger age (OR = 0.98, p = 0.02). Among the 87 patients with >= 5 admissions, only 14 (16%) underwent liver transplantation during the study period. Substance abuse, medical co-morbidities, and low (<15) MELD scores were barriers to transplantation in this group. Conclusions: A small group of patients with cirrhosis account for a disproportionately high number of hospital admissions. Interventions targeting this high-risk group may decrease frequent hospital readmissions and increase access to transplantation.	[Ganesh, Swaytha; Rogal, Shari S.; Yadav, Dhiraj; Behari, Jaideep] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Humar, Abhinav] Univ Pittsburgh, Dept Surg, Div Transplantat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Behari, J (corresponding author), Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA.	beharij@upmc.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Berg CL, 2011, HEPATOLOGY, V54, P1313, DOI 10.1002/hep.24494; Berman K, 2011, CLIN GASTROENTEROL H, V9, P254, DOI 10.1016/j.cgh.2010.10.035; Davis SK, 2003, AM J PUBLIC HEALTH, V93, P447, DOI 10.2105/AJPH.93.3.447; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Hannan EL, 2011, JACC-CARDIOVASC INTE, V4, P569, DOI 10.1016/j.jcin.2011.01.010; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Heuman DM, 2004, HEPATOLOGY, V40, P802, DOI 10.1002/hep.20405; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jiang HJ, 2005, AM J PUBLIC HEALTH, V95, P1561, DOI 10.2105/AJPH.2004.044222; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kanwal F, 2010, CLIN GASTROENTEROL H, V8, P709, DOI 10.1016/j.cgh.2010.03.028; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Laditka JN, 2006, ETHNIC HEALTH, V11, P247, DOI 10.1080/13557850600565640; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Punamiya SJ, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/398291; Sanchez W, 2006, GASTROENTEROLOGY, V130, pA810, DOI 10.1053/j.gastro.2005.11.055; Sigal SH, 2006, AM J GASTROENTEROL, V101, P1490, DOI 10.1111/j.1572-0241.2006.00649.x; Terra C, 2005, GASTROENTEROLOGY, V129, P1944, DOI 10.1053/j.gastro.2005.09.024; Thuluvath PJ, 2006, AM J GASTROENTEROL, V101, P2244, DOI 10.1111/j.1572-0241.2006.00800.x; Volk ML, 2012, AM J GASTROENTEROL, V107, P247, DOI 10.1038/ajg.2011.314; Volk ML, 2010, GASTROENTEROLOGY, V139, P14, DOI 10.1053/j.gastro.2010.05.017	23	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55140	10.1371/journal.pone.0055140	http://dx.doi.org/10.1371/journal.pone.0055140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383085	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500060
J	Tajerian, M; Alvarado, S; Millecamps, M; Vachon, P; Crosby, C; Bushnell, MC; Szyf, M; Stone, LS				Tajerian, Maral; Alvarado, Sebastian; Millecamps, Magali; Vachon, Pascal; Crosby, Cecilia; Bushnell, M. Catherine; Szyf, Moshe; Stone, Laura S.			Peripheral Nerve Injury Is Associated with Chronic, Reversible Changes in Global DNA Methylation in the Mouse Prefrontal Cortex	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; LOW-BACK-PAIN; NEUROPATHIC PAIN; LUMINOMETRIC METHYLATION; HISTONE DEACETYLASES; PERSISTENT PAIN; RAT MODEL; BRAIN; HYPOMETHYLATION; EXPRESSION	Changes in brain structure and cortical function are associated with many chronic pain conditions including low back pain and fibromyalgia. The magnitude of these changes correlates with the duration and/or the intensity of chronic pain. Most studies report changes in common areas involved in pain modulation, including the prefrontal cortex (PFC), and pain-related pathological changes in the PFC can be reversed with effective treatment. While the mechanisms underlying these changes are unknown, they must be dynamically regulated. Epigenetic modulation of gene expression in response to experience and environment is reversible and dynamic. Epigenetic modulation by DNA methylation is associated with abnormal behavior and pathological gene expression in the central nervous system. DNA methylation might also be involved in mediating the pathologies associated with chronic pain in the brain. We therefore tested a) whether alterations in DNA methylation are found in the brain long after chronic neuropathic pain is induced in the periphery using the spared nerve injury modal and b) whether these injury-associated changes are reversible by interventions that reverse the pathologies associated with chronic pain. Six months following peripheral nerve injury, abnormal sensory thresholds and increased anxiety were accompanied by decreased global methylation in the PFC and the amygdala but not in the visual cortex or the thalamus. Environmental enrichment attenuated nerve injury-induced hypersensitivity and reversed the changes in global PFC methylation. Furthermore, global PFC methylation correlated with mechanical and thermal sensitivity in neuropathic mice. In summary, induction of chronic pain by peripheral nerve injury is associated with epigenetic changes in the brain. These changes are detected long after the original injury, at a long distance from the site of injury and are reversible with environmental manipulation. Changes in brain structure and cortical function that are associated with chronic pain conditions may therefore be mediated by epigenetic mechanisms.	[Tajerian, Maral; Millecamps, Magali; Bushnell, M. Catherine; Stone, Laura S.] McGill Univ, Fac Med, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada; [Bushnell, M. Catherine; Stone, Laura S.] McGill Univ, Dept Anesthesiol, Montreal, PQ, Canada; [Tajerian, Maral; Bushnell, M. Catherine; Stone, Laura S.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Alvarado, Sebastian; Crosby, Cecilia; Szyf, Moshe; Stone, Laura S.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Alvarado, Sebastian; Crosby, Cecilia; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Millecamps, Magali; Bushnell, M. Catherine; Stone, Laura S.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Vachon, Pascal] Univ Montreal, Dept Vet Biomed, St Hyacinthe, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca; laura.s.stone@mcgill.ca	Alvarado, Sebastian/S-7607-2018	Alvarado, Sebastian/0000-0001-5866-4043; Tajerian, Maral/0000-0002-4598-1012	Canadian Institutes for Health Research [MOP-102586, MOP-42411]; Eli Lilly Canada Inc	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Eli Lilly Canada Inc(Eli Lilly)	Funding was received by Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca) MOP-102586 to L.S.S., MOP-42411 to M.S., and a grant from Eli Lilly Canada Inc to M.C.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; BONICA JJ, 1979, PAIN, V6, P247, DOI 10.1016/0304-3959(79)90046-0; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Chiechio S, 2010, TRENDS PHARMACOL SCI, V31, P153, DOI 10.1016/j.tips.2009.12.003; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; ESPADA J, 2007, NUCL ACIDS RES; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Karimi M, 2006, EPIGENETICS-US, V1, P45; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kashiwagi K, 2011, NUCLEIC ACIDS RES, V39, P874, DOI 10.1093/nar/gkq870; Kiguchi N, 2011, J PHARM EXP THER; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; SCHUFFENHAUER S, 1995, HUM GENET, V96, P562, DOI 10.1007/BF00197412; Schweinhardt P, 2010, J CLIN INVEST, V120, P3788, DOI 10.1172/JCI43498; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Stefanska B, 2011, CANC RES; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tajerian M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-65; Tochiki KK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-14; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Wang Y, 2011, BRAIN RES, V1418, P64, DOI 10.1016/j.brainres.2011.08.040; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	42	96	99	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55259	10.1371/journal.pone.0055259	http://dx.doi.org/10.1371/journal.pone.0055259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383129	Green Published, gold			2022-12-27	WOS:000315211500068
J	Upadhya, R; Campbell, LT; Donlin, MJ; Aurora, R; Lodge, JK				Upadhya, Rajendra; Campbell, Leona T.; Donlin, Maureen J.; Aurora, Rajeev; Lodge, Jennifer K.			Global Transcriptome Profile of Cryptococcus neoformans during Exposure to Hydrogen Peroxide Induced Oxidative Stress	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYMES; CYTOCHROME-C PEROXIDASE; ANTIFUNGAL DRUG-RESISTANCE; TO-CELL SPREAD; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; FUNGAL PATHOGEN; NITROSATIVE STRESS; GENE-EXPRESSION; NITRIC-OXIDE	The ability of the opportunistic fungal pathogen Cryptococcus neoformans to resist oxidative stress is one of its most important virulence related traits. To cope with the deleterious effect of cellular damage caused by the oxidative burst inside the macrophages, C. neoformans has developed multilayered redundant molecular responses to neutralize the stress, to repair the damage and to eventually grow inside the hostile environment of the phagosome. We used microarray analysis of cells treated with hydrogen peroxide (H2O2) at multiple time points in a nutrient defined medium to identify a transcriptional signature associated with oxidative stress. We discovered that the composition of the medium in which fungal cells were grown and treated had a profound effect on their capacity to degrade exogenous H2O2. We determined the kinetics of H2O2 breakdown by growing yeast cells under different conditions and accordingly selected an appropriate media composition and range of time points for isolating RNA for hybridization. Microarray analysis revealed a robust transient transcriptional response and the intensity of the global response was consistent with the kinetics of H2O2 breakdown by treated cells. Gene ontology analysis of differentially expressed genes related to oxidation-reduction, metabolic process and protein catabolic processes identified potential roles of mitochondrial function and protein ubiquitination in oxidative stress resistance. Interestingly, the metabolic pathway adaptation of C. neoformans to H2O2 treatment was remarkably distinct from the response of other fungal organisms to oxidative stress. We also identified the induction of an antifungal drug resistance response upon the treatment of C. neoformans with H2O2. These results highlight the complexity of the oxidative stress response and offer possible new avenues for improving our understanding of mechanisms of oxidative stress resistance in C. neoformans.	[Upadhya, Rajendra; Campbell, Leona T.; Lodge, Jennifer K.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Donlin, Maureen J.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Donlin, Maureen J.; Aurora, Rajeev] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	Washington University (WUSTL); Saint Louis University; Saint Louis University	Lodge, JK (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	lodgej@wusm.wustl.edu	Donlin, Maureen J./M-4709-2019	Aurora, Rajeev/0000-0002-6609-6055; Lodge, Jennifer/0000-0002-2526-1210; Donlin, Maureen/0000-0001-7312-079X	NIH NIAID [R01AI050184]; NIH NHLBI [R01HL088905]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050184] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH NIAID R01AI050184 and NIH NHLBI R01HL088905 grants to JKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Alonso-Monge R, 2009, MICROBIOL-SGM, V155, P413, DOI 10.1099/mic.0.023309-0; Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Brown SM, 2010, EUKARYOT CELL, V9, P971, DOI 10.1128/EC.00271-09; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Charizanis C, 1999, MOL GEN GENET, V262, P437, DOI 10.1007/s004380051103; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cuellar-Cruz M, 2008, EUKARYOT CELL, V7, P814, DOI 10.1128/EC.00011-08; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; Demasi APD, 2006, FEBS J, V273, P805, DOI 10.1111/j.1742-4658.2006.05116.x; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Fernandez MR, 2007, CELL MOL LIFE SCI, V64, P1419, DOI 10.1007/s00018-007-7091-1; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerik KJ, 2008, EUKARYOT CELL, V7, P1685, DOI 10.1128/EC.00146-08; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Giles SS, 2005, FUNGAL GENET BIOL, V42, P20, DOI 10.1016/j.fgb.2004.09.003; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Guerrero-Castillo S, 2011, J BIOENERG BIOMEMBR, V43, P323, DOI 10.1007/s10863-011-9356-5; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.mi.46.100192.003025; Hasenberg M, 2011, INT J MED MICROBIOL, V301, P436, DOI 10.1016/j.ijmm.2011.04.012; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hiraishi H, 2006, BIOSCI BIOTECH BIOCH, V70, P2762, DOI 10.1271/bbb.60250; Honjoh K, 2010, AMINO ACIDS, V38, P1173, DOI 10.1007/s00726-009-0328-6; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Hwang GW, 2008, LIFE SCI, V82, P1182, DOI 10.1016/j.lfs.2008.04.002; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Jin JHQ, 2003, MICROBIOL-SGM, V149, P3371, DOI 10.1099/mic.0.26644-0; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kim SH, 2005, ANAL CHEM, V77, P6828, DOI 10.1021/ac0507340; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Kwon M, 2003, BBA-GEN SUBJECTS, V1623, P1, DOI 10.1016/S0304-4165(03)00151-X; Leach MD, 2011, MOL MICROBIOL, V79, P1574, DOI 10.1111/j.1365-2958.2011.07542.x; Lopes Joao, 2010, Open Microbiol J, V4, P75, DOI 10.2174/1874285801004010075; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Mak S, 2010, ENVIRON HEALTH PERSP, V118, P653, DOI 10.1289/ehp.0901448; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Missall TA, 2006, EUKARYOT CELL, V5, P518, DOI 10.1128/EC.5.3.518-529.2006; Missall TA, 2005, MICROBIOL-SGM, V151, P2573, DOI 10.1099/mic.0.28132-0; Missall TA, 2005, MOL MICROBIOL, V57, P847, DOI 10.1111/j.1365-2958.2005.04735.x; Missall TA, 2005, EUKARYOT CELL, V4, P487, DOI 10.1128/EC.4.2.487-489.2005; Missall TA, 2004, EUKARYOT CELL, V3, P835, DOI 10.1128/EC.3.4.835-846.2004; Missall TA, 2004, MOL MICROBIOL, V51, P1447, DOI 10.1111/j.1365-2958.2004.03921.x; Morgan Brian A., 2007, V44, P253; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Reed SH, 2007, DNA REPAIR, V6, P149, DOI 10.1016/j.dnarep.2006.10.026; Roetzer A, 2011, FEBS LETT, V585, P319, DOI 10.1016/j.febslet.2010.12.006; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Soriano FX, 2009, MOL CELLS, V27, P279, DOI 10.1007/s10059-009-0050-y; Sorrell Tania C., 1997, Revista Iberoamericana de Micologia, V14, P42; Steen BR, 2003, EUKARYOT CELL, V2, P1336, DOI 10.1128/EC.2.6.1336-1349.2003; Toffaletti DL, 2004, CURR GENET, V46, P193, DOI 10.1007/s00294-004-0521-9; Toffaletti DL, 2003, MICROBIOL-SGM, V149, P1041, DOI 10.1099/mic.0.26021-0; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Venkateswarlu K, 1997, ANTIMICROB AGENTS CH, V41, P748, DOI 10.1128/AAC.41.4.748; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wood PM, 2003, PEST MANAG SCI, V59, P499, DOI 10.1002/ps.655; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x	88	47	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55110	10.1371/journal.pone.0055110	http://dx.doi.org/10.1371/journal.pone.0055110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383070	Green Published, gold			2022-12-27	WOS:000315211500058
J	Balgi, AD; Wang, J; Cheng, DYH; Ma, CL; Pfeifer, TA; Shimizu, Y; Anderson, HJ; Pinto, LH; Lamb, RA; DeGrado, WF; Roberge, M				Balgi, Aruna D.; Wang, Jun; Cheng, Daphne Y. H.; Ma, Chunlong; Pfeifer, Tom A.; Shimizu, Yoko; Anderson, Hilary J.; Pinto, Lawrence H.; Lamb, Robert A.; DeGrado, William F.; Roberge, Michel			Inhibitors of the Influenza A Virus M2 Proton Channel Discovered Using a High-Throughput Yeast Growth Restoration Assay	PLOS ONE			English	Article							ADAMANTANE RESISTANCE; PANDEMIC INFLUENZA; PROTEIN; TRANSPORT; DERIVATIVES; MECHANISM; AMILORIDE; IDENTIFICATION; OSELTAMIVIR; DYNAMICS	The M2 proton channel of the influenza A virus is the target of the anti-influenza drugs amantadine and rimantadine. The effectiveness of these drugs has been dramatically limited by the rapid spread of drug resistant mutations, mainly at sites S31N, V27A and L26F in the pore of the channel. Despite progress in designing inhibitors of V27A and L26F M2, there are currently no drugs targeting these mutated channels in clinical trials. Progress in developing new drugs has been hampered by the lack of a robust assay with sufficient throughput for discovery of new active chemotypes among chemical libraries and sufficient sensitivity to provide the SAR data essential for their improvement and development as drugs. In this study we adapted a yeast growth restoration assay, in which expression of the M2 channel inhibits yeast growth and exposure to an M2 channel inhibitor restores growth, into a robust and sensitive high-throughput screen for M2 channel inhibitors. A screen of over 250,000 pure chemicals and semi-purified fractions from natural extracts identified 21 active compounds comprising amantadine, rimantadine, 13 related adamantanes and 6 non-adamantanes. Of the non-adamantanes, hexamethylene amiloride and a triazine derivative represented new M2 inhibitory chemotypes that also showed antiviral activity in a plaque reduction assay. Of particular interest is the fact that the triazine derivative was not sufficiently potent for detection as an inhibitor in the traditional two electrode voltage clamp assay for M2 channel activity, but its discovery in the yeast assay led to testing of analogues of which one was as potent as amantadine.	[Balgi, Aruna D.; Cheng, Daphne Y. H.; Anderson, Hilary J.; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Wang, Jun; DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Ma, Chunlong; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Lamb, Robert A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA; [Lamb, Robert A.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA; [Pfeifer, Tom A.; Shimizu, Yoko; Roberge, Michel] Ctr Drug Res & Dev, Vancouver, BC, Canada	University of British Columbia; University of California System; University of California San Francisco; Northwestern University; Northwestern University; Howard Hughes Medical Institute; Northwestern University	Roberge, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	michelr@mail.ubc.ca	Wang, Jun/G-6504-2010; Ma, Chunlong/AAT-7097-2021	Wang, Jun/0000-0002-4845-4621; 	Centre for Drug Research and Development; National Institutes of Health [GM56423, AI74571]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074571, R01AI020201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056423] Funding Source: NIH RePORTER	Centre for Drug Research and Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Centre for Drug Research and Development and National Institutes of Health grants GM56423 and AI74571. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; [Anonymous], 2009, PAND H1N1 2009 UPD 7; Astrahan P, 2011, BBA-BIOMEMBRANES, V1808, P394, DOI 10.1016/j.bbamem.2010.08.021; Balannik V, 2010, PFLUG ARCH EUR J PHY, V459, P593, DOI 10.1007/s00424-009-0760-1; Balannik V, 2009, BIOCHEMISTRY-US, V48, P11872, DOI 10.1021/bi9014488; Balgi Aruna D., 2009, V486, P125, DOI 10.1007/978-1-60327-545-3_9; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Cady SD, 2011, J AM CHEM SOC, V133, P4274, DOI 10.1021/ja102581n; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Camp D, 2012, J NAT PROD, V75, P72, DOI 10.1021/np200687v; Curman D, 2001, J BIOL CHEM, V276, P17914, DOI 10.1074/jbc.M100728200; Das K, 2012, J MED CHEM ASAP; Duque M.D., 2011, RECENT ADV PHARM SCI, P35; Eleftheratos S, 2010, BIOORG MED CHEM LETT, V20, P4182, DOI 10.1016/j.bmcl.2010.05.049; Ewart GD, 2002, EUR BIOPHYS J BIOPHY, V31, P26, DOI 10.1007/s002490100177; Fiorin G, 2010, SCIENCE, V330, P456, DOI 10.1126/science.1197748; Furuse Y, 2009, ANTIMICROB AGENTS CH, V53, P4457, DOI 10.1128/AAC.00650-09; Furuse Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-67; GIFFIN K, 1995, FEBS LETT, V357, P269, DOI 10.1016/0014-5793(94)01369-C; Govorkova EA, 2012, CURR TOP MICROBIOL I; GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I; GRAMBAS S, 1992, VIROLOGY, V190, P11, DOI 10.1016/0042-6822(92)91187-Y; Hayden FG, 2011, J INFECT DIS, V203, P6, DOI 10.1093/infdis/jiq012; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Hu WH, 2010, J MED CHEM, V53, P3831, DOI 10.1021/jm901664a; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Karpenko I, 2010, ANTIMICROB AGENTS CH, V54, P2017, DOI 10.1128/AAC.01186-09; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; KURTZ S, 1995, ANTIMICROB AGENTS CH, V39, P2204, DOI 10.1128/AAC.39.10.2204; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Lin TI, 1997, J GEN VIROL, V78, P767, DOI 10.1099/0022-1317-78-4-767; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; MARTINEZ AG, 1995, J MED CHEM, V38, P4474, DOI 10.1021/jm00022a012; Moore C, 2011, J INFECT DIS, V203, P18, DOI 10.1093/infdis/jiq007; Nicholls H, 2006, PLOS BIOL, V4, P156, DOI 10.1371/journal.pbio.0040050; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Quinn RJ, 2008, J NAT PROD, V71, P464, DOI 10.1021/np070526y; Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Sheu TG, 2011, J INFECT DIS, V203, P13, DOI 10.1093/infdis/jiq005; SIMCHOWITZ L, 1986, MOL PHARMACOL, V30, P112; Stouffer AL, 2008, NATURE, V452, P380, DOI 10.1038/nature06845; Viboud C, 2012, LANCET INFECT DIS, V12, P651, DOI 10.1016/S1473-3099(12)70152-4; Vottero Eduardo, 2006, Biotechnology Journal, V1, P282, DOI 10.1002/biot.200600001; Wang J, 2011, J AM CHEM SOC, V133, P12834, DOI 10.1021/ja204969m; Wang J, 2011, ACS MED CHEM LETT, V2, P307, DOI 10.1021/ml100297w; Wang J, 2011, CURR OPIN STRUC BIOL, V21, P68, DOI 10.1016/j.sbi.2010.12.002; Wang J, 2009, J AM CHEM SOC, V131, P8066, DOI 10.1021/ja900063s; WHO, 2009, INFL SEAS; Zhao X, 2011, EUR J MED CHEM, V46, P52, DOI 10.1016/j.ejmech.2010.10.010	55	45	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55271	10.1371/journal.pone.0055271	http://dx.doi.org/10.1371/journal.pone.0055271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383318	Green Submitted, Green Published, gold			2022-12-27	WOS:000314597900025
J	Duncan, SS; Valk, PL; McClain, MS; Shaffer, CL; Metcalf, JA; Bordenstein, SR; Cover, TL				Duncan, Stacy S.; Valk, Pieter L.; McClain, Mark S.; Shaffer, Carrie L.; Metcalf, Jason A.; Bordenstein, Seth R.; Cover, Timothy L.			Comparative Genomic Analysis of East Asian and Non-Asian Helicobacter pylori Strains Identifies Rapidly Evolving Genes	PLOS ONE			English	Article							BINDING HEMAGGLUTININ; BIOLOGICAL-ACTIVITY; DNA-REPAIR; EVOLUTION; SEQUENCE; CAGA; PROTEIN; DIVERSITY; ADHESIN; RISK	Helicobacter pylori infection is a risk factor for the development of gastric adenocarcinoma, a disease that has a high incidence in East Asia. Genes that are highly divergent in East Asian H. pylori strains compared to non-Asian strains are predicted to encode proteins that differ in functional activity and could represent novel determinants of virulence. To identify such proteins, we undertook a comparative analysis of sixteen H. pylori genomes, selected equally from strains classified as East Asian or non-Asian. As expected, the deduced sequences of two known virulence determinants (CagA and VacA) are highly divergent, with 77% and 87% mean amino acid sequence identities between East Asian and non-Asian groups, respectively. In total, we identified 57 protein sequences that are highly divergent between East Asian and non-Asian strains, but relatively conserved within East Asian strains. The most highly represented functional groups are hypothetical proteins, cell envelope proteins and proteins involved in DNA metabolism. Among the divergent genes with known or predicted functions, population genetic analyses indicate that 86% exhibit evidence of positive selection. McDonald-Kreitman tests further indicate that about one third of these highly divergent genes, including cagA and vacA, are under diversifying selection. We conclude that, similar to cagA and vacA, most of the divergent genes identified in this study evolved under positive selection, and represent candidate factors that may account for the disproportionately high incidence of gastric cancer associated with East Asian H. pylori strains. Moreover, these divergent genes represent robust biomarkers that can be used to differentiate East Asian and non-Asian H. pylori strains.	[Duncan, Stacy S.; Valk, Pieter L.; McClain, Mark S.; Cover, Timothy L.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Shaffer, Carrie L.; Bordenstein, Seth R.; Cover, Timothy L.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Metcalf, Jason A.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA; [Cover, Timothy L.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Bordenstein, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	s.bordenstein@vanderbilt.edu; timothy.l.cover@vanderbilt.edu	McClain, Mark S/A-6942-2009; Shaffer, Carrie/X-6106-2019; Cover, Timothy/I-3814-2015	McClain, Mark S/0000-0002-9857-4883; Cover, Timothy/0000-0001-8503-002X; Shaffer, Carrie L./0000-0002-7457-7422	National Institutes of Health (NIH) [AI068009, AI039657, CA116087]; Department of Veterans Affairs; NIH [GM085163]; NATIONAL CANCER INSTITUTE [P01CA116087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068009, R01AI039657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM085163] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health (NIH) AI068009, AI039657, and CA116087, and the Department of Veterans Affairs to TLC and NIH GM085163 to SRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Amundsen SK, 2008, MOL MICROBIOL, V69, P994, DOI 10.1111/j.1365-2958.2008.06336.x; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Bennett HJ, 2005, FEMS IMMUNOL MED MIC, V44, P163, DOI 10.1016/j.femsim.2004.11.008; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; BLASER MJ, 1995, CANCER RES, V55, P2111; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Devi SH, 2010, J BACTERIOL, V192, P6488, DOI 10.1128/JB.01110-10; Duncan SS, 2012, J BACTERIOL, V194, P1593, DOI 10.1128/JB.06340-11; EXNER MM, 1995, INFECT IMMUN, V63, P1567, DOI 10.1128/IAI.63.4.1567-1572.1995; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Farnbacher Max, 2010, BMC Genomics, V11, P335, DOI 10.1186/1471-2164-11-335; Figueiredo C, 2002, J NATL CANCER I, V94, P1680, DOI 10.1093/jnci/94.22.1680; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Furuta Y, 2011, P NATL ACAD SCI USA, V108, P1501, DOI 10.1073/pnas.1012579108; Gangwer KA, 2010, J BACTERIOL, V192, P6126, DOI 10.1128/JB.01081-10; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Howitt MR, 2011, MBIO, V2, DOI 10.1128/mBio.00098-11; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Ito Y, 1997, J CLIN MICROBIOL, V35, P1710, DOI 10.1128/JCM.35.7.1710-1714.1997; Jones AC, 1997, J BACTERIOL, V179, P5643, DOI 10.1128/jb.179.17.5643-5647.1997; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu H, 2007, J BIOL CHEM, V282, P6242, DOI 10.1074/jbc.M611178200; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Maiden MCJ, 2008, CURR OPIN MICROBIOL, V11, P467, DOI 10.1016/j.mib.2008.09.002; Martincorena I, 2012, NATURE, V485, P95, DOI 10.1038/nature10995; McClain MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-3; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; OHNISHI N, 2008, P NATL ACAD SCI US; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; OTOOLE PW, 1995, J BACTERIOL, V177, P6049, DOI 10.1128/jb.177.21.6049-6057.1995; Peck B, 1999, NUCLEIC ACIDS RES, V27, P3325, DOI 10.1093/nar/27.16.3325; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiberge JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-368; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Torres-Morquecho A, 2010, INFECT GENET EVOL, V10, P764, DOI 10.1016/j.meegid.2010.04.005; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P2597, DOI 10.1128/JCM.36.9.2597-2603.1998; van Doorn LJ, 1999, GASTROENTEROLOGY, V116, P823, DOI 10.1016/S0016-5085(99)70065-X; Wang G, 2009, INFECT IMMUN, V77, P286, DOI 10.1128/IAI.00970-08; Yao Jiqiang, 2007, In Silico Biology, V7, P195	72	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55120	10.1371/journal.pone.0055120	http://dx.doi.org/10.1371/journal.pone.0055120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383074	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600065
J	Jones, KH; Ford, DV; Jones, PA; John, A; Middleton, RM; Lockhart-Jones, H; Peng, J; Osborne, LA; Noble, JG				Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Peng, Jeffrey; Osborne, Lisa A.; Noble, J. Gareth			The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register	PLOS ONE			English	Article							SCALE MSIS-29	Introduction: The MSIS-29 was developed to assess the physical and psychological impact of MS. The aims of this study were to use the responses to the MSIS-29 via the web portal of the UK MS Register to: examine the internal properties of the scale delivered via the internet, profile the cohort, and assess how well the scale measures impact of disability on the potential workforce. Methods: Between May 2011 and April 2012, 4558 people with MS completed the MSIS-29(v.1). The responses were collated with basic demographic and descriptive MS data and the resulting dataset was analysed in SPSS(v.20). Results: Internal consistency was high (Cronbach's alpha 0.97 MSIS-29-PHYS, 0.92 MSIS-29-PSYCH). The mean MSIS-29-PHYS score was 60.5 (50.6%) with a median of 62 and the mean MSIS-29-PSYCH score was 24.8 (43.8%) with a median of 24. Physical scores increased with age and disease duration (p<0.001, p<0.001), but there was a weak negative relationship between psychological scores and age (p<0.001). The odds of people having an employment status of sick/disabled were 7.2 (CI 5.5, 9.4, p<0.001) for people with a moderate physical score, and 22.3 (CI 17.0, 29.3, p<0.001) for people with a high physical score (relative to having a low physical score). Conclusions: This largest known study of its kind has demonstrated how the MSIS-29 can be administered via the internet to characterise a cohort, and to predict the likely impact of disability on taking an active part in the workforce, as a reasonable proxy for the effects of MS on general activities. The findings examining MSIS-29-PHYS and MSIS-29-PSYCH scores against age support the use of two sub-scales, not a combined score. These results underline the importance of using a scale such as this to monitor disability levels regularly in guiding MS care to enable people to be as active as possible.	[Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Peng, Jeffrey; Noble, J. Gareth] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Osborne, Lisa A.] Swansea Univ, Coll Human & Hlth Sci, Long Term & Chron Condit Ctr, Swansea, W Glam, Wales	Swansea University; Swansea University	Jones, KH (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	k.h.jones@swansea.ac.uk		Jones, Kerina/0000-0001-8164-3718; Ford, David/0000-0001-6551-721X; Noble, Gareth/0000-0002-4588-049X; Middleton, Rodden/0000-0002-2130-4420; John, Ann/0000-0002-5657-6995	MS Society of Great Britain and Northern Ireland; ESRC [ES/L007444/1] Funding Source: UKRI; MRC [MR/K006525/1] Funding Source: UKRI; Economic and Social Research Council [ES/L007444/1] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish	MS Society of Great Britain and Northern Ireland; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study is funded by the MS Society of Great Britain and Northern Ireland (http://www.mssociety.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ETH REV RES DAT; Boot CRL, 2010, HEALTH INFORM J, V16, P145, DOI 10.1177/1460458210364786; European Medicines Agency, 2012, EMACHMP7718152011; Ford DV, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-73; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Good Alice, 2007, J Healthc Inf Manag, V21, P72; Gray OM, 2009, MULT SCLER, V15, P75, DOI 10.1177/1352458508096872; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hobart J, 2009, HLTH TECHNOLOGY ASSE, V13; Hobart JC, 2005, J NEUROL NEUROSUR PS, V76, P1539, DOI 10.1136/jnnp.2005.064584; Hoogervorst ELJ, 2004, MULT SCLER, V10, P569, DOI 10.1191/1352458504ms1078oa; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; McGuigan C, 2004, J NEUROL NEUROSUR PS, V75, P266; Multiple Sclerosis International Federation website, ATL MS DAT PROF COUN; Noble JG, 2012, MULT SCLER J, V18, P1718, DOI 10.1177/1352458512457847; Office for National Statistics, NOM OFF LAB MARK STA; Osborne LA, INT J HEALT IN PRESS; Osborne LA, 2012, INT J HEALTHC INF SY, V7, P27, DOI 10.4018/jhisi.2012070103; Ramp M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-58; Riazi A, 2002, J NEUROL NEUROSUR PS, V73, P701, DOI 10.1136/jnnp.73.6.701; van der Linden FAH, 2005, J NEUROL NEUROSUR PS, V76, P1677, DOI 10.1136/jnnp.2005.065227; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zajicek JP, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-88; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	26	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55422	10.1371/journal.pone.0055422	http://dx.doi.org/10.1371/journal.pone.0055422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23383186	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600101
J	Lally, JSV; Herbst, EAF; Matravadia, S; Maher, AC; Perry, CGR; Ventura-Clapier, R; Holloway, GP				Lally, James S. V.; Herbst, Eric A. F.; Matravadia, Sarthak; Maher, Amy C.; Perry, Christopher G. R.; Ventura-Clapier, Renee; Holloway, Graham P.			Over-Expressing Mitofusin-2 in Healthy Mature Mammalian Skeletal Muscle Does Not Alter Mitochondrial Bioenergetics	PLOS ONE			English	Article							CARNITINE-PALMITOYLTRANSFERASE-I; FATTY-ACID OXIDATION; OUTER-MEMBRANE; PALMITATE OXIDATION; 2A GENE; PROTEIN; FUSION; MORPHOLOGY; RETICULUM; INCREASES	The role of mitofusin-2 (MFN-2) in regulating mitochondrial dynamics has been well-characterized in lower order eukaryotic cell lines through the complete ablation of MFN-2 protein. However, to support the contractile function of mature skeletal muscle, the subcellular architecture and constituent proteins of this tissue differ substantially from simpler cellular organisms. Such differences may also impact the role of MFN-2 in mature mammalian muscle, and it is unclear if minor fluctuations in MFN-2, as observed in response to physiological perturbations, has a functional consequence. Therefore, we have transiently transfected MFN-2 cDNA into rat tibialis anterior muscle to determine the effect of physiolgically relevant increases in MFN-2 protein on mitochondrial bioenergetics. Permeabilized muscle fibres generated from muscle following MFN-2-transfection were used for functional assessments of mitochondrial bioenergetics. In addition, we have further established a novel method for selecting fibre bundles that are positively transfected, and using this approach transient transfection increased MFN-2 protein similar to 2.3 fold in selected muscle fibres. However, this did not alter maximal rates of oxygen consumption or the sensitivity for ADP-stimulated respiration. In addition, MFN-2 over-expression did not alter rates of H2O2 emission. Altogether, and contrary to evidence from lower order cell lines, our results indicate that over-expressing MFN-2 in healthy muscle does not influence mitochondrial bioenergetics in mature mammalian skeletal muscle.	[Lally, James S. V.; Herbst, Eric A. F.; Matravadia, Sarthak; Maher, Amy C.; Perry, Christopher G. R.; Holloway, Graham P.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Ventura-Clapier, Renee] Univ Paris 11, INSERM, U769, Paris, France	University of Guelph; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Holloway, GP (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	ghollowa@uoguelph.ca		Ventura-Clapier, Renee/0000-0002-7488-4123	Federal funding through the Canadian government	Federal funding through the Canadian government	Federal funding through the Canadian government funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Holloway GP, 2007, J PHYSIOL-LONDON, V582, P393, DOI 10.1113/jphysiol.2007.135301; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Murphy RM, 2011, J APPL PHYSIOL, V110, P820, DOI 10.1152/japplphysiol.01082.2010; Ogata T, 1997, ANAT REC, V248, P214; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Santel A, 2001, J CELL SCI, V114, P867; Schertzer JD, 2006, MOL THER, V13, P795, DOI 10.1016/j.ymthe.2005.09.019; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Zhang JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1099; Zorzano A, 2006, IUBMB LIFE, V58, P441, DOI 10.1080/15216540600644838	44	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55660	10.1371/journal.pone.0055660	http://dx.doi.org/10.1371/journal.pone.0055660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383258	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600142
J	Mateus, C; Lemos, R; Silva, MF; Reis, A; Fonseca, P; Oliveiros, B; Castelo-Branco, M				Mateus, Catarina; Lemos, Raquel; Silva, Maria Fatima; Reis, Aldina; Fonseca, Pedro; Oliveiros, Barbara; Castelo-Branco, Miguel			Aging of Low and High Level Vision: From Chromatic and Achromatic Contrast Sensitivity to Local and 3D Object Motion Perception	PLOS ONE			English	Article							MAGNOCELLULAR IMPAIRMENT; SPEED DISCRIMINATION; AGE; PERIMETRY; PATTERNS; GLAUCOMA; INTEGRATION; MECHANISMS; PATHWAYS; DEFICITS	The influence of normal aging in early, intermediate and high-level visual processing is still poorly understood. We have addressed this important issue in a large cohort of 653 subjects divided into five distinct age groups, [20; 30[, [30; 40[, [40; 50[, [50; 60[and [60;[. We applied a broad range of psychophysical tests, testing distinct levels of the visual hierarchy, from local processing to global integration, using simple gratings (spatial contrast sensitivity -CS- using high temporal/low spatial frequency or intermediate spatial frequency static gratings), color CS using Landolt patches, moving dot stimuli (Local Speed Discrimination) and dot patterns defining 3D objects (3D Structure from Motion, 3D SFM). Aging data were fitted with linear or quadratic regression models, using the adjusted coefficient of determination (R-a(2)) to quantify the effect of aging. A significant effect of age was found on all visual channels tested, except for the red-green chromatic channel. The high temporal low spatial frequency contrast sensitivity channel showed a mean sensitivity loss of 0.75 dB per decade (R-a(2) = 0.17, p < 0.001), while the lower intermediate spatial frequency channel showed a more pronounced decrease, around 2.35 dB (R-a(2) = 0.55, p, 0.001). Concerning low-level motion perception, speed discrimination decreased 2.71 degrees/s (R-a(2) = 0.18, p < 0.001) and 3.15 degrees/s (R-a(2) = 0.13, p < 0.001) only for short presentations for horizontal and oblique meridians, respectively. The 3D SFM task, requiring high-level integration across dorsal and ventral streams, showed the strongest (quadratic) decrease of motion coherence perception with age, especially when the task was temporally constrained (R-a(2) = 0.54, p < 0.001). These findings show that visual channels are influenced by aging into different extent, with time presenting a critical role, and high-level dorso-ventral dominance of deterioration, which accelerates with aging, in contrast to the other channels that show a linear pattern of deterioration.	[Mateus, Catarina; Lemos, Raquel; Silva, Maria Fatima; Reis, Aldina; Oliveiros, Barbara; Castelo-Branco, Miguel] Fac Med, Visual Neurosci Lab, IBILI, Coimbra, Portugal; [Reis, Aldina; Fonseca, Pedro] Univ Hosp Coimbra, Dept Ophthalmol, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)	Castelo-Branco, M (corresponding author), Fac Med, Visual Neurosci Lab, IBILI, Coimbra, Portugal.	mcbranco@ibili.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Castelo-Branco, Miguel/E-5689-2010; Oliveiros, Bárbara/AHD-0826-2022; Oliveiros, Bárbara/AAR-4529-2020; Silva, Maria Fatima/A-2812-2017	Castelo-Branco, Miguel/0000-0003-4364-6373; Oliveiros, Bárbara/0000-0001-7836-8161; Mateus, Catarina/0000-0003-4472-5049; Silva, Maria Fatima/0000-0002-3270-7575; Reis, Aldina/0000-0001-7598-8736; Lemos, Raquel/0000-0003-1221-915X	Foundation for Science and Technology Portugal [SFRH/BD/64306/2009, SFRH/BD/74070/2010, SFRH/BPD/72029/2010, PIC_IC_82986_2007]; Aging Program of the Calouste Gulbenkian Foundation	Foundation for Science and Technology Portugal(Portuguese Foundation for Science and Technology); Aging Program of the Calouste Gulbenkian Foundation	This research was supported by the following grants from the Foundation for Science and Technology Portugal: SFRH/BD/64306/2009 (to CM), SFRH/BD/74070/2010 (to RL), SFRH/BPD/72029/2010 (to MFS) and PIC_IC_82986_2007 (to MCB); and Aging Program of the Calouste Gulbenkian Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CW, 1999, OPTOMETRY VISION SCI, V76, P582, DOI 10.1097/00006324-199908000-00027; Anderson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1540, DOI 10.1167/iovs.04-0968; BALL K, 1986, J GERONTOL, V41, P176, DOI 10.1093/geronj/41.2.176; Bennett PJ, 2007, VISION RES, V47, P799, DOI 10.1016/j.visres.2007.01.001; Bidwell LC, 2006, PSYCHIAT RES, V145, P1, DOI 10.1016/j.psychres.2005.05.019; Billino J, 2008, VISION RES, V48, P1254, DOI 10.1016/j.visres.2008.02.014; CAPRIOLI J, 1991, AM J OPHTHALMOL, V111, P235, DOI 10.1016/S0002-9394(14)72266-4; Castelo-Branco M, 2006, NEUROPSYCHOLOGIA, V44, P238, DOI 10.1016/j.neuropsychologia.2005.05.005; Castelo-Branco M, 2004, INVEST OPHTH VIS SCI, V45, P499, DOI 10.1167/iovs.03-0815; Castelo-Branco M, 2002, P NATL ACAD SCI USA, V99, P13914, DOI 10.1073/pnas.202049999; Castelo-Branco M, 2009, NEUROPSYCHOLOGIA, V47, P314, DOI 10.1016/j.neuropsychologia.2008.09.003; Clement CI, 2009, BRIT J OPHTHALMOL, V93, P582, DOI 10.1136/bjo.2007.119909; Conlon E, 2008, AGING NEUROPSYCHOL C, V15, P446, DOI 10.1080/13825580701878008; CRASSINI B, 1988, PERCEPTION, V17, P315, DOI 10.1068/p170315; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; DEREFELDT G, 1979, ACTA OPHTHALMOL, V57, P679; ELLIOTT DB, 1987, OPHTHAL PHYSL OPT, V7, P415, DOI 10.1111/j.1475-1313.1987.tb00771.x; Elliott SL, 2010, J VISION, V10, DOI 10.1167/10.4.4; Gardiner SK, 2006, OPTOMETRY VISION SCI, V83, P438, DOI 10.1097/01.opx.0000225108.13284.fc; GILMORE GC, 1992, PSYCHOL AGING, V7, P654, DOI 10.1037/0882-7974.7.4.654; Goulart PRK, 2008, VISUAL NEUROSCI, V25, P445, DOI 10.1017/S0952523808080589; Graewe B, 2012, CEREB CORTE IN PRESS; Habak C, 2000, VISION RES, V40, P943, DOI 10.1016/S0042-6989(99)00235-7; Hendry SHC, 1998, TRENDS NEUROSCI, V21, P344, DOI 10.1016/S0166-2236(98)01245-4; Lam B, 2005, ELECTROPHYSIOLOGY VI, P151; Lemos R, 2012, J ALZHEIMERS DIS, V28, P885, DOI 10.3233/JAD-2011-110719; Maia-Lopes S, 2008, INVEST OPHTH VIS SCI, V49, P1191, DOI 10.1167/iovs.07-1051; McKendrick AM, 2007, INVEST OPHTH VIS SCI, V48, P2115, DOI 10.1167/iovs.06-1208; Mendes M, 2005, COGNITIVE BRAIN RES, V25, P788, DOI 10.1016/j.cogbrainres.2005.09.005; Nakayama Miyuki, 1993, Nippon Ganka Gakkai Zasshi, V97, P403; Norman JF, 2003, PERCEPTION, V32, P85, DOI 10.1068/p3478; OWSLEY C, 1987, BRIT J OPHTHALMOL, V71, P791, DOI 10.1136/bjo.71.10.791; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Paramei GV, 2012, J OPT SOC AM A, V29, pA290, DOI 10.1364/JOSAA.29.00A290; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; Raghuram A, 2005, J OPT SOC AM A, V22, P2269, DOI 10.1364/JOSAA.22.002269; Reis A, 2011, J NEUROL, V258, P1695, DOI 10.1007/s00415-011-6008-y; Ribeiro MJ, 2012, INVEST OPHTH VIS SCI, V53, P287, DOI 10.1167/iovs.11-8225; SALTHOUSE TA, 1995, J GERONTOL B-PSYCHOL, V50, pP297, DOI 10.1093/geronb/50B.6.P297; Sampaio J, 2011, NEUROPSYCHOLOGIA, V49, P34, DOI 10.1016/j.neuropsychologia.2010.11.002; Silva MF, 2008, VISION RES, V48, P127, DOI 10.1016/j.visres.2007.10.018; Silva MF, 2010, J VISION, V10, DOI 10.1167/10.6.26; Silva MF, 2005, BRAIN, V128, P2260, DOI 10.1093/brain/awh581; Snowden RJ, 2006, PERCEPTION, V35, P9, DOI 10.1068/p5399; Turpin A, 2002, INVEST OPHTH VIS SCI, V43, P322; Van Den Boomen C., 2012, FRONT PSYCHIATRY, V3, P1; Willis A, 2000, INVEST OPHTH VIS SCI, V41, P325; WRIGHT CE, 1985, DOC OPHTHALMOL, V59, P385, DOI 10.1007/BF00159172	48	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55348	10.1371/journal.pone.0055348	http://dx.doi.org/10.1371/journal.pone.0055348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383163	gold, Green Published			2022-12-27	WOS:000314610600090
J	Oggianu, L; Lancellotti, S; Pitocco, D; Zaccardi, F; Rizzo, P; Martini, F; Ghirlanda, G; De Cristofaro, R				Oggianu, Laura; Lancellotti, Stefano; Pitocco, Dario; Zaccardi, Francesco; Rizzo, Paola; Martini, Francesca; Ghirlanda, Giovanni; De Cristofaro, Raimondo			The Oxidative Modification of Von Willebrand Factor Is Associated with Thrombotic Angiopathies in Diabetes Mellitus	PLOS ONE			English	Article							INCREASED PLASMA-LEVELS; LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; FACTOR MULTIMERS; SHEAR-STRESS; RISK; ATHEROSCLEROSIS; COMPLICATIONS; DYSFUNCTION	The thrombogenic activity of Von Willebrand factor (VWF) is proportional to its molecular size and inversely related to its proteolysis by ADAMTS-13. Oxidation of VWF severely impairs its proteolysis by the metalloprotease. This study was aimed at assessing in patients with type 1 and type 2 diabetes whether protein carbonyls, marker of oxidative stress, are associated with both the level and oxidation status of VWF as well as with micro-and macroangiopathic complications. Eighty-three diabetic patients (41 type 1 and 42 type 2 diabetic subjects) and their respective eighty-three healthy controls were studied after verifying the availability, through institutional databases, of clinical biochemistry records spanning at least 3 years. VWF and protein carbonyls were measured by immunoassays, whereas VWF multimers were studied by SDS-agarose gel electrophoresis. Type 2 diabetic subjects had higher levels of VWF antigen (VWF:ag), VWF activity (VWF: act) and plasma proteins' carbonyls compared to both their controls and type 1 diabetic subjects. Moreover, high molecular weight VWF multimers and specific VWF-bound carbonyls were significantly increased in subjects with micro-and macro-angiopathic complications. In both type 1 and type 2 diabetic subjects, ADAMTS-13 activity was in the normal range. In a multivariable analysis, only VWF-bound carbonyls were significantly associated with any form of thrombotic angiopathy in the entire group of T1- and T2 diabetic patients. These data provide first evidence that not only high VWF levels but also its oxidation status and the presence of high molecular weight VWF multimers that are not observed in SDS-agarose gel electrophoresis of normal subjects are associated with thrombotic angiopathies in diabetes mellitus. These findings may help identify diabetic patients particularly at risk for these complications and elucidate a new pathophysiological mechanism of thrombotic angiopathies in this clinical setting.	[Oggianu, Laura; Lancellotti, Stefano; Rizzo, Paola; De Cristofaro, Raimondo] Univ Cattolica Sacro Cuore, Sch Med, Inst Internal Med, I-00168 Rome, Italy; [Oggianu, Laura; Lancellotti, Stefano; Rizzo, Paola; De Cristofaro, Raimondo] Univ Cattolica Sacro Cuore, Sch Med, Geriatr & Haemostasis Res Ctr, I-00168 Rome, Italy; [Oggianu, Laura] Rome Tre Univ, Sect Biol Appl Human Hlth, Rome, Italy; [Pitocco, Dario; Zaccardi, Francesco; Rizzo, Paola; Martini, Francesca; Ghirlanda, Giovanni] Univ Cattolica Sacro Cuore, Sch Med, Diabet Care Unit, Dept Internal Med, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Roma Tre University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Cristofaro, R (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Internal Med, I-00168 Rome, Italy.	rdecristofaro@rm.unicatt.it	De Cristofaro, Raimondo/K-3942-2018; LANCELLOTTI, Stefano/AAA-2950-2022; Pitocco, Dario/K-4210-2018; Lancellotti, Stefano/K-3939-2018	De Cristofaro, Raimondo/0000-0002-8066-8849; LANCELLOTTI, Stefano/0000-0002-8090-9040; Pitocco, Dario/0000-0002-6220-686X	MIUR Ministero dell'Istruzione, dell'Universita e della Ricerca [2007T9HTFB_003]; Catholic University School of Medicine [Linea D1-2009]	MIUR Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Catholic University School of Medicine	RDC gratefully acknowledges financial support from MIUR Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN2007-Grant:2007T9HTFB_003) and Catholic University School of Medicine (Grant Linea D1-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniyi A, 2002, J NATL MED ASSOC, V94, P1025; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen J, 2011, BLOOD, V115, P706; De Cristofaro R, 2005, J BIOL CHEM, V280, P23295, DOI 10.1074/jbc.M501143200; De Filippis V, 2012, BIOCHEM J, V442, P423, DOI 10.1042/BJ20111798; De Meyer SF, 2012, STROKE, V43, P599, DOI 10.1161/STROKEAHA.111.628867; Di Stasio E, 2010, BIOPHYS CHEM, V153, P1, DOI 10.1016/j.bpc.2010.07.002; Frankel DS, 2008, CIRCULATION, V118, P2533, DOI 10.1161/CIRCULATIONAHA.108.792986; Fu XY, 2011, BLOOD, V118, P5283, DOI 10.1182/blood-2011-01-331074; GANDHI CR, 1979, INDIAN J EXP BIOL, V17, P585; George JN, 2006, NEW ENGL J MED, V354, P1927, DOI 10.1056/NEJMcp053024; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; HAWIGER J, 1991, ANN NY ACAD SCI, V614, P270, DOI 10.1111/j.1749-6632.1991.tb43709.x; Vera RH, 2012, ARTERIOSCL THROM VAS, V32, P2141, DOI 10.1161/ATVBAHA.112.255281; Katz MH., 2011, MULTIVARIABLE ANAL A; Kemperman FAW, 2002, NEPHRON, V91, P547, DOI 10.1159/000065012; Lancellotti S, 2010, FREE RADICAL BIO MED, V48, P446, DOI 10.1016/j.freeradbiomed.2009.11.020; Leopold JA, 2009, FREE RADICAL BIO MED, V47, P1673, DOI 10.1016/j.freeradbiomed.2009.09.009; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Ferreiro JL, 2011, CIRCULATION, V123, P798, DOI 10.1161/CIRCULATIONAHA.109.913376; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Markus HS, 2011, STROKE, V42, P2149, DOI 10.1161/STROKEAHA.111.616649; MORISE T, 1995, DIABETES CARE, V18, P87, DOI 10.2337/diacare.18.1.87; Navarrete AM, 2012, BLOOD, V120, P2723, DOI 10.1182/blood-2012-03-420042; Nicolucci A, 2007, EUR HEART J, V28, P1925, DOI 10.1093/eurheartj/ehm248; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Parastatidis I, 2008, J BIOL CHEM, V283, P33846, DOI 10.1074/jbc.M805522200; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Pozzi N, 2012, BIOPHYS CHEM, V160, P1, DOI 10.1016/j.bpc.2011.07.007; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Seligman BGS, 2000, DIABETES CARE, V23, P1395, DOI 10.2337/diacare.23.9.1395; SINCLAIR AJ, 1994, DIABETIC MED, V11, P893, DOI 10.1111/j.1464-5491.1994.tb00375.x; Skeppholm M, 2009, BLOOD COAGUL FIBRIN, V20, P619, DOI 10.1097/MBC.0b013e32832da183; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; STEPHENSON JM, 1995, DIABETOLOGIA, V38, P599; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Taniguchi S, 2010, THROMB RES, V125, pE310, DOI 10.1016/j.thromres.2010.02.013; Udvardy ML, 2009, THROMB HAEMOSTASIS, V102, P412, DOI 10.1160/TH09-01-0032; Ulrichts H, 2011, BLOOD, V118, P757, DOI 10.1182/blood-2010-11-317859; van Schie MC, 2012, J THROMB HAEMOST, V10, P550, DOI 10.1111/j.1538-7836.2012.04634.x; van Schooten CJM, 2007, BLOOD, V109, P2430, DOI 10.1182/blood-2006-06-032706; Vepa S, 1999, AM J PHYSIOL-LUNG C, V277, pL150, DOI 10.1152/ajplung.1999.277.1.L150	49	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55396	10.1371/journal.pone.0055396	http://dx.doi.org/10.1371/journal.pone.0055396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383177	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600097
J	Clay, Z; de Waal, FBM				Clay, Zanna; de Waal, Frans B. M.			Bonobos Respond to Distress in Others: Consolation across the Age Spectrum	PLOS ONE			English	Article							POST-CONFLICT BEHAVIOR; POSTCONFLICT 3RD-PARTY AFFILIATION; RECONCILIATION; CHIMPANZEES; EMPATHY; CHILDREN; ATTACHMENT; MONKEYS; MOTHERS	How animals respond to conflict provides key insights into the evolution of socio-cognitive and emotional capacities. Evidence from apes has shown that, after social conflicts, bystanders approach victims of aggression to offer stress-alleviating contact behavior, a phenomenon known as consolation. This other-orientated behavior depends on sensitivity to the other's emotional state, whereby the consoler acts to ameliorate the other's situation. We examined post-conflict interactions in bonobos (Pan paniscus) to identify the determinants of consolation and reconciliation. Thirty-six semi-free bonobos of all ages were observed at the Lola ya Bonobo Sanctuary, DR Congo, using standardized Post-conflict/Matched Control methods. Across age and sex classes, bonobos consoled victims and reconciled after conflicts using a suite of affiliative and socio-sexual behaviors including embracing, touching, and mounting. Juveniles were more likely to console than adults, challenging the assumption that comfort-giving rests on advanced cognitive mechanisms that emerge only with age. Mother-reared individuals were more likely to console than orphans, highlighting the role of rearing in emotional development. Consistent with previous studies, bystanders were more likely to console relatives or closely bonded partners. Effects of kinship, affiliation and rearing were similarly indicated in patterns of reconciliation. Nearby bystanders were significantly more likely to contact victims than more distal ones, and consolation was more likely in non-food contexts than during feeding. The results did not provide convincing evidence that bystander contacts served for self-protection or as substitutes for reconciliation. Overall, results indicate that a suite of social, developmental and contextual factors underlie consolation and reconciliation in bonobos and that a sensitivity to the emotions of others and the ability to provide appropriate consolatory behaviors emerges early in development.	[Clay, Zanna; de Waal, Frans B. M.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University	Clay, Z (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	zannaclay@emory.edu			Living Links Center; Yerkes National Primate Research Center; Emory's College for Arts Sciences; Ministry of Research; Ministry of Environment in the Democratic Republic of Congo [MIN.RS/SG/004/2009]	Living Links Center; Yerkes National Primate Research Center; Emory's College for Arts Sciences; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Ministry of Environment in the Democratic Republic of Congo	Funding for the study has come from the Living Links Center, part of the Yerkes National Primate Research Center, and Emory's College for Arts & Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Pitshou Nsele Kayanga for assistance in data collection. We are grateful to Claudine Andre, Fanny Mehl, Dominique Morel, Valery Dhanani and Pierrot Mbonzo for their collaboration and to the Ministry of Research and the Ministry of Environment in the Democratic Republic of Congo for supporting our research ( research permit: MIN.RS/SG/004/2009). We thank all the staff of Lola ya Bonobo for their support, particularly to Stany Mokando, Jean-Claude Nzumbi and Philippe Kunaka. We thank Brian Hare for his ongoing support and Tim Eppley for valuable practical assistance. We are grateful to Noah Snyder-Mackler for statistical assistance. We thank Kim Bard, Philippe Rochat and Malini Suchak for insightful comments; Robert O'Reilly and Nigel Lo for their support in data management, and two anonymous reviewers for their valuable comments.	Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F., 2000, NATURAL CONFLICT RES; Byrne R, 2008, J CONSCIOUSNESS STUD, V15, P10; Call J, 2002, ANIM BEHAV, V63, P209, DOI 10.1006/anbe.2001.1908; CHENEY DL, 1989, BEHAVIOUR, V110, P258, DOI 10.1163/156853989X00501; Clay Z, 2011, ETHOLOGY, V117, P1158, DOI 10.1111/j.1439-0310.2011.01975.x; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; De Bellis MD, 2005, CHILD MALTREATMENT, V10, P150, DOI 10.1177/1077559505275116; De Waal F.B., 1999, PHILOS TOPICS, V27, P255, DOI 10.5840/philtopics199927122; de Waal FBM, 2011, EMPATHY; De Waal Frans B. M., 1996, P80; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DeWaal FBM, 1997, ANN NY ACAD SCI, V807, P317; Eisenberg N, 1992, REV PERSONALITY SOCI, P119; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010605; Fuentes A, 2002, PRIMATES, V43, P223, DOI 10.1007/BF02629650; Furuichi T, 2008, BONOBOS BEHAV ECOLOG; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Harlow H. F., 1965, P287; Hastings RP, 2006, AM J MENT RETARD, V111, P48, DOI 10.1352/0895-8017(2006)111[48:MDAEEC]2.0.CO;2; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Judge PG, 2005, ANIM BEHAV, V69, P1345, DOI 10.1016/j.anbehav.2004.08.016; JUDGE PG, 1991, AM J PRIMATOL, V23, P225, DOI 10.1002/ajp.1350230403; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; Liszkowski U, 2006, J COGN DEV, V7, P173, DOI 10.1207/s15327647jcd0702_2; Mallavarapu S, 2006, AM J PRIMATOL, V68, P789, DOI 10.1002/ajp.20279; MINEKA S, 1978, PSYCHOL BULL, V85, P1376, DOI 10.1037/0033-2909.85.6.1376; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Radke-Yarrow M., 1984, DEV MAINTENANCE PROS, P81, DOI 10.1007/978-1-4613-2645-8; RADKEYARROW M, 1994, CHILD DEV, V65, P1405, DOI 10.1111/j.1467-8624.1994.tb00825.x; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Romero T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022173; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Rosati AG, 2012, ANIM BEHAV IN PRESS; Roth-Hanania R, 2011, INFANT BEHAV DEV, V34, P447, DOI 10.1016/j.infbeh.2011.04.007; Schino G, 2004, J COMP PSYCHOL, V118, P340, DOI 10.1037/0735-7036.118.3.340; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Suomi SJ, 2008, INTEGR PSYCHOL BEHAV, V42, P354, DOI 10.1007/s12124-008-9072-9; Surbeck M, 2011, P ROY SOC B-BIOL SCI, V278, P590, DOI 10.1098/rspb.2010.1572; Tabachnick BG, 2001, MULTIVARIATE STAT; TIZARD B, 1978, J CHILD PSYCHOL PSYC, V19, P99, DOI 10.1111/j.1469-7610.1978.tb00453.x; van IJzendoorn MH, 2009, DEV PSYCHOBIOL, V51, P173, DOI 10.1002/dev.20356; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P1038, DOI 10.1037/0012-1649.28.6.1038; ZAHNWAXLER C, 1995, DEV PSYCHOPATHOL, V7, P27, DOI 10.1017/S0954579400006325; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	62	91	91	4	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55206	10.1371/journal.pone.0055206	http://dx.doi.org/10.1371/journal.pone.0055206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383110	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800130
J	Fry, JP; Laestadius, LI; Grechis, C; Nachman, KE; Neff, RA				Fry, Jillian P.; Laestadius, Linnea I.; Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.			Investigating the Role of State and Local Health Departments in Addressing Public Health Concerns Related to Industrial Food Animal Production Sites	PLOS ONE			English	Article							EASTERN NORTH-CAROLINA; FEEDING OPERATIONS; ENVIRONMENTAL INJUSTICE; RESPIRATORY HEALTH; SWINE OPERATIONS; HOG INDUSTRY; RESIDENTS; COMMUNITY; EXPOSURE; EMISSIONS	Objectives: Evidence of community health concerns stemming from industrial food animal production (IFAP) facilities continues to accumulate. This study examined the role of local and state health departments in responding to and preventing community-driven concerns associated with IFAP. Methods: We conducted semi-structured qualitative interviews with state and county health department staff and community members in eight states with high densities or rapid growth of IFAP operations. We investigated the extent to which health concerns associated with IFAP sites are reported to health departments, the nature of health departments' responses, and barriers to involvement. Results: Health departments' roles in these matters are limited by political barriers, lack of jurisdiction, and finite resources, expertise, and staff. Community members reported difficulties in engaging health departments on these issues. Conclusions: Our investigation suggests that health departments frequently lack resources or jurisdiction to respond to health concerns related to IFAP sites, resulting in limited engagement. Since agencies with jurisdiction over IFAP frequently lack a health focus, increased health department engagement may better protect public health.	[Fry, Jillian P.; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Fry, Jillian P.; Laestadius, Linnea I.; Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Livable Future, Baltimore, MD USA; [Laestadius, Linnea I.; Grechis, Clare; Nachman, Keeve E.; Neff, Roni A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fry, JP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.	jfry@jhsph.edu	Laestadius, Linnea/AAC-1911-2019	Laestadius, Linnea/0000-0003-3272-9317; Neff, Roni/0000-0002-0010-2635; Nachman, Keeve/0000-0003-4925-4151				American Public Health Association, 10 ESS PUBL HLTH SER; Association of State and Territorial Health Officials, 2012, BUDG CUTS CONT AFF H; Avery RC, 2004, ARCH ENVIRON HEALTH, V59, P101, DOI 10.3200/AEOH.59.2.101-108; Burkholder J, 2007, ENVIRON HEALTH PERSP, V115, P308, DOI 10.1289/ehp.8839; Cartiglia N., 2022, 17 TRENT WORKSH ADV; Centner TJ, 2011, J ANIM SCI, V89, P4364, DOI 10.2527/jas.2011-4256; Donham KJ, 2010, J ANIM SCI, V88, pE102, DOI 10.2527/jas.2009-2554; Erwin PC, 2011, AM J PUBLIC HEALTH, V101, P609, DOI 10.2105/AJPH.2009.177451; Graham JP, 2010, J WATER HEALTH, V8, P646, DOI 10.2166/wh.2010.075; Horton RA., 2009, AM J PUBLIC HEALTH, V99, pS610, DOI [10.2105/ajph.2008.148924, 10.2105/AJPH.2008.148924., DOI 10.2105/AJPH.2008.148924, 10.2105/AJPH.2008.148924]; Hyde JK, 2012, AM J PREV MED, V42, pS29, DOI 10.1016/j.amepre.2012.01.021; Johns Hopkins Bloomberg School of Public Health, 2008, NE MID PROF ENV PUBL; Juzych Nadia Shalauta, 2007, Am J Public Health, V97 Suppl 1, pS163, DOI 10.2105/AJPH.2006.096453; Kanarek N, 2006, J PUBLIC HEALTH MAN, V12, P522; Kufel JSZ, 2011, AM J PUBLIC HEALTH, V101, P1495, DOI 10.2105/AJPH.2011.300137; Maxwell JA, 2010, QUAL INQ, V16, P475, DOI 10.1177/1077800410364740; Merchant JA, 2005, ENVIRON HEALTH PERSP, V113, P350, DOI 10.1289/ehp.7240; Mirabelli MC, 2006, ENVIRON HEALTH PERSP, V114, P591, DOI 10.1289/ehp.8586; Missouri Department of Health and Senior Services, 2003, HLTH CONS FIN REP EX; Mitloehner FM, 2008, J AGRIC SAF HEALTH, V14, P163, DOI 10.13031/2013.24349; National Association of County and City Health Officials, 2012, LOC HLTH DEP JOB LOS; National Conference of State Legislatures, 2008, NAT C STAT LEG CONC; Nimmermark S, 2004, ANN AGR ENV MED, V11, P163; Osterberg D, 2004, AM J PUBLIC HEALTH, V94, P1703, DOI 10.2105/AJPH.94.10.1703; Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84; Resnick BA, 2009, J PUBLIC HEALTH MAN, pS40, DOI 10.1097/PHH.0b013e3181b3492d; Schenker MB, 1998, AM J RESP CRIT CARE, V158, pS1; Schiffman SS, 2001, AGR FOREST METEOROL, V108, P213, DOI 10.1016/S0168-1923(01)00239-8; SCHIFFMAN SS, 1995, BRAIN RES BULL, V37, P369, DOI 10.1016/0361-9230(95)00015-1; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Thu K, 1997, J AGR SAF HLTH, V3, P13, DOI DOI 10.13031/2013.17747; Thu K M, 2002, J Agric Saf Health, V8, P175; Trabue S, 2010, ATMOS ENVIRON, V44, P3538, DOI 10.1016/j.atmosenv.2010.06.009; US Census Bureau, 2010, INC POV HLTH INS COV; US Centers for Disease Control and Prevention, 1980, NAT SURV ASTHM US 19; US Department of Agriculture, CENS AGR HIST ARCH; US Department of Agriculture, CENS AGR QUICK STATS; US Department of Agriculture, 2009, EC INF B, VEIB-43; US Environmental Protection Agency, 2012, FY 2012 OFF ENF COMP; Williams DL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-72; Wilson SM, 2007, ATMOS ENVIRON, V41, P4977, DOI 10.1016/j.atmosenv.2006.12.055; Wilson SM, 2002, ENVIRON HEALTH PERSP, V110, P195, DOI 10.1289/ehp.02110s2195; Wing S, 2002, ENVIRON HEALTH PERSP, V110, P437, DOI 10.1289/ehp.02110437; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P233, DOI 10.2307/3454439	45	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54720	10.1371/journal.pone.0054720	http://dx.doi.org/10.1371/journal.pone.0054720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382947	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800069
J	Lilja, AM; Luo, Y; Yu, QS; Rojdner, J; Li, YZ; Marini, AM; Marutle, A; Nordberg, A; Greig, NH				Lilja, Anna M.; Luo, Yu; Yu, Qian-sheng; Rojdner, Jennie; Li, Yazhou; Marini, Ann M.; Marutle, Amelia; Nordberg, Agneta; Greig, Nigel H.			Neurotrophic and Neuroprotective Actions of (-)- and (+)-Phenserine, Candidate Drugs for Alzheimer's Disease	PLOS ONE			English	Article							BRAIN; PROTEIN; NEUROGENESIS; DOUBLECORTIN; HIPPOCAMPAL; PATHWAYS; NEURONS; BIOLOGY; DEATH; MEK2	Neuronal dysfunction and demise together with a reduction in neurogenesis are cardinal features of Alzheimer's disease (AD) induced by a combination of oxidative stress, toxic amyloid-beta peptide (A beta) and a loss of trophic factor support. Amelioration of these was assessed with the Ab lowering A beta experimental drugs (+)-phenserine and (-)-phenserine in neuronal cultures, and actions in mice were evaluated with (+)-phenserine. Both experimental drugs together with the metabolite N1-norphenserine induced neurotrophic actions in human SH-SY5Y cells that were mediated by the protein kinase C (PKC) and extracellular signal-regulated kinases (ERK) pathways, were evident in cells expressing amyloid precursor protein Swedish mutation (APP(SWE)), and retained in the presence of A beta and oxidative stress challenge. (+)-Phenserine, together with its (2) enantiomer as well as its N1- and N8-norphenserine and N1,N8-bisnorphenserine metabolites, likewise provided neuroprotective activity against oxidative stress and glutamate toxicity via the PKC and ERK pathways. These neurotrophic and neuroprotective actions were evident in primary cultures of subventricular zone (SVZ) neural progenitor cells, whose neurosphere size and survival were augmented by (+)-phenserine. Translation of these effects in vivo was assessed in wild type and AD APP(swe) transgenic (Tg2576) mice by doublecortin (DCX) immunohistochemical analysis of neurogenesis in the SVZ, which was significantly elevated by 16 day systemic (+)-phenserine treatment, in the presence of a (+)-phenserine-induced elevation in brain-derived neurotrophic factor (BDNF).	[Lilja, Anna M.; Rojdner, Jennie; Marutle, Amelia; Nordberg, Agneta] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Neurobiol Ctr, Stockholm, Sweden; [Lilja, Anna M.; Yu, Qian-sheng; Li, Yazhou; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Neurosci Lab, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Luo, Yu] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH USA; [Rojdner, Jennie; Nordberg, Agneta] Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA	Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Case Western Reserve University; Karolinska Institutet; Karolinska University Hospital; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Lilja, AM (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Neurobiol Ctr, Stockholm, Sweden.	anna.lilja@ki.se; greign@grc.nia.nih.gov	nordberg, agneta/ABD-2479-2021	Nordberg, Agneta/0000-0001-7345-5151; Luo, Yu/0000-0002-7939-5505	Swedish Medical Research Council [05817]; Stockholm County Council-Karolinska Institutet (ALF grant); Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Power; Brain Foundation; Gun and Bertil Stohnes Foundation; Foundation for Old Servants; Magnus Bergvalls Foundation; Dementia Association; Lars Hierta Memorial Foundation; Olle Engkvist Byggma "stare Foundation, KI Foundations; Karolinska Institutet agreement with Johnson Johnson; Alzheimer Association Sweden; Karolinska Institutet KID; Erik and Edith Fernstroms Foundation, Karolinska Insitutet; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council-Karolinska Institutet (ALF grant); Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Power; Brain Foundation; Gun and Bertil Stohnes Foundation; Foundation for Old Servants; Magnus Bergvalls Foundation; Dementia Association; Lars Hierta Memorial Foundation; Olle Engkvist Byggma "stare Foundation, KI Foundations; Karolinska Institutet agreement with Johnson Johnson; Alzheimer Association Sweden; Karolinska Institutet KID(Karolinska Institutet); Erik and Edith Fernstroms Foundation, Karolinska Insitutet; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research study was partly funded by the Swedish Medical Research Council (Project no. 05817), Stockholm County Council-Karolinska Institutet (ALF grant), the Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Power, the Brain Foundation, Gun and Bertil Stohnes Foundation, the Foundation for Old Servants, the Magnus Bergvalls Foundation, The Dementia Association, The Lars Hierta Memorial Foundation, Olle Engkvist Byggma "stare Foundation, KI Foundations, Karolinska Institutet agreement with Johnson & Johnson, and Alzheimer Association Sweden. A. M. L was supported by a PhD scholarship from Karolinska Institutet KID-funding, as well as Erik and Edith Fernstroms Foundation, Karolinska Insitutet for her stay at National Institutes of Health. This work was also supported by the Intramural Research Program, National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bailey JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021954; Becker RE, 2012, ALZHEIMERS DEMENT; Becker RE, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000446; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Claeysen S, 2012, CELL SIGNAL; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Corbett A, 2012, EXPERT OPIN EMERG DR, V17, P147, DOI 10.1517/14728214.2012.675327; Cuello AC, 2010, J MOL NEUROSCI, V40, P230, DOI 10.1007/s12031-009-9238-z; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Greig Nigel H., 2005, Current Alzheimer Research, V2, P281, DOI 10.2174/1567205054367829; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Jonsson L, 2009, PHARMACOECONOMICS, V27, P391, DOI 10.2165/00019053-200927050-00004; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Lahiri Debomoy K., 2006, Current Alzheimer Research, V3, P475, DOI 10.2174/156720506779025224; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; LAMBERT DG, 1990, PROG BRAIN RES, V84, P31; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Maccecchini ML, 2012, J NEUROL NEUROSURG P; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Niewiadomska G, 2011, BEHAV BRAIN RES, V221, P515, DOI 10.1016/j.bbr.2010.02.024; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Perry EK, 2012, NEUROBIOL DIS; Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010; Pouryamout L, 2012, DRUGS, V72, P789, DOI 10.2165/11631830-000000000-00000; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Sambamurti Kumar, 2006, Current Alzheimer Research, V3, P81, DOI 10.2174/156720506775697142; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Skarpen E, 2008, FASEB J, V22, P466, DOI 10.1096/fj.07-8650com; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Sugaya K, 2007, CURR ALZHEIMER RES, V4, P370, DOI 10.2174/156720507781788936; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200; VAUGHAN PFT, 1995, GEN PHARMACOL-VASC S, V26, P1191, DOI 10.1016/0306-3623(94)00312-B; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Wicklund L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015600; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Yu QS, 2013, ANTIINFLAMM IN PRESS; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	59	39	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54887	10.1371/journal.pone.0054887	http://dx.doi.org/10.1371/journal.pone.0054887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382994	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800087
J	Loh, NY; Bentley, L; Dimke, H; Verkaart, S; Tammaro, P; Gorvin, CM; Stechman, MJ; Ahmad, BN; Hannan, FM; Piret, SE; Evans, H; Bellantuono, I; Hough, TA; Fraser, WD; Hoenderop, JGJ; Ashcroft, FM; Brown, SDM; Bindels, RJM; Cox, RD; Thakker, RV				Loh, Nellie Y.; Bentley, Liz; Dimke, Henrik; Verkaart, Sjoerd; Tammaro, Paolo; Gorvin, Caroline M.; Stechman, Michael J.; Ahmad, Bushra N.; Hannan, Fadil M.; Piret, Sian E.; Evans, Holly; Bellantuono, Ilaria; Hough, Tertius A.; Fraser, William D.; Hoenderop, Joost G. J.; Ashcroft, Frances M.; Brown, Steve D. M.; Bindels, Rene J. M.; Cox, Roger D.; Thakker, Rajesh V.			Autosomal Dominant Hypercalciuria in a Mouse Model Due to a Mutation of the Epithelial Calcium Channel, TRPV5	PLOS ONE			English	Article							CA2+ CHANNEL; SENSING RECEPTOR; IDIOPATHIC HYPERCALCIURIA; ABSORPTIVE HYPERCALCIURIA; TRANSPORT PROTEINS; PLASMA-MEMBRANE; BONE-RESORPTION; XENOPUS OOCYTES; KNOCKOUT MICE; VITAMIN-D	Hypercalciuria is a major cause of nephrolithiasis, and is a common and complex disorder involving genetic and environmental factors. Identification of genetic factors for monogenic forms of hypercalciuria is hampered by the limited availability of large families, and to facilitate such studies, we screened for hypercalciuria in mice from an N-ethyl-N-nitrosourea mutagenesis programme. We identified a mouse with autosomal dominant hypercalciuria (HCALC1). Linkage studies mapped the Hcalc1 locus to a 11.94 Mb region on chromosome 6 containing the transient receptor potential cation channel, subfamily V, members 5 (Trpv5) and 6 (Trpv6) genes. DNA sequence analysis of coding regions, intron-exon boundaries and promoters of Trpv5 and Trpv6 identified a novel T to C transition in codon 682 of TRPV5, mutating a conserved serine to a proline (S682P). Compared to wild-type littermates, heterozygous (Trpv5(682P/+)) and homozygous (Trpv5(682P/682P)) mutant mice had hypercalciuria, polyuria, hyperphosphaturia and a more acidic urine, and similar to 10% of males developed tubulointerstitial nephritis. Trpv5(682P/682P) mice also had normal plasma parathyroid hormone but increased 1,25-dihydroxyvitamin D-3 concentrations without increased bone resorption, consistent with a renal defect for the hypercalciuria. Expression of the S682P mutation in human embryonic kidney cells revealed that TRPV5-S682P-expressing cells had a lower baseline intracellular calcium concentration than wild-type TRPV5-expressing cells, suggesting an altered calcium permeability. Immunohistological studies revealed a selective decrease in TRPV5-expression from the renal distal convoluted tubules of Trpv5(682P/+) and Trpv5(682P/682P) mice consistent with a trafficking defect. In addition, Trpv5(682P/682P) mice had a reduction in renal expression of the intracellular calcium-binding protein, calbindin-D-28K, consistent with a specific defect in TRPV5-mediated renal calcium reabsorption. Thus, our findings indicate that the TRPV5 S682P mutant is functionally significant and study of HCALC1, a novel model for autosomal dominant hypercalciuria, may help further our understanding of renal calcium reabsorption and hypercalciuria.	[Loh, Nellie Y.; Gorvin, Caroline M.; Stechman, Michael J.; Ahmad, Bushra N.; Hannan, Fadil M.; Piret, Sian E.; Thakker, Rajesh V.] Univ Oxford, Churchill Hosp, OCDEM, Nuffield Dept Med,Acad Endocrine Unit, Oxford, England; [Bentley, Liz; Hough, Tertius A.; Brown, Steve D. M.; Cox, Roger D.] MRC, Mammalian Genet Unit, Harwell, Oxon, England; [Bentley, Liz; Hough, Tertius A.; Brown, Steve D. M.; Cox, Roger D.] MRC, Mary Lyon Ctr, Harwell, Oxon, England; [Dimke, Henrik; Verkaart, Sjoerd; Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6525 ED Nijmegen, Netherlands; [Tammaro, Paolo; Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Evans, Holly; Bellantuono, Ilaria] Univ Sheffield, Sch Med, Acad Unit Bone Biol, Sheffield, S Yorkshire, England; [Fraser, William D.] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England	University of Oxford; Radboud University Nijmegen; University of Oxford; University of Sheffield; University of East Anglia	Thakker, RV (corresponding author), Univ Oxford, Churchill Hosp, OCDEM, Nuffield Dept Med,Acad Endocrine Unit, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013; Gorvin, Caroline/T-2406-2019; Dimke, Henrik/M-3319-2019; Dimke, Henrik/G-7970-2011	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; Gorvin, Caroline/0000-0002-1361-9174; Dimke, Henrik/0000-0002-9170-2168; Piret, Sian/0000-0002-3586-7654; Thakker, Rajesh/0000-0002-1438-3220; Hannan, Fadil/0000-0002-2975-5170; Tammaro, Paolo/0000-0002-6183-8187; Bellantuono, Ilaria/0000-0001-9994-6987; Cox, Roger/0000-0001-7170-5014	European Union; EuReGene Framework Programme 6; Medical Research Council UK; Kidney Research UK; Wellcome Trust; Glaxo SmithKline; University of Oxford; European Young Investigator award; Dutch Kidney Foundation [C05.2134]; GlaxoSmithKline; Kidney Research UK [RP52/2012] Funding Source: researchfish; Medical Research Council [MC_U142661184, G1000467, G0600702, G9825289, MC_UP_1502/1, MC_U142684172] Funding Source: researchfish; MRC [G1000467, MC_U142684172, G0600702, MC_UP_1502/1, MC_U142661184, G9825289] Funding Source: UKRI	European Union(European Commission); EuReGene Framework Programme 6; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Wellcome Trust(Wellcome Trust); Glaxo SmithKline(GlaxoSmithKline); University of Oxford; European Young Investigator award; Dutch Kidney Foundation; GlaxoSmithKline(GlaxoSmithKline); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by grants from the European Union, EuReGene Framework Programme 6, the Medical Research Council UK, Kidney Research UK, the Wellcome Trust, Glaxo SmithKline, and the University of Oxford, European Young Investigator award, and the Dutch Kidney Foundation C05.2134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The ENU mutagenesis programme at the MRC unit at Harwell had originally received funding from GlaxoSmithKline. However, there has been no further funding from GlaxoSmithKline for similar to 10 years, and the authors acknowledged their funding at the set up as a matter of courtesy. The data and materials are freely available without commercial links. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexander RT, 2009, J AM SOC NEPHROL, V20, P2371, DOI 10.1681/ASN.2008121273; Barbaric I, 2008, PHYSIOL GENOMICS, V32, P311, DOI 10.1152/physiolgenomics.00116.2007; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Chamoux E, 2010, J BIOL CHEM, V285, P25354, DOI 10.1074/jbc.M109.075234; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Coleman RA, 2000, AM J PHYSIOL-RENAL, V279, pF874, DOI 10.1152/ajprenal.2000.279.5.F874; Eknoyan G, 1999, ATLAS DIS KIDNEY, V2, P61; Embark HM, 2004, CELL PHYSIOL BIOCHEM, V14, P203, DOI 10.1159/000080329; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Gloor JM, 1999, ATLAS DIS KIDNEY, V2, P81; Goldfarb DS, 2005, KIDNEY INT, V67, P1053, DOI 10.1111/j.1523-1755.2005.00170.x; Gong M, 2006, CLIN SCI, V110, P315, DOI 10.1042/CS20050208; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmeister MV, 2011, ADV EXP MED BIOL, V704, P277, DOI 10.1007/978-94-007-0265-3_15; Hong CJ, PLOS ONE, V5; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Hunter DJ, 2002, CLIN SCI, V103, P259, DOI 10.1042/cs1030259; Jeong WS, 2005, J BIOCHEM MOL BIOL, V38, P167; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Lieben Liesbet, 2012, Front Endocrinol (Lausanne), V3, P99, DOI 10.3389/fendo.2012.00099; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Loh NY, 2000, J CELL SCI, V113, P2715; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Moe OW, 2005, J AM SOC NEPHROL, V16, P729, DOI 10.1681/ASN.2004100888; Muller D, 2002, NEPHROL DIAL TRANSPL, V17, P1614, DOI 10.1093/ndt/17.9.1614; Na T, 2009, AM J PHYSIOL-RENAL, V296, pF1042, DOI 10.1152/ajprenal.90771.2008; Nijenhuis T, 2004, J AM SOC NEPHROL, V15, P549, DOI 10.1097/01.ASN.0000113318.56023.B6; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Noveroske JK, 2000, MAMM GENOME, V11, P478, DOI 10.1007/s003350010093; PAK CYC, 1975, NEW ENGL J MED, V292, P497, DOI 10.1056/NEJM197503062921002; PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Reed BY, 1999, J CLIN ENDOCR METAB, V84, P3907, DOI 10.1210/jc.84.11.3907; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Renkema KY, 2005, J AM SOC NEPHROL, V16, P3188, DOI 10.1681/ASN.2005060632; Rio DC, 2010, COLD SPRING HARB PRO; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Slingerland AS, 2006, REV ENDOCR METAB DIS, V7, P171, DOI 10.1007/s11154-006-9014-0; Stechman MJ, 2010, LAB ANIM-UK, V44, P218, DOI 10.1258/la.2010.009128; Stechman MJ, 2009, PEDIATR NEPHROL, V24, P2321, DOI 10.1007/s00467-008-0807-0; Suzuki Y, 2008, HUM MOL GENET, V17, P1613, DOI 10.1093/hmg/ddn048; Tchekneva EE, 2008, J AM SOC NEPHROL, V19, P1955, DOI 10.1681/ASN.2008030296; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; VanBaal J, 1996, AM J PHYSIOL-RENAL, V271, pF985, DOI 10.1152/ajprenal.1996.271.5.F985; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Vezzoli G, 2011, KIDNEY INT, V80, P587, DOI 10.1038/ki.2010.430; Wang DL, 2006, P NATL ACAD SCI USA, V103, P13520, DOI 10.1073/pnas.0604661103; Worcester EM, 2008, SEMIN NEPHROL, V28, P120, DOI 10.1016/j.semnephrol.2008.01.005; Wu F, 2009, NEPHRON PHYSIOL, V112, pP53, DOI 10.1159/000225944	62	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55412	10.1371/journal.pone.0055412	http://dx.doi.org/10.1371/journal.pone.0055412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383183	Green Published, Green Accepted, gold			2022-12-27	WOS:000315563800152
J	York, TP; Brumelle, J; Juusola, J; Kendler, KS; Eaves, LJ; Amstadter, AB; Aggen, SH; Jones, KH; Ferreira-Gonzalez, A; Jackson-Cook, C				York, Timothy P.; Brumelle, Jenni; Juusola, Jane; Kendler, Kenneth S.; Eaves, Lindon J.; Amstadter, Ananda B.; Aggen, Steven H.; Jones, Kimberly H.; Ferreira-Gonzalez, Andrea; Jackson-Cook, Colleen			Increased Frequency of Micronuclei in Adults with a History of Childhood Sexual Abuse: A Discordant Monozygotic Twin Study	PLOS ONE			English	Article							POPULATION-BASED TWIN; CHROMOSOMAL INSTABILITY; HUMAN-LYMPHOCYTES; MAJOR DEPRESSION; SCORING CRITERIA; TELOMERE LENGTH; ASSOCIATION; STRESS; ASSAY; HETEROCHROMATIN	Background: Childhood sexual abuse (CSA) is a traumatic life event associated with an increased lifetime risk for psychopathology/morbidity. The long-term biological consequences of CSA-elicited stress on chromosomal stability in adults are unknown. The primary aim of this study was to determine if the rate of acquired chromosomal changes, measured using the cytokinesis-block micronucleus assay on stimulated peripheral blood lymphocytes, differs in adult female monozygotic twins discordant for CSA. Methods: Monozygotic twin pairs discordant for CSA were identified from a larger population-based sample of female adult twins for whom the experience of CSA was assessed by self-report (51 individuals including a reference sample). Micronuclei (MN) contain chromatin from structurally normal or abnormal chromosomes that are excluded from the daughter nuclei during cell division and serve as a biomarker to assess acquired chromosomal instability. Results: Female twins exposed to CSA exhibited a 1.63-fold average increase in their frequency of MN compared to their nonexposed genetically identical cotwins (Paired t-test, t(16) = 2.65, P = 0.017). No additional effects of familial factors were detected after controlling for the effect of CSA exposure. A significant interaction between CSA history and age was observed, suggesting that the biological effects of CSA on MN formation may be cumulative. Conclusions: These data support a direct link between CSA exposure and MN formation measured in adults that is not attributable to genetic or environmental factors shared by siblings. Further research is warranted to understand the biological basis for the observed increase in acquired chromosomal findings in people exposed to CSA and to determine if acquired somatic chromosomal abnormalities/somatic clonal mosaicism might mediate the adult pathology associated with CSA.	[York, Timothy P.; Brumelle, Jenni; Kendler, Kenneth S.; Eaves, Lindon J.; Jackson-Cook, Colleen] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [York, Timothy P.; Kendler, Kenneth S.; Eaves, Lindon J.; Amstadter, Ananda B.; Aggen, Steven H.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Brumelle, Jenni; Juusola, Jane; Jones, Kimberly H.; Ferreira-Gonzalez, Andrea; Jackson-Cook, Colleen] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Kendler, Kenneth S.; Eaves, Lindon J.; Amstadter, Ananda B.; Aggen, Steven H.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Jones, Kimberly H.] Neodiagnostix Inc, Rockville, MD USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	York, TP (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	tpyork@vcu.edu	Kendler, Kenneth/AAF-2876-2019		National Institute on Aging [R01AG037986]; National Institute of Environmental Health Sciences [R01 ES12074]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037986] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute on Aging [R01AG037986 (CJC, TPY)] and the National Institute of Environmental Health Sciences [R01 ES12074 (CJC)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2010, R LANG ENV STAT COMP; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; Battershill JM, 2008, MUTAGENESIS, V23, P423, DOI 10.1093/mutage/gen040; Bonassi S, 2001, ENVIRON MOL MUTAGEN, V37, P31; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Bulik CM, 2001, BRIT J PSYCHIAT, V179, P444, DOI 10.1192/bjp.179.5.444; Chen MH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-199; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Day JP, 1998, CARCINOGENESIS, V19, P259, DOI 10.1093/carcin/19.2.259; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Dinwiddie S, 2000, PSYCHOL MED, V30, P41, DOI 10.1017/S0033291799001373; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drury SS, 2011, MOL PSYCHIAT; EASTMOND DA, 1989, ENVIRON MOL MUTAGEN, V13, P34, DOI 10.1002/em.2850130104; Faggioli F, 2011, MECH AGEING DEV, V132, P429, DOI 10.1016/j.mad.2011.04.008; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fauth E, 1998, MUTAGENESIS, V13, P235, DOI 10.1093/mutage/13.3.235; Federici C, 2008, AM J CARDIOL, V102, P1296, DOI 10.1016/j.amjcard.2008.07.024; FENECH M, 1985, MUTAT RES, V148, P99, DOI 10.1016/0027-5107(85)90212-X; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Fenech M, 2011, MUTAGENESIS, V26, P63, DOI 10.1093/mutage/geq084; Filatov L, 1998, ONCOGENE, V16, P1825, DOI 10.1038/sj.onc.1201711; Glass Daniel, 2010, Biol Psychiatry, V68, pe21, DOI 10.1016/j.biopsych.2010.02.026; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Heim, 2000, JAMA, V284, P2321; Hernandez R, 1997, CYTOGENET CELL GENET, V76, P196, DOI 10.1159/000134548; Herrera LA, 2008, CURR GENOMICS, V9, P43, DOI 10.2174/138920208783884883; Iourov IY, 2008, CURR GENOMICS, V9, P452, DOI 10.2174/138920208786241216; Iourov IY, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-26; Jones KH, 2011, MUTAGENESIS, V26, P745, DOI 10.1093/mutage/ger042; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kendler K, 2011, PSYCHOL SCI; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P257; Kendler KS, 1999, ARCH GEN PSYCHIAT, V56, P39, DOI 10.1001/archpsyc.56.1.39; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Kendler KS, 1998, AM J PSYCHIAT, V155, P1016, DOI 10.1176/ajp.155.8.1016; Kendler KS, 2006, UNDERSTANDING CAUSES; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; Kirsch-Volders M, 2011, ARCH TOXICOL, V85, P873, DOI 10.1007/s00204-011-0691-4; Leach NT, 2004, MECH AGEING DEV, V125, P563, DOI 10.1016/j.mad.2004.06.006; Leach NT, 2001, MUTAT RES-GEN TOX EN, V495, P11, DOI 10.1016/S1383-5718(01)00194-2; Lindberg HK, 2007, MUTAT RES-FUND MOL M, V617, P33, DOI 10.1016/j.mrfmmm.2006.12.002; MARTIN J, 1993, CHILD ABUSE NEGLECT, V17, P383, DOI 10.1016/0145-2134(93)90061-9; Mateuca R, 2006, BIOCHIMIE, V88, P1515, DOI 10.1016/j.biochi.2006.07.004; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; Miller B, 1998, MUTAT RES-REV MUTAT, V410, P81, DOI 10.1016/S1383-5742(97)00030-6; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Murgia E, 2007, MUTAT RES-FUND MOL M, V621, P113, DOI 10.1016/j.mrfmmm.2007.02.015; Nelson EC, 2002, ARCH GEN PSYCHIAT, V59, P139, DOI 10.1001/archpsyc.59.2.139; Petrozzi L, 2002, NEUROL SCI, V23, pS97, DOI 10.1007/s100720200087; Rodriguez MJ, 2001, MUTAGENESIS, V16, P109, DOI 10.1093/mutage/16.2.109; Samanta S, 2010, DIAGNOSTIC CYTOPATHO; Samper E, 2001, J CELL BIOL, V154, P49, DOI 10.1083/jcb.200103049; SCHMID M, 1983, CYTOGENET CELL GENET, V36, P554, DOI 10.1159/000131972; Schwartz JL, 2001, GENE CHROMOSOME CANC, V30, P236, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1085>3.3.CO;2-7; Scott J, 2010, ARCH GEN PSYCHIAT, V67, P111, DOI 10.1001/archgenpsychiatry.2009.188; STACEY M, 1995, J MED GENET, V32, P502, DOI 10.1136/jmg.32.7.502; Surowy H, 2011, MUTAGENESIS, V26, P111, DOI 10.1093/mutage/geq059; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; van Leeuwen DM, 2011, MUTAGENESIS, V26, P27, DOI 10.1093/mutage/geq074; Yan B, 2009, METHODS MOL BIOL, V512, P15, DOI 10.1007/978-1-60327-530-9_2	67	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55337	10.1371/journal.pone.0055337	http://dx.doi.org/10.1371/journal.pone.0055337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383158	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800141
J	Barnett, J; Vasileiou, K; Gowland, MH; Raats, MM; Lucas, JS				Barnett, Julie; Vasileiou, Konstantina; Gowland, M. Hazel; Raats, Monique M.; Lucas, Jane S.			Beyond Labelling: What Strategies Do Nut Allergic Individuals Employ to Make Food Choices? A Qualitative Study	PLOS ONE			English	Article							PEANUT ALLERGY; PSYCHOLOGICAL BURDEN; OF-LIFE; CHILDREN; PREVALENCE; PARENTS; ADOLESCENTS; ADULTS; RISK	Objective: Food labelling is an important tool that assists people with peanut and tree nut allergies to avoid allergens. Nonetheless, other strategies are also developed and used in food choice decision making. In this paper, we examined the strategies that nut allergic individuals deploy to make safe food choices in addition to a reliance on food labelling. Methods: Three qualitative methods: an accompanied shop, in-depth semi-structured interviews, and the product choice reasoning task - were used with 32 patients that had a clinical history of reactions to peanuts and/or tree nuts consistent with IgE-mediated food allergy. Thematic analysis was applied to the transcribed data. Results: Three main strategies were identified that informed the risk assessments and food choice practices of nut allergic individuals. These pertained to: (1) qualities of product such as the product category or the country of origin, (2) past experience of consuming a food product, and (3) sensory appreciation of risk. Risk reasoning and risk management behaviours were often contingent on the context and other physiological and socio-psychological needs which often competed with risk considerations. Conclusions: Understanding and taking into account the complexity of strategies and the influences of contextual factors will allow healthcare practitioners, allergy nutritionists, and caregivers to advise and educate patients more effectively in choosing foods safely. Governmental bodies and policy makers could also benefit from an understanding of these food choice strategies when risk management policies are designed and developed.	[Barnett, Julie; Vasileiou, Konstantina] Brunel Univ, Dept Informat Syst & Comp, Uxbridge UB8 3PH, Middx, England; [Gowland, M. Hazel] Allergy Act, Farnborough, Hants, England; [Raats, Monique M.] Univ Surrey, Fac Arts & Human Sci, Sch Psychol, Guildford GU2 5XH, Surrey, England; [Lucas, Jane S.] Univ Southampton, Fac Med, Univ Hosp Southampton NHS Fdn Trust, Southampton SO9 5NH, Hants, England	Brunel University; University of Surrey; University of Southampton; University Hospital Southampton NHS Foundation Trust	Barnett, J (corresponding author), Brunel Univ, Dept Informat Syst & Comp, Uxbridge UB8 3PH, Middx, England.	Julie.Barnett@brunel.ac.uk	Lucas, Jane S/C-3620-2013; Raats, Monique/G-5348-2012	Raats, Monique/0000-0002-8057-2783; Vasileiou, Konstantina/0000-0001-5047-3920; Barnett, Julie/0000-0001-5740-0863; Lucas, Jane/0000-0001-8701-9975; Gowland, M Hazel/0000-0002-5513-5979	United Kingdom Food Standards Agency [T07058]; Anaphylaxis Campaign	United Kingdom Food Standards Agency; Anaphylaxis Campaign	This study was funded by the United Kingdom Food Standards Agency under project code T07058 (http://www.food.gov.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They provided comment on a full draft of this paper.; We acknowledge the support of the Anaphylaxis Campaign and also the contribution of Jo Leftwich and Kate Muncer who collected the data on which the analysis is based.	Al-Muhsen S, 2003, CAN MED ASSOC J, V168, P1279; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Barnett J, 2011, ALLERGY, V66, P969, DOI 10.1111/j.1398-9995.2011.02563.x; Barnett J, 2010, T07058 FOOD STAND AG; Barnett Julie, 2012, Clin Transl Allergy, V2, P12, DOI 10.1186/2045-7022-2-12; Barnett J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-734; Ben-Shoshan M, 2009, J ALLERGY CLIN IMMUN, V123, P783, DOI 10.1016/j.jaci.2009.02.004; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Connors M, 2001, APPETITE, V36, P189, DOI 10.1006/appe.2001.0400; Cornelisse-Vermaat JR, 2008, EUR J PUBLIC HEALTH, V18, P115, DOI 10.1093/eurpub/ckm032; Cummings AJ, 2010, ALLERGY, V65, P933, DOI 10.1111/j.1398-9995.2010.02342.x; Cummings AJ, 2010, PEDIAT ALLERG IMM-UK, V21, P586, DOI 10.1111/j.1399-3038.2009.00975.x; Enright G, 2010, QUALITATIVE RES EXPL; Ericsson K. A., 1984, PROTOCOL ANAL VERBAL; Falk LW, 1996, J NUTR EDUC, V28, P257; Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019; Gallagher M, 2011, CLIN EXP ALLERGY, V41, P869, DOI 10.1111/j.1365-2222.2011.03743.x; Gallagher M, 2009, ALLERGY, V64, P1117, DOI 10.1111/j.1398-9995.2009.02065.x; Green JM, 2003, HEALTH RISK SOC, V5, P33, DOI 10.1080/1369857031000065998; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Higginson C. S., 2002, Nutrition & Food Science, V32, P92, DOI 10.1108/00346650210423392; Horlick-Jones T, 2007, HEALTH RISK SOC, V9, P83, DOI 10.1080/13698570601181623; Hourihane JO, 1997, CLIN EXP ALLERGY, V27, P634, DOI [10.1111/j.1365-2222.1997.tb01190.x, 10.1046/j.1365-2222.1997.d01-559.x]; Joshi P, 2002, J ALLERGY CLIN IMMUN, V109, P1019, DOI 10.1067/mai.2002.123305; Leftwich J, 2011, CLIN EXP ALLERGY, V41, P243, DOI 10.1111/j.1365-2222.2010.03649.x; Lupton DA, 2005, SOCIOL HEALTH ILL, V27, P448, DOI 10.1111/j.1467-9566.2005.00451.x; Macadam Clare, 2012, Clin Transl Allergy, V2, P3, DOI 10.1186/2045-7022-2-3; Nielsen J, 2002, NORD C COMP HUM INT; Noimark L, 2009, PEDIATR ALLERGY IMMU, V20, P500, DOI 10.1111/j.1399-3038.2008.00796.x; Otnes Cele C., 1995, J RETAIL CONSUM SERV, V2, P97; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pieretti MM, 2009, J ALLERGY CLIN IMMUN, V124, P337, DOI 10.1016/j.jaci.2009.05.032; Primeau MN, 2000, CLIN EXP ALLERGY, V30, P1135, DOI 10.1046/j.1365-2222.2000.00889.x; Pumphrey RSH, 2007, J ALLERGY CLIN IMMUN, V119, P1018, DOI 10.1016/j.jaci.2007.01.021; QSR International Pty Ltd, 2020, NVIVO; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Sampson HA, 1996, BRIT MED J, V312, P1050; Sampson HA, 2002, NEW ENGL J MED, V346, P1294, DOI 10.1056/NEJMcp012667; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P128, DOI 10.1067/mai.2001.115755; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V103, P559, DOI 10.1016/S0091-6749(99)70224-1; Sommer I, 2012, ALLERGY, V67, P1319, DOI 10.1111/j.1398-9995.2012.02883.x; Teufel M, 2007, WORLD J GASTROENTERO, V13, P3456, DOI 10.3748/wjg.v13.i25.3456; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x	48	19	19	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55293	10.1371/journal.pone.0055293	http://dx.doi.org/10.1371/journal.pone.0055293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383141	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315483200010
J	Lin, HC; Gean, PW; Wang, CC; Chan, YH; Chen, PS				Lin, Hui-Ching; Gean, Po-Wu; Wang, Chao-Chuan; Chan, Yun-Han; Chen, Po See			The Amygdala Excitatory/Inhibitory Balance in a Valproate-Induced Rat Autism Model	PLOS ONE			English	Article							PRENATAL EXPOSURE; ANIMAL-MODEL; SYNAPTIC PLASTICITY; SOCIAL-BEHAVIOR; IN-VIVO; BRAIN; FEAR; ACID; CHILDREN; ADOLESCENTS	The amygdala is an important structure contributing to socio-emotional behavior. However, the role of the amygdala in autism remains inconclusive. In this study, we used the 28-35 days valproate (VPA)-induced rat model of autism to observe the autistic phenotypes and evaluate their synaptic characteristics in the lateral nucleus (LA) of the amygdala. The VPA-treated offspring demonstrated less social interaction, increased anxiety, enhanced fear learning and impaired fear memory extinction. Slice preparation and electrophysiological recordings of the amygdala showed significantly enhanced long-term potentiation (LTP) while stimulating the thalamic-amygdala pathway of the LA. In addition, the pair pulse facilitation (PPF) at 30- and 60-ms intervals decreased significantly. Whole-cell recordings of the LA pyramidal neurons showed an increased miniature excitatory postsynaptic current (EPSC) frequency and amplitude. The relative contributions of the AMPA receptor and NMDA receptor to the EPSCs did not differ significantly between groups. These results suggested that the enhancement of the presynaptic efficiency of excitatory synaptic transmission might be associated with hyperexcitibility and enhanced LTP in LA pyramidal neurons. Disruption of the synaptic excitatory/inhibitory (E/I) balance in the LA of VPA-treated rats might play certain roles in the development of behaviors in the rat that may be relevant to autism. Further experiments to demonstrate the direct link are warranted.	[Lin, Hui-Ching] Natl Yang Ming Univ, Sch Med, Dept & Inst Physiol, Taipei 112, Taiwan; [Lin, Hui-Ching] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Gean, Po-Wu; Chan, Yun-Han] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Wang, Chao-Chuan] Kaohsiung Med Univ, Coll Med, Dept Anat, Kaohsiung, Taiwan; [Chan, Yun-Han] Ctr Drug Evaluat, Taipei, Taiwan; [Chen, Po See] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan 70101, Taiwan; [Chen, Po See] Natl Cheng Kung Univ, Addict Res Ctr, Tainan 70101, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chen, PS (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan 70101, Taiwan.	chenps@mail.ncku.edu.tw	Chen, Po See/AAA-6492-2021	Lin, Hui-Ching/0000-0002-1639-9293	National Science Council, Taiwan [NSC 99-2628-B-006-013, NSC 96-2314-B-006-056, NSC 100-2320-B-010-033-MY2]; Aim for the Top University Plan from the National Cheng Kung University; Aim for the Top University Plan from the National Yang-Ming University; National Cheng Kung Hospital [NCKUH-10005008]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan from the National Cheng Kung University; Aim for the Top University Plan from the National Yang-Ming University; National Cheng Kung Hospital	Funding provided by the National Science Council, Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp=7; NSC 99-2628-B-006-013, NSC 96-2314-B-006-056, NSC 100-2320-B-010-033-MY2); Aim for the Top University Plan from the National Cheng Kung University (http://top-en.ncku.edu.tw/bin/home.php); Aim for the Top University Plan from the National Yang-Ming University (http://www.ym.edu.tw/top/eng/index.html); and National Cheng Kung Hospital (http://www.hosp.ncku.edu.tw/nckm/english/HomeStyle.aspx?Type=11&ContentPage=0; NCKUH-10005008). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2006, PROG BRAIN RES, V156, P363, DOI 10.1016/S0079-6123(06)56020-0; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barad M, 2006, BIOL PSYCHIAT, V60, P322, DOI 10.1016/j.biopsych.2006.05.029; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Becker B, 2012, BIOL PSYCHIAT, V72, P70, DOI 10.1016/j.biopsych.2011.11.024; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Blair RJR, 2006, J CHILD PSYCHOL PSYC, V47, P262, DOI 10.1111/j.1469-7610.2006.01596.x; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Chiao JY, 2008, J COGNITIVE NEUROSCI, V20, P2167, DOI 10.1162/jocn.2008.20151; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Cottraux J, 2005, CURR OPIN PSYCHIATR, V18, P51; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Damsa C, 2005, CURR OPIN PSYCHIATR, V18, P55; Du J, 2008, J NEUROSCI, V28, P68, DOI 10.1523/JNEUROSCI.3080-07.2008; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Evans DW, 2005, CHILD PSYCHIAT HUM D, V36, P3, DOI 10.1007/s10578-004-3619-x; Flagstad P, 2004, NEUROPSYCHOPHARMACOL, V29, P2052, DOI 10.1038/sj.npp.1300516; Gadziola MA, 2012, J NEUROPHYSIOL, V107, P1047, DOI 10.1152/jn.00422.2011; Genton P, 2006, DRUG SAFETY, V29, P1, DOI 10.2165/00002018-200629010-00001; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Hampton AN, 2007, NEURON, V55, P545, DOI 10.1016/j.neuron.2007.07.022; HERITCH AJ, 1990, J PSYCHIAT RES, V24, P251, DOI 10.1016/0022-3956(90)90014-H; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; Iwasaki-Sekino A, 2009, PSYCHONEUROENDOCRINO, V34, P226, DOI 10.1016/j.psyneuen.2008.09.003; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Kataoka S, 2011, INT J NEURO IN PRESS; Keightley ML, 2007, SOC COGN AFFECT NEUR, V2, P292, DOI 10.1093/scan/nsm024; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kleinhans NM, 2010, NEUROPSYCHOLOGIA, V48, P3665, DOI 10.1016/j.neuropsychologia.2010.07.022; Kuzmanovic B., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Lin HC, 2011, J NEUROSCI, V31, P8851, DOI 10.1523/JNEUROSCI.0979-11.2011; Lin HC, 2010, INT J NEUROPSYCHOPH, V13, P335, DOI 10.1017/S1461145709990678; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Mcrae K, 2012, SOC COGN AFFECT NEUR, V7, P11, DOI 10.1093/scan/nsr093; Miyazaki K, 2005, INT J DEV NEUROSCI, V23, P287, DOI 10.1016/j.ijdevneu.2004.05.004; Muscatell KA, 2012, NEUROIMAGE, V60, P1771, DOI 10.1016/j.neuroimage.2012.01.080; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nelson ED, 2011, J NEUROPHYSIOL, V106, P193, DOI 10.1152/jn.00751.2010; Pejic T, 2011, SOCIAL COGN IN PRESS; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rinaldi T, 2008, CEREB CORTEX, V18, P763, DOI 10.1093/cercor/bhm117; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Rojas DC, 2004, AM J PSYCHIAT, V161, P2038, DOI 10.1176/appi.ajp.161.11.2038; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Saygin ZM, 2011, NEUROIMAGE, V56, P1353, DOI 10.1016/j.neuroimage.2011.03.006; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Schneider T, 2007, PSYCHOPHARMACOLOGY, V193, P547, DOI 10.1007/s00213-007-0795-y; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Todd RM, 2009, NAT NEUROSCI, V12, P1217, DOI 10.1038/nn1009-1217; Tsuchiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003892; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walcott EC, 2011, J NEUROSCI, V31, P13097, DOI 10.1523/JNEUROSCI.1341-11.2011; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Whalley K, 2012, NAT REV NEUROSCI, V13, DOI 10.1038/nrn3163; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yu SY, 2008, J NEUROCHEM, V106, P889, DOI 10.1111/j.1471-4159.2008.05461.x	75	44	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55248	10.1371/journal.pone.0055248	http://dx.doi.org/10.1371/journal.pone.0055248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383124	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200059
J	Preininger, D; Boeckle, M; Sztatecsny, M; Hodl, W				Preininger, Doris; Boeckle, Markus; Sztatecsny, Marc; Hoedl, Walter			Divergent Receiver Responses to Components of Multimodal Signals in Two Foot-Flagging Frog Species	PLOS ONE			English	Article							DART-POISON FROG; WOLF SPIDER; MATE CHOICE; COURTSHIP DISPLAY; JUMPING SPIDERS; WESTERN-GHATS; COMMUNICATION; BEHAVIOR; RANIDAE; ENVIRONMENTS	Multimodal communication of acoustic and visual signals serves a vital role in the mating system of anuran amphibians. To understand signal evolution and function in multimodal signal design it is critical to test receiver responses to unimodal signal components versus multimodal composite signals. We investigated two anuran species displaying a conspicuous foot-flagging behavior in addition to or in combination with advertisement calls while announcing their signaling sites to conspecifics. To investigate the conspicuousness of the foot-flagging signals, we measured and compared spectral reflectance of foot webbings of Micrixalus saxicola and Staurois parvus using a spectrophotometer. We performed behavioral field experiments using a model frog including an extendable leg combined with acoustic playbacks to test receiver responses to acoustic, visual and combined audio-visual stimuli. Our results indicated that the foot webbings of S. parvus achieved a 13 times higher contrast against their visual background than feet of M. saxicola. The main response to all experimental stimuli in S. parvus was foot flagging, whereas M. saxicola responded primarily with calls but never foot flagged. Together these across-species differences suggest that in S. parvus foot-flagging behavior is applied as a salient and frequently used communicative signal during agonistic behavior, whereas we propose it constitutes an evolutionary nascent state in ritualization of the current fighting behavior in M. saxicola.	[Preininger, Doris; Sztatecsny, Marc; Hoedl, Walter] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Boeckle, Markus] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna; University of Vienna	Preininger, D (corresponding author), Univ Vienna, Dept Integrat Zool, Vienna, Austria.	doris.preininger@univie.ac.at	Boeckle, Markus/A-9968-2010	Boeckle, Markus/0000-0002-0738-2764; Preininger, Doris/0000-0001-6842-1133	Austrian Science Fund (FWF) [AP22069: B-17]; Austrian Science Fund (FWF) [P 22069] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Fund (FWF): AP22069: B-17 (www.fwf.ac.at/en/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2004, HERPETOLOGICA, V60, P420, DOI 10.1655/02-51; Arifin U, 2011, ZOOTAXA, P39; Borgia G, 2000, P ROY SOC B-BIOL SCI, V267, P1735, DOI 10.1098/rspb.2000.1203; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Burnham K.P., 2010, MODEL SELECTION MULT; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Chandran MDS, 2010, BIOREMEDIAT BIODIVER, V4, P54; Daniels RR., 2005, AMPHIBIANS PENINSULA; Elias DO, 2008, ANIM BEHAV, V76, P901, DOI 10.1016/j.anbehav.2008.01.032; Elias DO, 2010, BEHAV ECOL, V21, P868, DOI 10.1093/beheco/arq073; Fleishman LK, 2001, J EXP BIOL, V204, P1559; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gomez D, 2009, P ROY SOC B-BIOL SCI, V276, P2351, DOI 10.1098/rspb.2009.0168; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; Grafe TU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037965; Gururaja KV, 2010, ZOOTAXA, P45; Hartmann MT, 2005, J NAT HIST, V39, P1675, DOI 10.1080/00222930400008744; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hebets EA, 2000, BEHAV ECOL SOCIOBIOL, V47, P280, DOI 10.1007/s002650050667; Hebets EA, 2008, BEHAV ECOL, V19, P1250, DOI 10.1093/beheco/arn080; Hodl W, 2001, ANURAN COMMUNICATION, P121; Holt MM, 2010, ANIM BEHAV, V80, P351, DOI 10.1016/j.anbehav.2010.06.013; Hughes M, 1996, ANIM BEHAV, V52, P247, DOI 10.1006/anbe.1996.0170; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Krebs J. R., 1984, BEHAV ECOLOGY EVOLUT, V2, P380; Krishna SN, 2006, AMPHIBIA-REPTILIA, V27, P143, DOI 10.1163/156853806776052056; Lappin AK, 2006, AM NAT, V168, P100, DOI 10.1086/505161; Matsui M, 2007, ZOOL SCI, V24, P101, DOI 10.2108/zsj.24.101; Morris MR, 1996, ANIM BEHAV, V52, P1017, DOI 10.1006/anbe.1996.0249; Narins PM, 2005, P NATL ACAD SCI USA, V102, P2425, DOI 10.1073/pnas.0406407102; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Otovic P, 2009, ENCY NEUROSCIENCE, P1095; Partan S, 1999, SCIENCE, V283, P1272, DOI 10.1126/science.283.5406.1272; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Partan SR, 2004, HDB MULTISENSORY PRO, P225; Peter A, 2017, SOLOMON CODER VERSIO; Preininger D, 2013, BEHAV ECOLO IN PRESS; Preininger D, 2009, HERPETOLOGICA, V65, P166, DOI 10.1655/08-037R.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rosenthal GG, 2004, ANIM BEHAV, V68, P55, DOI 10.1016/j.anbehav.2003.07.013; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Scott J, 2010, EUR SOC, V12, P1, DOI 10.1080/14616690903574189; Scott-Phillips TC, 2012, P ROY SOC B-BIOL SCI, V279, P1943, DOI 10.1098/rspb.2011.2181; Stoffer B, 2012, ANIMAL BEHAV; Szamado S, 2008, ANIM BEHAV, V76, P1455, DOI 10.1016/j.anbehav.2008.07.010; Taylor RC, 2008, ANIM BEHAV, V76, P1089, DOI 10.1016/j.anbehav.2008.01.031; Taylor RC, 2011, CURR ZOOL, V57, P153, DOI 10.1093/czoolo/57.2.153; Van Dyk DA, 2008, BEHAV ECOL, V19, P895, DOI 10.1093/beheco/arn052; Vasudevan Karthikeyan, 2001, Cobra (Chennai), V44, P25; Viera VM, 2011, ANIM BEHAV, V82, P69, DOI 10.1016/j.anbehav.2011.04.001; Walsh RPD, 1996, J TROP ECOL, V12, P385, DOI 10.1017/S0266467400009585; Wilgers DJ, 2012, ETHOLOGY, V118, P387, DOI 10.1111/j.1439-0310.2012.02023.x; Wilgers DJ, 2011, CURR ZOOL, V57, P175, DOI 10.1093/czoolo/57.2.175	54	27	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55367	10.1371/journal.pone.0055367	http://dx.doi.org/10.1371/journal.pone.0055367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383168	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200022
J	Batary, P; Sutcliffe, L; Dormann, CF; Tscharntke, T				Batary, Perer; Sutcliffe, Laura; Dormann, Carsten F.; Tscharntke, Teja			Organic Farming Favours Insect-Pollinated over Non-Insect Pollinated Forbs in Meadows and Wheat Fields	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; PROMOTING BIODIVERSITY; FARMLAND BIODIVERSITY; LANDSCAPE COMPLEXITY; CEREAL FIELDS; DIVERSITY; PLANT; BEES; MANAGEMENT; CROPS	The aim of this study was to determine the relative effects of landscape-scale management intensity, local management intensity and edge effect on diversity patterns of insect-pollinated vs. non-insect pollinated forbs in meadows and wheat fields. Nine landscapes were selected differing in percent intensively used agricultural area (IAA), each with a pair of organic and conventional winter wheat fields and a pair of organic and conventional meadows. Within fields, forbs were surveyed at the edge and in the interior. Both diversity and cover of forbs were positively affected by organic management in meadows and wheat fields. This effect, however, differed significantly between pollination types for species richness in both agroecosystem types (i.e. wheat fields and meadows) and for cover in meadows. Thus, we show for the first time in a comprehensive analysis that insect-pollinated plants benefit more from organic management than non-insect pollinated plants regardless of agroecosystem type and landscape complexity. These benefits were more pronounced in meadows than wheat fields. Finally, the community composition of insect-pollinated and non-insect-pollinated forbs differed considerably between management types. In summary, our findings in both agroecosystem types indicate that organic management generally supports a higher species richness and cover of insect-pollinated plants, which is likely to be favourable for the density and diversity of bees and other pollinators.	[Batary, Perer; Sutcliffe, Laura; Tscharntke, Teja] Univ Gottingen, D-37073 Gottingen, Germany; [Batary, Perer] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Dormann, Carsten F.] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Dormann, Carsten F.] Univ Freiburg, D-79106 Freiburg, Germany	University of Gottingen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg	Batary, P (corresponding author), Univ Gottingen, D-37073 Gottingen, Germany.	pbatary@gmail.com	Tscharntke, Teja/N-5123-2014; Sutcliffe, Laura/AAF-6241-2020; Batáry, Péter/A-2349-2008	Batáry, Péter/0000-0002-1017-6996; Dormann, Carsten/0000-0002-9835-1794	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [DFG BA 4438/1-1]; University of Gottingen	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Gottingen	P.B. was supported by the Alexander von Humboldt Foundation and during the preparation of the paper by the Deutsche Forschungsgemeinschaft (DFG BA 4438/1-1). The publication was funded by the University of Gottingen in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengot L, 2011, AGR ECOSYST ENVIRON, V142, P311, DOI 10.1016/j.agee.2011.06.001; Batary P, 2012, AGR ECOSYST ENVIRON, V146, P130, DOI 10.1016/j.agee.2011.10.018; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Batary P, 2010, AGR ECOSYST ENVIRON, V136, P35, DOI 10.1016/j.agee.2009.11.004; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Caballero-Lopez B, 2010, AGR ECOSYST ENVIRON, V137, P288, DOI 10.1016/j.agee.2010.02.014; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Concepcion ED, 2008, LANDSCAPE ECOL, V23, P135, DOI 10.1007/s10980-007-9150-2; Dauber J, 2003, AGR ECOSYST ENVIRON, V98, P321, DOI 10.1016/S0167-8809(03)00092-6; Ekroos J, 2010, AGR ECOSYST ENVIRON, V135, P288, DOI 10.1016/j.agee.2009.10.007; Flohre A, 2011, ECOL APPL, V21, P1772, DOI 10.1890/10-0645.1; Gabriel D, 2005, PERSPECT PLANT ECOL, V7, P85, DOI 10.1016/j.ppees.2005.04.001; Gabriel D, 2007, AGR ECOSYST ENVIRON, V118, P43, DOI 10.1016/j.agee.2006.04.005; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Guerrero I, 2010, AGR ECOSYST ENVIRON, V138, P103, DOI 10.1016/j.agee.2010.04.006; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2008, OIKOS, V117, P354, DOI 10.1111/j.2007.0030-1299.16303.x; Jose-Maria L, 2011, AGR ECOSYST ENVIRON, V145, P77, DOI 10.1016/j.agee.2010.12.020; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Klotz F., 2002, BIOLFLOR DATENBANK B; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Kovacs-Hostyanszki A, 2011, AGR ECOSYST ENVIRON, V141, P296, DOI 10.1016/j.agee.2011.03.004; Krauss J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019502; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; Oksanen J., 2011, VEGAN PACKAGE COMMUN; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pinheiro J., 2011, NLME PACKAGE LINEAR; Potts SG, 2009, J APPL ECOL, V46, P369, DOI 10.1111/j.1365-2664.2009.01609.x; Power EF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038073; Pywell RF, 2006, BIOL CONSERV, V129, P192, DOI 10.1016/j.biocon.2005.10.034; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REGAL PJ, 1982, ANNU REV ECOL SYST, V13, P497, DOI 10.1146/annurev.es.13.110182.002433; Romero A, 2008, AGR ECOSYST ENVIRON, V124, P97, DOI 10.1016/j.agee.2007.08.002; Smith H. G., 2010, Aspects of Applied Biology, P225; Venables WN., 2002, MODERN APPL STAT S 4; Whittingham MJ, 2011, J APPL ECOL, V48, P509, DOI 10.1111/j.1365-2664.2011.01987.x	42	28	30	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54818	10.1371/journal.pone.0054818	http://dx.doi.org/10.1371/journal.pone.0054818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382979	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500031
J	de Andres, MC; Kingham, E; Imagawa, K; Gonzalez, A; Roach, HI; Wilson, DI; Oreffo, ROC				de Andres, Maria C.; Kingham, Emmajayne; Imagawa, Kei; Gonzalez, Antonio; Roach, Helmtrud I.; Wilson, David I.; Oreffo, Richard O. C.			Epigenetic Regulation during Fetal Femur Development: DNA Methylation Matters	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MARROW STROMAL CELLS; ADULT HUMAN BONE; GENE-TRANSCRIPTION; OSTEOCALCIN GENE; CPG SITES; EXPRESSION; MICE; ACTIVATION; PROMOTER	Epigenetic modifications are heritable changes in gene expression without changes in DNA sequence. DNA methylation has been implicated in the control of several cellular processes including differentiation, gene regulation, development, genomic imprinting and X-chromosome inactivation. Methylated cytosine residues at CpG dinucleotides are commonly associated with gene repression; conversely, strategic loss of methylation during development could lead to activation of lineage-specific genes. Evidence is emerging that bone development and growth are programmed; although, interestingly, bone is constantly remodelled throughout life. Using human embryonic stem cells, human fetal bone cells (HFBCs), adult chondrocytes and STRO-1(+) marrow stromal cells from human bone marrow, we have examined a spectrum of developmental stages of femur development and the role of DNA methylation therein. Using pyrosequencing methodology we analysed the status of methylation of genes implicated in bone biology; furthermore, we correlated these methylation levels with gene expression levels using qRT-PCR and protein distribution during fetal development evaluated using immunohistochemistry. We found that during fetal femur development DNA methylation inversely correlates with expression of genes including iNOS (NOS2) and COL9A1, but not catabolic genes including MMP13 and IL1B. Furthermore, significant demethylation was evident in the osteocalcin promoter between the fetal and adult developmental stages. Increased TET1 expression and decreased expression of DNA (cytosine-5(-))-methyltransferase 1 (DNMT1) in adult chondrocytes compared to HFBCs could contribute to the loss of methylation observed during fetal development. HFBC multipotency confirms these cells to be an ideal developmental system for investigation of DNA methylation regulation. In conclusion, these findings demonstrate the role of epigenetic regulation, specifically DNA methylation, in bone development, informing and opening new possibilities in development of strategies for bone repair/tissue engineering.	[de Andres, Maria C.; Kingham, Emmajayne; Imagawa, Kei; Roach, Helmtrud I.; Oreffo, Richard O. C.] Univ Southampton, Bone & Joint Res Grp, Southampton, Hants, England; [de Andres, Maria C.; Kingham, Emmajayne; Imagawa, Kei; Roach, Helmtrud I.; Wilson, David I.; Oreffo, Richard O. C.] Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat Human Dev &, Southampton, Hants, England; [de Andres, Maria C.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Santiago De Compostela, Spain; [Imagawa, Kei] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [Oreffo, Richard O. C.] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southampton; University of Southampton; Complexo Hospitalario Universitario de Santiago de Compostela; Tohoku University; King Saud University	Oreffo, ROC (corresponding author), Univ Southampton, Bone & Joint Res Grp, Southampton, Hants, England.	roco@soton.ac.uk	Gonzalez, Antonio/C-4444-2008; Wilson, David/A-6264-2010; de Andrés González, M del Carmen/ABD-7612-2021; de+Andrés, María/AAP-1473-2020; Oreffo, Richard OC/A-4615-2011	Gonzalez, Antonio/0000-0002-2624-0606; Wilson, David/0000-0001-8779-2060; de Andrés González, M del Carmen/0000-0003-2260-6356; Oreffo, Richard OC/0000-0001-5995-6726	Wessex Medical Research [M19, BBSRC G006970/1]; Programa Sara Borrell, Instituto de Salud Carlos III, Spain; Comprehensive Local Research Network (National Institute for Health Research Clinical Research Network); Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish; BBSRC [BB/G010579/1] Funding Source: UKRI	Wessex Medical Research; Programa Sara Borrell, Instituto de Salud Carlos III, Spain; Comprehensive Local Research Network (National Institute for Health Research Clinical Research Network); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Grant support from Wessex Medical Research (M19; HIR and RO) and BBSRC G006970/1 (RO). MCA was supported by Programa Sara Borrell, Instituto de Salud Carlos III, Spain. Recruitment for fetal tissues was supported by funding from Comprehensive Local Research Network (National Institute for Health Research Clinical Research Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2001, AM J PATHOL, V158, P247, DOI 10.1016/S0002-9440(10)63963-6; Alizadeh BZ, 2005, ARTHRITIS RHEUM-US, V52, P1437, DOI 10.1002/art.21020; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Arnsdorf EJ, 2010, J BIOMECH, V43, P2881, DOI 10.1016/j.jbiomech.2010.07.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BROWN JP, 1984, LANCET, V1, P1091; CHARTRAIN NA, 1994, J BIOL CHEM, V269, P6765; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; CLARK BD, 1986, NUCLEIC ACIDS RES, V14, P7897, DOI 10.1093/nar/14.20.7897; COLLINOSDOBY P, 1995, J CELL BIOCHEM, V57, P399, DOI 10.1002/jcb.240570305; Corbett SA, 1999, J BONE JOINT SURG BR, V81B, P531, DOI 10.1302/0301-620X.81B3.8852; Cuzzocrea S, 2003, ENDOCRINOLOGY, V144, P1098, DOI 10.1210/en.2002-220597; da Silva MA, 2009, J ORTHOP RES, V27, P593, DOI 10.1002/jor.20799; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Delgado-Calle J, 2011, BONE, V49, P830, DOI 10.1016/j.bone.2011.06.006; Diwan AD, 2000, J BONE MINER RES, V15, P342, DOI 10.1359/jbmr.2000.15.2.342; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dreier R, 2008, MATRIX BIOL, V27, P319, DOI 10.1016/j.matbio.2008.01.006; El-Serafi AT, 2011, DIFFERENTIATION, V81, P35, DOI 10.1016/j.diff.2010.09.183; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Hashimoto K, 2007, EPIGENETICS-US, V2, P86, DOI 10.4161/epi.2.2.4203; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; Imagawa K, 2011, BIOCHEM BIOPH RES CO, V405, P362, DOI 10.1016/j.bbrc.2011.01.007; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Krattinger N, 2011, EUR CELLS MATER, V21, P46, DOI 10.22203/eCM.v021a04; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lanham SA, 2011, EUR CELLS MATER, V22, P332; Lanham Stuart A, 2011, Eur Cell Mater, V22, P321; LEVINE A, 1992, P NATL ACAD SCI USA, V89, P10119, DOI 10.1073/pnas.89.21.10119; Lu TY, 2009, J CELL BIOCHEM, V108, P315, DOI 10.1002/jcb.22256; Mirmalek-Sani SH, 2006, STEM CELLS, V24, P1042, DOI 10.1634/stemcells.2005-0368; Montjovent MO, 2004, BONE, V35, P1323, DOI 10.1016/j.bone.2004.07.001; PALMER RMJ, 1993, BIOCHEM BIOPH RES CO, V193, P398, DOI 10.1006/bbrc.1993.1637; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sengupta PK, 1998, BBA-GENE STRUCT EXPR, V1443, P75, DOI 10.1016/S0167-4781(98)00188-2; Stewart K, 1999, J BONE MINER RES, V14, P1345, DOI 10.1359/jbmr.1999.14.8.1345; Stewart K, 2003, CELL TISSUE RES, V313, P281, DOI 10.1007/s00441-003-0762-9; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tardif G, 1997, BIOCHEM J, V323, P13, DOI 10.1042/bj3230013; Turner CH, 1997, BONE, V21, P487, DOI 10.1016/S8756-3282(97)00202-0; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Vickaryous N, 2005, REPROD FERT DEVELOP, V17, P335, DOI 10.1071/RD04133; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Wang FS, 2004, BONE, V35, P114, DOI 10.1016/j.bone.2004.02.012; Wang FS, 2004, ENDOCRINOLOGY, V145, P2148, DOI 10.1210/en.2003-1074; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Zaragoza C, 2006, J CELL SCI, V119, P1896, DOI 10.1242/jcs.02895; Zhang P, 2003, J BIOL CHEM, V278, P117, DOI 10.1074/jbc.M208049200; Zhu W, 2001, J BONE MINER RES, V16, P535, DOI 10.1359/jbmr.2001.16.3.535	63	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54957	10.1371/journal.pone.0054957	http://dx.doi.org/10.1371/journal.pone.0054957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383012	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315211500039
J	Jia, ZF; Wang, K; Wang, GX; Zhang, AL; Pu, PY				Jia, Zhifan; Wang, Kun; Wang, Guangxiu; Zhang, Anling; Pu, Peiyu			MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7	PLOS ONE			English	Article							PAPILLARY THYROID-CARCINOMA; EXPRESSION; MICRORNAS; GENE; PREDICTION; SURVIVAL; CANCER	MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by targeting the mRNAs of hundreds of human genes. Variations in miRNA expression levels were shown to be associated with glioma. We have previously found miR-30a-5p overexpression in glioma cell lines and specimens. Bioinformatics analyses predict that several miRNAs, including miR-30a-5p, are involved in the post-transcriptional regulation of SEPT7. SEPT7 is a member of the septin family, which is a highly conserved subfamily of GTPases implicated in exocytosis, apoptosis, synaptogenesis, neurodegeneration and tumorigenesis. Our previous study has also demonstrated that SEPT7 expression is decreased in astrocytic gliomas with different grades and plays a tumor suppressor role. In the present study, we knocked down miR-30a-5p with antisense oligonucleotide (miR-30a-5p AS) in LN229 and SNB19 glioblastoma(GBM) cells, and found that cell growth and invasion were inhibited, while apoptosis was induced. miR-30a-5p AS treated cells showed upregulation of SEPT7 and downregulation of PCNA, cyclin D1, Bcl2, MMP2 and MMP9. In contrast, when miR-30a-5p mimics were transfected into LN229 and SNB19 GBM cells, cell growth and invasion were promoted and the expression of relevant proteins increased. Meanwhile, the effect of miR-30a-5p mimics on glioma cells can be reversed by transfection of SEPT7 construct. Additionaly, miR-30a-5p directly targeting SEPT7 was identified by the reporter gene assay. Our study demonstrates, for the first time, that miR-30a-5p is a bona fide negative regulator of SEPT7 and the oncogenic activity of miR-30a-5p in human gliomas is at least in part through the repression of SEPT7.	[Jia, Zhifan; Wang, Guangxiu; Zhang, Anling; Pu, Peiyu] Tianjin Med Univ, Dept Neurosurg, Gen Hosp,Minist Educ,Tianjin Key Lab Injuries Var, Tianjin Neurolg Inst,Lab Neurooncol,Key Lab Postt, Tianjin, Peoples R China; [Wang, Kun] Zhejiang Univ, Dept Neurosurg, Hangzhou Xiasha Hosp, Coll Med,Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Tianjin Medical University; Zhejiang University	Pu, PY (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp,Minist Educ,Tianjin Key Lab Injuries Var, Tianjin Neurolg Inst,Lab Neurooncol,Key Lab Postt, Tianjin, Peoples R China.	pupeiyu33@hotmail.com	Zhang, An/GRS-5852-2022		China National Natural Scientific Fund [30872985]	China National Natural Scientific Fund(National Natural Science Foundation of China (NSFC))	This work was supported by the China National Natural Scientific Fund (30872985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniskin A, 2012, CARCINOGENESIS, V33, P732, DOI 10.1093/carcin/bgs020; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jia ZF, 2010, J NEURO-ONCOL, V98, P329, DOI 10.1007/s11060-009-0092-1; Jiang R.C., 2002, CHIN J CLIN NEUROSCI, V10, P227; [江荣才 Jiang Rongcai], 2004, [中华神经外科杂志, Chinese Journal of Neurosurgery], V20, P18; Kartmann B, 2001, J CELL SCI, V114, P839; Kimura S, 2010, ONCOL REP, V23, P1625, DOI 10.3892/or_00000804; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Michael MZ, 2003, MOL CANCER RES, V1, P882; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; NAKATSURU S, 1994, BIOCHEM BIOPH RES CO, V202, P82, DOI 10.1006/bbrc.1994.1896; Ruan JS, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-16; Schutte B, 1998, J NEUROSCI METH, V86, P63, DOI 10.1016/S0165-0270(98)00147-2; Schwertheim S, 2009, HORM METAB RES, V41, P475, DOI 10.1055/s-0029-1215593; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xu Song, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P262	24	56	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55008	10.1371/journal.pone.0055008	http://dx.doi.org/10.1371/journal.pone.0055008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383034	Green Published, gold			2022-12-27	WOS:000315211500044
J	Mohanraj, L; Kim, HS; Li, W; Cai, Q; Kim, KE; Shin, HJ; Lee, YJ; Lee, WJ; Kim, JH; Oh, Y				Mohanraj, Lathika; Kim, Ho-Seong; Li, Wei; Cai, Qing; Kim, Ki Eun; Shin, Hye-Jung; Lee, Yong-Jae; Lee, Woo Jung; Kim, Jung Hyun; Oh, Youngman			IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis	PLOS ONE			English	Article							FACTOR-KAPPA-B; VISCERAL FAT ACCUMULATION; IGF-BINDING PROTEIN-3; BODY-MASS INDEX; GROWTH-FACTOR-I; ADIPOSE-TISSUE; CROSS-TALK; OBESITY; DISEASE; ACTIVATION	Metabolic syndrome is associated with visceral obesity, insulin resistance and an increased risk of cardiovascular diseases. Visceral fat tissue primarily consists of adipocytes that secrete cytokines leading to a state of systemic inflammation in obese conditions. One of the IGF-independent functions of IGFBP-3 is its role as an anti-inflammatory molecule. Our study in obese adolescents show a decrease in total IGFBP-3 levels and increase in proteolyzed IGFBP-3 in circulation when compared to their normal counterparts and establishes a positive correlation between IGFBP-3 proteolysis and adiposity parameters as well as insulin resistance. In human adipocytes, we show that IGFBP-3 inhibits TNF-alpha-induced NF-kappa B activity in an IGF-independent manner, thereby restoring the deregulated insulin signaling and negating TNF-alpha-induced inhibition of glucose uptake. IGFBP-3 further inhibits TNF-alpha, CRP and high glucose-induced NF-kappa B activity in human aortic endothelial cells (HAECs) and subsequently suppresses monocyte adhesion to HAEC through the IGFBP-3 receptor. In conclusion, these findings suggest that reduced levels of IGFBP-3 in circulation and reduced expression of IGFBP-3 in macrophages in obesity may result in suppression of its anti-inflammatory functions and therefore IGFBP-3 may present itself as a therapeutic for obesity-induced insulin resistance and for events occurring in the early stages of atherosclerosis.	[Mohanraj, Lathika; Cai, Qing; Oh, Youngman] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA; [Kim, Ho-Seong; Lee, Woo Jung; Kim, Jung Hyun] Yonsei Univ, Coll Med, Inst Endocrinol, Dept Pediat, Seoul, South Korea; [Li, Wei; Oh, Youngman] Biocure Pharma LLC, Richmond, VA USA; [Kim, Ki Eun] CHA Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Shin, Hye-Jung] Natl Med Ctr, Dept Pediat, Seoul, South Korea; [Lee, Yong-Jae] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea	Virginia Commonwealth University; Yonsei University; Yonsei University Health System; Pochon Cha University; National Medical Center - Korea; Yonsei University; Yonsei University Health System	Oh, Y (corresponding author), Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA.	yoh@mcvh-vcu.edu		Kim, Ho-Seong/0000-0003-1135-099X; Mohanraj, Lathika/0000-0002-5504-1518	United States Department of Defense (DOD) [PC061151]; Yonsei University College of Medicine-MSD Grant [6-2006-0151]	United States Department of Defense (DOD)(United States Department of Defense); Yonsei University College of Medicine-MSD Grant	This work was supported by United States Department of Defense (DOD) grant (PC061151) to YO and the Yonsei University College of Medicine-MSD Grant (6-2006-0151) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini MG, 2004, J PEDIATR ENDOCR MET, V17, P749; Bang P, 1997, ENDOCRINOLOGY, V138, P3912, DOI 10.1210/en.138.9.3912; BANG P, 1994, J CLIN ENDOCR METAB, V78, P1119, DOI 10.1210/jc.78.5.1119; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Buckway CK, 2001, J CLIN ENDOCR METAB, V86, P4943, DOI 10.1210/jc.86.10.4943; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Collard TJ, 2006, INT J ONCOL, V29, P1279; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; DUBUC PU, 1976, METABOLISM, V25, P1567, DOI 10.1016/0026-0495(76)90109-8; Firth Sue M., 1995, Progress in Growth Factor Research, V6, P223, DOI 10.1016/0955-2235(95)00009-7; Gatenby VK, 2010, EXPERT OPIN THER TAR, V14, P1333, DOI 10.1517/14728222.2010.528930; Gomez JM, 2004, GROWTH HORM IGF RES, V14, P91, DOI 10.1016/j.ghir.2003.11.004; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Han JF, 2011, CANCER LETT, V307, P200, DOI 10.1016/j.canlet.2011.04.004; HOSSENLOPP P, 1990, J CLIN ENDOCR METAB, V71, P797, DOI 10.1210/jcem-71-4-797; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Jialal I, 2001, Am J Clin Pathol, V116 Suppl, pS108; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; KANAI H, 1990, HYPERTENSION, V16, P484, DOI 10.1161/01.HYP.16.5.484; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kaplan RC, 2007, J CLIN ENDOCR METAB, V92, P1319, DOI 10.1210/jc.2006-1631; Kielczewski JL, 2011, AM J PATHOL, V178, P1517, DOI 10.1016/j.ajpath.2010.12.031; Kim HS, 2007, PEDIATR RES, V61, P159, DOI 10.1203/pdr.0b013e31802d8a30; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Maile LA, 1999, GROWTH HORM IGF RES, V9, P85, DOI 10.1054/ghir.1999.0096; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Maury E, 2009, J CLIN ENDOCR METAB, V94, P1393, DOI 10.1210/jc.2008-2196; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; NAKAMURA T, 1994, ATHEROSCLEROSIS, V107, P239, DOI 10.1016/0021-9150(94)90025-6; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; OH YM, 1993, J BIOL CHEM, V268, P14964; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; Palau N, 2012, ENDOCRINOLOGY, V153, P177, DOI 10.1210/en.2011-0181; Schuler-Luttmann, 2000, Arterioscler Thromb Vasc Biol, V20, pE10; Silha JV, 2002, AM J PHYSIOL-ENDOC M, V283, pE937, DOI 10.1152/ajpendo.00014.2002; Skolnik Edward Y., 1996, Cytokine and Growth Factor Reviews, V7, P161, DOI 10.1016/1359-6101(96)00021-4; Spilcke-Liss E, 2011, CLIN ENDOCRINOL OXF; Tikellis C, 2008, ATHEROSCLEROSIS, V199, P55, DOI 10.1016/j.atherosclerosis.2007.10.038; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams AC, 2007, CELL DEATH DIFFER, V14, P137, DOI 10.1038/sj.cdd.4401919; Wilson SH, 2000, ATHEROSCLEROSIS, V148, P23, DOI 10.1016/S0021-9150(99)00211-7; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita S, 1996, DIABETES CARE, V19, P287, DOI 10.2337/diacare.19.3.287	52	33	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55084	10.1371/journal.pone.0055084	http://dx.doi.org/10.1371/journal.pone.0055084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383064	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500054
J	Milekovic, T; Ball, T; Schulze-Bonhage, A; Aertsen, A; Mehring, C				Milekovic, Tomislav; Ball, Tonio; Schulze-Bonhage, Andreas; Aertsen, Ad; Mehring, Carsten			Detection of Error Related Neuronal Responses Recorded by Electrocorticography in Humans during Continuous Movements	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; HUMAN SENSORIMOTOR CORTEX; PRESURGICAL EVALUATION; SPECTRAL-ANALYSIS; CORTICAL CONTROL; NEURAL-CONTROL; GAMMA-ACTIVITY; EEG; PERFORMANCE; POTENTIALS	Background: Brain-machine interfaces (BMIs) can translate the neuronal activity underlying a user's movement intention into movements of an artificial effector. In spite of continuous improvements, errors in movement decoding are still a major problem of current BMI systems. If the difference between the decoded and intended movements becomes noticeable, it may lead to an execution error. Outcome errors, where subjects fail to reach a certain movement goal, are also present during online BMI operation. Detecting such errors can be beneficial for BMI operation: (i) errors can be corrected online after being detected and (ii) adaptive BMI decoding algorithm can be updated to make fewer errors in the future. Methodology/Principal Findings: Here, we show that error events can be detected from human electrocorticography (ECoG) during a continuous task with high precision, given a temporal tolerance of 300-400 milliseconds. We quantified the error detection accuracy and showed that, using only a small subset of 262 ECoG electrodes, 82% of detection information for outcome error and 74% of detection information for execution error available from all ECoG electrodes could be retained. Conclusions/Significance: The error detection method presented here could be used to correct errors made during BMI operation or to adapt a BMI algorithm to make fewer errors in the future. Furthermore, our results indicate that smaller ECoG implant could be used for error detection. Reducing the size of an ECoG electrode implant used for BMI decoding and error detection could significantly reduce the medical risk of implantation.	[Milekovic, Tomislav; Ball, Tonio; Schulze-Bonhage, Andreas; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; [Milekovic, Tomislav; Mehring, Carsten] Univ Freiburg, Inst Biol 1, Fac Biol, Freiburg, Germany; [Milekovic, Tomislav; Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Milekovic, Tomislav; Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England; [Ball, Tonio; Schulze-Bonhage, Andreas] Univ Med Ctr Freiburg, Epilepsy Ctr, Freiburg, Germany; [Aertsen, Ad] Univ Freiburg, Inst Biol 3, Fac Biol, Freiburg, Germany	University of Freiburg; University of Freiburg; Imperial College London; Imperial College London; University of Freiburg; University of Freiburg	Milekovic, T (corresponding author), Brown Univ, Inst Brain Sci, Dept Neurosci, Providence, RI 02912 USA.	Tomislav_Milekovic@brown.edu	Milekovic, Tomislav/R-7972-2017; Schulze-Bonhage, Andreas/AAJ-3107-2020; Mehring, Carsten/R-8986-2019	Milekovic, Tomislav/0000-0001-6769-6506; Mehring, Carsten/0000-0001-8125-5205	German Federal Ministry of Education and Research (BMBF) [01GQ0420, 01GQ0830]; BMBF GoBio [0313891]; Imperial College London	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF GoBio(Federal Ministry of Education & Research (BMBF)); Imperial College London(General Electric)	This work was supported by the German Federal Ministry of Education and Research (BMBF) grant 01GQ0420 to BCCN Freiburg, BMBF 01GQ0830 grant to BFNT Freiburg and Tubingen, BMBF GoBio grant 0313891 and the Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman N, 2007, J NEURAL ENG, V4, P336, DOI 10.1088/1741-2560/4/3/018; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Bashashati Ali, 2007, Comput Intell Neurosci, P84386, DOI 10.1155/2007/84386; Bechtereva NP, 2005, INT J PSYCHOPHYSIOL, V58, P227, DOI 10.1016/j.ijpsycho.2005.06.005; Blankertz B, 2003, IEEE T NEUR SYS REH, V11, P127, DOI 10.1109/TNSRE.2003.814456; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Blumberg J, 2007, P ANN INT IEEE EMBS, P2536, DOI 10.1109/IEMBS.2007.4352845; Boatman-Reich D, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00004; Bohm G., 2010, INTRO STAT DATA ANAL; Buttfield A, 2006, IEEE T NEUR SYS REH, V14, P164, DOI 10.1109/TNSRE.2006.875555; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Coombs C. H., 1970, MATH PSYCHOL ELEMENT; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; DiGiovanna J, 2009, IEEE T BIO-MED ENG, V56, P54, DOI 10.1109/TBME.2008.926699; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Ferrez PW, 2008, IEEE T BIO-MED ENG, V55, P923, DOI 10.1109/TBME.2007.908083; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gurel T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00164; Hasan BAS, 2010, MED BIOL ENG COMPUT, V48, P245, DOI 10.1007/s11517-009-0550-0; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hwang EJ, 2009, J NEUROSCI, V29, P14363, DOI 10.1523/JNEUROSCI.2081-09.2009; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Jung J, 2010, HUM BRAIN MAPP, V31, P1217, DOI 10.1002/hbm.20930; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Kirkeby BS, 2005, J RES PERS, V39, P263, DOI 10.1016/j.jrp.2004.04.001; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Kovalev D, 2005, AM J NEURORADIOL, V26, P1078; Koyama S, 2010, J COMPUT NEUROSCI, V29, P73, DOI 10.1007/s10827-009-0196-9; Krigolson OE, 2006, NEUROSCIENCE, V137, P13, DOI 10.1016/j.neuroscience.2005.10.064; Krigolson OE, 2007, BRAIN RES, V1155, P70, DOI 10.1016/j.brainres.2007.04.024; Krigolson OE, 2008, EXP BRAIN RES, V190, P401, DOI 10.1007/s00221-008-1482-x; Krigolson OE, 2007, PSYCHOPHYSIOLOGY, V44, P586, DOI 10.1111/j.1469-8986.2007.00523.x; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Lee HC, 2007, J CLIN NEUROPHYSIOL, V24, P137, DOI 10.1097/WNP.0b013e318033715b; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Levine SP, 2000, IEEE T REHABIL ENG, V8, P180, DOI 10.1109/86.847809; MacKay D. J. C., 2003, INFORM THEORY INFERE, pxii; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; McFarland DJ, 2005, IEEE T NEUR SYS REH, V13, P372, DOI 10.1109/TNSRE.2005.848627; Meier R, 2008, J CLIN NEUROPHYSIOL, V25, P119, DOI 10.1097/WNP.0b013e3181775993; Milekovic T, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046003; Milekovic T, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026007; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moore D., 2009, INTRO PRACTICE STAT, V6th; Moran D, 2010, CURR OPIN NEUROBIOL, V20, P741, DOI 10.1016/j.conb.2010.09.010; Ojemann GA, 2004, NEUROPSYCHOLOGIA, V42, P1383, DOI 10.1016/j.neuropsychologia.2004.01.008; Ojemann GA, 2003, INT J PSYCHOPHYSIOL, V48, P141, DOI 10.1016/S0167-8760(03)00051-5; Parra LC, 2003, IEEE T NEUR SYS REH, V11, P173, DOI 10.1109/TNSRE.2003.814446; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Rana P, 2012, BIOMEDICAL ENG IEEE, P1; Ray S, 2008, CLIN NEUROPHYSIOL, V119, P116, DOI 10.1016/j.clinph.2007.09.136; Riffenburgh RH, 2006, STATISTICS IN MEDICINE, 2ND EDITION, P1; Rotermund D, 2006, BIOL CYBERN, V95, P243, DOI 10.1007/s00422-006-0083-7; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Schalk G, 2000, CLIN NEUROPHYSIOL, V111, P2138, DOI 10.1016/S1388-2457(00)00457-0; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schalk G, 2010, PRACTICAL GUIDE TO BRAIN-COMPUTER INTERFACING WITH BCI2000, P3, DOI 10.1007/978-1-84996-092-2_1; Schmidt NM, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-19; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; Solis-Escalante T, 2008, J NEUROSCI METH, V175, P148, DOI 10.1016/j.jneumeth.2008.07.019; STEINIER J, 1972, ANAL CHEM, V44, P1906, DOI 10.1021/ac60319a045; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Victor JD, 2000, NEURAL COMPUT, V12, P2797, DOI 10.1162/089976600300014728; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Wang W, 2009, IEEE ENG MED BIO, P586, DOI 10.1109/IEMBS.2009.5333704; Wilson J Adam, 2009, Front Neuroeng, V2, P11, DOI 10.3389/neuro.16.011.2009; Wisneski KJ, 2008, STROKE, V39, P3351, DOI 10.1161/STROKEAHA.108.518175; Wong C, 2009, ACTA NEUROCHIR, V151, P37, DOI 10.1007/s00701-008-0171-7; Zanolie K, 2008, NEUROPSYCHOLOGIA, V46, P117, DOI 10.1016/j.neuropsychologia.2007.08.009	88	37	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55235	10.1371/journal.pone.0055235	http://dx.doi.org/10.1371/journal.pone.0055235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383315	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900022
J	Czimmerer, Z; Hulvely, J; Simandi, Z; Varallyay, E; Havelda, Z; Szabo, E; Varga, A; Balazs, D; Balogh, M; Horvath, A; Domokos, B; Torok, Z; Nagy, L; Balint, BL				Czimmerer, Zsolt; Hulvely, Julianna; Simandi, Zoltan; Varallyay, Eva; Havelda, Zoltan; Szabo, Erzsebet; Varga, Attila; Balazs Dezso; Balogh, Maria; Horvath, Attila; Domokos, Balint; Torok, Zsolt; Nagy, Laszlo; Balint, Balint L.			A Versatile Method to Design Stem-Loop Primer-Based Quantitative PCR Assays for Detecting Small Regulatory RNA Molecules	PLOS ONE			English	Article							RT-PCR; MICRORNAS; QUANTIFICATION; REPRESSION; DISCOVERY; CANCER	Short regulatory RNA-s have been identified as key regulators of gene expression in eukaryotes. They have been involved in the regulation of both physiological and pathological processes such as embryonal development, immunoregulation and cancer. One of their relevant characteristics is their high stability, which makes them excellent candidates for use as biomarkers. Their number is constantly increasing as next generation sequencing methods reveal more and more details of their synthesis. These novel findings aim for new detection methods for the individual short regulatory RNA-s in order to be able to confirm the primary data and characterize newly identified subtypes in different biological conditions. We have developed a flexible method to design RT-qPCR assays that are very sensitive and robust. The newly designed assays were tested extensively in samples from plant, mouse and even human formalin fixed paraffin embedded tissues. Moreover, we have shown that these assays are able to quantify endogenously generated shRNA molecules. The assay design method is freely available for anyone who wishes to use a robust and flexible system for the quantitative analysis of matured regulatory RNA-s.	[Czimmerer, Zsolt; Simandi, Zoltan; Szabo, Erzsebet; Horvath, Attila; Nagy, Laszlo; Balint, Balint L.] Univ Debrecen, Dept Biochem & Mol Biol, Res Ctr Mol Med, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Hulvely, Julianna; Varga, Attila; Horvath, Attila; Domokos, Balint; Torok, Zsolt] Astrid Res Ltd, Debrecen, Hungary; [Varallyay, Eva; Havelda, Zoltan] Agr Biotechnol Ctr, Plant Dev Biol Grp, H-2101 Godollo, Hungary; [Balazs Dezso] Univ Debrecen, Inst Pathol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Nagy, Laszlo] Univ Debrecen, MTA DE Lendulet Immunogen Res Grp, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Balogh, Maria; Balint, Balint L.] Univ Debrecen, Ctr Clin Genom & Personalized Med, Res Ctr Mol Med, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Balint, Balint L.] UD Genomed Ltd, Debrecen, Hungary; [Torok, Zsolt] Univ Debrecen, Dept Comp Graph & Image Proc, Ctr Arts Humanities & Sci, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Balint, BL (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Res Ctr Mol Med, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary.	lbalint@med.unideb.hu	SIMANDI, Zoltan/A-9619-2012; Nagy, Laszlo/A-3814-2008; Varallyay, Eva/D-5196-2012; Horvath, Attila/AAA-9075-2020	SIMANDI, Zoltan/0000-0001-8894-1259; Nagy, Laszlo/0000-0001-6653-2155; Dezso, Balazs/0000-0002-7871-0219; Havelda, Zoltan/0000-0002-6349-7646; Varallyay, Eva/0000-0002-9085-942X; Balint, Balint/0000-0002-6163-7190; Horvath, Attila/0000-0002-6127-8925	European Union; European Social Fund;  [TAMOP-4.2.2/B-10/1-2010-0024]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); 	BLB is a Szodoray Fellow of the University of Debrecen. ZC is a pre-doctoral fellow supported by the TAMOP-4.2.2/B-10/1-2010-0024 project co-financed by the European Union and the European Social Fund. Some of the reagents used for measurements were provided kindly by Roche Hungary and UDGenomed Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Du LQ, 2011, J MOL CELL BIOL, V3, P176, DOI 10.1093/jmcb/mjq058; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2008, P NATL ACAD SCI USA, V105, P4951, DOI 10.1073/pnas.0708743105; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Tili E, 2008, NAT CLIN PRACT RHEUM, V4, P534, DOI 10.1038/ncprheum0885; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Xie Y, 2010, LUNG CANCER, V67, P170, DOI 10.1016/j.lungcan.2009.04.004; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	24	77	79	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55168	10.1371/journal.pone.0055168	http://dx.doi.org/10.1371/journal.pone.0055168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383094	Green Accepted, Green Published, gold			2022-12-27	WOS:000314610600070
J	Repetto, D; Aramu, S; Erba, EB; Sharma, N; Grasso, S; Russo, I; Jensen, ON; Cabodi, S; Turco, E; Di Stefano, P; Defilippi, P				Repetto, Daniele; Aramu, Simona; Erba, Elisabetta Boeri; Sharma, Nanaocha; Grasso, Silvia; Russo, Isabella; Jensen, Ole N.; Cabodi, Sara; Turco, Emilia; Di Stefano, Paola; Defilippi, Paola			Mapping of p140Cap Phosphorylation Sites: The EPLYA and EGLYA Motifs Have a Key Role in Tyrosine Phosphorylation and Csk Binding, and Are Substrates of the Abl Kinase	PLOS ONE			English	Article							HELICOBACTER-PYLORI CAGA; FAMILY KINASES; PROTEIN; SRC; MECHANISMS; EVOLUTION	Protein phosphorylation tightly regulates specific binding of effector proteins that control many diverse biological functions of cells (e.g. signaling, migration and proliferation). p140Cap is an adaptor protein, specifically expressed in brain, testis and epithelial cells, that undergoes phosphorylation and tunes its interactions with other regulatory molecules via post-translation modification. In this work, using mass spectrometry, we found that p140Cap is in vivo phosphorylated on tyrosine (Y) within the peptide GEGLpYADPYGLLHEGR (from now on referred to as EGLYA) as well as on three serine residues. Consistently, EGLYA has the highest score of in silico prediction of p140Cap phosphorylation. To further investigate the p140Cap function, we performed site specific mutagenesis on tyrosines inserted in EGLYA and EPLYA, a second sequence with the same highest score of phosphorylation. The mutant protein, in which both EPLYA/EGLYA tyrosines were converted to phenylalanine, was no longer tyrosine phosphorylated, despite the presence of other tyrosine residues in p140Cap sequence. Moreover, this mutant lost its ability to bind the C-terminal Src kinase (Csk), previously shown to interact with p140Cap by Far Western analysis. In addition, we found that in vitro and in HEK-293 cells, the Abelson kinase is the major kinase involved in p140Cap tyrosine phosphorylation on the EPLYA and EGLYA sequences. Overall, these data represent an original attempt to in vivo characterise phosphorylated residues of p140Cap. Elucidating the function of p140Cap will provide novel insights into its biological activity not only in normal cells, but also in tumors.	[Repetto, Daniele; Aramu, Simona; Sharma, Nanaocha; Grasso, Silvia; Russo, Isabella; Cabodi, Sara; Turco, Emilia; Di Stefano, Paola; Defilippi, Paola] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Erba, Elisabetta Boeri] Univ J Fourier, Inst Biol Struct JP Ebel, Grenoble, France; [Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Turin; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Southern Denmark	Di Stefano, P (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	paola.distefano@unito.it; paola.defilippi@unito.it	DEFILIPPI, Paola/L-2232-2014; Erba, Elisabetta Boeri/J-1058-2014; Jensen, Ole N/J-1763-2012	Erba, Elisabetta Boeri/0000-0002-5910-4707; Jensen, Ole N/0000-0003-1862-8528; Cabodi, Sara/0000-0003-1248-6549; Defilippi, Paola/0000-0001-6427-4906	Associazione Italiana Ricerca Cancro (AIRC); Ministero Universita Ricerca (MIUR); University of Torino Compagnia San Paolo, Torino; Regione Piemonte; Progetto Druidi	Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Universita Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Torino Compagnia San Paolo, Torino; Regione Piemonte(Regione Piemonte); Progetto Druidi	This study was funded by Associazione Italiana Ricerca Cancro (AIRC), Ministero Universita Ricerca (MIUR) and University of Torino Compagnia San Paolo, Torino; Progetto d'Ateneo. The authors also received financial support from the following: Regione Piemonte, Progetto Druidi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Casnici C, 2011, HYBRIDOMA, V30, P261, DOI 10.1089/hyb.2010.0122; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Damiano L, 2012, P140CAP SUPPRESSES; DeGiorgis JA, 2005, J PROTEOME RES, V4, P306, DOI 10.1021/pr0498436; Di Stefano P, 2004, MOL BIOL CELL, V15, P787, DOI 10.1091/mbc.E03-09-0689; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Ia KK, 2010, GROWTH FACTORS, V28, P329, DOI 10.3109/08977194.2010.484424; Ito H, 2008, J NEUROCHEM, V107, P61, DOI 10.1111/j.1471-4159.2008.05585.x; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Koegl M, 1995, ONCOGENE, V11, P2317; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Miller Martin L., 2009, V527, P299, DOI 10.1007/978-1-60327-834-8_22; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Safari F, 2011, P NATL ACAD SCI USA, V108, P14938, DOI 10.1073/pnas.1107740108; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200; Thingholm Tine E., 2009, V527, P47, DOI 10.1007/978-1-60327-834-8_4	30	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54931	10.1371/journal.pone.0054931	http://dx.doi.org/10.1371/journal.pone.0054931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383002	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600052
J	Simon, AB; Griffeth, VEM; Wong, EC; Buxton, RB				Simon, Aaron B.; Griffeth, Valerie E. M.; Wong, Eric C.; Buxton, Richard B.			A Novel Method of Combining Blood Oxygenation and Blood Flow Sensitive Magnetic Resonance Imaging Techniques to Measure the Cerebral Blood Flow and Oxygen Metabolism Responses to an Unknown Neural Stimulus	PLOS ONE			English	Article							BOLD SIGNAL FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; OXIDATIVE-METABOLISM; NOISE-REDUCTION; TISSUE SIGNAL; MOTOR CORTEX; HUMAN BRAIN; FMRI; ACTIVATION; DYNAMICS	Simultaneous implementation of magnetic resonance imaging methods for Arterial Spin Labeling (ASL) and Blood Oxygenation Level Dependent (BOLD) imaging makes it possible to quantitatively measure the changes in cerebral blood flow (CBF) and cerebral oxygen metabolism (CMRO2) that occur in response to neural stimuli. To date, however, the range of neural stimuli amenable to quantitative analysis is limited to those that may be presented in a simple block or event related design such that measurements may be repeated and averaged to improve precision. Here we examined the feasibility of using the relationship between cerebral blood flow and the BOLD signal to improve dynamic estimates of blood flow fluctuations as well as to estimate metabolic-hemodynamic coupling under conditions where a stimulus pattern is unknown. We found that by combining the information contained in simultaneously acquired BOLD and ASL signals through a method we term BOLD Constrained Perfusion (BCP) estimation, we could significantly improve the precision of our estimates of the hemodynamic response to a visual stimulus and, under the conditions of a calibrated BOLD experiment, accurately determine the ratio of the oxygen metabolic response to the hemodynamic response. Importantly we were able to accomplish this without utilizing a priori knowledge of the temporal nature of the neural stimulus, suggesting that BOLD Constrained Perfusion estimation may make it feasible to quantitatively study the cerebral metabolic and hemodynamic responses to more natural stimuli that cannot be easily repeated or averaged.	[Simon, Aaron B.; Griffeth, Valerie E. M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Simon, Aaron B.; Griffeth, Valerie E. M.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Wong, Eric C.; Buxton, Richard B.] Univ Calif San Diego, Dept Radiol, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA; [Buxton, Richard B.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Buxton, RB (corresponding author), Univ Calif San Diego, Dept Radiol, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA.	rbuxton@ucsd.edu			National Institutes of Health [NS-36722]; GE healthcare [A-44 20114049]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036722, R21NS081405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE healthcare(General ElectricGE Healthcare); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS-36722 and Grant A-44 20114049 from GE healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: 1) Research grant from GE healthcare; 2) Patent Application (Invention Disclosure filed). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Blockley NP, 2012, NEUROIMAGE, V60, P279, DOI 10.1016/j.neuroimage.2011.11.081; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton Richard B, 2010, Front Neuroenergetics, V2, P8, DOI 10.3389/fnene.2010.00008; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Chen JJ, 2010, NEUROIMAGE, V53, P383, DOI 10.1016/j.neuroimage.2010.07.003; Chen JJ, 2009, NEUROIMAGE, V46, P559, DOI 10.1016/j.neuroimage.2009.03.015; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; DIXON WT, 1991, MAGN RESON MED, V18, P257, DOI 10.1002/mrm.1910180202; Donahue MJ, 2009, J CEREBR BLOOD F MET, V29, P1856, DOI 10.1038/jcbfm.2009.107; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Fransson P, 1998, MAGNET RESON MED, V39, P912, DOI 10.1002/mrm.1910390608; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Fukunaga M, 2008, J CEREBR BLOOD F MET, V28, P1377, DOI 10.1038/jcbfm.2008.25; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Griffeth VEM, 2011, NEUROIMAGE, V58, P198, DOI 10.1016/j.neuroimage.2011.05.077; Griffeth VEM, 2011, NEUROIMAGE, V57, P809, DOI 10.1016/j.neuroimage.2011.04.064; Griffeth VEM, 2012, P INT SOC MAG RESON, V20, P1; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kauppi Jukka-Pekka, 2010, Front Neuroinform, V4, P5, DOI 10.3389/fninf.2010.00005; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; Liau J, 2008, NEUROIMAGE, V42, P296, DOI 10.1016/j.neuroimage.2008.04.177; Liu TT, 2005, NEUROIMAGE, V24, P207, DOI 10.1016/j.neuroimage.2004.09.047; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Owen DG, 2008, PAIN, V136, P85, DOI 10.1016/j.pain.2007.06.021; Perthen JE, 2008, NEUROIMAGE, V40, P237, DOI 10.1016/j.neuroimage.2007.10.049; Press WH., 2002, NUMERICAL RECIPES C, V2; Restom K, 2006, NEUROIMAGE, V31, P1104, DOI 10.1016/j.neuroimage.2006.01.026; St Lawrence KS, 2005, MAGN RESON MED, V53, P735, DOI 10.1002/mrm.20396; Uludag K, 2008, MAGN RESON IMAGING, V26, P863, DOI 10.1016/j.mri.2008.01.049; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Wong E, 1998, MAGNETIC RESONANCE I; Wong EC, 2005, J MAGN RESON IMAGING, V22, P727, DOI 10.1002/jmri.20459; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.0.CO;2-M; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	51	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54816	10.1371/journal.pone.0054816	http://dx.doi.org/10.1371/journal.pone.0054816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382977	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600045
J	Spindler, EC; Boyle, NR; Hancock, REW; Gill, RT				Spindler, Eileen C.; Boyle, Nanette R.; Hancock, Robert E. W.; Gill, Ryan T.			Genome-Wide Identification of Genes Conferring Energy Related Resistance to a Synthetic Antimicrobial Peptide (Bac8c)	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; BACTERIA; MECHANISMS	A fundamental issue in the design and development of antimicrobials is the lack of understanding of complex modes of action and how this complexity affects potential pathways for resistance evolution. Bac8c (RIWVIWRR-NH2) is an 8 amino acid antimicrobial peptide (AMP) that has been shown to have enhanced activity against a range of pathogenic Gram-positive and Gram-negative bacteria, as well as yeast. We have previously demonstrated that Bac8c appears to interfere with multiple targets, at least in part through the disruption of cytoplasmic membrane related functions, and that resistance to this peptide does not easily develop using standard laboratory methods. Here, we applied a genomics approach, SCalar Analysis of Library Enrichement (SCALEs), to map the effect of gene overexpression onto Bac8c resistance in parallel for all genes and gene combinations (up to similar to 10 adjacent genes) in the E. coli genome (a total of similar to 500,000 individual clones were mapped). Our efforts identified an elaborate network of genes for which overexpression leads to low-level resistance to Bac8c (including biofilm formation, multi-drug transporters, etc). This data was analyzed to provide insights into the complex relationships between mechanisms of action and potential routes by which resistance to this synthetic AMP can develop.	[Spindler, Eileen C.; Boyle, Nanette R.; Gill, Ryan T.] Univ Colorado Boulder, Dept Biol & Chem Engn, Boulder, CO 80302 USA; [Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada	University of Colorado System; University of Colorado Boulder; University of British Columbia	Gill, RT (corresponding author), Univ Colorado Boulder, Dept Biol & Chem Engn, Boulder, CO 80302 USA.	rtg@colorado.edu	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding to REWH from the Canadian Institutes of Health Research is gratefully acknowledged. REWH holds a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; BODANSZKY M, 1969, SCIENCE, V163, P352, DOI 10.1126/science.163.3865.352; Bonomo J, 2008, METAB ENG, V10, P109, DOI 10.1016/j.ymben.2007.10.002; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cloete TE, 2003, INT BIODETER BIODEGR, V51, P277, DOI 10.1016/S0964-8305(03)00042-8; Fernandez L, 2011, DRUG RESIST UPDATE, V14, P1, DOI 10.1016/j.drup.2011.01.001; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Gall S, 2008, METAB ENG, V10, P382, DOI 10.1016/j.ymben.2008.08.003; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hancock REW, 2010, MEMBRANE ACTIVE PEPT, P3; HEITKAMP M, 1981, BIOCHIM BIOPHYS ACTA, V676, P345, DOI 10.1016/0304-4165(81)90169-0; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KRULWICH TA, 1990, MICROBIOL REV, V54, P52, DOI 10.1128/MMBR.54.1.52-65.1990; Lynch MD, 2004, METAB ENG, V6, P177, DOI 10.1016/j.ymben.2004.01.002; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Sambrook J, 2001, MOL CLONING LAB MANU, P561; Sambrook J, 2001, MOL CLONING LAB MANU; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Warnecke TE, 2010, METAB ENG, V12, P241, DOI 10.1016/j.ymben.2009.12.002; Warnecke TE, 2008, METAB ENG, V10, P154, DOI 10.1016/j.ymben.2008.04.004; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wu MH, 1999, ANTIMICROB AGENTS CH, V43, P1274, DOI 10.1128/AAC.43.5.1274	30	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55052	10.1371/journal.pone.0055052	http://dx.doi.org/10.1371/journal.pone.0055052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383054	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600061
J	Stiegler, AL; Grant, TD; Luft, JR; Calderwood, DA; Snell, EH; Boggon, TJ				Stiegler, Amy L.; Grant, Thomas D.; Luft, Joseph R.; Calderwood, David A.; Snell, Edward H.; Boggon, Titus J.			Purification and SAXS Analysis of the Integrin Linked Kinase, PINCH, Parvin (IPP) Heterotrimeric Complex	PLOS ONE			English	Article							FOCAL ADHESION PROTEIN; BIOLOGICAL MACROMOLECULES; STRUCTURAL BASIS; CELL-ADHESION; DEPENDENT REGULATION; SOLUTION SCATTERING; ADAPTER PROTEIN; ALPHA-PARVIN; ILK; PREDICTION	The heterotrimeric protein complex containing the integrin linked kinase (ILK), parvin, and PINCH proteins, termed the IPP complex, is an essential component of focal adhesions, where it interacts with many proteins to mediate signaling from integrin adhesion receptors. Here we conduct a biochemical and structural analysis of the minimal IPP complex, comprising full-length human ILK, the LIM1 domain of PINCH1, and the CH2 domain of alpha-parvin. We provide a detailed purification protocol for IPP and show that the purified IPP complex is stable and monodisperse in solution. Using small-angle X-ray scattering (SAXS), we also conduct the first structural characterization of IPP, which reveals an elongated shape with dimensions 120x60x40 angstrom. Flexibility analysis using the ensemble optimization method (EOM) is consistent with an IPP complex structure with limited flexibility, raising the possibility that inter-domain interactions exist. However, our studies suggest that the inter-domain linker in ILK is accessible and we detect no inter-domain contacts by gel filtration analysis. This study provides a structural foundation to understand the conformational restraints that govern the IPP complex.	[Stiegler, Amy L.; Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Grant, Thomas D.; Luft, Joseph R.; Snell, Edward H.] Hauptman Woodward Med Res Inst, Buffalo, NY USA; [Luft, Joseph R.; Snell, Edward H.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA	Yale University; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	titus.boggon@yale.edu	Snell, Edward/G-2055-2018; Grant, Thomas/T-2921-2019; Calderwood, David A/AAC-6954-2019; Grant, Thomas/GXH-9990-2022	Snell, Edward/0000-0001-8714-3191; Grant, Thomas/0000-0002-8583-3700; Calderwood, David A/0000-0002-0791-4142; Grant, Thomas/0000-0002-8583-3700	U.S. National Institutes of Health [R01GM088240, R01GM088396]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088240, R01GM088396] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by U.S. National Institutes of Health grants R01GM088240 and R01GM088396. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Bernado P, 2008, J MOL BIOL, V376, P492, DOI 10.1016/j.jmb.2007.11.066; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chiswell BP, 2010, J STRUCT BIOL, V170, P157, DOI 10.1016/j.jsb.2009.12.002; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2005, MOL CELL BIOL, V25, P3056, DOI 10.1128/MCB.25.8.3056-3062.2005; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Olski TM, 2001, J CELL SCI, V114, P525; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Stanchi F, 2005, J CELL SCI, V118, P5899, DOI 10.1242/jcs.02686; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Vakaloglou KM, 2012, J CELL SCI; Velyvis A, 2001, J BIOL CHEM, V276, P4932, DOI 10.1074/jbc.M007632200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yang YW, 2009, J BIOL CHEM, V284, P5836, DOI 10.1074/jbc.M805319200; Yoshimi R, 2006, J IMMUNOL, V176, P3611, DOI 10.4049/jimmunol.176.6.3611; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55591	10.1371/journal.pone.0055591	http://dx.doi.org/10.1371/journal.pone.0055591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383235	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600130
J	Zhu, JW; Wu, XJ; Lu, ZF; Luo, D; Cai, SQ; Zheng, M				Zhu, Jian-Wei; Wu, Xian-Jie; Lu, Zhong-Fa; Luo, Dan; Cai, Sui-Qing; Zheng, Min			Role of VEGF Receptors in Normal and Psoriatic Human Keratinocytes: Evidence from Irradiation with Different UV Sources	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; HUMAN EPIDERMAL-KERATINOCYTES; ULTRAVIOLET-B; TYROSINE KINASE; SKIN INFLAMMATION; FACTOR EXPRESSION; ACTIVATION; RADIATION; CELLS	Vascular endothelial growth factor (VEGF) promotes angiogenesis and plays important roles both in physiological and pathological conditions. VEGF receptors (VEGFRs) are high-affinity receptors for VEGF and are originally considered specific to endothelial cells. We previously reported that VEGFRs were also constitutively expressed in normal human keratinocytes and overexpressed in psoriatic epidermis. In addition, UVB can activate VEGFRs in normal keratinocytes, and the activated VEGFR-2 signaling is involved in the pro-survival mechanism. Here, we show that VEGFRs were also upregulated and activated by UVA in normal human keratinocytes via PKC, and interestingly, both the activated VEGFR-1 and VEGFR-2 protected against UVA-induced cell death. As VEGFRs were over-expressed in psoriatic epidermis, we further investigated whether narrowband UVB (NB-UVB) phototherapy or topical halomethasone monohydrate 0.05% cream could affect their expression. Surprisingly, the over-expressed VEGFRs in psoriatic epidermis were significantly attenuated by both treatments. During NB-UVB therapy, VEGFRs declined first in the basal, and then gradually in the upper psoriatic epidermis. VEGFRs were activated in psoriatic epidermis, their activation was enhanced by NB-UVB, but turned undetectable after whole therapy. This process was quite different from that by halomethasone, in which VEGFRs and phospho-VEGFRs decreased in a gradual, homogeneous manner. Our findings further suggest that UV-induced activation of VEGFRs serves as a pro-survival signal for keratinocytes. In addition, VEGFRs may be involved in the pathological process of psoriasis, and UV phototherapy is effective for psoriasis by directly modulating the expression of VEGFRs.	[Zhu, Jian-Wei; Wu, Xian-Jie; Lu, Zhong-Fa; Cai, Sui-Qing; Zheng, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Dan] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Nanjing Medical University	Zheng, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China.	minz@zju.edu.cn			National Natural Science Fundation of China (NSFC) [30972643, 81171497, 81171521]	National Natural Science Fundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grant 30972643, 81171497 and 81171521 from the National Natural Science Fundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman A, 2009, CLIN EXP DERMATOL, V34, pE202, DOI 10.1111/j.1365-2230.2008.02991.x; Arun SN, 2011, ONCOGENE, V30, P1586, DOI 10.1038/onc.2010.540; Barbagallo J, 2001, CUTIS, V68, P345; Battie C, 2012, INDIAN J DERMATOL VE, V78, P9, DOI 10.4103/0378-6323.97350; Brauchle M, 1996, J BIOL CHEM, V271, P21793, DOI 10.1074/jbc.271.36.21793; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Canavese M, 2010, J DERMATOL SCI, V58, P171, DOI 10.1016/j.jdermsci.2010.03.023; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; Decraene D, 2004, J INVEST DERMATOL, V122, P484, DOI 10.1046/j.0022-202X.2004.22215.x; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Detmar M, 1997, J INVEST DERMATOL, V108, P263, DOI 10.1111/1523-1747.ep12286453; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Flisiak I, 2010, CYTOKINE, V52, P225, DOI 10.1016/j.cyto.2010.09.012; Fuh G, 2000, J BIOL CHEM, V275, P26690; Gille J, 2000, J INVEST DERMATOL, V115, P30, DOI 10.1046/j.1523-1747.2000.00020.x; GSCHWENDT M, 1994, FEBS LETT, V347, P85, DOI 10.1016/0014-5793(94)00514-1; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; He YY, 2004, J BIOL CHEM, V279, P53867, DOI 10.1074/jbc.M405781200; Herve MAJ, 2006, J ENDOCRINOL, V188, P91, DOI 10.1677/joe.1.06184; Hirakawa S, 2005, BLOOD, V105, P2392, DOI 10.1182/blood-2004-06-2435; JEANMOUGIN M, 1987, ANN DERMATOL VENER, V114, P671; Kim EJ, 2005, EXP DERMATOL, V14, P625, DOI 10.1111/j.0906-6705.2005.00345.x; Kosmadaki MG, 2003, FASEB J, V17, P446, DOI 10.1096/fj.02-0379fje; Lapolla W, 2011, J AM ACAD DERMATOL, V64, P936, DOI 10.1016/j.jaad.2009.12.054; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; Lee EJ, 2010, FREE RADICAL BIO MED, V48, P1133, DOI 10.1016/j.freeradbiomed.2010.01.034; Li CM, 2011, MOL CELL BIOCHEM, V346, P173, DOI 10.1007/s11010-010-0602-7; Man XY, 2009, CLIN EXP DERMATOL, V34, P396, DOI 10.1111/j.1365-2230.2008.03104.x; Man XY, 2008, J CELL MOL MED, V12, P649, DOI 10.1111/j.1582-4934.2007.00112.x; Man XY, 2006, MOL MED, V12, P127, DOI 10.2119/2006-00024.Man; MATSUI MS, 1994, PHOTOCHEM PHOTOBIOL, V59, P53; Matsui MS, 1996, PHOTODERMATOL PHOTO, V12, P103, DOI 10.1111/j.1600-0781.1996.tb00185.x; Mildner M, 1999, PHOTOCHEM PHOTOBIOL, V70, P674, DOI 10.1562/0031-8655(1999)070<0674:UAURDR>2.3.CO;2; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nofal A, 2009, J EUR ACAD DERMATOL, V23, P803, DOI 10.1111/j.1468-3083.2009.03181.x; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Ravnbak MH, 2007, ARCH DERMATOL RES, V299, P25, DOI 10.1007/s00403-006-0728-3; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; SEETHARAM L, 1995, ONCOGENE, V10, P135; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Supp DM, 2000, J INVEST DERMATOL, V114, P5, DOI 10.1046/j.1523-1747.2000.00824.x; Syed DN, 2012, PHOTOCHEM PHOTOBIOL, V88, P1184, DOI 10.1111/j.1751-1097.2012.01115.x; Tapia JA, 2003, J BIOL CHEM, V278, P35220, DOI 10.1074/jbc.M303119200; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Umeda J, 2003, FASEB J, V17, P610, DOI 10.1096/fj.02-0597com; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Weninger W, 1996, LAB INVEST, V75, P647; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Wilgus TA, 2005, AM J PATHOL, V167, P1257, DOI 10.1016/S0002-9440(10)61213-8; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Yang XH, 2006, BIOCHEM BIOPH RES CO, V349, P31, DOI 10.1016/j.bbrc.2006.07.213; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033; Zhu JW, 2012, INT J BIOCHEM CELL B, V44, P246, DOI 10.1016/j.biocel.2011.10.022	60	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55463	10.1371/journal.pone.0055463	http://dx.doi.org/10.1371/journal.pone.0055463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383198	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600107
J	Bandiera, S; Cartault, F; Jannot, AS; Hatem, E; Girard, M; Rifai, L; Loiseau, C; Munnich, A; Lyonnet, S; Henrion-Caude, A				Bandiera, Simonetta; Cartault, Francois; Jannot, Anne-Sophie; Hatem, Elie; Girard, Muriel; Rifai, Laila; Loiseau, Clemence; Munnich, Arnold; Lyonnet, Stanislas; Henrion-Caude, Alexandra			Genetic Variations Creating MicroRNA Target Sites in the FXN 3 '-UTR Affect Frataxin Expression in Friedreich Ataxia	PLOS ONE			English	Article							TRIPLET REPEAT EXPANSION; WEB SERVER; DISEASE; PREDICTION; RESOURCE; 3'UTR	Friedreich's ataxia (FRDA) is a severe neurodegenerative disease caused by GAA repeat expansion within the first intron of the frataxin gene. It has been suggested that the repeat is responsible for the disease severity due to impaired transcription thereby reducing expression of the protein. However, genotype-phenotype correlation is imperfect, and the influence of other gene regions of the frataxin gene is unknown. We hypothesized that FRDA patients may harbor specific regulatory variants in the 3'-UTR. We sequenced the 3'-UTR region of the frataxin gene in a cohort of 57 FRDA individuals and 58 controls. Seven single nucleotide polymorphisms (SNPs) out of 19 were polymorphic in our case-control sample. These SNPs defined several haplotypes with one reaching 89% of homozygosity in patients versus 24% in controls. In another cohort of 47 FRDA Reunionese patients, 94% patients were found to be homozygous for this haplotype. We found that this FRDA 3'-UTR conferred a 1.2-fold decrease in the expression of a reporter gene versus the alternative haplotype configuration. We established that differential targeting by miRNA could account for this functional variability. We specifically demonstrated the involvement of miR-124 (i.e hsa-mir-124-3p) in the down-regulation of FRDA-3'-UTR. Our results suggest for the first time that post-transcriptional regulation of frataxin occurs through the 3'-UTR and involves miRNA targeting. We propose that the involvement of miRNAs in a FRDA-specific regulation of frataxin may provide a rationale to increase residual levels of frataxin through miRNA-inhibitory molecules.	[Bandiera, Simonetta; Jannot, Anne-Sophie; Girard, Muriel; Munnich, Arnold; Lyonnet, Stanislas; Henrion-Caude, Alexandra] Univ Paris Descartes Sorbonne Cite, INSERM, U781, Hop Necker Enfants Malad,Inst Imagine, Paris, France; [Cartault, Francois; Hatem, Elie; Loiseau, Clemence] Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Cartault, Francois] Ctr Hosp Reg La Reunion, Dept Genet, St Denis, Reunion, France; [Rifai, Laila] Natl Inst Hlth, Dept Med Genet, Rabat, Morocco	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Reunion	Henrion-Caude, A (corresponding author), Univ Paris Descartes Sorbonne Cite, INSERM, U781, Hop Necker Enfants Malad,Inst Imagine, Paris, France.	alexandra.caude@inserm.fr	Lyonnet, Stanislas/H-5483-2017; Girard, Muriel/B-7156-2018; Caude, Alexandra A Henrion/I-2778-2016	Lyonnet, Stanislas/0000-0001-5426-9417; Girard, Muriel/0000-0003-0050-1035; Caude, Alexandra A Henrion/0000-0002-8170-2260; Jannot, Anne-Sophie/0000-0002-8001-8539; Bandiera, Simonetta/0000-0002-7368-8155	AFAF (French association against Friedreich ataxia); AFAF	AFAF (French association against Friedreich ataxia); AFAF	This work was financially supported by the AFAF (French association against Friedreich ataxia, http://www.afaf.asso.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to the AFAF, particularly to Juliette Dieusaert and Marianne Kerdougli for financial support of this work. We thank Patrick Munier for technical help. We sincerely thank Pr Josue Feingold for helpful discussion, and Pr Jean-Paul Bonnefont and Dr Benoit Funalot, Hopital Necker, Paris, the Centre de Ressources Biologiques, CHR Felix Guyon, Saint-Denis, La Reunion, and the Centre de Reference des Maladies neuromusculaires et neurologiques rares du CHR de la Reunion for providing genomic DNA.	Acquaviva F, 2008, CEREBELLUM, V7, P360, DOI 10.1007/s12311-008-0036-x; Alagarasu K, 2009, J CLIN IMMUNOL, V29, P196, DOI 10.1007/s10875-008-9234-z; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bilen J, 2006, CELL CYCLE, V5, P2835, DOI 10.4161/cc.5.24.3579; Boehm T, 2011, NEUROL SCI, V32, P327, DOI 10.1007/s10072-010-0326-1; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chattopadhyay B, 2004, ANN HUM GENET, V68, P189, DOI 10.1046/j.1529-8817.2003.00087.x; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griseri P, 2007, HUM MUTAT, V28, P168, DOI 10.1002/humu.20397; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Juvonen V, 2002, HUM GENET, V110, P36, DOI 10.1007/s00439-001-0642-x; Kelly M, 2011, J MOL CELL CARDIOL, V51, P848, DOI 10.1016/j.yjmcc.2011.07.001; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Liu J, 2011, STEM CELL REV REP, V7, P703, DOI 10.1007/s12015-010-9210-x; Mahishi LH, 2012, J NEUROSCI, V32, P9369, DOI 10.1523/JNEUROSCI.0059-12.2012; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Pelletier C, 2011, CELL CYCLE, V10, P90, DOI 10.4161/cc.10.1.14359; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Rufini A, 2011, HUM MOL GENET, V20, P1253, DOI 10.1093/hmg/ddq566; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Sonntag KC, 2012, EXP NEUROL, V235, P427, DOI 10.1016/j.expneurol.2011.11.035; Yang YC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S4	38	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54791	10.1371/journal.pone.0054791	http://dx.doi.org/10.1371/journal.pone.0054791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382970	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800079
J	Dobon, A; Wulff, BBH; Canet, JV; Fort, P; Tornero, P				Dobon, Albor; Wulff, Brande B. H.; Vicente Canet, Juan; Fort, Patrocinio; Tornero, Pablo			An Allele of Arabidopsis COI1 with Hypo- and Hypermorphic Phenotypes in Plant Growth, Defence and Fertility	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; DISEASE RESISTANCE; SIGNALING PATHWAYS; METHYL JASMONATE; PHYTOTOXIN CORONATINE; TRANSCRIPTION FACTOR; GENETIC-ANALYSIS; CROSS-TALK; THALIANA	Resistance to biotrophic pathogens is largely dependent on the hormone salicylic acid (SA) while jasmonic acid (JA) regulates resistance against necrotrophs. JA negatively regulates SA and is, in itself, negatively regulated by SA. A key component of the JA signal transduction pathway is its receptor, the COI1 gene. Mutations in this gene can affect all the JA phenotypes, whereas mutations in other genes, either in JA signal transduction or in JA biosynthesis, lack this general effect. To identify components of the part of the resistance against biotrophs independent of SA, a mutagenised population of NahG plants (severely depleted of SA) was screened for suppression of susceptibility. The screen resulted in the identification of intragenic and extragenic suppressors, and the results presented here correspond to the characterization of one extragenic suppressor, coi1-40. coi1-40 is quite different from previously described coi1 alleles, and it represents a strategy for enhancing resistance to biotrophs with low levels of SA, likely suppressing NahG by increasing the perception to the remaining SA. The phenotypes of coi1-40 lead us to speculate about a modular function for COI1, since we have recovered a mutation in COI1 which has a number of JA-related phenotypes reduced while others are equal to or above wild type levels.	[Dobon, Albor; Wulff, Brande B. H.; Vicente Canet, Juan; Fort, Patrocinio; Tornero, Pablo] Univ Politecn Valencia, CSIC, IBMCP, CPI, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Tornero, P (corresponding author), Univ Politecn Valencia, CSIC, IBMCP, CPI, E-46071 Valencia, Spain.	ptornero@ibmcp.upv.es	Wulff, Brande B/N-4273-2013; Wulff, Brande BH/C-7465-2013	Wulff, Brande BH/0000-0003-4044-4346; Tornero, Pablo/0000-0001-9755-7726	"Ministerio de Economia y Competitividad" (MINECO) of Spain [BIO201018896]; Generalitat Valenciana [ACOMP/2012/105]; JAE-CSIC Fellowship; FPI-MINECO; European Molecular Biology Organization; Human Frontier Science Program	"Ministerio de Economia y Competitividad" (MINECO) of Spain(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); JAE-CSIC Fellowship; FPI-MINECO(Spanish Government); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by grant BIO201018896 from "Ministerio de Economia y Competitividad" (MINECO) of Spain and by grant ACOMP/2012/105 from "Generalitat Valenciana" to PT, a JAE-CSIC Fellowship to JVC, a FPI-MINECO to AD, and Fellowships from the European Molecular Biology Organization and the Human Frontier Science Program to BBHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaran E, 2009, PLANT CELL, V21, P954, DOI 10.1105/tpc.108.063164; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Canet JV, 2010, PLANT BIOTECHNOL J, V8, P126, DOI 10.1111/j.1467-7652.2009.00468.x; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; CELENZA JL, 1995, GENE DEV, V9, P2131, DOI 10.1101/gad.9.17.2131; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Coego A, 2005, PLANT CELL, V17, P2123, DOI 10.1105/tpc.105.032375; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; DeFraia CT, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-28; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dobon A, 2011, PLANTA, V234, P671, DOI 10.1007/s00425-011-1436-6; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Fernandez-Arbaizar A, 2012, PLANT CELL PHYSIOL, V53, P53, DOI 10.1093/pcp/pcr174; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Genoud T, 1999, TRENDS PLANT SCI, V4, P503, DOI 10.1016/S1360-1385(99)01498-3; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; He YJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003018; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; JOHNSON G. M. et al., 1957, Plant and Soil, V8, P337, DOI 10.1007/BF01666323; JURGENS G, 1991, DEVELOPMENT, P27; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Macho AP, 2010, NEW PHYTOL, V187, P1018, DOI 10.1111/j.1469-8137.2010.03381.x; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; MITTAL S, 1995, MOL PLANT MICROBE IN, V8, P165, DOI 10.1094/MPMI-8-0165; Nawrath C, 2006, MULTIGENIC AND INDUCED SYSTEMIC RESISTANCE IN PLANTS, P143, DOI 10.1007/0-387-23266-4_7; Payne CT, 2000, GENETICS, V156, P1349; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; ROSS AF, 1961, VIROLOGY, V14, P340, DOI 10.1016/0042-6822(61)90319-1; Shan XY, 2009, J EXP BOT, V60, P3849, DOI 10.1093/jxb/erp223; Sun JQ, 2009, PLANT CELL, V21, P1495, DOI 10.1105/tpc.108.064303; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Ton J, 2002, PLANT J, V29, P11, DOI 10.1046/j.1365-313x.2002.01190.x; Tornero P, 2002, PLANT CELL, V14, P435, DOI 10.1105/tpc.010393; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Traw MB, 2003, PLANT PHYSIOL, V133, P1367, DOI 10.1104/pp.103.027086; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Canet JV, 2010, PLANT CELL ENVIRON, V33, P1911, DOI 10.1111/j.1365-3040.2010.02194.x; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yoshida Y, 2009, DEVELOPMENT, V136, P1039, DOI 10.1242/dev.030585; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819	74	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55115	10.1371/journal.pone.0055115	http://dx.doi.org/10.1371/journal.pone.0055115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383073	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800112
J	He, Z; Ferguson, SA; Cui, L; Greenfield, LJ; Paule, MG				He, Zhen; Ferguson, Sherry A.; Cui, Li; Greenfield, L. John, Jr.; Paule, Merle G.			Role of Neural Stem Cell Activity in Postweaning Development of the Sexually Dimorphic Nucleus of the Preoptic Area in Rats	PLOS ONE			English	Article							SEX-DIFFERENCES; GLOBAL-ISCHEMIA; BED NUCLEUS; BRAIN; HYPOTHALAMUS; NEUROGENESIS; APOPTOSIS; DIFFERENTIATION; MIGRATION; FEMALE	The sexually dimorphic nucleus of the preoptic area (SDN-POA) has received increased attention due to its apparent sensitivity to estrogen-like compounds found in food and food containers. The mechanisms that regulate SDN-POA volume remain unclear as is the extent of postweaning development of the SDN-POA. Here we demonstrate that the female Sprague-Dawley SDN-POA volume increased from weaning to adulthood, although this increase was not statistically significant as it was in males. The number of cells positive for Ki67, a marker of cell proliferation, in both the SDN-POA and the hypothalamus was significantly higher at weaning than at adulthood in male rats. In contrast, the number of Ki67-positive cells was significantly higher in the hypothalamus but not in the SDN-POA (p>0.05) at weaning than at adulthood in female rats. A subset of the Ki67-positive cells in the SDN-POA displayed the morphology of dividing cells. Nestin-immunoreactivity delineated a potential macroscopic neural stem cell niche in the rostral end of the 3rd ventricle. In conclusion, stem cells may partially account for the sexually dimorphic postweaning development of the SDN-POA.	[He, Zhen; Ferguson, Sherry A.; Paule, Merle G.] US FDA, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [He, Zhen; Cui, Li; Greenfield, L. John, Jr.] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA	US Food & Drug Administration (FDA); University of Arkansas System; University of Arkansas Medical Sciences	He, Z (corresponding author), US FDA, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	zhen.he@fda.hhs.gov	he, zhen/F-5133-2013	he, zhen/0000-0001-9972-9114; Ferguson, Sherry/0000-0002-5120-0219	National Center for Toxicological Research/FDA [Protocol P00710, Protocol P00706]; National Institutes of Health [R01-NS049389]; UAMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049389] Funding Source: NIH RePORTER	National Center for Toxicological Research/FDA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Center for Toxicological Research/FDA (Protocol P00710 to ZH and Protocol P00706 to SAF). LC was supported by National Institutes of Health, Grant R01-NS049389 and UAMS institutional funds to LJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; Bodo C, 2008, ENDOCRINOLOGY, V149, P4142, DOI 10.1210/en.2008-0183; Budefeld T, 2008, DEV NEUROBIOL, V68, P981, DOI 10.1002/dneu.20638; Chung WCJ, 2000, J NEUROBIOL, V43, P234, DOI 10.1002/(SICI)1097-4695(20000605)43:3<234::AID-NEU2>3.3.CO;2-V; Dahiya S, 2011, J NEUROPATH EXP NEUR, V70, P622, DOI 10.1097/NEN.0b013e31822200aa; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; Dugger BN, 2008, NEUROENDOCRINOLOGY, V88, P17, DOI 10.1159/000119740; Edelmann M, 2007, DEV NEUROBIOL, V67, P1371, DOI 10.1002/dneu.20507; Ernst C, 2005, EUR J NEUROSCI, V22, P3059, DOI 10.1111/j.1460-9568.2005.04499.x; Gilmore RF, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-5; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; Gorski RA, 1989, NEUROLOGY NEUROBIOLO, V50, P33; He Z, 2005, NEUROREPORT, V16, P1541, DOI 10.1097/01.wnr.0000179074.32035.46; He Z, 2005, CURR NEUROVASC RES, V2, P365, DOI 10.2174/156720205774962674; He Z, 2004, CURR NEUROVASC RES, V1, P399, DOI 10.2174/1567202043361893; He Z, 1997, NUTR RES, V17, P305, DOI 10.1016/S0271-5317(96)00260-6; He Z, 2006, CURR NEUROVASC RES, V3, P181, DOI 10.2174/156720206778018802; He Z, 2012, NEUROTOXICOL TERATOL, V34, P329, DOI 10.1016/j.ntt.2012.03.004; He Z, 2011, ACS CHEM NEUROSCI, V2, P600, DOI 10.1021/cn2000487; He Z, 2009, CURR NEUROVASC RES, V6, P54, DOI 10.2174/156720209787466055; Henderson RG, 1999, J NEUROBIOL, V41, P252, DOI 10.1002/(SICI)1097-4695(19991105)41:2<252::AID-NEU8>3.0.CO;2-W; HOFMAN MA, 1989, J ANAT, V164, P55; JACOBSON CD, 1985, DEV BRAIN RES, V21, P7, DOI 10.1016/0165-3806(85)90019-7; Kato Y, 2012, NEUROSCI LETT, V516, P290, DOI 10.1016/j.neulet.2012.04.017; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Meredith JM, 2001, J NEUROSCI METH, V104, P113, DOI 10.1016/S0165-0270(00)00331-9; Orikasa C, 2010, NEUROSCI RES, V68, P9, DOI 10.1016/j.neures.2010.05.008; Orikasa C, 2010, J COMP NEUROL, V518, P3618, DOI 10.1002/cne.22419; Park JJ, 1996, J NEUROBIOL, V30, P315, DOI 10.1002/(SICI)1097-4695(199607)30:3<315::AID-NEU1>3.0.CO;2-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; PFEIFFER B, 1989, BRAIN RES, V476, P120, DOI 10.1016/0006-8993(89)91543-6; Prince KN, 1998, BRAIN RES BULL, V47, P349, DOI 10.1016/S0361-9230(98)00118-X; Roselli CE, 2007, ENDOCRINOLOGY, V148, P4450, DOI 10.1210/en.2007-0454; Sakuma Y, 2009, J NEUROENDOCRINOL, V21, P410, DOI 10.1111/j.1365-2826.2009.01856.x; Sickel MJ, 2000, J NEUROENDOCRINOL, V12, P397; Tsukahara S, 2009, J NEUROENDOCRINOL, V21, P370, DOI 10.1111/j.1365-2826.2009.01855.x; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weiss S, 1996, J NEUROSCI, V16, P7599; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yamamoto Masako, 2005, Journal of Toxicological Sciences, V30, P7; YOUNG JK, 1982, BRAIN RES, V239, P233, DOI 10.1016/0006-8993(82)90844-7	45	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54927	10.1371/journal.pone.0054927	http://dx.doi.org/10.1371/journal.pone.0054927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383001	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800089
J	Liou, LB; Tsai, WP; Chang, CJ; Chao, WJ; Chen, MH				Liou, Lieh-bang; Tsai, Wen-pin; Chang, Chee J.; Chao, Wan-ju; Chen, Meng-hsin			Blood Monocyte Chemotactic Protein-1 (MCP-1) and Adapted Disease Activity Score28-MCP-1: Favorable Indicators for Rheumatoid Arthritis Activity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG PENTRAXIN PTX3; ERYTHROCYTE SEDIMENTATION-RATE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SERUM-AMYLOID-P; RECOGNITION RECEPTOR PTX3; ACTIVITY SCORE DAS28; CHEMOATTRACTANT PROTEIN-1; METHOTREXATE THERAPY; MONOCLONAL-ANTIBODY	We assessed blood pentraxin 3 (PTX3) and macrophage chemotactic factor-1 (MCP-1) levels as indicators of disease activity in rheumatoid arthritis (RA) patients, because data on disease activity score 28 (DAS28)-erythrocyte sedimentation rate (ESR) and DAS28-C-reactive protein (CRP) are still imperfect. Methods: In 111 patients with RA, we examined longitudinal and cross-sectional correlations of blood PTX3, MCP-1, CRP, and ESR levels with measures of clinical arthritic activity, namely, swollen joint count (SJC), tender joint count (TJC), visual analog scale for general health (GH), DAS28, and adapted DAS28-MCP-1. Results: Blood MCP-1, but not PTX3, was significantly correlated with SJC, TJC, DAS28, and DAS28-CRP. DAS28-MCP-1 was strongly correlated with DAS28 (r = 0.984, P<0.001) and DAS28-CRP (r = 0.971, P<0.001), and modestly correlated with CRP (r = 0.350, P<0.001), and ESR (r = 0.386, P<0.001). Similarly, the duration of arthritic symptoms, but not sex, was significantly correlated with variables of arthritic activity. In particular, DAS28-MCP-1 significantly correlated with DAS28 during a 6-month period (r = 0.944, P<0.001; r = 0.951, P<0.001; r = 0.862, P<0.001; and r = 0.865, P<0.001 for month 0, 1, 3, and 6, respectively). Conclusion: Blood MCP-1 and adapted DAS28-MCP-1, but not blood PTX3, may be useful in monitoring RA activity.	[Liou, Lieh-bang; Chao, Wan-ju; Chen, Meng-hsin] Chang Gung Mem Hosp Lin Kou, Dept Rheumatol Allergy & Immunol, Kwei San Hsiang, Tao Yuan County, Taiwan; [Liou, Lieh-bang] Chang Gung Univ, Coll Med, Kwei San Hsiang, Tao Yuan County, Taiwan; [Tsai, Wen-pin] Chang Gung Mem Hosp Kee Lung, Dept Rheumatol Allergy & Immunol, Kee Lung City, Taiwan; [Chang, Chee J.] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Kwei San Hsiang, Tao Yuan County, Taiwan; [Chang, Chee J.] Chang Gung Univ, Inst Clin Med Sci, Kwei San Hsiang, Tao Yuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Liou, LB (corresponding author), Chang Gung Mem Hosp Lin Kou, Dept Rheumatol Allergy & Immunol, Kwei San Hsiang, Tao Yuan County, Taiwan.	b890121@cgmh.org.tw		Chang, Chee Jen/0000-0002-7725-7555	Chang Gung Medical Foundation Research Grant [CMRPG 360171-2]	Chang Gung Medical Foundation Research Grant	This work was supported by Chang Gung Medical Foundation Research Grant (CMRPG 360171-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Aletaha D, 2009, ARTHRITIS RHEUM, V60, P1242, DOI 10.1002/art.24433; ALLES VV, 1994, BLOOD, V84, P3483; Baldini M, 2012, ARTHRITIS RHEUM-US, V64, P854, DOI 10.1002/art.33411; Baruah P, 2006, BLOOD, V107, P151, DOI 10.1182/blood-2005-03-1112; Bassi N, 2010, ANN RHEUM DIS, V69, P1704, DOI 10.1136/ard.2009.117804; Bevelacqua V, 2006, INT J MOL MED, V18, P415; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Cader MZ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-187; Chen HS, 2007, RHEUMATOLOGY, V46, P539, DOI 10.1093/rheumatology/kel343; Crowson CS, 2009, J RHEUMATOL, V36, P1606, DOI 10.3899/jrheum.081188; den Broeder AA, 2002, ANN RHEUM DIS, V61, P311, DOI 10.1136/ard.61.4.311; Dessein PH, 2004, J RHEUMATOL, V31, P1095; Ellingsen T, 2001, J RHEUMATOL, V28, P41; Gardiner PV, 2005, ANN RHEUM DIS, V64, P506, DOI 10.1136/ard.2004.025015; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hensor EMA, 2010, RHEUMATOLOGY, V49, P1521, DOI 10.1093/rheumatology/keq117; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Keenan RT, 2008, CLIN EXP RHEUMATOL, V26, P814; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kim J, 2009, CLIN EXP RHEUMATOL, V27, P773; Klimiuk PA, 2005, J RHEUMATOL, V32, P1666; Kou CF, 2008, CLIN RHEUMATOL, V27, P231; Kravitz MS, 2005, J CLIN IMMUNOL, V25, P582, DOI 10.1007/s10875-005-7828-2; Kremer JM, 2003, ARTHRITIS RHEUM, V48, P1493, DOI 10.1002/art.11142; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEE GW, 1993, J IMMUNOL, V150, P1804; Liou LB, 2003, CLIN EXP RHEUMATOL, V21, P437; Liu FC, 2008, CLIN RHEUMATOL, V27, P463, DOI 10.1007/s10067-007-0729-4; Luchetti MM, 2004, CLIN EXP RHEUMATOL, V22, pS66; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Mamehara Akira, 2010, Kobe J Med Sci, V56, pE98; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Mauri T, 2008, CRIT CARE MED, V36, P2302, DOI 10.1097/CCM.0b013e3181809aaf; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Norata GD, 2008, ARTERIOSCL THROM VAS, V28, P925, DOI 10.1161/ATVBAHA.107.160606; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Nyhall-Wahlin BM, 2011, SCAND J RHEUMATOL, V40, P81, DOI 10.3109/03009742.2010.509103; Ortega-Hernandez OD, 2009, SEMIN ARTHRITIS RHEU, V39, P38, DOI 10.1016/j.semarthrit.2008.03.006; Pincus T, 2009, RHEUM DIS CLIN N AM, V35, P731, DOI 10.1016/j.rdc.2009.10.007; Pope JE, 2011, SCAND J RHEUMATOL, V40, P232, DOI 10.3109/03009742.2010.517548; Pransen J, 2005, ANN RHEUM DIS, V64, P1294; Prevoo ML, 1995, ARTHRITIS RHEUM, V39, P44; Rajasekhar L, 2004, CLIN EXP RHEUMATOL, V22, P597; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Sato Y, 2005, J THORAC CARDIOV SUR, V130, P346, DOI 10.1016/j.jtcvs.2004.12.028; Taylor WJ, 2008, RHEUMATOLOGY, V47, P514, DOI 10.1093/rheumatology/ken004; Toussirot E, 2000, HUM IMMUNOL, V61, P303, DOI 10.1016/S0198-8859(99)00126-3; van Rossum AP, 2006, ARTHRITIS RHEUM-US, V54, P986, DOI 10.1002/art.21669; van Rossum AP, 2004, ARTHRITIS RHEUM-US, V50, P2667, DOI 10.1002/art.20370; van Tuyl LHD, 2010, ARTHRIT CARE RES, V62, P108, DOI 10.1002/acr.20021; Ward MM, 2004, J RHEUMATOL, V31, P884; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Wolfe F, 1997, J RHEUMATOL, V24, P1477; Wolfe F, 2009, J RHEUMATOL, V36, P1568, DOI 10.3899/jrheum.090386; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	60	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55346	10.1371/journal.pone.0055346	http://dx.doi.org/10.1371/journal.pone.0055346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383162	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800144
J	Knaupp, AS; Keleher, S; Yang, L; Dai, WW; Bottomley, SP; Pearce, MC				Knaupp, Anja S.; Keleher, Shani; Yang, Li; Dai, Weiwen; Bottomley, Stephen P.; Pearce, Mary C.			The Roles of Helix I and Strand 5A in the Folding, Function and Misfolding of alpha(1)-Antitrypsin	PLOS ONE			English	Article							SERPIN POLYMERIZATION; CONFORMATIONAL-CHANGES; METASTABLE SERPIN; MOLECULAR-BASIS; F-HELIX; MECHANISM; ALPHA-1-ANTITRYPSIN; STABILITY; DISEASE; ALPHA(1)-ANTICHYMOTRYPSIN	alpha(1)-Antitrypsin, the archetypal member of the serpin superfamily, is a metastable protein prone to polymerization when exposed to stressors such as elevated temperature, low denaturant concentrations or through the presence of deleterious mutations which, in a physiological context, are often associated with disease. Experimental evidence suggests that alpha(1)-Antitrypsin can polymerize via several alternative mechanisms in vitro. In these polymerization mechanisms different parts of the molecule are proposed to undergo conformational change. Both strand 5 and helix I are proposed to adopt different conformations when forming the various polymers, and possess a number of highly conserved residues however their role in the folding and misfolding of alpha(1)-Antitrypsin has never been examined. We have therefore created a range of alpha(1)-Antitypsin variants in order to explore the role of these conserved residues in serpin folding, misfolding, stability and function. Our data suggest that key residues in helix I mediate efficient folding from the folding intermediate and residues in strand 5A ensure native state stability in order to prevent misfolding. Additionally, our data indicate that helix I is involved in the inhibitory process and that both structural elements undergo differing conformational rearrangements during unfolding and misfolding. These findings suggest that the ability of alpha(1)-Antitrypsin to adopt different types of polymers under different denaturing conditions may be due to subtle conformational differences in the transiently populated structures adopted prior to the I and M* states.	[Knaupp, Anja S.; Keleher, Shani; Yang, Li; Dai, Weiwen; Bottomley, Stephen P.; Pearce, Mary C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University	Bottomley, SP (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	steve.bottomley@monash.edu; mary.pearce@monash.edu		Knaupp, Anja/0000-0003-0493-7872	NHMRC National Health and Medical Research Council Program Grant; PRF fellowship from the NHMRC; AlphaOne Foundation	NHMRC National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); PRF fellowship from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); AlphaOne Foundation	This project was supported by a NHMRC National Health and Medical Research Council Program Grant, a PRF fellowship from the NHMRC to SPB, and an Postdoctoral Fellowship from the AlphaOne Foundation to MCP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabrita LD, 2004, BIOCHEMISTRY-US, V43, P9834, DOI 10.1021/bi0491346; Cabrita LD, 2002, BIOCHEMISTRY-US, V41, P4575, DOI 10.1021/bi0158932; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Crowther DC, 2003, BIOCHEMISTRY-US, V42, P2355, DOI 10.1021/bi0259305; Dafforn TR, 2004, METHODS, V32, P150, DOI 10.1016/S1046-2023(03)00206-8; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Devlin GL, 2002, J MOL BIOL, V324, P859, DOI 10.1016/S0022-2836(02)01088-4; Devlin GL, 2005, FRONT BIOSCI-LANDMRK, V10, P288, DOI 10.2741/1528; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Huntington JA, 2010, BIOL CHEM, V391, P973, DOI 10.1515/BC.2010.085; Im H, 1999, J BIOL CHEM, V274, P11072, DOI 10.1074/jbc.274.16.11072; Im H, 2000, PROTEIN SCI, V9, P934, DOI 10.1110/ps.9.5.934; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; James EL, 1998, ARCH BIOCHEM BIOPHYS, V356, P296, DOI 10.1006/abbi.1998.0751; James EL, 1999, J BIOL CHEM, V274, P9482, DOI 10.1074/jbc.274.14.9482; Knaupp AS, 2011, J MOL BIOL, V413, P888, DOI 10.1016/j.jmb.2011.09.013; Knaupp AS, 2010, J MOL BIOL, V396, P375, DOI 10.1016/j.jmb.2009.11.048; Koloczek H, 1996, J PROTEIN CHEM, V15, P447, DOI 10.1007/BF01886851; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; Levina V, 2009, PROTEIN EXPR PURIF; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; Pearce MC, 2000, J BIOL CHEM, V275, P28513, DOI 10.1074/jbc.M004310200; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; Tew DJ, 2001, J MOL BIOL, V313, P1161, DOI 10.1006/jmbi.2001.5104; Tsutsui Y, 2012, P NATL ACAD SCI US; Tsutsui Y, 2007, J MOL BIOL, V371, P245, DOI 10.1016/j.jmb.2007.05.039; Tsutsui Y, 2012, P NATL ACAD SCI USA, V109, P4467, DOI 10.1073/pnas.1109125109; Whisstock JC, 2000, J MOL BIOL, V296, P685, DOI 10.1006/jmbi.1999.3520; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhou A, 2001, J BIOL CHEM, V276, P9115, DOI 10.1074/jbc.M010631200; Zhou AW, 2003, J BIOL CHEM, V278, P15116, DOI 10.1074/jbc.M211663200	37	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54766	10.1371/journal.pone.0054766	http://dx.doi.org/10.1371/journal.pone.0054766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382962	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200060
J	Hawse, JR; Subramaniam, M; Cicek, M; Wu, XL; Gingery, A; Grygo, SB; Sun, ZF; Pitel, KS; Lingle, WL; Goetz, MP; Ingle, JN; Spelsberg, TC				Hawse, John R.; Subramaniam, Malayannan; Cicek, Muzaffer; Wu, Xianglin; Gingery, Anne; Grygo, Sarah B.; Sun, Zhifu; Pitel, Kevin S.; Lingle, Wilma L.; Goetz, Matthew P.; Ingle, James N.; Spelsberg, Thomas C.			Endoxifen's Molecular Mechanisms of Action Are Concentration Dependent and Different than That of Other Anti-Estrogens	PLOS ONE			English	Article							BREAST-CANCER-CELLS; ESTROGEN-RECEPTOR; TAMOXIFEN METABOLITE; RANDOMIZED-TRIALS; CYP2D6 GENOTYPE; INHIBITORS; THERAPY; GROWTH; ALPHA	Endoxifen, a cytochrome P450 mediated tamoxifen metabolite, is being developed as a drug for the treatment of estrogen receptor (ER) positive breast cancer. Endoxifen is known to be a potent anti-estrogen and its mechanisms of action are still being elucidated. Here, we demonstrate that endoxifen-mediated recruitment of ER alpha to known target genes differs from that of 4-hydroxy-tamoxifen (4HT) and ICI-182,780 (ICI). Global gene expression profiling of MCF7 cells revealed substantial differences in the transcriptome following treatment with 4HT, endoxifen and ICI, both in the presence and absence of estrogen. Alterations in endoxifen concentrations also dramatically altered the gene expression profiles of MCF7 cells, even in the presence of clinically relevant concentrations of tamoxifen and its metabolites, 4HT and N-desmethyl-tamoxifen (NDT). Pathway analysis of differentially regulated genes revealed substantial differences related to endoxifen concentrations including significant induction of cell cycle arrest and markers of apoptosis following treatment with high, but not low, concentrations of endoxifen. Taken together, these data demonstrate that endoxifen's mechanism of action is different from that of 4HT and ICI and provide mechanistic insight into the potential importance of endoxifen in the suppression of breast cancer growth and progression.	[Hawse, John R.; Subramaniam, Malayannan; Cicek, Muzaffer; Wu, Xianglin; Gingery, Anne; Grygo, Sarah B.; Pitel, Kevin S.; Spelsberg, Thomas C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Sun, Zhifu] Mayo Clin, Bioinformat Core, Div Biomed Stat & Informat, Rochester, MN USA; [Lingle, Wilma L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Goetz, Matthew P.; Ingle, James N.] Mayo Clin, Dept Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Hawse, JR (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	hawse.john@mayo.edu	Goetz, Matthew P/AAH-2333-2020	Gingery, Anne/0000-0002-1690-7382; Harrington, Jon/0000-0003-1293-5201; Sun, Zhifu/0000-0001-8461-7523	Breast Cancer Research Foundation; Mayo Clinic Breast Cancer [SPORE: P50CA116201]; National Center for Advancing Translational Sciences; Mayo Foundation; Paul Calabresi K12 award NCI [CA90628]; CTSA Grant [UL1 TR000135]; Susan G. Komen for the Cure [KG100142]; NATIONAL CANCER INSTITUTE [P50CA116201, K12CA090628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Mayo Clinic Breast Cancer; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; Paul Calabresi K12 award NCI; CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a Breast Cancer Research Foundation grant (JNI), Susan G. Komen for the Cure KG100142 (JRH), the Mayo Clinic Breast Cancer SPORE: P50CA116201 (JNI), a generous gift from Bruce and Martha Atwater (TCS, JRH, MPG, JNI), a Paul Calabresi K12 award NCI CA90628 (JRH), a CTSA Grant: UL1 TR000135 supporting JRH from the National Center for Advancing Translational Sciences and the Mayo Foundation (TCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; Borges S, 2006, CLIN PHARMACOL THER, V80, P61, DOI 10.1016/j.clpt.2006.03.013; BORGNA JL, 1981, J BIOL CHEM, V256, P859; Clarke R, 2001, PHARMACOL REV, V53, P25; COEZY E, 1982, CANCER RES, V42, P317; Crewe HK, 2004, BRIT J CLIN PHARMACO, V58, pS744, DOI 10.1111/j.1365-2125.2004.02282.x; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Early Breast Cancer Trialists' Collaborative G., 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Early Breast Cancer Trialists' Collaborative Group, 1998, LANCET, V351, P1451; Hawse JR, 2008, MOL ENDOCRINOL, V22, P1579, DOI 10.1210/me.2007-0253; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Jordan V C, 1982, Breast Cancer Res Treat, V2, P123, DOI 10.1007/BF01806449; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; Lim YC, 2005, CANCER CHEMOTH PHARM, V55, P471, DOI 10.1007/s00280-004-0926-7; Lim YC, 2006, J PHARMACOL EXP THER, V318, P503, DOI 10.1124/jpet.105.100511; Madlensky L, 2011, CLIN PHARMACOL THER, V89, P718, DOI 10.1038/clpt.2011.32; MAUVAISJARVIS P, 1986, CANCER RES, V46, P1521; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933	23	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54613	10.1371/journal.pone.0054613	http://dx.doi.org/10.1371/journal.pone.0054613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382923	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500020
J	Lin, M; Wen, YF; Wu, JR; Wang, Q; Zheng, L; Liu, GR; Huang, Y; Yang, H; Lin, F; Zhan, XF; Lin, CP; Yang, HT; Weng, QQ; Huang, FT; Wang, Y; Yao, MQ; Chen, HZ; Wu, DH; Zeng, JB; Zeng, RX; Yang, H; Li, GC; Lu, M; Zhu, JJ; Xie, LX; Wang, JL; Yang, LY				Lin, Min; Wen, Ying-Fang; Wu, Jiao-Ren; Wang, Qian; Zheng, Lei; Liu, Gui-Rong; Huang, Yue; Yang, Hui; Lin, Fen; Zhan, Xiao-Fen; Lin, Chun-Ping; Yang, Hui-Tian; Weng, Qiu-Qing; Huang, Fen-Ting; Wang, Yuan; Yao, Mei-Qiong; Chen, Hui-Zhou; Wu, Di-Hong; Zeng, Jing-Bo; Zeng, Ri-Xin; Yang, Hua; Li, Gui-Cai; Lu, Min; Zhu, Juan-Juan; Xie, Long-Xu; Wang, Jun-Li; Yang, Li-Ye			Hemoglobinopathy: Molecular Epidemiological Characteristics and Health Effects on Hakka People in the Meizhou Region, Southern China	PLOS ONE			English	Article							BETA-THALASSEMIA; GUANGDONG PROVINCE; PREVALENCE; DISORDERS; ALPHA; POPULATIONS; SPECTRUM; GUANGXI; DISEASE; BURDEN	Background: Hemoglobinopathies are the most common inherited diseases in southern China. However, there have been only a few epidemiological studies of hemoglobinopathies in Guangdong province. Materials and Methods: Peripheral blood samples were collected from 15299 "healthy'' unrelated subjects of dominantly ethnic Hakka in the Meizhou region, on which hemoglobin electrophoresis and routine blood tests were performed. Suspected cases with hemoglobin variants and hereditary persistence of fetal hemoglobin (HPFH) were further characterized by PCR, DNA sequencing, reverse dot blot (RDB) or multiplex ligation-dependent probe amplification (MLPA). In addition, 1743 samples were randomly selected from the 15299 subjects for thalassemia screening, and suspected thalassemia carriers were identified by PCR and RDB. Results: The gene frequency of hemoglobin variants was 0.477% (73/15299). The five main subgroups of the ten hemoglobin variants were Hb E, Hb G-Chinese, Hb Q-Tahiland, Hb New York and Hb J-Bangkok. 277 cases (15.89%, 277/1743) of suspected thalassemia carriers with microcytosis (MCV<82 fl) were found by thalassemia screening, and were tested by a RDB gene chip to reveal a total of 196 mutant chromosomes: including 124 alpha-thalassemia mutant chromosomes and 72 beta-thalassemia mutant chromosomes. These results give a heterozygote frequency of 11.24% for common alpha and beta thalassemia in the Hakka population in the Meizhou region. 3 cases of HPFH/delta beta-thalassemia were found, including 2 cases of Vietnamese HPFH (FPFH-7) and a rare Belgian (G)gamma((A)gamma delta beta)(0) -thalassemia identified in Chinese. Conclusions: Our results provide a detailed prevalence and molecular characterization of hemoglobinopathies in Hakka people of the Meizhou region. The estimated numbers of pregnancies each year in the Meizhou region, in which the fetus would be at risk for beta thalassemia major or intermedia, Bart's hydrops fetalis, and Hb H disease, are 25 (95% CI, 15 to 38), 40 (95% CI, 26 to 57), and 15 (95% CI, 8 to 23), respectively.	[Lin, Min; Wu, Jiao-Ren; Huang, Yue; Yang, Hui; Lin, Fen; Zhan, Xiao-Fen; Lin, Chun-Ping; Yang, Hui-Tian; Li, Gui-Cai; Yang, Li-Ye] So Med Univ, Chaozhou Cent Hosp, Lab Med Ctr, Chaozhou, Guangdong, Peoples R China; [Wen, Ying-Fang; Liu, Gui-Rong; Weng, Qiu-Qing; Huang, Fen-Ting] Meixian Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Wang, Qian; Zheng, Lei] So Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Yuan] Jiaoling Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Yao, Mei-Qiong] Pingyuan Women & Children Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Chen, Hui-Zhou] Fengshun Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Wu, Di-Hong] Dabu Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Zeng, Jing-Bo] Xingning Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Zeng, Ri-Xin] Wuhua Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Yang, Hua] Meizhou Entry Exit Inspect & Quarantine Bur, Dept Hlth Examinat, Meizhou, Guangdong, Peoples R China; [Lu, Min; Zhu, Juan-Juan; Xie, Long-Xu] Chaozhou Hybribio Ltd Corp, Chaozhou, Guangdong, Peoples R China; [Wang, Jun-Li] Youjiang Med Coll Nationalities, Affiliated Hosp, Ctr Clin Lab, Baise, Guangxi, Peoples R China	Southern Medical University - China; Southern Medical University - China; Youjiang Medical University for Nationalities	Yang, LY (corresponding author), So Med Univ, Chaozhou Cent Hosp, Lab Med Ctr, Chaozhou, Guangdong, Peoples R China.	yangleeyee@sina.com			National Natural Science Foundation of China [81101329]; Social Development Program of Guangdong province [2011B031800329]; Science and Technology Program of Meizhou [2011B31]; Social Development Program of Chaozhou [2009S14]; Foundation the Health Department of Guangxi Province, China [2012713]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Program of Guangdong province; Science and Technology Program of Meizhou; Social Development Program of Chaozhou; Foundation the Health Department of Guangxi Province, China	This work was partially supported by the National Natural Science Foundation of China (contract/grant number 81101329 to Min Lin), Social Development Program of Guangdong province (contract/grant number 2011B031800329 to Min Lin), Science and Technology Program of Meizhou (contract/grant number 2011B31 to Ying-Fang Wen), Social Development Program of Chaozhou contract/grant number 2009S14 to Gui-Cai Li) and Foundation the Health Department of Guangxi Province, China (contract/grant number 2012713 to Jun-Li Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WQ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-31; Colah R, 2010, EXPERT REV HEMATOL, V3, P103, DOI [10.1586/ehm.09.74, 10.1586/EHM.09.74]; Du RF, 2004, POPULATION GENETICS, P202; Du RF, 2004, POPULATION GENETICS, P220; FLATZ G, 1965, ANN HUM GENET, V29, P151, DOI 10.1111/j.1469-1809.1965.tb00511.x; FLATZ G, 1967, HUMANGENETIK, V3, P189, DOI 10.1007/BF00273124; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Hu SP, 2007, AM J PHYS ANTHROPOL, V132, P140, DOI 10.1002/ajpa.20460; Lau YL, 1997, NEW ENGL J MED, V336, P1298, DOI 10.1056/NEJM199705013361805; Li ZS, 2006, HEMOGLOBIN, V30, P9, DOI 10.1080/03630260500453818; Lin M, 2012, CLIN GENET, V81, P165, DOI 10.1111/j.1399-0004.2011.01627.x; Lin M, 2008, BLOOD CELL MOL DIS, V41, P259, DOI 10.1016/j.bcmd.2008.06.001; Lin M, 2012, BLOOD CELL MOL DIS, V48, P86, DOI 10.1016/j.bcmd.2011.12.001; Liu Z, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P41; Manca L, 2008, IUBMB LIFE, V60, P94, DOI 10.1002/iub.4; MOTUM PI, 1993, HUM MUTAT, V2, P179, DOI 10.1002/humu.1380020305; Pan HF, 2007, CLIN GENET, V71, P419, DOI 10.1111/j.1399-0004.2007.00791.x; Qin LY, 2003, B MED RES, V32, P12; Singsanan S, 2010, BLOOD CELL MOL DIS, V45, P210, DOI 10.1016/j.bcmd.2010.06.001; So CC, 2009, J CLIN PATHOL, V62, P1107, DOI 10.1136/jcp.2009.067538; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Thein SL, 2008, BRIT J HAEMATOL, V141, P357, DOI 10.1111/j.1365-2141.2008.07084.x; Wang WZ, 2010, AM J PHYS ANTHROPOL, V141, P124, DOI 10.1002/ajpa.21124; Wang YZ, 1983, MEIJIANG MED, V1, P40; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Xu XM, 2000, AM J HEMATOL, V65, P183, DOI 10.1002/1096-8652(200011)65:3<183::AID-AJH1>3.0.CO;2-R; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456	29	26	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55024	10.1371/journal.pone.0055024	http://dx.doi.org/10.1371/journal.pone.0055024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383304	Green Published, gold			2022-12-27	WOS:000314597900011
J	Aistleitner, K; Heinz, C; Hormann, A; Heinz, E; Montanaro, J; Schulz, F; Maier, E; Pichler, P; Benz, R; Horn, M				Aistleitner, Karin; Heinz, Christian; Hoermann, Alexandra; Heinz, Eva; Montanaro, Jacqueline; Schulz, Frederik; Maier, Elke; Pichler, Peter; Benz, Roland; Horn, Matthias			Identification and Characterization of a Novel Porin Family Highlights a Major Difference in the Outer Membrane of Chlamydial Symbionts and Pathogens	PLOS ONE			English	Article							SINGLE-CHANNEL ANALYSIS; MATRIX PROTEIN PORIN; PROTOCHLAMYDIA-AMOEBOPHILA; ESCHERICHIA-COLI; DEVELOPMENTAL CYCLE; SIGNAL PEPTIDES; CELL-WALL; TRACHOMATIS; PSITTACI; EXPRESSION	The Chlamydiae constitute an evolutionary well separated group of intracellular bacteria comprising important pathogens of humans as well as symbionts of protozoa. The amoeba symbiont Protochlamydia amoebophila lacks a homologue of the most abundant outer membrane protein of the Chlamydiaceae, the major outer membrane protein MOMP, highlighting a major difference between environmental chlamydiae and their pathogenic counterparts. We recently identified a novel family of putative porins encoded in the genome of P. amoebophila by in silico analysis. Two of these Protochlamydia outer membrane proteins, PomS (pc1489) and PomT (pc1077), are highly abundant in outer membrane preparations of this organism. Here we show that all four members of this putative porin family are toxic when expressed in the heterologous host Escherichia coli. Immunofluorescence analysis using antibodies against heterologously expressed PomT and PomS purified directly from elementary bodies, respectively, demonstrated the location of both proteins in the outer membrane of P. amoebophila. The location of the most abundant protein PomS was further confirmed by immuno-transmission electron microscopy. We could show that pomS is transcribed, and the corresponding protein is present in the outer membrane throughout the complete developmental cycle, suggesting an essential role for P. amoebophila. Lipid bilayer measurements demonstrated that PomS functions as a porin with anion-selectivity and a pore size similar to the Chlamydiaceae MOMP. Taken together, our results suggest that PomS, possibly in concert with PomT and other members of this porin family, is the functional equivalent of MOMP in P. amoebophila. This work contributes to our understanding of the adaptations of symbiotic and pathogenic chlamydiae to their different eukaryotic hosts.	[Aistleitner, Karin; Heinz, Christian; Hoermann, Alexandra; Heinz, Eva; Montanaro, Jacqueline; Schulz, Frederik; Horn, Matthias] Univ Vienna, Dept Microbial Ecol, Vienna, Austria; [Maier, Elke] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forschungsgemeinschaft, Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Pichler, Peter] Christian Doppler Lab Mass Spectrometry, Vienna, Austria; [Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany	University of Vienna; German Research Foundation (DFG); University of Wurzburg; University of Bremen	Horn, M (corresponding author), Univ Vienna, Dept Microbial Ecol, Vienna, Austria.	horn@microbial-ecology.net	Heinz, Eva/I-2053-2014; Horn, Matthias/G-1136-2011	Heinz, Eva/0000-0003-4413-3756; Horn, Matthias/0000-0002-8309-5855; Benz, Roland/0000-0002-9510-9265	German Science Foundation [BE 865/16]; Austrian Science Fund (FWF) [Y277-B03]; Austrian Science Fund (FWF) [Y 277] Funding Source: researchfish	German Science Foundation(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the German Science Foundation to RB (BE 865/16) and the Austrian Science Fund (FWF) to MH (Y277-B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Abeyrathne PD, 2007, CAN J MICROBIOL, V53, P526, DOI 10.1139/W07-007; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Alphen W V, 1977, J Bacteriol, V131, P623; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Bagos PG., 2004, WSEAS T BIOL BIOMED, V2, P186; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; Benz R, 2001, PORINS STRUCTURE FUC; Benz R., 1994, BACTERIAL CELL WALL; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Borges V, 2010, J MICROBIOL METH, V82, P256, DOI 10.1016/j.mimet.2010.06.013; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; CALDWELL HD, 1982, INFECT IMMUN, V38, P745, DOI 10.1128/IAI.38.2.745-754.1982; Collier TS, 2010, ANAL CHEM, V82, P8696, DOI 10.1021/ac101978b; Collingro A, 2005, INT J SYST EVOL MICR, V55, P1863, DOI 10.1099/ijs.0.63572-0; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; EVERETT KDE, 1995, J BACTERIOL, V177, P877, DOI 10.1128/jb.177.4.877-882.1995; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; Gomes JP, 2005, MICROBES INFECT, V7, P410, DOI 10.1016/j.micinf.2004.11.014; HACKSTADT T, 1985, J BACTERIOL, V161, P25, DOI 10.1128/JB.161.1.25-31.1985; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; HATCH TP, 1981, J BACTERIOL, V146, P426, DOI 10.1128/JB.146.1.426-429.1981; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hatch TP, 1996, J BACTERIOL, V178, P1; HATCH TP, 1984, J BACTERIOL, V157, P13, DOI 10.1128/JB.157.1.13-20.1984; Heinz Christian, 2003, Methods Mol Biol, V228, P139, DOI 10.1385/1-59259-400-X:139; Heinz E, 2010, PROTEOMICS, V10, P4363, DOI 10.1002/pmic.201000302; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; Heinz E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-634; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P73; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANN REV MIC IN PRESS, V62; Hughes ES, 2001, INFECT IMMUN, V69, P1671, DOI 10.1128/IAI.69.3.1671-1678.2001; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; IOST I, 1992, J BACTERIOL, V174, P619, DOI 10.1128/jb.174.2.619-622.1992; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; KOEHLER JE, 1992, MOL MICROBIOL, V6, P1087; Kubo A, 2000, MOL MICROBIOL, V38, P772, DOI 10.1046/j.1365-2958.2000.02167.x; Liu XY, 2010, J BACTERIOL, V192, P2852, DOI 10.1128/JB.01628-09; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; LUDWIG O, 1986, BIOCHIM BIOPHYS ACTA, V860, P268, DOI 10.1016/0005-2736(86)90523-7; MCCAFFERTY MC, 1995, INFECT IMMUN, V63, P2387, DOI 10.1128/IAI.63.6.2387-2389.1995; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; NEWHALL WJ, 1987, INFECT IMMUN, V55, P162, DOI 10.1128/IAI.55.1.162-168.1987; NEWHALL WJ, 1983, J BACTERIOL, V154, P998, DOI 10.1128/JB.154.2.998-1001.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pal S, 1997, INFECT IMMUN, V65, P3361, DOI 10.1128/IAI.65.8.3361-3369.1997; PEELING R, 1984, INFECT IMMUN, V46, P484, DOI 10.1128/IAI.46.2.484-488.1984; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; RAULSTON JE, 1995, MOL MICROBIOL, V15, P607, DOI 10.1111/j.1365-2958.1995.tb02370.x; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; RITTER K, 1991, J IMMUNOL METHODS, V137, P209, DOI 10.1016/0022-1759(91)90026-C; SALARI SH, 1981, J GEN MICROBIOL, V123, P197; SCHINDLER H, 1978, P NATL ACAD SCI USA, V75, P3751, DOI 10.1073/pnas.75.8.3751; SEN K, 1988, J BIOL CHEM, V263, P1182; Stephens RS, 1999, CHLAMYDIA, P9; STEPHENS RS, 1982, J IMMUNOL, V128, P1083; Stothard DR, 1998, INFECT IMMUN, V66, P3618, DOI 10.1128/IAI.66.8.3618-3625.1998; SU H, 1991, INFECT IMMUN, V59, P2843, DOI 10.1128/IAI.59.8.2843-2845.1991; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; TAN TW, 1990, INFECT IMMUN, V58, P3101, DOI 10.1128/IAI.58.9.3101-3108.1990; Tanzer RJ, 2001, J BACTERIOL, V183, P2686, DOI 10.1128/JB.183.8.2686-2690.2001; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; TRIAS J, 1992, SCIENCE, V258, P1479, DOI 10.1126/science.1279810; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; WARD ME, 1984, J GEN MICROBIOL, V130, P1765; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; WELTE W, 1995, KIDNEY INT, V48, P930, DOI 10.1038/ki.1995.374; Wyllie S, 1998, INFECT IMMUN, V66, P5202, DOI 10.1128/IAI.66.11.5202-5207.1998; Wyllie S, 1999, FEBS LETT, V445, P192, DOI 10.1016/S0014-5793(99)00121-0; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	86	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55010	10.1371/journal.pone.0055010	http://dx.doi.org/10.1371/journal.pone.0055010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383036	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600055
J	Chen, ST; Hsueh, C; Chiou, WK; Lin, JD				Chen, Szu-Tah; Hsueh, Chuen; Chiou, Wen-Ko; Lin, Jen-Der			Disease-Specific Mortality and Secondary Primary Cancer in Well-Differentiated Thyroid Cancer with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							RISK; IMPACT; AGE	Background: Increased body mass index is related to the incidence of thyroid cancer. However, the presentation and therapeutic outcomes of different thyroid cancers and type 2 diabetes mellitus (DM) have not been studied. This study investigated the effect of type 2 DM on the clinical presentations and therapeutic outcome of well-differentiated thyroid cancer. Methods and Findings: A retrospective analysis of adult thyroid cancer patients with or without type 2 DM admitted between January 2001 and December 2010 was performed at an institution. A total of 1,687 well-differentiated thyroid cancer patients with different histological patterns were enrolled. Among these subjects, 122 were type 2 DM patients. Patients with thyroid cancer and type 2 DM were significantly older than non-DM patients. After a mean follow-up period of 5.6 +/- 0.1 years, patients with thyroid cancer and type 2 DM showed a higher percentage of disease progression than non-DM patients (24.6% vs. 17.4%). In addition, disease-specific mortality was higher in the type 2 DM group (10.7% vs. 3.8%). Thyroid cancer patients with type 2 DM showed a higher percentage of secondary primary cancers than those without DM (10.7% vs. 4.9%). Thyroid cancer-specific survival rates in the type 2 DM and non-DM groups were 82.2% and 94.9% at 5 years, 72.9% and 91.4% at 10 years, and 36.5% and 61.3% at 20 years, respectively. Multivariate analysis showed that type 2 DM was independent of thyroid cancer-specific mortality. Conclusion: Patients with type 2 DM and well-differentiated thyroid cancer had an advanced tumor-node-metastasis stage at the time of diagnosis and an increased disease-specific mortality. Aggressive surgical procedures and close follow-up for well-differentiated thyroid cancer patients with type 2 DM are therefore necessary.	[Chen, Szu-Tah; Lin, Jen-Der] Chang Gung Univ, Dept Internal Med, Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Hsueh, Chuen] Chang Gung Univ, Dept Pathol, Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Chiou, Wen-Ko] Chang Gung Univ, Dept Ind Design, Hlth Aging Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Lin, JD (corresponding author), Chang Gung Univ, Dept Internal Med, Chang Gung Mem Hosp, Tao Yuan, Taiwan.	einjd@adm.cgmh.org.tw		Hsueh, Chuen/0000-0001-7860-5964	National Science Council in Taiwan [NMRPD1B0311]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant to J.D.L. from National Science Council in Taiwan (NMRPD1B0311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist M, 2011, CANCER CAUSE CONTROL, V22, P743, DOI 10.1007/s10552-011-9747-2; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Aschebrook-Kilfoy B, 2011, THYROID, V21, P957, DOI 10.1089/thy.2010.0396; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Chang CJ, 2000, DIABETES RES CLIN PR, V50, pS49, DOI 10.1016/S0168-8227(00)00179-0; Chiou WK, 2011, ASIAN PAC J CANCER P, V12, P1577; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; DELELLIS RA, 2004, PATHOLOGY GENETICS T; Huang H S, 1989, Taiwan Yi Xue Hui Za Zhi, V88, P43; Johnson JA, 2010, DIABETOLOGIA, V53, P2086, DOI 10.1007/s00125-010-1855-0; Jonklaas J, 2012, J CLIN ENDOCR METAB, V97, pE878, DOI 10.1210/jc.2011-2864; LIN JD, 1994, J SURG ONCOL, V57, P252, DOI 10.1002/jso.2930570409; Lin JD, 2000, ONCOLOGY-BASEL, V58, P280, DOI 10.1159/000012113; Lin JD, 2008, RADIOTHER ONCOL, V89, P97, DOI 10.1016/j.radonc.2008.05.011; Mijovic T, 2009, THYROID, V19, P467, DOI 10.1089/thy.2008.0386; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Onitilo AA, 2012, CANCER CAUSE CONTROL, V23, P991, DOI 10.1007/s10552-012-9971-4; Oyer SL, 2012, OTOLARYNG HEAD NECK, V147, P221, DOI 10.1177/0194599812441587; Paes JE, 2010, J CLIN ENDOCR METAB, V95, P4244, DOI 10.1210/jc.2010-0440; Rezzonico J, 2011, METAB SYNDR RELAT D, V9, P69, DOI 10.1089/met.2010.0026; Schvartz C, 2012, J CLIN ENDOCR METAB, V97, P1526, DOI 10.1210/jc.2011-2512; Sobin LH, 2002, TNM CLASS MAL TUM, P52; Verlato G, 2003, DIABETES CARE, V26, P1047, DOI 10.2337/diacare.26.4.1047; Zhang DD, 2002, STAT MED, V21, P701, DOI 10.1002/sim.1011	24	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55179	10.1371/journal.pone.0055179	http://dx.doi.org/10.1371/journal.pone.0055179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383099	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600072
J	Christiansson, L; Soderlund, S; Svensson, E; Mustjoki, S; Bengtsson, M; Simonsson, B; Olsson-Stromberg, U; Loskog, ASI				Christiansson, Lisa; Soderlund, Stina; Svensson, Emma; Mustjoki, Satu; Bengtsson, Mats; Simonsson, Bengt; Olsson-Stromberg, Ulla; Loskog, Angelica S. I.			Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; TUMOR BURDEN; B7-H1 PD-L1; PHASE-I; IMATINIB; CANCER; SAFETY; INTERLEUKIN-2-RECEPTOR; ARGINASE; ANTIBODY	Immunotherapy (eg interferon alpha) in combination with tyrosine kinase inhibitors is currently in clinical trials for treatment of chronic myeloid leukemia (CML). Cancer patients commonly have problems with so called immune escape mechanisms that may hamper immunotherapy. Hence, to study the function of the immune system in CML is of interest. In the present paper we have identified immune escape mechanisms in CML with focus on those that directly hamper T cells since these cells are important to control tumor progression. CML patient samples were investigated for the presence of myeloid-derived suppressor cells (MDSCs), expression of programmed death receptor ligand 1/programmed death receptor 1 (PD-L1/PD-1), arginase 1 and soluble CD25. MDSC levels were increased in samples from Sokal high risk patients (p<0,05) and the cells were present on both CD34 negative and CD34 positive cell populations. Furthermore, expression of the MDSC-associated molecule arginase 1, known to inhibit T cells, was increased in the patients (p = 0,0079). Myeloid cells upregulated PD-L1 (p<0,05) and the receptor PD-1 was present on T cells. However, PD-L1 blockade did not increase T cell proliferation but upregulated IL-2 secretion. Finally, soluble CD25 was increased in high risk patients (p<0,0001). In conclusion T cells in CML patients may be under the control of different immune escape mechanisms that could hamper the use of immunotherapy in these patients. These escape mechanisms should be monitored in trials to understand their importance and how to overcome the immune suppression.	[Christiansson, Lisa; Svensson, Emma; Bengtsson, Mats; Loskog, Angelica S. I.] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Soderlund, Stina; Simonsson, Bengt; Olsson-Stromberg, Ulla] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Soderlund, Stina; Simonsson, Bengt; Olsson-Stromberg, Ulla] Univ Uppsala Hosp, Dept Hematol, Uppsala, Sweden; [Mustjoki, Satu] Univ Helsinki, Dept Med, Div Hematol, Hematol Res Unit Helsinki, Helsinki, Finland; [Mustjoki, Satu] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Bengtsson, Mats] Univ Uppsala Hosp, Sect Clin Immunol & Transfus Med, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Uppsala University; Uppsala University Hospital	Christiansson, L (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	lisa.christiansson@igp.uu.se	Mustjoki, Satu/AAD-9974-2020	Mustjoki, Satu/0000-0002-0816-8241; Loskog, Angelica/0000-0001-8583-6138	Nordic CML study group; EuropeanLeukemiaNet; Uppsala University Hospital; Medical Faculty at Uppsala University; Cancer Foundation Finland sr [100118, 110101] Funding Source: researchfish	Nordic CML study group; EuropeanLeukemiaNet; Uppsala University Hospital; Medical Faculty at Uppsala University; Cancer Foundation Finland sr	The study was supported by the Nordic CML study group (http://www.nordiccml.org/), EuropeanLeukemiaNet (http://www.leukemia-net.org/content/home/), Uppsala University Hospital and the Medical Faculty at Uppsala University (http://www.akademiska.se/, http://www.medfarm.uu.se/medicinska_fakulteten/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Butt NM, 2005, HAEMATOLOGICA, V90, P1315; Chen XL, 2008, CANCER BIOL THER, V7, P622, DOI 10.4161/cbt.7.5.5689; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; El-Hady SBM, 2012, ANN HEMATOL, V91, P1193, DOI 10.1007/s00277-012-1427-0; Eleftheriadis T, 2012, RENAL FAILURE, V34, P1118, DOI 10.3109/0886022X.2012.713297; Ennishi D, 2009, ANN ONCOL, V20, P526, DOI 10.1093/annonc/mdn677; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Gabitass RF, 2011, CANC IMMUNOL IMMUNOT; Gadiot J, 2011, CANCER-AM CANCER SOC, V117, P2192, DOI 10.1002/cncr.25747; GAUSE A, 1992, ANN ONCOL, V3, pS49, DOI 10.1093/annonc/3.suppl_4.S49; Gross S, 2008, IMMUNOL LETT, V116, P7, DOI 10.1016/j.imlet.2007.11.012; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Hehlmann R, 2011, J CLIN ONCOL, V29, P1634, DOI 10.1200/JCO.2010.32.0598; Herrmann H, 2011, ASH ANN M, V118, P961; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; HOROWITZ MM, 1990, BLOOD, V75, P555; Jiao ZJ, 2012, WORLD J GASTROENTERO, V18, P5454, DOI 10.3748/wjg.v18.i38.5454; Kawatani T, 1997, INT J HEMATOL, V65, P123; Kitagawa JI, 2009, J CANCER RES CLIN, V135, P53, DOI 10.1007/s00432-008-0440-0; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; LEU SY, 1992, CANCER, V70, P733, DOI 10.1002/1097-0142(19920815)70:4<733::AID-CNCR2820700403>3.0.CO;2-6; Li ZH, 2005, CLIN CANCER RES, V11, P4460, DOI 10.1158/1078-0432.CCR-05-0250; Lindqvist CA, 2010, IMMUNOLOGY, V131, P371, DOI 10.1111/j.1365-2567.2010.03308.x; Loos M, 2011, ANN THORAC SURG, V91, P1025, DOI 10.1016/j.athoracsur.2010.12.041; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; MOTOI T, 1989, BLOOD, V74, P1052; Mumprecht S, 2009, BLOOD, V114, P1528, DOI 10.1182/blood-2008-09-179697; Mustjoki S, 2010, LEUKEMIA, V24, P219, DOI 10.1038/leu.2009.190; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Or R, 2003, BLOOD, V101, P441, DOI 10.1182/blood-2002-02-0535; Panteli KE, 2005, BRIT J HAEMATOL, V130, P709, DOI 10.1111/j.1365-2141.2005.05674.x; Perez-Encinas M, 1998, HAEMATOLOGICA, V83, P752; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Preudhomme C, 2010, NEW ENGL J MED, V363, P2511, DOI 10.1056/NEJMoa1004095; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; RUBIN LA, 1986, J IMMUNOL, V137, P3841; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Salih HR, 2006, EXP HEMATOL, V34, P888, DOI 10.1016/j.exphem.2006.03.006; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Simonsson B, 2011, BLOOD, V118, P3228, DOI 10.1182/blood-2011-02-336685; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	54	91	93	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55818	10.1371/journal.pone.0055818	http://dx.doi.org/10.1371/journal.pone.0055818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383287	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600164
J	Honarvar, B; Moghadami, M; Moattari, A; Emami, A; Odoomi, N; Lankarani, KB				Honarvar, Behnam; Moghadami, Mohsen; Moattari, Afagh; Emami, Amir; Odoomi, Neda; Lankarani, Kamran Bagheri			Seroprevalence of Anti-Rubella and Anti-Measles IgG Antibodies in Pregnant Women in Shiraz, Southern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Campaign	PLOS ONE			English	Article							CHILDBEARING AGE; INFECTION; IMMUNITY; ELIMINATION; POPULATION; UNIVERSITY; PROGRESS	Objective: Nonimmune pregnant women are at risk of developing congenital rubella syndrome and measles complications. We aimed to identify pregnant women susceptible to rubella or measles in order to determine the need for immunity screening and supplemental immunization in women of childbearing age. Method: This seroprevalence survey was conducted by convenience sampling in obstetric hospitals affiliated with Shiraz University of Medical Sciences (southern Iran). Serum IgG levels were measured by ELISA. Result: Mean age of the 175 pregnant women was 27.3 +/- 5.3 (range 16 to 42) years. The geometric mean concentration of anti-rubella IgG was 14.9 IU/mL (CI 95%,14.1-15.5), and that of anti-measles IgG was 13.8 IU/mL (CI 95%, 13-14.5). One hundred sixty-eight women (96%) had a protective serologic level (>11 IU/mL) of IgG against rubella, and 143 (81.7%) had a protective level against measles. Except for a significant inverse correlation that was showed by univariate analysis between anti-rubella IgG and the women's age (P = 0.01), immunity did not correlate with demographic or obstetric characteristics or medical history. There was no significant correlation between anti-rubella and anti-measles IgG levels (P = 0.25). Conclusion: Nearly a decade after Iran's nationwide measles-rubella vaccination campaign for the population aged 5-25 years, most pregnant women up to 34 years of age had humoral immunity against rubella. We recommend rubella immunity screening or catch-up immunization for women older than 35 years who wish to become pregnant, and measles immunity screening and appropriate vaccination for all women of childbearing age.	[Honarvar, Behnam; Lankarani, Kamran Bagheri] Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran; [Moghadami, Mohsen] Shiraz Univ Med Sci, HIV AIDS Res Ctr, Shiraz, Iran; [Moattari, Afagh; Emami, Amir] Shiraz Univ Med Sci, Dept Virol, Sch Med, Shiraz, Iran; [Odoomi, Neda] Shiraz Univ Med Sci, Dept Hlth, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Honarvar, B (corresponding author), Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran.	honarvarbh32@yahoo.com	Lankarani, Kamran B/P-5336-2019; Moattari, Afagh/U-8143-2017; moghadami, mohsen/T-6539-2018; Honarvar, Behnam/K-1623-2013; Lankarani, Kamran Bagheri/P-2066-2017; Emami, Amir/H-1024-2016; lankarani, kamran b/D-5901-2012	Lankarani, Kamran B/0000-0002-7524-9017; Moattari, Afagh/0000-0003-4394-9622; moghadami, mohsen/0000-0001-8015-0313; Honarvar, Behnam/0000-0002-1081-5778; Lankarani, Kamran Bagheri/0000-0002-7524-9017; Emami, Amir/0000-0002-4510-1820; 	Health Policy Research Center [HP-90-2]; Shiraz University of Medical Sciences, Shiraz, Iran	Health Policy Research Center; Shiraz University of Medical Sciences, Shiraz, Iran	This study was implemented by authors and based on priorities that have been announced by Health Policy Research Center affiliated with Shiraz University of Medical Sciences. The Health Policy Research Center sponsored this study by grunt number of HP-90-2. However, This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the Health Policy Research Center affiliated with Shiraz University of Medical Sciences, Shiraz, Iran. We thank the pregnant women and their partners for their consent to participate in this study, and the obstetrics clinic staff members at Hafez and Zeinabieh Hospitals in Shiraz for providing a comfortable environment for the interviews that was respectful of participants' privacy. We also thank K. Shashok (AuthorAID in the Eastern Mediterranean) for improving the use of English in the manuscript.	Aksakal FN, 2007, JPN J INFECT DIS, V60, P157; Ali ME, 1997, INT J GYNECOL OBSTET, V59, P109, DOI 10.1016/S0020-7292(97)00196-3; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; Anselem O, 2011, PRESSE MED, V40, P1001, DOI 10.1016/j.lpm.2011.07.002; BABOONIAN C, 1983, BRIT J OBSTET GYNAEC, V90, P1168, DOI 10.1111/j.1471-0528.1983.tb06466.x; Byrne L, 2012, VACCINE, V30, P161, DOI 10.1016/j.vaccine.2011.11.045; Chiba ME, 2003, J INFECTION, V47, P40, DOI 10.1016/S0163-4453(03)00045-8; Dayan GH, 2005, EPIDEMIOL INFECT, V133, P861, DOI 10.1017/S0950268805004437; de Oliveira SA, 2011, J INFECT DIS, V204, pS664, DOI 10.1093/infdis/jir356; EBERHARTPHILLIPS JE, 1993, OBSTET GYNECOL, V82, P797; Enders M, 2007, BUNDESGESUNDHEITSBLA, V50, P1393, DOI 10.1007/s00103-007-0195-9; Esteghamati A, 2007, PEDIATR INFECT DIS J, V26, P1137, DOI 10.1097/INF.0b013e3181462090; Ghazizadeh SH, 2004, TXB PUBLIC HLTH, V3, P1317; Hamdan HZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-217; Hamkar R, 2006, AM J INFECT CONTROL, V34, P588, DOI 10.1016/j.ajic.2005.11.005; Karakoc GB, 2003, EUR J EPIDEMIOL, V18, P81, DOI 10.1023/A:1022538407514; Kennedy Colleen M, 2006, Infect Dis Obstet Gynecol, V2006, P13890; Lin CC, 2011, BJOG-INT J OBSTET GY, V118, P706, DOI 10.1111/j.1471-0528.2011.02903.x; Mahmoudi M, 2007, MED J MASHHAD U MED, V50, P177; Majlessi F., 2008, Eastern Mediterranean Health Journal, V14, P590; Miller EM, 2009, AM J HUM BIOL, V21, P401, DOI 10.1002/ajhb.20882; Mora-García Gustavo J, 2011, Rev. salud pública, V13, P288; Onakewhor JU, 2011, NIGER J CLIN PRACT, V14, P140, DOI 10.4103/1119-3077.84002; Pehlivan E, 2007, PUBLIC HEALTH, V121, P462, DOI 10.1016/j.puhe.2006.09.021; Pourabbas B, 2008, INT J INFECT DIS, V12, P43, DOI 10.1016/j.ijid.2007.03.013; Qian Xiao-hua, 2010, Zhongguo Yi Miao He Mian Yi, V16, P146; Rasmussen SA, 2012, BIRTH DEFECTS RES A, V94, P123, DOI 10.1002/bdra.22887; Reef SE, 2011, J INFECT DIS, V204, pS24, DOI 10.1093/infdis/jir155; Sadighi J, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-44; Sathanandan D, 2005, AUST NZ J OBSTET GYN, V45, P435, DOI 10.1111/j.1479-828X.2005.00467.x; Sauerbrei A, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P10, DOI 10.1007/s00103-003-0689-z; Seker S, 2004, SAUDI MED J, V25, P575; Shoda A, 2011, BJOG-INT J OBSTET GY, V118, P88, DOI 10.1111/j.1471-0528.2010.02764.x; Tabatabaei M, 2006, PRINCIPLES DIS PREVE, P77; WHO, RUB; World Health Organization, 2011, MEASL FACT SHEET 286; Wysokinska T, 2004, VACCINE, V22, P1899, DOI 10.1016/j.vaccine.2003.11.004; Yekta Z., 2009, Eastern Mediterranean Health Journal, V15, P516; Zahraei SM, 2011, J INFECT DIS, V204, pS305, DOI 10.1093/infdis/jir076	39	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55043	10.1371/journal.pone.0055043	http://dx.doi.org/10.1371/journal.pone.0055043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383049	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600059
J	Ma, YY; Guan, TP; Yao, HB; Yu, S; Chen, LG; Xia, YJ; He, XJ; Wang, HJ; Jiang, XT; Tao, HQ				Ma, Ying-Yu; Guan, Tian-Pei; Yao, Hai-Bo; Yu, Sheng; Chen, Le-Gao; Xia, Ying-Jie; He, Xu-Jun; Wang, Hui-Ju; Jiang, Xiao-Ting; Tao, Hou-Quan			The MDM2 309T > G Polymorphism and Ovarian Cancer Risk: A Meta-Analysis of 1534 Cases and 2211 Controls	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; ACCELERATES TUMOR-FORMATION; SNP309 POLYMORPHISM; P53; BREAST; SUSCEPTIBILITY; CARCINOMA; PATHWAY; WOMEN; ASSOCIATION	Background: Recently, there have been a number of studies on the association between MDM2 (Murine Double Minute 2) 309 polymorphism and ovarian cancer risk. However, the results of previous reports remain controversial and ambiguous. Thus, we performed a meta-analysis to explore more precisely the association between MDM2 309 polymorphism and the risk of ovarian cancer. Methods: A meta-analysis was performed to examine the association between MDM2 309T>G polymorphism and ovarian cancer risk. Odds ratio (OR) and its 95% confidence interval (CI) were used for statistical analysis. Results: Our publication search identified a total of 6 studies with 1534 cases and 2211 controls. No significant association was found between MDM2 309T>G polymorphism and ovarian cancer risk in total population analysis. In the subgroup meta-analysis by ethnicity, a negative association was shown in Asian subgroup (G vs. T OR = 0.774, 95% CI = 0.628-0.955, P = 0.017, P-het = 0.327; GG vs. TT: OR = 0.601, 95% CI = 0.395-0.914, P = 0.017, P-het = 0.417; dominant model TG+GG vs. TT: OR = 0.661, 95% CI = 0.468-0.934, P = 0.019, P-het = 0.880), and no significant association in any genetic models among Caucasians was observed. Conclusions: This meta-analysis provides evidence for the association between MDM2 309 polymorphism and ovarian cancer risk, supporting the hypothesis that MDM2 SNP309 G allele acts as an important ovarian cancer protective factor in Asians but not in Caucasians.	[Ma, Ying-Yu; Xia, Ying-Jie; He, Xu-Jun; Wang, Hui-Ju; Tao, Hou-Quan] Zhejiang Prov Peoples Hosp, Key Lab Gastroenterol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Guan, Tian-Pei; Yao, Hai-Bo; Yu, Sheng; Chen, Le-Gao] Wenzhou Med Coll, Dept Surg, Wenzhou, Peoples R China; [Jiang, Xiao-Ting] Zhejiang Prov Peoples Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Tao, Hou-Quan] Zhejiang Prov Peoples Hosp, Dept Gastrointestinal Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Wenzhou Medical University; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Jiang, XT (corresponding author), Zhejiang Prov Peoples Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China.	jiangxiaoting2008@yahoo.cn; taohouquan2008@yahoo.com.cn	He, Xujun/O-8446-2018	He, Xujun/0000-0002-6979-2072	National Natural Science Foundation of China [81071991]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents and Medicine; Project of Science and Technology of Zhejiang Province [2010C 33018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents and Medicine; Project of Science and Technology of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (No.81071991), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents and Medicine and Project of Science and Technology of Zhejiang Province (No. 2010C 33018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; Bartel F, 2008, CLIN CANCER RES, V14, P89, DOI 10.1158/1078-0432.CCR-07-1192; Bjornslett M, 2011, J CLIN ONCOL S, V29; Bond GL, 2007, ONCOGENE, V26, P1317, DOI 10.1038/sj.onc.1210199; Bond GL, 2006, J MED GENET, V43, P950, DOI 10.1136/jmg.2006.043539; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Campbell IG, 2006, CANCER LETT, V240, P195, DOI 10.1016/j.canlet.2005.09.003; Copson ER, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-80; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Economopoulos KP, 2010, BREAST CANCER RES TR, V120, P211, DOI 10.1007/s10549-009-0467-1; Galic V, 2007, GENE CHROMOSOME CANC, V46, P239, DOI 10.1002/gcc.20407; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirshfield KM, 2010, J ONCOL, V2010, DOI 10.1155/2010/297671; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; Hu ZB, 2007, CANCER EPIDEM BIOMAR, V16, P2717, DOI 10.1158/1055-9965.EPI-07-0634; Kang S, 2009, INT J GYNECOL CANCER, V19, P572, DOI 10.1111/IGC.0b013e3181a130ab; Knappskog S, 2012, EUR J CANCER, V48, P1988, DOI 10.1016/j.ejca.2011.10.024; Knappskog S, 2011, ONCOTARGET, V2, P251; Knappskog S, 2011, CANCER CELL, V19, P273, DOI 10.1016/j.ccr.2010.12.019; Krekac D, 2008, ONCOLOGY-BASEL, V74, P84, DOI 10.1159/000139135; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leitao MM, 2003, GYNECOL ONCOL, V91, P123, DOI 10.1016/S0090-8258(03)00464-5; Li Y, 2011, HUM CELL, V24, P57, DOI 10.1007/s13577-011-0013-4; Liu GY, 2011, ARCH MED RES, V42, P149, DOI 10.1016/j.arcmed.2011.02.002; Liu J, 2011, ASIAN PAC J CANCER P, V12, P1899; Ueda M, 2009, HUM CELL, V22, P49, DOI 10.1111/j.1749-0774.2009.00068.x; Wan Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-208; Wilkening S, 2007, CARCINOGENESIS, V28, P2262, DOI 10.1093/carcin/bgm191; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Yarden RI, 2008, BREAST CANCER RES TR, V111, P497, DOI 10.1007/s10549-007-9797-z; Zhang XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/humu.20277; Zhou GQ, 2007, CLIN CANCER RES, V13, P2627, DOI 10.1158/1078-0432.CCR-06-2281	35	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55019	10.1371/journal.pone.0055019	http://dx.doi.org/10.1371/journal.pone.0055019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383041	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600056
J	Ren, SY; Li, XL; Wen, JY; Zhang, WJ; Liu, P				Ren, Shiyan; Li, Xianlun; Wen, Jianyan; Zhang, Wenjian; Liu, Peng			Systematic Review of Randomized Controlled Trials of Different Types of Patch Materials during Carotid Endarterectomy	PLOS ONE			English	Review							SAPHENOUS-VEIN PATCH; LONG-TERM OUTCOMES; LATE FOLLOW-UP; PRIMARY CLOSURE; POLYTETRAFLUOROETHYLENE PATCH; JUGULAR-VEIN; VENOUS PATCH; ANGIOPLASTY; DACRON	Background and Purpose: Carotid endarterectomy (CEA) with patch angioplasty produces greater results than with primary closure; however, there remains uncertainty on the optimal patch material in CEA. A systematic review of randomized controlled trials (RCTs) was performed to evaluate the effect of angioplasty using venous patch versus synthetic patch material, and Dacron patch versus polytetrafluoroethelene (PTFE) patch material during CEA. Methods: A multiple electronic health database screening was performed including the Cochrane library, Pubmed, Ovid, EMBASE and Google Scholar on all randomized controlled trials (RCTs) published before November 2012 that compared the outcomes of patients undergoing CEA with venous patch versus synthetic patch. RCTs were included if they compared carotid patch angioplasty with autologus venous patch versus synthetic patch material, or compared one type of synthetic patch with another. Results: Thirteen RCTs were identified. Ten trials, involving 1946 CEAs, compared venous patch with synthetic patch materials. Two trials, involving 400 CEAs in 380 patients, compared Dacron patch with PTFE patch. The hemostasis time in CEA with PTFE patch was significantly longer than with venous patch (P<0.0001), and longer than with Dacron patch (P<0.0001). There was no significant difference of mortality rate, stroke rate, restenosis, and operative time in CEA with venous patch versus synthetic patch material, or in CEA with Dacron patch versus PTFE patch (all P>0.05). One RCT of 95 CEAs in 92 patients compared bovine pericardium with Dacron patch, and demonstrated a statistically significant decrease in intraoperative suture line bleeding with bovine pericardium compared with Dacron patch (P<0.001). Conclusions: The hemostasis time in CEA with PTFE patch was longer than with venous patch or Dacron patch. The overall perioperative and long-term mortality rate, stroke rate, restenosis, and operative time were similar when using venous patch versus synthetic patch material or Dacron patch versus PTFE patch material during CEA. More data are required to clarify differences between different patch materials.	[Ren, Shiyan; Li, Xianlun; Liu, Peng] China Japan Friendship Hosp, Ctr Cardiovasc, Beijing, Peoples R China; [Wen, Jianyan; Zhang, Wenjian] China Japan Friendship Hosp, Clin Res Inst, Beijing, Peoples R China	China-Japan Friendship Hospital; China-Japan Friendship Hospital	Ren, SY (corresponding author), China Japan Friendship Hosp, Ctr Cardiovasc, Beijing, Peoples R China.	shiyanr@yahoo.com; lixianlun@hotmail.com; liupeng61@yahoo.com.cn		wen, jianyan/0000-0001-5762-6504	National Sciences Foundation of China [81070230]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by National Sciences Foundation of China (grant 81070230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This paper is supported in part by National Sciences Foundation of China (Grant No. 81070230). Dr. Ren is the guarantor for this article, and takes responsibility for the integrity of the work as a whole.	AbuRahma AF, 2003, ANN SURG, V237, P885, DOI 10.1097/00000658-200306000-00018; AbuRahma AF, 2002, J VASC SURG, V35, P125, DOI 10.1067/mva.2002.119034; AbuRahma AF, 1996, J VASC SURG, V24, P998, DOI 10.1016/S0741-5214(96)70045-9; AbuRahma AF, 1998, J VASC SURG, V27, P222, DOI 10.1016/S0741-5214(98)70353-2; AbuRahma AF, 2007, J VASC SURG, V45, P881, DOI 10.1016/j.jvs.2007.01.038; Bond R, 2004, J VASC SURG, V40, P1126, DOI 10.1016/j.jvs.2004.08.048; Bond R, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000071.PUB2; Carney W I Jr, 1987, Ann Vasc Surg, V1, P583, DOI 10.1016/S0890-5096(06)61445-3; CLAGETT GP, 1989, J VASC SURG, V9, P213, DOI 10.1067/mva.1989.vs0090213; Counsell C, 2000, COCHRANE DB SYST REV; Golledge J, 2011, EUR J VASC ENDOVASC, V42, pS39, DOI 10.1016/j.ejvs.2011.06.034; GONZALEZFAJARDO JA, 1994, J CARDIOVASC SURG, V35, P523; Grego F, 2003, J VASC SURG, V38, P1232, DOI 10.1016/S0741-5214(03)00912-1; HANS SS, 1991, AM J SURG, V162, P50, DOI 10.1016/0002-9610(91)90201-N; Hayes PD, 2001, J VASC SURG, V33, P994, DOI 10.1067/mva.2001.115005; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Katz SG, 1996, SURGERY, V119, P297, DOI 10.1016/S0039-6060(96)80116-4; LeGrand D R, 1990, Ann Vasc Surg, V4, P209, DOI 10.1007/BF02009445; LORD RSA, 1989, J VASC SURG, V9, P521, DOI 10.1067/mva.1989.vs0090521; Louagie Y, 2011, EUR J VASC ENDOVASC, V42, P766, DOI 10.1016/j.ejvs.2011.08.017; Mannheim D, 2005, J VASC SURG, V41, P403, DOI 10.1016/j.jvs.2004.11.036; Marien BJ, 2002, ARCH SURG-CHICAGO, V137, P785, DOI 10.1001/archsurg.137.7.785; Meerwaldt R, 2008, EUR J VASC ENDOVASC, V36, P45, DOI 10.1016/j.ejvs.2008.02.009; Naylor R, 2004, J VASC SURG, V39, P985, DOI 10.1016/j.jvs.2004.01.037; O'Hara PJ, 2002, J VASC SURG, V35, P324, DOI 10.1067/mva.2002.120047; Ren SY, 2012, ANN THORAC CARDIOVAS, V18, P228, DOI 10.5761/atcs.oa.12.01928; Rerkasem K, 2011, ASIAN J SURG, V34, P32, DOI 10.1016/S1015-9584(11)60016-X; Rerkasem K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001081.pub2; Rerkasem K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000071.pub3; RICCO JB, 1994, J MAL VASCUL, V19, P10; STEWART GW, 1987, ARCH SURG-CHICAGO, V122, P364; TENHOLTER JBM, 1990, J CARDIOVASC SURG, V31, P58	32	27	32	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55050	10.1371/journal.pone.0055050	http://dx.doi.org/10.1371/journal.pone.0055050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383053	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600060
J	Roll, S; Reinhold, T; Pach, D; Brinkhaus, B; Icke, K; Staab, D; Jackel, T; Wegscheider, K; Willich, SN; Witt, CM				Roll, Stephanie; Reinhold, Thomas; Pach, Daniel; Brinkhaus, Benno; Icke, Katja; Staab, Doris; Jaeckel, Tanja; Wegscheider, Karl; Willich, Stefan N.; Witt, Claudia M.			Comparative Effectiveness of Homoeopathic vs. Conventional Therapy in Usual Care of Atopic Eczema in Children: Long-Term Medical and Economic Outcomes	PLOS ONE			English	Article							DERMATITIS; PREVALENCE; DISEASES	Background: One in five children visiting a homeopathic physician suffers from atopic eczema. Objectives: We aimed to examine the long-term effectiveness, safety and costs of homoeopathic vs. conventional treatment in usual medical care of children with atopic eczema. Methods: In this prospective multi-centre comparative observational non-randomized rater-blinded study, 135 children (48 homoeopathy, 87 conventional) with mild to moderate atopic eczema were included by their respective physicians. Depending on the specialisation of the physician, the primary treatment was either standard conventional treatment or individualized homeopathy as delivered in routine medical care. The main outcome was the SCORAD (SCORing Atopic Dermatitis) at 36 months by a blinded rater. Further outcomes included quality of life, conventional medicine consumption, safety and disease related costs at six, 12 and 36 months after baseline. A multilevel ANCOVA was used, with physician as random effect and the following fixed effects: age, gender, baseline value, severity score, social class and parents' expectation. Results: The adjusted mean SCORAD showed no significant differences between the groups at 36 months (13.7 95% CI [7.9-19.5] vs. 14.9 [10.4-19.4], p = 0.741). The SCORAD response rates at 36 months were similar in both groups (33% response: homoeopathic 63.9% vs. conventional 64.5%, p = 0.94; 50% response: 52.0% vs. 52.3%, p = 0.974). Total costs were higher in the homoeopathic versus the conventional group (months 31-36 200.54 Euro [132.33-268.76] vs. 68.86 Euro [9.13-128.58], p = 0.005). Conclusions: Taking patient preferences into account, while being unable to rule out residual confounding, in this long-term observational study, the effects of homoeopathic treatment were not superior to conventional treatment for children with mild to moderate atopic eczema, but involved higher costs.	[Roll, Stephanie; Reinhold, Thomas; Pach, Daniel; Brinkhaus, Benno; Icke, Katja; Jaeckel, Tanja; Willich, Stefan N.; Witt, Claudia M.] Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Staab, Doris] Charite, Med Ctr, Dept Paediat Pulmonol & Immunol, D-13353 Berlin, Germany; [Wegscheider, Karl] Univ Med Ctr, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University System of Maryland; University of Maryland Baltimore	Roll, S (corresponding author), Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany.	stephanie.roll@charite.de	Witt, Claudia M./AAX-2370-2021; Brinkhaus, Benno/AAU-2428-2021	Witt, Claudia M./0000-0002-5440-7805; Brinkhaus, Benno/0000-0001-6290-744X; Reinhold, Thomas/0000-0001-5169-7029; Roll, Stephanie/0000-0003-1191-3289; Pach, Daniel/0000-0002-2459-6596	Robert Bosch Foundation [12.5.1060.0083.1]	Robert Bosch Foundation	Funding source: Robert Bosch Foundation (grant number 12.5.1060.0083.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PC, 2009, CURR OPIN PEDIATR, V21, P131, DOI 10.1097/MOP.0b013e32832130a9; Augustin M, 2001, ALLERGOLOGIE, V24, P433; Becker-Witt C, 2004, FORSCH KOMP KLAS NAT, V11, P98, DOI 10.1159/000078231; [Committee on Comparative Effectiveness Research Prioritization Institute of Medicine], 2009, IN NAT PRIOR COMP EF, P29; Emerson RM, 2001, BRIT J DERMATOL, V144, P514, DOI 10.1046/j.1365-2133.2001.04077.x; Fineberg H, 2009, IN NAT PRIOR COMP EF; Herd RM, 2002, ARCH DERMATOL, V138, P819, DOI 10.1001/archderm.138.6.819; Hoare DY, 2000, HEALTH TECHNOL ASSES, V4, P1; Keil T, 2008, COMPLEMENT THER MED, V16, P15, DOI 10.1016/j.ctim.2006.10.001; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Schafer T, 2002, ALLERGY, V57, P694, DOI 10.1034/j.1398-9995.2002.23469.x; Schlaud M, 2007, BUNDESGESUNDHEITSBLA, V50, P701, DOI 10.1007/s00103-007-0231-9; Schwabe U, 2007, ARZNEIVERORDNUNGSREP; Siebenwirth J, 2009, FORSCH KOMPLEMENTMED, V16, P315, DOI 10.1159/000242434; Szucs T, 1995, SOZIOOKONOMISCHE ASP, P49; Witt CM, 2009, DERMATOLOGY, V219, P329, DOI 10.1159/000248854; Witt CM, 2009, ACTA DERM-VENEREOL, V89, P182, DOI 10.2340/00015555-0580	18	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54973	10.1371/journal.pone.0054973	http://dx.doi.org/10.1371/journal.pone.0054973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383019	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600054
J	Balique, F; Colson, P; Barry, AO; Nappez, C; Ferretti, A; Al Moussawi, K; Ngounga, T; Lepidi, H; Ghigo, E; Mege, JL; Lecoq, H; Raoult, D				Balique, Fanny; Colson, Philippe; Barry, Abdoulaye Oury; Nappez, Claude; Ferretti, Audrey; Al Moussawi, Khatoun; Ngounga, Tatsiana; Lepidi, Hubert; Ghigo, Eric; Mege, Jean-Louis; Lecoq, Herve; Raoult, Didier			Tobacco Mosaic Virus in the Lungs of Mice following Intra-Tracheal Inoculation	PLOS ONE			English	Article							PLANT-VIRUS; FRANKLINIELLA-OCCIDENTALIS; INSECT VECTOR; RNA; PROTEIN; CELL; TRANSMISSION; IMMUNIZATION; PROTECTION; INFECTION	Plant viruses are generally considered incapable of infecting vertebrates. Accordingly, they are not considered harmful for humans. However, a few studies questioned the certainty of this paradigm. Tobacco mosaic virus (TMV) RNA has been detected in human samples and TMV RNA translation has been described in animal cells. We sought to determine if TMV is detectable, persists, and remains viable in the lung tissues of mice following intratracheal inoculation, and we attempted to inoculate mouse macrophages with TMV. In the animal model, mice were intratracheally inoculated with 10(11) viral particles and were sacrificed at different time points. The virus was detected in the mouse lungs using immunohistochemistry, electron microscopy, real-time RT-PCR and sequencing, and its viability was studied with an infectivity assay on plants. In the cellular model, the culture medium of murine bone marrow derived macrophages (BMDM) was inoculated with different concentrations of TMV, and the virus was detected with real-time RT-PCR and immunofluorescence. In addition, anti-TMV antibodies were detected in mouse sera with ELISA. We showed that infectious TMV could enter and persist in mouse lungs via the intratracheal route. Over 14 days, the TMV RNA level decreased by 5 log(10) copies/ml in the mouse lungs and by 3.5 log(10) in macrophages recovered from bronchoalveolar lavage. TMV was localized to lung tissue, and its infectivity was observed on plants until 3 days after inoculation. In addition, anti-TMV antibody seroconversions were observed in the sera from mice 7 days after inoculation. In the cellular model, we observed that TMV persisted over 15 days after inoculation and it was visualized in the cytoplasm of the BMDM. This work shows that a plant virus, Tobacco mosaic virus, could persist and enter in cells in mammals, which raises questions about the potential interactions between TMV and human hosts.	[Balique, Fanny; Colson, Philippe; Barry, Abdoulaye Oury; Nappez, Claude; Al Moussawi, Khatoun; Ngounga, Tatsiana; Lepidi, Hubert; Ghigo, Eric; Mege, Jean-Louis; Raoult, Didier] Aix Marseille Univ, Fac Med & Pharm, IHU Mediterranee Infect,URMITE, UM CNRS IRD INSERM 3R198 U1095 63 7278, Marseille, France; [Colson, Philippe; Ferretti, Audrey; Mege, Jean-Louis; Raoult, Didier] CHU Timone, Assistance Publ Hop Marseille, Federat Bacteriol Hyg Virol, Marseille, France; [Balique, Fanny; Lecoq, Herve] INRA, UR 407, F-84143 Montfavet, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; INRAE	Colson, P (corresponding author), Aix Marseille Univ, Fac Med & Pharm, IHU Mediterranee Infect,URMITE, UM CNRS IRD INSERM 3R198 U1095 63 7278, Marseille, France.	philippe.colson@univ-amu.fr	RAOULT, Didier/A-8434-2008; MEGE, JEAN-LOUIS/O-6063-2016; Eric, Ghigo/N-9427-2016; Colson, Philippe/P-6355-2014	RAOULT, Didier/0000-0002-0633-5974; Colson, Philippe/0000-0001-6285-0308	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	Recurrent funding from the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2009, ARCH VIROL, V154, P1967, DOI 10.1007/s00705-009-0506-6; Balique F, 2012, J CLIN VIROL, V55, P374, DOI 10.1016/j.jcv.2012.08.012; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Bothwell PW, 1960, LANCET, V1; Bousbia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011298; Brennan FR, 1999, J VIROL, V73, P930, DOI 10.1128/JVI.73.2.930-938.1999; Cao L, 1998, J CLIN MICROBIOL, V36, P3028, DOI 10.1128/JCM.36.10.3028-3031.1998; Colson P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010041; de Medeiros RB, 2005, P NATL ACAD SCI USA, V102, P1175, DOI 10.1073/pnas.0406668102; DIMITRIADIS GJ, 1975, NUCLEIC ACIDS RES, V2, P1719, DOI 10.1093/nar/2.10.1719; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; ERICKSON JO, 1953, J IMMUNOL, V71, P30; ERICKSON JO, 1957, J IMMUNOL, V78, P94; Fujiyama K, 2006, J BIOSCI BIOENG, V101, P398, DOI 10.1263/jbb.101.398; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; Harrison BD, 1999, PHILOS T ROY SOC B, V354, P521, DOI 10.1098/rstb.1999.0403; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Karasev AV, 2005, VACCINE, V23, P1875, DOI 10.1016/j.vaccine.2004.11.021; KATSILAMBROS L, 1960, LANCET, V2, P934; KITAJIMA EW, 1983, INTERVIROLOGY, V19, P129, DOI 10.1159/000149347; KNOWLAND J, 1974, GENETICS, V78, P383; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; LaScola B, 1997, INFECT IMMUN, V65, P2443, DOI 10.1128/IAI.65.6.2443-2447.1997; LECLAIR RA, 1967, AM REV RESPIR DIS, V95, P510; Li L, 2012, BIOSCIENCE REP, V32, P171, DOI 10.1042/BSR20110069; McCormick AA, 2006, BIOCONJUGATE CHEM, V17, P1330, DOI 10.1021/bc060124m; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Modelska A, 1998, P NATL ACAD SCI USA, V95, P2481, DOI 10.1073/pnas.95.5.2481; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Pascual DW, 2007, P NATL ACAD SCI USA, V104, P10757, DOI 10.1073/pnas.0704516104; Rae CS, 2005, VIROLOGY, V343, P224, DOI 10.1016/j.virol.2005.08.017; Rogers SO, 2004, MED HYPOTHESES, V63, P773, DOI 10.1016/j.mehy.2004.04.004; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; SALOMON R, 1982, J GEN VIROL, V62, P343, DOI 10.1099/0022-1317-62-2-343; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X; Vogler H, 2007, J VIROL, V81, P10379, DOI 10.1128/JVI.00727-07; Wahyuni W. S., 2008, J BIOSCIENCE, V15, P118, DOI DOI 10.4308/HJB.15.3.118; Wales SQ, 2004, CLIN DIAGN LAB IMMUN, V11, P42, DOI 10.1128/CDLI.11.1.42-49.2004; WETTER C, 1975, NATURWISSENSCHAFTEN, V62, P533, DOI 10.1007/BF00609072; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	45	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54993	10.1371/journal.pone.0054993	http://dx.doi.org/10.1371/journal.pone.0054993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383021	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800091
J	Dentzien-Dias, PC; Poinar, G; de Figueiredo, AEQ; Pacheco, ACL; Horn, BLD; Schultz, CL				Dentzien-Dias, Paula C.; Poinar, George, Jr.; de Figueiredo, Ana Emilia Q.; Pacheco, Ana Carolina L.; Horn, Bruno L. D.; Schultz, Cesar L.			Tapeworm Eggs in a 270 Million-Year-Old Shark Coprolite	PLOS ONE			English	Article							BASIN	Remains of parasites in vertebrates are rare from the Mesozoic and Paleozoic. Once most parasites that live in - or pass through - the gastrointestinal tract of vertebrates, fossil feces (coprolites) or even intestinal contents (enterolites) can eventually preserve their remains. Here we announce the discovery of a spiral shark coprolite from the Paleozoic bearing a cluster of 93 small oval-elliptical smooth-shelled structures, interpreted as eggs of a tapeworm. The eggs were found in a thin section of an elasmobranch coprolite. Most of the eggs are filled by pyrite and some have a special polar swelling (operculum), suggesting they are non-erupted eggs. One of the eggs contains a probable developing larva. The eggs are approximately 145-155 mu m in length and 88-100 mu m in width and vary little in size within the cluster. The depositional and morphological features of the eggs closely resemble those of cestodes. Not only do the individual eggs have features of extant tapeworms, but their deposition all together in an elongate segment is typical to modern tapeworm eggs deposited in mature segments (proglottids). This is the earliest fossil record of tapeworm parasitism of vertebrates and establishes a timeline for the evolution of cestodes. This discovery shows that the fossil record of vertebrate intestinal parasites is much older than was hitherto known and that the interaction between tapeworms and vertebrates occurred at least since the Middle-Late Permian.	[Dentzien-Dias, Paula C.] Univ Fed Rio Grande, Inst Oceanog, Lab Paleontol & Paleoceanog, Rio Grande, Brazil; [Poinar, George, Jr.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [de Figueiredo, Ana Emilia Q.; Horn, Bruno L. D.; Schultz, Cesar L.] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil; [Pacheco, Ana Carolina L.] Univ Fed Piaui, Picos, Piaui, Brazil	Universidade Federal do Rio Grande; Oregon State University; Universidade Federal do Rio Grande do Sul; Universidade Federal do Piaui	Dentzien-Dias, PC (corresponding author), Univ Fed Rio Grande, Inst Oceanog, Lab Paleontol & Paleoceanog, Rio Grande, Brazil.	pauladentzien@gmail.com	Schultz, Cesar/I-4127-2013; Dentzien-Dias, Paula/AAZ-3945-2020; Quezado de Figueiredo, Ana Emilia/L-8057-2015	Schultz, Cesar/0000-0001-7121-0409; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil (CNPq); Edital MCT/CNPq [478914/2006-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Edital MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil (CNPq) through a study grant (PCD-D, AEQF and BH) and the Project 478914/2006-7 (Edital MCT/CNPq 02/2006 - Universal). This work was also partially funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) through scholarships granted to AEQF, BH and CLS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avantin F, 2007, PALEOPARASITOLOGIE C, P203; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P47, DOI 10.1590/S0074-02762003000900009; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P95, DOI 10.1590/S0074-02762003000900015; Bouchet F, 1996, CR ACAD SCI III-VIE, V319, P147; Caira J.N., 2005, MARINE PARASITOLOGY, P92; Caira JN, 2004, CRC MAR BIOL SER, P523; Campbell RA, 1998, FOLIA PARASIT, V45, P47; Chin K., 2007, MICROSC MICROANAL, V13, P50, DOI DOI 10.1017/S143192760707540X; Cisneros JC, 2012, P NATL ACAD SCI USA, V109, P1584, DOI 10.1073/pnas.1115975109; Cisneros JC, 2011, SCIENCE, V331, P1603, DOI 10.1126/science.1200305; Conn DB, 2008, FOLIA PARASIT, V55, P42, DOI 10.14411/fp.2008.006; Dentzien-Dias PC, 2012, J S AM EARTH SCI, V40, P53, DOI 10.1016/j.jsames.2012.09.008; Erasmus DA, 1972, BIOL TREMATODES; FERREIRA LF, 1979, C BRAS PAR 1979, P56; Goncalves MLC, 2003, MEM I OSWALDO CRUZ, V98, P103, DOI 10.1590/S0074-02762003000900016; Halstead L.B., 1990, P381; Hoberg EP, 1999, SYST PARASITOL, V42, P1, DOI 10.1023/A:1006099009495; Holz M, 2010, J S AM EARTH SCI, V29, P381, DOI 10.1016/j.jsames.2009.04.004; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Langer M.C., 1998, J AFR EARTH SCI, V27, P158; Levine N.D., 1978, TXB VET PARASITOLOGY; Moravec F, 2007, FOLIA PARASIT, V54, P239, DOI 10.14411/fp.2007.033; Neumayer L., 1904, Palaeontogr, Vli, P121; Poinar G, 2006, PARASITOLOGY, V133, P245, DOI 10.1017/S0031182006000138; Poinar G, 2008, WHAT BUGGED THE DINOSAURS INSECTS, DISEASE, AND DEATH IN THE CRETACEOUS, P102; Reinhard K.J., 1992, ARCHAEOLOGICAL METHO, P245; Reinhard KJ, 1998, MUMMIES DIS ANCIENT, P377; Rohde K., 2005, Marine parasitology, DOI 10.1079/9780643090255.0000; Schell SC., 1970, KNOW TREMATODES; Smith RMH, 2011, PALAEOGEOGR PALAEOCL, V312, P40, DOI 10.1016/j.palaeo.2011.09.006; Smyth JD, 1969, PHYSL CESTODES; Southwell T, 1925, MONOGRAPH TETRAPHYLL; SPENCER FM, 1961, COLOR ATLAS INTESTIN; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Yamaguti S., 1959, CESTODES VERTEBRATES, VII; Yamaguti S., 1961, SYSTEMA HELMINTHUM N, VIII; Zangere R., 1976, Palaeontographica Abt A, V154, P107	37	71	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55007	10.1371/journal.pone.0055007	http://dx.doi.org/10.1371/journal.pone.0055007			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383033	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800103
J	Eitan, R; Krissi, H; Levavi, H; Sabah, G; Peled, Y				Eitan, Ram; Krissi, Haim; Levavi, Hanoch; Sabah, Gad; Peled, Yoav			Clinical Course of Patients Treated for Advanced Ovarian Carcinoma without Surgical Intervention	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; CANCER; SURVIVAL; METAANALYSIS; CARBOPLATIN; PACLITAXEL; CISPLATIN	Objective: To describe the clinical course and outcome of patients with non-surgically-treated advanced ovarian cancer attending a single institute. Methodology/Principal Findings: We reviewed the medical charts of all patients with advanced epithelial ovarian cancer who underwent chemotherapy at a tertiary medical center between January 2005 and December 2010 but were never operated. Data on patient characteristics, disease course, and outcome were collected from patient files. Sixteen patients met the inclusion criteria. Eight (50%) were diagnosed with apparent FIGO stage IIIC disease, and 8 with stage IV. Five patients (31%) achieved a complete clinical response, and 11 (69%) achieved a partial response. Among the complete responders, the median disease-free interval was 8 months (range 7-11 months). In all of them, the disease recurred and second-line chemotherapy was administered. Of them, four (80%) achieved a second complete response. Partial responders had up to four lines of chemotherapy, with continued disease progression. The median overall survival of the whole group was 19.5 months, and of the complete responders, 28 months. Conclusions/Significance: Most patients with advanced ovarian carcinoma who will not undergo surgery respond only partially to first-line chemotherapy. Having no surgery is associated with a short disease-free interval.	[Eitan, Ram] Helen Schneider Hosp Women, Rabin Med Ctr, Div Gynecol Oncol, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Eitan, R (corresponding author), Helen Schneider Hosp Women, Rabin Med Ctr, Div Gynecol Oncol, Petah Tiqwa, Israel.	eitanr@clalit.org.il						Aletti GD, 2006, OBSTET GYNECOL, V107, P77, DOI 10.1097/01.AOG.0000192407.04428.bb; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bookman MA, 2003, INT J GYNECOL CANCER, V13, P735, DOI 10.1111/j.1525-1438.2003.13602.x; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Bristow RE, 2006, GYNECOL ONCOL, V103, P1070, DOI 10.1016/j.ygyno.2006.06.025; CHAMBERS JT, 1990, GYNECOL ONCOL, V37, P327, DOI 10.1016/0090-8258(90)90361-N; DeVita VT, 2001, CANC PRINCIPLES PRAC, P1092; du Bois A, 2004, ANN ONCOL S8, pviii7; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974, DOI 10.1016/S0002-9378(94)70090-7; Ozols RF, 2005, SEMIN ONCOL, V32, pS4, DOI 10.1053/j.seminoncol.2005.06.023; Schwartz PE, 2002, BEST PRACT RES CL OB, V16, P585, DOI 10.1053/beog.2002.0304; Vergote I, 1998, GYNECOL ONCOL, V71, P431, DOI 10.1006/gyno.1998.5213; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806	14	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55645	10.1371/journal.pone.0055645	http://dx.doi.org/10.1371/journal.pone.0055645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383254	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800179
J	Freymond, SB; Briefer, EF; Von Niederhausern, R; Bachmann, I				Freymond, Sabrina Briefer; Briefer, Elodie F.; Von Niederhaeusern, Rudolf; Bachmann, Iris			Pattern of Social Interactions after Group Integration: A Possibility to Keep Stallions in Group	PLOS ONE			English	Article							YOUNG HORSES; DOMESTIC HORSES; DAMA-DAMA; BEHAVIOR; AGGRESSION; HERD	Horses are often kept in individual stables, rather than in outdoor groups, despite such housing system fulfilling many of their welfare needs, such as the access to social partners. Keeping domestic stallions in outdoor groups would mimic bachelor bands that are found in the wild. Unfortunately, the high level of aggression that unfamiliar stallions display when they first encounter each other discourages owners from keeping them in groups. However, this level of aggression is likely to be particularly important only during group integration, when the dominance hierarchy is being established, whereas relatively low aggression rates have been observed among stable feral bachelor bands. We investigated the possibility of housing breeding stallions owned by the Swiss National Stud in groups on a large pasture (5 stallions in 2009 and 8 stallions in 2010). We studied the pattern of agonistic, ritual and affiliative interactions after group integration (17-23 days), and the factors influencing these interactions (time after group integration, dominance rank, age or experience of group housing). We found that stallions displayed generally more ritual than agonistic and than affiliative interactions. The frequency of agonistic and ritual interactions decreased quickly within the first three to four days. The frequency of affiliative interactions increased slowly with time before decreasing after 9-14 days. A stable hierarchy could be measured after 2-3 months. The highest-ranking males had less ritual interactions than the lowest-ranking. Males had also less agonistic, ritual and affiliative interactions if they had already been housed in a group the previous year. Therefore, we found that breeding stallions could be housed together on a large pasture, because the frequency of agonistic interactions decreased quickly and remained at a minimal level from the fourth day following group integration. This housing system could potentially increase horse welfare and reduce labour associated with horse management.	[Freymond, Sabrina Briefer; Von Niederhaeusern, Rudolf; Bachmann, Iris] Swiss Natl Stud Farm SNSTF, Agroscope Liebefeld Posieux Res Stn ALP Haras, Les Longs Pres, Avenches, Switzerland; [Briefer, Elodie F.] Queen Mary Univ London, Biol & Expt Psychol Grp, Sch Biol & Chem Sci, London, England	Swiss Federal Research Station Agroscope; University of London; Queen Mary University London	Freymond, SB (corresponding author), Swiss Natl Stud Farm SNSTF, Agroscope Liebefeld Posieux Res Stn ALP Haras, Les Longs Pres, Avenches, Switzerland.	sabrina.briefer@haras.admin.ch	Mandel-Briefer, Elodie/D-3912-2018	Mandel-Briefer, Elodie/0000-0003-4147-0319	Swiss National Science Foundation fellowship	Swiss National Science Foundation fellowship(Swiss National Science Foundation (SNSF))	E. Briefer is funded by a Swiss National Science Foundation fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, R FDN STAT COMP; Bachmann I, 2003, EQUINE VET J, V35, P158, DOI 10.2746/042516403776114216; Bates D., 2011, IME4 LINEAR MIXED EF; Berger J., 1986, WILD HORSES GREAT BA; Bourjade M, 2009, ETHOL ECOL EVOL, V21, P1, DOI 10.1080/08927014.2009.9522507; Bourjade M, 2008, DEV PSYCHOBIOL, V50, P408, DOI 10.1002/dev.20301; Bourjade M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004888; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Christensen JW, 2011, APPL ANIM BEHAV SCI, V133, P199, DOI 10.1016/j.applanim.2011.05.013; Christensen JW, 2002, APPL ANIM BEHAV SCI, V76, P11, DOI 10.1016/S0168-1591(01)00208-8; Christensen JW, 2002, APPL ANIM BEHAV SCI, V75, P233, DOI 10.1016/S0168-1591(01)00196-4; Cooper J, 1998, EQUINE VET J S, V27, P5; CRAIG JV, 1986, J ANIM SCI, V62, P1120, DOI 10.2527/jas1986.6241120x; Dawkins MS, 2003, ZOOLOGY, V106, P383, DOI 10.1078/0944-2006-00122; FEH C, 1988, APPL ANIM BEHAV SCI, V21, P71, DOI 10.1016/0168-1591(88)90101-3; FEIST JD, 1976, Z TIERPSYCHOL, V41, P337; Fureix C, 2012, APPL ANIM BEHAV SCI, V138, P216, DOI 10.1016/j.applanim.2012.02.009; Hartmann E, 2012, APPL ANIM BEHAV SCI, V136, P77, DOI 10.1016/j.applanim.2011.10.004; Hartmann E, 2009, APPL ANIM BEHAV SCI, V121, P214, DOI 10.1016/j.applanim.2009.10.004; Heitor F, 2006, BEHAV PROCESS, V73, P231, DOI 10.1016/j.beproc.2006.05.005; Heitor F, 2010, J ETHOL, V28, P133, DOI 10.1007/s10164-009-0165-9; Heitor F, 2010, J ETHOL, V28, P35, DOI 10.1007/s10164-009-0152-1; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; HOUPT KA, 1978, APPL ANIM ETHOL, V4, P273, DOI 10.1016/0304-3762(78)90117-7; JENSEN P, 1993, APPL ANIM BEHAV SCI, V37, P161, DOI 10.1016/0168-1591(93)90108-2; Jorgensen GHM, 2009, APPL ANIM BEHAV SCI, V120, P94, DOI 10.1016/j.applanim.2009.05.005; KLINGEL H, 1975, J REPROD FERTIL, P7; Krueger K, 2010, ANIM COGN, V14, P245; Ladewig J, 2005, Domestic Horse: The Origins, Development and Management of Its Behaviour, P139; Lehmann K, 2006, APPL ANIM BEHAV SCI, V96, P343, DOI 10.1016/j.applanim.2005.06.010; Lemasson A, 2009, ANIM COGN, V12, P693, DOI 10.1007/s10071-009-0229-9; MCCORT WD, 1984, J ANIM SCI, V58, P493, DOI 10.2527/jas1984.582493x; McDonnell M.D, 2003, EQUID ETHOGRAM PRACT, Vfirst; MCDONNELL SM, 1995, APPL ANIM BEHAV SCI, V43, P147, DOI 10.1016/0168-1591(94)00550-X; McElligott AG, 1998, ETHOLOGY, V104, P789; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rivera E, 2002, APPL ANIM BEHAV SCI, V78, P235, DOI 10.1016/S0168-1591(02)00091-6; Rose-Meierhofer S, 2010, J EQUINE VET SCI, V30, P624, DOI 10.1016/j.jevs.2010.10.005; RUBENSTEIN DI, 1992, EVOL ECOL, V6, P254, DOI 10.1007/BF02214165; Sigurjonsdottir H, 2003, BEHAVIOUR, V140, P783, DOI 10.1163/156853903322370670; Sondergaard E, 2004, APPL ANIM BEHAV SCI, V87, P105, DOI 10.1016/j.applanim.2003.12.010; TILSON RL, 1988, APPL ANIM BEHAV SCI, V21, P169, DOI 10.1016/0168-1591(88)90106-2; Van Dierendonck M. C., 2006, THESIS UTRECHT U; VanDierendonck MC, 2012, APPL ANIM BEHAV SCI, V138, P194, DOI 10.1016/j.applanim.2012.02.007; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; WELLS SM, 1979, Z TIERPSYCHOL, V49, P363; Zharkikh Tatjana L., 2009, Zoologische Garten, V78, P282	52	18	18	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54688	10.1371/journal.pone.0054688	http://dx.doi.org/10.1371/journal.pone.0054688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382940	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800064
J	Jacobs, SR; Elliott, KH; Gaston, AJ				Jacobs, Shoshanah R.; Elliott, Kyle Hamish; Gaston, Anthony J.			Parents are a Drag: Long-Lived Birds Share the Cost of Increased Foraging Effort with Their Offspring, but Males Pass on More of the Costs than Females	PLOS ONE			English	Article							THICK-BILLED MURRES; GUILLEMOTS URIA-LOMVIA; BODY CONDITION; BRUNNICHS GUILLEMOTS; ARCTIC SEABIRD; PLASMA-CORTICOSTERONE; MONOMORPHIC SEABIRD; REPRODUCTIVE COSTS; ATLANTIC PUFFINS; ANTARCTIC PETREL	Life history theory predicts that parents will balance benefits from investment in current offspring against benefits from future reproductive investments. Long-lived organisms are therefore less likely to increase parental effort when environmental conditions deteriorate. To investigate the effect of decreased foraging capacity on parental behaviour of long-lived monogamous seabirds, we experimentally increased energy costs for chick-rearing thick-billed murres (Uria lomvia). Handicapped birds had lighter chicks and lower provisioning rates, supporting the prediction that long-lived animals would pass some of the costs of impaired foraging ability on to their offspring. Nonetheless, handicapped birds spent less time underwater, had longer inter-dive surface intervals, had lower body mass, showed lower resighting probabilities in subsequent years and consumed fewer risky prey items. Corticosterone levels were similar between control and handicapped birds. Apparently, adults shared some of the costs of impaired foraging, but those costs were not measurable in all metrics. Handicapped males had higher plasma neutral lipid concentrations (higher energy mobilisation) and their chicks exhibited lower growth rates than handicapped females, suggesting different sex-specific investment strategies. Unlike other studies of auks, partners did not compensate for handicapping, despite good foraging conditions for unhandicapped birds. In conclusion, parental murres and their offspring shared the costs of experimentally increased foraging constraints, with females investing more than males.	[Jacobs, Shoshanah R.] Dept Integrated Biol, Guelph, ON, Canada; [Elliott, Kyle Hamish] Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada; [Gaston, Anthony J.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada	University of Manitoba; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Elliott, KH (corresponding author), Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada.	urialomvia@gmail.com	Elliott, Kyle/S-9185-2019	Elliott, Kyle/0000-0001-5304-3993	University of Ottawa Doctoral Research Award; Northern Scientific Training Program; Weinberger Award for Environmental Research; Heather Glendinning McMurter Award for Environmental Research; Maas Family Scholarship; NSERC PGSM and Vanier Awards; Natural Sciences and Engineering Research Council Northern Research Internship; Mountain Equipment Co-op Studentship; Arctic Institute of North America; American Ornithologists' Union Research Grant; Society of Canadian Ornithologists/Bird Studies Canada Taverner; American Museum of Natural History Frank M. Chapman Award; Science and technology Branch of Environment Canada, the University of Manitoba	University of Ottawa Doctoral Research Award; Northern Scientific Training Program; Weinberger Award for Environmental Research; Heather Glendinning McMurter Award for Environmental Research; Maas Family Scholarship; NSERC PGSM and Vanier Awards; Natural Sciences and Engineering Research Council Northern Research Internship; Mountain Equipment Co-op Studentship; Arctic Institute of North America; American Ornithologists' Union Research Grant; Society of Canadian Ornithologists/Bird Studies Canada Taverner; American Museum of Natural History Frank M. Chapman Award; Science and technology Branch of Environment Canada, the University of Manitoba	SRJ benefited from the University of Ottawa Doctoral Research Award, Northern Scientific Training Program, Weinberger Award for Environmental Research, Heather Glendinning McMurter Award for Environmental Research, and Maas Family Scholarship. KHE benefited from funding provided by NSERC PGSM and Vanier Awards, Natural Sciences and Engineering Research Council Northern Research Internship, Northern Scientific Training Program, Mountain Equipment Co-op Studentship, Arctic Institute of North America Grant-in-aid, American Ornithologists' Union Research Grant, Society of Canadian Ornithologists/Bird Studies Canada Taverner and James L. Baillie Awards and an American Museum of Natural History Frank M. Chapman Award. Additional financial support came from Science and technology Branch of Environment Canada, the University of Manitoba and 2007-08 International Polar Year. R. Armstrong at the Nunavut Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Angelier F, 2007, PHYSIOL BIOCHEM ZOOL, V80, P283, DOI 10.1086/512585; Angelier F, 2009, J EXP BIOL, V212, P2824, DOI 10.1242/jeb.027722; Baillie SM, 2004, WATERBIRDS, V27, P102, DOI 10.1675/1524-4695(2004)027[0102:ROAPTA]2.0.CO;2; Barrett RT, 1996, ICES J MAR SCI, V53, P713, DOI 10.1006/jmsc.1996.0090; BARRETT RT, 1992, COLON WATERBIRD, V15, P24, DOI 10.2307/1521351; Beaulieu M, 2010, J EXP BIOL, V213, P33, DOI 10.1242/jeb.035378; Beaulieu M, 2009, ANIM BEHAV, V78, P313, DOI 10.1016/j.anbehav.2009.05.006; Benvenuti S, 2002, POLAR BIOL, V25, P474, DOI 10.1007/s00300-002-0372-0; Bijleveld AI, 2009, BEHAV ECOL, V20, P736, DOI 10.1093/beheco/arp054; Blem C.R., 1990, Current Ornithology, V7, P59; BLEM CR, 1976, AM ZOOL, V16, P671; Burke CM, 2008, WATERBIRDS, V31, P372, DOI 10.1675/1524-4695-31.3.372; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; CHAURAND T, 1994, IBIS, V136, P285, DOI 10.1111/j.1474-919X.1994.tb01097.x; CLARK CW, 1990, EVOL ECOL, V4, P21, DOI 10.1007/BF02270712; CROLL DA, 1991, CONDOR, V93, P496, DOI 10.2307/1368181; Davoren GK, 2003, MAR ECOL PROG SER, V258, P253, DOI 10.3354/meps258253; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; DRENT RH, 1980, ARDEA, V68, P225; Elliott KH, 2005, IBIS, V147, P783, DOI 10.1111/j.1474-919x.2005.00462.x; Elliott KH, 2008, J FIELD ORNITHOL, V79, P298, DOI 10.1111/j.1557-9263.2008.00177.x; Elliott KH, 2007, CAN J ZOOL, V85, P352, DOI 10.1139/Z07-012; Elliott KH, 2012, MAR ECOL PROG SER, V466, P1, DOI 10.3354/meps09975; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Elliott KH, 2009, MAR BIOL, V156, P1809, DOI 10.1007/s00227-009-1214-1; Elliott KH, 2008, J AVIAN BIOL, V39, P619, DOI 10.1111/j.1600-048X.2008.04316.x; Elliott Kyle Hamish, 2008, Marine Ornithology, V36, P25; Elliott KH, 2008, ANIM BEHAV, V75, P1311, DOI 10.1016/j.anbehav.2007.10.026; Elliott KH, 2008, MAR ECOL PROG SER, V354, P289, DOI 10.3354/meps07221; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; Elliott KH, 2009, WATERBIRDS, V32, P183, DOI 10.1675/063.032.0123; Erikstad KE, 1998, ECOLOGY, V79, P1781; Erikstad KE, 1997, BEHAV ECOL SOCIOBIOL, V40, P95, DOI 10.1007/s002650050320; FISHER HI, 1975, AUK, V92, P433, DOI 10.2307/4084599; Pereira RJG, 2009, J WILDLIFE MANAGE, V73, P772, DOI 10.2193/2008-184; Gaston AJ, 2006, J AVIAN BIOL, V37, P101; Gaston AJ, 2006, IBIS, V148, P106, DOI 10.1111/j.1474-919X.2006.00489.x; Gaston AJ, 2005, J ANIM ECOL, V74, P832, DOI 10.1111/j.1365-2656.2005.00982.x; Gaston AJ, 2003, ARCTIC, V56, P227; GASTON AJ, 1983, CAN J ZOOL, V61, P2465, DOI 10.1139/z83-327; Gaston AT, 2009, CONDOR, V111, P111, DOI 10.1525/cond.2009.080077; Gill VA, 2002, IBIS, V144, P268, DOI 10.1046/j.1474-919X.2002.00043.x; Gladbach A, 2009, POLAR BIOL, V32, P1315, DOI 10.1007/s00300-009-0628-z; Golet GH, 2004, ECOL MONOGR, V74, P353, DOI 10.1890/02-4029; Granadeiro JP, 2004, J SEA RES, V52, P227, DOI 10.1016/j.seares.2004.01.005; Groscolas R, 2000, AM J PHYSIOL-REG I, V279, pR2104, DOI 10.1152/ajpregu.2000.279.6.R2104; Hamer KC, 2006, BEHAV ECOL, V17, P132, DOI 10.1093/beheco/arj008; Harding AMA, 2009, ANIM BEHAV, V78, P321, DOI 10.1016/j.anbehav.2009.05.009; Harding AMA, 2007, ECOLOGY, V88, P2024, DOI 10.1890/06-1695.1; Harding AMA, 2009, FUNCT ECOL, V23, P348, DOI 10.1111/j.1365-2435.2008.01488.x; HEDGREN S, 1981, ORNIS SCAND, V12, P51, DOI 10.2307/3675904; Hipfner JM, 2006, CAN J ZOOL, V84, P931, DOI 10.1139/Z06-066; Hipfner JM, 1997, CONDOR, V99, P353, DOI 10.2307/1369941; Hipfner JM, 1999, ECOLOGY, V80, P1289, DOI 10.2307/177075; Hipfner JM, 2001, AUK, V118, P1076, DOI 10.1642/0004-8038(2001)118[1076:FRCORI]2.0.CO;2; Ito M, 2010, AQUAT BIOL, V8, P279, DOI 10.3354/ab00229; Jacobs SR, 2012, PHYSIOL BIOCHEM ZOOL, V85, P85, DOI 10.1086/663832; Jacobs SR, 2011, COMP BIOCHEM PHYS B, V158, P77, DOI 10.1016/j.cbpb.2010.09.011; Jacobs SR, 2009, J AVIAN BIOL, V40, P327, DOI 10.1111/j.1600-048X.2008.04625.x; JACOBSEN KO, 1995, ECOLOGY, V76, P1636, DOI 10.2307/1938164; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; JENNIEIERMANN S, 1992, PHYSIOL ZOOL, V65, P112, DOI 10.1086/physzool.65.1.30158242; Jensen BH, 2001, FISH PHYSIOL BIOCHEM, V25, P141, DOI 10.1023/A:1020564121935; Keedwell RJ, 2003, J FIELD ORNITHOL, V74, P217, DOI 10.1648/0273-8570-74.3.217; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; Kitaysky AS, 2003, HORM BEHAV, V43, P140, DOI 10.1016/S0018-506X(02)00030-2; Kitaysky AS, 2001, BEHAV ECOL, V12, P619, DOI 10.1093/beheco/12.5.619; Landys MTM, 2004, HORM BEHAV, V46, P574, DOI 10.1016/j.yhbeh.2004.06.006; Landys-Ciannelli MM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P101, DOI 10.1086/338285; Lewis S, 2006, J ANIM ECOL, V75, P1304, DOI 10.1111/j.1365-2656.2006.01152.x; Lewis S, 2009, OIKOS, V118, P521, DOI 10.1111/j.1600-0706.2009.17308.x; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; MAUCK RA, 1995, ANIM BEHAV, V49, P999, DOI 10.1006/anbe.1995.0129; McWilliams SR, 2004, J AVIAN BIOL, V35, P377, DOI 10.1111/j.0908-8857.2004.03378.x; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; Paredes R, 2005, ANIM BEHAV, V69, P197, DOI 10.1016/j.anbehav.2003.12.029; Paredes R, 2006, BEHAVIOUR, V143, P451, DOI 10.1163/156853906776240641; PARTRIDGE L, 1988, SCIENCE, V241, P1449, DOI 10.1126/science.241.4872.1449; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; RICKLEFS RE, 1992, ANIM BEHAV, V43, P895, DOI 10.1016/0003-3472(92)90003-R; RICKLEFS RE, 1984, ORNIS SCAND, V15, P162, DOI 10.2307/3675957; RICKLEFS RE, 1981, AUK, V98, P361; Robin JP, 2001, J AVIAN BIOL, V32, P303, DOI 10.1111/j.0908-8857.2001.320403.x; Robin JP, 1998, AM J PHYSIOL-REG I, V274, pR746, DOI 10.1152/ajpregu.1998.274.3.R746; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; SAETHER BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P147, DOI 10.1007/BF00216594; Takahashi A, 2003, FUNCT ECOL, V17, P590, DOI 10.1046/j.1365-2435.2003.00772.x; Takahashi A, 2008, DEEP-SEA RES PT II, V55, P1837, DOI 10.1016/j.dsr2.2008.04.005; Thaxter CB, 2010, J EXP BIOL, V213, P1018, DOI 10.1242/jeb.037390; Thaxter CB, 2009, J AVIAN BIOL, V40, P75, DOI 10.1111/j.1600-048X.2008.04507.x; Tremblay Y, 2003, J EXP BIOL, V206, P1929, DOI 10.1242/jeb.00363; Tveraa T, 1998, J ANIM ECOL, V67, P699, DOI 10.1046/j.1365-2656.1998.00234.x; Velando A, 2003, J ANIM ECOL, V72, P846, DOI 10.1046/j.1365-2656.2003.00756.x; WANLESS S, 1988, CONDOR, V90, P816, DOI 10.2307/1368838; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilhelm SI, 2004, ATLANTIC SEABIRDS, V6, P47; Winkler DW, 1995, AUK, V112, P737; [No title captured]	101	20	20	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54594	10.1371/journal.pone.0054594	http://dx.doi.org/10.1371/journal.pone.0054594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382921	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800056
J	Jiang, L; Fang, X; Bao, Y; Zhou, JY; Shen, XY; Ding, MH; Chen, Y; Hu, GH; Lu, YC				Jiang, Lei; Fang, Xiao; Bao, Yi; Zhou, Jue-Yu; Shen, Xiao-Yan; Ding, Mao-Hua; Chen, Yi; Hu, Guo-Han; Lu, Yi-Cheng			Association between the XRCC1 Polymorphisms and Glioma Risk: A Meta-Analysis of Case-Control Studies	PLOS ONE			English	Article							REPAIR GENE XRCC1; BASE EXCISION-REPAIR; MAMMALIAN DNA-REPAIR; LUNG-CANCER; BREAST-CANCER; ARG194TRP POLYMORPHISM; LIGASE-III; SUSCEPTIBILITY; POPULATION; EPIDEMIOLOGY	Background: X-ray repair cross-complementing group 1 (XRCC1) is one of the DNA repair genes encoding a scaffolding protein that participate in base excision repair (BER) pathway. However, studies on the association between polymorphisms in this gene and glioma have yielded conflicting results. This meta-analysis was performed to derive a more precise estimation between XRCC1 polymorphisms (Arg399Gln, Arg194Trp, and Arg280His) and glioma risk. Methods: Data were collected from several electronic databases, with the last search up to November 28, 2012. Meta-analysis was performed by critically reviewing 9 studies for Arg399Gln polymorphism (3146 cases and 4296 controls), 4 studies for Arg194Trp polymorphism (2557 cases and 4347 controls), and 4 studies for Arg280His polymorphism (1936 cases and 2895 controls). All of the statistical analyses were performed using the software programs STATA (version 11.0). Results: The combined results showed that Arg399Gln polymorphism was significantly associated with glioma risk (Gln/Gln versus Arg/Arg: OR = 1.52, 95% CI = 1.03-2.23; recessive model: OR = 1.32, 95% CI = 1.01-1.73; additive model: OR = 1.21, 95% CI = 1.00-1.47), whereas Arg194Trp/Arg280His polymorphisms were all not significantly associated with glioma risk. As for ethnicity, Arg399Gln polymorphism was associated with increased risk of glioma among Asians (Gln/Gln versus Arg/Arg: OR = 1.78, 95% CI = 1.29-2.47; Arg/Gln versus Arg/Arg: OR = 1.28, 95% CI = 1.05-1.56; recessive model: OR = 1.59, 95% CI = 1.16-2.17; dominant model: OR = 1.36, 95% CI = 1.13-1.65; additive model: OR = 1.32, 95% CI = 1.15-1.52), but not among Caucasians. Stratified analyses by histological subtype indicated that the Gln allele of Arg399Gln polymorphism showed borderline association with the risk of glioblastoma among Caucasians. However, no evidence was observed in subgroup analyses for Arg194Trp/Arg280His polymorphisms. Conclusions: Our meta-analysis suggested that Arg399Gln polymorphism was associated with increased risk of glioma among Asians and borderline increased risk for glioblastoma among Caucasians, whereas Arg194Trp/Arg280His polymorphisms might have no influence on the susceptibility of glioma in different ethnicities.	[Jiang, Lei; Fang, Xiao; Shen, Xiao-Yan; Ding, Mao-Hua; Chen, Yi; Hu, Guo-Han; Lu, Yi-Cheng] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Bao, Yi] Second Mil Med Univ, Changzheng Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Zhou, Jue-Yu] Southern Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China	Naval Medical University; Naval Medical University; Southern Medical University - China	Zhou, JY (corresponding author), Southern Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China.	zhoujueyu@126.com; guohanphd@126.com		Fang, Xiao/0000-0002-7549-0214	Key Program of the National Natural Science Foundation of China [30930094]; Natural Science Foundation of Guangdong Province, China [S2011040003050, S2012010009404]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [LYM11038]; National Natural Science Foundation of China [81201565, 30901540, 81172398]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20124433120001]; Medical Scientific Research Foundation of Guangdong Province, China [B2012202]; Program of the Pearl River Young Talents of Science and Technology in Guangzhou, China [2013029]	Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Talents in Higher Education of Guangdong, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Medical Scientific Research Foundation of Guangdong Province, China; Program of the Pearl River Young Talents of Science and Technology in Guangzhou, China	This work was supported by the Key Program of the National Natural Science Foundation of China (No. 30930094), Natural Science Foundation of Guangdong Province, China (S2011040003050, S2012010009404), Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (LYM11038), National Natural Science Foundation of China (No. 81201565, No. 30901540 and No. 81172398), Specialized Research Fund for the Doctoral Program of Higher Education of China (20124433120001), Medical Scientific Research Foundation of Guangdong Province, China (B2012202) and Program of the Pearl River Young Talents of Science and Technology in Guangzhou, China (2013029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethke L, 2008, HUM MOL GENET, V17, P800, DOI 10.1093/hmg/ddm351; BLAIR A, 1995, REGUL TOXICOL PHARM, V22, P189, DOI 10.1006/rtph.1995.1084; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cengiz SL, 2008, NEUROSCIENCES, V13, P227; Chacko P, 2005, BREAST CANCER RES TR, V89, P15, DOI 10.1007/s10549-004-1004-x; Chen B, 2012, MOL BIOL REP, V39, P1305, DOI 10.1007/s11033-011-0863-6; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Curtin K, 2009, CANCER EPIDEM BIOMAR, V18, P3384, DOI 10.1158/1055-9965.EPI-09-0955; Custodio AC, 2011, GENET MOL RES, V10, P1120, DOI 10.4238/vol10-2gmr1125; Dai LP, 2012, MOL BIOL REP, V39, P9535, DOI 10.1007/s11033-012-1818-2; Dai LP, 2009, INT J CANCER, V125, P1102, DOI 10.1002/ijc.24446; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doecke J, 2008, INT J CANCER, V123, P174, DOI 10.1002/ijc.23410; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Felini MJ, 2007, NEUROEPIDEMIOLOGY, V29, P55, DOI 10.1159/000108919; Geng J, 2009, UROLOGY, V74, P648, DOI 10.1016/j.urology.2009.02.046; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hamajima Nobuyuki, 2002, Asian Pac J Cancer Prev, V3, P197; Han X., 2012, HEPATOGASTROENTEROLO, P59; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong YC, 2005, INT J CANCER, V116, P428, DOI 10.1002/ijc.21019; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Huang J, 2011, MOL BIOL REP, V38, P4565, DOI 10.1007/s11033-010-0588-y; Jacobs DI, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-97; Jiang JW, 2010, J THORAC ONCOL, V5, P1741, DOI 10.1097/JTO.0b013e3181f0c409; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; Kiuru A, 2008, J NEURO-ONCOL, V88, P135, DOI 10.1007/s11060-008-9556-y; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Li HH, 2009, BREAST, V18, P183, DOI 10.1016/j.breast.2009.03.008; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044441; Liu J, 2011, XIANDAI YUFANG YIXUE, V38, P3340; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; Monaco R, 2007, PROTEIN J, V26, P541, DOI 10.1007/s10930-007-9095-y; Moullan N, 2003, CANCER EPIDEM BIOMAR, V12, P1168; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Pachouri SS, 2007, DNA CELL BIOL, V26, P186, DOI 10.1089/dna.2006.9999; Qian BY, 2011, LUNG CANCER, V73, P138, DOI 10.1016/j.lungcan.2010.11.018; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Saadat M, 2009, BREAST CANCER RES TR, V115, P137, DOI 10.1007/s10549-008-0051-0; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shen MR, 1998, CANCER RES, V58, P604; Sun JY, 2012, ASIAN PAC J CANCER P, V13, P4783, DOI 10.7314/APJCP.2012.13.9.4783; Tae K, 2004, INT J CANCER, V111, P805, DOI 10.1002/ijc.20338; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Wang B, 2010, INT J COLORECTAL DIS, V25, P313, DOI 10.1007/s00384-009-0866-0; Wang CY, 2008, UROLOGY, V72, P869, DOI 10.1016/j.urology.2007.12.059; Wang DH, 2012, GENE, V509, P223, DOI 10.1016/j.gene.2012.08.023; Wang LE, 2004, CANCER RES, V64, P5560, DOI 10.1158/0008-5472.CAN-03-2181; Wang LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034897; Wang R, 2012, LEUK LYMPHOMA; Wei B, 2011, PROSTATE CANCER P D, V14, P225, DOI 10.1038/pcan.2011.26; Wei X, 2012, MOL BIOL REP; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu KS, 2011, ASIAN PAC J CANCER P, V12, P2237; Xie T, 2012, WORLD J GASTROENTERO, V18, P4207, DOI 10.3748/wjg.v18.i31.4207; Yosunkaya E, 2010, BRIT J NEUROSURG, V24, P561, DOI 10.3109/02688697.2010.489655; Zhang HJ, 2011, ANTICANCER RES, V31, P3945; Zhang XM, 2005, CANCER RES, V65, P722; Zhou CC, 2009, TOHOKU J EXP MED, V219, P43, DOI 10.1620/tjem.219.43; Zhou LQ, 2011, ASIAN PAC J CANCER P, V12, P2547	64	28	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55597	10.1371/journal.pone.0055597	http://dx.doi.org/10.1371/journal.pone.0055597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383237	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800172
J	Miyazaki, K; Itoh, N; Ohyama, S; Kadota, K; Oishi, K				Miyazaki, Koyomi; Itoh, Nanako; Ohyama, Sumika; Kadota, Koji; Oishi, Katsutaka			Continuous Exposure to a Novel Stressor Based on Water Aversion Induces Abnormal Circadian Locomotor Rhythms and Sleep-Wake Cycles in Mice	PLOS ONE			English	Article							CHRONIC MILD STRESS; GLYCOGEN-SYNTHASE KINASE-3-BETA; BODY-TEMPERATURE; CHRONIC INSOMNIA; DEPRIVATION; RATS; BEHAVIOR; CORTICOSTERONE; RESTRICTION; EXPRESSION	Psychological stressors prominently affect diurnal rhythms, including locomotor activity, sleep, blood pressure, and body temperature, in humans. Here, we found that a novel continuous stress imposed by the perpetual avoidance of water on a wheel (PAWW) affected several physiological diurnal rhythms in mice. One week of PAWW stress decayed robust circadian locomotor rhythmicity, while locomotor activity was evident even during the light period when the mice are normally asleep. Daytime activity was significantly upregulated, whereas nighttime activity was downregulated, resulting in a low amplitude of activity. Total daily activity gradually decreased with increasing exposure to PAWW stress. The mice could be exposed to PAWW stress for over 3 weeks without adaptation. Furthermore, continuous PAWW stress enhanced food intake, but decreased body weight and plasma leptin levels, indicating that sleep loss and PAWW stress altered the energy balance in these mice. The diurnal rhythm of corticosterone levels was not severely affected. The body temperature rhythm was diurnal in the stressed mice, but significantly dysregulated during the dark period. Plasma catecholamines were elevated in the stressed mice. Continuous PAWW stress reduced the duration of daytime sleep, especially during the first half of the light period, and increased nighttime sleepiness. Continuous PAWW stress also simultaneously obscured sleep/wake and locomotor activity rhythms compared with control mice. These sleep architecture phenotypes under stress are similar to those of patients with insomnia. The stressed mice could be entrained to the light/dark cycle, and when they were transferred to constant darkness, they exhibited a free-running circadian rhythm with a timing of activity onset predicted by the phase of their entrained rhythms. Circadian gene expression in the liver and muscle was unaltered, indicating that the peripheral clocks in these tissues remained intact.	[Miyazaki, Koyomi; Itoh, Nanako; Ohyama, Sumika; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biol Clock Res Grp, Tsukuba, Ibaraki, Japan; [Kadota, Koji] Univ Tokyo, Agr Bioinformat Res Unit, Grad Sch Agr & Life Sci, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Miyazaki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Biol Clock Res Grp, Tsukuba, Ibaraki, Japan.	k-miyazaki@aist.go.jp	, Kadota/AAP-2804-2020; Kadota, Koji/C-9168-2011; Oishi, Katsutaka/L-6906-2018; Miyazaki, Koyomi/L-6539-2018	, Kadota/0000-0002-3907-4336; Kadota, Koji/0000-0002-3907-4336; Oishi, Katsutaka/0000-0002-4870-0837; Miyazaki, Koyomi/0000-0002-5464-1095	AIST; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23607040]; Yamada Bee Farm Grant for Honeybee Research; Grants-in-Aid for Scientific Research [23617040] Funding Source: KAKEN	AIST; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Bee Farm Grant for Honeybee Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by operational subsidies from AIST, and a Grant-in Aid for Scientific Research KAKENHI 23607040 to K. Miyazaki from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The study was also partially funded by a Yamada Bee Farm Grant for Honeybee Research (http://grant.bee-lab.jp/) to K. Oishi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnum CJ, 2007, J NEUROENDOCRINOL, V19, P632, DOI 10.1111/j.1365-2826.2007.01571.x; Basta M, 2007, SLEEP MED CLIN, V2, P279, DOI 10.1016/j.jsmc.2007.04.002; Bhatnagar S, 2006, J NEUROENDOCRINOL, V18, P13, DOI 10.1111/j.1365-2826.2005.01375.x; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Gold PW, 2005, P NATL ACAD SCI USA, V102, P8303, DOI 10.1073/pnas.0503069102; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; Grandin LD, 2006, CLIN PSYCHOL REV, V26, P679, DOI 10.1016/j.cpr.2006.07.001; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; Gronli J, 2004, BEHAV BRAIN RES, V150, P139, DOI 10.1016/S0166-4328(03)00252-3; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Ibuka N, 1980, Waking Sleeping, V4, P167; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Jiang WG, 2011, BRAIN RES, V1399, P25, DOI 10.1016/j.brainres.2011.05.001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Kim Y, 2007, P NATL ACAD SCI USA, V104, P10697, DOI 10.1073/pnas.0610351104; Kinn AM, 2008, PHYSIOL BEHAV, V95, P553, DOI 10.1016/j.physbeh.2008.07.031; Kinoshita C, 2012, NEUROREPORT, V23, P98, DOI 10.1097/WNR.0b013e32834e7ec2; Koban M, 2006, ENDOCRINOLOGY, V147, P421, DOI 10.1210/en.2005-0695; Kronfeld-Schor N, 2012, NEUROPHARMACOLOGY, V62, P101, DOI 10.1016/j.neuropharm.2011.08.020; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Lack LC, 2008, SLEEP MED REV, V12, P307, DOI 10.1016/j.smrv.2008.02.003; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Lopez-Rodriguez F, 2004, NEUROPSYCHOPHARMACOL, V29, P1105, DOI 10.1038/sj.npp.1300406; Masaki M, 2012, MOL NUTR FOOD RES, V56, P304, DOI 10.1002/mnfr.201100181; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; Meerlo, 1996, Stress, V1, P21; Meerlo P, 2002, J NEUROENDOCRINOL, V14, P397, DOI 10.1046/j.0007-1331.2002.00790.x; Miyazaki K, 2010, GENES CELLS, V15, P351, DOI 10.1111/j.1365-2443.2010.01384.x; Mochizuki T, 2006, AM J PHYSIOL-REG I, V291, pR533, DOI 10.1152/ajpregu.00887.2005; Ohkura N, 2007, CHRONOBIOL INT, V24, P651, DOI 10.1080/07420520701534673; Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125; Oishi K, 2010, NEUROENDOCRINOL LETT, V31, P198; Pandi-Perumal SR, 2005, EXP GERONTOL, V40, P911, DOI 10.1016/j.exger.2005.08.009; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Shirayama M, 2003, SLEEP MED, V4, P427, DOI 10.1016/S1389-9457(03)00101-1; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Storch C, 2004, J NEUROSCI METH, V133, P173, DOI 10.1016/j.jneumeth.2003.10.008; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TSAI LL, 1992, SLEEP, V15, P537, DOI 10.1093/sleep/15.6.537; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ushijima K, 2006, BEHAV BRAIN RES, V173, P326, DOI 10.1016/j.bbr.2006.06.038; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787	44	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55452	10.1371/journal.pone.0055452	http://dx.doi.org/10.1371/journal.pone.0055452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383193	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800157
J	Liu, CX; Wang, LQ; Li, WR; Zhang, XM; Tian, YZ; Zhang, N; He, SG; Chen, T; Huang, JC; Liu, MJ				Liu, Chenxi; Wang, Liqin; Li, Wenrong; Zhang, Xuemei; Tian, Yongzhi; Zhang, Ning; He, Sangang; Chen, Tong; Huang, Juncheng; Liu, Mingjun			Highly Efficient Generation of Transgenic Sheep by Lentivirus Accompanying the Alteration of Methylation Status	PLOS ONE			English	Article							GENE-TRANSFER; STEM-CELLS; PREIMPLANTATION EMBRYOS; MAMMALIAN-CELLS; FARM-ANIMALS; COPY NUMBER; VECTORS; EXPRESSION; PIGS; MICE	Background: Low efficiency of gene transfer and silence of transgene expression are the critical factors hampering the development of transgenic livestock. Recently, transfer of recombinant lentivirus has been demonstrated to be an efficient transgene delivery method in various animals. However, the lentiviral transgenesis and the methylation status of transgene in sheep have not been well addressed. Methodology/Principle Findings: EGFP transgenic sheep were generated by injecting recombinant lentivirus into zygotes. Of the 13 lambs born, 8 carried the EGFP transgene, and its chromosomal integration was identified in all tested tissues. Western blotting showed that GFP was expressed in all transgenic founders and their various tissues. Analysis of CpG methylation status of CMV promoter by bisulfate sequencing unraveled remarkable variation of methylation levels in transgenic sheep. The average methylation levels ranged from 37.6% to 79.1% in the transgenic individuals and 34.7% to 83% in the tested tissues. Correlative analysis of methylation status with GFP expression revealed that the GFP expression level was inversely correlated with methylation density. The similar phenomenon was also observed in tested tissues. Transgene integration determined by Southern blotting presented multiple integrants ranging from 2 to 6 copies in the genome of transgenic sheep. Conclusions/Significance: Injection of lentiviral transgene into zygotes could be a promising efficient gene delivery system to generate transgenic sheep and achieved widespread transgene expression. The promoter of integrants transferred by lentiviral vector was subjected to dramatic alteration of methylation status and the transgene expression level was inversely correlative with promoter methylation density. Our work illustrated for the first time that generation of transgenic sheep by injecting recombinant lentivirus into zygote could be an efficient tool to improve sheep performance by genetic modification.	[Liu, Chenxi; Wang, Liqin; Li, Wenrong; Zhang, Xuemei; Tian, Yongzhi; Zhang, Ning; He, Sangang; Chen, Tong; Huang, Juncheng; Liu, Mingjun] Xinjiang Lab Anim Biotechnol, Urumqi, Xinjiang, Peoples R China; [Liu, Chenxi; Wang, Liqin; Li, Wenrong; Zhang, Xuemei; Tian, Yongzhi; Zhang, Ning; He, Sangang; Chen, Tong; Huang, Juncheng; Liu, Mingjun] Minist Agr, Key Lab Genet Breeding & Reprod Grass Feeding Liv, Urumqi, Xinjiang, Peoples R China; [Wang, Liqin; Li, Wenrong; Zhang, Xuemei; Tian, Yongzhi; Zhang, Ning; He, Sangang; Chen, Tong; Huang, Juncheng; Liu, Mingjun] Xinjiang Acad Anim Sci, Anim Biotechnol Res Ctr, Urumqi, Xinjiang, Peoples R China; [Liu, Chenxi] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Xinjiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Xinjiang University	Liu, MJ (corresponding author), Xinjiang Lab Anim Biotechnol, Urumqi, Xinjiang, Peoples R China.	mingjun_1@sina.com	贺, 三刚/GYJ-3892-2022		National Key Program for Transgenic Sheep Breeding [2008ZX08006-003]	National Key Program for Transgenic Sheep Breeding	The studies were supported by the grant of "National Key Program for Transgenic Sheep Breeding". Grant numbers: 2008ZX08006-003. http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Glud AN, 2010, ACTA NEUROBIOL EXP, V70, P308; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hofmann A, 2004, BIOL REPROD, V71, P405, DOI 10.1095/biolreprod.104.028472; Hofmann A, 2003, EMBO REP, V4, P1054, DOI 10.1038/sj.embor.7400007; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Lavitrano M, 2002, P NATL ACAD SCI USA, V99, P14230, DOI 10.1073/pnas.222550299; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Mohamedali A, 2004, MOL THER, V10, P249, DOI 10.1016/j.ymthe.2004.05.002; Niemann H, 2004, P NATL ACAD SCI USA, V101, P7211, DOI 10.1073/pnas.0402011101; Pfeifer A, 2004, TRANSGENIC RES, V13, P513, DOI 10.1007/s11248-004-2735-5; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Reichenbach M, 2010, TRANSGENIC RES, V19, P549, DOI 10.1007/s11248-009-9333-5; Ritchie WA, 2009, MOL REPROD DEV, V76, P61, DOI 10.1002/mrd.20930; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rudolph NS, 1999, TRENDS BIOTECHNOL, V17, P367, DOI 10.1016/S0167-7799(99)01341-4; Saeki K, 2004, P NATL ACAD SCI USA, V101, P6361, DOI 10.1073/pnas.0308111101; Schweizer J, 1998, DNA CELL BIOL, V17, P427, DOI 10.1089/dna.1998.17.427; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Singer O, 2006, NAT PROTOC, V1, P286, DOI 10.1038/nprot.2006.44; Tessanne K, 2012, MOL REPROD DEV, V79, P176, DOI 10.1002/mrd.22007; Wang Y, 2010, TRANSGENIC RES, V19, P775, DOI 10.1007/s11248-009-9355-z; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolfgang MJ, 2001, P NATL ACAD SCI USA, V98, P10728, DOI 10.1073/pnas.181336098; Yang SH, 2008, GENESIS, V46, P711, DOI 10.1002/dvg.20435; Zielske SP, 2004, MOL THER, V9, P923, DOI 10.1016/j.ymthe.2004.02.017	35	15	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54614	10.1371/journal.pone.0054614	http://dx.doi.org/10.1371/journal.pone.0054614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382924	gold, Green Submitted, Green Published			2022-12-27	WOS:000315483200032
J	Gomez, FA; Tobar, JA; Henriquez, V; Sola, M; Altamirano, C; Marshall, SH				Gomez, Fernando A.; Tobar, Jaime A.; Henriquez, Vitalia; Sola, Mariel; Altamirano, Claudia; Marshall, Sergio H.			Evidence of the Presence of a Functional Dot/Icm Type IV-B Secretion System in the Fish Bacterial Pathogen Piscirickettsia salmonis	PLOS ONE			English	Article							PHAGOSOME-LYSOSOME FUSION; LEGIONELLA-PNEUMOPHILA; COXIELLA-BURNETII; RAINBOW-TROUT; AGROBACTERIUM-TUMEFACIENS; HELICOBACTER-PYLORI; PROTEIN SECRETION; VIRULENCE GENES; DOTA PROTEIN; CELL-LINE	Piscirickettsia salmonis is a fish bacterial pathogen that has severely challenged the sustainability of the Chilean salmon industry since its appearance in 1989. As this Gram-negative bacterium has been poorly characterized, relevant aspects of its life cycle, virulence and pathogenesis must be identified in order to properly design prophylactic procedures. This report provides evidence of the functional presence in P. salmonis of four genes homologous to those described for Dot/Icm Type IV Secretion Systems. The Dot/Icm System, the major virulence mechanism of phylogenetically related pathogens Legionella pneumophila and Coxiella burnetii, is responsible for their intracellular survival and multiplication, conditions that may also apply to P. salmonis. Our results demonstrate that the four P. salmonis dot/icm homologues (dotB, dotA, icmK and icmE) are expressed both during in vitro tissue culture cells infection and growing in cell-free media, suggestive of their putative constitutive expression. Additionally, as it happens in other referential bacterial systems, temporal acidification of cell-free media results in over expression of all four P. salmonis genes, a well-known strategy by which SSTIV-containing bacteria inhibit phagosome-lysosome fusion to survive. These findings are very important to understand the virulence mechanisms of P. salmonis in order to design new prophylactic alternatives to control the disease.	[Gomez, Fernando A.; Henriquez, Vitalia; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso, Chile; [Henriquez, Vitalia; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Valparaiso, Chile; [Tobar, Jaime A.; Sola, Mariel] Lab Centrovet, Santiago, Chile; [Marshall, Sergio H.] Fraunhofer Chile Res Fdn, Ctr Syst Biotechnol, Santiago, Chile; [Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Marshall, SH (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso, Chile.	smarshal@ucv.cl		Altamirano, Claudia/0000-0002-6389-086X; Gomez, Fernando/0000-0002-8191-2153; Henriquez, Vitalia/0000-0002-3447-4031; marshall, sergio/0000-0003-0438-8252	FONDECYT [1120584]; Conicyt Doctoral Scholarship	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt Doctoral Scholarship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT grant 1120584 for Sergio H. Marshall and by a Conicyt Doctoral Scholarship for Fernando A. Gomez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendras FE, 1997, CAN J VET RES, V61, P66; Andrews HL, 1998, INFECT IMMUN, V66, P950, DOI 10.1128/IAI.66.3.950-958.1998; Angelini A, 2008, PROTEINS, V72, P1212, DOI 10.1002/prot.22014; ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Arkush KD, 2005, DIS AQUAT ORGAN, V63, P139, DOI 10.3354/dao063139; Athanassopoulou F, 2004, J APPL ICHTHYOL, V20, P525, DOI 10.1111/j.1439-0426.2004.00571.x; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Birkbeck TH, 2004, INFECT IMMUN, V72, P3693, DOI 10.1128/IAI.72.6.3693-3694.2004; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Bravo S., 1989, CHILE PESQUERO, V54, P47; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Carle A, 2006, INFECT IMMUN, V74, P108, DOI 10.1128/IAI.74.1.108-117.2006; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Flores-Herrera O, 2003, MENSAJE BIOQUIMICO, VXXVII; Fryer JL, 2003, J FISH DIS, V26, P251, DOI 10.1046/j.1365-2761.2003.00460.x; FRYER JL, 1990, FISH PATHOL, V25, P107, DOI 10.3147/jsfp.25.107; Fryer JL, 1997, EMERG INFECT DIS, V3, P137, DOI 10.3201/eid0302.970206; Funato K, 1997, J BIOL CHEM, V272, P16147, DOI 10.1074/jbc.272.26.16147; Gal-Mor O, 2002, J BACTERIOL, V184, P3823, DOI 10.1128/JB.184.14.3823-3833.2002; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Gangwar D, 2009, MALARIA J, V18, P8; Gomez F, 2009, ARCH MED VET, V41, P261, DOI 10.4067/S0301-732X2009000300011; Gomez FA, 2011, FEMS MICROBIOL LETT, V317, P83, DOI 10.1111/j.1574-6968.2011.02218.x; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Joiner KA, 1997, J CLIN INVEST, V99, P1814, DOI 10.1172/JCI119347; Jones KM, 2007, J BACTERIOL, V189, P2133, DOI 10.1128/JB.00116-06; Krause S, 2000, P NATL ACAD SCI USA, V97, P3067, DOI 10.1073/pnas.050578697; Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIN JS, 1995, INFECT IMMUN, V63, P1409, DOI 10.1128/IAI.63.4.1409-1414.1995; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall S, 1998, APPL ENVIRON MICROB, V64, P3066; Marshall SH, 2012, RES MICROBIOL, V163, P557, DOI 10.1016/j.resmic.2012.08.002; Marshall SH, 2011, FEMS MICROBIOL LETT, V314, P18, DOI 10.1111/j.1574-6968.2010.02132.x; Mauel MJ, 2008, J VET DIAGN INVEST, V20, P213, DOI 10.1177/104063870802000211; Mauel MJ, 2003, DIS AQUAT ORGAN, V53, P249, DOI 10.3354/dao053249; Mauel MJ, 1999, DIS AQUAT ORGAN, V35, P115, DOI 10.3354/dao035115; McCarthy UM, 2008, FISH SHELLFISH IMMUN, V25, P477, DOI 10.1016/j.fsi.2008.07.005; Mikalsen J, 2008, FEMS MICROBIOL LETT, V278, P43, DOI 10.1111/j.1574-6968.2007.00977.x; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; Nagai H, 2001, EMBO J, V20, P5962, DOI 10.1093/emboj/20.21.5962; Olsen A. B., 1993, NORSK FISKEOPPDRETT, V12, P40; Pena Andrea A, 2010, BMC Res Notes, V3, P101, DOI 10.1186/1756-0500-3-101; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rajas V, 2009, J CELL BIOCHEM, V108, P631, DOI 10.1002/jcb.22295; Rashkova S, 1997, J BACTERIOL, V179, P583, DOI 10.1128/jb.179.3.583-591.1997; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rojas V, 2010, J CELL BIOCHEM, V110, P468, DOI 10.1002/jcb.22560; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Sauer JD, 2005, INFECT IMMUN, V73, P4494, DOI 10.1128/IAI.73.8.4494-4504.2005; Scaturro M, 2009, J MICROBIOL, V47, P768, DOI 10.1007/s12275-009-0103-0; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Segal G, 1999, MOL MICROBIOL, V33, P669, DOI 10.1046/j.1365-2958.1999.01512.x; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Sexton JA, 2005, MOL MICROBIOL, V57, P70, DOI 10.1111/j.1365-2958.2005.04667.x; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Tobar JA, 2004, J IMMUNOL, V173, P4058, DOI 10.4049/jimmunol.173.6.4058; Tobar JA, 2011, VACCINE, V317, P83; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Rojas MV, 2008, MICROB PATHOGENESIS, V44, P370, DOI 10.1016/j.micpath.2007.10.012; Vincent CD, 2006, J BACTERIOL, V188, P8231, DOI 10.1128/JB.00937-06; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Yanez AJ, 2012, DIS AQUAT ORGAN, V97, P197, DOI 10.3354/dao02403; Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zimmerli S, 1996, J CELL BIOL, V132, P49, DOI 10.1083/jcb.132.1.49; Zink SD, 2002, INFECT IMMUN, V70, P1657, DOI 10.1128/IAI.70.3.1657-1663.2002; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	73	50	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54934	10.1371/journal.pone.0054934	http://dx.doi.org/10.1371/journal.pone.0054934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383004	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500036
J	Pechlaner, R; Knoflach, M; Matosevic, B; Ruecker, M; Schmidauer, C; Kiechl, S; Willeit, J				Pechlaner, Raimund; Knoflach, Michael; Matosevic, Benjamin; Ruecker, Michael; Schmidauer, Christoph; Kiechl, Stefan; Willeit, Johann			Recanalization of Extracranial Internal Carotid Artery Occlusion after i.v. Thrombolysis for Acute Ischemic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; THERAPY	Background: Although extracranial internal carotid artery (e-ICA) occlusion is a common pathology in patients undergoing intravenous thrombolysis for treatment of acute ischemic stroke, no data on e-ICA recanalization rate or potential effects on outcome are yet available. Methods and Results: This study included 52 consecutive patients with e-ICA occlusion and ischemic stroke undergoing standard intravenous thrombolysis. The rate of e-ICA recanalization was 30.8% [95% CI, 18.2-43.3], documented at 3.5 [2.0-11.8] (median [IQR]) days after stroke, as compared to 8.6% [95% CI, 3.5-13.7] in a series of 116 consecutive patients with symptomatic e-ICA occlusion not undergoing thrombolysis (P < 0.001 for difference). Functional outcome three months after stroke did not significantly differ for those with or without e-ICA recanalization following intravenous thrombolysis (modified Rankin scale <= 2: 31.3% vs. 22.2%, odds ratio 1.6 [95% CI, 0.4-5.9], P = 0.506). In patients with e-ICA occlusion of atherothrombotic origin, recanalization resulted in most instances in residual high-grade stenosis (13 of 14). Conclusions: Recanalization of e-ICA occlusion after stroke thrombolysis occurred in about one third of patients. Although e-ICA recanalization had no significant effect on patient outcome, control sonography in the early days after thrombolysis is recommended for the detection of potential residual e-ICA stenosis.	[Pechlaner, Raimund; Knoflach, Michael; Matosevic, Benjamin; Ruecker, Michael; Schmidauer, Christoph; Kiechl, Stefan; Willeit, Johann] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Tyrol, Austria	Medical University of Innsbruck	Willeit, J (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Tyrol, Austria.	Johann.Willeit@i-med.ac.at		Pechlaner, Raimund/0000-0001-9006-5606; Knoflach, Michael/0000-0001-5576-6562				Christou I, 2001, INT ANGIOL, V20, P208; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Georgiadis D, 2004, NEUROLOGY, V63, P22, DOI 10.1212/01.WNL.0000132524.82310.91; Linfante I, 2002, STROKE, V33, P2066, DOI 10.1161/01.STR.0000021001.18101.A5; Mokin M, 2012, STROKE, V43, P2362, DOI 10.1161/STROKEAHA.112.655621; Nederkoorn PJ, 2003, STROKE, V34, P1324, DOI 10.1161/01.STR.0000068367.08991.A2; Paciaroni M, 2005, CEREBROVASC DIS, V20, P108, DOI 10.1159/000086800; Papanagiotou P, 2011, J AM COLL CARDIOL, V58, P2363, DOI 10.1016/j.jacc.2011.08.044; Ruecker M, 2012, NEUROLOGY, V79, P31, DOI 10.1212/WNL.0b013e31825dcdf0; Seet RC, 2012, ARCH NEUROL-CHICAGO, V24, P1; WOLPERT SM, 1993, AM J NEURORADIOL, V14, P3; Zangerle A, 2007, NEUROLOGY, V68, P39, DOI 10.1212/01.wnl.0000250341.38014.d2	12	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55318	10.1371/journal.pone.0055318	http://dx.doi.org/10.1371/journal.pone.0055318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383152	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500075
J	Wei, QX; Claus, R; Hielscher, T; Mertens, D; Raval, A; Oakes, CC; Tanner, SM; de la Chapelle, A; Byrd, JC; Stilgenbauer, S; Plass, C				Wei, Quan-Xiang; Claus, Rainer; Hielscher, Thomas; Mertens, Daniel; Raval, Aparna; Oakes, Christopher C.; Tanner, Stephan M.; de la Chapelle, Albert; Byrd, John C.; Stilgenbauer, Stephan; Plass, Christoph			Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							COLON-CANCER PATIENTS; GENE-EXPRESSION; MONOALLELIC EXPRESSION; COLORECTAL-CANCER; DOWN-REGULATION; METHYLATION; EPIMUTATION; GENOME; TGFBR1; DNA	We previously reported a rare germline variant (c.1-6531) that resulted in allele-specific expression (ASE) of death-associated protein kinase 1 (DAPK1) and predisposition to chronic lymphocytic leukemia (CLL). We investigated a cohort of CLL patients lacking this mutation for the presence of ASE of DAPK1. We developed a novel strategy that combines single-nucleotide primer extension (SNuPE) with MALDI-TOF mass spectrometry, and detected germline DAPK1 ASE in 17 out of 120 (14.2%) CLL patients associated with a trend towards younger age at diagnosis. ASE was absent in 63 healthy controls. Germline cells of CLL patients with ASE showed increased levels of DNA methylation in the promoter region, however, neither genetic nor further epigenetic aberrations could be identified in the DAPK1 5' upstream regulatory region, within distinct exons or in the 3'-UTR. We identified B-lymphoid malignancy related cell line models harboring allelic imbalance and found that allele-specific methylation in DAPK1 is associated with ASE. Our data indicate that ASE at the DAPK1 gene locus is a recurrent event, mediated by epigenetic mechanisms and potentially predisposing to CLL.	[Wei, Quan-Xiang; Claus, Rainer; Oakes, Christopher C.; Plass, Christoph] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Claus, Rainer] Univ Freiburg, Med Ctr, Dept Hematol Oncol, Freiburg, Germany; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Mertens, Daniel] German Canc Res Ctr, Cooperat Unit Mech Leukemogenesis, Heidelberg, Germany; [Mertens, Daniel; Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Raval, Aparna] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA; [Tanner, Stephan M.; de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; [Byrd, John C.] Ohio State Univ, Dept Internal Med, Div Hematol, Ctr Comprehens Canc, Columbus, OH 43210 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Stanford University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Claus, R (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany.	r.claus@dkfz.de	Mertens, Daniel/F-4681-2011; Oakes, Christopher C/H-7288-2014; Plass, Christoph/H-7192-2014; Stilgenbauer, Stephan/ABE-6609-2020; Claus, Rainer/AAZ-5606-2020	Mertens, Daniel/0000-0003-0227-7188; Oakes, Christopher C/0000-0001-8000-9694; Claus, Rainer/0000-0003-2617-8766	German Cancer Aid (Deutsche Krebshilfe); National Cancer Institute [P01 CA1019563, P50 CA140158, P30-CA016058-35]; German Research Council (DFG) [CL 427/2-1]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA101956, P50CA140158, P01CA081534] Funding Source: NIH RePORTER	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Council (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the German Cancer Aid (Deutsche Krebshilfe) and The National Cancer Institute grants P01 CA101956 (to CP and JCB), P50 CA140158 (to JCB and ADC), and P30-CA016058-35 (OSU CCC). RC received a fellowship from the German Research Council (DFG, CL 427/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Crowther-Swanepoel D, 2009, HAEMATOL-HEMATOL J, V94, P606, DOI 10.3324/haematol.2009.006296; DAVIES L, 1993, J AM STAT ASSOC, V88, P782, DOI 10.2307/2290763; Davies P, 1993, J AM STAT ASSOC, V88, P782; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Guda K, 2009, CANCER RES, V69, P4959, DOI 10.1158/0008-5472.CAN-09-0225; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Horsthemke B, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573b; Howlader N, 2011, SEER CANC STAT REV 1; Huang WH, 2009, BIOL PSYCHIAT, V65, P702, DOI 10.1016/j.biopsych.2008.11.024; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Lynch HT, 2008, CANCER GENET CYTOGEN, V186, P95, DOI 10.1016/j.cancergencyto.2008.06.014; Martin DIK, 2005, ANN NY ACAD SCI, V1054, P68, DOI 10.1196/annals.1345.009; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Palacios R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004150; Pinheiro H, 2010, HUM MOL GENET, V19, P943, DOI 10.1093/hmg/ddp537; R Core Team, 2018, R LANG ENV STAT COMP; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Rohde C, BMC BIOINFORMATICS, V11, P230; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Snell C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1858; Tomsic J, 2010, CARCINOGENESIS, V31, P1800, DOI 10.1093/carcin/bgq165; Valle L, 2008, SCIENCE, V321, P1361, DOI 10.1126/science.1159397; Walker EJ, 2012, CANCER RES, V72, P636, DOI 10.1158/0008-5472.CAN-11-2266; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yuille MR, 2000, BRIT J HAEMATOL, V109, P794, DOI 10.1046/j.1365-2141.2000.02111.x; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55261	10.1371/journal.pone.0055261	http://dx.doi.org/10.1371/journal.pone.0055261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383130	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500069
J	Brzoska, T; Suzuki, Y; Mogami, H; Sano, H; Urano, T				Brzoska, Tomasz; Suzuki, Yuko; Mogami, Hideo; Sano, Hideto; Urano, Tetsumei			Binding of Thrombin-Activated Platelets to a Fibrin Scaffold through alpha(IIb)beta(3) Evokes Phosphatidylserine Exposure on Their Cell Surface	PLOS ONE			English	Article							GLYCOPROTEIN-IIB-IIIA; ANTICOAGULANT PROTEIN-I; AMINOPHOSPHOLIPID EXPOSURE; INTEGRIN ALPHA(IIB)BETA(3); CONFORMATIONAL-CHANGES; PROCOAGULANT ACTIVITY; BLOOD-COAGULATION; TERMINAL PORTION; SCOTT-SYNDROME; ANNEXIN-V	Recently, by employing intra-vital confocal microscopy, we demonstrated that platelets expose phosphatidylserine ( PS) and fibrin accumulate only in the center of the thrombus but not in its periphery. To address the question how exposure of platelet anionic phospholipids is regulated within the thrombus, an in-vitro experiment using diluted platelet-rich plasma was employed, in which the fibrin network was formed in the presence of platelets, and PS exposure on the platelet surface was analyzed using Confocal Laser Scanning Microscopy. Almost all platelets exposed PS after treatment with tissue factor, thrombin or ionomycin. Argatroban abrogated fibrin network formation in all samples, however, platelet PS exposure was inhibited only in tissue factor- and thrombin-treated samples but not in ionomycin-treated samples. FK633, an alpha(IIb)beta(3) antagonist, and cytochalasin B impaired platelet binding to the fibrin scaffold and significantly reduced PS exposure evoked by thrombin. Gly-Pro-Arg-Pro amide abrogated not only fibrin network formation, but also PS exposure on platelets without suppressing platelet binding to fibrin/fibrinogen. These results suggest that outside-in signals in platelets generated by their binding to the rigid fibrin network are essential for PS exposure after thrombin treatment.	[Brzoska, Tomasz; Suzuki, Yuko; Sano, Hideto; Urano, Tetsumei] Hamamatsu Univ Sch Med, Dept Med Physiol, Hamamatsu, Shizuoka 4313192, Japan; [Mogami, Hideo] Hamamatsu Univ, Dept Hlth & Nutr Sci, Fac Hlth Promot Sci, Hamamatsu, Shizuoka, Japan; [Mogami, Hideo] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Japan Science & Technology Agency (JST)	Urano, T (corresponding author), Hamamatsu Univ Sch Med, Dept Med Physiol, Hamamatsu, Shizuoka 4313192, Japan.	uranot@hama-med.ac.jp	Sano, Hideto/GZM-5074-2022	Sano, Hideto/0000-0002-4185-3224; Urano, Tetsumei/0000-0002-7398-9732	Japan Society for the Promotion of Science (JSPS) [C:22590826, C:21590230]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [24590273] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (C:22590826[YS] and C:21590230[TU]) from the Japan Society for the Promotion of Science (JSPS), and by a grant from the Smoking Research Foundation (TU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1998, BIOCHEMISTRY-US, V37, P1640, DOI 10.1021/bi972350c; ADELMAN B, 1990, CIRC RES, V67, P941, DOI 10.1161/01.RES.67.4.941; Aoki T, 1999, CARDIOVASC DRUG REV, V17, P147, DOI 10.1111/j.1527-3466.1999.tb00010.x; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Budel S, 2001, AM J PHYSIOL-HEART C, V281, pH1156, DOI 10.1152/ajpheart.2001.281.3.H1156; CHEN YP, 1994, BLOOD, V84, P1857; DACHARYPRIGENT J, 1993, BLOOD, V81, P2554; Diaz-Ricart M, 2002, AM J PATHOL, V160, P329, DOI 10.1016/S0002-9440(10)64376-3; Dicker IB, 2001, THROMB HAEMOSTASIS, V86, P1065; Fox JEB, 1996, J BIOL CHEM, V271, P7004, DOI 10.1074/jbc.271.12.7004; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Honda S, 1998, BLOOD, V92, P3675, DOI 10.1182/blood.V92.10.3675.422k38_3675_3683; Kasatkina L, 2010, NEUROCHEM INT, V56, P711, DOI 10.1016/j.neuint.2010.02.008; KAWASAKI K, 1993, CHEM PHARM BULL, V41, P975; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; Leung R, 2007, J THROMB HAEMOST, V5, P560, DOI 10.1111/j.1538-7836.2007.02354.x; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; MASSINI P, 1980, BIOCHIM BIOPHYS ACTA, V598, P575, DOI 10.1016/0005-2736(80)90037-1; Matsumoto Y, 1999, THROMB RES, V95, P19, DOI 10.1016/S0049-3848(98)00189-3; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; PLOW EF, 1982, P NATL ACAD SCI-BIOL, V79, P3711, DOI 10.1073/pnas.79.12.3711; Razmara M, 2007, CELL MOL LIFE SCI, V64, P999, DOI 10.1007/s00018-007-6546-8; Reutelingsperger CPM, 2001, THROMB HAEMOSTASIS, V86, P413; Reverter JC, 1996, J CLIN INVEST, V98, P863, DOI 10.1172/JCI118859; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SMITH JW, 1990, J BIOL CHEM, V265, P12267; Suehiro K, 1997, J BIOL CHEM, V272, P5360, DOI 10.1074/jbc.272.8.5360; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; TAIT JF, 1989, J BIOL CHEM, V264, P7944; Tanaka KA, 2009, ANESTH ANALG, V108, P1433, DOI 10.1213/ane.0b013e31819bcc9c; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; van der Meijden PEJ, 2012, CELL MOL LIFE SCI, V69, P3481, DOI 10.1007/s00018-012-1033-2; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Weiss HJ, 1997, BLOOD, V89, P1599, DOI 10.1182/blood.V89.5.1599.1599_1599_1611; Yeh RW, 2006, AM HEART J, V151, P1131, DOI 10.1016/j.ahj.2005.09.002; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	41	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55466	10.1371/journal.pone.0055466	http://dx.doi.org/10.1371/journal.pone.0055466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383331	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900038
J	Decano, JL; Moran, AM; Giordano, N; Ruiz-Opazo, N; Herrera, VLM				Decano, Julius L.; Moran, Ann Marie; Giordano, Nicholas; Ruiz-Opazo, Nelson; Herrera, Victoria L. M.			Analysis of CD45-[CD34+/KDR+] Endothelial Progenitor Cells as Juvenile Protective Factors in a Rat Model of Ischemic-Hemorrhagic Stroke	PLOS ONE			English	Article							INJURY; NEOVASCULARIZATION; MOBILIZATION; RELEVANCE; CAPACITY	Background: Identification of juvenile protective factors (JPFs) which are altered with age and contribute to adult-onset diseases could identify novel pathways for reversing the effects of age, an accepted non-modifiable risk factor to adult-onset diseases. Since endothelial progenitor cells (EPCs) have been observed to be altered in stroke, hypertension and hypercholesterolemia, said EPCs are candidate JPFs for adult-onset stroke. A priori, if EPC aging plays a 'master-switch JPF-role' in stroke pathogenesis, juvenile EPC therapy alone should delay stroke-onset. Using a hypertensive, transgenic-hyperlipidemic rat model of spontaneous ischemic-hemorrhagic stroke, spTg25, we tested the hypothesis that freshly isolated juvenile EPCs are JPFs that can attenuate stroke progression and delay stroke onset. Methodology/Principal Findings: FACS analysis revealed that CD45- [CD34+/KDR+] EPCs decrease with progression to stroke in spTg25 rats, exhibit differential expression of the dual endodthelin-1/VEGFsp receptor (DEspR) and undergo differential DEspR-subtype specific changes in number and in vitro angiogenic tube-incorporation. In vivo EPC infusion of male, juvenile non-expanded CD45-[CD34+/KDR+] EPCs into female stroke-prone rats prior to stroke attenuated delayed stroke onset (P<0.003). Detection of Y-chromosome DNA in brain microvessels of EPC-treated female spTg25 rats indicates integration of male EPCs into female rat brain microvessels. Gradient-echo MRI showed delay of ischemic-hemorrhagic lesions in EPC-treated rats. Real-time RT-PCR pathway-specific array-analysis revealed age-associated gene expression changes in CD45-[CD34+/KDR]EPC subtypes, which were accelerated in stroke-prone rats. Pro-angiogenic genes implicated in intimal hyperplasia were increased in stroke-prone rat EPCs (P<0.0001), suggesting a maladaptive endothelial repair system which acts like a double-edged sword repairing while predisposing to age-associated intimal hyperplasia. Conclusions/Significance: Altogether, the data demonstrate that CD45-[CD34/KDR+]EPCs are juvenile protective factors for ischemic hemorrhagic stroke as modeled in the spTg25-rat model. The ability to delay stroke onset emphasizes the importance of EPC-mediated roles in vascular health for ischemic-hemorrhagic stroke, a high unmet need.	[Herrera, Victoria L. M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University; Boston University	Herrera, VLM (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	vherrera@bu.edu		Herrera, Victoria/0000-0001-8991-2134; Ruiz-Opazo, Nelson/0000-0001-8234-1332	National Institutes of Health [RO1 AG032649]; NATIONAL INSTITUTE ON AGING [R01AG032649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health RO1 AG032649 to VLMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 1997, J ANDROL, V18, P289; Bergerat A, 2011, MOL MED, V17, P588, DOI 10.2119/molmed.2010.00228; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Decano JL, 2009, CIRCULATION, V119, P1501, DOI 10.1161/CIRCULATIONAHA.108.833327; del Zoppo GJ, 2009, CEREBROVASC DIS, V27, P65, DOI 10.1159/000200442; Desai A, 2009, ARTERIOSCL THROM VAS, V29, P121, DOI 10.1161/ATVBAHA.108.174573; Edelberg JM, 2002, CIRC RES, V90, pE89, DOI 10.1161/01.RES.0000020861.20064.7E; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Gennaro G, 2003, CIRCULATION, V107, P230, DOI 10.1161/01.CIR.0000050652.47145.4C; Herrera VLM, 2005, PHYSIOL GENOMICS, V23, P257, DOI 10.1152/physiolgenomics.00144.2005; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; Hunter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036893; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Navarro-Sobrino M, 2010, MICROVASC RES, V80, P317, DOI 10.1016/j.mvr.2010.05.008; Payne GW, 2006, MICROCIRCULATION, V13, P275, DOI 10.1080/10739680600618710; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Taguchi A, 2011, J CEREBR BLOOD F MET, V31, P855, DOI 10.1038/jcbfm.2010.165; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; VRACKO R, 1970, J CELL BIOL, V47, P281, DOI 10.1083/jcb.47.1.281; Williamson K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00030; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11	23	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55222	10.1371/journal.pone.0055222	http://dx.doi.org/10.1371/journal.pone.0055222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383116	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600076
J	Izaurralde, RC; Rice, CW; Wielopolski, L; Ebinger, MH; Reeves, JB; Thomson, AM; Harris, R; Francis, B; Mitra, S; Rappaport, AG; Etchevers, JD; Sayre, KD; Govaerts, B; McCarty, GW				Izaurralde, Roberto C.; Rice, Charles W.; Wielopolski, Lucian; Ebinger, Michael H.; Reeves, James B., III; Thomson, Allison M.; Harris, Ronny; Francis, Barry; Mitra, Sudeep; Rappaport, Aaron G.; Etchevers, Jorge D.; Sayre, Kenneth D.; Govaerts, Bram; McCarty, Gregory W.			Evaluation of Three Field-Based Methods for Quantifying Soil Carbon	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY; INDUCED BREAKDOWN SPECTROSCOPY; MITIGATION; STORAGE	Three advanced technologies to measure soil carbon (C) density (g C m(-2)) are deployed in the field and the results compared against those obtained by the dry combustion (DC) method. The advanced methods are: a) Laser Induced Breakdown Spectroscopy (LIBS), b) Diffuse Reflectance Fourier Transform Infrared Spectroscopy (DRIFTS), and c) Inelastic Neutron Scattering (INS). The measurements and soil samples were acquired at Beltsville, MD, USA and at Centro International para el Mejoramiento del Maiz y el Trigo (CIMMYT) at El Batan, Mexico. At Beltsville, soil samples were extracted at three depth intervals (0-5, 5-15, and 15-30 cm) and processed for analysis in the field with the LIBS and DRIFTS instruments. The INS instrument determined soil C density to a depth of 30 cm via scanning and stationary measurements. Subsequently, soil core samples were analyzed in the laboratory for soil bulk density (kg m(-3)), C concentration (g kg(-1)) by DC, and results reported as soil C density (kg m(-2)). Results from each technique were derived independently and contributed to a blind test against results from the reference (DC) method. A similar procedure was employed at CIMMYT in Mexico employing but only with the LIBS and DRIFTS instruments. Following conversion to common units, we found that the LIBS, DRIFTS, and INS results can be compared directly with those obtained by the DC method. The first two methods and the standard DC require soil sampling and need soil bulk density information to convert soil C concentrations to soil C densities while the INS method does not require soil sampling. We conclude that, in comparison with the DC method, the three instruments (a) showed acceptable performances although further work is needed to improve calibration techniques and (b) demonstrated their portability and their capacity to perform under field conditions.	[Izaurralde, Roberto C.; Thomson, Allison M.; Rappaport, Aaron G.] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Izaurralde, Roberto C.; Thomson, Allison M.; Rappaport, Aaron G.] Univ Maryland, College Pk, MD 20742 USA; [Rice, Charles W.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Wielopolski, Lucian; Mitra, Sudeep] Brookhaven Natl Lab, Dept Environm Sci, Upton, NY 11973 USA; [Ebinger, Michael H.; Harris, Ronny] Los Alamos Natl Lab, Los Alamos, NM USA; [Reeves, James B., III; Francis, Barry] ARS, EMBUL, USDA, Beltsville, MD USA; [Etchevers, Jorge D.] Rappaport & Associates, Joint Global Change Res Inst, College Pk, MD USA; [Sayre, Kenneth D.] Colegio Postgrad, Nat Resources Inst, Soil Fertil Lab, Texcoco, State Of Mexico, Mexico; [Govaerts, Bram] CIMMYT, Mexico City, DF, Mexico; [McCarty, Gregory W.] ARS, HRSL, USDA, BARC W, Beltsville, MD USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; Kansas State University; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Agriculture (USDA); Colegio de Postgraduados - Mexico; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); United States Department of Agriculture (USDA)	Izaurralde, RC (corresponding author), Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA.	cesar.izaurralde@pnnl.gov	Izaurralde, Roberto César/E-5257-2019; Thomson, Allison/GRO-3207-2022; Thomson, Allison M/B-1254-2010	Thomson, Allison M/0000-0001-5326-1755; Govaerts, Bram/0000-0002-6109-7286; ETCHEVERS, J. D./0000-0003-4663-6306; Izaurralde, Roberto/0000-0002-8797-9500	United States Agency for International Development, Global Climate Change Office; United States Department of Energy's Office of Science, Biological and Environmental Research (BER); Consortium of Agricultural Soils Mitigation of Greenhouse Gases (CASMGS); Robertson Foundation; Div Of Biological Infrastructure [1043393] Funding Source: National Science Foundation; Office Of The Director [0903806] Funding Source: National Science Foundation	United States Agency for International Development, Global Climate Change Office(United States Agency for International Development (USAID)); United States Department of Energy's Office of Science, Biological and Environmental Research (BER)(United States Department of Energy (DOE)); Consortium of Agricultural Soils Mitigation of Greenhouse Gases (CASMGS); Robertson Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	The authors acknowledge the financial support of the United States Agency for International Development, Global Climate Change Office, the United States Department of Energy's Office of Science, Biological and Environmental Research (BER) funding to the Consortium for Research on Enhancing Carbon Sequestration in Terrestrial Ecosystems (CSiTE), the USDA CSREES through its support of the Consortium of Agricultural Soils Mitigation of Greenhouse Gases (CASMGS), and the Robertson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jowder O, 1999, J AGR FOOD CHEM, V47, P3210, DOI 10.1021/jf981196d; Bertelli D, 2007, FOOD CHEM, V101, P1565, DOI 10.1016/j.foodchem.2006.04.010; Brown D.J., 2010, EOS T AGU, V91, P441, DOI DOI 10.1029/2010EO470001; Carayannis E., 2011, PLANET EARTH 2011 GL, P467; Chatterjee A, 2009, CRIT REV PLANT SCI, V28, P164, DOI 10.1080/07352680902776556; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Cremers DA, 2001, J ENVIRON QUAL, V30, P2202, DOI 10.2134/jeq2001.2202; Csikai J, 1987, HDB FAST NEUTRON GEN; Ebinger MH, 2003, SOIL SCI SOC AM J, V67, P1616, DOI 10.2136/sssaj2003.1616; Ebinger MH, 2010, United States Patent No, Patent No. [7,692, 789 B1, 7692789]; Gish TJ, 2004, PROCEEDINGS OF THE TENTH INTERNATIONAL CONFERENCE ON GROUND PENETRATING RADAR, VOLS 1 AND 2, P493; Govaerts B, 2006, SOIL TILL RES, V87, P163, DOI 10.1016/j.still.2005.03.005; Govaerts B, 2009, SOIL TILL RES, V103, P222, DOI 10.1016/j.still.2008.05.018; Harmon RS, 2005, GEOCHEM-EXPLOR ENV A, V5, P21, DOI 10.1144/1467-7873/03-059; Heymsfield SB, 1997, ANNU REV NUTR, V17, P527, DOI 10.1146/annurev.nutr.17.1.527; Izaurralde R. C., 2006, Carbon sequestration in soils of Latin America, P457; Izaurralde RC, 2005, CLIMATE CHANGE AND GLOBAL FOOD SECURITY, P467; Izaurralde RC, 2001, ADV AGRON, V70, P1; Izaurralde RC, 1998, ADV SOIL S, P433; Janik LJ, 1998, AUST J EXP AGR, V38, P681, DOI 10.1071/EA97144; Janzen HH, 1998, SOIL TILL RES, V47, P181, DOI 10.1016/S0167-1987(98)00105-6; Lal R, 1999, J SOIL WATER CONSERV, V54, P374; Macauley-Patrick S, 2003, BIOTECHNOL LETT, V25, P257, DOI 10.1023/A:1022351001284; McCarty GW, 2006, SOIL SCI, V171, P94, DOI 10.1097/01.ss.0000187377.84391.54; McCarty GW, 2002, SOIL SCI SOC AM J, V66, P640, DOI 10.2136/sssaj2002.0640; Moenke-Blankenburg L., 1989, LASER MICROANALYSIS; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Post WM, 2001, CLIMATIC CHANGE, V51, P73, DOI 10.1023/A:1017514802028; RADZIEMSKI LJ, 1989, LASER INDUCED PLASMA, P295; Reeves JB, 2001, J AGR FOOD CHEM, V49, P766, DOI 10.1021/jf0011283; Rusak DA, 1997, CRIT REV ANAL CHEM, V27, P257, DOI 10.1080/10408349708050587; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Wielopolski L, 2011, GEODERMA, V160, P394, DOI 10.1016/j.geoderma.2010.10.009; Wielopolski L., 2004, 722002004 BNL; Wielopolski L, 2008, SOIL SCI SOC AM J, V72, P1269, DOI 10.2136/sssaj2007.0177; Wielopolski L, 2010, FOREST ECOL MANAG, V260, P1132, DOI 10.1016/j.foreco.2010.06.039; Wielopolski L, 2010, SOIL SCI SOC AM J, V74, P812, DOI 10.2136/sssaj2009.0205	37	17	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55560	10.1371/journal.pone.0055560	http://dx.doi.org/10.1371/journal.pone.0055560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383225	Green Published, gold			2022-12-27	WOS:000314610600126
J	Klagges, C; Campoy, JA; Quero-Garcia, J; Guzman, A; Mansur, L; Gratacos, E; Silva, H; Rosyara, UR; Iezzoni, A; Meisel, LA; Dirlewanger, E				Klagges, Carolina; Antonio Campoy, Jose; Quero-Garcia, Jose; Guzman, Alejandra; Mansur, Levi; Gratacos, Eduardo; Silva, Herman; Rosyara, Umesh R.; Iezzoni, Amy; Meisel, Lee A.; Dirlewanger, Elisabeth			Construction and Comparative Analyses of Highly Dense Linkage Maps of Two Sweet Cherry Intra-Specific Progenies of Commercial Cultivars	PLOS ONE			English	Article							ROSACEAE; MICROSATELLITE; DATABASE; PEACH	Despite the agronomical importance and high synteny with other Prunus species, breeding improvements for cherry have been slow compared to other temperate fruits, such as apple or peach. However, the recent release of the peach genome v1.0 by the International Peach Genome Initiative and the sequencing of cherry accessions to identify Single Nucleotide Polymorphisms (SNPs) provide an excellent basis for the advancement of cherry genetic and genomic studies. The availability of dense genetic linkage maps in phenotyped segregating progenies would be a valuable tool for breeders and geneticists. Using two sweet cherry (Prunus avium L.) intra-specific progenies derived from crosses between 'Black Tartarian' x 'Kordia' (BTxK) and 'Regina' x 'Lapins'(RxL), high-density genetic maps of the four parental lines and the two segregating populations were constructed. For BTxK and RxL, 89 and 121 F-1 plants were used for linkage mapping, respectively. A total of 5,696 SNP markers were tested in each progeny. As a result of these analyses, 723 and 687 markers were mapped into eight linkage groups (LGs) in BTxK and RxL, respectively. The resulting maps spanned 752.9 and 639.9 cM with an average distance of 1.1 and 0.9 cM between adjacent markers in BTxK and RxL, respectively. The maps displayed high synteny and co-linearity between each other, with the Prunus bin map, and with the peach genome v1.0 for all eight LGs (LG1-LG8). These maps provide a useful tool for investigating traits of interest in sweet cherry and represent a qualitative advance in the understanding of the cherry genome and its synteny with other members of the Rosaceae family.	[Klagges, Carolina; Meisel, Lee A.] Univ Andres Bello, Ctr Biotecnol Vegetal, Fac Ciencias Biol, Santiago, Chile; [Antonio Campoy, Jose; Quero-Garcia, Jose; Dirlewanger, Elisabeth] INRA, UR419, UREF, Villenave Dornon, France; [Guzman, Alejandra; Mansur, Levi; Gratacos, Eduardo] Pontificia Univ Catolica Valparaiso, Fac Agron, Estn Expt La Palma, Quillota, Chile; [Silva, Herman] Univ Chile, Fac Ciencias Agron, Dept Agr Prod, Lab Genom Func & Bioinformat, Santiago, Chile; [Rosyara, Umesh R.; Iezzoni, Amy] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Meisel, Lee A.] Univ Chile, INTA, Santiago, Chile	Universidad Andres Bello; INRAE; Pontificia Universidad Catolica de Valparaiso; Universidad de Chile; Michigan State University; Universidad de Chile	Meisel, LA (corresponding author), Univ Andres Bello, Ctr Biotecnol Vegetal, Fac Ciencias Biol, Santiago, Chile.	lmeisel@inta.uchile.cl; edirlewan@bordeaux.inra.fr	Campoy, José A/L-2699-2015; Meisel, Lee Ann/J-6755-2012; Silva, Herman P/C-7252-2012	Campoy, José A/0000-0002-6018-5698; Meisel, Lee Ann/0000-0002-4806-6864; Silva, Herman P/0000-0003-1007-7442; Dirlewanger, Elisabeth/0000-0003-3244-5197	INNOVA Chile CORFO project [07CN13PBT-167]; INRA's Department of "Genetic and Plant Breeding"; Universidad Andres Bello [DI-78-12/I]; USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project "RosBREED: Enabling marker-assisted breeding in Rosaceae" [2009-51181-05808]; CONICYT [1120261, 1121021, 21120115, 24121484]; "Programa de Formacion Postdoctoral de Personal Investigador" of the "Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia", Spain; Conseil Regional d'Aquitaine [01 00122000568]	INNOVA Chile CORFO project; INRA's Department of "Genetic and Plant Breeding"; Universidad Andres Bello; USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project "RosBREED: Enabling marker-assisted breeding in Rosaceae"; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); "Programa de Formacion Postdoctoral de Personal Investigador" of the "Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia", Spain; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This work was funded by 07CN13PBT-167 INNOVA Chile CORFO project, and by INRA's Department of "Genetic and Plant Breeding" and the Conseil Regional d'Aquitaine 2011 project "convention 2011-12 01 00122000568" for analyses performed in France. Additional funding was provided by Universidad Andres Bello DI-78-12/I project, the USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project "RosBREED: Enabling marker-assisted breeding in Rosaceae" (2009-51181-05808), CONICYT Fondecyt/regular number 1120261 and CONICYT Fondecyt/regular number 1121021. CK holds a CONICYT doctoral fellowship (21120115 and 24121484). JC is holder of a postdoctoral fellowship from the "Programa de Formacion Postdoctoral de Personal Investigador" of the "Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia", Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arus P, 2012, TREE GENET GENOMES, V8, P531, DOI 10.1007/s11295-012-0493-8; Bargioni G, 1996, SWEET CHERRY SCIONS, P73; Brettin TS, 2000, J HERED, V91, P75, DOI 10.1093/jhered/91.1.75; Cabrera A, 2012, TREE GENET GENOMES, V8, P237, DOI 10.1007/s11295-011-0436-9; Campoy JA, 2011, SCI HORTIC-AMSTERDAM, V130, P357, DOI 10.1016/j.scienta.2011.07.011; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Clarke JB, 2009, TREE GENET GENOMES, V5, P41, DOI 10.1007/s11295-008-0166-9; Dirlewanger E, 2008, ACTA HORTIC, P115, DOI 10.17660/ActaHortic.2008.795.13; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E, 1998, THEOR APPL GENET, V97, P888, DOI 10.1007/s001220050969; Dirlewanger E., 2007, Fruits and nuts, P103; Faust M., 1997, Horticultural Reviews, V19, P263; Gratacos E, 2008, ACTA HORTIC, P239, DOI 10.17660/ActaHortic.2008.795.32; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Iezzoni A., 1991, GENETIC RESOURCES TE, V290, P111, DOI [10.17660/ActaHortic.1991.290.4, DOI 10.17660/ACTAHORTIC.1991.290.4]; Iezzoni A. F., 2008, P151, DOI 10.1007/978-1-4020-6907-9_5; Illumina, 2008, GENOMESTUDIO GEN MOD; Illumina, 2010, UND ILL QUAL SCOR; Illumina I, 2010, INF GEN DAT AN GUID; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Kappel F, 1996, HORTSCIENCE, V31, P443, DOI 10.21273/HORTSCI.31.3.443; Kappel F, 2012, HANDB PLANT BREED, V8, P459, DOI 10.1007/978-1-4419-0763-9_13; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Luedeling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020155; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; OLDEN EJ, 1968, HEREDITAS-GENETISK A, V59, P327; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; Peace C, 2012, PLOS ONE IN PRESS; PROEBSTING EL, 1987, HORTSCIENCE, V22, P227; Sherman W, 2002, CLIMATIC ADAPTATION, P411; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Sosinski B., 2010, 5 INT GEN C NOV STEL; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Tao R, 2010, SCI HORTIC-AMSTERDAM, V124, P423, DOI 10.1016/j.scienta.2010.01.025; Tavassolian I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-551; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Van Ooijen J., 2006, SOFTWARE CALCULATION; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Webster A. D., 1996, P127; Zhebentyayeva TN, 2008, TREE GENET GENOMES, V4, P403, DOI 10.1007/s11295-007-0119-8	44	54	55	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54743	10.1371/journal.pone.0054743	http://dx.doi.org/10.1371/journal.pone.0054743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382953	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600037
J	Robin, S; Arese, M; Forte, E; Sarti, P; Kolaj-Robin, O; Giuffre, A; Soulimane, T				Robin, Sylvain; Arese, Marzia; Forte, Elena; Sarti, Paolo; Kolaj-Robin, Olga; Giuffre, Alessandro; Soulimane, Tewfik			Functional Dissection of the Multi-Domain Di-Heme Cytochrome c(550) from Thermus thermophilus	PLOS ONE			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; SULFITE-OXIDIZING ENZYMES; SWISS-MODEL; BIOCHEMICAL-CHARACTERIZATION; FLAVOCYTOCHROME-C; MOLECULAR-BIOLOGY; CAA(3) OXIDASE; METABOLISM; COMPLEX; C(4)	In bacteria, oxidation of sulfite to sulfate, the most common strategy for sulfite detoxification, is mainly accomplished by the molybdenum-containing sulfite: acceptor oxidoreductases (SORs). Bacterial SORs are very diverse proteins; they can exist as monomers or homodimers of their core subunit, as well as heterodimers with an additional cytochrome c subunit. We have previously described the homodimeric SOR from Thermus thermophilus HB8 (SORTTHB8), identified its physiological electron acceptor, cytochrome c(550), and demonstrated the key role of the latter in coupling sulfite oxidation to aerobic respiration. Herein, the role of this di-heme cytochrome c was further investigated. The cytochrome was shown to be composed of two conformationally independent domains, each containing one heme moiety. Each domain was separately cloned, expressed in E. coli and purified to homogeneity. Stopped-flow experiments showed that: i) the N-terminal domain is the only one accepting electrons from SORTTHB8; ii) the N- and C-terminal domains are in rapid redox equilibrium and iii) both domains are able to transfer electrons further to cytochrome c(552), the physiological substrate of the ba(3) and caa(3) terminal oxidases. These findings show that cytochrome c(550) functions as a electron shuttle, without working as an electron wire with one heme acting as the electron entry and the other as the electron exit site. Although contribution of the cytochrome c(550) C-terminal domain to T. thermophilus sulfur respiration seems to be dispensable, we suggest that di-heme composition of the cytochrome physiologically enables storage of the two electrons generated from sulfite oxidation, thereof ensuring efficient contribution of sulfite detoxification to the respiratory chain-mediated energy generation.	[Robin, Sylvain; Kolaj-Robin, Olga; Soulimane, Tewfik] Univ Limerick, Chem & Environm Sci Dept, Mat & Surface Sci Inst, Limerick, Ireland; [Arese, Marzia; Forte, Elena; Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, Fdn Cenci Bolognetti, Rome, Italy; [Arese, Marzia; Forte, Elena; Sarti, Paolo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Sarti, Paolo; Giuffre, Alessandro] Ist Biol & Patol Mol, Consiglio Nazl Ric, Rome, Italy	University of Limerick; Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Giuffre, A (corresponding author), Ist Biol & Patol Mol, Consiglio Nazl Ric, Rome, Italy.	alessandro.giuffre@uniroma1.it; tewfik.soulimane@ul.ie	Forte, Elena/K-6015-2015; Giuffrè, Alessandro/K-4341-2015	Giuffrè, Alessandro/0000-0001-5301-0681; ARESE, Marzia/0000-0002-6140-2287; Sarti, Paolo/0000-0002-8219-4827; FORTE, Elena/0000-0001-9049-6916	Science Foundation Ireland [BICF685]; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy [FIRB RBFR08F41U_001, FIRB RBIN06E9Z8]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR))	Work partially supported by Science Foundation Ireland (BICF685) to TF and Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (FIRB RBFR08F41U_001 to AG and FIRB RBIN06E9Z8 to PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel C, 2003, STRUCTURE, V11, P547, DOI 10.1016/S0969-2126(03)00072-8; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Brune DC, 1995, ANOXYGENIC PHOTOSYNT, P847, DOI 10.1007/0-306-47954-0_39; Chang HY, 2010, BIOCHEMISTRY-US, V49, P7494, DOI 10.1021/bi1004574; CHARLES AM, 1965, BIOCHEM BIOPH RES CO, V19, P686, DOI 10.1016/0006-291X(65)90311-6; CHEN ZW, 1994, SCIENCE, V266, P430, DOI 10.1126/science.7939681; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; COHEN HJ, 1971, J BIOL CHEM, V246, P367; CONRAD LS, 1995, EUR J BIOCHEM, V231, P133, DOI 10.1111/j.1432-1033.1995.tb20679.x; Cook AM, 2006, ADV EXP MED BIOL, V583, P3; D'Errico G, 2006, J BACTERIOL, V188, P694, DOI 10.1128/JB.188.2.694-701.2006; Denger K, 2008, MICROBIOL-SGM, V154, P256, DOI 10.1099/mic.0.2007/011650-0; Di Rocco G, 2008, J BIOL INORG CHEM, V13, P789, DOI 10.1007/s00775-008-0366-7; Di Salle A, 2006, EXTREMOPHILES, V10, P587, DOI 10.1007/s00792-006-0534-z; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Emesh S, 2009, BIOCHEMISTRY-US, V48, P2156, DOI 10.1021/bi801553q; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Gerscher S, 1998, BIOSPECTROSCOPY, V4, P365, DOI 10.1002/(SICI)1520-6343(1998)4:6<365::AID-BSPY2>3.0.CO;2-C; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; GRIFFITH OW, 1987, METHOD ENZYMOL, V143, P366; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heitmann D, 2005, BIOCHEMISTRY-US, V44, P12411, DOI 10.1021/bi0509999; Higuchi M, 2009, PHOTOSYNTH RES, V102, P77, DOI 10.1007/s11120-009-9492-5; Janzon J, 2007, IUBMB LIFE, V59, P563, DOI 10.1080/15216540701242482; Kadziola A, 1997, STRUCTURE, V5, P203, DOI 10.1016/S0969-2126(97)00179-2; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Kappler U, 2011, BBA-BIOENERGETICS, V1807, P1, DOI 10.1016/j.bbabio.2010.09.004; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; Low L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00058; Malarte G, 2005, BIOCHEMISTRY-US, V44, P6471, DOI 10.1021/bi048425b; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Moore G. R., 1990, CYTOCHROMES C EVOLUT; Mooser D, 2005, BBA-BIOENERGETICS, V1708, P262, DOI 10.1016/j.bbabio.2005.03.008; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; Pettigrew G.W., 1987, CYTOCHROMES C BIOL A; PETTIGREW GW, 1988, BIOCHEM J, V252, P427, DOI 10.1042/bj2520427; Raffalt AC, 2009, J INORG BIOCHEM, V103, P717, DOI 10.1016/j.jinorgbio.2009.01.004; Reichenbecher W, 1999, ARCH MICROBIOL, V172, P387, DOI 10.1007/s002030050775; Robin S, 2011, J BACTERIOL, V193, P3988, DOI 10.1128/JB.05186-11; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SOROKIN DY, 1995, MICROBIOLOGY+, V64, P295; Soulimane T, 1997, BIOCHEM BIOPH RES CO, V237, P572, DOI 10.1006/bbrc.1997.7041; Soulimane T, 2002, PRACTICAL GUIDE MEMB, P229; VANBEEUMEN JJ, 1991, J BIOL CHEM, V266, P12921; Wilson JJ, 2009, BBA-BIOENERGETICS, V1787, P1516, DOI 10.1016/j.bbabio.2009.07.005	53	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55129	10.1371/journal.pone.0055129	http://dx.doi.org/10.1371/journal.pone.0055129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383080	Green Published, gold			2022-12-27	WOS:000314610600067
J	Wu, XY; Ma, J				Wu, Xinyi; Ma, Jun			The Formation Mechanism of Defects, Spiral Wave in the Network of Neurons	PLOS ONE			English	Article							SPATIOTEMPORAL CHAOS; PATTERN-FORMATION; VENTRICULAR-FIBRILLATION; TARGET WAVES; TRANSITION; MODEL; SUPPRESSION; NOISE; TACHYCARDIA; TURBULENCE	A regular network of neurons is constructed by using the Morris-Lecar (ML) neuron with the ion channels being considered, and the potential mechnism of the formation of a spiral wave is investigated in detail. Several spiral waves are initiated by blocking the target wave with artificial defects and/or partial blocking (poisoning) in ion channels. Furthermore, possible conditions for spiral wave formation and the effect of partial channel blocking are discussed completely. Our results are summarized as follows. 1) The emergence of a target wave depends on the transmembrane currents with diversity, which mapped from the external forcing current and this kind of diversity is associated with spatial heterogeneity in the media. 2) Distinct spiral wave could be induced to occupy the network when the target wave is broken by partially blocking the ion channels of a fraction of neurons (local poisoned area), and these generated spiral waves are similar with the spiral waves induced by artificial defects. It is confirmed that partial channel blocking of some neurons in the network could play a similar role in breaking a target wave as do artificial defects; 3) Channel noise and additive Gaussian white noise are also considered, and it is confirmed that spiral waves are also induced in the network in the presence of noise. According to the results mentioned above, we conclude that appropriate poisoning in ion channels of neurons in the network acts as 'defects' on the evolution of the spatiotemporal pattern, and accounts for the emergence of a spiral wave in the network of neurons. These results could be helpful to understand the potential cause of the formation and development of spiral waves in the cortex of a neuronal system.	[Wu, Xinyi; Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China	Lanzhou University of Technology	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China.	hyperchaos@163.com	Ma, Jun/G-2376-2010; Wu, xinyi/AGX-5050-2022	Ma, Jun/0000-0002-6127-000X; 	National Nature Science of Foundation of China [11265008]	National Nature Science of Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the National Nature Science of Foundation of China under the Grant No.11265008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARANSON I, 1995, PHYSICA D, V85, P142, DOI 10.1016/0167-2789(95)00113-I; Bordyugov G, 2007, PHYSICA D, V228, P49, DOI 10.1016/j.physd.2007.02.005; Cai MC, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016208; Cao ZJ, 2007, CHAOS, V17, DOI 10.1063/1.2713688; Christini DJ, 2002, CHAOS, V12, P732, DOI 10.1063/1.1504061; Christoph J, 2002, CHAOS, V12, P215, DOI 10.1063/1.1449956; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Crotti P, 2011, THESIS; Erichsen R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061917; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Gao JH, 2007, PHYS LETT A, V371, P96, DOI 10.1016/j.physleta.2007.06.018; Gollub JP, 1999, REV MOD PHYS, V71, pS396, DOI 10.1103/RevModPhys.71.S396; Gu HG, 2013, PHYSICA A, V392, P1361, DOI 10.1016/j.physa.2012.11.049; HAGAN PS, 1982, SIAM J APPL MATH, V42, P762, DOI 10.1137/0142054; He DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055204; HILDEBRAND M, 1995, PHYS REV LETT, V75, P1503, DOI 10.1103/PhysRevLett.75.1503; Hou ZH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.280601; Hu G, 1998, PHYS REV LETT, V80, P1884, DOI 10.1103/PhysRevLett.80.1884; Huang L, 2013, J BIOL SYST, V21, DOI 10.1142/S0218339013500022; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jensen FG, 2002, CHAOS, V12, P16, DOI 10.1063/1.1429968; Jiang LL, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103001; KAPRAL R, 1995, PHYSICA D, V86, P149, DOI 10.1016/0167-2789(95)00096-M; KEYNES RD, 1973, J PHYSIOL-LONDON, V229, P409, DOI 10.1113/jphysiol.1973.sp010146; Kistler WM, 1998, PHYSICA D, V114, P273, DOI 10.1016/S0167-2789(97)00195-4; Kremmydas GP, 2002, CHAOS SOLITON FRACT, V13, P1659, DOI 10.1016/S0960-0779(01)00173-4; Liao XH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056204; Liu FC, 2007, CHINESE PHYS, V16, P2640, DOI 10.1088/1009-1963/16/9/024; Lou Q, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026213; Ma J, 2006, COMMUN THEOR PHYS, V45, P121; Ma J, 2007, CHINESE J CHEM PHYS, V20, P53, DOI 10.1360/cjcp2007.20(1).53.6; Ma J, 2013, SCI CHINA PHYS MECH, V56, P952, DOI 10.1007/s11433-013-5070-0; Ma J, 2010, APPL MATH COMPUT, V217, P3844, DOI 10.1016/j.amc.2010.09.043; Ma J, 2010, COMMUN THEOR PHYS, V54, P583, DOI 10.1088/0253-6102/54/3/38; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Nie HC, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056204; Ouyang Q, 2000, PHYS REV LETT, V84, P1047, DOI 10.1103/PhysRevLett.84.1047; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Pivik L., 1995, IEEE T CIRCUITS-I, V42, P638; Puwal S, 2009, IEEE T BIO-MED ENG, V56, P532, DOI 10.1109/TBME.2008.2003279; Qian Y, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/10/108201; Rinzel J., 1989, METHODS NEURONAL MOD, P251; Roth BJ, 2001, PHYSICA D, V150, P127, DOI 10.1016/S0167-2789(01)00145-2; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Samie FH, 2000, CIRC RES, V86, P684, DOI 10.1161/01.RES.86.6.684; Samie FH, 2001, CARDIOVASC RES, V50, P242, DOI 10.1016/S0008-6363(00)00289-3; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Schmid G, 2004, PHYS BIOL, V1, P61, DOI 10.1088/1478-3967/1/2/002; Schulze TP, 1999, PHYSICA D, V132, P520, DOI 10.1016/S0167-2789(99)00108-6; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; Sinha S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015101; Smith G.D., 2002, INTERD APPL, VVolume 20, P285; Stich M, 2006, PHYSICA D, V215, P38, DOI 10.1016/j.physd.2006.01.011; Tang Z, 2012, COMMUN THEOR PHYS, V57, P61, DOI 10.1088/0253-6102/57/1/10; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Yagisita H, 1998, PHYSICA D, V124, P126, DOI 10.1016/S0167-2789(98)00182-1; Yuan GY, 2005, EUROPHYS LETT, V72, P908, DOI 10.1209/epl/i2004-10553-2; Zhang H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188301; Zhang H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026134; Zykov VS, 2009, PHYSICA D, V238, P931, DOI 10.1016/j.physd.2008.06.009	63	49	52	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55403	10.1371/journal.pone.0055403	http://dx.doi.org/10.1371/journal.pone.0055403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383179	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600099
J	Allard, MW; Luo, Y; Strain, E; Pettengill, J; Timme, R; Wang, C; Li, C; Keys, CE; Zheng, J; Stones, R; Wilson, MR; Musser, SM; Brown, EW				Allard, Marc W.; Luo, Yan; Strain, Errol; Pettengill, James; Timme, Ruth; Wang, Charles; Li, Cong; Keys, Christine E.; Zheng, Jie; Stones, Robert; Wilson, Mark R.; Musser, Steven M.; Brown, Eric W.			On the Evolutionary History, Population Genetics and Diversity among Isolates of Salmonella Enteritidis PFGE Pattern JEGX01.0004	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; FIELD GEL-ELECTROPHORESIS; COMPLETE GENOME SEQUENCE; VIRULENCE PLASMIDS; PROVIDES INSIGHTS; ESCHERICHIA-COLI; HOST ADAPTATION; TYPING SCHEME; GENES; STRAINS	Facile laboratory tools are needed to augment identification in contamination events to trace the contamination back to the source (traceback) of Salmonella enterica subsp. enterica serovar Enteritidis (S. Enteritidis). Understanding the evolution and diversity within and among outbreak strains is the first step towards this goal. To this end, we collected 106 new S. Enteriditis isolates within S. Enteriditis Pulsed-Field Gel Electrophoresis (PFGE) pattern JEGX01.0004 and close relatives, and determined their genome sequences. Sources for these isolates spanned food, clinical and environmental farm sources collected during the 2010 S. Enteritidis shell egg outbreak in the United States along with closely related serovars, S. Dublin, S. Gallinarum biovar Pullorum and S. Gallinarum. Despite the highly homogeneous structure of this population, S. Enteritidis isolates examined in this study revealed thousands of SNP differences and numerous variable genes (n = 366). Twenty-one of these genes from the lineages leading to outbreak-associated samples had nonsynonymous (causing amino acid changes) changes and five genes are putatively involved in known Salmonella virulence pathways. While chromosome synteny and genome organization appeared to be stable among these isolates, genome size differences were observed due to variation in the presence or absence of several phages and plasmids, including phage RE-2010, phage P125109, plasmid pSEEE3072_19 (similar to pSENV), plasmid pOU1114 and two newly observed mobile plasmid elements pSEEE1729_15 and pSEEE0956_35. These differences produced modifications to the assembled bases for these draft genomes in the size range of approximately 4.6 to 4.8 mbp, with S. Dublin being larger (similar to 4.9 mbp) and S. Gallinarum smaller (4.55 mbp) when compared to S. Enteritidis. Finally, we identified variable S. Enteritidis genes associated with virulence pathways that may be useful markers for the development of rapid surveillance and typing methods, potentially aiding in traceback efforts during future outbreaks involving S. Enteritidis PFGE pattern JEGX01.0004.	[Allard, Marc W.; Pettengill, James; Timme, Ruth; Wang, Charles; Li, Cong; Keys, Christine E.; Zheng, Jie; Musser, Steven M.; Brown, Eric W.] US FDA, Off Regulatory Sci, Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Luo, Yan; Strain, Errol] US FDA, Off Food Def Commun & Emergency Response, Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Stones, Robert] Food & Environm Res Agcy, York, N Yorkshire, England; [Wilson, Mark R.] Western Carolina Univ, Forens Sci Program, Cullowhee, NC 28723 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Food & Environment Research Agency; University of North Carolina; Western Carolina University	Allard, MW (corresponding author), US FDA, Off Regulatory Sci, Ctr Food Safety & Appl Nutr, College Pk, MD USA.	marc.allard@fda.hhs.gov		Timme, Ruth/0000-0002-9705-5897	Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	Food and Drug Administration research funds were provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Battesti A, 2012, J BACTERIOL, V194, P2470, DOI 10.1128/JB.00132-12; Betancor Laura, 2012, Open Microbiol J, V6, P5, DOI 10.2174/1874285801206010005; Bono JL, 2012, MOL BIOL EVOL, V29, P2047, DOI 10.1093/molbev/mss072; Botteldoorn N, 2010, ZOONOSES PUBLIC HLTH, V57, P345, DOI 10.1111/j.1863-2378.2008.01216.x; Boyd EF, 2012, ADV VIRUS RES, V82, P91, DOI 10.1016/B978-0-12-394621-8.00014-5; Brankatschk K, 2012, INT J FOOD MICROBIOL, V155, P247, DOI 10.1016/j.ijfoodmicro.2012.01.024; Cebula TA, 2005, EXPERT REV MOL DIAGN, V5, P431, DOI 10.1586/14737159.5.3.431; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chu CS, 2008, GENOMICS, V92, P339, DOI 10.1016/j.ygeno.2008.07.010; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; David R, 2012, NAT REV MICROBIOL, V10, P309, DOI 10.1038/nrmicro2784; den Bakker HC, 2011, APPL ENVIRON MICROB, V77, P8648, DOI 10.1128/AEM.06538-11; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Engelthaler DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001347; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Feng Y, 2012, INFECT GENET EVOL, V12, P1058, DOI 10.1016/j.meegid.2012.03.004; Feng Y, 2012, J BACTERIOL, V194, P744, DOI 10.1128/JB.06507-11; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Frerichs RR, 2012, CLIN MICROBIOL INFEC, V18, pE158, DOI 10.1111/j.1469-0691.2012.03841.x; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gillece JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028550; Goloboff PA, 1996, CLADISTICS, V12, P199, DOI 10.1111/j.1096-0031.1996.tb00009.x; Goloboff PA, 2008, CLADISTICS, V24, P591, DOI 10.1111/j.1096-0031.2007.00189.x; Grepinet O, 2012, J BACTERIOL, V194, P2387, DOI 10.1128/JB.00256-12; Guard Jean, 2011, BMC Res Notes, V4, P369, DOI 10.1186/1756-0500-4-369; Hanna LF, 2012, APPL ENVIRON MICROB, V78, P1785, DOI 10.1128/AEM.07241-11; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Hudson CR, 2001, AVIAN DIS, V45, P875, DOI 10.2307/1592867; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Karberg KA, 2011, P NATL ACAD SCI USA, V108, P20154, DOI 10.1073/pnas.1109451108; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Lee JH, 2012, J VIROL, V86, P3404, DOI 10.1128/JVI.07226-11; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-88; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Lienau EK, 2012, PLOS ONE IN PRESS; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; OLSEN JE, 1994, J MED MICROBIOL, V40, P15, DOI 10.1099/00222615-40-1-15; Olson AB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-87; Osborne SE, 2012, J BIOL CHEM, V287, P15242, DOI 10.1074/jbc.M112.348227; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Saeed AM, 2006, J AOAC INT, V89, P504; Shah DH, 2012, FOODBORNE PATHOG DIS, V9, P258, DOI 10.1089/fpd.2011.1009; Shin H, 2012, J VIROL, V86, P1284, DOI 10.1128/JVI.06696-11; Silva CA, 2012, INFECT IMMUN, V80, P839, DOI 10.1128/IAI.05497-11; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; STANLEY J, 1992, FEMS MICROBIOL LETT, V90, P153, DOI [10.1111/j.1574-6968.1992.tb05143.x, 10.1016/0378-1097(92)90620-4]; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Tang YT, 2012, CHEM BIOL DRUG DES, V79, P1007, DOI 10.1111/j.1747-0285.2012.01362.x; Tankouo-Sandjong B, 2012, FEMS MICROBIOL LETT, V331, P165, DOI 10.1111/j.1574-6968.2012.02568.x; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Timme RE, 2012, J BACTERIOL, V194, P5994, DOI 10.1128/JB.01289-12; WARD LR, 1987, EPIDEMIOL INFECT, V99, P291, DOI 10.1017/S0950268800067765; Wise MG, 2009, J MICROBIOL METH, V76, P18, DOI 10.1016/j.mimet.2008.09.006; Wright AM, 2011, ARCH PATHOL LAB MED, V135, P1447, DOI 10.5858/2011-0362-SAIR.1; Xi ML, 2008, J FOOD PROTECT, V71, P2067, DOI 10.4315/0362-028X-71.10.2067; Yue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038596; Zheng J, 2007, EMERG INFECT DIS, V13, P1932, DOI 10.3201/eid1312.070185; Zwickl DJ., 2006, THESIS	70	103	106	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55254	10.1371/journal.pone.0055254	http://dx.doi.org/10.1371/journal.pone.0055254			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383127	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800136
J	Nguyen, T; Rich, A; Dahl, R				Tan Nguyen; Rich, Audrey; Dahl, Richard			MiR-24 Promotes the Survival of Hematopoietic Cells	PLOS ONE			English	Article							UP-REGULATION; MYELOID-LEUKEMIA; APOPTOSIS; EXPRESSION; MICRORNAS; DIFFERENTIATION; PROGENITORS; INHIBITION; BCL-X(L); PATHWAYS	The microRNA, miR-24, inhibits B cell development and promotes myeloid development of hematopoietic progenitors. Differential regulation of cell survival in myeloid and lymphoid cells by miR-24 may explain how miR-249s affects hematopoietic progenitors. MiR-24 is reported to regulate apoptosis, either positively or negatively depending on cell context. However, no role for miR-24 in regulating cell death has been previously described in blood cells. To examine miR-249s effect on survival, we expressed miR-24 via retrovirus in hematopoietic cells and induced cell death with cytokine or serum withdrawal. We observed that miR-24 enhanced survival of myeloid and B cell lines as well as primary hematopoietic cells. Additionally, antagonizing miR-24 with shRNA in hematopoietic cells made them more sensitive to apoptotic stimuli, suggesting miR-24 functions normally to promote blood cell survival. Since we did not observe preferential protection of myeloid over B cells, miR-249s pro-survival effect does not explain its promotion of myelopoiesis. Moreover, expression of pro-survival protein, Bcl-xL, did not mimic miR-249s impact on cellular differentiation, further supporting this conclusion. Our results indicate that miR-24 is a critical regulator of hematopoietic cell survival. This observation has implications for leukemogenesis. Several miRNAs that regulate apoptosis have been shown to function as either tumor suppressors or oncogenes during leukemogenesis. MiR-24 is expressed highly in primary acute myelogenous leukemia, suggesting that its pro-survival activity could contribute to the transformation of hematopoietic cells.	[Tan Nguyen; Dahl, Richard] Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN USA; [Rich, Audrey] Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Dahl, Richard] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	Indiana University System; Indiana University South Bend; University of New Mexico; University of New Mexico's Health Sciences Center; University of Notre Dame	Dahl, R (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN USA.	richdahl@iupui.edu		Dahl, Richard/0000-0002-6341-5604	American Cancer Society [RSG-06-170-01-LIB]; Indiana University School of Medicine	American Cancer Society(American Cancer Society); Indiana University School of Medicine	This study was funded by the American Cancer Society (RSG-06-170-01-LIB), and a Biomedical Enhancement Grant from the Indiana University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; FRIEDMAN AD, 1991, BLOOD, V78, P2426; Gaines P, 2005, J LEUKOCYTE BIOL, V77, P669, DOI 10.1189/jlb.1004567; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kong KY, 2010, EXP HEMATOL, V38, P629, DOI 10.1016/j.exphem.2010.04.004; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lima RT, 2011, EUR J CANCER, V47, P163, DOI 10.1016/j.ejca.2010.11.005; Lin SC, 2010, ORAL ONCOL, V46, P204, DOI 10.1016/j.oraloncology.2009.12.005; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; MERINO R, 1995, J IMMUNOL, V155, P3830; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Singh R, 2012, J CELL SCI; Srivastava N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2861; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Zaidi SK, 2009, CANCER RES, V69, P8249, DOI 10.1158/0008-5472.CAN-09-1567	31	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55406	10.1371/journal.pone.0055406	http://dx.doi.org/10.1371/journal.pone.0055406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383180	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800149
J	Xie, SL; Zhu, MG; Lv, GY; Geng, YJ; Chen, GF; Ma, J; Wang, GY				Xie, Shuli; Zhu, Mingguang; Lv, Guoyue; Geng, Yajun; Chen, Guofu; Ma, Jian; Wang, Guangyi			Overexpression of Ras Homologous C (RhoC) Induces Malignant Transformation of Hepatocytes In Vitro and in Nude Mouse Xenografts	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; CELL INVASION; HEPATITIS-B; PROLIFERATION; EXPRESSION; GENE; METASTASIS; PROTEINS; GTPASES	Ras homologous C (RhoC) is expressed in various cancers, including hepatocellular carcinoma (HCC). In this study, we first analyzed RhoC expression in 46 HCC tissue specimens and found that RhoC expression was significantly increased in HCC tissues compared to the adjacent normal liver tissues. Next, we investigated the role of RhoC in malignant transformation of normal hepatocytes. The HL7702 cell line was stably transfected with a RhoC expression vector and then subjected to cell proliferation, differentiation, colony formation, migration and invasion assays, as well as nude mouse xenograft assays. Gene expressions in these cells were determined using RT-PCR and Western blot. Overexpression of RhoC significantly promoted proliferation and anchorage-independent growth of HL7702 cells, but suppressed cell differentiation, as compared with the parental cells and the empty vector-transfected control cells. Moreover, RhoC overexpression induced migration and invasion of HL7702 cells in vitro. Molecularly, RhoC increased the expression of cell cycle-related genes, matrix metalloprotease 2 (MMP2), MMP9 and vascular endothelial growth factor (VEGF). In addition, RhoC-transfected cells formed tumors in nude mice, whereas vector-transfected HL7702 cells did not form any tumors in nude mice. This study demonstrated the role of RhoC overexpression in malignant transformation of normal human hepatocytes, suggesting that RhoC may function as an oncogene in hepatocytes.	[Xie, Shuli; Lv, Guoyue; Geng, Yajun; Chen, Guofu; Ma, Jian; Wang, Guangyi] Jilin Univ, Hosp 1, Dept Gen Surg, Changchun 130023, Jilin, Peoples R China; [Zhu, Mingguang] Jilin Univ, Sch Basic Med Sci, Dept Immunol, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University	Wang, GY (corresponding author), Jilin Univ, Hosp 1, Dept Gen Surg, Changchun 130023, Jilin, Peoples R China.	xieshuli6310@hotmail.com						Abedin ZR, 2010, CELL CYCLE, V9, P2456, DOI 10.4161/cc.9.12.12055; Abraham MT, 2001, LARYNGOSCOPE, V111, P1285, DOI 10.1097/00005537-200107000-00027; Anzola M, 2004, J VIRAL HEPATITIS, V11, P383, DOI 10.1111/j.1365-2893.2004.00521.x; Baranwal S, 2011, CURR DRUG TARGETS, V12, P1194, DOI 10.2174/138945011795906534; Bauvois B., 2011, BIOCHIM BIOPHYS ACTA, V1825, P29; Bostrom Pia, 2009, BMC Res Notes, V2, P140, DOI 10.1186/1756-0500-2-140; Chen LL, 2010, ACTA PHARMACOL SIN, V31, P1165, DOI 10.1038/aps.2010.94; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Denoyelle C, 2003, CELL SIGNAL, V15, P327, DOI 10.1016/S0898-6568(02)00124-9; Deshpande A, 2009, CELL CYCLE, V8, P3592, DOI 10.4161/cc.8.21.9993; Faried A, 2006, EUR J CANCER, V42, P1455, DOI 10.1016/j.ejca.2006.02.012; Farley J, 2011, GYNECOL ONCOL, V121, P395, DOI 10.1016/j.ygyno.2010.11.023; Ferenci P, 2010, J CLIN GASTROENTEROL, V44, P239, DOI 10.1097/MCG.0b013e3181d46ef2; Frame MC, 2002, CURR OPIN GENET DEV, V12, P36, DOI 10.1016/S0959-437X(01)00261-1; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Hoshino D, 2011, J BIOL CHEM, V286, P3139, DOI 10.1074/jbc.M110.159715; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; Liu N, 2007, J MOL MED-JMM, V85, P1149, DOI 10.1007/s00109-007-0217-y; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Okabe H, 2001, CANCER RES, V61, P2129; Perez R, 2003, J GASTROINTEST SURG, V7, P884, DOI 10.1016/j.gassur.2003.08.001; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Ruth MC, 2006, J INVEST DERMATOL, V126, P862, DOI 10.1038/sj.jid.5700211; Sun HW, 2007, WORLD J GASTROENTERO, V13, P3517, DOI 10.3748/wjg.v13.i25.3517; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Vecchiarelli-Federico LM, 2010, CANCER RES, V70, P863, DOI 10.1158/0008-5472.CAN-09-3592; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang W, 2003, WORLD J GASTROENTERO, V9, P1950, DOI 10.3748/wjg.v9.i9.1950; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Xie SL, 2012, MED ONCOL, V29, P1802, DOI 10.1007/s12032-011-0003-0; Xie SY., 2009, THESIS; Yang Y, 2007, EUR J NEUROSCI, V26, P2979, DOI 10.1111/j.1460-9568.2007.05914.x	42	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54493	10.1371/journal.pone.0054493	http://dx.doi.org/10.1371/journal.pone.0054493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382905	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800050
J	Colombo, E; Franceschetti, S; Avanzini, G; Mantegazza, M				Colombo, Elisa; Franceschetti, Silvana; Avanzini, Giuliano; Mantegazza, Massimo			Phenytoin Inhibits the Persistent Sodium Current in Neocortical Neurons by Modifying Its Inactivation Properties	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MAMMALIAN CNS NEURONS; GATED NA+ CHANNELS; PYRAMIDAL NEURONS; SLOW INACTIVATION; MOLECULAR DETERMINANTS; SENSORIMOTOR CORTEX; STATUS EPILEPTICUS; LOCAL-ANESTHETICS; SINGLE-CHANNEL	The persistent Na+ current (I-NaP) is important for neuronal functions and can play a role in several pathologies, although it is small compared to the transient Na+ current (I-NaT). Notably, I-NaP is not a real persistent current because it undergoes inactivation with kinetics in the order of tens of seconds, but this property has often been overlooked. Na+ channel blockers, drugs used for treating epilepsy and other diseases, can inhibit I-NaP, but the mechanism of this action and the conditions in which I-NaP can be actually inhibited have not been completely clarified yet. We evaluated the action of phenytoin (PHT), a prototype anti-epileptic Na+ channel blocker, on I-NaP inactivation in pyramidal neurons of rat sensorimotor cortical slices at different concentrations, from 5 to 100 mu M. PHT did not modify I-NaP evoked with depolarizing voltage ramps of 50 or 100 mVs(-1), but decreased I-NaP evoked by slower voltage ramps (10 mVs(-1)). However, at all of the tested concentrations, PHT decreased I-NaP evoked by faster ramps when they were preceded by inactivating pre-pulses. Moreover, PHT shifted towards negative potentials the voltage-dependence of I-NaP inactivation and accelerated its kinetics of development also at depolarized potentials (+40 mV), not consistently with a simple inactivated state stabilizer. Therefore, our study shows a prominent PHT effect on I-NaP inactivation rather than an open channel block, which is instead often implied. I-NaP is inhibited by PHT only in conditions that induce major I-NaP inactivation. These results highlight the importance of I-NaP inactivation not only for physiological functions but also as drug target, which could be shared by other therapeutic drugs. Through this action PHT can reduce I-NaP-induced long-lasting pathological depolarisations and intracellular sodium overload, whereas shorter I-NaP actions should not be modified. These properties set the conditions of efficacy and the limits of PHT as I-NaP inhibitor.	[Colombo, Elisa; Franceschetti, Silvana; Avanzini, Giuliano; Mantegazza, Massimo] Fdn IRCCS Neurol Inst C Besta, Epilepsy Ctr, Dept Neurophysiopathol, Milan, Italy; [Mantegazza, Massimo] CNRS, Inst Pharmacol Mol & Cellulaire, UMR7275, F-06560 Valbonne, France; [Mantegazza, Massimo] Univ Nice Sophia Antipolis, Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Mantegazza, M (corresponding author), Fdn IRCCS Neurol Inst C Besta, Epilepsy Ctr, Dept Neurophysiopathol, Milan, Italy.	mantegazza@ipmc.cnrs.fr	Mantegazza, Massimo/J-8802-2016; Franceschetti, Silvana/K-3438-2016	Mantegazza, Massimo/0000-0002-1070-7929; Franceschetti, Silvana/0000-0002-1921-6755	European Integrated Project EPICURE [EFP6-037315]; Mariani Foundation; Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale	European Integrated Project EPICURE; Mariani Foundation; Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was supported in part by the European Integrated Project EPICURE EFP6-037315 http://www.epicureproject.eu (to MM, GA and SF), the Mariani Foundation www.fondazione-mariani.org (to SF), the Federation pour la Recherche sur le Cerveau http://www.frc.asso.fr/(to MM) and the Fondation pour la Recherche Medicale, http://www.frm.org (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, EPILEPSIA, V44, P1601, DOI 10.1111/j.0013-9580.2003.23103.x; ALZHEIMER C, 1994, J PHYSIOL-LONDON, V479, P199, DOI 10.1113/jphysiol.1994.sp020288; Aracri P, 2006, J NEUROPHYSIOL, V95, P3460, DOI 10.1152/jn.00588.2005; Artinian J, 2011, J NEUROSCI, V31, P10811, DOI 10.1523/JNEUROSCI.0388-11.2011; Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; Avanzini G, 2007, EPILEPSIA, V48, P51, DOI 10.1111/j.1528-1167.2007.01067.x; Carlier E, 2006, J PHYSIOL-LONDON, V577, P141, DOI 10.1113/jphysiol.2006.118026; Cestele S, 2008, J NEUROSCI, V28, P7273, DOI 10.1523/JNEUROSCI.4453-07.2008; CHAO TI, 1995, NEUROREPORT, V6, P1778, DOI 10.1097/00001756-199509000-00017; Chatelier A, 2010, PFLUG ARCH EUR J PHY, V460, P77, DOI 10.1007/s00424-010-0801-9; Chen S, 2011, J NEUROPHYSIOL, V105, P117, DOI 10.1152/jn.00184.2010; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Enomoto A, 2006, J NEUROSCI, V26, P3412, DOI 10.1523/JNEUROSCI.5274-05.2006; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Fleidervish IA, 2008, P NATL ACAD SCI USA, V105, P18994, DOI 10.1073/pnas.0803464105; Franceschetti S, 2000, J PHYSIOL-LONDON, V528, P291, DOI 10.1111/j.1469-7793.2000.00291.x; FRANCESCHETTI S, 1995, BRAIN RES, V696, P127, DOI 10.1016/0006-8993(95)00807-3; Fung ML, 2000, CLIN EXP PHARMACOL P, V27, P569, DOI 10.1046/j.1440-1681.2000.03309.x; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Harnmarstrom AKM, 2002, EUR BIOPHYS J BIOPHY, V31, P323, DOI 10.1007/s00249-002-0218-2; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Kiernan MC, 2009, EXP NEUROL, V218, P1, DOI 10.1016/j.expneurol.2009.03.039; Kole MHP, 2011, NEURON, V71, P671, DOI 10.1016/j.neuron.2011.06.024; KUO CC, 1994, MOL PHARMACOL, V46, P716; Kuo CC, 1997, MOL PHARMACOL, V51, P1077, DOI 10.1124/mol.51.6.1077; Lampl I, 1998, J PHARMACOL EXP THER, V284, P228; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Magistretti J, 1998, BIOPHYS J, V74, P831, DOI 10.1016/S0006-3495(98)74007-X; Magistretti J, 1999, J GEN PHYSIOL, V114, P491, DOI 10.1085/jgp.114.4.491; Mantegazza M, 2005, J NEUROSCI, V25, P3341, DOI 10.1523/JNEUROSCI.0104-05.2005; Mantegazza M, 1998, J PHYSIOL-LONDON, V507, P105, DOI 10.1111/j.1469-7793.1998.105bu.x; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Mantegazza M, 2010, EPILEPSY RES, V92, P1, DOI 10.1016/j.eplepsyres.2010.08.003; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Marini Carla, 2010, Expert Rev Clin Pharmacol, V3, P371, DOI 10.1586/ecp.10.20; Martella G, 2005, EPILEPSIA, V46, P624, DOI 10.1111/j.1528-1167.2005.34904.x; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Niespodziany I, 2004, NEUROREPORT, V15, P1049, DOI 10.1097/00001756-200404290-00023; Osorio N, 2010, J PHYSIOL-LONDON, V588, P651, DOI 10.1113/jphysiol.2010.183798; QUANDT FN, 1988, MOL PHARMACOL, V34, P557; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Rhodes TH, 2004, P NATL ACAD SCI USA, V101, P11147, DOI 10.1073/pnas.0402482101; Segal MM, 1997, J NEUROPHYSIOL, V77, P3021, DOI 10.1152/jn.1997.77.6.3021; Stafstrom Carl E, 2007, Epilepsy Curr, V7, P15, DOI 10.1111/j.1535-7511.2007.00156.x; Stuart G, 1999, NAT NEUROSCI, V2, P144, DOI 10.1038/5698; Sun GC, 2007, EPILEPSIA, V48, P774, DOI 10.1111/j.1528-1167.2007.01001.x; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Taverna S, 1999, J PHARMACOL EXP THER, V288, P960; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Vreugdenhil M, 2004, EUR J NEUROSCI, V19, P2769, DOI 10.1111/j.1460-9568.2004.03400.x; Waxman SG, 2008, NAT CLIN PRACT NEURO, V4, P159, DOI 10.1038/ncpneuro0735; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005	56	22	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55329	10.1371/journal.pone.0055329	http://dx.doi.org/10.1371/journal.pone.0055329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383157	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200047
J	Visani, M; de Biase, D; Marucci, G; Taccioli, C; Baruzzi, A; Pession, A				Visani, Michela; de Biase, Dario; Marucci, Gianluca; Taccioli, Cristian; Baruzzi, Agostino; Pession, Annalisa		PERNO Study Grp	Definition of miRNAs Expression Profile in Glioblastoma Samples: The Relevance of Non-Neoplastic Brain Reference	PLOS ONE			English	Article							MICRORNAS	Glioblastoma is the most aggressive brain tumor that may occur in adults. Regardless of the huge improvements in surgery and molecular therapy, the outcome of neoplasia remains poor. MicroRNAs are small molecules involved in several cellular processes, and their expression is altered in the vast majority of tumors. Several studies reported the expression of different miRNAs in glioblastoma, but one of the most critical point in understanding glioblastoma miRNAs profile is the comparison of these studies. In this paper, we focused our attention on the non-neoplastic references used for determining miRNAs expression. The aim of this study was to investigate if using three different non-neoplastic brain references (normal adjacent the tumor, commercial total RNA, and epileptic specimens) could provide discrepant results. The analysis of 19 miRNAs was performed using Real-Time PCR, starting from the set of samples described above and the expression values compared. Moreover, the three different normal RNAs were used to determine the miRNAs profile in 30 glioblastomas. The data showed that different non-neoplastic controls could lead to different results and emphasize the importance of comparing miRNAs profiles obtained using the same experimental condition.	[Visani, Michela; de Biase, Dario; Pession, Annalisa] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [de Biase, Dario; Marucci, Gianluca] Univ Bologna, Dept Hematol & Oncol Sci, Bologna, Italy; [Taccioli, Cristian] UCL, Paul OGorman Canc Inst, Dept Canc Biol, London, England; [Baruzzi, Agostino] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Baruzzi, Agostino] IRCCS Ist Sci Neurol Bologna, Bologna, Italy	University of Bologna; University of Bologna; University of London; University College London; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)	de Biase, D (corresponding author), Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.	dario.debiase@unibo.it	de Biase, Dario/B-9274-2012; Baldin, Elisa/AAC-1311-2020; pisanello, anna/AAM-4486-2020; Visani, Michela/K-5597-2016; Immovilli, Paolo/AAC-8360-2021; Marucci, Gianluca/F-1426-2019; Morandi, Luca/A-3191-2016; Taccioli, Cristian/F-8801-2010; Franceschi, Claudio/L-4484-2017; Rizzi, Romana/R-7051-2016; fiorica, francesco/K-8036-2016; cenni, patrizia/AAL-3588-2020; SILINI, ENRICO MARIA/AAB-8747-2019; Iaccarino, Corrado/L-3190-2013; Nichelli, Paolo/F-7336-2015; Taccioli, Cristian/ABC-3379-2020; Meletti, Stefano/O-3622-2015; bertolini, francesco/AAC-9780-2019; Servadei, Franco/ABX-4656-2022; Rinaldi, Rita/K-7004-2016	de Biase, Dario/0000-0002-0609-8817; Baldin, Elisa/0000-0002-3277-5623; Visani, Michela/0000-0002-9051-2231; Immovilli, Paolo/0000-0001-9417-3903; Marucci, Gianluca/0000-0003-4508-3359; Morandi, Luca/0000-0002-3810-9760; Taccioli, Cristian/0000-0003-2995-5612; Franceschi, Claudio/0000-0001-9841-6386; Rizzi, Romana/0000-0002-0875-8575; fiorica, francesco/0000-0002-9404-3655; cenni, patrizia/0000-0001-7911-8500; SILINI, ENRICO MARIA/0000-0003-2578-3059; Iaccarino, Corrado/0000-0002-5133-6327; Nichelli, Paolo/0000-0001-9756-6796; Taccioli, Cristian/0000-0003-2995-5612; Meletti, Stefano/0000-0003-0334-539X; bertolini, francesco/0000-0001-5660-3255; Casmiro, Mario/0000-0003-0283-5987; Pasini, Elena/0000-0001-6298-455X; Michelucci, Roberto/0000-0002-9655-7940; Pession, Annalisa/0000-0001-9035-9698; Mostacci, Barbara/0000-0002-6994-0821; Granieri, Enrico/0000-0003-4038-3192; Latini, Francesco/0000-0002-4702-526X; Palandri, Giorgio/0000-0002-9306-0242; CARELLI, VALERIO/0000-0003-4923-6404; Bonora, Elena/0000-0001-6132-7734; tinuper, paolo/0000-0002-0588-3063; /0000-0001-9734-8035; Servadei, Franco/0000-0002-3595-3464; Rinaldi, Rita/0000-0002-4564-7284; morelli, nicola/0000-0003-3787-2243; Brandes, Alba/0000-0002-2503-9089; Bisulli, Francesca/0000-0002-1109-7296; Giorgi, Carlotta/0000-0002-2494-7405; franceschi, enrico/0000-0001-9332-4677; Dall'Agata, Monia/0000-0002-2270-5269; Bigliardi, Guido/0000-0001-5312-7206				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Brandes AA, 2009, J CLIN ONCOL, V27, P1275, DOI 10.1200/JCO.2008.19.4969; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; de Biase D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035596; Dong H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S16; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Henriksson R, 2011, J NEURO-ONCOL, V104, P639, DOI 10.1007/s11060-011-0565-x; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; LeBrun D.G., 2011, MOL CELL PHARM, V3, P93; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; The WHO, 2020, CLASSIFICATION TUMOU; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014681; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	19	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55314	10.1371/journal.pone.0055314	http://dx.doi.org/10.1371/journal.pone.0055314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383149	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200019
J	Petit, E; LaTouf, WG; Coppi, MV; Warnick, TA; Currie, D; Romashko, I; Deshpande, S; Haas, K; Alvelo-Maurosa, JG; Wardman, C; Schnell, DJ; Leschine, SB; Blanchard, JL				Petit, Elsa; LaTouf, W. Greg; Coppi, Maddalena V.; Warnick, Thomas A.; Currie, Devin; Romashko, Igor; Deshpande, Supriya; Haas, Kelly; Alvelo-Maurosa, Jesus G.; Wardman, Colin; Schnell, Danny J.; Leschine, Susan B.; Blanchard, Jeffrey L.			Involvement of a Bacterial Microcompartment in the Metabolism of Fucose and Rhamnose by Clostridium phytofermentans	PLOS ONE			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; SEROVAR TYPHIMURIUM LT2; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; POLYHEDRAL BODIES; ORGANELLES; OPERON; GENES; PROTEIN; IDENTIFICATION	Background: Clostridium phytofermentans, an anaerobic soil bacterium, can directly convert plant biomass into biofuels. The genome of C. phytofermentans contains three loci with genes encoding shell proteins of bacterial microcompartments (BMC), organelles composed entirely of proteins. Methodology and Principal Findings: One of the BMC loci has homology to a BMC-encoding locus implicated in the conversion of fucose to propanol and propionate in a human gut commensal, Roseburia inulinivorans. We hypothesized that it had a similar role in C. phytofermentans. When C. phytofermentans was grown on fucose, the major products identified were ethanol, propanol and propionate. Transmission electron microscopy of fucose-and rhamnose-grown cultures revealed polyhedral structures, presumably BMCs. Microarray analysis indicated that during growth on fucose, operons coding for the BMC locus, fucose dissimilatory enzymes, and an ATP-binding cassette transporter became the dominant transcripts. These data are consistent with fucose fermentation producing a 1,2-propanediol intermediate that is further metabolized in the microcompartment encoded in the BMC locus. Growth on another deoxyhexose sugar, rhamnose, resulted in the expression of the same BMC locus and similar fermentation products. However, a different set of dissimilatory enzymes and transport system genes were induced. Quite surprisingly, growth on fucose or rhamnose also led to the expression of a diverse array of complex plant polysaccharide-degrading enzymes. Conclusions/Significance: Based on physiological, genomic, and microarray analyses, we propose a model for the fermentation of fucose and rhamnose in C. phytofermentans that includes enzymes encoded in the same BMC locus. Comparative genomic analysis suggests that this BMC may be present in other clostridial species.	[Petit, Elsa; LaTouf, W. Greg; Coppi, Maddalena V.; Warnick, Thomas A.; Currie, Devin; Romashko, Igor; Deshpande, Supriya; Haas, Kelly; Alvelo-Maurosa, Jesus G.; Wardman, Colin; Leschine, Susan B.; Blanchard, Jeffrey L.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Petit, Elsa; Schnell, Danny J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Leschine, Susan B.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Blanchard, JL (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	blanchard@microbio.umass.edu	Wardman, Colin/S-8924-2019; Blanchard, Jeffrey/AAA-5173-2020	Blanchard, Jeffrey/0000-0002-7310-9678; Haas, Kelly/0000-0002-6232-0056; Wardman, Colin/0000-0002-1067-213X	U.S. Department of Energy [DE-FG02-02ER15330]; Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station [MAS00923, MAS009582]; Qteros; UMass College of Natural Sciences and Mathematics Excellence Initiatives; Commonwealth College Research Grant; Life Sciences Junior Fellowship; Howard Hughes Medical Institute Award; National Science Foundation [NSF BBS 8714235]	U.S. Department of Energy(United States Department of Energy (DOE)); Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Qteros; UMass College of Natural Sciences and Mathematics Excellence Initiatives; Commonwealth College Research Grant; Life Sciences Junior Fellowship; Howard Hughes Medical Institute Award(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF))	This research was supported by U.S. Department of Energy grant DE-FG02-02ER15330 and Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station Project No. MAS00923 to SL and Project No. MAS009582 to JB, a Sponsored Research Agreement between Qteros and JB and SL, UMass College of Natural Sciences and Mathematics Excellence Initiatives funding to EP, a Commonwealth College Research Grant to IR, a Life Sciences Junior Fellowship to DC, a Howard Hughes Medical Institute Award to the University of Massachusetts Amherst and a National Science Foundation grant NSF BBS 8714235 to the University of Massachusetts Amherst Central Microscopy Facility. One of the funders, Qteros, was involved in identifying microbial fermentation products presented in Fig 1 using HPLC and GC. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADIA J, 1989, FEMS MICROBIOL LETT, V65, P253, DOI 10.1016/0378-1097(89)90226-7; BADIA J, 1985, J BACTERIOL, V161, P435; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bolstad BM, 2005, STAT BIOL HEALTH, P33; BORONAT A, 1981, J BACTERIOL, V147, P181, DOI 10.1128/JB.147.1.181-185.1981; CHEN YM, 1987, J BACTERIOL, V169, P3712, DOI 10.1128/jb.169.8.3712-3719.1987; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Cheng SQ, 2010, J BACTERIOL, V192, P5071, DOI 10.1128/JB.00575-10; Choi IG, 1998, J BIOCHEM MOL BIOL, V31, P130; CODD GA, 1976, PLANTA, V130, P323, DOI 10.1007/BF00387840; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorham J, 2008, BIOFUELS TECHNOLOGY, V1; GUNN FJ, 1994, MOL MICROBIOL, V12, P799, DOI 10.1111/j.1365-2958.1994.tb01066.x; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen TE, 1961, P IOWA ACAD SCI, V68, P89; Ju YH, 2010, BIOTECHNOL LETT, V32, P299, DOI 10.1007/s10529-009-0154-7; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; MAYER C, 2005, HEXOSE PENTOSE HEXIT; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Park D, 2007, GLYCOBIOLOGY, V17, P955, DOI 10.1093/glycob/cwm066; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Persson B, 1994, MED BIOCH, V22, P15; POHLSCHRODER M, 1995, J BACTERIOL, V177, P6625, DOI 10.1128/jb.177.22.6625-6629.1995; Raynaud C, 2003, P NATL ACAD SCI USA, V100, P5010, DOI 10.1073/pnas.0734105100; Richardson JS, 2004, J BACTERIOL, V186, P8433, DOI 10.1128/JB.186.24.8433-8442.2004; Rivas R, 2001, J MICROBIOL METH, V47, P59, DOI 10.1016/S0167-7012(01)00292-5; Rondo M, 1995, J BACTERIOL, P5434; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; TOBIN JF, 1987, J MOL BIOL, V196, P789, DOI 10.1016/0022-2836(87)90405-0; Vallet A, 2009, APPL MICROBIOL BIOT, V82, P87, DOI 10.1007/s00253-008-1721-x; Warnick TA, 2002, INT J SYST EVOL MICR, V52, P1155, DOI [10.1099/ijs.0.02125-0, 10.1099/00207713-52-4-1155]; YAMADA M, 1988, J MOL BIOL, V203, P569, DOI 10.1016/0022-2836(88)90193-3; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	51	83	83	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54337	10.1371/journal.pone.0054337	http://dx.doi.org/10.1371/journal.pone.0054337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382892	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500010
J	Illigens, BMW; Gibbons, CH				Illigens, Ben M. W.; Gibbons, Christopher H.			A Human Model of Small Fiber Neuropathy to Study Wound Healing	PLOS ONE			English	Article							REFLEX-RELATED VASODILATION; CUTANEOUS WOUNDS; TOPICAL CAPSAICIN; GROWTH-FACTOR; DOUBLE-BLIND; SKIN BIOPSY; INNERVATION; FOOT; QUANTIFICATION; REGENERATION	The aim of this study was to develop a human model of acute wound healing that isolated the effects of small fiber neuropathy on the healing process. Twenty-five healthy subjects had the transient receptor vanilloid 1 agonist capsaicin and placebo creams topically applied to contralateral areas on the skin of the thigh for 48 hours. Subjects had shallow (1.2 millimeter) and deep (>3 millimeter) punch skin biopsies from each thigh on days 1 and 14. Biopsy wound healing was monitored photographically until closure. Intra-epidermal and sweat-gland nerve fiber densities were measured for each biopsy. Shallow wounds in capsaicin-treated sites healed more slowly than in placebo treated skin with biopsies taken on day 1 (P<0.001) and day 14 (P<0.001). Deep biopsies in the capsaicin and placebo areas healed at similar rates at both time points. Nerve fiber densities were reduced only in capsaicin treated regions (P<0.01). In conclusion, topical application of capsaicin causes a small fiber neuropathy and is associated with a delay in healing of shallow, but not deep wounds. This novel human model may prove valuable in the study of wound healing in patients with neuropathy.	[Illigens, Ben M. W.; Gibbons, Christopher H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Gibbons, CH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA.	cgibbons@bidmc.harvard.edu			National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS) [K23 NS050209]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS050209] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS) K23 NS050209 (CHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Berghoff M, 2002, J APPL PHYSIOL, V92, P780, DOI 10.1152/japplphysiol.01167.2000; BIESBROECK R, 1995, ADV THER, V12, P111; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; Caselli A, 2003, NEUROLOGY, V60, P297, DOI 10.1212/01.WNL.0000040250.31755.F9; Chan F C, 2007, J Wound Care, V16, P359; Dabby R, 2007, J PERIPHER NERV SYST, V12, P98, DOI 10.1111/j.1529-8027.2007.00128.x; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Fuchs E, 1998, Harvey Lect, V94, P47; Gibbons CH, 2006, NEUROLOGY, V66, P256, DOI 10.1212/01.wnl.0000194314.86486.a2; Gibbons CH, 2010, ANN NEUROL, V68, P888, DOI 10.1002/ana.22126; Gibbons CH, 2010, MUSCLE NERVE, V42, P112, DOI 10.1002/mus.21626; Gibbons CH, 2009, NEUROLOGY, V72, P1479, DOI 10.1212/WNL.0b013e3181a2e8b8; Hamdy O, 2001, DIABETES CARE, V24, P344, DOI 10.2337/diacare.24.2.344; Jacobsen JN, 2010, APMIS, V118, P753, DOI 10.1111/j.1600-0463.2010.02654.x; Kramer HH, 2004, DIABETES, V53, P769, DOI 10.2337/diabetes.53.3.769; Krishnan STM, 2007, DIABETES CARE, V30, P3058, DOI 10.2337/dc07-1421; Lai Xinan, 2002, Chin J Traumatol, V5, P176; Laing T, 2010, J SURG RES, V161, P336, DOI 10.1016/j.jss.2009.01.024; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; LOW PA, 1995, PAIN, V62, P163, DOI 10.1016/0304-3959(94)00261-C; LOW PA, 1983, ANN NEUROL, V14, P573, DOI 10.1002/ana.410140513; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinez-Martinez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036421; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Miller SJ, 1998, J INVEST DERMATOL, V110, P13, DOI 10.1046/j.1523-1747.1998.00087.x; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; O'Sullivan JB, 2010, IRJMEDSCI; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P857; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P883; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P911; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Thomson SE, 2010, DIABETOLOGIA, V53, P572, DOI 10.1007/s00125-009-1610-6; Wang NS, 2011, J HISTOCHEM CYTOCHEM, V59, P382, DOI 10.1369/0022155410396931; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198	38	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54760	10.1371/journal.pone.0054760	http://dx.doi.org/10.1371/journal.pone.0054760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382960	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600039
J	Rudnicki, J; Zysko, D; Kozlowski, D; Kuliczkowski, W; Kozluk, E; Lelonek, M; Piatkowska, A; Gajek, J; Negrusz-Kawecka, M; Agrawal, AK				Rudnicki, Jerzy; Zysko, Dorota; Kozlowski, Dariusz; Kuliczkowski, Wiktor; Kozluk, Edward; Lelonek, Malgorzata; Piatkowska, Agnieszka; Gajek, Jacek; Negrusz-Kawecka, Marta; Agrawal, Anil Kumar			The Choice of Surgical Specialization by Medical Students and Their Syncopal History	PLOS ONE			English	Article							QUALITY-OF-LIFE; VASOVAGAL SYNCOPE; MENSTRUAL-CYCLE; SURGERY; CAREERS; GENDER; RISK	Background: The aim of the study was to assess whether medical students' fainting outside the university or while witnessing surgical procedures and/or autopsies influenced their choice of a specialization. Materials and Methods: The study group consisted of 605 medical students (from fourth to sixth year of study) from five medical universities in Poland (325 women, 212 men and 8 responders of an unspecified gender). The median age of subjects studied was 23 years, and the interquartile range was 23-24 years. The students at each university were chosen randomly by the author who worked there and had contact with them. An anonymous questionnaire was developed to gather information regarding demographics, the specialization which each student wanted to choose, the syncope occurrence in the medical history, the syncope and presyncope occurrence during surgery and autopsy as well as the syncopal events' characteristics. Results: The group of 15% of women and 30% of men declared to have pursued the surgical specialization (P<0.001), 29% of women and 56% of men declared the intention to pursue an invasive specialization (P<0.001). As many as 36.0% of women studied and 13.1% of men studied reported syncopal spells outside university (P<0.001). Only 41 students (6.8%) reported that syncope or presyncope in any studied circumstances had an impact on their specialization choice. The multivariate analysis showed that the choice of surgical specialization is related to the male gender and the absence of syncopal spells outside the university. Conclusions: Syncopal and presyncopal spells may affect the professional choices of the medical students. The male gender and a lack of syncope occurrence outside operating room are related to the choice of surgical specialization.	[Rudnicki, Jerzy] Wroclaw Med Univ, Dept Minimally Invas Surg & Proctol, Wroclaw, Poland; [Zysko, Dorota] Wroclaw Med Univ, Teaching Dept Emergency Med Serv, Wroclaw, Poland; [Kozlowski, Dariusz] Med Univ Gdansk, Dept Cardiol, Gdansk, Poland; [Kuliczkowski, Wiktor] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland; [Kozluk, Edward; Piatkowska, Agnieszka] Warsaw Med Univ, Dept Cardiol, Warsaw, Poland; [Lelonek, Malgorzata] Med Univ Lodz, Dept Cardiol, Lodz, Poland; [Gajek, Jacek; Negrusz-Kawecka, Marta] Wroclaw Med Univ, Dept Cardiol, Wroclaw, Poland; [Agrawal, Anil Kumar] Wroclaw Med Univ, Dept Gen & Oncol Surg 2, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw; Medical University of Warsaw; Medical University Lodz; Wroclaw Medical University; Wroclaw Medical University	Zysko, D (corresponding author), Wroclaw Med Univ, Teaching Dept Emergency Med Serv, Wroclaw, Poland.	dzysko@wp.pl	Lelonek, Malgorzata/S-9339-2016; Gajek, Jacek/AAD-8948-2020; Kozluk, Edward/B-6950-2019	Gajek, Jacek/0000-0002-0038-1750; Negrusz-Kawecka, Marta/0000-0003-0764-1495; Lelonek, Malgorzata/0000-0003-0756-5541; Piatkowska, Agnieszka/0000-0001-8234-2773; Kozluk, Edward/0000-0002-7829-653X; Kuliczkowski, Wiktor/0000-0001-6284-0820; Rudnicki, Jerzy/0000-0001-8575-7595				Baron-Esquivias G, 2005, INT J CARDIOL, V102, P315, DOI 10.1016/j.ijcard.2004.10.019; Baxter N, 1996, AM J SURG, V172, P373, DOI 10.1016/S0002-9610(96)00185-7; Colman N, 2004, CLIN AUTON RES, V14, P9, DOI 10.1007/s10286-004-1003-3; Convertino VA, 1998, AM J PHYSIOL-REG I, V275, pR1909, DOI 10.1152/ajpregu.1998.275.6.R1909; Fedorowski A, 2013, J INTERN MED, V273, P322, DOI 10.1111/joim.12021; Ganzeboom KS, 2006, J CARDIOVASC ELECTR, V17, P1172, DOI 10.1111/j.1540-8167.2006.00595.x; Ganzeboom KS, 2003, AM J CARDIOL, V91, P1006, DOI 10.1016/S0002-9149(03)00127-9; Giada F, 2005, EUROPACE, V7, P465, DOI 10.1016/j.eupc.2005.05.008; Glynn RW, 2010, SURG-J R COLL SURG E, V8, P187, DOI 10.1016/j.surge.2009.11.005; Jamjoom AAB, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-14; Lefevre JH, 2010, J VISC SURG, V147, pE181, DOI 10.1016/j.jviscsurg.2010.08.004; Meendering JR, 2005, AM J PHYSIOL-HEART C, V289, pH631, DOI 10.1152/ajpheart.00029.2005; Rudnicki J, 2011, PACE, V34, P1486, DOI 10.1111/j.1540-8159.2011.03169.x; Santhouse J, 2007, EPILEPSIA, V48, P1019, DOI 10.1111/j.1528-1167.2006.00971.x; Serletis A, 2006, EUR HEART J, V27, P1965, DOI 10.1093/eurheartj/ehl147; Tambyraja AL, 2008, WORLD J SURG, V32, P960, DOI 10.1007/s00268-008-9529-5; Zysko D, 2010, RATUNEK, V4, P28; Zysko D, 2012, ARCH GYNECOL OBSTET, V286, P429, DOI 10.1007/s00404-012-2308-4	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55236	10.1371/journal.pone.0055236	http://dx.doi.org/10.1371/journal.pone.0055236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383122	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600079
J	Zwerling, A; Benedetti, A; Cojocariu, M; McIntosh, F; Pietrangelo, F; Behr, MA; Schwartzman, K; Menzies, D; Pai, M				Zwerling, Alice; Benedetti, Andrea; Cojocariu, Mihaela; McIntosh, Fiona; Pietrangelo, Filomena; Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar			Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability?	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; LATENT TUBERCULOSIS INFECTION; WITHIN-SUBJECT VARIABILITY; CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; GUIDELINES; DIAGNOSIS; SETTINGS; RISK	Background: Although North American hospitals are switching from tuberculin testing (TST) to interferon-gamma release assays (IGRAs), data are limited on the association between occupational exposure and serial QuantiFERON-TB Gold In-Tube (QFT) results in healthcare workers (HCWs). Methods: In a cohort of Canadian HCWs, TST and QFT were performed at study enrolment (TST1 and QFT1) and 1 year later (TST2 and QFT2). Conversion and reversion rates were estimated, and correlation with TB exposure was assessed. Results: Among 258 HCWs, median age was 36.8 years, 188/258 (73%) were female and 183/258 (71%) were Canadian-born. In 245 subjects with a negative QFT1 we found a QFT conversion rate of 5.3% (13/245, 95% CI 2.9-8.9%). Using more stringent definitions, QFT conversion rates ranged from 2.0 to 5.3%. No TST conversions were found among the 241 HCWs with negative TST1, and no measure of recent TB exposure was associated with QFT conversions. In the 13 HCWs with a positive QFT1, 62% reverted. Conclusion: Using the conventional QFT conversion definition, we found a higher than expected rate of conversion. Recent occupational exposures were not associated with QFT conversions, and no TST conversions occurred in this cohort, suggesting the 'conversions' may not reflect new TB infection.	[Zwerling, Alice; Benedetti, Andrea; Behr, Marcel A.; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Zwerling, Alice; Benedetti, Andrea; Cojocariu, Mihaela; Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Benedetti, Andrea; Behr, Marcel A.; Schwartzman, Kevin; Menzies, Dick] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ, Canada; [Pietrangelo, Filomena] McGill Univ, Ctr Hlth, Dept Occupat Hlth & Safety, Montreal, PQ, Canada; [Cojocariu, Mihaela; McIntosh, Fiona] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Pai, M (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Canadian Institutes of Health Research (CIHR) [81362]; Fonds de recherche du Quebec-Sante	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR) grant 81362. AZ received a doctoral fellowship from CIHR, and MP received a New Investigator Award from CIHR. MP also received a salary award from Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2000, AM J RESP CRIT CARE, V49, P1, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_3.ATS600; [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; [Anonymous], 2008, Canada Communicable Disease Report, V34, P1; Bartalesi F, 2012, J INFECTION; Belknap R, 2010, AM J RESP CRIT CARE, V181; Chiappini E, 2012, CLIN THER, V34, P1041, DOI 10.1016/j.clinthera.2012.03.006; Costa JT, 2011, INT ARCH OCC ENV HEA, V84, P461, DOI 10.1007/s00420-010-0571-x; Cummings KJ, 2009, INFECT CONT HOSP EP, V30, P1123, DOI 10.1086/644754; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Denkinger CM, 2012, J CLIN MICROBIOL; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Doberne D, 2011, J CLIN MICROBIOL, V49, P3061, DOI 10.1128/JCM.01136-11; DORMAN S, 2009, AM J RESP CRIT CARE, pA1010; Fong KS, 2012, CHEST, V142, P55, DOI 10.1378/chest.11-0992; Gandra S, 2011, INFECT CONT HOSP EP, V32, P518, DOI 10.1086/659957; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Joshi M, 2012, CAN RESPIR J, V19, P84, DOI 10.1155/2012/576324; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Loddenkemper R, 2012, CHEST, V142, P10, DOI 10.1378/chest.12-0045; Long R., 2007, CANADIAN TUBERCULOSI, V6th; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 2000, ANN INTERN MED, V133, P779, DOI 10.7326/0003-4819-133-10-200011210-00010; Menzies D, 1998, INT J TUBERC LUNG D, V2, pS98; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe J, 2012, AM J RESP CRIT CARE; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2012, CAN RESPIR J, V19, P81, DOI 10.1155/2012/420392; Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; PHAC, 2009, TUB CAN 2009 PRER; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Schablon Anja, 2010, GMS Krankenhhyg Interdiszip, V5, DOI 10.3205/dgkh000148; SSSQ, 2009, EP TUB QUEB 2004 200; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; Whitworth WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043790; World Health Organization, 2009, WHO POL TB INF CONTR; Zwerling A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043014; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	46	58	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54748	10.1371/journal.pone.0054748	http://dx.doi.org/10.1371/journal.pone.0054748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382955	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600038
J	Armsworth, PR; Cantu-Salazar, L; Parnell, M; Booth, JE; Stoneman, R; Davies, ZG				Armsworth, Paul R.; Cantu-Salazar, Lisette; Parnell, Mark; Booth, Josephine E.; Stoneman, Rob; Davies, Zoe G.			Opportunities for Cost-Sharing in Conservation: Variation in Volunteering Effort across Protected Areas	PLOS ONE			English	Article							MANAGEMENT; BENEFITS; SCALE	Efforts to expand protected area networks are limited by the costs of managing protected sites. Volunteers who donate labor to help manage protected areas can help defray these costs. However, volunteers may be willing to donate more labor to some protected areas than others. Understanding variation in volunteering effort would enable conservation organizations to account for volunteer labor in their strategic planning. We examined variation in volunteering effort across 59 small protected areas managed by Yorkshire Wildlife Trust, a regional conservation nonprofit in the United Kingdom. Three surveys of volunteering effort reveal consistent patterns of variation across protected areas. Using the most detailed of these sources, a survey of site managers, we estimate that volunteers provided 3200 days of labor per year across the 59 sites with a total value exceeding that of paid staff time spent managing the sites. The median percentage by which volunteer labor supplements management costs on the sites was 36%. Volunteering effort and paid management costs are positively correlated, after controlling for the effect of site area. We examined how well a range of characteristics of the protected areas and surrounding communities explain variation in volunteering effort. Protected areas that are larger have been protected for longer and that are located near to denser conurbations experience greater volunteering effort. Together these factors explain 38% of the observed variation in volunteering effort across protected areas.	[Armsworth, Paul R.; Cantu-Salazar, Lisette; Booth, Josephine E.; Davies, Zoe G.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Armsworth, Paul R.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Parnell, Mark] En Mapping GIS & Spatial Solut, Sheffield, S Yorkshire, England; [Stoneman, Rob] Yorkshire Wildlife Trust, York, N Yorkshire, England	University of Sheffield; University of Tennessee System; University of Tennessee Knoxville	Armsworth, PR (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	p.armsworth@utk.edu		Armsworth, Paul/0000-0003-0918-0573; Booth, Josephine/0000-0002-4553-6402	UK Population Biology Network (UKPopNet); Natural Environment Research Council [R8-H12-01, NER/S/R/2005/13940]; Natural England	UK Population Biology Network (UKPopNet); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural England	Funding was provided by the UK Population Biology Network (UKPopNet) supported by the Natural Environment Research Council (www.nerc.ac.uk, Agreement R8-H12-01 and NER/S/R/2005/13940) and Natural England (www.naturalengland.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando AW, 2010, RESOUR ENERGY ECON, V32, P203, DOI 10.1016/j.reseneeco.2009.11.013; Armsworth PR, 2012, BIOSCIENCE, V62, P271, DOI 10.1525/bio.2012.62.3.8; Armsworth PR, 2011, BIOL CONSERV, V144, P423, DOI 10.1016/j.biocon.2010.09.026; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Asah ST, 2012, CONSERV LETT, V5, P470, DOI 10.1111/j.1755-263X.2012.00263.x; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Bode M, 2011, CONSERV BIOL, V25, P295, DOI 10.1111/j.1523-1739.2010.01610.x; Booth JE, 2010, ECOL SOC, V15; Booth JE, 2009, BIOL CONSERV, V142, P3196, DOI 10.1016/j.biocon.2009.07.024; Bowman W, 2009, NONPROFIT MANAG LEAD, V19, P491, DOI 10.1002/nml.233; Bremer S, 2007, HUM ECOL, V35, P489, DOI 10.1007/s10745-006-9070-9; Bruyere B, 2007, J ENVIRON PLANN MAN, V50, P503, DOI 10.1080/09640560701402034; Bryce R, 2011, BIOL CONSERV, V144, P575, DOI 10.1016/j.biocon.2010.10.013; Campbell LM, 2006, ENVIRON MANAGE, V38, P84, DOI 10.1007/s00267-005-0188-0; Crall AW, 2010, BIOL INVASIONS, V12, P3419, DOI 10.1007/s10530-010-9740-9; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2633, DOI 10.1007/s10531-005-8392-z; Department for Communities and Local Government [DCLG], 2010, 2008 2009 CIT SURV V; DUFF DA, 1993, J N AM BENTHOL SOC, V12, P206, DOI 10.2307/1467354; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Harris R., 2005, GEODEMOGRAPHICS GIS, V8; Hopkins-Murphy SR, 2005, CHELONIAN CONSERV BI, V4, P930; Koss RS, 2010, OCEAN COAST MANAGE, V53, P447, DOI 10.1016/j.ocecoaman.2010.06.002; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Levrel H, 2010, ECOL ECON, V69, P1580, DOI 10.1016/j.ecolecon.2010.03.001; Lloyd, 2004, ENGLISH INDICES DEPR; Lovell S, 2009, BIODIVERS CONSERV, V18, P3295, DOI 10.1007/s10531-009-9642-2; Merenlender AM, 2009, CONSERV LETT, V2, P240, DOI 10.1111/j.1755-263X.2009.00073.x; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Newburn D, 2005, CONSERV BIOL, V19, P1411, DOI 10.1111/j.1523-1739.2005.00199.x; O'Brien L, 2010, VOLUNTAS, V21, P525, DOI 10.1007/s11266-010-9149-1; O'Brien L, 2011, PERSPECT PUBLIC HEAL, V131, P71, DOI 10.1177/1757913910384048; Ramsey CJ, 1996, NAT AREA J, V16, P36; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Zaradic PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007367; Zuur Alain F., 2009, P1	38	6	6	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55395	10.1371/journal.pone.0055395	http://dx.doi.org/10.1371/journal.pone.0055395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383176	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800148
J	Badro, DA; Douaihy, B; Haber, M; Youhanna, SC; Salloum, A; Ghassibe-Sabbagh, M; Johnsrud, B; Khazen, G; Matisoo-Smith, E; Soria-Hernanz, DF; Wells, RS; Tyler-Smith, C; Platt, DE; Zalloua, PA				Badro, Danielle A.; Douaihy, Bouchra; Haber, Marc; Youhanna, Sonia C.; Salloum, Angelique; Ghassibe-Sabbagh, Michella; Johnsrud, Brian; Khazen, Georges; Matisoo-Smith, Elizabeth; Soria-Hernanz, David F.; Wells, R. Spencer; Tyler-Smith, Chris; Platt, Daniel E.; Zalloua, Pierre A.		Genographic Consortium	Y-Chromosome and mtDNA Genetics Reveal Significant Contrasts in Affinities of Modern Middle Eastern Populations with European and African Populations	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL REGION SEQUENCES; MODERN HUMAN ORIGINS; SUB-SAHARAN; MEDITERRANEAN AREA; ALLELE FREQUENCIES; ARABIAN PENINSULA; HUMAN MIGRATIONS; HUMAN-EVOLUTION; HAPLOGROUP-J	The Middle East was a funnel of human expansion out of Africa, a staging area for the Neolithic Agricultural Revolution, and the home to some of the earliest world empires. Post LGM expansions into the region and subsequent population movements created a striking genetic mosaic with distinct sex-based genetic differentiation. While prior studies have examined the mtDNA and Y-chromosome contrast in focal populations in the Middle East, none have undertaken a broad-spectrum survey including North and sub-Saharan Africa, Europe, and Middle Eastern populations. In this study 5,174 mtDNA and 4,658 Y-chromosome samples were investigated using PCA, MDS, mean-linkage clustering, AMOVA, and Fisher exact tests of F-ST's, R-ST's, and haplogroup frequencies. Geographic differentiation in affinities of Middle Eastern populations with Africa and Europe showed distinct contrasts between mtDNA and Y-chromosome data. Specifically, Lebanon's mtDNA shows a very strong association to Europe, while Yemen shows very strong affinity with Egypt and North and East Africa. Previous Y-chromosome results showed a Levantine coastal-inland contrast marked by J1 and J2, and a very strong North African component was evident throughout the Middle East. Neither of these patterns were observed in the mtDNA. While J2 has penetrated into Europe, the pattern of Y-chromosome diversity in Lebanon does not show the widespread affinities with Europe indicated by the mtDNA data. Lastly, while each population shows evidence of connections with expansions that now define the Middle East, Africa, and Europe, many of the populations in the Middle East show distinctive mtDNA and Y-haplogroup characteristics that indicate long standing settlement with relatively little impact from and movement into other populations.	[Badro, Danielle A.; Douaihy, Bouchra; Haber, Marc; Youhanna, Sonia C.; Salloum, Angelique; Ghassibe-Sabbagh, Michella; Khazen, Georges; Zalloua, Pierre A.] Lebanese Amer Univ, Beirut, Lebanon; [Haber, Marc; Soria-Hernanz, David F.] Univ Pompeu Fabra, Dept Ciencies Salut & Vida, Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Johnsrud, Brian] Stanford Univ, Stanford, CA 94305 USA; [Matisoo-Smith, Elizabeth] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Soria-Hernanz, David F.; Wells, R. Spencer] Natl Geog Soc, Genog Project, Washington, DC USA; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, England; [Platt, Daniel E.] IBM TJ Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA; [Zalloua, Pierre A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Lebanese American University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Stanford University; University of Otago; National Geographic Society; Wellcome Trust Sanger Institute; International Business Machines (IBM); Harvard University; Harvard T.H. Chan School of Public Health	Zalloua, PA (corresponding author), Lebanese Amer Univ, Beirut, Lebanon.	pierre.zalloua@lau.edu.lb	Haber, Marc/D-2553-2012; Khazen, Georges/AAC-2923-2020; Haber, Marc/Y-5090-2019; Cooper, Alan/E-8171-2012; Santos, Fabrício Rodrigues/H-2370-2011; Haak, Wolfgang/C-2362-2014; Comas, David/D-5382-2014; Ghassibe-Sabbagh, Michella/AAG-5710-2019; Balanovsky, Oleg/G-1549-2014; Ghassibe, Michella/A-7256-2011	Haber, Marc/0000-0003-1000-1448; Haber, Marc/0000-0003-1000-1448; Cooper, Alan/0000-0002-7738-7851; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Haak, Wolfgang/0000-0003-2475-2007; Comas, David/0000-0002-5075-0956; Ghassibe-Sabbagh, Michella/0000-0003-2107-9929; Douaihy, Bouchra/0000-0001-7600-3409; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Quintana-Murci, Lluis/0000-0003-2429-6320; Royyuru, Ajay/0000-0003-4440-4755; Khazen, Geroges/0000-0002-9244-2978; zalloua, pierre/0000-0002-8494-5081; Badro, Danielle A/0000-0003-4487-9144; youhanna, sonia/0000-0002-9376-8478; mele, marta/0000-0001-8874-6453	National Geographic Society; Waitt Family Foundation; IBM	National Geographic Society(National Geographic Society); Waitt Family Foundation; IBM(International Business Machines (IBM))	The Genographic Project is supported by funding from the National Geographic Society, IBM and the Waitt Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Alshamali F, 2009, HUM HERED, V68, P45, DOI 10.1159/000210448; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Athey T. W., 2005, J GENET GENEAL, V1, P1; Athey TW., 2006, J GENET GENEAL, V2, P34; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; BARYOSEF O, 1992, PHILOS T ROY SOC B, V337, P193, DOI 10.1098/rstb.1992.0097; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Brandstatter A, 2004, INT J LEGAL MED, V118, P294, DOI 10.1007/s00414-004-0466-z; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Cerny V, 2008, AM J PHYS ANTHROPOL, V136, P128, DOI 10.1002/ajpa.20784; Cherni L, 2005, HUM BIOL, V77, P61, DOI 10.1353/hub.2005.0028; Chiaroni J, 2008, ANTIQUITY, V82, P281, DOI 10.1017/S0003598X00096800; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Dubut V, 2004, EUR J HUM GENET, V12, P293, DOI 10.1038/sj.ejhg.5201145; El-Sibai M, 2009, ANN HUM GENET, V73, P568, DOI 10.1111/j.1469-1809.2009.00538.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fattovich R, 1997, ENCY PRECOLONIAL AFR, P479; Ferri G, 2008, FORENSIC SCI INT, V175, P250, DOI 10.1016/j.forsciint.2007.06.007; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Gonzalez AM, 2008, ANN HUM BIOL, V35, P212, DOI 10.1080/03014460801946538; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Irwin J, 2008, INT J LEGAL MED, V122, P87, DOI 10.1007/s00414-007-0173-7; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Lewis Bernard, 1990, RACE SLAVERY MIDDLE; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; MERCIER N, 1993, J ARCHAEOL SCI, V20, P169, DOI 10.1006/jasc.1993.1012; NEI M, 1993, MOL BIOL EVOL, V10, P927; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Ottoni C, 2009, ANN HUM GENET, V73, P438, DOI 10.1111/j.1469-1809.2009.00526.x; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Petrejcikova E, 2011, FORENSIC SCI INT-GEN, V5, pE53, DOI 10.1016/j.fsigen.2010.08.003; Pilkington MM, 2008, MOL BIOL EVOL, V25, P517, DOI 10.1093/molbev/msm279; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REYNOLDS J, 1983, GENETICS, V105, P767; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Rowold DJ, 2007, J HUM GENET, V52, P436, DOI 10.1007/s10038-007-0132-7; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Saunier JL, 2009, FORENSIC SCI INT-GEN, V3, pE97, DOI 10.1016/j.fsigen.2008.09.004; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Segal Ronald, 2002, ISLAMS BLACK SLAVES; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; SLATKIN M, 1995, GENETICS, V139, P457; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Tchernov E., 1994, LATE QUATERNARY CHRO, P333; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Turchi C, 2009, FORENSIC SCI INT-GEN, V3, P166, DOI 10.1016/j.fsigen.2009.01.014; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; Venables WN., 2002, MODERN APPL STAT S 4; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	78	38	38	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54616	10.1371/journal.pone.0054616	http://dx.doi.org/10.1371/journal.pone.0054616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382925	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800057
J	Ben-Soussan, TD; Glicksohn, J; Goldstein, A; Berkovich-Ohana, A; Donchin, O				Ben-Soussan, Tal Dotan; Glicksohn, Joseph; Goldstein, Abraham; Berkovich-Ohana, Aviva; Donchin, Opher			Into the Square and out of the Box: The effects of Quadrato Motor Training on Creativity and Alpha Coherence	PLOS ONE			English	Article							EEG COHERENCE; POWER CHANGES; OLDER-ADULTS; BRAIN; ATTENTION; EXERCISE; PATTERNS; FLEXIBILITY; THINKING; TASK	The objective of the present study was to investigate the body-cognitive relationship through behavioral and electrophysiological measures in an attempt to uncover the underlying mediating neuronal mechanism for movement-induced cognitive change. To this end we examined the effects of Quadrato Motor Training (QMT), a new whole-body training paradigm on cognitive performance, including creativity and reaction time tasks, and electrophysiological change, using a within-subject pre-post design. Creativity was studied by means of the Alternate Uses Task, measuring ideational fluency and ideational flexibility. Electrophysiological effects were measured in terms of alpha power and coherence. In order to determine whether training-induced changes were driven by the cognitive or the motor aspects of the training, we used two control groups: Verbal Training (VT, identical cognitive training with verbal response) and Simple Motor Training (SMT, similar motor training with reduced choice requirements). Twenty-seven participants were randomly assigned to one of the groups. Following QMT, we found enhanced inter-hemispheric and intra-hemispheric alpha coherence, and increased ideational flexibility, which was not the case for either the SMT or VT groups. These findings indicate that it is the combination of the motor and cognitive aspects embedded in the QMT which is important for increasing ideational flexibility and alpha coherence.	[Ben-Soussan, Tal Dotan; Glicksohn, Joseph; Goldstein, Abraham; Berkovich-Ohana, Aviva] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Glicksohn, Joseph] Bar Ilan Univ, Dept Criminol, Ramat Gan, Israel; [Goldstein, Abraham] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Berkovich-Ohana, Aviva] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Donchin, Opher] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel	Bar Ilan University; Bar Ilan University; Bar Ilan University; Weizmann Institute of Science; Ben Gurion University	Ben-Soussan, TD (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel.	research@fondazionepatriziopaoletti.org	Donchin, Opher/A-4389-2008	Donchin, Opher/0000-0003-0963-4467; Ben-Soussan, Tal Dotan/0000-0002-9028-9658; Glicksohn, Joseph/0000-0001-5584-177X; Goldstein, Abraham/0000-0002-9349-0621	Bar-Ilan University; Gonda Brain Research Center	Bar-Ilan University; Gonda Brain Research Center	This research has been supported by the Bar-Ilan University doctoral scholarship of the Gonda Brain Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Archibald SJ, 2001, NEUROPSYCHOL REV, V11, P117, DOI 10.1023/A:1016673807158; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Ben-Soussan T.D., 2011, PROC FECHNER DAY, V27, P239; Berkovich-Ohana A, 2012, CLIN NEUROPHYSIOL, V123, P700, DOI 10.1016/j.clinph.2011.07.048; Bhattacharya J, 2005, HUM BRAIN MAPP, V26, P1, DOI 10.1002/hbm.20104; Blanchette DM, 2005, CREATIVITY RES J, V17, P257, DOI 10.1207/s15326934crj1702&3_10; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Camfield D, 2005, NEUROBIOLOGY OF EXCEPTIONALITY, P53, DOI 10.1007/0-306-48649-0_3; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Clarke AR, 2008, INT J PSYCHOPHYSIOL, V67, P35, DOI 10.1016/j.ijpsycho.2007.10.001; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Connell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033321; Cosmelli D., 2009, NEW PARADIGM COGNITI, P361; Crabbe JB, 2004, PSYCHOPHYSIOLOGY, V41, P563, DOI 10.1111/j.1469-8986.2004.00176.x; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Damasio A, 2000, FEELING WHAT HAPPENS; Dietrich A, 2004, CONSCIOUS COGN, V13, P746, DOI 10.1016/j.concog.2004.07.002; Dietrich A, 2004, BRAIN COGNITION, V55, P516, DOI 10.1016/j.bandc.2004.03.002; Dietrich A, 2006, PSYCHIAT RES, V145, P79, DOI 10.1016/j.psychres.2005.07.033; Donchin O, 2003, J NEUROSCI, V23, P9032; Dotan Ben-Soussan T, 2010, THESIS BAR ILAN U RA; Faw B, 2003, CONSCIOUS COGN, V12, P83, DOI 10.1016/S1053-8100(02)00030-2; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Fink A, 2009, NEUROIMAGE, V46, P854, DOI 10.1016/j.neuroimage.2009.02.036; FORD MR, 1986, INT J PSYCHOPHYSIOL, V4, P99, DOI 10.1016/0167-8760(86)90003-6; Gibson J.J., 1977, PERCEIVING ACTING KN, P67; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P395, DOI 10.3758/BF03201693; Glicksohn J, 2009, NEUROQUANTOLOGY, V7, P138, DOI 10.14704/nq.2009.7.1.215; Goleman D., 1993, CREATIVE SPIRIT; Guilford J.P., 1968, INTELLIGENCE CREATIV; Guilford J. P., 1978, ALTERNATE USES MANUA; Guntekin B, 2008, BRAIN RES, V1235, P109, DOI 10.1016/j.brainres.2008.06.028; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hocevar D, 1989, HDB CREATIVITY, P53, DOI DOI 10.1007/978-1-4757-5356-1_3; Horan R, 2009, CREATIVITY RES J, V21, P199, DOI 10.1080/10400410902858691; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kalapotharakos VI, 2006, AM J PHYS MED REHAB, V85, P61, DOI 10.1097/01.phm.0000179479.30543.1c; Kamei T, 2000, PERCEPT MOTOR SKILL, V90, P1027, DOI 10.2466/PMS.90.3.1027-1032; Klimkeit EI, 2005, CHILD NEUROPSYCHOL, V11, P153, DOI 10.1080/092970490911298; Lakoff George, 2003, METAPHOR WE LIVE BY; Levy-Drori S, 2006, AM J PSYCHOL, V119, P45, DOI 10.2307/20445318; Lui Y, 2003, J PSYCHOL ANTHR APPL, V22, P219; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Manganotti P, 1998, ELECTROMYOGR MOTOR C, V109, P50, DOI 10.1016/S0924-980X(97)00074-X; MORTIMER JA, 1982, NEUROLOGY, V32, P133, DOI 10.1212/WNL.32.2.133; Mosing MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047958; Netz Y, 2007, INT J SPORTS MED, V28, P82, DOI 10.1055/s-2006-924027; Neubauer AC, 2003, PERS INDIV DIFFER, V35, P811, DOI 10.1016/S0191-8869(02)00285-4; PAIVIO A, 1970, PSYCHOL BULL, V73, P385, DOI 10.1037/h0029180; Pangelinan MM, 2011, CEREB CORTEX, V21, P737, DOI 10.1093/cercor/bhq162; Paoletti P., 2008, CRESCERE NELL ECCELL; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Petsche H, 1996, INT J PSYCHOPHYSIOL, V24, P145, DOI 10.1016/S0167-8760(96)00050-5; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; RUNCO MA, 1986, J PSYCHOL, V120, P345, DOI 10.1080/00223980.1986.9712632; Russ SW, 1998, J CLIN CHILD PSYCHOL, V27, P469, DOI 10.1207/s15374424jccp2704_11; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; Shibata T, 1998, NEUROSCI RES, V31, P265, DOI 10.1016/S0168-0102(98)00046-7; Snyder A, 2004, CREATIVITY RES J, V16, P415; Srinivasan N, 2007, METHODS, V42, P109, DOI 10.1016/j.ymeth.2006.12.008; Sternberg RJ, 1996, AM PSYCHOL, V51, P677, DOI 10.1037/0003-066X.51.7.677; Tart C., 1969, ALTERED STATES CONSC; Taylor JG, 2002, TRENDS COGN SCI, V6, P206, DOI 10.1016/S1364-6613(02)01890-9; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Tomer R, 2002, NEUROPSY NEUROPSY BE, V15, P106, DOI 10.1097/01.WNN.0000016330.45409.33; Travis F, 2002, BIOL PSYCHOL, V61, P293, DOI 10.1016/S0301-0511(02)00048-0; Travis F, 2001, INT J PSYCHOPHYSIOL, V42, P1, DOI 10.1016/S0167-8760(01)00143-X; Travis F, 1999, CONSCIOUS COGN, V8, P302, DOI 10.1006/ccog.1999.0403; Travis F, 2009, INT J PSYCHOPHYSIOL, V71, P170, DOI 10.1016/j.ijpsycho.2008.09.007; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; van der Helden J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014482; van Vugt MK, 2007, J NEUROSCI METH, V162, P49, DOI 10.1016/j.jneumeth.2006.12.004; Varela FJ, 2017, EMBODIED MIND COGNIT; Volf NV, 1999, INT J PSYCHOPHYSIOL, V34, P113, DOI 10.1016/S0167-8760(99)00067-7; Vosburg SK, 1998, CREATIVITY RES J, V11, P165, DOI 10.1207/s15326934crj1102_6	79	30	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55023	10.1371/journal.pone.0055023	http://dx.doi.org/10.1371/journal.pone.0055023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383043	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800105
J	Celec, P; Tretinarova, D; Minarik, G; Ficek, A; Szemes, T; Lakatosova, S; Schmidtova, E; Turna, J; Kadasi, L; Ostatnikova, D				Celec, Peter; Tretinarova, Denisa; Minarik, Gabriel; Ficek, Andrej; Szemes, Tomas; Lakatosova, Silvia; Schmidtova, Eva; Turna, Jan; Kadasi, Ludevit; Ostatnikova, Daniela			Genetic Polymorphisms Related to Testosterone Metabolism in Intellectually Gifted Boys	PLOS ONE			English	Article							ANDROGEN RECEPTOR GENE; QUANTITATIVE TRAIT LOCUS; GENOME-WIDE SCAN; PROSTATE-CANCER; SEX-DIFFERENCES; CAG REPEAT; ENVIRONMENTAL-INFLUENCES; 5-YEAR-OLD CHILDREN; COGNITIVE FUNCTION; INTELLIGENCE	Prepubertal testosterone levels are lower in intellectually gifted boys. The aim of this pilot study was to analyze potential genetic factors related to testosterone metabolism in control and gifted boys. Intellectually gifted (IQ>130; n = 95) and control (n = 67) boys were genotyped. Polymorphisms of interests were chosen in genes including androgen and estrogen receptors, 5-alpha reductase, aromatase and sex hormone binding globulin. Significant differences between control and gifted boys in genotype distributions were found for ESR2 (rs928554) and SHBG (rs1799941). A significantly lower number of CAG repeats in the AR gene were found in gifted boys. Our results support the role of genetic factors related to testosterone metabolism in intellectual giftedness. Increased androgen signaling might explain previous results of lower testosterone levels in intellectually gifted boys and add to the understanding of variability in cognitive abilities.	[Celec, Peter; Minarik, Gabriel] Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia; [Celec, Peter] Comenius Univ, Inst Pathophysiol, Bratislava, Slovakia; [Celec, Peter; Tretinarova, Denisa; Minarik, Gabriel; Ficek, Andrej; Szemes, Tomas; Turna, Jan; Kadasi, Ludevit] Comenius Univ, Dept Mol Biol, Bratislava, Slovakia; [Minarik, Gabriel; Ficek, Andrej; Kadasi, Ludevit] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia; [Lakatosova, Silvia; Schmidtova, Eva; Ostatnikova, Daniela] Comenius Univ, Inst Physiol, Bratislava, Slovakia	Comenius University Bratislava; Comenius University Bratislava; Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava; Slovak Academy of Sciences	Celec, P (corresponding author), Comenius Univ, Inst Mol Biomed, Bratislava, Slovakia.	petercelec@gmail.com	Kadasi, Ludevit/A-4677-2013; Ficek, Andrej/O-5139-2018; Minarik, Gabriel/A-3493-2013; Turňa, Ján/T-2942-2019; Celec, Peter/I-7103-2012; Ostatnikova, Daniela/AAD-1359-2019	Turňa, Ján/0000-0001-5813-566X; Celec, Peter/0000-0001-5883-3580; Szemes, Tomas/0000-0002-0900-2534; Ficek, Andrej/0000-0001-7526-2361; Ostatnikova, Daniela/0000-0002-4960-5057	Framework Programme for Research and Technology Development; Building of Centre of Excellency for Sudden Cerebral Vascular Events; Comenius University Faculty of Medicine in Bratislava [ITMS: 26240120023]; European Regional Development Fund	Framework Programme for Research and Technology Development; Building of Centre of Excellency for Sudden Cerebral Vascular Events; Comenius University Faculty of Medicine in Bratislava; European Regional Development Fund(European Commission)	This work was funded by the Framework Programme for Research and Technology Development, project: Building of Centre of Excellency for Sudden Cerebral Vascular Events, Comenius University Faculty of Medicine in Bratislava (ITMS: 26240120023), cofinanced by European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azurmendi A, 2005, HORM BEHAV, V48, P187, DOI 10.1016/j.yhbeh.2005.03.003; Azurmendi A, 2006, HORM BEHAV, V50, P132, DOI 10.1016/j.yhbeh.2006.02.004; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P3681, DOI 10.1210/jc.84.10.3681; Bartels M, 2002, BEHAV GENET, V32, P237, DOI 10.1023/A:1019772628912; Beilin J, 2000, J MOL ENDOCRINOL, V25, P85, DOI 10.1677/jme.0.0250085; BENBOW CP, 1988, BEHAV BRAIN SCI, V11, P169, DOI 10.1017/S0140525X00049244; Bouchard TJ, 1998, HUM BIOL, V70, P257; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Buyske S, 2006, BEHAV GENET, V36, P65, DOI 10.1007/s10519-005-9008-9; Celec P, 2009, J PSYCHOPHYSIOL, V23, P1, DOI 10.1027/0269-8803.23.1.1; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Dick DM, 2007, BEHAV GENET, V37, P265, DOI 10.1007/s10519-006-9131-2; Ding DC, 2004, PROSTATE, V58, P23, DOI 10.1002/pros.10316; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Giton F, 2006, CLIN CHEM, V52, P474, DOI 10.1373/clinchem.2005.052126; Hardy DO, 1996, J CLIN ENDOCR METAB, V81, P4400, DOI 10.1210/jc.81.12.4400; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Henningsson S, 2009, PSYCHONEUROENDOCRINO, V34, P752, DOI 10.1016/j.psyneuen.2008.12.007; IRVINE RA, 1995, CANCER RES, V55, P1937; Irwing P, 2005, BRIT J PSYCHOL, V96, P505, DOI 10.1348/000712605X53542; Kutlu N, 2001, INT J NEUROSCI, V111, P1, DOI 10.3109/00207450108986548; Luciano M, 2006, BEHAV GENET, V36, P45, DOI 10.1007/s10519-005-9003-1; Matsumoto Y, 2009, BEHAV BRAIN RES, V205, P234, DOI 10.1016/j.bbr.2009.06.034; Muller M, 2005, NEUROLOGY, V64, P866, DOI 10.1212/01.WNL.0000153072.54068.E3; Ostatnikova D, 2007, NEUROPSYCHOLOGIA, V45, P1378, DOI 10.1016/j.neuropsychologia.2006.10.018; Paus T, 2010, HORM BEHAV, V57, P63, DOI 10.1016/j.yhbeh.2009.08.004; Plomin R, 2001, BEHAV GENET, V31, P497, DOI 10.1023/A:1013385125887; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Seshadri S, 2007, BMC MED GENET, V8, P14; Thakur MK, 2007, NEUROCHEM INT, V50, P314, DOI 10.1016/j.neuint.2006.08.019; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; van Leeuwen M, 2008, LEARN INDIVID DIFFER, V18, P76, DOI 10.1016/j.lindif.2007.04.006; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130	33	12	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54751	10.1371/journal.pone.0054751	http://dx.doi.org/10.1371/journal.pone.0054751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382957	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800074
J	Morgan, KS; Donnelley, M; Paganin, DM; Fouras, A; Yagi, N; Suzuki, Y; Takeuchi, A; Uesugi, K; Boucher, RC; Parsons, DW; Siu, KKW				Morgan, Kaye S.; Donnelley, Martin; Paganin, David M.; Fouras, Andreas; Yagi, Naoto; Suzuki, Yoshio; Takeuchi, Akihisa; Uesugi, Kentaro; Boucher, Richard C.; Parsons, David W.; Siu, Karen K. W.			Measuring Airway Surface Liquid Depth in Ex Vivo Mouse Airways by X-Ray Imaging for the Assessment of Cystic Fibrosis Airway Therapies	PLOS ONE			English	Article							HYPERTONIC SALINE; PATHOGENESIS; CLEARANCE	In the airways of those with cystic fibrosis (CF), the leading pathophysiological hypothesis is that an ion channel defect results in a relative decrease in airway surface liquid (ASL) volume, producing thick and sticky mucus that facilitates the establishment and progression of early fatal lung disease. This hypothesis predicts that any successful CF airway treatment for this fundamental channel defect should increase the ASL volume, but up until now there has been no method of measuring this volume that would be compatible with in vivo monitoring. In order to accurately monitor the volume of the ASL, we have developed a new x-ray phase contrast imaging method that utilizes a highly attenuating reference grid. In this study we used this imaging method to examine the effect of a current clinical CF treatment, aerosolized hypertonic saline, on ASL depth in ex vivo normal mouse tracheas, as the first step towards non-invasive in vivo ASL imaging. The ex vivo tracheas were treated with hypertonic saline, isotonic saline or no treatment using a nebuliser integrated within a small animal ventilator circuit. Those tracheas exposed to hypertonic saline showed a transient increase in the ASL depth, which continued for nine minutes post-treatment, before returning to baseline by twelve minutes. These findings are consistent with existing measurements on epithelial cell cultures, and therefore suggest promise for the future development of in vivo testing of treatments. Our grid-based imaging technique measures the ASL depth with micron resolution, and can directly observe the effect of treatments expected to increase ASL depth, prior to any changes in overall lung health. The ability to non-invasively observe micron changes in the airway surface, particularly if achieved in an in vivo setting, may have potential in pre-clinical research designed to bring new treatments for CF and other airway diseases to clinical trials.	[Morgan, Kaye S.; Paganin, David M.; Siu, Karen K. W.] Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia; [Donnelley, Martin; Parsons, David W.] Womens & Childrens Hosp, Adelaide, SA, Australia; [Donnelley, Martin; Parsons, David W.] Univ Adelaide, Dept Paediat & Reprod Hlth, Adelaide, SA, Australia; [Donnelley, Martin; Parsons, David W.] Univ Adelaide, Ctr Stem Cell Res, Adelaide, SA, Australia; [Fouras, Andreas] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Yagi, Naoto; Suzuki, Yoshio; Takeuchi, Akihisa; Uesugi, Kentaro] SPring 8 Japan Synchrotron Radiat Res Inst, Kouto, Hyogo, Japan; [Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Res & Treatment Ctr, Chapel Hill, NC USA; [Siu, Karen K. W.] Monash Univ, Melbourne, Vic 3004, Australia; [Siu, Karen K. W.] Australian Synchrotron, Melbourne, Vic, Australia	Monash University; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; Monash University; University of North Carolina; University of North Carolina Chapel Hill; Monash University	Morgan, KS (corresponding author), Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia.	kaye.morgan@monash.edu	Fouras, Andreas/A-9410-2008; Parsons, David Webb/A-5831-2011; Morgan, Kaye/A-3632-2011; Siu, Karen K W/C-1472-2008; Donnelley, Martin/A-1195-2019	Fouras, Andreas/0000-0002-8933-1759; Parsons, David Webb/0000-0003-1746-3290; Morgan, Kaye/0000-0001-6997-7977; Paganin, David/0000-0002-7758-7140; Uesugi, Kentaro/0000-0003-2579-513X; Donnelley, Martin/0000-0002-5320-7756	International Synchrotron Access Program (ISAP); Australian Government; Australian Research Council; National Health and Medical Research Council; Cure4CF Foundation Limited; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108808] Funding Source: NIH RePORTER	International Synchrotron Access Program (ISAP); Australian Government(Australian GovernmentCGIAR); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cure4CF Foundation Limited; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge travel funding provided by the International Synchrotron Access Program (ISAP) managed by the Australian Synchrotron and funded by the Australian Government. This work is supported by the Australian Research Council, the National Health and Medical Research Council and Cure4CF Foundation Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Brody AS, 2005, AM J RESP CRIT CARE, V172, P1246, DOI 10.1164/rccm.200503-401PP; Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Daviskas E, 1996, EUR RESPIR J, V9, P725, DOI 10.1183/09031936.96.09040725; Donaldson S, 2006, NEW ENGL J MED, V354, P250; Donnelley M, 2010, J SYNCHROTRON RADIAT, V17, P719, DOI 10.1107/S0909049510028451; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Griesenbach Uta, 2005, J Cyst Fibros, V4, P89, DOI 10.1016/j.jcf.2005.02.002; Hartmann J, 1900, ZT INSTRUMENTENKD, V29; Kitchen MJ, 2008, PHYS MED BIOL, V53, P6065, DOI 10.1088/0031-9155/53/21/012; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Mayo SC, 2004, OPT LETT, V29, P866, DOI 10.1364/OL.29.000866; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Morgan KS, 2012, AIP CONF PROC, V1466, P124, DOI 10.1063/1.4742280; Morgan KS, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694918; Morgan KS, 2011, OPT EXPRESS, V19, P19781, DOI 10.1364/OE.19.019781; Morgan KS, 2011, OPT LETT, V36, P55, DOI 10.1364/OL.36.000055; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ratjen F, 2012, CURR PHARM DESIGN, V18, P614, DOI 10.2174/138161212799315984; Shack RV, 1971, J OPTICAL SOC AM, V61; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6	28	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55822	10.1371/journal.pone.0055822	http://dx.doi.org/10.1371/journal.pone.0055822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383288	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800189
J	Wen, J; Chen, ZB; Cai, XD				Wen, Ji; Chen, Zhibin; Cai, Xiaodong			A Biophysical Model for Identifying Splicing Regulatory Elements and Their Interactions	PLOS ONE			English	Article							PRE-MESSENGER-RNA; TRACT BINDING-PROTEIN; MUSCLEBLIND PROTEINS; MYOTONIC-DYSTROPHY; EXON DEFINITION; GENE-REGULATION; CIS-REGULATION; IN-VIVO; IDENTIFICATION; SPECIFICITY	Alternative splicing (AS) of precursor mRNA (pre-mRNA) is a crucial step in the expression of most eukaryotic genes. Splicing factors (SFs) play an important role in AS regulation by binding to the cis-regulatory elements on the pre-mRNA. Although many splicing factors (SFs) and their binding sites have been identified, their combinatorial regulatory effects remain to be elucidated. In this paper, we derive a biophysical model for AS regulation that integrates combinatorial signals of cis-acting splicing regulatory elements (SREs) and their interactions. We also develop a systematic framework for model inference. Applying the biophysical model to a human RNA-Seq data set, we demonstrate that our model can explain 49.1%-66.5% variance of the data, which is comparable to the best result achieved by biophysical models for transcription. In total, we identified 119 SRE pairs between different regions of cassette exons that may regulate exon or intron definition in splicing, and 77 SRE pairs from the same region that may arise from a long motif or two different SREs bound by different SFs. Particularly, putative binding sites of polypyrimidine tract-binding protein (PTB), heterogeneous nuclear ribonucleoprotein (hnRNP) F/H and E/K are identified as interacting SRE pairs, and have been shown to be consistent with the interaction models proposed in previous experimental results. These results show that our biophysical model and inference method provide a means of quantitative modeling of splicing regulation and is a useful tool for identifying SREs and their interactions. The software package for model inference is available under an open source license.	[Wen, Ji; Cai, Xiaodong] Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA; [Chen, Zhibin] Univ Miami, Dept Microbiol & Immunol, Miami, FL USA	University of Miami; University of Miami	Cai, XD (corresponding author), Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA.	x.cai@miami.edu		Wen, Ji/0000-0002-3327-5591	National Science Foundation [CCF-0746882]; Division of Computing and Communication Foundations [0746882] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation under grant CCF-0746882 to XC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir-Ahmady B, 2005, RNA, V11, P699, DOI 10.1261/rna.2250405; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown JWS, 1998, ANNU REV PLANT PHYS, V49, P77, DOI 10.1146/annurev.arplant.49.1.77; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Das Debopriya, 2007, Methods Mol Biol, V377, P95; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Das D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000269; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2012, J R STAT SOC B, V74, P37, DOI 10.1111/j.1467-9868.2011.01005.x; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310; Friedman BA, 2008, GENOME RES, V18, P1643, DOI 10.1101/gr.080085.108; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; GORLACH M, 1994, J BIOL CHEM, V269, P23074; HASTIE T, 2009, SPRINGER SERIES STAT; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hori T, 2005, NUCLEIC ACIDS RES, V33, P190, DOI 10.1093/nar/gki153; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; Ke SD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r84; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Merritt H, 1997, PLANT J, V12, P937, DOI 10.1046/j.1365-313X.1997.12040937.x; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Peng R, 2002, RNA, V8, P1334, DOI 10.1017/S1355838202022070; Perez I, 1997, RNA, V3, P764; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Reid DC, 2009, RNA, V15, P2385, DOI 10.1261/rna.1821809; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Suyama M, 2010, NUCLEIC ACIDS RES, V38, P7916, DOI 10.1093/nar/gkq705; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HW, 2010, NUCLEIC ACIDS RES, V38, P3760, DOI 10.1093/nar/gkq028; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen J, 2010, NUCLEIC ACIDS RES, V38, P7895, DOI 10.1093/nar/gkq679; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	96	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54885	10.1371/journal.pone.0054885	http://dx.doi.org/10.1371/journal.pone.0054885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382993	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800086
J	Xia, Z; Huynh, T; Ren, PY; Zhou, RH				Xia, Zhen; Tien Huynh; Ren, Pengyu; Zhou, Ruhong			Large Domain Motions in Ago Protein Controlled by the Guide DNA-Strand Seed Region Determine the Ago-DNA-mRNA Complex Recognition Process	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; POSTTRANSCRIPTIONAL REGULATION; FORCE-FIELD; EWALD SUMS; MICRORNAS; CHARMM; ARGONAUTE; ENERGY; INTERFERENCE; MECHANISM	The recognition mechanism and cleavage activity of argonaute (Ago), miRNA, and mRNA complexes are the core processes to the small non-coding RNA world. The 59 nucleation at the 'seed' region (position 2-8) of miRNA was believed to play a significant role in guiding the recognition of target mRNAs to the given miRNA family. In this paper, we have performed allatom molecular dynamics simulations of the related and recently revealed Ago-DNA: mRNA ternary complexes to study the dynamics of the guide-target recognition and the effect of mutations by introducing "damaging" C? C mismatches at different positions in the seed region of the DNA-RNA duplex. Our simulations show that the A-form-like helix duplex gradually distorts as the number of seed mismatches increases and the complex can survive no more than two such mismatches. Severe distortions of the guide-target heteroduplex are observed in the ruinous 4-sites mismatch mutant, which give rise to a bending motion of the PAZ domain along the L1/L2 "hinge-like" connection segment, resulting in the opening of the nucleic-acid-binding channel. These long-range interactions between the seed region and PAZ domain, moderated by the L1/L2 segments, reveal the central role of the seed region in the guide-target strands recognition: it not only determines the guide-target heteroduplex's nucleation and propagation, but also regulates the dynamic motions of Ago domains around the nucleic-acid-binding channel.	[Xia, Zhen; Tien Huynh; Zhou, Ruhong] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, New York, NY 10598 USA; [Xia, Zhen; Ren, Pengyu] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Zhou, Ruhong] Columbia Univ, Dept Chem, New York, NY 10027 USA	International Business Machines (IBM); University of Texas System; University of Texas Austin; Columbia University	Zhou, RH (corresponding author), IBM Thomas J Watson Res Ctr, Computat Biol Ctr, New York, NY 10598 USA.	ruhongz@us.ibm.com	Xia, Zhen/B-3391-2014; Ren, Pengyu/Q-6872-2017	Ren, Pengyu/0000-0002-5613-1910; Zhou, Ruhong/0000-0001-8624-5591	IBM Blue Gene Science program	IBM Blue Gene Science program(International Business Machines (IBM))	This work was supported by the IBM Blue Gene Science program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; De Guire V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq354; Denning EJ, 2011, J COMPUT CHEM, V32, P1929, DOI 10.1002/jcc.21777; Deserno M, 1998, J CHEM PHYS, V109, P7694, DOI 10.1063/1.477415; Deserno M, 1998, J CHEM PHYS, V109, P7678, DOI 10.1063/1.477414; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kumar S, 2008, IBM J RES DEV, V52, P177, DOI 10.1147/rd.521.0177; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Ming D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-470; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Neria E, 1996, J CHEM PHYS, V105, P10812, DOI 10.1063/1.472889; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Priyakumar UD, 2008, J PHYS CHEM B, V112, P1515, DOI 10.1021/jp709827m; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; van der Spoel D., 2005, GROMACS USER MANUAL; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wang YH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000866; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xia Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00569; Xia Z, 2012, BIOPHYS J, V102, P1453, DOI 10.1016/j.bpj.2012.01.043; Xia Z, 2009, BIOPHYS J, V96, P1761, DOI 10.1016/j.bpj.2008.11.047; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998	52	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54620	10.1371/journal.pone.0054620	http://dx.doi.org/10.1371/journal.pone.0054620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382927	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200039
J	Kock, A; O'Riain, MJ; Mauff, K; Meyer, M; Kotze, D; Griffiths, C				Kock, Alison; O'Riain, M. Justin; Mauff, Katya; Meyer, Michael; Kotze, Deon; Griffiths, Charles			Residency, Habitat Use and Sexual Segregation of White Sharks, Carcharodon carcharias in False Bay, South Africa	PLOS ONE			English	Article							FORAGING BEHAVIOR; GUADALUPE ISLAND; FARALLON-ISLANDS; PATTERNS; CONSERVATION; MIGRATION; MOVEMENTS; PREDATOR; MANAGEMENT; FISH	White sharks (Carcharodon carcharias) are threatened apex predators and identification of their critical habitats and how these are used are essential to ensuring improved local and ultimately global white shark protection. In this study we investigated habitat use by white sharks in False Bay, South Africa, using acoustic telemetry. 56 sharks (39 female, 17 male), ranging in size from 1.7-5 m TL, were tagged with acoustic transmitters and monitored on an array of 30 receivers for 975 days. To investigate the effects of season, sex and size on habitat use we used a generalized linear mixed effects model. Tagged sharks were detected in the Bay in all months and across all years, but their use of the Bay varied significantly with the season and the sex of the shark. In autumn and winter males and females aggregated around the Cape fur seal colony at Seal Island, where they fed predominantly on young of the year seals. In spring and summer there was marked sexual segregation, with females frequenting the Inshore areas and males seldom being detected. The shift from the Island in autumn and winter to the Inshore region in spring and summer by females mirrors the seasonal peak in abundance of juvenile seals and of migratory teleost and elasmobranch species respectively. This study provides the first evidence of sexual segregation at a fine spatial scale and demonstrates that sexual segregation in white sharks is not restricted to adults, but is apparent for juveniles and sub-adults too. Overall, the results confirm False Bay as a critical area for white shark conservation as both sexes, across a range of sizes, frequent the Bay on an annual basis. The finding that female sharks aggregate in the Inshore regions when recreational use peaks highlights the need for ongoing shark-human conflict mitigation strategies.	[Kock, Alison; O'Riain, M. Justin; Griffiths, Charles] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa; [Kock, Alison] Shark Spotters, Cape Town, South Africa; [Mauff, Katya] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Meyer, Michael; Kotze, Deon] Oceans & Coasts Branch, Dept Environm Affairs, Cape Town, South Africa	University of Cape Town; University of Cape Town; Department of Environment, Forestry & Fisheries	Kock, A (corresponding author), Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa.	alison@sharkspotters.org.za		O'Riain, M. Justin/0000-0001-5233-8327; Kock, Alison/0000-0001-9981-1652	National Research Foundation; National Research Foundation (South Africa); Save Our Seas Foundation	National Research Foundation; National Research Foundation (South Africa)(National Research Foundation - South Africa); Save Our Seas Foundation	Bursary funding for AAK was provided for her MSc research from the National Research Foundation and for her PhD research through a grant to CG from the National Research Foundation (South Africa) (http://www.nrf.ac.za) SEAChange Programme. The Department of Environmental Affairs provided additional research equipment and ship time. The Save Our Seas Foundation provided a grant to AAK to conduct this research. The funders had no role in study design, analysis and decision to publish. MM and DK (employees of the Department of Environmental Affairs who supplied research equipment and ship time) assisted in collection of the data and contribution of materials. Both also reviewed the manuscript before publication.	Anderson SG, 2003, LASER FOCUS WORLD, V39, P89; Andrews KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012549; ATKINS GR, 1970, T ROY SOC S AFR, V39, P139, DOI 10.1080/00359197009519109; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bozogan H., 1987, PSYCHOMETRIKA, V52, P345; Bruce B., 2008, SHARKS OPEN OCEAN BI, P69, DOI DOI 10.1002/9781444302516; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce B. D, 2005, SITE FIDELITY RESIDE; Bruce Barry D., 2012, P225; Carlson JK, 2008, ESTUAR COAST, V31, P931, DOI 10.1007/s12237-008-9075-2; Clark BM, 1996, MAR ECOL PROG SER, V131, P35, DOI 10.3354/meps131035; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Cliff G, 2006, WWF S AFRICA REPORT; De Vos A, 2010, THESIS U CAPE TOWN S; Dicken ML, 2006, AFR J MAR SCI, V28, P603, DOI 10.2989/18142320609504210; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier Michael L., 2012, P133; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dudley Sheldon F.J., 2012, P511; Fergusson I, 2005, IUCN 2011 IUCN RED L; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2004, CRC MAR BIOL SER, P487; Hussey Nigel E., 2012, P27; Johnson R, 2009, ENVIRON BIOL FISH, V85, P189, DOI 10.1007/s10641-009-9477-4; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; KIME DE, 1982, COMP BIOCHEM PHYS B, V71, P675, DOI 10.1016/0305-0491(82)90480-1; KLIMLEY AP, 1992, COPEIA, P680; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Kock AA, 2012, GLOBAL PERSPECTIVES, P447; Lacroix GL, 2000, ADV FISH TELEMETRY, P37; LAMBERTH SJ, 1995, S AFR J MARINE SCI, V15, P157; Laroche RK, 2008, ANIM BEHAV, V76, P1901, DOI 10.1016/j.anbehav.2008.06.025; Malcolm H., 2001, REV BIOL STATUS WHIT; McCullagh P, 1989, GEN LINEAR MODELS; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; MUSICK JA, 2000, FISHERIES, V25; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pyle P, 1996, GREAT WHITE SHARKS, P281, DOI 10.1016/B978-012415031-7/50027-6; Robbins RL, 2007, J FISH BIOL, V70, P1350, DOI 10.1111/j.1095-8649.2007.01414.x; Robbins Rachel L., 2012, P287; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Sims David W., 2005, P127; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2001, MAR BIOL, V139, P1165; SPARGO PE, 1991, T ROY SOC S AFR, V47, P363; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; van Herwerden L., 1989, OCEAN SHORELINE MANA, V12, P331, DOI https://doi.org/10.1016/0951-8312(89)90067-2; Ward-Paige CA, 2012, J FISH BIOL, V80, P1844, DOI 10.1111/j.1095-8649.2012.03246.x; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Wirsing AJ, 2007, ANIM BEHAV, V74, P93, DOI 10.1016/j.anbehav.2006.11.016	64	89	89	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55048	10.1371/journal.pone.0055048	http://dx.doi.org/10.1371/journal.pone.0055048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383052	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500051
J	Khireddine, I; Le Ray, C; Dupont, C; Rudigoz, RC; Bouvier-Colle, MH; Deneux-Tharaux, C				Khireddine, Imane; Le Ray, Camille; Dupont, Corinne; Rudigoz, Rene-Charles; Bouvier-Colle, Marie-Helene; Deneux-Tharaux, Catherine			Induction of Labor and Risk of Postpartum Hemorrhage in Low Risk Parturients	PLOS ONE			English	Article							ELECTIVE INDUCTION; EXPECTANT MANAGEMENT; NULLIPAROUS WOMEN; OXYTOCIN; PREGNANCIES; POPULATION; GESTATION	Objective: Labor induction is an increasingly common procedure, even among women at low risk, although evidence to assess its risks remains sparse. Our objective was to assess the association between induction of labor and postpartum hemorrhage (PPH) in low-risk parturients, globally and according to its indications and methods. Method: Population-based case-control study of low-risk women who gave birth in 106 French maternity units between December 2004 and November 2006, including 4450 women with PPH, 1125 of them severe, and 1744 controls. Indications for labor induction were standard or non-standard, according to national guidelines. Induction methods were oxytocin or prostaglandins. Multilevel multivariable logistic regression modelling was used to test the independent association between induction and PPH, quantified as odds ratios. Results: After adjustment for all potential confounders, labor induction was associated with a significantly higher risk of PPH (adjusted odds ratio, AOR1.22, 95%CI 1.04-1.42). This excess risk was found for induction with both oxytocin (AOR 1.52, 95%CI 1.19-1.93 for all and 1.57, 95%CI 1.11-2.20 for severe PPH) and prostaglandins (AOR 1.21, 95%CI 0.97-1.51 for all and 1.42, 95%CI 1.04-1.94 for severe PPH). Standard indicated induction was significantly associated with PPH (AOR1.28, 95%CI 1.06-1.55) while no significant association was found for non-standard indicated inductions. Conclusion: Even in low risk women, induction of labor, regardless of the method used, is associated with a higher risk of PPH than spontaneous labor. However, there was no excess risk of PPH in women who underwent induction of labor for non-standard indications. This raises the hypothesis that the higher risk of PPH associated with labor induction may be limited to unfavorable obstetrical situations.	[Khireddine, Imane; Le Ray, Camille; Bouvier-Colle, Marie-Helene; Deneux-Tharaux, Catherine] Univ Paris 06, INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France; [Le Ray, Camille] Univ Paris 05, Grp Hosp Cochin Broca Hotel Dieu, AP HP, Sorbonne Paris Cite, Paris, France; [Dupont, Corinne; Rudigoz, Rene-Charles] Univ Lyon 1, Aurore Perinatal Network, Hop Croix Rousse, Hosp Civils Lyon,EA 4129, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Deneux-Tharaux, C (corresponding author), Univ Paris 06, INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France.	catherine.deneux-tharaux@inserm.fr	DUPONT, Corinne/ABD-5045-2020; deneux-tharaux, catherine/R-1111-2016	deneux-tharaux, catherine/0000-0002-6561-3321; Le Ray, Camille/0000-0003-0891-1063	French Ministry of Health under its Clinical Research Hospital Program [27-35]; Caisse Nationale d'Assurance Maladie (CNAMTS); l'Institut de Recherche en Sante Publique (IRESP)	French Ministry of Health under its Clinical Research Hospital Program; Caisse Nationale d'Assurance Maladie (CNAMTS); l'Institut de Recherche en Sante Publique (IRESP)	The project was funded by the French Ministry of Health under its Clinical Research Hospital Program (contract no.27-35) and the Caisse Nationale d'Assurance Maladie (CNAMTS). IK was supported by a grant from l'Institut de Recherche en Sante Publique (IRESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Al-Zirqi I, 2009, AM J OBSTET GYNECOL, V201; [Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Belghiti J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000514; Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Bouvier-Colle MH, 2011, J GYNECOL OBST BIO R, V40, P87, DOI 10.1016/j.jgyn.2010.12.007; Caughey AB, 2009, ANN INTERN MED, V151, P252, DOI 10.7326/0003-4819-151-4-200908180-00007; COMBS CA, 1991, OBSTET GYNECOL, V77, P69; Deneux-Tharaux C, 2010, BJOG-INT J OBSTET GY, V117, P1278, DOI 10.1111/j.1471-0528.2010.02648.x; Dunne C, 2009, J OBSTET GYNAECOL CA, V31, P1124, DOI 10.1016/S1701-2163(16)34372-9; Gelisen O, 2005, EUR J OBSTET GYN R B, V120, P164, DOI 10.1016/j.ejogrb.2004.08.013; Goffinet F, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, P638; Goldman JB, 1999, OBSTET GYNECOL, V93, P271, DOI 10.1016/S0029-7844(98)00359-7; Grotegut CA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.023; Guerra GV, 2011, B WORLD HEALTH ORGAN, V89, P657, DOI 10.2471/BLT.08.061226; Haute Autorite de Sante, 2008, DECL ART TRAV PART 3; Hussain AA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S5; Kelly AJ, 2003, COCHRANE DB SYST REV, V2003; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Le Ray C, 2007, ACTA OBSTET GYN SCAN, V86, P657, DOI 10.1080/00016340701245427; Lydon-Rochelle MT, 2007, MED CARE, V45, P505, DOI 10.1097/MLR.0b013e3180330e26; Magalhaes JKRS, 2009, REPROD SCI, V16, P501, DOI 10.1177/1933719108329954; Mamelle N, 2004, Gynecol Obstet Fertil, V32 Spec No 1, P4; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; National Institute for Health and Clinical Excellence, 2008, IND LAB, V2nd; Nicholson JM, 2004, AM J OBSTET GYNECOL, V191, P1516, DOI 10.1016/j.ajog.2004.07.002; Osmundson S, 2011, OBSTET GYNECOL, V117, P583, DOI 10.1097/AOG.0b013e31820caf12; Osmundson SS, 2010, OBSTET GYNECOL, V116, P601, DOI 10.1097/AOG.0b013e3181eb6e9b; Robinson C, 2003, AM J OBSTET GYNECOL, V188, P497, DOI 10.1067/mob.2003.22; Sosa CG, 2009, OBSTET GYNECOL, V113, P1313, DOI 10.1097/AOG.0b013e3181a66b05; Zhang J, 2002, J REPROD MED, V47, P120; Zimbeck M, 2009, EUR J OBSTET GYN R B, V146, P149, DOI 10.1016/j.ejogrb.2009.07.017	33	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e54858	10.1371/journal.pone.0054858	http://dx.doi.org/10.1371/journal.pone.0054858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23382990	Green Published, gold, Green Submitted			2022-12-27	WOS:000315210400036
J	Gong, P; Wang, YX; Liu, GV; Zhang, J; Wang, ZY				Gong, Peng; Wang, Yingxin; Liu, Gavin; Zhang, Jing; Wang, Zhongyu			New Insight into Ki67 Expression at the Invasive Front in Breast Cancer	PLOS ONE			English	Article							PHASE-II; KI-67	Purpose: To investigate the distribution of Ki67+ cells in breast cancer in relation to clinical-pathological parameters and prognosis. Materials and Methods: Ki67 expression status was detected in 1,086 breast cancer specimens using immunohistochemistry staining and examining the relationship between the Ki67+ cells' location. Subsequently, clinical-pathological parameters and prognosis were determined. Results: In total, Ki67 protein expression was found in 781 (71.92%) of the 1,086 breast cancer specimens. Among the 781 Ki67+ cases, 461 were defined as diffuse type and 320 were defined as borderline type. After universal correlation analysis, significant differences were observed in age, histological grade, metastatic nodes, postoperative distant metastasis, and molecular subtype between Ki67+ and Ki67- cases (P = 0.01, 0.001, 0.001, 0.001, and 0.001, respectively). After subgroup analysis, the borderline cases were found to be characterized by a high distant metastasis rate compared to the diffuse cases as well as the Ki67- cases (P = 0.001). No differences were observed between diffuse type or Ki67- cases (P = 0.105). Multivariate analysis showed that age, tumor size, histological grade, lymph node metastasis, molecular subtype, and the Ki67 distribution pattern were observed to be related to postoperative distant metastasis (all P<0.05). Furthermore, borderline type was shown to attain a significantly more distant bone and liver metastasis and worse disease-specific survival than the other types (P = 0.001). In the Cox regression test, the Ki67 distribution pattern was detected as an independent prognostic factor (P = 0.001). Conclusion: The distribution pattern of Ki67 may be a new independent prognostic factor for breast cancer.	[Gong, Peng; Wang, Yingxin; Liu, Gavin; Zhang, Jing; Wang, Zhongyu] Dalian Med Univ, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China	Dalian Medical University	Gong, P (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China.	gongpengdalian@163.com		WANG, YINGXIN/0000-0001-9032-9990	China National Natural Science Foundation [81102029, 81172047]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was funded by the China National Natural Science Foundation (No. 81102029 and 81172047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonanni B, 2012, J CLIN ONCOL, V30, P2593, DOI 10.1200/JCO.2011.39.3769; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Campana LG, 2012, BREAST CANCER RES TR, V134, P1169, DOI 10.1007/s10549-012-2095-4; Delpech Y, 2012, BREAST CANCER RES TR, V135, P619, DOI 10.1007/s10549-012-2194-2; Dilaveri CA, 2012, INT J WOMENS HEALTH, V4, P35, DOI 10.2147/IJWH.S27624; Dowling EC, 2010, J MED SCREEN, V17, P139, DOI 10.1258/jms.2010.010033; Esteva FJ, 2005, CLIN CANCER RES, V11, P3315, DOI 10.1158/1078-0432.CCR-04-1707; Fredslund SO, 2012, INT J CIRCUMPOL HEAL, V71, P1; Koo DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039880; Mamounas EP, 2010, J CLIN ONCOL, V28, P1677, DOI 10.1200/JCO.2009.23.7610; Sanchez-Rovira P, 2012, CLIN TRANSL ONCOL, V14, P430, DOI 10.1007/s12094-012-0820-4; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sinicropi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040092; Strehl JD, 2011, BREAST CARE, V6, P258, DOI 10.1159/000331339; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Wang L, 2011, ANN SURG ONCOL, V18, P1553, DOI 10.1245/s10434-010-1519-9; Wojnar A, 2011, ANTICANCER RES, V31, P3027; Wu QJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042607	18	24	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54912	10.1371/journal.pone.0054912	http://dx.doi.org/10.1371/journal.pone.0054912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382998	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600050
J	Stamatiou, G; Vidaurre, DP; Shim, I; Tang, XR; Moeder, W; Bonetta, D; McCourt, P				Stamatiou, George; Vidaurre, Danielle P.; Shim, Isaac; Tang, Xurong; Moeder, Wolfgang; Bonetta, Dario; McCourt, Peter			Forward Genetic Screening for the Improved Production of Fermentable Sugars from Plant Biomass	PLOS ONE			English	Article							CELL-WALL; INFLORESCENCE DEVELOPMENT; ARABIDOPSIS-THALIANA; STARCH DEGRADATION; BIOFUEL PRODUCTION; AUXIN TRANSPORT; MUTANTS; RECALCITRANCE; MANIPULATION; SWITCHGRASS	With their unique metabolism and the potential to produce large amounts of biomass, plants are an excellent bio-energy feedstock for a variety of industrial purposes. Here we developed a high-throughput strategy, using the model plant Arabidopsis thaliana, to identify mutants with improved sugar release from plant biomass. Molecular analysis indicates a variety of processes including starch degradation, cell wall composition and polar transport of the plant hormone auxin can contribute to this improved saccharification. To demonstrate translatability, polar auxin transport in maize was either genetically or chemical inhibited and this also resulted in increased sugar release from plant tissues. Our forward genetic approach using Arabidopsis not only uncovers new functions that contribute to cell wall integrity but also demonstrates that information gleaned from this genetic model can be directly translated to monocotyledonous crops such as maize to improve sugar extractability from biomass.	[Stamatiou, George; Vidaurre, Danielle P.; Moeder, Wolfgang; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Shim, Isaac; Tang, Xurong; Bonetta, Dario] Univ Ontario Inst Technol, Fac Sci, Oshawa, ON, Canada	University of Toronto; Ontario Tech University	Bonetta, D (corresponding author), Univ Ontario Inst Technol, Fac Sci, Oshawa, ON, Canada.	dario.bonetta@uoit.ca		Moeder, Wolfgang/0000-0003-3889-6183	NSERC grants	NSERC grants	This work was funded by NSERC grants to P.M. and D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Chuck GS, 2011, P NATL ACAD SCI USA, V108, P17550, DOI 10.1073/pnas.1113971108; Dische Z., 1962, METHODS CARBOHYDRATE, V1, P477; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Pauly M, 2010, CURR OPIN PLANT BIOL, V13, P305, DOI 10.1016/j.pbi.2009.12.009; Pingali SV, 2010, BIOMACROMOLECULES, V11, P2329, DOI 10.1021/bm100455h; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Sanchez-Rodriguez C, 2010, TRENDS PLANT SCI, V15, P291, DOI 10.1016/j.tplants.2010.03.002; Skirpan A, 2008, PLANT J, V55, P787, DOI 10.1111/j.1365-313X.2008.03546.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Vanholme R, 2010, TRENDS BIOTECHNOL, V28, P543, DOI 10.1016/j.tibtech.2010.07.008; Vidaurre D, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00119; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Weise SE, 2012, PLANT BIOTECHNOL J, V10, P545, DOI 10.1111/j.1467-7652.2012.00684.x; Williams ME, 2005, PLANT PHYSIOL, V138, P686, DOI 10.1104/pp.105.061317; Wu XT, 2007, AM J BOT, V94, P1745, DOI 10.3732/ajb.94.11.1745; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319; Zhong RQ, 2003, PLANT PHYSIOL, V132, P544, DOI 10.1104/pp.103.021444	36	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55616	10.1371/journal.pone.0055616	http://dx.doi.org/10.1371/journal.pone.0055616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383246	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600136
J	Wang, XJ; Zielinski, MC; Misawa, R; Wen, P; Wang, TY; Wang, CZ; Witkowski, P; Hara, M				Wang, Xiaojun; Zielinski, Mark C.; Misawa, Ryosuke; Wen, Patrick; Wang, Tian-Yuan; Wang, Cheng-Zhang; Witkowski, Piotr; Hara, Manami			Quantitative Analysis of Pancreatic Polypeptide Cell Distribution in the Human Pancreas	PLOS ONE			English	Article							ISLET ARCHITECTURE; GHRELIN; QUANTIFICATION; GALLBLADDER; SURVIVAL; CANCER; RICH	The pancreatic islet is mainly composed of beta-, alpha- and delta-cells with small numbers of pancreatic polypeptide (PP) and epsilon cells. It is known that there is a region in the head of the pancreas that is rich in PP-cells. In the present study, we examined the distribution of PP-cells, and assessed the influence of the PP-cell rich region to quantify the total islet mass. Pancreatic tissues were collected from donors with no history of diabetes or pancreatic diseases (n = 12). A stereological approach with a computer-assisted large-scale analysis of whole pancreatic sections was applied to quantify the entire distribution of endocrine cells within a given section. The initial whole pancreas analysis showed that a PP-cell rich region was largely restricted to the uncinate process with a clear boundary. The distinct distribution of PP-cells includes irregularly shaped clusters composed solely of PP-cells. Furthermore, in the PP-cell rich region, beta- and alpha- cell mass is significantly reduced compared to surrounding PP-cell poor regions. The results suggest that the analysis of the head region should distinguish the PP-cell rich region, which is best examined separately. This study presents an important implication for the regional selection and interpretation of the results.	[Wang, Xiaojun; Misawa, Ryosuke; Witkowski, Piotr] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Wang, Xiaojun] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China; [Zielinski, Mark C.; Wen, Patrick; Wang, Tian-Yuan; Wang, Cheng-Zhang; Hara, Manami] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; Army Medical University; University of Chicago	Hara, M (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mhara@uchicago.edu	Hara, Masayuki/AAH-4361-2019; Wen, Patrick/AAE-3776-2022	Zielinski, Mark/0000-0002-6950-6689	US Public Health Service Grant [DK-081527, DK-042086, DK-20595, DK-072473]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK081527, P60DK020595, P30DK042086, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042151] Funding Source: NIH RePORTER	US Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study is supported by US Public Health Service Grant DK-081527, DK-042086 and DK-20595 to the University of Chicago Diabetes Research and Training Center (Animal Models Core), DK-072473, and a gift from the Kovler Family Foundation (M.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN TE, 1982, AM J PHYSIOL, V243, pG204, DOI 10.1152/ajpgi.1982.243.3.G204; Andralojc KM, 2009, DIABETOLOGIA, V52, P486, DOI 10.1007/s00125-008-1238-y; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; Bartosch-Harlid A, 2010, PANCREATOLOGY, V10, P423, DOI 10.1159/000264676; Bouvier AM, 2010, PANCREAS, V39, P1243, DOI 10.1097/MPA.0b013e3181e1d5b3; Chandra J, 2012, CLIN RADIOL; Cui YF, 2012, ENDOCR-RELAT CANCER, V19, pF9, DOI 10.1530/ERC-12-0105; Floyd J C Jr, 1976, Recent Prog Horm Res, V33, P519; GEPTS W, 1977, DIABETOLOGIA, V13, P27, DOI 10.1007/BF00996324; GERSELL DJ, 1979, DIABETES, V28, P11, DOI 10.2337/diabetes.28.1.11; GREENBERG GR, 1978, LANCET, V2, P1280; Hasselby JP, 2012, APMIS, V120, P157, DOI 10.1111/j.1600-0463.2011.02831.x; HAZELWOOD RL, 1993, P SOC EXP BIOL MED, V202, P44; HEITZ P, 1976, VIRCHOWS ARCH B, V21, P259; Jacobsson H, 2012, CLIN NUCL MED, V37, P362, DOI 10.1097/RLU.0b013e3182485110; Kahleova H, 2012, J DIABETES COMPLICAT, V26, P442, DOI 10.1016/j.jdiacomp.2012.05.003; Kilimnik G, 2012, ISLETS, V4, P167, DOI 10.4161/isl.19256; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kim A, 2011, JOVE-J VIS EXP, DOI 10.3791/2471; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; LIN TM, 1977, AM J PHYSIOL, V232, pE311, DOI 10.1152/ajpendo.1977.232.3.E311; MALAISSELAGAE F, 1979, DIABETOLOGIA, V17, P361, DOI 10.1007/BF01236270; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Nathan H, 2009, J SURG ONCOL, V99, P87, DOI 10.1002/jso.21189; ORCI L, 1978, LANCET, V2, P1200; RAHIER J, 1983, J CLIN ENDOCR METAB, V56, P441, DOI 10.1210/jcem-56-3-441; Sata N, 2009, J HEPATO-BILIARY-PAN, V16, P485, DOI 10.1007/s00534-009-0077-7; SCHWARTZ TW, 1979, SCAND J GASTROENTERO, V14, P93; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Ueberberg B, 2009, HORM METAB RES, V41, P814, DOI 10.1055/s-0029-1233462; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vignjevic S, 2012, CELLS TISSUES ORGANS, V196, P362, DOI 10.1159/000335469; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8	36	44	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55501	10.1371/journal.pone.0055501	http://dx.doi.org/10.1371/journal.pone.0055501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383206	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600113
J	Grainger, S; Hryniuk, A; Lohnes, D				Grainger, Stephanie; Hryniuk, Alexa; Lohnes, David			Cdx1 and Cdx2 Exhibit Transcriptional Specificity in the Intestine	PLOS ONE			English	Article							HOMEOBOX GENE CDX1; DIFFERENTIAL REGULATION; GASTROINTESTINAL-TRACT; EMBRYONIC INTESTINE; EPITHELIAL-CELLS; PROTEINS CDX1; MOUSE EMBRYO; COLON-CANCER; MUTANT MICE; HOX GENES	The caudal-related homeodomain transcription factors Cdx1 and Cdx2 are expressed in the developing endoderm with expression persisting into adulthood. Cdx1(-)/(-) mutants are viable and fertile and display no overt intestinal phenotype. Cdx2 null mutants are peri-implantation lethal; however, conditional mutation approaches have revealed that Cdx2 is required for patterning the intestinal epithelium and specification of the colon. Cdx2 is also necessary for homeostasis of the intestinal tract in the adult, where Cdx1 and Cdx2 appear to functionally overlap in the distal colon, but not during intestinal development. Cdx1 and Cdx2 exhibit complete overlap of expression in the intestine, although they differ in their relative levels, with Cdx1 maximal in the distal colon and Cdx2 peaking in the proximal cecum. Moreover, Cdx1 protein is graded along the crypt-villus axis, being abundant in the crypts and diminishing towards the villi. Cdx2 is expressed uniformly along this axis, but is differentially phosphorylated; the functional relevance of these expression domains and phosphorylation is currently unknown. Cdx1 and Cdx2 have been suggested to exhibit functional specificity in the intestinal tract. In the present study, using cell-based models, we found that relative to Cdx1, Cdx2 was significantly less potent at effecting a transcriptional response from the Cdx1 promoter, a known Cdx target gene. We subsequently assessed this relationship in vivo using a "gene swap'' approach and found that Cdx2 cannot substitute for Cdx1 in this autoregulatory loop. This is in marked contrast with the ability of Cdx2 to support Cdx1 expression and function in paraxial mesoderm and vertebral patterning, thus providing novel in vivo evidence of context-dependent transcriptional specificity between these transcription factors.	[Grainger, Stephanie; Hryniuk, Alexa; Lohnes, David] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa	Lohnes, D (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	dlohnes@uottawa.ca	Grainger, Stephanie/AAT-4518-2020	Grainger, Stephanie/0000-0001-6889-7174; , Alexa/0000-0002-6778-2006	Canadian Institutes of Health Research [MOP14412]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP14412 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhoury F, 2005, AM J PHYSIOL-GASTR L, V289, pG285, DOI 10.1152/ajpgi.00037.2005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Beland M, 2004, MOL CELL BIOL, V24, P5028, DOI 10.1128/MCB.24.11.5028-5038.2004; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Bonhomme C, 2008, ONCOGENE, V27, P4497, DOI 10.1038/onc.2008.78; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Crissey MAS, 2011, GASTROENTEROLOGY, V140, P517, DOI 10.1053/j.gastro.2010.11.033; CULLING CFA, 1975, J CLIN PATHOL, V28, P656, DOI 10.1136/jcp.28.8.656; DEAROLF CR, 1989, NATURE, V341, P340, DOI 10.1038/341340a0; DUPREY P, 1988, GENE DEV, V2, P1647, DOI 10.1101/gad.2.12a.1647; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gaunt SJ, 2008, DEVELOPMENT, V135, P2511, DOI 10.1242/dev.015909; Gautier-Stein A, 2003, NUCLEIC ACIDS RES, V31, P5238, DOI 10.1093/nar/gkg747; Grainger S, 2012, DEV BIOL, V361, P1, DOI 10.1016/j.ydbio.2011.09.034; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Grainger S, 2009, DEV BIOL, V331, P528, DOI 10.1016/j.ydbio.2009.05.526; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Grossmann J, 2002, AM J GASTROENTEROL, V97, P1421, DOI 10.1016/S0002-9270(02)04143-6; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; JAMES R, 1991, J BIOL CHEM, V266, P3246; JAMES R, 1994, J BIOL CHEM, V269, P15229; Kakizaki F, 2010, GASTROENTEROLOGY, V138, P627, DOI 10.1053/j.gastro.2009.10.047; Koslowski M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-77; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Lee YJ, 1999, J BIOL CHEM, V274, P1566, DOI 10.1074/jbc.274.3.1566; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lynch JP, 2008, NEOPLASIA, V10, P8, DOI 10.1593/neo.07703; Ma L, 2012, AM J PHYSIOL-GASTR L, V302, pG123, DOI 10.1152/ajpgi.00102.2011; Muncan V, 2007, EMBO REP, V8, P966, DOI 10.1038/sj.embor.7401071; Munoz J, 2012, EMBO J; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Rings EHHM, 2001, GASTROENTEROLOGY, V121, P1437, DOI 10.1053/gast.2001.29618; Santagati F, 2005, DEVELOPMENT, V132, P4927, DOI 10.1242/dev.02078; SAVORY JGA, 2011, DEVELOPMENT; Savory JGA, 2011, DEVELOPMENT, V138, P1361, DOI 10.1242/dev.056622; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Subramanian V, 1998, DIFFERENTIATION, V64, P11, DOI 10.1046/j.1432-0436.1998.6410011.x; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Taylor JK, 1997, NUCLEIC ACIDS RES, V25, P2293, DOI 10.1093/nar/25.12.2293; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Verzi MP, 2011, MOL CELL BIOL; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010	56	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54757	10.1371/journal.pone.0054757	http://dx.doi.org/10.1371/journal.pone.0054757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382958	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800075
J	Klein, E; Moeller, K; Glauche, V; Weiller, C; Willmes, K				Klein, Elise; Moeller, Korbinian; Glauche, Volkmar; Weiller, Cornelius; Willmes, Klaus			Processing Pathways in Mental Arithmetic-Evidence from Probabilistic Fiber Tracking	PLOS ONE			English	Article							MULTI-DIGIT ADDITION; WORKING-MEMORY; STRUCTURAL CONNECTIVITY; NUMBER REPRESENTATION; INTRAPARIETAL SULCUS; SYMBOL MANIPULATION; LANGUAGE PATHWAYS; BRAIN ACTIVATION; PARIETAL CORTEX; ANGULAR GYRUS	Numerical cognition is a case of multi-modular and distributed cerebral processing. So far neither the anatomo-functional connections between the cortex areas involved nor their integration into established frameworks such as the differentiation between dorsal and ventral processing streams have been specified. The current study addressed this issue combining a re-analysis of previously published fMRI data with probabilistic fiber tracking data from an independent sample. We aimed at differentiating neural correlates and connectivity for relatively easy and more difficult addition problems in healthy adults and their association with either rather verbally mediated fact retrieval or magnitude manipulations, respectively. The present data suggest that magnitude-and fact retrieval-related processing seem to be subserved by two largely separate networks, both of them comprising dorsal and ventral connections. Importantly, these networks not only differ in localization of activation but also in the connections between the cortical areas involved. However, it has to be noted that even though seemingly distinct anatomically, these networks operate as a functionally integrated circuit for mental calculation as revealed by a parametric analysis of brain activation.	[Klein, Elise; Willmes, Klaus] Rhein Westfal TH Aachen, Univ Hosp, Sect Neuropsychol, Dept Neurol, Aachen, Germany; [Klein, Elise; Willmes, Klaus] Univ Hosp RWTH Aachen, Interdisciplinary Ctr Clin Res, Neurofunct Imaging Lab, Aachen, Germany; [Klein, Elise; Moeller, Korbinian] IWM KMRC, Knowledge Media Res Ctr, Tubingen, Germany; [Glauche, Volkmar; Weiller, Cornelius] Univ Med Ctr Freiburg, Dept Neurol, Freiburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; Leibniz Institut fur Wissensmedien; University of Freiburg	Klein, E (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Sect Neuropsychol, Dept Neurol, Aachen, Germany.	e.klein@iwm-kmrc.de	Willmes, Klaus F/A-1268-2014; Moeller, Korbinian/AAC-6387-2020	Willmes, Klaus F/0000-0002-9012-0553; 				Anderson JR, 2005, COGNITIVE SCI, V29, P313, DOI 10.1207/s15516709cog0000_22; Anderson JR, 2003, PSYCHON B REV, V10, P241, DOI 10.3758/BF03196490; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P302, DOI 10.1080/14640746608400047; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Brysbaert M, 1998, COGNITION, V66, P51, DOI 10.1016/S0010-0277(98)00006-7; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Chassy P, 2011, CEREB CORTEX, DOI 101093/cercor/bhr219; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Delazer M, 2005, NEUROIMAGE, V25, P838, DOI 10.1016/j.neuroimage.2004.12.009; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; Delazer Margarete, 2004, Cortex, V40, P166, DOI 10.1016/S0010-9452(08)70936-5; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Grabner RH, 2009, NEUROPSYCHOLOGIA, V47, P604, DOI 10.1016/j.neuropsychologia.2008.10.013; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Imbo I, 2007, PSYCHOL RES-PSYCH FO, V71, P467, DOI 10.1007/s00426-006-0044-8; Imbo I, 2007, Q J EXP PSYCHOL, V60, P708, DOI 10.1080/17470210600762447; Ischebeck A, 2007, NEUROIMAGE, V36, P993, DOI 10.1016/j.neuroimage.2007.03.051; Ischebeck A, 2006, NEUROIMAGE, V30, P1365, DOI 10.1016/j.neuroimage.2005.11.016; Kazui H, 2000, PSYCHIAT CLIN NEUROS, V54, P479, DOI 10.1046/j.1440-1819.2000.00739.x; Klein E, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-70; Klein E, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-42; Klein E, 2010, ACTA PSYCHOL, V135, P67, DOI 10.1016/j.actpsy.2010.06.002; Knops A, 2006, NEUROPSYCHOLOGIA, V44, P2270, DOI 10.1016/j.neuropsychologia.2006.05.011; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Kong H, 2005, COGNITIVE BRAIN RES, V22, P397, DOI 10.1016/j.cogbrainres.2004.09.011; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; Krueger F, 2011, HUM BRAIN MAPP, V32, P1419, DOI 10.1002/hbm.21119; LeFevre J, 1996, J EXP PSYCHOL LEARN, V22, P216, DOI 10.1037/0278-7393.22.1.216; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; Menon V, 2000, COGNITIVE BRAIN RES, V9, P343, DOI 10.1016/S0926-6410(00)00010-0; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MILNER AD, 1996, VISUAL BRAIN ACTION; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; Montojo CA, 2008, NEURON, V59, P173, DOI 10.1016/j.neuron.2008.05.012; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Noel MP, 1998, PSYCHOL BELG, V38, P231; Oishi K, 2011, MRI ATLAS HUMAN WHIT, VSecond; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Parsons S., 2005, DOES NUMERACY MATTER; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Qin YL, 2004, P NATL ACAD SCI USA, V101, P5686, DOI 10.1073/pnas.0401227101; Ratinckx E, 2002, NEUROPSYCHOLOGY, V16, P217, DOI 10.1037//0894-4105.16.2.217; Ratinckx E, 2001, THESIS U GHENT; Ratinckx E, 2006, CORTEX, V42, P1128, DOI 10.1016/S0010-9452(08)70225-9; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rusconi E, 2007, COGNITIVE ASPECTS OF BILINGUALISM, P153, DOI 10.1007/978-1-4020-5935-3_5; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; Umarova RM, 2010, CEREB CORTEX, V20, P121, DOI 10.1093/cercor/bhp086; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Venkatraman V, 2006, J COGNITIVE NEUROSCI, V18, P64, DOI 10.1162/089892906775250030; Weiller C, 2011, BRAIN LANG, V118, P29, DOI 10.1016/j.bandl.2011.01.005; Weis S, 2011, HUM BRAIN MAPP, V32, P1544, DOI 10.1002/hbm.21126; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Whalen J, 2002, COGN NEUROPSYCHOL, V19, P505, DOI 10.1080/02643290244000086; Willmes Klaus, 2008, Handb Clin Neurol, V88, P339, DOI 10.1016/S0072-9752(07)88017-1; Wise RJS, 2003, BRIT MED BULL, V65, P95, DOI 10.1093/bmb/65.1.95; Wood G, 2008, BRAIN RES, V1187, P154, DOI 10.1016/j.brainres.2007.09.094; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261; Zaunmuller L, 2009, NEUROPSYCHOL REHABIL, V19, P422, DOI 10.1080/09602010802296378	89	78	79	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55455	10.1371/journal.pone.0055455	http://dx.doi.org/10.1371/journal.pone.0055455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383194	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800158
J	Kota, KP; Eaton, B; Lane, D; Ulrich, M; Ulrich, R; Peyser, BD; Robinson, CG; Jaissle, JG; Pegoraro, G; Bavari, S; Panchal, RG				Kota, Krishna P.; Eaton, Brett; Lane, Douglas; Ulrich, Melanie; Ulrich, Ricky; Peyser, Brian D.; Robinson, Camenzind G.; Jaissle, James G.; Pegoraro, Gianluca; Bavari, Sina; Panchal, Rekha G.			Integrating High-Content Imaging and Chemical Genetics to Probe Host Cellular Pathways Critical for Yersinia Pestis Infection	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; PNEUMONIC PLAGUE; MACROPHAGES; INVASION; MICE; PATHOGENESIS; APOPTOSIS; RNAI; PHENOTHIAZINES	The molecular machinery that regulates the entry and survival of Yersinia pestis in host macrophages is poorly understood. Here, we report the development of automated high-content imaging assays to quantitate the internalization of virulent Y. pestis CO92 by macrophages and the subsequent activation of host NF-kappa B. Implementation of these assays in a focused chemical screen identified kinase inhibitors that inhibited both of these processes. Rac-2-ethoxy-3 octadecanamido-1-propylphosphocholine (a protein Kinase C inhibitor), wortmannin (a PI3K inhibitor), and parthenolide (an I kappa B kinase inhibitor), inhibited pathogen-induced NF-kappa B activation and reduced bacterial entry and survival within macrophages. Parthenolide inhibited NF-kappa B activation in response to stimulation with Pam3CSK4 (a TLR2 agonist), E. coli LPS (a TLR4 agonist) or Y. pestis infection, while the PI3K and PKC inhibitors were selective only for Y. pestis infection. Together, our results suggest that phagocytosis is the major stimulus for NF-kappa B activation in response to Y. pestis infection, and that Y. pestis entry into macrophages may involve the participation of protein kinases such as PI3K and PKC. More importantly, the automated image-based screening platform described here can be applied to the study of other bacteria in general and, in combination with chemical genetic screening, can be used to identify host cell functions facilitating the identification of novel antibacterial therapeutics.	[Eaton, Brett; Ulrich, Melanie; Ulrich, Ricky; Bavari, Sina; Panchal, Rekha G.] USA, Med Res Inst Infect Dis, Dept Target Discovery & Cellular Microbiol, Frederick, MD USA; [Kota, Krishna P.; Pegoraro, Gianluca] Perkin Elmer, Waltham, MA USA; [Lane, Douglas; Peyser, Brian D.] NCI Frederick, SAIC Frederick, Target Struct Based Drug Discovery Grp, Frederick, MD USA; [Robinson, Camenzind G.] USA, Med Res Inst Infect Dis, Div Pathol, Frederick, MD USA; [Jaissle, James G.] USA, Med Res Inst Infect Dis, Diagnost Syst Div, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Panchal, RG (corresponding author), USA, Med Res Inst Infect Dis, Dept Target Discovery & Cellular Microbiol, Frederick, MD USA.	rekha.panchal@amedd.army.mil	Robinson, Camenzind G/O-5097-2018; Kota, Krishna/GPF-8474-2022; Bavari, Sina/L-3642-2019; Peyser, Brian/ABB-8010-2020; Eaton, Brett/G-1796-2019; Panchal, Rekha/None; Pegoraro, Gianluca/K-4233-2016	Robinson, Camenzind G/0000-0002-7277-692X; Bavari, Sina/0000-0001-8424-5635; Peyser, Brian/0000-0002-3455-5181; Eaton, Brett/0000-0002-3060-2913; Panchal, Rekha/0000-0001-8621-9078; Pegoraro, Gianluca/0000-0003-2843-9464	Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA) [JSTO-CBD 2.10019_09_RD_B]; National Cancer Institute, National Institutes of Health [N01-CO-12400]; Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute	Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)	This project was funded by the Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA) JSTO-CBD 2.10019_09_RD_B (to RGP). This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. This research was supported, in part, by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; Bartfeld S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-21; Basu LR, 2005, MICROBIOL RES, V160, P95, DOI 10.1016/j.micres.2004.10.002; Benedek O, 2004, MICROB PATHOGENESIS, V37, P47, DOI 10.1016/j.micpath.2004.04.001; Bosio CM, 2005, J IMMUNOL, V175, P6750, DOI 10.4049/jimmunol.175.10.6750; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Caie PD, 2010, MOL CANCER THER, V9, P1913, DOI 10.1158/1535-7163.MCT-09-1148; Chan YY, 2007, ANTIMICROB AGENTS CH, V51, P623, DOI 10.1128/AAC.01033-06; Christensen DR, 2006, CLIN CHEM, V52, P141, DOI 10.1373/clinchem.2005.052522; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; DREVETS DA, 1995, J IMMUNOL METHODS, V187, P69, DOI 10.1016/0022-1759(95)00168-A; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Gurumurthy RK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000651; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; JANSSEN WA, 1969, SCIENCE, V163, P950, DOI 10.1126/science.163.3870.950; Jenkins AL, 2009, J MICROBIOL METH, V77, P316, DOI 10.1016/j.mimet.2009.02.013; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Kristiansen JE, 1997, J ANTIMICROB CHEMOTH, V40, P319, DOI 10.1093/jac/40.3.319; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; Leo JC, 2011, ADV EXP MED BIOL, V715, P1, DOI 10.1007/978-94-007-0940-9_1; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Low J, 2008, CURR OPIN DRUG DISC, V11, P338; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Neish AS, 2011, TRENDS MICROBIOL, V19, P596, DOI 10.1016/j.tim.2011.08.004; Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Ponnusamy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042211; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; ROSENSHINE I, 1992, INFECT IMMUN, V60, P2211, DOI 10.1128/IAI.60.6.2211-2217.1992; Saadane A, 2007, AM J RESP CELL MOL, V36, P728, DOI 10.1165/rcmb.2006-0323OC; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Scibelli A, 2007, VET J, V173, P482, DOI 10.1016/j.tvjl.2006.01.010; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Zhang Y, 2005, CURR TOP MICROBIOL, V289, P151; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003	51	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55167	10.1371/journal.pone.0055167	http://dx.doi.org/10.1371/journal.pone.0055167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383093	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800125
J	Sikoglu, EM; Jensen, JE; Vitaliano, G; Navarro, AAL; Renshaw, PF; Frazier, JA; Moore, CM				Sikoglu, Elif M.; Jensen, J. Eric; Vitaliano, Gordana; Navarro, Ana A. Liso; Renshaw, Perry F.; Frazier, Jean A.; Moore, Constance M.			Bioenergetic Measurements in Children with Bipolar Disorder: A Pilot P-31 Magnetic Resonance Spectroscopy Study	PLOS ONE			English	Article							BRAIN PHOSPHORUS-METABOLISM; MITOCHONDRIAL DYSFUNCTION; INTRACELLULAR PH; RATING-SCALE; CORTEX	Background: Research exploring Bipolar Disorder (BD) phenotypes and mitochondrial dysfunction, particularly in younger subjects, has been insufficient to date. Previous studies have found abnormal cerebral pH levels in adults with BD, which may be directly linked to abnormal mitochondrial activity. To date no such studies have been reported in children with BD. Methods: Phosphorus Magnetic Resonance Spectroscopy (P-31 MRS) was used to determine pH, phopshocreatine (PCr) and inorganic phosphate (Pi) levels in 8 subjects with BD and 8 healthy comparison subjects (HCS) ages 11 to 20 years old. Results: There was no significant difference in pH between the patients and HCS. However, frontal pH values for patients with BD increased with age, contrary to studies of HCS and the pH values in the frontal lobe correlated negatively with the YMRS values. Global Pi was significantly lower in subjects with BD compared with HCS. There were no significant differences in PCr between the groups. Global PCr-to-Pi ratio (PCr/Pi) was significantly higher in subjects with BD compared with HCS. Conclusions: The change in Pi levels for the patients with BD coupled with the no difference in PCr levels, suggest an altered mitochondrial phosphorylation. However, our findings require further investigation of the underlying mechanisms with the notion that a mitochondrial dysfunction may manifest itself differently in children than that in adults. Limitations: Further investigations with larger patient populations are necessary to draw further conclusions.	[Sikoglu, Elif M.; Navarro, Ana A. Liso; Frazier, Jean A.; Moore, Constance M.] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Jensen, J. Eric; Vitaliano, Gordana] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA; [Renshaw, Perry F.] Univ Utah, Deparment Psychiat, Salt Lake City, UT USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; McLean Hospital; Utah System of Higher Education; University of Utah	Moore, CM (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA.	Constance.Moore@umassmed.edu	Renshaw, Perry/O-1384-2018		National Institute for Mental Health [MH082335]; Stanley Medical Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073998, R21MH082335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanley Medical Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The National Institute for Mental Health (CMM: MH082335) and the Stanley Medical Research Institute (PFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbiroli B, 1998, BIOCHIMIE, V80, P847, DOI 10.1016/S0300-9084(00)88879-3; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Chance B, 2006, NMR BIOMED, V19, P904, DOI 10.1002/nbm.1109; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450; Hamakawa H, 2004, PSYCHIAT CLIN NEUROS, V58, P82, DOI 10.1111/j.1440-1819.2004.01197.x; KATO T, 1992, J AFFECT DISORDERS, V26, P223, DOI 10.1016/0165-0327(92)90099-R; Kato T, 1998, EUR ARCH PSY CLIN N, V248, P301, DOI 10.1007/s004060050054; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Mato S, 2010, GLIA, V58, P1739, DOI 10.1002/glia.21044; Moore CM, 2007, J AM ACAD CHILD PSY, V46, P524, DOI 10.1097/chi.0b013e31802f5f2c; Nissim I, 1999, AM J PHYSIOL-RENAL, V277, pF493, DOI 10.1152/ajprenal.1999.277.4.F493; PETTEGREW JW, 1991, ARCH GEN PSYCHIAT, V48, P563; Poznanski E.O., 1996, CHILDRENS DEPRESSION; POZNANSKI EO, 1979, PEDIATRICS, V64, P442; Quiroz JA, 2008, NEUROPSYCHOPHARMACOL, V33, P2551, DOI 10.1038/sj.npp.1301671; Rae C, 2003, DEV NEUROSCI-BASEL, V25, P324, DOI 10.1159/000073509; Rezin GT, 2009, NEUROCHEM RES, V34, P1021, DOI 10.1007/s11064-008-9865-8; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Yildiz A, 2005, PSYCHIAT RES-NEUROIM, V138, P51, DOI 10.1016/j.pscychresns.2003.10.005; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	23	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54536	10.1371/journal.pone.0054536	http://dx.doi.org/10.1371/journal.pone.0054536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382910	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800053
J	Silk, AD; Gast, CE; Davies, PS; Fakhari, FD; Vanderbeek, GE; Mori, M; Wong, MH				Silk, Alain D.; Gast, Charles E.; Davies, Paige S.; Fakhari, Farnaz D.; Vanderbeek, Gretchen E.; Mori, Motomi; Wong, Melissa H.			Fusion between Hematopoietic and Epithelial Cells in Adult Human Intestine	PLOS ONE			English	Article							MARROW-DERIVED CELLS; BONE-MARROW; PURKINJE NEURONS; STEM-CELLS; VASCULAR ENDOTHELIUM; HEPATOCYTES; LIVER; INFLAMMATION	Following transplantation of hematopoietic lineage cells, genetic markers unique to the transplanted cells have been detected in non-hematopoietic recipient cells of human liver, vascular endothelium, intestinal epithelium and brain. The underlying mechanisms by which this occurs are unclear. Evidence from mice suggests it is due in part to fusion between cells of hematopoietic and non-hematopoietic origins; however, direct evidence for this in humans is scant. Here, by quantitative and statistical analysis of X-and Y-chromosome numbers in epithelial and non-epithelial intestinal cells from gender-mismatched hematopoietic cell transplant patients, we provide evidence that transplanted cells of the hematopoietic lineage incorporate into human intestinal epithelium through cell fusion. This is the first definitive identification of cell fusion between hematopoietic cells and any epithelial cell type in humans, and provides the basis for further understanding the physiological and potential pathological consequences of cell fusion in humans.	[Silk, Alain D.; Davies, Paige S.; Fakhari, Farnaz D.; Vanderbeek, Gretchen E.; Wong, Melissa H.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Silk, Alain D.; Davies, Paige S.; Mori, Motomi; Wong, Melissa H.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Gast, Charles E.] Oregon Hlth & Sci Univ, Program Cell & Mol Biol, Portland, OR 97201 USA; [Mori, Motomi] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Wong, MH (corresponding author), Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA.	wongme@ohsu.edu			NIH [R01CA118235]; National Cancer Institute of the National Institutes of Health [T32CA106195]; NCI CCSG [R01CA118235, T32CA106195, P30CA069533]; NATIONAL CANCER INSTITUTE [R01CA118235, T32CA106195, P30CA069533, R21CA172334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01CA118235 to M. H. W. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award number T32CA106195. Funding for this work was also provided by NCI CCSG P30CA069533 to the Biostatistics Shared Resource of the Knight Cancer Institute, T32CA106195 to A. D. S, and R01CA118235 to M. H. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Diaz D, 2012, CELL TRANSPLANT; Fujino H, 2007, FASEB J, V21, P3499, DOI 10.1096/fj.06-6109com; HAM A W, 1979; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kemp K, 2012, BRAIN; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Newsome PN, 2003, GASTROENTEROLOGY, V124, P1891, DOI 10.1016/S0016-5085(03)00401-3; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Quintana-Bustamante O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033945; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Yilmaz Y, 2005, BONE MARROW TRANSPL, V35, P1021, DOI 10.1038/sj.bmt.1704939	25	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55572	10.1371/journal.pone.0055572	http://dx.doi.org/10.1371/journal.pone.0055572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383228	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800167
J	Siskova, Z; Reynolds, RA; O'Connor, V; Perry, VH				Siskova, Zuzana; Reynolds, Richard A.; O'Connor, Vincent; Perry, V. Hugh			Brain Region Specific Pre-Synaptic and Post-Synaptic Degeneration Are Early Components of Neuropathology in Prion Disease	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; SYNAPTIC DEGENERATION; DENDRITIC SPINE; NERVOUS-SYSTEM; AUTOPHAGY; MICE; ABNORMALITIES	Synaptic abnormalities, one of the key features of prion disease pathogenesis, gives rise to functional deficits and contributes to the devastating clinical outcome. The synaptic compartment is the first to succumb in several neurodegenerative diseases linked with protein misfolding but the mechanisms underpinning this are poorly defined. In our current study we document that a focal intrahippocampal injection of the mouse-adapted 22L scrapie strain produces a complex, region-specific pathology in the brain. Our findings reveal that early synaptic changes in the stratum radiatum of the hippocampus, identical to those observed with the ME7 strain, occur when 22L strain is introduced into the hippocampus. The pathology was defined by degenerating Type I pre-synaptic elements progressively enveloped by the post-synaptic density of the dendritic spine. In contrast, the pathology in the cerebellum suggested that dendritic disintegration rather than pre-synaptic abnormalities dominate the early degenerative changes associated with the Purkinje cells. Indeed, both of the major synaptic inputs into the cerebellum, which arise from the parallel and climbing fibers, remained intact even at late stage disease. Immunolabeling with pathway selective antibodies reinforced these findings. These observations demonstrate that neuronal vulnerability to pathological protein misfolding is strongly dependent on the structure and function of the target neurons.	[Siskova, Zuzana; Reynolds, Richard A.; O'Connor, Vincent; Perry, V. Hugh] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Siskova, Zuzana] Univ Bonn, Deutsch Zentrum Neurodegenerat Erkrankungen, Bonn, Germany	University of Southampton; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Siskova, Z (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	Zuzana.Siskova@dzne.de	Perry, V. Hugh/Y-2935-2019		UK Medical Research Council (MRC) [G0501636]; Medical Research Council [G0501636] Funding Source: researchfish; MRC [G0501636] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MRC) grant G0501636. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski JJ, 2003, J NEUROSCI, V23, P3469; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; BRAAK H, 1989, J NEUROL SCI, V93, P277, DOI 10.1016/0022-510X(89)90197-4; Cantalupo C, 2010, CORTEX, V46, P821, DOI 10.1016/j.cortex.2009.10.004; Cataldo AM, 1996, ADV EXP MED BIOL, V389, P271; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; FERRER I, 1988, CLIN NEUROPATHOL, V7, P22; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Frey D, 2000, J NEUROSCI, V20, P2534; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gillingwater TH, 2006, BRAIN, V129, P1546, DOI 10.1093/brain/awl101; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Harvey RJ, 2005, EUR J NEUROSCI, V21, P1777, DOI 10.1111/j.1460-9568.2005.04010.x; Ironside JW, 1996, NEUROPATH APPL NEURO, V22, P446, DOI 10.1111/j.1365-2990.1996.tb00919.x; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jeffrey M, 2011, ACTA NEUROPATHOL, V121, P113, DOI 10.1007/s00401-010-0700-3; KIM YS, 1987, J GEN VIROL, V68, P695, DOI 10.1099/0022-1317-68-3-695; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Saab CY, 2003, BRAIN RES REV, V42, P85, DOI 10.1016/S0165-0173(03)00151-6; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Wegiel J, 1999, BRAIN RES, V818, P41, DOI 10.1016/S0006-8993(98)01279-7	34	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55004	10.1371/journal.pone.0055004	http://dx.doi.org/10.1371/journal.pone.0055004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383030	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800100
J	Doufas, AG; Tian, L; Padrez, KA; Suwanprathes, P; Cardell, JA; Maecker, HT; Panousis, P				Doufas, Anthony G.; Tian, Lu; Padrez, Kevin A.; Suwanprathes, Puntarica; Cardell, James A.; Maecker, Holden T.; Panousis, Periklis			Experimental Pain and Opioid Analgesia in Volunteers at High Risk for Obstructive Sleep Apnea	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-BINDING PROTEIN-1; INFLAMMATORY MARKERS; INTERMITTENT HYPOXIA; RECURRENT HYPOXEMIA; PRACTICE PARAMETERS; SENSITIVITY; DEPRIVATION; CYTOKINES; MODEL	Background: Obstructive sleep apnea (OSA) is characterized by recurrent nocturnal hypoxia and sleep disruption. Sleep fragmentation caused hyperalgesia in volunteers, while nocturnal hypoxemia enhanced morphine analgesic potency in children with OSA. This evidence directly relates to surgical OSA patients who are at risk for airway compromise due to postoperative use of opioids. Using accepted experimental pain models, we characterized pain processing and opioid analgesia in male volunteers recruited based on their risk for OSA. Methods: After approval from the Intitutional Review Board and informed consent, we assessed heat and cold pain thresholds and tolerances in volunteers after overnight polysomnography (PSG). Three pro-inflammatory and 3 hypoxia markers were determined in the serum. Pain tests were performed at baseline, placebo, and two effect site concentrations of remifentanil (1 and 2 mu g/ml), an mu-opioid agonist. Linear mixed effects regression models were employed to evaluate the association of 3 PSG descriptors [wake after sleep onset, number of sleep stage shifts, and lowest oxyhemoglobin saturation (SaO(2)) during sleep] and all serum markers with pain thresholds and tolerances at baseline, as well as their changes under remifentanil. Results: Forty-three volunteers (12 normal and 31 with a PSG-based diagnosis of OSA) were included in the analysis. The lower nadir SaO(2) and higher insulin growth factor binding protein-1 (IGFBP-1) were associated with higher analgesic sensitivity to remifentanil (SaO(2), P = 0.0440; IGFBP-1, P = 0.0013). Other pro-inflammatory mediators like interleukin-1 beta and tumor necrosis factor-alpha (TNF-alpha) were associated with an enhanced sensitivity to the opioid analgesic effect (IL-1 beta, P = 0.0218; TNF-alpha, P = 0.0276). Conclusions: Nocturnal hypoxemia in subjects at high risk for OSA was associated with an increased potency of opioid analgesia. A serum hypoxia marker (IGFBP-1) was associated with hypoalgesia and increased potency to opioid analgesia; other pro-inflammatory mediators also predicted an enhanced opioid potency.	[Doufas, Anthony G.; Panousis, Periklis] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Sch Med, Stanford, CA 94305 USA; [Tian, Lu] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Padrez, Kevin A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Suwanprathes, Puntarica; Cardell, James A.] Stanford Univ, Sch Med, Stanford Sleep Med Ctr, Stanford, CA 94305 USA; [Maecker, Holden T.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Maecker, Holden T.] Stanford Univ, Human Immune Monitoring Ctr, Sch Med, Stanford, CA 94305 USA; [Doufas, Anthony G.] Cleveland Clin, Outcomes Res Consortium, Cleveland, OH 44106 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University; Cleveland Clinic Foundation	Doufas, AG (corresponding author), Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Sch Med, Stanford, CA 94305 USA.	agdoufas@stanford.edu	Doufas, Anthony G/L-9297-2019	tian, lu/0000-0002-5893-0169	Department of Anesthesia, Stanford University School of Medicine	Department of Anesthesia, Stanford University School of Medicine	This work was solely supported by the Department of Anesthesia, Stanford University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Ankichetty Saravanan, 2011, J Anaesthesiol Clin Pharmacol, V27, P447, DOI 10.4103/0970-9185.86574; Ankichetty S, 2011, CURR OPIN ANESTHESIO, V24, P605, DOI 10.1097/ACO.0b013e32834a10c7; Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; Blake DW, 2008, ANAESTH INTENS CARE, V36, P379, DOI 10.1177/0310057X0803600309; BONNET MH, 1992, SLEEP, V15, P526; Brown KA, 2004, ANESTHESIOLOGY, V100, P806, DOI 10.1097/00000542-200404000-00009; Brown KA, 2003, ANESTHESIOLOGY, V99, P586, DOI 10.1097/00000542-200309000-00013; Brown KA, 2006, ANESTHESIOLOGY, V105, P665, DOI 10.1097/00000542-200610000-00009; Brown KA, 2009, ANESTHESIOLOGY, V110, P922, DOI 10.1097/ALN.0b013e31819c480a; Chennaoui M, 2011, CYTOKINE, V56, P318, DOI 10.1016/j.cyto.2011.06.002; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; Chesson AL, 2003, SLEEP, V26, P907, DOI 10.1093/sleep/26.7.907; Chhangani BS, 2009, SLEEP, V32, P1011; Chung F, 2008, ANESTHESIOLOGY, V108, P822, DOI 10.1097/ALN.0b013e31816d91b5; Bravo MD, 2007, SLEEP BREATH, V11, P177, DOI 10.1007/s11325-007-0100-7; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Eastwood PR, 2002, LANCET, V359, P1207, DOI 10.1016/S0140-6736(02)08224-7; Edwards RR, 2009, EUR J PAIN, V13, P1043, DOI 10.1016/j.ejpain.2008.12.007; Edwards RR, 2008, PAIN, V137, P202, DOI 10.1016/j.pain.2008.01.025; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Finkel KJ, 2009, SLEEP MED, V10, P753, DOI 10.1016/j.sleep.2008.08.007; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Gali B, 2007, J CLIN SLEEP MED, V3, P582; Gali B, 2009, ANESTHESIOLOGY, V110, P869, DOI 10.1097/ALN.0b013e31819b5d70; Gupta RM, 2001, MAYO CLIN PROC, V76, P897, DOI 10.4065/76.9.897; Haack M, 2012, EUR J PAIN, V16, P522, DOI 10.1016/j.ejpain.2011.07.007; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Haack M, 2009, PAIN, V145, P136, DOI 10.1016/j.pain.2009.05.029; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; Hua S, 2010, TRENDS PHARMACOL SCI, V31, P427, DOI 10.1016/j.tips.2010.05.008; Huang STJ, 2004, FASEB J, V18, P1348, DOI 10.1096/fj.03-1377com; Irwin MR, 2008, BIOL PSYCHIAT, V64, P538, DOI 10.1016/j.biopsych.2008.05.004; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Khalid I, 2011, SLEEP, V34, P1687, DOI 10.5665/sleep.1436; Krampl E, 2002, OBSTET GYNECOL, V99, P594, DOI 10.1016/S0029-7844(01)01784-7; Krueger JM, 2011, PROG BRAIN RES, V193, P39, DOI 10.1016/B978-0-444-53839-0.00003-X; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Kundermann B, 2004, PSYCHOSOM MED, V66, P932, DOI 10.1097/01.psy.0000145912.24553.c0; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Laferriere A, 2003, BRAIN RES BULL, V59, P307, DOI 10.1016/S0361-9230(02)00915-2; Lerman Jerrold, 2006, Anesthesiology, V105, P645, DOI 10.1097/00000542-200610000-00004; LUE FA, 1988, INT J NEUROSCI, V42, P179; Melzack R., 1984, TXB PAIN, V2nd, P186; Meoli AL, 2003, SLEEP, V26, P1060; Mills PJ, 2004, BRAIN BEHAV IMMUN, V18, P298, DOI 10.1016/j.bbi.2003.10.004; Minto CF, 1997, ANESTHESIOLOGY, V86, P10, DOI 10.1097/00000542-199701000-00004; Minto CF, 1997, ANESTHESIOLOGY, V86, P24, DOI 10.1097/00000542-199701000-00005; Mohan S, 2010, J NEUROIMMUNOL, V227, P26, DOI 10.1016/j.jneuroim.2010.06.007; Moss IR, 2006, ANESTHESIOLOGY, V105, P715, DOI 10.1097/00000542-200610000-00017; Niikura K, 2010, TRENDS PHARMACOL SCI, V31, P299, DOI 10.1016/j.tips.2010.04.003; OLSON LG, 1995, AM J RESP CRIT CARE, V152, P717, DOI 10.1164/ajrccm.152.2.7633732; Onen SH, 2001, J SLEEP RES, V10, P35, DOI 10.1046/j.1365-2869.2001.00240.x; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Plaghki L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010269; Pollmacher T, 2000, ANN NY ACAD SCI, V917, P488; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Punjabi NM, 2009, AM J RESP CRIT CARE, V179, P235, DOI 10.1164/rccm.200809-1392OC; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Sachs D, 2011, BRIT J PHARMACOL, V162, P72, DOI 10.1111/j.1476-5381.2010.00895.x; Schafers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052; Schepers RJ, 2009, NEUROSCI BIOBEHAV R, V33, P205, DOI 10.1016/j.neubiorev.2008.07.009; Smith MT, 2008, PAIN, V138, P497, DOI 10.1016/j.pain.2008.01.028; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith MT, 2009, SLEEP, V32, P779, DOI 10.1093/sleep/32.6.779; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Steinmiller CL, 2010, EXP CLIN PSYCHOPHARM, V18, P277, DOI 10.1037/a0018899; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Waters KA, 2002, J APPL PHYSIOL, V92, P1987, DOI 10.1152/japplphysiol.00619.2001; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	89	72	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54807	10.1371/journal.pone.0054807	http://dx.doi.org/10.1371/journal.pone.0054807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382975	gold, Green Published, Green Submitted			2022-12-27	WOS:000315483200027
J	Sherman, SP; Pyle, AD				Sherman, Sean P.; Pyle, April D.			Small Molecule Screening with Laser Cytometry Can Be Used to Identify Pro-Survival Molecules in Human Embryonic Stem Cells	PLOS ONE			English	Article							ENHANCES SURVIVAL; SPHINGOSINE-1-PHOSPHATE; APOPTOSIS; CULTURE; GROWTH; LINES	Differentiated cells from human embryonic stem cells (hESCs) provide an unlimited source of cells for use in regenerative medicine. The recent derivation of human induced pluripotent cells (hiPSCs) provides a potential supply of pluripotent cells that avoid immune rejection and could provide patient-tailored therapy. In addition, the use of pluripotent cells for drug screening could enable routine toxicity testing and evaluation of underlying disease mechanisms. However, prior to establishment of patient specific cells for cell therapy it is important to understand the basic regulation of cell fate decisions in hESCs. One critical issue that hinders the use of these cells is the fact that hESCs survive poorly upon dissociation, which limits genetic manipulation because of poor cloning efficiency of individual hESCs, and hampers production of large-scale culture of hESCs. To address the problems associated with poor growth in culture and our lack of understanding of what regulates hESC signaling, we successfully developed a screening platform that allows for large scale screening for small molecules that regulate survival. In this work we developed the first large scale platform for hESC screening using laser scanning cytometry and were able to validate this platform by identifying the pro-survival molecule HA-1077. These small molecules provide targets for both improving our basic understanding of hESC survival as well as a tool to improve our ability to expand and genetically manipulate hESCs for use in regenerative applications.	[Sherman, Sean P.; Pyle, April D.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Pyle, April D.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Pyle, AD (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	apyle@mednet.ucla.edu		Sherman, Sean/0000-0002-6295-0680	CIRM [T1-00005, TG2-01169]; MIMG Warsaw Fellowship; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064855] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); MIMG Warsaw Fellowship; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by CIRM Predoctoral training grants (T1-00005 and TG2-01169) and MIMG Warsaw Fellowship to S.P.S. and by Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA funding to A.D.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PD, 2010, BIOCHEM J, V432, P21, DOI 10.1042/BJ20101022; Ardehali R, 2011, P NATL ACAD SCI USA, V108, P3282, DOI 10.1073/pnas.1019047108; Bai H, 2012, STEM CELL RES, V8, P26, DOI 10.1016/j.scr.2011.08.002; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Barbaric I, 2011, CRYOBIOLOGY, V63, P298, DOI 10.1016/j.cryobiol.2011.10.002; Barbaric I, 2010, STEM CELL RES, V5, P104, DOI 10.1016/j.scr.2010.04.006; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Inniss K, 2006, STEM CELLS DEV, V15, P789, DOI 10.1089/scd.2006.15.789; Kamei KI, 2009, LAB CHIP, V9, P555, DOI 10.1039/b809105f; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Sherman SP, 2011, METHODS MOL BIOL, V767, P283, DOI 10.1007/978-1-61779-201-4_21; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Xu Y., 2010, P NATL ACAD SCI US; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	23	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54948	10.1371/journal.pone.0054948	http://dx.doi.org/10.1371/journal.pone.0054948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383009	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200055
J	Tikhonenko, M; Lydic, TA; Opreanu, M; Calzi, SL; Bozack, S; McSorley, KM; Sochacki, AL; Faber, MS; Hazra, S; Duclos, S; Guberski, D; Reid, GE; Grant, MB; Busik, JV				Tikhonenko, Maria; Lydic, Todd A.; Opreanu, Madalina; Calzi, Sergio Li; Bozack, Svetlana; McSorley, Kelly M.; Sochacki, Andrew L.; Faber, Matthew S.; Hazra, Sugata; Duclos, Shane; Guberski, Dennis; Reid, Gavin E.; Grant, Maria B.; Busik, Julia V.			N-3 Polyunsaturated Fatty Acids Prevent Diabetic Retinopathy by Inhibition of Retinal Vascular Damage and Enhanced Endothelial Progenitor Cell Reparative Function	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DOCOSAHEXAENOIC ACID; STEM-CELLS; DISEASE; COMPLICATIONS; ACTIVATION; MELLITUS; CERAMIDE; PATHWAY; DEATH	Objective: The vasodegenerative phase of diabetic retinopathy is characterized by not only retinal vascular degeneration but also inadequate vascular repair due to compromised bone marrow derived endothelial progenitor cells (EPCs). We propose that n-3 polyunsaturated fatty acid (PUFA) deficiency in diabetes results in activation of the central enzyme of sphingolipid metabolism, acid sphingomyelinase (ASM) and that ASM represents a molecular metabolic link connecting the initial damage in the retina and the dysfunction of EPCs. Research Design and Methods: Type 2 diabetic rats on control or docosahexaenoic acid (DHA)-rich diet were studied. The number of acellular capillaries in the retinas was assessed by trypsin digest. mRNA levels of interleukin (IL)-1 beta, IL-6, intracellular adhesion molecule (ICAM)-1 in the retinas from diabetic animals were compared to controls and ASM protein was assessed by western analysis. EPCs were isolated from blood and bone marrow and their numbers and ability to form colonies in vitro, ASM activity and lipid profiles were determined. Results: DHA-rich diet prevented diabetes-induced increase in the number of retinal acellular capillaries and significantly enhanced the life span of type 2 diabetic animals. DHA-rich diet blocked upregulation of ASM and other inflammatory markers in diabetic retina and prevented the increase in ASM activity in EPCs, normalized the numbers of circulating EPCs and improved EPC colony formation. Conclusions: In a type 2 diabetes animal model, DHA-rich diet fully prevented retinal vascular pathology through inhibition of ASM in both retina and EPCs, leading to a concomitant suppression of retinal inflammation and correction of EPC number and function.	[Tikhonenko, Maria; Lydic, Todd A.; Opreanu, Madalina; Bozack, Svetlana; McSorley, Kelly M.; Sochacki, Andrew L.; Faber, Matthew S.; Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Opreanu, Madalina; Bozack, Svetlana] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Reid, Gavin E.] Michigan State Univ, Dept Chem & Biochem & Mol Biol, E Lansing, MI 48824 USA; [Duclos, Shane; Guberski, Dennis] Biomed Res Models Inc, Worcester, MA USA; [Calzi, Sergio Li; Hazra, Sugata; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	Michigan State University; Michigan State University; Michigan State University; State University System of Florida; University of Florida	Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	busik@msu.edu	Busik, Julia V/A-2698-2010; Lydic, Todd A./ADB-0177-2022	Busik, Julia V/0000-0003-3453-7124; Faber, Matthew/0000-0002-5583-5115; Reid, Gavin/0000-0002-9675-1444	National Institutes of Health [EY 016077, RR 025386, DK090730, EY 012601, EY 007739]; Michigan Experimental Agricaltural Station [MICL02163]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025386] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016077, R01EY007739, P30EY011373, R29EY007739, R01EY012601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Experimental Agricaltural Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (EY 016077 to JB, RR 025386 to GR and JB, DK090730 to MG and JB, EY 012601 and EY 007739 to MG) and Michigan Experimental Agricaltural Station MICL02163 to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh E, 2006, METABOLISM, V55, P168, DOI 10.1016/j.metabol.2005.08.009; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Bodin S, 2005, MOL BIOL CELL, V16, P5773, DOI 10.1091/mbc.E05-04-0358; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chen WQ, 2005, INVEST OPHTH VIS SCI, V46, P4342, DOI 10.1167/iovs.05-0601; Churdchomjan W, BMC ENDOCR DISORD, V10, P5; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Decsi T, 2002, PROSTAG LEUKOTR ESS, V67, P203, DOI 10.1054/plef.2002.0420; Estrada R, 2004, J MASS SPECTROM, V39, P1531, DOI 10.1002/jms.759; Estrada R, 2004, J MASS SPECTROM, V39, P412, DOI 10.1002/jms.603; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FUTTERMAN S, 1968, INVEST OPHTH VISUAL, V7, P105; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hu FB, 2003, CIRCULATION, V107, P1852, DOI 10.1161/01.CIR.0000062644.42133.5F; Humpert PM, 2008, MOL MED, V14, P301, DOI 10.2119/2007-00052.Humpert; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Kielczewski JL, 2011, INVEST OPHTH VIS SCI, V52, P8278, DOI 10.1167/iovs.11-8167; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Kusunoki Masataka, 2007, J Med Invest, V54, P243, DOI 10.2152/jmi.54.243; Li MF, 2011, DIABETES-METAB RES, V27, P185, DOI 10.1002/dmrr.1159; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miller-Kasprzak E, 2007, ARCH IMMUNOL THER EX, V55, P247, DOI 10.1007/s00005-007-0027-5; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Opreanu M, 2011, DIABETES, V60, P2370, DOI 10.2337/db10-0550; Opreanu M, 2010, INVEST OPHTH VIS SCI, V51, P3253, DOI 10.1167/iovs.09-4731; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Reslewic S, 2005, APPL ENVIRON MICROB, V71, P5511, DOI 10.1128/AEM.71.9.5511-5522.2005; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Sekiguchi H, 2009, J CELL PHYSIOL, V219, P235, DOI 10.1002/jcp.21672; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Tirabassi RS, 2004, ILAR J, V45, P292, DOI 10.1093/ilar.45.3.292; Tooke JE, 1999, DIABETIC MED, V16, P710, DOI 10.1046/j.1464-5491.1999.00099.x; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; YANG ZH, 1993, J BIOL CHEM, V268, P20520; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225	54	65	69	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55177	10.1371/journal.pone.0055177	http://dx.doi.org/10.1371/journal.pone.0055177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383097	Green Published, gold			2022-12-27	WOS:000315483200045
J	Ali, WH; Chen, Q; Delgiorno, KE; Su, WJ; Hall, JC; Hongu, T; Tian, H; Kanaho, Y; Di Paolo, G; Crawford, HC; Frohman, MA				Ali, Wahida H.; Chen, Qin; Delgiorno, Kathleen E.; Su, Wenjuan; Hall, Jason C.; Hongu, Tsunaki; Tian, Huasong; Kanaho, Yasunori; Di Paolo, Gilbert; Crawford, Howard C.; Frohman, Michael A.			Deficiencies of the Lipid-Signaling Enzymes Phospholipase D1 and D2 Alter Cytoskeletal Organization, Macrophage Phagocytosis, and Cytokine-Stimulated Neutrophil Recruitment	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; YERSINIA-PSEUDOTUBERCULOSIS; ACTIN CYTOSKELETON; FOCAL ADHESIONS; SURFACE-CHARGE; ACTIVATION; GAMMA; RHO	Cell migration and phagocytosis ensue from extracellular-initiated signaling cascades that orchestrate dynamic reorganization of the actin cytoskeleton. The reorganization is mediated by effector proteins recruited to the site of activity by locally-generated lipid second messengers. Phosphatidic acid (PA), a membrane phospholipid generated by multiple enzyme families including Phospholipase D (PLD), has been proposed to function in this role. Here, we show that macrophages prepared from mice lacking either of the classical PLD isoforms PLD1 or PLD2, or wild-type macrophages whose PLD activity has been pharmacologically inhibited, display isoform-specific actin cytoskeleton abnormalities that likely underlie decreases observed in phagocytic capacity. Unexpectedly, PA continued to be detected on the phagosome in the absence of either isoform and even when all PLD activity was eliminated. However, a disorganized phagocytic cup was observed as visualized by imaging PA, F-actin, Rac1, an organizer of the F-actin network, and DOCK2, a Rac1 activator, suggesting that PLD-mediated PA production during phagocytosis is specifically critical for the integrity of the process. The abnormal F-actin reorganization additionally impacted neutrophil migration and extravasation from the vasculature into interstitial tissues. Although both PLD1 and PLD2 were important in these processes, we also observed isoform-specific functions. PLD1-driven processes in particular were observed to be critical in transmigration of macrophages exiting the vasculature during immune responses such as those seen in acute pancreatitis or irritant-induced skin vascularization.	[Ali, Wahida H.; Chen, Qin; Delgiorno, Kathleen E.; Su, Wenjuan; Hall, Jason C.; Crawford, Howard C.; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Ali, Wahida H.; Chen, Qin; Delgiorno, Kathleen E.; Su, Wenjuan; Hall, Jason C.; Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Ali, Wahida H.; Delgiorno, Kathleen E.; Hall, Jason C.; Crawford, Howard C.; Frohman, Michael A.] SUNY Stony Brook, Grad Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Hongu, Tsunaki; Kanaho, Yasunori] Univ Tsukuba, Dept Physiol Chem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Hongu, Tsunaki; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan; [Tian, Huasong; Di Paolo, Gilbert] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tsukuba; University of Tsukuba; Columbia University	Frohman, MA (corresponding author), SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA.	michael@pharm.stonybrook.edu	DelGiorno, Kathy/AAJ-9911-2021	DelGiorno, Kathy/0000-0002-5749-8394; Hanel, Wahida/0000-0003-0196-8040	NIH [GM084251]; NATIONAL CANCER INSTITUTE [R01CA159222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518, R01GM100109, R01GM084251] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (www.nih.gov/) through an R01 award (GM084251). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Bombardelli L, 2010, GASTROENTEROLOGY, V138, P2531, DOI 10.1053/j.gastro.2010.02.043; Botelho RJ, 2011, CURR BIOL, V21, pR533, DOI 10.1016/j.cub.2011.05.053; Botelho RJ, 2009, J BIOL CHEM, V284, P28522, DOI 10.1074/jbc.M109.009514; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Cougoule C, 2006, J BIOL CHEM, V281, P8756, DOI 10.1074/jbc.M513731200; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Dart AE, 2012, J CELL SCI, V125, P2825, DOI 10.1242/jcs.106583; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Grinstein S, 2010, AM J PHYSIOL-CELL PH, V299, pC876, DOI 10.1152/ajpcell.00342.2010; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Machesky L, 2008, EMBO REP, V9, P139, DOI 10.1038/sj.embor.7401162; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; Martin A, 1996, J BIOL CHEM, V271, P17397, DOI 10.1074/jbc.271.29.17397; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Okada M, 2012, BIOCH BIOPHYS RES CO; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Pleskot R, 2010, PLANT J, V62, P494, DOI 10.1111/j.1365-313X.2010.04168.x; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Schwarz K, 2011, J NEUROSCI, V31, P15996, DOI 10.1523/JNEUROSCI.2965-11.2011; Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630; Su WJ, 2009, FUTURE ONCOL, V5, P1477, DOI [10.2217/fon.09.110, 10.2217/FON.09.110]; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Yanase Y, 2010, BIOCHEM J, V425, P179, DOI 10.1042/BJ20091122; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Zhang Y, 2011, INFECT IMMUN; Zhang Y, 2008, INFECT IMMUN, V76, P4299, DOI 10.1128/IAI.00183-08; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	62	49	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55325	10.1371/journal.pone.0055325	http://dx.doi.org/10.1371/journal.pone.0055325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383154	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500076
J	Cai, MS; Li, ML; Wang, KZ; Wang, S; Lu, Q; Yan, JH; Mossman, KL; Lin, RT; Zheng, CF				Cai, Mingsheng; Li, Meili; Wang, Kezhen; Wang, Shuai; Lu, Qiong; Yan, Jinghua; Mossman, Karen L.; Lin, Rongtuan; Zheng, Chunfu			The Herpes Simplex Virus 1-Encoded Envelope Glycoprotein B Activates NF-kappa B through the Toll-Like Receptor 2 and MyD88/TRAF6-Dependent Signaling Pathway	PLOS ONE			English	Article							CUTTING EDGE; HEPARAN-SULFATE; CELL ACTIVATION; RECOGNITION; INNATE; TLR2; CD14; CYTOKINE; BINDING; PROTEIN	The innate immune response plays a critical role in the host defense against invading pathogens, and TLR2, a member of the Toll-like receptor (TLR) family, has been implicated in the immune response and initiation of inflammatory cytokine secretion against several human viruses. Previous studies have demonstrated that infectious and ultraviolet-inactivated herpes simplex virus 1 (HSV-1) virions lead to the activation of nuclear factor kappa B (NF-kappa B) and secretion of proinflammatory cytokines via TLR2. However, except for the envelope glycoprotein gH and gL, whether there are other determinants of HSV-1 responsible for TLR2 mediated biological effects is not known yet. Here, we demonstrated that the HSV-1-encoded envelope glycoprotein gB displays as molecular target recognized by TLR2. gB coimmunoprecipitated with TLR2, TLR1 and TLR6 in transfected and infected human embryonic kidney (HEK) 293T cells. Treatment of TLR2-transfected HEK293T (HEK293T-TLR2) cells with purified gB results in the activation of NF-kappa B reporter, and this activation requires the recruitment of the adaptor molecules myeloid differentiation primary-response protein 88 (MyD88) and tumor necrosis factor receptor-associated factor 6 (TRAF6) but not CD14. Furthermore, activation of NF-kB was abrogated by anti-gB and anti-TLR2 blocking antibodies. In addition, the expression of interleukin-8 induced by gB was abrogated by the treatment of the human monocytic cell line THP-1 with anti-TLR2 blocking antibody or by the incubation of gB with anti-gB antibody. Taken together, these results indicate the importance and potency of HSV-1 gB as one of pathogen-associated molecular patterns (PAMPs) molecule recognized by TLR2 with immediate kinetics.	[Wang, Kezhen; Wang, Shuai; Zheng, Chunfu] Soochow Univ, Inst Biol & Med Sci, Suzhou, Peoples R China; [Cai, Mingsheng; Wang, Kezhen; Wang, Shuai; Zheng, Chunfu] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Peoples R China; [Cai, Mingsheng; Li, Meili] Guangzhou Med Univ, Dept Pathogen Biol & Immunol, Guangzhou, Guangdong, Peoples R China; [Cai, Mingsheng] Foshan Sci & Technol Univ, Dept Vet Med, Foshan, Peoples R China; [Lu, Qiong; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Mossman, Karen L.] McMaster Univ, Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Lin, Rongtuan] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Lin, Rongtuan] McGill Univ, Dept Med, Montreal, PQ, Canada	Soochow University - China; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Guangzhou Medical University; Foshan University; Chinese Academy of Sciences; Institute of Microbiology, CAS; McMaster University; Lady Davis Institute; McGill University; McGill University	Zheng, CF (corresponding author), Soochow Univ, Inst Biol & Med Sci, Suzhou, Peoples R China.	zheng.alan@hotmail.com	zheng, Chunfu/F-2404-2012; Lin, Rongtuan/A-1442-2008	zheng, Chunfu/0000-0002-8797-1322; Lin, Rongtuan/0000-0002-2238-3503	National Natural Science Foundation of China [81171584, 31200120]; Major State Basic Research Development Program of China (973 Program) [2010CB530105, 2011CB504802]; Medical Scientific Research Foundation of Guangdong Province, China [B2012165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Medical Scientific Research Foundation of Guangdong Province, China	This work was supported by grants from the National Natural Science Foundation of China (81171584 and 31200120); the Major State Basic Research Development Program of China (973 Program) (2010CB530105 and 2011CB504802); Medical Scientific Research Foundation of Guangdong Province, China (B2012165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ankel H, 1998, VIROLOGY, V251, P317, DOI 10.1006/viro.1998.9432; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Boyle KA, 1998, J VIROL, V72, P1826, DOI 10.1128/JVI.72.3.1826-1833.1998; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Cooper A, 2005, J IMMUNOL, V175, P3165, DOI 10.4049/jimmunol.175.5.3165; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Duesberg U, 2002, IMMUNOL LETT, V84, P89, DOI 10.1016/S0165-2478(02)00178-5; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Ingalls RR, 1999, INFECT DIS CLIN N AM, V13, P341, DOI 10.1016/S0891-5520(05)70078-7; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Knipe DM, 2007, FIELDS VIROLOGY; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kopp M, 2002, J VIROL, V76, P8820, DOI 10.1128/JVI.76.17.8820-8833.2002; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Leoni V, 2012, J VIROL, V86, P6555, DOI 10.1128/JVI.00295-12; Li QL, 2010, CONSTRUCTIVE COMPUTATION IN STOCHASTIC MODELS WITH APPLICATIONS: THE RG-FACTORIZATION, P1; Li Y, 2011, ARCH VIROL, V156, P2267, DOI 10.1007/s00705-011-1094-9; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu XQ, 2008, P NATL ACAD SCI USA, V105, P11335, DOI 10.1073/pnas.0801617105; Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Michaud F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013742; Mossman KL, 2005, VIRAL IMMUNOL, V18, P267, DOI 10.1089/vim.2005.18.267; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Sugawara S, 2001, INFECT IMMUN, V69, P4951, DOI 10.1128/IAI.69.8.4951-4957.2001; Wang JP, 2005, J VIROL, V79, P12658, DOI 10.1128/JVI.79.20.12658-12666.2005; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Xing JJ, 2011, J VIROL, V85, P1881, DOI 10.1128/JVI.01730-10; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	51	66	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54586	10.1371/journal.pone.0054586	http://dx.doi.org/10.1371/journal.pone.0054586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382920	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500019
J	Roetynck, S; Olotu, A; Simam, J; Marsh, K; Stockinger, B; Urban, B; Langhorne, J				Roetynck, Sophie; Olotu, Ally; Simam, Joan; Marsh, Kevin; Stockinger, Brigitta; Urban, Britta; Langhorne, Jean			Phenotypic and Functional Profiling of CD4 T Cell Compartment in Distinct Populations of Healthy Adults with Different Antigenic Exposure	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; LYMPHOCYTE SUBSETS; IMMUNE ACTIVATION; LEISHMANIA-MAJOR; MEMORY; PROTECTION; RESPONSES; ANTIBODIES; EFFECTOR	Background: Multiparameter flow cytometry has revealed extensive phenotypic and functional heterogeneity of CD4 T cell responses in mice and humans, emphasizing the importance of assessing multiple aspects of the immune response in correlation with infection or vaccination outcome. The aim of this study was to establish and validate reliable and feasible flow cytometry assays, which will allow us to characterize CD4 T cell population in humans in field studies more fully. Methodology/Principal Findings: We developed polychromatic flow cytometry antibody panels for immunophenotyping the major CD4 T cell subsets as well as broadly characterizing the functional profiles of the CD4 T cells in peripheral blood. We then validated these assays by conducting a pilot study comparing CD4 T cell responses in distinct populations of healthy adults living in either rural or urban Kenya. This study revealed that the expression profile of CD4 T cell activation and memory markers differed significantly between African and European donors but was similar amongst African individuals from either rural or urban areas. Adults from rural Kenya had, however, higher frequencies and greater polyfunctionality among cytokine producing CD4 T cells compared to both urban populations, particularly for "Th1" type of response. Finally, endemic exposure to malaria in rural Kenya may have influenced the expansion of few discrete CD4 T cell populations with specific functional signatures. Conclusion/Significance: These findings suggest that environmentally driven T cell activation does not drive the dysfunction of CD4 T cells but is rather associated with greater magnitude and quality of CD4 T cell response, indicating that the level or type of microbial exposure and antigenic experience may influence and shape the functionality of CD4 T cell compartment. Our data confirm that it is possible and mandatory to assess multiple functional attributes of CD4 T cell response in the context of infection.	[Roetynck, Sophie; Langhorne, Jean] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Olotu, Ally; Simam, Joan; Marsh, Kevin; Urban, Britta] Ctr Geog Med Res, Kenya Med Res Inst, Wellcome Trust Res Programme, Kilifi, Kenya; [Marsh, Kevin] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Stockinger, Brigitta] Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; [Urban, Britta] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	MRC National Institute for Medical Research; Kenya Medical Research Institute; University of Oxford; MRC National Institute for Medical Research; Liverpool School of Tropical Medicine; University of Liverpool	Langhorne, J (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England.	jlangho@nimr.mrc.ac.uk	Urban, Britta/W-6087-2018	Urban, Britta/0000-0002-4197-8393; Langhorne, Jean/0000-0002-2257-9733; Stockinger, Brigitta/0000-0001-8781-336X	MRC National Institute for Medical Research, London, UK [U117584248]; Wellcome Trust [079082]; Framework 7 programme of the European Union; MRC [MC_U117584248, MC_U117512792] Funding Source: UKRI; Medical Research Council [MC_U117512792, MC_U117584248] Funding Source: researchfish	MRC National Institute for Medical Research, London, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Framework 7 programme of the European Union; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the MRC National Institute for Medical Research (U117584248), London, UK, and a Wellcome Trust Senior Fellowship Award to BCU (079082). This is part of the EviMalar European Network of Excellence supported by the Framework 7 programme of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alexander TH, 2003, JAIDS-J ACQ IMM DEF, V34, P475, DOI 10.1097/00126334-200312150-00005; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Bejon P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000164; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bentwich Z, 1998, CLIN EXP IMMUNOL, V111, P1; Bohler T, 2007, CLIN VACCINE IMMUNOL, V14, P775, DOI 10.1128/CVI.00043-07; Borkow G, 2000, J CLIN INVEST, V106, P1053, DOI 10.1172/JCI10182; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Chattopadhyay Pratip K, 2005, Curr Protoc Immunol, VChapter 12, DOI 10.1002/0471142735.im1212s65; Chelimo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024852; Chuma J, 2009, HEALTH POLICY PLANN, V24, P83, DOI 10.1093/heapol/czn050; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; do Rosario APF, 2012, J IMMUNOL, V188, P1178, DOI 10.4049/jimmunol.1102755; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Gitau EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030095; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; KREMSNER PG, 1995, AM J TROP MED HYG, V53, P532, DOI 10.4269/ajtmh.1995.53.532; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Mahnke YD, 2007, CLIN LAB MED, V27, P469, DOI 10.1016/j.cII.2007.05.002; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Messele T, 1999, CLIN EXP IMMUNOL, V115, P443; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mordmuller BG, 1997, EUR CYTOKINE NETW, V8, P29; Ndungu FM, 2012, P NATL ACAD SCI USA, V109, P8247, DOI 10.1073/pnas.1200472109; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Palmer BE, 2004, J IMMUNOL, V172, P3337, DOI 10.4049/jimmunol.172.5.3337; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; RILEY EM, 1993, PARASITE IMMUNOL, V15, P513, DOI 10.1111/j.1365-3024.1993.tb00639.x; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tang J, 2000, J MICROBIOL METH, V39, P121, DOI 10.1016/S0167-7012(99)00107-4; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Walson JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000644; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Weinberg A, 2010, J IMMUNOL METHODS, V363, P42, DOI 10.1016/j.jim.2010.09.032; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005	63	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55195	10.1371/journal.pone.0055195	http://dx.doi.org/10.1371/journal.pone.0055195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383106	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000315211500064
J	Sarkar, S; Henderson, JA; Robinson, PA				Sarkar, Somwrita; Henderson, James A.; Robinson, Peter A.			Spectral Characterization of Hierarchical Network Modularity and Limits of Modularity Detection	PLOS ONE			English	Article							ORGANIZATION	Many real world networks are reported to have hierarchically modular organization. However, there exists no algorithm-independent metric to characterize hierarchical modularity in a complex system. The main results of the paper are a set of methods to address this problem. First, classical results from random matrix theory are used to derive the spectrum of a typical stochastic block model hierarchical modular network form. Second, it is shown that hierarchical modularity can be fingerprinted using the spectrum of its largest eigenvalues and gaps between clusters of closely spaced eigenvalues that are well separated from the bulk distribution of eigenvalues around the origin. Third, some well-known results on fingerprinting non-hierarchical modularity in networks automatically follow as special cases, threreby unifying these previously fragmented results. Finally, using these spectral results, it is found that the limits of detection of modularity can be empirically established by studying the mean values of the largest eigenvalues and the limits of the bulk distribution of eigenvalues for an ensemble of networks. It is shown that even when modularity and hierarchical modularity are present in a weak form in the network, they are impossible to detect, because some of the leading eigenvalues fall within the bulk distribution. This provides a threshold for the detection of modularity. Eigenvalue distributions of some technological, social, and biological networks are studied, and the implications of detecting hierarchical modularity in real world networks are discussed.	[Sarkar, Somwrita; Henderson, James A.; Robinson, Peter A.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Robinson, Peter A.] Univ Sydney, Sydney Med Sch Western, Brain Dynam Ctr, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney	Sarkar, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	sarkar@physics.usyd.edu.au	; Henderson, James/C-7197-2018	Robinson, Peter/0000-0002-5050-9804; Henderson, James/0000-0001-6278-9973	Australian Research Council; Westmead Millenium Institute	Australian Research Council(Australian Research Council); Westmead Millenium Institute	The Australian Research Council and Westmead Millenium Institute supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braitenberg V, 1998, CORTEX STAT GEOMETRY; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chauhan S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056114; Farkas IJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026704; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FUREDI Z, 1981, COMBINATORICA, V1, P233, DOI 10.1007/BF02579329; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gray RT, 2009, NEUROCOMPUTING, V72, P1565, DOI 10.1016/j.neucom.2008.09.006; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leskovec J., STANFORD LARGE NETWO; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Nadakuditi RR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188701; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ripeanu M, 2002, IEEE INTERNET COMPUT, V6, P50, DOI 10.1109/4236.978369; Robinson PA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108104; Sarkar S, NETWORK SPECTR UNPUB; Sarkar S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046114; Sporns O., 2011, NETWORKS BRAIN; Trevino S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002391; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	26	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54383	10.1371/journal.pone.0054383	http://dx.doi.org/10.1371/journal.pone.0054383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382895	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500011
J	Chaubey, S; Jones, GE; Shah, AM; Cave, AC; Wells, CM				Chaubey, Sanjay; Jones, Gareth E.; Shah, Ajay M.; Cave, Alison C.; Wells, Claire M.			Nox2 Is Required for Macrophage Chemotaxis towards CSF-1	PLOS ONE			English	Article							NADPH OXIDASE; NAD(P)H OXIDASE; ANGIOTENSIN-II; REVERSIBLE INACTIVATION; GENE-EXPRESSION; ACTIVATION; RAC; KINASE; CELLS; CDC42	Macrophage migration and infiltration is an important first step in many pathophysiological processes, in particular inflammatory diseases. Redox modulation of the migratory signalling processes has been reported in endothelial cells, vascular smooth muscle cells and fibroblasts. However the redox modulation of the migratory process in macrophages and in particular that from the NADPH oxidase-2 (Nox2) dependent ROS has not been established. To investigate the potential role of Nox2 in the migratory response of macrophages, bone marrow derived macrophages were obtained from WT and NOX2 knockout mice (Nox2KO) and subjected to CSF-1 stimulation. We report here that loss of Nox2 expression in BMM resulted in a significant reduction in the CSF-1 induced spreading response suggesting that Nox2 can modulate cytoskeletal events. Moreover, Nox2KO BMMs were deficient in cellular displacement in the presence of CSF-1. More significantly, when challenged with a gradient of CSF-1, Nox2KO BMMs showed a complete loss of chemotaxis accompanied by a reduction in cell migration speed and directional migration persistence. These results point to a specific role for Nox2KO downstream of CSF-1 during the BMM migratory response. Indeed, we have further found that Nox2KO BMMs display a significant reduction in the levels of ERK1/2 phosphorylation following stimulation with CSF-1. Thus Nox2 is important in BMM cellular motion to CSF-1 stimulation and necessary for their directed migration towards a CSF-1 gradient, highlighting Nox2 dependent signalling as a potential anti-inflammatory target.	[Chaubey, Sanjay; Shah, Ajay M.; Cave, Alison C.] Kings Coll London, BHF Ctr Excellence, James Black Ctr, Div Cardiovasc, London WC2R 2LS, England; [Jones, Gareth E.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Wells, Claire M.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Wells, CM (corresponding author), Kings Coll London, Div Canc Studies, London WC2R 2LS, England.	claire.wells@kcl.ac.uk	Jones, Gareth E/H-2282-2012	Jones, Gareth E/0000-0001-5879-3048; Shah, Ajay/0000-0002-6547-0631	British Heart Foundation; Guy's and St. Thomas Charity; Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre award; King's College London; King's College Hospital NHS Foundation Trust; MRC [G0100152] Funding Source: UKRI; British Heart Foundation [RG/08/011/25922] Funding Source: researchfish; Medical Research Council [G0100152] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Guy's and St. Thomas Charity; Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre award; King's College London; King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SC, AC and AMS were supported by the British Heart Foundation. CW is supported by the Guy's and St. Thomas Charity. The authors also acknowledge support from the Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Bengtsson T, 2006, CELL BIOL INT, V30, P154, DOI 10.1016/j.cellbi.2005.10.017; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Cui WH, 2011, HEPATOLOGY, V54, P949, DOI 10.1002/hep.24465; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liu JH, 2003, ARTERIOSCL THROM VAS, V23, P776, DOI 10.1161/01.ATV.0000066684.37829.16; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Morimatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P206, DOI 10.1006/bbrc.1996.5881; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Ridley AJ, 2004, CELL, V116, P357, DOI 10.1016/S0092-8674(04)00123-0; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Sester DP, 2005, IMMUNOBIOLOGY, V210, P97, DOI 10.1016/j.imbio.2005.05.004; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stokes KY, 2001, CIRC RES, V88, P499, DOI 10.1161/01.RES.88.5.499; Thomas M, 2006, CIRCULATION, V114, P404, DOI 10.1161/CIRCULATIONAHA.105.607168; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Umanskiy K, 2003, SURGERY, V134, P378, DOI 10.1067/msy.2003.253; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Vendrov AE, 2007, ARTERIOSCL THROM VAS, V27, P2714, DOI 10.1161/ATVBAHA.107.152629; Ward SG, 2004, TRENDS IMMUNOL, V25, P67, DOI 10.1016/j.it.2003.12.003; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	53	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54869	10.1371/journal.pone.0054869	http://dx.doi.org/10.1371/journal.pone.0054869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383302	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900009
J	Hinaut, X; Dominey, PF				Hinaut, Xavier; Dominey, Peter Ford			Real-Time Parallel Processing of Grammatical Structure in the Fronto-Striatal System: A Recurrent Network Simulation Study Using Reservoir Computing	PLOS ONE			English	Article							ECHO-STATE-NETWORKS; SENTENCE COMPREHENSION; BRAIN POTENTIALS; PARKINSONS-DISEASE; DECLARATIVE/PROCEDURAL MODEL; DISTRIBUTED REPRESENTATIONS; NEUROLINGUISTIC MODEL; NATURAL-LANGUAGE; RHESUS-MONKEY; BASAL GANGLIA	Sentence processing takes place in real-time. Previous words in the sentence can influence the processing of the current word in the timescale of hundreds of milliseconds. Recent neurophysiological studies in humans suggest that the fronto-striatal system (frontal cortex, and striatum - the major input locus of the basal ganglia) plays a crucial role in this process. The current research provides a possible explanation of how certain aspects of this real-time processing can occur, based on the dynamics of recurrent cortical networks, and plasticity in the cortico-striatal system. We simulate prefrontal area BA47 as a recurrent network that receives on-line input about word categories during sentence processing, with plastic connections between cortex and striatum. We exploit the homology between the cortico-striatal system and reservoir computing, where recurrent frontal cortical networks are the reservoir, and plastic cortico-striatal synapses are the readout. The system is trained on sentence-meaning pairs, where meaning is coded as activation in the striatum corresponding to the roles that different nouns and verbs play in the sentences. The model learns an extended set of grammatical constructions, and demonstrates the ability to generalize to novel constructions. It demonstrates how early in the sentence, a parallel set of predictions are made concerning the meaning, which are then confirmed or updated as the processing of the input sentence proceeds. It demonstrates how on-line responses to words are influenced by previous words in the sentence, and by previous sentences in the discourse, providing new insight into the neurophysiology of the P600 ERP scalp response to grammatical complexity. This demonstrates that a recurrent neural network can decode grammatical structure from sentences in real-time in order to generate a predictive representation of the meaning of the sentences. This can provide insight into the underlying mechanisms of human cortico-striatal function in sentence processing.	[Hinaut, Xavier; Dominey, Peter Ford] INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France; [Hinaut, Xavier; Dominey, Peter Ford] Univ Lyon 1, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dominey, PF (corresponding author), INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France.	peter.dominey@inserm.fr	Dominey, Peter/H-3832-2012	Dominey, Peter/0000-0002-9318-179X; Hinaut, Xavier/0000-0002-1924-1184	EC [231267 Organic, 270490 EFAA]	EC(European CommissionEuropean Commission Joint Research Centre)	This work has been financed by the EC FP7-ICT Projects 231267 Organic, and 270490 EFAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnickel T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006393; BATES E, 1991, BRAIN LANG, V41, P123, DOI 10.1016/0093-934X(91)90149-U; BATES E, 1982, COGNITION, V11, P245, DOI 10.1016/0010-0277(82)90017-8; Busing L, 2010, NEURAL COMPUT, V22, P1272, DOI 10.1162/neco.2009.01-09-947; CAPLAN D, 1985, COGNITION, V21, P117, DOI 10.1016/0010-0277(85)90048-4; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Chang F, 2000, J PSYCHOLINGUIST RES, V29, P217, DOI 10.1023/A:1005101313330; Chang F., 2002, COGNITIVE SCI, V93, P1, DOI [10.1207/s15516709cog2605_3, DOI 10.1207/S15516709COG2605_3]; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; Collobert R., 2008, P 25 ICML, V25, P160, DOI DOI 10.1145/1390156.1390177; Di Filippo M, 2009, BEHAV BRAIN RES, V199, P108, DOI 10.1016/j.bbr.2008.09.025; DOMINEY P, 1995, J COGNITIVE NEUROSCI, V7, P311, DOI 10.1162/jocn.1995.7.3.311; Dominey PF, 2009, CORTEX, V45, P1012, DOI 10.1016/j.cortex.2009.03.007; Dominey PF, 2006, J COGNITIVE NEUROSCI, V18, P2088, DOI 10.1162/jocn.2006.18.12.2088; Dominey PF, 2006, CORTEX, V42, P476, DOI 10.1016/S0010-9452(08)70381-2; Dominey PF, 2009, BRAIN LANG, V109, P80, DOI 10.1016/j.bandl.2008.08.002; Dominey PF, 2000, LANG COGNITIVE PROC, V15, P87, DOI 10.1080/016909600386129; DOMINEY PF, 1995, BIOL CYBERN, V73, P265, DOI 10.1007/BF00201428; Dominey PF, 2005, ARTIF INTELL, V167, P31, DOI 10.1016/j.artint.2005.06.007; Dominey PF, 2003, BRAIN LANG, V86, P207, DOI 10.1016/S0093-934X(02)00529-1; Elman J., 1990, COGNITIVE, V15, P179, DOI DOI 10.1207/S15516709C0G1402_1; ELMAN JL, 1991, MACH LEARN, V7, P195, DOI 10.1007/BF00114844; Frank SL, 2011, PSYCHOL SCI, V22, P829, DOI 10.1177/0956797611409589; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Friederici AD, 2003, NEUROPSYCHOLOGY, V17, P133, DOI 10.1037/0894-4105.17.1.133; Friederici AD, 2001, COGNITIVE BRAIN RES, V11, P305, DOI 10.1016/S0926-6410(00)00065-3; Frisch S, 2003, CLIN NEUROPHYSIOL, V114, P336, DOI 10.1016/S1388-2457(02)00366-8; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gibson E, 2000, J PSYCHOLINGUIST RES, V29, P231, DOI 10.1023/A:1005153330168; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Graben PB, 2008, COGN NEURODYNAMICS, V2, P229, DOI 10.1007/s11571-008-9041-5; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hagoort P, 2007, PHILOS T R SOC B, V362, P801, DOI 10.1098/rstb.2007.2089; Hinaut X, 2012, LECT NOTES COMPUTER, P596; Hinaut X, 2011, J PHYSIOL-PARIS, V105, P16, DOI 10.1016/j.jphysparis.2011.07.010; Hochstadt J, 2006, BRAIN LANG, V97, P243, DOI 10.1016/j.bandl.2005.10.011; Hochstadt J, 2009, CORTEX, V45, P991, DOI 10.1016/j.cortex.2009.03.010; Hopf JM, 2003, COGNITIVE BRAIN RES, V15, P165, DOI 10.1016/S0926-6410(02)00149-0; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaegera H, 2007, NEURAL NETWORKS, V20, P335, DOI 10.1016/j.neunet.2007.04.016; Kotz SA, 2003, J INT NEUROPSYCH SOC, V9, P1053, DOI 10.1017/S1355617703970093; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lewis RL, 2000, J PSYCHOLINGUIST RES, V29, P241, DOI 10.1023/A:1005105414238; Lieven E, 2003, J CHILD LANG, V30, P333, DOI 10.1017/S0305000903005592; Liu YY, 2008, IEEE T NEURAL NETWOR, V19, P983, DOI 10.1109/TNN.2007.915114; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; McClelland J.L., 1989, LANG COGNITIVE PROC, V4, P287; Miikkulainen R, 1996, COGNITIVE SCI, V20, P47, DOI 10.1207/s15516709cog2001_2; Moro A, 2001, NEUROIMAGE, V13, P110, DOI 10.1006/nimg.2000.0668; Ogawa K, 2008, NEUROREPORT, V19, P811, DOI 10.1097/WNR.0b013e3282ffda89; Roland D, 2007, J MEM LANG, V57, P348, DOI 10.1016/j.jml.2007.03.002; Service E, 2007, J COGNITIVE NEUROSCI, V19, P1193, DOI 10.1162/jocn.2007.19.7.1193; Tomasello M., 2003, CONSTRUCTING LANGUAG; Tong MH, 2007, NEURAL NETWORKS, V20, P424, DOI 10.1016/j.neunet.2007.04.013; Toni I, 2002, CEREB CORTEX, V12, P1040, DOI 10.1093/cercor/12.10.1040; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van der Velde F, 2006, BEHAV BRAIN SCI, V29, P37, DOI 10.1017/S0140525X06009022; VANHOESEN GW, 1981, J COMP NEUROL, V199, P205, DOI 10.1002/cne.901990205; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Voegtlin T, 2005, NEURAL NETWORKS, V18, P878, DOI 10.1016/j.neunet.2005.01.005; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; YETERIAN EH, 1989, J COMP NEUROL, V282, P80, DOI 10.1002/cne.902820107; Yildiz IB, 2012, NEURAL NETWORKS, V35, P1, DOI 10.1016/j.neunet.2012.07.005	72	85	85	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e52946	10.1371/journal.pone.0052946	http://dx.doi.org/10.1371/journal.pone.0052946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383296	Green Published, gold			2022-12-27	WOS:000314597900003
J	Hilbers, FS; Meijers, CM; Laros, JFJ; van Galen, M; Hoogerbrugge, N; Vasen, HFA; Nederlof, PM; Wijnen, JT; van Asperen, CJ; Devilee, P				Hilbers, Florentine S.; Meijers, Caro M.; Laros, Jeroen F. J.; van Galen, Michiel; Hoogerbrugge, Nicoline; Vasen, Hans F. A.; Nederlof, Petra M.; Wijnen, Juul T.; van Asperen, Christi J.; Devilee, Peter			Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC PREDISPOSITION; LINKAGE ANALYSIS; BRCA1; CARCINOMAS; MUTATIONS; XRCC2	The bulk of familial breast cancer risk (similar to 70%) cannot be explained by mutations in the known predisposition genes, primarily BRCA1 and BRCA2. Underlying genetic heterogeneity in these cases is the probable explanation for the failure of all attempts to identify further high-risk alleles. While exome sequencing of non-BRCA1/2 breast cancer cases is a promising strategy to detect new high-risk genes, rational approaches to the rigorous pre-selection of cases are needed to reduce heterogeneity. We selected six families in which the tumours of multiple cases showed a specific genomic profile on array comparative genomic hybridization (aCGH). Linkage analysis in these families revealed a region on chromosome 4 with a LOD score of 2.49 under homogeneity. We then analysed the germline DNA of two patients from each family using exome sequencing. Initially focusing on the linkage region, no potentially pathogenic variants could be identified in more than one family. Variants outside the linkage region were then analysed, and we detected multiple possibly pathogenic variants in genes that encode DNA integrity maintenance proteins. However, further analysis led to the rejection of all variants due to poor co-segregation or a relatively high allele frequency in a control population. We concluded that using CGH results to focus on a sub-set of families for sequencing analysis did not enable us to identify a common genetic change responsible for the aggregation of breast cancer in these families. Our data also support the emerging view that non-BRCA1/2 hereditary breast cancer families have a very heterogeneous genetic basis.	[Hilbers, Florentine S.; Meijers, Caro M.; Laros, Jeroen F. J.; Wijnen, Juul T.; Devilee, Peter] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Laros, Jeroen F. J.; van Galen, Michiel] Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands; [Hoogerbrugge, Nicoline] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Vasen, Hans F. A.] Netherlands Fdn Detect Hereditary Tumors, Leiden, Netherlands; [Nederlof, Petra M.] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; [Wijnen, Juul T.; van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hilbers, FS (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	f.s.m.hilbers@lumc.nl	Devilee, Peter/GXV-8005-2022; DEVILEE, PETER/ABR-2140-2022; Hoogerbrugge, Nicoline/O-1016-2013; van Asperen, Christi J/D-3970-2012; Hilbers, Florentine/AAB-8162-2019	Hoogerbrugge, Nicoline/0000-0003-2393-8141; van Asperen, Christi J/0000-0002-1436-7650; Hilbers, Florentine/0000-0002-6764-3102; Laros, Jeroen F.J./0000-0002-8715-7371; Devilee, Peter/0000-0002-8023-2009; Vasen, Hans/0000-0003-2682-2603	Dutch Cancer Society [UL 2009-4388]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was financially supported by the Dutch Cancer Society (grant UL 2009-4388). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed M, 2009, EXPERT REV ANTICANC, V9, P1103, DOI 10.1586/ERA.09.38; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarez S, 2005, CLIN CANCER RES, V11, P1146; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Didraga MA, 2011, BREAST CANCER RES TR, V130, P425, DOI 10.1007/s10549-011-1357-x; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; EASTON DF, 1993, AM J HUM GENET, V52, P678; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordon A.H., 2010, FASTX TOOLKIT; Gronwald J, 2005, INT J CANCER, V114, P230, DOI 10.1002/ijc.20723; Hilbers FS, 2012, J MED GENET, V49, P618, DOI 10.1136/jmedgenet-2012-101191; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Joosse SA, 2012, BREAST CANCER RES TR, V132, P379, DOI 10.1007/s10549-010-1016-7; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mangia A, 2008, CANCER GENET CYTOGEN, V182, P75, DOI 10.1016/j.cancergencyto.2008.01.002; Muranen TA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3015; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; NHLBI Exome Sequencing Project (ESP), 2012, EX VAR SERV; Oldenburg RA, 2008, GENE CHROMOSOME CANC, V47, P947, DOI 10.1002/gcc.20597; Park DJ, 2012, AM J HUM GENET, V90, P734, DOI 10.1016/j.ajhg.2012.02.027; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tirkkonen M, 1997, CANCER RES, V57, P1222; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; University of Washington, 2011, SEATTLESEQ; van Beers EH, 2005, CANCER RES, V65, P822; Wessels LFA, 2002, CANCER RES, V62, P7110; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	38	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55734	10.1371/journal.pone.0055734	http://dx.doi.org/10.1371/journal.pone.0055734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383274	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600154
J	Miller, TC; Sun, GH; Hasebe, T; Fu, LZ; Heimeier, RA; Das, B; Ishizuya-Oka, A; Shi, YB				Miller, Thomas C.; Sun, Guihong; Hasebe, Takashi; Fu, Liezhen; Heimeier, Rachel A.; Das, Biswajit; Ishizuya-Oka, Atsuko; Shi, Yun-Bo			Tissue-Specific Upregulation of MDS/EVI Gene Transcripts in the Intestine by Thyroid Hormone during Xenopus Metamorphosis	PLOS ONE			English	Article							STEM-CELLS; SONIC HEDGEHOG; LAEVIS INTESTINE; SELF-RENEWAL; EXPRESSION; EVI1; PROLIFERATION; EMBRYOGENESIS; EPITHELIUM; INSIGHTS	Background: Intestinal remodeling during amphibian metamorphosis resembles the maturation of the adult intestine during mammalian postembryonic development when the adult epithelial self-renewing system is established under the influence of high concentrations of plasma thyroid hormone (T3). This process involves de novo formation and subsequent proliferation and differentiation of the adult stem cells. Methodology/Principal Findings: The T3-dependence of the formation of adult intestinal stem cell during Xenopus laevis metamorphosis offers a unique opportunity to identify genes likely important for adult organ-specific stem cell development. We have cloned and characterized the ectopic viral integration site 1 (EVI) and its variant myelodysplastic syndrome 1 (MDS)/EVI generated via transcription from the upstream MDS promoter and alternative splicing. EVI and MDS/EVI have been implicated in a number of cancers including breast, leukemia, ovarian, and intestinal cancers. We show that EVI and MDS/EVI transcripts are upregulated by T3 in the epithelium but not the rest of the intestine in Xenopus laevis when adult stem cells are forming in the epithelium. Conclusions/Significance: Our results suggest that EVI and MDS/EVI are likely involved in the development and/or proliferation of newly forming adult intestinal epithelial cells.	[Miller, Thomas C.; Fu, Liezhen; Heimeier, Rachel A.; Das, Biswajit; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD USA; [Sun, Guihong] Wuhan Univ, Sch Med, Key Lab Allergy & Immune Related Dis, Wuhan 430072, Peoples R China; [Sun, Guihong] Wuhan Univ, Sch Med, Med Res Ctr, Wuhan 430072, Peoples R China; [Hasebe, Takashi; Ishizuya-Oka, Atsuko] Nippon Med Sch, Dept Biol, Kawasaki, Kanagawa, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wuhan University; Wuhan University; Nippon Medical School	Ishizuya-Oka, A (corresponding author), Nippon Med Sch, Dept Biol, Kosugi Cho, Kawasaki, Kanagawa, Japan.	a-oka@nms.ac.jp; Shi@helix.nih.gov		Shi, Yun-Bo/0000-0002-6330-0639; Hasebe, Takashi/0000-0001-7200-8173	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; National Natural Science Foundation of China [30870113]; Grants-in-Aid for Scientific Research [25440160] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901, ZIAHD008858] Funding Source: NIH RePORTER	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health and the National Natural Science Foundation of China No. 30870113. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 1998, DEV GROWTH DIFFER, V40, P177; Bard-Chapeau E, 2012, P NATL ACAD SCI USA, V109; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Gao JS, 2011, FEBS LETT, V585, P693, DOI 10.1016/j.febslet.2011.01.033; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Hasebe T, 2012, DEV DYNAM, V241, P403, DOI 10.1002/dvdy.23723; Hasebe T, 2011, STEM CELLS, V29, P154, DOI 10.1002/stem.560; Heimeier RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r55; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2001, DIFFERENTIATION, V69, P27, DOI 10.1046/j.1432-0436.2001.690103.x; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; IshizuyaOka A, 1996, CELL TISSUE RES, V286, P467, DOI 10.1007/s004410050716; Kataoka K, 2012, CANC SCI; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Kress E, 2009, MOL CELL ENDOCRINOL, V313, P36, DOI 10.1016/j.mce.2009.08.028; Kumano K, 2010, J CELL PHYSIOL, V222, P282, DOI 10.1002/jcp.21953; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; Matsuda H, 2010, STEM CELLS, V28, P2073, DOI 10.1002/stem.529; Matsuura K, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-25; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Mead PE, 2005, GENE EXPR PATTERNS, V5, P601, DOI 10.1016/j.modgep.2005.03.007; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; Shi YB, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-42; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Sterling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047407; STOLOW MA, 1995, NUCLEIC ACIDS RES, V23, P2555, DOI 10.1093/nar/23.13.2555; Sun GH, 2012, INT J BIOL SCI, V8, P1217, DOI 10.7150/ijbs.5109; Sun GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013605; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Toner P. G., 1971, DIGESTIVE SYSTEM ULT; Van Campenhout C, 2006, DEV BIOL, V294, P203, DOI 10.1016/j.ydbio.2006.02.040; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Yoshimi A, 2011, ONCOTARGET, V2, P575, DOI 10.18632/oncotarget.304; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	48	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55585	10.1371/journal.pone.0055585	http://dx.doi.org/10.1371/journal.pone.0055585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383234	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600129
J	Moiani, A; Miccio, A; Rizzi, E; Severgnini, M; Pellin, D; Suerth, JD; Baum, C; De Bellis, G; Mavilio, F				Moiani, Arianna; Miccio, Annarita; Rizzi, Ermanno; Severgnini, Marco; Pellin, Danilo; Suerth, Julia Debora; Baum, Christopher; De Bellis, Gianluca; Mavilio, Fulvio			Deletion of the LTR Enhancer/Promoter Has No Impact on the Integration Profile of MLV Vectors in Human Hematopoietic Progenitors	PLOS ONE			English	Article							CELL GENE-THERAPY; LENTIVIRAL VECTOR; RETROVIRAL INTEGRATION; SITE SELECTION; MOUSE MODEL; ACTIVATION; IMMUNODEFICIENCY; ELEMENTS; DESIGN; RISK	Moloney murine leukemia virus (MLV)-derived gamma-retroviral vectors integrate preferentially near transcriptional regulatory regions in the human genome, and are associated with a significant risk of insertional gene deregulation. Self-inactivating (SIN) vectors carry a deletion of the U3 enhancer and promoter in the long terminal repeat (LTR), and show reduced genotoxicity in pre-clinical assays. We report a high-definition analysis of the integration preferences of a SIN MLV vector compared to a wild-type-LTR MLV vector in the genome of CD34(+) human hematopoietic stem/progenitor cells (HSPCs). We sequenced 13,011 unique SIN-MLV integration sites and compared them to 32,574 previously generated MLV sites in human HSPCs. The SIN-MLV vector recapitulates the integration pattern observed for MLV, with the characteristic clustering of integrations around enhancer and promoter regions associated to H3K4me3 and H3K4me1 histone modifications, specialized chromatin configurations (presence of the H2A.Z histone variant) and binding of RNA Pol II. SIN-MLV and MLV integration clusters and hot spots overlap in most cases and are generated at a comparable frequency, indicating that the reduced genotoxicity of SIN-MLV vectors in hematopoietic cells is not due to a modified integration profile.	[Moiani, Arianna] Ist Sci H San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Miccio, Annarita; Mavilio, Fulvio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Rizzi, Ermanno; Severgnini, Marco; De Bellis, Gianluca] CNR, Inst Biomed Technol, I-20133 Milan, Italy; [Pellin, Danilo] Univ Vita Salute San Raffaele, CUSSB, Milan, Italy; [Suerth, Julia Debora; Baum, Christopher] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Mavilio, Fulvio] Genethon, Evry, France	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Vita-Salute San Raffaele University; Hannover Medical School	Mavilio, F (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.	fmavilio@genethon.fr	De Bellis, Gianluca/H-9725-2013; rizzi, ermanno/Q-3399-2016; Miccio, Annarita/H-9585-2017; MAVILIO, Fulvio/J-6125-2013; Severgnini, Marco/F-5832-2013	De Bellis, Gianluca/0000-0002-1622-4477; rizzi, ermanno/0000-0002-9898-2326; Miccio, Annarita/0000-0002-3409-9665; Severgnini, Marco/0000-0001-8655-1206; Mavilio, Fulvio/0000-0003-0459-4320	European Commission (PERSIST); European Research Council (GT-SKIN); Italian National Research Council (CNR - EPIGEN)	European Commission (PERSIST); European Research Council (GT-SKIN); Italian National Research Council (CNR - EPIGEN)	This work was supported by grants from the European Commission (PERSIST), the European Research Council (GT-SKIN), and the Italian National Research Council (CNR - EPIGEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Almarza D, 2011, GENE THER, V18, P674, DOI 10.1038/gt.2011.12; Bosticardo M, 2009, MOL THER, V17, P1910, DOI 10.1038/mt.2009.172; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cattoglio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015688; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cesana D, 2012, J CLIN INVEST, V122, P1667, DOI 10.1172/JCI62189; Coffin J, 1997, RETROVIRUSES; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Heckl D, 2012, MOL THER, V20, P1187, DOI 10.1038/mt.2012.59; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kim SY, 2007, PLOS GENET, V3, P1572, DOI 10.1371/journal.pgen.0030147; Krause D, 2011, HEMATOLOGIST, V8, P10; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova O, 2010, SEMIN CANCER BIOL, V20, P269, DOI 10.1016/j.semcancer.2010.06.003; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Maruggi G, 2009, MOL THER, V17, P851, DOI 10.1038/mt.2009.51; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Moiani A, 2012, J CLIN INVEST, V122, P1653, DOI 10.1172/JCI61852; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Studamire B, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-48; Thornhill SI, 2008, MOL THER, V16, P590, DOI 10.1038/sj.mt.6300393; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang GP, 2009, MOL THER, V17, P844, DOI 10.1038/mt.2009.16; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; ZYCHLINSKI D, 2008, MOL THER	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55721	10.1371/journal.pone.0055721	http://dx.doi.org/10.1371/journal.pone.0055721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383272	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600152
J	Ogawa, Y; Tanaka, M; Tanabe, M; Suzuki, T; Togawa, T; Fukushige, T; Kanekura, T; Sakuraba, H; Oishi, K				Ogawa, Yasuhiro; Tanaka, Makoto; Tanabe, Miho; Suzuki, Toshihiro; Togawa, Tadayasu; Fukushige, Tomoko; Kanekura, Takuro; Sakuraba, Hitoshi; Oishi, Kazuhiko			Impaired Neural Differentiation of Induced Pluripotent Stem Cells Generated from a Mouse Model of Sandhoff Disease	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; GROWTH-FACTOR RECEPTOR; EPSTEIN-BARR-VIRUS; LOOP-HELIX GENES; HUMAN TAY-SACHS; PRECURSOR CELLS; EPIGENETIC CONTROL; PLASMID REPLICON; NERVOUS-SYSTEM; IN-VITRO	Sandhoff disease (SD) is a glycosphingolipid storage disease that arises from mutations in the Hexb gene and the resultant deficiency in beta-hexosaminidase activity. This deficiency results in aberrant lysosomal accumulation of the ganglioside GM2 and related glycolipids, and progressive deterioration of the central nervous system. Dysfunctional glycolipid storage causes severe neurodegeneration through a poorly understood pathogenic mechanism. Induced pluripotent stem cell (iPSC) technology offers new opportunities for both elucidation of the pathogenesis of diseases and the development of stem cell-based therapies. Here, we report the generation of disease-specific iPSCs from a mouse model of SD. These mouse model-derived iPSCs (SD-iPSCs) exhibited pluripotent stem cell properties and significant accumulation of GM2 ganglioside. In lineage-directed differentiation studies using the stromal cell-derived inducing activity method, SD-iPSCs showed an impaired ability to differentiate into early stage neural precursors. Moreover, fewer neurons differentiated from neural precursors in SD-iPSCs than in the case of the wild type. Recovery of the Hexb gene in SD-iPSCs improved this impairment of neuronal differentiation. These results provide new insights as to understanding the complex pathogenic mechanisms of SD.	[Ogawa, Yasuhiro; Tanaka, Makoto; Tanabe, Miho; Oishi, Kazuhiko] Meiji Pharmaceut Univ, Dept Pharmacol, Tokyo, Japan; [Suzuki, Toshihiro; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo, Japan; [Togawa, Tadayasu] Meiji Pharmaceut Univ, Dept Funct Bioanal, Tokyo, Japan; [Fukushige, Tomoko; Kanekura, Takuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Kagoshima 890, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan	Meiji Pharmaceutical University; Meiji Pharmaceutical University; Meiji Pharmaceutical University; Kagoshima University; Meiji Pharmaceutical University	Oishi, K (corresponding author), Meiji Pharmaceut Univ, Dept Pharmacol, Tokyo, Japan.	oishikz@my-pharm.ac.jp		Ogawa, Yasuhiro/0000-0003-3306-277X	High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S0801043]; Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [09-15]; JSPS Asia/Africa Scientific Platform Program; Japan Society for the Promotion of Science (JSPS) [21390314]	High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); JSPS Asia/Africa Scientific Platform Program; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (S0801043); the Program for Research on Intractable Diseases of Health and Labor Science Research; the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (ID: 09-15); and the JSPS Asia/Africa Scientific Platform Program; and the Japan Society for the Promotion of Science (JSPS ID: 21390314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Ahmed RPH, 2011, CIRC RES, V109, P60, DOI 10.1161/CIRCRESAHA.110.240010; Bieberich E, 2004, GLYCOCONJUGATE J, V21, P315, DOI 10.1023/B:GLYC.0000046274.35732.47; Bieberich E, 2012, NEUROCHEM RES, V37, P1208, DOI 10.1007/s11064-011-0698-5; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kwak DH, 2011, EXP MOL MED, V43, P379, DOI 10.3858/emm.2011.43.7.048; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lindner SE, 2007, PLASMID, V58, P1, DOI 10.1016/j.plasmid.2007.01.003; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Meuillet EJ, 2000, EXP CELL RES, V256, P74, DOI 10.1006/excr.1999.4509; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Mohammad HP, 2010, NAT BIOTECHNOL, V28, P1033, DOI 10.1038/nbt1010-1033; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Oishi K, 2002, J PHYSIOL-LONDON, V540, P139, DOI 10.1113/jphysiol.2001.013278; Oishi K, 2006, BIOCHEM BIOPH RES CO, V349, P1065, DOI 10.1016/j.bbrc.2006.08.135; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pelled D, 2003, NEUROPATH APPL NEURO, V29, P341, DOI 10.1046/j.1365-2990.2003.00455.x; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Sango K, 2002, NEUROPATH APPL NEURO, V28, P23, DOI 10.1046/j.1365-2990.2002.00366.x; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sargeant TJ, 2011, HUM MOL GENET, V20, P4371, DOI 10.1093/hmg/ddr364; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; TAI T, 1987, J BIOL CHEM, V262, P6803; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Volk BW, 1964, PATHOLOGIC ANATOMY; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; YAMANAKA S, 1994, GENOMICS, V21, P588, DOI 10.1006/geno.1994.1318; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419	57	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55856	10.1371/journal.pone.0055856	http://dx.doi.org/10.1371/journal.pone.0055856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383290	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600165
J	Rossi, N; Mantelatto, FL				Rossi, Natalia; Mantelatto, Fernando Luis			Molecular Analysis of the Freshwater Prawn Macrobrachium olfersii (Decapoda, Palaemonidae) Supports the Existence of a Single Species throughout Its Distribution	PLOS ONE			English	Article							POPULATION-GENETICS; MITOCHONDRIAL-DNA; 1868 CRUSTACEA; RIVER SHRIMP; PHYLOGENY; DIVERGENCE; EVOLUTION; MODEL; MORPHOTYPES; SYSTEMATICS	Macrobrachium olfersii is an amphidromous freshwater prawn, widespread along the eastern coasts of the Americas. This species shows great morphological modifications during ontogenesis, and several studies have verified the existence of a wide intraspecific variation. Because of this condition, the species is often misidentified, and several synonyms have been documented. To elucidate these aspects, individuals of M. olfersii from different populations along its range of distribution were investigated. The taxonomic limit was established, and the degree of genetic variability of this species was described. We extracted DNA from 53 specimens of M. olfersii, M. americanum, M. digueti and M. faustinum, which resulted in 84 new sequences (22 of 16S mtDNA, 45 of Cythocrome Oxidase I (COI) mtDNA, and 17 of Histone (H3) nDNA). Sequences of three genes (single and concatenated) from these species were used in the Maximum Likelihood and Bayesian Inference phylogenetic analyses and COI sequences from M. olfersii were used in population analysis. The genetic variation was evaluated through the alignment of 554 bp from the 16S, 638 bp from the COI, and 338 bp from the H3. The rates of genetic divergence among populations were lower at the intraspecific level. This was confirmed by the haplotype net, which showed a continuous gene flow among populations. Although a wide distribution and high morphological intraspecific variation often suggest the existence of more than one species, genetic similarity of Caribbean and Brazilian populations of M. olfersii supported them as a single species.	[Rossi, Natalia; Mantelatto, Fernando Luis] Univ Sao Paulo, Lab Bioecol & Crustacean Systemat LBSC, Program Comparat Biol, Dept Biol,Fac Philosophy Sci & Letters Ribeirao P, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Rossi, N (corresponding author), Univ Sao Paulo, Lab Bioecol & Crustacean Systemat LBSC, Program Comparat Biol, Dept Biol,Fac Philosophy Sci & Letters Ribeirao P, BR-14049 Ribeirao Preto, SP, Brazil.	nataliarossi.bio@gmail.com; flmantel@usp.br	Mantelatto, Fernando/GQI-1333-2022; Mantelatto, Fernando/N-9536-2019; Rossi, Natalia/B-5877-2011; Fapesp, Biota/F-8655-2017	Mantelatto, Fernando/0000-0002-8497-187X; Mantelatto, Fernando/0000-0002-8497-187X; Rossi, Natalia/0000-0002-1706-2238; Fapesp, Biota/0000-0002-9887-8449	Fundacaco de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2009/12409-5, Tematico Biota 2010/50188-8, Colecoes Cientificas 2009/54931-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472746/2004-9, 473050/2007-2, 491490/2004-6, 490353/2007-0, 471011/2011-8, PQ 301261/2004-0, 302748/2010-5]	Fundacaco de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This contribution is part of a multidisciplinary research project Tematico BIOTA - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), which aims to produce a fine-scale assessment of the marine/estuarine decapod biodiversity. This research is also part of the MSc Dissertation of NR and was supported by a fellowship from the Fundacaco de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2009/12409-5). Partial support for visits to European museums was provided by the Senckenberg Naturmuseum und Forschungsinstitut to NR. Additional support for this study was also provided by FAPESP (Tematico Biota 2010/50188-8; Colecoes Cientificas 2009/54931-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Research Grants 472746/2004-9, 473050/2007-2, 491490/2004-6, 490353/2007-0, 471011/2011-8; Research Scholarships PQ 301261/2004-0, 302748/2010-5) to FLM. The ongoing PhD fellowship to NR was awarded by CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar Dib, 2001, Revista Brasileira de Zoologia, V18, P529, DOI 10.1590/S0101-81752001000200024; ANDERSON G, 1980, CRUSTACEANA, V39, P90, DOI 10.1163/156854080X00319; Ashelby CW, 2012, ZOOL SCR, V41, P293, DOI 10.1111/j.1463-6409.2012.00535.x; Baker N, 2008, FRESHWATER BIOL, V53, P1592, DOI 10.1111/j.1365-2427.2008.01996.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barros M.P., 1995, BIOCI NCIAS, V3, P239; Bauer RT, 2008, J CRUSTACEAN BIOL, V28, P622, DOI 10.1651/08-2977.1; Bauer Raymond T., 2011, V15, P145; Bowles DE, 2000, J CRUSTACEAN BIOL, V20, P158, DOI 10.1651/0278-0372(2000)020[0158:MDCPIT]2.0.CO;2; Boxshall GA, 2000, ADV ECOL RES, V31, P61, DOI 10.1016/S0065-2504(00)31007-8; Bracken Heather D., 2009, Arthropod Systematics & Phylogeny, V67, P99; Chace F. A., 1969, Bulletin United States National Museum, V292, P1; CHOUDHURY P C, 1970, Crustaceana (Leiden), V18, P113, DOI 10.1163/156854070X00743; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Crandall KA, 2000, P ROY SOC B-BIOL SCI, V267, P1679, DOI 10.1098/rspb.2000.1195; Crandall KA, 1996, SYST BIOL, V45, P1; De Grave S., 2011, Zoologische Mededelingen (Leiden), V85, P195; DUGGER D M, 1975, Crustaceana (Leiden), V29, P1, DOI 10.1163/156854075X00018; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GAMBA A L, 1982, Caribbean Journal of Science, V18, P23; GAMBA AL, 1987, B MAR SCI, V40, P454; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEDGPETH JOEL W., 1949, TEXAS JOUR SCI, V1, P28; Holthuis L. B., 1952, Occasional Papers of the Allan Hancock Foundation, VNo. 12, P1; HOLTHUIS L B, 1970, Crustaceana (Leiden), V19, P211, DOI 10.1163/156854070X00545; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JALIHAL DR, 1993, CRUSTACEANA, V65, P363, DOI 10.1163/156854093X00793; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; KNOWLTON N, 1993, SCIENCE, V260, P1629, DOI 10.1126/science.8503007; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KURIS AM, 1987, J CRUSTACEAN BIOL, V7, P219, DOI 10.2307/1548603; Liu MY, 2007, ZOOL STUD, V46, P272; Mantelatto F.L., 2009, CRUSTACEAN ISSUES DE, P567, DOI [10.1201/9781420092592-38, DOI 10.1201/9781420092592-C29]; Mantelatto FL, 2007, ZOOL J LINN SOC-LOND, V150, P211, DOI 10.1111/j.1096-3642.2007.00298.x; Mantelatto FL, 2009, ZOOTAXA, P20, DOI 10.11646/zootaxa.2133.1.2; Mathews LM, 2006, MOL ECOL, V15, P4049, DOI 10.1111/j.1365-294X.2006.03077.x; Melo GAS., 2003, MANUAL IDENTIFICA O, P289; Mishler BD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P44; Moraes-Riodades PMC, 2004, AQUACULTURE, V236, P297, DOI 10.1016/j.aquaculture.2004.02.015; Morrison CL, 2004, MOL PHYLOGENET EVOL, V30, P563, DOI 10.1016/S1055-7903(03)00252-5; Mossolin EC, 2003, CRUSTACEANA, V76, P363, DOI 10.1163/156854003765911748; Mossolin EC, 2002, J CRUSTACEAN BIOL, V22, P367, DOI 10.1651/0278-0372(2002)022[0367:RBOMOD]2.0.CO;2; Muller YMR, 2003, J CRUSTACEAN BIOL, V23, P869, DOI 10.1651/C-2408; Munasinghe DHN, 2010, J NATL SCI FOUND SRI, V38, P193, DOI 10.4038/jnsfsr.v38i3.2309; Murphy NP, 2005, ZOOL SCR, V34, P187, DOI 10.1111/j.1463-6409.2005.00185.x; Murphy NP, 2004, AUST J ZOOL, V52, P549, DOI 10.1071/ZO03062; Ng PKL, 2010, ZOOL STUD, V49, P544; Ortmann A.E., 1897, REV MUSEU PAULISTA, V2, P173; Page TJ, 2008, J N AM BENTHOL SOC, V27, P68, DOI 10.1899/07-044R.1; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Pileggi LG, 2012, IHERINGIA SER ZOOL, V102, P426, DOI 10.1590/S0073-47212012005000012; Pileggi LG, 2010, INVERTEBR SYST, V24, P194, DOI 10.1071/IS09043; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ranbaut A, 2007, FIGTREE; RATHBUN M. J., 1900, P WASHINGTON ACAD SC, V2, P133; Robles Rafael, 2009, Crustacean Issues, V18, P309; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sawaya M. P., 1946, Boletim da Faculdade de Filosofia Ciencias e Letras Universidade de Sao Paulo Zoologica, VNo. 11, P393; Schnabel KE, 2011, MOL PHYLOGENET EVOL, V58, P157, DOI 10.1016/j.ympev.2010.11.011; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Schwander T, 2011, TRENDS ECOL EVOL, V26, P143, DOI 10.1016/j.tree.2010.12.010; Short JW, 2004, HYDROBIOLOGIA, V525, P1, DOI 10.1023/B:HYDR.0000038871.50730.95; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Templeton A.R., 1994, Experientia Supplementum (Basel), V69, P455; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torati LS, 2012, J CRUSTACEAN BIOL, V32, P625, DOI 10.1163/193724012X635322; Valencia Diego M., 2007, Zootaxa, V1456, P1; Vergamini FG, 2011, CONTRIB ZOOL, V80, P67, DOI 10.1163/18759866-08001003; Villalobos F.A., 1969, FAO FISHERIES REPORT, V57, P1055; von Rintelen K, 2012, MOL PHYLOGENET EVOL, V63, P82, DOI 10.1016/j.ympev.2011.12.015; Williams A.B., 1984, pi; Wortham JL, 2012, J CRUSTACEAN BIOL, V32, P545, DOI 10.1163/193724012X637311; Wowor D, 2009, MOL PHYLOGENET EVOL, V52, P340, DOI 10.1016/j.ympev.2009.01.002; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	82	41	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54698	10.1371/journal.pone.0054698	http://dx.doi.org/10.1371/journal.pone.0054698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382941	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600035
J	Yu, MM; Jiang, Q; Gu, XJ; Ju, LL; Ji, Y; Wu, KH; Jiang, HX				Yu, Minmin; Jiang, Qian; Gu, Xiaojun; Ju, Lili; Ji, Ying; Wu, Kaihua; Jiang, Hongxiu			Correlation between Vertical Transmission of Hepatitis B Virus and the Expression of HBsAg in Ovarian Follicles and Placenta	PLOS ONE			English	Article							HBV INTRAUTERINE INFECTION; DNA; SPERMATOZOA; HBCAG; PATHOGENESIS; MECHANISM; BARRIER; OVA	Background: The aim of this study was to investigate the correlation between the expression of hepatitis B surface antigen (HBsAg) in human ovary and placenta and the vertical transmission of hepatitis B virus (HBV). Methodology/Principal Fidnings: Ovarian and placental tissue specimens of pregnant women infected with HBV were collected during cesarean section and immunostained for HBsAg. The sera of the corresponding newborns were tested for HBV markers and HBV DNA. HBsAg was detected in 15 out of 33 (45%) placental tissues and was further detected in capillary endothelial cells in 4 specimens (26%), of which 3 (75%) corresponding infants were infected with HBV in utero. Out of the 33 ovarian tissues, 7 (21%) were positive for HBsAg, of which 2 (28%) showed HBsAg in ovarian follicles and the 2 corresponding infants (100%) had intrauterine HBV infection. Conclusions/Significance: HBsAg expression in cells of the ovarian follicle or placental capillary endothelium signal a higher risk for intrauterine HBV infection.	[Yu, Minmin; Ju, Lili; Ji, Ying; Wu, Kaihua; Jiang, Hongxiu] Southeast Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China; [Jiang, Qian] Yixing Peoples Hosp, Dept Obstet & Gynecol, Yixing, Jiangsu, Peoples R China; [Gu, Xiaojun] Southeast Univ, Affiliated Hosp 2, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Yu, MM (corresponding author), Southeast Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China.	yuminmin324@126.com; 999gu@163.com			Natural Science Foundation of Jiangsu Province [BK2008070]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by Natural Science Foundation of Jiangsu Province (Grant No. BK2008070). We are grateful to associate professor Lanxia Liu and Hongmei Zhang in our hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BA, 2005, MOL REPROD DEV, V70, P30, DOI 10.1002/mrd.20185; Amarapurkar Deepak N, 2002, Ann Hepatol, V1, P192; Bai GQ, 2011, ARCH GYNECOL OBSTET, V283, P317, DOI 10.1007/s00404-010-1366-8; Bai H, 2007, WORLD J GASTROENTERO, V13, P3625, DOI 10.3748/wjg.v13.i26.3625; Bhat P, 2007, J VIROL, V81, P7200, DOI 10.1128/JVI.02371-06; Chen LZ, 2005, WORLD J GASTROENTERO, V11, P5565, DOI 10.3748/wjg.v11.i35.5565; Chunyan Y, 2000, J HEPATOL, V8, P124; DAVISON F, 1987, J HEPATOL, V4, P37, DOI 10.1016/S0168-8278(87)80007-7; Gatta A, 2008, CLIN EXP RHEUMATOL, V26, pS33; HADCHOUEL M, 1985, J MED VIROL, V16, P61, DOI 10.1002/jmv.1890160109; Han Steven-Huy B, 2004, Clin Liver Dis, V8, P403, DOI 10.1016/j.cld.2004.02.003; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Lang Z W, 1993, Zhonghua Yi Xue Za Zhi, V73, P329; Li XM, 2004, WORLD J GASTROENTERO, V10, P3215; LIN CY, 1993, NEPHRON, V63, P58, DOI 10.1159/000187144; Lou H, 2010, J INT MED RES, V38, P214, DOI 10.1177/147323001003800125; Ma J, 2000, Zhonghua Fu Chan Ke Za Zhi, V35, P654; Ranger-Rogez S, 2002, PATHOL BIOL, V50, P568, DOI 10.1016/S0369-8114(02)00351-6; URSELL PC, 1984, HUM PATHOL, V15, P481, DOI 10.1016/S0046-8177(84)80085-4; Wang An-hui, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P51; Xia Guo-liang, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P362; Ye F, 2006, AM J OBSTET GYNECOL, V194, P387, DOI 10.1016/j.ajog.2005.07.011; Ye F, 2005, WORLD J GASTROENTERO, V11, P5718, DOI 10.3748/wjg.v11.i36.5718; Zhang SL, 2004, WORLD J GASTROENTERO, V10, P437	24	18	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54246	10.1371/journal.pone.0054246	http://dx.doi.org/10.1371/journal.pone.0054246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382883	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600026
J	Allam, SR; Kruger, B; Mehrotra, A; Schiano, T; Schroppel, B; Murphy, B				Allam, Sridhar R.; Krueger, Bernd; Mehrotra, Anita; Schiano, Thomas; Schroeppel, Bernd; Murphy, Barbara			The Association of IL28B Polymorphism and Graft Survival in Patients with Hepatitis C Undergoing Liver Transplantation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; SPONTANEOUS CLEARANCE; PEGYLATED INTERFERON; RIBAVIRIN THERAPY; UNITED-STATES; VIRUS; EXPRESSION; INFECTION; GENOTYPE	Hepatitis C virus (HCV) infection is the leading cause of liver transplantation (LT) in Western countries. Polymorphism in the IL28B gene region has a major impact on the natural history and response to antiviral treatment in HCV. We investigated whether IL28B polymorphism was associated with graft survival in patients with or without HCV undergoing LT. 1,060 adult patients (age >18 years) underwent LT between years 2000 and 2008. Patients with previous LT, living donor LT and patients dying or requiring retransplants within 30 days of LT were excluded. DNA samples of 620 (84%) recipients and 377 (51%) donors were available for genotyping of IL28B rs12979860C>T. Donor IL28B genotypes had no significant differences in graft survival irrespective of HCV status. There was no difference in graft outcome in the non-HCV cohort (n = 293) based on recipient IL28B genotype. In the HCV group (n = 327), recipients with CC or CT genotype had better graft survival compared to TT genotype (62% vs. 48%, p = 0.02). HCV recipients with CC or CT genotype had delayed time to clinically relevant HCV recurrence compared to TT (10.4 vs. 6.7 months, p = 0.002). The beneficial effect of the CC/CT genotype on HCV recurrence and graft survival was independent of antiviral treatment. In conclusion, our study demonstrated that in contrast to donor IL28B genotype recipient IL28B was associated with graft survival and clinically relevant HCV recurrence in HCV infected recipients. No effect of IL28B genotype was manifest in non-HCV LT recipients.	[Allam, Sridhar R.; Mehrotra, Anita; Schroeppel, Bernd; Murphy, Barbara] Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA; [Krueger, Bernd] Heidelberg Univ, Med Fak Mannheim, Univ Med Mannheim, Med Klin 5, Mannheim, Germany; [Schiano, Thomas] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA; [Schiano, Thomas] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Ruprecht Karls University Heidelberg; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Murphy, B (corresponding author), Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA.	Barbara.Murphy@mssm.edu	Allam, Sridhar/AAQ-8582-2020; Krüger, Bernd/F-5781-2011	Allam, Sridhar/0000-0001-6051-9443; 	American Society of Transplant Surgeons (ASTS) - Pfizer mid-level faculty award; National Institutes of Health (NIH) [UL1RR029887]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER	American Society of Transplant Surgeons (ASTS) - Pfizer mid-level faculty award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by American Society of Transplant Surgeons (ASTS) - Pfizer mid-level faculty award (B. S.), and National Institutes of Health (NIH) grant UL1RR029887 (B.M.). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Charlton MR, 2011, HEPATOLOGY, V53, P317, DOI 10.1002/hep.24074; Cisneros E, 2012, TRANSPLANTATION, V94, P275, DOI 10.1097/TP.0b013e31825668f6; Coto-Llerena M, 2011, AM J TRANSPLANT, V11, P1051, DOI 10.1111/j.1600-6143.2011.03491.x; Coto-Llerena M, 2012, J HEPATOL, V56, P355, DOI 10.1016/j.jhep.2011.07.027; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Duarte-Rojo A, 2012, TRANSPLANTATION, V94, P197, DOI 10.1097/TP.0b013e3182547551; Eurich D, 2011, LIVER TRANSPLANT, V17, P289, DOI 10.1002/lt.22235; Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghobrial RM, 2001, ANN SURG, V234, P384, DOI 10.1097/00000658-200109000-00012; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Kemmer N, 2007, TRANSPL P, V39, P1477, DOI 10.1016/j.transproceed.2006.11.012; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Lange CM, 2011, J HEPATOL, V55, P322, DOI 10.1016/j.jhep.2010.10.037; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Shebl FM, 2010, GASTROENTEROLOGY, V139, P1422, DOI 10.1053/j.gastro.2010.07.055; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thuluvath PJ, 2007, LIVER TRANSPLANT, V13, P719, DOI 10.1002/lt.21123; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; U.S. Department of Health and Human Services HRaSA Healthcare Systems Bureau Division of Transplantation, 2008, 2008 ANN REP US ORG; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Veldt BJ, 2008, AM J TRANSPLANT, V8, P2426, DOI 10.1111/j.1600-6143.2008.02362.x; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019	31	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54854	10.1371/journal.pone.0054854	http://dx.doi.org/10.1371/journal.pone.0054854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382988	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800082
J	Colleoni, F; Padmanabhan, N; Yung, HW; Watson, ED; Cetin, I; van Patot, MCT; Burton, GJ; Murray, AJ				Colleoni, Francesca; Padmanabhan, Nisha; Yung, Hong-wa; Watson, Erica D.; Cetin, Irene; van Patot, Martha C. Tissot; Burton, Graham J.; Murray, Andrew J.			Suppression of Mitochondrial Electron Transport Chain Function in the Hypoxic Human Placenta: A Role for miRNA-210 and Protein Synthesis Inhibition	PLOS ONE			English	Article							HIGH-ALTITUDE HYPOXIA; OXIDATIVE STRESS; NITRIC-OXIDE; METABOLIC ADAPTATION; GROWTH RESTRICTION; SKELETAL-MUSCLE; OXYGEN; MICRORNA-210; PREECLAMPSIA; RESPIRATION	Fetal growth is critically dependent on energy metabolism in the placenta, which drives active exchange of nutrients. Placental oxygen levels are therefore vital, and chronic hypoxia during pregnancy impairs fetal growth. Here we tested the hypothesis that placental hypoxia alters mitochondrial electron transport chain (ETS) function, and sought to identify underlying mechanisms. We cultured human placental cells under different oxygen concentrations. Mitochondrial respiration was measured, alongside levels of ETS complexes. Additionally, we studied placentas from sea-level and high-altitude pregnancies. After 4 d at 1% O-2 (1.01 KPa), complex I-supported respiration was 57% and 37% lower, in trophoblast-like JEG3 cells and fibroblasts, respectively, compared with controls cultured at 21% O-2 (21.24 KPa); complex IV-supported respiration was 22% and 30% lower. Correspondingly, complex I levels were 45% lower in placentas from high-altitude pregnancies than those from sea-level pregnancies. Expression of HIF-responsive microRNA-210 was increased in hypoxic fibroblasts and high-altitude placentas, whilst expression of its targets, iron-sulfur cluster scaffold (ISCU) and cytochrome c oxidase assembly protein (COX10), decreased. Moreover, protein synthesis inhibition, a feature of the high-altitude placenta, also suppressed ETS complex protein levels. Our results demonstrate that mitochondrial function is altered in hypoxic human placentas, with specific suppression of complexes I and IV compromising energy metabolism and potentially contributing to impaired fetal growth.	[Colleoni, Francesca; Padmanabhan, Nisha; Yung, Hong-wa; Watson, Erica D.; van Patot, Martha C. Tissot; Burton, Graham J.; Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Colleoni, Francesca; Padmanabhan, Nisha; Yung, Hong-wa; Watson, Erica D.; van Patot, Martha C. Tissot; Burton, Graham J.; Murray, Andrew J.] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Cetin, Irene] Univ Milan, Unit Obstet & Gynecol, Dept Clin Sci Luigi Sacco, Milan, Italy	University of Cambridge; University of Cambridge; University of Milan; Luigi Sacco Hospital	Colleoni, F (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	fc316@cam.ac.uk	cetin, irene/K-6112-2016; Padmanabhan, Nisha/ABE-4879-2020	cetin, irene/0000-0002-9217-3034; Padmanabhan, Nisha/0000-0003-1253-2162; Watson, Erica/0000-0003-4496-2271; Murray, Andrew/0000-0002-0929-9315; Tissot van Patot, Martha/0000-0002-2934-366X	Research Councils UK; Wellcome Trust [084804/2/08/Z]; Action Medical Research [SP4545]; Action Medical Research [1776] Funding Source: researchfish	Research Councils UK(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research; Action Medical Research	Dr Murray thanks the Research Councils UK for supporting his academic fellowship and Prof Burton gratefully acknowledges support for his research from the Wellcome Trust (084804/2/08/Z). This study was primarily supported by Action Medical Research, project grant number SP4545. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Burton GJ, 2011, PREGNANCY HYPERTENS, V1, P72, DOI 10.1016/j.preghy.2010.12.002; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Colleoni F, 2012, PLACENTA, V33, P122, DOI 10.1016/j.placenta.2011.11.019; Gandley RE, 2008, HYPERTENSION, V52, P387, DOI 10.1161/HYPERTENSIONAHA.107.107532; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Illsley NP, 2010, INT J DEV BIOL, V54, P409, DOI 10.1387/ijdb.082798ni; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lee DC, 2011, AM J PATHOL, V179, P590, DOI 10.1016/j.ajpath.2011.04.035; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Many A, 2000, AM J PATHOL, V156, P321, DOI 10.1016/S0002-9440(10)64733-5; MATSUO H, 1994, ENDOCRINOLOGY, V135, P1135, DOI 10.1210/en.135.3.1135; Melillo G, 1997, J BIOL CHEM, V272, P12236, DOI 10.1074/jbc.272.18.12236; Moore LG, 2003, HIGH ALT MED BIOL, V4, P141, DOI 10.1089/152702903322022767; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; Murray AJ, 2012, PLACENTA, V33, pE16, DOI 10.1016/j.placenta.2012.06.006; Murray AJ, 2007, CURR OPIN CLIN NUTR, V10, P704, DOI 10.1097/MCO.0b013e3282f0ecbe; Murray AJ, 2009, GENOME MED, V1, DOI 10.1186/gm117; Palmer SK, 1999, AM J OBSTET GYNECOL, V180, P1161, DOI 10.1016/S0002-9378(99)70611-3; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rennie J.M., 2002, FETAL MATERN MED REV, V13, P157, DOI [10.1017/S0965539502000311, DOI 10.1017/S0965539502000311]; Simon MC, 2006, CELL METAB, V3, P150, DOI 10.1016/j.cmet.2006.02.007; Tannetta DS, 2008, PLACENTA, V29, P680, DOI 10.1016/j.placenta.2008.04.009; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; van Patot MCT, 2010, AM J PHYSIOL-REG I, V298, pR166, DOI 10.1152/ajpregu.00383.2009; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082; Zamudio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008551; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	51	84	88	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55194	10.1371/journal.pone.0055194	http://dx.doi.org/10.1371/journal.pone.0055194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383105	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800127
J	Denner, J; Eschricht, M; Lauck, M; Semaan, M; Schlaermann, P; Ryu, H; Akyuz, L				Denner, Joachim; Eschricht, Magdalena; Lauck, Michael; Semaan, Marwan; Schlaermann, Philipp; Ryu, Hyunmi; Akyuez, Levent			Modulation of Cytokine Release and Gene Expression by the Immunosuppressive Domain of gp41 of HIV-1	PLOS ONE			English	Article							PROTEIN-KINASE-C; SYNTHETIC PEPTIDE; SEQUENCE IDENTITY; ENVELOPE PROTEIN; LYMPHOCYTE-PROLIFERATION; IMMUNE-RESPONSE; INNATE IMMUNITY; HUMAN MONOCYTES; IL-6 LEVELS; VIRUS	The transmembrane envelope protein gp41 of the human immunodeficiency virus HIV-1 plays an important role during infection allowing fusion of the viral and cellular membrane. In addition, there is increasing evidence that gp41 may contribute to the immunodeficiency induced by HIV-1. Recombinant gp41 and a synthetic peptide corresponding to a highly conserved domain in gp41, the immunosuppressive (isu) domain, have been shown to inhibit mitogen-induced activation of human peripheral blood mononuclear cells (PBMCs) and to increase release of IL-6 and IL-10 from these cells. We recently reported that a single mutation in the isu domain of gp41 abrogated the immunosuppressive properties and that HIV-1 sequences containing such abrogating mutations had never been isolated from infected individuals. Here, we studied the influence of the isu peptide on the release of 66 cytokines and the expression of 27,000 genes in PBMCs. Incubation of PBMCs with isu peptide homopolymers increased the expression of 16 cytokines among them IL-6 and IL-10, and decreased that of IL-2 and CXCL9. Interestingly, the extend of cytokine modulation was donor-dependent. Among the genes up-regulated were IL-6, IL-8, IL-10 but also MMP-1, TREM-1 and IL-1beta. Most importantly, genes involved in innate immunity such as FCN1 and SEPP1 were found down-regulated. Many changes in cytokine expression demonstrated in our experiments were also found in HIV-1 infected individuals. These data indicate that the isu domain of gp41 has a broad impact on gene expression and cytokine release and therefore may be involved in HIV-1 induced immunopathogenesis.	[Denner, Joachim; Eschricht, Magdalena; Lauck, Michael; Semaan, Marwan; Schlaermann, Philipp; Ryu, Hyunmi; Akyuez, Levent] Robert Koch Inst, Berlin, Germany	Robert Koch Institute	Denner, J (corresponding author), Robert Koch Inst, Berlin, Germany.	Denner@rki.de	Schlaermann, Philipp/AAN-4861-2020	Schlaermann, Philipp/0000-0001-8586-6417	German AIDS Foundation; Berliner Sparkassenstiftung Medizin	German AIDS Foundation; Berliner Sparkassenstiftung Medizin	The authors thank the German AIDS Foundation (http://www.aids-stiftung.de/) and the Berliner Sparkassenstiftung Medizin (http://www.berliner-sparkassenstiftung-medizin.de/) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAVENA C, 1995, BIOL TRACE ELEM RES, V47, P133, DOI 10.1007/BF02790110; Avota E, 2001, NAT MED, V7, P725, DOI 10.1038/89106; Barcova M, 1999, PFLUG ARCH EUR J PHY, V437, P538, DOI 10.1007/s004240050815; Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; BREEN EC, 1990, J IMMUNOL, V144, P480; CHEN YH, 1993, IMMUNOL LETT, V37, P41, DOI 10.1016/0165-2478(93)90130-T; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; Denner J, 1998, ANN NY ACAD SCI, V862, P75, DOI 10.1111/j.1749-6632.1998.tb09119.x; Denner J, 1996, J ACQ IMMUN DEF SYND, V12, P442, DOI 10.1097/00042560-199608150-00002; DENNER J, 1994, AIDS, V8, P1063, DOI 10.1097/00002030-199408000-00005; Denner J, 2000, J HUMAN VIROL, V3, P81; Denner J, 1995, J CANCER RES CLIN, V121, P35; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DWORKIN BM, 1994, CHEM-BIOL INTERACT, V91, P181, DOI 10.1016/0009-2797(94)90038-8; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Eskdale J, 1998, P NATL ACAD SCI USA, V95, P9465, DOI 10.1073/pnas.95.16.9465; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Ghorpade A, 2001, J VIROL, V75, P6572, DOI 10.1128/JVI.75.14.6572-6583.2001; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Gomez-Pina V, 2012, J LEUKOCYTE BIOL, V91, P933, DOI 10.1189/jlb.0711340; GOTTLIEB RA, 1990, J IMMUNOL, V145, P2566; HARAGUCHI S, 1995, IMMUNOL TODAY, V16, P595, DOI 10.1016/0167-5699(95)80083-2; Haraguchi S, 2008, IMMUNOL RES, V41, P46, DOI 10.1007/s12026-007-0039-6; Hartman AL, 2008, J VIROL, V82, P5348, DOI 10.1128/JVI.00215-08; HENDERSON LA, 1993, J BIOL CHEM, V268, P15291; HONDA M, 1990, J IMMUNOL, V145, P4059; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Hulkkonen J, 2001, ARTHRITIS RHEUM, V44, P176, DOI 10.1002/1529-0131(200101)44:1<176::AID-ANR23>3.0.CO;2-K; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; KADOTA J, 1991, MICROBIOL IMMUNOL, V35, P443, DOI 10.1111/j.1348-0421.1991.tb01575.x; Koutsonikolis A, 1997, IMMUNOL LETT, V55, P109, DOI 10.1016/S0165-2478(97)02695-3; Lane BR, 2001, J VIROL, V75, P5812, DOI 10.1128/JVI.75.13.5812-5822.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangeney M, 2001, J GEN VIROL, V82, P2515, DOI 10.1099/0022-1317-82-10-2515; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Marie JC, 2001, IMMUNITY, V14, P69, DOI 10.1016/S1074-7613(01)00090-5; Morozov VA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-67; Moss WJ, 2004, INT J BIOCHEM CELL B, V36, P1380, DOI 10.1016/j.biocel.2004.01.019; Nagase H, 2000, MATRIX METALLOPROTEI; Nicholas J, 2005, J INTERF CYTOK RES, V25, P373, DOI 10.1089/jir.2005.25.373; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; OOSTENDORP RAJ, 1993, CRIT REV ONCOL HEMAT, V14, P189, DOI 10.1016/1040-8428(93)90009-S; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; RUEGG CL, 1989, J VIROL, V63, P3250, DOI 10.1128/JVI.63.8.3250-3256.1989; RUEGG CL, 1990, J IMMUNOL, V144, P3928; RUEGG CL, 1991, CELL IMMUNOL, V137, P1, DOI 10.1016/0008-8749(91)90051-C; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Speth C, 2000, AIDS, V14, P629, DOI 10.1097/00002030-200004140-00001; Stone CA, 2010, NUTR REV, V68, P671, DOI 10.1111/j.1753-4887.2010.00337.x; TAKESHITA S, 1995, CELL IMMUNOL, V165, P234, DOI 10.1006/cimm.1995.1210; Tan JQ, 1997, J IMMUNOL, V158, P475; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10	60	33	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55199	10.1371/journal.pone.0055199	http://dx.doi.org/10.1371/journal.pone.0055199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383108	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800129
J	Drehmer, M; Duncan, BB; Kac, G; Schmidt, MI				Drehmer, Michele; Duncan, Bruce Bartholow; Kac, Gilberto; Schmidt, Maria Ines			Association of Second and Third Trimester Weight Gain in Pregnancy with Maternal and Fetal Outcomes	PLOS ONE			English	Article							BODY-MASS INDEX; RISK; WOMEN; RECOMMENDATIONS; BIRTH; MACROSOMIA; OVERWEIGHT; DIETARY; OBESITY; PATTERN	Objective: To investigate the association between weekly weight gain, during the second and third trimesters, classified according to the 2009 Institute of Medicine (IOM/NRC) recommendations, and maternal and fetal outcomes. Methods: Gestational weight gain was evaluated in 2,244 pregnant women of the Brazilian Study of Gestational Diabetes (Estudo Brasileiro do Diabetes Gestacional - EBDG). Outcomes were cesarean delivery, preterm birth and small or large for gestational age birth (SGA, LGA). Associations between inadequate weight gain and outcomes were estimated using robust Poisson regression adjusting for pre-pregnancy body mass index, trimester-specific weight gain, age, height, skin color, parity, education, smoking, alcohol consumption, gestational diabetes and hypertensive disorders in pregnancy. Results: In fully adjusted models, in the second trimester, insufficient weight gain was associated with SGA (relative risk [RR] 1.72, 95% confidence interval [CI] 1.26-2.33), and excessive weight gain with LGA (RR 1.64, 95% CI 1.16-2.31); in third trimester, excessive weight gain with preterm birth (RR 1.70, 95% CI 1.08-2.70) and cesarean delivery (RR 1.21, 95% CI 1.03-1.44). Women with less than recommended gestational weight gain in the 2nd trimester had a lesser risk of cesarean deliveries (RR 0.82, 95% CI 0.71-0.96) than women with adequate gestational weight gain in this trimester. Conclusion: Though insufficient weight gain in the 3rd trimester was not associated with adverse outcomes, other deviations from recommended weight gain during second and third trimester were associated with adverse pregnancy outcomes. These findings support, in part, the 2009 IOM/NRC recommendations for nutritional monitoring during pregnancy.	[Drehmer, Michele; Duncan, Bruce Bartholow; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Dept Social Med, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Kac, Gilberto] Univ Fed Rio de Janeiro, Dept Social & Appl Nutr, Josue de Castro Nutr Inst, Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro	Drehmer, M (corresponding author), Univ Fed Rio Grande do Sul, Dept Social Med, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil.	michele.drehmer@gmail.com	Kac, Gilberto/H-6862-2012; Drehmer, Michele/I-1105-2012; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria Inês/AGT-5691-2022; Duncan, Bruce B/L-4140-2016; Schmidt, Maria/V-3196-2019	Kac, Gilberto/0000-0001-8603-9077; Schmidt, Maria Inês/0000-0002-3837-0731; Duncan, Bruce B/0000-0002-7491-2630; 	National Support Program for Centers of Excellence (PRONEX); Brazilian National Council of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Level Personnel (CAPES)	National Support Program for Centers of Excellence (PRONEX); Brazilian National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was funded by the National Support Program for Centers of Excellence (PRONEX)(http://www.cnpq.br/web/guest/historia), the Brazilian National Council of Technological and Scientific Development (CNPq)(http://www.cnpq.br/web/guest) and the Coordination for the Improvement of Higher Level Personnel (CAPES)(http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS B, 1995, OBSTET GYNECOL, V86, P170, DOI 10.1016/0029-7844(95)00119-C; Abrams Barbara, 2000, American Journal of Clinical Nutrition, V71, p1233S; American College of Obstetrics and Gynecology, 1986, MAN PREECL, P91; Amorim AR, 2008, MATERN CHILD NUTR, V4, P1, DOI 10.1111/j.1740-8709.2007.00093.x; Artal R, 2010, OBSTET GYNECOL, V115, P152, DOI 10.1097/AOG.0b013e3181c51908; Asbee SM, 2009, OBSTET GYNECOL, V113, P305, DOI 10.1097/AOG.0b013e318195baef; Bertoldi Nucci L, 2001, Cad Saude Publica, V17, P1367, DOI 10.1590/S0102-311X2001000600020; Bodnar LM, 2011, AM J EPIDEMIOL, V174, P136, DOI 10.1093/aje/kwr064; Carmichael S, 1997, AM J PUBLIC HEALTH, V87, P1984, DOI 10.2105/AJPH.87.12.1984; Claesson IM, 2008, BJOG-INT J OBSTET GY, V115, P44, DOI 10.1111/j.1471-0528.2007.01531.x; COGSWELL ME, 1995, AM J OBSTET GYNECOL, V172, P705, DOI 10.1016/0002-9378(95)90598-7; DeVader SR, 2007, OBSTET GYNECOL, V110, P745, DOI 10.1097/01.AOG.0000284451.37882.85; Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a; Drehmer M, 2010, CAD SAUDE PUBLICA, V26, P1024, DOI 10.1590/S0102-311X2010000500024; Gardner B, 2011, OBES REV, V12, pE602, DOI 10.1111/j.1467-789X.2011.00884.x; Hedderson MM, 2006, OBSTET GYNECOL, V108, P1153, DOI 10.1097/01.AOG.0000242568.75785.68; Hickey CA, 1996, OBSTET GYNECOL, V88, P490, DOI 10.1016/0029-7844(96)00262-1; IBGE Diretoria de Pesquisas, 2010, COORD TRAB REND PESQ; IOM (Institute of Medicine) and NRC (National Research Council), 2009, WEIGHT GAIN PREGNANC; Kabali C, 2007, INT J GYNECOL OBSTET, V97, P100, DOI 10.1016/j.ijgo.2007.02.001; Kaiser PS, 2001, OBSTET GYNECOL, V97, P39, DOI 10.1016/S0029-7844(00)01078-4; Kiel DW, 2007, OBSTET GYNECOL, V110, P752, DOI 10.1097/01.AOG.0000278819.17190.87; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; Rode L, 2007, OBSTET GYNECOL, V109, P1309, DOI 10.1097/01.AOG.0000266556.69952.de; Schieve LA, 1999, EPIDEMIOLOGY, V10, P141, DOI 10.1097/00001648-199903000-00010; SCHMIDT MI, 1993, REV SAUDE PUBL, V27, P271, DOI 10.1590/S0034-89101993000400007; Schmidt MI, 2001, DIABETES CARE, V24, P1151, DOI 10.2337/diacare.24.7.1151; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; SIEGARIZ AM, 1994, OBSTET GYNECOL, V84, P565; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Stotland NE, 2004, OBSTET GYNECOL, V104, P671, DOI 10.1097/01.AOG.0000139515.97799.f6; Strauss RS, 1999, J NUTR, V129, P988, DOI 10.1093/jn/129.5.988; Tanentsapf I, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-81; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; *WHO, 1994, PREV DIAB MELL REP W; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007	37	70	78	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54704	10.1371/journal.pone.0054704	http://dx.doi.org/10.1371/journal.pone.0054704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382944	Green Published, gold			2022-12-27	WOS:000315563800066
J	Kathania, M; Zadeh, M; Lightfoot, YL; Roman, RM; Sahay, B; Abbott, JR; Mohamadzadeh, M				Kathania, Mahesh; Zadeh, Mojgan; Lightfoot, Yaima L.; Roman, Robert M.; Sahay, Bikash; Abbott, Jeffrey R.; Mohamadzadeh, Mansour			Colonic Immune Stimulation by Targeted Oral Vaccine	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTHRAX PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; DENDRITIC CELLS; T-CELLS; MUCOSAL; IMMUNIZATION; RECEPTORS; DELIVERY; MICE	Background: Currently, sufficient data exist to support the use of lactobacilli as candidates for the development of new oral targeted vaccines. To this end, we have previously shown that Lactobacillus gasseri expressing the protective antigen (PA) component of anthrax toxin genetically fused to a dendritic cell (DC)-binding peptide (DCpep) induced efficacious humoral and T cell-mediated immune responses against Bacillus anthracis Sterne challenge. Methodology/Principal Finding: In the present study, we investigated the effects of a dose dependent treatment of mice with L. gasseri expressing the PA-DCpep fusion protein on intestinal and systemic immune responses and confirmed its safety. Treatment of mice with different doses of L. gasseri expressing PA-DCpep stimulated colonic immune responses, resulting in the activation of innate immune cells, including dendritic cells, which induced robust Th1, Th17, CD4(+)Foxp3(+) and CD8(+)Foxp3(+) T cell immune responses. Notably, high doses of L. gasseri expressing PA-DCpep (10(12) CFU) were not toxic to the mice. Treatment of mice with L. gasseri expressing PA-DCpep triggered phenotypic maturation and the release of proinflammatory cytokines by dendritic cells and macrophages. Moreover, treatment of mice with L. gasseri expressing PA-DCpep enhanced antibody immune responses, including IgA, IgG(1), IgG(2b), IgG(2c) and IgG(3). L. gasseri expressing PA-DCpep also increased the gene expression of numerous pattern recognition receptors, including Toll-like receptors, C-type lectin receptors and NOD-like receptors. Conclusion/Significance: These findings suggest that L. gasseri expressing PA-DCpep has substantial immunopotentiating properties, as it can induce humoral and T cell-mediated immune responses upon oral administration and may be used as a safe oral vaccine against anthrax challenge.	[Kathania, Mahesh; Zadeh, Mojgan; Lightfoot, Yaima L.; Roman, Robert M.; Sahay, Bikash; Abbott, Jeffrey R.; Mohamadzadeh, Mansour] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA; [Mohamadzadeh, Mansour] Univ Florida, Div Hepatol Gastroenterol & Nutr, Gainesville, FL USA; [Mohamadzadeh, Mansour] Univ Florida, Dept Med, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mohamadzadeh, M (corresponding author), Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA.	m.zadeh@ufl.edu	Kathania, Mahesh/AAA-5766-2021; Abbott, Jeffrey/AAI-2817-2020	Abbott, Jeffrey/0000-0002-7830-435X; Sahay, Bikash/0000-0003-0905-733X; Kathania, Mahesh/0000-0002-4784-8581	National Institutes of Health [1R01AI098833-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant 1R01AI098833-01. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielinska AU, 2007, INFECT IMMUN, V75, P4020, DOI 10.1128/IAI.00070-07; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Dickinson EC, 1998, SURGERY, V124, P284, DOI 10.1016/S0039-6060(98)70132-1; Erskine CL, 2011, J IMMUNOL, V187, P316, DOI 10.4049/jimmunol.1100658; Flick-Smith HC, 2002, INFECT IMMUN, V70, P2022, DOI 10.1128/IAI.70.4.2022-2028.2002; Friedlander AM, 1999, JAMA-J AM MED ASSOC, V282, P2104, DOI 10.1001/jama.282.22.2104; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Glomski IJ, 2007, J IMMUNOL, V178, P2646, DOI 10.4049/jimmunol.178.5.2646; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mercenier A, 2003, CURR PHARM DESIGN, V9, P175, DOI 10.2174/1381612033392224; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P1155, DOI 10.1586/14760584.7.8.1155; Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P163, DOI 10.1586/14760584.7.2.163; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Mohamadzadeh M, 2010, FUTURE MICROBIOL, V5, P1289, DOI 10.2217/FMB.10.78; Pouwels PH, 1998, INT J FOOD MICROBIOL, V41, P155, DOI 10.1016/S0168-1605(98)00048-8; Roberts M, 2000, INFECT IMMUN, V68, P6041, DOI 10.1128/IAI.68.10.6041-6043.2000; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saklani-Jusforgues H, 2003, INFECT IMMUN, V71, P1083, DOI 10.1128/IAI.71.3.1083-1090.2003; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Stevenson A, 2003, FEMS IMMUNOL MED MIC, V37, P121, DOI 10.1016/S0928-8244(03)00068-3; Tournier JN, 2010, TRENDS MOL MED, V16, P303, DOI 10.1016/j.molmed.2010.04.006; Tournier JN, 2009, EXPERT REV ANTI-INFE, V7, P219, DOI 10.1586/14787210.7.2.219; Welkos S, 2001, MICROBIOL-SGM, V147, P1677, DOI 10.1099/00221287-147-6-1677; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840	34	24	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55143	10.1371/journal.pone.0055143	http://dx.doi.org/10.1371/journal.pone.0055143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383086	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800120
J	Tang, Q; Cao, B; Wu, HY; Cheng, G				Tang, Qiong; Cao, Bin; Wu, Haiyan; Cheng, Gang			Cholesterol-Peptide Hybrids to Form Liposome-Like Vesicles for Gene Delivery	PLOS ONE			English	Article							DNA; THERAPY; OLIGOPEPTIDES; HISTIDINE; POLYMERS	In this paper, four amphiphilic cholesterol-peptide conjugates (Ch-R5H5, Ch-R3H3, Ch-R5 and Ch-R5) were designed and synthesized, and their properties in gene delivery were evaluated in vitro with an aim of developing more efficient gene delivery carriers. These amphiphilic cholesterol-peptide conjugates are composed of hydrophobic cholesterol and positively charged peptides. They were able to self-assemble into micelles at low concentrations and their critical micelle concentrations in phosphate buffered saline (pH 7.4) are <= 85 mu g/mL. Amphiphilic cholesterol-peptide conjugates condensed DNA more efficiently than a hydrophilic cationic oligoarginine (R10) peptide with no hydrophobic segment. Their transfection efficiencies were at least two orders of magnitude greater than that of R10 peptide in HEK-293 cells. Moreover, the introduction of histidine residues in cholesterol-peptide conjugates led to higher gene expression efficiency compared with cholesterol-peptides without histidine (Ch-R5 and Ch-R3), and the luciferase expression level was comparable or even higher than that induced by PEI at its optimal N/P ratio. In particular, Ch-R5H5 condensed DNA into smaller nanoparticles than Ch-R3H3 at higher N/P ratios, and the minimum size of Ch-R5H5/DNA complexes was 180 nm with zeta potential of 23 mV, achieved at the N/P ratio of 30. This liposome-like vesicle may be a promising gene delivery carrier for intravenous therapy.	[Tang, Qiong; Cao, Bin; Wu, Haiyan; Cheng, Gang] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Cheng, Gang] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA	University System of Ohio; University of Akron; Northeast Ohio Medical University (NEOMED)	Cheng, G (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	gc@uakron.edu			National Science Foundation [NSF DMR-12062923]; University of Akron Research Foundation	National Science Foundation(National Science Foundation (NSF)); University of Akron Research Foundation	This work is supported by National Science Foundation (NSF DMR-12062923) and University of Akron Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2003, BIOCONJUGATE CHEM, V14, P979, DOI 10.1021/bc034067y; BEHR JP, 1993, ACCOUNTS CHEM RES, V26, P274, DOI 10.1021/ar00029a008; Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2; Chen MM, 2011, CARBOHYD POLYM, V84, P1244, DOI 10.1016/j.carbpol.2011.01.012; Chen QR, 2002, NUCLEIC ACIDS RES, V30, P1338, DOI 10.1093/nar/30.6.1338; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; Dominguez A, 1997, J CHEM EDUC, V74, P1227, DOI 10.1021/ed074p1227; Guo XD, 2008, BIOMATERIALS, V29, P4838, DOI 10.1016/j.biomaterials.2008.07.053; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Mitchell P, 1998, LANCET, V351, P346, DOI 10.1016/S0140-6736(05)78325-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478; Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923; Obata Y, 2010, J CONTROL RELEASE, V142, P267, DOI 10.1016/j.jconrel.2009.10.023; Pathak Atul, 2009, Biotechnology Journal, V4, P1559, DOI 10.1002/biot.200900161; Patil SN, 2008, J ORG CHEM, V73, P4476, DOI 10.1021/jo702762u; Pichon C, 2001, ADV DRUG DELIVER REV, V53, P75, DOI 10.1016/S0169-409X(01)00221-6; Preuss M, 2003, ORG BIOMOL CHEM, V1, P2430, DOI 10.1039/b302361c; Read ML, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni085; Saccardo P, 2009, BIOTECHNOL ADV, V27, P432, DOI 10.1016/j.biotechadv.2009.03.004; Sennato S, 2005, BBA-BIOMEMBRANES, V1714, P11, DOI 10.1016/j.bbamem.2005.06.004; Seow WY, 2009, ADV MATER, V21, P86, DOI 10.1002/adma.200800928; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Tang Q, 2012, LANGMUIR, V28, P16126, DOI 10.1021/la303299s; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Wiradharma N, 2008, ADV FUNCT MATER, V18, P943, DOI 10.1002/adfm.200700884; Yudovin-Farber I, 2007, MAT SCI ENG C-BIO S, V27, P595, DOI 10.1016/j.msec.2006.05.044	31	28	31	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54460	10.1371/journal.pone.0054460	http://dx.doi.org/10.1371/journal.pone.0054460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382899	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800049
J	Xie, XQ; White, EP; Mehnert, JM				Xie, Xiaoqi; White, Eileen P.; Mehnert, Janice M.			Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma	PLOS ONE			English	Article							PHASE-II TRIAL; SIGNALING PATHWAYS; CANCER CELLS; METASTATIC MELANOMA; MOUSE MODELS; DOUBLE-BLIND; IN-VITRO; SURVIVAL; TEMSIROLIMUS; COMPLEX	The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway promotes melanoma tumor growth and survival while suppressing autophagy, a catabolic process through which cells collect and recycle cellular components to sustain energy homeostasis in starvation. Conversely, inhibitors of the PI3K/AKT/mTOR pathway, in particular the mTOR inhibitor temsirolimus (CCI-779), induce autophagy, which can promote tumor survival and thus, these agents potentially limit their own efficacy. We hypothesized that inhibition of autophagy in combination with mTOR inhibition would block this tumor survival mechanism and hence improve the cytotoxicity of mTOR inhibitors in melanoma. Here we found that melanoma cell lines of multiple genotypes exhibit high basal levels of autophagy. Knockdown of expression of the essential autophagy gene product ATG7 resulted in cell death, indicating that survival of melanoma cells is autophagy-dependent. We also found that the lysosomotropic agent and autophagy inhibitor hydroxychloroquine (HCQ) synergizes with CCI-779 and led to melanoma cell death via apoptosis. Combination treatment with CCI-779 and HCQ suppressed melanoma growth and induced cell death both in 3-dimensional (3D) spheroid cultures and in tumor xenografts. These data suggest that coordinate inhibition of the mTOR and autophagy pathways promotes apoptosis and could be a new therapeutic paradigm for the treatment of melanoma.	[Xie, Xiaoqi; White, Eileen P.; Mehnert, Janice M.] Canc Inst New Jersey, New Brunswick, NJ USA; [Xie, Xiaoqi; Mehnert, Janice M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Med Oncol, Piscataway, NJ 08854 USA; [White, Eileen P.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [White, Eileen P.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	White, EP (corresponding author), Canc Inst New Jersey, New Brunswick, NJ USA.	whiteei@umdnj.edu; mehnerja@umdnj.edu	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065	V Foundation for Cancer Research; Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE [R01CA163591, R01CA130893] Funding Source: NIH RePORTER	V Foundation for Cancer Research; Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Translational Grant from the V Foundation for Cancer Research and by an IMPACT Pilot Award from The Cancer Institute of New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algazy K, 2011, AACR ANN M 2011, V2011, P4500; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Armstrong JL, 2011, CLIN CANCER RES, V17, P2216, DOI 10.1158/1078-0432.CCR-10-3003; Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Beevers CS, 2006, INT J CANCER, V119, P757, DOI 10.1002/ijc.21932; Bray K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041831; Carew JS, 2010, J CELL MOL MED, V14, P2448, DOI 10.1111/j.1582-4934.2009.00832.x; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fan QW, 2011, AUTOPHAGY, V7, P536, DOI 10.4161/auto.7.5.14779; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ghadimi MP, 2012, MOL CANCER THER, V11, P1758, DOI 10.1158/1535-7163.MCT-12-0015; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hui B, 2012, CANCER; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ladoire S, 2012, AUTOPHAGY, V8, P1175, DOI 10.4161/auto.20353; Lazova R, 2012, CLIN CANCER RES, V18, P370, DOI 10.1158/1078-0432.CCR-11-1282; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Ma XH, 2011, CLIN CANC RES; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Margolin K, 2005, CANCER-AM CANCER SOC, V104, P1045, DOI 10.1002/cncr.21265; Margolin KA, 2012, CLIN CANCER RES, V18, P1129, DOI 10.1158/1078-0432.CCR-11-2488; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Marino ML, 2012, J BIOL CHEM; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McAfee Q, 2012, P NATL ACAD SCI USA, V109, P8253, DOI 10.1073/pnas.1118193109; Mehnert JM, 2012, CURRENT ONCOLOGY REP; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Miracco C, 2010, HUM PATHOL, V41, P503, DOI 10.1016/j.humpath.2009.09.004; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Munster T, 2002, ARTHRITIS RHEUM-US, V46, P1460, DOI 10.1002/art.10307; Populo H, 2011, PIGM CELL MELANOMA R, V24, P254, DOI 10.1111/j.1755-148X.2010.00796.x; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rosich L, 2012, CLIN CANC RES OFFICI; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smalley KSM, 2005, ANN NY ACAD SCI, V1059, P16, DOI 10.1196/annals.1339.005; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Tang Y, 2011, CELL DEATH DIFFER, V18, P602, DOI 10.1038/cdd.2010.117; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Verschooten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048264; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; White E, 2012, NATURE REV CANC; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yazbeck VY, 2008, EXP HEMATOL, V36, P443, DOI 10.1016/j.exphem.2007.12.008; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028	72	111	114	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55096	10.1371/journal.pone.0055096	http://dx.doi.org/10.1371/journal.pone.0055096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383069	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800110
J	Park, M; Costa, ELV; Maciel, AT; Silva, DPE; Friedrich, N; Barbosa, EVS; Hirota, AS; Schettino, G; Azevedo, LCP				Park, Marcelo; Vieira Costa, Eduardo Leite; Maciel, Alexandre Toledo; Prudencio e Silva, Debora; Friedrich, Natalia; Santos Barbosa, Edzangela Vasconcelos; Hirota, Adriana Sayuri; Schettino, Guilherme; Pontes Azevedo, Luciano Cesar			Determinants of Oxygen and Carbon Dioxide Transfer during Extracorporeal Membrane Oxygenation in an Experimental Model of Multiple Organ Dysfunction Syndrome	PLOS ONE			English	Article							IONIZED CALCIUM; AFFINITY	Extracorporeal membrane oxygenation (ECMO) has gained renewed interest in the treatment of respiratory failure since the advent of the modern polymethylpentene membranes. Limited information exists, however, on the performance of these membranes in terms of gas transfers during multiple organ failure (MOF). We investigated determinants of oxygen and carbon dioxide transfer as well as biochemical alterations after the circulation of blood through the circuit in a pig model under ECMO support before and after induction of MOF. A predefined sequence of blood and sweep flows was tested before and after the induction of MOF with fecal peritonitis and saline lavage lung injury. In the multivariate analysis, oxygen transfer had a positive association with blood flow (slope = 66, p<0.001) and a negative association with premembrane PaCO2 (slope = -0.96, P = 0.001) and SatO(2) (slope = 21.7, p<0.001). Carbon dioxide transfer had a positive association with blood flow (slope = 17, p<0.001), gas flow (slope = 33, p<0.001), pre-membrane PaCO2 (slope = 1.2, p<0.001) and a negative association with the hemoglobin (slope = -3.478, P = 0.042). We found an increase in pH in the baseline from 7.50[7.46,7.54] to 7.60[7.55,7.65] (p<0.001), and during the MOF from 7.19[6.92,7.32] to 7.41[7.13,7.5] (p<0.001). Likewise, the PCO2 fell in the baseline from 35 [32,39] to 25 [22,27] mmHg (p<0.001), and during the MOF from 59 [47,91] to 34 [28,45] mmHg (p<0.001). In conclusion, both oxygen and carbon dioxide transfers were significantly determined by blood flow. Oxygen transfer was modulated by the pre-membrane SatO(2) and CO2, while carbon dioxide transfer was affected by the gas flow, pre-membrane CO2 and hemoglobin.	[Park, Marcelo; Vieira Costa, Eduardo Leite; Maciel, Alexandre Toledo; Schettino, Guilherme; Pontes Azevedo, Luciano Cesar] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Park, Marcelo; Vieira Costa, Eduardo Leite; Maciel, Alexandre Toledo; Prudencio e Silva, Debora; Friedrich, Natalia; Santos Barbosa, Edzangela Vasconcelos; Hirota, Adriana Sayuri; Pontes Azevedo, Luciano Cesar] Univ Sao Paulo, Sch Med, Hosp Clin, Intens Care Unit, Sao Paulo, Brazil	Hospital Sirio Libanes; Universidade de Sao Paulo	Park, M (corresponding author), Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil.	marcelo.park@hc.fm.usp.br	Costa, Eduardo/K-5841-2012; Azevedo, Luciano CP/H-2652-2012	Costa, Eduardo/0000-0002-6941-3626; Azevedo, Luciano CP/0000-0001-6759-3910	Brazil	Brazil	The authors received a donation of PLS systems from MAQUET cardiovascular from Brazil, and Marcelo Park, Luciano Cesar Pontes Azevedo, Eduardo Leite Vieira Costa and Guilherme Pinto Paula Schettino were lecturers from three Brazilian courses of mechanical ventilation sponsored for MAQUET cardiovascular from Brazil. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and material.	Bosticardo GM, 2010, NEPHROL DIAL TRANSPL, V25, P3458, DOI 10.1093/ndt/gfq422; Almeida JRD, 2010, J TRAUMA, V69, P375, DOI 10.1097/TA.0b013e3181e12b3a; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; DOUGLAS AR, 1988, J APPL PHYSIOL, V65, P473; FIGGE J, 1991, J LAB CLIN MED, V117, P453; Kellum JA, 1998, SHOCK, V9, P364, DOI 10.1097/00024382-199805000-00009; KOLOBOW T, 1977, T AM SOC ART INT ORG, V23, P17; MELIONES JN, 1991, CRIT CARE MED, V19, P1247, DOI 10.1097/00003246-199110000-00006; Morgan T John, 2009, Clin Biochem Rev, V30, P41; MULHAUSEN RO, 1970, CIRCULATION, V42, P195, DOI 10.1161/01.CIR.42.2.195; Nguyen MK, 2006, J APPL PHYSIOL, V100, P1293, DOI 10.1152/japplphysiol.01274.2005; Noah MA, 2011, JAMA; Patroniti N, 2011, INTENS CARE MED, V37, P1447, DOI 10.1007/s00134-011-2301-6; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Pontes De Azevedo LC, 2007, CLINICS, V62, P491, DOI 10.1590/S1807-59322007000400017; R Core Team, 2020, R LANG ENV STAT COMP; RIGGS TE, 1973, J CLIN INVEST, V52, P2660, DOI 10.1172/JCI107459; Rosario AL, 2011, SHOCK; Sethi S, 2011, ANN CARD ANAESTH, V14, P156, DOI [10.4103/0971-9784.81576, 10.4103/0971-9784.84030]; Sidebotham D, 2009, J CARDIOTHORAC VASC; SIGGAARDANDERSEN O, 1977, SCAND J CLIN LAB INV, V37, P15, DOI 10.3109/00365517709098927; Zimmermann AK, 2007, J BIOMED MATER RES B, V80B, P433, DOI 10.1002/jbm.b.30614	22	26	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54954	10.1371/journal.pone.0054954	http://dx.doi.org/10.1371/journal.pone.0054954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383011	gold, Green Submitted, Green Published			2022-12-27	WOS:000315483200021
J	Park, SH; Chen, WC; Hoffman, C; Marsh, LM; West, J; Grunig, G				Park, Sung-Hyun; Chen, Wen-Chi; Hoffman, Carol; Marsh, Leigh M.; West, James; Grunig, Gabriele			Modification of Hemodynamic and Immune Responses to Exposure with a Weak Antigen by the Expression of a Hypomorphic BMPR2 Gene	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; REGULATORY T-CELLS; PROTEIN-RECEPTOR-II; TGF-BETA; AIRWAY INFLAMMATION; CYTOKINE PRODUCTION; ENDOTHELIAL INJURY; MUSCLE-CELLS; IFN-GAMMA; MUTATION	Background: Hypomorphic mutations in the bone morphogenic protein receptor (BMPR2) confer a much greater risk for developing pulmonary arterial hypertension (PAH). However, not all carriers of a mutation in the BMPR2 gene suffer from PAH. We have previously shown that prolonged T helper 2 (Th2) responses in the lungs to a mild antigen delivered via the airways induce severe pulmonary arterial remodeling, but no pulmonary hypertension. The current studies were designed to test the idea that Th2 responses to a mild antigen together with the expression of a hypomorphic BMPR2 gene would trigger pulmonary hypertension. Methodology/Principal Findings: Mice that expressed a hypomorphic BMPR2 transgene (transgene-positive) and transgene-negative mice were either exposed to saline, or primed and exposed to a mild antigen (Ovalbumin) over a prolonged period of time. Only transgene-positive but not transgene-negative mice exposed to antigen developed significantly increased right ventricular systolic pressures, while both groups showed pulmonary artery remodeling with severe muscularization and airway inflammation to a similar degree. Antigen exposure resulted in a smaller increase in the percentage of Interleukin (IL)-13 positive T cells in the lymph nodes, and in a smaller increase in resistin-like-molecule (RELM)alpha expression and a decreased ratio of expression of IL-33 relative to its receptor (IL-1-receptor-like 1, IL1RL1-ST2) in the right ventricles of transgene-positive mice compared to transgene-negative animals. Furthermore, only antigen-challenged transgene-positive mice showed a significant increase in Interferon (IFN)gamma positive T cells over saline-exposed controls. Conclusions/Significance: Our study suggests that exposure with a mild Th2 antigen can trigger pulmonary hypertension on the background of the expression of a hypomorphic BMPR2 gene and that conversely, the expression of the hypomorphic BMPR2 gene can alter the immune response to a mild, inhaled antigen.	[Park, Sung-Hyun; Chen, Wen-Chi; Hoffman, Carol; Grunig, Gabriele] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Marsh, Leigh M.] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [West, James] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN USA; [Grunig, Gabriele] NYU, Sch Med, Dept Med, Div Pulm Med, New York, NY USA	New York University; Ludwig Boltzmann Institute; Vanderbilt University; New York University	Grunig, G (corresponding author), NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA.	ggrunig1@earthlink.net	Marsh, Leigh/AAB-5125-2021; West, James/E-2960-2010	Marsh, Leigh/0000-0002-1754-9249; West, James/0000-0002-6004-0202	National Institutes of Health [1R21HL092370-01, 1R01 HL095764-01, R01HL082694]; American Heart Association [0855943D]; Stony Wold - Herbert Fund, New York; NIEHS Center [5P30ES00260-47]; Cancer Center Support Grant [5P30CA016087-31]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092370, R01HL082694, R01HL095797, R01HL095764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Stony Wold - Herbert Fund, New York; NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was funded in part by the National Institutes of Health 1R21HL092370-01 (G. G.), 1R01 HL095764-01 (GG); R01HL082694 (J.W.); American Heart Association, Founders affiliate (0855943D, G. G.); Stony Wold - Herbert Fund, New York; (S. H. P.). The NIEHS Center Grant 5P30ES00260-47 and the Cancer Center Support Grant (C. C. S. G.) 5P30CA016087-31 provided Core Facility support. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Austin ED, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-6; Baum JR, 2012, AM J PHYSIOL-HEART C, V302, pH790, DOI 10.1152/ajpheart.00498.2011; Chen WC, 2012, J VISUALIZE IN PRESS; Crnkovic S, 2011, RESP PHYSIOL NEUROBI, V179, P342, DOI 10.1016/j.resp.2011.09.016; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Ford JG, 2001, J IMMUNOL, V167, P1769, DOI 10.4049/jimmunol.167.3.1769; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Girerd B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-73; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hoffman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027629; Hoffmann J, 2011, EUR RESPIR J, V37, P1400, DOI 10.1183/09031936.00043310; Johnson JA, 2012, AM J PHYSIOL-LUNG C, V302, pL474, DOI 10.1152/ajplung.00202.2011; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu D, 2012, EUR RESPIR J, V39, P597, DOI 10.1183/09031936.00072911; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Munitz A, 2012, AM J RESP CELL MOL, V46, P703, DOI 10.1165/rcmb.2011-0391OC; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Mushaben EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032468; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Newman JH, 2004, J AM COLL CARDIOL, V43, p33S, DOI 10.1016/j.jacc.2004.02.028; Newman JH, 2001, NEW ENGL J MED, V345, P319, DOI 10.1056/NEJM200108023450502; Padilla J, 2005, J IMMUNOL, V174, P8097, DOI 10.4049/jimmunol.174.12.8097; Perros F, 2005, SEMIN RESP CRIT CARE, V26, P355, DOI 10.1055/s-2005-916149; Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pfarr N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-99; Phillips JA, 2008, GENET MED, V10, P359, DOI 10.1097/GIM.0b013e318172dcdf; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rastogi D, 2004, PEDIATR PULM, V37, P50, DOI 10.1002/ppul.10363; Reynolds LA, 2012, J IMMUNOL, V189, P1113, DOI 10.4049/jimmunol.1200991; Rosenzweig EB, 2008, J HEART LUNG TRANSPL, V27, P668, DOI 10.1016/j.healun.2008.02.009; Said SI, 2010, EUR RESPIR J, V35, P730, DOI 10.1183/09031936.00097109; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Serre K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020731; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Sztrymf B, 2008, AM J RESP CRIT CARE, V177, P1377, DOI 10.1164/rccm.200712-1807OC; Talati M, 2010, AM J PHYSIOL-LUNG C, V299, pL363, DOI 10.1152/ajplung.00295.2009; Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Upton PD, 2009, CURR OPIN PHARMACOL, V9, P274, DOI 10.1016/j.coph.2009.02.007; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17; West J, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-45; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zaiman A, 2005, AM J RESP CELL MOL, V33, P425, DOI 10.1165/rcmb.F307	63	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55180	10.1371/journal.pone.0055180	http://dx.doi.org/10.1371/journal.pone.0055180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383100	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200042
J	Rositch, AF; Gravitt, PE; Tobian, AAR; Newell, K; Quinn, TC; Serwadda, D; Ssebbowa, P; Kiggundu, V; Gray, RH; Reynolds, SJ				Rositch, Anne F.; Gravitt, Patti E.; Tobian, Aaron A. R.; Newell, Kevin; Quinn, Thomas C.; Serwadda, David; Ssebbowa, Paschal; Kiggundu, Valerian; Gray, Ronald H.; Reynolds, Steven J.			Frequent Detection of HPV before and after Initiation of Antiretroviral Therapy among HIV/HSV-2 Co-Infected Women in Uganda	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL NEOPLASIA; HIV; PREVALENCE; RISK; PERSISTENCE; CLEARANCE; DISEASE	Objectives: Most data on HPV and antiretroviral therapy (ART) come from high-resource countries with infrequent sampling for HPV pre- and post-ART initiation. Therefore, we examined the frequency of cervical HPV DNA detection among HIV/HSV-2 co-infected women followed monthly for 6 months both before and after initiation of ART in Rakai, Uganda. Methods: Linear Array was used to detect 37 HPV genotypes in self-collected cervicovaginal swabs from 96 women who initiated ART. Random-effects log-binomial regression was used to compare the prevalence of HPV detection in the pre- and post-ART periods and determine other potential risk factors, including CD4 counts and HIV viral load. Results: Nearly all women had detectable HPV in the 6 months preceding ART initiation (92%) and the cumulative prevalence remained high following initiation of therapy (90%). We found no effect of ART on monthly HPV DNA detection (prevalence ratio: 1.0; 95% confidence interval: 0.96, 1.08), regardless of immune reconstitution or HIV viral suppression. Older age and higher pre-ART CD4 counts were associated with a significantly lower risk of HPV DNA detection. Conclusions: ART did not impact HPV detection within 6 months of therapy initiation, highlighting the importance of continued and consistent screening, even after ART-initiation and immune reconstitution.	[Rositch, Anne F.; Gravitt, Patti E.; Tobian, Aaron A. R.; Gray, Ronald H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Gravitt, Patti E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Gravitt, Patti E.] Perdana Univ Grad Sch Med, Serdang, Malaysia; [Tobian, Aaron A. R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Newell, Kevin] SAIC Frederick Inc, Clin Res Directorate, Clin Monitoring Res Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Serwadda, David; Ssebbowa, Paschal; Kiggundu, Valerian; Gray, Ronald H.; Reynolds, Steven J.] Rakai Hlth Sci Program, Entebbe, Uganda; [Quinn, Thomas C.; Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Reynolds, Steven J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Perdana University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Rakai Health Sciences Program; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University	Rositch, AF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	arositch@jhsph.edu		Reynolds, Steven/0000-0002-5403-2759; Rositch, Anne/0000-0002-0403-8482	Institutional Research Cancer Epidemiology Fellowship; National Cancer Institute [T32 CA0009314]; National Institutes of Health (NIH) [1K23AI093152-01A1]; Doris Duke Charitable Foundation [22006.02]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH [PO1 AI-30731-19]; National Cancer Institute, NIH [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases; Office of Cyberinfrastructure and Computational Biology (OCICB), NIAID; NATIONAL CANCER INSTITUTE [T32CA009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361, P01AI030731, K23AI093152] Funding Source: NIH RePORTER	Institutional Research Cancer Epidemiology Fellowship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Cyberinfrastructure and Computational Biology (OCICB), NIAID; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A. F. Rositch was supported by the Institutional Research Cancer Epidemiology Fellowship funded by the National Cancer Institute T32 CA0009314. A. A. R. Tobian was supported by the National Institutes of Health (NIH) 1K23AI093152-01A1 and the Doris Duke Charitable Foundation Clinician Scientist Development Award (22006.02). The trial was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, and in part through program project grant PO1 AI-30731-19. This project has been funded in part by the National Cancer Institute, NIH under contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. This research was supported [in part] by the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the study participants, the Rakai Health Science Program staff members and the Rakai Community Advisory Board whose commitment and cooperation made this study possible. Also, we thank the Office of Cyberinfrastructure and Computational Biology (OCICB), NIAID for their support.	Adler DH, 2012, AIDS; Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165; Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; Ahdieh-Grant L, 2004, JNCI-J NATL CANCER I, V96, P1070, DOI 10.1093/jnci/djh192; Banura C, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-11; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bratcher LF, 2010, INFECT AGENTS CANCER, V12, P5; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Coutlee F, 2002, J CLIN MICROBIOL, V40, P902, DOI 10.1128/JCM.40.3.902-907.2002; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; Del Mistro A, 2004, CLIN INFECT DIS, V38, P737, DOI 10.1086/381681; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Fife KH, 2009, JAIDS-J ACQ IMM DEF, V51, P274, DOI 10.1097/QAI.0b013e3181a97be5; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Heard I, 2002, AIDS, V16, P1799, DOI 10.1097/00002030-200209060-00013; Heard I, 2006, ANTIVIR THER, V11, P1091; La Ruche G, 1998, INT J CANCER, V76, P480, DOI 10.1002/(SICI)1097-0215(19980518)76:4&lt;480::AID-IJC6&gt;3.0.CO;2-N; Lillo FB, 2001, J INFECT DIS, V184, P547, DOI 10.1086/322856; Marks MA, 2011, CYTOKINE, V56, P798, DOI 10.1016/j.cyto.2011.09.012; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Palefsky JM, 2003, CURR OPIN ONCOL, V15, P382, DOI 10.1097/00001622-200309000-00007; Reynolds SJ, 2012, LANCET INFECT DIS, V12, P441, DOI 10.1016/S1473-3099(12)70037-3; Safaeian M, 2008, CANCER EPIDEM BIOMAR, V17, P1300, DOI 10.1158/1055-9965.EPI-07-2678; Schuman P, 2003, J INFECT DIS, V188, P128, DOI 10.1086/375783; Shrestha S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-295; Sirera G, 2008, J ANTIMICROB CHEMOTH, V61, P191, DOI 10.1093/jac/dkm412; Soncini Emanuele, 2007, Acta Biomed, V78, P36; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	38	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55383	10.1371/journal.pone.0055383	http://dx.doi.org/10.1371/journal.pone.0055383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383171	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200029
J	Doesburg, SM; Ibrahim, GM; Smith, ML; Sharma, R; Viljoen, A; Chu, B; Rutka, JT; Snead, OC; Pang, EW				Doesburg, Sam M.; Ibrahim, George M.; Smith, Mary Lou; Sharma, Rohit; Viljoen, Amrita; Chu, Bill; Rutka, James T.; Snead, O. Carter, III; Pang, Elizabeth W.			Altered Rolandic Gamma-Band Activation Associated with Motor Impairment and Ictal Network Desynchronization in Childhood Epilepsy	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; EPILEPTOGENIC NETWORKS; NEURAL SYNCHRONY; DYNAMICS; EEG; POWER; BRAIN; COMMUNICATION; CONNECTIVITY; COHERENCE	Epilepsy is associated with an abnormal expression of neural oscillations and their synchronization across brain regions. Oscillatory brain activation and synchronization also play an important role in cognition, perception and motor control. Childhood epilepsy is associated with a variety of cognitive and motor deficits, but the relationship between altered functional brain responses in various frequency ranges and functional impairment in these children remains poorly understood. We investigated functional magnetoencephalographic (MEG) responses from motor cortex in multiple functionally relevant frequency bands following median nerve stimulation in twelve children with epilepsy, including four children with motor impairments. We demonstrated that children with motor impairments exhibit an excessive gamma-band response from Rolandic cortex, and that the magnitude of this Rolandic gamma response is negatively associated with motor function. Abnormal responses from motor cortex were also associated with ictal desynchronization of oscillations within Rolandic cortex measured using intracranial EEG (iEEG). These results provide the evidence that ictal disruption of motor networks is associated with an altered functional response from motor cortex, which is in turn associated with motor impairment.	[Doesburg, Sam M.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Doesburg, Sam M.; Smith, Mary Lou; Snead, O. Carter, III; Pang, Elizabeth W.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Doesburg, Sam M.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Ibrahim, George M.; Rutka, James T.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Ibrahim, George M.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Smith, Mary Lou; Sharma, Rohit; Viljoen, Amrita; Chu, Bill; Snead, O. Carter, III; Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Smith, Mary Lou] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Doesburg, SM (corresponding author), Hosp Sick Children, Dept Diagnost Imaging, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sam.doesburg@sickkids.ca			Hospital for Sick Children, Foundation Student Scholarship Program; Hospital for Sick Children Centre for Brain and Behavior; Ontario Brain Institute; Wiley Family and Jack Beqaj Funds for Epilepsy Surgery Research; University of Toronto Surgeon-Scientist Program; Royal College of Physicians and Surgeons of Canada Clinician-Investigator Program	Hospital for Sick Children, Foundation Student Scholarship Program; Hospital for Sick Children Centre for Brain and Behavior; Ontario Brain Institute; Wiley Family and Jack Beqaj Funds for Epilepsy Surgery Research; University of Toronto Surgeon-Scientist Program; Royal College of Physicians and Surgeons of Canada Clinician-Investigator Program	This work was supported by the Hospital for Sick Children, Foundation Student Scholarship Program, the Hospital for Sick Children Centre for Brain and Behavior, the Ontario Brain Institute, the Wiley Family and Jack Beqaj Funds for Epilepsy Surgery Research, the University of Toronto Surgeon-Scientist Program, and the Royal College of Physicians and Surgeons of Canada Clinician-Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2011, EPILEPSIA, V52, P1802, DOI 10.1111/j.1528-1167.2011.03199.x; Bartolomei F, 2005, CLIN NEUROPHYSIOL, V116, P2473, DOI 10.1016/j.clinph.2005.05.013; Benasich AA, 2008, BEHAV BRAIN RES, V195, P215, DOI 10.1016/j.bbr.2008.08.049; Benifla M, 2009, J NEUROSURG-PEDIATR, V4, P199, DOI 10.3171/2009.3.PEDS08459; Berg AT, 2011, EPILEPSIA, V52, P7, DOI 10.1111/j.1528-1167.2010.02905.x; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Chu B, 2007, NEW FRONTIERS BIOMAG, V1300; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Ibrahim GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039326; Jacobs J, 2008, EPILEPSIA, V49, P1893, DOI 10.1111/j.1528-1167.2008.01656.x; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Kulandaivel K, 2011, EPILEPSY BEHAV, V20, P700, DOI 10.1016/j.yebeh.2011.02.021; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; Matthew C.G., 1964, GROOVED PEGBOARD INS; Moazami-Goudarzi M, 2008, NEUROIMAGE, V41, P985, DOI 10.1016/j.neuroimage.2008.03.032; Ochi A, 2007, EPILEPSIA, V48, P286, DOI 10.1111/j.1528-1167.2007.00923.x; Oishi M, 2003, J NEUROL NEUROSUR PS, V74, P1649, DOI 10.1136/jnnp.74.12.1649; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Reitan RM., 1969, MANUAL ADM NEUROPSYC; Ribary U, 2005, PROG BRAIN RES, V150, P127, DOI 10.1016/S0079-6123(05)50010-4; Sarnthein J, 2006, BRAIN, V129, P55, DOI 10.1093/brain/awh631; Sarnthein J, 2007, J NEUROSCI, V27, P124, DOI 10.1523/JNEUROSCI.2411-06.2007; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Sharma R, 2007, NEW FRONTIERS BIOMAG, V1300; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; Stoffers D, 2008, NEUROIMAGE, V41, P212, DOI 10.1016/j.neuroimage.2008.02.027; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang Y, 2011, J NEUROSCI, V31, P13204, DOI 10.1523/JNEUROSCI.6227-10.2011; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Womelsdorf T, 2006, J PHYSIOL-PARIS, V100, P182, DOI 10.1016/j.jphysparis.2007.01.005	45	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54943	10.1371/journal.pone.0054943	http://dx.doi.org/10.1371/journal.pone.0054943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383007	Green Submitted, gold, Green Published			2022-12-27	WOS:000315211500037
J	Ransom, JI; Hobbs, NT; Bruemmer, J				Ransom, Jason I.; Hobbs, N. Thompson; Bruemmer, Jason			Contraception can Lead to Trophic Asynchrony between Birth Pulse and Resources	PLOS ONE			English	Article							PORCINE ZONAE-PELLUCIDAE; CLIMATE-CHANGE; IMMUNIZATION; PHENOLOGY; IMMUNOCONTRACEPTION; MARES; MECHANISMS; FERTILITY; ADJUVANTS	Abiotic inputs such as photoperiod and temperature can regulate reproductive cyclicity in many species. When humans perturb this process by intervening in reproductive cycles, the ecological consequences may be profound. Trophic mismatches between birth pulse and resources in wildlife species may cascade toward decreased survival and threaten the viability of small populations. We followed feral horses (Equus caballus) in three populations for a longitudinal study of the transient immunocontraceptive porcine zona pellucida (PZP), and found that repeated vaccinations extended the duration of infertility far beyond the targeted period. After the targeted years of infertility, the probability of parturition from post-treated females was 25.6% compared to 64.1% for untreated females, when the data were constrained only to females that had demonstrated fertility prior to the study. Estimated time to parturition increased 411.3 days per year of consecutive historical treatment. Births from untreated females in these temperate latitude populations were observed to peak in the middle of May, indicating peak conception occurred around the previous summer solstice. When the post-treated females did conceive and give birth, parturition was an estimated 31.5 days later than births from untreated females, resulting in asynchrony with peak forage availability. The latest neonate born to a post-treated female arrived 7.5 months after the peak in births from untreated females, indicating conception occurred within 24-31 days of the winter solstice. These results demonstrate surprising physiological plasticity for temperate latitude horses, and indicate that while photoperiod and temperature are powerful inputs driving the biological rhythms of conception and birth in horses, these inputs may not limit their ability to conceive under perturbed conditions. The protracted infertility observed in PZP-treated horses may be of benefit for managing overabundant wildlife, but also suggests caution for use in small refugia or rare species.	[Ransom, Jason I.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Hobbs, N. Thompson] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Bruemmer, Jason] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA	United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University	Ransom, JI (corresponding author), Natl Pk Serv, Biol Resource Management Div, Ft Collins, CO USA.	Jason_I_Ransom@nps.gov	Ransom, Jason/AAT-4025-2020; Hobbs, Tom/C-5263-2016	Ransom, Jason/0000-0002-5930-4004; Bruemmer, Jason/0000-0002-4236-756X	United States Geological Survey (USGS) Wildlife Program	United States Geological Survey (USGS) Wildlife Program	The late F.J. Singer acquired funding and initiated the precursor to this project with the assistance of L. Coates-Markle and A.J. Kane. This research was funded by the United States Geological Survey (USGS) Wildlife Program and conducted through a cooperative effort between the USGS Fort Collins Science Center, Bureau of Land Management, United States Department of Agriculture Animal and Plant Health Inspection Service, and Colorado State University. No agency administration or funding program had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the United States Government.	Berger J., 1986, WILD HORSES GREAT BA; Card C, 1993, EQUINE REPROD, P567; DUNBAR BS, 1989, FERTIL STERIL, V52, P311; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Feh C, 2012, INT WILD EQ C, P69; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; GARROTT RA, 1992, J WILDLIFE MANAGE, V56, P456, DOI 10.2307/3808859; Ginther OJ, 2001, ANIM REPROD, V1, P31; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; Gray ME, 2010, REPRODUCTION, V139, P45, DOI 10.1530/REP-08-0456; Grubaugh W, 1982, J Reprod Fertil Suppl, V32, P293; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hone J., 2007, WILDLIFE DAMAGE CONT; HOWELL CE, 1951, J ANIM SCI, V10, P789, DOI 10.2527/jas1951.104789x; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Kirkpatrick JF, 2002, REPRODUCTION, P197; LIU IKM, 1989, J REPROD FERTIL, V85, P19, DOI 10.1530/jrf.0.0850019; Lyda RO, 2005, J ZOO WILDLIFE MED, V36, P610, DOI 10.1638/04104.1; Madosky JM, 2010, APPL ANIM BEHAV SCI, V128, P50, DOI 10.1016/j.applanim.2010.09.013; MAHIBROWN CA, 1985, BIOL REPROD, V32, P761, DOI 10.1095/biolreprod32.4.761; Munson Linda, 2005, P66; National Research Council, 2007, NUTR REQ HORS; Nunez CMV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013635; Nunez CMV, 2009, APPL ANIM BEHAV SCI, V117, P74, DOI 10.1016/j.applanim.2008.12.001; Palmer E, 1982, J Reprod Fertil Suppl, V32, P275; Palmer E, 1998, REPROD DOMEST ANIM, V33, P205, DOI 10.1111/j.1439-0531.1998.tb01343.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Powell D. M., 2001, Journal of Applied Animal Welfare Science, V4, P271, DOI 10.1207/S15327604JAWS0404_04; Ransom JI, 2011, WILDLIFE SOC B, V35, P343, DOI 10.1002/wsb.66; Ransom JI, 2010, APPL ANIM BEHAV SCI, V124, P51, DOI 10.1016/j.applanim.2010.01.015; Ransom JI, 2012, POPULATION ECOLOGY F; Reitor RJ, 1983, PINEAL; Roelle JE, 2010, US GEOLOGICAL SURVEY; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Stoops MA, 2006, REPROD FERT DEVELOP, V18, P667, DOI 10.1071/RD05045; Tan B, 2011, IEEE J-STARS, V4, P361, DOI 10.1109/JSTARS.2010.2075916; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Turner A, 2002, REPRODUCTION, P187; Turner JW, 2002, REPRODUCTION, P177; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Waring G, 1983, HORSE BEHAV; WOOD DM, 1981, BIOL REPROD, V25, P439, DOI 10.1095/biolreprod25.2.439	44	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54972	10.1371/journal.pone.0054972	http://dx.doi.org/10.1371/journal.pone.0054972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383018	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500043
J	Song, YX; Ye, X; Ye, LQ; Li, BJ; Wang, LJ; Hua, YY				Song, Yingxiang; Ye, Xiao; Ye, Leqin; Li, Bijun; Wang, Lijun; Hua, Yanyin			Disturbed Subjective Sleep in Chinese Females with Type 2 Diabetes on Insulin Therapy	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; RESISTANCE; QUALITY; APNEA; DURATION; MELLITUS; IMPACT; RISK; ASSOCIATIONS	Objective:The aim of this study is to investigate the prevalence and determine the possible risk factors of poor sleep quality in Chinese type 2 diabetes patients with insulin treatment. Methods: 140 type 2 diabetes patients with insulin treatments were enrolled in our study. General characteristics and laboratory testing such glycosylated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), post-prandial plasma glucose (PPG) were measured. Every patient completed Chinese version of Pittsburgh Sleep Quality Index (PSQI) questionnaire. PSQI global score>5 was defined as poor sleep quality. Results: Global PSQI score was significantly higher in female type 2 diabetes patients with insulin treatment than male (7.52 vs 6.08, P<0.05). After adjusting for age, BMI, FPG, PPG, HbA1c and duration of diabetes, female is still an independent risk factor for poor sleep quality [OR = 2.55, 95% confidence interval (CI) = 1.24-5.27, P = 0.01]. Conclusion: The results suggest that we found poor sleep quality in female Chinese type 2 diabetes patients with insulin treatment and these findings may contribute to sleep disorder control in female type 2 diabetes.	[Song, Yingxiang; Ye, Xiao; Ye, Leqin; Li, Bijun; Wang, Lijun; Hua, Yanyin] Zhejiang Prov Peoples Hosp, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital	Hua, YY (corresponding author), Zhejiang Prov Peoples Hosp, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China.	Yanyin_hua@sina.com						Bidulescu A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-581; Bloomgarden ZT, 1999, DIABETES CARE, V22, P1739, DOI 10.2337/diacare.22.10.1739; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Dunn SE, 2007, J EXP MED, V204, P321, DOI 10.1084/jem.20061839; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Kita T, 2012, DIABETES CARE, V35, P313, DOI 10.2337/dc11-1455; Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962; Liu R, 2011, SLEEP MED, V12, P914, DOI 10.1016/j.sleep.2011.04.006; Natl Ctr Sleep Disorders Res, 1999, SLEEP, V22, pS402; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Perciaccante Antonio, 2006, BMC Cardiovasc Disord, V6, P19, DOI 10.1186/1471-2261-6-19; Rajendran A, 2012, DIABETES METAB J, V36, P70, DOI 10.4093/dmj.2012.36.1.70; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011; Tasali E, 2008, J CLIN ENDOCR METAB, V93, P3878, DOI 10.1210/jc.2008-0925; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Terzano MG, 2004, SLEEP MED, V5, P67, DOI 10.1016/j.sleep.2003.09.006; Trento M, 2008, ACTA DIABETOL, V45, P225, DOI 10.1007/s00592-008-0047-6; Tsai YW, 2012, FAM PRACT, V29, P30, DOI 10.1093/fampra/cmr041; van Dijk M, 2011, DIABETOLOGIA, V54, P1967, DOI 10.1007/s00125-011-2184-7; West SD, 2006, THORAX, V61, P945, DOI 10.1136/thx.2005.057745; Yang SH, 2010, NEW ENGL J MED, V362, P2425; Zambon A, 2006, ARTERIOSCL THROM VAS, V26, P977, DOI 10.1161/01.ATV.0000204327.96431.9a	27	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54951	10.1371/journal.pone.0054951	http://dx.doi.org/10.1371/journal.pone.0054951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383010	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500038
J	Gay-Jordi, G; Guash, E; Benito, B; Brugada, J; Nattel, S; Mont, L; Serrano-Mollar, A				Gay-Jordi, Gemma; Guash, Eduard; Benito, Begona; Brugada, Josep; Nattel, Stanley; Mont, Lluis; Serrano-Mollar, Anna			Losartan Prevents Heart Fibrosis Induced by Long-Term Intensive Exercise in an Animal Model	PLOS ONE			English	Article							II TYPE-1 RECEPTOR; ANGIOTENSIN-CONVERTING ENZYME; LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL FIBROSIS; CARDIAC FIBROBLASTS; ATRIAL-FIBRILLATION; ESSENTIAL-HYPERTENSION; ALDOSTERONE SYSTEM; COLLAGEN; BLOCKADE	Rationale: Recently it has been shown that long-term intensive exercise practice is able to induce myocardial fibrosis in an animal model. Angiotensin II is a profibrotic hormone that could be involved in the cardiac remodeling resulting from endurance exercise. Objective: This study examined the antifibrotic effect of losartan, an angiotensin II type 1 receptor antagonist, in an animal model of heart fibrosis induced by long-term intense exercise. Methods and Results: Male Wistar rats were randomly distributed into 4 experimental groups: Exercise, Exercise plus losartan, Sedentary and Sedentary plus losartan. Exercise groups were conditioned to run vigorously for 16 weeks. Losartan was orally administered daily before each training session (50 mg/kg/day). Time-matched sedentary rats served as controls. After euthanasia, heart hypertrophy was evaluated by histological studies; ventricular collagen deposition was quantified by histological and biochemical studies; and messenger RNA and protein expression of transforming growth factor-beta 1, fibronectin-1, matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-1, procollagen-I and procollagen-III was evaluated in all 4 cardiac chambers. Daily intensive exercise caused hypertrophy in the left ventricular heart wall and originated collagen deposition in the right ventricle. Additionally long-term intensive exercise induced a significant increase in messenger RNA expression and protein synthesis of the major fibrotic markers in both atria and in the right ventricle. Losartan treatment was able to reduce all increases in messenger RNA expression and protein levels caused by exercise, although it could not completely reverse the heart hypertrophy. Conclusions: Losartan treatment prevents the heart fibrosis induced by endurance exercise in training animals.	[Gay-Jordi, Gemma; Serrano-Mollar, Anna] Inst Invest Biomed Barcelona IIBB CSIC, Dept Expt Pathol, Barcelona, Spain; [Gay-Jordi, Gemma; Guash, Eduard; Benito, Begona; Brugada, Josep; Mont, Lluis; Serrano-Mollar, Anna] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain; [Guash, Eduard; Benito, Begona; Brugada, Josep; Mont, Lluis] Univ Barcelona, Dept Cardiol, Thorax Inst, Hosp Clin, Barcelona, Catalonia, Spain; [Guash, Eduard; Benito, Begona; Nattel, Stanley] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Guash, Eduard; Benito, Begona; Nattel, Stanley] Univ Montreal, Montreal, PQ, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Universite de Montreal; Universite de Montreal	Serrano-Mollar, A (corresponding author), Inst Invest Biomed Barcelona IIBB CSIC, Dept Expt Pathol, Barcelona, Spain.	anna.serranomollar@iibb.csic.es	Benito, Begoña/D-7401-2014; Mont, Lluís/AAO-9518-2021; Guasch, Eduard/D-1243-2013; Serrano-Mollar, Anna/S-1583-2019	Mont, Lluís/0000-0002-8115-5906; Guasch, Eduard/0000-0003-4238-5319; Nattel, Stanley/0000-0002-5565-3311; BRUGADA, JOSEP/0000-0002-5662-8302; Serrano-Mollar, Anna/0000-0002-4990-8162	Sociedad Espanola de Cardiologia; Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III [PI050210, PS09/02362]; Rio Hortega from the Spanish Health Ministry [CM06/00189, CM08/00201]; Universitats i Recerca [2005SGR00497]	Sociedad Espanola de Cardiologia(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III; Rio Hortega from the Spanish Health Ministry; Universitats i Recerca	This work was supported by grants from the Sociedad Espanola de Cardiologia, Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III (PI050210 and PS09/02362), and Rio Hortega (CM06/00189 and CM08/00201) from the Spanish Health Ministry, Universitats i Recerca (2005SGR00497). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanza AC, 2009, J HUM HYPERTENS, V23, P259, DOI 10.1038/jhh.2008.127; Baldesberger S, 2008, EUR HEART J, V29, P71, DOI 10.1093/eurheartj/ehm555; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Bernstein KE, 2006, HYPERTENSION, V47, P509, DOI 10.1161/01.HYP.0000196266.23639.c6; Biffi A, 2002, J AM COLL CARDIOL, V40, P446, DOI 10.1016/S0735-1097(02)01977-0; CASALE PN, 1986, ANN INTERN MED, V105, P173, DOI 10.7326/0003-4819-105-2-173; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Chen YJ, 2000, J APPL PHYSIOL, V88, P1749, DOI 10.1152/jappl.2000.88.5.1749; D'Amore A, 2005, HYPERTENSION, V46, P1347, DOI 10.1161/01.HYP.0000193504.51489.cf; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; DAHLOF B, 1992, AM J HYPERTENS, V5, P900; Fagard R, 2003, HEART, V89, P1455, DOI 10.1136/heart.89.12.1455; Fleming I, 2006, CURR OPIN NEPHROL HY, V15, P8, DOI 10.1097/01.mnh.0000196146.65330.ea; GANAU A, 1992, J AM COLL CARDIOL, V19, P1550, DOI 10.1016/0735-1097(92)90617-V; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; Jiang YN, 2002, HYPERTENS RES, V25, P191, DOI 10.1291/hypres.25.191; Julius S, 2007, AM J CARDIOL, V100, p32J, DOI 10.1016/j.amjcard.2007.05.012; La Gerche Andre, 2007, Heart Lung Circ, V16 Suppl 3, pS102, DOI 10.1016/j.hlc.2007.03.014; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lindsay MM, 2007, BRIT J SPORT MED, V41, P447, DOI 10.1136/bjsm.2006.031534; Liu YH, 1997, J CLIN INVEST, V99, P1926, DOI 10.1172/JCI119360; Marshall RP, 2004, AM J PHYSIOL-LUNG C, V286, pL156, DOI 10.1152/ajplung.00313.2002; Molina-Molina M, 2006, THORAX, V61, P604, DOI 10.1136/thx.2005.051946; Mont L, 2002, EUR HEART J, V23, P477, DOI 10.1053/euhj.2001.2802; Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263; Norton GR, 1997, CIRCULATION, V96, P1991, DOI 10.1161/01.CIR.96.6.1991; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Querejeta R, 2000, CIRCULATION, V101, P1729; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; SCHIEFFER B, 1994, CIRCULATION, V89, P2273, DOI 10.1161/01.CIR.89.5.2273; Sun Y, 1998, ANN MED, V30, P3; Taniike M, 2008, CIRCULATION, V117, P545, DOI 10.1161/CIRCULATIONAHA.107.710434; Verzola RMM, 2006, BRAZ J MED BIOL RES, V39, P621, DOI 10.1590/S0100-879X2006000500009; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Weber KT, 1997, CIRCULATION, V96, P4065; Whyte G, 2008, BRIT J SPORT MED, V42, P304, DOI 10.1136/bjsm.2007.038158; Wilson M, 2011, J APPL PHYSIOL, V110, P1622, DOI 10.1152/japplphysiol.01280.2010; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wu L, 2002, ARTERIOSCL THROM VAS, V22, P49, DOI 10.1161/hq0102.102277; Yoshiji H, 2007, J GASTROEN HEPATOL, V22, pS93, DOI 10.1111/j.1440-1746.2006.04663.x; Zhou GP, 1996, MOL CELL BIOCHEM, V154, P171, DOI 10.1007/BF00226785	42	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55427	10.1371/journal.pone.0055427	http://dx.doi.org/10.1371/journal.pone.0055427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383330	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900037
J	Lee, SW; Devlin, JM; Markham, JF; Noormohammadi, AH; Browning, GF; Ficorilli, NP; Hartley, CA; Markham, PF				Lee, Sang-Won; Devlin, Joanne M.; Markham, John F.; Noormohammadi, Amir H.; Browning, Glenn F.; Ficorilli, Nino P.; Hartley, Carol A.; Markham, Philip F.			Phylogenetic and Molecular Epidemiological Studies Reveal Evidence of Multiple Past Recombination Events between Infectious Laryngotracheitis Viruses	PLOS ONE			English	Article							LIVE ATTENUATED VACCINES; GENOME SEQUENCE; HERPESVIRUS-INFECTION; GLYCOPROTEIN-G; DNA; INFERENCE; DYNAMICS; CHICKEN; ORIGIN; FAMILY	In contrast to the RNA viruses, the genome of large DNA viruses such as herpesviruses have been considered to be relatively stable. Intra-specific recombination has been proposed as an important, but underestimated, driving force in herpesvirus evolution. Recently, two distinct field strains of infectious laryngotracheitis virus (ILTV) have been shown to have arisen from independent recombination events between different commercial ILTV vaccines. In this study we sequenced the genomes of additional ILTV strains and also utilized other recently updated complete genome sequences of ILTV to confirm the existence of a number of ILTV recombinants in nature. Multiple recombination events were detected in the unique long and repeat regions of the genome, but not in the unique short region. Most recombinants contained a pair of crossover points between two distinct lineages of ILTV, corresponding to the European origin and the Australian origin vaccine strains of ILTV. These results suggest that there are two distinct genotypic lineages of ILTV and that these commonly recombine in the field.	[Lee, Sang-Won; Devlin, Joanne M.; Browning, Glenn F.; Ficorilli, Nino P.; Hartley, Carol A.; Markham, Philip F.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia; [Noormohammadi, Amir H.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Werribee, Vic, Australia; [Markham, John F.] Univ Melbourne, Natl ICT Australia NICTA Victoria Res Lab, Dept Elect & Elect Engn, Sch Engn, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; NICTA; University of Melbourne	Lee, SW (corresponding author), Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia.	leesw@unimelb.edu.au	Browning, Glenn Francis/P-4459-2014	Browning, Glenn Francis/0000-0002-0903-2469; Markham, John/0000-0002-5738-3861; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; Devlin, Joanne/0000-0003-0400-9670; Hartley, Carol/0000-0001-6174-7341	Rural Industries Research and Development Corporation, Australia; National ICT, Australia (NICTA); Australian Government; Australian Research Council through the ICT Centre of Excellence program	Rural Industries Research and Development Corporation, Australia; National ICT, Australia (NICTA); Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council)	The Rural Industries Research and Development Corporation, Australia, funded this study. This work is supported by National ICT, Australia (NICTA). NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, APVMA GAZETTE, P12; BAGUST TJ, 1986, AVIAN DIS, V30, P179, DOI 10.2307/1590631; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Bagust TJ, 1991, EPO patent, Patent No. [1991,002,053, 1991002053]; BirdLife International, 2012, SPEC FACTSH GALL GAL; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chandra YG, 2012, VIRUS GENES, V44, P470, DOI 10.1007/s11262-012-0728-7; Cheng TP, 2010, J VIROL, V84, P2623, DOI 10.1128/JVI.02142-09; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2011, VACCINE, V29, P5699, DOI 10.1016/j.vaccine.2011.06.002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2010, GEN V5 0; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; FAHEY KJ, 1983, AVIAN PATHOL, V12, P505, DOI 10.1080/03079458308436195; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; JUKES T H, 1969, P21; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Peters GA, 2006, J VIROL, V80, P9850, DOI 10.1128/JVI.00715-06; PULSFORD M. F., 1956, Australian Veterinary Journal, V32, P138, DOI 10.1111/j.1751-0813.1956.tb05637.x; PULSFORD M. L., 1953, AUSTRALIAN VET JOUR, V29, P8, DOI 10.1111/j.1751-0813.1953.tb05189.x; PURCELL DA, 1974, AUST VET J, V50, P419, DOI 10.1111/j.1751-0813.1974.tb05357.x; ROIZMANN B, 1992, ARCH VIROL, V123, P425, DOI 10.1007/BF01317276; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; Schynts F, 2003, J VIROL, V77, P12535, DOI 10.1128/JVI.77.23.12535-12542.2003; Spatz SJ, 2012, VIRUS GENES, V44, P273, DOI 10.1007/s11262-011-0696-3; Szpara ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002282; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; Trewin D, 2001, YB AUSTR 2001, P611; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Wilkinson DE, 2003, IUBMB LIFE, V55, P451, DOI 10.1080/15216540310001612237; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	45	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55121	10.1371/journal.pone.0055121	http://dx.doi.org/10.1371/journal.pone.0055121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383306	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900013
J	Bogani, C; Bartalucci, N; Martinelli, S; Tozzi, L; Guglielmelli, P; Bosi, A; Vannucchi, AM				Bogani, Costanza; Bartalucci, Niccolo; Martinelli, Serena; Tozzi, Lorenzo; Guglielmelli, Paola; Bosi, Alberto; Vannucchi, Alessandro M.		Associazione Italiana Ric Canc AGI	mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms	PLOS ONE			English	Article							POLYCYTHEMIA-VERA; PRIMARY MYELOFIBROSIS; HEMATOPOIETIC STEM; EXPRESSION; MUTATION; PATHOGENESIS; JAK2(V617F); JAK2V617F; THERAPY; RUXOLITINIB	Background: Dysregulated signaling of the JAK/STAT pathway is a common feature of chronic myeloproliferative neoplasms (MPN), usually associated with JAK2V617F mutation. Recent clinical trials with JAK2 inhibitors showed significant improvements in splenomegaly and constitutional symptoms in patients with myelofibrosis but meaningful molecular responses were not documented. Accordingly, there remains a need for exploring new treatment strategies of MPN. A potential additional target for treatment is represented by the PI3K/AKT/mammalian target of rapamycin (mTOR) pathway that has been found constitutively activated in MPN cells; proof-of-evidence of efficacy of the mTOR inhibitor RAD001 has been obtained recently in a Phase I/II trial in patients with myelofibrosis. The aim of the study was to characterize the effects in vitro of mTOR inhibitors, used alone and in combination with JAK2 inhibitors, against MPN cells. Findings: Mouse and human JAK2V617F mutated cell lines and primary hematopoietic progenitors from MPN patients were challenged with an allosteric (RAD001) and an ATP-competitive (PP242) mTOR inhibitor and two JAK2 inhibitors (AZD1480 and ruxolitinib). mTOR inhibitors effectively reduced proliferation and colony formation of cell lines through a slowed cell division mediated by changes in cell cycle transition to the S-phase. mTOR inhibitors also impaired the proliferation and prevented colony formation from MPN hematopoietic progenitors at doses significantly lower than healthy controls. JAK2 inhibitors produced similar antiproliferative effects in MPN cell lines and primary cells but were more potent inducers of apoptosis, as also supported by differential effects on cyclinD1, PIM1 and BcLxL expression levels. Co-treatment of mTOR inhibitor with JAK2 inhibitor resulted in synergistic activity against the proliferation of JAK2V617F mutated cell lines and significantly reduced erythropoietin-independent colony growth in patients with polycythemia vera. Conclusions/Significance: These findings support mTOR inhibitors as novel potential drugs for the treatment of MPN and advocate for clinical trials exploiting the combination of mTOR and JAK2 inhibitor.	[Bogani, Costanza; Bartalucci, Niccolo; Martinelli, Serena; Tozzi, Lorenzo; Guglielmelli, Paola; Bosi, Alberto; Vannucchi, Alessandro M.; Associazione Italiana Ric Canc AGI] Univ Florence, Sect Hematol, Dept Med & Surg Care, Florence, Italy	University of Florence	Vannucchi, AM (corresponding author), Univ Florence, Sect Hematol, Dept Med & Surg Care, Florence, Italy.	amvannucchi@unifi.it	Vannucchi, Alessandro M./K-7499-2016; Bartalucci, Niccolò/AAB-3612-2019; Guglielmelli, Paola/K-7509-2016	Vannucchi, Alessandro M./0000-0001-5755-0730; Bartalucci, Niccolò/0000-0002-9328-3948; Guglielmelli, Paola/0000-0003-1809-284X; Tozzi, Lorenzo/0000-0002-0679-5030; martinelli, serena/0000-0003-4992-2252; BOSI, ALBERTO/0000-0002-5486-4838	Associazione Italiana per la Ricerca sul Cancro-"AIRC 5 per Mille"; Ministero Italiano della Universita e della Ricerca (MIUR) [FIRB-RBAP11CZLK]	Associazione Italiana per la Ricerca sul Cancro-"AIRC 5 per Mille"(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a special grant from Associazione Italiana per la Ricerca sul Cancro-"AIRC 5 per Mille''- to AGIMM, "AIRC-Gruppo Italiano Malattie Mieloproliferative''. Supported by Ministero Italiano della Universita e della Ricerca (MIUR), project FIRB-RBAP11CZLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Beer PA, 2008, BLOOD, V112, P141, DOI 10.1182/blood-2008-01-131664; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Drayer AL, 2006, STEM CELLS, V24, P105, DOI 10.1634/stemcells.2005-0062; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ghaffari S, 2006, BLOOD, V107, P1888, DOI 10.1182/blood-2005-06-2304; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Grimwade LF, 2009, BRIT J HAEMATOL, V147, P495, DOI 10.1111/j.1365-2141.2009.07870.x; Guglielmelli P, 2011, BLOOD, V118, P2069, DOI 10.1182/blood-2011-01-330563; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Li G, 2010, LEUKEMIA, V24, P1397, DOI 10.1038/leu.2010.131; Li G, 2009, BLOOD, V114, p3902A; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu PCC, 2009, CLIN CANCER RES, V15, P6891, DOI 10.1158/1078-0432.CCR-09-1298; Marty C, 2010, BLOOD, V116, P783, DOI 10.1182/blood-2009-12-257063; Maruani DM, 2012, ONCOGENE; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Pardanani A, 2011, LEUKEMIA, V25, P1834, DOI 10.1038/leu.2011.161; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Pardanani AD, 2008, BLOOD, V112, P43, DOI 10.1182/blood.V112.11.97.97; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Ugo V, 2004, EXP HEMATOL, V32, P179, DOI 10.1016/j.exphem.2003.11.003; Vainchenker W, 2011, BLOOD, V118, P1723, DOI 10.1182/blood-2011-02-292102; Vannucchi AM, 2008, BLOOD, V112, P844, DOI 10.1182/blood-2008-01-135897; Vannucchi AM, 2009, CA-CANCER J CLIN, V59, P171, DOI 10.3322/caac.20009; Vannucchi AM, 2005, AM J PATHOL, V167, P849, DOI 10.1016/S0002-9440(10)62056-1; Verstovsek S, 2010, BLOOD, V116, P313, DOI 10.1182/blood.V116.21.313.313; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	57	65	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54826	10.1371/journal.pone.0054826	http://dx.doi.org/10.1371/journal.pone.0054826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382981	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600046
J	Dunn, KA; Jiang, WY; Field, C; Bielawski, JP				Dunn, Katherine A.; Jiang, Wenyi; Field, Christopher; Bielawski, Joseph P.			Improving Evolutionary Models for Mitochondrial Protein Data with Site-Class Specific Amino Acid Exchangeability Matrices	PLOS ONE			English	Article							MIXTURE MODEL; PHYLOGENETIC ANALYSES; DIVERGENCE TIMES; DNA-SEQUENCES; CODING GENES; LIKELIHOOD; SUBSTITUTION; REPLACEMENT; RATES	Adequate modeling of mitochondrial sequence evolution is an essential component of mitochondrial phylogenomics (comparative mitogenomics). There is wide recognition within the field that lineage-specific aspects of mitochondrial evolution should be accommodated through lineage-specific amino-acid exchangeability matrices (e.g., mtMam for mammalian data). However, such a matrix must be applied to all sites and this implies that all sites are subject to the same, or largely similar, evolutionary constraints. This assumption is unjustified. Indeed, substantial differences are expected to arise from three-dimensional structures that impose different physiochemical environments on individual amino acid residues. The objectives of this paper are (1) to investigate the extent to which amino acid evolution varies among sites of mitochondrial proteins, and (2) to assess the potential benefits of explicitly modeling such variability. To achieve this, we developed a novel method for partitioning sites based on amino acid physiochemical properties. We apply this method to two datasets derived from complete mitochondrial genomes of mammals and fish, and use maximum likelihood to estimate amino acid exchangeabilities for the different groups of sites. Using this approach we identified large groups of sites evolving under unique physiochemical constraints. Estimates of amino acid exchangeabilities differed significantly among such groups. Moreover, we found that joint estimates of amino acid exchangeabilities do not adequately represent the natural variability in evolutionary processes among sites of mitochondrial proteins. Significant improvements in likelihood are obtained when the new matrices are employed. We also find that maximum likelihood estimates of branch lengths can be strongly impacted. We provide sets of matrices suitable for groups of sites subject to similar physiochemical constraints, and discuss how they might be used to analyze real data. We also discuss how the general approach might be employed to improve a variety of mitogenomic-based research activities.	[Dunn, Katherine A.; Bielawski, Joseph P.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Jiang, Wenyi; Field, Christopher; Bielawski, Joseph P.] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Dunn, KA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	kathy.dunn@dal.ca		Bielawski, Joseph/0000-0002-1621-1772; Dunn, Katherine/0000-0002-9516-589X	Natural Sciences and Engineering Research Council of Canada (NSERC); Tula Foundation; Centre for Comparative Genomics and Evolutionary Bioinformatics Dalhousie University	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tula Foundation; Centre for Comparative Genomics and Evolutionary Bioinformatics Dalhousie University	Sources of funding that supported this work include: Natural Sciences and Engineering Research Council of Canada (NSERC), Tula Foundation, and Centre for Comparative Genomics and Evolutionary Bioinformatics Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2007, MOL BIOL EVOL, V24, P1; Bay RA, J MOL EVOL UNPUB; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; Dang CC, 2012, MOL BIOL EVOL; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Gardiner Brian G., 1996, P117, DOI 10.1016/B978-012670950-6/50007-2; Garvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024127; Gaston D, 2011, BIOINFORMATICS, V27, P2655, DOI 10.1093/bioinformatics/btr470; Goldman N, 1998, GENETICS, V149, P445; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hess J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022783; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KIDERA A, 1985, J PROTEIN CHEM, V4, P23, DOI 10.1007/BF01025492; Koshi JM, 1998, PROTEINS, V32, P289, DOI 10.1002/(SICI)1097-0134(19980815)32:3<289::AID-PROT4>3.3.CO;2-3; KOSHI JM, 1995, PROTEIN ENG, V8, P641; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mathura VS, 2005, BIOINFORMATION, V1, P2, DOI 10.6026/97320630001002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paijmans J. L. A., 2012, MOL PHYLOGENET EVOL; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; Patterson C., 1973, Zoological J Linn Soc, V53, P233; Pupko T, 2002, P ROY SOC B-BIOL SCI, V269, P1313, DOI 10.1098/rspb.2002.2025; Quang LS, 2008, BIOINFORMATICS, V24, P2317, DOI 10.1093/bioinformatics/btn445; R Development Core Team, 2007, R LANG ENV STAT COMP; Robinson DM, 2003, MOL BIOL EVOL, V20, P1692, DOI 10.1093/molbev/msg184; Rokas A, 2008, MOL BIOL EVOL, V25, P1943, DOI 10.1093/molbev/msn143; Rota-Stabelli O, 2009, MOL PHYLOGENET EVOL, V52, P268, DOI 10.1016/j.ympev.2009.01.011; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Wang HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-331; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888	45	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55816	10.1371/journal.pone.0055816	http://dx.doi.org/10.1371/journal.pone.0055816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383286	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600163
J	Valencia-Cruz, AI; Uribe-Figueroa, LI; Galindo-Murillo, R; Baca-Lopez, K; Gutierrez, AG; Vazquez-Aguirre, A; Ruiz-Azuara, L; Hernandez-Lemus, E; Mejia, C				Idan Valencia-Cruz, Alejandra; Uribe-Figueroa, Laura I.; Galindo-Murillo, Rodrigo; Baca-Lopez, Karol; Gutierrez, Anllely G.; Vazquez-Aguirre, Adriana; Ruiz-Azuara, Lena; Hernandez-Lemus, Enrique; Mejia, Carmen			Whole Genome Gene Expression Analysis Reveals Casiopeina-Induced Apoptosis Pathways	PLOS ONE			English	Article							CELLS IN-VITRO; MIXED CHELATE; HELA-CELLS; MECHANISM; COMPLEX; INHIBITION; DEATH; CYTOTOXICITY; GLUTATHIONE; GENERATION	Copper-based chemotherapeutic compounds Casiopeinas, have been presented as able to promote selective programmed cell death in cancer cells, thus being proper candidates for targeted cancer therapy. DNA fragmentation and apoptosis-in a process mediated by reactive oxygen species-for a number of tumor cells, have been argued to be the main mechanisms. However, a detailed functional mechanism (a model) is still to be defined and interrogated for a wide variety of cellular conditions before establishing settings and parameters needed for their wide clinical application. In order to shorten the gap in this respect, we present a model proposal centered in the role played by intrinsic (or mitochondrial) apoptosis triggered by oxidative stress caused by the chemotherapeutic agent. This model has been inferred based on genome wide expression profiling in cervix cancer (HeLa) cells, as well as statistical and computational tests, validated via functional experiments (both in the same HeLa cells and also in a Neuroblastoma model, the CHP-212 cell line) and assessed by means of data mining studies.	[Idan Valencia-Cruz, Alejandra; Uribe-Figueroa, Laura I.] Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico; [Idan Valencia-Cruz, Alejandra; Uribe-Figueroa, Laura I.] Natl Inst Genom Med, Microarray Core Facil, Mexico City, DF, Mexico; [Galindo-Murillo, Rodrigo] Univ Nacl Autonoma Mexico, Inst Chem, Dept Chem Phys, Mexico City 04510, DF, Mexico; [Galindo-Murillo, Rodrigo] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA; [Baca-Lopez, Karol] Autonomous Univ State Mexico, Sch Sci, Toluca, Mexico; [Gutierrez, Anllely G.; Vazquez-Aguirre, Adriana] Univ Nacl Autonoma Mexico, Inst Biomed Res, Genom Med & Environm Toxicol Dept, Mexico City 04510, DF, Mexico; [Ruiz-Azuara, Lena] Univ Nacl Autonoma Mexico, Sch Chem, Nucl & Inorgan Chem Dept, Mexico City 04510, DF, Mexico; [Hernandez-Lemus, Enrique] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City 04510, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Utah System of Higher Education; University of Utah; Universidad Autonoma del Estado de Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hernandez-Lemus, E (corresponding author), Natl Inst Genom Med, Computat Genom Dept, Mexico City, DF, Mexico.	ehernandez@inmegen.gob.mx; Maria.C.Mejia@uv.es		Ruiz-Azuara, Lena/0000-0003-3035-4507; Hernandez-Lemus, Enrique/0000-0002-1872-1397	Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) [PIUTE10-92, PICSA10-61]; Universidad Nacional Autonoma de Mexico [PAPIIT-UNAM 204511]; National Institute of Genomic Medicine	Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); National Institute of Genomic Medicine	The authors gratefully acknowledge support by grants: PIUTE10-92 and PICSA10-61 from the Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF), and PAPIIT-UNAM 204511 from the Universidad Nacional Autonoma de Mexico, as well as federal funding from the National Institute of Genomic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemon-Medina R, 2008, TOXICOL IN VITRO, V22, P710, DOI 10.1016/j.tiv.2007.11.011; Alemon-Medina R, 2007, CANCER CHEMOTH PHARM, V60, P219, DOI 10.1007/s00280-006-0364-9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baca-Lopez K, 2009, REV MEX FIS, V55, P456; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Garcia-Ramos JC, 2012, DALTON T, V41, P10164, DOI 10.1039/c2dt30224a; Carvallo-Chaigneau F, 2008, BIOMETALS, V21, P17, DOI 10.1007/s10534-007-9089-4; Chikira M, 2002, J INORG BIOCHEM, V89, P163, DOI 10.1016/S0162-0134(02)00378-1; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P12; De Vizcaya-Ruiz A, 2000, TOXICOL IN VITRO, V14, P1, DOI 10.1016/S0887-2333(99)00082-X; Deighton RF, 2010, PROTEOMICS, V10, P1307, DOI 10.1002/pmic.200900112; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Bravo-Gomez ME, 2009, J INORG BIOCHEM, V103, P299, DOI 10.1016/j.jinorgbio.2008.10.006; FranceLanord V, 1997, J NEUROCHEM, V69, P1612; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Gutierrez AG, 2013, MITOCHONDRI IN PRESS; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez-Esquivel L, 2006, TOXICOL APPL PHARM, V212, P79, DOI 10.1016/j.taap.2005.06.023; Hernandez-Lemus E., 2012, THYROID CANC DIAGNOS; JOUINI M, 1986, J INORG BIOCHEM, V26, P269, DOI 10.1016/0162-0134(86)80051-4; Kachadourian R, 2010, TOXICOLOGY, V268, P176, DOI 10.1016/j.tox.2009.12.010; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kim JW, 2012, J INT MED RES, V40, P486, DOI 10.1177/147323001204000210; Kiningham KK, 1999, FASEB J, V13, P1601, DOI 10.1096/fasebj.13.12.1601; Lazebnik Y, 2002, CANCER CELL, V2, P179, DOI 10.1016/S1535-6108(02)00133-2; Leal-Garcia M, 2007, BASIC CLIN PHARMACOL, V101, P151, DOI 10.1111/j.1742-7843.2007.00038.x; Lim YB, 2008, J BIOL CHEM, V283, P33110, DOI 10.1074/jbc.M804255200; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Majima HJ, 1998, J BIOL CHEM, V273, P8217, DOI 10.1074/jbc.273.14.8217; Marin-Hernandez A, 2012, ARCH TOXICOL, V86, P753, DOI 10.1007/s00204-012-0809-3; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Mejia C, 2008, PATHOL ONCOL RES, V14, P467, DOI 10.1007/s12253-008-9060-x; Moshe Y, 2011, J BIOL CHEM, V286, P16647, DOI 10.1074/jbc.M111.223339; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Rivero-Muller A, 2007, CHEM-BIOL INTERACT, V165, P189, DOI 10.1016/j.cbi.2006.12.002; Rodriguez-Enriquez S, 2008, J CELL PHYSIOL, V216, P189, DOI 10.1002/jcp.21392; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shtyrlin VG, 2012, DALTON T, V41, P1216, DOI 10.1039/c1dt11309g; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Speisky H, 2008, BIOORGAN MED CHEM, V16, P6568, DOI 10.1016/j.bmc.2008.05.026; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Trejo-Solis C, 2005, NEOPLASIA, V7, P563, DOI 10.1593/neo.04607; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0	49	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54664	10.1371/journal.pone.0054664	http://dx.doi.org/10.1371/journal.pone.0054664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382936	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600033
J	Muanprasat, C; Wongborisuth, C; Pathomthongtaweechai, N; Satitsri, S; Hongeng, S				Muanprasat, Chatchai; Wongborisuth, Chokdee; Pathomthongtaweechai, Nutthapoom; Satitsri, Saravut; Hongeng, Suradej			Protection against Oxidative Stress in Beta Thalassemia/Hemoglobin E Erythrocytes by Inhibitors of Glutathione Efflux Transporters	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; BLOOD-CELLS; CFTR; DISULFIDE; MEMBRANE; EXPORT; PATHOPHYSIOLOGY; MODULATION; NUCLEOTIDE; PLASMA	In beta thalassemia/hemoglobin E (Hb E), abnormally high levels of oxidative stress account for accelerated senescence and increased destruction of erythrocytes. The present study aimed to investigate the role of glutathione efflux transporters, namely cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein 1 (MRP1), in the control of glutathione levels and protection against oxidative challenges in beta thalassemia/Hb E erythrocytes. We found that CFTR protein was expressed in the erythrocytes of beta thalassemia/Hb E patients. Treatments with GlyH-101 (50 mu M), a small molecule CFTR inhibitor, and MK571 (50 mu M), an MRP1 inhibitor, reduced H2O2-induced free radical generation in the erythrocytes by similar to 80% and 50%, respectively. Furthermore, combined treatment with GlyH-101 and MK571 completely abolished the induction of reactive oxygen radicals. Increased oxidative stress in the erythrocytes following H2O2 challenges was accompanied by a decrease in intracellular level of reduced glutathione (GSH), which was prevented by treatments with GlyH-101 and MK571. CMFDA-based assays revealed that GlyH-101 and MK571 reduced H2O2-induced glutathione efflux from the erythrocytes by 87% and 66%, respectively. Interestingly, H2O2-induced osmotic tolerance of erythrocytes, a sign of erythrocyte aging, was ameliorated by treatment with GlyH-101. Our study indicates that oxidative stress induces glutathione efflux via CFTR and MRP1 in beta thalassemia/Hb E erythrocytes. Pharmacological inhibition of glutathione efflux represents a potential therapy to delay aging and premature destruction of erythrocytes in beta thalassemia/Hb E.	[Muanprasat, Chatchai; Pathomthongtaweechai, Nutthapoom; Satitsri, Saravut] Mahidol Univ, Fac Sci, Dept Physiol, Res Ctr Transport Prot Med Innovat, Bangkok 10400, Thailand; [Wongborisuth, Chokdee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10400, Thailand; [Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand	Mahidol University; Mahidol University; Mahidol University	Muanprasat, C (corresponding author), Mahidol Univ, Fac Sci, Dept Physiol, Res Ctr Transport Prot Med Innovat, Bangkok 10400, Thailand.	chatchai.mua@mahidol.ac.th; suradej.hon@mahidol.ac.th	Satitsri, Saravut/I-6616-2013	Satitsri, Saravut/0000-0002-1555-4917; Hongeng, Suradej/0000-0002-7376-9393; Pathomthongtaweechai, Nutthapoom/0000-0003-4641-5829	Mahidol University research grant; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund [MRG5380125]; Mahidol University	Mahidol University research grant; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University	This work was supported by Mahidol University research grant (CM and SH), the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative (CM) and an MRG5380125 grant from the Thailand Research Fund, the Office of the Higher Education Commission and Mahidol University (CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer J, 2004, CYTOM PART A, V60A, P73, DOI 10.1002/cyto.a.20017; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Barrand MA, 2012, BIOCHEM J, V448, P389, DOI 10.1042/BJ20121050; Cakir Y, 2013, BLOOD CELL MOL DIS, V50, P1, DOI 10.1016/j.bcmd.2012.07.001; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004; Freikman I, 2011, J MEMBRANE BIOL, V240, P73, DOI 10.1007/s00232-011-9345-y; Fucharoen S, 2000, CURR OPIN HEMATOL, V7, P106, DOI 10.1097/00062752-200003000-00006; Fucharoen Suthat, 2011, Indian J Med Res, V134, P498; HARRIS RR, 1995, INT J IMMUNOPHARMACO, V17, P147, DOI 10.1016/0192-0561(94)00093-4; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Kalpravidh RW, 2010, CLIN BIOCHEM, V43, P424, DOI 10.1016/j.clinbiochem.2009.10.057; Kariya C, 2007, AM J PHYSIOL-LUNG C, V292, pL1590, DOI 10.1152/ajplung.00365.2006; Kock K, 2007, CLIN PHARMACOKINET, V46, P449; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; l'Hoste S, 2010, AM J PHYSIOL-RENAL, V298, pF435, DOI 10.1152/ajprenal.00286.2009; L'hoste S, 2009, FREE RADICAL BIO MED, V46, P1017, DOI 10.1016/j.freeradbiomed.2008.12.009; Lange T, 2006, MOL MEMBR BIOL, V23, P317, DOI 10.1080/09687860600738304; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Origa Raffaella, 2011, Pediatr Endocrinol Rev, V8 Suppl 2, P263; Pulaski L, 1996, EUR J BIOCHEM, V241, P644, DOI 10.1111/j.1432-1033.1996.00644.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; RUND D, 1995, CRIT REV ONCOL HEMAT, V20, P237, DOI 10.1016/1040-8428(95)00162-Z; Rund D, 2001, SEMIN HEMATOL, V38, P343, DOI 10.1053/shem.2001.27579; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; SHINAR E, 1990, SEMIN HEMATOL, V27, P70; Tesoriere L, 2001, FREE RADICAL RES, V34, P529, DOI 10.1080/10715760100300461; Weiss J, 2007, DRUG METAB DISPOS, V35, P340, DOI 10.1124/dmd.106.012765; Yildiz D, 2012, BIOL TRACE ELEM RES, V150, P451, DOI 10.1007/s12011-012-9491-9	31	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55685	10.1371/journal.pone.0055685	http://dx.doi.org/10.1371/journal.pone.0055685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383265	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600146
J	Sun, Q; Zhang, Y; Zhu, SL; Tian, HF; Huang, GH; Cui, H; Li, XL; Yan, DM; Zhu, Z; Li, J; Zheng, P; Jiang, HF; Zhang, B; Tan, XJ; Zhu, H; An, HQ; Xu, WB				Sun, Qiang; Zhang, Yong; Zhu, Shuangli; Tian, Huifang; Huang, Guohong; Cui, Hui; Li, Xiaolei; Yan, Dongmei; Zhu, Zhen; Li, Jing; Zheng, Peng; Jiang, Huafang; Zhang, Bo; Tan, Xiaojuan; Zhu, Hui; An, Hongqiu; Xu, Wenbo			Transmission of Human Enterovirus 85 Recombinants Containing New Unknown Serotype HEV-B Donor Sequences in Xinjiang Uighur Autonomous Region, China	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; ACUTE FLACCID PARALYSIS; COMPLETE GENOME SEQUENCE; MOLECULAR-IDENTIFICATION; ASEPTIC-MENINGITIS; PROTEIN; ECHOVIRUS-19; OUTBREAK; STRAIN; CHILD	Background: Human enterovirus 85 (HEV85), whose prototype strain (Strain BAN00-10353/BAN/2000) was isolated in Bangladesh in 2000, is a recently identified serotype within the human enterovirus B (HEV-B) species. At present, only one nucleotide sequence of HEV85 (the complete genome sequence of the prototype strain) is available in the GenBank database. Principal Findings: In this study, we report the genetic characteristics of 33 HEV85 isolates that circulated in the Xinjiang Uighur autonomous region of China in 2011. Sequence analysis revealed that all these Chinese HEV85 isolates belong to 2 transmission chains, and intertypic recombination was found with the new unknown serotype HEV-B donor sequences. Two HEV85 isolates recovered from a patient presenting acute flaccid paralysis and one of his contacts were temperature-insensitive strains, and some nucleotide substitutions in the non-coding regions and in the 2C or 3D coding regions may have affected the temperature sensitivity of HEV85 strains. Conclusions: The Chinese HEV85 recombinant described in this study trapped a new unknown serotype HEV-B donor sequence, indicating that new unknown HEV-B serotypes exist or circulate in Xinjiang of China. Our study also indicated that HEV85 is a prevalent and common enterovirus serotype in Xinjiang.	[Sun, Qiang; Zhang, Yong; Zhu, Shuangli; Huang, Guohong; Li, Xiaolei; Yan, Dongmei; Zhu, Zhen; Li, Jing; Zheng, Peng; Jiang, Huafang; Zhang, Bo; Tan, Xiaojuan; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Key Lab Med Virol & Viral Dis, Minist Hlth,Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Tian, Huifang] Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Cui, Hui] Xinjiang Uygur Autonomous Reg Ctr Dis Control & P, Urumqi, Xinjiang Uygur, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Key Lab Med Virol & Viral Dis, Minist Hlth,Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [30900063, 81101303]; National Key Technology R&D Program of China [2008BAI56B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program)	This study was supported by the National Natural Science Foundation of China (Project Nos. 30900063 and 81101303) and the National Key Technology R&D Program of China (Project No. 2008BAI56B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 2009, J INFECT DIS, V199, P391, DOI 10.1086/596052; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Avellon A, 2006, EMERG INFECT DIS, V12, P1609, DOI 10.3201/eid1210.060353; Bailly JL, 2004, VIRUS RES, V99, P147, DOI 10.1016/j.virusres.2003.11.006; Bergamini G, 2000, RNA, V6, P1781, DOI 10.1017/S1355838200001679; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; Faustini A, 2006, INT J INFECT DIS, V10, P291, DOI 10.1016/j.ijid.2005.06.008; GEORGESCU MM, 1995, J VIROL, V69, P5278, DOI 10.1128/JVI.69.9.5278-5286.1995; Harvala H, 2011, J VIROL, V85, P4480, DOI 10.1128/JVI.02285-10; Junttila N, 2007, J MED VIROL, V79, P393, DOI 10.1002/jmv.20825; Knowles N., 2011, VIRUS TAXONOMY CLASS, P855; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lewthwaite P, 2010, EMERG INFECT DIS, V16, P1780, DOI 10.3201/eid1611.100672; dos Santos GPL, 2011, J MED VIROL, V83, P2164, DOI 10.1002/jmv.22235; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Norder L, 2002, J GEN VIROL, V83, P1721, DOI 10.1099/0022-1317-83-7-1721; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 2007, ARCH VIROL, V152, P1587, DOI 10.1007/s00705-007-0978-1; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J GEN VIROL, V85, P3205, DOI 10.1099/vir.0.80148-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Oberste MS, 2001, J GEN VIROL, V82, P409, DOI 10.1099/0022-1317-82-2-409; Piralla A, 2010, EMERG INFECT DIS, V16, P1018, DOI 10.3201/eid1606.091533; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Smura TP, 2007, J GEN VIROL, V88, P849, DOI 10.1099/vir.0.82510-0; Starlin R, 2001, CLIN INFECT DIS, V33, P730, DOI 10.1086/322624; Sun Q, 2012, J VIROL, V86, P10228, DOI 10.1128/JVI.01567-12; Svitkin YV, 2001, RNA, V7, P1743; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Wang JT, 2012, ARCH VIROL, V157, P1593, DOI 10.1007/s00705-012-1332-9; World Health Organization, 2004, WHOIVB0410; Yamashita T, 2010, J GEN VIROL, V91, P1063, DOI 10.1099/vir.0.016014-0; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y., 2010, MANAGEMENT WORLD, V2, P1; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	43	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55480	10.1371/journal.pone.0055480	http://dx.doi.org/10.1371/journal.pone.0055480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383202	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600111
J	de Brouwer, AJ; de Poel, HJ; Hofmijster, MJ				de Brouwer, Anouk J.; de Poel, Harjo J.; Hofmijster, Mathijs J.			Don't Rock the Boat: How Antiphase Crew Coordination Affects Rowing	PLOS ONE			English	Article							PHASE-TRANSITIONS; STROKE RATE; FLUCTUATIONS; MECHANISM; VELOCITY; POWER; MODEL	It is generally accepted that crew rowing requires perfect synchronization between the movements of the rowers. However, a long-standing and somewhat counterintuitive idea is that out-of-phase crew rowing might have benefits over in-phase (i.e., synchronous) rowing. In synchronous rowing, 5 to 6% of the power produced by the rower(s) is lost to velocity fluctuations of the shell within each rowing cycle. Theoretically, a possible way for crews to increase average boat velocity is to reduce these fluctuations by rowing in antiphase coordination, a strategy in which rowers perfectly alternate their movements. On the other hand, the framework of coordination dynamics explicates that antiphase coordination is less stable than in-phase coordination, which may impede performance gains. Therefore, we compared antiphase to in-phase crew rowing performance in an ergometer experiment. Nine pairs of rowers performed a two-minute maximum effort in-phase and antiphase trial at 36 strokes min(-1) on two coupled free-floating ergometers that allowed for power losses to velocity fluctuations. Rower and ergometer kinetics and kinematics were measured during the trials. All nine pairs easily acquired antiphase rowing during the warm-up, while one pair's coordination briefly switched to in-phase during the maximum effort trial. Although antiphase interpersonal coordination was indeed less accurate and more variable, power production was not negatively affected. Importantly, in antiphase rowing the decreased power loss to velocity fluctuations resulted in more useful power being transferred to the ergometer flywheels. These results imply that antiphase rowing may indeed improve performance, even without any experience with antiphase technique. Furthermore, it demonstrates that although perfectly synchronous coordination may be the most stable, it is not necessarily equated with the most efficient or optimal performance.	[de Brouwer, Anouk J.; Hofmijster, Mathijs J.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [de Brouwer, Anouk J.; de Poel, Harjo J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	Vrije Universiteit Amsterdam; University of Groningen	de Brouwer, AJ (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	a.j.de.brouwer@vu.nl		de Poel, Harjo/0000-0001-8812-5390	Netherlands Organisation for Scientific Research, NWO-MaGW grant [404-10-142]	Netherlands Organisation for Scientific Research, NWO-MaGW grant	This study was partly supported by the Netherlands Organisation for Scientific Research, NWO-MaGW grant 404-10-142. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alben S, 2010, J R SOC INTERFACE, V7, P1545, DOI 10.1098/rsif.2010.0171; Angst F., 1982, FISA COACH, V11, P188; Arago F., 1962, CHRISTIAAN HUYGENS P; Baudouin A, 2004, J BIOMECH, V37, P969, DOI 10.1016/j.jbiomech.2003.11.011; Baudouin A, 2002, BRIT J SPORT MED, V36, P396, DOI 10.1136/bjsm.36.6.396; Brearley M.N., 1998, MATH GAZ, V82, P389; Colloud F, 2006, J SPORT SCI, V24, P479, DOI 10.1080/02640410500189256; de Poel HJ, 2008, PSYCHOL RES-PSYCH FO, V72, P123, DOI 10.1007/s00426-006-0096-9; Elliott Bruce, 2002, Sports Biomech, V1, P123, DOI 10.1080/14763140208522791; Fish FE, 2003, MAR MAMMAL SCI, V19, P515, DOI 10.1111/j.1748-7692.2003.tb01318.x; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hill H, 2009, SCAND J MED SCI SPOR, V19, P585, DOI 10.1111/j.1600-0838.2008.00819.x; Hofmijster MJ, 2008, MED SCI SPORT EXER, V40, P1101, DOI 10.1249/MSS.0b013e3181668671; Hofmijster MJ, 2007, J SPORT SCI, V25, P403, DOI 10.1080/02640410600718046; Hove JR, 2001, J EXP BIOL, V204, P1459; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Kleshnev V, 1999, P 17 INT S BIOM SPOR, P224; LAMB DH, 1989, AM J SPORT MED, V17, P367, DOI 10.1177/036354658901700310; MacMillan R, 2000, MATH GAZ, V84, P316; MARTIN TP, 1980, MED SCI SPORT EXER, V12, P250; Neumeister I, 2004, NEW SCI, V184, P31; Nolte V, 2007, ROWING NEWS, P62; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Rivera G, 2011, J EXP BIOL, V214, P1153, DOI 10.1242/jeb.046045; SANDERSON B, 1986, MED SCI SPORT EXER, V18, P454; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; SCRAGG CA, 1993, MAR TECHNOL SNAME N, V30, P84; STROGATZ SH, 1993, SCI AM, V269, P102, DOI 10.1038/scientificamerican1293-102; Temprado JJ, 2004, ACTA PSYCHOL, V115, P1, DOI 10.1016/j.actpsy.2003.09.002; Temprado JJ, 2002, EUR J NEUROSCI, V16, P1390, DOI 10.1046/j.1460-9568.2002.02190.x; Varlet M, 2011, J BIOMECH, V44, P1200, DOI 10.1016/j.jbiomech.2011.02.001; Wing Alan M., 1995, Journal of Sports Sciences, V13, P187, DOI 10.1080/02640419508732227; Winter D, 2005, BIOMECHANICS MOTOR C; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	37	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54996	10.1371/journal.pone.0054996	http://dx.doi.org/10.1371/journal.pone.0054996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383024	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800094
J	Hatakeyama, K; Suwabe, K; Tomita, RN; Kato, T; Nunome, T; Fukuoka, H; Matsumoto, S				Hatakeyama, Katsunori; Suwabe, Keita; Tomita, Rubens Norio; Kato, Takeyuki; Nunome, Tsukasa; Fukuoka, Hiroyuki; Matsumoto, Satoru			Identification and Characterization of Crr1a, a Gene for Resistance to Clubroot Disease (Plasmodiophora brassicae Woronin) in Brassica rapa L.	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; CHINESE-CABBAGE; CONFERRING RESISTANCE; ARABIDOPSIS-THALIANA; FULL-LENGTH; TRANSCRIPTS; LOCUS; COLONIZATION; POPULATIONS; CULTIVARS	Clubroot disease, caused by the obligate biotrophic protist Plasmodiophora brassicae Woronin, is one of the most economically important diseases of Brassica crops in the world. Although many clubroot resistance (CR) loci have been identified through genetic analysis and QTL mapping, the molecular mechanisms of defense responses against P. brassicae remain unknown. Fine mapping of the Crr1 locus, which was originally identified as a single locus, revealed that it comprises two gene loci, Crr1a and Crr1b. Here we report the map-based cloning and characterization of Crr1a, which confers resistance to clubroot in Brassica rapa. Crr1a(G004), cloned from the resistant line G004, encodes a Toll-Interleukin-1 receptor/nucleotide-binding site/leucine-rich repeat (TIR-NB-LRR) protein expressed in the stele and cortex of hypocotyl and roots, where secondary infection of the pathogen occurs, but not in root hairs, where primary infection occurs. Gain-of-function analysis proved that Crr1a(G004) alone conferred resistance to isolate Ano-01 in susceptible Arabidopsis and B. rapa. In comparison, the susceptible allele Crr1a(A9709) encodes a truncated NB-LRR protein, which lacked more than half of the TIR domain on account of the insertion of a solo-long terminal repeat (LTR) in exon 1 and included several substitutions and insertion-deletions in the LRR domain. This study provides a basis for further molecular analysis of defense mechanisms against P. brassicae and will contribute to the breeding of resistant cultivars of Brassica vegetables by marker-assisted selection. Data deposition The sequence reported in this paper has been deposited in the GenBank database (accession no. AB605024).	[Hatakeyama, Katsunori; Tomita, Rubens Norio; Kato, Takeyuki; Nunome, Tsukasa; Fukuoka, Hiroyuki; Matsumoto, Satoru] NARO Inst Vegetable & Tea Sci, Vegetable Breeding & Genome Res Div, Tsu, Mie, Japan; [Suwabe, Keita; Kato, Takeyuki] Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan	Mie University	Matsumoto, S (corresponding author), NARO Inst Vegetable & Tea Sci, Vegetable Breeding & Genome Res Div, Tsu, Mie, Japan.	ssmats@affrc.go.jp			MEXT KAKENHI [19380008, 24580015]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT KAKENHI Grant number 19380008, 24580015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, DNA RES, V18, P277, DOI 10.1093/dnares/dsr018; Ariizumi T, 2002, PLANT CELL REP, V21, P90, DOI 10.1007/s00299-002-0487-3; Ayliffe MA, 1999, PLANT J, V17, P287, DOI 10.1046/j.1365-313X.1999.00377.x; Botella MA, 1998, PLANT CELL, V10, P1847, DOI 10.1105/tpc.10.11.1847; BUCZACKI ST, 1975, T BRIT MYCOL SOC, V65, P295, DOI 10.1016/S0007-1536(75)80013-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Dixon GR, 2009, J PLANT GROWTH REGUL, V28, P194, DOI 10.1007/s00344-009-9090-y; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Hatakeyama K, 2004, BREEDING SCI, V54, P197, DOI 10.1270/jsbbs.54.197; Hayashida N, 2008, J JPN SOC HORTIC SCI, V77, P150, DOI 10.2503/jjshs1.77.150; Hirai M, 2004, THEOR APPL GENET, V108, P639, DOI 10.1007/s00122-003-1475-x; Hirai M, 2006, BREEDING SCI, V56, P223, DOI 10.1270/jsbbs.56.223; Hiramoto T., 2011, PLANT CELL REP, P1; Ikegami H., 1981, GROWTH PLASMODIOPHOR; JONES DR, 1982, PLANT PATHOL, V31, P239, DOI 10.1111/j.1365-3059.1982.tb01274.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jubault M, 2008, THEOR APPL GENET, V117, P191, DOI 10.1007/s00122-008-0765-8; Kato T, 2012, BREEDING SCI, V62, P282, DOI 10.1270/jsbbs.62.282; Kobelt P, 2000, MYCOL RES, V104, P220, DOI 10.1017/S0953756299001781; KROLL TK, 1983, PHYTOPATHOL Z, V108, P97; Kuginuki Y, 1999, EUR J PLANT PATHOL, V105, P327, DOI 10.1023/A:1008705413127; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Manzanares-Dauleux MJ, 2001, PLANT PATHOL, V50, P165, DOI 10.1046/j.1365-3059.2001.00557.x; Matsumoto E, 1998, EUPHYTICA, V104, P79, DOI 10.1023/A:1018370418201; Matsumoto E, 2005, J JPN SOC HORTIC SCI, V74, P367, DOI 10.2503/jjshs.74.367; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Niwa R, 2011, PROTIST, V162, P423, DOI 10.1016/j.protis.2011.02.005; Piao ZY, 2009, J PLANT GROWTH REGUL, V28, P252, DOI 10.1007/s00344-009-9093-8; Piao ZY, 2004, THEOR APPL GENET, V108, P1458, DOI 10.1007/s00122-003-1577-5; Saito M, 2006, THEOR APPL GENET, V114, P81, DOI 10.1007/s00122-006-0412-1; Sakamoto K, 2008, THEOR APPL GENET, V117, P759, DOI 10.1007/s00122-008-0817-0; Siemens J, 2009, J PLANT GROWTH REGUL, V28, P245, DOI 10.1007/s00344-009-9091-x; Some A, 1996, PLANT PATHOL, V45, P432, DOI 10.1046/j.1365-3059.1996.d01-155.x; Suwabe K, 2003, THEOR APPL GENET, V107, P997, DOI 10.1007/s00122-003-1309-x; Suwabe K, 2006, GENETICS, V173, P309, DOI 10.1534/genetics.104.038968; Suwabe K, 2012, BREEDING SCI, V62, P170, DOI 10.1270/jsbbs.62.170; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; Takasaki T, 1997, BREEDING SCI, V47, P127; Tanaka Shuhei, 2006, Journal of General Plant Pathology, V72, P205, DOI 10.1007/s10327-006-0276-x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; WILLIAMS PH, 1966, PHYTOPATHOLOGY, V56, P624; Yoshikawa H., 1981, Chinese cabbage. Proceedings of the first international symposium., P405; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474	49	107	126	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54745	10.1371/journal.pone.0054745	http://dx.doi.org/10.1371/journal.pone.0054745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382954	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800073
J	Thonpho, A; Rojvirat, P; Jitrapakdee, S; MacDonald, MJ				Thonpho, Ansaya; Rojvirat, Pinnara; Jitrapakdee, Sarawut; MacDonald, Michael J.			Characterization of the Distal Promoter of the Human Pyruvate Carboxylase Gene in Pancreatic Beta Cells	PLOS ONE			English	Article							NUCLEAR-FACTOR-Y; GLYCEROL PHOSPHATE DEHYDROGENASE; STIMULATED INSULIN-SECRETION; NF-Y; TRANSCRIPTIONAL REGULATION; PROXIMAL PROMOTER; CCAAT BOXES; RAT; REGIONS; BINDING	Pyruvate carboxylase (PC) is an enzyme that plays a crucial role in many biosynthetic pathways in various tissues including glucose-stimulated insulin secretion. In the present study, we identify promoter usage of the human PC gene in pancreatic beta cells. The data show that in the human, two alternative promoters, proximal and distal, are responsible for the production of multiple mRNA isoforms as in the rat and mouse. RT-PCR analysis performed with cDNA prepared from human liver and islets showed that the distal promoter, but not the proximal promoter, of the human PC gene is active in pancreatic beta cells. A 1108 bp fragment of the human PC distal promoter was cloned and analyzed. It contains no TATA box but possesses two CCAAT boxes, and other putative transcription factor binding sites, similar to those of the distal promoter of rat PC gene. To localize the positive regulatory region in the human PC distal promoter, 5'-truncated and the 25-bp and 15-bp internal deletion mutants of the human PC distal promoter were generated and used in transient transfections in INS-1 832/13 insulinoma and HEK293T (kidney) cell lines. The results indicated that positions -340 to -315 of the human PC distal promoter serve as (an) activator element(s) for cell-specific transcription factor, while the CCAAT box at -71/-67, a binding site for nuclear factor Y (NF-Y), as well as a GC box at -54/-39 of the human PC distal promoter act as activator sequences for basal transcription.	[Thonpho, Ansaya; Rojvirat, Pinnara; Jitrapakdee, Sarawut] Mahidol Univ, Fac Sci, Dept Biochem, Mol Metab Res Grp, Bangkok 10400, Thailand; [MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI USA	Mahidol University; University of Wisconsin System; University of Wisconsin Madison	Jitrapakdee, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Mol Metab Res Grp, Bangkok 10400, Thailand.	sarawut.jit@mahidol.ac.th; mjmacdon@wisc.edu		MacDonald, Michael/0000-0002-0201-9245	Thailand Research Fund [BRG5480002]; Faculty of Science, Mahidol University; NIH [DK28348]; Royal Golden Jubilee-PhD program from the Thailand Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK028348, R01DK028348] Funding Source: NIH RePORTER	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Golden Jubilee-PhD program from the Thailand Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Thailand Research Fund (BRG5480002) and the Faculty of Science, Mahidol University to SJ and NIH grant DK28348 to MJM. AT was supported by a Royal Golden Jubilee-PhD program from the Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernadt CT, 2005, GENE EXPRESSION, V12, P193, DOI 10.3727/000000005783992052; Boonsaen T, 2007, BIOCHEM J, V405, P359, DOI 10.1042/BJ20070276; Carbone MA, 1998, AM J HUM GENET, V62, P1312, DOI 10.1086/301884; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; Eggers A, 1998, J BIOL CHEM, V273, P18499, DOI 10.1074/jbc.273.29.18499; Ferre-D'Amare A.R., 1992, EMBO J, V13, P181; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hazelton SR, 2008, J DAIRY SCI, V91, P91, DOI 10.3168/jds.2007-0542; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hou Y, 2010, INT J BIOL SCI, V6, P655; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2005, J BIOL CHEM, V280, P27466, DOI 10.1074/jbc.M503836200; Jitrapakdee S, 1996, BIOCHEM BIOPH RES CO, V223, P695, DOI 10.1006/bbrc.1996.0958; Jitrapakdee S, 2001, BIOCHEM BIOPH RES CO, V287, P411, DOI 10.1006/bbrc.2001.5599; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; JITRAPAKDEE S, 1997, J BIOL CHEM, V272, P20520; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Large V, 1999, DIABETES, V48, P1251, DOI 10.2337/diabetes.48.6.1251; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; MacDonald MJ, 2012, HORM METAB IN PRESS; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Nicolas M, 2003, BIOCHEM J, V371, P265, DOI 10.1042/BJ20021166; PAPAZAFIRI P, 1991, J BIOL CHEM, V266, P5790; Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015; Rojvirat P, 2011, BBA-GENE REGUL MECH, V1809, P541, DOI 10.1016/j.bbagrm.2011.06.011; Shi Q, 2001, HYPERTENSION, V38, P332, DOI 10.1161/01.HYP.38.3.332; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sunyakumthorn P, 2005, BIOCHEM BIOPH RES CO, V329, P188, DOI 10.1016/j.bbrc.2005.01.108; Thonpho A, 2010, BIOCHEM BIOPH RES CO, V393, P714, DOI 10.1016/j.bbrc.2010.02.067; Wang D, 2008, MOL GENET METAB, V95, P31, DOI 10.1016/j.ymgme.2008.06.006; WEXLER ID, 1994, BBA-MOL BASIS DIS, V1227, P46, DOI 10.1016/0925-4439(94)90105-8; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9	37	14	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55139	10.1371/journal.pone.0055139	http://dx.doi.org/10.1371/journal.pone.0055139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383084	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800119
J	Reuter, M; van Vliet, AHM				Reuter, Mark; van Vliet, Arnoud H. M.			Signal Balancing by the CetABC and CetZ Chemoreceptors Controls Energy Taxis in Campylobacter jejuni	PLOS ONE			English	Article							CHEMOTACTIC BEHAVIOR; RESPIRATORY OXIDASES; GENOME SEQUENCE; GROWTH; SYSTEM; DOMAIN; IDENTIFICATION; METABOLISM; AEROTAXIS; PROTEINS	The coupling of environmental sensing to flagella-mediated directed motility allows bacteria to move to optimum environments for growth and survival, either by sensing external stimuli (chemotaxis) or monitoring internal metabolic status (energy taxis). Sensing is mediated by transducer-like proteins (Tlp), either located in the membrane or in the cytoplasm, which commonly influence motility via the CheA-CheY chemotaxis pathway. In this study we have investigated the role of PAS-domain-containing intracellular Tlp-sensors in energy taxis of the food-borne pathogen Campylobacter jejuni, using plate-and tube-based assays utilising the conversion of the redox indicator dyes triphenyl tetrazolium chloride (TTC) and resazurin. Inactivation of the genes encoding the Campylobacter Energy Taxis system (CetA (Tlp9) and CetB (Aer2)) in C. jejuni strain NCTC 11168 resulted in reduced taxis. Inactivation of the cj1191c gene, encoding the CetB homolog CetC (Aer1), did not affect taxis per se, but the cetC gene complemented a cetB mutant in trans, indicating that CetC can form a functional signal transduction complex with CetA in the absence of CetB. Inactivation of both CetB and CetC resulted in greatly reduced taxis confirming the role of CetC in energy taxis. Inactivation of the cj1110c gene, encoding Tlp8 (CetZ), a cytoplasmic sensor with two PAS-domains, resulted in increased taxis, a phenotype opposite to that of CetAB. Inactivation of the cheA gene resulted in the same overall phenotype as the cetAB mutant in both wild-type and cetZ backgrounds, suggesting that both systems use the CheA system for signal transduction. Absence of both CetAB and CetZ resulted in the cetAB taxis phenotype, suggesting that CetZ is subordinate to CetAB. In conclusion, we present evidence that C. jejuni balances the input from two counteracting PAS-domain-containing sensory systems to position itself for optimal usage of energy resources.	[Reuter, Mark; van Vliet, Arnoud H. M.] Inst Food Res, Gut Hlth & Food Safety Programme, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	van Vliet, AHM (corresponding author), Inst Food Res, Gut Hlth & Food Safety Programme, Norwich Res Pk, Norwich, Norfolk, England.	arnoud.vanvliet@ifr.ac.uk	van Vliet, Arnoud HM/B-5155-2013	van Vliet, Arnoud/0000-0003-0203-1305	Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Programme (Biology and Complexity of Foodborne Bacterial Pathogens) [IFR/08/3]; Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Programme (Gut Health and Food Safety) [BB/J004529/1]; BBSRC [BBS/E/F/00044403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044403] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Programme (Biology and Complexity of Foodborne Bacterial Pathogens)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (BBSRC) through the Institute Strategic Programme (Gut Health and Food Safety)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, http://www.bbsrc.ac.uk) through the Institute Strategic Programmes IFR/08/3 (Biology and Complexity of Foodborne Bacterial Pathogens) and BB/J004529/1 (Gut Health and Food Safety) to the Institute of Food Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre G, 2010, MICROBIOL-SGM, V156, P2283, DOI 10.1099/mic.0.039214-0; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Edwards JC, 2006, MOL MICROBIOL, V62, P823, DOI 10.1111/j.1365-2958.2006.05411.x; Elliott KT, 2008, MOL MICROBIOL, V69, P1091, DOI 10.1111/j.1365-2958.2008.06357.x; Elliott KT, 2009, J BACTERIOL, V191, P375, DOI 10.1128/JB.00578-08; ERB RE, 1950, J DAIRY SCI, V33, P853, DOI 10.3168/jds.S0022-0302(50)91981-3; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; Hartley-Tassell LE, 2010, MOL MICROBIOL, V75, P710, DOI 10.1111/j.1365-2958.2009.07010.x; Hendrixson DR, 2001, MOL MICROBIOL, V40, P214, DOI 10.1046/j.1365-2958.2001.02376.x; Holmes K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-214; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Howitt MR, 2011, MBIO, V2, DOI 10.1128/mBio.00098-11; HUGDAHL MB, 1988, INFECT IMMUN, V56, P1560, DOI 10.1128/IAI.56.6.1560-1566.1988; Jackson RJ, 2007, J BACTERIOL, V189, P1604, DOI 10.1128/JB.00897-06; Jacobs-Reitsma W, 2008, CAMPYLOBACTER, 3RD EDITION, P627; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kelly DJ, 2008, CAMPYLOBACTER, 3RD EDITION, P41; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Lacal J, 2010, ENVIRON MICROBIOL, V12, P2873, DOI 10.1111/j.1462-2920.2010.02325.x; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Marchant J, 2002, TRENDS MICROBIOL, V10, P155, DOI 10.1016/S0966-842X(02)02323-5; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09; Schweinitzer T, 2010, ARCH MICROBIOL, V192, P507, DOI 10.1007/s00203-010-0575-7; Slavny P, 2010, MOL MICROBIOL, V75, P61, DOI 10.1111/j.1365-2958.2009.06956.x; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tareen AM, 2010, MICROBIOL-SGM, V156, P3123, DOI 10.1099/mic.0.039438-0; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; TENGERDY RP, 1967, APPL MICROBIOL, V15, P954, DOI 10.1128/AEM.15.4.954-955.1967; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; Van Vliet AHM, 1998, METHOD MICROBIOL, V27, P407; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; van Vliet AHM, 2001, FEMS MICROBIOL LETT, V196, P189, DOI 10.1016/S0378-1097(01)00067-2; Vegge CS, 2009, APPL ENVIRON MICROB, V75, P5308, DOI 10.1128/AEM.00287-09; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; Wright JA, 2009, MICROBIOL-SGM, V155, P80, DOI 10.1099/mic.0.021790-0; Wuichet K, 2007, METHOD ENZYMOL, V422, P3, DOI 10.1016/S0076-6879(06)22001-9; Xie ZH, 2010, P NATL ACAD SCI USA, V107, P2235, DOI 10.1073/pnas.0910055107	46	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54390	10.1371/journal.pone.0054390	http://dx.doi.org/10.1371/journal.pone.0054390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382896	Green Submitted, Green Published, gold			2022-12-27	WOS:000315483200053
J	Zaugg, I; Benrey, B; Bacher, S				Zaugg, Isabelle; Benrey, Betty; Bacher, Sven			Bottom-Up and Top-Down Effects Influence Bruchid Beetle Individual Performance but Not Population Densities in the Field	PLOS ONE			English	Article							ACANTHOSCELIDES-OBTECTUS SAY; HOST-PLANT GENOTYPE; INSECT HERBIVORE; RELATIVE ROLES; BEAN WEEVIL; DINARMUS-BASALIS; PARASITOID WASP; QUALITY AFFECTS; SEX-RATIOS; COLEOPTERA	Plant quality (bottom-up) and natural enemies (top-down) can influence the individual performance of herbivorous insects on their host plants, but few studies measured at the same time the influence on population densities in the field. We investigated if plant quality of different wild common bean populations, Phaseolus vulgaris L. (Fabaceae), affects the performance of the bean weevil, Acanthoscelides obtectus (Say) (Coleoptera: Bruchidae), and one of its enemies, the ectoparasitoid Dinarmus basalis (Rondani) (Hymenoptera: Pteromalidae), in controlled laboratory experiments. Additionally, we examined if parasitoids influence the beetles' development and if increased individual beetle and parasitoid fitness lead to higher field population densities. We show that bean quality and parasitoids affected individual bean weevil performance under laboratory and field conditions. In the presence of parasitoids, fewer and smaller beetles emerged. However, beetle and parasitoid performance were not correlated. Increased individual performance was not leading to higher population densities; we found no correlations between measured performance components and beetle field infestation levels or parasitism rates. We conclude that bottom-up or top-down effects measured at the individual level do not always translate into population effects; therefore it is important to discriminate between effects acting on individual insects and those acting on populations.	[Zaugg, Isabelle; Bacher, Sven] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland; [Benrey, Betty] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Fribourg; University of Neuchatel	Bacher, S (corresponding author), Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland.	sven.bacher@unifr.ch	Benrey, Betty/AAL-1374-2020; Bacher, Sven/F-5431-2010	Benrey, Betty/0000-0002-3230-4450; Bacher, Sven/0000-0001-5147-7165	National Center of Competence in Research (NCCR)	National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This study was funded by the National Center of Competence in Research (NCCR), "Plant Survival." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 1998, GENET RESOUR CROP EV, V45, P235, DOI 10.1023/A:1008636132108; Aebi A, 2004, MOL ECOL NOTES, V4, P707, DOI 10.1111/j.1471-8286.2004.00766.x; Alvarez N, 2005, J ZOOL SYST EVOL RES, V43, P29, DOI 10.1111/j.1439-0469.2004.00286.x; Alvarez N, 2006, ECOL ENTOMOL, V31, P582, DOI 10.1111/j.1365-2311.2006.00817.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Bacher S, 1997, J INSECT PHYSIOL, V43, P945, DOI 10.1016/S0022-1910(97)00058-9; Ball SL, 1996, ECOLOGY, V77, P1116, DOI 10.2307/2265580; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Benrey B, 1998, BIOL CONTROL, V11, P130, DOI 10.1006/bcon.1997.0590; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bowler DE, 2011, OECOLOGIA, V166, P111, DOI 10.1007/s00442-010-1820-0; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Bull JC, 2008, J ANIM ECOL, V77, P1296, DOI 10.1111/j.1365-2656.2008.01449.x; CARDONA C, 1990, ENTOMOL EXP APPL, V56, P197, DOI 10.1007/BF00163462; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1, DOI 10.1105/tpc.3.1.1; Cronin JT, 1999, OECOLOGIA, V121, P392, DOI 10.1007/s004420050944; Dicke M, 2003, BASIC APPL ECOL, V4, P3, DOI 10.1078/1439-1791-00129; Forkner RE, 2000, ECOLOGY, V81, P1588, DOI 10.1890/0012-9658(2000)081[1588:WGUMCD]2.0.CO;2; Fox J., 2019, R COMPANION APPL REG, V.; FOX LR, 1990, OECOLOGIA, V83, P414, DOI 10.1007/BF00317569; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Hansson C, 2004, ZOOTAXA, P1; Hartweck LM, 1997, THEOR APPL GENET, V95, P1012, DOI 10.1007/s001220050655; Harvey JA, 2003, J ANIM ECOL, V72, P520, DOI 10.1046/j.1365-2656.2003.00722.x; Harvey JA, 2007, ECOL ENTOMOL, V32, P15, DOI 10.1111/j.1365-2311.2006.00838.x; Harvey JA, 2012, J INSECT PHYSIOL, V58, P1463, DOI 10.1016/j.jinsphys.2012.08.013; Harvey JA, 2011, OECOLOGIA, V166, P421, DOI 10.1007/s00442-010-1861-4; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; HOWE R. W., 1964, BULL ENTOMOL RES, V55, P437, DOI 10.1017/S0007485300049580; Huignard J, 1996, BIOL CONTROL BRUCHID; Hunter MD, 1997, P NATL ACAD SCI USA, V94, P9176, DOI 10.1073/pnas.94.17.9176; HUNTER MD, 1992, ECOLOGY, V73, P724; Hunter MD, 2003, AGR FOREST ENTOMOL, V5, P1, DOI 10.1046/j.1461-9563.2003.00168.x; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; KING BH, 1989, OECOLOGIA, V78, P420, DOI 10.1007/BF00379119; KINGSOLVER JM, 1968, P ENTOMOL SOC WASH, V70, P4; KISTLER RA, 1985, ENVIRON ENTOMOL, V14, P507, DOI 10.1093/ee/14.4.507; KOHLER SL, 1989, ECOLOGY, V70, P1811, DOI 10.2307/1938114; Kos M, 2011, FUNCT ECOL, V25, P1113, DOI 10.1111/j.1365-2435.2011.01871.x; Lacoume S, 2006, J INSECT PHYSIOL, V52, P249, DOI 10.1016/j.jinsphys.2005.11.003; LaSalle John, 1995, P315; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Mayhew PJ, 1997, OECOLOGIA, V110, P218, DOI 10.1007/s004420050153; MEYHOFER R, 1994, PHYSIOL ENTOMOL, V19, P349, DOI 10.1111/j.1365-3032.1994.tb01062.x; MINNEY BHP, 1990, J INSECT PHYSIOL, V36, P757, DOI 10.1016/0022-1910(90)90049-L; Mutshinda CM, 2009, P ROY SOC B-BIOL SCI, V276, P2923, DOI 10.1098/rspb.2009.0523; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Newton E, 2009, ECOL ENTOMOL, V34, P614, DOI 10.1111/j.1365-2311.2009.01111.x; Nishimura K, 1997, FUNCT ECOL, V11, P336, DOI 10.1046/j.1365-2435.1997.00092.x; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; OSBORN TC, 1988, SCIENCE, V240, P207, DOI 10.1126/science.240.4849.207; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Price PW, 2005, J ANIM ECOL, V74, P917, DOI 10.1111/j.1365-2656.2005.00989.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richmond DS, 2004, ECOL ENTOMOL, V29, P353, DOI 10.1111/j.1365-2311.2004.00598.x; Romero J, 1999, COLEOPTS BULL, V53, P87; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Sarfraz M, 2009, BIOL CONTROL, V51, P34, DOI 10.1016/j.biocontrol.2009.07.004; Schadler M, 2010, ENTOMOL EXP APPL, V135, P162, DOI 10.1111/j.1570-7458.2010.00976.x; Schmale I, 2001, BIOL CONTROL, V21, P134, DOI 10.1006/bcon.2000.0911; SCHOONHOVEN AV, 1983, J ECON ENTOMOL, V76, P1255, DOI 10.1093/jee/76.6.1255; Singer MS, 2005, ECOL LETT, V8, P1247, DOI 10.1111/j.1461-0248.2005.00835.x; SKELLY DK, 1990, ECOLOGY, V71, P2313, DOI 10.2307/1938642; STAMOPOULOS DC, 1988, J APPL ENTOMOL, V105, P317, DOI 10.1111/j.1439-0418.1988.tb00193.x; Stenberg JA, 2012, BIOL CONTROL, V60, P54, DOI 10.1016/j.biocontrol.2011.09.004; Teder T, 2002, ECOL ENTOMOL, V27, P94, DOI 10.1046/j.0307-6946.2001.00381.x; Teixeira IRV, 2002, J STORED PROD RES, V39, P131; Teixeira IRV, 2012, INSECT SCI, V19, P102, DOI 10.1111/j.1744-7917.2011.01425.x; THIERY D, 1984, J STORED PROD RES, V20, P177, DOI 10.1016/0022-474X(84)90001-8; THIERY D, 1994, J CHEM ECOL, V20, P1867, DOI 10.1007/BF02066228; Underwood N, 2000, ECOLOGY, V81, P1565, DOI 10.1890/0012-9658(2000)081[1565:TEOHPG]2.0.CO;2; Velten G, 2008, BIOL CONTROL, V47, P133, DOI 10.1016/j.biocontrol.2008.07.009; Velten G, 2007, BIOL CONTROL, V43, P78, DOI 10.1016/j.biocontrol.2007.05.003; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Walker M, 2008, J ANIM ECOL, V77, P1063, DOI 10.1111/j.1365-2656.2008.01406.x; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Zaugg I, 2013, THEOR APPL GENET, V126, P647, DOI 10.1007/s00122-012-2008-2	83	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55317	10.1371/journal.pone.0055317	http://dx.doi.org/10.1371/journal.pone.0055317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383151	gold, Green Published			2022-12-27	WOS:000315483200013
J	Bai, LL; Yin, WB; Chen, YH; Niu, LL; Sun, YR; Zhao, SM; Yang, FQ; Wang, RRC; Wu, Q; Zhang, XQ; Hu, ZM				Bai, Li-Li; Yin, Wei-Bo; Chen, Yu-Hong; Niu, Li-Li; Sun, Yong-Ru; Zhao, Shi-Min; Yang, Fu-Quan; Wang, Richard R. -C.; Wu, Qing; Zhang, Xiang-Qi; Hu, Zan-Min			A New Strategy to Produce a Defensin: Stable Production of Mutated NP-1 in Nitrate Reductase-Deficient Chlorella ellipsoidea	PLOS ONE			English	Article							N-TERMINAL METHIONINE; ANTIMICROBIAL PEPTIDES; GROWTH-HORMONE; EXPRESSION; GENE; PURIFICATION; CHLOROPLAST; PROTEINS; ALGA	Defensins are small cationic peptides that could be used as the potential substitute for antibiotics. However, there is no efficient method for producing defensins. In this study, we developed a new strategy to produce defensin in nitrate reductase (NR)-deficient C. ellipsoidea (nrm-4). We constructed a plant expression vector carrying mutated NP-1 gene (mNP-1), a mature alpha-defensin NP-1 gene from rabbit with an additional initiator codon in the 5'-terminus, in which the selection markers were NptII and NR genes. We transferred mNP-1 into nrm-4 using electroporation and obtained many transgenic lines with high efficiency under selection chemicals G418 and NaNO3. The mNP-1 was characterized using N-terminal sequencing after being isolated from transgenic lines. Excitingly, mNP-1 was produced at high levels (approximately 11.42 mg/l) even after 15 generations of continuous fermentation. In addition, mNP-1 had strong activity against Escherichia coli at 5 mu g/ml. This research developed a new method for producing defensins using genetic engineering.	[Bai, Li-Li; Yin, Wei-Bo; Chen, Yu-Hong; Sun, Yong-Ru; Zhao, Shi-Min; Zhang, Xiang-Qi; Hu, Zan-Min] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Niu, Li-Li; Yang, Fu-Quan] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China; [Wang, Richard R. -C.] Utah State Univ, FRRL, USDA ARS, Logan, UT 84322 USA; [Wu, Qing] Polo Biol Sci Pk Co Ltd, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Hu, ZM (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	zmhu@genetics.ac.cn	Wang, Richard Ruey-Chyi/S-3053-2018	Wang, Richard Ruey-Chyi/0000-0003-3622-2572	Ministry of Science and Technology of China [2011AA10A212, 2011CB200902]; Chinese Academy of Sciences [Yz200947, KSCX2-YW-R-2]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by "863" Program number 2011AA10A212 (to ZMH), "973" Program number 2011CB200902 (to YHC) from the Ministry of Science and Technology of China and the projects numbers Yz200947 and KSCX2-YW-R-2 (to ZMH) from Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balous A, 1991, MANUAL CLIN MICROBIO, P1138; Befus AD, 1999, J IMMUNOL, V163, P947; BORENSTEIN LA, 1991, INFECT IMMUN, V59, P1368, DOI 10.1128/IAI.59.4.1368-1377.1991; Chebolu S, 2009, CURR TOP MICROBIOL, V332, P33, DOI 10.1007/978-3-540-70868-1_3; Chen HH, 2006, IEEE VEH TECHNOL MAG, V1, P2, DOI 10.1109/MVT.2006.307302; Chen Y, 2001, CURR GENET, V39, P365, DOI 10.1007/s002940100205; Cipakova I, 2005, PROTEIN PEPTIDE LETT, V12, P551, DOI 10.2174/0929866054395761; Corrales-Garcia LL, 2011, AMINO ACIDS, V40, P5, DOI 10.1007/s00726-010-0493-7; Dawson HN, 1997, CURR MICROBIOL, V35, P356, DOI 10.1007/s002849900268; ENDO H, 1974, AGR BIOL CHEM TOKYO, V38, P9, DOI 10.1080/00021369.1974.10861121; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Fuchs C, 2002, J BIOTECHNOL, V93, P243, DOI 10.1016/S0168-1656(01)00402-3; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; GANZ T, 1989, J IMMUNOL, V143, P1358; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hawkins RL, 1999, CURR MICROBIOL, V38, P335, DOI 10.1007/PL00006813; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; JARVIS EE, 1991, CURR GENET, V19, P317, DOI 10.1007/BF00355062; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kim DH, 2002, MAR BIOTECHNOL, V4, P63, DOI 10.1007/s1012601-0070-x; LEHRER RI, 1985, J VIROL, V54, P467, DOI 10.1128/JVI.54.2.467-472.1985; Liao YD, 2004, PROTEIN SCI, V13, P1802, DOI 10.1110/ps.04679104; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Manuell AL, 2007, PLANT BIOTECHNOL J, V5, P402, DOI 10.1111/j.1467-7652.2007.00249.x; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; MARUYAMA M, 1994, BIOTECHNOL TECH, V8, P821, DOI 10.1007/BF00152891; MIYASAKI KT, 1990, ORAL MICROBIOL IMMUN, V5, P315, DOI 10.1111/j.1399-302X.1990.tb00432.x; Nichols HW., 1975, HDB PHYCOLOGICAL MET, P7; Nozdrachev A D, 2006, Neurosci Behav Physiol, V36, P313, DOI 10.1007/s11055-006-0018-8; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; Potvin G, 2010, BIOTECHNOL ADV, V28, P910, DOI 10.1016/j.biotechadv.2010.08.006; Raj PA, 2000, BIOCHEM J, V347, P633, DOI 10.1042/0264-6021:3470633; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; SELSTED ME, 1985, INFECT IMMUN, V49, P202, DOI 10.1128/IAI.49.1.202-206.1985; SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984; TAYLOR MG, 1993, PLANT CELL REP, V12, P491, DOI 10.1007/BF00236093; Ting ZW, 2011, AFR J BIOTECHNOL, V10, P9218; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Wang YQ, 2005, J APPL PHYCOL, V17, P281, DOI 10.1007/s10811-005-5559-7; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Zelitch I, 1971, PHOTOSYNTHESIS PHOTO, P275; Zhou L, 2007, PROTEOMICS, V7, P3194, DOI 10.1002/pmic.200700137	45	38	40	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54966	10.1371/journal.pone.0054966	http://dx.doi.org/10.1371/journal.pone.0054966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383016	gold, Green Submitted, Green Published			2022-12-27	WOS:000315211500041
J	Brun, J; Dieudonne, FX; Marty, C; Muller, J; Schule, R; Patino-Garcia, A; Lecanda, F; Fromigue, O; Marie, PJ				Brun, Julia; Dieudonne, Francois-Xavier; Marty, Caroline; Mueller, Judith; Schuele, Roland; Patino-Garcia, Ana; Lecanda, Fernando; Fromigue, Olivia; Marie, Pierre J.			FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo	PLOS ONE			English	Article							ONLY PROTEIN FHL2; BETA-CATENIN; CELL-DIFFERENTIATION; OXIDATIVE STRESS; LIM; EXPRESSION; INTERACTS; COACTIVATOR; DISEASE; DOMAIN	Background: The molecular mechanisms that are involved in the growth and invasiveness of osteosarcoma, an aggressive and invasive primary bone tumor, are not fully understood. The transcriptional co-factor FHL2 (four and a half LIM domains protein 2) acts as an oncoprotein or as a tumor suppressor depending on the tissue context. In this study, we investigated the role of FHL2 in tumorigenesis in osteosarcoma model. Methodology/Principal Findings: Western blot analyses showed that FHL2 is expressed above normal in most human and murine osteosarcoma cells. Tissue microarray analysis revealed that FHL2 protein expression is high in human osteosarcoma and correlates with osteosarcoma aggressiveness. In murine osteosarcoma cells, FHL2 silencing using shRNA decreased canonical Wnt/beta-catenin signaling and reduced the expression of Wnt responsive genes as well as of the key Wnt molecules Wnt5a and Wnt10b. This effect resulted in inhibition of osteosarcoma cell proliferation, invasion and migration in vitro. Using xenograft experiments, we showed that FHL2 silencing markedly reduced tumor growth and lung metastasis occurence in mice. The anti-oncogenic effect of FHL2 silencing in vivo was associated with reduced cell proliferation and decreased Wnt signaling in the tumors. Conclusion/Significance: Our findings demonstrate that FHL2 acts as an oncogene in osteosarcoma cells and contributes to tumorigenesis through Wnt signaling. More importantly, FHL2 depletion greatly reduces tumor cell growth and metastasis, which raises the potential therapeutic interest of targeting FHL2 to efficiently impact primary bone tumors.	[Brun, Julia; Dieudonne, Francois-Xavier; Marty, Caroline; Fromigue, Olivia; Marie, Pierre J.] INSERM, UMR 606, Paris, France; [Brun, Julia; Dieudonne, Francois-Xavier; Marty, Caroline; Fromigue, Olivia; Marie, Pierre J.] Univ Paris Diderot, Paris, France; [Mueller, Judith; Schuele, Roland] Univ Freiburg Klinikum, Urol Klink Frauenklin, Freiburg, Germany; [Mueller, Judith; Schuele, Roland] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Patino-Garcia, Ana; Lecanda, Fernando] Univ Navarra, Div Oncol, Ctr Appl Med Res, E-31080 Pamplona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; University of Navarra	Marie, PJ (corresponding author), INSERM, UMR 606, Paris, France.	pierre.marie@inserm.fr	Patiño-Garcia, Ana/I-4299-2012; Fromigue, Olivia/B-8225-2013	Patiño-Garcia, Ana/0000-0002-4066-8203; Fromigue, Olivia/0000-0002-3050-6155	DIM Stem Pole Ile de France (Paris, France)	DIM Stem Pole Ile de France (Paris, France)	Julia Brun is a recipient of a Ph.D. Award from the DIM Stem Pole Ile de France (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bruland OS, 2005, CLIN CANCER RES, V11, P4666, DOI 10.1158/1078-0432.CCR-05-0165; Chen K, 2008, PEDIATR BLOOD CANCER, V51, P349, DOI 10.1002/pbc.21595; Dieudonne FX, 2010, CANCER RES, V70, P5399, DOI 10.1158/0008-5472.CAN-10-0090; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Entz-Werle N, 2007, NEOPLASIA, V9, P678, DOI 10.1593/neo.07367; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gullotti L, 2011, LAB INVEST, V91, P1695, DOI 10.1038/labinvest.2011.109; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Himelstein Bruce P., 1998, Current Opinion in Oncology, V10, P326, DOI 10.1097/00001622-199807000-00009; Jaffe N, 2009, CANCER TREAT RES, V152, P239, DOI 10.1007/978-1-4419-0284-9_12; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Khanna C, 2001, CANCER RES, V61, P3750; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kinoshita M, 2005, INT J UROL, V12, P390, DOI 10.1111/j.1442-2042.2005.01093.x; Kleiber K, 2007, ANTICANCER RES, V27, P55; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Labalette C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010371; Lai CF, 2006, J BONE MINER RES, V21, P17, DOI 10.1359/JBMR.050915; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Lu BJ, 2012, MOL MED REP, V5, P1033, DOI 10.3892/mmr.2012.772; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Martin BT, 2007, CELL CYCLE, V6, P1779, DOI 10.4161/cc.6.14.4448; McQueen P, 2011, EXPERT REV ANTICANC, V11, P1223, DOI [10.1586/era.11.94, 10.1586/ERA.11.94]; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Ng CF, 2011, CANCER LETT, V304, P97, DOI 10.1016/j.canlet.2011.02.001; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Park J, 2008, FASEB J, V22, P2508, DOI 10.1096/fj.07-095521; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Scholl FA, 2000, J CELL BIOL, V151, P495, DOI 10.1083/jcb.151.3.495; Tanahashi H, 2000, HUM MOL GENET, V9, P2281, DOI 10.1093/oxfordjournals.hmg.a018919; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wend P, 2012, ACTA PHYSIOL, V204, P34, DOI 10.1111/j.1748-1716.2011.02296.x; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang WJ, 2011, EUR J CANCER, V47, P121, DOI 10.1016/j.ejca.2010.07.045	54	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55034	10.1371/journal.pone.0055034	http://dx.doi.org/10.1371/journal.pone.0055034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383046	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500049
J	Fischer, MD; Goldmann, T; Wallrapp, C; Muhlfriedel, R; Beck, SC; Stern-Schneider, G; Ueffing, M; Wolfrum, U; Seeliger, MW				Fischer, M. Dominik; Goldmann, Tobias; Wallrapp, Christine; Muehlfriedel, Regine; Beck, Susanne C.; Stern-Schneider, Gabi; Ueffing, Marius; Wolfrum, Uwe; Seeliger, Mathias W.			Successful Subretinal Delivery and Monitoring of MicroBeads in Mice	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; GLUCAGON-LIKE PEPTIDE-1; OPTICAL COHERENCE TOMOGRAPHY; MESENCHYMAL STEM-CELLS; MAMMALIAN PHOTORECEPTOR CELLS; SCANNING LASER OPHTHALMOSCOPY; LEBERS CONGENITAL AMAUROSIS; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; ANIMAL-MODELS	Background: To monitor viability of implanted genetically engineered and microencapsulated human stem cells (MicroBeads) in the mouse eye, and to study the impact of the beads and/or xenogenic cells on retinal integrity. Methodology/Principal Findings: MicroBeads were implanted into the subretinal space of SV126 wild type mice using an ab externo approach. Viability of microencapsulated cells was monitored by noninvasive retinal imaging (Spectralis (TM) HRA+OCT). Retinal integrity was also assessed with retinal imaging and upon the end of the study by light and electron microscopy. The implanted GFP-marked cells encapsulated in subretinal MicroBeads remained viable over a period of up to 4 months. Retinal integrity and viability appeared unaltered apart from the focal damage due to the surgical implantation, GFAP upregulation, and opsin mistargeting in the immediate surrounding tissue. Conclusions/Significance: The accessibility for routine surgery and its immune privileged state make the eye an ideal target for release system implants for therapeutic substances, including neurotrophic and anti-angiogenic compounds or protein based biosimilars. Microencapsulated human stem cells (MicroBeads) promise to overcome limitations inherent with single factor release systems, as they are able to produce physiologic combinations of bioactive compounds.	[Fischer, M. Dominik] Univ Tubingen, Univ Eye Hosp, Ctr Ophthalmol, Tubingen, Germany; [Fischer, M. Dominik] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX2 6AW, England; [Goldmann, Tobias; Stern-Schneider, Gabi; Wolfrum, Uwe] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Cell & Matrix Biol, Mainz, Germany; [Wallrapp, Christine] CellMed AG, Alzenau, Germany; [Muehlfriedel, Regine; Beck, Susanne C.; Seeliger, Mathias W.] Univ Tubingen, Div Ocular Neurodegenerat, Tubingen, Germany; [Muehlfriedel, Regine; Beck, Susanne C.; Ueffing, Marius; Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Oxford; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Fischer, MD (corresponding author), Univ Tubingen, Univ Eye Hosp, Ctr Ophthalmol, Tubingen, Germany.	Dominik.Fischer@merton.ox.ac.uk		Goldmann, Tobias/0000-0001-9754-9144	DFG [Se837/5-2, Se837/6-1, Se837/7-1]; BMBF [0314106]; EU [LSHG-CT-512036, EU HEALTH-F2-2008-200234]; Kerstan Foundation; Hochbaum Foundation; Fortuene Program University of Tuebingen; FAUN-Stiftung, Nurnberg; MRC [MR/K003690/1] Funding Source: UKRI; Medical Research Council [MR/K003690/1] Funding Source: researchfish	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Kerstan Foundation(European Commission); Hochbaum Foundation; Fortuene Program University of Tuebingen; FAUN-Stiftung, Nurnberg; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by DFG grants Se837/5-2, Se837/6-1, Se837/7-1; BMBF grant 0314106; EU grants LSHG-CT-512036, EU HEALTH-F2-2008-200234; Kerstan Foundation; Hochbaum Foundation; Fortuene Program University of Tuebingen; FAUN-Stiftung, Nurnberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beltran WA, 2008, ADV EXP MED BIOL, V613, P45; Beltran WA, 2007, EXP EYE RES, V84, P753, DOI 10.1016/j.exer.2006.12.019; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Gekeler F, 2007, GRAEF ARCH CLIN EXP, V245, P230, DOI 10.1007/s00417-006-0339-x; Glage S, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-18; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hauck SM, 2007, J PROTEOME RES, V6, P2121, DOI 10.1021/pr060668y; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Helb HM, 2010, ACTA OPHTHALMOL, V88, P842, DOI 10.1111/j.1755-3768.2009.01602.x; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Jaissle GB, 2010, GRAEF ARCH CLIN EXP, V248, P1063, DOI 10.1007/s00417-009-1253-9; Klinge PM, 2011, NEUROSCI LETT, V497, P6, DOI 10.1016/j.neulet.2011.03.092; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mao H, 2012, HUM GENE THER; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Schwahn HN, 2001, GRAEF ARCH CLIN EXP, V239, P961, DOI 10.1007/s004170100368; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Thanos CG, 2004, TISSUE ENG, V10, P1617, DOI 10.1089/ten.2004.10.1617; VERDERBER L, 1995, INVEST OPHTH VIS SCI, V36, P1137; Weber C, 2010, ADV BIOCHEM ENG BIOT, V123, P143, DOI 10.1007/10_2009_25; Weber Christian, 2007, Open Biomed Eng J, V1, P64, DOI 10.2174/1874120700701010064; Weber Christian, 2007, Open Biomed Eng J, V1, P38, DOI 10.2174/1874120700701010038; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Zhang R, 2011, ACTA OPHTHALMOL, V89, pE320, DOI 10.1111/j.1755-3768.2010.02044.x; Zhang R, 2011, RETINA-J RET VIT DIS, V31, P785, DOI 10.1097/IAE.0b013e3181f27509; Zhang R, 2010, ACTA OPHTHALMOL, V88, pe348, DOI 10.1111/j.1755-3768.2009.01762.x	37	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55173	10.1371/journal.pone.0055173	http://dx.doi.org/10.1371/journal.pone.0055173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383096	gold, Green Submitted, Green Published			2022-12-27	WOS:000315211500061
J	Hentze, JL; Moeller, ME; Jorgensen, AF; Bengtsson, MS; Bordoy, AM; Warren, JT; Gilbert, LI; Andersen, O; Rewitz, KF				Hentze, Julie L.; Moeller, Morten E.; Jorgensen, Anne F.; Bengtsson, Meghan S.; Bordoy, Anna M.; Warren, James T.; Gilbert, Lawrence I.; Andersen, Ole; Rewitz, Kim F.			Accessory Gland as a Site for Prothoracicotropic Hormone Controlled Ecdysone Synthesis in Adult Male Insects	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; MOSQUITO AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; MOLTING HORMONE; MANDUCA-SEXTA; ECDYSTEROIDOGENIC PATHWAY; CYTOCHROME-P450 ENZYME; JUVENILE-HORMONE; P450 ENZYMES; BOMBYX-MORI	Insect steroid hormones (ecdysteroids) are important for female reproduction in many insect species and are required for the initiation and coordination of vital developmental processes. Ecdysteroids are also important for adult male physiology and behavior, but their exact function and site of synthesis remains unclear, although previous studies suggest that the reproductive system may be their source. We have examined expression profiles of the ecdysteroidogenic Halloween genes, during development and in adults of the flour beetle Tribolium castaneum. Genes required for the biosynthesis of ecdysone (E), the precursor of the molting hormone 20-hydroxyecdysone (20E), are expressed in the tubular accessory glands (TAGs) of adult males. In contrast, expression of the gene encoding the enzyme mediating 20E synthesis was detected in the ovaries of females. Further, Spookiest (Spot), an enzyme presumably required for endowing tissues with competence to produce ecdysteroids, is male specific and predominantly expressed in the TAGs. We also show that prothoracicotropic hormone (PTTH), a regulator of E synthesis during larval development, regulates ecdysteroid levels in the adult stage in Drosophila melanogaster and the gene for its receptor Torso seems to be expressed specifically in the accessory glands of males. The composite results suggest strongly that the accessory glands of adult male insects are the main source of E, but not 20E. The finding of a possible male-specific source of E raises the possibility that E and 20E have sex-specific roles analogous to the vertebrate sex steroids, where males produce primarily testosterone, the precursor of estradiol. Furthermore this study provides the first evidence that PTTH regulates ecdysteroid synthesis in the adult stage and could explain the original finding that some adult insects are a rich source of PTTH.	[Hentze, Julie L.; Jorgensen, Anne F.; Bengtsson, Meghan S.; Bordoy, Anna M.; Andersen, Ole] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Moeller, Morten E.; Rewitz, Kim F.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Warren, James T.; Gilbert, Lawrence I.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Roskilde University; University of Copenhagen; University of North Carolina; University of North Carolina Chapel Hill	Rewitz, KF (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	Kim.Rewitz@bio.ku.dk	Moeller, Morten E./P-4663-2018; Rewitz, Kim F/M-6012-2014; Møller, Morten/N-2269-2014	Moeller, Morten E./0000-0001-7411-7189; Rewitz, Kim F/0000-0002-4409-9941; Møller, Morten/0000-0001-7411-7189; Jorgensen, Anne Faerch/0000-0001-9836-7393; Hentze, Julie Lilith/0000-0002-8572-2090	Danish Council for Independent Research - Natural Sciences	Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by funding from the The Danish Council for Independent Research - Natural Sciences to OA and KFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Beckstead RB, 2007, INSECT BIOCHEM MOLEC, V37, P570, DOI 10.1016/j.ibmb.2007.03.001; Belles X, 2005, INVERTEBR REPROD DEV, V47, P23, DOI 10.1080/07924259.2005.9652144; BRIERS T, 1983, COMP BIOCHEM PHYS A, V74, P521, DOI 10.1016/0300-9629(83)90541-8; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carney GE, 2000, GENETICS, V154, P1203; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; DAI JD, 1991, DEV BIOL, V144, P309, DOI 10.1016/0012-1606(91)90424-2; Dalton JE, 2009, CURR BIOL, V19, P1447, DOI 10.1016/j.cub.2009.06.063; De Loof Arnold, 2006, Insect Science, V13, P325, DOI 10.1111/j.1744-7917.2006.00101.x; De Loof A, 2010, J INSECT PHYSIOL, V56, P919, DOI 10.1016/j.jinsphys.2010.02.021; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fletcher JC, 1997, P NATL ACAD SCI USA, V94, P4582, DOI 10.1073/pnas.94.9.4582; Ganter GK, 2011, J INSECT PHYSIOL, V57, P1179, DOI 10.1016/j.jinsphys.2011.05.007; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gilbert LI, 2009, ECDYSONE STRUCTURES, P229; GILLOTT C, 1995, INVERTEBR REPROD DEV, V27, P65, DOI 10.1080/07924259.1995.9672435; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Grillo M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00762; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; HAPP GM, 1992, ANNU REV ENTOMOL, V37, P303, DOI 10.1146/annurev.en.37.010192.001511; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Ishimoto H, 2010, GENETICS, V185, P269, DOI 10.1534/genetics.110.114587; Ishimoto H, 2009, P NATL ACAD SCI USA, V106, P6381, DOI 10.1073/pnas.0810213106; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73, DOI 10.1080/00021369.1991.10870535; KOOLMAN J, 1979, EXPERIENTIA, V35, P134, DOI 10.1007/BF01917923; Lafont R., 2012, INSECT ENDOCRINOLOGY, P106, DOI DOI 10.1016/13978-0-12-384749-2.10004.4; Luine VN, 2008, J NEUROENDOCRINOL, V20, P866, DOI 10.1111/j.1365-2826.2008.01710.x; Manolakou P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-59; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; MEISTER MF, 1985, MOL CELL ENDOCRINOL, V41, P27, DOI 10.1016/0303-7207(85)90140-6; Minami R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032302; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Morris LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046109; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Ono H, 2012, BIOCHEM BIOPH RES CO, V421, P561, DOI 10.1016/j.bbrc.2012.04.045; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; Perriere C, 1992, CAMP BIOCH PHYSL A, V104A, P51; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pondeville E, 2008, P NATL ACAD SCI USA, V105, P19631, DOI 10.1073/pnas.0809264105; Rewitz KF, 2006, BIOCHEM SOC T, V34, P1256, DOI 10.1042/BST0341256; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; Riddiford L., 1993, DEV DROSOPHILA MELAN, V2, P899; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Rosen O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015281; Rybczynski R, 2009, ARCH INSECT BIOCHEM, V70, P217, DOI 10.1002/arch.20295; Schonbauer C, 2011, NATURE, V479, P406, DOI 10.1038/nature10559; Schwedes C, 2011, J INSECT PHYSIOL, V57, P899, DOI 10.1016/j.jinsphys.2011.03.027; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Simonet G, 2004, J NEUROENDOCRINOL, V16, P649, DOI 10.1111/j.1365-2826.2004.01222.x; Smith WA, 2012, INSECT ENDOCRINOLOGY, P1, DOI [10.1016/B978-0-12-384749-2.10001-9, DOI 10.1016/B978-0-12-384749-2.10001-9]; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Svechnikov K, 2008, BEST PRACT RES CL EN, V22, P95, DOI 10.1016/j.beem.2007.09.002; Terashima J, 2005, J ENDOCRINOL, V187, P69, DOI 10.1677/joe.1.06220; Tricoire H, 2009, MECH AGEING DEV, V130, P547, DOI 10.1016/j.mad.2009.05.004; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; Wang C, 2011, DEV BIOL, V351, P146, DOI 10.1016/j.ydbio.2010.12.042; Warren JT, 2009, INSECT BIOCHEM MOLEC, V39, P677, DOI 10.1016/j.ibmb.2009.08.004; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; WARREN JT, 1986, INSECT BIOCHEM, V16, P65, DOI 10.1016/0020-1790(86)90080-6; WEEVERS RDG, 1966, J EXP BIOL, V44, P163; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	74	53	57	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55131	10.1371/journal.pone.0055131	http://dx.doi.org/10.1371/journal.pone.0055131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383307	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900014
J	Chen, HH; Wang, HM; Fan, KH; Lin, CY; Yen, TC; Liao, CT; Chen, IH; Kang, CJ; Huang, SF				Chen, Hsuan-Ho; Wang, Hung-Ming; Fan, Kang-Hsing; Lin, Chien-Yu; Yen, Tzu-Chen; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu			Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; POSITRON-EMISSION-TOMOGRAPHY; ACUTE-PHASE PROTEINS; SCC-ANTIGEN; NECK-CANCER; NEOADJUVANT CHEMOTHERAPY; F-18 FLUORODEOXYGLUCOSE; TREATMENT RESPONSE; COLORECTAL-CANCER; CERVICAL-CANCER	The levels of squamous cell carcinoma antigen (SCC-Ag) and C-reactive protein (CRP) can be used to predict tumor invasion, lymph node metastasis, staging and survival in patients with oral cavity cancer. The present study analyzed the relationship between pre-treatment levels of SCC-Ag and CRP in relation to clinicopathological factors in patients with pharyngolaryngeal cancer (PLC) and determined whether elevated levels of CRP and SCC-Ag were associated with tumor metabolic activity via [18F] fluorodeoxyglucose positron emission tomography (FDG-PET). We retrospectively recruited one hundred and six PLC patients between June 2008 and December 2011. All patients received computed tomography (CT)/magnetic resonance imaging (MRI) and FDG-PET staging analyses, and the serum levels of SCC-Ag and CRP in these patients were measured prior to treatment. A SCC-Ag level >= 2.0 ng/ml and a CRP level >= 5.0 mg/L were significantly associated with clinical stage (P < 0.001), clinical tumor status (P < 0.001), and clinical nodal status (P < 0.001). The elevation of both SCC-Ag and CRP levels was correlated with the standardized uptake value (SUV) max of the tumor (>= 8.6 mg/L) and lymph nodes (>= 5.7 ng/ml) (P = 0.019). The present study demonstrated that the presence of high levels of both pre-treatment SCC-Ag and CRP acts as a predictor of clinical stage, clinical tumor status, and clinical nodal status in patients with PLC. Moreover, elevated levels of SCC-Ag and CRP were associated with a high metabolic rate as well as the proliferative activity measured according to the SUVmax of the tumor and lymph nodes. Therefore, elevated levels of these two factors have the potential to serve as biomarkers for the prediction of tumor aggressiveness in cases of PLC.	[Chen, Hsuan-Ho; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu] Chang Gung Mem Hosp, Dept Otolaryngol, Linkou, Taiwan; [Chen, Hsuan-Ho; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu] Chang Gung Mem Hosp, Dept Head & Neck Surg, Linkou, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Div Hematol Oncol, Linkou, Taiwan; [Fan, Kang-Hsing; Lin, Chien-Yu] Chang Gung Mem Hosp, Linkou, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Nucl Med & Mol Imaging Ctr, Linkou, Taiwan; [Chen, Hsuan-Ho; Wang, Hung-Ming; Fan, Kang-Hsing; Lin, Chien-Yu; Yen, Tzu-Chen; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Linkou, Taiwan; [Chen, Hsuan-Ho; Wang, Hung-Ming; Fan, Kang-Hsing; Lin, Chien-Yu; Yen, Tzu-Chen; Liao, Chun-Ta; Chen, I-How; Kang, Chung-Jan; Huang, Shiang-Fu] Chang Gung Univ, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, SF (corresponding author), Chang Gung Mem Hosp, Dept Otolaryngol, Linkou, Taiwan.	shiangfu.huang@gmail.com	Fan, K/GXH-3734-2022	Fan, Kang-Hsing/0000-0002-0910-7803				Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Chen HH, 2011, CLIN OTOLARYNGOL, V36, P147, DOI 10.1111/j.1749-4486.2011.02274.x; Chen PH, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-101; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Department-of-Health, 2009, CANC REG ANN REP TAI; Dhankhar R, 2011, CLIN LAB, V57, P795; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Emoto T, 2008, BIOCHEM BIOPH RES CO, V370, P495, DOI 10.1016/j.bbrc.2008.03.132; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; GALLO O, 1995, EUR ARCH OTO-RHINO-L, V252, P159; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Huang SF, 2012, ANN SURG ONCOL; Huang SF, 2008, CANCER, V112, P1066, DOI 10.1002/cncr.23278; Il'yasova D, 2005, CANCER EPIDEM BIOMAR, V14, P2413, DOI 10.1158/1055-9965.EPI-05-0316; Jablonska Ewa, 1997, Pathol Oncol Res, V3, P126; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Khandavilli SD, 2009, ORAL ONCOL, V45, P912, DOI 10.1016/j.oraloncology.2009.03.015; Kidd EA, 2007, CANCER, V110, P1738, DOI 10.1002/cncr.22974; Kim SY, 2007, J NUCL MED, V48, P752, DOI 10.2967/jnumed.107.039610; Kimura Y, 2000, CANCER LETT, V155, P163, DOI 10.1016/S0304-3835(00)00423-7; Krimmel M, 1998, J CRANIO MAXILL SURG, V26, P243, DOI 10.1016/S1010-5182(98)80020-6; Kulpa J, 2004, NEOPLASMA, V51, P103; Lachowicz MA, 1999, CLIN OTOLARYNGOL, V24, P270, DOI 10.1046/j.1365-2273.1999.00239.x; LARA PC, 1995, CANCER, V76, P758, DOI 10.1002/1097-0142(19950901)76:5<758::AID-CNCR2820760508>3.0.CO;2-9; Liao CT, 2008, ANN SURG ONCOL, V15, P915, DOI 10.1245/s10434-007-9761-5; Liao CT, 2010, INT J RADIAT ONCOL, V77, P421, DOI 10.1016/j.ijrobp.2009.05.002; Liao CT, 2009, INT J RADIAT ONCOL, V74, P1054, DOI 10.1016/j.ijrobp.2008.09.045; Lin WH, 2011, LARYNGOSCOPE, V121, P971, DOI 10.1002/lary.21721; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Molina R, 1996, TUMOR BIOL, V17, P81, DOI 10.1159/000217970; Nakamura K, 2010, GYNECOL ONCOL, V119, P81, DOI 10.1016/j.ygyno.2010.04.020; Ng SH, 2005, J NUCL MED, V46, P1136; Ng SH, 2006, J CLIN ONCOL, V24, P4371, DOI 10.1200/JCO.2006.05.7349; NGAN HYS, 1990, GYNECOL ONCOL, V37, P260, DOI 10.1016/0090-8258(90)90344-K; Oka M, 1996, CANCER RES, V56, P2776; Pectasides D, 1996, AM J CLIN ONCOL-CANC, V19, P271, DOI 10.1097/00000421-199606000-00013; SCAMBIA G, 1991, AM J OBSTET GYNECOL, V164, P631, DOI 10.1016/S0002-9378(11)80037-2; Schoder H, 2006, J NUCL MED, V47, P755; Schwarz JK, 2007, JAMA-J AM MED ASSOC, V298, P2289, DOI 10.1001/jama.298.19.2289; Shimoda Wataru, 2007, Breast Cancer, V14, P260, DOI 10.2325/jbcs.14.260; Sueoka K, 2005, INT J ONCOL, V27, P1345; Takeda A, 2002, BIOL CHEM, V383, P1231, DOI 10.1515/BC.2002.136; Tartour E, 1997, CANCER, V79, P1401, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1401::AID-CNCR18>3.3.CO;2-H; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201, DOI 10.1200/JCO.1999.17.10.3201; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Wensing BM, 2006, LARYNGOSCOPE, V116, P809, DOI 10.1097/01.mlg.0000209151.78362.d0; Yasumatsu R, 2001, CANCER LETT, V167, P205, DOI 10.1016/S0304-3835(01)00445-1; Zeng YC, 2012, TUMOR BIOL, V33, P891, DOI 10.1007/s13277-012-0330-6; Zhang BT, 2010, ACTA OTO-LARYNGOL, V130, P756, DOI 10.3109/00016480903402981	54	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55327	10.1371/journal.pone.0055327	http://dx.doi.org/10.1371/journal.pone.0055327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383155	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600088
J	Eskens, BJM; Mooij, HL; Cleutjens, JPM; Roos, JMA; Cobelens, JE; Vink, H; VanTeeffelen, JWGE				Eskens, Bart J. M.; Mooij, Hans L.; Cleutjens, Jack P. M.; Roos, Jozef M. A.; Cobelens, Johanna E.; Vink, Hans; VanTeeffelen, Jurgen W. G. E.			Rapid Insulin-Mediated Increase in Microvascular Glycocalyx Accessibility in Skeletal Muscle May Contribute to Insulin-Mediated Glucose Disposal in Rats	PLOS ONE			English	Article							ENDOTHELIAL-CELL GLYCOCALYX; CAPILLARY-TUBE HEMATOCRIT; FREE LAYER; BARRIER PROPERTIES; TIME-COURSE; RECRUITMENT; PERFUSION; PERMEABILITY; SENSITIVITY; RESISTANCE	It has been demonstrated that insulin-mediated recruitment of microvascular blood volume is associated with insulin sensitivity. We hypothesize that insulin rapidly stimulates penetration of red blood cells (RBC) and plasma into the glycocalyx and thereby promotes insulin-mediated glucose uptake by increasing intracapillary blood volume. Experiments were performed in rats; the role of the glycocalyx was assessed by enzymatic degradation using a bolus of hyaluronidase. First, the effect of insulin on glycocalyx accessibility was assessed by measuring the depth of penetration of RBCs into the glycocalyx in microvessels of the gastrocnemius muscle with Sidestream Dark-field imaging. Secondly, peripheral insulin sensitivity was determined using intravenous insulin tolerance tests (IVITT). In addition, in a smaller set of experiments, intravital microscopy of capillary hemodynamics in cremaster muscle and histological analysis of the distribution of fluorescently labeled 40 kDa dextrans (D40) in hindlimb muscle was used to evaluate insulin-mediated increases in capillary blood volume. Insulin increased glycocalyx penetration of RBCs by 0.34 +/- 0.44 mu m (P < 0.05) within 10 minutes, and this effect of insulin was greatly impaired in hyaluronidase treated rats. Further, hyaluronidase treated rats showed a 35 +/- 25% reduction in whole-body insulin-mediated glucose disposal compared to control rats. Insulin-mediated increases in capillary blood volume were reflected by a rapid increase in capillary tube hematocrit from 21.1 +/- 10.1% to 29.0 +/- 9.8% (P < 0.05), and an increase in D40 intensity in individual capillaries of 134 +/- 138% compared to baseline at the end of the IVITT. These effects of insulin were virtually abolished in hyaluronidase treated animals. In conclusion, insulin rapidly increases glycocalyx accessibility for circulating blood in muscle, and this is associated with an increased blood volume in individual capillaries. Hyaluronidase treatment of the glycocalyx abolishes the effects of insulin on capillary blood volume and impairs insulin-mediated glucose disposal.	[Eskens, Bart J. M.; Mooij, Hans L.; Roos, Jozef M. A.; Cobelens, Johanna E.; Vink, Hans; VanTeeffelen, Jurgen W. G. E.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands; [Mooij, Hans L.; Vink, Hans] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Cleutjens, Jack P. M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Eskens, BJM (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Maastricht, Netherlands.	B.Eskens@maastrichtuniversity.nl	Cleutjens, Jack P.M./F-6242-2012	Cleutjens, Jack P.M./0000-0002-4346-1785	Dutch Diabetes Research Foundation [2006.00.027]; Netherlands Heart Foundation [2005T037]; Center for Translational Molecular Medicine [01C-104-04-PREDICCT]	Dutch Diabetes Research Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); Center for Translational Molecular Medicine	The study was supported by the Dutch Diabetes Research Foundation (grant number 2006.00.027), the Netherlands Heart Foundation (grant number 2005T037) and the Center for Translational Molecular Medicine (Work package 01C-104-04-PREDICCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINMOKUN A, 1992, DIABETIC MED, V9, P432, DOI 10.1111/j.1464-5491.1992.tb01813.x; Baron AD, 1996, AM J PHYSIOL-ENDOC M, V271, pE1067, DOI 10.1152/ajpendo.1996.271.6.E1067; Barrett EJ, 2009, DIABETOLOGIA, V52, P752, DOI 10.1007/s00125-009-1313-z; Barrett EJ, 2011, AM J PHYSIOL-ENDOC M, V301, pE252, DOI 10.1152/ajpendo.00186.2011; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Borghouts LB, 1999, EUR J APPL PHYSIOL O, V80, P461, DOI 10.1007/s004210050618; Brands J, 2010, AM J PHYSIOL-HEART C, V298, pH515, DOI 10.1152/ajpheart.01306.2008; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Cabrales P, 2007, J APPL PHYSIOL, V102, P2251, DOI 10.1152/japplphysiol.01155.2006; Chiu JD, 2008, DIABETES, V57, P828, DOI 10.2337/db07-1444; Clark MG, 2008, AM J PHYSIOL-ENDOC M, V295, pE732, DOI 10.1152/ajpendo.90477.2008; Clark MG, 2008, J APPL PHYSIOL, V104, P889, DOI 10.1152/japplphysiol.00779.2007; Clerk LH, 2004, DIABETES-METAB RES, V20, P3, DOI 10.1002/dmrr.414; Clerk LH, 2002, DIABETES, V51, P1138, DOI 10.2337/diabetes.51.4.1138; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Constantinescu AA, 2001, AM J PHYSIOL-HEART C, V280, pH1051, DOI 10.1152/ajpheart.2001.280.3.H1051; DESJARDINS C, 1990, AM J PHYSIOL, V258, pH647, DOI 10.1152/ajpheart.1990.258.3.H647; DESJARDINS C, 1987, AM J PHYSIOL, V252, pH494, DOI 10.1152/ajpheart.1987.252.3.H494; Dominighini A, 2010, CLIN HEMORHEOL MICRO, V44, P217, DOI 10.3233/CH-2010-1265; DULING BR, 1987, NEWS PHYSIOL SCI, V2, P66; Eggleston EM, 2007, DIABETES, V56, P2958, DOI 10.2337/db07-0670; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Gudbjornsdottir S, 2003, J CLIN ENDOCR METAB, V88, P4559, DOI 10.1210/jc.2003-030434; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Herkner H, 2003, EUR J CLIN INVEST, V33, P141, DOI 10.1046/j.1365-2362.2003.01106.x; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; JARETT L, 1975, P NATL ACAD SCI USA, V72, P3526, DOI 10.1073/pnas.72.9.3526; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1526, DOI 10.1152/ajpheart.01090.2006; Kim S, 2009, BIORHEOLOGY, V46, P181, DOI 10.3233/BIR-2009-0530; KLITZMAN B, 1979, AM J PHYSIOL, V237, pH481, DOI 10.1152/ajpheart.1979.237.4.H481; Li JA, 2002, MICROVASC RES, V64, P38, DOI 10.1006/mvre.2002.2399; Meijer RI, 2012, MICROCIRCULATION, V19, P494, DOI 10.1111/j.1549-8719.2012.00174.x; Muniyappa R, 2007, CURR OPIN CLIN NUTR, V10, P523, DOI 10.1097/MCO.0b013e32819f8ecd; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Ong PK, 2010, AM J PHYSIOL-HEART C, V298, pH1870, DOI 10.1152/ajpheart.01182.2009; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; SARELIUS IH, 1982, AM J PHYSIOL, V243, pH1018, DOI 10.1152/ajpheart.1982.243.6.H1018; Schrauwen-Hinderling VB, 2003, J CLIN ENDOCR METAB, V88, P1610, DOI 10.1210/jc.2002-021464; Sheikh MY, 2009, DIGEST DIS SCI, V54, P2706, DOI 10.1007/s10620-008-0664-5; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; TOBERMEYER BK, 1981, LAB ANIM, V15, P111, DOI 10.1258/002367781780959071; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Van Teeffelen JWGE, 2008, J PHYSIOL-LONDON, V586, P3207, DOI 10.1113/jphysiol.2008.152975; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; VanTeeffelen JWGE, 2010, CARDIOVASC RES, V87, P311, DOI 10.1093/cvr/cvq114; VanTeeffelen JWGE, 2005, AM J PHYSIOL-HEART C, V289, pH447, DOI 10.1152/ajpheart.01298.2004; Vincent MA, 2005, CLIN EXP PHARMACOL P, V32, P302, DOI 10.1111/j.1440-1681.2005.04188.x; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Vink H., 2012, BIORHEOLOGY, V49, P172; Vlahu CA, 2012, J AM SOC NEPHROL, V23, P1900, DOI 10.1681/ASN.2011121181; Wheatley CM, 2004, AM J PHYSIOL-ENDOC M, V287, pE804, DOI 10.1152/ajpendo.00077.2004; YANG YJ, 1989, J CLIN INVEST, V84, P1620, DOI 10.1172/JCI114339; Zhang L, 2004, DIABETES, V53, P447, DOI 10.2337/diabetes.53.2.447; Zuurbier CJ, 2005, J APPL PHYSIOL, V99, P1471, DOI 10.1152/japplphysiol.00436.2005	59	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55399	10.1371/journal.pone.0055399	http://dx.doi.org/10.1371/journal.pone.0055399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383178	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600098
J	Gad, W; Nair, MG; Van Belle, K; Wahni, K; De Greve, H; Van Ginderachter, JA; Vandenbussche, G; Endo, Y; Artis, D; Messens, J				Gad, Wael; Nair, Meera G.; Van Belle, Karolien; Wahni, Khadija; De Greve, Henri; Van Ginderachter, Jo A.; Vandenbussche, Guy; Endo, Yaeta; Artis, David; Messens, Joris			The Quiescin Sulfhydryl Oxidase ( hQSOX1b) Tunes the Expression of Resistin-Like Molecule Alpha (RELM-alpha or mFIZZ1) in a Wheat Germ Cell-Free Extract	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; BOND FORMATION; ESCHERICHIA-COLI; PULMONARY INFLAMMATION; ENDOPLASMIC-RETICULUM; TYPE-2 INFLAMMATION; SECONDARY STRUCTURE; SINGLE CYSTEINE; GENE-EXPRESSION; FAMILY	Background: Although disulfide bond formation in proteins is one of the most common types of post-translational modifications, the production of recombinant disulfide-rich proteins remains a challenge. The most popular host for recombinant protein production is Escherichia coli, but disulfide-rich proteins are here often misfolded, degraded, or found in inclusion bodies. Methodology/Principal findings: We optimize an in vitro wheat germ translation system for the expression of an immunological important eukaryotic protein that has to form five disulfide bonds, resistin-like alpha (mFIZZ1). Expression in combination with human quiescin sulfhydryl oxidase (hQSOX1b), the disulfide bond-forming enzyme of the endoplasmic reticulum, results in soluble, intramolecular disulfide bonded, monomeric, and biological active protein. The mFIZZ1 protein clearly suppresses the production of the cytokines IL-5 and IL-13 in mouse splenocytes cultured under Th2 permissive conditions. Conclusion/Significance: The quiescin sulfhydryl oxidase hQSOX1b seems to function as a chaperone and oxidase during the oxidative folding. This example for mFIZZ1 should encourage the design of an appropriate thiol/disulfide oxidoreductase-tuned cell free expression system for other challenging disulfide rich proteins.	[Gad, Wael; Van Belle, Karolien; Wahni, Khadija; Messens, Joris] Brussels Ctr Redox Biol, Brussels, Belgium; [Gad, Wael; Van Belle, Karolien; Wahni, Khadija; De Greve, Henri; Messens, Joris] VIB, Dept Biol Struct, Brussels, Belgium; [Gad, Wael; Van Belle, Karolien; Wahni, Khadija; De Greve, Henri; Messens, Joris] Vrije Univ Brussel, Brussels, Belgium; [Van Ginderachter, Jo A.] Vrije Univ Brussel, Cellular & Mol Immunol Lab, Brussels, Belgium; [Van Ginderachter, Jo A.] VIB, Myeloid Cell Immunol Lab, Brussels, Belgium; [Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Nair, Meera G.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nair, Meera G.; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vandenbussche, Guy] Univ Libre Bruxelles, Ctr Biol Struct & Bioinformat Struct & Fonct Memb, Brussels, Belgium; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Nair, Meera G.] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Ehime University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Universite Libre de Bruxelles; University of Pennsylvania; University of California System; University of California Riverside	Messens, J (corresponding author), Brussels Ctr Redox Biol, Brussels, Belgium.	joris.messens@vib-vub.be	Van Ginderachter, Jo A/H-5473-2013; Messens, Joris/AAH-3008-2020	Van Ginderachter, Jo A/0000-0002-4442-7474; Messens, Joris/0000-0002-2128-8264; Gad, Wael/0000-0003-3208-9110; Nair, Meera/0000-0002-1807-5161; Artis, David/0000-0002-1753-4100; Vandenbussche, Guy/0000-0001-9592-2304	Vlaams Instituut voor Biotechnologie (VIB); Flanders Hercules Foundation [HERC16]; European Student Exchange Program "Erasmus Mundus ECW II'' [141085-EM-1-2008-BE-ERA Mundus-ECW]; National Institutes of Health [AI091759, AI061570, AI074878]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074878, R01AI091759, R01AI061570] Funding Source: NIH RePORTER	Vlaams Instituut voor Biotechnologie (VIB); Flanders Hercules Foundation; European Student Exchange Program "Erasmus Mundus ECW II''; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was made possible thanks to financial support from Vlaams Instituut voor Biotechnologie (VIB) and the Hercules grant from the Flanders Hercules Foundation (HERC16). JM is group leader Redox Biology of the VIB. WG supported by the European Student Exchange Program "Erasmus Mundus ECW II'' reference (141085-EM-1-2008-BE-ERA Mundus-ECW). MGN and DA are supported by the National Institutes of Health (AI091759 to MGN; AI061570, AI074878 to DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abskharon RNN, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-6; Alon A, 2010, FEBS LETT, V584, P1521, DOI 10.1016/j.febslet.2010.03.001; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAI H, 1994, J BIOL CHEM, V269, P24550; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; GRYNBERG A, 1977, CR ACAD SCI D NAT, V284, P235; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Juan CC, 2003, J BIOTECHNOL, V103, P113, DOI 10.1016/S0168-1656(03)00099-3; Karala AR, 2010, J MOL BIOL, V396, P883, DOI 10.1016/j.jmb.2009.12.014; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Munitz A, 2009, J IMMUNOL, V182, P2357, DOI 10.4049/jimmunol.0803130; Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Nguyen VD, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-1; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Panchaud A, 2008, MOL CELL PROTEOMICS, V7, P800, DOI 10.1074/mcp.M700216-MCP200; Park S, 2011, BIOCHEMISTRY-US, V50, P2567, DOI 10.1021/bi2000214; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Plesa M, 2006, RES MICROBIOL, V157, P582, DOI 10.1016/j.resmic.2005.11.015; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Rancy PC, 2008, BIOCHEMISTRY-US, V47, P12047, DOI 10.1021/bi801604x; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Updegrove TB, 2011, RNA, V17, P489, DOI 10.1261/rna.2452111; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Wittke I, 2003, CANCER RES, V63, P7742; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019	49	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55621	10.1371/journal.pone.0055621	http://dx.doi.org/10.1371/journal.pone.0055621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383248	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600138
J	Kalber, TL; Campbell-Washburn, AE; Siow, BM; Sage, E; Price, AN; Ordidge, KL; Walker-Samuel, S; Janes, SM; Lythgoe, MF				Kalber, Tammy L.; Campbell-Washburn, Adrienne E.; Siow, Bernard M.; Sage, Elizabeth; Price, Anthony N.; Ordidge, Katherine L.; Walker-Samuel, Simon; Janes, Sam M.; Lythgoe, Mark F.			Primed Infusion with Delayed Equilibrium of Gd.DTPA for Enhanced Imaging of Small Pulmonary Metastases	PLOS ONE			English	Article							EARLY LUNG-CANCER; MAGNETIC-RESONANCE; MRI; TUMOR; MICROENVIRONMENT; PERMEABILITY; TOMOGRAPHY; VALIDATION; DENSITY; NODULES	Objective: To use primed infusions of the magnetic resonance imaging (MRI) contrast agent Gd.DTPA (Magnevist), to achieve an equilibrium between blood and tissue (eqMRI). This may increase tumor Gd concentrations as a novel cancer imaging methodology for the enhancement of small tumor nodules within the low signal-to-noise background of the lung. Methods: A primed infusion with a delay before equilibrium (eqMRI) of the Gd(III) chelator Gd.DTPA, via the intraperitoneal route, was used to evaluate gadolinium tumor enhancement as a function of a bolus injection, which is applied routinely in the clinic, compared to gadolinium maintained at equilibrium. A double gated (respiration and cardiac) spin-echo sequence at 9.4T was used to evaluate whole lungs pre contrast and then at 15 (representative of bolus enhancement), 25 and 35 minutes (representative of eqMRI). This was carried out in two lung metastasis models representative of high and low tumor cell seeding. Lungs containing discrete tumor nodes where inflation fixed and taken for haematoxylin and eosin staining as well as CD34 staining for correlation to MRI. Results: We demonstrate that sustained Gd enhancement, afforded by Gd equilibrium, increases the detection of pulmonary metastases compared to bolus enhancement and those tumors which enhance at equilibrium are sub-millimetre in size (<0.7 mm(2)) with a similar morphology to early bronchoalveolar cell carcinomas. Conclusion: As Gd-chelates are routinely used in the clinic for detecting tumors by MRI, this methodology is readily transferable to the clinic and advances MRI as a methodology for the detection of small pulmonary tumors.	[Kalber, Tammy L.; Campbell-Washburn, Adrienne E.; Siow, Bernard M.; Price, Anthony N.; Ordidge, Katherine L.; Walker-Samuel, Simon; Lythgoe, Mark F.] UCL, Div Med, UCL Ctr Adv Biomed Imaging, London, England; [Kalber, Tammy L.; Campbell-Washburn, Adrienne E.; Siow, Bernard M.; Price, Anthony N.; Ordidge, Katherine L.; Walker-Samuel, Simon; Lythgoe, Mark F.] UCL, Inst Child Hlth, London, England; [Kalber, Tammy L.; Sage, Elizabeth; Ordidge, Katherine L.; Janes, Sam M.] UCL, Dept Med, Ctr Resp Res, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Kalber, TL (corresponding author), UCL, Div Med, UCL Ctr Adv Biomed Imaging, London, England.	t.kalber@ucl.ac.uk	Siow, Bernard/ABC-4414-2020	Siow, Bernard/0000-0002-8687-8783; Campbell-Washburn, Adrienne/0000-0002-7169-5693; Price, Anthony/0000-0002-6907-7554; Kalber, Tammy/0000-0002-3378-3748; Lythgoe, Mark/0000-0002-4945-0171; Janes, Sam/0000-0002-6634-5939	Nanotech Grand Challenge Engineering and Physical Sciences Research Council (EPSRC) [EP/G06262072/1]; British Heart Foundation; King's College London; University College London Comprehensive Cancer Imaging Centre CR-UK EPSRC; Medical Research Council (MRC); Medical Research Council Capacity Building Studentship; Department of Health's NIHR Biomedical Research Centres funding scheme; Department of Health (England)	Nanotech Grand Challenge Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); King's College London; University College London Comprehensive Cancer Imaging Centre CR-UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Capacity Building Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Department of Health (England)	The main funding for this study was provided by the Nanotech Grand Challenge Engineering and Physical Sciences Research Council (EPSRC) grant (EP/G06262072/1 - http://www.epsrc.ac.uk), the British Heart Foundation, the King's College London and University College London Comprehensive Cancer Imaging Centre CR-UK & EPSRC, in association with the Medical Research Council (MRC) and Department of Health (England), and a Medical Research Council Capacity Building Studentship (KLO). This study was partly undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. SMJ is a Wellcome Trust Senior fellow in Clinical Science (WT091730MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013; ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Branca RT, 2010, P NATL ACAD SCI USA, V107, P3693, DOI 10.1073/pnas.1000386107; Campbell AE, 2011, J CARDIOVASC MAGN S1, V13, pO60; Driehuys B, 2007, TOXICOL PATHOL, V35, P49, DOI 10.1080/01926230601132048; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Fan XB, 2004, MAGNET RESON MED, V51, P487, DOI 10.1002/mrm.10737; Fleming JB, 2003, J CELL BIOCHEM, V90, P492, DOI 10.1002/jcb.10644; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561; FROST JK, 1984, AM REV RESPIR DIS, V130, P549; Fukumura D, 1997, AM J PATHOL, V151, P679; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Garbow JR, 2004, CANCER RES, V64, P2740, DOI 10.1158/0008-5472.CAN-03-3258; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; GUPTA NC, 1992, RADIOLOGY, V184, P441, DOI 10.1148/radiology.184.2.1620844; Hatabu H, 1999, EUR J RADIOL, V29, P114, DOI 10.1016/S0720-048X(98)00174-0; Hatabu H, 1999, EUR J RADIOL, V29, P245, DOI 10.1016/S0720-048X(98)00169-7; Hoekstra CJ, 2005, J CLIN ONCOL, V23, P8362, DOI 10.1200/JCO.2005.01.1189; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Kennel SJ, 2000, MED PHYS, V27, P1101, DOI 10.1118/1.598974; Kokuryo D, 2012, MAGN RESON MED, V67, P156, DOI 10.1002/mrm.23005; KUBOTA K, 1990, J NUCL MED, V31, P1927; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; Padhani AR, 1999, BRIT J RADIOL, V72, P427, DOI 10.1259/bjr.72.857.10505003; Padhani AR, 2001, CLIN RADIOL, V56, P607, DOI 10.1053/crad.2001.0762; Parker GJM, 2003, P 11 ISMRM TOR; Patz EF, 2001, RADIOLOGY, V221, P587, DOI 10.1148/radiol.2213001643; Price AN, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-44; RINCK PA, 1984, FORTSCHR RONTG NEUEN, V140, P239, DOI 10.1055/s-2008-1052964; RUNGE VM, 1988, MAGN RESON IMAGING, V6, P595, DOI 10.1016/0730-725X(88)90135-X; Saam BT, 2000, MAGN RESON MED, V44, P174, DOI 10.1002/1522-2594(200008)44:2<174::AID-MRM2>3.0.CO;2-4; Salerno M, 2001, EUR J RADIOL, V40, P33, DOI 10.1016/S0720-048X(01)00347-3; Semelka RC, 2001, RADIOLOGY, V218, P27, DOI 10.1148/radiology.218.1.r01ja2427; Song JW, 2009, LUNG CANCER, V65, P333, DOI 10.1016/j.lungcan.2008.12.004; Spiro SG, 2012, RESPIROLOGY, V17, P237, DOI 10.1111/j.1440-1843.2011.02114.x; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Tidwell VK, 2012, MAGN RESON MED, V67, P572, DOI 10.1002/mrm.22951; TOFTS PS, 1994, MAGN RESON IMAGING, V12, P81, DOI 10.1016/0730-725X(94)92355-8; Togao O, 2010, MAGN RESON MED, V64, P1491, DOI 10.1002/mrm.22521; VAUPEL P, 1989, CANCER RES, V49, P6449; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54903	10.1371/journal.pone.0054903	http://dx.doi.org/10.1371/journal.pone.0054903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382996	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600048
J	Kataria, H; Wadhwa, R; Kaul, SC; Kaur, G				Kataria, Hardeep; Wadhwa, Renu; Kaul, Sunil C.; Kaur, Gurcharan			Withania somnifera Water Extract as a Potential Candidate for Differentiation Based Therapy of Human Neuroblastomas	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; HEAT-SHOCK RESPONSE; POLYSIALIC ACID; CYCLIN D1; RETINOIC ACID; MATRIX METALLOPROTEINASES; NEURITE OUTGROWTH; NERVOUS-SYSTEM; CANCER-CELLS; TUMOR-CELLS	Neuroblastoma is an aggressive childhood disease of the sympathetic nervous system. Treatments are often ineffective and have serious side effects. Conventional therapy of neuroblastoma includes the differentiation agents. Unlike chemo-radiotherapy, differentiation therapy shows minimal side effects on normal cells, because normal non-malignant cells are already differentiated. Keeping in view the limited toxicity of Withania somnifera (Ashwagandha), the current study was aimed to investigate the efficacy of Ashwagandha water extract (ASH-WEX) for anti-proliferative potential in neuroblastoma and its underlying signalling mechanisms. ASH-WEX significantly reduced cell proliferation and induced cell differentiation as indicated by morphological changes and NF200 expression in human IMR-32 neuroblastoma cells. The induction of differentiation was accompanied by HSP70 and mortalin induction as well as pancytoplasmic translocation of the mortalin in ASH-WEX treated cells. Furthermore, the ASH-WEX treatment lead to induction of neural cell adhesion molecule (NCAM) expression and reduction in its polysialylation, thus elucidating its anti-migratory potential, which was also supported by downregulation of MMP 2 and 9 activity. ASH-WEX treatment led to cell cycle arrest at G0/G1 phase and increase in early apoptotic population. Modulation of cell cycle marker Cyclin D1, anti-apoptotic marker bcl-xl and Akt-P provide evidence that ASH-WEX may prove to be a promising phytotherapeutic intervention in neuroblatoma related malignancies.	[Kataria, Hardeep; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Guru Nanak Dev University; National Institute of Advanced Industrial Science & Technology (AIST)	Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com	Kaur, Gurcharan/V-6033-2019; Wadhwa, Renu/L-8898-2018; Kataria, Hardeep/AAI-8411-2020; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Kataria, Hardeep/0000-0001-8413-0600	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by grants from the Department of Biotechnology, Government of India to Guru Nanak Dev University, under DBT-AIST, Japan collaboration program. H. K. is supported by fellowship grant from the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO;2-O; Armstrong JL, 2007, BRIT J CANCER, V96, P1675, DOI 10.1038/sj.bjc.6603779; Armstrong JL, 2005, BRIT J CANCER, V92, P696, DOI 10.1038/sj.bjc.6602398; BLACK MM, 1991, J NEUROSCI, V11, P1163; Bruses JL, 1998, J CELL BIOL, V140, P1177, DOI 10.1083/jcb.140.5.1177; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Cesi V, 2002, CELL DEATH DIFFER, V9, P1232, DOI 10.1038/sj.cdd.4401103; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Deb S, 1996, J NEUROCHEM, V66, P1641; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DOLE MG, 1995, CANCER RES, V55, P2576; Donnellan R, 1998, J CLIN PATHOL-MOL PA, V51, P1; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Evangelopoulos ME, 2009, J NEUROSCI RES, V87, P2138, DOI 10.1002/jnr.22025; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Fukuda M, 1996, CANCER RES, V56, P2237; Gallagher HC, 2000, J NEUROSCI RES, V61, P636, DOI 10.1002/1097-4547(20000915)61:6<636::AID-JNR7>3.3.CO;2-6; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Gupta Girdhari Lal, 2007, Indian J Physiol Pharmacol, V51, P345; HEIKKILA JJ, 1993, DEV GENET, V14, P87, DOI 10.1002/dvg.1020140202; Hildebrandt H, 1998, CANCER RES, V58, P779; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; Hsu WM, 2008, CLIN CANCER RES, V14, P6237, DOI 10.1158/1078-0432.CCR-07-4181; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huerta S, 2001, SURGERY, V130, P834, DOI 10.1067/msy.2001.116415; Jayaprakasam B, 2010, PHYTOTHER RES, V24, P859, DOI 10.1002/ptr.3033; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kataria H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep188; Katayama M, 1997, EXP CELL RES, V236, P412, DOI 10.1006/excr.1997.3757; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kuboyama T, 2002, NEUROREPORT, V13, P1715, DOI 10.1097/00001756-200210070-00005; Kumar S, 2010, PHYTOTHER RES, V24, P1567, DOI 10.1002/ptr.3261; Loones MT, 2000, CELL STRESS CHAPERON, V5, P291, DOI 10.1379/1466-1268(2000)005<0291:TDOHSP>2.0.CO;2; Mahal LK, 2001, SCIENCE, V294, P380, DOI 10.1126/science.1062192; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; MARTINI R, 1994, GLIA, V10, P70, DOI 10.1002/glia.440100109; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Matthay KK, 2007, J CLIN ONCOL, V25, P1054, DOI 10.1200/JCO.2006.09.3484; McClellan KA, 2006, CELL CYCLE, V5, P1506, DOI 10.4161/cc.5.14.2980; Misra L, 2008, PHYTOCHEMISTRY, V69, P1000, DOI 10.1016/j.phytochem.2007.10.024; Misra L, 2012, J ASIAN NAT PROD RES, V14, P39, DOI 10.1080/10286020.2011.622719; Miyazaki T, 2008, GLYCOBIOLOGY, V18, P187, DOI 10.1093/glycob/cwm132; Molenaar JJ, 2010, ONCOGENE, V29, P2739, DOI 10.1038/onc.2010.21; Molenaar JJ, 2008, CANCER RES, V68, P2599, DOI 10.1158/0008-5472.CAN-07-5032; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Mulabagal V, 2009, PHYTOTHER RES, V23, P987, DOI 10.1002/ptr.2736; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Njar Vincent C O, 2006, Med Chem, V2, P431, DOI 10.2174/157340606777724022; Noujaim D, 2002, ONCOGENE, V21, P4549, DOI 10.1038/sj.onc.1205552; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Pestell RG, 1999, ENDOCR REV, V20, P501, DOI 10.1210/er.20.4.501; Qu MY, 2011, BRAIN RES, V1368, P336, DOI 10.1016/j.brainres.2010.10.068; RAY SD, 1994, ARCH BIOCHEM BIOPHYS, V311, P180, DOI 10.1006/abbi.1994.1224; REICHARDT LF, 1989, DEV NEUROSCI-BASEL, V11, P332, DOI 10.1159/000111910; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Sallinen SL, 1999, J PATHOL, V188, P289; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Shim JW, 2004, J NEUROSCI, V24, P843, DOI 10.1523/JNEUROSCI.3977-03.2004; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Singh AP, 2012, INT J ONCOL, V40, P99, DOI 10.3892/ijo.2011.1225; Spix C, 2006, EUR J CANCER, V42, P2081, DOI 10.1016/j.ejca.2006.05.008; Sukumari-Ramesh S, 2011, INT J DEV NEUROSCI, V29, P701, DOI 10.1016/j.ijdevneu.2011.06.002; Sumrejkanchanakij P, 2006, BIOCHEM BIOPH RES CO, V340, P302, DOI 10.1016/j.bbrc.2005.11.181; Sumrejkanchanakij P, 2003, ONCOGENE, V22, P8723, DOI 10.1038/sj.onc.1206870; Takahashi K, 2011, MOL CELL NEUROSCI, V48, P217, DOI 10.1016/j.mcn.2011.08.002; Takashima S, 1998, J BIOL CHEM, V273, P7675, DOI 10.1074/jbc.273.13.7675; Tanaka F, 2000, CANCER RES, V60, P3072; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; WADHWA R, 1995, INT J ONCOL, V7, P69; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yoshida Y, 1996, J BIOL CHEM, V271, P30167, DOI 10.1074/jbc.271.47.30167	80	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55316	10.1371/journal.pone.0055316	http://dx.doi.org/10.1371/journal.pone.0055316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383150	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600087
J	Li, SW; Lin, K; Ma, P; Zhang, ZL; Zhou, YD; Lu, SY; Zhou, X; Liu, SM				Li, Si-Wei; Lin, Kun; Ma, Pei; Zhang, Zhen-Lu; Zhou, Yi-Dan; Lu, Shuang-Yan; Zhou, Xin; Liu, Song-Mei			FADS Gene Polymorphisms Confer the Risk of Coronary Artery Disease in a Chinese Han Population through the Altered Desaturase Activities: Based on High-Resolution Melting Analysis	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; DIETARY SATURATED FAT; VARIANTS; OMEGA-6; CLUSTER; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATION; TISSUES	Objective: We explored the desaturase activities and the correlation of fatty acid desaturases (FADS) gene single nucleotide polymorphisms (SNPs) with plasma fatty acid in coronary artery disease (CAD) patients in a Chinese Han population. Methods: Plasma fatty acids were measured by gas chromatography in CAD patients (n=505) and a control group (n=510). Five SNPs in the FADS gene were genotyped with high-resolution melting (HRM) methods. Results: After adjustment, D6D activity, assessed as arachidonic acid (AA, C20:4n-6)/linoleic acid (LA, C18:2n-6), was higher in CAD patients (p<0.001). D9D activity, which was estimated as the ratio of palmitoleic acid (C16:1)/palmitic acid (C16: 0) or oleic acid (C18:1n-9) to stearic acid (C18:0), was also increased (p<0.001). The genotype distributions of rs174537 G>T and rs174460 C>T were different between the two groups. The rs174537 T allele was associated with a lower risk of CAD [ OR 0.743, 95% CI (0.624, 0.884), p=0.001]. Carriers of the rs174460 C allele were associated with a higher risk of CAD [ OR 1.357, 95% CI (1.106, 1.665), p=0.003]. Conclusions: We firstly report that the rs174460 C allele is associated with a higher risk of CAD, and confirm that the rs174537 T allele is associated with a lower risk of CAD. Our results indicate that FADS gene polymorphisms are likely to influence plasma fatty acid concentrations and desaturase activities.	[Li, Si-Wei; Lin, Kun; Ma, Pei; Zhang, Zhen-Lu; Lu, Shuang-Yan; Zhou, Xin; Liu, Song-Mei] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China; [Zhang, Zhen-Lu] Wuhan Asia Heart Hosp, Dept Cardiol, Wuhan, Hubei, Peoples R China; [Zhou, Yi-Dan] Jianghan Univ, Sch Life Sci, Wuhan, Hubei, Peoples R China	Wuhan University; Jianghan University	Zhou, X (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China.	zhouxjyk@163.com; smliu@whu.edu.cn			National Basic Research Program of China (973 Program) [2012CB720600, 2012CB720605]; National Natural Science Foundation of China [81271919]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (2012CB720600, 2012CB720605) and the National Natural Science Foundation of China (81271919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/315134; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Das UN, 2007, PROSTAG LEUKOTR ESS, V76, P251, DOI 10.1016/j.plefa.2007.03.001; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; FOLCH J, 1957, J BIOL CHEM, V226, P497; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kim OY, 2013, NUTR METAB CARDIOVAS, V23, P366, DOI 10.1016/j.numecd.2011.06.006; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lee TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042051; Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Martinelli N, 2009, J NUTRIGENET NUTRIGE, V2, P129, DOI 10.1159/000238177; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Pedrono F, 2010, J LIPID RES, V51, P472, DOI 10.1194/jlr.M000588; Petersson H, 2008, BRIT J NUTR, V99, P1186, DOI 10.1017/S0007114507871674; RAPAPORT E, 1979, CIRCULATION, V59, P607; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Warensjo E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203	27	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55869	10.1371/journal.pone.0055869	http://dx.doi.org/10.1371/journal.pone.0055869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383292	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600167
J	Marsot, M; Chapuis, JL; Gasqui, P; Dozieres, A; Masseglia, S; Pisanu, B; Ferquel, E; Vourc'h, G				Marsot, Maud; Chapuis, Jean-Louis; Gasqui, Patrick; Dozieres, Anne; Masseglia, Sebastien; Pisanu, Benoit; Ferquel, Elisabeth; Vourc'h, Gwenael			Introduced Siberian Chipmunks (Tamias sibiricus barberi) Contribute More to Lyme Borreliosis Risk than Native Reservoir Rodents	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; IXODES-RICINUS TICKS; DISEASE SPIROCHETE; DIFFERENTIAL TRANSMISSION; FRANCE; HOSTS; DIVERSITY; INFECTION; EUROPE; ASSOCIATION	The variation of the composition in species of host communities can modify the risk of disease transmission. In particular, the introduction of a new host species can increase health threats by adding a new reservoir and/or by amplifying the circulation of either exotic or native pathogens. Lyme borreliosis is a multi-host vector-borne disease caused by bacteria belonging to the Borrelia burgdorferi sensu lato complex. It is transmitted by the bite of hard ticks, especially Ixodes ricinus in Europe. Previous studies showed that the Siberian chipmunk, Tamias sibiricus barberi, an introduced ground squirrel in the Forest of Senart (near Paris, France) was highly infested by I. ricinus, and consequently infected by B. burgdorferi sl. An index of the contribution of chipmunks to the density of infected questing nymphs on the vegetation (i.e., the acarological risk for humans) was compared to that of bank voles (Myodes glareolus) and of wood mice (Apodemus sylvaticus), two known native and sympatric competent reservoir hosts. Chipmunks produced nearly 8.5 times more infected questing nymphs than voles and mice. Furthermore, they contribute to a higher diversity of B. burgdorferi sl genospecies (B. afzelii, B. burgdorferi sensu stricto and B. garinii). The contribution of chipmunks varied between years and seasons, according to tick availability. As T. s. barberi must be a competent reservoir, it should amplify B. burgdorferi sl infection, hence increasing the risk of Lyme borreliosis in humans.	[Marsot, Maud; Gasqui, Patrick; Masseglia, Sebastien; Vourc'h, Gwenael] INRA, Epidemiol Anim UR346, St Genes Champanelle, France; [Marsot, Maud; Chapuis, Jean-Louis; Dozieres, Anne; Pisanu, Benoit] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, Conservat Especes UMR 7204, MNHN CNRS P6, F-75231 Paris, France; [Ferquel, Elisabeth] Inst Pasteur, Equipe Borrelia, Paris, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vourc'h, G (corresponding author), INRA, Epidemiol Anim UR346, St Genes Champanelle, France.	gvourch@clermont.inra.fr	Marsot, Maud/ABF-8575-2021	Marsot, Maud/0000-0002-2307-8957	Conseil Regional d'Ile-de-France [08-953MN07]; Office National des Forets; Merial	Conseil Regional d'Ile-de-France(Region Ile-de-France); Office National des Forets; Merial	This work was supported by Conseil Regional d'Ile-de-France (http://www.iledefrance.fr/missions-et-competences/le-conseil-regional), "Biodiversity Grant'' number 08-953MN07, the Office National des Forets (http://www.onf.fr/) and Merial (http://fr.merial.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Brisson D, 2007, P ROYAL SOC B, V101, P1175; BROWN LE, 1956, J ANIM ECOL, V25, P54, DOI 10.2307/1850; Chapuis JL, 2005, REV ECOL-TERRE VIE, V60, P239; Chapuis JL., 2011, DATASHEET TAMIAS SIB; CRAINE NG, 1995, FOLIA PARASIT, V42, P73; Daszak P, 2000, SCIENCE, V287, P1756; Dorn W., 1999, Proceedings of the 3rd International Conference on Urban Pests. Czech University of Agriculture, Prague, Czech Republic, 19-22 July 1999., P463; Efford M. G., 2012, SECR SPATIALLY EXPLI; Efford MG, 2009, ECOLOGY, V90, P2676, DOI 10.1890/08-1735.1; Gern L, 1998, ZBL BAKT-INT J MED M, V287, P196; Hanincova K, 2003, PARASITOLOGY, V126, P11, DOI 10.1017/S0031182002002548; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Humair PF, 1998, ACTA TROP, V69, P213, DOI 10.1016/S0001-706X(97)00126-5; Humair PF, 1999, PARASITOLOGY, V118, P33, DOI 10.1017/S0031182098003564; HUMAIR PF, 1995, J MED ENTOMOL, V32, P433, DOI 10.1093/jmedent/32.4.433; Johnson N.L., 1992, BIOMETRICAL J, V36, P565, DOI [10.1002/bimj.4710360207, DOI 10.1002/BIMJ.4710360207]; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; KIKKAWA J, 1964, J ANIM ECOL, V33, P259, DOI 10.2307/2631; Kozubikova E, 2009, CONSERV BIOL, V23, P1204, DOI 10.1111/j.1523-1739.2009.01240.x; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; Kybicova K, 2008, VECTOR-BORNE ZOONOT, V8, P645, DOI 10.1089/vbz.2007.0249; MARCONI RT, 1992, J CLIN MICROBIOL, V30, P2830, DOI 10.1128/JCM.30.11.2830-2834.1992; Maresca B., 2000, FREQUENTATION FORETS; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Marmet J, 2008, TRAITS HIST VIE TAMI; Marmet J, 2011, J ETHOL, V29, P23, DOI 10.1007/s10164-010-0215-3; Marmet J, 2009, EUR J WILDLIFE RES, V55, P497, DOI 10.1007/s10344-009-0266-3; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5516; Marsot M, 2008, DYNAMIQUE TEMPORELLE, V1, P34; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; MATUSCHKA FR, 1990, PARASITOL RES, V76, P540, DOI 10.1007/BF00931062; McCullagh P, 1989, GEN LINEAR MODELS; MCLEAN RG, 1993, J WILDLIFE DIS, V29, P527, DOI 10.7589/0090-3558-29.4.527; O'Brien VA, 2011, P ROY SOC B-BIOL SCI, V278, P239, DOI 10.1098/rspb.2010.1098; Obolenskaya EV, 2009, MAMMALIA, V73, P281, DOI 10.1515/MAMM.2009.047; Paterson S, 2003, TRENDS PARASITOL, V19, P370, DOI 10.1016/S1471-4922(03)00149-1; Paulauskas A, 2008, INT J MED MICROBIOL, V298, P180, DOI 10.1016/j.ijmm.2008.04.003; Pisanu B, 2008, PARASITE, V15, P35, DOI 10.1051/parasite/2008151035; Pisanu B, 2010, INT J PARASITOL, V40, P1277, DOI 10.1016/j.ijpara.2010.03.012; Pisanu B, 2013, BIOL INVASIONS, DOI 101007/s10530-012-0375-x; POLLOCK KH, 1983, BIOMETRICS, V39, P1035, DOI 10.2307/2531337; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Radda A., 1968, Oecologia, V1, P219, DOI 10.1007/BF00383139; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; RANDOLPH SE, 1995, J MED ENTOMOL, V32, P765, DOI 10.1093/jmedent/32.6.765; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Rexstad E., 1992, USERS GUIDE INTERACT; Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2; Schmidt KA, 1999, J MED ENTOMOL, V36, P749, DOI 10.1093/jmedent/36.6.749; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Smith R, 2006, EUROSURVEILLANCE, V11, DOI [10.2807/esw.11.25.02977-en, DOI 10.2807/ESW.11.25.02977-EN]; Talleklint L, 1997, EXP APPL ACAROL, V21, P755, DOI 10.1023/A:1018473122070; Telfer S, 2012, FUNCT ECOL, V26, P1288, DOI 10.1111/j.1365-2435.2012.02049.x; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Vourc'h G, 2012, NEW FRONTIERS OF MOLECULAR EPIDEMIOLOGY OF INFECTIOUS DISEASES, P291, DOI 10.1007/978-94-007-2114-2_13; Vourc'h G, 2007, VECTOR-BORNE ZOONOT, V7, P637, DOI 10.1089/vbz.2007.0111; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008	61	44	46	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55377	10.1371/journal.pone.0055377	http://dx.doi.org/10.1371/journal.pone.0055377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383170	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600094
J	Wijesundara, DK; Tscharke, DC; Jackson, RJ; Ranasinghe, C				Wijesundara, Danushka K.; Tscharke, David C.; Jackson, Ronald J.; Ranasinghe, Charani			Reduced Interleukin-4 Receptor alpha Expression on CD8(+) T Cells Correlates with Higher Quality Anti-Viral Immunity	PLOS ONE			English	Article							HIGH-AVIDITY CTL; VACCINIA VIRUS; IN-VIVO; LYMPHOCYTE-RESPONSES; CYTOKINE EXPRESSION; VIRAL-INFECTION; PROTECTIVE ROLE; IL-4; GAMMA; IL-4R-ALPHA	With the hope of understanding how interleukin (IL)-4 and IL-13 modulated quality of anti-viral CD8(+) T cells, we evaluated the expression of receptors for these cytokines following a range of viral infections (e.g. pox viruses and influenza virus). Results clearly indicated that unlike other IL-4/IL-13 receptor subunits, IL-4 receptor alpha (IL-4R alpha) was significantly down-regulated on anti-viral CD8(+) T cells in a cognate antigen dependent manner. The infection of gene knockout mice and wild-type (WT) mice with vaccinia virus (VV) or VV expressing IL-4 confirmed that IL-4, IL-13 and signal transducer and activator of transcription 6 (STAT6) were required to increase IL-4R alpha expression on CD8(+) T cells, but not interferon (IFN)-gamma. STAT6 dependent elevation of IL-4R alpha expression on CD8(+) T cells was a feature of poor quality anti-viral CD8(+) T cell immunity as measured by the production of IFN-gamma and tumor necrosis factor alpha (TNF-alpha) in response to VV antigen stimulation in vitro. We propose that down-regulation of IL-4R alpha, but not the other IL-4/IL-13 receptor subunits, is a mechanism by which CD8(+) T cells reduce responsiveness to IL-4 and IL-13. This can improve the quality of anti-viral CD8(+) T cell immunity. Our findings have important implications in understanding anti-viral CD8(+) T cell immunity and designing effective vaccines against chronic viral infections.	[Wijesundara, Danushka K.; Jackson, Ronald J.; Ranasinghe, Charani] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT 2601, Australia; [Tscharke, David C.] Australian Natl Univ, Res Sch Biol, Viruses & Immun Lab, Div Biomed Sci & Biochem, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Wijesundara, DK (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT 2601, Australia.	danushka.wijesundara@anu.edu.au	Tscharke, David/C-9133-2009	Tscharke, David/0000-0001-6825-9172; Wijesundara, Danushka/0000-0002-0740-8362	Australian National Health and Medical Research Council [525431, APP1000703]; Australian Centre for Hepatitis and HIV Virology EOI grant	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for Hepatitis and HIV Virology EOI grant	This work was supported by the Australian National Health and Medical Research Council project grant award 525431 (CR) and development grant award APP1000703 (CR) and the Australian Centre for Hepatitis and HIV Virology EOI grant 2010 (CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinheiro AAD, 2007, J LEUKOCYTE BIOL, V81, P1102, DOI 10.1189/jlb.0906583; Albanesi C, 2007, J IMMUNOL, V179, P984, DOI 10.4049/jimmunol.179.2.984; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Apte SH, 2010, J IMMUNOL, V185, P998, DOI 10.4049/jimmunol.0903372; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Derby MA, 2001, J IMMUNOL, V166, P1690, DOI 10.4049/jimmunol.166.3.1690; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kienzle N, 2005, J IMMUNOL, V174, P2021, DOI 10.4049/jimmunol.174.4.2021; Kroger CJ, 2008, J IMMUNOL, V180, P5784, DOI 10.4049/jimmunol.180.9.5784; La Gruta NL, 2006, EUR J IMMUNOL, V36, P2951, DOI 10.1002/eji.200636390; MAGGI E, 1994, J EXP MED, V180, P489, DOI 10.1084/jem.180.2.489; Marsland BJ, 2005, EUR J IMMUNOL, V35, P1391, DOI 10.1002/eji.200425768; Mohrs M, 1999, J IMMUNOL, V162, P7302; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Perona-Wright G, 2010, J IMMUNOL, V184, P615, DOI 10.4049/jimmunol.0902408; Ranasinghe C, 2007, J IMMUNOL, V178, P2370, DOI 10.4049/jimmunol.178.4.2370; Ranasinghe C, 2006, VACCINE, V24, P5881, DOI 10.1016/j.vaccine.2006.04.023; Ranasinghe C, 2009, EUR J IMMUNOL, V39, P1819, DOI 10.1002/eji.200838995; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Serpier H, 1997, J INVEST DERMATOL, V109, P158, DOI 10.1111/1523-1747.ep12319207; Sharma DP, 1996, J VIROL, V70, P7103, DOI 10.1128/JVI.70.10.7103-7107.1996; Sivaprasad U, 2010, J IMMUNOL, V185, P6802, DOI 10.4049/jimmunol.1002118; Tabata Y, 2007, CURR ALLERGY ASTHM R, V7, P338, DOI 10.1007/s11882-007-0051-x; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Yuen TJ, 2010, J VIROL, V84, P10220, DOI 10.1128/JVI.01281-10; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	35	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55788	10.1371/journal.pone.0055788	http://dx.doi.org/10.1371/journal.pone.0055788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383283	Green Published, gold			2022-12-27	WOS:000314610600160
J	Knizhnik, AV; Roos, WP; Nikolova, T; Quiros, S; Tomaszowski, KH; Christmann, M; Kaina, B				Knizhnik, Anna V.; Roos, Wynand P.; Nikolova, Teodora; Quiros, Steve; Tomaszowski, Karl-Heinz; Christmann, Markus; Kaina, Bernd			Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage	PLOS ONE			English	Article							MISMATCH REPAIR; ALKYLATING-AGENTS; IN-VIVO; O-6-METHYLGUANINE; CANCER; MGMT; ATM; P53; O(6)-METHYLGUANINE; GENOTOXICITY	Apoptosis, autophagy, necrosis and cellular senescence are key responses of cells that were exposed to genotoxicants. The types of DNA damage triggering these responses and their interrelationship are largely unknown. Here we studied these responses in glioma cells treated with the methylating agent temozolomide (TMZ), which is a first-line chemotherapeutic for this malignancy. We show that upon TMZ treatment cells undergo autophagy, senescence and apoptosis in a specific time-dependent manner. Necrosis was only marginally induced. All these effects were completely abrogated in isogenic glioma cells expressing O-6-methylguanine-DNA methyltransferase (MGMT), indicating that a single type of DNA lesion, O-6-methylguanine (O(6)MeG), is able to trigger all these responses. Studies with mismatch repair mutants and MSH6, Rad51 and ATM knockdowns revealed that autophagy induced by O(6)MeG requires mismatch repair and ATM, and is counteracted by homologous recombination. We further show that autophagy, which precedes apoptosis, is a survival mechanism as its inhibition greatly ameliorated the level of apoptosis following TMZ at therapeutically relevant doses (<100 mu M). Cellular senescence increases with post-exposure time and, similar to autophagy, precedes apoptosis. If autophagy was abrogated, TMZ-induced senescence was reduced. Therefore, we propose that autophagy triggered by O(6)MeG adducts is a survival mechanism that stimulates cells to undergo senescence rather than apoptosis. Overall, the data revealed that a specific DNA adduct, O(6)MeG, has the capability of triggering autophagy, senescence and apoptosis and that the decision between survival and death is determined by the balance of players involved. The data also suggests that inhibition of autophagy may ameliorate the therapeutic outcome of TMZ-based cancer therapy.	[Knizhnik, Anna V.; Roos, Wynand P.; Nikolova, Teodora; Quiros, Steve; Tomaszowski, Karl-Heinz; Christmann, Markus; Kaina, Bernd] Med Univ Ctr, Dept Toxicol, Mainz, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kaina, B (corresponding author), Med Univ Ctr, Dept Toxicol, Mainz, Germany.	kaina@uni-mainz.de	Kaina, Bernd/AAE-4692-2020; Quiros, Steve/A-2969-2015; Roos, Wynand/B-4846-2008	Quiros, Steve/0000-0002-9377-0199; Roos, Wynand/0000-0002-0474-7414	BMBF [02NUK016]; DFG [KA724]	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	Work was supported by BMBF 02NUK016 and DFG KA724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Baker SD, 1999, CLIN CANCER RES, V5, P309; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Caporali S, 2004, MOL PHARMACOL, V66, P478; Chen LH, 2011, BIOCHEM PHARMACOL, V81, P594, DOI 10.1016/j.bcp.2010.12.011; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Hammond LA, 1999, J CLIN ONCOL, V17, P2604, DOI 10.1200/JCO.1999.17.8.2604; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hirose Y, 2001, CANCER RES, V61, P5843; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Lin CJ, 2012, FREE RADICAL BIO MED, V52, P377, DOI 10.1016/j.freeradbiomed.2011.10.487; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Ochs K, 2000, CANCER RES, V60, P5815; Palumbo S, 2012, J CELL BIOCH; Patschan S, 2008, AM J PHYSIOL-HEART C, V294, pH1119, DOI 10.1152/ajpheart.00713.2007; Quiros S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027183; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Roos WP, 2012, CANC LETT; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singh K, 2012, AUTOPHAGY, V8, P236, DOI 10.4161/auto.8.2.18600; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vasilevskaya IA, 2004, MOL PHARMACOL, V65, P235, DOI 10.1124/mol.65.1.235; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	40	181	185	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55665	10.1371/journal.pone.0055665	http://dx.doi.org/10.1371/journal.pone.0055665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383259	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800182
J	Li, L; Nie, W; Zhou, HF; Yuan, WF; Li, WF; Huang, WJ				Li, Li; Nie, Wei; Zhou, Hongfeng; Yuan, Weifeng; Li, Weifeng; Huang, Wenjie			Association between Plasminogen Activator Inhibitor-1-675 4G/5G Polymorphism and Sepsis: A Meta-Analysis	PLOS ONE			English	Article							PROMOTER POLYMORPHISM; PLASMINOGEN-ACTIVATOR-INHIBITOR-1 GENE; SEPTIC SHOCK; PAI-1 GENE; INCREASE; COAGULATION; PROGNOSIS; MORTALITY; SEVERITY; GENOTYPE	Background: Several studies have evaluated the association between plasminogen activator inhibitor-1 (PAI-1) -675 4G/5G polymorphism and sepsis in different populations. However, the available results are conflicting. Methods: A search of Pubmed and EMBASE databases was performed to identify relevant studies for inclusion in the meta-analysis. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were determined using a random-effects model. Results: Twelve case-control studies and three cohort studies were included. Overall, a significant association between 4G/5G polymorphism and sepsis risk was observed for 4G/4G vs. 4G/5G +5G/5G (OR = 1.30, 95% CI 1.08-1.56, P = 0.006). In addition, there was a significant association between PAI-1 4G/5G polymorphism and sepsis-related mortality (OR = 1.72, 95% CI 1.27-2.33, P = 0.0005). In subgroup analyses, increased sepsis risk and mortality risk were found in Caucasians and in patients with sepsis. Conclusions: This meta-analysis suggested that the PAI-1 -675 4G/5G polymorphism was a risk factor for sepsis and sepsis mortality.	[Li, Li; Yuan, Weifeng; Li, Weifeng; Huang, Wenjie] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Nie, Wei] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China; [Zhou, Hongfeng] First Municipal Peoples Hosp Guangzhou, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Naval Medical University; South China University of Technology	Huang, WJ (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	huangyelu1029@vip.163.com			National Natural Science Foundation of China [81070003]; Natural Science Foundation of Guangdong province [10151001002000005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Natural Science Foundation of China (NO. 81070003) and Natural Science Foundation of Guangdong province (NO. 10151001002000005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIEMOND BJ, 1995, CLIN SCI, V88, P587, DOI 10.1042/cs0880587; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; Garcia-Segarra G, 2007, INTENS CARE MED, V33, P1354, DOI 10.1007/s00134-007-0695-y; Geishofer G, 2005, EUR J PEDIATR, V164, P486, DOI 10.1007/s00431-005-1673-4; Haralambous E, 2003, CRIT CARE MED, V31, P2788, DOI 10.1097/01.CCM.0000100122.57249.5D; Henckaerts L, 2009, CRIT CARE MED, V37, P192, DOI 10.1097/CCM.0b013e31819263d8; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; Hermans PWM, 2005, CLIN INFECT DIS, V41, pS453, DOI 10.1086/431996; Horrevoets AJG, 2004, BRIT J HAEMATOL, V125, P12, DOI 10.1111/j.1365-2141.2004.04844.x; Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Madach K, 2010, CRIT CARE, V14, DOI 10.1186/cc8992; Madoiwa S, 2006, INT J HEMATOL, V84, P398, DOI 10.1532/IJH97.05190; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Menges T, 2001, LANCET, V357, P1096, DOI 10.1016/S0140-6736(00)04311-7; Mesters RM, 1996, THROMB HAEMOSTASIS, V75, P902; Nie W, 2012, CYTOKINE, V60, P849, DOI 10.1016/j.cyto.2012.08.023; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042062; Wingeyer SP, 2012, J INFECT DEV COUNTR, V6, P555; Wingeyer SP, 2010, THROMB RES, V125, P367, DOI 10.1016/j.thromres.2009.04.006; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Semeraro N, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.024; Sipahi T, 2006, CLIN APPL THROMB-HEM, V12, P47, DOI 10.1177/107602960601200108; Sutherland AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7702; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; WEI Y, 2008, CHIN J EVID BASED PE, V3, P280; Westendorp RGJ, 1999, LANCET, V354, P561, DOI 10.1016/S0140-6736(98)09376-3; Wong HR, 2012, CRIT CARE MED, V40, P1618, DOI 10.1097/CCM.0b013e318246b546; Zeerleder S, 2006, THROMB RES, V118, P205, DOI 10.1016/j.thromres.2005.06.007; Zhan Zhi-ya, 2005, Zhonghua Yi Xue Za Zhi, V85, P2404	39	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54883	10.1371/journal.pone.0054883	http://dx.doi.org/10.1371/journal.pone.0054883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382992	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800085
J	Merino, S; Knirel, YA; Regue, M; Tomas, JM				Merino, Susana; Knirel, Yuriy A.; Regue, Miguel; Tomas, Juan M.			Experimental Identification of Actinobacillus pleuropneumoniae Strains L20 and JL03 Heptosyltransferases, Evidence for a New Heptosyltransferase Signature Sequence	PLOS ONE			English	Article							CORE BIOSYNTHESIS GENE; CAPSULAR POLYSACCHARIDES; VIRULENCE FACTORS; LIPOPOLYSACCHARIDE; EXPRESSION; OLIGOSACCHARIDES; PATHOGENESIS; TEMPERATURE; SEROTYPES; PREVALENT	We experimentally identified the activities of six predicted heptosyltransferases in Actinobacillus pleuropneumoniae genome serotype 5b strain L20 and serotype 3 strain JL03. The initial identification was based on a bioinformatic analysis of the amino acid similarity between these putative heptosyltrasferases with others of known function from enteric bacteria and Aeromonas. The putative functions of all the Actinobacillus pleuropneumoniae heptosyltrasferases were determined by using surrogate LPS acceptor molecules from well-defined A. hydrophyla AH-3 and A. salmonicida A450 mutants. Our results show that heptosyltransferases APL_0981 and APJL_1001 are responsible for the transfer of the terminal outer core D-glycero-D-manno-heptose (D,D-Hep) residue although they are not currently included in the CAZY glycosyltransferase 9 family. The WahF heptosyltransferase group signature sequence [S(T/S)(GA)XXH] differs from the heptosyltransferases consensus signature sequence [D(TS)(GA)XXH], because of the substitution of D-261 for S-261, being unique.	[Merino, Susana; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Knirel, Yuriy A.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia; [Regue, Miguel] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitarias, E-08028 Barcelona, Spain	University of Barcelona; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; University of Barcelona	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014; Knirel, Yuriy A/E-2058-2014	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259; 	Plan Nacional de I+D+i grant (Ministerio de Educacion, Ciencia y Deporte); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)	Plan Nacional de I+D+i grant (Ministerio de Educacion, Ciencia y Deporte); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya)	This work was supported by Plan Nacional de I+D+i grant (Ministerio de Educacion, Ciencia y Deporte) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Baltes N, 2007, VET MICROBIOL, V123, P110, DOI 10.1016/j.vetmic.2007.03.026; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Canals R, 2006, INFECT IMMUN, V74, P537, DOI 10.1128/IAI.74.1.537-548.2006; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Dubreuil J. Daniel, 2000, Animal Health Research Reviews, V1, P73, DOI 10.1017/S1466252300000074; FELSENSTEIN J, 1992, GENET RES, V60, P209, DOI 10.1017/S0016672300030962; Foote SJ, 2008, J BACTERIOL, V190, P1495, DOI 10.1128/JB.01845-07; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gottschalk M, 2006, DIS SWINE, P563; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Gronow S, 2005, J BACTERIOL, V187, P6242, DOI 10.1128/JB.187.17.6242-6247.2005; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haesebrouck F, 1997, VET MICROBIOL, V58, P239, DOI 10.1016/S0378-1135(97)00162-4; Harper M, 2007, INFECT IMMUN, V75, P3885, DOI 10.1128/IAI.00212-07; Hiratsuka K, 2005, J BACTERIOL, V187, P5156, DOI 10.1128/JB.187.15.5156-5165.2005; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Izquierdo L, 2003, J BACTERIOL, V185, P7213, DOI 10.1128/JB.185.24.7213-7221.2003; Jacobsen MJ, 1996, VET MICROBIOL, V49, P159, DOI 10.1016/0378-1135(95)00184-0; Jacques M, 2004, CAN J VET RES, V68, P81; Jacques M, 1996, TRENDS MICROBIOL, V4, P408, DOI 10.1016/0966-842X(96)10054-8; Jacques M, 1998, FEMS MICROBIOL REV, V22, P45, DOI 10.1016/S0168-6445(98)00007-2; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Jimenez N, 2009, J BACTERIOL, V191, P2228, DOI 10.1128/JB.01395-08; Kaplan JB, 2005, VET MICROBIOL, V108, P89, DOI 10.1016/j.vetmic.2005.02.011; Knirel YA, 2004, CARBOHYD RES, V339, P787, DOI 10.1016/j.carres.2003.12.008; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; MacLean LL, 2004, INFECT IMMUN, V72, P5925, DOI 10.1128/IAI.72.10.5925-5930.2004; MERINO S, 1992, INFECT IMMUN, V60, P4343, DOI 10.1128/IAI.60.10.4343-4349.1992; Michael FS, 2004, CARBOHYD RES, V339, P1973, DOI 10.1016/j.carres.2004.04.019; Moreau F, 2008, BIOORG MED CHEM LETT, V18, P4022, DOI 10.1016/j.bmcl.2008.05.117; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; Perry MB, 2004, CARBOHYD RES, V339, P1399, DOI 10.1016/j.carres.2004.03.011; PRADEL E, 1991, J BACTERIOL, V173, P6428, DOI 10.1128/jb.173.20.6428-6431.1991; Ramjeet M, 2005, J BIOL CHEM, V280, P39104, DOI 10.1074/jbc.M502852200; Ramjeet M, 2008, MOL MICROBIOL, V70, P221, DOI 10.1111/j.1365-2958.2008.06409.x; Rioux S, 2000, MICROB PATHOGENESIS, V28, P279, DOI 10.1006/mpat.1999.0347; Sambrock J, 1989, MOL CLONING LAB MANU, V1; St Michael F, 2005, GLYCOBIOLOGY, V15, P323, DOI 10.1093/glycob/cwi015; St Michael F, 2005, CARBOHYD RES, V340, P59, DOI 10.1016/j.carres.2004.10.017; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Ward CK, 1998, INFECT IMMUN, V66, P3326, DOI 10.1128/IAI.66.7.3326-3336.1998; WARD CK, 1994, J IMMUNOL, V153, P2110; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Zhan BJ, 2010, J BACTERIOL, V192, P5846, DOI 10.1128/JB.00867-10	51	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55546	10.1371/journal.pone.0055546	http://dx.doi.org/10.1371/journal.pone.0055546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383222	Green Published, gold			2022-12-27	WOS:000315563800164
J	Oliver, MJ; Irwin, A; Moline, MA; Fraser, W; Patterson, D; Schofield, O; Kohut, J				Oliver, Matthew J.; Irwin, Andrew; Moline, Mark A.; Fraser, William; Patterson, Donna; Schofield, Oscar; Kohut, Josh			Adelie Penguin Foraging Location Predicted by Tidal Regime Switching	PLOS ONE			English	Article							SAN-JUAN ISLANDS; DIVING BEHAVIOR; CLIMATE-CHANGE; SPHENISCUS MAGELLANICUS; DELAWARE BAY; PHYTOPLANKTON; ZOOPLANKTON; VARIABILITY; CHANNEL; WEST	Penguin foraging and breeding success depend on broad-scale environmental and local-scale hydrographic features of their habitat. We investigated the effect of local tidal currents on a population of Adelie penguins on Humble Is., Antarctica. We used satellite-tagged penguins, an autonomous underwater vehicle, and historical tidal records to model of penguin foraging locations over ten seasons. The bearing of tidal currents did not oscillate daily, but rather between diurnal and semidiurnal tidal regimes. Adelie penguins foraging locations changed in response to tidal regime switching, and not to daily tidal patterns. The hydrography and foraging patterns of Adelie penguins during these switching tidal regimes suggest that they are responding to changing prey availability, as they are concentrated and dispersed in nearby Palmer Deep by variable tidal forcing on weekly timescales, providing a link between local currents and the ecology of this predator.	[Oliver, Matthew J.; Moline, Mark A.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Irwin, Andrew] Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB E0A 3C0, Canada; [Fraser, William; Patterson, Donna] Polar Oceans Res Grp, Sheridan, MT USA; [Schofield, Oscar; Kohut, Josh] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA	University of Delaware; Mount Allison University; Rutgers State University New Brunswick	Oliver, MJ (corresponding author), Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA.	moliver@udel.edu	Schofield, Oscar/H-4169-2018	Schofield, Oscar/0000-0003-2359-4131; Irwin, Andrew/0000-0001-7784-2319	National Aeronautics and Space Administration [NNG06GH75G1/3]; National Science Foundation Office of Polar Programs [ANT-0823101, ANT-1019839]; Gordon and Betty Moore Foundation; Directorate For Geosciences [1440435, 1019838] Funding Source: National Science Foundation	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	These efforts were only possible with funding support provided by the National Aeronautics and Space Administration Biodiversity program (NNG06GH75G1/3 to M. Oliver, http://www.nasa.gov/), the National Science Foundation Office of Polar Programs (ANT-0823101 to Co-PI O. Schofield; ANT-1019839 to M. Moline, http://www.nsf.gov/), and the Gordon and Betty Moore Foundation, http://www.moore.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; ALLDREDGE AL, 1980, ESTUAR COAST MAR SCI, V10, P31, DOI 10.1016/S0302-3524(80)80047-8; Amos A, 1993, ANTARCT J US, V28, P162; Argo data management, 2008, ARG US MAN VERS 2 1; BARLOW JP, 1955, BIOL BULL, V109, P211, DOI 10.2307/1538722; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BENGTSON JL, 1993, ANTARCT SCI, V5, P9, DOI 10.1017/S0954102093000033; BOWDEN KF, 1963, AIR WATER POLLUT, V7, P343; BOWMAN MJ, 1981, J MAR RES, V39, P587; Cimino MA, 2013, GLOBAL CHANGE BIOL, V19, P136, DOI 10.1111/gcb.12016; Clarke J., 1994, CCAMLR SCI, V1, P155; CLOERN JE, 1991, J MAR RES, V49, P203, DOI 10.1357/002224091784968611; Cotte C, 2005, MAR ECOL PROG SER, V288, P199, DOI 10.3354/meps288199; CROLL DA, 1991, CONDOR, V93, P777, DOI 10.2307/1368216; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Emslie SD, 2001, ANTARCT SCI, V13, P289, DOI 10.1017/S0954102001000414; Emslie SD, 1998, ANTARCT SCI, V10, P257, DOI 10.1017/S0954102098000352; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; EPIFANIO CE, 1987, J CRUSTACEAN BIOL, V7, P513, DOI 10.2307/1548299; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Franks PJS, 1996, J MAR RES, V54, P631, DOI 10.1357/0022240963213718; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Freitas C, 2010, ARGOSFILTER ARGOS LO; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Garrett C. J. R., 1978, ATMOS OCEAN, V16, P403, DOI [10.1080/07055900.1978.9649046, DOI 10.1080/07055900.1978.9649046]; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Gille ST, 2010, J CLIMATE, P4749; Gregory Paul R., 2001, Aquatic Mammals, V27, P105; Holm HJ, 2002, WATERBIRDS, V25, P312; Hunt GL, 1997, ICES J MAR SCI, V54, P600; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; Jones PL, 2008, J EXP MAR BIOL ECOL, V361, P98, DOI 10.1016/j.jembe.2008.05.004; Kahl LA, 2010, INTEGR COMP BIOL, V50, P1041, DOI 10.1093/icb/icq098; Kato A, 2003, POLAR BIOL, V26, P389, DOI 10.1007/s00300-003-0493-0; Kils U, 1982, SWIMMING BEHAV SWIMM; Lascara CM, 1999, DEEP-SEA RES PT I, V46, P951, DOI 10.1016/S0967-0637(98)00099-5; Loder J.W., 1985, P NIN EUR MAR BIOL S, P3; Luque SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015850; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Moline MA, 1996, MAR ECOL PROG SER, V145, P143, DOI 10.3354/meps145143; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; NAITO Y, 1990, CONDOR, V92, P582, DOI 10.2307/1368676; PINGREE RD, 1985, ESTUAR COAST SHELF S, V20, P1, DOI 10.1016/0272-7714(85)90115-5; Prezelin BB, 2004, J MAR RES, V62, P419, DOI 10.1357/0022240041446173; Prezelin BB, 2000, J MAR RES, V58, P165, DOI 10.1357/002224000321511133; RALSTON SL, 1986, J EXP MAR BIOL ECOL, V98, P35, DOI 10.1016/0022-0981(86)90074-2; Rey AR, 2010, J ORNITHOL, V151, P933, DOI 10.1007/s10336-010-0531-y; ROWE PM, 1994, MAR ECOL PROG SER, V110, P115, DOI 10.3354/meps110115; ROWE PM, 1994, MAR ECOL PROG SER, V110, P105, DOI 10.3354/meps110105; Schofield O, 2007, J FIELD ROBOT, V24, P473, DOI 10.1002/rob.20200; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Vlietstra LS, 2005, FISH OCEANOGR, V14, P196, DOI 10.1111/j.1365-2419.2005.00369.x; Williams T.D., 1995, PENGUINS; Wilson RP, 2001, J AVIAN BIOL, V32, P83, DOI 10.1034/j.1600-048X.2001.320113.x; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e; WOOLDRIDGE T, 1980, ESTUAR COAST MAR SCI, V11, P107, DOI 10.1016/S0302-3524(80)80033-8; Zamon JE, 2001, FISH OCEANOGR, V10, P353, DOI 10.1046/j.1365-2419.2001.00180.x; Zamon JE, 2002, MAR ECOL PROG SER, V226, P193, DOI 10.3354/meps226193; Zar JH, 1999, BIOSTATISTICAL ANAL	62	35	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55163	10.1371/journal.pone.0055163	http://dx.doi.org/10.1371/journal.pone.0055163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383091	Green Published, gold			2022-12-27	WOS:000315563800124
J	Olsen, AMS; Fosbol, EL; Lindhardsen, J; Andersson, C; Folke, F; Nielsen, MB; Kober, L; Hansen, PR; Torp-Pedersen, C; Gislason, GH				Olsen, Anne-Marie Schjerning; Fosbol, Emil L.; Lindhardsen, Jesper; Andersson, Charlotte; Folke, Fredrik; Nielsen, Mia B.; Kober, Lars; Hansen, Peter R.; Torp-Pedersen, Christian; Gislason, Gunnar H.			Cause-Specific Cardiovascular Risk Associated with Nonsteroidal Anti-Inflammatory Drugs among Myocardial Infarction Patients - A Nationwide Study	PLOS ONE			English	Article							HOSPITAL DISCHARGE REGISTER; MORTALITY; DEATH; INHIBITION; VALIDITY; VALIDATION; PREDICTION; DIAGNOSIS	Background: Non steroidal anti-inflammatory drugs (NSAIDs) increase mortality and morbidity after myocardial infarction (MI). We examined cause-specific mortality and morbidity associated with NSAIDs in a nationwide cohort of MI patients. Methods and Results: By individual-level linkage of nationwide registries of hospitalization and drug dispensing from pharmacies in Denmark, patients aged >30 years admitted with first-time MI during 1997-2009 and their subsequent NSAID use were identified. The risk of three cardiovascular specific endpoints: cardiovascular death, the composite of coronary death and nonfatal MI, and the composite of fatal and nonfatal stroke, associated with NSAID use was analyzed by Cox proportional hazard analyses. Of 97,698 patients included 44.0% received NSAIDs during follow-up. Overall use of NSAIDs was associated with an increased risk of cardiovascular death (hazard ratio [HR] 1.42, 95% confidence interval [CI] 1.36-1.49). In particular use of the nonselective NSAID diclofenac and the selective cyclooxygenase-2 inhibitor rofecoxib was associated with increased risk of cardiovascular death (HR 1.96 [1.79-2.15] and HR1.66 [1.44-1.91], respectively) with a dose dependent increase in risk. Use of ibuprofen was associated with increased risk of cardiovascular death (HR 1.34[1.26-1.44]), whereas naproxen was associated with the lowest risk of (e.g., HR 1.27[1.01-1.59]. Conclusion: Use of individual NSAIDs is associated with different cause-specific cardiovascular risk and in particular rofecoxib and diclofenac were associated with increased cardiovascular morbidity and mortality. These results support caution with use of all NSAIDs in patients with prior MI.	[Olsen, Anne-Marie Schjerning; Fosbol, Emil L.; Lindhardsen, Jesper; Andersson, Charlotte; Folke, Fredrik; Nielsen, Mia B.; Hansen, Peter R.; Torp-Pedersen, Christian; Gislason, Gunnar H.] Copenhagen Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Kober, Lars] Rigshosp, Copenhagen Univ Hosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Fosbol, Emil L.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	University of Copenhagen; Rigshospitalet; University of Copenhagen; Duke University	Olsen, AMS (corresponding author), Copenhagen Univ Hosp, Dept Cardiol, Hellerup, Denmark.	amschjerning@gmail.com	Gislason, Gunnar/B-7561-2009; Torp-Pedersen, Christian/E-5931-2013; Andersson, Charlotte/P-4849-2014; Hansen, Peter Riis/AAR-7659-2020; Folke, Fredrik/P-3601-2014	Gislason, Gunnar/0000-0002-0548-402X; Hansen, Peter Riis/0000-0002-9056-535X; Kober, Lars/0000-0002-6635-1466; Fosbol, Emil/0000-0002-2048-4167; Folke, Fredrik/0000-0002-2284-7857	Department of Cardiology; Copenhagen University Hospital Gentofte, Denmark [DK-2900]; FUKAP; Novo Nordisk Foundation	Department of Cardiology; Copenhagen University Hospital Gentofte, Denmark; FUKAP; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was supported by the Department of Cardiology, Copenhagen University Hospital Gentofte, DK-2900, Denmark, FUKAP. The funding source had no influence on study design, interpretation of the results or the decision to submit the article. Dr. Gislason is supported by an independent research scholarship from the Novo Nordisk Foundation.	Andersen TF, 1999, DAN MED BULL, V46, P263; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Antman EM, 2005, CIRCULATION, V112, P759, DOI 10.1161/CIRCULATIONAHA.105.568451; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Fosbol EL, 2010, CIRC-CARDIOVASC QUAL, V3, P395, DOI 10.1161/CIRCOUTCOMES.109.861104; Gaist D, 1997, DAN MED BULL, V44, P445; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Gislason GH, 2009, ARCH INTERN MED, V169, P141, DOI 10.1001/archinternmed.2008.525; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; Madsen JK, 1997, CIRCULATION, V96, P748; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Minuz P, 2008, J AM COLL CARDIOL, V52, P1637, DOI 10.1016/j.jacc.2008.08.042; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Psaty BM, 2007, NEW ENGL J MED, V356, P328, DOI 10.1056/NEJMp068286; Rasmussen S, 2005, MED CARE, V43, P970, DOI 10.1097/01.mlr.0000178195.07110.d3; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; Ross JS, 2010, ARCH INTERN MED, V170, P2035, DOI 10.1001/archinternmed.2010.461; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3	28	38	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54309	10.1371/journal.pone.0054309	http://dx.doi.org/10.1371/journal.pone.0054309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382889	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800043
J	Simon-Areces, J; Acaz-Fonseca, E; Ruiz-Palmero, I; Garcia-Segura, LM; Arevalo, MA				Simon-Areces, Julia; Acaz-Fonseca, Estefania; Ruiz-Palmero, Isabel; Garcia-Segura, Luis-Miguel; Arevalo, Maria-Angeles			A CRM1-Mediated Nuclear Export Signal Is Essential for Cytoplasmic Localization of Neurogenin 3 in Neurons	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; DETERMINATION GENES; PANCREAS; SPECIFICATION; EXPRESSION; TRANSPORT; PROTEINS; CRM1; DIFFERENTIATION; IDENTITY	Neurogenin 3 (Ngn3), a proneural gene, regulates dendritogenesis and synaptogenesis in mouse hippocampal neurons. Ngn3 is transiently exported from the cell nucleus to the cytoplasm when neuronal polarity is initiated, suggesting that the nucleo-cytoplasmic transport of the protein is important for its action on neuronal development. In this study, we identified for the first time a functional nuclear export sequence (NES2; (131)YIWALTQTLRIA(142)) in Ngn3. The green fluorescent protein (EGFP)-NES2 fusion protein was localized in the cytoplasm and its nucleo-cytoplasmic shuttling was blocked by the CRM1 specific export inhibitor leptomycin B. Mutation of a leucine residue to alanine (L135A) in the NES2 motif resulted in both cytoplasmic and nuclear localization of the EGFP-NES2 fusion protein and in the nuclear accumulation of ectopic full-length myc-Ngn3. In addition, point mutation of the leucine 135 counteracted the effects of Ngn3 on neuronal morphology and synaptic inputs indicating that the cytoplasmic localization of Ngn3 is important for neuronal development. Pharmacological perturbation of the cytoskeleton revealed that cytoplasmic Ngn3 is associated with microtubules.	[Simon-Areces, Julia; Acaz-Fonseca, Estefania; Ruiz-Palmero, Isabel; Garcia-Segura, Luis-Miguel; Arevalo, Maria-Angeles] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Arevalo, MA (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	arevalo@cajal.csic.es	Garcia-Segura, Luis M/U-3711-2017; Arevalo, Maria-Angeles/J-7000-2014; Acaz-Fonseca, Estefania/S-5884-2016	Garcia-Segura, Luis M/0000-0002-2450-2916; Arevalo, Maria-Angeles/0000-0002-4303-9576; Acaz-Fonseca, Estefania/0000-0003-2549-6420; Ruiz Palmero, Isabel/0000-0002-8721-4591	Ministerio de Ciencia e Innovacion, Spain [BFU2011-30217-C03-01]; Comunidad de Madrid [CCG08-CSIC/SAL-3617]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	The authors acknowledge financial support from the Ministerio de Ciencia e Innovacion, Spain (BFU2011-30217-C03-01) and from Comunidad de Madrid (CCG08-CSIC/SAL-3617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Dehmelt L, 2005, GENOME BIOL, V6; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Fode C, 2000, GENE DEV, V14, P67; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fu SC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr493; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lee J, 2003, DEV BIOL, V253, P84, DOI 10.1006/dbio.2002.0868; Lejonklou MH, 2009, PANCREAS, V38, P259, DOI 10.1097/MPA.0b013e3181930818; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma WX, 2009, MOL CELL NEUROSCI, V40, P187, DOI 10.1016/j.mcn.2008.10.006; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Onischenko E, 2011, CURR OPIN CELL BIOL, V23, P293, DOI 10.1016/j.ceb.2011.01.002; Pelling M, 2011, DEV BIOL, V349, P406, DOI 10.1016/j.ydbio.2010.11.007; Rubio-Cabezas O, 2011, DIABETES, V60, P1349, DOI 10.2337/db10-1008; Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783.x; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Simon-Areces J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021825; Simon-Areces J, 2010, J COMP NEUROL, V518, P1814, DOI 10.1002/cne.22304; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Zhang MJ, 1998, BIOCHEM BIOPH RES CO, V243, P113, DOI 10.1006/bbrc.1997.8070	41	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55237	10.1371/journal.pone.0055237	http://dx.doi.org/10.1371/journal.pone.0055237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383123	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800134
J	Sun, HT; Cheng, SX; Tu, Y; Li, XH; Zhang, S				Sun, Hong-Tao; Cheng, Shi-Xiang; Tu, Yue; Li, Xiao-Hong; Zhang, Sai			FoxQ1 Promotes Glioma Cells Proliferation and Migration by Regulating NRXN3 Expression	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; NEUREXIN GENES; FOXM1; IDENTIFICATION; PROTEINS; ALPHA; HAIR	Background: Forkhead box Q1 (FoxQ1) is a member of the forkhead transcription factor family, and it has recently been found to participate in cancer development. However, whether FoxQ1 expression contributes to glioma development and progression is not known. We investigate FoxQ1 expression in gliomas and the role of FoxQ1 during tumorgenesis. Methods: Reverse transcription quantitative real-time PCR (RT-qPCR) and Western blot were used to determine the FoxQ1 and Neurexins 3 (NRXN3) expression in gliomas. Chromatin immunoprecipitation (ChIP) and luciferase assays were used to determine the regulation between FoxQ1 and NRXN3. We established depleted FoxQ1 stable clones in U-87MG cells and overexpressed FoxQ1 stable clones in SW1088 cells. MTT and transwell were used to evaluate the ability of proliferation and migration, respectively. Results: FoxQ1 mRNA and protein were up-regulated in gliomas and negatively related to the NRXN3 expression (r = -0.373, P = 0.042). FoxQ1 directly binds to NRXN3 promoter region and suppresses the promoter activity. Furthermore, the ability of proliferation and migration is reduced in depleted FoxQ1 cells. Conclusion: FoxQ1 promotes glioma cell proliferation and migration by down-regulation of NRXN3 expression.	[Sun, Hong-Tao; Cheng, Shi-Xiang; Tu, Yue; Li, Xiao-Hong; Zhang, Sai] Chinese Peoples Armed Police Forces, Inst Traumat Brain Injury & Neurol, Tianjin, Peoples R China		Zhang, S (corresponding author), Chinese Peoples Armed Police Forces, Inst Traumat Brain Injury & Neurol, Tianjin, Peoples R China.	zhangsai718@yahoo.com			National Natural Science Foundation of China [30872668]; Logistics College of Chinese People's Armed Police Forces [WYM201015, WYM201109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Logistics College of Chinese People's Armed Police Forces	This work was supported by the National Natural Science Foundation of China (30872668) and intramural research programs from Logistics College of Chinese People's Armed Police Forces (WYM201015 and WYM201109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Cao DF, 2004, CANCER BIOL THER, V3, P1081, DOI 10.4161/cbt.3.11.1175; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039937; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Hong HK, 2001, GENESIS, V29, P163, DOI 10.1002/gene.1020; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Katoh M, 2004, INT J ONCOL, V25, P1495; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kusinska R, 2012, MOL BIOL REP, V39, P2915, DOI 10.1007/s11033-011-1053-2; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Occhi G, 2002, BIOCHEM BIOPH RES CO, V298, P151, DOI 10.1016/S0006-291X(02)02403-8; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	31	33	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55693	10.1371/journal.pone.0055693	http://dx.doi.org/10.1371/journal.pone.0055693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383267	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800185
J	Zhu, YD; Warin, RF; Soroka, DN; Chen, HD; Sang, SM				Zhu, Yingdong; Warin, Renaud F.; Soroka, Dominique N.; Chen, Huadong; Sang, Shengmin			Metabolites of Ginger Component [6]-Shogaol Remain Bioactive in Cancer Cells and Have Low Toxicity in Normal Cells: Chemical Synthesis and Biological Evaluation	PLOS ONE			English	Article							PREVENTION; INSTITUTE; FOOD	Our previous study found that [6]-shogaol, a major bioactive component in ginger, is extensively metabolized in cancer cells and in mice. It is unclear whether these metabolites retain bioactivity. The aim of the current study is to synthesize the major metabolites of [6]-shogaol and evaluate their inhibition of growth and induction of apoptosis in human cancer cells. Twelve metabolites of [6]-shogaol (M1, M2, and M4-M13) were successfully synthesized using simple and easily accessible chemical methods. Growth inhibition assays showed that most metabolites of [6]-shogaol had measurable activities against human cancer cells HCT-116 and H-1299. In particular, metabolite M2 greatly retained the biological activities of [6]-shogaol, with an IC50 of 24.43 mu M in HCT-116 human colon cancer cells and an IC50 of 25.82 mu M in H-1299 human lung cancer cells. Also exhibiting a relatively high potency was thiol-conjugate M13, with IC50 values of 45.47 and 47.77 mu M toward HCT-116 and H-1299 cells, respectively. The toxicity evaluation of the synthetic metabolites (M1, M2, and M4-M13) against human normal fibroblast colon cells CCD-18Co and human normal lung cells IMR-90 demonstrated a detoxifying metabolic biotransformation of [6]-shogaol. The most active metabolite M2 had almost no toxicity to CCD-18Co and IMR-90 normal cells with IC(50)s of 99.18 and 98.30 mu M, respectively. TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) assay indicated that apoptosis was triggered by metabolites M2, M13, and its two diastereomers M13-1 and M13-2. There was no significant difference between the apoptotic effect of [6]-shogaol and the effect of M2 and M13 after 6 hour treatment.	[Zhu, Yingdong; Warin, Renaud F.; Soroka, Dominique N.; Chen, Huadong; Sang, Shengmin] North Carolina Agr & Tech State Univ, Ctr Excellence Postharvest Technol, Kannapolis, NC USA	University of North Carolina; North Carolina A&T State University	Sang, SM (corresponding author), North Carolina Agr & Tech State Univ, Ctr Excellence Postharvest Technol, North Carolina Res Campus, Kannapolis, NC USA.	ssang@ncat.edu	Chen, Huadong/H-2272-2013		National Institutes of Health [CA138277, CA138277S1]; NATIONAL CANCER INSTITUTE [R21CA138277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA138277 and CA138277S1 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliga MS, 2011, CRIT REV FOOD SCI, V51, P499, DOI 10.1080/10408391003698669; Chen HD, 2012, DRUG METAB DISPOS, V40, P742, DOI 10.1124/dmd.111.043331; Constantino MG, 1998, QUIM NOVA, V21, P719, DOI 10.1590/S0100-40421998000600009; Crowell JA, 2005, EUR J CANCER, V41, P1889, DOI 10.1016/j.ejca.2005.04.016; Haniadka R, 2012, J ALTERN COMPLEM MED, V18, P440, DOI 10.1089/acm.2010.0737; Hu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039664; Karakaya S, 2004, CRIT REV FOOD SCI, V44, P453, DOI 10.1080/10408690490886683; Key TJ, BR J CANC, V104, P6; Kim JS, 2008, ARCH PHARM RES, V31, P415, DOI 10.1007/s12272-001-1172-y; Kubra IR, 2012, CRIT REV FOOD SCI, V52, P651, DOI 10.1080/10408398.2010.505689; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Sang SM, 2009, J AGR FOOD CHEM, V57, P10645, DOI 10.1021/jf9027443; Sarkar FH, 2009, CANCER TREAT REV, V35, P597, DOI 10.1016/j.ctrv.2009.07.001; SOWDEN JC, 1962, J ORG CHEM, V27, P1791, DOI 10.1021/jo01052a074; Stan SD, 2008, J CELL BIOCHEM, V104, P339, DOI 10.1002/jcb.21623; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Toyota M, 2005, ORG LETT, V7, P3929, DOI 10.1021/ol051411t; Wild CP, 2001, BRIT J NUTR, V86, pS37, DOI 10.1079/BJN2001338; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Wu H, 2010, MOL NUTR FOOD RES, V54, P1296, DOI 10.1002/mnfr.200900409	20	37	37	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54677	10.1371/journal.pone.0054677	http://dx.doi.org/10.1371/journal.pone.0054677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382939	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800063
J	Rocco, A; Kierzek, AM; McFadden, J				Rocco, Andrea; Kierzek, Andrzej M.; McFadden, Johnjoe			Slow Protein Fluctuations Explain the Emergence of Growth Phenotypes and Persistence in Clonal Bacterial Populations	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; SINGLE-CELL; HETEROGENEITY; TRANSCRIPTOME; METABOLISM; BIOFILMS; DORMANCY; NOISE; CYCLE	One of the most challenging problems in microbiology is to understand how a small fraction of microbes that resists killing by antibiotics can emerge in a population of genetically identical cells, the phenomenon known as persistence or drug tolerance. Its characteristic signature is the biphasic kill curve, whereby microbes exposed to a bactericidal agent are initially killed very rapidly but then much more slowly. Here we relate this problem to the more general problem of understanding the emergence of distinct growth phenotypes in clonal populations. We address the problem mathematically by adopting the framework of the phenomenon of so-called weak ergodicity breaking, well known in dynamical physical systems, which we extend to the biological context. We show analytically and by direct stochastic simulations that distinct growth phenotypes can emerge as a consequence of slow-down of stochastic fluctuations in the expression of a gene controlling growth rate. In the regime of fast gene transcription, the system is ergodic, the growth rate distribution is unimodal, and accounts for one phenotype only. In contrast, at slow transcription and fast translation, weakly non-ergodic components emerge, the population distribution of growth rates becomes bimodal, and two distinct growth phenotypes are identified. When coupled to the well-established growth rate dependence of antibiotic killing, this model describes the observed fast and slow killing phases, and reproduces much of the phenomenology of bacterial persistence. The model has major implications for efforts to develop control strategies for persistent infections.	[Rocco, Andrea; Kierzek, Andrzej M.; McFadden, Johnjoe] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Surrey	Rocco, A (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	a.rocco@surrey.ac.uk	Rocco, Andrea/N-7076-2017	Rocco, Andrea/0000-0002-0974-5522; McFadden, Johnjoe/0000-0003-2145-0046; Kierzek, Andrzej/0000-0002-2605-9057	Wellcome Trust [088677]; Biotechnology and Biological Sciences Research Council [BB/J002097/1] Funding Source: researchfish; BBSRC [BB/J002097/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge support from The Wellcome Trust (ref: 088677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BOUCHAUD JP, 1992, J PHYS I, V2, P1705, DOI 10.1051/jp1:1992238; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cooper S, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-10; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dannenberg JH, 2010, CELL, V141, P18, DOI 10.1016/j.cell.2010.03.020; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dorfman J. R., 1999, CAMBRIDGE LECT NOTES, V14; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kubitschek HE, 1968, ANL7535; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Mattsson AE, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155101; POWELL EO, 1956, J GEN MICROBIOL, V15, P492, DOI 10.1099/00221287-15-3-492; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rebenshtok A, 2008, J STAT PHYS, V133, P565, DOI 10.1007/s10955-008-9610-3; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Trott J, 2012, MOL BIOSYST, V8, P744, DOI 10.1039/c1mb05398a; Valluri SR, 2000, CAN J PHYS, V78, P823, DOI 10.1139/cjp-78-9-823; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Waddington C., 1957, STRATEGY GENES; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Weber M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-11; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; ZWANZIG R, 1990, ACCOUNTS CHEM RES, V23, P148, DOI 10.1021/ar00173a005	40	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54272	10.1371/journal.pone.0054272	http://dx.doi.org/10.1371/journal.pone.0054272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382887	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200054
J	Dediu, D; Cysouw, M				Dediu, Dan; Cysouw, Michael			Some Structural Aspects of Language Are More Stable than Others: A Comparison of Seven Methods	PLOS ONE			English	Article							BAYESIAN-INFERENCE; EVOLUTION; GENE; PHYLOGENY; FREQUENCY; SPEECH	Understanding the patterns and causes of differential structural stability is an area of major interest for the study of language change and evolution. It is still debated whether structural features have intrinsic stabilities across language families and geographic areas, or if the processes governing their rate of change are completely dependent upon the specific context of a given language or language family. We conducted an extensive literature review and selected seven different approaches to conceptualising and estimating the stability of structural linguistic features, aiming at comparing them using the same dataset, the World Atlas of Language Structures. We found that, despite profound conceptual and empirical differences between these methods, they tend to agree in classifying some structural linguistic features as being more stable than others. This suggests that there are intrinsic properties of such structural features influencing their stability across methods, language families and geographic areas. This finding is a major step towards understanding the nature of structural linguistic features and their interaction with idiosyncratic, lineage- and area-specific factors during language change and evolution.	[Dediu, Dan] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Dediu, Dan] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Cysouw, Michael] Univ Marburg, Forschungszentrum Deutsch Sprachatlas, Marburg, Germany	Max Planck Society; Radboud University Nijmegen; Philipps University Marburg	Dediu, D (corresponding author), Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands.	Dan.Dediu@mpi.nl	Dediu, Dan/E-3279-2012	Dediu, Dan/0000-0002-0704-6365; Cysouw, Michael/0000-0003-3168-4946	European Research Council [240816]	European Research Council(European Research Council (ERC)European Commission)	Michael Cysouw was funded by European Research Council Starting Grant 240816 "Quantitative modeling of historical-comparative linguistics: Unraveling the phylogeny of native South American languages (QuantHistLing)." http://erc.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, SUBJECTIVE OBJECTIVE; Aris-Brosou S, 2005, MOL BIOL EVOL, V22, P200, DOI 10.1093/molbev/msi006; Bickel B, 2010, DISTRIBUTIONAL UNPUB; Campbell Lyle., 2004, HIST LINGUISTICS INT, VSecondedition; Campbell Lyle, 2008, LANGUAGE CLASSIFICAT; Clark NL, 2008, HDB HUMAN MOL EVOLUT, V2, P1158; Cox T. F, 1994, MULTIDIMENSIONAL SCA; Crystal D, 2006, FIGHT ENGLISH; Culbertson J, 2012, COGNITION, V122, P306, DOI 10.1016/j.cognition.2011.10.017; Cysouw M, 2008, STUF-LANG TYPOL UNIV, V61, P263; Cysouw Michael., 2011, LINGUIST TYPOL, V15, P415, DOI [10.1515/lity.2011.028, DOI 10.1515/LITY.2011.028]; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Dediu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045198; Dediu D, 2011, HUM BIOL, V83, P279, DOI 10.3378/027.083.0208; Dediu D, 2011, P ROY SOC B-BIOL SCI, V278, P474, DOI 10.1098/rspb.2010.1595; Dryer M., 1997, CHICAGO LINGUISTIC S, V33, P123; Dunn M, 2005, SCIENCE, V309, P2072, DOI 10.1126/science.1114615; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Dunn M, 2008, LANGUAGE, V84, P710; Fedzechkina M, 2012, P NATL ACAD SCI USA, V109, P17897, DOI 10.1073/pnas.1215776109; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fridriksson F, 2008, THESIS U GOTHENBURG; GILL J, 2002, BAYESIAN METHODS SOC; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Greenhill SJ, 2010, P R SOC B; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hammarstrom H, 2010, DIACHRONICA, V27, P197, DOI 10.1075/dia.27.2.02ham; Haspelmath Martin, 2005, WORLD ATLAS LANGUAGE; HOLM S, 1979, SCAND J STAT, V6, P65; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2008, HDB HUMAN MOL EVOLUT, V2, P1063; Hunley K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000239; Johnston MO, 2008, HDB HUMAN MOL EVOLUT, V1, P108; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lewiss M, 2009, ETHNOLOGUE LANGUAGES; MANTEL N, 1967, CANCER RES, V27, P209; Maslova E, 2002, 3 WINT TYP SCH MOSC; Maslova E., 2004, VOPR YAZYKOZNANIYA, V5, P3; Maslova E, 2008, STOCHASTIC UNIVERSAL; Maslova Elena, 2000, LINGUIST TYPOL, V4, P307, DOI DOI 10.1515/LITY.2000.4.3.307; Meade Andrew, 2006, PHYLOGENETIC METHODS, P173; Metzgar D, 2008, HDB HUMAN MOL EVOLUT, V1, P123; Nei M., 2000, MOL EVOLUTION PHYLOG; Nichols J, 2008, HDB HIST LINGUISTICS, P283; Nichols J., 1999, LINGUISTIC DIVERSITY; Nunn CL, 2010, PHILOS T R SOC B, V365, P3807, DOI 10.1098/rstb.2010.0009; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Parkvall M, 2008, STUF-LANG TYPOL UNIV, V61, P234; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Swadesh M., 1952, P AM PHILOS SOC, V96, p452 ; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tadmor U, 2010, DIACHRONICA, V27, P226, DOI 10.1075/dia.27.2.04tad; Thomason S. G., 1988, LANGUAGE CONTACT CRE; Tily H, 2011, LINGUIST TYPOL, V15, P479; Wichmann Soren, 2009, ASSESSING TEMPORAL S; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	65	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55009	10.1371/journal.pone.0055009	http://dx.doi.org/10.1371/journal.pone.0055009			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	093SF	23383035	Green Published, gold			2022-12-27	WOS:000315211500045
J	Okamura, K; Dummer, P; Kopp, J; Qiu, LR; Levi, M; Faubel, S; Blaine, J				Okamura, Kayo; Dummer, Patrick; Kopp, Jeffrey; Qiu, Liru; Levi, Moshe; Faubel, Sarah; Blaine, Judith			Endocytosis of Albumin by Podocytes Elicits an Inflammatory Response and Induces Apoptotic Cell Death	PLOS ONE			English	Article							PROXIMAL TUBULE CELLS; ENDOPLASMIC-RETICULUM STRESS; GLOMERULAR-FILTRATION-RATE; RISK POPULATION COHORTS; KAPPA-B ACTIVATION; COLLABORATIVE METAANALYSIS; DEPENDENT PATHWAY; EPITHELIAL-CELLS; KIDNEY-FUNCTION; NADPH OXIDASE	The presence of albuminuria is strongly associated with progression of chronic kidney disease. While albuminuria has been shown to injure renal proximal tubular cells, the effects of albumin on podocytes have been less well studied. We have addressed the hypothesis that exposure of podocytes to albumin initiates an injury response. We studied transformed human-urine derived podocytes-like epithelial cells (HUPECS, or podocytes). Upon differentiation, these cells retain certain characteristics of differentiated podocytes, including expression of synaptopodin, CD2AP, and nestin. We exposed podocytes to recombinant human albumin, which lacks lipids and proteins that bind serum albumin; this reagent allowed a direct examination of the effects of albumin. Podocytes endocytosed fluoresceinated albumin and this process was inhibited at 4 degrees C, suggesting an energy-dependent process. Exposure to albumin at concentrations of 5 and 10 mg/ml was associated with increased cell death in a dose-dependent manner. The mechanism of cell death may involve apoptosis, as caspase 3/7 were activated and the pan-caspase inhibitor z-VAD reduced cell death. Albumin exposure also increased nuclear factor (NF)-mu B activation and increased transcription and release of interleukin (IL-) 1 beta, tumor necrosis factor (TNF), and IL-6. We extended these findings to an in vivo model. Glomeruli isolated from mice with nephrotic syndrome also had increased expression of IL-1 beta and TNF RNA. These data suggest that while podocyte injury begets albuminuria, albumin in the glomerular ultrafiltrate may also beget podocyte injury. Thus, an additional mechanism by which anti-proteinuric therapies are beneficial in the treatment of glomerular diseases may be a reduction in injury to the podocyte by albumin.	[Okamura, Kayo; Qiu, Liru; Levi, Moshe; Faubel, Sarah; Blaine, Judith] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Dummer, Patrick; Kopp, Jeffrey] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Blaine, J (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO USA.	Judith.Blaine@ucdenver.edu	qiu, liru/AAA-4648-2022; Kopp, Jeffrey B/O-2681-2015	qiu, liru/0000-0002-1583-7183; Kopp, Jeffrey B/0000-0001-9052-186X; Levi, Moshe/0000-0002-6225-946X	National Institutes of Health K08 grant [DK080989]; Intramural Research Program at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK099544, P30DK048520, K08DK080989] Funding Source: NIH RePORTER	National Institutes of Health K08 grant; Intramural Research Program at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health K08 grant (DK080989) to JB and by the Intramural Research Program at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Cao W, 2011, J HYPERTENS, V29, P1411, DOI 10.1097/HJH.0b013e32834786f0; Chang AM, 2012, NEPHROL DIAL TRANSPL, V27, P1330, DOI 10.1093/ndt/gfr483; Chen S, 2011, CELL CALCIUM, V50, P523, DOI 10.1016/j.ceca.2011.08.008; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; He FF, 2011, GENE, V484, P18, DOI 10.1016/j.gene.2011.05.025; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Nicotera P, 1999, BIOL CHEM, V380, P1035, DOI 10.1515/BC.1999.129; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Peti-Peterdi J, 2009, AM J PHYSIOL-RENAL, V296, pF1255, DOI 10.1152/ajprenal.00144.2009; Prabakaran T, 2012, NEPHROL DIAL TRANSPL, V27, P3156, DOI 10.1093/ndt/gfr794; Prabakaran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025065; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sandoval RM, 2012, J AM SOC NEPHROL, V23, P447, DOI 10.1681/ASN.2011070666; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Takaya K, 2003, AM J PHYSIOL-RENAL, V284, pF1037, DOI 10.1152/ajprenal.00230.2002; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Tanner GA, 2009, AM J PHYSIOL-RENAL, V296, pF1258, DOI 10.1152/ajprenal.90638.2008; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tryggvason K, 2005, PHYSIOLOGY, V20, P96, DOI 10.1152/physiol.00045.2004; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Yoshida S, 2008, NEPHRON EXP NEPHROL, V108, pE57, DOI 10.1159/000124236; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x	36	64	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54817	10.1371/journal.pone.0054817	http://dx.doi.org/10.1371/journal.pone.0054817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382978	Green Submitted, gold, Green Published			2022-12-27	WOS:000315211500030
J	Shi, TX; Li, RY; Zhao, ZK; Ding, GD; Long, Y; Meng, JL; Xu, FS; Shi, L				Shi, Taoxiong; Li, Ruiyuan; Zhao, Zunkang; Ding, Guangda; Long, Yan; Meng, Jinling; Xu, Fangsen; Shi, Lei			QTL for Yield Traits and Their Association with Functional Genes in Response to Phosphorus Deficiency in Brassica napus	PLOS ONE			English	Article							ORYZA-SATIVA L.; OILSEED RAPE; ARABIDOPSIS-THALIANA; MAPPING QTLS; SEED YIELD; SOIL-PHOSPHORUS; COMPLEX TRAITS; USE EFFICIENCY; LOCI ANALYSIS; ROOT HAIR	Background: Oilseed rape (Brassica napus L.) is one of the most important oil crops. A primary limitation to the cultivation of this crop is the lack of available phosphorus (P) in soils. To elucidate the genetic control of P deficiency tolerance in Brassica napus, quantitative trait locus (QTL) for seed yield and yield related-traits in response to P deficiency were identified using a double haploid mapping population (TN DH) derived from a cross between a P-efficient cultivar, Ningyou 7 and a P-inefficient cultivar, Tapidor. Results: Three field trials were conducted to determine seed yield (SY), plant height (PH), number of primary branches (BN), height to the first primary branch (FBH), relative first primary branch height (RBH), pod number per plant (PN), seed number per pod (SN) and seed weight of 1,000 seeds (SW) in 188 lines of TN DH population exposed to low P (LP) and optimal P (OP) conditions. P deficiency decreased PH, BN, SN, PN and SY, and increased FBH and RBH with no effect on SW. Three reproducible LP-specific QTL regions were identified on chromosomes A2, A3 and A5 that controlled SN, PN and SW respectively. In addition, six reproducible constitutive regions were also mapped with two each for SY-LP on A2, and FBH-LP on C6 and one each for PH-LP and SW-LP on A3. About 30 markers derived from 19 orthologous genes involved in Arabidopsis P homeostasis were mapped on 24 QTL regions by comparative mapping between Arabidopsis and Brassica napus. Among these genes, GPT1, MGD2 and SIZ1 were associated with two major loci regulating SY-LP and other yield-related traits on A2 between 77.1 and 95.0 cM. Conclusion: The stable QTLs detected under LP conditions and their candidate genes may provide useful information for marker-assisted selection in breeding high-yield B. napus varieties with improved P efficiency.	[Shi, Taoxiong; Li, Ruiyuan; Zhao, Zunkang; Ding, Guangda; Long, Yan; Meng, Jinling; Xu, Fangsen; Shi, Lei] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Shi, Taoxiong; Li, Ruiyuan; Zhao, Zunkang; Ding, Guangda; Long, Yan; Meng, Jinling; Xu, Fangsen; Shi, Lei] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Peoples R China; [Shi, Taoxiong; Zhao, Zunkang; Ding, Guangda; Xu, Fangsen; Shi, Lei] Huazhong Agr Univ, Key Lab Arable Land Conservat Middle & Lower Reac, Minist Agr, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Shi, L (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	leish@mail.hzau.edu.cn	Ding, Guangda/ABG-3651-2020; Ding, Guangda/AAH-5026-2021	Ding, Guangda/0000-0003-3702-5087; 	Natural Science Funds for Distinguished Young Scholar in Hubei Province [2011CDA090]; National Basic Research and Development Program [2011CB100301]; Fundamental Research Funds for the Central Universities [2012PY006]	Natural Science Funds for Distinguished Young Scholar in Hubei Province; National Basic Research and Development Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors sincerely thank funding agencies, the Natural Science Funds for Distinguished Young Scholar in Hubei Province (2011CDA090), the National Basic Research and Development Program (2011CB100301) and the Fundamental Research Funds for the Central Universities (2012PY006) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; CHURCHILL GA, 1994, GENETICS, V138, P963; Ding GD, 2012, ANN BOT-LONDON, V109, P747, DOI 10.1093/aob/mcr323; Ding GD, 2011, EUPHYTICA, V181, P305, DOI 10.1007/s10681-011-0428-8; Ding GD, 2010, ANN BOT-LONDON, V105, P1221, DOI 10.1093/aob/mcq050; Duan HY, 2009, J PLANT NUTR, V32, P1148, DOI 10.1080/01904160902943171; Fageria NK, 2008, J PLANT NUTR, V31, P1121, DOI 10.1080/01904160802116068; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Hammond JP, 2011, PLANT PHYSIOL, V156, P1230, DOI 10.1104/pp.111.175612; Hammond JP, 2009, J EXP BOT, V60, P1953, DOI 10.1093/jxb/erp083; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Li YD, 2005, EUPHYTICA, V142, P137, DOI 10.1007/s10681-005-1192-4; Li YY, 2007, AUST J AGR RES, V58, P759, DOI 10.1071/AR06350; Li YY, 2006, EUPHYTICA, V152, P25, DOI 10.1007/s10681-006-9173-9; Liang QA, 2010, ANN BOT-LONDON, V106, P223, DOI 10.1093/aob/mcq097; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Liu J, 2009, PLANT SOIL, V320, P255, DOI 10.1007/s11104-009-9891-6; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Long Y, 2011, GENETICS, V189, P1093, DOI 10.1534/genetics.111.131615; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Ming F, 2000, CHINESE SCI BULL, V45, P520, DOI 10.1007/BF02887097; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Ni JJ, 1998, THEOR APPL GENET, V97, P1361, DOI 10.1007/s001220051030; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Quijada PA, 2006, THEOR APPL GENET, V113, P549, DOI 10.1007/s00122-006-0323-1; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shi TaoXiong, 2010, Plant Nutrition and Fertilizer Science, V16, P959; Su JY, 2009, PLANT SCI, V176, P824, DOI 10.1016/j.plantsci.2009.03.006; Su JY, 2006, PLANT SOIL, V281, P25, DOI 10.1007/s11104-005-3771-5; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Udall JA, 2006, THEOR APPL GENET, V113, P597, DOI 10.1007/s00122-006-0324-0; Van Ooijen J.W., 2006, JOINMAP4 SOFTWARE CA; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Wissuwa M, 2002, THEOR APPL GENET, V105, P890, DOI 10.1007/s00122-002-1051-9; Wu J, 2008, PLANT SOIL, V310, P25, DOI 10.1007/s11104-008-9625-1; Yan XL, 2004, PLANT SOIL, V265, P17, DOI 10.1007/s11104-005-0693-1; Yang M, 2011, PLANT SOIL, V339, P97, DOI 10.1007/s11104-010-0516-x; Yang M, 2010, THEOR APPL GENET, V121, P181, DOI 10.1007/s00122-010-1301-1; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhao JJ, 2008, PLANT CELL ENVIRON, V31, P887, DOI 10.1111/j.1365-3040.2008.01791.x; Zhu JM, 2005, PLANT SOIL, V270, P299, DOI 10.1007/s11104-004-1697-y	53	30	37	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54559	10.1371/journal.pone.0054559	http://dx.doi.org/10.1371/journal.pone.0054559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382913	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500016
J	Zukewich, J; Kurella, V; Doebeli, M; Hauert, C				Zukewich, Joshua; Kurella, Venu; Doebeli, Michael; Hauert, Christoph			Consolidating Birth-Death and Death-Birth Processes in Structured Populations	PLOS ONE			English	Article							EVOLUTIONARY STABILITY; PRISONERS-DILEMMA; COOPERATION; GAMES	Network models extend evolutionary game theory to settings with spatial or social structure and have provided key insights on the mechanisms underlying the evolution of cooperation. However, network models have also proven sensitive to seemingly small details of the model architecture. Here we investigate two popular biologically motivated models of evolution in finite populations: Death-Birth (DB) and Birth-Death (BD) processes. In both cases reproduction is proportional to fitness and death is random; the only difference is the order of the two events at each time step. Although superficially similar, under DB cooperation may be favoured in structured populations, while under BD it never is. This is especially troubling as natural populations do not follow a strict one birth then one death regimen (or vice versa); such constraints are introduced to make models more tractable. Whether structure can promote the evolution of cooperation should not hinge on a simplifying assumption. Here, we propose a mixed rule where in each time step DB is used with probability delta and BD is used with probability 1-delta. We derive the conditions for selection favouring cooperation under the mixed rule for all social dilemmas. We find that the only qualitatively different outcome occurs when using just BD (delta=0). This case admits a natural interpretation in terms of kin competition counterbalancing the effect of kin selection. Finally we show that, for any mixed BD-DB update and under weak selection, cooperation is never inhibited by population structure for any social dilemma, including the Snowdrift Game.	[Zukewich, Joshua; Kurella, Venu; Doebeli, Michael; Hauert, Christoph] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Doebeli, Michael] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Zukewich, J (corresponding author), Univ British Columbia, Dept Math, Vancouver, BC, Canada.	jzuke@math.ubc.ca	Hauert, Christoph/E-5369-2011	Hauert, Christoph/0000-0002-1239-281X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	MD and CH acknowledge financial support by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fu F, 2010, J THEOR BIOL, V266, P358, DOI 10.1016/j.jtbi.2010.06.042; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046707; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauert C, 2006, J THEOR BIOL, V239, P195, DOI 10.1016/j.jtbi.2005.08.040; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2006, J THEOR BIOL, V240, P627, DOI 10.1016/j.jtbi.2005.10.024; Hofbauer J., 1988, THEORY EVOLUTION DYN; Maynard Smith J., 1982, pi; Moran P., 1962, STAT PROCESSES EVOLU; Morita S, 2008, PROG THEOR PHYS, V119, P29, DOI 10.1143/PTP.119.29; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Ohtsuki H, 2008, J THEOR BIOL, V251, P698, DOI 10.1016/j.jtbi.2008.01.005; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tarnita CE, 2011, P NATL ACAD SCI USA, V108, P2334, DOI 10.1073/pnas.1016008108; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971	25	54	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54639	10.1371/journal.pone.0054639	http://dx.doi.org/10.1371/journal.pone.0054639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382931	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500022
J	Kesavachandran, CN; Haamann, F; Nienhaus, A				Kesavachandran, Chandrasekharan Nair; Haamann, Frank; Nienhaus, Albert			Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based Analysis	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; PLUS RIBAVIRIN; DESTRUCTIVE THYROIDITIS; PEGYLATED INTERFERON; NATURAL-HISTORY; AUTOIMMUNE-THYROIDITIS; AUTOANTIBODY PATTERN; ANTIVIRAL THERAPY; DISEASE; DISORDERS	Background: Thyroid dysfunction is the commonest endocrinopathy associated with HCV infection due to interferon-based treatment. This comprehensive and systematic review presents the available evidence for newly developed thyroid antibodies and dysfunctions during interferon treatment (both single and combination) in HCV patients. Methodology/Principal Findings: This systematic review was conducted in accordance with the PRISMA guidelines. The data generated were used to analyze the risk for thyroid dysfunctions during interferon (IFN) treatment in HCV patients. There was a wide range in the incidence of newly developed thyroid dysfunctions and thyroid antibodies in HCV patients during IFN treatment (both single and combination). The wide range of incidence also denoted the possibility of factors other than IFN treatment for thyroid-related abnormalities in HCV patients. These other factors include HCV viral factors, genetic predisposition, environmental factors, and patho-physiological factors. Variations in IFN dosage, treatment duration of IFN, definition/criteria followed in each study for thyroid dysfunction and irregular thyroid function testing during treatment in different studies influence the outcome of the single studies and jeopardise the validity of a pooled risk estimate of side effects of thyroid dysfunction. Importantly, reports differ as to whether the thyroid-related side effects disappear totally after withdrawal of the IFN treatment. Conclusions/Significance: The present review shows that there is a wide range in the incidence of newly developed thyroid dysfunctions and thyroid antibodies in IFN treated HCV patients. This is a comprehensive attempt to collate relevant data from 56 publications across several nations about IFN (both mono and combination therapy) related thyroid dysfunction among HCV patients. The role of each factor in causing thyroid dysfunctions in HCV patients treated with IFN should be analyzed in detail in future studies, for a better understanding of the problem and sounder clinical management of the disease.	[Kesavachandran, Chandrasekharan Nair; Nienhaus, Albert] Univ Med Ctr Hamburg Eppendorf, Ctr Epidemiol & Hlth Serv Res Nursing Profess CV, Hamburg, Germany; [Haamann, Frank; Nienhaus, Albert] Inst Statutory Accid Insurance & Prevent Hlth & W, Dept Occupat Hlth Res, Hamburg, Germany; [Kesavachandran, Chandrasekharan Nair] CSIR Indian Inst Toxicol Res, Div Epidemiol, Lucknow, Uttar Pradesh, India	University of Hamburg; University Medical Center Hamburg-Eppendorf; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Kesavachandran, CN (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Epidemiol & Hlth Serv Res Nursing Profess CV, Hamburg, Germany.	ckesavac@uke.uni-hamburg.de			German Accident Insurance Institution for the Health and Welfare Services (BGW), Hamburg, Germany	German Accident Insurance Institution for the Health and Welfare Services (BGW), Hamburg, Germany	This research project was funded by the German Accident Insurance Institution for the Health and Welfare Services (BGW), Hamburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, J Hepatol, V31 Suppl 1, P3; Antonelli A, 2004, AM J MED, V117, P10, DOI 10.1016/j.amjmed.2004.01.023; Barut S, 2012, BRAZ J INFECT DIS, V16, P448, DOI 10.1016/j.bjid.2012.05.002; BAUDIN E, 1993, CLIN ENDOCRINOL, V39, P657, DOI 10.1111/j.1365-2265.1993.tb02423.x; BERRIS B, 1991, DIGEST DIS SCI, V36, P1657, DOI 10.1007/BF01296413; Bini EJ, 2004, ARCH INTERN MED, V164, P2371, DOI 10.1001/archinte.164.21.2371; CARELLA C, 1995, HORM RES, V44, P110, DOI 10.1159/000184606; Carella C, 2004, J CLIN ENDOCR METAB, V89, P3656, DOI 10.1210/jc.2004-0627; Carella C, 2002, EUR J ENDOCRINOL, V146, P743, DOI 10.1530/eje.0.1460743; Carella C, 2001, J CLIN ENDOCR METAB, V86, P1925, DOI 10.1210/jc.86.5.1925; Chan WB, 2003, J ROY SOC MED, V96, P481, DOI 10.1258/jrsm.96.10.481; Costelloe SJ, 2010, CLIN ENDOCRINOL, V73, P249, DOI 10.1111/j.1365-2265.2010.03785.x; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dabrowska MM, 2010, HEPATO-GASTROENTEROL, V57, P826; Dalgard O, 2002, J INTERN MED, V251, P400, DOI 10.1046/j.1365-2796.2002.00974.x; Andrade LJD, 2011, BRAZ J INFECT DIS, V15, P377, DOI 10.1590/S1413-86702011000400013; Deutsch M, 1997, HEPATOLOGY, V26, P206, DOI 10.1002/hep.510260127; Doi F, 2005, LIVER INT, V25, P242, DOI 10.1111/j.1478-3231.2005.01089.x; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Fernandez-Soto L, 1998, ARCH INTERN MED, V158, P1445, DOI 10.1001/archinte.158.13.1445; Floreani A, 1998, ITAL J GASTROENTEROL, V30, P71; Fontaine H, 2001, HUM PATHOL, V32, P904, DOI 10.1053/hupa.2001.28228; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Friedrich-Rust M, 2009, J VIRAL HEPATITIS, V16, P168, DOI 10.1111/j.1365-2893.2008.01059.x; Gehring S, 2006, WORLD J GASTROENTERO, V12, P5787, DOI 10.3748/wjg.v12.i36.5787; Gelu-Simeon M, 2009, WORLD J GASTROENTERO, V15, P328, DOI 10.3748/wjg.15.328; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gowans EJ, 2000, SEMIN LIVER DIS, V20, P85, DOI 10.1055/s-2000-9503; Gupta VK, 2011, MJAFI, V67, P1; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hsieh MC, 2000, EUR J ENDOCRINOL, V142, P431, DOI 10.1530/eje.0.1420431; Huang JF, 2006, J VIRAL HEPATITIS, V13, P396, DOI 10.1111/j.1365-2893.2005.00705.x; Hultgren C, 1998, J GEN VIROL, V79, P2381, DOI 10.1099/0022-1317-79-10-2381; IMAGAWA A, 1995, J CLIN ENDOCR METAB, V80, P922, DOI 10.1210/jc.80.3.922; Jamil KM, 2009, J GASTROEN HEPATOL, V24, P1017, DOI 10.1111/j.1440-1746.2008.05690.x; Kakizaki S, 1999, J HEPATOL, V30, P794, DOI 10.1016/S0168-8278(99)80131-7; Kee KM, 2006, J GASTROEN HEPATOL, V21, P319, DOI 10.1111/j.1440-1746.2005.03947.x; Kim BK, 2011, J KOREAN MED SCI, V26, P1638, DOI 10.3346/jkms.2011.26.12.1638; KODAMA T, 1994, J GASTROENTEROL, V29, P289, DOI 10.1007/BF02358367; Kowala-Piaskowska A, 2007, PHARMACOEPIDEM DR S, V16, P1095, DOI 10.1002/pds.1458; Krupinska J, 2011, ENDOKRYNOL POL, V62, P517; Kryczka W, 2001, Med Sci Monit, V7 Suppl 1, P221; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; LISKERMELMAN M, 1992, GASTROENTEROLOGY, V102, P2155, DOI 10.1016/0016-5085(92)90348-3; Lloyd AR, 2007, IMMUNOL CELL BIOL, V85, P24, DOI 10.1038/sj.icb.7100010; Loviselli A, 1999, J ENDOCRINOL INVEST, V22, P660, DOI 10.1007/BF03343626; Mandac JC, 2006, HEPATOLOGY, V43, P661, DOI 10.1002/hep.21146; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marazuela M, 1996, CLIN ENDOCRINOL, V44, P635, DOI 10.1046/j.1365-2265.1996.751768.x; MARCELLIN P, 1995, J HEPATOL, V22, P364, DOI 10.1016/0168-8278(95)80291-6; Masood N, 2008, JCPSP-J COLL PHYSICI, V18, P347, DOI 06.2008/JCPSP.347351; Mazziotti G, 2002, J ENDOCRINOL INVEST, V25, P624, DOI 10.1007/BF03345087; Minelli R, 1999, CLIN ENDOCRINOL, V50, P95, DOI 10.1046/j.1365-2265.1999.00616.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moncoucy X, 2005, GASTROEN CLIN BIOL, V29, P339, DOI 10.1016/S0399-8320(05)80778-X; Monzani F, 2004, CLIN EXP MED, V3, P199, DOI 10.1007/s10238-004-0026-3; Morisco F, 2001, DIGEST LIVER DIS, V33, P247, DOI 10.1016/S1590-8658(01)80715-5; Murakami M, 1999, Nihon Rinsho, V57, P1779; Nadeem A, 2009, JCPSP-J COLL PHYSICI, V19, P86, DOI 02.2009/JCPSP.8689; NAGAYAMA Y, 1994, ENDOCR J, V41, P565, DOI 10.1507/endocrj.41.565; Okanoue T, 1996, J HEPATOL, V25, P283, DOI 10.1016/S0168-8278(96)80113-9; Parana R, 2000, Braz J Infect Dis, V4, P284; PATERON D, 1993, J HEPATOL, V17, P417, DOI 10.1016/S0168-8278(05)80228-4; Plockinger U, 2007, AM J GASTROENTEROL, V102, P2724, DOI 10.1111/j.1572-0241.2007.01445.x; PREZIATI D, 1995, EUR J ENDOCRINOL, V132, P587, DOI 10.1530/eje.0.1320587; Prummel MF, 2003, THYROID, V13, P547, DOI 10.1089/105072503322238809; Ramos-Casals M, 2003, RHEUMATOLOGY, V42, P818, DOI 10.1093/rheumatology/keg299; Rocco A, 2001, NEUROENDOCRINOL LETT, V22, P39; Rose NR, 1999, ENVIRON HEALTH PERSP, V107, P749, DOI 10.2307/3434337; Roti E, 1996, AM J MED, V101, P482, DOI 10.1016/S0002-9343(96)00259-8; Russo MW, 2003, GASTROENTEROLOGY, V124, P1711, DOI 10.1016/S0016-5085(03)00394-9; Testa A, 2006, Eur Rev Med Pharmacol Sci, V10, P183; Themistoklis V, 2011, ANN ACAD MED SINGAP, V40, P394; Tomer Y, 2007, ENDOCRIN METAB CLIN, V36, P1051, DOI 10.1016/j.ecl.2007.07.001; TRAN A, 1993, HEPATOLOGY, V18, P253, DOI 10.1002/hep.1840180205; Tran HA, 2009, QJM-INT J MED, V102, P117, DOI 10.1093/qjmed/hcn150; Tran Huy A, 2005, BMC Endocr Disord, V5, P8, DOI 10.1186/1472-6823-5-8; Tran HA, 2007, J GASTROEN HEPATOL, V22, P472, DOI 10.1111/j.1440-1746.2006.04771.x; Tran HA, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-2; Tran HA, 2009, INT J ENDOCRINOL, V2009, DOI 10.1155/2009/241786; Tran HA, 2009, J GASTROEN HEPATOL, V24, P1163, DOI 10.1111/j.1440-1746.2009.05874.x; Vezali E, 2009, J GASTROEN HEPATOL, V24, P1024, DOI 10.1111/j.1440-1746.2009.05812.x; Villanueva RB, 2002, THYROID, V12, P737, DOI 10.1089/105072502760258730; Wang SH, 2002, J IMMUNOL, V168, P2470, DOI 10.4049/jimmunol.168.5.2470; WATANABE U, 1994, AM J GASTROENTEROL, V89, P399; Wirth S, 2005, HEPATOLOGY, V41, P1013, DOI 10.1002/hep.20661; Wong V, 2002, CLIN ENDOCRINOL, V56, P793, DOI 10.1046/j.1365-2265.2002.01553.x; Yan ZH, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6390	90	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55364	10.1371/journal.pone.0055364	http://dx.doi.org/10.1371/journal.pone.0055364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383326	gold, Green Published, Green Submitted			2022-12-27	WOS:000314597900033
J	Allen, M; Bird, C; Feng, W; Liu, GL; Li, WQ; Perrone-Bizzozero, NI; Feng, Y				Allen, Megan; Bird, Clark; Feng, Wei; Liu, Guanglu; Li, Wenqi; Perrone-Bizzozero, Nora I.; Feng, Yue			HuD Promotes BDNF Expression in Brain Neurons via Selective Stabilization of the BDNF Long 3 ' UTR mRNA	PLOS ONE			English	Article							BINDING PROTEIN HUD; NEUROTROPHIC FACTOR; POSTTRANSCRIPTIONAL REGULATION; DEPENDENT TRANSLATION; NEURITE OUTGROWTH; UP-REGULATION; GAP-43 GENE; LOCALIZATION; CELLS; OVEREXPRESSION	Complex regulation of brain-derived neurotrophic factor (BDNF) governs its intricate functions in brain development and neuronal plasticity. Besides tight transcriptional control from multiple distinct promoters, alternative 3'end processing of the BDNF transcripts generates either a long or a short 3'untranslated region (3'UTR). Previous reports indicate that distinct RNA sequence in the BDNF 3'UTRs differentially regulates BDNF production in the brain to accommodate neuronal activity changes, conceivably through differential interactions with undefined trans-acting factors that regulate stability and translation of these BDNF mRNA isoforms. In this study, we report that the neuronal RNA-binding protein (RBP) HuD interacts with a highly conserved AU-rich element (ARE) specifically located in the BDNF long 3'UTR. Such interaction is necessary and sufficient for selective stabilization of mRNAs that contain the BDNF long 3'UTR in vitro and in vivo. Moreover, in a HuD transgenic mouse model, the BDNF long 3'UTR mRNA is increased in the hippocampal dentate granule cells (DGCs), leading to elevated expression of BDNF protein that is transported and stored in the mossy fiber (MF) terminals. Our results identify HuD as the first trans-acting factor that enhances BDNF expression specifically through the long 3'UTR and a novel mechanism that regulates BDNF protein production in selected neuronal populations by HuD abundance.	[Allen, Megan; Feng, Wei; Liu, Guanglu; Li, Wenqi; Feng, Yue] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Bird, Clark; Perrone-Bizzozero, Nora I.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	Emory University; University of New Mexico	Perrone-Bizzozero, NI (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	nbizzozero@salud.unm.edu; yfeng@emory.edu	FENG, WEI/B-8713-2018	FENG, WEI/0000-0002-9106-4258; Feng, Yue/0000-0002-7905-2182; Bird, Clark/0000-0001-7712-6531	National Institutes of Health [5R01NS070526]; March of Dimes [6-FY2012-378, 5R01NS030255, 1R01DA034097]; Fraxa postdoctoral fellowship;  [5T32GM008602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602, T32GM008367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030255, R01NS070526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034097, R21DA034452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Fraxa postdoctoral fellowship; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health 5R01NS070526 and March of Dimes 6-FY2012-378 to YF, 5R01NS030255 and 1R01DA034097 to NPB. WF is partly supported by the Fraxa postdoctoral fellowship. MA is a trainee supported by 5T32GM008602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Anderson KD, 2003, EXP NEUROL, V183, P100, DOI 10.1016/S0014-4886(03)00103-1; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Anderson KD, 2001, EXP NEUROL, V168, P250, DOI 10.1006/exnr.2000.7599; Beckel-Mitchener AC, 2002, J BIOL CHEM, V277, P27996, DOI 10.1074/jbc.M201982200; Bolognani F, 2006, J NEUROCHEM, V96, P790, DOI 10.1111/j.1471-4159.2005.03607.x; Bolognani F, 2004, NEUROSCI LETT, V371, P152, DOI 10.1016/j.neulet.2004.08.074; Bolognani F, 2007, NEUROCHEM RES, V32, P2142, DOI 10.1007/s11064-007-9388-8; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Castren E, 1998, PROG BRAIN RES, V117, P57; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chung SM, 1997, J BIOL CHEM, V272, P6593, DOI 10.1074/jbc.272.10.6593; Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004; Danzer SC, 2004, HIPPOCAMPUS, V14, P345, DOI 10.1002/hipo.10190; Deschenes-Furry J, 2006, BIOESSAYS, V28, P822, DOI 10.1002/bies.20449; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Miura P, 2012, J NEUROCHEM, V120, P230, DOI 10.1111/j.1471-4159.2011.07583.x; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Obata N, 2011, BIOCHEM BIOPH RES CO, V408, P139, DOI 10.1016/j.bbrc.2011.03.137; Okano HJ, 1997, J NEUROSCI, V17, P3024; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Pattabiraman PP, 2005, MOL CELL NEUROSCI, V28, P556, DOI 10.1016/j.mcn.2004.11.010; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Perrone-Bizzozero N, 2012, FRONTIERS BIOSCIENCE; Perrone-Bizzozero NI, 2011, ASN NEURO, V3, DOI 10.1042/AN20110015; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Tiruchinapalli DM, 2008, J NEUROCHEM, V107, P1529, DOI 10.1111/j.1471-4159.2008.05718.x; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006; Zhao LX, 2010, P NATL ACAD SCI USA, V107, P19061, DOI 10.1073/pnas.1007487107	44	39	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55718	10.1371/journal.pone.0055718	http://dx.doi.org/10.1371/journal.pone.0055718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383270	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600150
J	Jagu, S; Kwak, K; Karanam, B; Huh, WK; Damotharan, V; Chivukula, SV; Roden, RBS				Jagu, Subhashini; Kwak, Kihyuck; Karanam, Balasubramanyam; Huh, Warner K.; Damotharan, Vijayarangam; Chivukula, Sudha V.; Roden, Richard B. S.			Optimization of Multimeric Human Papillomavirus L2 Vaccines	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; CROSS-NEUTRALIZATION EPITOPE; VIRUS-LIKE PARTICLES; DOUBLE-BLIND; YOUNG-WOMEN; TYPE-16; HPV; IMMUNIZATION; ANTIBODIES; INFECTION	We sought to define the protective epitopes within the amino terminus of human papillomavirus (HPV) type 16 minor capsid protein L2. Passive transfer of mice with rabbit antisera to HPV16 L2 peptides 17-36, 32-51 and 65-81 provided significant protection against vaginal HPV16 challenge, whereas antisera to 47-66, 108-120 or 373-392 did not. Vaccination with L1 virus-like particles induces a high titer, but generally type-restricted neutralizing antibody response. Conversely, vaccination with L2 11-88, especially multimers thereof, induces antibodies that neutralize a broad range of papillomavirus types, albeit at lower titers than for L1 VLP. With the intent of enhancing the immunogenicity and the breadth of protection by focusing the immune response to the key protective epitopes, we designed L2 fusion proteins consisting of residues similar to 11-88 of eight divergent mucosal HPV types 6, 16, 18, 31, 39, 51, 56, 73 (11-88 x 8) or residues, similar to 13-47 of fifteen HPV types (13-47 x 15). The 11-88 x 8 was significantly more immunogenic than 13-47 x 15 in Balb/c mice regardless of the adjuvant used, suggesting the value of including the 65-81 protective epitope in the vaccine. Since the L2 47-66 peptide antiserum failed to elicit significant protection, we generated an 11-88 x 8 construct deleted for this region in each subunit (11-88 x 8 Delta). Mice were vaccinated with 11-88 x 8 and 11-88 x 8 Delta to determine if deletion of this non-protective epitope enhanced the neutralizing antibody response. However, 11-88 x 8 Delta was significantly less immunogenic than 11-88 x 8, and even the addition of a known T helper epitope, PADRE, to the construct (11-88 x 8 Delta PADRE) failed to recover the immunogenicity of 11-88 x 8 in C57BL/6 mice, suggesting that while L2 47-66 is not a critical protective or T helper epitope, it nevertheless contributes to the immunogenicity of the L2 11- 8868 multimer vaccine.	[Jagu, Subhashini; Kwak, Kihyuck; Karanam, Balasubramanyam; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA; [Huh, Warner K.] Univ Alabama Birmingham, Dept Gynecol Oncol, Birmingham, AL USA; [Damotharan, Vijayarangam; Chivukula, Sudha V.] Shantha Biotech Ltd, Hyderabad, Andhra Pradesh, India	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Sanofi-Aventis	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	roden@jhmi.edu	Kwak, Kihyuck/Y-4377-2018	Kwak, Kihyuck/0000-0002-7386-9589	Public Health Service grant [CA133749, CA118790, P50 CA098252, RC2 CA148499]; American Cancer Society RSG [116279]; Sanofi Pasteur/Shantha Biotechnics; NATIONAL CANCER INSTITUTE [R01CA133749, RC2CA148499, R01CA118790, P50CA098252] Funding Source: NIH RePORTER	Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); American Cancer Society RSG(American Cancer Society); Sanofi Pasteur/Shantha Biotechnics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Public Health Service grants CA133749, CA118790, P50 CA098252 and RC2 CA148499, and by the American Cancer Society RSG 116279 and Sanofi Pasteur/Shantha Biotechnics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bronnimann MP, 2012, J VIROL; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Campo MS, 2010, J VIROL, V84, P1214, DOI 10.1128/JVI.01927-09; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; CHANDRACHUD LM, 1995, VIROLOGY, V211, P204, DOI 10.1006/viro.1995.1392; CHRISTENSEN ND, 1991, VIROLOGY, V181, P572, DOI 10.1016/0042-6822(91)90890-N; Embers ME, 2002, J VIROL, V76, P9798, DOI 10.1128/JVI.76.19.9798-9805.2002; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kawana K, 1998, VIROLOGY, V245, P353, DOI 10.1006/viro.1998.9168; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kawana K, 2003, VACCINE, V21, P4256, DOI 10.1016/S0264-410X(03)00454-7; Kawana K, 2001, VACCINE, V19, P1496, DOI 10.1016/S0264-410X(00)00367-4; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Mustafa AS, 2006, TUBERCULOSIS, V86, P115, DOI 10.1016/j.tube.2005.05.001; Nakao S, 2012, VIROLOGY, V434, P110, DOI 10.1016/j.virol.2012.09.006; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Rosa DS, 2004, IMMUNOL LETT, V92, P259, DOI 10.1016/j.imlet.2004.01.006; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Rubio I, 2009, VACCINE, V27, P1949, DOI 10.1016/j.vaccine.2009.01.102; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Varsani A, 2003, J VIROL, V77, P8386, DOI 10.1128/JVI.77.15.8386-8393.2003; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	42	46	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55538	10.1371/journal.pone.0055538	http://dx.doi.org/10.1371/journal.pone.0055538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383218	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600122
J	Miller, MF; Cohen, ED; Baggs, JE; Hogenesch, JB; Morrisey, EE				Miller, Mayumi F.; Cohen, Ethan David; Baggs, Julie E.; Hogenesch, John B.; Morrisey, Edward E.			High Throughput Genomic Screen Identifies Multiple Factors That Promote Cooperative Wnt Signaling	PLOS ONE			English	Article							BETA-CATENIN; EMBRYONIC-DEVELOPMENT; DEPENDENT ACTIVATION; HOMEOBOX GENE; EXPRESSION; INTERACT; MOUSE; CELLS; MSX2; COACTIVATORS	Previous studies have demonstrated that certain Wnt ligands can promote high levels of cooperative signaling in a cell type specific manner. To explore the underlying mechanism of this cooperative Wnt signaling, we performed a high-throughput screen of more than 14,000 cDNAs to identify genes that promote cooperative Wnt signaling in the context of a single Wnt ligand, Wnt2. This screen identified several homeobox factors including Msx2, Nkx5.2, and Esx1, in addition to other factors known to promote Wnt signaling including Pias4. Generation of dominant-active or dominant-negative forms of Msx2 indicate that the mechanism by which homeobox factors cooperatively promote Wnt signaling is through their ability to repress gene transcription. These data identify a broad homeobox code, which acts to increase Wnt signaling through transcriptional repression.	[Miller, Mayumi F.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Baggs, Julie E.; Hogenesch, John B.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Cohen, Ethan David] Univ Rochester, Sch Med & Dent, Dept Med, Div Endocrinol & Metab, Rochester, NY 14642 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Rochester	Morrisey, EE (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu			National Institutes for Health [HL087825, HL100405, HL110942]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL110942, R01HL087825, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by funding from the National Institutes for Health (HL087825, HL100405, HL110942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; BOBER E, 1994, DEV BIOL, V162, P288, DOI 10.1006/dbio.1994.1086; Boras K, 2002, J BIOL CHEM, V277, P1120, DOI 10.1074/jbc.M109912200; Boras-Granic K, 2006, INT J DEV BIOL, V50, P601, DOI 10.1387/ijdb.062153kb; Cajanek L, 2010, J CELL BIOCHEM, V111, P1077, DOI 10.1002/jcb.22771; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Gitler AD, 2003, DEV DYNAM, V228, P643, DOI 10.1002/dvdy.10418; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; HOLLAND PWH, 1991, GENE, V98, P253, DOI 10.1016/0378-1119(91)90182-B; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; Li YH, 1997, DEV BIOL, V188, P85, DOI 10.1006/dbio.1997.8640; Marfil V, 2010, J BIOL CHEM, V285, P5726, DOI 10.1074/jbc.M109.046649; Miller KA, 2007, DEV BIOL, V311, P665, DOI 10.1016/j.ydbio.2007.07.022; Miller MF, 2012, PNAS; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rossol-Allisone J, 2009, CELL SIGNAL, V21, P1559, DOI 10.1016/j.cellsig.2009.05.010; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Song LY, 2009, DEVELOPMENT, V136, P3161, DOI 10.1242/dev.037440; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204	28	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55782	10.1371/journal.pone.0055782	http://dx.doi.org/10.1371/journal.pone.0055782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383281	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600158
J	Nubel, U; Nachtnebel, M; Falkenhorst, G; Benzler, J; Hecht, J; Kube, M; Brocker, F; Moelling, K; Buhrer, C; Gastmeier, P; Piening, B; Behnke, M; Dehnert, M; Layer, F; Witte, W; Eckmanns, T				Nuebel, Ulrich; Nachtnebel, Matthias; Falkenhorst, Gerhard; Benzler, Justus; Hecht, Jochen; Kube, Michael; Broecker, Felix; Moelling, Karin; Buehrer, Christoph; Gastmeier, Petra; Piening, Brar; Behnke, Michael; Dehnert, Manuel; Layer, Franziska; Witte, Wolfgang; Eckmanns, Tim			MRSA Transmission on a Neonatal Intensive Care Unit: Epidemiological and Genome-Based Phylogenetic Analyses	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HIV-1 TRANSMISSION; SPREAD; INFECTION; OUTBREAK; LESSONS	Background: Methicillin-resistant Staphylococcus aureus (MRSA) may cause prolonged outbreaks of infections in neonatal intensive care units (NICUs). While the specific factors favouring MRSA spread on neonatal wards are not well understood, colonized infants, their relatives, or health-care workers may all be sources for MRSA transmission. Whole-genome sequencing may provide a new tool for elucidating transmission pathways of MRSA at a local scale. Methods and Findings: We applied whole-genome sequencing to trace MRSA spread in a NICU and performed a case-control study to identify risk factors for MRSA transmission. MRSA genomes had accumulated sequence variation sufficiently fast to reflect epidemiological linkage among individual patients, between infants and their mothers, and between infants and staff members, such that the relevance of individual nurses' nasal MRSA colonization for prolonged transmission could be evaluated. In addition to confirming previously reported risk factors, we identified an increased risk of transmission from infants with as yet unknown MRSA colonisation, in contrast to known MRSA-positive infants. Conclusions: The integration of epidemiological (temporal, spatial) and genomic data enabled the phylogenetic testing of several hypotheses on specific MRSA transmission routes within a neonatal intensive-care unit. The pronounced risk of transmission emanating from undetected MRSA carriers suggested that increasing the frequency or speed of microbiological diagnostics could help to reduce transmission of MRSA.	[Nuebel, Ulrich; Layer, Franziska; Witte, Wolfgang] Robert Koch Inst, Dept Infect Dis, Unit Nosocomial Infect, Wernigerode, Germany; [Nachtnebel, Matthias; Falkenhorst, Gerhard; Benzler, Justus; Dehnert, Manuel; Eckmanns, Tim] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Nachtnebel, Matthias] Robert Koch Inst, Berlin, Germany; [Nachtnebel, Matthias] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Hecht, Jochen; Kube, Michael; Broecker, Felix; Moelling, Karin] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Hecht, Jochen] Charite, Med Ctr, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Moelling, Karin] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Buehrer, Christoph] Charite, Dept Neonatol, Med Ctr, D-13353 Berlin, Germany; [Gastmeier, Petra; Piening, Brar; Behnke, Michael] Charite, Med Ctr, Inst Hyg & Environm Med, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; European Centre for Disease Prevention & Control; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Nubel, U (corresponding author), Robert Koch Inst, Dept Infect Dis, Unit Nosocomial Infect, Wernigerode, Germany.	nuebelu@rki.de	Piening, Brar/E-2622-2014	Piening, Brar/0000-0002-4478-5597; Gastmeier, Petra/0000-0001-5520-4287; Layer, Franziska/0000-0002-4613-6478; nachtnebel, matthias/0000-0001-7077-5694; Behnke, Michael/0000-0002-3993-9651	European Programme for Intervention Epidemiology Training (EPIET); European Centre for Disease Prevention and Control, Stockholm, Sweden; Institute of Medical Virology, University of Zurich, Switzerland	European Programme for Intervention Epidemiology Training (EPIET); European Centre for Disease Prevention and Control, Stockholm, Sweden; Institute of Medical Virology, University of Zurich, Switzerland	MN received a fellowship from the European Programme for Intervention Epidemiology Training (EPIET), provided by the European Centre for Disease Prevention and Control, Stockholm, Sweden. The study was partially funded by a grant from the Institute of Medical Virology, University of Zurich, Switzerland (to KM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; DREWS MB, 1995, J HOSP INFECT, V30, P65, DOI 10.1016/0195-6701(95)90250-3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Garcia Robin, 2011, Adv Neonatal Care, V11, P200, DOI 10.1097/ANC.0b013e31821bab47; Geva A, 2011, PEDIATRICS, V128, pE1173, DOI 10.1542/peds.2010-2562; Gould IM, 2009, EPIDEMIOL INFECT, V137, P1242, DOI 10.1017/S0950268809002234; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Khandavilli S, 2009, J HOSP INFECT, V71, P29, DOI 10.1016/j.jhin.2008.09.011; Khoury J, 2005, INFECT CONT HOSP EP, V26, P616, DOI 10.1086/502590; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Maraqa NF, 2011, AM J INFECT CONTROL, V39, P35, DOI 10.1016/j.ajic.2010.07.013; McAdams RM, 2008, PEDIATR INT, V50, P810, DOI 10.1111/j.1442-200X.2008.02646.x; Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599; Nuebel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032698; Nubel U, 2011, INT J MED MICROBIOL, V301, P614, DOI 10.1016/j.ijmm.2011.09.007; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Rachinger A, 2011, AIDS, V25, P1035, DOI 10.1097/QAD.0b013e3283467020; Saiman L, 2003, INFECT CONT HOSP EP, V24, P317, DOI 10.1086/502217; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; Senn L, 2011, J HOSP INFECT, V79, P202, DOI 10.1016/j.jhin.2011.04.021; Shopsin B, 2001, EMERG INFECT DIS, V7, P323, DOI 10.3201/eid0702.010236; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vergnano S, 2011, PEDIATR INFECT DIS J, V30, P850, DOI 10.1097/INF.0b013e318224546d; Waterhouse M, 2011, J HOSP INFECT, V78, P92, DOI 10.1016/j.jhin.2011.01.016; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109	33	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54898	10.1371/journal.pone.0054898	http://dx.doi.org/10.1371/journal.pone.0054898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382995	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600047
J	Padilla, FM; Mommer, L; de Caluwe, H; Smit-Tiekstra, AE; Wagemaker, CAM; Ouborg, NJ; de Kroon, H				Padilla, Francisco M.; Mommer, Liesje; de Caluwe, Hannie; Smit-Tiekstra, Annemiek E.; Wagemaker, Cornelis A. M.; Ouborg, N. Joop; de Kroon, Hans			Early Root Overproduction Not Triggered by Nutrients Decisive for Competitive Success Belowground	PLOS ONE			English	Article							INTERSPECIFIC COMPETITION; PLANT DIVERSITY; NICHE DIFFERENTIATION; SEED YIELD; PRODUCTIVITY; COMMUNITIES; MAINTENANCE; MECHANISMS; ABUNDANCE; FEEDBACK	Background: Theory predicts that plant species win competition for a shared resource by more quickly preempting the resource in hotspots and by depleting resource levels to lower concentrations than its competitors. Competition in natural grasslands largely occurs belowground, but information regarding root interactions is limited, as molecular methods quantifying species abundance belowground have only recently become available. Principal Findings: In monoculture, the grass Festuca rubra had higher root densities and a faster rate of soil nitrate depletion than Plantago lanceolata, projecting the first as a better competitor for nutrients. However, Festuca lost in competition with Plantago. Plantago not only replaced the lower root mass of its competitor, but strongly overproduced roots: with only half of the plants in mixture than in monoculture, Plantago root densities in mixture were similar or higher than those in its monocultures. These responses occurred equally in a nutrient-rich and nutrient-poor soil layer, and commenced immediately at the start of the experiment when root densities were still low and soil nutrient concentrations high. Conclusions/Significance: Our results suggest that species may achieve competitive superiority for nutrients by root growth stimulation prior to nutrient depletion, induced by the presence of a competitor species, rather than by a better ability to compete for nutrients per se. The root overproduction by which interspecific neighbors are suppressed independent of nutrient acquisition is consistent with predictions from game theory. Our results emphasize that root competition may be driven by other mechanisms than is currently assumed. The long-term consequences of these mechanisms for community dynamics are discussed.	[Padilla, Francisco M.; Mommer, Liesje; de Caluwe, Hannie; Smit-Tiekstra, Annemiek E.; Wagemaker, Cornelis A. M.; Ouborg, N. Joop; de Kroon, Hans] Radboud Univ Nijmegen, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Mommer, Liesje] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Radboud University Nijmegen; Wageningen University & Research	Padilla, FM (corresponding author), Univ Almeria, Dept Agron, La Canada De San Urbano, Almeria, Spain.	f.padilla@ual.es	de Kroon, Hans/B-3359-2009; Mommer, Liesje/ABF-7005-2020; Wagemaker, C.A.M./N-6570-2018; Ouborg, Joop/C-1028-2011; Padilla, Francisco/C-5204-2009	de Kroon, Hans/0000-0001-6151-3561; Mommer, Liesje/0000-0002-3775-0716; Padilla, Francisco/0000-0003-1021-0258	Spanish Ministry of Education; Stipendium Bottelier (KNBV); Veni grant [016091116]	Spanish Ministry of Education(Spanish Government); Stipendium Bottelier (KNBV); Veni grant	F.M.P. was supported by a postdoc grant (Spanish Ministry of Education) and Stipendium Bottelier (KNBV), and L.M. by a Veni grant (016091116, NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bartelheimer M, 2006, PLANT SOIL, V280, P101, DOI 10.1007/s11104-005-2612-x; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; BERENDSE F, 1979, OECOLOGIA, V43, P19, DOI 10.1007/BF00346669; BERENDSE F, 1981, OECOLOGIA, V48, P334, DOI 10.1007/BF00346491; BERENDSE F, 1983, J ECOL, V71, P379, DOI 10.2307/2259721; Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Brassard BW, 2011, FUNCT ECOL, V25, P238, DOI 10.1111/j.1365-2435.2010.01769.x; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chen BJW, 2012, PLANT SCI, V195, P157, DOI 10.1016/j.plantsci.2012.07.006; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Craine JM, 2005, J ECOL, V93, P1041, DOI 10.1111/j.1365-2745.2005.01043.x; Craine JM, 2005, NEW PHYTOL, V166, P933, DOI 10.1111/j.1469-8137.2005.01386.x; Craine JM, 2006, PLANT SOIL, V285, P171, DOI 10.1007/s11104-006-9002-x; de Kroon H, 2007, SCIENCE, V318, P1562, DOI 10.1126/science.1150726; de Kroon H, 2012, J ECOL, V100, P6, DOI 10.1111/j.1365-2745.2011.01906.x; DE WIT C. T., 1960, Versl. landbouwkund. Onderzoek; Fargione J, 2006, FUNCT ECOL, V20, P533, DOI 10.1111/j.1365-2435.2006.01116.x; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; Goldberg D. E., 1990, Perspectives on plant competition., P27; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Grime J. P., 1994, EXPLOITATION ENV HET, P1; Hendriks M, 2013, J ECOLOGY IN PRESS; Inderjit, 2011, TRENDS ECOL EVOL, V26, P655, DOI 10.1016/j.tree.2011.08.003; Kulmatiski A, 2012, P ROY SOC B-BIOL SCI, V279, P3020, DOI 10.1098/rspb.2012.0285; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; MAHALL BE, 1992, ECOLOGY, V73, P2145, DOI 10.2307/1941462; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Mitchell CE, 2010, ECOL LETT, V13, P1525, DOI 10.1111/j.1461-0248.2010.01543.x; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mommer L, 2008, MOL ECOL RESOUR, V8, P947, DOI 10.1111/j.1755-0998.2008.02130.x; Mommer L, 2011, PLANT SOIL, V348, P115, DOI 10.1007/s11104-011-0962-0; Mommer L, 2010, J ECOL, V98, P1117, DOI 10.1111/j.1365-2745.2010.01702.x; O'Brien EE, 2005, NEW PHYTOL, V168, P401, DOI 10.1111/j.1469-8137.2005.01520.x; O'Brien EE, 2007, P ROY SOC B-BIOL SCI, V274, P929, DOI 10.1098/rspb.2006.0113; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Piper JK, 1998, AGR ECOSYST ENVIRON, V68, P1, DOI 10.1016/S0167-8809(97)00097-2; Polley HW, 2007, BASIC APPL ECOL, V8, P209, DOI 10.1016/j.baae.2006.02.006; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431, DOI 10.1098/rspb.1999.0656; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; Schenk HJ, 2006, J ECOL, V94, P725, DOI 10.1111/j.1365-2745.2006.01124.x; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Semchenko M, 2007, NEW PHYTOL, V176, P644, DOI 10.1111/j.1469-8137.2007.02211.x; Semchenko M, 2010, EVOL ECOL, V24, P1433, DOI 10.1007/s10682-010-9401-6; Tilman D., 1982, Monographs in Population Biology, pi; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; VANDENBERGH JP, 1970, J APPL ECOL, V7, P311, DOI 10.2307/2401382; Venterink HO, 2010, FUNCT ECOL, V24, P877, DOI 10.1111/j.1365-2435.2010.01692.x; von Felten S, 2012, ECOLOGY, V93, P2386, DOI 10.1890/11-1439.1; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180	62	57	61	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55805	10.1371/journal.pone.0055805	http://dx.doi.org/10.1371/journal.pone.0055805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383284	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600161
J	Zheng, LD; Qi, T; Yang, DH; Qi, M; Li, D; Xiang, X; Huang, K; Tong, QS				Zheng, Liduan; Qi, Teng; Yang, Dehua; Qi, Meng; Li, Dan; Xiang, Xuan; Huang, Kai; Tong, Qiangsong			microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1	PLOS ONE			English	Article							REGULATES E-CADHERIN; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; OVARIAN-CANCER; BREAST-CANCER; EXPRESSION; CARCINOMA; MIR-9; ADENOCARCINOMA; PROTOONCOGENE	Recent evidence shows that altered microRNA-9 (miR-9) expression is implicated in the progression of gastric cancer. However, the exact roles and underlying mechanisms of miR-9 in the proliferation, invasion and metastasis of gastric cancer still remain unknown. In this study, miR-9 was found to be down-regulated and inversely correlated with the expression of cyclin D1 and v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets1) in gastric cancer tissues and cell lines. Bioinformatics analysis revealed the putative miR-9 binding sites in the 3'-untranslated regions (3'-UTR) of cyclin D1 and Ets1 mRNA. Ectopic expression or knockdown of miR-9 resulted in responsively altered expression of cyclin D1, Ets1 and their downstream targets phosphorylated retinoblastoma and matrix metalloproteinase 9 in cultured gastric cancer cell lines SGC-7901 and AGS. In the luciferase reporter system, miR-9 directly targeted the 3'-UTR of cyclin D1 and Ets1, and these effects were abolished by mutating the miR-9 binding sites. Over-expression of miR-9 suppressed the proliferation, invasion, and metastasis of SGC-7901 and AGS cells in vitro and in vivo. Restoration of miR-9-mediated down-regulation of cyclin D1 and Ets1 by transient transfection, rescued the cancer cells from decrease in proliferation, migration and invasion. Furthermore, anti-miR-9 inhibitor promoted the proliferation, migration and invasion of gastric cancer cells, while knocking down of cyclin D1 or Ets1 partially phenocopied the effects of miR-9 over-expression. These data indicate that miR-9 suppresses the expression of cyclin D1 and Ets1 via the binding sites in their 3'-UTR, thus inhibiting the proliferation, invasion and metastasis of gastric cancer.	[Zheng, Liduan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, Wuhan 430074, Hubei Province, Peoples R China; [Zheng, Liduan; Huang, Kai; Tong, Qiangsong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Genom Res, Wuhan 430074, Hubei Province, Peoples R China; [Qi, Teng; Yang, Dehua; Qi, Meng; Li, Dan; Xiang, Xuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, Wuhan 430074, Hubei Province, Peoples R China; [Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tong, QS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Genom Res, Wuhan 430074, Hubei Province, Peoples R China.	qs_tong@hotmail.com	Tong, Qiangsong/B-4500-2014	Tong, Qiangsong/0000-0002-2615-6404; Zheng, Liduan/0000-0001-5566-673X	National Natural Science Foundation of China [30600278, 30772359, 81071997, 81072073, 81272779]; Program for New Century Excellent Talents in University [NCET-06-0641]; Scientific Research Foundation for the Returned Overseas Chinese Scholars [2008-889]; Fundamental Research Funds for the Central Universities [2012QN224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Supported by the National Natural Science Foundation of China (No. 30600278, No. 30772359, No. 81071997, No. 81072073, No. 81272779), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2012QN224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Endo K, 2006, HUM PATHOL, V37, P1111, DOI 10.1016/j.humpath.2006.03.020; Guo LM, 2009, FEBS J, V276, P5537, DOI 10.1111/j.1742-4658.2009.07237.x; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hsu PY, 2009, CANCER RES, V69, P5936, DOI 10.1158/0008-5472.CAN-08-4914; Inoue T, 2012, ONCOL REP, V27, P1759, DOI 10.3892/or.2012.1709; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Jiang GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031379; KATO J, 1993, GENE DEV, V7, P331; Ke Yang, 1994, Zhonghua Zhongliu Zazhi, V16, P7; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Liu SJ, 2012, J PATHOL, V226, P61, DOI 10.1002/path.2964; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Nakayama T, 2001, MODERN PATHOL, V14, P415, DOI 10.1038/modpathol.3880328; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Noguchi T, 2001, AM J CLIN PATHOL, V115, P828; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Rotkrua P, 2011, INT J CANCER, V129, P2611, DOI 10.1002/ijc.25923; Sahin A, 2005, INT J MOL MED, V15, P771; Saito Y, 2012, BIOCHEM BIOPH RES CO, V426, P33, DOI 10.1016/j.bbrc.2012.08.012; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Terry MB, 2002, SEMIN RADIAT ONCOL, V12, P111, DOI 10.1053/srao.30814; Tong OS, 2008, ANTI-CANCER DRUG, V19, P573, DOI 10.1097/CAD.0b013e3282fc46b0; Tsai KW, 2011, EPIGENETICS-US, V6, P1189, DOI 10.4161/epi.6.10.16535; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wan HY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-16; Wang HJ, 2010, EUR J CANCER, V46, P2295, DOI 10.1016/j.ejca.2010.05.012; Wang XT, 2012, WORLD J GASTROENTERO, V18, P1903, DOI 10.3748/wjg.v18.i16.1903; Wilting SM, 2013, ONCOGENE, V32, P106, DOI 10.1038/onc.2012.20; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Younger ST, 2011, NUCLEIC ACIDS RES, V39, P5682, DOI 10.1093/nar/gkr155; Yu Y, 2003, WORLD J GASTROENTERO, V9, P2154; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	50	144	152	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55719	10.1371/journal.pone.0055719	http://dx.doi.org/10.1371/journal.pone.0055719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383271	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600151
J	Joeng, KS; Long, FX				Joeng, Kyu Sang; Long, Fanxin			Constitutive Activation of Gli2 Impairs Bone Formation in Postnatal Growing Mice	PLOS ONE			English	Article							INDIAN-HEDGEHOG; CHONDROCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; ENDOCHONDRAL OSSIFICATION; GROWTH-PLATE; IHH; CARTILAGE; PROTEIN; PTHRP; PROLIFERATION	Indian hedgehog (Ihh) signaling is indispensable for osteoblast differentiation during endochondral bone development in the mouse embryo. We have previously shown that the Gli2 transcription activator critically mediates Ihh function in osteoblastogenesis. To explore the possibility that activation of Hedgehog (Hh) signaling may enhance bone formation, we generated mice that expressed a constitutively active form of Gli2 in the Osx-lineage cells. Unexpectedly, these mice exhibited severe osteopenia due to a marked decrease in osteoblast number and function, although bone resorption was not affected. Quantitative analyses of the molecular markers indicated that osteoblast differentiation was impaired in the mutant mouse. However, the osteoblast-lineage cells isolated from these mice exhibited more robust osteoblast differentiation than normal in vitro. Similarly, pharmacological stimulation of Hh signaling enhanced osteoblast differentiation from Osx-expressing cells isolated from the wild-type mouse. Thus, even though Hh signaling directly promotes osteoblast differentiation in vitro, constitutive activation of this pathway impairs bone formation in vivo, perhaps through an indirect mechanism.	[Joeng, Kyu Sang; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Joeng, Kyu Sang; Long, Fanxin] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	flong@wustl.edu			National Institutes of Health [R01 DK065789]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study is funded by National Institutes of Health R01 DK065789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Heller E, 2012, CANCER RES, V72, P897, DOI 10.1158/0008-5472.CAN-11-2681; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hilton MJ, 2007, DEV BIOL, V308, P93, DOI 10.1016/j.ydbio.2007.05.011; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kesper DA, 2010, DEV DYNAM, V239, P1818, DOI 10.1002/dvdy.22301; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Long FX, 2001, DEVELOPMENT, V128, P5099; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010	24	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55134	10.1371/journal.pone.0055134	http://dx.doi.org/10.1371/journal.pone.0055134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383082	gold, Green Published			2022-12-27	WOS:000315563800117
J	Kuhnen, CM; Samanez-Larkin, GR; Knutson, B				Kuhnen, Camelia M.; Samanez-Larkin, Gregory R.; Knutson, Brian			Serotonergic Genotypes, Neuroticism, and Financial Choices	PLOS ONE			English	Article							GENETIC-VARIATION; TESTOSTERONE; POLYMORPHISM; PERSONALITY; ASSOCIATION; DECISIONS; AGE	Life financial outcomes carry a significant heritable component, but the mechanisms by which genes influence financial choices remain unclear. Focusing on a polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR), we found that individuals possessing the short allele of this gene invested less in equities, were less engaged in actively making investment decisions, and had fewer credit lines. Short allele carriers also showed higher levels of the personality trait neuroticism, despite not differing from others with respect to cognitive skills, education, or wealth. Mediation analysis suggested that the presence of the 5-HTTLPR short allele decreased real life measures of financial risk taking through its influence on neuroticism. These findings show that 5-HTTLPR short allele carriers avoid risky and complex financial choices due to negative emotional reactions, and have implications for understanding and managing individual differences in financial choice.	[Kuhnen, Camelia M.] Northwestern Univ, Kellogg Sch Management, Dept Finance, Evanston, IL 60208 USA; [Samanez-Larkin, Gregory R.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Knutson, Brian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Northwestern University; Vanderbilt University; Stanford University	Kuhnen, CM (corresponding author), Northwestern Univ, Kellogg Sch Management, Dept Finance, Evanston, IL 60208 USA.	c-kuhnen@kellogg.northwestern.edu	Samanez-Larkin, Gregory/A-1139-2007	Samanez-Larkin, Gregory/0000-0001-7846-3804; Knutson, Brian/0000-0002-7669-426X	FINRA Investor Education Foundation; National Institute on Aging [AG030778]; Zell Center for Risk Research at the Kellogg School of Management; NATIONAL INSTITUTE ON AGING [F31AG032804, K99AG042596, R21AG030778] Funding Source: NIH RePORTER	FINRA Investor Education Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Zell Center for Risk Research at the Kellogg School of Management; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work received funding from the FINRA Investor Education Foundation, the National Institute on Aging (AG030778) and the Zell Center for Risk Research at the Kellogg School of Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, BROOKINGS PAP ECO AC, P51, DOI 10.1353/eca.0.0067; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Barnea A, 2010, J FINANC ECON, V98, P583, DOI 10.1016/j.jfineco.2010.08.001; Beauchamp JP, 2011, J ECON PERSPECT, V25, P57, DOI 10.1257/jep.25.4.57; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Brav A, 2005, J FINANC ECON, V77, P483, DOI 10.1016/j.jfineco.2004.07.004; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cesarini D, 2010, J FINANC, V65, P1725, DOI 10.1111/j.1540-6261.2010.01592.x; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Costa P.T., 1992, PSYCHOL ASSESSMENT, V4, P5, DOI [https://doi.org/10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5, 10.1037/1040-3590.4.1.5]; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; Cronqvist H, 2010, ORIGINS SAVINGS BEHA; De Neve JE, 2010, GENES EC HAPPINESS; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Frydman C, 2011, P ROY SOC B-BIOL SCI, V278, P2053, DOI 10.1098/rspb.2010.2304; Grinblatt M, J FINANCE IN PRESS; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; Knutson B, 1998, AM J PSYCHIAT, V155, P373, DOI 10.1176/ajp.155.3.373; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Knutson B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024390; Korniotis G, REV EC STAT IN PRESS; Kraus MW, 2009, J PERS SOC PSYCHOL, V97, P992, DOI 10.1037/a0016357; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kuhnen CM, 2011, J FINANC QUANT ANAL, V46, P605, DOI 10.1017/S0022109011000123; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Loewenstein G, 2003, SER AFFECTIVE SCI, P619; Malmendier U, J FINANCE IN PRESS; Malmendier U, 2011, Q J ECON, V126, P373, DOI 10.1093/qje/qjq004; Puri M, 2007, J FINANC ECON, V86, P7199; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Repin DV, 2005, AM ECON REV, V95; Roiser JP, 2009, J NEUROSCI, V29, P5985, DOI 10.1523/JNEUROSCI.0407-09.2009; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; Wechsler D., 1997, WECHSLER ADULT INTEL; WRIGHT WF, 1992, ORGAN BEHAV HUM DEC, V52, P276, DOI 10.1016/0749-5978(92)90039-A; Zethraeus N, 2009, P NATL ACAD SCI USA, V106, P6535, DOI 10.1073/pnas.0812757106; Zhong SF, 2009, P ROY SOC B-BIOL SCI, V276, P4181, DOI 10.1098/rspb.2009.1312	49	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54632	10.1371/journal.pone.0054632	http://dx.doi.org/10.1371/journal.pone.0054632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382929	Green Published, gold			2022-12-27	WOS:000315563800059
J	Liu, HB; Wu, Y; Lv, TF; Yao, YW; Xiao, YY; Yuan, DM; Song, Y				Liu, Hong-bing; Wu, Ying; Lv, Tang-feng; Yao, Yan-wen; Xiao, Yong-ying; Yuan, Dong-mei; Song, Yong			Skin Rash could Predict the Response to EGFR Tyrosine Kinase Inhibitor and the Prognosis for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							EXPANDED ACCESS PROGRAM; ERLOTINIB MONOTHERAPY; CUTANEOUS TOXICITIES; 2ND-LINE ERLOTINIB; PERFORMANCE STATUS; GEFITINIB ZD1839; CLINICAL-TRIALS; PHASE-III; EFFICACY; CHEMOTHERAPY	Background: The aim of this study was to assess the role of skin rash in predicting the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and the prognosis of patients with non-small cell lung cancer (NSCLC). Method: We systematically searched for eligible articles investigating the association between rash and the efficacy of EGFR-TKIs and the prognosis of patients with NSCLC. The summary risk ratio (RR) and hazard ratio (HR) were calculated using meta-analysis. Results: We identified 33 eligible trials involving 6,798 patients. We used two different standards to group the patients [standard 1: rash vs. no rash, standard 2: rash (>= stage 2) vs. rash (stage 0, 1)]. For standard 1, the objective response rate (ORR) and disease control rate (DCR) of the rash group were significantly higher than the no rash group [RR = 3.28; 95% CI: 2.41-4.47(corrected RR = 2.225, 95% CI: 1.658-2.986); RR = 1.96, 95% CI: 1.58-2.43]. The same results were observed for standard 2. For standards 1 and 2, the progression-free survival (PFS) (HR = 0.45, 95% CI: 0.37-0.53; HR = 0.57, 95% CI: 0.50-0.65) and overall survival (OS) (HR = 0.40, 95% CI: 0.28-0.52; HR = 0.53, 95% CI: 0.35-0.71) of the rash group were significantly longer than the control group, and the same results were observed in the subgroup analysis. Conclusions: skin rash after EGFR-TKI treatment may be an efficient clinical marker for predicting the response of patients with NSCLC to EGFR-TKIs. Furthermore, skin rash is also the prognostic factor of patients with NSCLC. Patients with skin rash have a longer PFS and OS.	[Liu, Hong-bing; Lv, Tang-feng; Yao, Yan-wen; Xiao, Yong-ying; Yuan, Dong-mei; Song, Yong] Nanjing Univ, Sch Med, Jinling Hosp, Resp Dept, Nanjing, Jiangsu, Peoples R China; [Wu, Ying] Jiangsu Prov Geriatr Hosp, Jiangsu Prov Geriatr Inst, Dept Resp Med, Nanjing, Jiangsu, Peoples R China	Nanjing University	Song, Y (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Resp Dept, Nanjing, Jiangsu, Peoples R China.	yong_song6310@yahoo.com			National Natural Science Foundation of China [81170064]; Natural Science Foundation of Jiangsu Province [BK2011658]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (NO. 81170064) and the Natural Science Foundation of Jiangsu Province (NO. BK2011658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2006, J THORAC ONCOL, V1, P52, DOI 10.1097/01243894-200601000-00011; Cadranel J, 2009, J THORAC ONCOL, V4, P1126, DOI 10.1097/JTO.0b013e3181abeb5d; Cedres S, 2009, LUNG CANCER, V66, P257, DOI 10.1016/j.lungcan.2009.01.014; Chen XF, 2011, BIOMED PHARMACOTHER, V65, P542, DOI 10.1016/j.biopha.2011.04.017; Chiu CH, 2005, LUNG CANCER, V47, P129, DOI 10.1016/j.lungcan.2004.05.014; Dahabreh IJ, 2010, CLIN CANCER RES, V16, P291, DOI 10.1158/1078-0432.CCR-09-1660; Dudek AZ, 2006, LUNG CANCER, V51, P89, DOI 10.1016/j.lungcan.2005.09.002; Faehling M, 2010, ONCOLOGY-BASEL, V78, P249, DOI 10.1159/000315731; Gao GH, 2012, INT J CANCER, V131, pE822, DOI 10.1002/ijc.27396; Hata A, 2011, JPN J CLIN ONCOL, V41, P1366, DOI 10.1093/jjco/hyr159; Heigener DF, 2011, LUNG CANCER, V74, P274, DOI 10.1016/j.lungcan.2011.02.017; Jackman DM, 2007, J CLIN ONCOL, V25, P760, DOI 10.1200/JCO.2006.07.5754; Janne PA, 2004, LUNG CANCER-J IASLC, V44, P221, DOI 10.1016/j.lungcan.2003.12.014; Johnson JR, 2005, CLIN CANCER RES, V11, P6414, DOI 10.1158/1078-0432.CCR-05-0790; Joshi SS, 2010, CANCER-AM CANCER SOC, V116, P3916, DOI 10.1002/cncr.25090; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lara-Guerra H, 2009, J CLIN ONCOL, V27, P6229, DOI 10.1200/JCO.2009.22.3370; Lee Y, 2012, CLIN CANCER RES, V18, P1760, DOI 10.1158/1078-0432.CCR-11-2582; Li TH, 2009, TARGET ONCOL, V4, P107, DOI 10.1007/s11523-009-0114-0; Liam CK, 2006, RESPIROLOGY, V11, P287, DOI 10.1111/j.1440-1843.2006.00840.x; Lilenbaum R, 2008, J CLIN ONCOL, V26, P863, DOI 10.1200/JCO.2007.13.2720; Lynch TJ, 2007, ONCOLOGIST, V12, P610, DOI 10.1634/theoncologist.12-5-610; Mazzoni F, 2011, TUMORI J, V97, P160, DOI 10.1700/667.7777; Melosky B, 2008, CURR ONCOL, V15, P279; Mita AC, 2011, BRIT J CANCER, V105, P938, DOI 10.1038/bjc.2011.332; Mohamed MK, 2005, ANN ONCOL, V16, P780, DOI 10.1093/annonc/mdi157; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; NANNEY LB, 1990, J INVEST DERMATOL, V94, P742, DOI 10.1111/1523-1747.ep12874601; Park J, 2004, CLIN CANCER RES, V10, P4383, DOI 10.1158/1078-0432.CCR-04-0189; Perez-Soler R, 2005, ONCOLOGIST, V10, P345, DOI 10.1634/theoncologist.10-5-345; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Perez-Soler R, 2011, CLIN CANCER RES, V17, P6766, DOI 10.1158/1078-0432.CCR-11-0545; Perng RP, 2008, LUNG CANCER, V62, P78, DOI 10.1016/j.lungcan.2008.02.023; Petrelli F, 2012, CLIN LUNG CANCER, V13, P107, DOI 10.1016/j.cllc.2011.08.005; Pircher A, 2011, ANTICANCER RES, V31, P2949; Platania M, 2011, TARGET ONCOL, V6, P181, DOI 10.1007/s11523-011-0185-6; Surguladze D, 2009, CANCER RES, V69, P5643, DOI 10.1158/0008-5472.CAN-09-0487; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tiseo M, 2010, LUNG CANCER, V67, P355, DOI 10.1016/j.lungcan.2009.04.021; Tiseo M, 2009, LUNG CANCER, V64, P199, DOI 10.1016/j.lungcan.2008.09.001; Uhm JE, 2009, J THORAC ONCOL, V4, P1136, DOI 10.1097/JTO.0b013e3181b270a7; Veronese ML, 2005, CANCER INVEST, V23, P296, DOI 10.1081/CNV-200061528; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; West HL, 2006, J CLIN ONCOL, V24, P1807, DOI 10.1200/JCO.2005.04.9890; Wong S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e13647; Zhou SW, 2009, RESPIROLOGY, V14, P709, DOI 10.1111/j.1440-1843.2009.01564.x; Zhu YJ, 2010, CHINESE MED J-PEKING, V123, P3200, DOI 10.3760/cma.j.issn.0366-6999.2010.22.005	49	86	93	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55128	10.1371/journal.pone.0055128	http://dx.doi.org/10.1371/journal.pone.0055128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383079	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800115
J	Wang, J; Chen, YL; Gao, N; Wang, YS; Tian, YP; Wu, JM; Zhang, JL; Zhu, JP; Fan, DY; An, J				Wang, Juan; Chen, Yanlei; Gao, Na; Wang, Yisong; Tian, Yanping; Wu, Jiangman; Zhang, Junlei; Zhu, Junping; Fan, Dongying; An, Jing			Inhibitory Effect of Glutathione on Oxidative Liver Injury Induced by Dengue Virus Serotype 2 Infections in Mice	PLOS ONE			English	Article							INFLUENZA-A VIRUS; INDUCED LETHAL DISEASE; N-ACETYLCYSTEINE; MOUSE MODEL; REDUCED GLUTATHIONE; HIV-INFECTION; IN-VITRO; REPLICATION; CELLS; GSH	The pathogenesis of dengue virus (DV) infection has not been completely defined and change of redox status mediated by depletion of glutathione (GSH) in host cell is a common result of viral infection. Our previous study has demonstrated that DV serotype 2 (DV2) infection alters host intracellular GSH levels, and exogenous GSH inhibits viral production by modulating the activity of NF-kappa B in HepG2 cells. GSH is the most powerful intracellular antioxidant and involved in viral infections. Thus, this study was to investigate whether DV2 infection can induce alteration in redox balance and effect of GSH on the disease in HepG2 xenografts SCID mice. Our results revealed that mice infected with DV2 showed alterations in oxidative stress by increasing the level of malondialdehyde (MDA), an end product of lipid peroxidation, and GSSG/GSH ratio. DV2-infected mice also showed a decrease in the activity of catalase (CAT) and total superoxide dismutase (T-SOD) in the serum and/or observed organs, especially the liver. Moreover, DV2 infection resulted in elevated serum levels of the cytokines tumor necrosis factor-alpha and interlukin-6 and obvious histopathological changes in the liver. The administration of exogenous GSH significantly reversed all of the aforementioned pathological changes and prevented significant liver damage. Furthermore, in vitro treatment of HepG2 cells with antioxidants such as GSH inhibited viral entry as well as the production of reactive oxygen species in HepG2 cells. These results suggest that GSH prevents DV2-induced oxidative stress and liver injury in mice by inhibiting proinflammatory cytokine production, and GSH and may be a promising therapeutic agent for prevention of oxidative liver damage during DV infection.	[Wang, Juan; Chen, Yanlei; Gao, Na; Wang, Yisong; Wu, Jiangman; Zhu, Junping; Fan, Dongying; An, Jing] Capital Med Univ, Dept Microbiol, Sch Basic Med Sci, Beijing, Peoples R China; [Tian, Yanping; Zhang, Junlei] Third Mil Med Univ, Dept Histol & Embryol, Chongqing, Peoples R China	Capital Medical University; Army Medical University	An, J (corresponding author), Capital Med Univ, Dept Microbiol, Sch Basic Med Sci, Beijing, Peoples R China.	anjing@ccmu.edu.cn			National Key Programs on Basic Research of China [2011CB504703]; National Natural Science Foundation of China [81271839, 30800983]; Funding Project of Beijing Municipal Commission of Education [SQKM201210025005]; Military Major Project [BWS11]	National Key Programs on Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project of Beijing Municipal Commission of Education; Military Major Project	This work was supported by grants from the National Key Programs on Basic Research of China (2011CB504703, http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (81271839, 30800983, http://www.nsfc.gov.cn/), Funding Project of Beijing Municipal Commission of Education (SQKM201210025005, http://www.bjedu.gov.cn/) and the Military Major Project(BWS11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Coaccioli S, 2010, CLIN TER, V161, P55; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; De Rosa SC, 2000, EUR J CLIN INVEST, V30, P915, DOI 10.1046/j.1365-2362.2000.00736.x; Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090; DROGE W, 1994, FASEB J, V8, P1131; Fierbinteanu-Braticevici C, 2009, ROM J MORPHOL EMBRYO, V50, P407; Fraternale A, 2009, MOL ASPECTS MED, V30, P99, DOI 10.1016/j.mam.2008.09.001; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Garaci E, 1997, J LEUKOCYTE BIOL, V62, P54, DOI 10.1002/jlb.62.1.54; Geiler J, 2010, BIOCHEM PHARMACOL, V79, P413, DOI 10.1016/j.bcp.2009.08.025; Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652; HENNET T, 1992, J GEN VIROL, V73, P39, DOI 10.1099/0022-1317-73-1-39; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A; Mahmuduzzaman M, 2011, Mymensingh Med J, V20, P349; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Palamara AT, 1996, AIDS RES HUM RETROV, V12, P1373, DOI 10.1089/aid.1996.12.1373; PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A; Papi A, 2008, J BIOL CHEM, V283, P28595, DOI 10.1074/jbc.M805766200; Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; SCHOLZ RW, 1989, ANN NY ACAD SCI, V570, P514; Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; SMITH JA, 1993, J IMMUNOL METHODS, V162, P261, DOI 10.1016/0022-1759(93)90391-J; Suliman HB, 2001, AM J PHYSIOL-LUNG C, V280, pL69, DOI 10.1152/ajplung.2001.280.1.L69; Tian YP, 2010, BIOCHEM BIOPH RES CO, V397, P420, DOI 10.1016/j.bbrc.2010.05.108; Treitinger Aricio, 2004, Braz J Infect Dis, V8, P363, DOI 10.1590/S1413-86702004000500005; Ungheri D, 2000, INT J IMMUNOPATH PH, V13, P123; World Health Organization, 2012, DENGUE DENGUE HEMORR; YOSHIOKA T, 1979, AM J OBSTET GYNECOL, V135, P372, DOI 10.1016/0002-9378(79)90708-7	41	53	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55407	10.1371/journal.pone.0055407	http://dx.doi.org/10.1371/journal.pone.0055407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383181	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800150
J	Koh, GCKW; Schreiber, MF; Bautista, R; Maude, RR; Dunachie, S; Limmathurotsakul, D; Day, NPJ; Dougan, G; Peacock, SJ				Koh, Gavin C. K. W.; Schreiber, M. Fernanda; Bautista, Ruben; Maude, Rapeephan R.; Dunachie, Susanna; Limmathurotsakul, Direk; Day, Nicholas P. J.; Dougan, Gordon; Peacock, Sharon J.			Host Responses to Melioidosis and Tuberculosis Are Both Dominated by Interferon-Mediated Signaling	PLOS ONE			English	Article							RECOGNITION; BEADARRAY; SIGNATURE; INFECTION; INSIGHTS; DATABASE; GAMMA; MICE; CD14	Melioidosis (Burkholderia pseudomallei infection) is a common cause of community-acquired sepsis in Northeast Thailand and northern Australia. B. pseudomallei is a soil saprophyte endemic to Southeast Asia and northern Australia. The clinical presentation of melioidosis may mimic tuberculosis (both cause chronic suppurative lesions unresponsive to conventional antibiotics and both commonly affect the lungs). The two diseases have overlapping risk profiles (e.g., diabetes, corticosteroid use), and both B. pseudomallei and Mycobacterium tuberculosis are intracellular pathogens. There are however important differences: the majority of melioidosis cases are acute, not chronic, and present with severe sepsis and a mortality rate that approaches 50% despite appropriate antimicrobial therapy. By contrast, tuberculosis is characteristically a chronic illness with mortality <2% with appropriate antimicrobial chemotherapy. We examined the gene expression profiles of total peripheral leukocytes in two cohorts of patients, one with acute melioidosis (30 patients and 30 controls) and another with tuberculosis (20 patients and 24 controls). Interferon-mediated responses dominate the host response to both infections, and both type 1 and type 2 interferon responses are important. An 86-gene signature previously thought to be specific for tuberculosis is also found in melioidosis. We conclude that the host responses to melioidosis and to tuberculosis are similar: both are dominated by interferon-signalling pathways and this similarity means gene expression signatures from whole blood do not distinguish between these two diseases.	[Koh, Gavin C. K. W.; Schreiber, M. Fernanda; Bautista, Ruben; Dougan, Gordon; Peacock, Sharon J.] Wellcome Trust Sanger Inst, Cambridge, England; [Koh, Gavin C. K. W.; Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Koh, Gavin C. K. W.; Maude, Rapeephan R.; Dunachie, Susanna; Limmathurotsakul, Direk; Day, Nicholas P. J.; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Koh, Gavin C. K. W.] Birmingham Heartlands Hosp, Dept Infect & Trop Dis, Birmingham B9 5ST, W Midlands, England; [Peacock, Sharon J.] Mahidol Univ, Dept Microbiol, Bangkok 10700, Thailand	Wellcome Trust Sanger Institute; University of Cambridge; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Heart of England NHS Foundation Trust; University of Birmingham; Mahidol University	Koh, GCKW (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	gavin.koh@gmail.com	Maude, Rapeephan/AHB-3558-2022; Peacock, Sharon J/ABE-6331-2020	Dunachie, Susanna/0000-0001-5665-6293; Peacock, Sharon/0000-0002-1718-2782; Koh, Gavin/0000-0002-7336-1566; Maude, Rapeephan/0000-0002-3383-3629; Limmathurotsakul, Direk/0000-0001-7240-5320	Wellcome Trust of Great Britain [086532/Z/08/Z, 089275/Z/09/Z]; NIHR Cambridge Biomedical Research Centre; National Institute for Health Research [CL-2008-13-010] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Wellcome Trust of Great Britain (grants 086532/Z/08/Z and 089275/Z/09/Z, www.wellcome.ac.uk). SJP is supported by the NIHR Cambridge Biomedical Research Centre (www.cambridge-brc.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Breitbach K, 2009, INFECT IMMUN; Brewer C. A., 2003, CARTOGR GEOGR INF SC, V30, P5, DOI [10.1559/152304003100010929, DOI 10.1559/152304003100010929]; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Cairns JM, 2008, BIOINFORMATICS, V24, P2921, DOI 10.1093/bioinformatics/btn557; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Chierakul W, 2005, AM J TROP MED HYG, V73, P1165, DOI 10.4269/ajtmh.2005.73.1165; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gutierrez O, 2004, FEBS LETT, V568, P79, DOI 10.1016/j.febslet.2004.04.095; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hebenstreit D, CYTOKINE GROWTH FACT, V17, P173; Jung ID, 2011, CANCER RES, V71, P2858, DOI 10.1158/0008-5472.CAN-10-3487; Khoo JJ, 2011, J INTERF CYTOK RES, V31, P13, DOI 10.1089/jir.2010.0095; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Koh GCKW, 2011, CLIN INFECT DIS, V52, P717, DOI 10.1093/cid/ciq192; Koh GCKW, 2010, ANTIMICROB AGENTS CH, V54, P4520, DOI 10.1128/AAC.00805-10; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Neuwirth E, 2007, RCOLORBREWER COLORBR; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Propst KL, 2010, ANTIMICROB AGENTS CH, V54, P1785, DOI 10.1128/AAC.01513-09; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V136, P277, DOI 10.1111/j.1365-2249.2004.02445.x; WARNES GR, 2010, GPLOTS VARIOUS R PRO; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53	44	73	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54961	10.1371/journal.pone.0054961	http://dx.doi.org/10.1371/journal.pone.0054961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383015	gold, Green Published			2022-12-27	WOS:000315483200033
J	Pruvost, I; Dubos, F; Chazard, E; Hue, V; Duhamel, A; Martinot, A				Pruvost, Isabelle; Dubos, Francois; Chazard, Emmanuel; Hue, Valerie; Duhamel, Alain; Martinot, Alain			The Value of Body Weight Measurement to Assess Dehydration in Children	PLOS ONE			English	Article							ROTAVIRUS DISEASE; CLINICAL SIGNS; MANAGEMENT	Dehydration secondary to gastroenteritis is one of the most common reasons for office visits and hospital admissions. The indicator most commonly used to estimate dehydration status is acute weight loss. Post-illness weight gain is considered as the gold-standard to determine the true level of dehydration and is widely used to estimate weight loss in research. To determine the value of post-illness weight gain as a gold standard for acute dehydration, we conducted a prospective cohort study in which 293 children, aged 1 month to 2 years, with acute diarrhea were followed for 7 days during a 3-year period. The main outcome measures were an accurate pre-illness weight (if available within 8 days before the diarrhea), post-illness weight, and theoretical weight (predicted from the child's individual growth chart). Post-illness weight was measured for 231 (79%) and both theoretical and post-illness weights were obtained for 111 (39%). Only 62 (21%) had an accurate pre-illness weight. The correlation between post-illness and theoretical weight was excellent (0.978), but bootstrapped linear regression analysis showed that post-illness weight underestimated theoretical weight by 0.48 kg (95% CI: 0.06-0.79, p<0.02). The mean difference in the fluid deficit calculated was 4.0% of body weight (95% CI: 3.2-4.7, p<0.0001). Theoretical weight overestimated accurate pre-illness weight by 0.21 kg (95% CI: 0.08-0.34, p = 0.002). Postillness weight underestimated pre-illness weight by 0.19 kg (95% CI: 0.03-0.36, p = 0.02). The prevalence of 5% dehydration according to post-illness weight (21%) was significantly lower than the prevalence estimated by either theoretical weight (60%) or clinical assessment (66%, p<0.0001). These data suggest that post-illness weight is of little value as a gold standard to determine the true level of dehydration. The performance of dehydration signs or scales determined by using post-illness weight as a gold standard has to be reconsidered.	[Pruvost, Isabelle; Dubos, Francois; Duhamel, Alain; Martinot, Alain] Univ Lille Nord France, UDSL, Lille, France; [Dubos, Francois; Duhamel, Alain; Martinot, Alain] Publ Hlth Epidemiol & Qual Care EA2694, Lille, France; [Pruvost, Isabelle; Dubos, Francois; Hue, Valerie; Martinot, Alain] CHU Lille, Paediat Emergency & Infect Dis Unit, F-59037 Lille, France; [Chazard, Emmanuel; Duhamel, Alain] CHU Lille, Dept Biostat, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Martinot, A (corresponding author), Univ Lille Nord France, UDSL, Lille, France.	alain.martinot@chru-lille.fr	Duhamel, Alain/A-4899-2013; Martinot, Alain/M-6780-2016; Dubos, Francois/AGD-5638-2022	Martinot, Alain/0000-0002-2146-8273; dubos, francois/0000-0003-2151-1638	Sanofi-Pasteur MSD pharmaceuticals, France	Sanofi-Pasteur MSD pharmaceuticals, France	The study was supported by grants from Sanofi-Pasteur MSD pharmaceuticals, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Duggan C, 1996, J PEDIATR GASTR NUTR, V22, P56, DOI 10.1097/00005176-199601000-00009; Frifdman JN, 2004, J PEDIATR-US, V145, P201, DOI 10.1016/j.jpeds.2004.05.035; GLASS RI, 1991, J PEDIATR-US, V118, pS27, DOI 10.1016/S0022-3476(05)81422-2; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, pS81, DOI 10.1097/MPG.0b013e31816f7b16; MACKENZIE A, 1989, LANCET, V2, P605; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Porter SC, 2003, ANN EMERG MED, V41, P196, DOI 10.1067/mem.2003.5; SAAVEDRA JM, 1991, AM J DIS CHILD, V145, P296, DOI 10.1001/archpedi.1991.02160030064022; Soriano-Gabarro M, 2006, PEDIATR INFECT DIS J, V25, pS7, DOI 10.1097/01.inf.0000197622.98559.01; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; Teach SJ, 1997, CLIN PEDIATR, V36, P395, DOI 10.1177/000992289703600703; Vega RM, 1997, PEDIATR EMERG CARE, V13, P179, DOI 10.1097/00006565-199706000-00001; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Yilmaz K, 2002, J PAEDIATR CHILD H, V38, P226, DOI 10.1046/j.1440-1754.2002.00792.x	17	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55063	10.1371/journal.pone.0055063	http://dx.doi.org/10.1371/journal.pone.0055063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383058	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200031
J	McCarthy, JM; Franke, M; Resenberger, UK; Waldron, S; Simpson, JC; Tatzelt, J; Appelhans, D; Rogers, MS				McCarthy, James M.; Franke, Markus; Resenberger, Ulrike K.; Waldron, Sibeal; Simpson, Jeremy C.; Tatzelt, Joerg; Appelhans, Dietmar; Rogers, Mark S.			Anti- Prion Drug mPPIg5 Inhibits PrPC Conversion to PrPSc	PLOS ONE			English	Article							BRANCHED POLYAMINES; AMYLOID PEPTIDES; DENDRIMERS; PROTEIN; ACCUMULATION; AGGREGATION; ALZHEIMERS; VESICLES	Prion diseases, also known as transmissible spongiform encephalopathies, are a group of fatal neurodegenerative diseases that include scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle and Creutzfeldt-Jakob disease (CJD) in humans. The 'protein only hypothesis' advocates that PrPSc, an abnormal isoform of the cellular protein PrPC, is the main and possibly sole component of prion infectious agents. Currently, no effective therapy exists for these diseases at the symptomatic phase for either humans or animals, though a number of compounds have demonstrated the ability to eliminate PrPSc in cell culture models. Of particular interest are synthetic polymers known as dendrimers which possess the unique ability to eliminate PrPSc in both an intracellular and in vitro setting. The efficacy and mode of action of the novel anti-prion dendrimer mPPIg5 was investigated through the creation of a number of innovative bio-assays based upon the scrapie cell assay. These assays were used to demonstrate that mPPIg5 is a highly effective anti-prion drug which acts, at least in part, through the inhibition of PrPC to PrPSc conversion. Understanding how a drug works is a vital component in maximising its performance. By establishing the efficacy and method of action of mPPIg5, this study will help determine which drugs are most likely to enhance this effect and also aid the design of dendrimers with anti-prion capabilities for the future.	[McCarthy, James M.; Waldron, Sibeal; Simpson, Jeremy C.; Rogers, Mark S.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Franke, Markus; Appelhans, Dietmar] Leibniz Inst Polymer Res Dresden, Dresden, Germany; [Resenberger, Ulrike K.; Tatzelt, Joerg] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Tatzelt, Joerg] German Ctr Neurodegenerat Dis DZNE, Munich, Germany	University College Dublin; Leibniz Institut fur Polymerforschung Dresden; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	McCarthy, JM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	jim.mccarthy@ucd.ie	Rogers, Mark/M-4524-2013	Rogers, Mark/0000-0002-5288-0295; Simpson, Jeremy/0000-0002-7956-7805; Tatzelt, Jorg/0000-0001-5017-5528	University College Dublin; Irish Research Council for Science, Engineering & Technology (IRCSET); European Union [COST TD0802, FOOD-CT-2004-506579]; Irish Department of Agriculture, Food and Rural Development [FIRM 01-RD-D-160]; Saxon Ministry for Science and Art; German Ministry for Education and Science; DFG [SFB 596]	University College Dublin; Irish Research Council for Science, Engineering & Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); European Union(European Commission); Irish Department of Agriculture, Food and Rural Development; Saxon Ministry for Science and Art; German Ministry for Education and Science; DFG(German Research Foundation (DFG))	This work was supported by funding from University College Dublin, the Irish Research Council for Science, Engineering & Technology (IRCSET) the European Union (Dendrimers in Biomedical Applications - COST TD0802, Neuroprion - FOOD-CT-2004-506579), the Irish Department of Agriculture, Food and Rural Development (FIRM 01-R&D-D-160), the Saxon Ministry for Science and Art and The German Ministry for Education and Science, as well as the DFG SFB 596 (to Jorg Tatzelt and Ulrike K. Resenberger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Fischer M, 2010, BIOMACROMOLECULES, V11, P1314, DOI 10.1021/bm100101s; Ghaemmaghami S, 2010, J BIOL CHEM, V285, P10415, DOI 10.1074/jbc.M109.045112; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Heegaard PMH, 2007, MACROMOL BIOSCI, V7, P1047, DOI 10.1002/mabi.200700051; Heegaard PMH, 2004, FEBS LETT, V577, P127, DOI 10.1016/j.febslet.2004.09.073; Janaszewska A, 2012, NEW J CHEM, V36, P350, DOI 10.1039/c1nj20444k; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Klajnert B, 2006, BIOMACROMOLECULES, V7, P2186, DOI 10.1021/bm060229s; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V345, P21, DOI 10.1016/j.bbrc.2006.04.041; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V339, P577, DOI 10.1016/j.bbrc.2005.11.053; Klajnert B, 2008, CHEM-EUR J, V14, P7030, DOI 10.1002/chem.200800342; Klajnert B, 2007, BIOCHEM BIOPH RES CO, V364, P20, DOI 10.1016/j.bbrc.2007.09.083; Klajnert B, 2007, MACROMOL BIOSCI, V7, P1065, DOI 10.1002/mabi.200700049; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lim YB, 2010, BIOMATERIALS, V31, P2025, DOI 10.1016/j.biomaterials.2009.11.085; Masel J, 2000, BIOPHYS CHEM, V88, P47, DOI 10.1016/S0301-4622(00)00197-6; MCKINLEY MP, 1991, LAB INVEST, V65, P622; Miesbauer M, 2009, J BIOL CHEM, V284, P24384, DOI 10.1074/jbc.M109.023135; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Nishina KA, 2007, ANAL BIOCHEM, V363, P318, DOI 10.1016/j.ab.2007.01.032; Perez AP, 2011, INT J NANOMED, V6, P2715, DOI 10.2147/IJN.S25235; Pless DD, 1996, J CELL BIOCHEM, V62, P27, DOI 10.1002/(SICI)1097-4644(199607)62:1<27::AID-JCB4>3.0.CO;2-3; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Solassol J, 2004, J GEN VIROL, V85, P1791, DOI 10.1099/vir.0.19726-0; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Waldron S, 2008, THESIS U COLL DUBLIN; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Yam AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009316	42	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55282	10.1371/journal.pone.0055282	http://dx.doi.org/10.1371/journal.pone.0055282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383136	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500071
J	Calzone, FJ; Cajulis, E; Chung, YA; Tsai, MM; Mitchell, P; Lu, J; Chen, C; Sun, JL; Radinsky, R; Kendall, R; Beltran, PJ				Calzone, Frank J.; Cajulis, Elaina; Chung, Young-Ah; Tsai, Mei-Mei; Mitchell, Petia; Lu, John; Chen, Ching; Sun, Jilin; Radinsky, Robert; Kendall, Richard; Beltran, Pedro J.			Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODIES; I RECEPTOR; INSULIN-RECEPTOR; DEGRADATION; BINDING; CANCER; SIGNAL; CELLS	Background: Therapeutic antibodies targeting the IGF1R have shown diverse efficacy and safety signals in oncology clinical trials. The success of these agents as future human therapeutics depends on understanding the specific mechanisms by which these antibodies target IGF1R signaling. Methodology/Principal Findings: A panel of well-characterized assays was used to investigate the mechanisms by which ganitumab, a fully human anti-IGF1R antibody undergoing clinical testing, inhibits IGF1R activity. Epitope mapping using IGF1R subdomains localized the ganitumab binding site to the L2 domain. Binding of ganitumab inhibited the high-affinity interaction of IGF-1 and IGF-2 required to activate IGF1R in cells engineered for IGF1R hypersensitivity and in human cancer cell lines, resulting in complete blockade of ligand-induced cellular proliferation. Inhibition of IGF1R activity by ganitumab did not depend on endosomal sequestration, since efficient ligand blockade was obtained without evidence of receptor internalization and degradation. Clinically relevant concentrations of ganitumab also inhibited the activation of hybrid receptors by IGF-1 and IGF-2. Ganitumab was not an agonist of homodimeric IGF1R or hybrid receptors in MCF-7 and COLO 205 cells, but low-level IGF1R activation was detected in cells engineered for IGF1R hypersensitivity. This activation seems biologically irrelevant since ganitumab completely inhibited ligand-driven proliferation. The in vivo efficacy profile of ganitumab was equivalent or better than CR and FnIII-1 domain-specific antibodies, alone or in combination with irinotecan. CR domain-specific antibodies only blocked IGF-1 binding to IGF1R but were more potent than ganitumab at inducing homodimer and hybrid receptor downregulation in vitro, however this difference was less obvious in vivo. No inhibition of hybrid receptors was observed with the FnIII-1 domain antibodies, which were relatively strong homodimer and hybrid agonists. Conclusions/Significance: The safety and efficacy profile of ganitumab and other anti-IGF1R antibodies may be explained by the distinct molecular mechanisms by which they inhibit receptor signaling.	[Calzone, Frank J.; Cajulis, Elaina; Chung, Young-Ah; Mitchell, Petia; Radinsky, Robert; Kendall, Richard; Beltran, Pedro J.] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA; [Tsai, Mei-Mei] Amgen Inc, Biol Discovery, Thousand Oaks, CA 91320 USA; [Lu, John] Amgen Inc, Metab Disorders, Thousand Oaks, CA 91320 USA; [Chen, Ching] Amgen Inc, Biol Optimizat, Thousand Oaks, CA 91320 USA; [Sun, Jilin] Amgen Inc, Clin Immunol, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen; Amgen	Beltran, PJ (corresponding author), Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA.	pbeltran@amgen.com						Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Baserga Renato, 1998, P269; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Belleudi F, 2012, CELL CYCLE, V11, P1455, DOI 10.4161/cc.19861; Beltran PJ, 2011, J PHARMACOL EXP THER, V337, P644, DOI 10.1124/jpet.110.178400; Beltran PJ, 2007, P 19 INT EORTC NCI A, pA67; Beltran PJ, 2009, MOL CANC THERAPEUTIC; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Doern A, 2009, J BIOL CHEM, V284, P10254, DOI 10.1074/jbc.M809709200; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hailey J, 2002, MOL CANCER THER, V1, P1349; Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; KULL FC, 1983, J BIOL CHEM, V258, P6561; Mazot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033581; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Rosen LS, 2012, CLIN CANC RES; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Martins AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019846; SOOS MA, 1992, J BIOL CHEM, V267, P12955; STEELEPERKINS G, 1990, BIOCHEM BIOPH RES CO, V171, P1244, DOI 10.1016/0006-291X(90)90819-9; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; XIONG LM, 1992, P NATL ACAD SCI USA, V89, P5356, DOI 10.1073/pnas.89.12.5356; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258	32	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55135	10.1371/journal.pone.0055135	http://dx.doi.org/10.1371/journal.pone.0055135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383308	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900015
J	Freudenburg, W; Gautam, M; Chakraborty, P; James, J; Richards, J; Salvatori, AS; Baldwin, A; Schriewer, J; Buller, RML; Corbett, JA; Skowyra, D				Freudenburg, Wieke; Gautam, Madhav; Chakraborty, Pradipta; James, Jared; Richards, Jennifer; Salvatori, Alison S.; Baldwin, Aaron; Schriewer, Jill; Buller, R. Mark L.; Corbett, John A.; Skowyra, Dorota			Reduction in ATP Levels Triggers Immunoproteasome Activation by the 11S (PA28) Regulator during Early Antiviral Response Mediated by IFN beta in Mouse Pancreatic beta-Cells (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							DOUBLE-STRANDED RNA; INTERFERON-GAMMA; PROTEASOME SYSTEM; 26S PROTEASOMES; POTENTIAL ROLE; T-CELLS; EXPRESSION; GENES; INDUCTION; ALPHA	Autoimmune destruction of insulin producing pancreatic beta-cells is the hallmark of type I diabetes. One of the key molecules implicated in the disease onset is the immunoproteasome, a protease with multiple proteolytic sites that collaborates with the constitutive 19S and the inducible 11S (PA28) activators to produce immunogenic peptides for presentation by MHC class I molecules. Despite its importance, little is known about the function and regulation of the immunoproteasome in pancreatic beta-cells. Of special interest to immunoproteasome activation in beta-cells are the effects of IFN beta, a type I IFN secreted by virus-infected cells and implicated in type I diabetes onset, compared to IFN gamma, the classic immunoproteasome inducer secreted by cells of the immune system. By qPCR analysis, we show that mouse insulinoma MIN6 cells and mouse islets accumulate the immune proteolytic beta 1(i), beta 2(i) and beta 5(i), and 11S mRNAs upon exposure to IFN beta or IFN gamma. Higher concentrations of IFN beta than IFN gamma are needed for similar expression, but in each case the expression is transient, with maximal mRNA accumulation in 12 hours, and depends primarily on Interferon Regulatory Factor 1. IFNs do not alter expression of regular proteasome genes, and in the time frame of IFN beta-mediated response, the immune and regular proteolytic subunits co-exist in the 20S particles. In cell extracts with ATP, these particles have normal peptidase activities and degrade polyubiquitinated proteins with rates typical of the regular proteasome, implicating normal regulation by the 19S activator. However, ATP depletion rapidly stimulates the catalytic rates in a manner consistent with levels of the 11S activator. These findings suggest that stochastic combination of regular and immune proteolytic subunits may increase the probability with which unique immunogenic peptides are produced in pancreatic beta-cells exposed to IFN beta, but primarily in cells with reduced ATP levels that stimulate the 11S participation in immunoproteasome function.	[Freudenburg, Wieke; Gautam, Madhav; Chakraborty, Pradipta; James, Jared; Richards, Jennifer; Salvatori, Alison S.; Skowyra, Dorota] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Freudenburg, Wieke; Schriewer, Jill; Buller, R. Mark L.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA; [Baldwin, Aaron; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Saint Louis University; Saint Louis University; Medical College of Wisconsin	Skowyra, D (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	skowyra@slu.edu			American Diabetes Foundation [ADA 7-11-BS138, ADA 7-06-PST-03]; United States National Institutes of Health [DK52194, AI-44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	American Diabetes Foundation(American Diabetes Association); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Basic Science Award ADA 7-11-BS138 (DS) and Physician Scientist Training award ADA 7-06-PST-03 (WF) from American Diabetes Foundation (http://www.diabetes.org/); and DK52194 (JC) and AI-44458 (JC) from the United States National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Alba A, 2004, J IMMUNOL, V173, P6667, DOI 10.4049/jimmunol.173.11.6667; Arnush M, 1998, J IMMUNOL, V160, P2684; Baldeon ME, 1997, DIABETES, V46, P770, DOI 10.2337/diabetes.46.5.770; Baldeon ME, 1998, AM J PHYSIOL, V275, P25; Brucet M, 2004, GENES IMMUN, V5, P26, DOI 10.1038/sj.gene.6364035; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chakrabarti D, 1996, J IMMUNOL, V157, P522; Chatterjee-Kishore M, 1998, J BIOL CHEM, V273, P16177, DOI 10.1074/jbc.273.26.16177; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Fairweather D, 2002, NAT IMMUNOL, V3, P338, DOI 10.1038/ni0402-338; Foss GS, 1999, J BIOL CHEM, V274, P35196, DOI 10.1074/jbc.274.49.35196; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Geng Q, 2009, BIOCHEM BIOPH RES CO, V390, P1136, DOI 10.1016/j.bbrc.2009.10.067; Goettrup M, 1995, J BIOL CHEM, V270, P23808; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUANG XJ, 1994, IMMUNITY, V1, P469, DOI 10.1016/1074-7613(94)90089-2; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kiefer SM, 2002, J BIOL CHEM, V277, P14869, DOI 10.1074/jbc.M200052200; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kopp F, 2001, J MOL BIOL, V313, P465, DOI 10.1006/jmbi.2001.5063; Lehner PJ, 2003, IMMUNITY, V18, P315, DOI 10.1016/S1074-7613(03)00061-X; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; MA CP, 1992, J BIOL CHEM, V267, P10515; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Namiki S, 2005, FEBS LETT, V579, P2781, DOI 10.1016/j.febslet.2005.04.012; Pavlovic D, 1999, EUR CYTOKINE NETW, V10, P403; Pelegrin M, 1998, J BIOL CHEM, V273, P12332, DOI 10.1074/jbc.273.20.12332; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Rasschaert J, 2003, DIABETOLOGIA, V46, P1641, DOI 10.1007/s00125-003-1245-y; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Schwarz K, 2000, J IMMUNOL, V165, P768, DOI 10.4049/jimmunol.165.2.768; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shin EC, 2007, J INTERF CYTOK RES, V27, P985, DOI 10.1089/jir.2007.0039; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; SOMOZA N, 1994, J IMMUNOL, V153, P1360; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; White LC, 1996, IMMUNITY, V5, P365, DOI 10.1016/S1074-7613(00)80262-9; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	59	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e52408	10.1371/journal.pone.0052408	http://dx.doi.org/10.1371/journal.pone.0052408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383295	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900002
J	Kim, EJ; Cho, SW; Shin, JO; Lee, MJ; Kim, KS; Jung, HS				Kim, Eun-Jung; Cho, Sung-Won; Shin, Jeong-Oh; Lee, Min-Jung; Kim, Kye-Seong; Jung, Han-Sung			Ihh and Runx2/Runx3 Signaling Interact to Coordinate Early Chondrogenesis: A Mouse Model	PLOS ONE			English	Article							INDIAN-HEDGEHOG; CHONDROCYTE DIFFERENTIATION; GENE-EXPRESSION; GROWTH; ROLES; BMP; PROLIFERATION; DISRUPTION; MATURATION; INDUCTION	Endochondral bone formation begins with the development of a cartilage intermediate that is subsequently replaced by calcified bone. The mechanisms occurring during early chondrogenesis that control both mesenchymal cell differentiation into chondrocytes and cell proliferation are not clearly understood in vertebrates. Indian hedgehog (Ihh), one of the hedgehog signaling molecules, is known to control both the hypertrophy of chondrocytes and bone replacement; these processes are particularly important in postnatal endochondral bone formation rather than in early chondrogenesis. In this study, we utilized the maternal transfer of 5E1 to E12.5 in mouse embryos, a process that leads to an attenuation of Ihh activity. As a result, mouse limb bud chondrogenesis was inhibited, and an exogenous recombinant IHH protein enhanced the proliferation and differentiation of mesenchymal cells. Analysis of the genetic relationships in the limb buds suggested a more extensive role for Ihh and Runx genes in early chondrogenesis. The transfer of 5E1 decreased the expression of Runx2 and Runx3, whereas an exogenous recombinant IHH protein increased Runx2 and Runx3 expression. Moreover, a transcription factor Gli1 in hedgehog pathway enhances the direct induction of both Runx2 and Runx3 transcription. These findings suggested that Ihh signaling plays an important role in chondrocyte proliferation and differentiation via interactions with Runx2 and Runx3.	[Kim, Eun-Jung; Cho, Sung-Won; Shin, Jeong-Oh; Lee, Min-Jung; Jung, Han-Sung] Yonsei Univ, Coll Dent, Oral Sci Res Ctr,Res Ctr Orofacial Hard Tissue Re, Brain Korea 21 Project,Div Anat & Dev Biol,Dept O, Seoul 120749, South Korea; [Kim, Kye-Seong] Hanyang Univ, Grad Sch Biomed Sci & Engn, Coll Anat & Cell Biol, Seoul 133791, South Korea	Yonsei University; Yonsei University Health System; Hanyang University	Kim, EJ (corresponding author), Yonsei Univ, Coll Dent, Oral Sci Res Ctr,Res Ctr Orofacial Hard Tissue Re, Brain Korea 21 Project,Div Anat & Dev Biol,Dept O, Seoul 120749, South Korea.	blueleah@yuhs.ac; hsjung@yuhs.ac	Jung, Han-Sung/I-3848-2012; CHO, Sung-Won/HDO-3680-2022	Kim, Eun-Jung/0000-0002-9515-7590; Cho, Sung-Won/0000-0001-7505-9769; Jung, Han-Sung/0000-0003-2795-531X	Bio and Medical Technology Development Program [2012M3A9B4028738]; National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea	Bio and Medical Technology Development Program; National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the grant for the Bio and Medical Technology Development Program (2012M3A9B4028738) funded by the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bruce SJ, 2010, J BIOL CHEM, V285, P27967, DOI 10.1074/jbc.M109.091785; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Haaijman A, 2000, GROWTH FACTORS, V17, P177, DOI 10.3109/08977190009001067; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai LP, 2005, J CELL BIOCHEM, V96, P1163, DOI 10.1002/jcb.20635; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Minina E, 2001, DEVELOPMENT, V128, P4523; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; Shimizu H, 2007, DEV GROWTH DIFFER, V49, P449, DOI 10.1111/j.1440-169x.2007.00945.x; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takamoto M, 2003, J ENDOCRINOL, V177, P413, DOI 10.1677/joe.0.1770413; Tickle C, 2002, AM J MED GENET, V112, P250, DOI 10.1002/ajmg.10774; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Towers M, 2012, CURR OPIN CELL BIOL, V24, P181, DOI 10.1016/j.ceb.2011.11.005; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	35	39	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55296	10.1371/journal.pone.0055296	http://dx.doi.org/10.1371/journal.pone.0055296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383321	Green Submitted, gold, Green Published			2022-12-27	WOS:000314597900028
J	Merkl, C; Saalfrank, A; Riesen, N; Kuhn, R; Pertek, A; Eser, S; Hardt, MS; Kind, A; Saur, D; Wurst, W; Iglesias, A; Schnieke, A				Merkl, Claudia; Saalfrank, Anja; Riesen, Nathalie; Kuehn, Ralf; Pertek, Anna; Eser, Stefan; Hardt, Markus Sebastian; Kind, Alexander; Saur, Dieter; Wurst, Wolfgang; Iglesias, Antonio; Schnieke, Angelika			Efficient Generation of Rat Induced Pluripotent Stem Cells Using a Non-Viral Inducible Vector	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; IN-VITRO DIFFERENTIATION; GENE KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; GENOMIC INTEGRATION; PHI-C31 INTEGRASE; MAMMALIAN-CELLS; PHAGE INTEGRASE; EXPRESSION; TETRACYCLINE	Current methods of generating rat induced pluripotent stem cells are based on viral transduction of pluripotency inducing genes (Oct4, Sox2, c-myc and Klf4) into somatic cells. These activate endogenous pluripotency genes and reprogram the identity of the cell to an undifferentiated state. Epigenetic silencing of exogenous genes has to occur to allow normal iPS cell differentiation. To gain more control over the expression of exogenous reprogramming factors, we used a novel doxycycline-inducible plasmid vector encoding Oct4, Sox2, c-Myc and Klf4. To ensure efficient and controlled generation of iPS cells by plasmid transfection we equipped the reprogramming vector with a bacteriophage phi C31 attB site and used a phi C31 integrase expression vector to enhance vector integration. A series of doxycycline-independent rat iPS cell lines were established. These were characterized by immunocytochemical detection of Oct4, SSEA1 and SSEA4, alkaline phosphatase staining, methylation analysis of the endogenous Oct4 promoter and RT-PCR analysis of endogenous rat pluripotency genes. We also determined the number of vector integrations and the extent to which reprogramming factor gene expression was controlled. Protocols were developed to generate embryoid bodies and rat iPS cells demonstrated as pluripotent by generating derivatives of all three embryonic germ layers in vitro, and teratoma formation in vivo. All data suggest that our rat iPS cells, generated by plasmid based reprogramming, are similar to rat ES cells. Methods of DNA transfection, protein transduction and feeder-free monolayer culture of rat iPS cells were established to enable future applications.	[Merkl, Claudia; Saalfrank, Anja; Riesen, Nathalie; Hardt, Markus Sebastian; Kind, Alexander; Schnieke, Angelika] Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany; [Eser, Stefan; Saur, Dieter] Tech Univ Munich, Klinikum Rechts Isar 2, D-80290 Munich, Germany; [Kuehn, Ralf; Pertek, Anna; Wurst, Wolfgang] Helmholtz Ctr Munich, Inst Dev Genet, Munich, Germany; [Kuehn, Ralf; Wurst, Wolfgang] Tech Univ Munich, D-80290 Munich, Germany; [Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV, Munich, Germany; [Iglesias, Antonio] L Hoffmann La Roche Ltd, Small Mol Res Discovery Technol, Pharma Res & Early Dev, Basel, Switzerland	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Roche Holding	Schnieke, A (corresponding author), Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany.	schnieke@wzw.tum.de	Kühn, Ralf/U-1278-2017; Saur, Dieter/O-8355-2015	Kühn, Ralf/0000-0003-1694-9803; Saur, Dieter/0000-0001-5874-0210; Wurst, Wolfgang/0000-0003-4422-7410; Schnieke, Angelika/0000-0002-5761-9635	German Ministry of Education and Research [FKZ 01 GN 0806]; F. Hoffmann-La Roche Ltd.	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	This work was supported by the German Ministry of Education and Research (FKZ 01 GN 0806) and F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd. set the overall goal of the project, but had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript. The manuscript was approved in its final form by F. Hoffmann-La Roche Ltd.; AI is an employee of Small Molecules Research - Discovery Technologies, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd. - a pharmaceutical company involved in biomedical research and manufacture of medical products. This work was supported, in part, by F. Hoffmann-La Roche Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao N, 2011, CELL RES, V21, P1316, DOI 10.1038/cr.2011.48; Chalberg TW, 2005, INVEST OPHTH VIS SCI, V46, P2140, DOI 10.1167/iovs.04-1252; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; Crowe J, 1995, MOL BIOTECHNOL, V4, P247, DOI 10.1007/BF02779018; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hamanaka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022008; Hirabayashi M, 2010, MOL REPROD DEV, V77, P474, DOI 10.1002/mrd.21181; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Karow M, 2011, STEM CELLS, V29, P1696, DOI 10.1002/stem.730; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liskovykh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027345; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Meek S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014225; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Yamamoto S, 2011, TRANSGENIC RES; Ye L, 2010, P NATL ACAD SCI USA, V107, P19467, DOI 10.1073/pnas.1012677107	45	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55170	10.1371/journal.pone.0055170	http://dx.doi.org/10.1371/journal.pone.0055170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383095	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600071
J	Parameshwaran, D; Bhalla, US				Parameshwaran, Dhanya; Bhalla, Upinder S.			Theta Frequency Background Tunes Transmission but Not Summation of Spiking Responses	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; IN-VIVO; GAMMA-OSCILLATIONS; RAT HIPPOCAMPUS; POTENTIAL OSCILLATIONS; CORTICAL-NEURONS; PHASE-PRECESSION; NETWORK ACTIVITY; MEMORY TASK; SYNCHRONIZATION	Hippocampal neurons are known to fire as a function of frequency and phase of spontaneous network rhythms, associated with the animal's behaviour. This dependence is believed to give rise to precise rate and temporal codes. However, it is not well understood how these periodic membrane potential fluctuations affect the integration of synaptic inputs. Here we used sinusoidal current injection to the soma of CA1 pyramidal neurons in the rat brain slice to simulate background oscillations in the physiologically relevant theta and gamma frequency range. We used a detailed compartmental model to show that somatic current injection gave comparable results to more physiological synaptically driven theta rhythms incorporating excitatory input in the dendrites, and inhibitory input near the soma. We systematically varied the phase of synaptic inputs with respect to this background, and recorded changes in response and summation properties of CA1 neurons using whole-cell patch recordings. The response of the cell was dependent on both the phase of synaptic inputs and frequency of the background input. The probability of the cell spiking for a given synaptic input was up to 40% greater during the depolarized phases between 30-135 degrees of theta frequency current injection. Summation gain on the other hand, was not affected either by the background frequency or the phasic afferent inputs. This flat summation gain, coupled with the enhanced spiking probability during depolarized phases of the theta cycle, resulted in enhanced transmission of summed inputs during the same phase window of 30-135 degrees. Overall, our study suggests that although oscillations provide windows of opportunity to selectively boost transmission and EPSP size, summation of synaptic inputs remains unaffected during membrane oscillations.	[Parameshwaran, Dhanya; Bhalla, Upinder S.] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Bhalla, US (corresponding author), TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	bhalla@ncbs.res.in		Bhalla, Upinder/0000-0003-1722-5188	Department of Biotechnology, India,; National Centre for Biological Sciences (NCBS)/Tata Institute of Fundamental Research (TIFR) funds	Department of Biotechnology, India,(Department of Biotechnology (DBT) India); National Centre for Biological Sciences (NCBS)/Tata Institute of Fundamental Research (TIFR) funds	Supported by a grant from the Department of Biotechnology, India, to USB, and National Centre for Biological Sciences (NCBS)/Tata Institute of Fundamental Research (TIFR) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akam T, 2012, NAT NEUROSCI; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bower JM, 1998, BOOK GENESIS EXPLORI; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Burchell TR, 1998, NEUROSCI LETT, V255, P151, DOI 10.1016/S0304-3940(98)00676-4; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deshmukh SS, 2003, J NEUROSCI, V23, P1903; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Fellous JM, 2001, J NEUROPHYSIOL, V85, P1782, DOI 10.1152/jn.2001.85.4.1782; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Holscher C, 1997, J NEUROSCI, V17, P6470; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kwag J, 2009, NAT NEUROSCI, V12, P1219, DOI 10.1038/nn.2388; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; McLelland D, 2009, J PHYSIOL-LONDON, V587, P769, DOI 10.1113/jphysiol.2008.164111; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Parameshwaran D, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00071; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Shu YS, 2003, J NEUROSCI, V23, P10388; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wyble BP, 2000, J NEUROPHYSIOL, V83, P2138, DOI 10.1152/jn.2000.83.4.2138	57	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55607	10.1371/journal.pone.0055607	http://dx.doi.org/10.1371/journal.pone.0055607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383242	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600134
J	Wasser, L; Day, R; Chasmer, L; Taylor, A				Wasser, Leah; Day, Rick; Chasmer, Laura; Taylor, Alan			Influence of Vegetation Structure on Lidar-derived Canopy Height and Fractional Cover in Forested Riparian Buffers During Leaf-Off and Leaf-On Conditions	PLOS ONE			English	Article							AIRBORNE SCANNING LASER; SMALL-FOOTPRINT; WATER-QUALITY; FLYING ALTITUDES; STAND; DENSITY; MANAGEMENT; INTENSITY; PARAMETERS; ELEVATION	Estimates of canopy height (H) and fractional canopy cover (FC) derived from lidar data collected during leaf-on and leaf-off conditions are compared with field measurements from 80 forested riparian buffer plots. The purpose is to determine if existing lidar data flown in leaf-off conditions for applications such as terrain mapping can effectively estimate forested riparian buffer H and FC within a range of riparian vegetation types. Results illustrate that: 1) leaf-off and leaf-on lidar percentile estimates are similar to measured heights in all plots except those dominated by deciduous compound-leaved trees where lidar underestimates H during leaf off periods; 2) canopy height models (CHMs) underestimate H by a larger margin compared to percentile methods and are influenced by vegetation type (conifer needle, deciduous simple leaf or deciduous compound leaf) and canopy height variability, 3) lidar estimates of FC are within 10% of plot measurements during leaf-on periods, but are underestimated during leaf-off periods except in mixed and conifer plots; and 4) depth of laser pulse penetration lower in the canopy is more variable compared to top of the canopy penetration which may influence within canopy vegetation structure estimates. This study demonstrates that leaf-off lidar data can be used to estimate forested riparian buffer canopy height within diverse vegetation conditions and fractional canopy cover within mixed and conifer forests when leaf-on lidar data are not available.	[Wasser, Leah; Taylor, Alan] Penn State Univ, University Pk, PA 16802 USA; [Wasser, Leah] Natl Ecol Observ Network, Boulder, CO USA; [Day, Rick] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Chasmer, Laura] Wilfrid Laurier Univ, Cold Reg Res Ctr, Waterloo, ON N2L 3C5, Canada; [Taylor, Alan] Penn State Univ, Dept Geog, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Wilfrid Laurier University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wasser, L (corresponding author), Penn State Univ, University Pk, PA 16802 USA.	leahwasser@gmail.com		Wasser, Leah/0000-0002-8177-6550	National Consortium for Rural Geospatial Innovations in America; Penn State Geospatial Technology Program housed in the Department of Crop and Soil Sciences at Penn State; Penn State Forest Vegetation Dynamics Laboratory	National Consortium for Rural Geospatial Innovations in America; Penn State Geospatial Technology Program housed in the Department of Crop and Soil Sciences at Penn State; Penn State Forest Vegetation Dynamics Laboratory	LAW has been supported in part by a grant from the National Consortium for Rural Geospatial Innovations in America (www.ruralgis.org) and the Penn State Geospatial Technology Program housed in the Department of Crop and Soil Sciences at Penn State and by the Penn State Forest Vegetation Dynamics Laboratory (http://www.geog.psu.edu/research/physical-geography/vegetation-dynamics-lab). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2005, INT J REMOTE SENS, V26, P3889, DOI 10.1080/01431160500181671; Arroyo LA, 2010, FOREST ECOL MANAG, V259, P598, DOI 10.1016/j.foreco.2009.11.018; Bain M. B., 2000, ENVIRON SCI POLICY, V3, P89, DOI DOI 10.1016/S1462-9011(00)00029-0; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Brandtberg T, 2003, REMOTE SENS ENVIRON, V85, P290, DOI 10.1016/S0034-4257(03)00008-7; Brandtberg T, 2007, ISPRS J PHOTOGRAMM, V61, P325, DOI 10.1016/j.isprsjprs.2006.10.006; Broadmeadow S, 2004, HYDROL EARTH SYST SC, V8, P286, DOI 10.5194/hess-8-286-2004; Brooks R, 2009, ENVIRON MONIT ASSESS, V150, P101, DOI 10.1007/s10661-008-0673-z; Chasmer L, 2008, REMOTE SENS ENVIRON, V112, P4344, DOI 10.1016/j.rse.2008.08.003; Chen JM, 2006, AGR FOREST METEOROL, V140, P257, DOI 10.1016/j.agrformet.2006.08.005; Claggett PR, 2010, J AM WATER RESOUR AS, V46, P334, DOI 10.1111/j.1752-1688.2010.00424.x; Crew R, 2007, RIPARIAN FOREST WETL; DeWalle DR, 2010, J AM WATER RESOUR AS, V46, P323, DOI 10.1111/j.1752-1688.2010.00423.x; Farve R, 2010, EVALUATION LASER REN; Gaveau DLA, 2003, CAN J REMOTE SENS, V29, P650, DOI 10.5589/m03-023; Goetz SJ, 2006, J AM WATER RESOUR AS, V42, P133, DOI 10.1111/j.1752-1688.2006.tb03829.x; Goodwin NR, 2006, REMOTE SENS ENVIRON, V103, P140, DOI 10.1016/j.rse.2006.03.003; Hall RK, 2009, ENVIRON MONIT ASSESS, V159, P63, DOI 10.1007/s10661-008-0613-y; Hawbaker TJ, 2010, FOREST SCI, V56, P313; Hill RA, 2009, ISPRS J PHOTOGRAMM, V64, P223, DOI 10.1016/j.isprsjprs.2008.12.004; Hopkinson C, 2009, REMOTE SENS ENVIRON, V113, P275, DOI 10.1016/j.rse.2008.09.012; Hopkinson C, 2007, CAN J REMOTE SENS, V33, P312, DOI 10.5589/m07-029; Hopkinson C, 2006, CAN J REMOTE SENS, V32, P139, DOI 10.5589/m06-006; Hopkinson C, 2005, CAN J REMOTE SENS, V31, P191, DOI 10.5589/m05-007; Hyer EJ, 2004, AGR FOREST METEOROL, V122, P157, DOI 10.1016/j.agrformet.2003.09.013; Ishii HT, 2004, FOREST SCI, V50, P342; Johansen K, 2010, REMOTE SENS ENVIRON, V114, P2679, DOI 10.1016/j.rse.2010.06.004; Kim S, 2009, REMOTE SENS ENVIRON, V113, P1575, DOI 10.1016/j.rse.2009.03.017; Korpela I, 2011, MAPPING UNDERSTORY T, P6; Korpela I, 2010, SILVA FENN, V44, P319, DOI 10.14214/sf.156; Lattin PD, 2004, J AM WATER RESOUR AS, V40, P215, DOI 10.1111/j.1752-1688.2004.tb01020.x; Leblanc SG, 2005, AGR FOREST METEOROL, V129, P187, DOI 10.1016/j.agrformet.2004.09.006; Lowrance R, 1997, ENVIRON MANAGE, V21, P687, DOI 10.1007/s002679900060; Magnussen S, 2010, REMOTE SENS ENVIRON, V114, P700, DOI 10.1016/j.rse.2009.11.007; Malhado ACM, 2010, GLOBAL ECOL BIOGEOGR, V19, P852, DOI 10.1111/j.1466-8238.2010.00567.x; Mayer P.M., 2005, RIPARIAN BUFFER WIDT; Morsdorf F, 2008, INT J REMOTE SENS, V29, P1387, DOI 10.1080/01431160701736349; Morsdorf F, 2005, P ISPRS WG 3 3 3 4 3; Morsdorf F, 2006, REMOTE SENS ENVIRON, V104, P50, DOI 10.1016/j.rse.2006.04.019; Naesset E, 2005, REMOTE SENS ENVIRON, V98, P356, DOI 10.1016/j.rse.2005.07.012; Naesset E, 1997, REMOTE SENS ENVIRON, V61, P246, DOI 10.1016/S0034-4257(97)00041-2; Naesset E, 2002, REMOTE SENS ENVIRON, V80, P88, DOI 10.1016/S0034-4257(01)00290-5; Naesset E, 2004, REMOTE SENS ENVIRON, V91, P243, DOI 10.1016/j.rse.2004.03.009; Naesset E, 2002, REMOTE SENS ENVIRON, V79, P105, DOI 10.1016/S0034-4257(01)00243-7; Naesset E, 2011, SAMPLING MAPPING FOR, P297; Naesset E, 2009, REMOTE SENS ENVIRON, V113, P148, DOI 10.1016/j.rse.2008.09.001; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Niinemets U, 1998, PLANT ECOL, V134, P1, DOI 10.1023/A:1009773704558; Nilsson M, 1996, REMOTE SENS ENVIRON, V56, P1, DOI 10.1016/0034-4257(95)00224-3; Orka HO, 2010, REMOTE SENS ENVIRON, V114, P1445, DOI 10.1016/j.rse.2010.01.024; Orka HO, 2009, REMOTE SENS ENVIRON, V113, P1163, DOI 10.1016/j.rse.2009.02.002; Perry CD, 1999, J WATER RES PL-ASCE, V125, P117, DOI 10.1061/(ASCE)0733-9496(1999)125:3(117); PETERSEN RC, 1992, FRESHWATER BIOL, V27, P295, DOI 10.1111/j.1365-2427.1992.tb00541.x; Schuft MJ, 1999, PHOTOGRAMM ENG REM S, V65, P1157; Seavy NE, 2009, ECOL APPL, V19, P1848, DOI 10.1890/08-1124.1; Smith AMS, 2009, CAN J REMOTE SENS, V35, P447, DOI 10.5589/m09-038; Smith TA, 2008, SOUTHEAST NAT, V7, P277, DOI 10.1656/1528-7092(2008)7[277:EOVMOB]2.0.CO;2; Snyder CD, 2003, LANDSCAPE ECOL, V18, P647, DOI 10.1023/B:LAND.0000004178.41511.da; Snyder MN, 2005, J AM WATER RESOUR AS, V41, P659, DOI 10.1111/j.1752-1688.2005.tb03762.x; Song J.H., 2002, INT ARCH PHOTOGRAMM, V34, P259; Speiran GK, 2010, J AM WATER RESOUR AS, V46, P246, DOI 10.1111/j.1752-1688.2010.00427.x; Sumida A, 1997, ANN BOT-LONDON, V80, P759, DOI 10.1006/anbo.1997.0519; Sutton AJ, 2010, WATER AIR SOIL POLL, V208, P101, DOI 10.1007/s11270-009-0152-3; USTIN SL, 1991, IEEE T GEOSCI REMOTE, V29, P843, DOI 10.1109/TGRS.1991.1019468; Valladares F., 2007, FUNCTIONAL PLANT ECO, P101, DOI DOI 10.1201/9781420007626.CH4; Vidon P, 2010, HYDROL PROCESS, V24, P1532, DOI 10.1002/hyp.7740; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Warman L, 2011, OIKOS, V120, P813, DOI 10.1111/j.1600-0706.2010.19344.x	69	81	81	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54776	10.1371/journal.pone.0054776	http://dx.doi.org/10.1371/journal.pone.0054776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382966	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600041
J	Yu, CC; Yang, JC; Chang, YC; Chuang, JG; Lin, CW; Wu, MS; Chow, LP				Yu, Cheng-Chou; Yang, Jyh-Chin; Chang, Yen-Ching; Chuang, Jiing-Guang; Lin, Chung-Wu; Wu, Ming-Shiang; Chow, Lu-Ping			VCP Phosphorylation-Dependent Interaction Partners Prevent Apoptosis in Helicobacter pylori-Infected Gastric Epithelial Cells	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; PROTEASOME-MEDIATED DEGRADATION; GROWTH-FACTOR RECEPTOR; ELEVATED EXPRESSION; TUMOR-SUPPRESSOR; CANCER; P97; UBIQUITIN; CYCLE; AKT	Previous studies have demonstrated that valosin-containing protein (VCP) is associated with H. pylori-induced gastric carcinogenesis. By identifying the interactome of VCP overexpressed in AGS cells using a subtractive proteomics approach, we aimed to characterize the cellular responses mediated by VCP and its functional roles in H. pylori-associated gastric cancer. VCP immunoprecipitations followed by proteomic analysis identified 288 putative interacting proteins, 18 VCP-binding proteins belonged to the PI3K/Akt signaling pathway. H. pylori infection increased the interaction between Akt and VCP, Akt-dependent phosphorylation of VCP, levels of ubiquitinated proteins, and aggresome formation in AGS cells. Furthermore, phosphorylated VCP co-localized with the aggresome, bound ubiquitinated proteins, and increased the degradation of cellular regulators to protect H. pylori-infected AGS cells from apoptosis. Our study demonstrates that VCP phosphorylation following H. pylori infection promotes both gastric epithelial cell survival, mediated by the PI3K/Akt pathway, and the degradation of cellular regulators. These findings provide novel insights into the mechanisms of H. pylori infection induced gastric carcinogenesis.	[Yu, Cheng-Chou; Chang, Yen-Ching; Chuang, Jiing-Guang; Chow, Lu-Ping] Natl Taiwan Univ Hosp, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan; [Yang, Jyh-Chin; Wu, Ming-Shiang] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Chung-Wu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chow, LP (corresponding author), Natl Taiwan Univ Hosp, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan.	chowip@ntu.edu.tw			Program for Excellence Research Teams of the Ministry of Education; National Science Council [98-2320-B-002-030-MY3]; Liver Disease Prevention & Treatment Research Foundation, Taiwan	Program for Excellence Research Teams of the Ministry of Education; National Science Council(Ministry of Science and Technology, Taiwan); Liver Disease Prevention & Treatment Research Foundation, Taiwan	This work was supported in part by the Program for Excellence Research Teams of the Ministry of Education, Grant 98-2320-B-002-030-MY3 from the National Science Council, and Liver Disease Prevention & Treatment Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Carloni S, 2012, NEUROSCIENCE, V203, P160, DOI 10.1016/j.neuroscience.2011.12.021; Chan CH, 2006, MOL CELL PROTEOMICS, V5, P702, DOI 10.1074/mcp.M500029-MCP200; CORREA P, 1985, SEMIN ONCOL, V12, P2; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Graaf AO, 2004, LEUKEMIA, V18, P1751, DOI 10.1038/sj.leu.2403493; Deans DAC, 2006, BRIT J CANCER, V95, P1568, DOI 10.1038/sj.bjc.6603446; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eguchi H, 2003, CANCER RES, V63, P4739; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; GONDA MA, 1976, J NATL CANCER I, V56, P245, DOI 10.1093/jnci/56.2.245; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Katoh M, 2007, CANCER BIOL THER, V6, P832, DOI 10.4161/cbt.6.6.4196; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li SP, 2010, BIOMED ENVIRON SCI, V23, P273, DOI 10.1016/S0895-3988(10)60063-3; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Moss SF, 1998, ALIMENT PHARM THER, V12, P91, DOI 10.1111/j.1365-2036.1998.00002.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Peek RM, 1999, CANCER RES, V59, P6124; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sheu BS, 1999, DIGEST DIS SCI, V44, P868, DOI 10.1023/A:1026627707103; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Sonenberg N, 2006, SCIENCE, V314, P428, DOI 10.1126/science.1134031; Tabassam FH, 2009, CELL MICROBIOL, V11, P70, DOI 10.1111/j.1462-5822.2008.01237.x; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; WANG JT, 1993, EUR J CLIN MICROBIOL, V12, P367, DOI 10.1007/BF01964436; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Wigley WC, 1999, J CELL BIOL, V145, P481; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Yamamoto S, 2004, ONCOLOGY-BASEL, V66, P468, DOI 10.1159/000079501; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Yamamoto S, 2003, J CLIN ONCOL, V21, P2537, DOI 10.1200/JCO.2003.12.102; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Yang LC, 2008, J NUTR, V138, P2084, DOI 10.3945/jn.108.090985; Zucchini C, 2008, INT J ONCOL, V32, P17	60	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55724	10.1371/journal.pone.0055724	http://dx.doi.org/10.1371/journal.pone.0055724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383273	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600153
J	Zhang, YG; Wang, XZ; Yang, Z; Zhang, H; Liu, M; Qiu, YS; Guo, X				Zhang, Yin-gang; Wang, Xuezhi; Yang, Zhi; Zhang, Hong; Liu, Miao; Qiu, Yushen; Guo, Xiong			The Therapeutic Effect of Negative Pressure in Treating Femoral Head Necrosis in Rabbits	PLOS ONE			English	Article							CELLS; OSTEONECROSIS; OSTEOGENESIS	Because negative pressure can stimulate vascular proliferation, improve blood circulation and promote osteogenic differentiation of bone marrow stromal cells, we investigated the therapeutic effect of negative pressure on femoral head necrosis (FHN) in a rabbit model. Animals were divided into four groups (n = 60/group): [1] model control, [2] core decompression, [3] negative pressure and [4] normal control groups. Histological investigation revealed that at 4 and 8 weeks postoperatively, improvements were observed in trabecular bone shape, empty lacunae and numbers of bone marrow hematopoietic cells and fat cells in the negative pressure group compared to the core decompression group. At week 8, there were no significant differences between the negative pressure and normal control groups. Immunohistochemistry staining revealed higher expression of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2) in the femoral heads in the negative pressure group compared with the core decompression group. Transmission electron microscopy revealed that cell organelles were further developed in the negative pressure group compared with the core decompression group. Microvascular ink staining revealed an increased number of bone marrow ink-stained blood vessels, a thicker vascular lumen and increased microvascular density in the negative pressure group relative to the core decompression group. Real-time polymerase chain reaction revealed that expression levels of both VEGF and BMP-2 were higher in the negative pressure group compared with the core decompression group. In summary, negative pressure has a therapeutic effect on FHN. This effect is superior to core decompression, indicating that negative pressure is a potentially valuable method for treating early FHN.	[Zhang, Yin-gang; Yang, Zhi; Zhang, Hong; Liu, Miao; Qiu, Yushen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Orthoped, Xian 710049, Peoples R China; [Wang, Xuezhi] Zhenghe Hosp, Dept Gen Surg, Xian, Peoples R China; [Guo, Xiong] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, YG (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Orthoped, Xian 710049, Peoples R China.	zyingang@mail.xjtu.edu.cn	Yang, Zhi/X-6447-2019		National Natural Science Foundation of China [81171761, 30973063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from the National Natural Science Foundation of China (No. 81171761, 30973063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JM, 2007, ORTHOP CLIN N AM, V38, P13, DOI 10.1016/j.ocl.2006.10.012; Castro F P Jr, 2000, Am J Orthop (Belle Mead NJ), V29, P187; Fan M, 2011, RHEUMATOL INT, V31, P983, DOI 10.1007/s00296-011-1819-9; Guan XY, 2010, J ORTHOP SCI, V15, P365, DOI 10.1007/s00776-010-1452-6; Hunter Judith E, 2007, Int Wound J, V4, P256, DOI 10.1111/j.1742-481X.2007.00361.x; Lausten GS, 1999, INT ORTHOP, V23, P193, DOI 10.1007/s002640050348; Rajpura A, 2011, HIP INT, V21, P385, DOI 10.5301/HIP.2011.8538; Rombouts J J, 1999, Acta Orthop Belg, V65 Suppl 1, P3; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Specchiulli F, 2000, Chir Organi Mov, V85, P395; Van Laere C, 1998, Acta Orthop Belg, V64, P269; Venturi ML, 2005, AM J CLIN DERMATOL, V6, P185, DOI 10.2165/00128071-200506030-00005; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Yang Z, 2009, J ZHEJIANG UNIV-SC B, V10, P188, DOI 10.1631/jzus.B0820240; Zhang YG, 2010, CONNECT TISSUE RES, V51, P14, DOI 10.3109/03008200902855891; Zhang YG, 2009, MED HYPOTHESES, V73, P906, DOI 10.1016/j.mehy.2009.06.052	17	7	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55745	10.1371/journal.pone.0055745	http://dx.doi.org/10.1371/journal.pone.0055745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383276	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600156
J	Gerhold, KA; Pellegrino, M; Tsunozaki, M; Morita, T; Leitch, DB; Tsuruda, PR; Brem, RB; Catania, KC; Bautista, DM				Gerhold, Kristin A.; Pellegrino, Maurizio; Tsunozaki, Makoto; Morita, Takeshi; Leitch, Duncan B.; Tsuruda, Pamela R.; Brem, Rachel B.; Catania, Kenneth C.; Bautista, Diana M.			The Star-Nosed Mole Reveals Clues to the Molecular Basis of Mammalian Touch	PLOS ONE			English	Article							CHANNEL; CELL; EXPRESSION; NEURONS; INNERVATION; NOCICEPTION; PREDICTION; CIRCUITS; ORGAN; COLD	Little is known about the molecular mechanisms underlying mammalian touch transduction. To identify novel candidate transducers, we examined the molecular and cellular basis of touch in one of the most sensitive tactile organs in the animal kingdom, the star of the star-nosed mole. Our findings demonstrate that the trigeminal ganglia innervating the star are enriched in tactile-sensitive neurons, resulting in a higher proportion of light touch fibers and lower proportion of nociceptors compared to the dorsal root ganglia innervating the rest of the body. We exploit this difference using transcriptome analysis of the star-nosed mole sensory ganglia to identify novel candidate mammalian touch and pain transducers. The most enriched candidates are also expressed in mouse somatosesensory ganglia, suggesting they may mediate transduction in diverse species and are not unique to moles. These findings highlight the utility of examining diverse and specialized species to address fundamental questions in mammalian biology.	[Gerhold, Kristin A.; Pellegrino, Maurizio; Tsunozaki, Makoto; Morita, Takeshi; Tsuruda, Pamela R.; Brem, Rachel B.; Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Gerhold, Kristin A.; Morita, Takeshi; Bautista, Diana M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Leitch, Duncan B.; Catania, Kenneth C.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Vanderbilt University	Bautista, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbautista@berkeley.edu	Leitch, Duncan/AAU-6744-2020	Leitch, Duncan/0000-0002-8513-888X; Morita, Takeshi/0000-0002-8570-6744	U.S. National Institutes of Health [DOD007123A]; Pew Scholars Program; McKnight Scholars Fund; NSF [0844743]; Division Of Integrative Organismal Systems [0844743] Funding Source: National Science Foundation	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; McKnight Scholars Fund; NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors are supported by a U.S. National Institutes of Health Innovator Award DOD007123A, the Pew Scholars Program, and the McKnight Scholars Fund (to DMB) and NSF grant 0844743 (to KCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; Biel M, 2009, J BIOL CHEM, V284, P9017, DOI 10.1074/jbc.R800075200; Catania KC, 2005, NATURE, V433, P519, DOI 10.1038/nature03250; Catania KC, 1996, J COMP NEUROL, V365, P343; CATANIA KC, 1995, J COMP NEUROL, V351, P536, DOI 10.1002/cne.903510405; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Guo T, 2011, NAT NEUROSCI, V14, P31, DOI 10.1038/nn.2710; Heine S, 2011, J NEUROSCI, V31, P11184, DOI 10.1523/JNEUROSCI.6159-10.2011; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krogh A, 1929, SCIENCE, V70, P200, DOI 10.1126/science.70.1809.200; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Lumpkin EA, 2010, J CELL BIOL, V191, P237, DOI 10.1083/jcb.201006074; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MARFURT CF, 1989, INVEST OPHTH VIS SCI, V30, P461; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martinez-Salgado C, 2007, J NEUROPHYSIOL, V98, P3802, DOI 10.1152/jn.00860.2007; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	39	32	33	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55001	10.1371/journal.pone.0055001	http://dx.doi.org/10.1371/journal.pone.0055001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383028	gold, Green Published			2022-12-27	WOS:000315563800098
J	Hirata, H; Ueno, K; Shahryari, V; Deng, GR; Tanaka, Y; Tabatabai, ZL; Hinoda, Y; Dahiya, R				Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Deng, Guoren; Tanaka, Yuichiro; Tabatabai, Z. Laura; Hinoda, Yuji; Dahiya, Rajvir			MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer	PLOS ONE			English	Article							SUPPRESSOR GENE; METASTASIS; MIR-182; PROGRESSION; EXPRESSION; RECK; OVEREXPRESSION; AGGRESSIVENESS; PATHWAY; CLUSTER	Recently miR-182 has been reported to be over-expressed in prostate cancer (PC) tissues, however detailed functional analysis of miR-182-5p has not been carried out. The purpose of this study was to: 1. analyze the function of miR-182-5p in prostate cancer, 2. assess its usefulness as a tumor marker, 3. identify miR-182-5p target genes in PC, 4. investigate the potential for miR-182-5p inhibitor to be used in PC treatment. Initially we found that miR-182-5p expression was significantly higher in prostate cancer tissues and cell lines compared to normal prostate tissues and cells. Moreover high miR-182-5p expression was associated with shorter overall survival in PC patients. To study the functional significance of miR-182-5p, we knocked down miR-182-5p with miR-182-5p inhibitor. After miR-182-5p knock-down, prostate cancer cell proliferation, migration and invasion were decreased. We identified FOXF2, RECK and MTSS1 as potential target genes of miR-182-5p using several algorithms which was confirmed by 3'UTR luciferase assay and Western analysis. Knock-down of miR-182-5p also significantly decreased in vivo prostate tumor growth. In conclusion this is the first report documenting that over-expression of miR-182-5p is associated with prostate cancer progression and potentially useful as a prognostic biomarker. Also knock down of miR-182-5p in order to increase expression of tumor suppressor genes FOXF2, RECK and MTSS1 may be of therapeutic benefit in prostate cancer treatment.	[Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Deng, Guoren; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; [Hirata, Hiroshi; Ueno, Koji; Shahryari, Varahram; Deng, Guoren; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Tabatabai, Z. Laura] San Francisco VA Med Ctr, Dept Pathol, San Francisco, CA USA; [Hinoda, Yuji] Yamaguchi Univ, Dept Oncol & Lab Med, Grad Sch Med, Yamaguchi, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Yamaguchi University	Dahiya, R (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [RO1CA138642, RO1CA130860, RO1CA160079]; VA Merit Review grants; VA Program Project; Yamada Science Foundation; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079, R01CA130860] Funding Source: NIH RePORTER; Veterans Affairs [IP1BX001604] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review grants(US Department of Veterans Affairs); VA Program Project; Yamada Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by National Center for Research Resources of the National Institutes of Health through Grant Number RO1CA138642, RO1CA130860, RO1CA160079, VA Merit Review grants, VA Program Project and Yamada Science Foundation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Chan JM, 2006, CANCER CAUSE CONTROL, V17, P199, DOI 10.1007/s10552-005-0413-4; Cheng L, 2001, CANCER-AM CANCER SOC, V91, P66, DOI 10.1002/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Clark JCM, 2011, CANCER-AM CANCER SOC, V117, P3517, DOI 10.1002/cncr.25757; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Li N, 2012, FEBS LETT, V586, P722, DOI 10.1016/j.febslet.2012.01.025; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Liu ZJ, 2012, J PATHOL, V228, P204, DOI 10.1002/path.4000; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Mustafa N, 2011, EXP THER MED, V2, P157, DOI 10.3892/etm.2010.184; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rabien A, 2012, PROSTATE, V72, P948, DOI 10.1002/pros.21498; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-14; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Roemeling S, 2006, J UROLOGY, V175, P1332, DOI 10.1016/S0022-5347(05)00698-1; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shukla S, 2005, NUTR CANCER, V53, P18, DOI 10.1207/s15327914nc5301_3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; van der Heul-Nieuwenhuijsen L, 2009, PROSTATE, V69, P1538, DOI 10.1002/pros.20996; Wang J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-227; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yoshida Y, 2012, ONCOGENE, V31, P4128, DOI 10.1038/onc.2011.570; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679	36	126	133	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55502	10.1371/journal.pone.0055502	http://dx.doi.org/10.1371/journal.pone.0055502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383207	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800161
J	Sabirov, RZ; Kurbannazarova, RS; Melanova, NR; Okada, Y				Sabirov, Ravshan Z.; Kurbannazarova, Ranokon S.; Melanova, Nazira R.; Okada, Yasunobu			Volume-Sensitive Anion Channels Mediate Osmosensitive Glutathione Release from Rat Thymocytes	PLOS ONE			English	Article							ATP RELEASE; INDUCED APOPTOSIS; CL-CHANNEL; GLUTAMATE RELEASE; MOUSE ASTROCYTES; GSH TRANSPORT; CELL-VOLUME; EFFLUX; BRAIN; ACTIVATION	Glutathione (GSH) is a negatively charged tripeptide, which is a major determinant of the cellular redox state and defense against oxidative stress. It is assembled inside and degraded outside the cells and is released under various physiological and pathophysiological conditions. The GSH release mechanism is poorly understood at present. In our experiments, freshly isolated rat thymocytes were found to release GSH under normal isotonic conditions at a low rate of 0.82 +/- 0.07 attomol/cell/min and that was greatly enhanced under hypoosomotic stimulation to reach a level of 6.1 +/- 0.4 attomol/cell/min. The swelling-induced GSH release was proportional to the cell density in the suspension and was temperature-dependent with relatively low activation energy of 5.4 +/- 0.6 kcal/mol indicating a predominant diffusion mechanism of GSH translocation. The osmosensitive release of GSH was significantly inhibited by blockers of volume-sensitive outwardly rectifying (VSOR) anion channel, DCPIB and phloretin. In patch-clamp experiments, osmotic swelling activated large anionic conductance with the VSOR channel phenotype. Anion replacement studies suggested that the thymic VSOR anion channel is permeable to GSH(-) with the permeability ratio P-GSH/P-Cl of 0.32 for influx and 0.10 for efflux of GSH. The osmosensitive GSH release was trans-stimulated by SLCO/OATP substrates, probenecid, taurocholic acid and estrone sulfate, and inhibited by an SLC22A/OAT blocker, p-aminohippuric acid (PAH). The inhibition by PAH was additive to the effect of DCPIB or phloretin implying that PAH and DCPIB/phloretin affected separate pathways. We suggest that the VSOR anion channel constitutes a major part of the gamma-glutamyl cycle in thymocytes and, in cooperation with OATP-like and OAT-like transporters, provides a pathway for the GSH efflux from osmotically swollen cells.	[Sabirov, Ravshan Z.; Kurbannazarova, Ranokon S.; Okada, Yasunobu] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan; [Sabirov, Ravshan Z.; Kurbannazarova, Ranokon S.; Melanova, Nazira R.] RUz, Acad Sci, Lab Mol Physiol, Inst Bioorgan Chem, Tashkent, Uzbekistan; [Sabirov, Ravshan Z.; Kurbannazarova, Ranokon S.] Natl Univ, Dept Biophys, Tashkent, Uzbekistan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Academy of Sciences of Uzbekistan; Sadykov Institute of Bioorganic Chemistry	Okada, Y (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan.	okada@nips.ac.jp	Kurbannazarova, Ranokhon/ABE-1836-2021; Sabirov, Ravshan/ABD-4896-2021	Sabirov, Ravshan/0000-0003-3512-0873; Ranokhon, Kurbannazarova/0000-0003-3819-910X; Tashmukhamedov, Bekjan/0000-0001-7383-1735	Ministry of Education, Culture, Sports, Science and Technology of Japan; Center for Science and Technology; Academy of Sciences of Uzbekistan; Japanese Government; Grants-in-Aid for Scientific Research [23659118] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Science and Technology; Academy of Sciences of Uzbekistan; Japanese Government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to YO and RZS) as well as by Grants-in-Aid from the Center for Science and Technology and Academy of Sciences of Uzbekistan to RZS and RSK. The authors acknowledge visiting scientist fellowships from the Japanese Government to RZS and RSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2003, J PHYSIOL-LONDON, V549, P749, DOI 10.1113/jphysiol.2003.039784; Akita T, 2011, CELL PHYSIOL BIOCHEM, V28, P1181, DOI 10.1159/000335867; Akita T, 2011, J PHYSIOL-LONDON, V589, P3909, DOI 10.1113/jphysiol.2011.208173; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; ANDINE P, 1991, J NEUROCHEM, V57, P230, DOI 10.1111/j.1471-4159.1991.tb02120.x; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; Briz O, 2006, J BIOL CHEM, V281, P30326, DOI 10.1074/jbc.M602048200; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; Circu ML, 2009, BIOCHEM PHARMACOL, V77, P76, DOI 10.1016/j.bcp.2008.09.011; Cowley EA, 2002, J PHYSIOL-LONDON, V543, P201, DOI 10.1113/jphysiol.2002.022400; Cullen KV, 2001, BIOCHEM PHARMACOL, V62, P417, DOI 10.1016/S0006-2952(01)00681-5; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Dutta AK, 2004, J PHYSIOL-LONDON, V559, P799, DOI 10.1113/jphysiol.2004.069245; Dutta AK, 2008, BIOPHYS J, V94, P1646, DOI 10.1529/biophysj.107.117820; Fan HT, 2001, BRIT J PHARMACOL, V133, P1096, DOI 10.1038/sj.bjp.0704159; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Franco R, 2008, J BIOL CHEM, V283, P36071, DOI 10.1074/jbc.M807061200; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Gao L, 2001, AM J PHYSIOL-LUNG C, V281, pL24, DOI 10.1152/ajplung.2001.281.1.L24; Garcia TB, 2011, NEUROCHEM RES, V36, P412, DOI 10.1007/s11064-010-0356-3; Haddoub Rose, 2009, Handb Exp Pharmacol, P385, DOI 10.1007/978-3-540-79885-9_19; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; HAUSSINGER D, 1990, EUR J BIOCHEM, V193, P891, DOI 10.1111/j.1432-1033.1990.tb19414.x; Hilgier W, 2010, TOXICOL SCI, V117, P163, DOI 10.1093/toxsci/kfq171; Hirrlinger J, 2002, J NEUROSCI RES, V69, P318, DOI 10.1002/jnr.10308; Hirrlinger J, 2010, BRAIN RES REV, V63, P177, DOI 10.1016/j.brainresrev.2009.10.003; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; Kannan R, 2000, BRAIN RES, V852, P374, DOI 10.1016/S0006-8993(99)02184-8; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Krasilnikov OV, 2011, J PHYSIOL SCI, V61, P267, DOI 10.1007/s12576-011-0144-0; Kurbannazarova RS, 2008, B EXP BIOL MED+, V145, P606, DOI 10.1007/s10517-008-0152-0; Kurbannazarova RS, 2011, INT J MOL SCI, V12, P9125, DOI 10.3390/ijms12129125; Kurbannazarova RS, 2003, GEN PHYSIOL BIOPHYS, V22, P221; l'Hoste S, 2010, AM J PHYSIOL-RENAL, V298, pF435, DOI 10.1152/ajprenal.00286.2009; L'hoste S, 2009, FREE RADICAL BIO MED, V46, P1017, DOI 10.1016/j.freeradbiomed.2008.12.009; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; Liu HT, 2008, PURINERG SIGNAL, V4, P147, DOI 10.1007/s11302-007-9077-8; Liu HT, 2008, CELL RES, V18, P558, DOI 10.1038/cr.2008.49; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Liu HT, 2009, J PHYSIOL-LONDON, V587, P2197, DOI 10.1113/jphysiol.2008.165084; Liu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC343; Marchan R, 2008, BBA-BIOMEMBRANES, V1778, P2413, DOI 10.1016/j.bbamem.2008.06.011; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; OKADA Y, 1994, JPN J PHYSIOL, V44, P403, DOI 10.2170/jjphysiol.44.403; Okada Y, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P283; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; ORWAR O, 1994, J NEUROCHEM, V63, P1371; Ranat S, 2007, NEUROSCI LETT, V415, P45, DOI 10.1016/j.neulet.2006.12.043; Rebbeor JF, 2002, BBA-BIOMEMBRANES, V1559, P171, DOI 10.1016/S0005-2736(01)00454-0; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sabirov R, 2009, J PHYSIOL SCI, V59, P3, DOI 10.1007/s12576-008-0008-4; Sabirov RZ, 2004, BIOPHYS J, V87, P1672, DOI 10.1529/biophysj.104.043174; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Sabirov RZ, 2000, J MEMBRANE BIOL, V177, P13, DOI 10.1007/s002320001090; Song Z, 2000, POULTRY SCI, V79, P1632, DOI 10.1093/ps/79.11.1632; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Ternovsky VI, 2004, FEBS LETT, V576, P433, DOI 10.1016/j.febslet.2004.09.051; Tetaud E, 1997, BIOCHEM J, V325, P569, DOI 10.1042/bj3250569; Trompier D, 2004, CANCER RES, V64, P4950, DOI 10.1158/0008-5472.CAN-04-0143; Wallin C, 1999, J NEUROCHEM, V73, P1566, DOI 10.1046/j.1471-4159.1999.0731566.x; Wang J, 2005, JPN J PHYSIOL, V55, P379, DOI 10.2170/jjphysiol.S655; YANG CS, 1994, J CHROMATOGR B, V661, P231, DOI 10.1016/S0378-4347(94)80050-2; ZANGERLE L, 1992, J NEUROCHEM, V59, P181, DOI 10.1111/j.1471-4159.1992.tb08889.x; Zhang H, 2012, SEMIN CELL IN PRESS	74	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55646	10.1371/journal.pone.0055646	http://dx.doi.org/10.1371/journal.pone.0055646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383255	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800180
J	Wang, YC; Srivathsan, A; Feng, CC; Salim, A; Shekelle, M				Wang, Yi-Chen; Srivathsan, Amrita; Feng, Chen-Chieh; Salim, Agus; Shekelle, Myron			Asian Primate Species Richness Correlates with Rainfall	PLOS ONE			English	Article							SUNDA SHELF; DIVERSITY; PATTERNS; PRODUCTIVITY; ISLANDS; BIOGEOGRAPHY; PHYLOGENY; ECOLOGY; LINE	Previous studies of meta-analyses found significantly positive correlations between primate species richness and rainfall for Africa, Madagascar and the Neotropics, with the exception of Asia, leaving the open question whether that anomaly is the result of sampling bias, biogeography, or some other factor. This study re-examines the question using modelled data, with primate species richness data from the Southeast Asian Mammals Databank and rainfall data from the Climatic Research Unit. Data processing with Geographical Information Systems resulted in 390 sample points. Reduced major axis and ordinary least squares regressions were employed to examine the relationship for six regions, including the whole study area of Southeast Asia, and the subareas of Huxley West, Huxley East, Mainland Southeast Asia, Borneo, and Sumatra. The results showed a significant positive relationship between primate species richness and mean annual rainfall for Southeast Asia (r = 0.26, P<0.001). Comparing the results for the large islands and Mainland Southeast Asia showed that Sumatra had the highest correlation (r = 0.58; P<0.05). After controlling for the major biogeographic effect associated with Huxley's Line, our results showed that primate species richness is positively associated with mean annual rainfall in Southeast Asia. Our findings contrast to prior studies of meta-analyses that showed no relationship between rainfall and primate species richness in Asia, and thereby bring Asia into agreement with results showing significant positive correlations between rainfall and primate species richness everywhere else in the world. The inference is that previous anomalous results for Asia were result of sampling bias in the meta-analysis.	[Wang, Yi-Chen; Feng, Chen-Chieh] Natl Univ Singapore, Dept Geog, Singapore 117548, Singapore; [Srivathsan, Amrita] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Salim, Agus] Hatfield Consultants, N Vancouver, BC, Canada; [Shekelle, Myron] Portland State Univ, Dept Biol, Museum Vertebrate Biol, Portland, OR 97207 USA	National University of Singapore; National University of Singapore; Portland State University	Shekelle, M (corresponding author), Portland State Univ, Dept Biol, Museum Vertebrate Biol, Portland, OR 97207 USA.	shekelle@tarsier.org	Wang, Yi-Chen/F-6885-2012; Feng, Chen-Chieh/F-9993-2012; Srivathsan, Amrita/F-6256-2013; Salim, Agus/P-1407-2014; Zimmermann, Elke/D-2281-2015	Wang, Yi-Chen/0000-0002-3034-7377; Feng, Chen-Chieh/0000-0003-0410-714X; Salim, Agus/0000-0003-3999-7701; 	Faculty of Science, National University of Singapore	Faculty of Science, National University of Singapore(National University of Singapore)	The Faculty of Science, National University of Singapore provided funding support for Shekelle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Blackburn TM, 1996, ECOGRAPHY, V19, P369, DOI 10.1111/j.1600-0587.1996.tb00247.x; Boitani L, 2006, SE ASIAN MAMMAL DATA; Catullo G, 2008, BIOL CONSERV, V141, P2730, DOI 10.1016/j.biocon.2008.08.019; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chuan G.K., 2005, PHYS GEOGRAPHY SE AS, P80; Cowlishaw G., 2000, PRIMATE CONSERVATION; ESRI, 2010, ARCGIS 10; Esselstyn JA, 2010, J BIOGEOGR, V37, P2054, DOI 10.1111/j.1365-2699.2010.02378.x; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Ganzhorn JU, 1997, BIOTROPICA, V29, P331, DOI 10.1111/j.1744-7429.1997.tb00434.x; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Harcourt AH, 1999, GLOBAL ECOL BIOGEOGR, V8, P55, DOI 10.1046/j.1365-2699.1999.00125.x; Harrison T, 2006, DEV PRIMATOL, P331; Hassel-Finnegan HM, 2009, THESIS STONY BROOK U; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; HEANEY LR, 1984, OECOLOGIA, V61, P11, DOI 10.1007/BF00379083; Hurlbert AH, 2003, AM NAT, V161, P83, DOI 10.1086/345459; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huxley TH, 1868, P ZOOL SOC LOND, P296; Kay RF, 1997, P NATL ACAD SCI USA, V94, P13023, DOI 10.1073/pnas.94.24.13023; Kozak KH, 2012, ECOLOGY, V93, pS167, DOI 10.1890/11-0542.1; Lawes MJ, 2000, J BIOGEOGR, V27, P1421, DOI 10.1046/j.1365-2699.2000.00510.x; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; MAC ARTHUR ROBERT H., 1967; Mayr E, 1944, Q REV BIOL, V19, P1, DOI 10.1086/394684; Mittermeier R.A., 1988, P145; Moody A, 2000, J BIOGEOGR, V27, P711, DOI 10.1046/j.1365-2699.2000.00435.x; Osborne P. L., 2000, TROPICAL ECOSYSTEMS; Pan XB, 2012, SCIENCE, V335, DOI [10.1126/science.1214786, 10.1126/science.1215042]; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Raven HC., 1935, B AM MUS NAT HIST, V68, P177; Reed KE, 2004, YEARB PHYS ANTHROPOL, V47, P2, DOI 10.1002/ajpa.20153; REED KE, 1995, P NATL ACAD SCI USA, V92, P7874, DOI 10.1073/pnas.92.17.7874; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SIMPSON GG, 1977, P AM PHILOS SOC, V121, P107; Smith BT, 2012, ECOL LETT, V15, P1318, DOI 10.1111/j.1461-0248.2012.01855.x; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Stevens RD, 2006, P ROY SOC B-BIOL SCI, V273, P2283, DOI 10.1098/rspb.2006.3596; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Wilson D. E., 2005, MAMMAL SPECIES WORLD	45	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54995	10.1371/journal.pone.0054995	http://dx.doi.org/10.1371/journal.pone.0054995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383023	gold, Green Published			2022-12-27	WOS:000315563800093
J	Warner, SE; Pickering, P; Panagiotopoulou, O; Pfau, T; Ren, L; Hutchinson, JR				Warner, Sharon Elaine; Pickering, Phillip; Panagiotopoulou, Olga; Pfau, Thilo; Ren, Lei; Hutchinson, John Richard			Size-Related Changes in Foot Impact Mechanics in Hoofed Mammals	PLOS ONE			English	Article							DYNAMIC SIMILARITY; IMPULSIVE FORCES; LIMB BONES; PREVALENCE; ALLOMETRY; LAMENESS; BIOMECHANICS; ATTENUATION; PATTERNS; WALKING	Foot-ground impact is mechanically challenging for all animals, but how do large animals mitigate increased mass during foot impact? We hypothesized that impact force amplitude scales according to isometry in animals of increasing size through allometric scaling of related impact parameters. To test this, we measured limb kinetics and kinematics in 11 species of hoofed mammals ranging from 18-3157 kg body mass. We found impact force amplitude to be maintained proportional to size in hoofed mammals, but that other features of foot impact exhibit differential scaling patterns depending on the limb; forelimb parameters typically exhibit higher intercepts with lower scaling exponents than hind limb parameters. Our explorations of the size-related consequences of foot impact advance understanding of how body size influences limb morphology and function, foot design and locomotor behaviour.	[Warner, Sharon Elaine; Pickering, Phillip; Panagiotopoulou, Olga; Hutchinson, John Richard] Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [Pfau, Thilo] Royal Vet Coll, Hatfield, Herts, England; [Ren, Lei] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Greater Manches, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Manchester	Warner, SE (corresponding author), Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England.	swarner@rvc.ac.uk	Panagiotopoulou, Olga/ABA-6654-2021; Hutchinson, John/AAH-1593-2020; Panagiotopoulou, Olga/M-5476-2013	Panagiotopoulou, Olga/0000-0002-6457-448X; Panagiotopoulou, Olga/0000-0002-6457-448X; Hutchinson, John/0000-0002-6767-7038	Biotechnology and Biological Sciences Research Council [BB/F01169/1, BB/H002782/1]; Biotechnology and Biological Sciences Research Council [BB/F000863/1] Funding Source: researchfish; BBSRC [BB/H002782/1, BB/F000863/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), grants BB/F01169/1 and BB/H002782/1 to JRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1979, J ZOOL, V189, P305; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; BIEWENER AA, 1983, J EXP BIOL, V105, P147; Blum Y, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/026006; Broster CE, 2009, EQUINE VET J, V41, P474, DOI 10.2746/042516409X373907; Buchner HHF, 1997, J BIOMECH, V30, P653, DOI 10.1016/S0021-9290(97)00005-5; Bullimore SR, 2008, J THEOR BIOL, V250, P339, DOI 10.1016/j.jtbi.2007.09.038; Bullimore SR, 2004, P ROY SOC B-BIOL SCI, V271, P285, DOI 10.1098/rspb.2003.2611; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Chi KJ, 2005, J BIOMECH, V38, P1387, DOI 10.1016/j.jbiomech.2004.06.020; COLLINS JJ, 1989, CLIN BIOMECH, V4, P179, DOI 10.1016/0268-0033(89)90023-5; Currey J.D., 2002, BONES STRUCTURE MECH; Denoth J., 1986, BIOMECHANICS RUNNING; FARLEY CT, 1993, J EXP BIOL, V185, P71; Gustas P, 2004, EQUINE VET J, V36, P737, DOI 10.2746/0425164044848136; Gustas P, 2001, Equine Vet J Suppl, P11; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; Herr HM, 2002, J EXP BIOL, V205, P959; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Johnston C., 1991, EQUINE EXERCISE PHYS, V3, P167; Ker R F, 1989, Proc Inst Mech Eng H, V203, P191, DOI 10.1243/PIME_PROC_1989_203_038_01; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Manske T, 2002, PREV VET MED, V54, P247, DOI 10.1016/S0167-5877(02)00018-1; MCMAHON TA, 1975, AM NAT, V109, P547, DOI 10.1086/283026; Michilsens F, 2009, J ZOOL, V279, P236, DOI 10.1111/j.1469-7998.2009.00611.x; More HL, 2010, P ROY SOC B-BIOL SCI, V277, P3563, DOI 10.1098/rspb.2010.0898; Mouttotou N, 1997, VET REC, V141, P115, DOI 10.1136/vr.141.5.115; Murray RD, 1996, VET REC, V138, P586, DOI 10.1136/vr.138.24.586; Parsons KJ, 2011, EQUINE VET J, V43, P216, DOI 10.1111/j.2042-3306.2010.00149.x; PRATT DJ, 1989, CLIN BIOMECH, V4, P51, DOI 10.1016/0268-0033(89)90068-5; RADIN EL, 1973, J BIOMECH, V6, P51, DOI 10.1016/0021-9290(73)90037-7; Ren L, 2010, P NATL ACAD SCI USA, V107, P7078, DOI 10.1073/pnas.0911396107; SIMON SR, 1972, J BIOMECH, V5, P267, DOI 10.1016/0021-9290(72)90042-5; Wakeling JM, 2001, J APPL PHYSIOL, V91, P1307, DOI 10.1152/jappl.2001.91.3.1307; Wassink GJ, 2003, VET REC, V152, P351, DOI 10.1136/vr.152.12.351; Whittle MW, 1999, GAIT POSTURE, V10, P264, DOI 10.1016/S0966-6362(99)00041-7	40	13	13	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54784	10.1371/journal.pone.0054784	http://dx.doi.org/10.1371/journal.pone.0054784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382967	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800077
J	Wyszko, E; Szymanski, M; Zeichhardt, H; Muller, F; Barciszewski, J; Erdmann, VA				Wyszko, Eliza; Szymanski, Maciej; Zeichhardt, Heinz; Mueller, Florian; Barciszewski, Jan; Erdmann, Volker A.			Spiegelzymes: Sequence Specific Hydrolysis of L-RNA with Mirror Image Hammerhead Ribozymes and DNAzymes	PLOS ONE			English	Article							IN-VITRO; ANTICOAGULANT; THERAPEUTICS; SELECTION; APTAMERS; LIGANDS; BIND; 1ST	In this manuscript we describe for the first time mirror image catalytic nucleic acids (Spiegelzymes), which hydrolyze sequence specifically L-ribonucleic acid molecules. The mirror image nucleic acid ribozymes designed are based upon the known hammerhead ribozyme and DNAzyme structures that contain L-ribose or L-deoxyribose instead of the naturally occurring D-ribose or D-deoxyribose, respectively. Both Spiegelzymes show similar hydrolytic activities with the same L-RNA target molecules and they also exhibit extra ordinary stabilities when tested with three different human sera. In this respect they are very similar to Spiegelmers (mirror image aptamers), which we had previously developed and for which it has been shown that they are non-toxic and non-immunogenic. Since we are also able to demonstrate that the hammerhead and DNAzyme Spiegelzymes can also hydrolyze mirror image oligonucleotide sequences, like they occur in Spiegelmers, in vivo, it seems reasonable to assume that Spiegelzymes may in principle be used as an antidote against Spiegelmers. Since the Spiegelzymes contain the same building blocks as the Spiegelmers, it can be expected that they will have similar favorable biological characteristics concerning toxicity and immunogenety. In trying to understand the mechanism of action of the Spiegelzymes described in this study, we have initiated for the first time a model building system with L-nucleic acids. The models for L-hammerhead ribozyme and L-DNAzyme interaction with the same L-RNA target will be presented.	[Wyszko, Eliza; Szymanski, Maciej; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Zeichhardt, Heinz] Charite, Inst Virol, D-13353 Berlin, Germany; [Mueller, Florian] Pentafolium Soft, Rosengarten, Germany; [Erdmann, Volker A.] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Erdmann, VA (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany.	vae@zedat.fu-berlin.de	Barciszewski, Jan/N-9283-2019	Barciszewski, Jan/0000-0001-7766-5594; Wyszko, Eliza/0000-0001-9524-0960; Szymanski, Maciej/0000-0001-7694-6706	Foreign Office of the Free University of Berlin; Berlin RNA Network; Federal Ministry of Science (BMBF); Deutsche Forschungsgemeinschaft [SFB Transregio 19]; Polish Ministry of Sciences of Higher Education	Foreign Office of the Free University of Berlin; Berlin RNA Network; Federal Ministry of Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Polish Ministry of Sciences of Higher Education	This study was supported by the Foreign Office of the Free University of Berlin. The authors are also grateful for additional financial support from the Berlin RNA Network, the Federal Ministry of Science (BMBF), the Deutsche Forschungsgemeinschaft for funding of the SFB Transregio 19 (project C1) and the Polish Ministry of Sciences of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker R C, 2007, Hamostaseologie, V27, P378; Bolik S, 2007, RNA, V13, P1877, DOI 10.1261/rna.564507; Burgess DJ, 2012, NAT REV CANCER, V12, P508, DOI 10.1038/nrc3328; Cai H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003960; Carothers J.M., 2006, APTAMER HDB FUNCTION, V1st, P1; Dass CR, 2008, MOL CANCER THER, V7, P243, DOI 10.1158/1535-7163.MCT-07-0510; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Eulberg D, 2006, APTAMER HDB FUNCTION; Fedor MJ, 2009, ANNU REV BIOPHYS, V38, P271, DOI 10.1146/annurev.biophys.050708.133710; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Gaglione M, 2010, MINI-REV MED CHEM, V10, P578, DOI 10.2174/138955710791384036; Hammann C, 2002, CHEMBIOCHEM, V3, P691; HERTEL KJ, 1992, NUCLEIC ACIDS RES, V20, P3252, DOI 10.1093/nar/20.12.3252; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2009, J PHARMACOL EXP THER, V328, P371, DOI 10.1124/jpet.108.142711; Mangasarian A, 2011, 5 ANN INT PARTN C MI; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Ninichuk V, 2008, AM J PATHOL, V172, P628, DOI 10.2353/ajpath.2008.070601; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; RUFFNER DE, 1989, GENE, V82, P31, DOI 10.1016/0378-1119(89)90027-9; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Rypniewski W, 2006, ACTA CRYSTALLOGR D, V62, P659, DOI 10.1107/S090744490601359X; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Scott WG, 2010, RNA TECHNOL, P305, DOI 10.1007/978-3-642-12168-5_14; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vallazza M, 2004, ACTA CRYSTALLOGR D, V60, P1, DOI 10.1107/S0907444903027690; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Wang J, 2009, CHEMBIOCHEM, V10, P2171, DOI 10.1002/cbic.200900408; Wedekind JE, 1998, ANNU REV BIOPH BIOM, V27, P475, DOI 10.1146/annurev.biophys.27.1.475; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475; Zaborowska Z, 2005, FEBS LETT, V579, P554, DOI 10.1016/j.febslet.2004.12.008	34	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54741	10.1371/journal.pone.0054741	http://dx.doi.org/10.1371/journal.pone.0054741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382952	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800072
J	Chen, XR; Chen, J; Wen, J; Xu, CY; Zhang, S; Zhou, YH; Hu, YL				Chen, Xiangru; Chen, Jie; Wen, Jian; Xu, Chenyu; Zhang, Shu; Zhou, Yi-Hua; Hu, Yali			Breastfeeding Is Not a Risk Factor for Mother-to-Child Transmission of Hepatitis B Virus	PLOS ONE			English	Article							PREVENT PERINATAL TRANSMISSION; LAMIVUDINE TREATMENT; INFANT TRANSMISSION; LATE PREGNANCY; RECOMMENDATIONS; IMMUNIZATION; MULTICENTER; INFECTION; EFFICACY; SAFETY	Background: Many clinicians do not encourage breastfeeding in hepatitis B virus (HBV) carriers, since HBV DNA can be detected in breast milk and breast lesions may increase exposure of infants to HBV. The aim of this study was to determine whether breastfeeding may add risk for perinatal HBV transmission. Methodology/Principal Findings: Totally 546 children (1-7-year-old) of 544 HBV-infected mothers were investigated, with 397 breastfed and 149 formula-fed; 137 were born to HBeAg-positive mothers. All children had been vaccinated against hepatitis B but only 53.3% received hepatitis B immune globulin (HBIG). The overall prevalence of HBsAg+, HBsAg-/anti-HBc+, and anti-HBs (>= 10 mIU/ml) in children was 2.4%, 3.1%, and 71.6% respectively. The HBsAg prevalence in breast-and formula-fed children was 1.5% and 4.7% respectively (P=0.063); the difference was likely due to the higher mothers' HBeAg-positive rate in formula-fed group (formula-fed 49.0% vs. breastfed 15.9%, P<0.001). Further logistic regression analyses showed that breastfeeding was not associated with the HBV infection in the children, adjusting for the effect of maternal HBeAg status and other factors different between the two groups. Conclusions/Significance: Under the recommended prophylaxis, breastfeeding is not a risk factor for mother-to-child transmission of HBV. Therefore, clinicians should encourage HBV-infected mothers to breastfeed their infants.	[Chen, Xiangru] Nanjing Med Univ, Fac Nursing, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Jie; Zhang, Shu; Hu, Yali] Nanjing Med Univ, Dept Obstet & Gynecol, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Wen, Jian; Xu, Chenyu] Zhenjiang Fourth Peoples Hosp, Dept Obstet & Gynecol, Zhenjiang, Jiangsu, Peoples R China; [Zhou, Yi-Hua] Nanjing Univ, Dept Expt Med, Nanjing Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Yi-Hua; Hu, Yali] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing Medical University; Nanjing University; Nanjing University; Nanjing University	Zhou, YH (corresponding author), Nanjing Univ, Dept Expt Med, Nanjing Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.	yzh20061111@yahoo.com; dtylhu@126.com			Special Research Grant for the Key Laboratory from the Department of Health, Jiangsu Province [XK201102]; Nanjing Medical Science and Technique Development Foundation, Nanjing [2011024]; National Key Basic Research Project (973 Planning), China [2010CB945104]	Special Research Grant for the Key Laboratory from the Department of Health, Jiangsu Province; Nanjing Medical Science and Technique Development Foundation, Nanjing; National Key Basic Research Project (973 Planning), China(National Basic Research Program of China)	This study was supported by a Special Research Grant (XK201102) for the Key Laboratory from the Department of Health, Jiangsu Province, by Nanjing Medical Science and Technique Development Foundation (2011024), Nanjing, and by a Grant (2010CB945104) from National Key Basic Research Project (973 Planning), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Joseph, 2010, Gastroenterol Hepatol (N Y), V6, P570; [Anonymous], 1998, J Int Assoc Physicians AIDS Care, V4, P20; BEASLEY RP, 1975, LANCET, V2, P740; Borgia G, 2012, WORLD J GASTROENTERO, V18, P4677, DOI 10.3748/wjg.v18.i34.4677; Chen HL, 2012, GASTROENTEROLOGY, V142, P773, DOI 10.1053/j.gastro.2011.12.035; de Oliveira PR, 2009, J CLIN VIROL, V45, P281, DOI 10.1016/j.jcv.2009.04.003; Dusheiko G, 2012, LANCET, V379, P2019, DOI 10.1016/S0140-6736(11)61182-3; Giles ML, 2006, MED J AUSTRALIA, V184, P389, DOI 10.5694/j.1326-5377.2006.tb00288.x; Guo Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-26; Han GR, 2011, J HEPATOL, V55, P1215, DOI 10.1016/j.jhep.2011.02.032; Heininger U, 2010, PEDIATR INFECT DIS J, V29, P248, DOI 10.1097/INF.0b013e3181bd7f89; Hill JB, 2002, OBSTET GYNECOL, V99, P1049, DOI 10.1016/S0029-7844(02)02000-8; Hu YL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-221; Kose S, 2011, J INFECT DEV COUNTR, V5, P303, DOI 10.3855/jidc.1398; Leung VKT, 2012, J MATERN-FETAL NEO M, V25, P2390, DOI 10.3109/14767058.2012.697941; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Peters MG, 2009, HEPATOLOGY, V49, pS146, DOI 10.1002/hep.22965; Qiu L, 2010, BREASTFEED MED, V5, P109, DOI 10.1089/bfm.2009.0093; Shi ZJ, 2011, ARCH PEDIAT ADOL MED, V165, P837, DOI 10.1001/archpediatrics.2011.72; Spada E, 2011, J INFECTION, V62, P165, DOI 10.1016/j.jinf.2010.11.014; US Department of Health Human Services, 2011, COMB SIL EP VIR HEP; van Zonneveld M, 2003, J VIRAL HEPATITIS, V10, P294, DOI 10.1046/j.1365-2893.2003.00440.x; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x; Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x; Zou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026748	28	23	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55303	10.1371/journal.pone.0055303	http://dx.doi.org/10.1371/journal.pone.0055303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383145	Green Published, Green Submitted, gold			2022-12-27	WOS:000315211500073
J	Easton, AH; Goulson, D				Easton, Amy H.; Goulson, Dave			The Neonicotinoid Insecticide Imidacloprid Repels Pollinating Flies and Beetles at Field-Realistic Concentrations	PLOS ONE			English	Article							BUMBLEBEE NEST DENSITY; COLONY GROWTH; PESTICIDES; SCALE; BEES	Neonicotinoids are widely used systemic insecticides which, when applied to flowering crops, are translocated to the nectar and pollen where they may impact upon pollinators. Given global concerns over pollinator declines, this potential impact has recently received much attention. Field exposure of pollinators to neonicotinoids depends on the concentrations present in flowering crops and the degree to which pollinators choose to feed upon them. Here we describe a simple experiment using paired yellow pan traps with or without insecticide to assess whether the commonly used neonicotinoid imidacloprid repels or attracts flying insects. Both Diptera and Coleoptera exhibited marked avoidance of traps containing imidacloprid at a field-realistic dose of 1 mu g L-1, with Diptera avoiding concentrations as low as 0.01 mu g L-1. This is to our knowledge the first evidence for any biological activity at such low concentrations, which are below the limits of laboratory detection using most commonly available techniques. Catch of spiders in pan traps was also slightly reduced by the highest concentrations of imidacloprid used (1 mu g L-1), but catch was increased by lower concentrations. It remains to be seen if the repellent effect on insects occurs when neonicotinoids are present in real flowers, but if so then this could have implications for exposure of pollinators to neonicotinoids and for crop pollination.	[Easton, Amy H.; Goulson, Dave] Univ Stirling, Sch Nat Sci, Stirling, Scotland	University of Stirling	Goulson, D (corresponding author), Univ Stirling, Sch Nat Sci, Stirling, Scotland.	dave.goulson@stir.ac.uk	Goulson, David/A-2462-2010	Goulson, David/0000-0003-4421-2876				[Anonymous], 2011, UK NAT EC ASS SYNTH; AOAC Official Method 2007.01, 2007, J AOAC INT, V90, P485; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2752; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Holden C, 2006, SCIENCE, V314, P397, DOI 10.1126/science.314.5798.397; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Tomizawa M., 1999, NICOTINOID INSECTICI, P271, DOI [10.1007/978-4-431-67933-2_13, DOI 10.1007/978-4-431-67933-2_13]; Vrdoljak SM, 2012, J INSECT CONSERV, V16, P345, DOI 10.1007/s10841-011-9420-9; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	26	42	44	1	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54819	10.1371/journal.pone.0054819	http://dx.doi.org/10.1371/journal.pone.0054819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382980	Green Published, gold, Green Accepted			2022-12-27	WOS:000315211500032
J	Granado, M; Fernandez, N; Monge, L; Figueras, JC; Carreno-Tarragona, G; Amor, S; Garcia-Villalon, AL				Granado, Miriam; Fernandez, Nuria; Monge, Luis; Carlos Figueras, Juan; Carreno-Tarragona, Gonzalo; Amor, Sara; Luis Garcia-Villalon, Angel			Effects of Coronary Ischemia-Reperfusion in a Rat Model of Early Overnutrition. Role of Angiotensin Receptors	PLOS ONE			English	Article							NEONATALLY OVERFED RATS; DIET-INDUCED OBESITY; II TYPE-2 RECEPTORS; ADIPOSE-TISSUE; GENE-EXPRESSION; AT(2) RECEPTOR; HEART-FAILURE; GLUCOCORTICOID METABOLISM; CARDIAC-HYPERTROPHY; INSULIN-RESISTANCE	Background: Obesity during childhood has dramatically increased worldwide in the last decades. Environmental factors acting early in life, including nutrition, play an important role in the pathogenesis of obesity and cardiovascular diseases in adulthood. Aims: To analyze the effects of early overfeeding on the heart and coronary circulation, the effect of ischemia-reperfusion (I/R) and the role of the renin-angiotensin system (RAS) were studied in isolated hearts from control and overfed rats during lactation. Methods and Results: On the day of birth litters were adjusted to twelve pups per mother (control) or to three pups per mother (overfed). At weaning (21 days) the rats were killed and the heart perfused in a Langendorff system and subjected to 30 min of ischemia followed by 15 min of reperfusion. The contractility (left developed intraventricular pressure) was lower in the hearts from overfed rats, and was reduced by I/R in hearts from control but not from overfed rats. I/R also reduced the coronary vasoconstriction to angiotensin II more in hearts from control than from overfed rats, and the vasodilatation to bradykinin similarly in both experimental groups. The expression of both angiotensin AGTRa and AGTR2 receptors was increased in the myocardium of overfed rats, and I/R increased the expression of both receptors in control rats but reduced it in overfed rats. The expression of apoptotic and antiapoptotic markers was increased in hearts of overfed rats compared with control, and further increased by I/R. Conclusions: These results suggest that both overfeeding and I/R impair cardiac and coronary function due, at least in part, to activation of the angiotensin pathway. However, overfeeding may reduce the impairment of ventricular contractility by I/R.	[Granado, Miriam; Fernandez, Nuria; Monge, Luis; Carlos Figueras, Juan; Carreno-Tarragona, Gonzalo; Amor, Sara; Luis Garcia-Villalon, Angel] Univ Autonoma Madrid, Fac Med, Dept Physiol, Madrid, Spain; [Granado, Miriam] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Garcia-Villalon, AL (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Physiol, Madrid, Spain.	angeluis.villalon@uam.es	Fernández, Nuria/AAM-7639-2021; Monge, Luis/M-3515-2014; Monge, Luis/O-6840-2019; Garcia-Villalon, Angel/AAA-3067-2019; Granado, Miriam/B-8978-2017; Monsalve, Nuria Fernández/E-6235-2013	Fernández, Nuria/0000-0002-9268-3333; Monge, Luis/0000-0001-7688-7531; Monge, Luis/0000-0001-7688-7531; Granado, Miriam/0000-0001-9178-8822; Monsalve, Nuria Fernández/0000-0002-9268-3333; Carreno-Tarragona, Gonzalo/0000-0002-9570-5542	Fundacion Mapfre; Fondo de Investigaciones Sanitarias [PS09/00394]	Fundacion Mapfre; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by Fundacion Mapfre (2011) and Fondo de Investigaciones Sanitarias (PS09/00394).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; Arena R, 2009, AM J CARDIOL, V104, P1116, DOI 10.1016/j.amjcard.2009.05.059; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barton M, 2003, INT J BIOCHEM CELL B, V35, P826, DOI 10.1016/S1357-2725(02)00307-2; Bonito PD, 2008, NUTR METAB CARDIOVAS, V18, P613; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Boullu-Ciocca S, 2008, DIABETES, V57, P669, DOI 10.2337/db07-1316; Boustany CM, 2004, AM J PHYSIOL-REG I, V287, pR943, DOI 10.1152/ajpregu.00265.2004; Cassis LA, 2008, CURR HYPERTENS REP, V10, P93, DOI 10.1007/s11906-008-0019-9; Chomczynski P, 1993, BIOTECHNIQUES, V15, P536; Davidowa H, 2000, NEUROSCI LETT, V293, P21, DOI 10.1016/S0304-3940(00)01475-0; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; Fainberg HP, 2011, P NUTR SOC, V70, P268, DOI 10.1017/S0029665110004921; Ford WR, 1996, CIRCULATION, V94, P3087, DOI 10.1161/01.CIR.94.12.3087; Fuente-Martin E, 2012, METABOLISM, V61, P812, DOI 10.1016/j.metabol.2011.11.003; Garcia-Villalon AL, 2005, EUR J PHARMACOL, V509, P165, DOI 10.1016/j.ejphar.2004.11.065; Garcia-Villalon AL, 2009, CARDIOVASC RES, V81, P336, DOI 10.1093/cvr/cvn321; Giacchetti G, 2000, INT J OBESITY, V24, pS142, DOI 10.1038/sj.ijo.0801305; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Goldenberg I, 2001, J HYPERTENS, V19, P1681, DOI 10.1097/00004872-200109000-00022; Gorzelniak K, 2002, J HYPERTENS, V20, P965, DOI 10.1097/00004872-200205000-00032; Granado M, 2012, OBESITY FACTS, V5, P138, DOI 10.1159/000336967; Ha KS, 2011, PEDIATR CARDIOL, V32, P659, DOI 10.1007/s00246-011-9952-5; Hainault I, 2002, AM J PHYSIOL-ENDOC M, V282, pE59, DOI 10.1152/ajpendo.2002.282.1.E59; Johren O, 2004, CARDIOVASC RES, V62, P460, DOI 10.1016/j.cardiores.2004.01.011; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lasaitiene D, 2006, CLIN PHYSIOL FUNCT I, V26, P197, DOI 10.1111/j.1475-097X.2006.00676.x; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logue J, 2011, CLIN PHARMACOL THER, V90, P174, DOI 10.1038/clpt.2011.88; Lopez M, 2007, INT J OBESITY, V31, P371, DOI 10.1038/sj.ijo.0803425; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Mehra MR, 2004, J AM COLL CARDIOL, V43, P1590, DOI 10.1016/j.jacc.2003.10.066; Miller JL, 2007, NAT CLIN PRACT ENDOC, V3, P810, DOI 10.1038/ncpendmet0669; Parlakpinar H, 2011, CYTOKINE, V56, P688, DOI 10.1016/j.cyto.2011.09.002; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Podhorska-Okolow M, 2006, HISTOL HISTOPATHOL, V21, P459, DOI 10.14670/HH-21.459; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Rodriguez A, 2007, ENDOCRINOLOGY, V148, P324, DOI 10.1210/en.2006-0940; Sabuhi R, 2011, AM J PHYSIOL-RENAL, V300, pF700, DOI 10.1152/ajprenal.00616.2010; Samuelsson AM, 2010, HYPERTENSION, V55, P76, DOI 10.1161/HYPERTENSIONAHA.109.139402; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Shah AS, 2011, DIABETOLOGIA, V54, P722, DOI 10.1007/s00125-010-1974-7; Simar D, 2012, NUTR METAB CARDIOVAS, V22, P269, DOI 10.1016/j.numecd.2010.11.007; van Harmelen V, 2000, INT J OBESITY, V24, P673, DOI 10.1038/sj.ijo.0801217; Velkoska E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1236, DOI 10.1152/ajpendo.00505.2004; Velkoska E, 2008, J NUTR, V138, P1622, DOI 10.1093/jn/138.9.1622; Virdis A, 2009, CURR PHARM DESIGN, V15, P1063, DOI 10.2174/138161209787846900; Wang XW, 2012, APOPTOSIS, V17, P908, DOI 10.1007/s10495-012-0721-6; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; Xu Y, 2002, AM J PHYSIOL-HEART C, V282, pH1206, DOI 10.1152/ajpheart.00839.2000; Xu ZG, 2005, CIRCULATION, V111, P1962, DOI 10.1161/01.CIR.0000161831.07637.63; Yan XH, 2003, AM J PHYSIOL-HEART C, V285, pH2179, DOI 10.1152/ajpheart.00361.2003; Yang ZQ, 2002, CIRCULATION, V106, P106, DOI 10.1161/01.CIR.0000020014.14176.6D; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	59	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54984	10.1371/journal.pone.0054984	http://dx.doi.org/10.1371/journal.pone.0054984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383303	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900010
J	Liu, GD; Zhang, L; Wei, XM; Zou, G; Qin, YQ; Ma, L; Li, J; Zheng, HJ; Wang, SY; Wang, CS; Xun, LY; Zhao, GP; Zhou, ZH; Qu, YB				Liu, Guodong; Zhang, Lei; Wei, Xiaomin; Zou, Gen; Qin, Yuqi; Ma, Liang; Li, Jie; Zheng, Huajun; Wang, Shengyue; Wang, Chengshu; Xun, Luying; Zhao, Guo-Ping; Zhou, Zhihua; Qu, Yinbo			Genomic and Secretomic Analyses Reveal Unique Features of the Lignocellulolytic Enzyme System of Penicillium decumbens	PLOS ONE			English	Article							TRICHODERMA-REESEI; SIMULTANEOUS SACCHARIFICATION; TRANSCRIPTIONAL REGULATION; BIOETHANOL PRODUCTION; ASPERGILLUS-NIDULANS; CELLULASE PRODUCTION; ETHANOL-PRODUCTION; XYLANASE GENES; PROTEIN; EXPRESSION	Many Penicillium species could produce extracellular enzyme systems with good lignocellulose hydrolysis performance. However, these species and their enzyme systems are still poorly understood and explored due to the lacking of genetic information. Here, we present the genomic and secretomic analyses of Penicillium decumbens that has been used in industrial production of lignocellulolytic enzymes in China for more than fifteen years. Comparative genomics analysis with the phylogenetically most similar species Penicillium chrysogenum revealed that P. decumbens has evolved with more genes involved in plant cell wall degradation, but fewer genes in cellular metabolism and regulation. Compared with the widely used cellulase producer Trichoderma reesei, P. decumbens has a lignocellulolytic enzyme system with more diverse components, particularly for cellulose binding domain-containing proteins and hemicellulases. Further, proteomic analysis of secretomes revealed that P. decumbens produced significantly more lignocellulolytic enzymes in the medium with cellulose-wheat bran as the carbon source than with glucose. The results expand our knowledge on the genetic information of lignocellulolytic enzyme systems in Penicillium species, and will facilitate rational strain improvement for the production of highly efficient enzyme systems used in lignocellulose utilization from Penicillium species.	[Liu, Guodong; Wei, Xiaomin; Qin, Yuqi; Li, Jie; Xun, Luying; Qu, Yinbo] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Zhang, Lei; Zou, Gen; Ma, Liang; Wang, Chengshu; Zhao, Guo-Ping; Zhou, Zhihua] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Qin, Yuqi; Qu, Yinbo] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Shandong, Peoples R China; [Zheng, Huajun; Wang, Shengyue; Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Xun, Luying] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Shandong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shandong University; Washington State University	Zhou, ZH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	zhouzhihua@sippe.ac.cn; quyinbo@sdu.edu.cn	Zou/AAH-5065-2019; Liu, Guodong/C-5806-2011; Wang, Chengshu/A-1656-2011	Liu, Guodong/0000-0002-8645-3531; Wang, Chengshu/0000-0003-1477-1466; Zhao, Guo-Ping/0000-0002-7621-6620; Zou, Gen/0000-0001-5574-1824; Zhou, Zhihua/0000-0001-8995-1838	National Basic Research Program of China [2011CB707403]; National Natural Sciences Foundation of China [31030001]; International S&T Cooperation Program of China [2010DFA32560]	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China	This study was supported by grants from National Basic Research Program of China (Grant no. 2011CB707403), National Natural Sciences Foundation of China (Grant no. 31030001) and International S&T Cooperation Program of China (2010DFA32560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; [Anonymous], 2007, IND ENZYMES; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Aro N, 2001, J BIOL CHEM, V276, P24309, DOI 10.1074/jbc.M003624200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Black GW, 1996, BIOCHEM J, V319, P515, DOI 10.1042/bj3190515; Blanco Enrique, 2007, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0403s18; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen M, 2010, ENZYME MICROB TECH, V46, P444, DOI 10.1016/j.enzmictec.2010.01.008; Chen S, 2011, ENZYME MICROB TECH, V48, P100, DOI 10.1016/j.enzmictec.2010.09.017; Cheng Y, 2009, J APPL MICROBIOL, V107, P1837, DOI 10.1111/j.1365-2672.2009.04362.x; Chevreux B, 1999, GERM C BIOINF; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Couturier M, 2011, APPL ENVIRON MICROB, V77, P237, DOI 10.1128/AEM.01761-10; Durbin R., 1999, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fang X, 2010, BIORESOURCE TECHNOL, V101, P4814, DOI 10.1016/j.biortech.2009.11.050; FIERRO F, 1993, MOL GEN GENET, V241, P573, DOI 10.1007/BF00279899; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gao L, 2012, J BIOL CHEM, V287, P15906, DOI 10.1074/jbc.M111.332890; Gao L, 2011, BIORESOURCE TECHNOL, V102, P8339, DOI 10.1016/j.biortech.2011.06.033; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gusakov AV, 2012, BIOFUELS-UK, V3, P463, DOI [10.4155/bfs.12.41, 10.4155/BFS.12.41]; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Himmel ME, 2010, BIOFUELS-UK, V1, P323, DOI 10.4155/bfs.09.25; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim PG, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/675741; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Kunitake E, 2013, APPL MICROBIOL BIOT, V97, P2017, DOI 10.1007/s00253-012-4305-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li DM, 2007, INT J HYDROGEN ENERG, V32, P1742, DOI 10.1016/j.ijhydene.2006.12.011; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li ZJ, 2010, APPL MICROBIOL BIOT, V87, P2001, DOI 10.1007/s00253-010-2676-2; Liu GD, 2010, J GEN APPL MICROBIOL, V56, P223, DOI 10.2323/jgam.56.223; Liu K, 2010, BIORESOURCE TECHNOL, V101, P4952, DOI 10.1016/j.biortech.2009.11.013; Lockington RA, 2002, FUNGAL GENET BIOL, V37, P190, DOI 10.1016/S1087-1845(02)00504-2; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Ma L, 2011, ENZYME MICROB TECH, V49, P366, DOI 10.1016/j.enzmictec.2011.06.013; MacCabe AP, 1998, J BACTERIOL, V180, P1331, DOI 10.1128/JB.180.5.1331-1333.1998; Mach-Aigner AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-644; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Muller T, 2002, MOL BIOL EVOL, V19, P8, DOI 10.1093/oxfordjournals.molbev.a003985; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nitta M, 2012, FUNGAL GENET BIOL, V49, P388, DOI 10.1016/j.fgb.2012.02.009; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Perez G, 2009, APPL ENVIRON MICROB, V75, P1427, DOI 10.1128/AEM.01889-08; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Qu Y, 1988, ACTA MICROBIOL SIN, V28, P121; Qu Y.-B., 1984, Acta Mycologica Sinica, V3, P238; QU YB, 1991, APPL BIOCHEM BIOTECH, V28-9, P363, DOI 10.1007/BF02922615; Qu Yinbo, 2006, Biotechnology Journal, V1, P1235, DOI 10.1002/biot.200600067; Rawlings N.D., 2010, NUCLEIC ACIDS RES S1, V38, P227, DOI [10.1093/nar/gkp971, DOI 10.1093/NAR/GKP971]; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen Y, 2008, BIORESOURCE TECHNOL, V99, P5099, DOI 10.1016/j.biortech.2007.09.046; Somerville C, 2006, SCIENCE, V312, P1277, DOI 10.1126/science.1130034; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Sun XY, 2008, ENZYME MICROB TECH, V42, P560, DOI 10.1016/j.enzmictec.2008.01.020; Sun XY, 2008, APPL BIOCHEM BIOTECH, V146, P119, DOI 10.1007/s12010-007-8049-3; Tabka MG, 2006, ENZYME MICROB TECH, V39, P897, DOI 10.1016/j.enzmictec.2006.01.021; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; TUKA K, 1992, APPL BIOCHEM BIOTECH, V37, P201, DOI 10.1007/BF02921671; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; Visser H., 2011, IND BIOTECHNOL, V7, P214, DOI [10.1089/ind.2011.7.214, DOI 10.1089/IND.2011.7.214]; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wei XM, 2010, J MICROBIOL BIOTECHN, V20, P265, DOI 10.4014/jmb.0904.04047; Wei XM, 2011, CR BIOL, V334, P806, DOI 10.1016/j.crvi.2011.06.002; Wurleitner E, 2003, EUKARYOT CELL, V2, P150, DOI 10.1128/EC.2.1.150-158.2003; Zeilinger S, 2001, MOL GENET GENOMICS, V266, P56; Zhao J, 2006, BIORESOURCE TECHNOL, V97, P1470, DOI 10.1016/j.biortech.2005.07.012	98	155	183	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55185	10.1371/journal.pone.0055185	http://dx.doi.org/10.1371/journal.pone.0055185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383313	Green Submitted, Green Published, gold			2022-12-27	WOS:000314597900020
J	Zhang, XY; Gong, ZY				Zhang, Xiaoyan; Gong, Zhiyuan			Fluorescent Transgenic Zebrafish Tg(nkx2.2a:mEGFP) Provides a Highly Sensitive Monitoring Tool for Neurotoxins	PLOS ONE			English	Article							ETHANOL NEUROTOXICITY; DANIO-RERIO; MODEL; ACETAMINOPHEN; RECEPTORS; BEHAVIOR; EMBRYOS; SYSTEM; TRAP; HCH	Previously a standard toxicological test termed as DarT (Danio rerio Teratogenic assay) using wild type zebrafish embryos has been established and it is widely applied in toxicological and chemical screenings. As an increasing number of fluorescent transgenic zebrafish lines with specific fluorescent protein expression specifically expressed in different organs and tissues, we envision that the fluorescent markers may provide more sensitive endpoints for monitoring chemical induced phenotypical changes. Here we employed Tg(nkx2.2a:mEGFP) transgenic zebrafish which have GFP expression in the central nervous system to investigate its potential for screening neurotoxic chemicals. Five potential neurotoxins (acetaminophen, atenolol, atrazine, ethanol and lindane) and one neuroprotectant (mefenamic acid) were tested. We found that the GFP-labeled ventral axons from trunk motoneurons, which were easily observed in live fry and measured for quantification, were a highly sensitive to all of the five neurotoxins and the length of axons was significantly reduced in fry which looked normal based on DarT endpoints at low concentrations of neurotoxins. Compared to the most sensitive endpoints of DarT, ventral axon marker could improve the detection limit of these neurotoxins by about 10 fold. In contrast, there was no improvement for detection of the mefenamic acid compared to all DarT endpoints. Thus, ventral axon lengths provide a convenient and measureable marker specifically for neurotoxins. Our study may open a new avenue to use other fluorescent transgenic zebrafish embryos/fry to develop sensitive and specific toxicological tests for different categories of chemicals.	[Zhang, Xiaoyan; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260	Singapore National Research Foundation under Environmental & Water Technologies Strategic Research Programme; PUB [R-154-000-328-272]	Singapore National Research Foundation under Environmental & Water Technologies Strategic Research Programme; PUB	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M, 1998, DRUG CHEM TOXICOL, V21, P35, DOI 10.3109/01480549809017849; Belloni V, 2011, TOXICOLOGY, V279, P19, DOI 10.1016/j.tox.2010.07.002; David A, 2009, J APPL TOXICOL, V29, P597, DOI 10.1002/jat.1446; Fan CY, 2010, NEUROTOXICOL TERATOL, V32, P91, DOI 10.1016/j.ntt.2009.04.065; Giusi G, 2010, CRIT REV TOXICOL, V40, P620, DOI 10.3109/10408444.2010.487479; Gong Z, 2001, GENETICA, V111, P213, DOI 10.1023/A:1013796810782; Gustafsson H, 2010, TOXICOL APPL PHARM, V245, P191, DOI 10.1016/j.taap.2010.02.018; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Heaton MB, 2000, ALCOHOL CLIN EXP RES, V24, P512, DOI 10.1097/00000374-200004000-00026; Heaton MB, 2000, J NEUROBIOL, V45, P95, DOI 10.1002/1097-4695(20001105)45:2<95::AID-NEU4>3.3.CO;2-P; Hill A, 2012, DRUG METAB REV, V44, P127, DOI 10.3109/03602532.2011.645578; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hinz B, 2008, FASEB J, V22, P383, DOI 10.1096/fj.07-8506com; Janitzky K, 2007, BEHAV BRAIN RES, V182, P109, DOI 10.1016/j.bbr.2007.05.015; Johri A, 2008, TOXICOL APPL PHARM, V231, P10, DOI 10.1016/j.taap.2008.03.019; Kanungo J, 2011, J APPL TOXICOLOGY JA; Kanungo J, 2011, NEUROTOXICOL TERATOL, V33, P618, DOI 10.1016/j.ntt.2011.08.013; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; KENNEDY LA, 1986, NEUROTOXICOL TERATOL, V8, P11; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kondrychyn I, 2011, ZEBRAFISH, V8, P181, DOI 10.1089/zeb.2011.0718; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Maskell PD, 2001, BRIT J PHARMACOL, V132, P205, DOI 10.1038/sj.bjp.0703824; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; Peng HC, 2010, COMP BIOCHEM PHYS C, V151, P480, DOI 10.1016/j.cbpc.2010.02.004; Posadas I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015360; Sukardi H, 2011, EXPERT OPIN DRUG MET, V7, P579, DOI 10.1517/17425255.2011.562197; Sylvain NJ, 2010, NEUROTOXICOL TERATOL, V32, P472, DOI 10.1016/j.ntt.2010.03.001; Teixeira CE, 2005, EUR J PHARMACOL, V519, P146, DOI 10.1016/j.ejphar.2005.07.011; Ton C, 2006, BIRTH DEFECTS RES A, V76, P553, DOI 10.1002/bdra.20281; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; Varadi G, 2003, PHYSIOL PLANTARUM, V118, P47, DOI 10.1034/j.1399-3054.2003.00089.x; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Weigt S, 2010, TOXICOLOGY, V275, P36, DOI 10.1016/j.tox.2010.05.012; Yang DR, 2011, TOXICOL SCI, V121, P146, DOI 10.1093/toxsci/kfr028; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Yang LX, 2009, REPROD TOXICOL, V28, P245, DOI 10.1016/j.reprotox.2009.04.013	44	30	31	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55474	10.1371/journal.pone.0055474	http://dx.doi.org/10.1371/journal.pone.0055474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383332	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900039
J	Demichelis, VT; Vilcaes, AA; Iglesias-Bartolome, R; Ruggiero, FM; Daniotti, JL				Demichelis, Vanina Torres; Vilcaes, Aldo A.; Iglesias-Bartolome, Ramiro; Ruggiero, Fernando M.; Daniotti, Jose L.			Targeted Delivery of Immunotoxin by Antibody to Ganglioside GD3: A Novel Drug Delivery Route for Tumor Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; CHO-K1 CELLS; EXPRESSION; MELANOMA; CYTOTOXICITY; SELECTIVITY; SYNTHASE; PROTEIN	Gangliosides are sialic acid-containing glycolipids expressed on plasma membranes from nearly all vertebrate cells. The expression of ganglioside GD3, which plays essential roles in normal brain development, decreases in adults but is up regulated in neuroectodermal and epithelial derived cancers. R24 antibody, directed against ganglioside GD3, is a validated tumor target which is specifically endocytosed and accumulated in endosomes. Here, we exploit the internalization feature of the R24 antibody for the selective delivery of saporin, a ribosome-inactivating protein, to GD3-expressing cells [human (SK-Mel-28) and mouse (B16) melanoma cells and Chinese hamster ovary (CHO)-K1 cells]. This immunotoxin showed a specific cytotoxicity on tumor cells grew on 2D monolayers, which was further evident by the lack of any effect on GD3-negative cells. To estimate the potential antitumor activity of R24-saporin complex, we also evaluated the effect of the immunotoxin on the clonogenic growth of SK-Mel-28 and CHO-K1(GD3+) cells cultured in attachment-free conditions. A drastic growth inhibition (>80-90%) of the cell colonies was reached after 3 days of immunotoxin treatment. By the contrary, colonies continue to growth at the same concentration of the immuntoxin, but in the absence of R24 antibody, or in the absence of both immunotoxin and R24, undoubtedly indicating the specificity of the effect observed. Thus, the ganglioside GD3 emerge as a novel and attractive class of cell surface molecule for targeted delivery of cytotoxic agents and, therefore, provides a rationale for future therapeutic intervention in cancer.	[Demichelis, Vanina Torres; Vilcaes, Aldo A.; Iglesias-Bartolome, Ramiro; Ruggiero, Fernando M.; Daniotti, Jose L.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar	Iglesias-Bartolome, Ramiro/H-4460-2014	Iglesias-Bartolome, Ramiro/0000-0002-0792-1254	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT)	This work was supported in part by Grants from Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC) (www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (www.conicet.gov.ar) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (www.agencia.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the technical assistance of G. Schachner, S. Deza, C. Sampedro and C. Mas. Rab5-GFP and Lamp1-GFP were generously supplied by J. Bonifacino (NICHD, National Institute of Health, Bethesda, MD, USA). V.T.D. and A.A.V. are recipients of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina) Fellowships. F.M.R. is recipient of Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina) Fellowship. J.L.D. is Career Investigator of CONICET.	Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; Daniotti JL, 2000, J NEUROCHEM, V74, P1711, DOI 10.1046/j.1471-4159.2000.0741711.x; Daniotti JL, 2002, NEUROCHEM RES, V27, P1421, DOI 10.1023/A:1021684018665; Daniotti JL, 1997, INT J DEV NEUROSCI, V15, P767, DOI 10.1016/S0736-5748(97)00027-0; GRAVOTTA D, 1989, J NEUROCHEM, V52, P768, DOI 10.1111/j.1471-4159.1989.tb02521.x; Guillemard V, 2004, ONCOGENE, V23, P3613, DOI 10.1038/sj.onc.1207463; Guillemard V, 2001, CANCER RES, V61, P694; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; Lee FT, 2001, CANCER RES, V61, P4474; Lo ASY, 2010, CLIN CANCER RES, V16, P2769, DOI 10.1158/1078-0432.CCR-10-0043; Daniotti JL, 2011, IUBMB LIFE, V63, P513, DOI 10.1002/iub.477; Nasi ML, 1997, MELANOMA RES, V7, pS155; Polito I, 2004, LEUKEMIA, V18, P1215, DOI 10.1038/sj.leu.2403378; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; RAVINDRANATH M H, 1991, International Reviews of Immunology, V7, P303, DOI 10.3109/08830189109114877; SCHENGRUND CL, 1988, NEUROCHEM PATHOL, V8, P189; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; Thomas PB, 2002, J PEDIATR SURG, V37, P539, DOI 10.1053/jpsu.2002.30856	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55304	10.1371/journal.pone.0055304	http://dx.doi.org/10.1371/journal.pone.0055304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383146	Green Published, gold			2022-12-27	WOS:000314610600085
J	Hamilton, CM; Martinuzzi, S; Plantinga, AJ; Radeloff, VC; Lewis, DJ; Thogmartin, WE; Heglund, PJ; Pidgeon, AM				Hamilton, Christopher M.; Martinuzzi, Sebastian; Plantinga, Andrew J.; Radeloff, Volker C.; Lewis, David J.; Thogmartin, Wayne E.; Heglund, Patricia J.; Pidgeon, Anna M.			Current and Future Land Use around a Nationwide Protected Area Network	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; CLIMATE-CHANGE; MINIMIZING IMPACTS; SPECIES RICHNESS; HOUSING DENSITY; FOREST-COVER; TRADE-OFF; LANDSCAPE; CONSERVATION; HABITAT	Land-use change around protected areas can reduce their effective size and limit their ability to conserve biodiversity because land-use change alters ecological processes and the ability of organisms to move freely among protected areas. The goal of our analysis was to inform conservation planning efforts for a nationwide network of protected lands by predicting future land use change. We evaluated the relative effect of three economic policy scenarios on land use surrounding the U.S. Fish and Wildlife Service's National Wildlife Refuges. We predicted changes for three land-use classes (forest/range, crop/pasture, and urban) by 2051. Our results showed an increase in forest/range lands (by 1.9% to 4.7% depending on the scenario), a decrease in crop/pasture between 15.2% and 23.1%, and a substantial increase in urban land use between 28.5% and 57.0%. The magnitude of land-use change differed strongly among different USFWS administrative regions, with the most change in the Upper Midwestern US (approximately 30%), and the Southeastern and Northeastern US (25%), and the rest of the U.S. between 15 and 20%. Among our scenarios, changes in land use were similar, with the exception of our "restricted-urban-growth'' scenario, which resulted in noticeably different rates of change. This demonstrates that it will likely be difficult to influence land-use change patterns with national policies and that understanding regional land-use dynamics is critical for effective management and planning of protected lands throughout the U.S.	[Hamilton, Christopher M.; Martinuzzi, Sebastian; Radeloff, Volker C.; Pidgeon, Anna M.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Plantinga, Andrew J.] Oregon State Univ, Dept Agr & Resource Econ, Corvallis, OR 97331 USA; [Lewis, David J.] Univ Puget Sound, Dept Econ, Tacoma, WA 98416 USA; [Thogmartin, Wayne E.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA; [Heglund, Patricia J.] US Fish & Wildlife Serv, Upper Midwest Environm Sci Ctr, La Crosse, WI USA	University of Wisconsin System; University of Wisconsin Madison; Oregon State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Hamilton, CM (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	cmhamilton2@wisc.edu	Thogmartin, Wayne/A-4461-2008; Lewis, David J/I-5700-2013; Lewis, David/AFQ-9010-2022; Radeloff, Volker C/B-6124-2016; Lewis, David/AAH-4137-2022	Thogmartin, Wayne/0000-0002-2384-4279; Lewis, David J/0000-0002-2161-4189; Lewis, David/0000-0002-2161-4189; Radeloff, Volker C/0000-0001-9004-221X; Lewis, David/0000-0002-2161-4189	USGS-USFWS Science Support Partnership program [G10AC00352]	USGS-USFWS Science Support Partnership program	This work is supported by the USGS-USFWS Science Support Partnership program, grant #G10AC00352. More information about the funding organization can be found on the world wide web at http://www.usgs.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attum O, 2008, J ZOOL, V275, P245, DOI 10.1111/j.1469-7998.2008.00435.x; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bowen ME, 2009, BIOL CONSERV, V142, P3051, DOI 10.1016/j.biocon.2009.08.005; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Burgman MA, 2005, ECOLOGY, V86, P2007, DOI 10.1890/04-0906; Comber A, 2012, REMOTE SENS ENVIRON, V127, P237, DOI 10.1016/j.rse.2012.09.005; Coreau A, 2009, ECOL LETT, V12, P1277, DOI 10.1111/j.1461-0248.2009.01392.x; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; D'Eon R, 2002, CONSERV ECOL, V6; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Davis BE, 2010, WATERBIRDS, V33, P349, DOI 10.1675/063.033.0311; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fleishman E, 2011, BIOSCIENCE, V61, P290, DOI 10.1525/bio.2011.61.4.9; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Gagne SA, 2010, ECOL SOC, V15; Gagne SA, 2010, BASIC APPL ECOL, V11, P723, DOI 10.1016/j.baae.2010.09.001; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gavier-Pizarro GI, 2010, LANDSCAPE ECOL, V25, P1505, DOI 10.1007/s10980-010-9516-8; Griffith B, 2009, ENVIRON MANAGE, V44, P1043, DOI 10.1007/s00267-009-9323-7; Gude PH, 2007, ECOL APPL, V17, P1004, DOI 10.1890/05-1108; Haim D, 2011, CLIMATE CHANGE EC, V2; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hansen AJ, 2007, ECOL APPL, V17, P972, DOI 10.1890/05-1112; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Leinwand IIF, 2010, LANDSCAPE URBAN PLAN, V97, P182, DOI 10.1016/j.landurbplan.2010.05.009; Lubowski RN, 2006, J ENVIRON ECON MANAG, V51, P135, DOI 10.1016/j.jeem.2005.08.001; MAUSER DM, 1994, J WILDLIFE MANAGE, V58, P88, DOI 10.2307/3809553; Merenlender AM, 2009, CONSERV LETT, V2, P240, DOI 10.1111/j.1755-263X.2009.00073.x; Meretsky VJ, 2006, BIOSCIENCE, V56, P135, DOI 10.1641/0006-3568(2006)056[0135:NDICFT]2.0.CO;2; Nelson AC, 1996, LAND USE POLICY, V13, P241, DOI 10.1016/0264-8377(96)84555-8; Nelson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014327; Nusser SM, 1997, ENVIRON ECOL STAT, V4, P181, DOI 10.1023/A:1018574412308; Olden JD, 2004, J ANIM ECOL, V73, P1190, DOI 10.1111/j.0021-8790.2004.00889.x; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; Pijanowski BC, 2011, LANDSCAPE URBAN PLAN, V102, P102, DOI 10.1016/j.landurbplan.2011.03.014; Predick KI, 2008, J ECOL, V96, P91, DOI 10.1111/j.1365-2745.2007.01329.x; Radeloff VC, 2012, ECOL APPL, V22, P1036, DOI 10.1890/11-0306.1; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schulte LA, 2005, CONSERV BIOL, V19, P1944, DOI 10.1111/j.1523-1739.2005.00254.x; Scott JM, 2004, NAT RESOUR J, V44, P1041; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Smith B, 2000, CLIMATIC CHANGE, V45, P223, DOI 10.1023/A:1005661622966; Sohl TL, 2012, AGR ECOSYST ENVIRON, V153, P1, DOI 10.1016/j.agee.2012.02.019; Sohl TL, 2010, LANDSCAPE ECOL, V25, P233, DOI 10.1007/s10980-009-9391-3; Sohngen B, 1998, AM ECON REV, V88, P686; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Theobald DM, 2009, J HYDROL ENG, V14, P362, DOI 10.1061/(ASCE)1084-0699(2009)14:4(362); Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; van Vuuren DP, 2006, ECOL SOC, V11; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; White D, 1997, CONSERV BIOL, V11, P349, DOI 10.1046/j.1523-1739.1997.95458.x; Wiens JA, 2009, LANDSCAPE ECOL, V24, P1053, DOI 10.1007/s10980-008-9284-x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Woo M, 2011, URBAN STUD, V48, P3511, DOI 10.1177/0042098011399594	66	65	68	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55737	10.1371/journal.pone.0055737	http://dx.doi.org/10.1371/journal.pone.0055737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23383275	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600155
J	Paaijmans, KP; Cator, LJ; Thomas, MB				Paaijmans, Krijn P.; Cator, Lauren J.; Thomas, Matthew B.			Temperature-Dependent Pre-Bloodmeal Period and Temperature-Driven Asynchrony between Parasite Development and Mosquito Biting Rate Reduce Malaria Transmission Intensity	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; VECTORIAL CAPACITY; GONOTROPHIC CYCLES; MODEL; CULICIDAE; DURATION; DIPTERA; RISK	A mosquito needs to bite at least twice for malaria transmission to occur: once to acquire parasites and, after these parasites complete their development in their mosquito host, once to transmit the parasites to the next vertebrate host. Here we investigate the relationship between temperature, parasite development, and biting frequency in a mosquito-rodent malaria model system. We show that the pre-bloodmeal period (the time lag between mosquito emergence and first bloodmeal) increases at lower temperatures. In addition, parasite development time and feeding exhibit different thermal sensitivities such that mosquitoes might not be ready to feed at the point at which the parasite is ready to be transmitted. Exploring these effects using a simple theoretical model of human malaria shows that delays in infection and transmission can reduce the vectorial capacity of malaria mosquitoes by 20 to over 60%, depending on temperature. These delays have important implications for disease epidemiology and control, and should be considered in future transmission models.	Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Paaijmans, KP (corresponding author), Barcelona Ctr Int Hlth Res, Barcelona, Spain.	krijn@paaijmans.nl	Paaijmans, Krijn/ABC-9928-2020		NSF-EID program [EF-0914384]; NIH-NIAID ICEMR award [U19AI089676-01]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089676] Funding Source: NIH RePORTER	NSF-EID program(National Science Foundation (NSF)); NIH-NIAID ICEMR award; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a NSF-EID program grant (#EF-0914384) and NIH-NIAID ICEMR award (#U19AI089676-01). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health. This project was also assisted by a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], 1949, MALARIOLOGY; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591; Cator LJ, 2012, TRENDS PARASITOL, V28, P466, DOI 10.1016/j.pt.2012.08.004; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; Fernandes L, 2005, J VECTOR ECOL, V30, P11; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; Joy DA, 2008, MOL BIOL EVOL, V25, P1245, DOI 10.1093/molbev/msn073; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661; Lardeux FJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-141; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Napp S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-4; Norris LC, 2010, AM J TROP MED HYG, V83, P33, DOI 10.4269/ajtmh.2010.09-0296; Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Scott TW, 2006, AM J TROP MED HYG, V75, P231, DOI 10.4269/ajtmh.2006.75.231; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Stone CM, 2011, ANIM BEHAV, V81, P765, DOI 10.1016/j.anbehav.2011.01.008; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; [No title captured]	35	39	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55777	10.1371/journal.pone.0055777	http://dx.doi.org/10.1371/journal.pone.0055777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383280	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600157
J	Wang, ZY; Zhang, XW; Chen, SY; Wang, DF; Wu, J; Liang, TM; Liu, C				Wang, Zhuyao; Zhang, Xiwen; Chen, Siyu; Wang, Danfeng; Wu, Jun; Liang, Tingming; Liu, Chang			Lithium Chloride Inhibits Vascular Smooth Muscle Cell Proliferation and Migration and Alleviates Injury-Induced Neointimal Hyperplasia via Induction of PGC-1 alpha	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; INFLAMMATION; ATHEROSCLEROSIS; PHOSPHORYLATION; CYCLE	The proliferation and migration of vascular smooth muscle cells (VSMCs) contributes importantly to the development of instent restenosis. Lithium has recently been shown to have beneficial effects on the cardiovascular system, but its actions in VSMCs and the direct molecular target responsible for its action remains unknown. On the other hand, PGC-1 alpha is a transcriptional coactivator which negatively regulates the pathological activation of VSMCs. Therefore, the purpose of the present study is to determine if lithium chloride (LiCl) retards VSMC proliferation and migration and if PGC-1 alpha mediates the effects of lithium on VSMCs. We found that pretreatment of LiCl increased PGC-1 alpha protein expression and nuclear translocation in a dose-dependent manner. MTT and EdU incorporation assays indicated that LiCl inhibited serum-induced VSMC proliferation. Similarly, deceleration of VSMC migration was confirmed by wound healing and transwell assays. LiCl also suppressed ROS generation and cell cycle progression. At the molecular level, LiCl reduced the protein expression levels or phosphorylation of key regulators involved in the cell cycle re-entry, adhesion, inflammation and motility. In addition, in vivo administration of LiCl alleviated the pathophysiological changes in balloon injury-induced neointima hyperplasia. More importantly, knockdown of PGC-1 alpha by siRNA significantly attenuated the beneficial effects of LiCl on VSMCs both in vitro and in vivo. Taken together, our results suggest that LiCl has great potentials in the prevention and treatment of cardiovascular diseases related to VSMC abnormal proliferation and migration. In addition, PGC-1 alpha may serve as a promising drug target to regulate cardiovascular physiological homeostasis.	[Wang, Zhuyao; Chen, Siyu; Wang, Danfeng; Liang, Tingming; Liu, Chang] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wang, Zhuyao; Chen, Siyu; Wang, Danfeng; Liang, Tingming; Liu, Chang] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiwen] Nanjing Med Univ, Dept Cardiol, Huaian Peoples Hosp 1, Huaian, Jiangsu, Peoples R China; [Wu, Jun] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Nanjing Medical University; Nanjing Medical University	Liu, C (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	changliu@njnu.edu.cn	Liang, Tingming/ACL-6141-2022	Chen, Siyu/0000-0002-3809-1062	National Basic Research Program of China [2012CB947600]; Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET); National Natural Science Foundation of China [31171137, 31271261]; Key Project of Chinese Ministry of Education [211062]; Research Fund for the Doctoral Program of Higher Education of China [20103207110007]; Fok Ying Tong Education Foundation [121022]; Major Program of Educational Commission of Jiangsu Province [09KJA180004]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); Major Program of Educational Commission of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Basic Research Program of China (973 Program) (2012CB947600), the Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET), the National Natural Science Foundation of China (31171137, 31271261), the Key Project of Chinese Ministry of Education (211062), the Research Fund for the Doctoral Program of Higher Education of China (20103207110007), the Fok Ying Tong Education Foundation (121022), the Major Program of Educational Commission of Jiangsu Province (09KJA180004) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761; [Anonymous], 2004, NAT REV DRUG DISCOV, V3, P101, DOI 10.1038/nrd1315; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Choi SE, 2010, VASC PHARMACOL, V53, P264, DOI 10.1016/j.vph.2010.09.004; De Meyer I, 2011, BRIT J PHARMACOL, V162, P1410, DOI 10.1111/j.1476-5381.2010.01152.x; Dickson M, 2004, NAT REV DRUG DISCOV, V3, P417, DOI 10.1038/nrd1382; GORDON D, 1986, CIRC RES, V59, P633, DOI 10.1161/01.RES.59.6.633; Holm PW, 2009, ANN MED, V41, P257, DOI 10.1080/07853890802516507; Hsueh WA, 1999, AM J CARDIOL, V84, p21J; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Jiang XH, 2010, MOL CELL ENDOCRINOL, V315, P74, DOI 10.1016/j.mce.2009.09.018; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Komatsu R, 1998, CIRCULATION, V98, P224, DOI 10.1161/01.CIR.98.3.224; Kornowski R, 1997, CIRCULATION, V95, P1366; Lee HJ, 2008, FEBS LETT, V582, P627, DOI 10.1016/j.febslet.2008.01.033; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Licht RW, 2012, CNS NEUROSCI THER, V18, P219, DOI 10.1111/j.1755-5949.2011.00260.x; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; O'Neal JH, 2010, HDB REHABILITATION P, P195; Qu AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC645, DOI 10.1152/ajpcell.00469.2008; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Serretti A, 2009, CURR MED CHEM, V16, P1917, DOI 10.2174/092986709788186101; Shao L, 2005, BIOL PSYCHIAT, V58, P879, DOI 10.1016/j.biopsych.2005.04.052; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Struewing IT, 2007, FEBS J, V274, P2749, DOI 10.1111/j.1742-4658.2007.05809.x; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Wang Y, 2009, BRIT J PHARMACOL, V157, P1004, DOI 10.1111/j.1476-5381.2009.00284.x; Yuskaitis CJ, 2009, CELL SIGNAL, V21, P264, DOI 10.1016/j.cellsig.2008.10.014; Zhang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001137; Zhu L, 2009, IEEE PHOTONICS J, V1, P1, DOI 10.1109/JPHOT.2009.2020963	37	28	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55471	10.1371/journal.pone.0055471	http://dx.doi.org/10.1371/journal.pone.0055471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383200	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600109
J	Dang, BN; Westbrook, RA; Black, WC; Rodriguez-Barradas, MC; Giordano, TP				Dang, Bich N.; Westbrook, Robert A.; Black, William C.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.			Examining the Link between Patient Satisfaction and Adherence to HIV Care: A Structural Equation Model	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SCREENING-TEST; UNITED-STATES; METAANALYSIS; RETENTION; QUESTION; ASSOCIATION; GUIDELINES; AMERICA; ENTRY	Introduction Analogous to the business model of customer satisfaction and retention, patient satisfaction could serve as an innovative, patient-centered focus for increasing retention in HIV care and adherence to HAART, and ultimately HIV suppression. Objective: To test, through structural equation modeling (SEM), a model of HIV suppression in which patient satisfaction influences HIV suppression indirectly through retention in HIV care and adherence to HAART. Methods: We conducted a cross-sectional study of adults receiving HIV care at two clinics in Texas. Patient satisfaction was based on two validated items, one adapted from the Consumer Assessment of Healthcare Providers and Systems survey ("Would you recommend this clinic to other patients with HIV?) and one adapted from the Delighted-Terrible Scale, ("Overall, how do you feel about the care you got at this clinic in the last 12 months?''). A validated, single-item question measured adherence to HAART over the past 4 weeks. Retention in HIV care was based on visit constancy in the year prior to the survey. HIV suppression was defined as plasma HIV RNA,48 copies/mL at the time of the survey. We used SEM to test hypothesized relationships. Results: The analyses included 489 patients (94% of eligible patients). The patient satisfaction score had a mean of 8.5 (median 9.2) on a 0- to 10-point scale. A total of 46% reported "excellent'' adherence, 76% had adequate retention, and 70% had HIV suppression. In SEM analyses, patient satisfaction with care influences retention in HIV care and adherence to HAART, which in turn serve as key determinants of HIV suppression (all p,. 0001). Conclusions: Patient satisfaction may have direct effects on retention in HIV care and adherence to HAART. Interventions to improve the care experience, without necessarily targeting objective clinical performance measures, could serve as an innovative method for optimizing HIV outcomes.	[Dang, Bich N.; Giordano, Thomas P.] Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX USA; [Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Dang, Bich N.; Rodriguez-Barradas, Maria C.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Dang, Bich N.; Giordano, Thomas P.] Harris Hlth Syst, Houston, TX USA; [Westbrook, Robert A.] Rice Univ, Jesse H Jones Grad Sch Business, Houston, TX USA; [Black, William C.] Louisiana State Univ, EJ Ourso Coll Business, Baton Rouge, LA 70803 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University; Louisiana State University System; Louisiana State University	Dang, BN (corresponding author), Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX USA.	bndang@bcm.edu		Giordano, Thomas/0000-0002-9346-5530	Department of Veterans Affairs; Veterans Health Administration; Office of Research and Development; Houston VA Health Services Research and Development Center of Excellence [HFP90-020]	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Houston VA Health Services Research and Development Center of Excellence	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and the Houston VA Health Services Research and Development Center of Excellence (HFP90-020). This material was also supported in part by the facilities and resources of Harris Health System, Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; ANDREWS FM, 1976, SOC INDIC RES, V3, P1, DOI 10.1007/BF00286161; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Baker R, 1996, BRIT J GEN PRACT, V46, P601; Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; CAHPS clinician & group survey adult primary care instrument, CAHPS CLIN GROUP SUR; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; COPE DW, 1986, J GEN INTERN MED, V1, P394, DOI 10.1007/BF02596425; Crow R, 2002, Health Technol Assess, V6, P1; Dang BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042980; Davies AR, 1981, R2711HHS RAND CORP; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gardner LI, 2012, CLIN INFECT DIS, V55, P1124, DOI 10.1093/cid/cis623; Giordano TP, 2010, AIDS PATIENT CARE ST, V24, P287, DOI 10.1089/apc.2009.0332; Hair J., 2010, MULTIVARIATE DATA AN, V7; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kane RL, 2005, UNDERSTANDING HLTH C; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Markus KA, 2010, STRUCT EQU MODELING, V17, P654, DOI 10.1080/10705511.2010.510068; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mittal V., 2010, MSI FAST FORWARD SER; MORRELL DC, 1986, BMJ-BRIT MED J, V292, P870, DOI 10.1136/bmj.292.6524.870; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; National Council on Patient Information and Education, 2007, ENH PRESCR MED ADH N; Netemeyer R.G., 2003, SCALING PROCEDURES I; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Parienti JJ, 2009, CLIN INFECT DIS, V48, P484, DOI 10.1086/596482; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rumptz MH, 2007, AIDS PATIENT CARE ST, V21, pS30, DOI 10.1089/apc.2007.9989; Simoni Jane M, 2008, Curr Infect Dis Rep, V10, P515, DOI 10.1007/s11908-008-0083-y; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Watkins CL, 2007, CLIN REHABIL, V21, P846, DOI 10.1177/0269215507079846; Wilson IB, 2010, JAIDS-J ACQ IMM DEF, V53, P338, DOI 10.1097/QAI.0b013e3181c7a245; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; Yedidia MJ, 2003, JAMA-J AM MED ASSOC, V290, P1157, DOI 10.1001/jama.290.9.1157	46	101	106	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54729	10.1371/journal.pone.0054729	http://dx.doi.org/10.1371/journal.pone.0054729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382948	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800070
J	Kishimoto, N; Nagai, J; Kinoshita, T; Ueno, K; Ohashi, Y; Mitsuhara, I				Kishimoto, Naoki; Nagai, Jun-ichi; Kinoshita, Takehito; Ueno, Keiichiro; Ohashi, Yuko; Mitsuhara, Ichiro			DNA Elements Reducing Transcriptional Gene Silencing Revealed by a Novel Screening Strategy	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; TOBACCO PLANTS; ARABIDOPSIS-THALIANA; TRANSGENIC RICE; CELL-DEATH; METHYLATION; EXPRESSION; INACTIVATION; ACCUMULATION; MECHANISMS	Transcriptional gene silencing (TGS)-a phenomenon observed in endogenous genes/transgenes in eukaryotes-is a huge hindrance to transgenic technology and occurs mainly when the genes involved share sequence homology in their promoter regions. TGS depends on chromosomal position, suggesting the existence of genomic elements that suppress TGS. However, no systematic approach to identify such DNA elements has yet been reported. Here, we developed a successful novel screening strategy to identify such elements (anti-silencing regions-ASRs), based on their ability to protect a flanked transgene from TGS. A silenced transgenic tobacco plant in which a subsequently introduced transgene undergoes obligatory promoter-homology dependent TGS in trans allowed the ability of DNA elements to prevent TGS to be used as the screening criterion. We also identified ASRs in a genomic library from a different plant species (Lotus japonicus: a perennial legume); the ASRs include portions of Ty1/copia retrotransposon-like and pararetrovirus-like sequences; the retrotransposon-like sequences also showed interspecies anti-TGS activity in a TGS-induction system in Arabidopsis. Anti-TGS elements could provide effective tools to reduce TGS and ensure proper regulation of transgene expression. Furthermore, the screening strategy described here will also facilitate the efficient identification of new classes of anti-TGS elements.	[Kishimoto, Naoki] NIAS, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan; [Nagai, Jun-ichi] Kagoshima Prefectural Inst Agr Dev KIAD, Tokunoshima Branch, Isen, Kagoshima, Japan; [Kinoshita, Takehito] Saga Prefectural Agr Res Ctr, Vegetable Flower & Ornamental Plant Div, Saga, Japan; [Ueno, Keiichiro] KIAD, Kumage Branch, Nishinoomote City, Kagoshima, Japan; [Ohashi, Yuko; Mitsuhara, Ichiro] NIAS, Div Plant Sci, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Mitsuhara, I (corresponding author), NIAS, Div Plant Sci, Tsukuba, Ibaraki, Japan.	mituhara@affrc.go.jp		Mitsuhara, Ichiro/0000-0001-8750-5017	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN)	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN)	This work was supported, in part, by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Brasset E, 2010, GENE, V450, P25, DOI 10.1016/j.gene.2009.09.015; Buchmann RC, 2009, J VIROL, V83, P5005, DOI 10.1128/JVI.01771-08; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; David Allis C., 2007, EPIGENETICS-US; FINNEGAN J, 1994, BIO-TECHNOL, V12, P883, DOI 10.1038/nbt0994-883; Fukuoka H, 2000, PLANT CELL REP, V19, P815, DOI 10.1007/s002990000191; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Hagan ND, 2003, PLANT BIOTECHNOL J, V1, P479, DOI 10.1046/j.1467-7652.2003.00043.x; Hisahara S, 1998, J CELL SCI, V111, P667; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kawahigashi H, 2007, J AGR FOOD CHEM, V55, P1241, DOI 10.1021/jf062339w; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kobayashi M, 2010, MOL PLANT MICROBE IN, V23, P1032, DOI 10.1094/MPMI-23-8-1032; Lisch D, 2011, INT REV CEL MOL BIO, V292, P119, DOI 10.1016/B978-0-12-386033-0.00003-7; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; Matzke MA, 1999, GENETICA, V107, P271, DOI 10.1023/A:1003921710672; Matzke Marjori A, 2002, Adv Genet, V46, P235; Mitsuhara I, 1999, CURR BIOL, V9, P775, DOI 10.1016/S0960-9822(99)80341-8; Mitsuhara I, 2002, GENETICS, V160, P343; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Mitsuhara I., 2006, PLANT BIOTECHNOLOGY, V23, P63, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.23.63; Mochizuki A, 1999, ENTOMOL EXP APPL, V93, P173, DOI 10.1023/A:1003849003354; Ohmido N, 2010, CHROMOSOME RES, V18, P287, DOI 10.1007/s10577-009-9103-5; Park YD, 1996, PLANT J, V9, P183, DOI 10.1046/j.1365-313X.1996.09020183.x; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Sasaki K, 2006, PLANT MOL BIOL, V62, P753, DOI 10.1007/s11103-006-9055-5; Seo S, 2011, PLANT PHYSIOL, V155, P502, DOI 10.1104/pp.110.162412; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P687, DOI 10.1093/nar/18.3.687; Sokal RR, 1995, BIOMETRY; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Thierry D, 1996, PLANT MOL BIOL, V32, P1075, DOI 10.1007/BF00041391; Tzfira T, 2004, TRENDS GENET, V20, P375, DOI 10.1016/j.tig.2004.06.004; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Wassenegger M, 2002, INT REV CYTOL, V219, P61; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Wolffe AP, 1997, CURR BIOL, V7, pR796, DOI 10.1016/S0960-9822(06)00408-8; Zar JH, 1999, BIOSTATISTICAL ANAL	42	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54670	10.1371/journal.pone.0054670	http://dx.doi.org/10.1371/journal.pone.0054670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382937	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800062
J	Yang, XF; Norma-Rashid, Y; Lourenco, WR; Zhu, MS				Yang, Xiaofeng; Norma-Rashid, Yusoff; Lourenco, Wilson R.; Zhu, Mingsheng			True Lateral Eye Numbers for Extant Buthids: A New Discovery on an Old Character	PLOS ONE			English	Article							MESOBUTHUS SCORPIONES BUTHIDAE; GENUS; CHINA; SYSTEMATICS	This study reports the results of a re-analysis of the number of lateral eyes in extant buthids. Specimens studied were confined mostly to those from China and the adjacent areas. 353 specimens belonging to 20 species (subspecies) and 8 genera were rechecked and found to have 5 pairs of lateral eyes contrary to earlier published works which reported the presence of 3 pairs of lateral eyes only. Combined with reported examples collected through reference investigation including 63 species from 16 genera, our study here shows a total of 79 species from 21 genera of scorpions spanning Asia and Africa had 5 pairs of lateral eyes. Reasons for not observing the presence of the extra lateral eyes are discussed and new protocols for examining specimens including using UV light are proposed to aid lateral eye recognition. Besides, a majority of genera in Buthidae are suggested to be in "Five-eye" model and a re-examination of all previously published taxonomic studies of buthid species is highly recommended.	[Yang, Xiaofeng; Zhu, Mingsheng] Hebei Univ, Coll Life Sci, Baoding, Hebei Province, Peoples R China; [Norma-Rashid, Yusoff] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Norma-Rashid, Yusoff] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Lourenco, Wilson R.] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France	Hebei University; Universiti Malaya; Harvard University; Museum National d'Histoire Naturelle (MNHN)	Yang, XF (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Hebei Province, Peoples R China.	YangxiaofengChina@yahoo.com	Norma-Rashid, Y/B-8028-2010	Norma-Rashid, Y/0000-0002-1450-1995				Birula A. A., 1911, Revue Russe d'Entomologie, V11; Birula A.A., 1904, ANNUAIRE MUSEE ZOOLO, V9, P20; Birula A.A., 1897, ANNUAIRE MUSEE ZOOLO, V2, P377; Birula A.A., 1917, MEMOIRES MUSEE CAUCA, V5, P1; Di ZY, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.82.715; Fet V, 2000, CATALOG OF THE SCORP; Fet Victor, 2003, Euscorpius, V4, P1; Finnegan S., 1932, Journal of the Linnean Society London, VVol. 38, P91; FLEISSNER G, 1977, J COMP PHYSIOL, V118, P101, DOI 10.1007/BF00612340; FLEISSNER G, 1974, J COMP PHYSIOL, V91, P399, DOI 10.1007/BF00694470; Kishida K, 1933, REPORT OF THE FIRST, V1, P49; Kjellesvig-Waering E. N., 1986, RESTUDY FOSSIL SCORP; Koch CL, 1837, UBERSICHT DES ARACHN; Kovaiik F, 2004, EUSCORPIUS, V16, P1, DOI DOI 10.18590/EUSCORPIUS.2004.VOL2004; Lankester E. R., 1883, Q J MICROSC SCI, V23, P177; Lankester ER, 1885, T ZOOL SOC LONDON, V11, P372; Lourenco W. R., 2010, Boletin de la S.E.A., P307; Lourenco W. R., 2005, CHINA BOLETIN SOCIED, V36, P57; Lourenco Wilson R., 2004, Revista Iberica de Aracnologia, V10, P225; Lourenco Wilson R., 2012, Boletin de la SEA, V50, P187; Lourenco Wilson R., 2010, Journal of Hebei University Natural Science Edition, V30, P307; Lourenco Wilson R., 2009, Boletin de la SEA, V44, P71; Lourenco Wilson R., 2008, Acta Zootaxonomica Sinica, V33, P264; Lourenco Wilson R., 2006, Boletin de la SEA, P59; Lourenco WR, 2005, ZOOTAXA, P1; Lowe G., 2009, EUSCORPIUS, V90, P1, DOI [10.18590/euscorpius.2009.vol2009.iss90.1, DOI 10.18590/EUSCORPIUS.2009.VOL2009.ISS90.1]; Lowe G, 2010, NORTHERN OMAN EUSCOR, P1; MAQSOOD JAVED S. M., 2010, EUSCORPIUS, V98, P1; Mirshamsi O, 2011, ZOOTAXA, P1; Mirza Zeeshan A., 2010, Journal of Threatened Taxa, V2, P789; Navidpour S, 2009, J ARACHNOL, V37, P45, DOI 10.1636/H08-44.1; Polis GA, 1990, BIOL SCORPIONS, pxxiii; Prendini L, 2004, J ARACHNOL, V32, P109, DOI 10.1636/H03-17; Prendini L, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)408<0001:DOTMOP>2.0.CO;2; Prendini L, 2004, ANN ENTOMOL SOC AM, V97, P37, DOI 10.1603/0013-8746(2004)097[0037:SOTGPK]2.0.CO;2; Prendini L, 2010, ZOOL J LINN SOC-LOND, V159, P673, DOI 10.1111/j.1096-3642.2009.00608.x; Qi Jian-Xin, 2004, Revista Iberica de Aracnologia, V10, P137; Qi JX, 2007, CR BIOL, V330, P80, DOI 10.1016/j.crvi.2006.09.005; Rein JO, 2012, THE SCORPION FILES; SCHLIWA M, 1980, CELL TISSUE RES, V206, P95, DOI 10.1007/BF00233611; Soleglad Michael E., 2003, Euscorpius, V11, P1; Spreitzer A, 2003, ZOOL ANZ, V242, P137, DOI 10.1078/0044-5231-00098; Stockwell SA, 1989, THESIS; Sun D, 2011, J ARACHNOL, V39, P59, DOI 10.1636/Ha10-36.1; Sun D, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.37.301; Sun D, 2010, J ARACHNOL, V38, P35, DOI 10.1636/Ha09-39.1; Sureshan P. M., 2007, Zoos Print Journal, V22, P2903; Teruel R, 2010, NEW HOTTENTOTTA BIRU, P1; Tikader BK, 1983, FAUNA OF INDIA SCORP, VIII; VACHON MAX, 1958, VIDENSK MEDDEL DANSK NATURHIST FOR KOBENHAVN, V120, P121; Zambre A. M., 2010, Boletin de la S.E.A., P115; Zambre Amod M., 2011, Euscorpius, V107, P1; Zambre Amod M., 2009, Journal of Threatened Taxa, V1, P621	53	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55125	10.1371/journal.pone.0055125	http://dx.doi.org/10.1371/journal.pone.0055125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383077	Green Published, gold			2022-12-27	WOS:000315563800114
J	Panouilleres, M; Gaveau, V; Socasau, C; Urquizar, C; Pelisson, D				Panouilleres, Muriel; Gaveau, Valerie; Socasau, Camille; Urquizar, Christian; Pelisson, Denis			Brain Processing of Visual Information during Fast Eye Movements Maintains Motor Performance	PLOS ONE			English	Article							SACCADE GAIN ADAPTATION; ADAPTIVE-CONTROL; SENSORIMOTOR ADAPTATION; ERROR; MECHANISMS; PLASTICITY; SYSTEM; SIGNALS; HUMANS; LOCALIZATION	Movement accuracy depends crucially on the ability to detect errors while actions are being performed. When inaccuracies occur repeatedly, both an immediate motor correction and a progressive adaptation of the motor command can unfold. Of all the movements in the motor repertoire of humans, saccadic eye movements are the fastest. Due to the high speed of saccades, and to the impairment of visual perception during saccades, a phenomenon called "saccadic suppression", it is widely believed that the adaptive mechanisms maintaining saccadic performance depend critically on visual error signals acquired after saccade completion. Here, we demonstrate that, contrary to this widespread view, saccadic adaptation can be based entirely on visual information presented during saccades. Our results show that visual error signals introduced during saccade execution-by shifting a visual target at saccade onset and blanking it at saccade offset-induce the same level of adaptation as error signals, presented for the same duration, but after saccade completion. In addition, they reveal that this processing of intra-saccadic visual information for adaptation depends critically on visual information presented during the deceleration phase, but not the acceleration phase, of the saccade. These findings demonstrate that the human central nervous system can use short intra-saccadic glimpses of visual information for motor adaptation, and they call for a reappraisal of current models of saccadic adaptation.	[Panouilleres, Muriel; Gaveau, Valerie; Urquizar, Christian; Pelisson, Denis] CNRS, INSERM, U1028, Lyon Neurosci Res Ctr,ImpAct Team,UMR5292, Lyon, France; [Panouilleres, Muriel; Gaveau, Valerie; Socasau, Camille; Urquizar, Christian; Pelisson, Denis] Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Panouilleres, M (corresponding author), CNRS, INSERM, U1028, Lyon Neurosci Res Ctr,ImpAct Team,UMR5292, Lyon, France.	muriel.panouilleres@inserm.fr	Pelisson, Denis/H-2916-2017; GAVEAU, Valérie VG/H-4779-2017	Pelisson, Denis/0000-0002-9114-7758; GAVEAU, Valérie VG/0000-0002-2255-5766; Panouilleres, Muriel/0000-0003-0264-2093	Institut National de la Sante et de la Recherche Medicale (INSERM) [U1028]; Region Rhone-Alpes [CLUSTER 11]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM) U1028 and by Region Rhone-Alpes (CLUSTER 11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL LA, 1978, ANN NEUROL, V4, P313, DOI 10.1002/ana.410040405; Alabyane N, 2004, INVEST OPHTH VIS SCI, V45, P123, DOI 10.1167/iovs.03-0570; Anand S, 2002, EXP BRAIN RES, V142, P335, DOI 10.1007/s00221-001-0937-0; Bahcall DO, 2000, VISION RES, V40, P2779, DOI 10.1016/S0042-6989(00)00117-6; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; BECKER W, 1969, VISION RES, V9, P1247, DOI 10.1016/0042-6989(69)90112-6; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; Cameron BD, 2009, EXP BRAIN RES, V195, P445, DOI 10.1007/s00221-009-1812-7; Catz N, 2008, P NATL ACAD SCI USA, V105, P7309, DOI 10.1073/pnas.0706032105; Collins T, 2012, J NEUROPHYS IN PRESS; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; DEUBEL H, 1986, HUM NEUROBIOL, V5, P245; Eggert T, 1999, EXP BRAIN RES, V129, P161, DOI 10.1007/s002210050947; Ethier V, 2008, J NEUROSCI, V28, P13929, DOI 10.1523/JNEUROSCI.3470-08.2008; Fujita M, 2002, COGNITIVE BRAIN RES, V13, P41, DOI 10.1016/S0926-6410(01)00088-X; Gaveau V, 2003, NEUROREPORT, V14, P875, DOI 10.1097/00001756-200305060-00020; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; HALLETT PE, 1976, VISION RES, V16, P99, DOI 10.1016/0042-6989(76)90083-3; Hamker FH, 2011, PHILOS T R SOC B, V366, P554, DOI 10.1098/rstb.2010.0229; Hernandez TD, 2008, J VISION, V8, DOI 10.1167/8.8.3; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Iwamoto Y, 2010, EXP BRAIN RES, V204, P145, DOI 10.1007/s00221-010-2314-3; Jing T, 2009, ANN NY ACAD SCI, V1164, P166, DOI 10.1111/j.1749-6632.2009.03853.x; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; KOMMERELL G, 1976, INVEST OPHTH VISUAL, V15, P657; Krekelberg B, 2010, CURR BIOL, V20, pR228, DOI 10.1016/j.cub.2009.12.018; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MILLER JM, 1981, J EXP PSYCHOL HUMAN, V7, P356, DOI 10.1037/0096-1523.7.2.356; Noto CT, 1999, J NEUROPHYSIOL, V81, P2798, DOI 10.1152/jn.1999.81.6.2798; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; OPTICAN LM, 1980, J NEUROPHYSIOL, V44, P1058, DOI 10.1152/jn.1980.44.6.1058; Panouilleres M, 2012, HUM BRAIN MAPP, V33, P1512, DOI 10.1002/hbm.21301; Panouilleres M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017329; Panouilleres M, 2009, J NEUROPHYSIOL, V101, P1550, DOI 10.1152/jn.90988.2008; Pelisson D, 2010, NEUROSCI BIOBEHAV R, V34, P1103, DOI 10.1016/j.neubiorev.2009.12.010; PRABLANC C, 1978, VISION RES, V18, P557, DOI 10.1016/0042-6989(78)90202-X; Prsa M, 2011, EUR J NEUROSCI, V33, P2114, DOI 10.1111/j.1460-9568.2011.07693.x; Prsa M, 2010, J NEUROSCI, V30, P15834, DOI 10.1523/JNEUROSCI.3901-10.2010; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Schnier F, 2012, J NEUROPHYS IN PRESS; Schnier F, 2011, J NEUROPHYSIOL, V106, P1399, DOI 10.1152/jn.00236.2011; Seeberger T, 2002, BRAIN RES, V956, P374, DOI 10.1016/S0006-8993(02)03577-1; SEMMLOW JL, 1989, J EXP PSYCHOL HUMAN, V15, P249, DOI 10.1037/0096-1523.15.2.249; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; STRAUBE A, 1995, VISION RES, V35, P3451, DOI 10.1016/0042-6989(95)00076-Q; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Wurtz R. H, 1989, NEUROBIOLOGY SACCADI; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Zimmermann E, 2010, J VISION, V10, DOI 10.1167/10.6.2	53	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54641	10.1371/journal.pone.0054641	http://dx.doi.org/10.1371/journal.pone.0054641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382932	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200014
J	Overbeek, SA; Braber, S; Koelink, PJ; Henricks, PAJ; Mortaz, E; Loi, ATL; Jackson, PL; Garssen, J; Wagenaar, GTM; Timens, W; Koenderman, L; Blalock, JE; Kraneveld, AD; Folkerts, G				Overbeek, Saskia A.; Braber, Saskia; Koelink, Pim J.; Henricks, Paul A. J.; Mortaz, Esmaeil; Loi, Adele T. LoTam; Jackson, Patricia L.; Garssen, Johan; Wagenaar, Gerry T. M.; Timens, Wim; Koenderman, Leo; Blalock, J. Edwin; Kraneveld, Aletta D.; Folkerts, Gert			Cigarette Smoke-Induced Collagen Destruction; Key to Chronic Neutrophilic Airway Inflammation?	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INDUCED SPUTUM; COPD; LUNG; CHEMOATTRACTANT; EXACERBATION; BURDEN; ROLES; MICE; PGP	Background: Cigarette smoking induces inflammatory responses in all smokers and is the major risk factor for lung disease such as chronic obstructive pulmonary disease (COPD). In this progressive disease, chronic inflammation in the lung contributes to lung tissue destruction leading to the formation of chemotactic collagen fragments such as N-acetylated Proline-Glycine-Proline (N-ac-PGP). The generation of this tripeptide is mediated by a multistep pathway involving matrix metalloproteases (MMPs) 8 and 9 and prolyl endopeptidase (PE). Here we investigated whether cigarette smoke extract (CSE) stimulates human PMNs to breakdown whole matrix collagen leading to the generation of the chemotactic collagen fragment N-ac-PGP. Methodology/Principal Findings: Incubating PMNs with CSE led to the release of chemo-attractant CXCL8 and proteases MMP8 and MMP9. PMNs constitutively expressed PE activity as well as PE protein. Incubating CSE-primed PMNs with collagen resulted in collagen breakdown and in N-ac-PGP generation. Incubation of PMNs with the tripeptide N-ac-PGP resulted in the release of CXCL8, MMP8 and MMP9. Moreover, we tested whether PMNs from COPD patients are different from PMNs from healthy donors. Here we show that the intracellular basal PE activity of PMNs from COPD patients increased 25-fold compared to PMNs from healthy donors. Immunohistological staining of human lung tissue for PE showed that besides neutrophils, macrophages and epithelial cells express PE. Conclusions: This study indicates that neutrophils activated by cigarette smoke extract can breakdown collagen into N-ac-PGP and that this collagen fragment itself can activate neutrophils, which may lead in vivo to a self-propagating cycle of neutrophil infiltration, chronic inflammation and lung emphysema. MMP-, PE-or PGP-inhibitors can serve as an attractive therapeutic target and may open new avenues towards effective treatment of COPD.	[Overbeek, Saskia A.; Braber, Saskia; Koelink, Pim J.; Henricks, Paul A. J.; Mortaz, Esmaeil; Garssen, Johan; Kraneveld, Aletta D.; Folkerts, Gert] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Mortaz, Esmaeil; Koenderman, Leo] Shahid Beheshti Univ Med Sci, Chron Resp Dis Res Ctr, NRITLD, Masih Daneshvari Hosp, Tehran, Iran; [Loi, Adele T. LoTam; Blalock, J. Edwin] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Jackson, Patricia L.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Jackson, Patricia L.] Univ Alabama Birmingham, Dept Med, UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Garssen, Johan] Danone Res Ctr Specialised Nutr, Wageningen, Netherlands; [Wagenaar, Gerry T. M.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands	Utrecht University; Shahid Beheshti University Medical Sciences; Utrecht University; Utrecht University Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Danone Nutricia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Folkerts, G (corresponding author), Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands.	G.Folkerts@uu.nl	Henricks, Paul/I-8255-2016; Kraneveld, Aletta D/J-3351-2016; Timens, Wim/K-5570-2013; Koenderman, Leo/AAE-7870-2020; Wagenaar, Gerry/GRS-3567-2022; garssen, johan/I-7159-2016; mortaz, esmael/G-7647-2017	Kraneveld, Aletta D/0000-0001-9819-383X; Timens, Wim/0000-0002-4146-6363; Koenderman, Leo/0000-0002-5636-6453; mortaz, esmael/0000-0002-6689-3556; Mortaz, Esmaeil/0000-0003-0250-087X; Blalock, J. Edwin/0000-0001-5303-8123; Wagenaar, Gerry/0000-0001-5716-6018	Dutch Top Institute Pharma [T1.103]; National Heart, Lung and Blood Institute [HL07783, HL090999, HL087824]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090999, R01HL087824, R01HL114439, F33HL007783, R01HL077783, R01HL110950] Funding Source: NIH RePORTER	Dutch Top Institute Pharma; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was performed within the framework of Dutch Top Institute Pharma (project number T1.103). This study was supported in part by National Heart, Lung and Blood Institute grants HL07783, HL090999, and HL087824 to J.E.B. The content is solely the responsibility of the authors and does not necessarily represent views of the National Heart, Lung and Blood Institute or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2010, MED PRIN PRACT, V19, P330, DOI 10.1159/000316368; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BAZZONI F, 1991, J EXP MED, V173, P771, DOI 10.1084/jem.173.3.771; Beeh KM, 2003, CHEST, V123, P1240, DOI 10.1378/chest.123.4.1240; Braber S, 2011, PATHOGENESIS LUNG EM; Braber S, 2011, EUR J PHARMACOL, V668, P443, DOI 10.1016/j.ejphar.2011.03.025; Braber S, 2011, AM J PHYSIOL-LUNG C, V300, pL255, DOI 10.1152/ajplung.00304.2010; BRUNNEMANN KD, 1991, CRIT REV TOXICOL, V21, P235, DOI 10.3109/10408449109017910; Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457; Henson PM, 2006, NAT MED, V12, P280, DOI 10.1038/nm0306-280; Ilumets H, 2008, SCAND J CLIN LAB INV, V68, P618, DOI 10.1080/00365510801983773; Ilumets Helen, 2007, Int J Chron Obstruct Pulmon Dis, V2, P369; Karimi K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-66; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Louhelainen Noora, 2009, BMC Pulm Med, V9, P25, DOI 10.1186/1471-2466-9-25; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mercer PF, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-151; Miller M, 2010, CHEST; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; O'Reilly PJ, 2009, J NEUROIMMUNOL, V217, P51, DOI 10.1016/j.jneuroim.2009.09.020; Overbeek SA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-75; Pfister RR, 1998, INVEST OPHTH VIS SCI, V39, P1744; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Stockley Robert A, 2009, Proc Am Thorac Soc, V6, P524, DOI 10.1513/pats.200904-016DS; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781	33	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55612	10.1371/journal.pone.0055612	http://dx.doi.org/10.1371/journal.pone.0055612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383243	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600135
J	Schoffelen, T; Illnait-Zaragozi, MT; Joosten, LAB; Netea, MG; Boekhout, T; Meis, JF; Sprong, T				Schoffelen, Teske; Illnait-Zaragozi, Maria-Teresa; Joosten, Leo A. B.; Netea, Mihai G.; Boekhout, Teun; Meis, Jacques F.; Sprong, Tom			Cryptococcus gattii Induces a Cytokine Pattern That Is Distinct from Other Cryptococcal Species	PLOS ONE			English	Article							POLYSACCHARIDE CAPSULE; VANCOUVER-ISLAND; HOST RESPONSE; NEOFORMANS; TOLL-LIKE-RECEPTOR-4; RECOGNITION; PATHOGEN; OUTBREAK; DEFENSE; MYD88	Understanding more about the host's immune response to different Cryptococcus spp. will provide additional insight into the pathogenesis of cryptocococcis. We hypothesized that the ability of C. gattii to cause disease in immunocompetent humans depends on a distinct innate cytokine response of the host to this emerging pathogen. In the current study we assessed the cytokine profile of human peripheral blood mononuclear cells (PBMCs) of healthy individuals, after in vitro stimulation with 40 different well-defined heat-killed isolates of C. gattii, C. neoformans and several hybrid strains. In addition, we investigated the involvement of TLR2, TLR4 and TLR9 in the pro-inflammatory cytokine response to C. gattii. Isolates of C. gattii induced higher concentrations of the pro-inflammatory cytokines IL-1 beta, TNF-alpha and IL-6 and the Th17/22 cytokine IL-17 and IL-22 compared to C. neoformans var neoformans and C. neoformans var grubii. In addition, clinical C. gattii isolates induced higher amounts of cytokines than environmental isolates. This difference was not observed in C. neoformans var. grubii isolates. Furthermore, we demonstrated a likely contribution of TLR4 and TLR9, but no role for TLR2, in the host's cytokine response to C. gattii. In conclusion, clinical heat-killed C. gattii isolates induced a more pronounced inflammatory response compared to other Cryptococcus species and non-clinical C. gattii. This is dependent on TLR4 and TLR9 as cellular receptors.	[Schoffelen, Teske; Joosten, Leo A. B.; Netea, Mihai G.; Sprong, Tom] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Schoffelen, Teske; Joosten, Leo A. B.; Netea, Mihai G.; Sprong, Tom] Radboud Univ Nijmegen, Med Ctr, N4i, NL-6525 ED Nijmegen, Netherlands; [Illnait-Zaragozi, Maria-Teresa] Inst Pedro Kouri, Dept Bacteriol & Mycol, Havana, Cuba; [Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Boekhout, Teun] Second Mil Med Univ, Changzheng Hosp, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Meis, Jacques F.; Sprong, Tom] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Sprong, Tom] Canisius Wilhelmina Hosp, Dept Med, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Naval Medical University; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital	Sprong, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	T.Sprong@cwz.nl	Boekhout, Teunis/ABF-2538-2020; Netea, Mihai/N-5155-2014; Meis, Jacques F/A-9241-2010; Joosten, Leo AB/H-3138-2015	Boekhout, Teunis/0000-0002-0476-3609; Meis, Jacques F/0000-0003-3253-6080; Joosten, Leo AB/0000-0001-6166-9830	Vici Grant of the Netherlands Organization for Scientific Research	Vici Grant of the Netherlands Organization for Scientific Research	M.G.N. was supported by a Vici Grant of the Netherlands Organization for Scientific Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondo C, 2005, EUR J IMMUNOL, V35, P870, DOI 10.1002/eji.200425799; Brown Gordon D., 2007, pVII; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Illnait-Zaragozi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009124; Kasperkovitz PV, 2011, INFECT IMMUN, V79, P4858, DOI 10.1128/IAI.05626-11; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; LEVITZ SM, 1991, J INFECT DIS, V163, P1108, DOI 10.1093/infdis/163.5.1108; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MODY CH, 1993, INFECT IMMUN, V61, P464, DOI 10.1128/IAI.61.2.464-469.1993; Nakamura K, 2008, J IMMUNOL, V180, P4067, DOI 10.4049/jimmunol.180.6.4067; Nakamura K, 2006, FEMS IMMUNOL MED MIC, V47, P148, DOI 10.1111/j.1574-695X.2006.00078.x; Ngamskulrungroj P, 2012, MBIO, V3; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Popa C, 2007, INFECT IMMUN, V75, P4831, DOI 10.1128/IAI.00237-07; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Siddiqui AA, 2006, INFECT IMMUN, V74, P5302, DOI 10.1128/IAI.00661-06; SPEED B, 1995, CLIN INFECT DIS, V21, P28, DOI 10.1093/clinids/21.1.28; Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; van de Veerdonk FL, 2010, CURR OPIN CRIT CARE, V16, P453, DOI 10.1097/MCC.0b013e32833e046e; van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776; Yauch LE, 2004, INFECT IMMUN, V72, P5373, DOI 10.1128/IAI.72.9.5373-5382.2004	29	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55579	10.1371/journal.pone.0055579	http://dx.doi.org/10.1371/journal.pone.0055579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383232	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600128
J	Takata, F; Dohgu, S; Yamauchi, A; Matsumoto, J; Machida, T; Fujishita, K; Shibata, K; Shinozaki, Y; Sato, K; Kataoka, Y; Koizumi, S				Takata, Fuyuko; Dohgu, Shinya; Yamauchi, Atsushi; Matsumoto, Junichi; Machida, Takashi; Fujishita, Kayoko; Shibata, Keisuke; Shinozaki, Youichi; Sato, Kaoru; Kataoka, Yasufumi; Koizumi, Schuichi			In Vitro Blood-Brain Barrier Models Using Brain Capillary Endothelial Cells Isolated from Neonatal and Adult Rats Retain Age-Related Barrier Properties	PLOS ONE			English	Article							P-GLYCOPROTEIN; EFFLUX TRANSPORT; VALPROIC ACID; EXPRESSION; PERICYTES; CULTURES; PENETRATION; OSELTAMIVIR; OCCLUDIN; INVITRO	The blood-brain barrier (BBB) restricts the entry of circulating drugs and xenobiotics into the brain, and thus its permeability to substances is a critical factor that determines their central effects. The infant brain is vulnerable to neurotoxic substances partly due to the immature BBB. The employment of in vitro BBB models to evaluate permeability of compounds provides higher throughput than that of in vivo animal experiments. However, existing in vitro BBB models have not been able to simulate the intrinsic neonatal BBB. To establish a neonatal BBB model that mimics age-related BBB properties, the neonatal and adult in vitro BBB models were constructed with brain endothelial cells isolated from 2- and 8-week-old rats, respectively. To evaluate BBB functions, transendothelial electrical resistance, permeability of sodium fluorescein and Evans blue-albumin, and transport of rhodamine123 were measured. Radiolabelled drugs were used for BBB permeability studies in the neonatal and adult BBB models (in vitro) and in age-matched rats (in vivo). The neonatal BBB model showed lower barrier and p-glycoprotein (P-gp) functions than the adult BBB model; these were well associated with lower expressions of the barrier-related proteins and P-gp, and a different distribution pattern of immunostained barrier-related proteins. Verapamil (a P-gp inhibitor) significantly increased the influx of rhodamine 123, supporting functional P-gp expression in the neonatal BBB model. Valproic acid, but not nicotine, showed higher BBB permeability in the neonatal BBB model, which was well in accordance with the in vivo BBB property. We established a neonatal BBB model in vitro. This could allow us to assess the age-dependent BBB permeability of drugs.	[Takata, Fuyuko; Dohgu, Shinya; Yamauchi, Atsushi; Matsumoto, Junichi; Machida, Takashi; Kataoka, Yasufumi] Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka 81401, Japan; [Takata, Fuyuko; Kataoka, Yasufumi] PharmaCo Cell Co Ltd, BBB Lab, Nagasaki, Japan; [Fujishita, Kayoko; Shibata, Keisuke; Shinozaki, Youichi; Koizumi, Schuichi] Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan; [Shibata, Keisuke; Shinozaki, Youichi; Koizumi, Schuichi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Sato, Kaoru] Natl Inst Hlth Sci, Div Pharmacol, Tokyo, Japan	Fukuoka University; University of Yamanashi; Japan Science & Technology Agency (JST); National Institute of Health Sciences - Japan	Koizumi, S (corresponding author), Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan.	skoizumi@yamanashi.ac.jp	Shinozaki, Youichi/AAC-9431-2019; Koizumi, Schuichi/E-8568-2010; Dohgu, Shinya/AAK-9992-2020; Shinozaki, Youichi/E-8594-2010	Shinozaki, Youichi/0000-0002-6448-1304; Koizumi, Schuichi/0000-0001-6184-3106; Shinozaki, Youichi/0000-0002-6448-1304	Food Safety Commission Japan [1003]; Japan Society for the Promotion of Science [21240034, 22590255, 21790102, 23790113, 21790257, 21790255]; central research institute of Fukuoka University [112505]; Grants-in-Aid for Scientific Research [22590255, 21700422, 22590163] Funding Source: KAKEN	Food Safety Commission Japan(Food Safety Commission of Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); central research institute of Fukuoka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid ((to SK) 1003) from Food Safety Commission Japan (http://www.fsc.go.jp/english/index.html), a Grant-in Aid for Scientific Research ((to SK)(A) 21240034), Grants-in-Aid for Scientific Research ((to YK)(C) 22590255), Grants-in-Aid for Young Scientists ((to FT)(B) 21790102, (to FT)(B) 23790113, (to SD)(B) 21790257, (to AY)(B) 21790255) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/), and Funds ((to SD) no. 112505) from the central research institute of Fukuoka University (http://www.adm.fukuoka-u.ac.jp/fu844/home2/Ronso/Ronso-top/Ronso_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Banks WA, 2000, AM J PHYSIOL-ENDOC M, V278, pE1158, DOI 10.1152/ajpendo.2000.278.6.E1158; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Costa LG, 2004, PHARMACOL REV, V56, P103, DOI 10.1124/pr.56.1.5; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dohgu S, 2007, CELL MOL NEUROBIOL, V27, P889, DOI 10.1007/s10571-007-9209-2; Dohgu S, 2011, MICROVASC RES, V81, P103, DOI 10.1016/j.mvr.2010.10.004; Ek CJ, 2012, NEUROTOXICOLOGY; FERGUSON RK, 1969, EXP BRAIN RES, V7, P181; Fontaine M, 1996, LIFE SCI, V59, P1521, DOI 10.1016/0024-3205(96)00483-3; Gibbs JP, 2004, EPILEPSY RES, V58, P53, DOI 10.1016/j.eplepsyres.2003.12.008; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Kakee A, 2002, MICROVASC RES, V63, P233, DOI 10.1006/mvre.2001.2378; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Matsuoka Y, 1999, J NEUROBIOL, V39, P383, DOI 10.1002/(SICI)1097-4695(19990605)39:3<383::AID-NEU5>3.0.CO;2-4; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mooradian AD, 2003, MECH AGEING DEV, V124, P143, DOI 10.1016/S0047-6374(02)00041-6; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Ose A, 2008, DRUG METAB DISPOS, V36, P427, DOI 10.1124/dmd.107.018556; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Shayo M, 1997, LIFE SCI, V60, pPL115, DOI 10.1016/S0024-3205(96)00685-6; Szabo C A, 1997, Neurobiology (Bp), V5, P1; Takashima T, 2011, J NUCL MED, V52, P950, DOI 10.2967/jnumed.110.083949; Takata F, 2008, NEUROSCI LETT, V441, P163, DOI 10.1016/j.neulet.2008.06.030; Takata F, 2009, NEUROSCI LETT, V449, P71, DOI 10.1016/j.neulet.2008.10.082; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; Urayama Akihiko, 2003, Drug Metab Pharmacokinet, V18, P310, DOI 10.2133/dmpk.18.310; Winneke G, 2011, J NEUROL SCI, V308, P9, DOI 10.1016/j.jns.2011.05.020	34	38	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55166	10.1371/journal.pone.0055166	http://dx.doi.org/10.1371/journal.pone.0055166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383092	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600069
J	Umbers, AJ; Stanisic, DI; Ome, M; Wangnapi, R; Hanieh, S; Unger, HW; Robinson, LJ; Lufele, E; Baiwog, F; Siba, PM; King, CL; Beeson, JG; Mueller, I; Aplin, JD; Glazier, JD; Rogerson, SJ				Umbers, Alexandra J.; Stanisic, Danielle I.; Ome, Maria; Wangnapi, Regina; Hanieh, Sarah; Unger, Holger W.; Robinson, Leanne J.; Lufele, Elvin; Baiwog, Francesca; Siba, Peter M.; King, Christopher L.; Beeson, James G.; Mueller, Ivo; Aplin, John D.; Glazier, Jocelyn D.; Rogerson, Stephen J.			Does Malaria Affect Placental Development? Evidence from In Vitro Models	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LOW-BIRTH-WEIGHT; TROPHOBLAST INVASION; CELL-MIGRATION; SPIRAL ARTERIES; MATERNAL ANEMIA; FETAL-GROWTH; BLOOD-FLOW; PREGNANCY; UTERINE	Background: Malaria in early pregnancy is difficult to study but has recently been associated with fetal growth restriction (FGR). The pathogenic mechanisms underlying malarial FGR are poorly characterized, but may include impaired placental development. We used in vitro methods that model migration and invasion of placental trophoblast into the uterine wall to investigate whether soluble factors released into maternal blood in malaria infection might impair placental development. Because trophoblast invasion is enhanced by a number of hormones and chemokines, and is inhibited by pro-inflammatory cytokines, many of which are dysregulated in malaria in pregnancy, we further compared concentrations of these factors in blood between malaria-infected and uninfected pregnancies. Methodology/Principal Findings: We measured trophoblast invasion, migration and viability in response to treatment with serum or plasma from two independent cohorts of Papua New Guinean women infected with Plasmodium falciparum or Plasmodium vivax in early pregnancy. Compared to uninfected women, serum and plasma from women with P. falciparum reduced trophoblast invasion (P = .06) and migration (P = .004). P. vivax infection did not alter trophoblast migration (P = .64). The P. falciparum-specific negative effect on placental development was independent of trophoblast viability, but associated with high-density infections. Serum from P. falciparum infected women tended to have lower levels of trophoblast invasion promoting hormones and factors and higher levels of invasion-inhibitory inflammatory factors. Conclusion/Significance: We demonstrate that in vitro models of placental development can be adapted to indirectly study the impact of malaria in early pregnancy. These infections could result in impaired trophoblast invasion with reduced transformation of maternal spiral arteries due to maternal hormonal and inflammatory disturbances, which may contribute to FGR by limiting the delivery of maternal blood to the placenta. Future prevention strategies for malaria in pregnancy should include protection in the first half of pregnancy.	[Umbers, Alexandra J.; Hanieh, Sarah; Unger, Holger W.; Rogerson, Stephen J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Stanisic, Danielle I.; Ome, Maria; Wangnapi, Regina; Robinson, Leanne J.; Lufele, Elvin; Baiwog, Francesca; Siba, Peter M.; Mueller, Ivo] Papua New Guinea Inst Med Res, Vector Borne Dis Unit, Goroka, Southern Highla, Papua N Guinea; [Stanisic, Danielle I.] Griffith Univ, Inst Glyc, Southport, Qld 4215, Australia; [Stanisic, Danielle I.; Robinson, Leanne J.; Beeson, James G.; Mueller, Ivo] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3050, Australia; [King, Christopher L.] Case Western Reserve Univ, Ctr Global Hlth, Cleveland, OH 44106 USA; [Beeson, James G.] Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Immunol, Melbourne, Vic, Australia; [Mueller, Ivo] Univ Barcelona, Barcelona Ctr Int Hlth, Barcelona, Spain; [Aplin, John D.; Glazier, Jocelyn D.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Inst Human Dev, Manchester, Lancs, England; [Aplin, John D.; Glazier, Jocelyn D.] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Melbourne; PNG Institute Of Medical Research; Griffith University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Case Western Reserve University; Burnet Institute; University of Barcelona; University of Manchester; University of Manchester	Umbers, AJ (corresponding author), Univ Melbourne, Dept Med, Melbourne, Vic, Australia.	alex.umbers@gmail.com	Aplin, John/AET-4363-2022	Aplin, John/0000-0001-8777-9261; Stanisic, Danielle/0000-0003-3908-7468; Rogerson, Stephen/0000-0003-4287-1982	NHMRC [509185, 575534]; Australian Research Council Future Fellowship; Australian Society for Medical Research International Research Award; Australian Society for Parasitology Researcher Exchange Award	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); Australian Society for Medical Research International Research Award; Australian Society for Parasitology Researcher Exchange Award	This project was supported by the NHMRC (Project Grant 509185 to SJR and Project Grant 575534 to JB and SR). JB was supported by an Australian Research Council Future Fellowship. Travel costs of AJU to Manchester University were supported by the Australian Society for Medical Research International Research Award, and the Australian Society for Parasitology Researcher Exchange Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Aplin JD, 1999, BIOL REPROD, V60, P828, DOI 10.1095/biolreprod60.4.828; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Brabin BJ, 2005, J REPROD IMMUNOL, V65, P1, DOI 10.1016/j.jri.2004.09.006; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Catarino C, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/684384; Chotivanich K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034509; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Forbes K, 2008, AM J PHYSIOL-CELL PH, V294, pC1313, DOI 10.1152/ajpcell.00035.2008; Fried M, 1998, J IMMUNOL, V160, P2523; Ganapathy R, 2006, HUM REPROD, V21, P1295, DOI 10.1093/humrep/dei482; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Greenwood B, 2007, LANCET INFECT DIS, V7, P169, DOI 10.1016/S1473-3099(07)70028-2; Griffin JB, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-319; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Hamann L, 2010, INFECT GENET EVOL, V10, P785, DOI 10.1016/j.meegid.2010.05.005; Harris LK, 2010, PLACENTA, V31, pA52; Harris LK, 2009, REPROD SCI, V16, P1082, DOI 10.1177/1933719109341842; Harris Lynda K, 2007, Reprod Sci, V14, P28, DOI 10.1177/1933719107309588; Huber AV, 2006, PLACENTA, V27, P127, DOI 10.1016/j.placenta.2005.02.012; Huppertz B, 2012, AM J REPROD IMMUNOL, V67, P349, DOI 10.1111/j.1600-0897.2012.01124.x; Hviid L, 2010, TRENDS PARASITOL, V26, P412, DOI 10.1016/j.pt.2010.04.010; Jovanovic M, 2009, PLACENTA, V30, P320, DOI 10.1016/j.placenta.2009.01.013; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Kadyrov M, 2006, AM J OBSTET GYNECOL, V194, P557, DOI 10.1016/j.ajog.2005.07.035; Kalilani L, 2010, T ROY SOC TROP MED H, V104, P416, DOI 10.1016/j.trstmh.2010.01.013; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Mayor A, 2012, JID; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Neale D, 2003, J Matern Fetal Neonatal Med, V13, P39, DOI 10.1080/713605755; PIJNENBORG R, 1981, PLACENTA, V2, P71, DOI 10.1016/S0143-4004(81)80042-2; Renaud SJ, 2005, BIOL REPROD, V73, P237, DOI 10.1095/biolreprod.104.038000; Renaud SJ, 2007, BIOL REPROD, V76, P448, DOI 10.1095/biolreprod.106.055376; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Robson A, 2012, FASEB J; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Roth I, 1999, DEV BIOL, V205, P194, DOI 10.1006/dbio.1998.9122; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; Whitley GSJ, 2009, J ANAT, V215, P21, DOI 10.1111/j.1469-7580.2008.01039.x; YAGEL S, 1993, J CLIN ENDOCR METAB, V77, P1506, DOI 10.1210/jc.77.6.1506	51	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55269	10.1371/journal.pone.0055269	http://dx.doi.org/10.1371/journal.pone.0055269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383132	Green Published, gold			2022-12-27	WOS:000314610600081
J	Gerasimova, A; Chavez, L; Li, B; Seumois, G; Greenbaum, J; Rao, A; Vijayanand, P; Peters, B				Gerasimova, Anna; Chavez, Lukas; Li, Bin; Seumois, Gregory; Greenbaum, Jason; Rao, Anjana; Vijayanand, Pandurangan; Peters, Bjoern			Predicting Cell Types and Genetic Variations Contributing to Disease by Combining GWAS and Epigenetic Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HISTONE MODIFICATIONS; CHILDHOOD ASTHMA; CHROMATIN STATES; SEQ DATA; EXPRESSION; ENHANCERS; VARIANTS; POPULATION; DIFFERENTIATION	Genome-wide association studies (GWASs) identify single nucleotide polymorphisms (SNPs) that are enriched in individuals suffering from a given disease. Most disease-associated SNPs fall into non-coding regions, so that it is not straightforward to infer phenotype or function; moreover, many SNPs are in tight genetic linkage, so that a SNP identified as associated with a particular disease may not itself be causal, but rather signify the presence of a linked SNP that is functionally relevant to disease pathogenesis. Here, we present an analysis method that takes advantage of the recent rapid accumulation of epigenomics data to address these problems for some SNPs. Using asthma as a prototypic example; we show that non-coding disease-associated SNPs are enriched in genomic regions that function as regulators of transcription, such as enhancers and promoters. Identifying enhancers based on the presence of the histone modification marks such as H3K4me1 in different cell types, we show that the location of enhancers is highly cell-type specific. We use these findings to predict which SNPs are likely to be directly contributing to disease based on their presence in regulatory regions, and in which cell types their effect is expected to be detectable. Moreover, we can also predict which cell types contribute to a disease based on overlap of the disease-associated SNPs with the locations of enhancers present in a given cell type. Finally, we suggest that it will be possible to re-analyze GWAS studies with much higher power by limiting the SNPs considered to those in coding or regulatory regions of cell types relevant to a given disease.	[Gerasimova, Anna; Chavez, Lukas; Li, Bin; Seumois, Gregory; Greenbaum, Jason; Rao, Anjana; Vijayanand, Pandurangan; Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	La Jolla Institute for Immunology	Gerasimova, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA USA.	agerasimova@liai.org		Chavez, Lukas/0000-0002-8718-8848; Seumois, Gregory/0000-0002-8164-6852	United States National Institutes of Health (NIH) [R01 HL114093, NIH U19 AI100275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100275] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by United States National Institutes of Health (NIH) R01 HL114093 and NIH U19 AI100275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Castro-Giner F, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-128; Chanock S, 2012, GENOME RES, V22, P1612, DOI 10.1101/gr.144980.112; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik Donna, 2009, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s28; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Miller EK, 2011, VACCINE, V29, P3431, DOI 10.1016/j.vaccine.2011.02.071; Milosavljevic A, 2011, TRENDS GENET, V27, P242, DOI 10.1016/j.tig.2011.03.001; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mondul AM, 2011, HUM MOL GENET, V20, P4724, DOI 10.1093/hmg/ddr387; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Pekowska A, 2010, GENOME RES, V20, P1493, DOI 10.1101/gr.109389.110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54359	10.1371/journal.pone.0054359	http://dx.doi.org/10.1371/journal.pone.0054359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382893	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000315563800046
J	Lee, A; Hakuno, F; Northcott, P; Pessin, JE; Adcock, MR				Lee, Andrew; Hakuno, Fumihiko; Northcott, Paul; Pessin, Jeffrey E.; Adcock, Maria Rozakis			Nexilin, a Cardiomyopathy-Associated F-Actin Binding Protein, Binds and Regulates IRS1 Signaling in Skeletal Muscle Cells	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; GLUCOSE-TRANSPORT; 3T3L1 ADIPOCYTES; L6 MYOTUBES; Z-DISC; MEMBRANE; 3-KINASE; PHOSPHORYLATION	Insulin stimulates glucose uptake through a highly organized and complex process that involves movement of the glucose transporter 4 (GLUT4) from intracellular storage sites to the plasma membrane. Previous studies in L6 skeletal muscle cells have shown that insulin-induced activation and assembly of insulin receptor substrate 1 (IRS1) and p85 alpha the regulatory subunit of the Type 1A phosphatidylinositol-3-kinase (PI3K), within remodeled actin-rich membrane structures is critical for downstream signalling mediating the translocation of GLUT4. The mechanism for localization within actin cytoskeletal scaffolds is not known, as direct interaction of IRS1 or p85 alpha with F-actin has not been demonstrated. Here we show that nexilin, a F-actin binding protein implicated in the pathogenesis of familial dilated cardiomyopathies, preferentially binds to IRS1 over IRS2 to influence glucose transport in skeletal muscle cells. Nexilin stably associates with IRS1 under basal conditions in L6 myotubes and this complex is disassembled by insulin. Exposure of L6 myotubes to Latrunculin B disrupts the spatial patterning of nexilin and its transient association with IRS1. Functional silencing of nexilin has no effect on insulin-stimulated IRS1 tyrosine phosphorylation, however it enhances recruitment of p85 alpha to IRS1 resulting in increased PI-3, 4, 5-P-3 formation, coincident with enhanced AKT activation and glucose uptake. By contrast, overexpression of nexilin inhibits transmission of IRS1 signals to AKT. Based on these findings we propose that nexilin may tether IRS1 to actin-rich structures under basal conditions, confining IRS1 signaling to specific subcellular locations in the cell. Insulin-elicited release of this constraint may enhance the efficiency of IRS1/PI3K interaction and PI-3, 4, 5-P-3 production at localized sites. Moreover, the selective binding of nexilin to IRS1 and not IRS2 may contribute to the differential specificity of IRS isoforms in the modulation of GLUT4 trafficking in skeletal muscle cells.	[Lee, Andrew; Northcott, Paul; Adcock, Maria Rozakis] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hakuno, Fumihiko] Univ Tokyo, Dept Anim Sci & Appl Biol Chem, Tokyo, Japan; [Pessin, Jeffrey E.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	University of Toronto; University of Tokyo; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Adcock, MR (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	maria.rozakis@utoronto.ca	Northcott, Paul A/N-4022-2018	Northcott, Paul A/0000-0002-1220-5252; Hakuno, Fumihiko/0000-0002-4447-6225	Canadian Diabetes Association; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER	Canadian Diabetes Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Canadian Diabetes Association and the Canadian Institutes of Health Research to MRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai O, 1998, J BIOL CHEM, V273, P29686, DOI 10.1074/jbc.273.45.29686; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Clark SF, 2000, J BIOL CHEM, V275, P3819, DOI 10.1074/jbc.275.6.3819; Emoto M, 2001, J BIOL CHEM, V276, P10677, DOI 10.1074/jbc.M010785200; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Higaki Y, 1999, J BIOL CHEM, V274, P20791, DOI 10.1074/jbc.274.30.20791; Hoffman NJ, 2011, TRENDS ENDOCRIN MET, V22, P110, DOI 10.1016/j.tem.2010.12.001; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kanzaki M, 2001, J BIOL CHEM, V276, P49331, DOI 10.1074/jbc.M109657200; Khayat ZA, 2000, J CELL SCI, V113, P279; KNIGHT JB, 1995, J BIOL CHEM, V270, P10199, DOI 10.1074/jbc.270.17.10199; Kriauciunas KM, 2000, MOL CELL BIOL, V20, P6849, DOI 10.1128/MCB.20.18.6849-6859.2000; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shimizu I, 2010, J CLIN INVEST, V120, P1506, DOI 10.1172/JCI40096; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; Waardenberg AJ, 2011, J BIOL CHEM, V286, P30837, DOI 10.1074/jbc.M111.271684; Wang H, 2010, AM J HUM GENET, V87, P687, DOI 10.1016/j.ajhg.2010.10.002; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074	33	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55634	10.1371/journal.pone.0055634	http://dx.doi.org/10.1371/journal.pone.0055634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383252	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800178
J	McIntyre, NJ; Fluck, RJ; McIntyre, CW; Fakis, A; Taal, MW				McIntyre, Natasha J.; Fluck, Richard J.; McIntyre, Christopher W.; Fakis, Apostolos; Taal, Maarten W.			Determinants of Arterial Stiffness in Chronic Kidney Disease Stage 3	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; SKIN-AUTOFLUORESCENCE; CARDIOVASCULAR EVENTS; AORTIC STIFFNESS; BLOOD-PRESSURE; RISK; MORTALITY; PREDICTOR; SURVIVAL; INDEX	Background: Early chronic kidney disease (CKD) is associated with increased cardiovascular (CV) risk but underlying mechanisms remain uncertain. Arterial stiffness (AS) is associated with increased CV risk in advanced CKD, but it is unclear whether AS is relevant to CV disease (CVD) in early CKD. Study Design: Cross-sectional. Setting and participants: 1717 patients with previous estimated glomerular filtration rate (eGFR) 59-30 mL/min/1.73 m(2); mean age 73 +/- 9y, were recruited from 32 general practices in primary care. Outcomes: Increased arterial stiffness. Measurements: Medical history was obtained and participants underwent clinical assessment, urine and serum biochemistry testing. Carotid to femoral pulse wave velocity (PWV) was determined as a measure of AS, using a Vicorder (TM) device. Results: Univariate analysis revealed significant correlations between PWV and risk factors for CVD including age (r = 0.456; p<0.001), mean arterial pressure (MAP) (r = 0.228; p<0.001), body mass index (r = 20.122; p<0.001), log urinary albumin to creatinine ratio (r = 0.124; p<0.001), Waist to Hip ratio (r = 0.124, p<0.001), eGFR (r = 20.074; p = 0.002), log high sensitivity c-reactive protein (r = 0.066; p = 0.006), HDL (r = -0.062; p = 0.01) and total cholesterol (r = -0.057; p = 0.02). PWV was higher in males (9.6 m/sec vs. 10.3 m/sec; p<0.001), diabetics (9.8 m/sec vs. 10.3 m/sec; p<0.001), and those with previous CV events (CVE) (9.8 m/s vs. 10.3 m/sec; p<0.001). Multivariable analysis identified age, MAP and diabetes as strongest independent determinants of higher PWV (adjusted R-2 = 0.29). An interactive term indicated that PWV increased to a greater extent with age in males versus females. Albuminuria was a weaker determinant of PWV and eGFR did not enter the model. Limitations: Data derived from one study visit, with absence of normal controls. Conclusion: In this cohort, age and traditional CV risk factors were the strongest determinants of AS. Albuminuria was a relatively weak determinant of AS and eGFR was not an independent determinant. Long-term follow-up will investigate AS as an independent risk factor for CVE in this cohort.	[McIntyre, Natasha J.; Fluck, Richard J.; McIntyre, Christopher W.; Fakis, Apostolos; Taal, Maarten W.] Royal Derby Hosp, Dept Renal Med, Derby, England; [McIntyre, Christopher W.] Univ Nottingham, Dept Vasc Med, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Taal, MW (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.	maarten.taal1@nhs.net	McIntyre, Christopher W/O-8927-2014	Taal, Maarten/0000-0002-9065-212X; Fakis, Apostolos/0000-0003-1220-3692	Kidney Research UK; British Renal Society; Roche Products plc	Kidney Research UK(Kidney Research UK (KRUK)); British Renal Society; Roche Products plc	This study was supported by a fellowship grant from Kidney Research UK and the British Renal Society, as well as an unrestricted educational grant from Roche Products plc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As regards potential competing interests the authors would like to clarify that the support from Roche Products plc was in the form of an unrestricted educational grant. Specifically this means that Roche played no role whatever in the initiation, design or conduct of the study and have no ownership of the data. The authors are not obligated to provide Roche with any publications prior to submission and are not required to seek approval from Roche for any publications. The authors are therefore able to confirm unequivocally that the sponsorship from Roche does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Blacher J, 1999, J HYPERTENS, V17, P237, DOI 10.1097/00004872-199917020-00008; Blacher J, 2003, KIDNEY INT, V63, P1852, DOI 10.1046/j.1523-1755.2003.00932.x; Briet M, 2006, KIDNEY INT, V69, P350, DOI 10.1038/sj.ki.5000047; Briet M, 2011, J AM SOC NEPHROL, V22, P967, DOI 10.1681/ASN.2010080863; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; de Lusignan S, 2011, NEPHRON CLIN PRACT, V117, pC213, DOI 10.1159/000320341; Evans PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034699; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hartog JWL, 2009, TRANSPLANTATION, V87, P1069, DOI 10.1097/TP.0b013e31819d3173; Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217; Hickson SS, 2009, HYPERTENS RES, V32, P1079, DOI 10.1038/hr.2009.154; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lilitkarntakul P, 2012, DIABETES CARE, V35, P1774, DOI 10.2337/dc11-2345; Lilitkarntakul P, 2011, ATHEROSCLEROSIS, V216, P217, DOI 10.1016/j.atherosclerosis.2011.01.045; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; LONDON GM, 1990, KIDNEY INT, V37, P137, DOI 10.1038/ki.1990.19; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; McIntyre NJ, 2011, NEPHRON CLIN PRACT, V119, pC269, DOI 10.1159/000329109; McIntyre NJ, 2011, CLIN J AM SOC NEPHRO; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meerwaldt R, 2007, DIABETES CARE, V30, P107, DOI 10.2337/dc06-1391; Mitchell GF, 2004, HYPERTENSION, V43, P151, DOI 10.1161/01.HYP.0000114581.77705.29; Mourad JJ, 2001, KIDNEY INT, V59, P1834, DOI 10.1046/j.1523-1755.2001.0590051834.x; Orr JS, 2008, HYPERTENSION, V51, P1519, DOI 10.1161/HYPERTENSIONAHA.108.112946; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Temmar M, 2010, J HYPERTENS, V28, P163, DOI 10.1097/HJH.0b013e328331b81e; The National Institute for Health and Clincal Excellence, 2008, CHRON KIDN DIS NAT C; Townsend RR, 2010, AM J HYPERTENS, V23, P282, DOI 10.1038/ajh.2009.240; Upadhyay A, 2009, J AM SOC NEPHROL, V20, P2044, DOI 10.1681/ASN.2009010074; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Wang MC, 2005, AM J KIDNEY DIS, V45, P494, DOI 10.1053/j.ajkd.2004.11.011; World Health Organization, 2006, DEF DIAGN DIAB MELL	44	32	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55444	10.1371/journal.pone.0055444	http://dx.doi.org/10.1371/journal.pone.0055444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383192	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800156
J	Nakamura, K; Sakurai, M; Miura, K; Morikawa, Y; Nagasawa, S; Ishizaki, M; Kido, T; Naruse, Y; Suwazono, Y; Nakagawa, H				Nakamura, Koshi; Sakurai, Masaru; Miura, Katsuyuki; Morikawa, Yuko; Nagasawa, Shin-ya; Ishizaki, Masao; Kido, Teruhiko; Naruse, Yuchi; Suwazono, Yasushi; Nakagawa, Hideaki			Nicotine Dependence and Cost-Effectiveness of Individualized Support for Smoking Cessation: Evidence from Practice at a Worksite in Japan	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; REPLACEMENT THERAPY; FAGERSTROM TEST; FOLLOW-UP; INTERVENTION; POPULATION; PROGRAM; QUESTIONNAIRE; COMPETITION; INCENTIVES	Given the lack of economic studies evaluating the outcomes of smoking cessation programs from the viewpoint of program sponsors, we conducted a case study to provide relevant information for worksites. The present study was carried out between 2006 and 2008 at a manufacturing factory in the Toyama Prefecture of Japan and included subjects who voluntarily entered a smoking cessation program. The program included face-to-face counselling followed by weekly contact to provide encouragement over six months using e-mail or inter-office mail. Nicotine patches were available if required. All 151 participants stopped smoking immediately. Over the 24-month study period, self-report showed 49.7% abstained continuously from smoking. The rate of 24-month consecutive abstinence was higher in participants with lower Fagerstrom Test scores for Nicotine Dependence at baseline than in those with higher scores (63.6% for 0-2 points vs. 46.5% for 3-6 points vs. 43.8% for 7-10 points; chi-square test p = 0.19). A logistic regression model showed a significant linear trend for the association between the score and abstinence status after adjustment for possible confounding factors (p = 0.03). The crude incremental cost for one individual to successfully quit smoking due to the support program was 46,379 (i.e., (sic)100 = $1.28, 0.83 pound, or (sic)1.03 at foreign exchange rates). The corresponding costs for the three categories of the Fagerstrom Test score for Nicotine Dependence were (sic)31,953, (sic)47,450 and 64,956, respectively. When a sensitivity analysis was conducted based on the 95% confidence interval of the success rate, the variance in the corresponding costs was (sic)25,514-45,034 for 0-2 points, (sic)38,344-61,824 for 3-6 points, and (sic)45,698-108,260 for 7-10 points. The degree of nicotine dependence may therefore be an important determinant of the cost-effectiveness of smoking cessation programs.	[Nakamura, Koshi; Sakurai, Masaru; Morikawa, Yuko; Nagasawa, Shin-ya; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 92002, Japan; [Miura, Katsuyuki] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 52021, Japan; [Ishizaki, Masao] Kanazawa Med Univ, Dept Social & Environm Med, Uchinada, Ishikawa 92002, Japan; [Kido, Teruhiko] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Sch Hlth Sci, Kanazawa, Ishikawa, Japan; [Naruse, Yuchi] Toyama Univ, Sch Nursing, Dept Human Sci & Fundamental Nursing, Toyama 930, Japan; [Suwazono, Yasushi] Chiba Univ, Grad Sch Med, Dept Occupat & Environm Med, Chiba, Japan	Kanazawa Medical University; Shiga University of Medical Science; Kanazawa Medical University; Kanazawa University; University of Toyama; Chiba University	Nakamura, K (corresponding author), Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 92002, Japan.	knaka@kanazawa-med.ac.jp	Sakurai, Masaru/AAC-6551-2021	Sakurai, Masaru/0000-0002-4929-3225	Ministry of Health, Labour and Welfare of Japan [H22-Junkankitou [Seishuu]-Ippan-012]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan (Comprehensive Research on Cardiovascular and Life-Style Related Disease: H22-Junkankitou [Seishuu]-Ippan-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1987, AM J PUBLIC HEALTH, V77, P162, DOI 10.2105/AJPH.77.2.162; Bertera R L, 1990, Am J Health Promot, V4, P187, DOI 10.4278/0890-1171-4.3.187; BLYTH CR, 1986, J AM STAT ASSOC, V81, P843, DOI 10.2307/2289018; Central Social Insurance Medical Council, 2007, EV REV MED SERV FEE; Chan M, 2008, WHO REPORT GLOBAL TO; DiFranza JR, 2012, ADDICT BEHAV, V37, P856, DOI 10.1016/j.addbeh.2012.03.013; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Erfurt J C, 1991, Am J Health Promot, V5, P438; Hawkins J, 2010, NICOTINE TOB RES, V12, P1228, DOI 10.1093/ntr/ntq175; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Indurkhya A, 2001, STAT MED, V20, P1469, DOI 10.1002/sim.683; Izumi Y, 2001, INT J EPIDEMIOL, V30, P616, DOI 10.1093/ije/30.3.616; JASON LA, 1995, BEHAV THER, V26, P393, DOI 10.1016/S0005-7894(05)80090-5; Kadowaki T, 2000, IND HEALTH, V38, P396, DOI 10.2486/indhealth.38.396; Kadowaki T, 2006, J OCCUP HEALTH, V48, P402, DOI 10.1539/joh.48.402; Katanoda K, 2008, J EPIDEMIOL, V18, P251, DOI 10.2188/jea.JE2007429; Kawakami N, 1999, ADDICT BEHAV, V24, P155, DOI 10.1016/S0306-4603(98)00127-0; Koffman DM, 1998, AM J HEALTH PROMOT, V13, P105, DOI 10.4278/0890-1171-13.2.105; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; MAHEU MM, 1989, PREV MED, V18, P867, DOI 10.1016/0091-7435(89)90022-4; Ministry of Health Labor and Welfare of Japan, 2010, 2009 NAT HLTH NUTR S; Ministry of Health Labour and Welfare, BAS SURV WAG STRUCT; Nakamura K, 2009, TOB CONTROL, V18, P345, DOI 10.1136/tc.2008.028795; Nakamura K, 2012, AM J HYPERTENS, V25, P979, DOI 10.1038/ajh.2012.37; Nakamura K, 2010, HYPERTENS RES, V33, P802, DOI 10.1038/hr.2010.81; Nakamura Masakazu, 2004, Environ Health Prev Med, V9, P152, DOI 10.1007/BF02898094; Ong MK, 2005, AM J PUBLIC HEALTH, V95, P969, DOI 10.2105/AJPH.2004.040667; Razavi D, 1999, EUR J CANCER, V35, P1238, DOI 10.1016/S0959-8049(99)00110-0; Ringen K, 2002, AM J IND MED, V42, P367, DOI 10.1002/ajim.10129; Sakurai M, 2012, METABOLISM, V61, P47, DOI 10.1016/j.metabol.2011.05.015; SALINA D, 1994, AM J COMMUN PSYCHOL, V22, P257, DOI 10.1007/BF02506865; Sawayama T, 2011, TEISHIN IGAKU, V63, P48; Shiffman S, 2005, TOB CONTROL, V14, P346, DOI 10.1136/tc.2004.009183; Shimizu J, 1999, JPN J PUBLIC HLTH, V46, P3; Takayama S, 2005, MANUAL SMOKING CESSA, P86; Tanaka H, 2006, J OCCUP HEALTH, V48, P175, DOI 10.1539/joh.48.175; Taniguchi C, 2011, JPN J TOB CONTROL, V6, P34; Terazawa T, 2001, Sangyo Eiseigaku Zasshi, V43, P207; Terry PE, 2011, POPUL HEALTH MANAG, V14, P117, DOI 10.1089/pop.2010.0026; The Japanese Circulation Society The Japan Lung Cancer Society The Japanese Cancer Association and The Japanese Respiratory Society, MAN SMOK CESS SUPP; Wu P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-300	41	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55836	10.1371/journal.pone.0055836	http://dx.doi.org/10.1371/journal.pone.0055836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383289	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800190
J	Sune, P; Sune, JM; Montoro, JB				Sune, Pilar; Maria Sune, Josep; Bruno Montoro, J.			Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results	PLOS ONE			English	Article							RANDOMIZED-TRIALS; EMPIRICAL-EVIDENCE; FOLLOW-UP; BIAS; PROTOCOLS; QUALITY; COHORT	Objectives: Publication bias may affect the validity of evidence based medical decisions. The aim of this study is to assess whether research outcomes affect the dissemination of clinical trial findings, in terms of rate, time to publication, and impact factor of journal publications. Methods and Findings: All drug-evaluating clinical trials submitted to and approved by a general hospital ethics committee between 1997 and 2004 were prospectively followed to analyze their fate and publication. Published articles were identified by searching Pubmed and other electronic databases. Clinical study final reports submitted to the ethics committee, final reports synopses available online and meeting abstracts were also considered as sources of study results. Study outcomes were classified as positive (when statistical significance favoring experimental drug was achieved), negative (when no statistical significance was achieved or it favored control drug) and descriptive (for non-controlled studies). Time to publication was defined as time from study closure to publication. A survival analysis was performed using a Cox regression model to analyze time to publication. Journal impact factors of identified publications were recorded. Publication rate was 48.4% (380/785). Study results were identified for 68.9% of all completed clinical trials (541/785). Publication rate was 84.9% (180/212) for studies with results classified as positive and 68.9% (128/186) for studies with results classified as negative (p<0.001). Median time to publication was 2.09 years (IC95 1.61-2.56) for studies with results classified as positive and 3.21 years (IC95 2.69-3.70) for studies with results classified as negative (hazard ratio 1.99 (IC95 1.55-2.55). No differences were found in publication impact factor between positive (median 6.308, interquartile range: 3.141-28.409) and negative result studies (median 8.266, interquartile range: 4.135-17.157). Conclusions: Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results. However, no differences have been found in terms of impact factor.	[Sune, Pilar; Bruno Montoro, J.] Hosp Univ Vall dHebron, Dept Pharm, Barcelona, Spain; [Maria Sune, Josep] Univ Barcelona, Fac Pharm, Barcelona, Spain	Hospital Universitari Vall d'Hebron; University of Barcelona	Sune, P (corresponding author), Hosp Univ Vall dHebron, Dept Pharm, Barcelona, Spain.	psune@vhebron.net	Montoro-Ronsano, J.Bruno/T-2232-2018	Montoro-Ronsano, J.Bruno/0000-0003-4390-2189; Sune-Martin, Pilar/0000-0003-2418-7693				Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Blumle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1828; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P319, DOI 10.1001/jama.279.4.319; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lee KP, 2006, MED J AUSTRALIA, V184, P621, DOI 10.5694/j.1326-5377.2006.tb00418.x; Littner Y, 2005, ARCH PEDIAT ADOL MED, V159, P1036, DOI 10.1001/archpedi.159.11.1036; Lynch JR, 2007, J BONE JOINT SURG AM, V89A, P1010, DOI 10.2106/JBJS.F.01152; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Okike K, 2008, J BONE JOINT SURG AM, V90A, P595, DOI 10.2106/JBJS.G.00279; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Penel N, 2009, INVEST NEW DRUG, V27, P287, DOI 10.1007/s10637-008-9186-4; Saha S, 2003, J MED LIBR ASSOC, V91, P42; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257	32	59	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54583	10.1371/journal.pone.0054583	http://dx.doi.org/10.1371/journal.pone.0054583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382919	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800055
J	Wang, JH; Li, LF; Zhang, KQ; Yu, Y; Li, B; Li, J; Yan, Z; Hu, ZL; Yen, Y; Wu, MC; Jiang, XQ; Qian, QJ				Wang, Jinghan; Li, Linfang; Zhang, Keqiang; Yu, Yong; Li, Bin; Li, Jiang; Yan, Zi; Hu, Zhenli; Yen, Yun; Wu, Mengchao; Jiang, Xiaoqing; Qian, Qijun			Characterization of Two Novel Cell Lines with Distinct Heterogeneity Derived from a Single Human Bile Duct Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER-CELLS; E-CADHERIN; MATRIX METALLOPROTEINASES; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; RISK-FACTORS; HUMAN BREAST; TUMOR; METASTASIS	Background: Intratumoral heterogeneity reflects subclonal diversity and accounts for a variety of clinically defined phenotypes including the development of drug resistance and recurrence. However, intratumoral heterogeneity of bile duct carcinoma (BDC) is rarely studied. Methods: Two highly heterogeneous cell lines named EH-CA1a and EH-CA1b were established from a primary tumor tissue of a pathologically proven BDC. Distinct heterogeneity and underlying mechanisms of two cell lines in karyotype, colony formation, tumorgenicity, and sensitivity to chemoradiotherapy were intensively studied. Results: Both cell lines showed typical morphology of cancer cells. EH-CA1a cells grew as free-floating aggregates, while EH-CA1b cells grew adherently as a monolayer. EH-CA1 alpha cells had higher cloning efficiencies and were able to keep proliferating under hypoxic condition. Coincidentally, hypoxia-induced factor-1a (HIF1 alpha) and vascular endothelial growth factor (VEGF) mRNA were significantly higher in EH-CA1a cells than in EH-CA1b cells. Both cell lines were tumorigenic in nude mouse, however, EH-CA1a cells showed more aggressive characteristics. Most importantly, the EH-CA1a cells showed much more resistance against radiation and chemotherapy with gemcitabine. Metastasis-related genes including matrix metalloproteinase 2 (MMP-2), MMP-9, epithelial-mesenchymal transition (EMT) markers such as Vimentin, Snail, and Twist, are more highly expressed in EH-CA1a cells than in EH-CA1b cells. Moreover, the percentage of cells expressing cancer stem cell-like marker, CD133, in EH-CA1a cells is much higher than that in EH-CA1b cells. Moreover, knockdown of CD133 in both EH-CA1a and EH-CA1b cells significantly reduced their invasive potential and increased their sensitivities to radiation and gemcitabine, suggesting the differential expression of CD133 protein may partially account for the difference in malignancy between these two cancer cells. Conclusion: Establishment of these two cell lines will not only shed light on intratumoral heterogeneities of BDC, but also potentially facilitate the development of novel therapeutic approaches of BDC.	[Wang, Jinghan; Li, Linfang; Yu, Yong; Li, Bin; Li, Jiang; Yan, Zi; Wu, Mengchao; Qian, Qijun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Lab Viral & Gene Therapy, Shanghai, Peoples R China; [Wang, Jinghan; Jiang, Xiaoqing] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Biliary Surg 1, Shanghai, Peoples R China; [Zhang, Keqiang; Yen, Yun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Hu, Zhenli] Second Mil Med Univ, Changhai Hosp, Dept Resp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; City of Hope; Beckman Research Institute of City of Hope; Naval Medical University	Jiang, XQ (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Biliary Surg 1, Shanghai, Peoples R China.	jxq1225@sina.com; qianqj@sino-gene.cn	Yen, Yun/H-9591-2016; Zhang, Keqiang/P-7082-2019		National Science Funds for Distinguished Young Scholar [30925037]; National Natural Science Foundation of China [30921006]	National Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Science Funds for Distinguished Young Scholar (No. 30925037) and supported by the Science Fund for Creative Research Group of National Natural Science Foundation of China (No. 30921006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic T, 2011, TRANSL RES, V157, P19, DOI 10.1016/j.trsl.2010.09.004; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boral Debasish, 2012, Front Biosci (Elite Ed), V4, P2502; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cardinale V, 2012, WORLD J GASTRO ONCOL, V4, P94, DOI 10.4251/wjgo.v4.i5.94; Chung JY, 2009, CLIN CANCER RES, V15, P660, DOI 10.1158/1078-0432.CCR-08-1084; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grosse-Gehling P, 2012, J PATHOL; Hambly RJ, 1997, BREAST CANCER RES TR, V43, P247, DOI 10.1023/A:1005756632293; Hui EP, 2002, CLIN CANCER RES, V8, P2595; KELLER G, 1995, AM J PATHOL, V147, P593; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kohga K, 2010, J HEPATOL, V52, P872, DOI 10.1016/j.jhep.2009.12.030; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kubo T, 2012, CANC SCI; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Li ZX, 2008, INT J DERMATOL, V47, P207, DOI 10.1111/j.1365-4632.2007.03318.x; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu YP, 2012, CANC RES; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moriyama T, 2010, CANCER-AM CANCER SOC, V116, P3357, DOI 10.1002/cncr.25121; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Poomphakwaen K, 2009, ASIAN PAC J CANCER P, V10, P251; Sato J, 2011, J HEPATO-BIL-PAN SCI, V18, P700, DOI 10.1007/s00534-011-0376-7; SEABRIGH.M, 1971, LANCET, V2, P971; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sprenger T, 2012, CANCER; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang XF, 2010, CANCER SCI, V101, P759, DOI 10.1111/j.1349-7006.2009.01435.x; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Yoshimoto M, 2012, GENE CHROMOSOME CANC, V51, P149, DOI 10.1002/gcc.20939; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang Bai-He, 2006, Hepatobiliary Pancreat Dis Int, V5, P278	49	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54377	10.1371/journal.pone.0054377	http://dx.doi.org/10.1371/journal.pone.0054377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382894	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800047
J	Gervasi, S; Gondhalekar, C; Olson, DH; Blaustein, AR				Gervasi, Stephanie; Gondhalekar, Carmen; Olson, Deanna H.; Blaustein, Andrew R.			Host Identity Matters in the Amphibian-Batrachochytrium dendrobatidis System: Fine-Scale Patterns of Variation in Responses to a Multi-Host Pathogen	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; INTERSPECIFIC VARIATION; PEPTIDE DEFENSES; CHYTRIDIOMYCOSIS; SUSCEPTIBILITY; DYNAMICS; TRANSMISSION; BIODIVERSITY; DECLINES; ECOLOGY	Species composition within ecological assemblages can drive disease dynamics including pathogen invasion, spread, and persistence. In multi-host pathogen systems, interspecific variation in responses to infection creates important context dependency when predicting the outcome of disease. Here, we examine the responses of three sympatric host species to a single fungal pathogen, Batrachochytrium dendrobatidis, which is associated with worldwide amphibian population declines and extinctions. Using an experimental approach, we show that amphibian species from three different genera display significant differences in patterns of pathgen-induced mortality as well as the magnitude and temporal dynamics of infection load. We exposed amphibians to one of four inoculation dose treatments at both larval and post- metamorphic stages and quantified infection load on day 8 and day 15 post-inoculation. Of the three species examined, only one (the Pacific treefrog; Pseudacris regilla) displayed "dose-dependent" responses; survival was reduced and infection load was elevated as inoculation dose was increased. We observed a reduction in survival but no differences in infection load across pathogen treatments in Cascades frogs (Rana cascadae). Western toads (Anaxyrus boreas) displayed differences in infection load but no differences in survival across pathogen treatments. Within species, responses to the pathogen varied with life history stage, and the most heavily infected species at the larval stage was different from the most heavily infected species at the post-metamorphic stage. Temporal changes in infection load were species and life history stage-specific. We show that variation in susceptibility to this multi-host pathogen is complex when viewed at a fine-scale and may be mediated through intrinsic host traits.	[Gervasi, Stephanie; Blaustein, Andrew R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Olson, Deanna H.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Blaustein, Andrew R.] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA	Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Gervasi, S (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	gervasis@science.oregonstate.edu			United States Forest Service (Pacific Northwest Research Station); Robert and Clarice MacVicar Animal Health Scholar Award through Oregon State University	United States Forest Service (Pacific Northwest Research Station)(United States Department of Agriculture (USDA)United States Forest Service); Robert and Clarice MacVicar Animal Health Scholar Award through Oregon State University	Funding for this study was provided by the United States Forest Service (Pacific Northwest Research Station; http://www.fs.fed.us/pnw/) and the Robert and Clarice MacVicar Animal Health Scholar Award (issued through Oregon State University to SG). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Begon Michael, 2008, P12; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; BLAUSTEIN AR, 1988, BEHAV GENET, V18, P449, DOI 10.1007/BF01065514; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Brutyn M, 2012, FUNGAL GENET BIOL, V49, P830, DOI 10.1016/j.fgb.2012.07.002; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; COX DR, 1972, J R STAT SOC B, V34, P187; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Daszak P, 2002, CONSERVATION MEDICINE, P40; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gosner K. L., 1960, Herpetologica, V16, P183; GROSHOLZ ED, 1992, ECOLOGY, V73, P507, DOI 10.2307/1940756; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; McMahon TA, P NATL ACAD IN PRESS; Olsen V, 2004, DIS AQUAT ORGAN, V61, P85, DOI 10.3354/dao061085; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Read AF, 2008, PLOS BIOL, V6, P2638, DOI 10.1371/journal.pbio.1000004; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Roedder Dennis, 2009, Diversity, V1, P52; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Venesky MD, 2009, INTEGR COMP BIOL, V49, pE176; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	53	67	70	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e54490	10.1371/journal.pone.0054490	http://dx.doi.org/10.1371/journal.pone.0054490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23382904	Green Published, gold			2022-12-27	WOS:000314023600060
J	Cheng, DY; Liang, H; Li, YH				Cheng, Daye; Liang, Bin; Li, Yunhui			Serum Vascular Endothelial Growth Factor (VEGF-C) as a Diagnostic and Prognostic Marker in Patients with Ovarian Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; CELL LUNG-CANCER; BREAST-CANCER; EXPRESSION; LYMPHANGIOGENESIS; MACROPHAGES; CARCINOMA; DENSITY; COX-2	VEGF-C is regarded as one of the most efficient factors in regulating lymphangiogenesis. The aim of this study was to better understand the role of VEGF-C in the progression of ovarian cancer and to assess its diagnostic and prognostic significance. A total of 109 patients with ovarian cancer, 76 patients with benign ovarian diseases, and 50 healthy controls were recruited in this study. Serum levels of VEGF-C were determined by ELISA method. The results showed that serum levels of VEGF-C were significantly higher in the patients with ovarian cancer than those with benign ovarian diseases and healthy controls (P<0.01). Serum level of VEGF-C was correlated with FIGO stage, lymph node metastasis, tumor resectability, and survival of the patients (P<0.05). The areas of receiver operating curves of VEGF-C were higher than those of CA125 in different screening groups. Analysis using the Kaplan-meier method indicated that patients with high VEGF-C had significantly shorter overall survival time than those with low VEGF-C (P<0.0001). In a multivariate analysis along with clinical prognostic parameters, serum VEGF-C was identified as an independent adverse prognostic variable for overall survival. These results indicated that serum VEGF-C may be a clinically useful indicator for diagnostic and prognostic evaluation in ovarian cancer patients.	[Cheng, Daye] China Med Univ, Hosp 1, Dept Transfus, Shenyang, Peoples R China; [Liang, Bin] China Med Univ, High Vocat Technol Coll, Shenyang, Peoples R China; [Li, Yunhui] 202 Hosp, Dept Clin Lab, Shenyang, Peoples R China	China Medical University; China Medical University	Cheng, DY (corresponding author), China Med Univ, Hosp 1, Dept Transfus, Shenyang, Peoples R China.	dayecheng_cmu@yahoo.cn			Liaoning Nature Science Fund [201102257]	Liaoning Nature Science Fund	This work was supported by a grant from the Liaoning Nature Science Fund (201102257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aishima S, 2008, MODERN PATHOL, V21, P256, DOI 10.1038/modpathol.3800985; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Coticchia Christine M, 2008, J Natl Compr Canc Netw, V6, P795; Feng LZ, 2011, J INT MED RES, V39, P1333, DOI 10.1177/147323001103900420; Gou HF, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-14; Guo XF, 2009, ACTA BIOCH BIOPH SIN, V41, P217, DOI 10.1093/abbs/gmp004; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huang KJ, 2012, MED ONCOL, V29, P318, DOI 10.1007/s12032-010-9817-4; Jeon BH, 2008, CANCER RES, V68, P1100, DOI 10.1158/0008-5472.CAN-07-2572; Joukov V, 1996, EMBO J, V15, P1751; Kim HS, 2008, ACTA OBSTET GYN SCAN, V87, P1136, DOI 10.1080/00016340802478158; Li XM, 2011, J GASTROINTEST SURG, V15, P2001, DOI 10.1007/s11605-011-1627-2; Nakamura Y, 2005, BREAST CANCER RES TR, V91, P125, DOI 10.1007/s10549-004-5783-x; Nakazato T, 2006, ONCOL REP, V15, P825; Ogawa E, 2004, BRIT J CANCER, V91, P498, DOI 10.1038/sj.bjc.6601992; Ozols RF, 2006, ANN ONCOL, V17, pV181, DOI 10.1093/annonc/mdj978; Sangoi AR, 2008, AM J SURG PATHOL, V32, P261, DOI 10.1097/PAS.0b013e318141fc7a; Schietroma C, 2003, CANCER, V98, P789, DOI 10.1002/cncr.11583; Schoppmann SF, 2006, SURGERY, V139, P839, DOI 10.1016/j.surg.2005.12.008; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Sinn BV, 2009, VIRCHOWS ARCH, V455, P461, DOI 10.1007/s00428-009-0851-6; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2004, APMIS, V112, P539, DOI 10.1111/j.1600-0463.2004.apm11207-0812.x; Ueda M, 2005, CLIN CANCER RES, V11, P3225, DOI 10.1158/1078-0432.CCR-04-1148; Yang J, 2006, ASIAN J ANDROL, V8, P169, DOI 10.1111/j.1745-7262.2006.00120.x; Zhao YC, 2012, MED ONCOL	26	31	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55309	10.1371/journal.pone.0055309	http://dx.doi.org/10.1371/journal.pone.0055309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383322	Green Submitted, Green Published, gold			2022-12-27	WOS:000314597900029
J	Riedel, A; Mofolo, B; Avota, E; Schneider-Schaulies, S; Meintjes, A; Mulder, N; Kneitz, S				Riedel, Alice; Mofolo, Boitumelo; Avota, Elita; Schneider-Schaulies, Sibylle; Meintjes, Ayton; Mulder, Nicola; Kneitz, Susanne			Accumulation of Splice Variants and Transcripts in Response to PI3K Inhibition in T Cells	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MEASLES-VIRUS; IMMUNE-RESPONSE; GENE-EXPRESSION; SR PROTEINS; ACTIVATION; IMMUNOSUPPRESSION; RNA; PROLIFERATION; SUPPRESSION	Background: Measles virus (MV) causes T cell suppression by interference with phosphatidylinositol-3-kinase (PI3K) activation. We previously found that this interference affected the activity of splice regulatory proteins and a T cell inhibitory protein isoform was produced from an alternatively spliced pre-mRNA. Hypothesis: Differentially regulated and alternatively splice variant transcripts accumulating in response to PI3K abrogation in T cells potentially encode proteins involved in T cell silencing. Methods: To test this hypothesis at the cellular level, we performed a Human Exon 1.0 ST Array on RNAs isolated from T cells stimulated only or stimulated after PI3K inhibition. We developed a simple algorithm based on a splicing index to detect genes that undergo alternative splicing (AS) or are differentially regulated (RG) upon T cell suppression. Results: Applying our algorithm to the data, 9% of the genes were assigned as AS, while only 3% were attributed to RG. Though there are overlaps, AS and RG genes differed with regard to functional regulation, and were found to be enriched in different functional groups. AS genes targeted extracellular matrix (ECM)-receptor interaction and focal adhesion pathways, while RG genes were mainly enriched in cytokine-receptor interaction and Jak-STAT. When combined, AS/RG dependent alterations targeted pathways essential for T cell receptor signaling, cytoskeletal dynamics and cell cycle entry. Conclusions: PI3K abrogation interferes with key T cell activation processes through both differential expression and alternative splicing, which together actively contribute to T cell suppression.	[Riedel, Alice; Avota, Elita; Schneider-Schaulies, Sibylle] Univ Wurzburg, Inst Virol & Immunobiol, Versbacher, Wuerzburg, Germany; [Kneitz, Susanne] Univ Wurzburg, Dept Physiol Chem 1, Bioctr, Wurzburg, Germany; [Mofolo, Boitumelo; Meintjes, Ayton; Mulder, Nicola] Univ Cape Town, Fac Hlth Sci, Computat Biol Grp, Dept Clin Lab Sci,Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Wurzburg; University of Wurzburg; University of Cape Town	Kneitz, S (corresponding author), Univ Wurzburg, Dept Physiol Chem 1, Bioctr, Wurzburg, Germany.	susanne.kneitz@uni-wuerzburg.de		Mulder, Nicola J/0000-0003-4905-0941	National Research Fund; Deutsche Forschungsgemeinschaft; German Cancer Research Foundation	National Research Fund(Luxembourg National Research Fund); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Research Foundation	This study was supported by the National Research Fund, the Deutsche Forschungsgemeinschaft and the German Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2007, CIRCULATION, V116, P1707, DOI 10.1161/CIRCULATIONAHA.107.699470; Anupam R, 2011, J BIOL CHEM, V286, P7661, DOI 10.1074/jbc.M110.176354; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Avota E, 2004, J VIROL, V78, P9552, DOI 10.1128/JVI.78.17.9552-9559.2004; Avota E, 2001, NAT MED, V7, P725, DOI 10.1038/89106; Avota E, 2006, CELL MICROBIOL, V8, P1826, DOI 10.1111/j.1462-5822.2006.00752.x; Avota E, 2010, MED MICROBIOL IMMUN, V199, P227, DOI 10.1007/s00430-010-0152-3; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Burke KP, 2010, IMMUNOL RES, V47, P216, DOI 10.1007/s12026-009-8152-3; Carrette F, 2009, ADV EXP MED BIOL, V665, P3; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cheung WMW, 2001, J BIOL CHEM, V276, P17083, DOI 10.1074/jbc.M010802200; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Cowper AE, 2001, J BIOL CHEM, V276, P48908, DOI 10.1074/jbc.M103967200; Fahey LM, 2010, CURR OPIN IMMUNOL, V22, P348, DOI 10.1016/j.coi.2010.03.004; Farnebo M, 2009, CELL CYCLE, V8, P2343, DOI 10.4161/cc.8.15.9223; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Gaidatzis D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp508; Gassert E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000623; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Griffin DE, 2010, IMMUNOL REV, V236, P176, DOI 10.1111/j.1600-065X.2010.00925.x; Grigoryev YA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007906; Ha KCH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-519; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HAYASHI K, 1992, P NATL ACAD SCI USA, V89, P12122, DOI 10.1073/pnas.89.24.12122; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Hu W, 2010, J BIOL CHEM, V285, P7964, DOI 10.1074/jbc.M109.063586; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kerdiles YM, 2006, REV MED VIROL, V16, P49, DOI 10.1002/rmv.486; Krummrei U, 2003, P NATL ACAD SCI USA, V100, P2444, DOI 10.1073/pnas.0438007100; Liu XF, 2003, J VIROL, V77, P2105, DOI 10.1128/JVI.77.3.2105-2115.2003; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Mahmoudi S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.90; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; Niewiesk S, 1997, J VIROL, V71, P7214, DOI 10.1128/JVI.71.10.7214-7219.1997; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Okkenhaug K, 2010, CURR TOP MICROBIOL, V346, P57, DOI 10.1007/82_2010_45; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-449; Rohrschneider LR, 2000, GENE DEV, V14, P505; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schlender J, 1996, P NATL ACAD SCI USA, V93, P13194, DOI 10.1073/pnas.93.23.13194; Schneider-Schaulies S, 2006, J GEN VIROL, V87, P1423, DOI 10.1099/vir.0.81713-0; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Tran-Van H, 2011, EUR J IMMUNOL, V41, P151, DOI 10.1002/eji.201040847; Tsuzaka K, 2006, J IMMUNOL, V176, P949, DOI 10.4049/jimmunol.176.2.949; Tsuzaka K, 2006, SPRINGER SEMIN IMMUN, V28, P185, DOI 10.1007/s00281-006-0035-2; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Ward SG, 2011, IMMUNOL LETT, V138, P15, DOI 10.1016/j.imlet.2011.02.007; Wernimont SA, 2011, J IMMUNOL, V187, P6256, DOI 10.4049/jimmunol.1102028; Whistler T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-496; Wolf I, 2000, GENOMICS, V69, P104, DOI 10.1006/geno.2000.6324; Yoshimoto K, 2006, INT IMMUNOL, V18, P1189, DOI 10.1093/intimm/dxl053	66	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e50695	10.1371/journal.pone.0050695	http://dx.doi.org/10.1371/journal.pone.0050695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383294	Green Submitted, gold, Green Published			2022-12-27	WOS:000314597900001
J	van Overveld, T; Matthysen, E				van Overveld, Thijs; Matthysen, Erik			Personality and Information Gathering in Free-Ranging Great Tits	PLOS ONE			English	Article							PARUS-MAJOR; INDIVIDUAL-DIFFERENCES; EXPLORATORY-BEHAVIOR; COPING STYLES; SPACE USE; FITNESS CONSEQUENCES; SOCIAL INFORMATION; SURVIVAL; POPULATIONS; DISPERSAL	One aspect of animal personality that has been well described in captivity, but received only little attention in studies in the wild, is that personality types may vary in their behavioural flexibility towards environmental changes. A fundamental factor underlying such differences is believed to be the degree to which individual behavior is guided by environmental stimuli. We tested this hypothesis in the wild using free-ranging great tits. Personality variation was quantified using exploratory behaviour in a novel environment, which has previously been shown to be repeatable and correlated with other behaviours in this and other populations of the same species. By temporarily removing food at feeding stations we examined whether birds with different personality differed in returning to visit empty feeders as this may provide information on how birds continue to sample their environment after a sudden change in conditions. In two summer experiments, we found that fast-exploring juveniles visited empty feeders less often compared to slow-exploring juveniles. In winter, sampling behaviour was sex dependent but not related to personality. In both seasons, we found that birds who sampled empty feeders more often were more likely to rediscover food after we again re-baited the feeding stations, but there was no effect of personality. Our results show that personality types may indeed differ in ways of collecting environmental information, which is consistent with the view of personalities as different styles of coping with environmental changes. The adaptive value of these alternative behavioural tactics, however, needs to be further explored.	[van Overveld, Thijs; Matthysen, Erik] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium	University of Antwerp	van Overveld, T (corresponding author), Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium.	thijs.vanoverveld@ua.ac.be	Overveld, Thijs/J-6501-2014	Matthysen, Erik/0000-0002-7521-9248; van Overveld, Mathijs/0000-0001-5472-0255	FWO-Flanders doctoral fellowship; BOF-NOI grant from the University of Antwerp	FWO-Flanders doctoral fellowship; BOF-NOI grant from the University of Antwerp	Financial support was received by a FWO-Flanders doctoral fellowship to TvO and a BOF-NOI grant from the University of Antwerp to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauchau V, 1995, J APPL STAT, V22, P1031, DOI 10.1080/02664769524775; Bello N, 2001, J VET DIAGN INVEST, V13, P162, DOI 10.1177/104063870101300212; BENUS RF, 1987, BEHAVIOUR, V100, P105, DOI 10.1163/156853987X00099; Boon AK, 2008, OIKOS, V117, P1321, DOI 10.1111/j.0030-1299.2008.16567.x; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; COX DR, 1972, J R STAT SOC B, V34, P187; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; DELAET J, 1984, ORNIS SCAND, V15, P73, DOI 10.2307/3675940; Dingemanse NJ, 2012, J ANIM ECOL, V81, P116, DOI 10.1111/j.1365-2656.2011.01877.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dingemanse NJ, 2011, ANIMAL PERSONALITIES; Drent P.J., 1999, P 22 INT ORNITHOLOGI, P896; DRENT PJ, 1987, ARDEA, V75, P59; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Herborn KA, 2010, ANIM BEHAV, V79, P835, DOI 10.1016/j.anbehav.2009.12.026; Hollander FA, 2008, ETHOLOGY, V114, P405, DOI 10.1111/j.1439-0310.2008.01488.x; Jenni L., 1994, BIOL MOULT BIRDS; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korsten P, 2010, MOL ECOL, V19, P832, DOI 10.1111/j.1365-294X.2009.04518.x; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Mathot KJ, 2012, OIKOS, V121, P1009, DOI 10.1111/j.1600-0706.2012.20339.x; Matthysen E., 1990, Current Ornithology, V7, P209; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Quinn JL, 2011, J ANIM ECOL, V80, P918, DOI 10.1111/j.1365-2656.2011.01835.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; SANDELL M, 1991, BEHAV ECOL SOCIOBIOL, V29, P147, DOI 10.1007/BF00166490; Schielzeth H, 2011, BEHAV ECOL, V22, P126, DOI 10.1093/beheco/arq184; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; van Overveld T, 2011, BEHAV ECOL, V22, P899, DOI 10.1093/beheco/arr063; van Overveld T, 2010, BIOL LETTERS, V6, P187, DOI 10.1098/rsbl.2009.0764; VANBALEN JH, 1967, ARDEA, V55, P1; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Wilson ADM, 2007, ANIM BEHAV, V74, P689, DOI 10.1016/j.anbehav.2007.01.009	44	17	17	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54199	10.1371/journal.pone.0054199	http://dx.doi.org/10.1371/journal.pone.0054199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383299	Green Submitted, Green Published, gold			2022-12-27	WOS:000314597900006
J	Garcia-Perez, B; Hobson, KA; Powell, RL; Still, CJ; Huber, GH				Garcia-Perez, Belen; Hobson, Keith A.; Powell, Rebecca L.; Still, Christopher J.; Huber, Gernot H.			Switching Hemispheres: A New Migration Strategy for the Disjunct Argentinean Breeding Population of Barn Swallow (Hirundo rustica)	PLOS ONE			English	Article							STABLE-ISOTOPES; SOUTHERN-HEMISPHERE; GENETICS; HYDROGEN; AMERICA; CARBON; MOLT; C-13	Background: Barn Swallows (Hirundo rustica) breed almost exclusively in the Northern Hemisphere. However, since the early 1980's, a small disjunct breeding population has become established in eastern Argentina, presumably by birds previously derived from those breeding in North America. Currently, it is unknown where these individuals go following breeding and how they have adjusted to a reversal in phenology. Their austral wintering period corresponds to the breeding period of the northern ancestral population and so they can potentially return to these more traditional breeding sites or they may occupy other South American wintering regions left vacant by conspecifics returning to the Northern Hemisphere. Principal Findings: We used a three-isotope (delta C-13, delta N-15, delta H-2) approach to investigate potential wintering areas in Central and South America of individuals breeding in Argentina. Feather isotope values differed from those expected and measured at local breeding sites in Argentina indicating molt after the austral breeding period and away from the breeding grounds. Potential molting origins were identified applying likelihood-based assignment methods to a delta H-2 isoscape for South America and dichotomous prior information on the distribution of C3 and C4 vegetation types based on modeled vegetation-delta C-13 values. Barn Swallows now breeding in Argentina have changed their migratory behavior but presumably use the same cues as those used by the ancestral population, molting their feathers during the austral winter, likely in northeastern South America.	[Garcia-Perez, Belen; Hobson, Keith A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada; [Powell, Rebecca L.] Wake Forest Univ, Ctr Energy Environm & Sustainabil, Winston Salem, NC 27109 USA; [Still, Christopher J.] Oregon State Univ, Corvallis, OR 97331 USA; [Still, Christopher J.] Oregon State Univ, Soc Geog, Corvallis, OR 97331 USA; [Huber, Gernot H.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	University of Saskatchewan; Environment & Climate Change Canada; Wake Forest University; Oregon State University; Oregon State University; Cornell University	Garcia-Perez, B (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	belen.garcia@usask.ca	Hobson, Keith/Q-9306-2019	Still, Christopher/0000-0002-8295-4494	Environment Canada; Isabel Maria Lopez Martinez Memorial Scholarship; University of Saskatchewan Department of Biology Graduate Scholarship	Environment Canada(CGIAR); Isabel Maria Lopez Martinez Memorial Scholarship; University of Saskatchewan Department of Biology Graduate Scholarship	This study was supported by Environment Canada. BGP received financial support from Isabel Maria Lopez Martinez Memorial Scholarship and University of Saskatchewan Department of Biology Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; BERTHOLD P, 1984, BIRD STUDY, V31, P19, DOI 10.1080/00063658409476810; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Billerman SM, 2011, AUK, V128, P506, DOI 10.1525/auk.2011.10252; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Brown C.R., 1999, BIRDS N AM ONLINE; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; ESRI, 2011, ARCGIS 9 3; France RL, 1997, CAN J FISH AQUAT SCI, V54, P1255, DOI 10.1139/f97-044; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; GWINNER E, 1987, ORNIS SCAND, V18, P251, DOI 10.2307/3676892; HOBSON KA, 2012, PLOS ONE, V7; Hobson KA, 2007, TERR ECOL SER, V1, P129; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Jenni-Eiermann S, 2002, J ORNITHOL, V143, P331; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; MARTINEZ M M, 1983, Neotropica (La Plata), V29, P83; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Paynter RA, 1995, NEARCTIC PASSERINE M; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Powell RL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00162.1; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; Pyle P, 1997, IDENTIFICATION GUIDE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rohwer S, 2011, AUK, V128, P522, DOI 10.1525/auk.2011.10273; Royle JA, 2004, ECOL APPL, V14, P1780; SNOW DW, 1978, BIRD STUDY, V25, P134, DOI 10.1080/00063657809476588; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Whittington PA, 1999, IBIS, V141, P327, DOI 10.1111/j.1474-919X.1999.tb07555.x; Wolfaardt AC, 2001, T ROY SOC S AFR, V56, P45, DOI 10.1080/00359190109520455	34	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55654	10.1371/journal.pone.0055654	http://dx.doi.org/10.1371/journal.pone.0055654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383257	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600141
J	Herman, T; Rosenberg-Katz, K; Jacob, Y; Auriel, E; Gurevich, T; Giladi, N; Hausdorff, JM				Herman, Talia; Rosenberg-Katz, Keren; Jacob, Yael; Auriel, Eitan; Gurevich, Tanya; Giladi, Nir; Hausdorff, Jeffrey M.			White Matter Hyperintensities in Parkinson's Disease: Do They Explain the Disparity between the Postural Instability Gait Difficulty and Tremor Dominant Subtypes?	PLOS ONE			English	Article							IMPAIRED EXECUTIVE FUNCTION; MILD COGNITIVE IMPAIRMENT; SMALL-VESSEL DISEASE; OLDER-PEOPLE; ELDERLY-PEOPLE; CAUTIOUS GAIT; RATING-SCALE; LESIONS; DISORDERS; PHENOTYPE	Background: Brain white matter hyperintensities (WMHs) commonly observed on brain imaging of older adults are associated with balance and gait impairment and have also been linked to cognitive deficits. Parkinson's disease (PD) is traditionally sub-classified into the postural instability gait difficulty (PIGD) sub-type, and the tremor dominant (TD) sub-type. Considering the known association between WMHs and axial symptoms like gait disturbances and postural instability, one can hypothesize that WMHs might contribute to the disparate clinical sub-types of patients with PD. Methods: 110 patients with PD underwent a clinical evaluation and a 3T MRI exam. Based on the Unified Parkinson Disease Rating Scale, the patients were classified into motor sub-types, i.e., TD or PIGD, and scores reflecting PIGD and TD symptoms were computed. We compared white matter burden using three previously validated methods: one using a semi-quantitative visual rating scale in specific brain regions and two automated methods. Results: Overall, MRI data were obtained in 104 patients. The mean WMHs scores and the percent of subjects with lesions in specific brain regions were similar in the two subtypes, p = 0.678. The PIGD and the TD scores did not differ even when comparing patients with a relatively high burden of WMHs to patients with a relatively low burden. Across most of the brain regions, mild to moderate correlations between WMHs and age were found (r = 0.23 to 0.41; p < 0.021). Conversely, no significant correlations were found between WMHs and the PIGD score or disease duration. In addition, depressive symptoms and cerebro-vascular risk factors were similar among the two subtypes. Conclusions: In contrast to what has been reported previously among older adults, the present study could not demonstrate any association between WMHs and the PIGD or TD motor sub-types in patients with PD.	[Herman, Talia; Rosenberg-Katz, Keren; Jacob, Yael; Auriel, Eitan; Gurevich, Tanya; Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Movement Disorders Unit, Dept Neurol, IL-69978 Tel Aviv, Israel; [Rosenberg-Katz, Keren; Jacob, Yael] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Funct Brain Imaging Unit, Wohl Inst Adv Imaging, IL-69978 Tel Aviv, Israel; [Herman, Talia; Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School	Hausdorff, JM (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Movement Disorders Unit, Dept Neurol, IL-69978 Tel Aviv, Israel.	jhausdor@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522	Michael J Fox Foundation	Michael J Fox Foundation	This work was supported by the Michael J Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya HJ, 2007, CAN J NEUROL SCI, V34, P56, DOI 10.1017/S0317167100005795; Alcalay RN, 2009, ARCH NEUROL-CHICAGO, V66, P1517, DOI 10.1001/archneurol.2009.267; Annweiler C, 2012, PANMINERVA MED, V54, P189; [Anonymous], 2012, NEURODEGENER DIS; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; BALOH RW, 1995, ARCH NEUROL-CHICAGO, V52, P975, DOI 10.1001/archneur.1995.00540340067014; Benninger DH, 2009, J NEUROL, V256, P256, DOI 10.1007/s00415-009-0092-2; Benson RR, 2002, NEUROLOGY, V58, P48, DOI 10.1212/WNL.58.1.48; Beyer MK, 2006, MOVEMENT DISORD, V21, P223, DOI 10.1002/mds.20704; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Blahak C, 2009, J NEUROL NEUROSUR PS, V80, P608, DOI 10.1136/jnnp.2008.154633; Bohnen NI, 2011, BRAIN, V134, P2358, DOI 10.1093/brain/awr139; Bohnen NI, 2011, NAT REV NEUROL, V7, P229, DOI 10.1038/nrneurol.2011.21; Bokde ALW, 2005, BRAIN RES PROTOC, V14, P135, DOI 10.1016/j.brainresprot.2004.10.001; Cameron IGM, 2010, NEUROPSYCHOLOGIA, V48, P1948, DOI 10.1016/j.neuropsychologia.2010.03.015; Choi SA, 2010, ACTA NEUROPATHOL, V119, P147, DOI 10.1007/s00401-009-0620-2; Dalaker TO, 2009, MOVEMENT DISORD, V24, P2233, DOI 10.1002/mds.22754; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franch O, 2009, J NEUROL SCI, V280, P84, DOI 10.1016/j.jns.2009.02.001; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Giladi N, 2007, J NEURAL TRANSM, V114, P1349, DOI 10.1007/s00702-007-0772-y; Giladi N, 2005, J NEUROL, V252, P300, DOI 10.1007/s00415-005-0641-2; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gouw AA, 2008, CEREBROVASC DIS, V25, P247, DOI 10.1159/000113863; Green J, 2002, NEUROLOGY, V59, P1320, DOI 10.1212/01.WNL.0000031426.21683.E2; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Gurevich T, 2003, PARKINSONISM RELAT D, V9, P169, DOI 10.1016/S1353-8020(02)00049-4; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hedden T., 2011, CEREB CORTEX; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Huber-Mahlin V, 2010, J NEUROL, V257, P1279, DOI 10.1007/s00415-010-5507-6; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kassubek J, 2002, NEUROSCI LETT, V323, P29, DOI 10.1016/S0304-3940(02)00111-8; Kostic VS, 2012, NEUROLOGY, V78, P409, DOI 10.1212/WNL.0b013e318245d23c; Lee SJ, 2009, ARCH GERONTOL GERIAT, V49, P255, DOI 10.1016/j.archger.2008.09.005; Marras C, 2011, NEUROLOGY, V77, P325, DOI 10.1212/WNL.0b013e318227042d; Murray ME, 2010, ARCH NEUROL-CHICAGO, V67, P1379, DOI 10.1001/archneurol.2010.280; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nieuwboer A, 2009, GAIT POSTURE; Novak V, 2009, MAGN RESON IMAGING, V27, P752, DOI 10.1016/j.mri.2009.01.010; Pantoni L, 2006, J AM GERIATR SOC, V54, P1095, DOI 10.1111/j.1532-5415.2006.00798.x; Petrovic IN, 2012, WHITE MATTER LESIONS; PICCINI P, 1995, ARCH NEUROL-CHICAGO, V52, P191, DOI 10.1001/archneur.1995.00540260097023; Poggesi A, 2008, J AM GERIATR SOC, V56, P1638, DOI 10.1111/j.1532-5415.2008.01832.x; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rodriguez-Ferreiro J, 2010, MOVEMENT DISORD, V25, P2136, DOI 10.1002/mds.23239; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Silbert LC, 2008, NEUROLOGY, V71, P108, DOI 10.1212/01.wnl.0000316799.86917.37; Slawek J, 2008, NEUROL NEUROCHIR POL, V42, P505; Smart Sean D, 2011, J Aging Res, V2011, P391783, DOI 10.4061/2011/391783; Sneed JR, 2011, AM J GERIAT PSYCHIAT, V19, P99, DOI 10.1097/JGP.0b013e318202fc8a; Soumare A, 2009, ANN NEUROL, V65, P706, DOI 10.1002/ana.21674; STERN MB, 1989, NEUROLOGY, V39, P1524, DOI 10.1212/WNL.39.11.1524; Stolze H, 2001, J NEUROL NEUROSUR PS, V70, P289, DOI 10.1136/jnnp.70.3.289; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; Verbaan D, 2007, J NEUROL NEUROSUR PS, V78, P1182, DOI 10.1136/jnnp.2006.112367; Verbaan D, 2007, NEUROLOGY, V69, P333, DOI 10.1212/01.wnl.0000266593.50534.e8; Wolfson L, 2005, J NEUROL SCI, V232, P23, DOI 10.1016/j.jns.2004.12.017; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67; Zheng JJJ, 2011, STROKE, V42, P2086, DOI 10.1161/STROKEAHA.110.610360; Zheng JJ, 2011, NEUROBIOL AGING	74	56	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55193	10.1371/journal.pone.0055193	http://dx.doi.org/10.1371/journal.pone.0055193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383104	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600074
J	Zhang, SD; Li, WY; Wang, WQ; Zhang, SS; Huang, P; Zhang, C				Zhang, Shaodan; Li, Weiyi; Wang, Wenqian; Zhang, Samuel S.; Huang, Ping; Zhang, Chun			Expression and Activation of STAT3 in the Astrocytes of Optic Nerve in a Rat Model of Transient Intraocular Hypertension	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; FIBRILLARY ACIDIC PROTEIN; REACTIVE ASTROCYTES; PROMOTES SURVIVAL; JAK/STAT PATHWAY; GENE-EXPRESSION; UP-REGULATION; NEURONS; ASTROGLIOSIS; INDUCTION	Lamina cribosa, an astrocyte-rich region, is the origin of axonal degeneration in glaucomatous neuropathy. Astrocytes are particularly activated during optic nerve (ON) degeneration and are likely to contribute to the pathogenesis of glaucomatous optic neuropathy. Signalling mechanisms that regulate different aspects of astrocyte reactiviation in response to intraocular hypertensive injury are not well defined. Signal transducer and activator of transcription protein-3 (STAT3) is a transcription factor that participates in many biological processes and has been implicated as activator of reactive astrogliosis. In this study, we investigated the role of STAT3 in regulating the activation of astrocytes to transient intraocular hypertension in vivo by using a rat ocular hypertension model. ON astrocytes hypertrophy was observed early after intraocular hypertensive stress. Morphological changes in glial fibrillary acidic protein (GFAP) positive cells coupled with axon loss in the optic nerve was detected at day 7 after the injury. Nestin was significantly upregulated in ON astrocytes as early as day 2 post injury and kept elevated through post injury day 7. Phosphorylated STAT3 (pSTAT3) was markedly upregulated in ON astrocytes at post injury day 1, prior to the reactivation of ON astrocytes. These findings indicate that STAT3 signalling is involved in the initiation of astrocyte reactivation in optic nerve injury.	[Zhang, Shaodan; Li, Weiyi; Wang, Wenqian; Huang, Ping; Zhang, Chun] Peking Univ, Ctr Eye, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China; [Zhang, Shaodan] 4th Peoples Hosp Shenyang, Dept Ophthalmol, Shenyang Inst Ophthalmol, Liaoning, Peoples R China; [Zhang, Samuel S.] Penn State Univ, Dept Neural & Behav Sci, Hershey, PA USA; [Zhang, Samuel S.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore	Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National University of Singapore; Singapore National Eye Center	Huang, P (corresponding author), Peking Univ, Ctr Eye, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China.	huangping512@hotmail.com			Chinese State Natural and Science [30772376, 81041008]	Chinese State Natural and Science	This work was supported by grants from Chinese State Natural and Science 30772376 and 81041008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Avraham BCR, 2008, CURR EYE RES, V33, P395, DOI 10.1080/02713680801932891; BALASINGAM V, 1994, J NEUROSCI, V14, P846; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Cho KJ, 2011, BRAIN RES, V1403, P67, DOI 10.1016/j.brainres.2011.06.005; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; CONNOR JR, 1985, NEUROSCIENCE, V16, P33, DOI 10.1016/0306-4522(85)90044-2; Correa-Cerro LS, 2007, J NEUROPATH EXP NEUR, V66, P169, DOI 10.1097/01.jnen.0000248555.53079.d5; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Guerette D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-164; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Ji JZ, 2004, EUR J NEUROSCI, V19, P265, DOI 10.1111/j.0953-816X.2003.03107.x; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Klein MA, 1997, GLIA, V19, P227, DOI 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W; Levison SW, 2000, GLIA, V32, P328, DOI 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Luna G, 2010, MOL VIS, V16, P2511; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Planas AM, 1996, EUR J NEUROSCI, V8, P2612, DOI 10.1111/j.1460-9568.1996.tb01556.x; Quigley HA, 2005, INVEST OPHTH VIS SCI, V46, P2663, DOI 10.1167/iovs.04-1070; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Roth S, 2003, INVEST OPHTH VIS SCI, V44, P5383, DOI 10.1167/iovs.03-0451; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Safavi-Abbasi S, 2001, GLIA, V36, P102, DOI 10.1002/glia.1099; Sakamoto K, 2006, EXP EYE RES, V82, P512, DOI 10.1016/j.exer.2005.08.011; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Son JL, 2010, GLIA, V58, P780, DOI 10.1002/glia.20962; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; Washburn KB, 2006, NEUROSCIENCE, V142, P411, DOI 10.1016/j.neuroscience.2006.06.034; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x; Zhang C, 2008, EXP EYE RES, V86, P991, DOI 10.1016/j.exer.2008.03.020; Zhang SSM, 2005, EXP EYE RES, V81, P103, DOI 10.1016/j.exer.2005.01.016; Zhang SSM, 2003, EXP EYE RES, V76, P421, DOI 10.1016/S0014-4835(03)00002-2	60	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55683	10.1371/journal.pone.0055683	http://dx.doi.org/10.1371/journal.pone.0055683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383263	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600145
J	Abdel-Moneim, AS; Kamel, MM; Al-Ghamdi, AS; Al-Malky, MIR				Abdel-Moneim, Ahmed S.; Kamel, Mahmoud M.; Al-Ghamdi, Abdullhamid S.; Al-Malky, Mater I. R.			Detection of Bocavirus in Children Suffering from Acute Respiratory Tract Infections in Saudi Arabia	PLOS ONE			English	Article							EPIDEMIOLOGIC PROFILE; HUMAN PARVOVIRUSES; FREQUENT DETECTION; VIRUS; INFANTS	Human bocavirus (HBoV) was recently discovered in children with respiratory distress and/or diarrhea. To our knowledge, no previous study has reported the existence of bocavirus in Saudi Arabia. Swabs samples from 80 children with respiratory tract infections were examined for the presence of HBoV. Real-time polymerase chain reaction was used as a sensitive method to detect the HBoV. Direct gene sequencing was used to determine the genotype of the detected virus isolates. HBoV was detected in 22.5% of the examined patients. The NP1 partial gene sequence from all patients showed that the circulated strains were related to HBoV-1 genotype. Most of HBoV infected patients showed evidence of mixed coinfection with other viral pathogens. The current study clearly demonstrated that genetically conserved HBoV1 circulates in Saudi Arabia. Interestingly, most of the HBoV1 infected cases were associated with high rates of co-infections with other viruses.	[Abdel-Moneim, Ahmed S.; Kamel, Mahmoud M.; Al-Ghamdi, Abdullhamid S.] Taif Univ, Coll Med, Al Taif, Saudi Arabia; [Abdel-Moneim, Ahmed S.] Beni Suef Univ, Dept Virol, Fac Vet Med, Bani Suwayf, Egypt; [Kamel, Mahmoud M.] Cairo Univ, Natl Canc Inst, Dept Clin Pathol, Cairo, Egypt; [Al-Malky, Mater I. R.] Pediat Hosp, Al Taif, Saudi Arabia	Taif University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt	Abdel-Moneim, AS (corresponding author), Taif Univ, Coll Med, Al Taif, Saudi Arabia.	asa@bsu.edu.eg	Al-Ghamdi, Abdulhamed/ABE-2906-2020; Abdel-Moneim, Ahmed S./G-7445-2012; Kamel, Mahmoud/CAE-9055-2022	Abdel-Moneim, Ahmed S./0000-0002-3148-6782; Kamel, Mahmoud/0000-0003-0264-3096; 0000-0002-3160-7687, 0000-0002-3160-7687/0000-0001-6264-6921	Taif University, Saudi Arabia [1652-433-1]	Taif University, Saudi Arabia	This study was supported by a research grant (Project No. 1652-433-1) through the Research Support of Taif University, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Christensen A, 2008, J CLIN VIROL, V41, P34, DOI 10.1016/j.jcv.2007.10.025; Claude M, 2004, 8 INT COMM TAX VIR; Foulongne V, 2006, EMERG INFECT DIS, V12, P1251, DOI 10.3201/eid1708.060213.; Kaplan NM, 2006, EMERG INFECT DIS, V12, P1418, DOI 10.3201/eid1209.060417; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Kupfer B, 2006, EMERG INFECT DIS, V12, P1614, DOI 10.3201/eid1210.060520; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Lin Feng, 2007, Infect Agent Cancer, V2, P3; Lindner J, 2008, VIRAL IMMUNOL, V21, P443, DOI 10.1089/vim.2008.0045; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Ghietto LM, 2012, BRAZ J INFECT DIS, V16, P38, DOI 10.1590/S1413-86702012000100007; Regamey N, 2007, PEDIATR INFECT DIS J, V26, P177, DOI 10.1097/01.inf.0000250623.43107.bc; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Smuts H, 2006, EMERG INFECT DIS, V12, P1457, DOI 10.3201/eid1209.051616; Vicente D, 2007, EMERG INFECT DIS, V13, P636, DOI 10.3201/eid1304.061501; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044876	31	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55500	10.1371/journal.pone.0055500	http://dx.doi.org/10.1371/journal.pone.0055500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383205	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800160
J	Bagshaw, ATM; Horwood, LJ; Liu, YF; Fergusson, DM; Sullivan, PF; Kennedy, MA				Bagshaw, Andrew T. M.; Horwood, L. John; Liu, Youfang; Fergusson, David M.; Sullivan, Patrick F.; Kennedy, Martin A.			No Effect of Genome-Wide Copy Number Variation on Measures of Intelligence in a New Zealand Birth Cohort	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CHROMOSOMAL REGIONS; GENETIC-ANALYSIS; LINKAGE; POLYMORPHISMS; DUPLICATIONS; HERITABILITY; ASSOCIATION; SCAN; IQ	Variation in human intelligence is approximately 50% heritable, but understanding of the genes involved is limited. Several forms of genetic variation remain under-studied in relation to intelligence, one of which is copy number variation (CNV). Using single-nucleotide polymorphism (SNP) - based microarrays, we genotyped CNVs genome-wide in a birth cohort of 723 New Zealanders, and correlated them with four intelligence-related phenotypes. We found no significant association for any common CNV after false discovery correction, which is consistent with previous work. In contrast to a previous study, however, we found no effect on any cognitive measure of rare CNV burden, defined as total number of bases inserted or deleted in CNVs rarer than 5%. We discuss possible reasons for this failure to replicate, including interaction between CNV and aging in determining the effects of rare CNVs. While our results suggest that no CNV assayable by SNP chips contributes more than a very small amount to variation in human intelligence, it remains possible that common CNVs in segmental duplication arrays, which are not well covered by SNP chips, are important contributors.	[Bagshaw, Andrew T. M.; Kennedy, Martin A.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Horwood, L. John; Fergusson, David M.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand; [Liu, Youfang; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of Otago; University of Otago; University of North Carolina; University of North Carolina Chapel Hill	Bagshaw, ATM (corresponding author), Univ Otago, Dept Pathol, Christchurch, New Zealand.	andrew.bagshaw@gmail.com	Kennedy, Martin A/A-4942-2008; Kennedy, Martin/O-4540-2019	Kennedy, Martin A/0000-0002-6445-8526; Kennedy, Martin/0000-0002-6445-8526; Fergusson, David/0000-0002-8117-017X; Horwood, L./0000-0003-4881-1956; Bagshaw, Andrew/0000-0002-2930-7298	Royal Society of New Zealand Marsden Grant [UOC 202]; Health Research Council of New Zealand; National Child Health Research Foundation; Canterbury Medical Research Foundation; New Zealand Lottery Grants Board; University of Otago; Carney Centre for Pharmacogenomics; James Hume Bequest Fund; US National Institutes of Health [MH077874]; NIDA [R01DA024413]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024413] Funding Source: NIH RePORTER	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); National Child Health Research Foundation; Canterbury Medical Research Foundation; New Zealand Lottery Grants Board; University of Otago; Carney Centre for Pharmacogenomics; James Hume Bequest Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	ATB and MAK were supported by a Royal Society of New Zealand Marsden Grant (UOC 202). This research was also funded by grants from the Health Research Council of New Zealand, the National Child Health Research Foundation, the Canterbury Medical Research Foundation, the New Zealand Lottery Grants Board, the University of Otago, the Carney Centre for Pharmacogenomics, the James Hume Bequest Fund, and US National Institutes of Health grant MH077874. Gene chip data were generated with NIDA support under "A developmental model of gene-environment interplay in SUDs (R01DA024413) 2007-2012''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baker K, 2012, CURR OPIN NEUROL, V25, P150, DOI 10.1097/WCO.0b013e328351820e; Banks GC, 2010, INTELLIGENCE, V38, P393, DOI 10.1016/j.intell.2010.04.003; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Buyske S, 2006, BEHAV GENET, V36, P65, DOI 10.1007/s10519-005-9008-9; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Dick DM, 2006, BEHAV GENET, V36, P77, DOI 10.1007/s10519-005-9009-8; Dumas L, 2009, COLD SH Q B, V74, P375, DOI 10.1101/sqb.2009.74.025; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Fergusson D.M., 2008, RES SOCIAL STRATIFIC, V26, P277, DOI [DOI 10.1016/J.RSSM.2008.05.001, 10.1016/j.rssm.2008.05.001]; Fergusson DM, 2001, AUST NZ J PSYCHIAT, V35, P287, DOI 10.1046/j.1440-1614.2001.00902.x; Fergusson DM, 1989, PAEDIATRIC PERINATAL, V3, P302, DOI DOI 10.1111/J.1365-3016.1989.TB00382.X; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Haworth CMA, 2009, BEHAV GENET, V39, P359, DOI 10.1007/s10519-009-9262-3; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Langley K, 2011, BRIT J PSYCHIAT, V199, P398, DOI 10.1192/bjp.bp.111.092130; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Luciano M, 2006, BEHAV GENET, V36, P45, DOI 10.1007/s10519-005-9003-1; Lundvall M, 2012, ACTA PAEDIATR, V101, P85, DOI 10.1111/j.1651-2227.2011.02417.x; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarthy M, 2006, LANCET NEUROL, V5, P907, DOI 10.1016/S1474-4422(06)70594-4; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Morley KI, 2001, BEHAV GENET, V31, P511, DOI 10.1023/A:1013337209957; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; NEED AC, 2009, HUM MOL GENET; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Posthuma D, 2005, AM J HUM GENET, V77, P318, DOI 10.1086/432647; Reid, 1981, BURT WORD READING TE; REID NA, 1981, TEST SCHOLASTIC ABIL; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shoukier M, 2012, CLIN GENET; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Vinkhuyzen AAE, 2012, BEHAV GENET, V42, P187, DOI 10.1007/s10519-011-9507-9; Wahlsten D, 2012, DEV PSYCHOBIOL; Wainwright MA, 2006, BEHAV GENET, V36, P56, DOI 10.1007/s10519-005-9013-z; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wechsler D., 2003, MANUAL WECHSLER INTE, V4th; Wechsler D., 2002, WECHSLER MEMORY SCAL; *WHO, 1997, COMP INT DIAGN INT C; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339	59	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55208	10.1371/journal.pone.0055208	http://dx.doi.org/10.1371/journal.pone.0055208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383111	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800131
J	Chen, H; Kobayashi, K; Miyao, A; Hirochika, H; Yamaoka, N; Nishiguchi, M				Chen, Hui; Kobayashi, Kappei; Miyao, Akio; Hirochika, Hirohiko; Yamaoka, Naoto; Nishiguchi, Masamichi			Both OsRecQ1 and OsRDR1 Are Required for the Production of Small RNA in Response to DNA-Damage in Rice	PLOS ONE			English	Article							SMALL SILENCING RNAS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CELLULAR-RESPONSE; GENE; REPAIR; PROTEIN; ARABIDOPSIS; POLYMERASE; ATM	Small RNA-mediated gene silencing pathways play important roles in the regulation of development, genome stability and various stress responses in many eukaryotes. Recently, a new type of small interfering RNAs (qiRNAs) approximately 20-21 nucleotides long in Neurospora crassa have been shown to mediate gene silencing in the DNA damage response (DDR) pathway. However, the mechanism for RNA silencing in the DDR pathway is largely unknown in plants. Here, we report that a class of small RNAs (qiRNAs) derived from rDNA was markedly induced after treatment by DNA-damaging agents [ ethyl methanesulphonate (EMS and UV-C)], and that aberrant RNAs (aRNAs) as precursors were also highly induced after the DNA damage treatment in rice. However, these RNAs were completely abolished in OsRecQ1 (RecQ DNA helicase homologue) and OsRDR1 (RNA-dependent RNA polymerase homologue) mutant lines where either gene was disrupted by the insertion of rice retrotransposon Tos17 after the same treatment. DNA damage resulted in a more significant increase in cell death and a more severe inhibition of root growth in both mutant lines than in the WT. Together, these results strongly suggest that both OsRecQ1 and OsRDR1 play a pivotal role in the aRNA and qiRNA biogenesis required for the DDR and repair pathway in rice, and it may be a novel mechanism of regulation to the DDR through the production of qiRNA in plants.	[Chen, Hui; Kobayashi, Kappei; Yamaoka, Naoto; Nishiguchi, Masamichi] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Miyao, Akio; Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	Ehime University; National Institute of Agrobiological Sciences - Japan	Chen, H (corresponding author), Agr & Agri Food Canada, Southern Crop Protect & Food Res Ctr, London, ON, Canada.	huichen98@hotmail.com; mnishigu@agr.ehime-u.ac.jp	Miyao, Akio/V-7306-2019; Chen, Hui/Y-4376-2019	Miyao, Akio/0000-0002-2822-2866; Chen, Hui/0000-0001-6050-0873	Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports and Technology of Japan [22119010]; Grants-in-Aid for Scientific Research [24580065] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN) and the Ministry of Education, Culture, Sports and Technology of Japan [Grant-in-Aid for Scientific Research for Scientific Research (C), No. 22119010] to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Aggarwal M, 2011, P NATL ACAD SCI USA, V108, P1525, DOI 10.1073/pnas.1006423108; BAKER CJ, 1994, PLANT CELL TISS ORG, V39, P7, DOI 10.1007/BF00037585; BASILE G, 1992, MOL CELL BIOL, V12, P3235, DOI 10.1128/MCB.12.7.3235; BATSCHAUER A, 1993, PLANT J, V4, P705, DOI 10.1046/j.1365-313X.1993.04040705.x; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe DC, 1999, CURR BIOL, V9, pR599, DOI 10.1016/S0960-9822(99)80383-2; Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Chen H, 2008, PLANT J, V56, P274, DOI 10.1111/j.1365-313X.2008.03587.x; Chen H, 2010, J GEN PLANT PATHOL, V76, P152, DOI 10.1007/s10327-010-0226-5; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Culligan KM, 2008, PLANT J, V55, P629, DOI 10.1111/j.1365-313X.2008.03530.x; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hajdu I, 2011, P NATL ACAD SCI USA, V108, P13130, DOI 10.1073/pnas.1110081108; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hartung F, 2007, P NATL ACAD SCI USA, V104, P18836, DOI 10.1073/pnas.0705998104; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Ishibashi T, 2006, DNA REPAIR, V5, P80, DOI 10.1016/j.dnarep.2005.07.010; Le Trionnaire G, 2011, J EXP BOT, V62, P1601, DOI 10.1093/jxb/erq399; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nielsen BL, 2010, J EXP BOT, V61, P2535, DOI 10.1093/jxb/erq163; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Wang S, 2011, DNA REPAIR, V10, P620, DOI 10.1016/j.dnarep.2011.04.009; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Wu YL, 2010, DNA REPAIR, V9, P315, DOI 10.1016/j.dnarep.2009.12.010; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yoshiyama K, 2009, P NATL ACAD SCI USA, V106, P12843, DOI 10.1073/pnas.0810304106	50	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55252	10.1371/journal.pone.0055252	http://dx.doi.org/10.1371/journal.pone.0055252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383126	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800135
J	Paine, SML; Anderson, G; Bedford, K; Lawler, K; Mayer, RJ; Lowe, J; Bedford, L				Paine, Simon M. L.; Anderson, Glenn; Bedford, Karen; Lawler, Karen; Mayer, R. John; Lowe, James; Bedford, Lynn			Pale Body-Like Inclusion Formation and Neurodegeneration following Depletion of 26S Proteasomes in Mouse Brain Neurones are Independent of alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; PROTEIN-DEGRADATION; LEWY BODIES; COMPLEX-I; UBIQUITIN; INHIBITION; AUTOPHAGY; SYSTEM; MODEL; DEGENERATION	Parkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra pars compacta (SNpc) dopaminergic neurones and the formation of Lewy bodies (LB) in a proportion of the remaining neurones. alpha-synuclein is the main component of LB, but the pathological mechanisms that lead to neurodegeneration associated with LB formation remain unclear. Three pivotal elements have emerged in the development of PD: alpha-synuclein, mitochondria and protein degradation systems. We previously reported a unique model, created by conditional genetic depletion of 26S proteasomes in the SNpc of mice, which mechanistically links these three elements with the neuropathology of PD: progressive neurodegeneration and intraneuronal inclusion formation. Using this model, we tested the hypothesis that alpha-synuclein was essential for the formation of inclusions and neurodegeneration caused by 26S proteasomal depletion. We found that both of these processes were independent of alpha-synuclein. This provides an important insight into the relationship between the proteasome, alpha-synuclein, inclusion formation and neurodegeneration. We also show that the autophagy-lysosomal pathway is not activated in 26S proteasome-depleted neurones. This leads us to suggest that the paranuclear accumulation of mitochondria in inclusions in our model may reflect a role for the ubiquitin proteasome system in mitochondrial homeostasis and that neurodegeneration may be mediated through mitochondrial factors linked to inclusion biogenesis.	[Paine, Simon M. L.] UCL, Inst Child Hlth, Neural Dev Unit, London, England; [Paine, Simon M. L.; Anderson, Glenn] Great Ormond St Hosp Sick Children, Dept Histopathol, London WC1N 3JH, England; [Bedford, Karen] Hull Royal Infirm, Hull Hosp, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bedford, Karen] Hull Royal Infirm, East Yorkshire Hosp, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Paine, Simon M. L.; Lawler, Karen; Mayer, R. John; Bedford, Lynn] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England; [Lowe, James] Univ Nottingham, Div Histopathol, Sch Mol Med Sci, Nottingham NG7 2RD, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Hull; University of Hull; University of Nottingham; University of Nottingham	Bedford, L (corresponding author), Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.	lynn.bedford@nottingham.ac.uk		Paine, Simon/0000-0002-1434-3931; Lowe, James/0000-0002-9856-1599	Parkinson's UK; Pathological Society of Great Britain; Pathological Society of Ireland; Alzheimers Research UK [ART-RF2004B-1] Funding Source: researchfish; National Institute for Health Research [ACF-2006-12-002] Funding Source: researchfish; Parkinson&quot;s UK [F-0702] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); Pathological Society of Great Britain; Pathological Society of Ireland; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by Parkinson's UK and a Centenary Clinical Research Training Fellowship from the Pathological Society of Great Britain and Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; BAYER SA, 1995, EXP BRAIN RES, V105, P191; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bove J, 2006, ANN NEUROL, V60, P260, DOI 10.1002/ana.20937; Chan NC, 2011, AUTOPHAGY, V7, P771, DOI 10.4161/auto.7.7.15453; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cook C, 2009, BBA-MOL BASIS DIS, V1792, P664, DOI 10.1016/j.bbadis.2009.01.012; DALE GE, 1992, ACTA NEUROPATHOL, V83, P525, DOI 10.1007/BF00310030; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; Dickson DW, 2008, ACTA NEUROPATHOL, V115, P437, DOI 10.1007/s00401-008-0345-7; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; GIBB WRG, 1989, ANN NEUROL, V26, P691, DOI 10.1002/ana.410260520; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Hawlitschka A, 2007, BRAIN RES, V1173, P137, DOI 10.1016/j.brainres.2007.07.072; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jantas D, 2011, NEUROTOXICOLOGY, V32, P845, DOI 10.1016/j.neuro.2011.05.013; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Keane PC, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/716871; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kordower JH, 2006, ANN NEUROL, V60, P264, DOI 10.1002/ana.20935; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Sai Y, 2012, NEUROSCI BIOBEHAV R, V36, P2034, DOI 10.1016/j.neubiorev.2012.06.007; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; Schapira AHV, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/159160; Schapira AHV, 2006, ANN NEUROL, V60, P253, DOI 10.1002/ana.20934; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zeng BY, 2006, ANN NEUROL, V60, P248, DOI 10.1002/ana.20932; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200; Zigoneanu IG, 2011, BIOCHIM BIOPHYS ACTA, V1818, P512	76	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54711	10.1371/journal.pone.0054711	http://dx.doi.org/10.1371/journal.pone.0054711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382946	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800068
J	Tani, H; Torimura, M; Akimitsu, N				Tani, Hidenori; Torimura, Masaki; Akimitsu, Nobuyoshi			The RNA Degradation Pathway Regulates the Function of GAS5 a Non-Coding RNA in Mammalian Cells	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; NECROSIS-FACTOR-ALPHA; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; GROWTH-ARREST; P-TEFB; 7SK SNRNA; GLUCOCORTICOID-RECEPTOR; CELLULAR INHIBITOR; MESSENGER-RNAS	Studies of various mRNAs have revealed that changes in the abundance of transcripts, through mRNA degradation, act as a critical step in the control of various biological pathways. Similarly, the regulation of non-coding RNA (ncRNA) levels is also considered to be important for their biological functions; however, far less is known about the mechanisms and biological importance of ncRNA turnover for the regulation of ncRNA functions. The growth arrest-specific 5 (GAS5) ncRNA accumulates during growth arrest induced by serum starvation and its transcript is degraded by the well characterized nonsense-mediated RNA decay (NMD) pathway. Historically, NMD was discovered as a RNA quality control system to eliminate aberrant transcripts; however, accumulating evidence shows that NMD also regulates the abundance of physiological transcripts. Interestingly, the GAS5 transcript has the ability to bind the glucocorticoid receptor (GR), resulting in the inhibition of its ligand-dependent association with DNA. The GR binds the promoters of various glucocorticoid-responsive genes, including apoptosis-related genes. In this study, we examined whether the RNA degradation pathway can regulate this function of GAS5. We measured the steady-state abundance and the decay rate of GAS5 in UPF1-depleted human cells using the 5'-bromo-uridine immunoprecipitation chase (BRIC) method, an inhibitor-free method for directly measuring RNA stability. We found that levels of the GAS5 transcript were elevated owing to prolonged decay rates in response to UPF1 depletion, and consequently the apoptosis-related genes, cIAP2 and SGK1, were down-regulated. In addition, serum starvation also increased the transcript levels of GAS5 because of prolonged decay rates, and conversely decreased levels of cIAP2 and SGK1 mRNA. Taken together, we found that the RNA degradation pathway can regulate the function of the GAS5 ncRNA in mammalian cells.	[Tani, Hidenori; Torimura, Masaki] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan; [Akimitsu, Nobuyoshi] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Tani, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan.	h.tani@aist.go.jp; akimitsu@ric.u-tokyo.ac.jp	Tani, Hidenori/A-7175-2017; Torimura, Masaki/M-8401-2018; Tani, Hidenori/F-2042-2010	Tani, Hidenori/0000-0001-6390-4136; Tani, Hidenori/0000-0001-6390-4136	Takeda Science Foundation; Naito Foundation; Japan Society for the Promotion of Science; Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was financially supported by the Takeda Science Foundation, the Naito Foundation, Grants-in-Aid for Scientific Research, Research Fellowship of the Japan Society for the Promotion of Science, the Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science, and Grant-in-Aid for Scientific Research on Innovative Areas 'Functional machinery for non-coding RNAs' from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2012, BIOCHEM BIOPH RES CO, V428, P44, DOI 10.1016/j.bbrc.2012.09.144; Alonso CR, 2012, TRENDS GENET, V28, P78, DOI 10.1016/j.tig.2011.10.005; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Blattner C, 2000, MOL CELL BIOL, V20, P3616, DOI 10.1128/MCB.20.10.3616-3625.2000; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Colley SM, 2011, BIOCHIMIE, V93, P1966, DOI 10.1016/j.biochi.2011.07.004; Cooper C, 2011, BIOCHIMIE, V93, P1973, DOI 10.1016/j.biochi.2011.07.002; Deblois G, 2003, J STEROID BIOCHEM, V85, P123, DOI 10.1016/S0960-0760(03)00225-5; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Emberley E, 2003, BIOCHEM BIOPH RES CO, V301, P509, DOI 10.1016/S0006-291X(02)03070-X; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Fleming JV, 1998, BIOCHEM J, V330, P573; Fontanier-Razzaq N, 2002, J NUTR, V132, P2137, DOI 10.1093/jn/132.8.2137; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gardner LB, 2008, CELL CYCLE, V7, P1916, DOI 10.4161/cc.7.13.6203; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hong SY, 2000, J BIOL CHEM, V275, P18022, DOI 10.1074/jbc.M001202200; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Ideue T, 2012, P NATL ACAD SCI USA, V109, P5693, DOI 10.1073/pnas.1200523109; Imamachi N, 2012, DRUG DISCOV THER, V6, P55, DOI 10.5582/ddt.2012.v6.2.55; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; Keene JD, 2010, ENDOCRINOLOGY, V151, P1391, DOI 10.1210/en.2009-1250; Kelly VR, 2010, MOL ENDOCRINOL, V24, P2281, DOI 10.1210/me.2010-0133; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kulkarni PA, 2004, RECENT PROG HORM RES, V59, P125, DOI 10.1210/rp.59.1.125; Lanz RB, 2002, P NATL ACAD SCI USA, V99, P16081, DOI 10.1073/pnas.192571399; Marz M, 2009, MOL BIOL EVOL, V26, P2821, DOI 10.1093/molbev/msp198; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Raghavan Arvind, 2004, Briefings in Functional Genomics & Proteomics, V3, P112, DOI 10.1093/bfgp/3.2.112; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruegger S, 2012, TRENDS BIOCHEM SCI, V37, P436, DOI 10.1016/j.tibs.2012.07.002; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Sharifi Neda. A., 2006, P97; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360; Tani H, 2012, RNA BIOL, V9, P1233, DOI 10.4161/rna.22036; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tani H, 2010, DRUG DISCOV THER, V4, P235; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zhang Z, 2012, WIRES RNA, V3, P593, DOI 10.1002/wrna.1114; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	84	129	131	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55684	10.1371/journal.pone.0055684	http://dx.doi.org/10.1371/journal.pone.0055684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383264	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800184
J	Giri, S; Karakoti, A; Graham, RP; Maguire, JL; Reilly, CM; Seal, S; Rattan, R; Shridhar, V				Giri, Shailendra; Karakoti, Ajay; Graham, Rondell P.; Maguire, Jacie L.; Reilly, Christopher M.; Seal, Sudipta; Rattan, Ramandeep; Shridhar, Viji			Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CERIUM OXIDE NANOPARTICLES; PHASE-II; TUMOR ANGIOGENESIS; BEVACIZUMAB; METASTASIS; ACTIVATION; EXPRESSION; PROTECTION; DAMAGE	Ovarian cancer (OvCa) is the fifth most common cause of death from all cancers among women in United Sates and the leading cause of death from gynecological malignancies. While most OvCa patients initially respond to surgical debulking and chemotherapy, 75% of patients later succumb to the disease. Thus, there is an urgent need to test novel therapeutic agents to counteract the high mortality rate associated with OvCa. In this context, we have developed and engineered Nanoceria (NCe), nanoparticles of cerium oxide, possessing anti-oxidant properties, to be used as a therapeutic agent in OvCa. We show for the first time that NCe significantly inhibited production of reactive oxygen species (ROS) in A2780 cells, attenuated growth factor (SDF1, HB-EGF, VEGF(165) and HGF) mediated cell migration and invasion of SKOV3 cells, without affecting the cell proliferation. NCe treatment also inhibited VEGF165 induced proliferation, capillary tube formation, activation of VEGFR2 and MMP2 in human umbilical vascular endothelial cells (HUVEC). NCe (0.1 mg/kg body weigh) treatment of A2780 ovarian cancer cells injected intra-peritoneally in nude mice showed significant reduction (p<0.002) in tumor growth accompanied by decreased tumor cell proliferation as evident from reduced tumor size and Ki67 staining. Accumulation of NCe was found in tumors isolated from treated group using transmission electron microscopy (TEM) and inductively coupled plasma mass spectroscopy (ICP-MS). Reduction of the tumor mass was accompanied by attenuation of angiogenesis, as observed by reduced CD31 staining and specific apoptosis of vascular endothelial cells. Collectively, these results indicate that cerium oxide based NCe is a novel nanoparticle that can potentially be used as an anti-angiogenic therapeutic agent in ovarian cancer.	[Giri, Shailendra; Maguire, Jacie L.; Shridhar, Viji] Mayo Clin, Coll Med, Dept Expt Pathol, Rochester, MN USA; [Karakoti, Ajay; Seal, Sudipta] Univ Cent Florida, Nanosci Technol Ctr, Adv Mat Proc Anal Ctr, Orlando, FL 32816 USA; [Graham, Rondell P.] Mayo Clin, Coll Med, Rochester, MN USA; [Reilly, Christopher M.] Virginia Tech, Via Virginia Coll Osteopath Med, Blacksburg, VA USA; [Reilly, Christopher M.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA; [Rattan, Ramandeep] Henry Ford Hlth Syst, Womens Hlth Serv, Detroit, MI USA	Mayo Clinic; State University System of Florida; University of Central Florida; Mayo Clinic; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Henry Ford Health System; Henry Ford Hospital	Seal, S (corresponding author), Univ Cent Florida, Nanosci Technol Ctr, Adv Mat Proc Anal Ctr, Orlando, FL 32816 USA.	shridhar.vijayalakshmi@mayo.edu; rrattan1@hfhs.org; Sudipta.Seal@ucf.edu	Karakoti, Ajay/AGI-8160-2022; Seal, Sudipta/A-7698-2012; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AAY-5886-2020	KARAKOTI, AJAY/0000-0001-9081-2325; Graham, Rondell/0000-0002-8686-4867; Reilly, Chris/0000-0003-4787-7750	Mayo Clinic College of Medicine; Marsh Rivkin grants; NSF CBET [0708172, 0930170];  [CA123249]; NATIONAL CANCER INSTITUTE [R01CA123249] Funding Source: NIH RePORTER	Mayo Clinic College of Medicine; Marsh Rivkin grants; NSF CBET(National Science Foundation (NSF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is mainly supported by CA123249 and support from Mayo Clinic College of Medicine to VS and partly supported by Marsh Rivkin grants to SG and RR. This work was partly supported by NSF CBET, 0708172 and 0930170 to SS (for the nanoparticle development in biomedical applications). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alili L, 2011, BIOMATERIALS; Amin KA, 2011, INT J NANOMED, V6, P143, DOI 10.2147/IJN.S15308; Bansal N, 2011, GYNECOL ONCOL, V120, P313, DOI 10.1016/j.ygyno.2010.10.002; Bast Robert C Jr, 2002, Cancer Treat Res, V107, P61; Bharali DJ, 2010, PHARMACOL THERAPEUT, V128, P324, DOI 10.1016/j.pharmthera.2010.07.007; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Colon J, 2010, NANOMED-NANOTECHNOL, V6, P698, DOI 10.1016/j.nano.2010.01.010; Colon J, 2009, NANOMED-NANOTECHNOL, V5, P225, DOI 10.1016/j.nano.2008.10.003; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Deshpande S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2061873; Ferrara N, 1996, EUR J CANCER, V32A, P2413, DOI 10.1016/S0959-8049(96)00387-5; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Friedlander ML, 1998, SEMIN ONCOL, V25, P305; Garcia AA, 2008, J CLIN ONCOL, V26, P76, DOI 10.1200/JCO.2007.12.1939; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Giri S, 2008, J NEUROCHEM, V105, P1820, DOI 10.1111/j.1471-4159.2008.05279.x; Gomez-Raposo C, 2009, CLIN TRANSL ONCOL, V11, P564, DOI 10.1007/s12094-009-0406-y; Hardas SS, 2010, TOXICOL SCI, V116, P562, DOI 10.1093/toxsci/kfq137; Hirst SM, 2011, ENVIRON TOXICOL; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Karakoti AS, 2007, J PHYS CHEM C, V111, P17232, DOI 10.1021/jp076164k; Karakoti AS, 2009, J AM CHEM SOC, V131, P14144, DOI 10.1021/ja9051087; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Koskas M, 2010, ANTICANCER RES, V30, P4743; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lecarpentier E, 2010, INVEST NEW DRUGS; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Lose F, 2010, GYNECOL ONCOL, V119, P479, DOI 10.1016/j.ygyno.2010.08.014; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Markman M, 2009, EXPERT OPIN PHARMACO, V10, P2269, DOI 10.1517/14656560903120907; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029; Penson RT, 2010, J CLIN ONCOL, V28, P154, DOI 10.1200/JCO.2009.22.7900; Penson RT, 2003, GYNECOL ONCOL, V28, P154; Randall LM, 2010, GYNECOL ONCOL, V117, P497, DOI 10.1016/j.ygyno.2010.02.021; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Seigneuric R, 2010, CURR MOL MED, V10, P640, DOI 10.2174/156652410792630634; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tarnuzzer RW, 2005, NANO LETT, V5, P2573, DOI 10.1021/nl052024f; Tempfer C, 1998, OBSTET GYNECOL, V92, P360, DOI 10.1016/S0029-7844(98)00190-2; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEIDNER N, 1993, AM J PATHOL, V143, P401; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567	55	164	176	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54578	10.1371/journal.pone.0054578	http://dx.doi.org/10.1371/journal.pone.0054578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382918	Green Published, gold			2022-12-27	WOS:000314610600031
J	Guo, L; Du, H; Yan, SQ; Wu, XP; McKhann, GM; Chen, JX; Yan, SS				Guo, Lan; Du, Heng; Yan, Shiqiang; Wu, Xiaoping; McKhann, Guy M.; Chen, John Xi; Yan, Shirley ShiDu			Cyclophilin D Deficiency Rescues Axonal Mitochondrial Transport in Alzheimer's Neurons	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; LONG-TERM DEPRESSION; PERMEABILITY TRANSITION; A-BETA; HIPPOCAMPAL-NEURONS; MOUSE MODEL; CELL-DEATH; SYNAPTIC DEGENERATION; CORTICAL-NEURONS; FREE-RADICALS	Normal axonal mitochondrial transport and function is essential for the maintenance of synaptic function. Abnormal mitochondrial motility and mitochondrial dysfunction within axons are critical for amyloid beta (A beta)-induced synaptic stress and the loss of synapses relevant to the pathogenesis of Alzheimer's disease (AD). However, the mechanisms controlling axonal mitochondrial function and transport alterations in AD remain elusive. Here, we report an unexplored role of cyclophilin D (CypD)-dependent mitochondrial permeability transition pore (mPTP) in A beta-impaired axonal mitochondrial trafficking. Depletion of CypD significantly protects axonal mitochondrial motility and dynamics from A beta toxicity as shown by increased axonal mitochondrial density and distribution and improved bidirectional transport of axonal mitochondria. Notably, blockade of mPTP by genetic deletion of CypD suppresses A beta-mediated activation of the p38 mitogen-activated protein kinase signaling pathway, reverses axonal mitochondrial abnormalities, improves synaptic function, and attenuates loss of synapse, suggesting a role of CypD-dependent signaling in A beta-induced alterations in axonal mitochondrial trafficking. The potential mechanisms of the protective effects of lacking CypD on A beta-induced abnormal mitochondrial transport in axon are increased axonal calcium buffer capability, diminished reactive oxygen species (ROS), and suppressing downstream signal transduction P38 activation. These findings provide new insights into CypD-dependent mitochondrial mPTP and signaling on mitochondrial trafficking in axons and synaptic degeneration in an environment enriched for A beta.	[Guo, Lan; Du, Heng; Yan, Shiqiang; Yan, Shirley ShiDu] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Guo, Lan; Du, Heng; Yan, Shiqiang; Yan, Shirley ShiDu] Univ Kansas, Sch Pharm, Higuchi Biosci Ctr, Lawrence, KS 66045 USA; [Yan, Shiqiang] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Gansu, Peoples R China; [Wu, Xiaoping; McKhann, Guy M.] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA; [Chen, John Xi] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA	University of Kansas; University of Kansas; Lanzhou University; Columbia University; Memorial Sloan Kettering Cancer Center	Yan, SS (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA.	shidu@ku.edu		Wu, Xiaoping/0000-0001-8578-4016	National Institute of Aging [R37AG037319, K99AG037716]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R37AG037319, K99AG037716] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from National Institute of Aging (R37AG037319 and K99AG037716) and the Alzheimer's Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Baines CP, 2007, AM J PHYSIOL-HEART C, V293, pH903, DOI 10.1152/ajpheart.00575.2007; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Billups B, 2002, J NEUROSCI, V22, P5840; Bus AI, 1999, NEUROBIOL AGING, V20, P339; Bush AI, 1999, NEUROBIOL AGING, V20, P335; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen KC, 2008, TOXICOL LETT, V180, P53, DOI 10.1016/j.toxlet.2008.05.014; David G, 2000, J NEUROSCI, V20, P7290; De Vos K, 2000, J CELL BIOL, V149, P1207, DOI 10.1083/jcb.149.6.1207; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2012, ANTIOXID REDOX SIGN, V16, P1467, DOI 10.1089/ars.2011.4277; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; Ferreira IL, 2011, CELL CALCIUM; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; HARTMANN H, 1993, BIOCHEM BIOPH RES CO, V194, P1216, DOI 10.1006/bbrc.1993.1952; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kim S, 2007, J VIROL, V81, P1714, DOI 10.1128/JVI.01863-06; Kimura A, 2000, J NEUROPHYSIOL, V84, P1894, DOI 10.1152/jn.2000.84.4.1894; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Lee MW, 2002, FEBS LETT, V512, P313, DOI 10.1016/S0014-5793(02)02225-1; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin FH, 1999, MOL BRAIN RES, V71, P131, DOI 10.1016/S0169-328X(99)00161-8; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Malaiyandi LM, 2005, J NEUROSCI, V25, P9507, DOI 10.1523/JNEUROSCI.0868-05.2005; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mao P, 2012, HUM MOL GENET; Matsuyama D, 2011, BASIC RES CARDIOL, V106, P815, DOI 10.1007/s00395-011-0178-8; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1995, NEUROBIOL AGING, V16, P679, DOI 10.1016/0197-4580(95)00063-K; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; MORRIS RL, 1993, J CELL SCI, V104, P917; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Origlia N, 2010, J NEUROSCI, V30, P11414, DOI 10.1523/JNEUROSCI.2127-10.2010; Parameshwaran K, 2007, SYNAPSE, V61, P367, DOI 10.1002/syn.20386; Perez JL, 2010, EXP NEUROL, V223, P410, DOI 10.1016/j.expneurol.2009.10.013; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rohrbough J, 1999, J NEUROSCI, V19, P8528; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Sberna G, 1997, J NEUROCHEM, V69, P1177; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Talbot JD, 2003, J NEUROPHYSIOL, V90, P491, DOI 10.1152/jn.00012.2003; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Trinchese F, 2004, J MOL NEUROSCI, V24, P15, DOI 10.1385/JMN:24:1:015; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032; Zhu XW, 2005, NEUROCHEM RES, V30, P791, DOI 10.1007/s11064-005-6872-x	77	88	91	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54914	10.1371/journal.pone.0054914	http://dx.doi.org/10.1371/journal.pone.0054914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382999	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600051
J	Hong, SJ; Jia, SX; Xie, P; Xu, W; Leung, KP; Mustoe, TA; Galiano, RD				Hong, Seok Jong; Jia, Sheng-Xian; Xie, Ping; Xu, Wei; Leung, Kai P.; Mustoe, Thomas A.; Galiano, Robert D.			Topically Delivered Adipose Derived Stem Cells Show an Activated-Fibroblast Phenotype and Enhance Granulation Tissue Formation in Skin Wounds	PLOS ONE			English	Article							STROMAL CELLS; REGENERATIVE MEDICINE; BONE-MARROW; THERAPEUTIC ANGIOGENESIS; DERMAL FIBROBLASTS; GROWTH-FACTORS; IN-VITRO; REPAIR; DIFFERENTIATION; MICE	Multipotent mesenchymal stem cells (MSCs) are found in various tissues and can proliferate extensively in vitro. MSCs have been used in preclinical animal studies and clinical trials in many fields. Adipose derived stem cells (ASCs) have several advantages compared to other MSCs for use in cell-based treatments because they are easy to isolate with relative abundance. However, quantitative approaches for wound repair using ASCs have been limited because of lack of animal models which allow for quantification. Here, we addressed the effect of topically delivered ASCs in wound repair by quantitative analysis using the rabbit ear model. We characterized rabbit ASCs, and analyzed their multipotency in comparison to bone marrow derived-MSCs (BM-MSCs) and dermal fibroblasts (DFs) in vitro. Topically delivered ASCs increased granulation tissue formation in wounds when compared to saline controls, whereas BM-MSCs or DFs did not. These studies suggest that ASCs and BM-MSCs are not identical, though they have similar surface markers. We found that topically delivered ASCs are engrafted and proliferate in the wounds. We showed that transplanted ASCs exhibited activated fibroblast phenotype, increased endothelial cell recruitment, and enhanced macrophage recruitment in vivo.	[Hong, Seok Jong; Jia, Sheng-Xian; Xie, Ping; Xu, Wei; Mustoe, Thomas A.; Galiano, Robert D.] Northwestern Univ, Dept Surg, Div Plast & Reconstruct Surg, Lab Wound Repair & Regenerat Med,Feinberg Sch Med, Chicago, IL 60611 USA; [Leung, Kai P.] US Army Dent & Trauma Res Detachment, Inst Surg Res, Microbiol Branch, Ft Sam Houston, TX USA	Northwestern University; Feinberg School of Medicine	Hong, SJ (corresponding author), Northwestern Univ, Dept Surg, Div Plast & Reconstruct Surg, Lab Wound Repair & Regenerat Med,Feinberg Sch Med, Chicago, IL 60611 USA.	seok-hong@northwestern.edu; rgaliano@nmh.org	Xu, Wei/AAE-6526-2020	Xu, Wei/0000-0003-0023-4045	United States Army Medical Research and Material Command [W81XWH-10-2-0054]; Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the United States Army Medical Research and Material Command (W81XWH-10-2-0054). Flow cytometry was supported by the Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178; Blasi A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-5; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brown SA, 2010, PLAST RECONSTR SURG, V126, P1936, DOI 10.1097/PRS.0b013e3181f44790; Bunnell Bruce A., 2008, V456, P155, DOI 10.1007/978-1-59745-245-8_12; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Cherubino M, 2011, ANN PLAS SURG, V66, P210, DOI 10.1097/SAP.0b013e3181e6d06c; DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Di Rocco G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/304562; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dubois Severine G., 2008, V449, P69, DOI 10.1007/978-1-60327-169-1_5; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.082405.095329; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hasebe Y, 2011, J DERMATOL SCI, V62, P98, DOI 10.1016/j.jdermsci.2011.01.012; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Hsiao ST, 2012, STEM CELLS DEV, DOI 22188562; Ii M, 2011, LAB INVEST, V91, P539, DOI 10.1038/labinvest.2010.191; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kroeze KL, 2009, J INVEST DERMATOL, V129, P1569, DOI 10.1038/jid.2008.405; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lee SH, 2011, ANN DERMATOL, V23, P150, DOI 10.5021/ad.2011.23.2.150; Li B, 2011, J TISSUE VIABILITY, V20, P108, DOI 10.1016/j.jtv.2009.11.004; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Lu L, 2005, J AM COLL SURGEONS, V201, P391, DOI 10.1016/j.jamcollsurg.2005.03.032; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Mogford JE, 2009, WOUND REPAIR REGEN, V17, P405, DOI 10.1111/j.1524-475X.2009.00481.x; Monaco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032481; Morishita R, 2002, CIRCULATION, V105, P1491, DOI 10.1161/01.CIR.0000012146.07240.FD; Murohara T, 2009, CURR PHARM DESIGN, V15, P2784, DOI 10.2174/138161209788923796; Mustoe TA, 2004, BRIT MED J, V328, P1329, DOI 10.1136/bmj.328.7452.1329; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nambu M, 2007, WOUND REPAIR REGEN, V15, P505, DOI 10.1111/j.1524-475X.2007.00258.x; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Saleh FA, 2011, CYTOTHERAPY, V13, P903, DOI 10.3109/14653249.2011.586998; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sisco M, 2003, METH MOLEC MED, V78, P55; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Steinberg JP, 2012, AESTHET SURG J, V32, P504, DOI 10.1177/1090820X12442679; Strioga M.M., 2012, STEM CELLS DEV; Tholpady SS, 2009, CURR OPIN ORGAN TRAN, V14, P51, DOI 10.1097/MOT.0b013e328320d2cf; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	68	76	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55640	10.1371/journal.pone.0055640	http://dx.doi.org/10.1371/journal.pone.0055640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383253	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600140
J	Li, G; Campbell, DA				Li, Gang; Campbell, Douglas A.			Rising CO2 Interacts with Growth Light and Growth Rate to Alter Photosystem II Photoinactivation of the Coastal Diatom Thalassiosira pseudonana	PLOS ONE			English	Article							CO2-CONCENTRATING MECHANISM; PHYSIOLOGICAL-RESPONSES; SEAWATER ACIDIFICATION; OCEAN ACIDIFICATION; RIVER ESTUARY; CELL-SIZE; PHYTOPLANKTON; PHOTOINHIBITION; PHOTOPROTECTION; ACCLIMATION	We studied the interactive effects of pCO(2) and growth light on the coastal marine diatom Thalassiosira pseudonana CCMP 1335 growing under ambient and expected end-of-the-century pCO(2) (750 ppmv), and a range of growth light from 30 to 380 mu mol photons.m(-2).s(-1). Elevated pCO(2) significantly stimulated the growth of T. pseudonana under sub-saturating growth light, but not under saturating to super-saturating growth light. Under ambient pCO(2) susceptibility to photoinactivation of photosystem II (sigma i) increased with increasing growth rate, but cells growing under elevated pCO(2) showed no dependence between growth rate and sigma i, so under high growth light cells under elevated pCO(2) were less susceptible to photoinactivation of photosystem II, and thus incurred a lower running cost to maintain photosystem II function. Growth light altered the contents of RbcL (RUBISCO) and PsaC (PSI) protein subunits, and the ratios among the subunits, but there were only limited effects on these and other protein pools between cells grown under ambient and elevated pCO(2).	[Li, Gang; Campbell, Douglas A.] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Li, Gang] Chinese Acad Sci, Key Lab Marine Bioresources Sustainable Utilizat, S China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China	Mount Allison University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Campbell, DA (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	dcampbell@mta.ca	Campbell, Douglas A./B-3768-2010	Campbell, Douglas A./0000-0001-8996-5463	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; National Natural Science Foundation of China [41206132]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) (DAC) and the National Natural Science Foundation of China (No. 41206132)(http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) (GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Barnett A. B, 2007, FIREWORX; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Burey SC, 2007, PLANT CELL ENVIRON, V30, P1422, DOI 10.1111/j.1365-3040.2007.01715.x; Campbell DA, 2012, BBA-BIOENERGETICS, V1817, P258, DOI 10.1016/j.bbabio.2011.04.010; Chen BZ, 2009, MAR ECOL PROG SER, V379, P77, DOI 10.3354/meps07888; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; CULLEN JJ, 1988, J PLANKTON RES, V10, P1039, DOI 10.1093/plankt/10.5.1039; EHRMAN J. M., 2012, CURRENT ADV ALGAL TA, P253; FALKOWSKI PG, 1981, PLANT PHYSIOL, V68, P969, DOI 10.1104/pp.68.4.969; Feng Y, 2010, DEEP-SEA RES PT I, V57, P368, DOI 10.1016/j.dsr.2009.10.013; Finkel Z., 2007, LIGHT ABSORPTION SIZ, P1; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Fuhrmann T, 2004, APPL PHYS B-LASERS O, V78, P257, DOI 10.1007/s00340-004-1419-4; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Grouneva I, 2013, PLANTA, V237, P399, DOI 10.1007/s00425-012-1744-5; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hong Y, 2008, PESTIC BIOCHEM PHYS, V90, P203, DOI 10.1016/j.pestbp.2007.11.009; Hoogstraten A, 2012, J PHYCOL, V48, P559, DOI 10.1111/j.1529-8817.2012.01148.x; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Hopkinson BM, 2010, LIMNOL OCEANOGR, V55, P2011, DOI 10.4319/lo.2010.55.5.2011; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; Ingalls AE, 2010, GEOCHIM COSMOCHIM AC, V74, P104, DOI 10.1016/j.gca.2009.09.012; Intergovernmental Panel on Climate Change Climate, 2007, CLIM CHANG 2007 MIT; Janknegt PJ, 2008, J PHYCOL, V44, P957, DOI 10.1111/j.1529-8817.2008.00553.x; Janknegt PJ, 2009, EUR J PHYCOL, V44, P525, DOI 10.1080/09670260902943273; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Lavaud J, 2007, FUNCT PLANT SCI BIOT, V1, P267; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Leonardos N, 2004, EUR J PHYCOL, V39, P173, DOI 10.1080/0967026042000201867; Lewis E., 1998, ORNLCDIAC105; Li G, 2011, MAR POLLUT BULL, V62, P1852, DOI 10.1016/j.marpolbul.2011.02.050; Litchman E, 2002, LIMNOL OCEANOGR, V47, P86, DOI 10.4319/lo.2002.47.1.0086; Loebl M, 2010, LIMNOL OCEANOGR, V55, P2150, DOI 10.4319/lo.2010.55.5.2150; Low-Decarie E, 2011, GLOBAL CHANGE BIOL, V17, P2525, DOI 10.1111/j.1365-2486.2011.02402.x; Macgillivary ML, 2011, DIATOM RES, V26, P321, DOI 10.1080/0269249X.2011.639145; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; McGinn PJ, 2005, CAN J BOT, V83, P711, DOI 10.1139/B05-055; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; MOREL A, 1981, DEEP-SEA RES, V28, P1375, DOI 10.1016/0198-0149(81)90039-X; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nielsen LT, 2012, AQUAT MICROB ECOL, V65, P271, DOI 10.3354/ame01554; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Oguchi R, 2011, PHYSIOL PLANTARUM, V142, P47, DOI 10.1111/j.1399-3054.2011.01452.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PENG T-H, 1987, Tellus Series B Chemical and Physical Meteorology, V39, P439, DOI 10.1111/j.1600-0889.1987.tb00205.x; PLATT T, 1980, J MAR RES, V38, P687; Quigg A, 2003, PLANT CELL ENVIRON, V26, P693, DOI 10.1046/j.1365-3040.2003.01004.x; Ragni M, 2008, J PHYCOL, V44, P670, DOI 10.1111/j.1529-8817.2008.00524.x; RAVEN JA, 1991, PLANT CELL ENVIRON, V14, P779, DOI 10.1111/j.1365-3040.1991.tb01442.x; Raven JA, 2012, PHILOS T R SOC B, V367, P493, DOI 10.1098/rstb.2011.0212; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Schippers P, 2004, ECOL LETT, V7, P446, DOI 10.1111/j.1461-0248.2004.00597.x; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Six C, 2009, PLANT PHYSIOL, V151, P379, DOI 10.1104/pp.109.140566; Takahashi S, 2010, PLANT PHYSIOL, V153, P988, DOI 10.1104/pp.110.155747; Thomas S, 2013, J PLANKTON IN PRESS; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Waring J, 2010, J PHYCOL, V46, P1206, DOI 10.1111/j.1529-8817.2010.00919.x; Wu HY, 2012, PLANT PHYSIOL, V160, P464, DOI 10.1104/pp.112.203067; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Yoshimura T., 2009, BIOGEOSCI DISCUSS, V6, P4143, DOI DOI 10.5194/BGD-6-4143-2009; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124; Zhai WD, 2005, MAR CHEM, V93, P21, DOI 10.1016/j.marchem.2004.07.003	82	73	77	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55562	10.1371/journal.pone.0055562	http://dx.doi.org/10.1371/journal.pone.0055562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383226	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600127
J	Romao, LF; Mendes, FA; Feitosa, NM; Faria, JCO; Coelho-Aguiar, JM; de Souza, JM; Neto, VM; Abreu, JG				Romao, Luciana F.; Mendes, Fabio A.; Feitosa, Natalia M.; Faria, Jane Cristina O.; Coelho-Aguiar, Juliana M.; de Souza, Jorge Marcondes; Moura Neto, Vivaldo; Abreu, Jose Garcia			Connective Tissue Growth Factor (CTGF/CCN2) Is Negatively Regulated during Neuron-Glioblastoma Interaction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEIN; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; FACTOR CTGF; IN-VITRO; THYROID-HORMONE; FACTOR-BETA; CCN FAMILY; IMMUNOHISTOCHEMICAL LOCALIZATION; CELL-PROLIFERATION	Connective-tissue growth factor (CTGF/CCN2) is a matricellular-secreted protein involved in complex processes such as wound healing, angiogenesis, fibrosis and metastasis, in the regulation of cell proliferation, migration and extracellular matrix remodeling. Glioblastoma (GBM) is the major malignant primary brain tumor and its adaptation to the central nervous system microenvironment requires the production and remodeling of the extracellular matrix. Previously, we published an in vitro approach to test if neurons can influence the expression of the GBM extracellular matrix. We demonstrated that neurons remodeled glioma cell laminin. The present study shows that neurons are also able to modulate CTGF expression in GBM. CTGF immnoreactivity and mRNA levels in GBM cells are dramatically decreased when these cells are co-cultured with neonatal neurons. As proof of particular neuron effects, neonatal neurons co-cultured onto GBM cells also inhibit the reporter luciferase activity under control of the CTGF promoter, suggesting inhibition at the transcription level. This inhibition seems to be contact-mediated, since conditioned media from embryonic or neonatal neurons do not affect CTGF expression in GBM cells. Furthermore, the inhibition of CTGF expression in GBM/neuronal co-cultures seems to affect the two main signaling pathways related to CTGF. We observed inhibition of TGF beta luciferase reporter assay; however phopho-SMAD2 levels did not change in these co-cultures. In addition levels of phospho-p44/42 MAPK were decreased in co-cultured GBM cells. Finally, in transwell migration assay, CTGF siRNA transfected GBM cells or GBM cells co-cultured with neurons showed a decrease in the migration rate compared to controls. Previous data regarding laminin and these results demonstrating that CTGF is down-regulated in GBM cells co-cultured with neonatal neurons points out an interesting view in the understanding of the tumor and cerebral microenvironment interactions and could open up new strategies as well as suggest a new target in GBM control.	[Romao, Luciana F.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Mendes, Fabio A.; Feitosa, Natalia M.; Faria, Jane Cristina O.; Coelho-Aguiar, Juliana M.; Moura Neto, Vivaldo; Abreu, Jose Garcia] Univ Fed Rio de Janeiro, Programa Anat, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Serv Neurocirurgia, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Abreu, JG (corresponding author), Univ Fed Rio de Janeiro, Programa Anat, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	garciajr@icb.ufrj.br	Mendes, Fabio/J-6911-2015; Romao, Luciana/I-4291-2015; Feitosa, Natalia M/B-6991-2013; Abreu, Jose G/ABB-1199-2021; Abreu, Jose G/G-6159-2010	Abreu, Jose G/0000-0002-1363-1755; Abreu, Jose G/0000-0002-9875-7786; /0000-0001-9425-8018	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Ary Frauzino para Pesquisa e Controle do Cancer (FAF); Programa de Nucleos de Excelencia (PRONEX); Programa de Ciencias Biomedicas (PCM); Instituto Nacional de Neurociencia Translacional (INNT)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Ary Frauzino para Pesquisa e Controle do Cancer (FAF); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Ciencias Biomedicas (PCM); Instituto Nacional de Neurociencia Translacional (INNT)	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Ary Frauzino para Pesquisa e Controle do Cancer (FAF); Programa de Nucleos de Excelencia (PRONEX); Programa de Ciencias Biomedicas (PCM); Instituto Nacional de Neurociencia Translacional (INNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alves TR, 2011, LIFE SCI, V89, P532, DOI 10.1016/j.lfs.2011.04.022; Amado NG, 2011, LIFE SCI, V89, P545, DOI 10.1016/j.lfs.2011.05.003; Amado NG, 2009, ANTI-CANCER DRUG, V20, P543, DOI 10.1097/CAD.0b013e32832d1149; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Crean JK, 2006, FASEB J, V20, P1712, DOI 10.1096/fj.05-5010fje; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; Dhar A., 2010, Experimental Oncology, V32, P2; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x; Garcia-Abreu J, 2000, GLIA, V29, P260, DOI 10.1002/(SICI)1098-1136(20000201)29:3<260::AID-GLIA7>3.0.CO;2-I; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; Gomes FCA, 1999, GLIA, V26, P97; Gomes FCA, 1999, GLIA, V25, P247, DOI 10.1002/(SICI)1098-1136(19990201)25:3<247::AID-GLIA5>3.0.CO;2-2; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hertel M, 2000, EUR J NEUROSCI, V12, P376, DOI 10.1046/j.1460-9568.2000.00930.x; Higgins SC, 2010, ANTICANCER RES, V30, P391; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kennedy L, 2007, EXP CELL RES, V313, P952, DOI 10.1016/j.yexcr.2006.12.006; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kleihues P, 2000, PATHOLOGY GENETICS T; Kondo Y, 1999, BRAIN RES, V834, P146, DOI 10.1016/S0006-8993(99)01517-6; Kothapalli D, 1997, CELL GROWTH DIFFER, V8, P61; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Spohr TCLDE, 2011, J NEUROCHEM, V119, P113, DOI 10.1111/j.1471-4159.2011.07421.x; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lima FRS, 1997, J ENDOCRINOL, V154, P167, DOI 10.1677/joe.0.1540167; Lin CS, 2002, BIOCHEM BIOPH RES CO, V295, P1014, DOI 10.1016/S0006-291X(02)00765-9; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Martinerie C, 1997, J CLIN PATHOL-MOL PA, V50, P310, DOI 10.1136/mp.50.6.310; Mason WP, 2008, EXPERT OPIN EMERG DR, V13, P81, DOI 10.1517/14728214.13.1.81 ; Mendes FA, 2003, DEV BRAIN RES, V142, P111, DOI 10.1016/S0165-3806(03)00036-1; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nagai N, 2009, INVEST OPHTH VIS SCI, V50, P1903, DOI 10.1167/iovs.08-2383; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Pan LH, 2002, NEUROL RES, V24, P677, DOI 10.1179/016164102101200573; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; PINDZOLA RR, 1993, DEV BIOL, V156, P34, DOI 10.1006/dbio.1993.1057; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shimo T, 2005, J BONE MINER RES, V20, P867, DOI 10.1359/JBMR.041235; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Soletti RC, 2010, ANTICANCER RES, V30, P1209; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sontheimer H, 2008, J NEUROCHEM, V105, P287, DOI 10.1111/j.1471-4159.2008.05301.x; Sousa VD, 2004, EUR J NEUROSCI, V19, P1721, DOI 10.1111/j.1460.9568.2004.03249.x; Spohr TCLDE, 2002, EUR J NEUROSCI, V16, P2059, DOI 10.1046/j.1460-9568.2002.02283.x; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Stipursky J, 2011, LIFE SCI, V89, P524, DOI 10.1016/j.lfs.2011.04.005; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Teymoortash A, 2003, ARCH ORAL BIOL, V48, P111, DOI 10.1016/S0003-9969(02)00168-1; TRENTIN AG, 1995, J NEUROSCI RES, V41, P409, DOI 10.1002/jnr.490410314; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wakimoto N, 2008, CANCER RES, V68, P6978, DOI 10.1158/0008-5472.CAN-07-5675; Wang SL, 2000, NEURON, V27, P197, DOI 10.1016/S0896-6273(00)00028-3; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Ziu M, 2006, J NEURO-ONCOL, V79, P125, DOI 10.1007/s11060-006-9121-5	77	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55605	10.1371/journal.pone.0055605	http://dx.doi.org/10.1371/journal.pone.0055605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383241	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600133
J	Sun, SC; Wang, XG; Ma, XS; Huang, XJ; Li, J; Liu, HL				Sun, Shao-Chen; Wang, Xu-Guang; Ma, Xue-Shan; Huang, Xian-Ju; Li, Juan; Liu, Hong-Lin			TBP Dynamics during Mouse Oocyte Meiotic Maturation and Early Embryo Development	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; ASSOCIATION; CELLS	To maintain cell lineage, cells develop a mechanism which can transmit the gene activity information to the daughter cells. In mitosis, TBP (TATA-binding protein), a transcription factor which belongs to TFIID was associated with M phase chromosomes and was proved to be a bookmark for cellular memory. Although previous work showed that TBP was dispensable for mouse oocyte maturation and early embryo development, exogenous TBP protein was detected in the nuclear of oocytes and early embryos. It is still unknown whether exogenous TBP can associate with condensed chromosomes during meiosis and mouse early embryo development. In present study by the injection of GFP-tagged TBP mRNA we for the first time investigated TBP dynamics in mouse early embryos and confirmed its localization pattern in oocytes. The exogenous TBP enriched at germinal vesicle at GV stage but disappeared from the chromosomes after GVBD. Moreover, exogenous TBP was still dispersed from the chromosomes of somatic donor nuclear in oocytes by nuclear transfer (NT), further proving that oocyte has some mechanism to remove TBP. During mouse embryo development, the exogenous TBP was removed from the chromosomes of M phase zygotes, but was found to express weakly at the M phase of 2-cell. Moreover, in the blastocyst TBP was also detected at the M phase chromosomes. Overexpression of TBP caused the failure of oocyte maturation and embryo development. Our results supported the idea that TBP might be a marker for transmitting cellular memory to daughter cells.	[Sun, Shao-Chen; Wang, Xu-Guang; Ma, Xue-Shan; Huang, Xian-Ju; Li, Juan; Liu, Hong-Lin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China [31072028]; Fundamental Research Funds for the Central Universities [KYRC201202, KYZ200914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (31072028) and the Fundamental Research Funds for the Central Universities (KYRC201202 and KYZ200914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-45; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Gazdag E, 2007, REPRODUCTION, V134, P51, DOI 10.1530/REP-06-0337; Gazdag E, 2009, GENE DEV, V23, P2210, DOI 10.1101/gad.535209; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Grealish S, 2011, CELL CYCLE, V10, P3421, DOI 10.4161/cc.10.20.17691; Jones KA, 2007, GENE DEV, V21, P2113, DOI 10.1101/gad.1598007; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kim JM, 2003, J CELL BIOL, V162, P37, DOI 10.1083/jcb.200303047; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Miyamoto K, 2011, CELL CYCLE, V10, DOI 10.4161/cc.10.18.16946; Mueller Ferenc, 2009, Journal of Biology (London), V8, P97, DOI 10.1186/jbiol196; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Simonsson S, 2005, CELL CYCLE, V4, P513, DOI 10.4161/cc.4.4.1581; Sun SC, 2011, CELL CYCLE, V10, P1853, DOI 10.4161/cc.10.11.15796; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; WORRAD DM, 1994, DEVELOPMENT, V120, P2347; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Zhu SY, 2011, CELL CYCLE, V10, P871, DOI 10.4161/cc.10.6.15035	23	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55425	10.1371/journal.pone.0055425	http://dx.doi.org/10.1371/journal.pone.0055425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383188	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600103
J	Yu, DC				Yu, Dongchuan			Additional Brain Functional Network in Adults with Attention-Deficit/Hyperactivity Disorder: A Phase Synchrony Analysis	PLOS ONE			English	Article							RESTING-STATE; SMALL-WORLD; DISCRIMINATIVE ANALYSIS; CHILDREN	We develop a method to construct a new type of functional networks by the usage of phase synchrony degree that is different from the widely used Pearson's correlation approach. By a series of very strict statistical tests, we found that there is an additional network in attention-deficit/hyperactivity disorder (ADHD) subjects, superimposing the original (normal) brain functional network corresponding to healthy controls. The additional network leads to the increase in clustering coefficient, cost, local efficiency, and global efficiency. Our findings are inconsistent with many previous researches (using the Pearson's correlation approach) revealing both increased and decreased functional connections between brain regions and many reports revealing that the brain functional networks of ADHD patients have slow information flow and low global efficiency. We also confirm that the additional network in ADHD subjects contains 6 communities, and three of them are associated with emotional control, sensory information integration, and motor control, respectively. Furthermore, we find that there is a pathway connecting the left insula and left anterior cingular gyrus via the frontal gyrus and putamen in the additional network in ADHD subjects. This implies that due to the pathway connecting brain regions in the salience network, the ADHD patients are more sensitive to external stimuli or internal thoughts and are easier to switch to the executive network and hence harder to inhibit. For clinical diagnostic purposes, we apply the k-means clustering method to distinguish ADHD patients with healthy controls at the individual subject level, and obtain a meaningful diagnostic result. More interestingly, we find that the suggested technique using phase synchrony degree to construct functional networks may obtain higher classification accuracy than the method using the Pearson's correlation coefficient.	[Yu, Dongchuan] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Yu, Dongchuan] Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Yu, DC (corresponding author), Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China.	dcyu@seu.edu.cn			Natural Science Foundation of China [61074126, 61273224, 10602026]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the Natural Science Foundation of China under Grant Nos. 61074126, 61273224, and 10602026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], [No title captured]; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Seidman LJ, 2004, PSYCHIAT CLIN N AM, V27, P323, DOI 10.1016/j.psc.2004.01.002; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Spencer T, 1998, J CLIN PSYCHIAT, V59, P59; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Yu DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024333; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zanin M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00630; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zhu CZ, 2005, LECT NOTES COMPUT SC, V3750, P468, DOI 10.1007/11566489_58	31	32	35	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54516	10.1371/journal.pone.0054516	http://dx.doi.org/10.1371/journal.pone.0054516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382908	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600029
J	Zhao, HY; Huang, Y; Xue, C; Chen, Y; Hou, X; Guo, Y; Zhao, LP; Hu, ZH; Huang, YJ; Luo, YZ; Zhang, L				Zhao, Hongyun; Huang, Yan; Xue, Cong; Chen, Yang; Hou, Xue; Guo, Ying; Zhao, Liping; Hu, Zhi Huang; Huang, Yujie; Luo, Yongzhang; Zhang, Li			Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; STAGE-I; TUMOR ANGIOGENESIS; BREAST-CANCER; SURFACE; SURVIVAL; NEOVASCULARIZATION; NEOANGIOGENESIS; SURGERY; MARKER	Nucleolin is implicated to play a role in angiogenesis, a vital process in tumor growth and metastasis. However, the presence and clinical relevance of nucleolin in human non small cell lung cancer (NSCLC) remains largely unknown. In this study, we explored the expression and prognostic implication of nucleolin in surgically resected NSCLC patients. A cohort of 146 NSCLC patients who underwent surgical resection was selected for tissue microarray. In this tissue microarray, nucleolin expression was measured by immunofluorescence. Staining for CD31, a marker of endothelial cells, was performed to mark blood vessels. A Cox proportional hazards model was used to assess the prognostic significance of nucleolin. Nucleolin expression was observed in 34.2% of all patients, and 64.1% in high CD31 expression patients. The disease-free survival (DFS) was significantly shorter in patients with high nucleolin (CD31(hi) NCLhi) compared to patients with low tumor blood vessels (CD31(lo) NCLlo) (5 ys of DFS 24% vs 64%, p = 0.002). Such a difference was demonstrated in the following stratified analyses: stage I (p<0.001), squamous cell carcinoma and adenosquamous cell carcinoma (p = 0.028), small tumor (<5 cm, p = 0.008), and surgery alone (p = 0.015). Multivariate analysis further revealed that nucleolin expression independently predicted for worse survival (p = 0.003). This study demonstrates that nucleolin is associated with the clinical outcomes in postoperative NSCLC patients. Thus, the expression levels of nucleolin may provide a new prognostic marker to identify patients at higher risk for treatment failure, especially in some subgroups.	[Zhao, Hongyun; Huang, Yan; Xue, Cong; Hou, Xue; Guo, Ying; Zhao, Liping; Hu, Zhi Huang; Zhang, Li] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yang; Huang, Yujie; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Natl Engn Lab Anti Tumor Prot Therapeut, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China; [Chen, Yang; Huang, Yujie; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Canc Biol Lab, Beijing 100084, Peoples R China	Sun Yat Sen University; Tsinghua University; Tsinghua University	Zhang, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	zhangli6@mail.sysu.edu.cn	Chen, Yang/C-9919-2016	Chen, Yang/0000-0003-4441-5614				Bremnes RM, 2006, LUNG CANCER, V51, P143, DOI 10.1016/j.lungcan.2005.09.005; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Demicheli R, 2001, BRIT J CANCER, V85, P490, DOI 10.1054/bjoc.2001.1969; Deng JS, 1996, MOL BIOL REP, V23, P191, DOI 10.1007/BF00351168; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fontanini G, 1997, CLIN CANCER RES, V3, P861; Fontanini G, 1997, BRIT J CANCER, V75, P1295, DOI 10.1038/bjc.1997.220; Giatromanolaki A, 1997, CLIN CANCER RES, V3, P2485; Ginisty H, 1999, J CELL SCI, V112, P761; Han H, 2001, ANN SURG ONCOL, V8, P72, DOI 10.1245/aso.2001.8.1.72; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He LR, 2010, ANN ONCOL, V21, P1675, DOI 10.1093/annonc/mdp592; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; HOSKINS WJ, 1989, BAILLIERE CLIN OB GY, V3, P59, DOI 10.1016/S0950-3552(89)80042-2; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Koukourakis MI, 1997, INT J CANCER, V74, P565, DOI 10.1002/(SICI)1097-0215(19971219)74:6<565::AID-IJC1>3.0.CO;2-S; Larrucea S, 1998, J BIOL CHEM, V273, P31718, DOI 10.1074/jbc.273.48.31718; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Maniwa Y, 2000, AM J SURG, V179, P122, DOI 10.1016/S0002-9610(00)00244-0; Matsuyama K, 1998, ANN THORAC SURG, V65, P1405, DOI 10.1016/S0003-4975(97)01416-1; Mitsudomi T, 1996, J SURG ONCOL, V63, P159, DOI 10.1002/(SICI)1096-9098(199611)63:3<159::AID-JSO5>3.0.CO;2-C; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Offersen BV, 2001, CANCER, V91, P1500, DOI 10.1002/1097-0142(20010415)91:8<1500::AID-CNCR1158>3.3.CO;2-D; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; ORRICK LR, 1973, P NATL ACAD SCI USA, V70, P1316, DOI 10.1073/pnas.70.5.1316; PFEIFLE J, 1983, BIOCHIM BIOPHYS ACTA, V762, P86, DOI 10.1016/0167-4889(83)90120-9; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Sinclair JF, 2002, J BIOL CHEM, V277, P2876, DOI 10.1074/jbc.M110230200; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Van der Pluijm G, 2001, J BONE MINER RES, V16, P1077, DOI 10.1359/jbmr.2001.16.6.1077; van Rens MTM, 2000, CHEST, V117, P374, DOI 10.1378/chest.117.2.374; VARANI J, 1981, J SURG ONCOL, V17, P9, DOI 10.1002/jso.2930170103; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yano T, 2000, EUR J CANCER, V36, P601, DOI 10.1016/S0959-8049(99)00327-5	43	23	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54674	10.1371/journal.pone.0054674	http://dx.doi.org/10.1371/journal.pone.0054674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382938	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600034
J	Boggs, ASP; Lowers, RH; Cloy-McCoy, JA; Guillette, LJ				Boggs, Ashley S. P.; Lowers, Russell H.; Cloy-McCoy, Jessica A.; Guillette, Louis J., Jr.			Organizational Changes to Thyroid Regulation in Alligator mississippiensis: Evidence for Predictive Adaptive Responses	PLOS ONE			English	Article							CENTRAL CONGENITAL HYPOTHYROIDISM; JUVENILE AMERICAN ALLIGATORS; HORMONE CONCENTRATIONS; NEONATAL HYPERTHYROIDISM; SEASONAL-VARIATION; GROWTH-RATES; HPT AXIS; FLORIDA; CONTAMINANTS; NUTRITION	During embryonic development, organisms are sensitive to changes in thyroid hormone signaling which can reset the hypothalamic-pituitary-thyroid axis. It has been hypothesized that this developmental programming is a 'predictive adaptive response', a physiological adjustment in accordance with the embryonic environment that will best aid an individual's survival in a similar postnatal environment. When the embryonic environment is a poor predictor of the external environment, the developmental changes are no longer adaptive and can result in disease states. We predicted that endocrine disrupting chemicals (EDCs) and environmentally-based iodide imbalance could lead to developmental changes to the thyroid axis. To explore whether iodide or EDCs could alter developmental programming, we collected American alligator eggs from an estuarine environment with high iodide availability and elevated thyroid-specific EDCs, a freshwater environment contaminated with elevated agriculturally derived EDCs, and a reference freshwater environment. We then incubated them under identical conditions. We examined plasma thyroxine and triiodothyronine concentrations, thyroid gland histology, plasma inorganic iodide, and somatic growth at one week (before external nutrition) and ten months after hatching (on identical diets). Neonates from the estuarine environment were thyrotoxic, expressing follicular cell hyperplasia (p = 0.01) and elevated plasma triiodothyronine concentrations (p = 0.0006) closely tied to plasma iodide concentrations (p = 0.003). Neonates from the freshwater contaminated site were hypothyroid, expressing thyroid follicular cell hyperplasia (p = 0.01) and depressed plasma thyroxine concentrations (p = 0.008). Following a ten month growth period under identical conditions, thyroid histology (hyperplasia p = 0.04; colloid depletion p = 0.01) and somatic growth (body mass p<0.0001; length p = 0.02) remained altered among the contaminated sites. This work supports the hypothesis that embryonic EDC exposure or iodide imbalance could induce adult metabolic disease states, thereby stressing the need to consider the multiple environmental variables present during development.	[Boggs, Ashley S. P.; Guillette, Louis J., Jr.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Boggs, Ashley S. P.; Guillette, Louis J., Jr.] Univ Florida, Dept Biol, Gainesville, FL USA; [Boggs, Ashley S. P.; Cloy-McCoy, Jessica A.; Guillette, Louis J., Jr.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Boggs, Ashley S. P.; Cloy-McCoy, Jessica A.; Guillette, Louis J., Jr.] Hollings Marine Lab, Charleston, SC USA; [Lowers, Russell H.] NASA, Kennedy Space Ctr, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical University of South Carolina; National Aeronautics & Space Administration (NASA)	Boggs, ASP (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.	aspboggs@gmail.com			National Aeronautics and Space Administration Graduate Student Research Program [NNX09AK51H- SF 425]; NASA's Kennedy Space Center	National Aeronautics and Space Administration Graduate Student Research Program; NASA's Kennedy Space Center	Funding for this research was provided, in part, by the National Aeronautics and Space Administration Graduate Student Research Program (grant number NNX09AK51H- SF 425) and NASA's Kennedy Space Center (https://fellowships.nasaprs.com/gsrp/nav/). Employees of the NASA Ecological Program (Innovative Health Applications) assisted in the collection of eggs from Merritt Island National Wildlife Refuge at Kennedy Space Center, but had no other influence on experimental design, experimental conduct, or the writing of this manuscript.	Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bermudez DS, 2005, COMP BIOCHEM PHYS A, V141, P8, DOI 10.1016/j.cbpb.2005.02.015; Boggs ASP, 2011, GEN COMP ENDOCR, V174, P362, DOI 10.1016/j.ygcen.2011.09.014; CHABRECK RH, 1979, HERPETOLOGICA, V35, P51; Crain DA, 1998, ENVIRON TOXICOL CHEM, V17, P446, DOI 10.1002/etc.5620170315; DANFORTH E, 1989, ANNU REV NUTR, V9, P201, DOI 10.1146/annurev.nu.09.070189.001221; DELANY MF, 1988, J WILDLIFE DIS, V24, P62, DOI 10.7589/0090-3558-24.1.62; DUSSAULT JH, 1982, ENDOCRINOLOGY, V110, P1037, DOI 10.1210/endo-110-3-1037; Fernie KJ, 2005, TOXICOL SCI, V88, P375, DOI 10.1093/toxsci/kfi295; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; GERWIEN RW, 1992, GEN COMP ENDOCR, V87, P312, DOI 10.1016/0016-6480(92)90036-J; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Grim KC, 2009, TOXICOL PATHOL, V37, P415, DOI 10.1177/0192623309335063; Grim KC, 2007, GUIDANCE DOCUMENT 2; Guillette Jr L.J., 1995, HUM ECOL RISK ASSESS, V1, P25; Guillette LJ, 1999, ARCH ENVIRON CON TOX, V36, P447, DOI 10.1007/PL00006617; Guillette LJ, 2003, PURE APPL CHEM, V75, P2275, DOI 10.1351/pac200375112275; GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HEINZ GH, 1991, ENVIRON MONIT ASSESS, V16, P277, DOI 10.1007/BF00397615; Hooth MJ, 2001, TOXICOL PATHOL, V29, P250, DOI 10.1080/019262301317052530; Kato Y, 2004, TOXICOL SCI, V81, P309, DOI 10.1093/toxsci/kfh225; Kempers MJE, 2005, J CLIN ENDOCR METAB, V90, P4094, DOI 10.1210/jc.2005-0197; Kempers MJE, 2003, J CLIN ENDOCR METAB, V88, P5851, DOI 10.1210/jc.2003-030665; Langer P, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-3; Legradi G, 1997, ENDOCRINOLOGY, V138, P2569, DOI 10.1210/en.138.6.2569; McNabb FMA, 2007, CRIT REV TOXICOL, V37, P163, DOI 10.1080/10408440601123552; McNabb FMA, 2004, TOXICOL SCI, V82, P106, DOI 10.1093/toxsci/kfh247; Moore BC, 2012, MOL CELL ENDOCRINOL, V354, P111, DOI 10.1016/j.mce.2011.10.020; Muller EB, 1996, ASTM STP; Ogilvy-Stuart AL, 2002, ARCH DIS CHILD-FETAL, V87, P165, DOI 10.1136/fn.87.3.F165; Phoojaroenchanachai M, 2001, CLIN ENDOCRINOL, V54, P365, DOI 10.1046/j.1365-2265.2001.01224.x; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; RAPOPORT B, 1974, AM J MED, V56, P586, DOI 10.1016/0002-9343(74)90628-7; Roti E, 2001, THYROID, V11, P493, DOI 10.1089/105072501300176453; TAPLIN LE, 1982, J COMP PHYSIOL, V149, P43, DOI 10.1007/BF00735713; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; WALKER P, 1985, ENDOCRINOLOGY, V116, P2246, DOI 10.1210/endo-116-6-2246; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; Wilson CM, 1997, GEN COMP ENDOCR, V107, P153, DOI 10.1006/gcen.1997.6906; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446	42	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55515	10.1371/journal.pone.0055515	http://dx.doi.org/10.1371/journal.pone.0055515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383213	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800162
J	Huang, Y; Chen, WJ; Wang, XY; Liu, HL; Chen, YY; Guo, L; Luo, F; Sun, JF; Mao, Q; Liang, P; Xie, ZZ; Zhou, CH; Tian, YL; Lv, XL; Huang, LS; Zhou, JJ; Hu, Y; Li, R; Zhang, F; Lei, HL; Li, WF; Hu, XC; Liang, C; Xu, J; Li, XR; Yu, XB				Huang, Yan; Chen, Wenjun; Wang, Xiaoyun; Liu, Hailiang; Chen, Yangyi; Guo, Lei; Luo, Fang; Sun, Jiufeng; Mao, Qiang; Liang, Pei; Xie, Zhizhi; Zhou, Chenhui; Tian, Yanli; Lv, Xiaoli; Huang, Lisi; Zhou, Juanjuan; Hu, Yue; Li, Ran; Zhang, Fan; Lei, Huali; Li, Wenfang; Hu, Xuchu; Liang, Chi; Xu, Jin; Li, Xuerong; Yu, Xinbing			The Carcinogenic Liver Fluke, Clonorchis sinensis: New Assembly, Reannotation and Analysis of the Genome and Characterization of Tissue Transcriptomes	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; PROTEIN-DEFICIENT; IDENTIFICATION; CLONING; BINDING; CHOLANGIOCARCINOMA; CHOLESTEROL; COMPONENTS; FEATURES; ANTIGEN	Clonorchis sinensis (C. sinensis), an important food-borne parasite that inhabits the intrahepatic bile duct and causes clonorchiasis, is of interest to both the public health field and the scientific research community. To learn more about the migration, parasitism and pathogenesis of C. sinensis at the molecular level, the present study developed an upgraded genomic assembly and annotation by sequencing paired-end and mate-paired libraries. We also performed transcriptome sequence analyses on multiple C. sinensis tissues (sucker, muscle, ovary and testis). Genes encoding molecules involved in responses to stimuli and muscle-related development were abundantly expressed in the oral sucker. Compared with other species, genes encoding molecules that facilitate the recognition and transport of cholesterol were observed in high copy numbers in the genome and were highly expressed in the oral sucker. Genes encoding transporters for fatty acids, glucose, amino acids and oxygen were also highly expressed, along with other molecules involved in metabolizing these substrates. All genes involved in energy metabolism pathways, including the beta-oxidation of fatty acids, the citrate cycle, oxidative phosphorylation, and fumarate reduction, were expressed in the adults. Finally, we also provide valuable insights into the mechanism underlying the process of pathogenesis by characterizing the secretome of C. sinensis. The characterization and elaborate analysis of the upgraded genome and the tissue transcriptomes not only form a detailed and fundamental C. sinensis resource but also provide novel insights into the physiology and pathogenesis of C. sinensis. We anticipate that this work will aid the development of innovative strategies for the prevention and control of clonorchiasis.	[Huang, Yan; Chen, Wenjun; Wang, Xiaoyun; Sun, Jiufeng; Mao, Qiang; Liang, Pei; Xie, Zhizhi; Zhou, Chenhui; Tian, Yanli; Lv, Xiaoli; Huang, Lisi; Zhou, Juanjuan; Hu, Yue; Li, Ran; Zhang, Fan; Lei, Huali; Li, Wenfang; Hu, Xuchu; Liang, Chi; Xu, Jin; Li, Xuerong; Yu, Xinbing] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Yan; Chen, Wenjun; Wang, Xiaoyun; Sun, Jiufeng; Mao, Qiang; Liang, Pei; Xie, Zhizhi; Zhou, Chenhui; Tian, Yanli; Lv, Xiaoli; Huang, Lisi; Zhou, Juanjuan; Hu, Yue; Li, Ran; Zhang, Fan; Lei, Huali; Li, Wenfang; Hu, Xuchu; Liang, Chi; Xu, Jin; Li, Xuerong; Yu, Xinbing] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Hailiang; Chen, Yangyi; Guo, Lei; Luo, Fang] Guangzhou iGen Co Ltd, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xu, J (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China.	xujin@mail.sysu.edu.cn; xuerong2@mail.sysu.edu.cn; yuxb@mail.sysu.edu.cn	Wang, Xiaoyun/F-1212-2015; sun, Jiufeng/CAG-6546-2022	sun, jiufeng/0000-0003-1047-929X; Liu, Hailiang/0000-0002-4364-2826	National Basic Research Program of China (973 program) [2010CB530000]; National Natural Science Foundation of China [81171602, 81101270]; National S & T Major Program [2012ZX10004-220]; Sun Yat-sen University [50000-3181310]; Sun Yat-sen University innovative talents cultivation program for excellent tutors	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; Sun Yat-sen University; Sun Yat-sen University innovative talents cultivation program for excellent tutors	This work was supported by the National Basic Research Program of China (973 program; No. 2010CB530000), the National Natural Science Foundation of China (No. 81171602, 81101270), the National S & T Major Program (No. 2012ZX10004-220), the Sun Yat-sen University grant (No. 50000-3181310), and the Sun Yat-sen University innovative talents cultivation program for excellent tutors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Choi D, 2006, J HEPATOL, V44, P1066, DOI 10.1016/j.jhep.2005.11.040; Choi YA, 2010, BIOL CELL, V102, P107, DOI 10.1042/BC20090073; CONNELLY MC, 1984, BIOCHEM BIOPH RES CO, V121, P931, DOI 10.1016/0006-291X(84)90766-6; COUSIN C, 1995, J MORPHOL, V223, P215, DOI 10.1002/jmor.1052230209; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Donlin Maureen J, 2007, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0909s17; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fried B, 2011, CANCER LETT, V305, P239, DOI 10.1016/j.canlet.2010.07.008; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Garg G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S14; Grosse Y, 2009, LANCET ONCOL, V10, P13, DOI 10.1016/S1470-2045(08)70286-9; Hernandez M, 2010, NEURO-ONCOLOGY, V12, P1014, DOI 10.1093/neuonc/noq078; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; Hu FY, 2009, MOL BIOCHEM PARASIT, V167, P127, DOI 10.1016/j.molbiopara.2009.05.003; Huang LS, 2012, MOL CELL BIOCHEM, V363, P367, DOI 10.1007/s11010-011-1189-3; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang Y, 2012, PARASITOL RES, V111, P1143, DOI 10.1007/s00436-012-2946-2; Iguchi N, 2002, MOL HUM REPROD, V8, P525, DOI 10.1093/molehr/8.6.525; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Janvilisri T, 2007, MOL CELL BIOCHEM, V305, P95, DOI 10.1007/s11010-007-9532-4; Ju JW, 2009, PROTEOMICS, V9, P3066, DOI 10.1002/pmic.200700613; Kiger L, 1998, BIOPHYS J, V75, P990, DOI 10.1016/S0006-3495(98)77587-3; Kim HG, 2009, WORLD J GASTROENTERO, V15, P86, DOI 10.3748/wjg.15.86; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leksomboon R, 2012, PARASITOL INT, V61, P107, DOI 10.1016/j.parint.2011.07.014; Li SY, 2008, PARASITOL RES, V103, P1019, DOI 10.1007/s00436-008-1084-3; Li XR, 2009, BIOCHEM BIOPH RES CO, V380, P454, DOI 10.1016/j.bbrc.2009.01.083; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Na BK, 2006, CELL MICROBIOL, V8, P1034, DOI 10.1111/j.1462-5822.2006.00685.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rashid AK, 1997, J BIOL CHEM, V272, P2992, DOI 10.1074/jbc.272.5.3000; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Santamaria I, 1999, J BIOL CHEM, V274, P13800, DOI 10.1074/jbc.274.20.13800; Schroder Bernd, 2010, Biochem J, V427, pe1, DOI 10.1042/BJ20100391; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Sim S, 2003, PARASITOL RES, V91, P338, DOI 10.1007/s00436-003-0869-7; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; Smout MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000611; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; TODD JR, 1966, EXP PARASITOL, V19, P151, DOI 10.1016/0014-4894(66)90063-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Grinsven KWA, 2009, MOL BIOCHEM PARASIT, V164, P74, DOI 10.1016/j.molbiopara.2008.11.008; VANVUGT F, 1980, VET SCI COMMUN, V3, P299; Wang XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r107; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045830; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Yoo WG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001208; Young ND, 2010, BIOTECHNOL ADV, V28, P859, DOI 10.1016/j.biotechadv.2010.07.006; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng MH, 2011, PARASITOL RES, V109, P737, DOI 10.1007/s00436-011-2316-5; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	60	58	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54732	10.1371/journal.pone.0054732	http://dx.doi.org/10.1371/journal.pone.0054732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382950	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800071
J	Qiu, LP; Wei, XR; Zhang, XC; Cheng, JM				Qiu, Liping; Wei, Xiaorong; Zhang, Xingchang; Cheng, Jimin			Ecosystem Carbon and Nitrogen Accumulation after Grazing Exclusion in Semiarid Grassland	PLOS ONE			English	Article							RESOURCE AVAILABILITY; OXIDE EMISSIONS; SOIL RESOURCES; DIOXIDE FLUXES; IMPACTS; SEQUESTRATION; DISTURBANCE; STORAGE; HETEROGENEITY; STEPPE	The grazing exclusion in degraded grassland has been extensively used to prevent the loss of grassland resources and to improve grassland services. The effects of grazing exclusion on C and N balance, however, have not been well addressed but are essential for assessing grassland C sinks, the sustainable use of grassland resources and the support of grassland services. To understand the response of ecosystem C and N to grazing exclusion in semiarid grassland, we determined the C and N in litter, aboveground biomass, roots and soils from ungrazed grassland fenced at different times in northwest China. Our results showed that the aboveground biomass, root biomass and plant litter were 70-92%, 56-151% and 59-141% higher, respectively, in grazer excluded grassland than in grazed grassland. Grazing exclusion significantly increased C and N stored in plant biomass and litter and increased the concentrations and stocks of C and N in soils. Grazing exclusion thus significantly increased the C and N stored in grassland ecosystems. The increase in C and N stored in soil contributed to more than 95% and 97% of the increases in ecosystem C and N storage. The highest C and N stocks in ecosystems were observed in 17-year grazer excluded grassland. The results from this study indicate that grazing exclusion has the potential to increase C and N storage in degraded semiarid grassland and that the recovery of ecosystem C and N was mainly due to the accumulation of C and N in soils.	[Qiu, Liping; Wei, Xiaorong; Zhang, Xingchang; Cheng, Jimin] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China	Northwest A&F University - China	Wei, XR (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	xrwei78@163.com			National Natural Science Foundation of China [40901145]; Chinese Academy of Sciences [KZCX2-XB3-13-02]; Science and Technology Development Research Program in Shaanxi Province [2011KJXX25]; Program for Youthful Talents in Northwest A F University; Program from Northwest A F University [QN2011147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Development Research Program in Shaanxi Province; Program for Youthful Talents in Northwest A F University; Program from Northwest A F University	This study was supported by the National Natural Science Foundation of China (40901145), Chinese Academy of Sciences (KZCX2-XB3-13-02), Science and Technology Development Research Program in Shaanxi Province (2011KJXX25), the Program for Youthful Talents in Northwest A & F University, and the Program from Northwest A & F University (QN2011147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bakker C, 2003, OECOLOGIA, V137, P385, DOI 10.1007/s00442-003-1360-y; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; De Deyn GB, 2004, J ECOL, V92, P824, DOI 10.1111/j.0022-0477.2004.00924.x; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; Follett RF, 2005, GRASSLAND: A GLOBAL RESOURCE, P265; Follett RF, 2010, RANGELAND ECOL MANAG, V63, P4, DOI 10.2111/08-225.1; Frank AB, 2002, ENVIRON POLLUT, V116, P397, DOI 10.1016/S0269-7491(01)00216-0; Gendron F, 2007, PLANT ECOL, V191, P199, DOI 10.1007/s11258-006-9237-x; Guodong HD, 2008, AGR ECOSYST ENVIRON, V125, P21, DOI 10.1016/j.agee.2007.11.009; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hiernaux P, 1999, J ARID ENVIRON, V41, P231, DOI 10.1006/jare.1998.0475; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huxman TE, 2004, OECOLOGIA, V141, P295, DOI 10.1007/s00442-003-1389-y; Ingram LJ, 2008, SOIL SCI SOC AM J, V72, P939, DOI 10.2136/sssaj2007.0038; Jia HongTao, 2009, Agricultural Research in the Arid Areas, V27, P33; Johnson LC, 2001, ECOLOGY, V82, P3377, DOI 10.1890/0012-9658(2001)082[3377:FAGRBP]2.0.CO;2; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Klumpp K, 2009, J ECOL, V97, P876, DOI 10.1111/j.1365-2745.2009.01549.x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li LH, 2002, ACTA BOT SIN, V44, P740; Liu TZ, 2011, NUTR CYCL AGROECOSYS, V91, P67, DOI 10.1007/s10705-011-9445-1; Liu YR, 2003, CHIN J APPL ECOL, V15, P1604; Neff JC, 2005, ECOL APPL, V15, P87, DOI 10.1890/04-0268; Owensby CE, 2006, RANGELAND ECOL MANAG, V59, P111, DOI 10.2111/05-116R2.1; Polley HW, 2008, GLOBAL CHANGE BIOL, V14, P1620, DOI 10.1111/j.1365-2486.2008.01599.x; Qiu LP, 2012, PLANT SOIL, V355, P299, DOI 10.1007/s11104-011-1099-x; Renne IJ, 2006, ECOLOGY, V87, P2264, DOI 10.1890/0012-9658(2006)87[2264:SIGIEO]2.0.CO;2; Saggar S, 2004, NUTR CYCL AGROECOSYS, V68, P243, DOI 10.1023/B:FRES.0000019463.92440.a3; Schuman GE, 1999, ECOL APPL, V9, P65, DOI 10.1890/1051-0761(1999)009[0065:IOGMOT]2.0.CO;2; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Shan YM, 2011, SOIL BIOL BIOCHEM, V43, P1943, DOI 10.1016/j.soilbio.2011.06.002; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Suttie J. M., 2006, P1; Tanentzap AJ, 2012, BIOL REV, V87, P72, DOI 10.1111/j.1469-185X.2011.00185.x; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Wang JY, 2012, ENVIRON POLLUT, V162, P223, DOI 10.1016/j.envpol.2011.11.027; Wang XD, 2012, PLANT SOIL, V354, P173, DOI 10.1007/s11104-011-1053-y; Wardle DA, 2002, COMMUNITIES ECOSYSTE; Wei X, 2013, J ARID ENVIRON, V88, P175, DOI 10.1016/j.jaridenv.2012.09.003; Werth M, 2005, J PLANT NUTR SOIL SC, V168, P472, DOI 10.1002/jpln.200421704; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; Wu HH, 2012, BIOL FERT SOILS, V48, P305, DOI 10.1007/s00374-011-0627-4; Yunwushan Natural Grassland Protection Zone Bureau (YNGPZB), 2000, COLL WORKS SCI INV M	47	59	68	12	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55433	10.1371/journal.pone.0055433	http://dx.doi.org/10.1371/journal.pone.0055433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383191	gold, Green Published, Green Submitted			2022-12-27	WOS:000315563800155
J	Satija, NK; Sharma, D; Afrin, F; Tripathi, RP; Gangenahalli, G				Satija, Neeraj Kumar; Sharma, Deepa; Afrin, Farhat; Tripathi, Rajendra P.; Gangenahalli, Gurudutta			High Throughput Transcriptome Profiling of Lithium Stimulated Human Mesenchymal Stem Cells Reveals Priming towards Osteoblastic Lineage	PLOS ONE			English	Article							MARROW STROMAL CELLS; INHIBITS OSTEOGENIC DIFFERENTIATION; BINDING PROTEIN-ALPHA; IN-VITRO EXPANSION; BONE-MARROW; GENE-EXPRESSION; GROWTH-FACTOR; KINASE ACTIVATION; MICROARRAY DATA; WNT	Human mesenchymal stem cells (hMSCs) present in the bone marrow are the precursors of osteoblasts, chondrocytes and adipocytes, and hold tremendous potential for osteoregenerative therapy. However, achieving directed differentiation into osteoblasts has been a major concern. The use of lithium for enhancing osteogenic differentiation has been documented in animal models but its effect in humans is not clear. We, therefore, performed high throughput transcriptome analysis of lithium-treated hMSCs to identify altered gene expression and its relevance to osteogenic differentiation. Our results show suppression of proliferation and enhancement of alkaline phosphatase (ALP) activity upon lithium treatment of hMSCs under non-osteogenic conditions. Microarray profiling of lithium-stimulated hMSC revealed decreased expression of adipogenic genes (CEBPA, CMKLR1, HSD11B1) and genes involved in lipid biosynthesis. Interestingly, osteoclastogenic factors and immune responsive genes (IL7, IL8, CXCL1, CXCL12, CCL20) were also downregulated. Negative transcriptional regulators of the osteogenic program (TWIST1 and PBX1) were suppressed while genes involved in mineralization like CLEC3B and ATF4 were induced. Gene ontology analysis revealed enrichment of upregulated genes related to mesenchymal cell differentiation and signal transduction. Lithium priming led to enhanced collagen 1 synthesis and osteogenic induction of lithium pretreated MSCs resulted in enhanced expression of Runx2, ALP and bone sialoprotein. However, siRNA-mediated knockdown of RRAD, CLEC3B and ATF4 attenuated lithium-induced osteogenic priming, identifying a role for RRAD, a member of small GTP binding protein family, in osteoblast differentiation. In conclusion, our data highlight the transcriptome reprogramming potential of lithium resulting in higher propensity of lithium "primed" MSCs for osteoblastic differentiation.	[Satija, Neeraj Kumar; Sharma, Deepa; Tripathi, Rajendra P.; Gangenahalli, Gurudutta] Inst Nucl Med & Allied Sci, Stem Cell & Gene Therapy Res Grp, Delhi, India; [Afrin, Farhat] Hamdard Univ, Dept Biotechnol, New Delhi, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Jamia Hamdard University	Gangenahalli, G (corresponding author), Inst Nucl Med & Allied Sci, Stem Cell & Gene Therapy Res Grp, Brig SK Mazumdar Marg, Delhi, India.	gugdutta@rediffmail.com	Afrin, Farhat/F-2346-2018	Afrin, Farhat/0000-0003-4443-4284; Satija, Neeraj/0000-0002-4571-327X	Defence Research and Development Organisation, Ministry of Defence, Government of India	Defence Research and Development Organisation, Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO))	This work was supported by funding from Defence Research and Development Organisation, Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghaban Eslaminejad M., 2008, IRAN J BASIC MED SCI, V11, P143; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Berridge M.V., 1996, BIOCHEMICA, V4, P14, DOI DOI 10.1155/2013/420601; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bolton JM, 2008, J CLIN PSYCHOPHARM, V28, P384, DOI 10.1097/JCP.0b013e31817d5943; Bujalska IJ, 2008, J ENDOCRINOL, V197, P297, DOI 10.1677/JOE-08-0050; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Choi YA, 2010, J PROTEOME RES, V9, P2946, DOI 10.1021/pr901110q; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gordon JAR, 2010, MOL CELL BIOL, V30, P3531, DOI 10.1128/MCB.00889-09; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Gregory CA, 2005, J BIOL CHEM, V280, P2309, DOI 10.1074/jbc.M406275200; Harmey D, 2004, J BONE MINER RES, V19, P661, DOI 10.1359/JBMR.040105; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hipskind Robert A., 1998, Frontiers in Bioscience, V3, pD804; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Johnston J, 2010, TRANSGENIC RES, V19, P1017, DOI 10.1007/s11248-010-9376-7; Justesen J, 2004, ENDOCRINOLOGY, V145, P1916, DOI 10.1210/en.2003-1427; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Klapholz-Brown Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000945; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Krause U, 2010, P NATL ACAD SCI USA, V107, P4147, DOI 10.1073/pnas.0914360107; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Larsen KH, 2010, J BONE MINER RES, V25, P796, DOI 10.1359/jbmr.091018; Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524; Li JJ, 2011, BONE, V48, P321, DOI 10.1016/j.bone.2010.09.033; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; McEachin RC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-158; Motomura H, 2007, BIOCHEM BIOPH RES CO, V357, P997, DOI 10.1016/j.bbrc.2007.04.035; Murie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-45; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Pandey R, 2004, BIOINFORMATICS, V20, P2156, DOI 10.1093/bioinformatics/bth215; Qu GW, 2006, BONE, V38, P21, DOI 10.1016/j.bone.2005.07.013; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; Rintala J, 1999, NEUROREPORT, V10, P3887, DOI 10.1097/00001756-199912160-00030; Rosario M, 1999, EMBO J, V18, P1270, DOI 10.1093/emboj/18.5.1270; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x; Seelan RS, 2008, NEUROSCIENCE, V151, P1184, DOI 10.1016/j.neuroscience.2007.10.045; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Shim M, 2003, J BIOL CHEM, V278, P19674, DOI 10.1074/jbc.M301356200; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; Tamura M, 2011, INT J BIOCHEM CELL B, V43, P760, DOI 10.1016/j.biocel.2011.01.021; Tang GH, 2011, J DENT RES, V90, P336, DOI 10.1177/0022034510389180; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P1, DOI 10.1007/s00223-004-0258-y; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Warden SJ, 2010, BONE, V46, P985, DOI 10.1016/j.bone.2009.12.031; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; Wilting I, 2007, BONE, V40, P1252, DOI 10.1016/j.bone.2006.12.055; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yoshida K, 2007, ORAL DIS, V13, P32, DOI 10.1111/j.1601-0825.2006.01239.x; Yoshiko Y, 2003, ENDOCRINOLOGY, V144, P4134, DOI 10.1210/en.2003-0130; Zamani A, 2009, BONE, V44, P331, DOI 10.1016/j.bone.2008.10.001; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhang WV, 2005, APOPTOSIS, V10, P75, DOI 10.1007/s10495-005-6063-x; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104	92	48	56	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55769	10.1371/journal.pone.0055769	http://dx.doi.org/10.1371/journal.pone.0055769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383279	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800188
J	Downs, CA; Trac, DQ; Kreiner, LH; Eaton, AF; Johnson, NM; Brown, A; Helms, MN				Downs, Charles A.; Trac, David Q.; Kreiner, Lisa H.; Eaton, Amity F.; Johnson, Nicholle M.; Brown, Ann; Helms, My N.			Ethanol Alters Alveolar Fluid Balance via Nadph Oxidase (NOX) Signaling to Epithelial Sodium Channels (ENaC) in the Lung	PLOS ONE			English	Article							CHRONIC ALCOHOL-ABUSE; MULTIPLE ORGAN DYSFUNCTION; NA+ TRANSPORT; IN-VIVO; CELLS; CLEARANCE; INFLAMMATION; MACROPHAGES; CONSUMPTION; INHIBITION	Chronic alcohol consumption is associated with increased incidence of ICU-related morbidity and mortality, primarily from acute respiratory distress syndrome (ARDS). However, the mechanisms involved are unknown. One explanation is that alcohol regulates epithelial sodium channels (ENaC) via oxidant signaling to promote a pro-injury environment. We used small rodent models to mimic acute and chronic alcohol consumption and tested the hypothesis that ethanol (EtOH) would affect lung fluid clearance by up-regulating ENaC activity in the lung. Fluorescence labeling of rat lung slices and in vivo mouse lung revealed an increase in ROS production in response to acute EtOH exposure. Using western blots and fluorescein-5-maleimide labeling, we conclude that EtOH exposure modifies cysteines of a-ENaC while data from single channel patch clamp analysis confirm that 0.16% EtOH increased ENaC activity in rat alveolar cells. In vivo lung fluid clearance demonstrated a latent increase in fluid clearance in mice receiving EtOH diet. Ethanol mice given a tracheal instillation of LPS demonstrated early lung fluid clearance compared to caloric control mice and C57Bl/6 mice. Standard biochemical techniques reveal that chronic EtOH consumption resulted in greater protein expression of the catalytic gp91(phox) subunit and the obligate Rac1 protein. Collectively these data suggest that chronic EtOH consumption may lead to altered regulation of ENaC, contributing to a 'pro-injury' environment in the alcohol lung.	[Downs, Charles A.] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Downs, Charles A.; Trac, David Q.; Kreiner, Lisa H.; Eaton, Amity F.; Johnson, Nicholle M.; Brown, Ann; Helms, My N.] Emory Univ, Dept Pediat, Emory Children Ctr Dev Lung Biol, Atlanta, GA 30322 USA; [Downs, Charles A.; Brown, Ann; Helms, My N.] Emory Univ, Emory Alcohol & Lung Biol Ctr, Atlanta, GA 30322 USA; [Kreiner, Lisa H.; Eaton, Amity F.; Johnson, Nicholle M.; Helms, My N.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Downs, CA (corresponding author), Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA.	mhelms@emory.edu		Eaton, Amity/0000-0003-0791-3411; Trac, David/0000-0002-0563-4964	Children's Center for Developmental Lung Biology; National Institute of Alcohol Abuse and Alcoholism [012197-08];  [HL092226-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL092226, K99HL092226] Funding Source: NIH RePORTER	Children's Center for Developmental Lung Biology; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by HL092226-05 and Children's Center for Developmental Lung Biology grants awarded to MNH and National Institute of Alcohol Abuse and Alcoholism 012197-08 awarded to LAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4; Bao HF, 2012, AM J PHYSIOL-CELL PH, V303, pC1129, DOI 10.1152/ajpcell.00139.2012; Brown LAS, 2006, ALCOHOL CLIN EXP RES, V30, P1624, DOI 10.1111/j.1530-0277.2006.00195.x; Brown SD, 2012, ALCOHOL CLIN EXP RES, V36, P1952, DOI 10.1111/j.1530-0277.2012.01825.x; Brown SD, 2009, ALCOHOL CLIN EXP RES, V33, P1782, DOI 10.1111/j.1530-0277.2009.01017.x; Clunes LA, 2008, J ANAL TOXICOL, V32, P201, DOI 10.1093/jat/32.3.201; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Downs CA, 2012, J BIOMEDICINE BIOTEC; Downs CA, 2012, AM J PHYSIOL-LUNG C, V302, pL1167, DOI 10.1152/ajplung.00038.2012; Dubowski K M, 1985, J Stud Alcohol Suppl, V10, P98; Dubowski KM, 1999, J ANAL TOXICOL, V23, P386, DOI 10.1093/jat/23.6.386; DUBOWSKI KM, 1974, CLIN CHEM, V20, P966; DUBOWSKI KM, 1980, AM J CLIN PATHOL, V74, P747; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Fukuda N, 2000, J APPL PHYSIOL, V89, P672, DOI 10.1152/jappl.2000.89.2.672; Goodson P, 2012, AM J PHYSIOL-LUNG C, V302, pL410, DOI 10.1152/ajplung.00260.2011; Guidot D, 1999, CHEST, V116, p82S, DOI 10.1378/chest.116.suppl_1.82S; Guidot DM, 2000, AM J PHYSIOL-LUNG C, V279, pL127, DOI 10.1152/ajplung.2000.279.1.L127; Helms MN, 2008, J BIOL CHEM, V283, P22875, DOI 10.1074/jbc.M801363200; Helms My N, 2010, J Vis Exp, DOI 10.3791/1941; Hummler E, 1997, P NATL ACAD SCI USA, V94, P11710, DOI 10.1073/pnas.94.21.11710; Jerrells TR, 2007, ALCOHOL, V41, P357, DOI 10.1016/j.alcohol.2007.07.001; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Li XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1193, DOI 10.1152/ajplung.00408.2006; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Moss M, 1999, CHEST, V116, p97S, DOI 10.1378/chest.116.suppl_1.97S-a; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Oldenburg PJ, 2012, AM J PHYSIOL-LUNG C, V302, pL308, DOI 10.1152/ajplung.00077.2011; Pierrakos Charalampos, 2012, J Clin Med Res, V4, P7, DOI 10.4021/jocmr761w; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Song KJ, 2002, J LEUKOCYTE BIOL, V72, P1109; Song WF, 2010, J BIOL CHEM, V285, P9716, DOI 10.1074/jbc.M109.073981; Takemura Y, 2010, AM J PHYSIOL-LUNG C, V298, pL509, DOI 10.1152/ajplung.00230.2009; Tan CD, 2011, PFLUG ARCH EUR J PHY, V462, P431, DOI 10.1007/s00424-011-0982-x; Thibodeau PH, 2013, CELL TISSUE RES, V351, P309, DOI 10.1007/s00441-012-1439-z; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; Yeligar SM, 2012, J IMMUNOL, V188, P3648, DOI 10.4049/jimmunol.1101278; Yeligar SM, 2010, J BIOL CHEM, V285, P35359, DOI 10.1074/jbc.M110.138636; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006	47	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54750	10.1371/journal.pone.0054750	http://dx.doi.org/10.1371/journal.pone.0054750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382956	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200026
J	Moore, SA; Hallsworth, K; Plotz, T; Ford, GA; Rochester, L; Trenell, MI				Moore, Sarah A.; Hallsworth, Kate; Ploetz, Thomas; Ford, Gary A.; Rochester, Lynn; Trenell, Michael I.			Physical Activity, Sedentary Behaviour and Metabolic Control following Stroke: A Cross-Sectional and Longitudinal Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; METAANALYSIS; TIME; PREVENTION; INACTIVITY; RECOVERY; RISK	Background: Physical activity and sedentary behaviour are key moderators of cardiovascular disease risk and metabolic control. Despite the importance of a physically active lifestyle, little is known about the effects of stroke on physical activity. We assessed physical activity and sedentary behaviour at three time points following stroke compared to a healthy control group. Methods: Physical activity and sedentary behaviour were objectively measured using a portable multi-sensor array in 31 stroke participants (73 +/- 9 years, National Institute of Health Stroke Scale 2 +/- 2, mobile 10 metres with/without aid) within seven days and at three and six months. Stroke data were compared with an age, sex and body mass index matched healthy control group (n = 31). Results: Within seven days of stroke, total energy expenditure and physical activity were significantly lower and sedentary time higher in the stroke group compared to controls (total energy expenditure 1840 +/- 354 vs. 2220 +/- 489 kcal, physical activity 28 +/- 32 vs. 79 +/- 46 min/day, steps 3111 +/- 2290 vs. 7996 +/- 2649, sedentary time 1383 +/- 42 vs. 1339 +/- 44 min/day, p<0.01). At three months physical activity levels had increased (64 +/- 58 min/day) but plateaued by six months (66 +/- 68 min/day). Conclusions: Physical activity levels are reduced immediately post-stroke and remain below recommended levels for health and wellbeing at the three and six month time points. Clinicians should explore methods to increase physical activity and reduce sedentary behaviour in both the acute and later stages following stroke.	[Moore, Sarah A.; Hallsworth, Kate; Trenell, Michael I.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Moore, Sarah A.; Hallsworth, Kate; Ford, Gary A.; Rochester, Lynn; Trenell, Michael I.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ploetz, Thomas] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Moore, SA (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	s.a.moore@ncl.ac.uk	Ford, Gary/AAY-6405-2020	Ford, Gary/0000-0001-8719-4968; Moore, Sarah/0000-0003-3158-4750; Hallsworth, Kate/0000-0002-1860-6970; Trenell, Michael/0000-0001-8253-5620; Rochester, Lynn/0000-0001-5774-9272	Newcastle Centre for Brain Ageing and Vitality; UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-Related Disease award; Medical Research Council; National Institute for Health Research; MRC [G0700718] Funding Source: UKRI; Medical Research Council [G0700718] Funding Source: researchfish; National Institute for Health Research [SRF-2011-04-017] Funding Source: researchfish	Newcastle Centre for Brain Ageing and Vitality; UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-Related Disease award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Newcastle Centre for Brain Ageing and Vitality, the UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-Related Disease award to the Newcastle upon Tyne Hospitals NHS Foundation Trust and the Medical Research Council. Professor Michael Trenell is supported by a Senior Research Fellowship, and Professor Gary Ford by a Senior Investigator Award from the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Camhi SM, 2011, PREV MED, V52, P358, DOI 10.1016/j.ypmed.2011.01.030; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; De Wit L, 2005, STROKE, V36, P1977, DOI 10.1161/01.STR.0000177871.59003.e3; De Wit L, 2007, STROKE, V38, P2101, DOI 10.1161/STROKEAHA.107.482869; Department of Health, 2011, START ACT STAY ACT R; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; International Physical Activity Questionnaire, 2005, INT PHYS ACT QUEST; Joint British Society, 2005, HEART S5, V91, P0; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Malavolti M, 2007, NUTR METAB CARDIOVAS, V17, P338, DOI 10.1016/j.numecd.2005.12.009; Manns PJ, 2009, STROKE, V40, P864, DOI 10.1161/STROKEAHA.108.531590; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Moore SA, 2012, STROKE, V43, P1660, DOI 10.1161/STROKEAHA.111.646257; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Shaughnessy M, 2005, STROKE, V36, P1305, DOI 10.1161/01.STR.0000166202.00669.d2; SKILBECK CE, 1983, J NEUROL NEUROSUR PS, V46, P5, DOI 10.1136/jnnp.46.1.5; Thijssen DHJ, 2011, J APPL PHYSIOL, V111, P1836, DOI 10.1152/japplphysiol.00394.2011; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168; World Health Organization, 2006, DEF DIAGN DIAB MELL	29	85	85	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55263	10.1371/journal.pone.0055263	http://dx.doi.org/10.1371/journal.pone.0055263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383131	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200048
J	Dean, P; Young, L; Quitard, S; Kenny, B				Dean, Paul; Young, Lorna; Quitard, Sabine; Kenny, Brendan			Insights into the Pathogenesis of Enteropathogenic E. coli Using an Improved Intestinal Enterocyte Model	PLOS ONE			English	Article							CELL-LINE CACO-2; ESCHERICHIA-COLI; SUCRASE-ISOMALTASE; SIGNALING PATHWAYS; EFFECTOR MOLECULES; HOST MITOCHONDRIA; ESPF EFFECTOR; PROTEIN; EPEC; BARRIER	Enteropathogenic E. coli (EPEC) is a human pathogen that targets the small intestine, causing severe and often fatal diarrhoea in infants. A defining feature of EPEC disease is the loss (effacement) of absorptive microvilli (MV) from the surface of small intestinal enterocytes. Much of our understanding of EPEC pathogenesis is derived from studies using cell lines such as Caco-2-the most extensively used small intestinal model. However, previous work has revealed fundamental differences between Caco-2 cells and in vivo differentiated enterocytes in relation to MV effacement. This, and the high heterogeneity and low transfection efficiency of the Caco-2 cell line prompted the isolation of several sub-clones (NCL-1-12) to identify a more tractable and improved in vivo-like cell model. Along with established Caco-2 clones (TC-7, BBE1), sub-clones were assessed for growth rate, apical surface morphology, epithelial barrier function and transfection efficiency. TC-7 cells provided the best all-round clone and exhibited highest levels of ectopic gene expression following cell polarisation. Novel alterations in EGFP-labelled mitochondria, that were not previously documented in non-polarised cell types, highlighted the potential of the TC-7 model for defining dynamic enterocyte-specific changes during infection. Crucially, the TC-7 cell line also mimicked ex vivo derived enterocytes with regard to MV effacement, enabling a better dissection of the process. Effacement activity caused by the EPEC protein Map in the Caco-2 but not ex vivo model, was linked to a defect in suppressing its Cdc42-dependent functionality. MV effacement activity of the EPEC protein EspF in the TC-7 model was dependent on its N-WASP binding motif, which is also shown to play an essential role in epithelial barrier dysfunction. Together, this study highlights the many advantages of using TC-7 cells as a small intestinal model to study host-pathogen interactions.	[Dean, Paul; Young, Lorna; Quitard, Sabine; Kenny, Brendan] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Dean, P (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.	p.dean@ncl.ac.uk; brendan.kenny@ncl.ac.uk		Dean, Paul/0000-0002-2822-4677; , Brendan/0000-0001-7455-360X	Faculty Research Fellowship; BBSRC; Wellcome Trust [WT064409MA]	Faculty Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Faculty Research Fellowship awarded to PD, a BBSRC-funded Studentship for LY and a Wellcome Trust grant (WT064409MA) awarded to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Artursson P., 2012, ADV DRUG DELIV REV; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Campellone KG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000191; CHANTRET I, 1994, J CELL SCI, V107, P213; Cheng HC, 2008, NATURE, V454, P1009, DOI 10.1038/nature07160; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Dean P, 2004, MOL MICROBIOL, V54, P665, DOI 10.1111/j.1365-2958.2004.04308.x; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Dean P, 2011, MICROBIOL-SGM, V157, P1761, DOI 10.1099/mic.0.047506-0; Dean P, 2010, CELL MICROBIOL, V12, P1308, DOI 10.1111/j.1462-5822.2010.01469.x; Dean P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000961; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kenny B, 2002, MOL MICROBIOL, V44, P1095, DOI 10.1046/j.1365-2958.2002.02952.x; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kenny B, 1996, MOL MICROBIOL, V20, P313, DOI 10.1111/j.1365-2958.1996.tb02619.x; LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Orchard RC, 2012, CELL, V148, P803, DOI 10.1016/j.cell.2011.11.063; PETERSON MD, 1992, J CELL SCI, V102, P581; PINTO M, 1983, BIOL CELL, V47, P323; Quitard S, 2006, CELL MICROBIOL, V8, P972, DOI 10.1111/j.1462-5822.2005.00680.x; ROUSSET M, 1985, J CELL PHYSIOL, V123, P377, DOI 10.1002/jcp.1041230313; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sarmento B, 2012, EXPERT OPIN DRUG MET, V8, P607, DOI 10.1517/17425255.2012.673586; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Shah P, 2006, BIOTECHNOL PROGR, V22, P186, DOI 10.1021/bp050208u; Shaw RK, 2005, INFECT IMMUN, V73, P1243, DOI 10.1128/IAI.73.2.1243-1251.2005; Simpson N, 2006, MOL MICROBIOL, V60, P349, DOI 10.1111/j.1365-2958.2006.05109.x; Volpe DA, 2008, J PHARM SCI-US, V97, P712, DOI 10.1002/jps.21010; WALTER E, 1995, EUR J PHARM SCI, V3, P215, DOI 10.1016/0928-0987(95)00010-B; Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x	41	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55284	10.1371/journal.pone.0055284	http://dx.doi.org/10.1371/journal.pone.0055284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383137	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500072
J	Yi, JP; Zhang, L; Tang, BS; Han, WW; Zhou, YF; Chen, Z; Jia, DD; Jiang, H				Yi, Jiping; Zhang, Li; Tang, Beisha; Han, Weiwei; Zhou, Yafang; Chen, Zhao; Jia, Dandan; Jiang, Hong			Sodium Valproate Alleviates Neurodegeneration in SCA3/MJD via Suppressing Apoptosis and Rescuing the Hypoacetylation Levels of Histone H3 and H4	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; MACHADO-JOSEPH-DISEASE; CREB-BINDING PROTEIN; ATAXIA TYPE-I; DROSOPHILA-MELANOGASTER; EXPANDED POLYGLUTAMINE; DEACETYLASE INHIBITION; ALTERED TRANSCRIPTION; GENE-EXPRESSION; MOUSE MODEL	Spinocerebellar ataxia type 3 (SCA3) also known as Machado-Joseph Disease (MJD), is one of nine polyglutamine (polyQ) diseases caused by a CAG-trinucelotide repeat expansion within the coding sequence of the ATXN3 gene. There are no disease-modifying treatments for polyQ diseases. Recent studies suggest that an imbalance in histone acetylation may be a key process leading to transcriptional dysregulation in polyQ diseases. Because of this possible imbalance, the application of histone deacetylase (HDAC) inhibitors may be feasible for the treatment of polyQ diseases. To further explore the therapeutic potential of HDAC inhibitors, we constructed two independent preclinical trials with valproic acid (VPA), a promising therapeutic HDAC inhibitor, in both Drosophila and cell SCA3 models. We demonstrated that prolonged use of VPA at specific dose partly prevented eye depigmentation, alleviated climbing disability, and extended the average lifespan of SCA3/MJD transgenic Drosophila. We found that VPA could both increase the acetylation levels of histone H3 and histone H4 and reduce the early apoptotic rate of cells without inhibiting the aggregation of mutant ataxin-3 proteins in MJDtr-Q68-expressing cells. These results collectively support the premise that VPA is a promising therapeutic agent for the treatment of SCA3 and other polyQ diseases.	[Yi, Jiping; Zhang, Li; Tang, Beisha; Han, Weiwei; Zhou, Yafang; Chen, Zhao; Jia, Dandan; Jiang, Hong] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Tang, Beisha; Jiang, Hong] Cent S Univ, Neurodegenerat Disorders Res Ctr, Changsha, Hunan, Peoples R China; [Tang, Beisha] Cent S Univ, Natl Lab Med Genet China, Changsha, Hunan, Peoples R China; [Yi, Jiping] Univ S China, Peoples Hosp Chenzhou 1, Dept Neurol, Chenzhou, Peoples R China; [Yi, Jiping] Univ S China, Peoples Hosp Chenzhou 1, Inst Translat Med, Chenzhou, Peoples R China	Central South University; Central South University; Central South University; University of South China; University of South China	Jiang, H (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.	jianghong73868@yahoo.com.cn			National Basic Research Program (973 Program) [2012CB944600, 2012CB517902, 2011CB510002]; New Century Excellent Talents in University [NCET-10-0836]; National Natural Science Foundation of China [81271260, 30971585, 30871354, 30710303061, 30400262]; Undergraduate Innovation Project of Central South University [CY12400]	National Basic Research Program (973 Program)(National Basic Research Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Undergraduate Innovation Project of Central South University	This study was supported by the National Basic Research Program (973 Program) (No. 2012CB944600, 2012CB517902 and 2011CB510002 to Hong Jiang), New Century Excellent Talents in University (No. NCET-10-0836 to Hong Jiang), the National Natural Science Foundation of China (No. 81271260, 30971585, 30871354, 30710303061, and 30400262 to Hong Jiang), and Undergraduate Innovation Project of Central South University (No. CY12400 to Hong Jiang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele M, 1997, BRAIN, V120, P2141, DOI 10.1093/brain/120.12.2141; Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Bettencourt C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-35; Bijur GN, 2000, J NEUROCHEM, V75, P2401, DOI 10.1046/j.1471-4159.2000.0752401.x; Burk K, 1999, J NEUROL, V246, P789, DOI 10.1007/s004150050456; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen T, 2002, ARCH BIOCHEM BIOPHYS, V408, P171, DOI 10.1016/S0003-9861(02)00564-7; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Evidente VGH, 2000, MAYO CLIN PROC, V75, P475; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kramer OH, 2001, TRENDS ENDOCRIN MET, V12, P294, DOI 10.1016/S1043-2760(01)00438-6; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; Li WZ, 2012, GENET MOL RES, V11, P1997, DOI 10.4238/2012.August.6.4; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Nightingale KP, 1998, EMBO J, V17, P2865, DOI 10.1093/emboj/17.10.2865; Palladino MJ, 2002, GENETICS, V161, P1197; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; U M, 2001, CELL DEATH DIFFER, V8, P377, DOI 10.1038/sj.cdd.4400819; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; WHEELER JC, 1995, P NATL ACAD SCI USA, V92, P10408, DOI 10.1073/pnas.92.22.10408; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Zhang ZZ, 2012, EXP EYE RES, V94, P98, DOI 10.1016/j.exer.2011.11.013	40	52	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54792	10.1371/journal.pone.0054792	http://dx.doi.org/10.1371/journal.pone.0054792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382971	gold, Green Submitted, Green Published			2022-12-27	WOS:000315211500027
J	Fasan, A; Alpermann, T; Haferlach, C; Grossmann, V; Roller, A; Kohlmann, A; Eder, C; Kern, W; Haferlach, T; Schnittger, S				Fasan, Annette; Alpermann, Tamara; Haferlach, Claudia; Grossmann, Vera; Roller, Andreas; Kohlmann, Alexander; Eder, Christiane; Kern, Wolfgang; Haferlach, Torsten; Schnittger, Susanne			Frequency and Prognostic Impact of CEBPA Proximal, Distal and Core Promoter Methylation in Normal Karyotype AML: A Study on 623 Cases	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; BINDING-PROTEIN-ALPHA; MINIMAL RESIDUAL DISEASE; C/EBP-ALPHA; DNA METHYLATION; MUTATIONS; GENE; EXPRESSION; HYPERMETHYLATION; CANCER	The clinical impact of aberrant CEBPA promoter methylation (PM) in AML is controversially discussed. The aim of this study was to clarify the significance of aberrant CEBPA PM with regard to clinical features in a cohort of 623 cytogenetically normal (CN) de novo AML. 555 cases had wild-type CEBPA, 68 cases harbored CEBPA mutations. The distal promoter was methylated in 238/623 cases (38.2%), the core promoter in 8 of 326 cases (2.5%), whereas proximal PM was never detected. CEBPA PM and CEBPA mutations were mutually exclusive. CEBPA distal PM positive cases were characterized by reduced CEBPA mRNA expression levels and elevated white blood cell counts. CEBPA distal PM was less frequent in patients with mutations in FLT3, NPM1 and TET2 and more frequent in cases with RUNX1 and IDH2R140 mutations. Overall, no association of methylation to prognosis was seen. However CEBPA distal PM was associated with inferior outcome in cases with low FLT3-ITD ratio or TET2 mutations. A distinct gene expression profile of CEBPA distal PM positive cases compared to CEBPA mutated and CEBPA distal PM negative cases was observed. In conclusion, the presence of aberrant CEBPA PM is associated with distinct biological features but impact on outcome is weak.	[Fasan, Annette; Alpermann, Tamara; Haferlach, Claudia; Grossmann, Vera; Roller, Andreas; Kohlmann, Alexander; Eder, Christiane; Kern, Wolfgang; Haferlach, Torsten; Schnittger, Susanne] MLL Munich Leukemia Lab, Munich, Germany	MLL Munich Leukemia Laboratory	Schnittger, S (corresponding author), MLL Munich Leukemia Lab, Munich, Germany.	susanne.schnittger@mll.com						Arber DA, 2008, WHO CLASSIFICATION T, P110; Barjesteh van Waalwijk van Doorn-Khosrovani Sahar, 2003, Hematol J, V4, P31; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chim CS, 2002, BRIT J HAEMATOL, V119, P988, DOI 10.1046/j.1365-2141.2002.03952.x; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Grimwade David, 2009, Hematology Am Soc Hematol Educ Program, P385, DOI 10.1182/asheducation-2009.1.385; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Haferlach T, 2003, J CLIN ONCOL, V21, P3004, DOI 10.1200/JCO.2003.99.091; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hollink IHIM, 2011, HAEMATOL-HEMATOL J, V96, P384, DOI 10.3324/haematol.2010.031336; Jost E, 2009, LEUKEMIA RES, V33, P443, DOI 10.1016/j.leukres.2008.07.027; Kern W, 2004, BLOOD, V104, P3078, DOI 10.1182/blood-2004-03-1036; Kohlmann A, 2010, LEUKEMIA, V24, P1216, DOI 10.1038/leu.2010.73; Kohlmann A, 2008, CLIN CHEM, V54, P1705, DOI 10.1373/clinchem.2008.108506; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Kumagai T, 2009, INT J CANCER, V124, P827, DOI 10.1002/ijc.23994; Lin TC, 2011, LEUKEMIA, V25, P32, DOI 10.1038/leu.2010.222; MITELMAN F, 1995, GUIDELINES CANC CY S; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Schnittger S, 2011, LEUKEMIA, V25, P1297, DOI 10.1038/leu.2011.97; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Snaddon J, 2003, GENE CHROMOSOME CANC, V37, P72, DOI 10.1002/gcc.10185; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486	30	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54365	10.1371/journal.pone.0054365	http://dx.doi.org/10.1371/journal.pone.0054365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383300	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900007
J	Michaillat, L; Mayer, A				Michaillat, Lydie; Mayer, Andreas			Identification of Genes Affecting Vacuole Membrane Fragmentation in Saccharomyces cerevisiae	PLOS ONE			English	Article							YEAST VACUOLE; PROTEIN COMPLEX; PHOSPHATIDATE PHOSPHATASE; MITOCHONDRIAL FISSION; ENDOPLASMIC-RETICULUM; TETHERING COMPLEX; LIPID-SYNTHESIS; CLATHRIN COATS; FUSION; PATHWAY	The equilibrium of membrane fusion and fission influences the volume and copy number of organelles. Fusion of yeast vacuoles has been well characterized but their fission and the mechanisms determining vacuole size and abundance remain poorly understood. We therefore attempted to systematically characterize factors necessary for vacuole fission. Here, we present results of an in vivo screening for deficiencies in vacuolar fragmentation activity of an ordered collection deletion mutants, representing 4881 non-essential genes of the yeast Saccharomyces cerevisiae. The screen identified 133 mutants with strong defects in vacuole fragmentation. These comprise numerous known fragmentation factors, such as the Fab1p complex, Tor1p, Sit4p and the V-ATPase, thus validating the approach. The screen identified many novel factors promoting vacuole fragmentation. Among those are 22 open reading frames of unknown function and three conspicuous clusters of proteins with known function. The clusters concern the ESCRT machinery, adaptins, and lipases, which influence the production of diacylglycerol and phosphatidic acid. A common feature of these factors of known function is their capacity to change membrane curvature, suggesting that they might promote vacuole fragmentation via this property.	[Michaillat, Lydie; Mayer, Andreas] Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland	University of Lausanne	Mayer, A (corresponding author), Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland.	Andreas.Mayer@unil.ch	Mayer, Andreas/AAE-4315-2020	Mayer, Andreas/0000-0001-6131-313X	European Research Council [233458]; Swiss National Science Foundation [3100A0-128661/1]	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Research Council (grant 233458) and the Swiss National Science Foundation (grant 3100A0-128661/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguer C, 2003, EUKARYOT CELL, V2, P729, DOI 10.1128/EC.2.4.729-736.2003; Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Brachmann CB, 1998, YEAST, V14, P115; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Catlett NL, 2000, CURR OPIN CELL BIOL, V12, P509, DOI 10.1016/S0955-0674(00)00124-1; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Hodge CA, 2010, J CELL SCI, V123, P141, DOI 10.1242/jcs.055046; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lachmann Jens, 2011, Small GTPases, V2, P182; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; LARKIN JM, 1986, J CELL BIOL, V103, P2619, DOI 10.1083/jcb.103.6.2619; LEE KS, 1994, J BIOL CHEM, V269, P19725; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2001, BIOCHEM SOC T, V29, P476, DOI 10.1042/BST0290476; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Michaillat L, 2012, MOL BIOL CELL, V23, P881, DOI 10.1091/mbc.E11-08-0703; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Phelan JP, 2006, J CELL SCI, V119, P4225, DOI 10.1242/jcs.03188; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Prunuske AJ, 2006, CURR OPIN CELL BIOL, V18, P108, DOI 10.1016/j.ceb.2005.12.004; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reinke CA, 2004, P NATL ACAD SCI USA, V101, P18018, DOI 10.1073/pnas.0408256102; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schmid S.L., 2011, ANN REV CELL DEV BIO; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Weisman LS, 2003, ANNU REV GENET, V37, P435, DOI 10.1146/annurev.genet.37.050203.103207; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200	99	53	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54160	10.1371/journal.pone.0054160	http://dx.doi.org/10.1371/journal.pone.0054160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383298	gold, Green Submitted, Green Published			2022-12-27	WOS:000314597900005
J	Sultana, R; Vemula, MH; Banerjee, S; Guruprasad, L				Sultana, Rafiya; Vemula, Mani Harika; Banerjee, Sharmishta; Guruprasad, Lalitha			The PE16 (Rv1430) of Mycobacterium tuberculosis Is an Esterase Belonging to Serine Hydrolase Superfamily of Proteins	PLOS ONE			English	Article							CUTINASE-LIKE PROTEINS; LIPASE ACTIVITY; PGRS PROTEINS; CELL-SURFACE; PPE; GENE; TRIACYLGLYCEROL; VIRULENCE; RV2430C; IMMUNOGENICITY	The PE and PPE multigene families, first discovered during the sequencing of M. tuberculosis H37Rv genome are responsible for antigenic variation and have been shown to induce increased humoral and cell mediated immune response in the host. Using the bioinformatics tools, we had earlier reported that the 225 amino acid residue PE-PPE domain (Pfam: PF08237) common to some PE and PPE proteins has a "serine alpha/beta hydrolase" fold and conserved Ser, Asp and His catalytic triad characteristic of lipase, esterase and cutinase activities. In order to prove experimentally that PE-PPE domain is indeed a serine hydrolase, we have cloned the full-length Rv1430 and its PE-PPE domain into pET-28a vector, expressed the proteins in E. coli and purified to homogeneity. The activity assays of both purified proteins were carried out using p-nitrophenyl esters of aliphatic carboxylic acids with varying chain length (C2-C16) to study the substrate specificity. To characterize the active site of the PE-PPE domain, we mutated the Ser199 to Ala. The activity of the protein in the presence of serine protease inhibitor- PMSF and the mutant protein were measured. Our results reveal that Rv1430 and its PE-PPE domain possess esterase activity and hydrolyse short to medium chain fatty acid esters with the highest specific activity for pNPC6 at 37 degrees C, 38 degrees C and pH 7.0, 8.0. The details of this work and the observed results are reported in this manuscript.	[Sultana, Rafiya; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India; [Vemula, Mani Harika; Banerjee, Sharmishta] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Guruprasad, L (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	lgpsc@uohyd.ernet.in			CSIR, India for Research fellowship; UPE2, University of Hyderabad	CSIR, India for Research fellowship; UPE2, University of Hyderabad	RS and MHV thank CSIR, India for Research fellowship. LGP and SB thank UPE2, University of Hyderabad for support.	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Barry CE, 2001, TRENDS MICROBIOL, V9, P237, DOI 10.1016/S0966-842X(01)02018-2; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Chaitra MG, 2008, J MED MICROBIOL, V57, P1079, DOI 10.1099/jmm.0.47565-0; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Choudhary RK, 2004, PROTEIN EXPRES PURIF, V36, P249, DOI 10.1016/j.pep.2004.03.016; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Guo JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013143; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Lopez-Lopez S, 2003, COMP BIOCHEM PHYS B, V135, P337, DOI 10.1016/S1096-4959(03)00087-3; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Pencreach G, 1996, ENZYME MICROB TECH, V18, P417, DOI 10.1016/0141-0229(95)00120-4; Pratt J, 2000, CURR MICROBIOL, V40, P306, DOI 10.1007/s002849910061; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sultana R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016745; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; World Health Organization (WHO), 2006, GLOB REG INC	49	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55320	10.1371/journal.pone.0055320	http://dx.doi.org/10.1371/journal.pone.0055320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383323	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900030
J	Uribe, PM; Mueller, MA; Gleichman, JS; Kramer, MD; Wang, Q; Sibrian-Vazquez, M; Strongin, RM; Steyger, PS; Cotanche, DA; Matsui, JI				Uribe, Phillip M.; Mueller, Melissa A.; Gleichman, Julia S.; Kramer, Matthew D.; Wang, Qi; Sibrian-Vazquez, Martha; Strongin, Robert M.; Steyger, Peter S.; Cotanche, Douglas A.; Matsui, Jonathan I.			Dimethyl Sulfoxide (DMSO) Exacerbates Cisplatin-induced Sensory Hair Cell Death in Zebrafish (Danio rerio)	PLOS ONE			English	Article							LATERAL-LINE; DIMETHYLSULFOXIDE; SUSCEPTIBILITY; IDENTIFICATION; REGENERATION; OTOTOXICITY; NEUROMASTS; REVEALS; SCREEN; AGENTS	Inner ear sensory hair cells die following exposure to aminoglycoside antibiotics or chemotherapeutics like cisplatin, leading to permanent auditory and/or balance deficits in humans. Zebrafish (Danio rerio) are used to study drug-induced sensory hair cell death since their hair cells are similar in structure and function to those found in humans. We developed a cisplatin dose-response curve using a transgenic line of zebrafish that expresses membrane-targeted green fluorescent protein under the control of the Brn3c promoter/enhancer. Recently, several small molecule screens have been conducted using zebrafish to identify potential pharmacological agents that could be used to protect sensory hair cells in the presence of ototoxic drugs. Dimethyl sulfoxide (DMSO) is typically used as a solvent for many pharmacological agents in sensory hair cell cytotoxicity assays. Serendipitously, we found that DMSO potentiated the effects of cisplatin and killed more sensory hair cells than treatment with cisplatin alone. Yet, DMSO alone did not kill hair cells. We did not observe the synergistic effects of DMSO with the ototoxic aminoglycoside antibiotic neomycin. Cisplatin treatment with other commonly used organic solvents (i.e. ethanol, methanol, and polyethylene glycol 400) also did not result in increased cell death compared to cisplatin treatment alone. Thus, caution should be exercised when interpreting data generated from small molecule screens since many compounds are dissolved in DMSO.	[Uribe, Phillip M.; Gleichman, Julia S.; Matsui, Jonathan I.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA; [Mueller, Melissa A.; Kramer, Matthew D.; Matsui, Jonathan I.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wang, Qi; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, Portland, OR 97201 USA; [Sibrian-Vazquez, Martha; Strongin, Robert M.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Cotanche, Douglas A.] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA; [Cotanche, Douglas A.] Harvard Univ, Sch Publ Hlth, Harvard Noise Induced Hearing Loss Res Grp, Boston, MA 02115 USA; [Cotanche, Douglas A.; Matsui, Jonathan I.] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, Boston, MA USA	Claremont Colleges; Pomona College; Harvard University; Oregon Health & Science University; Portland State University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Matsui, JI (corresponding author), Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA.	Jonathan.Matsui@pomona.edu	Strongin, Robert M./F-1026-2010; Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237; Cotanche, Douglas/0000-0001-7972-0446; Uribe, Phillip/0000-0002-7396-8907	Pomona College, National Institutes of Health (NIH) [DC010998, DC010231]; Harvard College; Sarah Fuller Funder; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010231, R15DC010998] Funding Source: NIH RePORTER	Pomona College, National Institutes of Health (NIH); Harvard College; Sarah Fuller Funder; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Pomona College, National Institutes of Health (NIH) DC010998 (JIM), NIH DC010231 (PSS, MSV, RMS), Harvard College (MAM, MDK), and Sarah Fuller Funder (DAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bever MM, 2002, DEV DYNAM, V223, P536, DOI 10.1002/dvdy.10062; Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63; Chiu LL, 2008, JARO-J ASSOC RES OTO, V9, P178, DOI 10.1007/s10162-008-0118-y; Coffin AB, 2010, ZEBRAFISH, V7, P3, DOI 10.1089/zeb.2009.0639; Fischer SJ, 2008, NEUROTOXICOLOGY, V29, P444, DOI 10.1016/j.neuro.2008.02.010; Giari L, 2011, J APPL TOXICOL; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hirose Y, 2011, JARO-J ASSOC RES OTO, V12, P719, DOI 10.1007/s10162-011-0278-z; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; Matsui JI, 2006, INVEST OPHTH VIS SCI, V47, P4589, DOI 10.1167/iovs.05-0971; Miller M, 2011, MIDWINTER M ASS RES; Murakami SL, 2003, HEARING RES, V186, P47, DOI 10.1016/S0378-5955(03)00259-4; Musial-Bright L, 2011, CHILD NERV SYST, V27, P407, DOI 10.1007/s00381-010-1300-1; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; Ou H, 2012, HEARING RES, V288, P58, DOI 10.1016/j.heares.2012.01.009; Ou HC, 2007, HEARING RES, V233, P46, DOI 10.1016/j.heares.2007.07.003; Ou HC, 2010, DRUG DISCOV TODAY, V15, P265, DOI 10.1016/j.drudis.2010.01.001; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Owens KN, 2007, J COMP NEUROL, V502, P522, DOI 10.1002/cne.21345; POMMIER RF, 1988, AM J OBSTET GYNECOL, V159, P848, DOI 10.1016/S0002-9378(88)80151-0; Qi WD, 2008, HEARING RES, V236, P52, DOI 10.1016/j.heares.2007.12.002; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Ryback L, 2007, PHARM OTOTOXICITY AU; Rybak Leonard P, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P364, DOI 10.1097/MOO.0b013e3282eee452; Safaei R, 2005, CLIN CANCER RES, V11, P756; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; SCHOENFELD RH, 1983, J AM OSTEOPATH ASSOC, V82, P570; SUNDQUIST WI, 1987, INORG CHEM, V26, P1524, DOI 10.1021/ic00257a013; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861	35	25	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55359	10.1371/journal.pone.0055359	http://dx.doi.org/10.1371/journal.pone.0055359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383324	gold, Green Published			2022-12-27	WOS:000314597900031
J	Gurven, M; Jaeggi, AV; Kaplan, H; Cummings, D				Gurven, Michael; Jaeggi, Adrian V.; Kaplan, Hillard; Cummings, Daniel			Physical Activity and Modernization among Bolivian Amerindians	PLOS ONE			English	Article							DOUBLY-LABELED WATER; ACTIVITY ENERGY-EXPENDITURE; DISEASE RISK-FACTORS; TSIMANE AMERINDIANS; METABOLIC-RATE; HEART-RATE; INFECTION; HUMANS; ADULTS	Background: Physical inactivity is a growing public health problem, and the fourth leading risk factor for global mortality. Conversely, indigenous populations living traditional lifestyles reportedly engage in vigorous daily activity that is protective against non-communicable diseases. Here we analyze physical activity patterns among the Tsimane, forager-horticulturalists of Amazonian Bolivia with minimal heart disease and diabetes. We assess age patterns of adult activity among men and women, test whether modernization affects activity levels, and examine whether nascent obesity is associated with reduced activity. Methods and Findings: A factorial method based on a large sample of behavioral observations was employed to estimate effects of age, sex, body mass index, and modernization variables on physical activity ratio (PAR), the ratio of total energy expenditure to basal metabolic rate. Accelerometry combined with heart rate monitoring was compared to the factorial method and used for nighttime sampling. Tsimane men and women display 24 hr physical activity level (PAL) of 2.02-2.15 and 1.73-1.85, respectively. Little time was spent "sedentary'', whereas most activity was light to moderate, rather than vigorous. Activity peaks by the late twenties in men, and declines thereafter, but remains constant among women after the early teens. Neither BMI, fat free mass or body fat percentage are associated with PAR. There was no negative effect of modernization on physical activity. Conclusions: Tsimane display relatively high PALs typical of other subsistence populations, but of moderate intensity, and not outside the range of developed populations. Despite rapidly increasing socioeconomic change, there is little evidence that total activity has yet been affected. Overweight and obesity are more prevalent among women than men, and Spanish fluency is associated with greater obesity in women. The lack of cardiovascular disease among Tsimane is unlikely caused by activity alone; further study of diet, food intake and infectious disease is needed.	[Gurven, Michael; Jaeggi, Adrian V.] Univ Calif Santa Barbara, Dept Anthropol, Integrat Anthropol Sci Unit, Santa Barbara, CA 93106 USA; [Jaeggi, Adrian V.] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA; [Kaplan, Hillard; Cummings, Daniel] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of New Mexico	Gurven, M (corresponding author), Univ Calif Santa Barbara, Dept Anthropol, Integrat Anthropol Sci Unit, Santa Barbara, CA 93106 USA.	gurven@anth.ucsb.edu	Jaeggi, Adrian V/L-1245-2019	Jaeggi, Adrian V/0000-0003-1695-0388; Gurven, Michael/0000-0002-5661-527X; Kaplan, Hillard/0000-0002-7398-7358	National Science Foundation [BCS-0422690, BCS0136274]; National Institute on Aging [R01AG024119-01, R56AG024119, P01AG022500]; Swiss National Science Foundation [PBZHP3-133443]; NATIONAL INSTITUTE ON AGING [R56AG024119, R01AG024119, P01AG022500] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was supported by the National Science Foundation (BCS-0422690, BCS0136274), the National Institute on Aging (R01AG024119-01, R56AG024119, P01AG022500) and the Swiss National Science Foundation (PBZHP3-133443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Assah FK, 2011, INT J EPIDEMIOL, V40, P112, DOI 10.1093/ije/dyq098; Barreira T, 2009, INT J EXER SCI, V2, P60; BENTLEY GR, 1993, CURR ANTHROPOL, V34, P778, DOI 10.1086/204223; Black AE, 1996, EUR J CLIN NUTR, V50, P72; BLACK FL, 1975, SCIENCE, V187, P515, DOI 10.1126/science.163483; Bogin B, 1999, ANN HUM BIOL, V26, P333; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; CDC, 2006, HEALTH BEHAVIORS OF; Christensen DL, 2012, AM J HUM BIOL, V24, P723, DOI 10.1002/ajhb.22303; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Dufour DL, 2008, AM J HUM BIOL, V20, P249, DOI 10.1002/ajhb.20764; Dugas LR, 2011, AM J CLIN NUTR, V93, P427, DOI 10.3945/ajcn.110.007278; EATON SB, 1988, AM J MED, V84, P739, DOI 10.1016/0002-9343(88)90113-1; Ekelund U, 2002, AM J CLIN NUTR, V76, P935, DOI 10.1093/ajcn/76.5.935; [FAO WHO UNU], 1985, PROTEIN AND ENERGY R; FAO/ WHO/ UNU (Food and Agriculture Organization of the United Nations/ World Health Organization/ United Nations University), 2004, FAO FOOD NUTR TECHN; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; Finch C, 2007, THE BIOLOGY OF HUMAN; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Godoy R, 2005, J ANTHROPOL RES, V61, P157, DOI 10.3998/jar.0521004.0061.202; Godoy RA, 2004, HUM ECOL, V32, P339, DOI 10.1023/B:HUEC.0000028085.47707.08; Godoy R, 2005, ECON HUM BIOL, V3, P136, DOI 10.1016/j.ehb.2005.01.001; Godoy RA, 2006, ECON HUM BIOL, V4, P184, DOI 10.1016/j.ehb.2005.11.001; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Gurven M, 2012, EXP GERONTOL, V47, P807, DOI 10.1016/j.exger.2012.05.006; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Gurven M, 2009, HUM NATURE-INT BIOS, V20, P151, DOI 10.1007/s12110-009-9062-8; Hardman A., 2009, PHYSICAL ACTIVITY AN; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hayes M, 2005, INT J OBESITY, V29, P151, DOI 10.1038/sj.ijo.0802842; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; HEWLETT BS, 1991, J ANTHROPOL RES, V47, P1; KASHIWAZAKI H, 1995, AM J CLIN NUTR, V62, P901, DOI 10.1093/ajcn/62.5.901; Kashiwazaki H, 2009, AM J HUM BIOL, V21, P337, DOI 10.1002/ajhb.20864; KATZMARZYK PT, 1994, AM J HUM BIOL, V6, P719, DOI 10.1002/ajhb.1310060606; Krishnaveni GV, 2009, EUR J CLIN NUTR, V63, P1313, DOI 10.1038/ejcn.2009.95; Lavie CJ, 2009, AM J MED, V122, P1106, DOI 10.1016/j.amjmed.2009.06.006; LAWRENCE M, 1988, EUR J CLIN NUTR, V42, P145; Leonard WR, 2010, J PHYS ACT HEALTH, V7, pS284, DOI 10.1123/jpah.7.s3.s284; Leonard WR, 1997, AM J PHYS ANTHROPOL, V103, P443, DOI 10.1002/(SICI)1096-8644(199708)103:4<443::AID-AJPA2>3.3.CO;2-5; Lindeberg S, 2010, FOOD AND WESTERN DIS; Lyden K, 2011, EUR J APPL PHYSIOL, V111, P187, DOI 10.1007/s00421-010-1639-8; Madimenos FC, 2011, AM J HUM BIOL, V23, P488, DOI 10.1002/ajhb.21163; Martin MA, 2012, MATERN CHILD NUTR, V8, P404, DOI 10.1111/j.1740-8709.2012.00412.x; Matsuzawa Y, 1997, DIABETES METAB REV, V13, P3, DOI 10.1002/(SICI)1099-0895(199703)13:1&lt;3::AID-DMR178&gt;3.0.CO;2-N; Nagata JM, 2009, ECON HUM BIOL, V7, P96, DOI 10.1016/j.ehb.2009.02.002; O'Donovan G, 2005, INT J OBESITY, V29, P1063, DOI 10.1038/sj.ijo.0803004; O'Keefe JH, 2010, AM J MED, V123, P1082, DOI 10.1016/j.amjmed.2010.04.026; Pennington R, 2001, BIOSOCIAL S, V13, P170; Pinheiro JC, 2012, NLME LINEAR AND NON; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; Steffen PR, 2006, PSYCHOSOM MED, V68, P386, DOI 10.1097/01.psy.0000221255.48190.32; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tataranni PA, 2003, INT J OBESITY, V27, P1578, DOI 10.1038/sj.ijo.0802469; Team RDC, 2012, R LANG ENV STAT COMP; Thomas DM, 2012, OBES REV, V13, P835, DOI 10.1111/j.1467-789X.2012.01012.x; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Vuori I., 2004, KINESIOLOGY, V36, P123; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Wyatt J, 2012, ACTILIFE 6 USERS MAN; Yngve A, 2003, MED SCI SPORT EXER, V35, P320, DOI 10.1249/01.MSS.0000048829.75758.A0	67	64	66	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55679	10.1371/journal.pone.0055679	http://dx.doi.org/10.1371/journal.pone.0055679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383262	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600144
J	Maier, JA; Lo, YT; Harfe, BD				Maier, Jennifer A.; Lo, YinTing; Harfe, Brian D.			Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs	PLOS ONE			English	Article							SONIC-HEDGEHOG; TRANSCRIPTION FACTORS; NOTOCHORD DEVELOPMENT; MESODERM FORMATION; PRIMITIVE STREAK; MOUSE EMBRYO; T-GENE; EXPRESSION; CELLS; MICE	The intervertebral disc (IVD) is composed of 3 main structures, the collagenous annulus fibrosus (AF), which surrounds the gel-like nucleus pulposus (NP), and hyaline cartilage endplates, which are attached to the vertebral bodies. An IVD is located between each vertebral body. Degeneration of the IVD is thought to be a major cause of back pain, a potentially chronic condition for which there exist few effective treatments. The NP forms from the embryonic notochord. Foxa1 and Foxa2, transcription factors in the forkhead box family, are expressed early during notochord development. However, embryonic lethality and the absence of the notochord in Foxa2 null mice have precluded the study of potential roles these genes may play during IVD formation. Using a conditional Foxa2 allele in conjunction with a tamoxifen-inducible Cre allele (ShhcreER(T2)), we removed Foxa2 from the notochord of E7.5 mice null for Foxa1. Foxa1(-/-); Foxa2(c/c); ShhcreER(T2) double mutant animals had a severely deformed nucleus pulposus, an increase in cell death in the tail, decreased hedgehog signaling, defects in the notochord sheath, and aberrant dorsal-ventral patterning of the neural tube. Embryos lacking only Foxa1 or Foxa2 from the notochord were indistinguishable from control animals, demonstrating a functional redundancy for these genes in IVD formation. In addition, we provide in vivo genetic evidence that Foxa genes are required for activation of Shh in the notochord.	[Harfe, Brian D.] Univ Florida, Coll Med, Gainesville, FL 32611 USA; Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Harfe, BD (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32611 USA.	bharfe@mgm.ufl.edu			University of Florida Alumni Fellowship; National Institutes of Health/National Institute on Aging [AG029353]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR055568]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029353] Funding Source: NIH RePORTER	University of Florida Alumni Fellowship(University of Florida); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.A.M. was supported by a University of Florida Alumni Fellowship. B.D.H. was supported by grants from the National Institutes of Health/National Institute on Aging (AG029353) and National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR055568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkhalek Hanaa Ben, 2004, Genes Dev, V18, P1725; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Bruggeman BJ, 2012, DEV DYNAM, V241, P675, DOI 10.1002/dvdy.23750; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Choi KS, 2012, MECH DEV; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Devereaux MW, 2007, NEUROL CLIN, V25, P331, DOI 10.1016/j.ncl.2007.02.003; Dufort D, 1998, DEVELOPMENT, V125, P3015; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Epstein DJ, 1999, DEVELOPMENT, V126, P281; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Gofflot F, 1997, DEV DYNAM, V210, P431, DOI 10.1002/(SICI)1097-0177(199712)210:4<431::AID-AJA7>3.0.CO;2-H; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; JUNQUEIRA LCU, 1982, HISTOCHEMISTRY, V74, P153, DOI 10.1007/BF00495061; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Martin BI, 2009, SPINE, V34, P2077, DOI 10.1097/BRS.0b013e3181b1fad1; Mavromatakis YE, 2011, MECH DEVELOP, V128, P90, DOI 10.1016/j.mod.2010.11.002; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Moore RJ, 2006, EUR SPINE J, V15, pS333, DOI 10.1007/s00586-006-0170-4; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; PAAVOLA LG, 1980, J EMBRYOL EXP MORPH, V55, P227; PEACOCK A, 1952, J ANAT, V86, P162; Peters H, 1999, DEVELOPMENT, V126, P5399; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x; Ribes V, 2010, GENE DEV, V24, P1186, DOI 10.1101/gad.559910; SASAKI H, 1993, DEVELOPMENT, V118, P47; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; STOTT D, 1993, GENE DEV, V7, P197, DOI 10.1101/gad.7.2.197; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tamplin OJ, 2011, DEV BIOL, V360, P415, DOI 10.1016/j.ydbio.2011.10.002; Ukita K, 2009, MECH DEVELOP, V126, P791, DOI 10.1016/j.mod.2009.08.003; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wang Y, 2012, SPINE; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wilson V, 1996, MECH DEVELOP, V55, P79, DOI 10.1016/0925-4773(95)00493-9; YAMADA K, 1963, NATURE, V198, P799, DOI 10.1038/198799a0; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016	71	50	50	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55528	10.1371/journal.pone.0055528	http://dx.doi.org/10.1371/journal.pone.0055528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383217	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600121
J	Sauter, KA; Bouhlel, MA; O'Neal, J; Sester, DP; Tagoh, H; Ingram, RM; Pridans, C; Bonifer, C; Hume, DA				Sauter, Kristin A.; Bouhlel, M. Amine; O'Neal, Julie; Sester, David P.; Tagoh, Hiromi; Ingram, Richard M.; Pridans, Clare; Bonifer, Constanze; Hume, David A.			The Function of the Conserved Regulatory Element within the Second Intron of the Mammalian Csf1r Locus	PLOS ONE			English	Article							ACTIVATOR GENE-TRANSCRIPTION; STIMULATING FACTOR-I; RECEPTOR C-FMS; EXPRESSION; MACROPHAGES; ENHANCERS; CSF-1; PROMOTER; ETS; LIPOPOLYSACCHARIDE	The gene encoding the receptor for macrophage colony-stimulating factor (CSF-1R) is expressed exclusively in cells of the myeloid lineages as well as trophoblasts. A conserved element in the second intron, Fms-Intronic Regulatory Element (FIRE), is essential for macrophage-specific transcription of the gene. However, the molecular details of how FIRE activity is regulated and how it impacts the Csf1r promoter have not been characterised. Here we show that agents that down-modulate Csf1r mRNA transcription regulated promoter activity altered the occupancy of key FIRE cis-acting elements including RUNX1, AP1, and Sp1 binding sites. We demonstrate that FIRE acts as an anti-sense promoter in macrophages and reversal of FIRE orientation within its native context greatly reduced enhancer activity in macrophages. Mutation of transcription initiation sites within FIRE also reduced transcription. These results demonstrate that FIRE is an orientation-specific transcribed enhancer element.	[Sauter, Kristin A.; O'Neal, Julie; Sester, David P.; Pridans, Clare; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin, Midlothian, Scotland; [Bouhlel, M. Amine; Tagoh, Hiromi; Ingram, Richard M.; Bonifer, Constanze] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Sect Expt Haematol, Leeds, W Yorkshire, England; [Bonifer, Constanze] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Sch Canc Sci, Birmingham, W Midlands, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Saint James's University Hospital; University of Leeds; University of Birmingham	Hume, DA (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin, Midlothian, Scotland.	david.hume@roslin.ed.ac.uk	Sester, David/GLR-2942-2022; Pridans, Clare/AAF-9953-2020; Tagoh, Hiromi/B-2954-2009	Pridans, Clare/0000-0001-9423-557X; Hume, David/0000-0002-2615-1478; Sauter, Kristin/0000-0002-8721-3222; Tagoh, Hiromi/0000-0001-9905-6992; Bonifer, Constanze/0000-0002-4267-0825	Medical Research Council [G0901193]; Roslin Foundation Grant; BBSRC [BBS/E/D/20251969, BB/I001220/1] Funding Source: UKRI; MRC [G0901193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I001220/1, BBS/E/D/20251969] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Roslin Foundation Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) Grant G0901193 and a Roslin Foundation Grant (http://www.roslin.ed.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chang S, 1999, J LEUKOCYTE BIOL, V66, P528, DOI 10.1002/jlb.66.3.528; Cook PR, 2003, J CELL SCI, V116, P4483, DOI 10.1242/jcs.00819; Costelloe EO, 1999, J LEUKOCYTE BIOL, V66, P172, DOI 10.1002/jlb.66.1.172; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; FAVOT P, 1995, ONCOGENE, V11, P1371; Follows GA, 2005, ONCOGENE, V24, P3643, DOI 10.1038/sj.onc.1208655; Follows GA, 2003, NUCLEIC ACIDS RES, V31, P5805, DOI 10.1093/nar/gkg804; Fowles LF, 2000, BIOCHEM J, V347, P313, DOI 10.1042/0264-6021:3470313; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; GUSELLA GL, 1990, J IMMUNOL, V144, P3574; Himes SR, 2005, ONCOGENE, V24, P5278, DOI 10.1038/sj.onc.1208657; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Ingram RM, 2011, EXP HEMATOL, V39, P730, DOI 10.1016/j.exphem.2011.04.004; Kanoksilaptham W, 2007, SILPAKORN U SCI TECH, V1, P7; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Orom UA, 2011, TRENDS GENET, V27, P433, DOI 10.1016/j.tig.2011.06.009; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; Ross IL, 1998, J BIOL CHEM, V273, P6662, DOI 10.1074/jbc.273.12.6662; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; STACEY KJ, 1995, MOL CELL BIOL, V15, P3430; Sweet MJ, 1998, J INFLAMM, V48, P67; Tagoh H, 2006, EMBO J, V25, P1070, DOI 10.1038/sj.emboj.7600997; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Tagoh H, 2002, GENE DEV, V16, P1721, DOI 10.1101/gad.222002; Tagoh H, 2006, METH MOL B, V325, P285; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; YUE X, 1993, MOL CELL BIOL, V13, P3191, DOI 10.1128/MCB.13.6.3191	40	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54935	10.1371/journal.pone.0054935	http://dx.doi.org/10.1371/journal.pone.0054935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383005	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600053
J	Spengler, JR; Haddock, E; Gardner, D; Hjelle, B; Feldmann, H; Prescott, J				Spengler, Jessica R.; Haddock, Elaine; Gardner, Don; Hjelle, Brian; Feldmann, Heinz; Prescott, Joseph			Experimental Andes Virus Infection in Deer Mice: Characteristics of Infection and Clearance in a Heterologous Rodent Host	PLOS ONE			English	Article							SIN-NOMBRE-VIRUS; MOUSE PEROMYSCUS-MANICULATUS; CHEMOKINE RECEPTOR CCR5; HANTAVIRUS PULMONARY SYNDROME; MONOCLONAL-ANTIBODIES; INTERFERON RESPONSES; FUNCTIONAL EXPRESSION; HEMORRHAGIC-FEVER; MOLECULAR-CLONING; LETHAL CHALLENGE	New World hantaviruses can cause hantavirus cardiopulmonary syndrome with high mortality in humans. Distinct virus species are hosted by specific rodent reservoirs, which also serve as the vectors. Although regional spillover has been documented, it is unknown whether rodent reservoirs are competent for infection by hantaviruses that are geographically separated, and known to have related, but distinct rodent reservoir hosts. We show that Andes virus (ANDV) of South America, carried by the long tailed pygmy rice rat (Oligoryzomys longicaudatus), infects and replicates in vitro and in vivo in the deer mouse (Peromyscus maniculatus), the reservoir host of Sin Nombre virus (SNV), found in North America. In experimentally infected deer mice, viral RNA was detected in the blood, lung, heart and spleen, but virus was cleared by 56 days post inoculation (dpi). All of the inoculated deer mice mounted a humoral immune response by 14 dpi, and produced measurable amounts of neutralizing antibodies by 21 dpi. An up-regulation of Ccl3, Ccl4, Ccl5, and Tgfb, a strong CD4(+) T-cell response, and down-regulation of Il17, Il21 and Il23 occurred during infection. Infection was transient with an absence of clinical signs or histopathological changes. This is the first evidence that ANDV asymptomatically infects, and is immunogenic in deer mice, a non-natural host species of ANDV. Comparing the immune response in this model to that of the immune response in the natural hosts upon infection with their co-adapted hantaviruses may help clarify the mechanisms governing persistent infection in the natural hosts of hantaviruses.	[Spengler, Jessica R.; Haddock, Elaine; Feldmann, Heinz; Prescott, Joseph] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA; [Spengler, Jessica R.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Gardner, Don] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA; [Hjelle, Brian] Univ New Mexico HSC, Dept Pathol, Albuquerque, NM USA; [Hjelle, Brian] Univ New Mexico HSC, Dept Biol, Albuquerque, NM USA; [Hjelle, Brian] Univ New Mexico HSC, Dept Mol Genet & Microbiol, Albuquerque, NM USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of New Mexico; University of New Mexico; University of New Mexico	Prescott, J (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA.	prescottjb@niaid.nih.gov	Spengler, Jessica R./AAN-9099-2020	Spengler, Jessica R./0000-0002-5383-0513; Prescott, Joseph/0000-0001-5718-5155	Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; ARIKAWA J, 1989, J GEN VIROL, V70, P615, DOI 10.1099/0022-1317-70-3-615; ARIKAWA J, 1992, ARCH VIROL, V126, P271, DOI 10.1007/BF01309700; Bi ZQ, 2008, J INFECT DEV COUNTR, V2, P3; Blanpain C, 1999, BLOOD, V94, P1899; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2001, COMPARATIVE MED, V51, P314; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; Brown KS, 2011, J VIROL, V85, P12781, DOI 10.1128/JVI.00794-11; Calisher CH, 1999, EMERG INFECT DIS, V5, P126, DOI 10.3201/eid0501.990115; CHILDS JE, 1991, AM J TROP MED HYG, V44, P117, DOI 10.4269/ajtmh.1991.44.117; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; DANTAS JR, 1986, VIROLOGY, V151, P379, DOI 10.1016/0042-6822(86)90058-9; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Easterbrook JD, 2008, J GEN VIROL, V89, P2723, DOI 10.1099/vir.0.2008/03715-0; Enria DA, 2000, INFECT DIS CLIN N AM, V14, P167, DOI 10.1016/S0891-5520(05)70223-3; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Geimonen E, 2002, P NATL ACAD SCI USA, V99, P13837, DOI 10.1073/pnas.192298899; Hjelle Brian, 2002, Expert Rev Vaccines, V1, P373, DOI 10.1586/14760584.1.3.373; Hooper JW, 2001, CURR TOP MICROBIOL, V256, P171; Klingstrom J, 2002, J MED VIROL, V68, P581, DOI 10.1002/jmv.10232; Levine JR, 2010, J VIROL, V84, P11790, DOI 10.1128/JVI.00916-10; LUNDKVIST A, 1992, ARCH VIROL, V126, P93, DOI 10.1007/BF01309687; Meissner JD, 2002, VIRUS RES, V89, P131, DOI 10.1016/S0168-1702(02)00129-6; Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403; MILLS JN, 1995, J MAMMAL, V76, P716, DOI 10.2307/1382742; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Plyusnin A, 2001, CURR TOP MICROBIOL, V256, P47; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; RAND MS, 1994, LAB ANIM SCI, V44, P301; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Ray N, 2010, J VIROL METHODS, V163, P416, DOI 10.1016/j.jviromet.2009.11.004; Sadeghi M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-65; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; Safronetz D, 2009, J VIROL, V83, P7285, DOI 10.1128/JVI.00373-09; Saksida A, 2008, J INFECT DIS, V197, P681, DOI 10.1086/527485; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; SCHMALJOHN CS, 1990, J VIROL, V64, P3162, DOI 10.1128/JVI.64.7.3162-3170.1990; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Schountz T, 2012, J VIROL, V86, P10015, DOI 10.1128/JVI.06875-11; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; Staudinger R, 2003, J BIOL CHEM, V278, P10389, DOI 10.1074/jbc.M212013200; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Viral Special Pathogens Branch CDC, 2012, HANT TECHN CLIN INF; Wang XH, 2003, BIOCHEM BIOPH RES CO, V307, P1066, DOI 10.1016/S0006-291X(03)01315-9; Warner GS, 1996, SOUTHERN MED J, V89, P264, DOI 10.1097/00007611-199603000-00002; Xiao RB, 2006, J INFECT DIS, V194, P1403, DOI 10.1086/508494; Yaeger MJ, 2002, J VET DIAGN INVEST, V14, P15, DOI 10.1177/104063870201400104; ZAKI SR, 1995, AM J PATHOL, V146, P552; ZHANG XK, 1989, ARCH VIROL, V105, P235, DOI 10.1007/BF01311360	52	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55310	10.1371/journal.pone.0055310	http://dx.doi.org/10.1371/journal.pone.0055310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383148	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600086
J	Bugault, F; Benati, D; Mouthon, L; Landires, I; Rohrlich, P; Pestre, V; Theze, J; Lortholary, O; Chakrabarti, LA				Bugault, Florence; Benati, Daniela; Mouthon, Luc; Landires, Ivan; Rohrlich, Pierre; Pestre, Vincent; Theze, Jacques; Lortholary, Olivier; Chakrabarti, Lisa A.			Altered Responses to Homeostatic Cytokines in Patients with Idiopathic CD4 Lymphocytopenia	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; T-CELL HOMEOSTASIS; HIV-INFECTION; CRYPTOCOCCAL MENINGITIS; INTERLEUKIN-7 RECEPTOR; CLONOGENIC CAPABILITY; SIGNAL-TRANSDUCTION; CXCR4 EXPRESSION; EPITHELIAL-CELL; CUTTING EDGE	Idiopathic CD4 lymphocytopenia (ICL) is a rare immune deficiency characterized by a protracted CD4(+) T cell loss of unknown etiology and by the occurrence of opportunistic infections similar to those seen in AIDS. We investigated whether a defect in responses to cytokines that control CD4(+) T cell homeostasis could play a role in ICL. Immunophenotype and signaling responses to interleukin-7 (IL-7), IL-2, and thymic stromal lymphopoietin (TSLP) were analyzed by flow cytometry in CD4(+) T cells from 15 ICL patients and 15 healthy blood donors. The induction of phospho-STAT5 after IL-7 stimulation was decreased in memory CD4(+) T cells of some ICL patients, which correlated with a decreased expression of the IL-7R alpha receptor chain (R = 0.74, p<0.005) and with lower CD4(+) T cell counts (R = 0.69, p<0.005). IL-2 responses were also impaired, both in the Treg and conventional memory subsets. Decreased IL-2 responses correlated with decreased IL-7 responses (R = 0.75, p<0.005), pointing to combined defects that may significantly perturb CD4(+) T cell homeostasis in a subset of ICL patients. Unexpectedly, responses to the IL-7-related cytokine TSLP were increased in ICL patients, while they remained barely detectable in healthy controls. TSLP responses correlated inversely with IL-7 responses (R = 20.41; p<0.05), suggesting a cross-regulation between the two cytokine systems. In conclusion, IL-7 and IL-2 signaling are impaired in ICL, which may account for the loss of CD4(+) T cell homeostasis. Increased TSLP responses point to a compensatory homeostatic mechanism that may mitigate defects in gamma c cytokine responses.	[Bugault, Florence; Benati, Daniela; Landires, Ivan; Theze, Jacques; Chakrabarti, Lisa A.] Inst Pasteur, Unite Immunogenet Cellulaire, Paris, France; [Mouthon, Luc; Pestre, Vincent] Univ Paris 05, Hop Cochin, AP HP, Paris, France; [Rohrlich, Pierre] INSERM, U645, Besancon, France; [Rohrlich, Pierre] Univ Besancon, F-25030 Besancon, France; [Rohrlich, Pierre] CHU Besancon, Serv Pediat, F-25030 Besancon, France; [Lortholary, Olivier] Inst Pasteur, Unite Mycol Mol, Paris, France; [Lortholary, Olivier] CNRS, URA 3012, Paris, France; [Lortholary, Olivier] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Malad Infect & Trop,Ctr Infectiol Necker Pas, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Chakrabarti, LA (corresponding author), Inst Pasteur, Unite Immunogenet Cellulaire, Paris, France.	chakra@pasteur.fr		Chakrabarti, Lisa/0000-0002-1895-3630; Landires, Ivan/0000-0001-6323-1170; Benati, Daniela/0000-0002-6599-7193; Rohrlich, Pierre S/0000-0001-8801-4164	SENACYT Research Agency from Panama; Assistance Publique des Hopitaux de Paris (AP-HP); Ligue contre le Cancer du Grand Est; Pasteur Institute, Paris	SENACYT Research Agency from Panama; Assistance Publique des Hopitaux de Paris (AP-HP); Ligue contre le Cancer du Grand Est; Pasteur Institute, Paris	I. L. is the recipient of a fellowship from the SENACYT Research Agency from Panama. This work was supported by Assistance Publique des Hopitaux de Paris (AP-HP), Ligue contre le Cancer du Grand Est, and by the Pasteur Institute, Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Alves NL, 2010, J IMMUNOL, V184, P5949, DOI 10.4049/jimmunol.1000601; Chahroudi A, 2010, EUR CYTOKINE NETW, V21, P202, DOI 10.1684/ecn.2010.0205; Cunningham-Rundles C, 1999, CLIN EXP IMMUNOL, V116, P322; Fruhwirth M, 2001, INT ARCH ALLERGY IMM, V125, P80, DOI 10.1159/000053800; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gorska MM, 2012, BLOOD, V119, P1399, DOI 10.1182/blood-2011-04-350686; HO DD, 1993, NEW ENGL J MED, V328, P380, DOI 10.1056/NEJM199302113280602; Hubert P, 2000, INT IMMUNOL, V12, P449, DOI 10.1093/intimm/12.4.449; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Isgro A, 2005, INT ARCH ALLERGY IMM, V136, P379, DOI 10.1159/000084258; Isgro A, 2008, CLIN INFECT DIS, V46, P1902, DOI 10.1086/588480; Jourdan P, 2000, J IMMUNOL, V165, P716, DOI 10.4049/jimmunol.165.2.716; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kuijpers TW, 2011, BLOOD, V117, P5892, DOI 10.1182/blood-2011-01-329052; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Laurence J, 1996, J CLIN INVEST, V97, P672, DOI 10.1172/JCI118464; Lee PI, 2009, J INFECT DIS, V199, P1664, DOI 10.1086/598953; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Malaspina A, 2007, BLOOD, V109, P2086, DOI 10.1182/blood-2006-06-031385; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Netea MG, 2004, CLIN INFECT DIS, V39, pE83, DOI 10.1086/425121; Niehues T, 2010, CLIN IMMUNOL, V135, P183, DOI 10.1016/j.clim.2010.01.013; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Pedroza-Martins L, 2002, J VIROL, V76, P6929, DOI 10.1128/JVI.76.14.6929-6943.2002; Puronen CE, 2012, J INFECT DIS, V205, P1382, DOI 10.1093/infdis/jis219; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Rochman Y, 2010, P NATL ACAD SCI US; Roger PM, 1999, CLIN INFECT DIS, V28, P1012, DOI 10.1086/514739; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Schmitt N, 2003, J VIROL, V77, P5784, DOI 10.1128/JVI.77.10.5784-5793.2003; Scott-Algara D, 2010, BLOOD, V115, P3708, DOI 10.1182/blood-2009-02-202796; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; SMITH DK, 1993, NEW ENGL J MED, V328, P373, DOI 10.1056/NEJM199302113280601; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Trojan T, 2009, CLIN EXP IMMUNOL, V156, P440, DOI 10.1111/j.1365-2249.2009.03910.x; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Walker UA, 2006, CURR OPIN RHEUMATOL, V18, P389, DOI 10.1097/01.bor.0000231908.57913.2f; Warnatz K, 2000, IMMUNOBIOLOGY, V202, P204, DOI 10.1016/S0171-2985(00)80068-6; Wohlmann A, 2010, BIOL CHEM, V391, P181, DOI [10.1515/BC.2010.029, 10.1515/bc.2010.029]; Yamada Y, 2009, INTERNAL MED, V48, P1967, DOI 10.2169/internalmedicine.48.2623; Yilmaz-Demirdag Y, 2008, ALLERGY ASTHMA PROC, V29, P421, DOI 10.2500/aap.2008.29.3143; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852; Zonios DI, 2008, BLOOD, V112, P287, DOI 10.1182/blood-2007-12-127878; Zonios DI, 2007, MEDICINE, V86, P78, DOI 10.1097/md.0b013e31803b52f5	58	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55570	10.1371/journal.pone.0055570	http://dx.doi.org/10.1371/journal.pone.0055570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383227	Green Submitted, gold, Green Published			2022-12-27	WOS:000315563800166
J	Chen, FL; Su, LF; Liu, YD; Hu, DW				Chen, Fanglin; Su, Longfei; Liu, Yadong; Hu, Dewen			Confirming the Diversity of the Brain after Normalization: An Approach Based on Identity Authentication	PLOS ONE			English	Article							OPEN ACCESS SERIES; MRI DATA; NETWORKS; CLASSIFICATION; SCHIZOPHRENIA; REGISTRATION; GENDER; IMAGES; MODES; YOUNG	During the development of neuroimaging, numerous analyses were performed to identify population differences, such as studies on age, gender, and diseases. Researchers first normalized the brain image and then identified features that represent key differences between groups. In these studies, the question of whether normalization (a pre-processing step widely used in neuroimaging studies) reduces the diversity of brains was largely ignored. There are a few studies that identify the differences between individuals after normalization. In the current study, we analyzed brain diversity on an individual level, both qualitatively and quantitatively. The main idea was to utilize brain images for identity authentication. First, the brain images were normalized and registered. Then, a pixel-level matching method was developed to compute the identity difference between different images for matching. Finally, by analyzing the performance of the proposed brain recognition strategy, the individual differences in brain images were evaluated. Experimental results on a 150-subject database showed that the proposed approach could achieve a 100% identification ratio, which indicated distinct differences between individuals after normalization. Thus, the results proved that after the normalization stage, brain images retain their main distinguishing information and features. Based on this result, we suggest that diversity (individual differences) should be considered when conducting group analysis, and that this approach may facilitate group pattern classification.	[Chen, Fanglin; Su, Longfei; Liu, Yadong; Hu, Dewen] Natl Univ Def Technol, Dept Automat Control, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Hu, DW (corresponding author), Natl Univ Def Technol, Dept Automat Control, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/AAN-8511-2020; Hu, Dewen/D-1978-2015; Chen, Fanglin/I-1527-2013	Chen, Fanglin/0000-0002-9193-5412; Su, Longfei/0000-0003-0573-2756	National 973 program of China [2011CB707802]; National Natural Science Foundation of China [61003202, 61005084]	National 973 program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National 973 program of China (2011CB707802) and National Natural Science Foundation of China (61003202, 61005084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Ashburner J., 1997, CLIN MRI DEV MR, V7, P26; Ashburner J., 2008, SPM8 MANUAL; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bergfield KL, 2010, NEUROIMAGE, V49, P1750, DOI 10.1016/j.neuroimage.2009.09.051; Buckner R., 2012, OPEN ACCESS SERIES I; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; Cappelli R, 2011, 2011 INT JOINT C BIO, P1; Chen FL, 2009, IEEE T IMAGE PROCESS, V18, P1665, DOI 10.1109/TIP.2009.2017995; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Devanand DP, 2012, NEUROIMAGE, V60, P1622, DOI 10.1016/j.neuroimage.2012.01.075; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fornito A, 2012, NEUROIMAGE IN PRESS; Friston K, 2009, STAT PARAMETRIC MAPP; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Giot Romain, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1128, DOI 10.1109/ICPR.2010.282; Holden M, 2008, IEEE T MED IMAGING, V27, P111, DOI 10.1109/TMI.2007.904691; Hollingsworth K. P., 2009, IEEE 3 INT C BIOM TH, P1; Hollingsworth KP, 2011, IEEE T PATTERN ANAL, V33, P2465, DOI 10.1109/TPAMI.2011.89; Jain A.K., 2005, BIOMETRICS PERSONAL; Jain A.K., 2011, HDB FACE RECOGNITION, V1; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Linchuan Zhang, 2010, 2010 9th IEEE International Conference on Cognitive Informatics (ICCI), P524, DOI 10.1109/COGINF.2010.5599683; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Marcus DS, 2010, J COGNITIVE NEUROSCI, V22, P2677, DOI 10.1162/jocn.2009.21407; Meda SA, 2012, NEUROIMAGE, V60, P1608, DOI 10.1016/j.neuroimage.2011.12.076; Miller M, 1997, Stat Methods Med Res, V6, P267, DOI 10.1191/096228097673360480; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Sabuncu M, 2011, CEREBRAL CORTEX; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Shinkareva SV, 2006, NEUROIMAGE, V33, P63, DOI 10.1016/j.neuroimage.2006.06.032; Takahashi R, 2011, HUM BRAIN MAPP, V32, P1050, DOI 10.1002/hbm.21088; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tonks J, 2011, BRAIN INJURY, V25, P1; Westbrook C, 2011, MRI PRACTICE; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yang YL, 2010, PSYCHIAT RES-NEUROIM, V182, P9, DOI 10.1016/j.pscychresns.2009.10.013; Zhang D, 2010, IEEE T INSTRUM MEAS, V59, P480, DOI 10.1109/TIM.2009.2028772; Zhou J, 2009, PATTERN RECOGN, V42, P896, DOI 10.1016/j.patcog.2008.09.011; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54328	10.1371/journal.pone.0054328	http://dx.doi.org/10.1371/journal.pone.0054328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382891	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800045
J	Istok, E; Friberg, A; Huotilainen, M; Tervaniemi, M				Istok, Eva; Friberg, Anders; Huotilainen, Minna; Tervaniemi, Mari			Expressive Timing Facilitates the Neural Processing of Phrase Boundaries in Music: Evidence from Event-Related Potentials	PLOS ONE			English	Article							CROSS-CULTURAL ERP; BRAIN POTENTIALS; PERCEPTION; COMPONENT; ATTENTION; MISMATCH; PITCH; N1; P2	The organization of sound into meaningful units is fundamental to the processing of auditory information such as speech and music. In expressive music performance, structural units or phrases may become particularly distinguishable through subtle timing variations highlighting musical phrase boundaries. As such, expressive timing may support the successful parsing of otherwise continuous musical material. By means of the event-related potential technique (ERP), we investigated whether expressive timing modulates the neural processing of musical phrases. Musicians and laymen listened to short atonal scale-like melodies that were presented either isochronously (deadpan) or with expressive timing cues emphasizing the melodies' two-phrase structure. Melodies were presented in an active and a passive condition. Expressive timing facilitated the processing of phrase boundaries as indicated by decreased N2b amplitude and enhanced P3a amplitude for target phrase boundaries and larger P2 amplitude for non-target boundaries. When timing cues were lacking, task demands increased especially for laymen as reflected by reduced P3a amplitude. In line, the N2b occurred earlier for musicians in both conditions indicating general faster target detection compared to laymen. Importantly, the elicitation of a P3a-like response to phrase boundaries marked by a pitch leap during passive exposure suggests that expressive timing information is automatically encoded and may lead to an involuntary allocation of attention towards significant events within a melody. We conclude that subtle timing variations in music performance prepare the listener for musical key events by directing and guiding attention towards their occurrences. That is, expressive timing facilitates the structuring and parsing of continuous musical material even when the auditory input is unattended.	[Istok, Eva; Huotilainen, Minna; Tervaniemi, Mari] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Istok, Eva; Huotilainen, Minna] Univ Jyvaskyla, Dept Mus, Finnish Ctr Excellence Interdisciplinary Mus Res, Jyvaskyla, Finland; [Friberg, Anders] KTH Royal Inst Technol, Dept Speech Mus & Hearing, Stockholm, Sweden; [Huotilainen, Minna] Finnish Inst Occupat Hlth, Helsinki, Finland; [Tervaniemi, Mari] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla; Royal Institute of Technology; Finnish Institute of Occupational Health; University of Jyvaskyla	Istok, E (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.	eva.istok@helsinki.fi	Friberg, Anders K/A-2490-2012	Tervaniemi, Mari/0000-0002-9651-2929; Huotilainen, Minna/0000-0002-7251-6984	European Commission [FP6-2004-NEST-PATH-028570-BrainTuning]; Finnish Centre of Excellence in Interdisciplinary Music Research	European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Centre of Excellence in Interdisciplinary Music Research	This work was supported by the European Commission FP6-2004-NEST-PATH-028570-BrainTuning (http://ec.europa.eu/research/fp6/index_en.cfm) and the Finnish Centre of Excellence in Interdisciplinary Music Research https://www.jyu.fi/hum/laitokset/musiikki/en/research/coe/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bregman A. S., 1999, AUDITORY SCENE ANAL; Carlson R., 1989, CONTEMP MUSIC REV, V4, P391, DOI [10.1080/07494468900640441, DOI 10.1080/07494468900640441]; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DOWLING WJ, 1973, PERCEPT PSYCHOPHYS, V14, P37, DOI 10.3758/BF03198614; Eimer M, 1996, J EXP PSYCHOL LEARN, V22, P970, DOI 10.1037/0278-7393.22.4.970; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friberg A, 2000, COMPUT MUSIC J, V24, P23, DOI 10.1162/014892600559407; Friberg A., 1995, SPEECH MUSIC HEARING, V36, P63; Friberg A, 2006, ADV COGN PSYCHOL, V2, P145, DOI DOI 10.2478/V10053-008-0052-X; James CE, 2012, HUM BRAIN MAPP, V33, P2751, DOI 10.1002/hbm.21397; Juslin P.N., 2002, MUSICAE SCI S, V5, P63, DOI DOI 10.1177/10298649020050S104; Knosche TR, 2005, HUM BRAIN MAPP, V24, P259, DOI 10.1002/hbm.20088; Koffka K, 1935, PRINCIPLES GESTALT P; Krumhansl CL, 2000, PSYCHOL BULL, V126, P159, DOI 10.1037/0033-2909.126.1.159; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Lerdahl F., 1983, GENERATIVE THEORY TO; Munte TF, 2003, ANN NY ACAD SCI, V999, P131, DOI 10.1196/annals.1284.014; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Nan Y, 2006, BRAIN RES, V1094, P179, DOI 10.1016/j.brainres.2006.03.115; Nan Y, 2009, BIOL PSYCHOL, V82, P70, DOI 10.1016/j.biopsycho.2009.06.002; Neuhaus C, 2006, J COGNITIVE NEUROSCI, V18, P472, DOI 10.1162/089892906775990642; Nittono H, 2000, BIOL PSYCHOL, V52, P1, DOI 10.1016/S0301-0511(99)00042-3; Palmer C, 2009, ANN NY ACAD SCI, V1169, P470, DOI 10.1111/j.1749-6632.2009.04584.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; REPP BH, 1992, COGNITION, V44, P241, DOI 10.1016/0010-0277(92)90003-Z; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Russeler J, 2003, COGNITIVE BRAIN RES, V15, P116, DOI 10.1016/S0926-6410(02)00145-3; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; Seppanen M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00043; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; Steinhauer K, 2003, BRAIN LANG, V86, P142, DOI 10.1016/S0093-934X(02)00542-4; TAN N, 1981, MEM COGNITION, V9, P533, DOI 10.3758/BF03202347; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283	40	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55150	10.1371/journal.pone.0055150	http://dx.doi.org/10.1371/journal.pone.0055150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383088	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800122
J	Paris, D; Beaulieu-Abdelahad, D; Mullan, M; Ait-Ghezala, G; Mathura, V; Bachmeier, C; Crawford, F; Mullan, MJ				Paris, Daniel; Beaulieu-Abdelahad, David; Mullan, Myles; Ait-Ghezala, Ghania; Mathura, Venkat; Bachmeier, Corbin; Crawford, Fiona; Mullan, Michael J.			Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; T-CELLS; IN-VIVO; DISEASE; NEURODEGENERATION; PHOSPHORYLATION; PATHOGENESIS; INHIBITION; TRANSDUCER; ACTIVATOR	Anatabine, a naturally occurring alkaloid, is becoming a commonly used human food supplement, taken for its claimed anti-inflammatory properties although this has not yet been reported in human clinical trials. We have previously shown that anatabine does display certain anti-inflammatory properties and readily crosses the blood-brain barrier suggesting it could represent an important compound for mitigating neuro-inflammatory conditions. The present study was designed to determine whether anatabine had beneficial effects on the development of experimental autoimmune encephalomyelitis (EAE) in mice and to precisely determine its underlying mechanism of action in this mouse model of multiple sclerosis (MS). We found that orally administered anatabine markedly suppressed neurological deficits associated with EAE. Analyses of cytokine production in the periphery of the animals revealed that anatabine significantly reduced Th1 and Th17 cytokines known to contribute to the development of EAE. Anatabine appears to significantly suppress STAT3 and p65 NF kappa B phosphorylation in the spleen and the brain of EAE mice. These two transcription factors regulate a large array of inflammatory genes including cytokines suggesting a mechanism by which anatabine antagonizes pro-inflammatory cytokine production. Additionally, we found that anatabine alleviated the infiltration of macrophages/microglia and astrogliosis and significantly prevented demyelination in the spinal cord of EAE mice. Altogether our data suggest that anatabine may be effective in the treatment of MS and should be piloted in clinical trials.	[Paris, Daniel; Beaulieu-Abdelahad, David; Mullan, Myles; Ait-Ghezala, Ghania; Mathura, Venkat; Bachmeier, Corbin; Crawford, Fiona; Mullan, Michael J.] Roskamp Inst, Sarasota, FL USA		Paris, D (corresponding author), Roskamp Inst, Sarasota, FL USA.	dparis@rfdn.org		Mullan, Michael/0000-0002-1473-7527; Ait-Ghezala, Ghania/0000-0002-9836-8617; Paris, Daniel/0000-0002-9622-0846	Rock Creek Pharmaceuticals	Rock Creek Pharmaceuticals	Rock Creek Pharmaceuticals partially funded this study. The Roskamp Institute is a not-for-profit public charity and none of its staff (who comprise all the authors on this paper) receive remuneration from Rock Creek Pharmaceuticals. Rock Creek Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; Caturegli P, 2012, ENDOCRINOLOGY, V153, P4580, DOI 10.1210/en.2012-1452; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Joe Y, 2011, J BIOL CHEM, V286, P24735, DOI 10.1074/jbc.M110.204859; Kim do Y., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0035476); Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Luessi F, 2012, EXPERT REV NEUROTHER, V12, P1061, DOI [10.1586/ERN.12.59, 10.1586/ern.12.59]; Martinelli V, 2009, NEUROL SCI, V30, P167, DOI 10.1007/s10072-009-0142-7; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Park SY, 2008, CYTOKINE, V44, P126, DOI 10.1016/j.cyto.2008.07.006; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rinaldi F, 2009, MULT SCLER J, V15, P1359, DOI 10.1177/1352458509107011; Russell SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047748; Segal BA, 2003, CURR ALLERGY ASTHM R, V3, P86, DOI 10.1007/s11882-003-0017-6; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Skundric DS, 2005, CURR NEUROVASC RES, V2, P349, DOI 10.2174/156720205774322601; Stangel M, 2012, CURR PHARM DESIGN, V18, P4471, DOI 10.2174/138161212802502189; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; VARTANIAN T, 1995, MOL MED, V1, P732, DOI 10.1007/BF03401888; Yamamoto I, 1998, ARCH INSECT BIOCHEM, V37, P24, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;24::AID-ARCH4&gt;3.0.CO;2-V	30	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55392	10.1371/journal.pone.0055392	http://dx.doi.org/10.1371/journal.pone.0055392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383175	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800147
J	Romer, D; Peters, E; Strasser, AA; Langleben, D				Romer, Daniel; Peters, Ellen; Strasser, Andrew A.; Langleben, Daniel			Desire versus Efficacy in Smokers' Paradoxical Reactions to Pictorial Health Warnings for Cigarettes	PLOS ONE			English	Article							ADDICTION; EMOTION; DISEASE	Pictorial health warnings on cigarette packs create aversive emotional reactions to smoking and induce thoughts about quitting; however, contrary to models of health behavior change, they do not appear to alter intentions to quit smoking. We propose and test a novel model of intention to quit an addictive habit such as smoking (the efficacy-desire model) that can explain this paradoxical effect. At the core of the model is the prediction that self-efficacy and desire to quit an addictive habit are inversely related. We tested the model in an online experiment that randomly exposed smokers (N = 3297) to a cigarette pack with one of three increasing levels of warning intensity. The results supported the model's prediction that despite the effects of warnings on aversion to smoking, intention to quit smoking is an inverted U-shape function of the smoker's self-efficacy for quitting. In addition, smokers with greater (lesser) quit efficacy relative to smoking efficacy increase (decrease) intentions to quit. The findings show that previous failures to observe effects of pictorial warning labels on quit intentions can be explained by the contradictory individual differences that warnings produce. Thus, the model explains the paradoxical finding that quit intentions do not change at the population level, even though smokers recognize the implications of warnings. The model suggests that pictorial warnings are effective for smokers with stronger quit-efficacy beliefs and provides guidance for how cigarette warnings and tobacco control strategies can be designed to help smokers quit.	[Romer, Daniel; Strasser, Andrew A.; Langleben, Daniel] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA; [Peters, Ellen] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Strasser, Andrew A.] Univ Penn, Dept Psychiat, Ctr Interdisciplinary Res Nicotine Addict, Philadelphia, PA 19104 USA; [Langleben, Daniel] Univ Penn, Dept Psychiat, Ctr Study Addict, Philadelphia, PA 19104 USA	University of Pennsylvania; University System of Ohio; Ohio State University; University of Pennsylvania; University of Pennsylvania	Romer, D (corresponding author), Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA 19104 USA.	dromer@asc.upenn.edu	Langleben, Daniel D/K-7407-2014		Annenberg Public Policy Center; Annenberg Foundation; NATIONAL CANCER INSTITUTE [R01CA157824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Annenberg Public Policy Center; Annenberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was funded in-house by the Annenberg Public Policy Center with funds from an endowment from the Annenberg Foundation. The Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annenberg Public Policy Center, 2011, FDA STUD UND IMP GRA; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Borland R, 2009, TOB CONTROL, V18, P358, DOI 10.1136/tc.2008.028043; Borland R, 2009, ADDICTION, V104, P669, DOI 10.1111/j.1360-0443.2009.02508.x; Centers for Disease Control and Prevention, 1989, 898411 CDCP US DEP H; Centers for Disease Control and Prevention, 2012, TRENDS CURR CIG SMOK; Centers for Disease Control and Prevention, 1988, 888406 CDCP US DEP H; Cutler DM, 2008, J ECON PERSPECT, V22, P3, DOI 10.1257/jep.22.4.3; Ericsson KA, 2007, CURR DIR PSYCHOL SCI, V16, P346, DOI 10.1111/j.1467-8721.2007.00533.x; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Hyland A, 2005, PSYCHOL ADDICT BEHAV, V19, P221, DOI 10.1037/0893-164X.19.2.221; JANIS I L, 1962, J Abnorm Soc Psychol, V65, P403, DOI 10.1037/h0047601; JANIS IL, 1953, J ABNORM SOC PSYCH, V48, P78, DOI 10.1037/h0060732; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kessels LTE, 2010, HEALTH PSYCHOL, V29, P346, DOI 10.1037/a0019372; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lubman DI, 2004, ADDICTION, V99, P1491, DOI 10.1111/j.1360-0443.2004.00808.x; Lynch BS., 1994, GROWING TOBACCO FREE; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nagengast B, 2011, PSYCHOL SCI, V22, P1058, DOI 10.1177/0956797611415540; Norman GJ, 2011, EMOT REV, V3, P349, DOI 10.1177/1754073911402403; Peters E, 2007, NICOTINE TOB RES, V9, P473, DOI 10.1080/14622200701239639; Robinson RJ, 1997, FDA2010N05680006, V151, P267; Robinson TN, 1997, ARCH PEDIAT ADOL MED, V151, P267, DOI 10.1001/archpedi.1997.02170400053010; Rogers R.W., 1997, HDB HLTH BEHAV RES, P113; Romer D, 2001, SMOKING: RISK, PERCEPTION, & POLICY, P216; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; U.S. Department of Health and Human Services, 1990, 908416 CDC US DEP HL; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; West R., 2006, THEORY ADDICTION; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Zhu SH, 2012, TOB CONTROL, V21, P110, DOI 10.1136/tobaccocontrol-2011-050371	41	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54937	10.1371/journal.pone.0054937	http://dx.doi.org/10.1371/journal.pone.0054937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	097OK	23383006	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200020
J	Simon, S; Demeure, C; Lamourette, P; Filali, S; Plaisance, M; Creminon, C; Volland, H; Carniel, E				Simon, Stephanie; Demeure, Christian; Lamourette, Patricia; Filali, Sofia; Plaisance, Marc; Creminon, Christophe; Volland, Herve; Carniel, Elisabeth			Fast and Simple Detection of Yersinia pestis Applicable to Field Investigation of Plague Foci	PLOS ONE			English	Article							BETA-BARREL PROTEINS; MONOCLONAL-ANTIBODIES; PLASMINOGEN-ACTIVATOR; SURFACE PROTEASE; GENOME SEQUENCE; ASSAY; ACETYLCHOLINESTERASE; HYBRIDIZATION; PERSISTENCE; EXPRESSION	Yersinia pestis, the plague bacillus, has a rodent-flea-rodent life cycle but can also persist in the environment for various periods of time. There is now a convenient and effective test (F1-dipstick) for the rapid identification of Y. pestis from human patient or rodent samples, but this test cannot be applied to environmental or flea materials because the F1 capsule is mostly produced at 37 degrees C. The plasminogen activator (PLA), a key virulence factor encoded by a Y. pestis-specific plasmid, is synthesized both at 20 degrees C and 37 degrees C, making it a good candidate antigen for environmental detection of Y. pestis by immunological methods. A recombinant PLA protein from Y. pestis synthesized by an Escherichia coli strain was used to produce monoclonal antibodies (mAbs). PLA-specific mAbs devoid of cross-reactions with other homologous proteins were further cloned. A pair of mAbs was selected based on its specificity, sensitivity, comprehensiveness, and ability to react with Y. pestis strains grown at different temperatures. These antibodies were used to develop a highly sensitive one-step PLA-enzyme immunoassay (PLA-EIA) and an immunostrip (PLA-dipstick), usable as a rapid test under field conditions. These two PLA-immunometric tests could be valuable, in addition to the F1-disptick, to confirm human plague diagnosis in nonendemic areas (WHO standard case definition). They have the supplementary advantage of allowing a rapid and easy detection of Y. pestis in environmental and flea samples, and would therefore be of great value for surveillance and epidemiological investigations of plague foci. Finally, they will be able to detect natural or genetically engineered F1-negative Y. pestis strains in human patients and environmental samples.	[Simon, Stephanie; Lamourette, Patricia; Plaisance, Marc; Creminon, Christophe; Volland, Herve] CEA Saclay, iBiTec S, Lab Etud & Rech Immunoanal, Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France; [Demeure, Christian; Filali, Sofia; Carniel, Elisabeth] Inst Pasteur, Yersinia Res Unit, Paris, France; [Demeure, Christian; Filali, Sofia; Carniel, Elisabeth] WHO Collaborating Ctr Yersinia, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Simon, S (corresponding author), CEA Saclay, iBiTec S, Lab Etud & Rech Immunoanal, Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France.	stephanie.simon@cea.fr	Demeure, Christian/AAD-4922-2020; Simon, Stephanie/E-4289-2012	Simon, Stephanie/0000-0002-6071-8255; Demeure, Christian E./0000-0001-7195-1645				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P278; BALTAZARD M., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1230; BEESLEY ED, 1967, J BACTERIOL, V94, P19, DOI 10.1128/JB.94.1.19-26.1967; Begon M, 2006, EMERG INFECT DIS, V12, P268; BERCOVIER H, 1980, CURR MICROBIOL, V4, P225, DOI 10.1007/BF02605861; Bertherat E, 2005, Med Trop (Mars), V65, P511; Bertherat E, 2007, EMERG INFECT DIS, V13, P1459, DOI 10.3201/eid1310.070284; Bertherat E, 2011, EMERG INFECT DIS, V17, P778, DOI 10.3201/eid1705.100029; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chanteau S, 2003, Med Trop (Mars), V63, P574; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; Chanteau S, 2000, INT J MED MICROBIOL, V290, P279; DEKKER N, 1995, EUR J BIOCHEM, V232, P214, DOI 10.1111/j.1432-1033.1995.tb20801.x; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Engelthaler DM, 2000, J MED ENTOMOL, V37, P422, DOI 10.1603/0022-2585(2000)037[0422:QOYPIF]2.0.CO;2; Eren E, 2010, STRUCTURE, V18, P809, DOI 10.1016/j.str.2010.03.013; Feodorova VA, 2000, J MED MICROBIOL, V49, P261, DOI 10.1099/0022-1317-49-3-261; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Freeman BA, 1985, TXB MICROBIOLOGY, P513; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; Frobert Y, 1998, METH MOL B, V80, P57; Gabitzsch ES, 2008, AM J TROP MED HYG, V79, P99, DOI 10.4269/ajtmh.2008.79.99; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; GRASSI J, 1989, J IMMUNOL METHODS, V123, P193, DOI 10.1016/0022-1759(89)90223-8; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Kenny JH, 2008, J MICROBIOL METH, V75, P293, DOI 10.1016/j.mimet.2008.06.021; Khreich N, 2008, ANAL BIOCHEM, V377, P182, DOI 10.1016/j.ab.2008.02.032; Kutyrev V, 1999, INFECT IMMUN, V67, P1359, DOI 10.1128/IAI.67.3.1359-1367.1999; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lowell JL, 2007, MICROBIOL-SGM, V153, P169, DOI 10.1099/mic.0.29059-0; Mahesh S, 2005, COMP IMMUNOL MICROB, V28, P131, DOI 10.1016/j.cimid.2004.08.002; MCCLEAN KL, 1995, CLIN INFECT DIS, V21, P650, DOI 10.1093/clinids/21.3.650; Meka-Mechenko TV, 2004, GENUS YERSINIA ENTER, P379; Meyer MHF, 2007, J MICROBIOL METH, V68, P218, DOI 10.1016/j.mimet.2006.08.004; Mollaret H, 1971, Bull Soc Pathol Exot Filiales, V64, P713; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1186; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; RAMALINGASWAMI V, 1995, NAT MED, V1, P1237, DOI 10.1038/nm1295-1237; Rasoamanana B, 1997, CLIN DIAGN LAB IMMUN, V4, P587, DOI 10.1128/CDLI.4.5.587-591.1997; REIK LM, 1987, J IMMUNOL METHODS, V100, P123, DOI 10.1016/0022-1759(87)90180-3; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sha J, 2011, J CLIN MICROBIOL, V49, P1708, DOI 10.1128/JCM.00064-11; Shen E L, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P40; Shen E L, 1990, Zhonghua Liu Xing Bing Xue Za Zhi, V11, P156; Simond, 1898, ANN I PASTEUR, P625; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Stepanov V. M., 1997, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, V0, P44; Suomalainen M, 2007, ADV EXP MED BIOL, V603, P268; Tarantola A, 2009, EUROSURVEILLANCE, V14; Torosian SD, 2009, CAN J MICROBIOL, V55, P1125, DOI [10.1139/W09-061, 10.1139/w09-061]; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Wimsatt J, 2009, J VECTOR DIS, V46, P85; WINTER C C, 1960, Bull World Health Organ, V23, P408; Yersin A, 1994, Rev Med Suisse Romande, V114, P393	66	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54947	10.1371/journal.pone.0054947	http://dx.doi.org/10.1371/journal.pone.0054947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383008	Green Published, gold			2022-12-27	WOS:000315483200028
J	Zhong, XM; Hou, L; Luo, XN; Shi, HS; Hu, GY; He, HB; Chen, XR; Zheng, D; Zhang, YF; Tan, Y; Liu, XJ; Mu, N; Chen, JP; Ning, YP				Zhong, Xiao-Mei; Hou, Le; Luo, Xin-Ni; Shi, Hai-Shan; Hu, Guo-Yan; He, Hong-Bo; Chen, Xin-Ru; Zheng, Dong; Zhang, Yue-Feng; Tan, Yan; Liu, Xue-Jun; Mu, Nan; Chen, Jian-Ping; Ning, Yu-Ping			Alterations of CSF Cystatin C Levels and Their Correlations with CSF A beta 40 and A beta 42 Levels in Patients with Alzheimer's Disease, Dementia with Lewy Bodies and the Atrophic Form of General Paresis	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; CEREBROSPINAL-FLUID LEVELS; BETA-PROTEIN; COGNITIVE IMPAIRMENT; NEURODEGENERATION; HEMORRHAGE; RISK; POLYMORPHISM; DEPOSITION; DIAGNOSIS	Immunohistochemical studies have revealed that cystatin C (CysC) co-localizes with amyloid-beta (A beta) in amyloid-laden vascular walls and in the senile plaque cores of amyloid. In vitro and in vivo animal studies suggest that CysC protects against neurodegeneration by inhibition of cysteine proteases, inhibition of A beta aggregation, induction of autophagy and induction of cell division. CysC levels may be altered and may have a potential link with cerebrospinal fluid (CSF) A beta levels in various types of dementia with characteristic amyloid deposits, such as Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and the atrophic form of general paresis (AF-GP). We assessed the serum and CSF levels of CysC and the CSF levels of A beta 40 and A beta 42 in patients with AD (n = 51), DLB (n = 26) and AF-GP (n = 43) and normal controls (n = 30). Using these samples, we explored the correlation between CSF CysC and CSF A beta levels. We found that in comparison to the normal control group, both CSF CysC and CSF A beta 42 levels were significantly lower in all three dementia groups (all p<0.001); serum CysC levels were the same in the AD and DLB groups, and were lower in the AF-GP group (p = 0.008). The CSF CysC levels were positively correlated with both the CSF A beta 40 and A beta 42 levels in the AD, AF-GP and normal control groups (r = 0.306 similar to 0.657, all p<0.05). Lower CSF CysC levels might be a common feature in dementia with characteristic amyloid deposits. Our results provide evidence for the potential role of CysC involvement in A beta metabolism and suggest that modulation of the CysC level in the brain might produce a disease-modifying effect in dementia with characteristic amyloid deposits.	[Zhong, Xiao-Mei; Hou, Le; Luo, Xin-Ni; Shi, Hai-Shan; Chen, Xin-Ru; Zheng, Dong; Zhang, Yue-Feng; Tan, Yan; Ning, Yu-Ping] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Hu, Guo-Yan; Liu, Xue-Jun; Chen, Jian-Ping] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [He, Hong-Bo] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Mol Biol Lab, Guangzhou, Peoples R China; [Mu, Nan] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Geriatr Psychiat, Guangzhou, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Ning, YP (corresponding author), Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	ningjeny@126.com			National Natural Science Foundation of China [30970902]; Guangzhou Municipal Science and Technology Program [2010Y1-C631]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Municipal Science and Technology Program	This study was supported by the following grants: National Natural Science Foundation of China (number 30970902) and Guangzhou Municipal Science and Technology Program (number 2010Y1-C631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Blennow K., 2012, COLD SPRING HARB PER, V2; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Crawford FC, 2000, NEUROLOGY, V55, P763, DOI 10.1212/WNL.55.6.763; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; Esiri MM, 2007, J NEUROIMMUNOL, V184, P4, DOI 10.1016/j.jneuroim.2006.11.013; Fujishiro H, 2010, NEUROSCI LETT, V486, P19, DOI 10.1016/j.neulet.2010.09.036; Gauthier Sebastien, 2011, Front Biosci (Schol Ed), V3, P541, DOI 10.2741/s170; Ghanem KG, 2010, CNS NEUROSCI THER, V16, pe157, DOI 10.1111/j.1755-5949.2010.00183.x; Ghidoni R, 2010, J ALZHEIMERS DIS, V22, P985, DOI 10.3233/JAD-2010-101095; HAAN J, 1994, ACTA NEUROL SCAND, V89, P367; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Kaur G, 2010, AM J PATHOL, V177, P2256, DOI 10.2353/ajpath.2010.100461; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Maetzler W, 2010, J ALZHEIMERS DIS, V19, P937, DOI 10.3233/JAD-2010-1289; Mares J, 2009, NEUROL SCI, V30, P1, DOI 10.1007/s10072-008-0005-7; MARUYAMA K, 1990, STROKE, V21, P397, DOI 10.1161/01.STR.21.3.397; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; MIKLOSSY J, 2006, ALZHEIMERS DIS NEW A, P429; Miklossy Judith, 2008, Handb Clin Neurol, V89, P825, DOI 10.1016/S0072-9752(07)01272-9; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Nagai A, 1998, MOL CHEM NEUROPATHOL, V33, P63, DOI 10.1007/BF02815860; NITSCH RM, 1995, ANN NEUROL, V37, P512, DOI 10.1002/ana.410370414; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Pirttila TJ, 2005, NEUROBIOL DIS, V20, P241, DOI 10.1016/j.nbd.2005.03.006; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Sundelof J, 2008, NEUROLOGY, V71, P1072, DOI 10.1212/01.wnl.0000326894.40353.93; Sundelof J, 2010, J ALZHEIMERS DIS, V21, P471, DOI 10.3233/JAD-2010-091594; Tizon B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009819; Wang JH, 2011, DEMENT GERIATR COGN, V31, P284, DOI 10.1159/000326908; Yamamoto-Watanabe Y, 2010, BRAIN RES, V1361, P140, DOI 10.1016/j.brainres.2010.09.033	43	23	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55328	10.1371/journal.pone.0055328	http://dx.doi.org/10.1371/journal.pone.0055328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383156	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200006
J	Pacak, CA; Eddy, MT; Woodhull, L; Wang, KR; Alpatov, I; Fullen, S; Dowd, RP; Choi, YH; Cowan, DB				Pacak, Christina A.; Eddy, Mau-Thek; Woodhull, Lindsey; Wang, Kai-Roy; Alpatov, Ivan; Fullen, Shelby; Dowd, Rory P.; Choi, Yeong-Hoon; Cowan, Douglas B.			Microcarrier-Based Expansion of Adult Murine Side Population Stem Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; PROGENITOR CELLS; IN-VITRO; REGENERATION; DIFFERENTIATION; EXPRESSION; PHENOTYPE; CULTURE; TISSUES; EFFLUX	The lack of reliable methods to efficiently isolate and propagate stem cell populations is a significant obstacle to the advancement of cell-based therapies for human diseases. One isolation technique is based on efflux of the fluorophore Hoechst 33342. Using fluorescence-activated cell sorting (FACS), a sub-population containing adult stem cells has been identified in a multitude of tissues in every mammalian species examined. These rare cells are referred to as the 'side population' or SP due to a distinctive FACS profile that results from weak staining by Hoechst dye. Although the SP contains multi-potent cells capable of differentiating toward hematopoietic and mesenchymal lineages; there is currently no method to efficiently expand them. Here, we describe a spinner-flask culture system containing C2C12 myoblasts attached to spherical microcarriers that act to support the growth of non-adherent, post-natal murine skeletal muscle and bone marrow SP cells. Using FACS and hemocytometry, we show expansion of unfractionated EGFP(+) SP cells over 6 wks. A significant number of these cells retain characteristics of freshly-isolated, unfractionated SP cells with respect to protein expression and dye efflux capacity. Expansion of the SP will permit further study of these heterogeneous cells and determine their therapeutic potential for regenerative and reparative therapies.	[Pacak, Christina A.; Eddy, Mau-Thek; Woodhull, Lindsey; Wang, Kai-Roy; Alpatov, Ivan; Fullen, Shelby; Dowd, Rory P.; Choi, Yeong-Hoon; Cowan, Douglas B.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Pacak, Christina A.; Alpatov, Ivan; Choi, Yeong-Hoon; Cowan, Douglas B.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Cowan, DB (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA.	douglas.cowan@childrens.harvard.edu		Cowan, Douglas/0000-0002-6309-2737; Pacak, Christina/0000-0002-7430-124X	National Institutes of Health [HL088206]; American Heart Foundation [12GRNT11910008]; Children's Hospital Medical Corporation Anesthesia Foundation; Cardiac Conduction Fund; Ryan Family Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Foundation(American Heart Association); Children's Hospital Medical Corporation Anesthesia Foundation; Cardiac Conduction Fund; Ryan Family Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by a Research Grant from the National Institutes of Health (HL088206), a Grant-in-Aid from the American Heart Foundation (12GRNT11910008), the Children's Hospital Medical Corporation Anesthesia Foundation, and philanthropic donations to the Cardiac Conduction Fund, the Ryan Family Fund, and by David Pullman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Chan YM, 1998, BIOCHEM BIOPH RES CO, V248, P134, DOI 10.1006/bbrc.1998.8920; Doyle MJ, 2011, J CELL BIOL, V195, P147, DOI 10.1083/jcb.201103159; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Lapidos KA, 2004, J CLIN INVEST, V114, P1577, DOI 10.1172/JCI200423071; Liadaki K, 2005, EXP CELL RES, V303, P360, DOI 10.1016/j.yexcr.2004.10.011; Liadaki K, 2012, J HISTOCHEM CYTOCHEM, V60, P31, DOI 10.1369/0022155411428991; Luth ES, 2008, J CELL SCI, V121, P1426, DOI 10.1242/jcs.021675; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Unno K, 2012, CIRC RES, V110, P1355, DOI 10.1161/CIRCRESAHA.111.243014; VANWEZEL AL, 1967, NATURE, V216, P64, DOI 10.1038/216064a0; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	20	4	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55187	10.1371/journal.pone.0055187	http://dx.doi.org/10.1371/journal.pone.0055187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383102	gold, Green Published, Green Submitted			2022-12-27	WOS:000315211500062
J	Udine, C; Brackman, G; Bazzini, S; Buroni, S; Van Acker, H; Pasca, MR; Riccardi, G; Coenye, T				Udine, Claudia; Brackman, Gilles; Bazzini, Silvia; Buroni, Silvia; Van Acker, Heleen; Pasca, Maria Rosalia; Riccardi, Giovanna; Coenye, Tom			Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems	PLOS ONE			English	Article							CELL-CELL COMMUNICATION; XANTHOMONAS-CAMPESTRIS; BIOFILM FORMATION; IN-VITRO; VIRULENCE; ACID; SUSCEPTIBILITY	Many putative virulence factors of Burkholderia cenocepacia are controlled by various quorum sensing (QS) circuits. These QS systems either use N-acyl homoserine lactones (AHL) or cis-2-dodecenoic acid ("Burkholderia diffusible signal factor'', BDSF) as signalling molecules. Previous work suggested that there is little cross-talk between both types of systems. We constructed mutants in B. cenocepacia strain J2315, in which genes encoding CepI (BCAM1870), CciI (BCAM0239a) and the BDSF synthase (BCAM0581) were inactivated, and also constructed double (Delta cepI Delta BCAM0581, Delta cciI Delta BCAM0581 and Delta cepI Delta cciI) mutants and a triple (Delta cepI Delta cciI Delta BCAM0581) mutant. Subsequently we investigated phenotypic properties (antibiotic susceptibility, biofilm formation, production of AHL and BDSF, protease activity and virulence in Caenorhabditis elegans) and measured gene expression in these mutants, and this in the presence and absence of added BDSF, AHL or both. The triple mutant was significantly more affected in biofilm formation, antimicrobial susceptibility, virulence in C. elegans, and protease production than either the single or double mutants. The Delta BCAM0581 mutant and the Delta cepI Delta BCAM0581 and Delta cciI Delta BCAM0581 double mutants produced significantly less AHL compared to the WT strain and the Delta cepI and Delta cciI single mutant, respectively. The expression of cepI and cciI in Delta BCAM0581, was approximately 3-fold and 7-fold (p < 0.05) lower than in the WT, respectively. The observed differences in AHL production, expression of cepI and cciI and QS-controlled phenotypes in the Delta BCAM0581 mutant could (at least partially) be restored by addition of BDSF. Our data suggest that, in B. cenocepacia J2315, AHL and BDSF-based QS systems co-regulate the same set of genes, regulate different sets of genes that are involved in the same phenotypes and/or that the BDSF system controls the AHL-based QS system. As the expression of the gene encoding the C6-HSL synthase CciI (and to a lesser extent the C8-HSL synthase CepI) is partially controlled by BDSF, it seems likely that the BDSF QS systems controls AHL production through this system.	[Udine, Claudia; Bazzini, Silvia; Buroni, Silvia; Pasca, Maria Rosalia; Riccardi, Giovanna] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Brackman, Gilles; Van Acker, Heleen; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium	University of Pavia; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	tom.coenye@ugent.be	Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Pasca, Maria Rosalia/J-8752-2016; Buroni, Silvia/AAX-5454-2020	Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Pasca, Maria Rosalia/0000-0002-8906-4937; RICCARDI, Giovanna/0000-0003-3295-0070; Buroni, Silvia/0000-0002-6979-2275	Italian Cystic Fibrosis Research Foundation [FFC-2012]; FWO-Vlaanderen; Ghent University	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); FWO-Vlaanderen(FWO); Ghent University(Ghent University)	This research was supported by a grant from Italian Cystic Fibrosis Research Foundation (FFC-2012). GB, HVA and TC acknowledge the support received from FWO-Vlaanderen. TC also acknowledges the support of the Special Research Fund of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2001, APPL ENVIRON MICROB, V67, P575, DOI 10.1128/AEM.67.2.575-585.2001; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Bi HK, 2012, MOL MICROBIOL, V83, P840, DOI 10.1111/j.1365-2958.2012.07968.x; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Brackman G, 2009, RES MICROBIOL, V160, P144, DOI 10.1016/j.resmic.2008.12.003; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Brackman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016084; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Deng YY, 2009, J BACTERIOL, V191, P7270, DOI 10.1128/JB.00681-09; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2005, CHRON RESP DIS, V2; Malott RJ, 2005, INFECT IMMUN, V73, P4982, DOI 10.1128/IAI.73.8.4982-4992.2005; McCarthy Y, 2010, MOL MICROBIOL, V77, P1220, DOI 10.1111/j.1365-2958.2010.07285.x; McKeon SA, 2011, J INFECT DIS, V203, P383, DOI 10.1093/infdis/jiq054; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Ryan RP, 2009, J BACTERIOL, V191, P5013, DOI 10.1128/JB.00473-09; Schmid N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049966; Sokol PA, 2007, FUTURE MICROBIOL, V2, P555, DOI 10.2217/17460913.2.5.555; Stiernagle Theresa, 2006, WormBook, P1; Tomlin KL, 2005, APPL ENVIRON MICROB, V71, P5208, DOI 10.1128/AEM.71.9.5208-5218.2005; Venturi V, 2004, RES MICROBIOL, V155, P238, DOI 10.1016/j.resmic.2004.01.006; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x	35	30	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e55112	10.1371/journal.pone.0055112	http://dx.doi.org/10.1371/journal.pone.0055112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383071	gold, Green Published			2022-12-27	WOS:000315211500059
J	Bringhenti, I; Moraes-Teixeira, JA; Cunha, MR; Ornellas, F; Mandarim-de-Lacerda, CA; Aguila, MB				Bringhenti, Isabele; Moraes-Teixeira, Jessica Andrade; Cunha, Michelle Rabello; Ornellas, Fernanda; Mandarim-de-Lacerda, Carlos Alberto; Aguila, Marcia Barbosa			Maternal Obesity during the Preconception and Early Life Periods Alters Pancreatic Development in Early and Adult Life in Male Mouse Offspring	PLOS ONE			English	Article							HIGH-FAT DIET; BETA-CELL MASS; INDUCED INSULIN-SECRETION; METABOLIC SYNDROME; ENDOCRINE PANCREAS; DIABETES-MELLITUS; SKELETAL-MUSCLE; C57BL/6 MICE; RICH DIET; IN-UTERO	Maternal obesity induced by a high fat (HF) diet may program susceptibility in offspring, altering pancreatic development and causing later development of chronic degenerative diseases, such as obesity and diabetes. Female mice were fed standard chow (SC) or an HF diet for 8 weeks prior to mating and during the gestational and lactational periods. The male offspring were assessed at birth, at 10 days, and at 3 months of age. The body mass (BM) gain was 50% greater before pregnancy and 80% greater during pregnancy in HF dams than SC dams. Dams fed an HF diet showed higher oral glucose tolerance test (OGTT), blood pressure, serum corticosterone, and insulin levels than dams fed SC. At 10 days of age and at 3 mo old the HF offspring showed greater BM and higher blood glucose levels than the SC offspring. The mean diameter of the islets had increased by 37% in the SC offspring and by 155% in the HF offspring at 10 days of age. The islet mass ratio (IM/PM) was 88% greater in the HF offspring at 10 days of age, and 107% greater at 3 mo of age, compared to the values obtained at birth. The HF offspring had a beta cell mass (BCM)/PM ratio 54% lower than SC offspring at birth. However, HF offspring displayed a 146% increase in the BCM/PM ratio at 10 days of age, and 112% increase at 3 months of age than values at birth. A 3 mo of age, the HF offspring showed a greater OGTT and higher levels of than SC offspring. In conclusion, a maternal HF diet consumed during the preconceptional period and throughout the gestational and lactational periods in mice results in dramatic alterations in the pancreata of the offspring.	[Bringhenti, Isabele; Moraes-Teixeira, Jessica Andrade; Cunha, Michelle Rabello; Ornellas, Fernanda; Mandarim-de-Lacerda, Carlos Alberto; Aguila, Marcia Barbosa] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Mandarim-de-Lacerda, CA (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	mandarim@uerj.br	Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia Barbosa/ABF-6505-2020; Aguila, Marcia/P-2349-2019; Mandarim-de-Lacerda, Carlos A/F-7125-2012	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Aguila, Marcia Barbosa/0000-0003-3994-4589; 	Brazilian Government (CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [302154/2001-6]; State of Rio de Janeiro (FAPERJ, Fundacao do Amparo a Pesquisa do Estado do Rio de Janeiro) [E-26/110.549/2010]	Brazilian Government (CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Rio de Janeiro (FAPERJ, Fundacao do Amparo a Pesquisa do Estado do Rio de Janeiro)	This work was supported by the Brazilian Government (CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 302154/2001-6 to CAML) and the State of Rio de Janeiro (FAPERJ, Fundacao do Amparo a Pesquisa do Estado do Rio de Janeiro, grant E-26/110.549/2010 to MBA and CAML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Aguila MB, 2010, OLIVES AND OLIVE OIL IN HEALTH AND DISEASE PREVENTION, P787, DOI 10.1016/B978-0-12-374420-3.00082-6; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Barbosa-da-Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039837; Barker G, 2012, J MATERN-FETAL NEO M, V25, P2274, DOI 10.3109/14767058.2012.686540; Bernard-Kargar C, 2001, DIABETES, V50, pS30, DOI 10.2337/diabetes.50.2007.S30; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bringhenti I, 2011, J NUTR BIOCHEM, V22, P1009, DOI 10.1016/j.jnutbio.2010.08.013; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Cerf ME, 2007, PANCREAS, V34, P347, DOI 10.1097/MPA.0b013e31802ee9ae; Cerf ME, 2007, MED SCI MONITOR, V13, pRA12; Cerf ME, 2010, ADV EXP MED BIOL, V654, P77, DOI 10.1007/978-90-481-3271-3_5; Cerf ME, 2006, BRIT J NUTR, V95, P391, DOI 10.1079/BJN20051632; Cerf ME, 2005, AM J PHYSIOL-REG I, V288, pR1122, DOI 10.1152/ajpregu.00335.2004; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Frantz EDC, 2011, MECH AGEING DEV, V132, P110, DOI 10.1016/j.mad.2011.01.003; Dhawan S, 2007, CURR OPIN CELL BIOL, V19, P634, DOI 10.1016/j.ceb.2007.09.015; Dobrian AD, 2000, HYPERTENSION, V35, P1009, DOI 10.1161/01.HYP.35.4.1009; DONOVAN DS, 1993, AM J PHYSIOL, V264, pE730, DOI 10.1152/ajpendo.1993.264.5.E730; Foot VL, 2010, HORM METAB RES, V42, P923, DOI 10.1055/s-0030-1267225; Frangioudakis G, 2005, ENDOCRINOLOGY, V146, P5596, DOI 10.1210/en.2005-0481; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gregorio BM, 2013, EUR J NUTR, V52, P759, DOI 10.1007/s00394-012-0382-9; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Halseth AE, 2000, AM J PHYSIOL-ENDOC M, V279, pE1064, DOI 10.1152/ajpendo.2000.279.5.E1064; Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025; Hotchkiss AK, 2005, CONTEMP TOP LAB ANIM, V44, P46; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; KARNIK AM, 1990, BRIT J CLIN PRACT, V44, P699; KARNIK PS, 1990, J BIOL CHEM, V265, P2550; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; Leonardi O, 2003, EUR J ENDOCRINOL, V149, P99, DOI 10.1530/eje.0.1490099; Levin BE, 2000, OBES RES, V8, P342, DOI 10.1038/oby.2000.41; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Mandarim-de-Lacerda CA, 2010, METHODS MOL BIOL, V611, P211, DOI 10.1007/978-1-60327-345-9_17; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Masiello P, 2006, INT J BIOCHEM CELL B, V38, P873, DOI 10.1016/j.biocel.2005.09.007; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Nascimento FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041740; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Plagemann A, 2008, NESTLE NUTR WORKS SE, V61, P91, DOI 10.1159/0000113179; PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P91, DOI 10.1055/s-0029-1211143; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Souza-Mello V, 2011, PANCREAS, V40, P715, DOI 10.1097/MPA.0b013e3182153922; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; STOFFEL M, 1995, GENOMICS, V28, P125, DOI 10.1006/geno.1995.1120; Symonds ME, 2009, P NUTR SOC, V68, P416, DOI 10.1017/S0029665109990152; Tannenbaum BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE1168, DOI 10.1152/ajpendo.1997.273.6.E1168; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wilkes JJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE679, DOI 10.1152/ajpendo.1998.275.4.E679; Yeh J, 2005, AM J OBSTET GYNECOL, V193, P1994, DOI 10.1016/j.ajog.2005.05.001; Zhang L, 2011, DOMEST ANIM ENDOCRIN, V40, P30, DOI 10.1016/j.domaniend.2010.08.004; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	68	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55711	10.1371/journal.pone.0055711	http://dx.doi.org/10.1371/journal.pone.0055711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383269	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600149
J	Nishiura, H; Yen, HL; Cowling, BJ				Nishiura, Hiroshi; Yen, Hui-Ling; Cowling, Benjamin J.			Sample Size Considerations for One-to-One Animal Transmission Studies of the Influenza A Viruses	PLOS ONE			English	Article							PANDEMIC INFLUENZA; FERRETS; PATHOGENESIS; MODEL; TRIALS; COHORT; HA	Background: Animal transmission studies can provide important insights into host, viral and environmental factors affecting transmission of viruses including influenza A. The basic unit of analysis in typical animal transmission experiments is the presence or absence of transmission from an infectious animal to a susceptible animal. In studies comparing two groups (e.g. two host genetic variants, two virus strains, or two arrangements of animal cages), differences between groups are evaluated by comparing the proportion of pairs with successful transmission in each group. The present study aimed to discuss the significance and power to estimate transmissibility and identify differences in the transmissibility based on one-to- one trials. The analyses are illustrated on transmission studies of influenza A viruses in the ferret model. Methodology/Principal Findings: Employing the stochastic general epidemic model, the basic reproduction number, R-0, is derived from the final state of an epidemic and is related to the probability of successful transmission during each one-to-one trial. In studies to estimate transmissibility, we show that 3 pairs of infectious/susceptible animals cannot demonstrate a significantly higher transmissibility than R-0 = 1, even if infection occurs in all three pairs. In comparisons between two groups, at least 4 pairs of infectious/susceptible animals are required in each group to ensure high power to identify significant differences in transmissibility between the groups. Conclusions: These results inform the appropriate sample sizes for animal transmission experiments, while relating the observed proportion of infected pairs to R-0, an interpretable epidemiological measure of transmissibility. In addition to the hypothesis testing results, the wide confidence intervals of R-0 with small sample sizes also imply that the objective demonstration of difference or similarity should rest on firmly calculated sample size.	[Nishiura, Hiroshi; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Yen, Hui-Ling] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Japan Science & Technology Agency (JST); University of Hong Kong	Nishiura, H (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	nishiura@hku.hk	Yen, Hui-Ling/C-4501-2009; Cowling, Benjamin John/C-4263-2009; Yen, Hui-Ling/GNH-5083-2022	Yen, Hui-Ling/0000-0003-2493-3609; Cowling, Benjamin John/0000-0002-6297-7154; Nishiura, Hiroshi/0000-0003-0941-8537	Japan Science and Technology Agency (JST) PRESTO program; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Japan Science and Technology Agency (JST) PRESTO program(Japan Science & Technology Agency (JST)); Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Area of Excellence Scheme of the Hong Kong University Grants Committee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HN received funding support from the Japan Science and Technology Agency (JST) PRESTO program. This work also received financial support from the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (Grant no. U54 GM088558) and the Area of Excellence Scheme of the Hong Kong University Grants Committee (Grant no. AoE/M-12/06). The funding bodies were not involved in the collection, analysis, and interpretation of data, the writing of the paper or the decision to submit for publication.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; BARTLETT MS, 1949, J R STAT SOC B, V11, P211; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; BILLARD L, 1993, IMA J MATH APPL MED, V10, P67; De Jong MC, 1994, VACCINE, V128, P761; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Kiso M, 2010, PLOS PATHOG, V26, P6, DOI DOI 10.1371/JOURNAL.PPAT.1001079; Klick B, 2011, EPIDEMIOLOGY, V22, P793, DOI 10.1097/EDE.0b013e3182302e8e; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Krishnamoorthy K, 2007, COMMUN STAT-SIMUL C, V36, P1171, DOI 10.1080/03610910701569218; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nishiura Hiroshi, 2012, Osong Public Health Res Perspect, V3, P121, DOI 10.1016/j.phrp.2012.07.010; Nishiura H, 2012, J THEOR BIOL, V294, P48, DOI 10.1016/j.jtbi.2011.10.039; Nishiura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017908; Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Roberts KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043303; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; THOMAS RG, 1992, CONTROL CLIN TRIALS, V13, P134, DOI 10.1016/0197-2456(92)90019-V; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Doremalen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025755; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Velthuis AGJ, 2007, EPIDEMIOL INFECT, V135, P202, DOI 10.1017/S095026880600673X; Velthuis AGJ, 2002, EPIDEMIOL INFECT, V128, P193, DOI 10.1017/S0950268801006707	33	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55358	10.1371/journal.pone.0055358	http://dx.doi.org/10.1371/journal.pone.0055358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383167	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600092
J	Yu, CC; Tsai, CH; Hsu, HI; Chang, YC				Yu, Cheng-Chia; Tsai, Chung-Hung; Hsu, Hsin-I; Chang, Yu-Chao			Elevation of S100A4 Expression in Buccal Mucosal Fibroblasts by Arecoline: Involvement in the Pathogenesis of Oral Submucous Fibrosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-I; NF-KAPPA-B; UP-REGULATION; CANCER; INHIBITOR; PROTEIN; VITRO; GENE	Background: S100A4, a member of the calcium-binding proteins, is dramatically elevated in a variety of fibrotic diseases. Areca quid chewing is the most important etiological factor in the pathogenesis of oral submucous fibrosis (OSF). OSF has been considered as a pre-cancerous condition of oral mucosa. The aim of this study was to determine the critical role of S100A4 expression in the pathogenesis of OSF both in vitro and in vivo. Methodology/Principal Finding: Thirty OSF tissues from areca quid chewers and ten normal buccal mucosa samples without areca quid chewing were analyzed by using immunohistochemistry for S100A4 expression in vivo. Collagen gel contraction capability and expression of tissue inhibitor of metalloproteinases 1 (TIMP1)/MMP9 in arecoline-stimulated BMFs with S100A4 knockdown was presented in vitro. Initially, S100A4 expression was higher in areca quid chewing-associated OSF specimens than normal buccal mucosa specimens (p = 0.001). Arecoline, a major areca nut alkaloid, led to dose- and time-dependent elevation of S100A4 expression in normal buccal mucosa fibroblasts BMFs (p<0.05). The additions of pharmacological agents rapamycin (mTOR inhibitor), PD98059 (ERK inhibitor), and Bay117082 (NF-kappa B inhibitor) were found to inhibit arecoline-induced S100A4 expression (p<0.05) in BMFs. Down-regulation of S100A4 by lentiviral infection significantly reversed arecoline-induced collagen gel contraction and TIMP1/MMP9 expression. Conclusion/Significance: These results suggest that S100A4 expression is significantly up-regulated in OSF specimens. Arecoline-induced S100A4 expression was down-regulated by rapamycin, PD98059, and Bay117082. Targeting S100A4 might be a potential therapeutic target for OSF through TIMP1/MMP9 down-regulation.	[Yu, Cheng-Chia; Hsu, Hsin-I] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Yu, Cheng-Chia; Chang, Yu-Chao] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Yu, Cheng-Chia; Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Tsai, Chung-Hung] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Tsai, Chung-Hung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Chang, YC (corresponding author), Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.	cyc@csmu.edu.tw			Taiwan National Science Council Research Grant [NSC100-2314-B-040-008, NSC100-2632-B-040-001-MY3]	Taiwan National Science Council Research Grant	This work was supported by research grants from a Taiwan National Science Council Research Grant (NSC100-2314-B-040-008, NSC100-2632-B-040-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YC, 2002, ORAL ONCOL, V38, P195, DOI 10.1016/S1368-8375(01)00045-8; Chang YC, 2002, ORAL ONCOL, V38, P425, DOI 10.1016/S1368-8375(01)00083-5; Chiu CJ, 2001, J DENT RES, V80, P2055, DOI 10.1177/00220345010800120601; Chole RH, 2012, ORAL ONCOL, V48, P393, DOI 10.1016/j.oraloncology.2011.11.021; Forst B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010374; Greenway S, 2004, AM J PATHOL, V164, P253, DOI 10.1016/S0002-9440(10)63115-X; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Kuo MYP, 1995, J DENT RES, V74, P1783, DOI 10.1177/00220345950740111101; Lin SC, 2005, INT J CANCER, V116, P526, DOI 10.1002/ijc.21104; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; More CB, 2012, ORAL ONCOL, V48, P200, DOI 10.1016/j.oraloncology.2011.10.011; Moutasim KA, 2011, J PATHOL, V223, P366, DOI 10.1002/path.2786; Ni WF, 2007, ORAL ONCOL, V43, P557, DOI 10.1016/j.oraloncology.2006.06.007; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai CH, 2005, ORAL ONCOL, V41, P940, DOI 10.1016/j.oraloncology.2005.05.006; Tsai CH, 2005, J ORAL PATHOL MED, V34, P100, DOI 10.1111/j.1600-0714.2004.00288.x; Tsai CH, 2004, ORAL DIS, V10, P360, DOI 10.1111/j.1601-0825.2004.01041.x; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Tsai CH, 2007, ORAL ONCOL, V43, P680, DOI 10.1016/j.oraloncology.2006.08.009; Tulchinsky E, 1997, J BIOL CHEM, V272, P4828, DOI 10.1074/jbc.272.8.4828; Yang SF, 2003, ORAL ONCOL, V39, P367, DOI 10.1016/S1368-8375(02)00123-9; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	28	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55122	10.1371/journal.pone.0055122	http://dx.doi.org/10.1371/journal.pone.0055122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383075	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600066
J	Ali, SS; Nugent, B; Mullins, E; Doohan, FM				Ali, Shahin S.; Nugent, Brian; Mullins, Ewen; Doohan, Fiona M.			Insights from the Fungus Fusarium oxysporum Point to High Affinity Glucose Transporters as Targets for Enhancing Ethanol Production from Lignocellulose	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HXT GENES; HEXOSE TRANSPORTERS; BIOETHANOL PRODUCTION; CHEMOSTAT CULTURES; DIRECT CONVERSION; RICE STRAW; FERMENTATION; WHEAT; EXPRESSION	Ethanol is the most-widely used biofuel in the world today. Lignocellulosic plant biomass derived from agricultural residue can be converted to ethanol via microbial bioprocessing. Fungi such as Fusarium oxysporum can simultaneously saccharify straw to sugars and ferment sugars to ethanol. But there are many bottlenecks that need to be overcome to increase the efficacy of microbial production of ethanol from straw, not least enhancement of the rate of fermentation of both hexose and pentose sugars. This research tested the hypothesis that the rate of sugar uptake by F. oxysporum would enhance the ethanol yields from lignocellulosic straw and that high affinity glucose transporters can enhance ethanol yields from this substrate. We characterized a novel hexose transporter (Hxt) from this fungus. The F. oxysporum Hxt represents a novel transporter with homology to yeast glucose signaling/transporter proteins Rgt2 and Snf3, but it lacks their C-terminal domain which is necessary for glucose signalling. Its expression level decreased with increasing glucose concentration in the medium and in a glucose uptake study the Km(glucose) was 0.9 mM, which indicated that the protein is a high affinity glucose transporter. Post-translational gene silencing or over expression of the Hxt in F. oxysporum directly affected the glucose and xylose transport capacity and ethanol yielded by F. oxysporum from straw, glucose and xylose. Thus we conclude that this Hxt has the capacity to transport both C5 and C6 sugars and to enhance ethanol yields from lignocellulosic material. This study has confirmed that high affinity glucose transporters are ideal candidates for improving ethanol yields from lignocellulose because their activity and level of expression is high in low glucose concentrations, which is very common during the process of consolidated processing.	[Ali, Shahin S.; Nugent, Brian; Doohan, Fiona M.] Univ Coll Dublin, Sch Biol & Environm Sci, Mol Plant Microbe Interact Lab, Dublin 2, Ireland; [Mullins, Ewen] Teagasc Crop Res Ctr, Dept Crop Sci, Carlow, Ireland	University College Dublin; Teagasc	Ali, SS (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Mol Plant Microbe Interact Lab, Dublin 2, Ireland.	shahin.ali@ucd.ie	Ali, Shahin S./H-8474-2019; Mullins, Ewen/AAN-2907-2021	Mullins, Ewen/0000-0003-3005-4264; Doohan, Fiona/0000-0002-1953-6070	Irish Department of Agriculture, Fisheries & Food Research Stimulus Fund [RSF 07 513]	Irish Department of Agriculture, Fisheries & Food Research Stimulus Fund	This work was supported by the Irish Department of Agriculture, Fisheries & Food Research Stimulus Fund (RSF 07 513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-16; Ali SS, 2012, IDENTIFICATION UNPUB; Ansari KI, 2007, THEOR APPL GENET, V114, P927, DOI 10.1007/s00122-006-0490-0; BRANDAO RL, 1990, APPL ENVIRON MICROB, V56, P2417; Brennan JM, 2005, PLANT PATHOL, V54, P156, DOI 10.1111/j.1365-3059.2005.01157.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CHRISTAKOPOULOS P, 1991, BIORESOURCE TECHNOL, V35, P297, DOI 10.1016/0960-8524(91)90128-7; CHRISTAKOPOULOS P, 1991, ENZYME MICROB TECH, V13, P272, DOI 10.1016/0141-0229(91)90141-V; Delgado-Jarana J, 2003, EUKARYOT CELL, V2, P708, DOI 10.1128/EC.2.4.708-717.2003; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESHPANDE V, 1986, ENZYME MICROB TECH, V8, P149, DOI 10.1016/0141-0229(86)90103-1; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; DOMBEK KM, 1987, APPL ENVIRON MICROB, V53, P1286, DOI 10.1128/AEM.53.6.1286-1291.1987; Doohan FM, 1998, PHYSIOL MOL PLANT P, V53, P253, DOI 10.1006/pmpp.1998.0178; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; Goshadrou A, 2011, IND CROP PROD, V34, P1219, DOI 10.1016/j.indcrop.2011.04.018; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Hector RE, 2008, APPL MICROBIOL BIOT, V80, P675, DOI 10.1007/s00253-008-1583-2; HIRAYAMA T, 1995, MOL GEN GENET, V249, P127, DOI 10.1007/BF00290358; Jeffries T W, 1983, Adv Biochem Eng Biotechnol, V27, P1; Jorgensen TR, 2007, MICROBIOL-SGM, V153, P1963, DOI 10.1099/mic.0.2006/005090-0; Karimi K, 2006, ENZYME MICROB TECH, V40, P138, DOI 10.1016/j.enzmictec.2005.10.046; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; KO CH, 1993, MOL CELL BIOL, V13, P638, DOI 10.1128/MCB.13.1.638; Kourtoglou E, 2009, NEW BIOTECHNOL, V25, pS263, DOI 10.1016/j.nbt.2009.06.588; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEAO C, 1982, BIOTECHNOL BIOENG, V24, P2601, DOI 10.1002/bit.260241124; LEAO C, 1985, APPL MICROBIOL BIOT, V22, P359, DOI 10.1007/BF00582420; Leung H, 1995, FUNGAL GENET NEWSL, V42, P41, DOI DOI 10.4148/1941-4765.1341; Luyten K, 2002, YEAST, V19, P713, DOI 10.1002/yea.869; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Madi L, 1997, GENETICS, V146, P499; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; MISHRA C, 1984, APPL ENVIRON MICROB, V48, P224, DOI 10.1128/AEM.48.1.224-228.1984; Mizuno R, 2009, BIOSCI BIOTECH BIOCH, V73, P1671, DOI 10.1271/bbb.90099; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Okamoto K, 2011, ENZYME MICROB TECH, V48, P273, DOI 10.1016/j.enzmictec.2010.12.001; Ozcan S, 1996, MOL CELL BIOL, V16, P5536; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Pall ML, 1993, FUNGAL GENET NEWSL, V40, P59, DOI DOI 10.4148/1941-4765.1413; RAO M, 1983, ENZYME MICROB TECH, V5, P133, DOI 10.1016/0141-0229(83)90048-0; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; RIDE JP, 1972, PHYSIOL PLANT PATHOL, V2, P7, DOI 10.1016/0048-4059(72)90043-4; SALMON JM, 1993, AM J ENOL VITICULT, V44, P56; Saloheimo A, 2007, APPL MICROBIOL BIOT, V74, P1041, DOI 10.1007/s00253-006-0747-1; Schertler G. F. X., 1992, CURR OPIN STRUC BIOL, V2, P534, DOI DOI 10.1016/0959-440X(92)90083-J; Scotti CT, 2001, BIOCHEM ENG J, V7, P1, DOI 10.1016/S1369-703X(00)00090-5; SINGH A, 1991, CRIT REV BIOTECHNOL, V11, P129, DOI 10.3109/07388559109040619; SNEATH P H, 1973, P573; Snedecor GW, 1980, STAT METHODS, V7th; THEODORIS G, 1994, GENETICS, V137, P957; Van Vleet JH, 2009, CURR OPIN BIOTECH, V20, P300, DOI 10.1016/j.copbio.2009.06.001; Walter S, 2008, FUNCT INTEGR GENOMIC, V8, P421, DOI 10.1007/s10142-008-0089-4; WENDELL DL, 1993, J BACTERIOL, V175, P7689, DOI 10.1128/JB.175.23.7689-7696.1993; WENDELL DL, 1994, J BACTERIOL, V176, P3730, DOI 10.1128/JB.176.12.3730-3737.1994; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006	64	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54701	10.1371/journal.pone.0054701	http://dx.doi.org/10.1371/journal.pone.0054701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382943	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800065
J	Flynn, KE; Hahn, CL; Kramer, JM; Check, DK; Dombeck, CB; Bang, S; Perlmutter, J; Khin-Maung-Gyi, FA; Weinfurt, KP				Flynn, Kathryn E.; Hahn, Cynthia L.; Kramer, Judith M.; Check, Devon K.; Dombeck, Carrie B.; Bang, Soo; Perlmutter, Jane; Khin-Maung-Gyi, Felix A.; Weinfurt, Kevin P.			Using Central IRBs for Multicenter Clinical Trials in the United States	PLOS ONE			English	Article								Research institutions differ in their willingness to defer to a single, central institutional review board (IRB) for multicenter clinical trials, despite statements from the FDA, OHRP, and NIH in support of using central IRBs to improve the efficiency of conducting trials. The Clinical Trials Transformation Initiative (CTTI) supported this project to solicit current perceptions of barriers to the use of central IRBs and to formulate potential solutions. We held discussions with IRB experts, interviewed representatives of research institutions, and held an expert meeting with diverse stakeholder groups and thought leaders. We found that many perceived barriers relate to conflating responsibilities of the institution with the ethical review responsibilities of the IRB. We identified the need for concrete tools to help research institutions separate institutional responsibilities from ethical responsibilities required of the IRB. One such tool is a document we created that delineates these responsibilities and how they might be assigned to each entity, or, in some cases, both entities. This tool and project recommendations will be broadly disseminated to facilitate the use of central IRBs in multicenter trials. The ultimate goal is to increase the nation's capacity to efficiently conduct the large number of high-quality trials.	[Flynn, Kathryn E.; Kramer, Judith M.; Check, Devon K.; Dombeck, Carrie B.; Weinfurt, Kevin P.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27710 USA; [Flynn, Kathryn E.; Weinfurt, Kevin P.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Hahn, Cynthia L.] North Shore Long Isl Hlth Syst, Feinstein Inst Med Res, Off Res Compliance, Manhasset, NY USA; [Kramer, Judith M.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Bang, Soo] Celgene Corp, Summit, NJ USA; [Perlmutter, Jane] Gemini Grp, Ann Arbor, MI USA; [Khin-Maung-Gyi, Felix A.] Chesapeake IRB, Columbia, MD USA	Duke University; Duke University; Northwell Health; Duke University; Bristol-Myers Squibb; Celgene Corporation	Weinfurt, KP (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27710 USA.	kevin.weinfurt@duke.edu	Flynn, Kathryn E/M-5346-2013	Flynn, Kathryn E/0000-0002-4427-3583	US Food and Drug Administration [U19FD003800]; CTTI; FOOD AND DRUG ADMINISTRATION [U19FD003800] Funding Source: NIH RePORTER	US Food and Drug Administration; CTTI; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Financial support for this project was provided by grant U19FD003800 from the US Food and Drug Administration (awarded to Duke University for the Clinical Trials Transformation Initiative [CTTI]) and pooled membership fees from CTTI's member organizations. In addition, members of CTTI contributed in-kind effort in support of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Department of Health and Human Services, 2011, FED REG, V76, P44512; Emanuel EJ, 2004, ANN INTERN MED, V141, P282, DOI 10.7326/0003-4819-141-4-200408170-00008; Jansen Lynn A, 2005, IRB, V27, P7, DOI 10.2307/3563955; Menikoff J., 2010, OHRP CORRES; Menikoff J, 2010, NEW ENGL J MED, V363, P1591, DOI 10.1056/NEJMp1005101; National Institute of Neurological Disorders and Stroke, NEURONEXT NETW EXC N; US Food and Drug Administration, 2006, GUID IND US CENTR IR; Wagner TH, 2010, J CLIN ONCOL, V28, P662, DOI 10.1200/JCO.2009.23.2470	8	37	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54999	10.1371/journal.pone.0054999	http://dx.doi.org/10.1371/journal.pone.0054999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383026	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800096
J	Melchiorre, MG; Chiatti, C; Lamura, G; Torres-Gonzales, F; Stankunas, M; Lindert, J; Ioannidi-Kapolou, E; Barros, H; Macassa, G; Soares, JFJ				Melchiorre, Maria Gabriella; Chiatti, Carlos; Lamura, Giovanni; Torres-Gonzales, Francisco; Stankunas, Mindaugas; Lindert, Jutta; Ioannidi-Kapolou, Elisabeth; Barros, Henrique; Macassa, Gloria; Soares, Joaquim F. J.			Social Support, Socio-Economic Status, Health and Abuse among Older People in Seven European Countries	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; ELDER MISTREATMENT; RISK-FACTORS; NETWORKS; FAMILY; DEPRESSION; DIFFERENCE; MORTALITY; SERVICES	Background: Social support has a strong impact on individuals, not least on older individuals with health problems. A lack of support network and poor family or social relations may be crucial in later life, and represent risk factors for elder abuse. This study focused on the associations between social support, demographics/socio-economics, health variables and elder mistreatment. Methods: The cross-sectional data was collected by means of interviews or interviews/self-response during January-July 2009, among a sample of 4,467 not demented individuals aged 60-84 years living in seven European countries (Germany, Greece, Italy, Lithuania, Portugal, Spain, and Sweden). Results: Multivariate analyses showed that women and persons living in large households and with a spouse/partner or other persons were more likely to experience high levels of social support. Moreover, frequent use of health care services and low scores on depression or discomfort due to physical complaints were indicators of high social support. Low levels of social support were related to older age and abuse, particularly psychological abuse. Conclusions: High levels of social support may represent a protective factor in reducing both the vulnerability of older people and risk of elder mistreatment. On the basis of these results, policy makers, clinicians and researchers could act by developing intervention programmes that facilitate friendships and social activities in old age.	[Melchiorre, Maria Gabriella; Lamura, Giovanni] INRCA Ancona, Italian Natl Inst Hlth & Sci Aging, Ctr Socioecon Res Ageing, Ancona, Italy; [Chiatti, Carlos] INRCA Ancona, Italian Natl Inst Hlth & Sci Aging, Sci Direct, Ancona, Italy; [Torres-Gonzales, Francisco] Univ Granada, Ctr Invest Biomed Red Salud Mental CIBERSAM, Granada, Spain; [Stankunas, Mindaugas] Griffith Univ, Sch Publ Hlth, Gold Coast, Qld, Australia; [Stankunas, Mindaugas] Lithuanian Univ Hlth Sci, Dept Hlth Management, Kaunas, Lithuania; [Lindert, Jutta] Protestant Univ Appl Sci, Dept Publ Hlth Sci, Ludwigsburg, Germany; [Ioannidi-Kapolou, Elisabeth] Natl Sch Publ Hlth, Dept Sociol, Athens, Greece; [Barros, Henrique] Univ Porto, Sch Med, Dept Hyg & Epidemiol, P-4100 Oporto, Portugal; [Macassa, Gloria; Soares, Joaquim F. J.] Mid Sweden Univ, Inst Hlth Sci, Dept Publ Hlth Sci, Sundsvall, Sweden; [Macassa, Gloria] Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden	IRCCS INRCA; IRCCS INRCA; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; Griffith University; Lithuanian University of Health Sciences; National & Kapodistrian University of Athens; Universidade do Porto; Mid-Sweden University; Karolinska Institutet	Melchiorre, MG (corresponding author), INRCA Ancona, Italian Natl Inst Hlth & Sci Aging, Ctr Socioecon Res Ageing, Ancona, Italy.	g.melchiorre@inrca.it	Melchiorre, Maria Gabriella/K-4625-2016; Stankunas, Mindaugas/B-1770-2019; Barros, Henrique/A-5488-2008; Barros, Henrique/Q-8609-2019; Chiatti, Carlos/J-4115-2012	Melchiorre, Maria Gabriella/0000-0002-4428-3749; Barros, Henrique/0000-0003-4699-6571; Chiatti, Carlos/0000-0003-4810-9630; Fernandes Soares, Joaquim Jorge/0000-0001-5221-9504	European Commission, through the Executive Agency for Health and Consumers (EAHC) [2007123]	European Commission, through the Executive Agency for Health and Consumers (EAHC)	This research was funded by grant support from the European Commission, through the Executive Agency for Health and Consumers (EAHC), (Public Health Programme 2008-2010), Grant Agreement n. 2007123, which made possible the realisation of the ABUEL Project, "Elder Abuse: A multinational prevalence survey". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Andrew MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002232; Antonovsky A., 1979, HLTH STRESS COPING N; Antonucci T. C., 1996, ENCY GERONTOLOGY, P505; ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685; Beehr T. A., 2001, RES OCCUPATIONAL STR, P97, DOI DOI 10.1016/S1479-3555; Berkman CS, 1998, J AGING HEALTH, V10, P81, DOI 10.1177/089826439801000105; Bierman A, 2010, J GERONTOL B-PSYCHOL, V65, P631, DOI 10.1093/geronb/gbp128; Borgonovi F, 2010, SOC SCI MED, V71, P1927, DOI 10.1016/j.socscimed.2010.09.018; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brahler E, 1995, GIESSENER BESCHWERDE, V2; Cantor M.H., 1979, RES AGING, V1, P434, DOI [10.1177/016402757914002, DOI 10.1177/016402757914002]; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; COULTON C, 1982, J HEALTH SOC BEHAV, V23, P330, DOI 10.2307/2136491; Dalgard OS, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-20; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; DALGARD OS, 1995, BRIT J PSYCHIAT, V166, P29, DOI 10.1192/bjp.166.1.29; de Belvis AG, 2008, PUBLIC HEALTH, V122, P784, DOI 10.1016/j.puhe.2007.08.018; Dong XQ, 2008, GERONTOLOGY, V54, P381, DOI 10.1159/000143228; Dong XQ, 2010, ARCH GERONTOL GERIAT, V50, P202, DOI 10.1016/j.archger.2009.03.011; Dong XQ, 2009, J WOMEN AGING; Edelbrock D, 2003, AUSTRALAS J AGEING, V22, P2, DOI 10.1111/j.1741-6612.2003.tb00455.x; EnglandKennedy ES, 2011, SOC SCI MED, V73, P1222, DOI 10.1016/j.socscimed.2011.07.006; Eurostat, 2012, TOT POP HAV COMPL LE; Fernandez-Ballesteros R, 2002, J SOC ISSUES, V58, P645, DOI 10.1111/1540-4560.00282; Flori KL, 2006, J GERONTOL B-PSYCHOL, V61, pP25, DOI 10.1093/geronb/61.1.P25; Folkhalsorapport, 2007, STOCKH COUNT COUNC S; Gadalla TM, 2010, J GERONTOL SOC WORK, V53, P512, DOI 10.1080/01634372.2010.490691; Gallie D., 2000, EUROPEAN WELFARE REG; George L.K., 1989, AGING STRESS SOCIAL, P241; Giordano GN, 2011, SOC SCI MED, V72, P1219, DOI 10.1016/j.socscimed.2011.02.029; Hall A., 1985, SOCIAL SUPPORT HLTH, P23; Hays JC, 2001, AM J PSYCHIAT, V158, P1850, DOI 10.1176/appi.ajp.158.11.1850; Heffner KL, 2011, SOC SCI MED, V72, P1482, DOI 10.1016/j.socscimed.2011.03.016; Heylen L, 2010, AGEING SOC, V30, P1177, DOI 10.1017/S0144686X10000292; Jacobzone S., 1999, OECD LABOUR MARKET S, V37, DOI [10.1787/18151981, DOI 10.1787/18151981]; Kinsella K, 1992, INT POPULATION REPOR; Krause N., 2001, HDB AGING SOCIAL SCI, P272; Kumar S, 2012, SOC SCI MED, V74, P696, DOI 10.1016/j.socscimed.2011.11.017; LACHS MS, 1994, J AM GERIATR SOC, V42, P169, DOI 10.1111/j.1532-5415.1994.tb04947.x; Leung KK, 2007, ARCH GERONTOL GERIAT, V44, P203, DOI 10.1016/j.archger.2006.05.001; Lindert J, 2012, EUR J PUBLIC HEALTH, V22, P662, DOI 10.1093/eurpub/ckr079; Litwin H, 2000, J AGING STUD, V14, P213, DOI 10.1016/S0890-4065(00)80012-2; Litwin H, 2010, J GERONTOL B-PSYCHOL, V65, P599, DOI 10.1093/geronb/gbp104; Lopes A., 2006, THESIS LONDON SCH EC; Lowenstein A, 2007, J GERONTOL B-PSYCHOL, V62, pS100, DOI 10.1093/geronb/62.2.S100; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Maulik PK, 2009, PSYCHIAT SERV, V60, P1222, DOI 10.1176/ps.2009.60.9.1222; Mowlam A., 2007, UK STUDY ABUSE NEGLE; Muramatsu N, 2010, SOC SCI MED, V70, P1050, DOI 10.1016/j.socscimed.2009.12.005; Okabayashi H, 2004, SOC SCI MED, V59, P2259, DOI 10.1016/j.socscimed.2004.02.024; Pierce GR, 1990, PERS RELATIONSHIP, P173; ROSS CE, 1989, J HEALTH SOC BEHAV, V30, P206, DOI 10.2307/2137014; Rundall T G, 1992, Med Care Rev, V49, P3, DOI 10.1177/002570879204900102; Ryser L, 2011, J WOMEN AGING, V23, P185, DOI 10.1080/08952841.2011.587734; Seeman TE, 2000, AM J HEALTH PROMOT, V14, P362, DOI 10.4278/0890-1171-14.6.362; Soares JJ, 2010, ABUSE HLTH ELDERLY E; Spitze G, 2000, RES AGING, V22, P451, DOI 10.1177/0164027500225001; Stansfeld SA, 1998, SOC PSYCH PSYCH EPID, V33, P1; Stepukonis F, 2009, GERONTOLOGIJA, V10, P199; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Stroebe W, 2000, SOCIAL PSYCHOL HLTH, P236; Stuckelberger, 1988, DANISH MED B J HLTH, V6, P2; Thanakwang K, 2011, J AGING HEALTH, V23, P1352, DOI 10.1177/0898264311418503; THOITS PA, 1995, J HEALTH SOC BEHAV, V35, P53, DOI 10.2307/2626957; Turagabeci AR, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-61; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Van Dussen DJ, 2009, J WOMEN AGING, V21, P251, DOI 10.1080/08952840903284560; Weyers S, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-13; Wu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033857; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	72	126	133	6	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54856	10.1371/journal.pone.0054856	http://dx.doi.org/10.1371/journal.pone.0054856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23382989	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800083
J	Pradel, N; Ji, BY; Gimenez, G; Talla, E; Lenoble, P; Garel, M; Tamburini, C; Fourquet, P; Lebrun, R; Bertin, P; Denis, Y; Pophillat, M; Barbe, V; Ollivier, B; Dolla, A				Pradel, Nathalie; Ji, Boyang; Gimenez, Gregory; Talla, Emmanuel; Lenoble, Patricia; Garel, Marc; Tamburini, Christian; Fourquet, Patrick; Lebrun, Regine; Bertin, Philippe; Denis, Yann; Pophillat, Matthieu; Barbe, Valerie; Ollivier, Bernard; Dolla, Alain			The First Genomic and Proteomic Characterization of a Deep-Sea Sulfate Reducer: Insights into the Piezophilic Lifestyle of Desulfovibrio piezophilus	PLOS ONE			English	Article							SP-NOV.; HYDROTHERMAL VENT; ESCHERICHIA-COLI; LOW-TEMPERATURE; HIGH-PRESSURE; BACTERIUM; SEQUENCE; ADAPTATION; PROTEIN; GROWTH	Desulfovibrio piezophilus strain C1TLV30(T) is a piezophilic anaerobe that was isolated from wood falls in the Mediterranean deep-sea. D. piezophilus represents a unique model for studying the adaptation of sulfate-reducing bacteria to hydrostatic pressure. Here, we report the 3.6 Mbp genome sequence of this piezophilic bacterium. An analysis of the genome revealed the presence of seven genomic islands as well as gene clusters that are most likely linked to life at a high hydrostatic pressure. Comparative genomics and differential proteomics identified the transport of solutes and amino acids as well as amino acid metabolism as major cellular processes for the adaptation of this bacterium to hydrostatic pressure. In addition, the proteome profiles showed that the abundance of key enzymes that are involved in sulfate reduction was dependent on hydrostatic pressure. A comparative analysis of orthologs from the non-piezophilic marine bacterium D. salexigens and D. piezophilus identified aspartic acid, glutamic acid, lysine, asparagine, serine and tyrosine as the amino acids preferentially replaced by arginine, histidine, alanine and threonine in the piezophilic strain. This work reveals the adaptation strategies developed by a sulfate reducer to a deep-sea lifestyle.	[Pradel, Nathalie; Garel, Marc; Tamburini, Christian; Ollivier, Bernard] Aix Marseille Univ, Univ Sud Toulon Var, CNRS INSU, IRD,MIO,UM110, Marseille, France; [Ji, Boyang; Talla, Emmanuel; Dolla, Alain] Aix Marseille Univ, CNRS, LCB, UMR 7283, Marseille, France; [Gimenez, Gregory] Fac Med Marseille, UMR 6236, F-13385 Marseille, France; [Lenoble, Patricia; Barbe, Valerie] Inst Genom Genoscope, CEA, Lab Finit, Evry, France; [Fourquet, Patrick; Pophillat, Matthieu] CIML, Marseille, France; [Lebrun, Regine; Denis, Yann] IBiSA Marseille Prote IMM CNRS, Plate Formes Prote & Transcriptom FR3479, Marseille, France; [Bertin, Philippe] Univ Louis Pasteur, CNRS, UMR 7156, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pradel, N (corresponding author), Aix Marseille Univ, Univ Sud Toulon Var, CNRS INSU, IRD,MIO,UM110, Marseille, France.	nathalie.pradel@ird.fr; dolla@imm.cnrs.fr	Tamburini, Christian/I-7821-2012; Ollivier, Bernard/I-6150-2016; Tamburini, Christian/AAO-8577-2020	Tamburini, Christian/0000-0003-3752-7423; Tamburini, Christian/0000-0003-3752-7423; Philippe, Bertin/0000-0003-1158-6396; Garel, Marc/0000-0002-4374-5905; Ji, Boyang/0000-0002-7269-4342; TALLA, Emmanuel/0000-0002-7775-8296	Institut de Recherche pour le Developpement; National Centre for Scientific Research	Institut de Recherche pour le Developpement; National Centre for Scientific Research	The work was supported by Institut de Recherche pour le Developpement and National Centre for Scientific Research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2007, BIOSCI BIOTECH BIOCH, V71, P2347, DOI 10.1271/bbb.70015; Alain K, 2010, INT J SYST EVOL MICR, V60, P33, DOI 10.1099/ijs.0.009449-0; Alazard D, 2003, INT J SYST EVOL MICR, V53, P173, DOI 10.1099/ijs.0.02323-0; Audiffrin C, 2003, INT J SYST EVOL MICR, V53, P1585, DOI 10.1099/ijs.0.02551-0; Bakermans C, 2009, EXTREMOPHILES, V13, P21, DOI 10.1007/s00792-008-0193-3; Bale SJ, 1997, INT J SYST BACTERIOL, V47, P515, DOI 10.1099/00207713-47-2-515; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Basak S, 2004, J BIOMOL STRUCT DYN, V22, P205, DOI 10.1080/07391102.2004.10506996; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Chikuma S, 2007, FEMS MICROBIOL LETT, V267, P108, DOI 10.1111/j.1574-6968.2006.00555.x; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Di Giulio M, 2005, GENE, V346, P7, DOI 10.1016/j.gene.2004.07.045; Di Giulio M, 2005, GENE, V346, P1, DOI 10.1016/j.gene.2004.10.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Hajj ZW, 2010, ANN NY ACAD SCI, V1189, P143, DOI 10.1111/j.1749-6632.2009.05178.x; El-Hajj ZW, 2009, J BACTERIOL, V191, P6383, DOI 10.1128/JB.00576-09; ELSGAARD L, 1995, OCEANOL ACTA, V18, P95; Fagervold SK, 2012, FEMS MICROB IN PRESS; Fauque G., 2004, MICROBIAL DIVERSITY, P169, DOI [10.1128/9781555817770.ch17, DOI 10.1128/9781555817770.CH17]; Fernandes PMB, 2004, FEBS LETT, V556, P153, DOI 10.1016/S0014-5793(03)01396-6; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hu YF, 2010, MAR BIOTECHNOL, V12, P719, DOI 10.1007/s10126-010-9259-1; Jeanthon C, 2002, INT J SYST EVOL MICR, V52, P765, DOI [10.1099/ijs.0.02025-0, 10.1099/00207713-52-3-765]; Jomaa A, 2009, J BACTERIOL, V191, P1924, DOI 10.1128/JB.01187-08; JORGENSEN BB, 1982, PHILOS T R SOC B, V298, P543, DOI 10.1098/rstb.1982.0096; Jun X, 2011, J BACTERIOL, V193, P4297, DOI 10.1128/JB.05345-11; Kallmeyer J, 2004, APPL ENVIRON MICROB, V70, P1231, DOI 10.1128/AEM.70.2.1231-1233.2004; Kaneko R, 2007, MAR BIOTECHNOL, V9, P429, DOI 10.1007/s10126-007-9003-7; Keller KL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00135; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Martin DD, 2002, EXTREMOPHILES, V6, P507, DOI 10.1007/s00792-002-0288-1; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004192; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Oger PM, 2010, RES MICROBIOL, V161, P799, DOI 10.1016/j.resmic.2010.09.017; Rhodes ME, 2010, ENVIRON MICROBIOL, V12, P2613, DOI 10.1111/j.1462-2920.2010.02232.x; Simonato F, 2006, J BIOTECHNOL, V126, P11, DOI 10.1016/j.jbiotec.2006.03.038; Skorko-Glonek J, 2008, MICROBIOL-SGM, V154, P3649, DOI 10.1099/mic.0.2008/020487-0; Stokke R, 2012, ENVIRON MICROBIOL, V14, P1333, DOI 10.1111/j.1462-2920.2012.02716.x; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Vossmeyer A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00253; Wilquet V, 1999, RES MICROBIOL, V150, P21, DOI 10.1016/S0923-2508(99)80043-6; YAYANOS AA, 1995, ANNU REV MICROBIOL, V49, P777, DOI 10.1146/annurev.mi.49.100195.004021	47	20	20	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55130	10.1371/journal.pone.0055130	http://dx.doi.org/10.1371/journal.pone.0055130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383081	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800116
J	Zhu, LJ; Mi, YY; You, XM; Wu, S; Shao, HB; Dai, F; Peng, T; Qin, F; Feng, NH				Zhu, Lijie; Mi, Yuanyuan; You, Xiaoming; Wu, Sheng; Shao, Hongbao; Dai, Feng; Peng, Tao; Qin, Feng; Feng, Ninghan			A Meta-Analysis of the Effects of the 5-Hydroxytryptamine Transporter Gene-Linked Promoter Region Polymorphism on Susceptibility to Lifelong Premature Ejaculation	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; DOUBLE-BLIND; INTERNATIONAL-SOCIETY; DELAYED EJACULATION; ANTIDEPRESSANTS; DYSFUNCTION; DEPRESSION; PAROXETINE; PHARMACOGENETICS; ASSOCIATION	Objective: Premature ejaculation (PE) has been reported as the most common male sexual dysfunction with global prevalence rates estimated at approximately 30%. The neurobiogenesis of ejaculation is very complex and involves the serotoninergic (5-hydroxytryptamine, 5-HT) system. Recently, genetic polymorphisms located on SLC6A4 gene codifying for 5-HT transporter (5-HTT), the major regulator of serotonic neurotransmission, have been linked with the pathogenesis and risk of PE. Apparently studies of this type of polymorphism in PE have show conflicting results. Methods: A meta-analysis was performed that are available in relation with 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism and the risk of lifelong PE (LPE) in men to clarify this relationship. We searched Pubmed and Embase (last search updated on Aug 2012) using 'premature ejaculation', 'polymorphism or variant', 'genotype', 'ejaculatory function', and 'rapid ejaculation' as keywords and reference lists of studies corresponded to the inclusion criteria for meta-analysis. These studies involved the total number of 481 LPE men and 466 health control men subjects. Odds ratio (OR) and 95% confidence intervals (CIs) were used to evaluate this relationship. Results: In the overall analysis, significant associations between LPE risk and 5-HTTLPR polymorphism were found (L-allele vs. S-allele OR = 0.86, 95% CI = 0.79-0.95, P = 0.002; LL vs. SS: OR = 0.80, 95% CI = 0.68-0.95, P = 0.009; LS vs. SS: OR = 0.85, 95% CI = 0.76-0.97, P = 0.012 and LL+LS vs. SS: OR = 0.88, 95% CI = 0.81-0.95, P = 0.002). Moreover, in subgroup analysis based on ethnicity, similar significant associations were detected. The Egger's test did not reveal presence of a publication bias. Conclusions: Our investigations demonstrate that 5-HTTLPR (L>S) polymorphism might protect men against LPE risk. Further studies based on larger sample size and gene-environment interactions should be conducted the role of 5-HTTLPR polymorphism and LPE risk.	[Zhu, Lijie; Mi, Yuanyuan; You, Xiaoming; Wu, Sheng; Shao, Hongbao; Dai, Feng; Peng, Tao; Qin, Feng] Nantong Univ, Affiliated Hosp 3, Dept Urol, Wuxi, Jiangsu, Peoples R China; [Feng, Ninghan] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nantong University; Nanjing Medical University	Mi, YY (corresponding author), Nantong Univ, Affiliated Hosp 3, Dept Urol, Wuxi, Jiangsu, Peoples R China.	loveisislove@sina.com	Feng, ninghan/ABB-3726-2021; Feng, Ninghan/ABA-8996-2021		National Nature Science Foundation of China [81272831]; Nature Science Foundation of Jiangsu Province [BK2010577]; Jiangsu Province's Outstanding Medical Academic Leader program [RC201178]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Medical Academic Leader program	This study was supported by the National Nature Science Foundation of China (Grant No.81272831), Nature Science Foundation of Jiangsu Province (NO.BK2010577) and Jiangsu Province's Outstanding Medical Academic Leader program (RC201178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althof SE, 2010, J SEX MED, V7, P2947, DOI 10.1111/j.1743-6109.2010.01975.x; Andrews PW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00117; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Corona G, 2008, J SEX MED, V5, P1991, DOI 10.1111/j.1743-6109.2008.00803.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; GODPODINOFF ML, 1989, J SEX MARITAL THER, V15, P130; Griffiths AJF, 2002, MODERNGENETIC ANAL I; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Heils A, 1996, J NEUROCHEM, V66, P2621; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Janssen PKC, 2009, J SEX MED, V6, P276, DOI 10.1111/j.1743-6109.2008.01033.x; Jern P, 2009, INT J IMPOT RES, V21, P62, DOI 10.1038/ijir.2008.61; Jern P, 2007, J SEX MED, V4, P1739, DOI 10.1111/j.1743-6109.2007.00599.x; Jern P, 2013, ARCH SEX BEHAV, V42, P45, DOI 10.1007/s10508-012-9991-x; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Luo Shun-wen, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P514; MANTEL N, 1959, J NATL CANCER I, V22, P719; McMahon CG, 2008, J SEX MED, V5, P1590, DOI 10.1111/j.1743-6109.2008.00901.x; Murphy GM, 2003, AM J PSYCHIAT, V160, P1830, DOI 10.1176/appi.ajp.160.10.1830; Ozbek E, 2009, ASIAN J ANDROL, V11, P351, DOI 10.1038/aja.2008.3; Patel K, 2009, CURR OPIN INVEST DR, V10, P681; Popp J, 2006, PHARMACOGENOMICS, V7, P159, DOI 10.2217/14622416.7.2.159; Rosen RC, 2008, J SEX MED, V5, P1296, DOI 10.1111/j.1743-6109.2008.00825.x; Rowland D, 2010, J SEX MED, V7, P1668, DOI 10.1111/j.1743-6109.2010.01782.x; Safarinejad MR, 2007, J CLIN PSYCHOPHARM, V27, P444, DOI 10.1097/jcp.0b013e31814b98d4; Safarinejad MR, 2006, CLIN NEUROPHARMACOL, V29, P243, DOI 10.1097/01.WNF.0000228210.12194.46; Safarinejad MR, 2009, J UROLOGY, V181, P2656, DOI 10.1016/j.juro.2009.01.105; Safarinejad MR, 2006, INT J IMPOT RES, V18, P164, DOI 10.1038/sj.ijir.3901384; Smith GS, 2004, NEUROPSYCHOPHARMACOL, V29, P2226, DOI 10.1038/sj.npp.1300552; Smits KM, 2004, MOL PSYCHIATR, V9, P433, DOI 10.1038/sj.mp.4001488; Waldinger MD, 2011, KOREAN J UROL, V52, P1, DOI 10.4111/kju.2011.52.1.1; Waldinger MD, 2009, J UROLOGY, V182, P2983, DOI 10.1016/j.juro.2009.08.069; Waldinger MD, 2009, ASIAN J ANDROL, V11, P524, DOI 10.1038/aja.2009.32; Waldinger MD, 1998, J CLIN PSYCHOPHARM, V18, P274, DOI 10.1097/00004714-199808000-00004; Waldinger MD, 2002, J UROLOGY, V168, P2359, DOI 10.1016/S0022-5347(05)64146-8; Waldinger MD, 1998, BEHAV BRAIN RES, V92, P111, DOI 10.1016/S0166-4328(97)00183-6; WALDINGER MD, 1994, AM J PSYCHIAT, V151, P1377; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zuccarello D, 2012, J SEX MED, V9, P1659, DOI 10.1111/j.1743-6109.2012.02715.x	44	19	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54994	10.1371/journal.pone.0054994	http://dx.doi.org/10.1371/journal.pone.0054994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383022	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800092
J	Choudhry, Z; Sengupta, SM; Grizenko, N; Harvey, WJ; Fortier, ME; Schmitz, N; Joober, R				Choudhry, Zia; Sengupta, Sarojini M.; Grizenko, Natalie; Harvey, William J.; Fortier, Marie-Eve; Schmitz, Norbert; Joober, Ridha			Body Weight and ADHD: Examining the Role of Self-Regulation	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SOCIOECONOMIC-STATUS; MASS INDEX; CHILDHOOD OBESITY; BULIMIA-NERVOSA; ANTHROPOMETRIC CHANGES; EATING-DISORDERS; BRAIN DOPAMINE; CHILDREN	Objective: Attention-Deficit/Hyperactivity Disorder (ADHD) is a complex and heterogeneous childhood disorder that often coexists with other psychiatric and somatic disorders. Recently, a link between ADHD and body weight dysregulation has been reported and often interpreted as impaired self-regulation that is shared between the two conditions. The objective of this study is to investigate the relation between body weight/BMI and cognitive, emotional and motor characteristics in children with ADHD. Methods: 284 ADHD children were stratified by weight status/BMI according to WHO classification and compared with regard to their neurocognitive characteristics, motivational style, and motor profile as assessed by a comprehensive battery of tests. All comparisons were adjusted for demographic characteristics of relevance including, socioeconomic status (SES). Results: Both Obese and overweight ADHD children exhibited significantly lower SES compared to normal weight ADHD children. No significant differences were observed between the three groups with regards to their neurocognitive, emotional and motor profile. Conclusions: Our findings provide evidence that differences in weight/BMI are not accounted for by cognitive, motivational and motor profiles. Socio-economic characteristics are strongly associated with overweight and obesity in ADHD children and may inform strategies aimed at promoting healthier weight.	[Choudhry, Zia; Fortier, Marie-Eve; Joober, Ridha] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sengupta, Sarojini M.; Grizenko, Natalie; Schmitz, Norbert; Joober, Ridha] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Harvey, William J.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Choudhry, Zia; Sengupta, Sarojini M.; Grizenko, Natalie; Harvey, William J.; Fortier, Marie-Eve; Schmitz, Norbert; Joober, Ridha] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Joober, R (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	ridha.joober@douglas.mcgill.ca	Schmitz, Norbert/AAH-3624-2020; Schmitz, Norbert/A-5177-2010	Schmitz, Norbert/0000-0001-7777-6323	Fonds de la recherche en sante du Quebec; Canadian Institutes of Health Research; AstraZeneca	Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca(AstraZeneca)	This work was supported in part by a grant from the Fonds de la recherche en sante du Quebec and the Canadian Institutes of Health Research to RJ and NG. And, no additional external funding was received for this study. Further, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Ridha Joober sits on the advisory boards and speakers' bureaus of Pfizer Canada and Janssen Ortho Canada; he has received grant funding from them and from AstraZeneca. He has received honoraria from Janssen Ortho Canada for CME presentations and royalties for Henry Stewart talks. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agranat-Meged AN, 2005, INT J EAT DISORDER, V37, P357, DOI 10.1002/eat.20096; Barkley R. A, 2014, ATTENTION DEFICIT HY; Barkley Russell A, 2010, J Clin Psychiatry, V71, pe17, DOI 10.4088/JCP.9066tx1c; Bhattacharya A, 2012, LEARN MEMORY, V19, P434, DOI 10.1101/lm.025007.111; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Calkins S.D., 2007, SOCIOEMOTIONAL DEV T, P261, DOI DOI 10.1002/(SICI)1098-2302(199709)31:2%3C125:AID-DEV5%3E3.0.CO;2-M; Calkins SD, 2002, DEV PSYCHOPATHOL, V14, P477, DOI 10.1017/S095457940200305X; Chen AY, 2010, OBESITY, V18, P210, DOI 10.1038/oby.2009.185; COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P281; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Cortese S, 2008, MED HYPOTHESES, V70, P12, DOI 10.1016/j.mehy.2007.04.036; Cortese S, 2007, J PSYCHOSOM RES, V63, P587, DOI 10.1016/j.jpsychores.2007.08.005; Cortese Samuele, 2012, Curr Top Behav Neurosci, V9, P199, DOI 10.1007/7854_2011_154; Cserjesi R, 2007, APPETITE, V49, P675, DOI 10.1016/j.appet.2007.04.001; Curtin Carol, 2005, BMC Pediatr, V5, P48, DOI 10.1186/1471-2431-5-48; Curtin C, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-11; Davis Caroline, 2006, Eat Behav, V7, P266, DOI 10.1016/j.eatbeh.2005.09.006; Dunton GF, 2009, MED SCI SPORT EXER, V41, P1698, DOI 10.1249/MSS.0b013e3181a06c9b; Ebenegger V, 2012, J CHILD NEUROL, V27, P852, DOI 10.1177/0883073811428009; Escaron AL, 2009, AM J PUBLIC HEALTH, V99, P1159, DOI 10.2105/AJPH.2009.159954; Fischer M, 1998, J LEARN DISABIL, V31, P608, DOI 10.1177/002221949803100611; Francis LA, 2009, ARCH PEDIAT ADOL MED, V163, P297, DOI 10.1001/archpediatrics.2008.579; Geary DC, 1999, J EXP CHILD PSYCHOL, V74, P213, DOI 10.1006/jecp.1999.2515; Graziano PA, 2011, INT J OBESITY; Grizenko N, 2006, J PSYCHIATR NEUROSCI, V31, P46; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742; Gupta R, 2009, PROG BRAIN RES, V176, P259, DOI 10.1016/S0079-6123(09)17614-8; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hjern A, 2010, ACTA PAEDIATR, V99, P920, DOI 10.1111/j.1651-2227.2009.01638.x; Holtkamp K, 2004, INT J OBESITY, V28, P685, DOI 10.1038/sj.ijo.0802623; Huang DY, 2012, J ADOLESCENCE; Huang XF, 2005, MOL BRAIN RES, V135, P150, DOI 10.1016/j.molbrainres.2004.12.013; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Karama S, 2009, J ATTEN DISORD, V12, P442, DOI 10.1177/1087054708314605; Katz DL, 2010, PREV CHRONIC DIS, V7; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Khalifa N, 2010, NORD J PSYCHIAT, V64, P11, DOI 10.3109/08039480903248096; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Lasky-Su J, 2007, BEHAV GENET, V37, P487, DOI 10.1007/s10519-006-9136-x; Li SX, 2012, AM J EPIDEMIOL, V176, pS142, DOI 10.1093/aje/kws236; Lieb DC, 2009, CLIN SPORT MED, V28, P349, DOI 10.1016/j.csm.2009.02.004; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Mana S, 2010, EUR PSYCHIAT, V25, P345, DOI 10.1016/j.eurpsy.2010.04.010; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Oliver LN, 2005, CAN J PUBLIC HEALTH, V96, P415, DOI 10.1007/BF03405180; Olsson GM, 2010, EAT WEIGHT DISORD-ST, V15, pE68; Oreskovic NM, 2009, ACAD PEDIATR, V9, P315, DOI 10.1016/j.acap.2009.02.009; Orsi CM, 2011, CURR OPIN ENDOCRINOL, V18, P14, DOI 10.1097/MED.0b013e3283423de1; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Poulton A, 2003, J PAEDIATR CHILD H, V39, P180, DOI 10.1046/j.1440-1754.2003.00107.x; Ptacek R, 2009, MED SCI MONITOR, V15, pCR595; Ptacek R, 2009, NEUROENDOCRINOL LETT, V30, P377; Rader R, 2009, AM FAM PHYSICIAN, V79, P657; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Reichenberg Abraham, 2005, Dialogues Clin Neurosci, V7, P31; Rosval L, 2006, INT J EAT DISORDER, V39, P590, DOI 10.1002/eat.20296; Sanchez-Vaznaugh EV, 2008, SOC SCI MED, V67, P1300, DOI 10.1016/j.socscimed.2008.06.015; Sanchez-Vaznaugh EV, 2009, AM J EPIDEMIOL, V169, P1102, DOI 10.1093/aje/kwp027; Schertz M, 1996, PEDIATRICS, V98, P763; Schweickert LA, 1997, INT J EAT DISORDER, V21, P299, DOI 10.1002/(SICI)1098-108X(199704)21:3<299::AID-EAT11>3.0.CO;2-W; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Singh GK, 2010, HEALTH AFFAIR, V29, P503, DOI 10.1377/hlthaff.2009.0730; Snyder EE, 2004, OBES RES, V12, P369, DOI 10.1038/oby.2004.47; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sokol MS, 1999, INT J EAT DISORDER, V25, P233, DOI 10.1002/(SICI)1098-108X(199903)25:2<233::AID-EAT14>3.0.CO;2-2; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P399, DOI 10.1111/j.1469-7610.1992.tb00875.x; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Surman CBH, 2006, J CLIN PSYCHIAT, V67, P351, DOI 10.4088/JCP.v67n0303; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Thakur GA, 2013, NICOTINE TOB RES, V15, P149, DOI 10.1093/ntr/nts102; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van den Heuvel E, 2007, ACTA PAEDIATR, V96, P454, DOI 10.1111/j.1651-2227.2006.00145.x; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Volkow ND, 2008, AM J PSYCHIAT, V165, P553, DOI 10.1176/appi.ajp.2008.08020237; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Waring ME, 2008, PEDIATRICS, V122, pE1, DOI 10.1542/peds.2007-1955; Welsh MC, 1988, ASSESSING FRONTAL LO, P199; Weschler D., 1992, WESCHLER INTELLIGENC; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006	94	24	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55351	10.1371/journal.pone.0055351	http://dx.doi.org/10.1371/journal.pone.0055351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	097OK	23383165	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200012
J	Robinson, CP; Schwarz, EM; Sternberg, PW				Robinson, Carmie Puckett; Schwarz, Erich M.; Sternberg, Paul W.			Identification of DVA Interneuron Regulatory Sequences in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; NERVOUS-SYSTEM; TRANSCRIPTION FACTORS; GENE-EXPRESSION; DNA-SEQUENCE; NEURON; DIFFERENTIATION; CELL; SPECIFICATION; CONSERVATION	Background: The identity of each neuron is determined by the expression of a distinct group of genes comprising its terminal gene battery. The regulatory sequences that control the expression of such terminal gene batteries in individual neurons is largely unknown. The existence of a complete genome sequence for C. elegans and draft genomes of other nematodes let us use comparative genomics to identify regulatory sequences directing expression in the DVA interneuron. Methodology/Principal Findings: Using phylogenetic comparisons of multiple Caenorhabditis species, we identified conserved non-coding sequences in 3 of 10 genes (fax-1, nmr-1, and twk-16) that direct expression of reporter transgenes in DVA and other neurons. The conserved region and flanking sequences in an 85-bp intronic region of the twk-16 gene directs highly restricted expression in DVA. Mutagenesis of this 85 bp region shows that it has at least four regions. The central 53 bp region contains a 29 bp region that represses expression and a 24 bp region that drives broad neuronal expression. Two short flanking regions restrict expression of the twk-16 gene to DVA. A shared GA-rich motif was identified in three of these genes but had opposite effects on expression when mutated in the nmr-1 and twk-16 DVA regulatory elements. Conclusions/Significance: We identified by multi-species conservation regulatory regions within three genes that direct expression in the DVA neuron. We identified four contiguous regions of sequence of the twk-16 gene enhancer with positive and negative effects on expression, which combined to restrict expression to the DVA neuron. For this neuron a single binding site may thus not achieve sufficient specificity for cell specific expression. One of the positive elements, an 8-bp sequence required for expression was identified in silico by sequence comparisons of seven nematode species, demonstrating the potential resolution of expanded multi-species phylogenetic comparisons.	[Robinson, Carmie Puckett; Schwarz, Erich M.; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Robinson, Carmie Puckett; Schwarz, Erich M.; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Robinson, Carmie Puckett] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Robinson, Carmie Puckett] Univ So Calif, Keck Sch Med, VA Greater Angeles Healthcare Syst, Los Angeles, CA 90033 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Southern California; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Sternberg, PW (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	pws@caltech.edu		Schwarz, Erich/0000-0003-3151-4381	Howard Hughes Medical Insitute; National Institutes of Health [GM084389]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084389] Funding Source: NIH RePORTER	Howard Hughes Medical Insitute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Howard Hughes Medical Insitute, with which PWS is an investigator; National Institutes of Health GM084389 (to PWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Bai XD, 2007, J PARASITOL, V93, P1343, DOI 10.1645/GE-1246.1; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830; BRENNER S, 1974, GENETICS, V77, P71; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; Cameron RA, 2005, P NATL ACAD SCI USA, V102, P11769, DOI 10.1073/pnas.0505291102; Ciche T., 2007, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.135.1, DOI 10.1895/WORMBOOK.1.135.1]; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Fire A, 2006, GENETICS, V173, P1259, DOI 10.1534/genetics.106.057364; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Haerty W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-399; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hobert O, 2005, SPECIFICATION NERVOU, DOI [10.1895/wormbook.1.12.2, DOI 10.1895/WORMBOOK.1.12.2]; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Hwang BJ, 2004, DEVELOPMENT, V131, P143, DOI 10.1242/dev.00924; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; Kiontke Karin, 2005, P1; Kirchhamer CV, 1996, P NATL ACAD SCI USA, V93, P9322, DOI 10.1073/pnas.93.18.9322; Korf I., 2003, BLAST; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Kuntz SG, 2008, GENOME RES, V18, P1955, DOI 10.1101/gr.085472.108; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; MADURO M, 1995, GENETICS, V141, P977; Morgan T. H., 1934, EMBRYOLOGY GENETICS; Mortazavi A, 2010, GENOME RES, V20, P1740, DOI 10.1101/gr.111021.110; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nokes EB, 2009, DEV DYNAM, V238, P3080, DOI 10.1002/dvdy.22147; Prakash A, 2005, NAT BIOTECHNOL, V23, P1249, DOI 10.1038/nbt1140; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Ruvinsky I, 2007, DEV BIOL, V302, P617, DOI 10.1016/j.ydbio.2006.09.014; Salkoff L, 2001, NEUROSCIENCE, V103, P853, DOI 10.1016/S0306-4522(01)00079-3; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Van Buskirk C, 2010, DEVELOPMENT, V137, P2065, DOI 10.1242/dev.040881; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 1996, J NEUROSCI, V16, P4017; Wightman B, 2005, DEV BIOL, V287, P74, DOI 10.1016/j.ydbio.2005.08.032	48	7	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54971	10.1371/journal.pone.0054971	http://dx.doi.org/10.1371/journal.pone.0054971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23383017	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315211500042
J	Kaur, S; Chakraborty, S; Baine, MJ; Mallya, K; Smith, LM; Sasson, A; Brand, R; Guha, S; Jain, M; Wittel, U; Singh, SK; Batra, SK				Kaur, Sukhwinder; Chakraborty, Subhankar; Baine, Michael J.; Mallya, Kavita; Smith, Lynette M.; Sasson, Aaron; Brand, Randall; Guha, Sushovan; Jain, Maneesh; Wittel, Uwe; Singh, Shailender K.; Batra, Surinder K.			Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; MACROPHAGE INHIBITORY CYTOKINE-1; MARKER; INFLAMMATION; ANTIGEN; CA-19-9; CA19-9	Pancreatic cancer (PC) is lethal malignancy with very high mortality rate. Absence of sensitive and specific marker(s) is one of the major factors for poor prognosis of PC patients. In pilot studies using small set of patients, secreted acute phase proteins neutrophil gelatinase associated lipocalin (NGAL) and TGF-beta family member macrophage inhibitory cytokine-1 (MIC-1) are proposed as most potential biomarkers specifically elevated in the blood of PC patients. However, their performance as diagnostic markers for PC, particularly in pre-treatment patients, remains unknown. In order to evaluate the diagnostic efficacy of NGAL and MIC-1, their levels were measured in plasma samples from patients with pre-treatment PC patients (n = 91) and compared it with those in healthy control (HC) individuals (n = 24) and patients with chronic pancreatitis (CP, n = 23). The diagnostic performance of these two proteins was further compared with that of CA19-9, a tumor marker commonly used to follow PC progression. The levels of all three biomarkers were significantly higher in PC compared to HCs. The mean (+/- standard deviation, SD) plasma NGAL, CA19-9 and MIC-1 levels in PC patients was 111.1 ng/mL (2.2), 219.2 U/mL (7.8) and 4.5 ng/mL (4.1), respectively. In comparing resectable PC to healthy patients, all three biomarkers were found to have comparable sensitivities (between 64%-81%) but CA19-9 and NGAL had a higher specificity (92% and 88%, respectively). For distinguishing resectable PC from CP patients, CA19-9 and MIC-1 were most specific (74% and 78% respectively). CA19-9 at an optimal cut-off of 54.1 U/ml is highly specific in differentiating resectable (stage 1/2) pancreatic cancer patients from controls in comparison to its clinical cut-off (37.1 U/ml). Notably, the addition of MIC-1 to CA19-9 significantly improved the ability to distinguish resectable PC cases from CP (p = 0.029). Overall, MIC-1 in combination with CA19-9 improved the diagnostic accuracy of differentiating PC from CP and HCs.	[Kaur, Sukhwinder; Chakraborty, Subhankar; Mallya, Kavita; Jain, Maneesh; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Baine, Michael J.; Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Smith, Lynette M.] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Sasson, Aaron] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA; [Singh, Shailender K.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA; [Brand, Randall] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Guha, Sushovan] UT MD Anderson Canc Ctr, Dept Gastroenterol, Houston, TX USA; [Guha, Sushovan] UT MD Anderson Canc Ctr, Dept Hepatol, Houston, TX USA; [Guha, Sushovan] UT MD Anderson Canc Ctr, Dept Nutr, Houston, TX USA; [Wittel, Uwe] Univ Klin Freiburg, Dept Gen & Visceral Surg, Freiburg, Germany	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Freiburg	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	sbatra@unmc.edu			National Institutes of Health [RO1 CA78590, UO1 CA111294, RO1 CA131944, RO1 CA133774, RO1 CA 138791, P50 CA127297]; MDACC McNair Foundation Scholar Award; Cyrus Scholar Award; NATIONAL CANCER INSTITUTE [P50CA127297, U01CA111294, R01CA138791, R01CA133774, R01CA131944, R01CA078590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDACC McNair Foundation Scholar Award; Cyrus Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SKB, SC, SK, KM, MJB, MJ and ARS are supported, in part, by grants from the National Institutes of Health (RO1 CA78590, UO1 CA111294, RO1 CA131944, RO1 CA133774, RO1 CA 138791 and P50 CA127297). SG is supported by grants from MDACC McNair Foundation Scholar Award and the Cyrus Scholar Award. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bedi MMS, 2009, INDIAN J GASTROENTER, V28, P24, DOI 10.1007/s12664-009-0005-4; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Buxbaum JL, 2010, J PANCREAS, V11, P536; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Chakraborty S, 2011, BBA-REV CANCER, V1815, P44, DOI 10.1016/j.bbcan.2010.09.002; Cho H, 2009, J HISTOCHEM CYTOCHEM, V57, P513, DOI 10.1369/jhc.2009.953257; DELVILLANO BC, 1983, CLIN CHEM, V29, P549; Duffy MJ, 1998, ANN CLIN BIOCHEM, V35, P364, DOI 10.1177/000456329803500304; El-Mesallamy HO, 2012, PANCREAS IN PRESS; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Hustinx SR, 2004, CANCER BIOL THER, V3, P1254, DOI 10.4161/cbt.3.12.1238; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Misek David E, 2007, J Natl Compr Canc Netw, V5, P1034; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Morris-Stiff G, 2009, HEPATOB PANCREAT DIS, V8, P620; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Ozkan H, 2011, PANCREATOLOGY, V11, P295, DOI 10.1159/000328963; Shnaper S, 2009, INT J CANCER, V125, P2624, DOI 10.1002/ijc.24639; Skipworth RJE, 2010, BRIT J CANCER, V102, P665, DOI 10.1038/sj.bjc.6605532; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Torigan DA, 2007, CA-CANCER J CLIN, V57, P206, DOI 10.3322/canjclin.57.4.206; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614	25	37	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55171	10.1371/journal.pone.0055171	http://dx.doi.org/10.1371/journal.pone.0055171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383312	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000314597900019
J	Tuul, M; Kitao, H; Iimori, M; Matsuoka, K; Kiyonari, S; Saeki, H; Oki, E; Morita, M; Maehara, Y				Tuul, Munkhbold; Kitao, Hiroyuki; Iimori, Makoto; Matsuoka, Kazuaki; Kiyonari, Shinichi; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko			Rad9, Rad17, TopBP1 and Claspin Play Essential Roles in Heat-Induced Activation of ATR Kinase and Heat Tolerance	PLOS ONE			English	Article							XENOPUS EGG EXTRACTS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; FANCONI-ANEMIA; HISTONE H2AX; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; CELLULAR-RESPONSE; GENOME INTEGRITY; S-PHASE	Hyperthermia is widely used to treat patients with cancer, especially in combination with other treatments such as radiation therapy. Heat treatment per se activates DNA damage responses mediated by the ATR-Chk1 and ATM-Chk2 pathways but it is not fully understood how these DNA damage responses are activated and affect heat tolerance. By performing a genetic analysis of human HeLa cells and chicken B lymphoma DT40 cells, we found that heat-induced Chk1 Ser345 phosphorylation by ATR was largely dependent on Rad9, Rad17, TopBP1 and Claspin. Activation of the ATR-Chk1 pathway by heat, however, was not associated with FancD2 monoubiquitination or RPA32 phosphorylation, which are known as downstream events of ATR kinase activation when replication forks are stalled. Downregulation of ATR, Rad9, Rad17, TopBP1 or Claspin drastically reduced clonogenic cell viability upon hyperthermia, while gene knockout or inhibition of ATM kinase reduced clonogenic viability only modestly. Suppression of the ATR-Chk1 pathway activation enhanced heat-induced phosphorylation of Chk2 Thr68 and simultaneous inhibition of ATR and ATM kinases rendered severe heat cytotoxicity. These data indicate that essential factors for activation of the ATR-Chk1 pathway at stalled replication forks are also required for heat-induced activation of ATR kinase, which predominantly contributes to heat tolerance in a non-overlapping manner with ATM kinase.	[Tuul, Munkhbold; Kitao, Hiroyuki; Iimori, Makoto] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka, Japan; [Tuul, Munkhbold; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan; [Kitao, Hiroyuki; Matsuoka, Kazuaki; Kiyonari, Shinichi; Maehara, Yoshihiko] Kyushu Univ, Innovat Anticanc Strategy Therapeut & Diag Grp, Innovat Ctr Med Redox Nav, Fukuoka, Japan; [Matsuoka, Kazuaki] Taiho Pharmaceut Co Ltd, Tokushima Res Ctr, Tokushima, Japan	Kyushu University; Kyushu University; Kyushu University; Taiho Pharmaceutical	Kitao, H (corresponding author), Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka, Japan.	hkitao@surg2.med.kyushu-u.ac.jp	Kiyonari, Shinichi/I-7329-2014	Iimori, Makoto/0000-0003-1697-0178	Ministry of Education, Culture, Sports, Science and Technology of Japan; Science and Technology Incubation Program in Advanced Regions; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Incubation Program in Advanced Regions; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (HK, HS, MM and YM). This work was also supported by the Science and Technology Incubation Program in Advanced Regions from the funding program 'Creation of Innovation Centers for Advanced Interdisciplinary Research Areas' from the Japan Science and Technology Agency, commissioned by the Ministry of Education, Culture, Sports, Science and Technology (YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAI H, 1988, CANCER LETT, V40, P33, DOI 10.1016/0304-3835(88)90259-5; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Fujinaka Y, 2012, DNA REPAIR, V11, P247, DOI 10.1016/j.dnarep.2011.11.005; Furusawa Y, 2012, APOPTOSIS, V17, P102, DOI 10.1007/s10495-011-0660-7; Horsman MR, 2007, CLIN ONCOL-UK, V19, P418, DOI 10.1016/j.clon.2007.03.015; Hunt CR, 2007, CANCER RES, V67, P3010, DOI 10.1158/0008-5472.CAN-06-4328; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kampinga HH, 2001, INT J RADIAT BIOL, V77, P399, DOI 10.1080/09553000010024687; Kaneko H, 2005, BIOCHEM BIOPH RES CO, V328, P1101, DOI 10.1016/j.bbrc.2005.01.073; Kim JE, 2005, MOL CELL BIOL, V25, P10907, DOI 10.1128/MCB.25.24.10907-10915.2005; Kim SM, 2005, J BIOL CHEM, V280, P38355, DOI 10.1074/jbc.M508673200; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Kobayashi M, 2004, GENES CELLS, V9, P291, DOI 10.1111/j.1356-9597.2004.00728.x; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Laszlo A, 2009, CANCER RES, V69, P2042, DOI 10.1158/0008-5472.CAN-08-1639; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; Medhurst AL, 2008, J CELL SCI, V121, P3933, DOI 10.1242/jcs.033688; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morita M, 2001, INT J RADIAT ONCOL, V49, P1259, DOI 10.1016/S0360-3016(00)01465-6; Ohno S, 1997, DIS COLON RECTUM, V40, P401, DOI 10.1007/BF02258383; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shigechi T, 2012, CANCER RES, V72, P1149, DOI 10.1158/0008-5472.CAN-11-2904; Sleeth KM, 2007, J MOL BIOL, V373, P38, DOI 10.1016/j.jmb.2007.07.068; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; Takao N, 1999, ONCOGENE, V18, P7002, DOI 10.1038/sj.onc.1203172; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang YZ, 2001, J BIOL CHEM, V276, P20579, DOI 10.1074/jbc.M100874200; WARTERS RL, 1982, CANCER RES, V42, P4427; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yan S, 2009, CELL CYCLE, V8, P2877, DOI 10.4161/cc.8.18.9485; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	38	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55361	10.1371/journal.pone.0055361	http://dx.doi.org/10.1371/journal.pone.0055361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383325	Green Published, gold, Green Submitted			2022-12-27	WOS:000314597900032
J	Aleksic, E; Merker, M; Cox, H; Reiher, B; Sekawi, Z; Hearps, AC; Ryan, CE; Lee, AV; Goursaud, R; Malau, C; O'Connor, J; Cherry, CL; Niemann, S; Crowe, SM				Aleksic, Eman; Merker, Matthias; Cox, Helen; Reiher, Bereka; Sekawi, Zamberi; Hearps, Anna C.; Ryan, Claire E.; Lee, Adele V.; Goursaud, Regis; Malau, Clement; O'Connor, Janet; Cherry, Catherine L.; Niemann, Stefan; Crowe, Suzanne M.			First Molecular Epidemiology Study of Mycobacterium tuberculosis in Kiribati	PLOS ONE			English	Article							STRAINS; IDENTIFICATION; LINEAGE; SPREAD	Tuberculosis incidence rates in Kiribati are among the highest in the Western Pacific Region, however the genetic diversity of circulating Mycobacterium tuberculosis complex strains (MTBC) and transmission dynamics are unknown. Here, we analysed MTBC strains isolated from culture positive pulmonary tuberculosis (TB) cases from the main TB referral centre between November 2007 and October 2009. Strain genotyping (IS6110 typing, spoligotyping, 24-loci MIRU-VNTR and SNP typing) was performed and demographic information collected. Among 73 MTBC strains analysed, we identified seven phylogenetic lineages, dominated by Beijing strains (49%). Beijing strains were further differentiated in two main branches, Beijing-A (n = 8) and -B (n = 28), that show distinct genotyping patterns and are characterized by specific deletion profiles (Beijing A: only RD105, RD207 deleted; Beijing B: RD150 and RD181 additionally deleted). Many Kiribati strains (59% based on IS6110 typing of all strains) occurred in clusters, suggesting ongoing local transmission. Beijing-B strains and over-crowded living conditions were associated with strain clustering (likely recent transmission), however little evidence of antituberculous drug resistance was observed. We suggest enhanced case finding amongst close contacts and continued supervised treatment of all identified cases using standard first-line drugs to reduce TB burden in Kiribati. Beijing strains can be subdivided in different principle branches that might be associated with differential spreading patterns in the population.	[Aleksic, Eman; Cox, Helen; Hearps, Anna C.; Ryan, Claire E.; Lee, Adele V.; Malau, Clement; Cherry, Catherine L.; Crowe, Suzanne M.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Merker, Matthias; Niemann, Stefan] Forschungszentrum, Natl Reference Ctr Mycobacteria, Borstel, Germany; [Cox, Helen; Crowe, Suzanne M.] Monash Univ, Dept Med, Clayton, Vic 3800, Australia; [Reiher, Bereka] Tungaru Cent Hosp, TB Clin, Tarawa, Kiribati; [Sekawi, Zamberi] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Goursaud, Regis] Inst Pasteur, Dept Microbiol, Noumea, New Caledonia; [Malau, Clement] Univ Melbourne, Nossal Inst Hlth, Melbourne, Vic 3010, Australia; [O'Connor, Janet] Secretariat Pacific Community, Noumea, New Caledonia; [Cherry, Catherine L.; Crowe, Suzanne M.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia	Burnet Institute; Monash University; Universiti Putra Malaysia; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Aleksic, E (corresponding author), Burnet Inst, Ctr Virol, Melbourne, Vic, Australia.	eman@burnet.edu.au	Sekawi, Zamberi/I-1755-2013; Nightingale, Claire Elizabeth/K-1667-2019; Merker, Matthias/P-7399-2015; Niemann, Stefan/C-9327-2011	Sekawi, Zamberi/0000-0002-5387-9640; Nightingale, Claire Elizabeth/0000-0002-4103-6240; Merker, Matthias/0000-0003-1386-2331; Cherry, Catherine Louise/0000-0001-9816-5193; Niemann, Stefan/0000-0002-6604-0684; Cox, Helen/0000-0002-6538-7192	Secretariat of the Pacific Community, Noumea, New Caledonia; National Health and Medical Research Council's Principal Research Fellowship Award	Secretariat of the Pacific Community, Noumea, New Caledonia; National Health and Medical Research Council's Principal Research Fellowship Award	This work was supported by the Secretariat of the Pacific Community, Noumea, New Caledonia; www.spc.int. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. Professor Suzanne Crowe AM is a recipient of a National Health and Medical Research Council's Principal Research Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Government K, 2010, KIRIBATI POPULATION; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Homolka S, 2009, J CLIN MICROBIOL, V47, P223, DOI 10.1128/JCM.01237-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Massey P. D., 2011, Journal of Rural and Tropical Public Health, V10, P44; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; O'Connor J, 2005, ADDRESSING TB EPIDEM; Region WP, 2011, TUBERCULOSIS CONTROL; Region WP, 2011, REGIONAL STRATEGY TO; Roetzer A, 2011, J CLIN MICROBIOL, V49, P4173, DOI 10.1128/JCM.05293-11; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; TACQUET A, 1961, ANN I PASTEUR PARIS, V100, P676; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; van Deutekom H, 2005, J CLIN MICROBIOL, V43, P4473, DOI 10.1128/JCM.43.9.4473-4479.2005; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Viney K, 2011, ASIA-PAC J PUBLIC HE, V23, P86, DOI 10.1177/1010539510390671; Viney Kerri, 2010, Pac Health Dialog, V16, P157; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	27	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55423	10.1371/journal.pone.0055423	http://dx.doi.org/10.1371/journal.pone.0055423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383187	Green Published, gold, Green Submitted			2022-12-27	WOS:000314610600102
J	Berryhill, ME; Wiener, M; Stephens, JA; Lohoff, FW; Coslett, HB				Berryhill, Marian E.; Wiener, Martin; Stephens, Jaclyn A.; Lohoff, Falk W.; Coslett, H. Branch			COMT and ANKK1-Taq-Ia Genetic Polymorphisms Influence Visual Working Memory	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; D2 RECEPTOR GENE; TRAUMATIC BRAIN-INJURY; RIGHT PARIETAL LOBE; VAL(158)MET POLYMORPHISM; PREFRONTAL CORTEX; BASAL GANGLIA; HEALTHY-VOLUNTEERS; EXECUTIVE FUNCTION; MESSENGER-RNA	Complex cognitive tasks such as visual working memory (WM) involve networks of interacting brain regions. Several neurotransmitters, including an appropriate dopamine concentration, are important for WM performance. A number of gene polymorphisms are associated with individual differences in cognitive task performance. COMT, for example, encodes catechol-o-methyl transferase the enzyme primarily responsible for catabolizing dopamine in the prefrontal cortex. Striatal dopamine function, linked with cognitive tasks as well as habit learning, is influenced by the Taq-Ia polymorphism of the DRD2/ANKK1 gene complex; this gene influences the density of dopamine receptors in the striatum. Here, we investigated the effects of these polymorphisms on a WM task requiring the maintenance of 4 or 6 items over delay durations of 1 or 5 seconds. We explored main effects and interactions between the COMT and DRD2/ANKK1-Taq-Ia polymorphisms on WM performance. Participants were genotyped for COMT (Val(158) Met) and DRD2/ANKK1-Taq-Ia (A1+, A1-) polymorphisms. There was a significant main effect of both polymorphisms. Participants' WM reaction times slowed with increased Val loading such that the Val/Val homozygotes made the slowest responses and the Met/Met homozygotes were the fastest. Similarly, WM reaction times were slower and more variable for the DRD2/ANKK1-Taq-Ia A1+ group than the A1- group. The main effect of COMT was only apparent in the DRD2/ANKK1-Taq-Ia A1- group. These findings link WM performance with slower dopaminergic metabolism in the prefrontal cortex as well as a greater density of dopamine receptors in the striatum.	[Berryhill, Marian E.; Stephens, Jaclyn A.] Univ Nevada, Dept Psychol, Memory & Brain Lab, Reno, NV 89557 USA; [Wiener, Martin; Coslett, H. Branch] Univ Penn, Dept Neurol, Perelman Sch Med, Lab Cognit & Neural Stimulat, Philadelphia, PA 19104 USA; [Lohoff, Falk W.] Univ Penn, Dept Psychiat, Perelman Sch Med, Translat Res Lab,Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Berryhill, ME (corresponding author), Univ Nevada, Dept Psychol, Memory & Brain Lab, Reno, NV 89557 USA.	mberryhill@unr.edu	Lohoff, Falk W/M-7951-2016	Berryhill, Marian/0000-0002-8218-6587	University of Nevada; COBRE [1P20GM103650-01, R15EY022775]; NATIONAL EYE INSTITUTE [R15EY022775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103650] Funding Source: NIH RePORTER	University of Nevada; COBRE; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by faculty start-up funds generously provided by the University of Nevada to MB and by COBRE 1P20GM103650-01 (PI M. Webster, project PI MB) and R15EY022775 to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Allen RJ, 2012, Q J EXP PSYCHOL, V65, P2369, DOI 10.1080/17470218.2012.687384; Anderson DE, 2012, J COGNITIVE NEUROSCI, V24, P1069, DOI 10.1162/jocn_a_00207; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1775, DOI 10.1016/j.neuropsychologia.2008.03.005; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1767, DOI 10.1016/j.neuropsychologia.2008.01.009; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Boscarino JA, 2012, NEUROPSYCH DIS TREAT, V8, P131, DOI 10.2147/NDT.S29508; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; CAMPS M, 1989, NEUROSCIENCE, V28, P275, DOI 10.1016/0306-4522(89)90179-6; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Cools R, 2008, J NEUROSCI, V28, P1208, DOI 10.1523/JNEUROSCI.4475-07.2008; Cools R, 2011, CURR OPIN NEUROBIOL, V21, P402, DOI 10.1016/j.conb.2011.04.002; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; Diamond A, 2007, CEREB CORTEX, V17, pI161, DOI [10.1093/cercor/bhm082, 10.1093/cercor/blini082]; Diaz-Asper CM, 2008, BIOL PSYCHIAT, V63, P72, DOI 10.1016/j.biopsych.2007.03.031; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Gruber AJ, 2006, J COMPUT NEUROSCI, V20, P153, DOI 10.1007/s10827-005-5705-x; Hazy TE, 2006, NEUROSCIENCE, V139, P105, DOI 10.1016/j.neuroscience.2005.04.067; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Ho T, 2012, J NEUROSCI, V32, P7992, DOI 10.1523/JNEUROSCI.0340-12.2012; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Nagel IE, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.001.2008; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble E P, 2000, Pharmacogenomics, V1, P309, DOI 10.1517/14622416.1.3.309; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Schellekens AF, 2012, ADDICTION BIOL; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Stefanis NC, 2005, AM J PSYCHIAT, V162, P1752, DOI 10.1176/appi.ajp.162.9.1752; Stelzel C, 2009, EUR J NEUROSCI, V29, P1056, DOI 10.1111/j.1460-9568.2009.06647.x; Stormer VS, 2012, DEV PSYCHOL, V48, P875, DOI 10.1037/a0026198; Tammimaki AE, 2010, PHARMACOGENET GENOM, V20, P717, DOI 10.1097/FPC.0b013e328340bdf2; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2012, CNS NEUROLOGICAL DIS; Wiener M, 2011, J COGNITIVE NEUROSCI, V23, P2811, DOI 10.1162/jocn.2011.21626; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Wishart HA, 2011, J INT NEUROPSYCH SOC, V17, P174, DOI 10.1017/S1355617710001402	62	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55862	10.1371/journal.pone.0055862	http://dx.doi.org/10.1371/journal.pone.0055862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383291	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600166
J	Pierro, VSD; Ferreira, DD; de Jesus, HE; Rosado, AS; Luiz, RR; dos Santos, KRN; Maia, LC				da Silva Pierro, Viviane Santos; Ferreira, Dennis de Carvalho; de Jesus, Hugo Emiliano; Rosado, Alexandre Soares; Luiz, Ronir Raggio; Netto dos Santos, Katia Regina; Maia, Lucianne Cople			Topical Effect of a Medically Prescribed Pediatric Antibiotic on Dental Biofilm: A Cross-Over, In Situ Study	PLOS ONE			English	Article							ENAMEL DEMINERALIZATION; CYSTIC-FIBROSIS; ANTIMICROBIAL SUSCEPTIBILITY; ADMINISTERED ANTIBIOTICS; MUTANS STREPTOCOCCI; SUCROSE EXPOSURE; CHILDREN; CARIES; HEALTH; PLAQUE	Objective: This study aimed to investigate the possible topical effect of a broad-spectrum antibiotic on dental biofilm formed in situ in the absence or presence of sucrose. Methods: A crossover study was conducted in three phases of 14 days each, during which 11 volunteers wore palatal devices containing 6 enamel blocks covered with meshes to allow biofilm formation. Dental blocks were extraorally submitted to a 20% sucrose solution at three different frequencies of exposure (0, 3 and 8 times/day), and to a suspension of amoxicillin/clavulanate potassium (A/CP) or a placebo (P) suspension at an 8-hour time interval application regimen. On the 14th day of each phase, biofilms were collected for microbiological (conventional culture) and molecular (Denaturing Gradient Gel Electrophoresis - DGGE) analyses. Results: In the absence of sucrose exposure (SE) and at the 3-time daily frequency, dental biofilms treated with A/CP showed lower total biofilm weight and lower counts of total microbiota than the ones treated with P (p > 0.05). A/CP presented higher counts of Candida spp. when compared with P in the presence of SE, especially at the 8-time daily frequency (p < 0.05). Considering the DGGE analysis, the mean number of bands was higher for P (p > 0.05), regardless of SE. However, DGGE profiles demonstrated large interindividual variability. Conclusion: Both conventional culture and DGGE have demonstrated some differences on total microbiota of dental biofilms when exposed to the A/CP or P suspensions, mainly in the absence of sucrose, which suggests a possible topical effect of the sugar-free A/CP suspension on dental biofilm.	[da Silva Pierro, Viviane Santos; Maia, Lucianne Cople] Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, Ilha Fundao, Rio De Janeiro, Brazil; [Ferreira, Dennis de Carvalho; de Jesus, Hugo Emiliano; Rosado, Alexandre Soares; Netto dos Santos, Katia Regina] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Ilha Fundao, Rio De Janeiro, Brazil; [Luiz, Ronir Raggio] Univ Fed Rio de Janeiro, Inst Studies Publ Hlth IESC, Ilha Fundao, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Pierro, VSD (corresponding author), Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, Ilha Fundao, Rio De Janeiro, Brazil.	vivipierro@gmail.com	Luiz, Ronir R/C-3372-2013; Maia, Lucianne Cople/E-9938-2011; Ferreira, Dennis/AAC-7407-2020; Rosado, Alexandre Soares/G-1955-2012; Luiz, Ronir Raggio/ABE-2684-2021	Luiz, Ronir R/0000-0002-7784-9905; Maia, Lucianne Cople/0000-0003-1026-9401; Rosado, Alexandre Soares/0000-0001-5135-1394; Luiz, Ronir Raggio/0000-0002-7784-9905; Ferreira, Dennis/0000-0003-4166-3284	CNPq [470693/2010-0, 302382/2009-7]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Processes No. 470693/2010-0 and 302382/2009-7). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Aires CP, 2006, CARIES RES, V40, P28, DOI 10.1159/000088902; Baglie S, 2007, INT J CLIN PHARM TH, V45, P556; Ccahuana-Vasquez RA, 2007, CARIES RES, V41, P9, DOI 10.1159/000096100; Papa AMCD, 2010, PEDIATR DENT, V32, P35; Ciofi Degli Atti ML, 2008, EUROSURVEILLANCE, V13, P1, DOI DOI 10.2807/ESE.13.41.19003-EN; Cury JA, 2000, CARIES RES, V34, P491, DOI 10.1159/000016629; Cury JA, 2001, CARIES RES, V35, P106, DOI 10.1159/000047440; de Jong J, 2009, ACTA PAEDIATR, V98, P1142, DOI 10.1111/j.1651-2227.2009.01309.x; DIBDIN GH, 1988, J DENT RES, V67, P890, DOI 10.1177/00220345880670060101; FEIGAL RJ, 1981, PEDIATRICS, V68, P416; Fukuda JT, 2005, PEDIATR DENT, V27, P186; Gammelsrud KW, 2011, CLIN MICROBIOL INFEC, V17, P1875, DOI 10.1111/j.1469-0691.2011.03528.x; Hara AT, 2003, CARIES RES, V37, P339, DOI 10.1159/000072165; JAGELS AE, 1976, J DENT RES, V55, P991, DOI 10.1177/00220345760550065101; Jiang W, 2011, MICROB ECOL, V61, P342, DOI 10.1007/s00248-010-9753-z; KARJALAINEN S, 1992, CARIES RES, V26, P310, DOI 10.1159/000261458; Leme AFP, 2004, J DENT RES, V83, P71, DOI 10.1177/154405910408300114; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; LITTLETON NW, 1964, J AM DENT ASSOC, V68, P520, DOI 10.14219/jada.archive.1964.0111; LOESCHE WJ, 1989, ORAL MICROBIOL IMMUN, V4, P77, DOI 10.1111/j.1399-302X.1989.tb00103.x; Maguire A, 1997, Community Dent Health, V14, P31; Maguire A, 1996, CARIES RES, V30, P16, DOI 10.1159/000262131; Maguire A, 1999, COMMUNITY DENT HLTH, V16, P138; Mariri BP, 2003, COMMUNITY DENT ORAL, V31, P40, DOI 10.1034/j.1600-0528.2003.00019.x; Marsh Philip D, 2010, Dent Clin North Am, V54, P441, DOI 10.1016/j.cden.2010.03.002; McBain AJ, 2003, ANTIMICROB AGENTS CH, V47, P3531, DOI 10.1128/AAC.47.11.3531-3538.2003; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P4770, DOI 10.1128/AEM.69.8.4770-4776.2003; MCMAHON J, 1993, EUR J CLIN NUTR, V47, P794; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Moynihan P, 2006, QUINTESSENCE INT, V37, P444; Nubel U, 1999, APPL ENVIRON MICROB, V65, P422; Pecharki GD, 2005, CARIES RES, V39, P123, DOI 10.1159/000083157; Ribeiro CCC, 2005, BRIT J NUTR, V94, P44, DOI 10.1079/BJN20051452; ROBERTS IF, 1979, BRIT MED J, V2, P14, DOI 10.1136/bmj.2.6181.14; STAVES E, 1991, Pediatric Dentistry, V13, P176; SWALLOW JN, 1967, ARCH DIS CHILD, V42, P311, DOI 10.1136/adc.42.223.311; Wefel J S, 1995, Adv Dent Res, V9, P335; Zero D T, 1995, Adv Dent Res, V9, P214	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55558	10.1371/journal.pone.0055558	http://dx.doi.org/10.1371/journal.pone.0055558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383224	gold, Green Submitted, Green Published			2022-12-27	WOS:000314610600125
J	Diaz, MR; Wadleigh, A; Kumar, S; De Schutter, E; Valenzuela, CF				Diaz, Marvin R.; Wadleigh, Aya; Kumar, Shyam; De Schutter, Erik; Valenzuela, C. Fernando			Na+/K+-ATPase Inhibition Partially Mimics the Ethanol-Induced Increase of the Golgi Cell-Dependent Component of the Tonic GABAergic Current in Rat Cerebellar Granule Cells	PLOS ONE			English	Article							GABA(A) RECEPTORS; SIMULATED ISCHEMIA; HIPPOCAMPAL CA1; TRANSMISSION; SPILLOVER; ACTIVATION; NEURONS; SUBUNIT; RELEASE; CORTEX	Cerebellar granule cells (CGNs) are one of many neurons that express phasic and tonic GABAergic conductances. Although it is well established that Golgi cells (GoCs) mediate phasic GABAergic currents in CGNs, their role in mediating tonic currents in CGNs (CGN-I-tonic) is controversial. Earlier studies suggested that GoCs mediate a component of CGN-I-tonic that is present only in preparations from immature rodents. However, more recent studies have detected a GoC-dependent component of CGN-I-tonic in preparations of mature rodents. In addition, acute exposure to ethanol was shown to potentiate the GoC component of CGN-I-tonic and to induce a parallel increase in spontaneous inhibitory postsynaptic current frequency at CGNs. Here, we tested the hypothesis that these effects of ethanol on GABAergic transmission in CGNs are mediated by inhibition of the Na+/K+-ATPase. We used whole-cell patch-clamp electrophysiology techniques in cerebellar slices of male rats (postnatal day 23-30). Under these conditions, we reliably detected a GoC-dependent component of CGN-I-tonic that could be blocked with tetrodotoxin. Further analysis revealed a positive correlation between basal sIPSC frequency and the magnitude of the GoC-dependent component of CGN-I-tonic. Inhibition of the Na+/K+-ATPase with a submaximal concentration of ouabain partially mimicked the ethanol-induced potentiation of both phasic and tonic GABAergic currents in CGNs. Modeling studies suggest that selective inhibition of the Na+/K+-ATPase in GoCs can, in part, explain these effects of ethanol. These findings establish a novel mechanism of action of ethanol on GABAergic transmission in the central nervous system.	[Diaz, Marvin R.; Wadleigh, Aya; Valenzuela, C. Fernando] Univ New Mexico, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Kumar, Shyam; De Schutter, Erik] Okinawa Inst Sci & Technol, Computat Neurosci Unit, Onna, Okinawa, Japan; [De Schutter, Erik] Univ Antwerp, Dept Theoret Neurobiol, Antwerp, Belgium	University of New Mexico; University of New Mexico's Health Sciences Center; Okinawa Institute of Science & Technology Graduate University; University of Antwerp	Valenzuela, CF (corresponding author), Univ New Mexico, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	fvalenzuela@salud.unm.edu	Sudhakar, Shyam Kumar/K-9321-2019; De Schutter, Erik/G-8460-2011; Zucca, Aya/G-2458-2015	De Schutter, Erik/0000-0001-8618-5138; Zucca, Aya/0000-0001-8613-8315; Diaz, Marvin/0000-0002-6786-5709	National Institutes of Health grant [AA14973]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014973, R56AA014973] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health grant AA14973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; Allen NJ, 2004, J PHYSIOL-LONDON, V561, P485, DOI 10.1113/jphysiol.2004.070490; Allen NJ, 2004, J NEUROSCI, V24, P3837, DOI 10.1523/JNEUROSCI.5539-03.2004; Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Botta P, 2011, ALCOHOLISM CLIN EXPT; Botta P, 2010, NEUROPSYCHOPHARMACOL, V35, P1984, DOI 10.1038/npp.2010.76; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Bright DP, 2011, J NEUROSCI, V31, P753, DOI 10.1523/JNEUROSCI.2996-10.2011; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Crowley JJ, 2009, NEURON, V63, P843, DOI 10.1016/j.neuron.2009.09.004; Diaz MR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2011.00148; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Hamada L, 2003, BRIT J PHARMACOL, V138, P1517, DOI 10.1038/sj.bjp.0705170; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Huang CM, 2007, ALCOHOL CLIN EXP RES, V31, P336, DOI 10.1111/j.1530-0277.2006.00309.x; Huang J, 2012, ALCOHOLISM CLIN EXPT; Hull C, 2012, NEURON, V73, P149, DOI 10.1016/j.neuron.2011.10.030; Ito M, 1984, CEREBELLUM NEURAL CO; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Koch U, 2009, CURR OPIN NEUROBIOL, V19, P305, DOI 10.1016/j.conb.2009.03.006; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ransom CB, 2010, J NEUROSCI, V30, P7672, DOI 10.1523/JNEUROSCI.0290-10.2010; Richards KS, 2007, J PHYSIOL-LONDON, V585, P491, DOI 10.1113/jphysiol.2007.144733; Rojas H, 2004, JPN J PHYSIOL, V54, P249, DOI 10.2170/jjphysiol.54.249; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Simoes de Souza Fabio M, 2011, Neural Syst Circuits, V1, P7, DOI 10.1186/2042-1001-1-7; Solinas S, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.002.2007; Szapiro G, 2009, NEUROSCIENCE, V162, P644, DOI 10.1016/j.neuroscience.2009.03.077; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Takeuchi A, 2006, J GEN PHYSIOL, V128, P495, DOI 10.1085/jgp.200609646; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Yamada J, 2007, CEREB CORTEX, V17, P1782, DOI 10.1093/cercor/bhl087; Yoon BE, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-42	50	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55673	10.1371/journal.pone.0055673	http://dx.doi.org/10.1371/journal.pone.0055673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383260	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600143
J	Goto, K; Kato, G; Kawahara, I; Luo, Y; Obata, K; Misawa, H; Ishikawa, T; Kuniyasu, H; Nabekura, J; Takaki, M				Goto, Kei; Kato, Go; Kawahara, Isao; Luo, Yi; Obata, Koji; Misawa, Hiromi; Ishikawa, Tatsuya; Kuniyasu, Hiroki; Nabekura, Junich; Takaki, Miyako			In Vivo Imaging of Enteric Neurogenesis in the Deep Tissue of Mouse Small Intestine	PLOS ONE			English	Article							REFLEX	One of the challenges of using imaging techniques as a tool to study cellular physiology has been the inability to resolve structures that are not located near the surface of the preparation. Nonlinear optical microscopy, in particular two photon-excited fluorescence microscopy (2PM), has overcome this limitation, providing deeper optical penetration (several hundred mm) in ex vivo and in vivo preparations. We have used this approach in the gut to achieve the first in vivo imaging of enteric neurons and nerve fibers in the mucosa, submucosa, submucosal and myenteric plexuses, and circular and longitudinal muscles of the small intestine in H-line: Thy1 promoter GFP mice. Moreover, we obtained clear three-dimensional imaging of enteric neurons that were newly generated after gut transection and reanastomosis. Neurogenesis was promoted by oral application of the 5-HT4-receptor agonist, mosapride citrate (MOS). The number of newly generated neurons observed in mice treated with MOS for one week was 421 +/- 89 per 864,900 mu m(2) (n = 5), which was significantly greater than that observed in preparations treated with MOS plus an antagonist (113 +/- 76 per 864,900 mu m(2)) or in 4 week vehicle controls (100 +/- 34 per 864,900 mu m(2)) (n = 4 both). Most neurons were located within 100 mu m of the surface. These results confirm that activation of enteric neural 5-HT4-receptor by MOS promotes formation of new enteric neurons. We conclude that in vivo 2PM imaging made it possible to perform high-resolution deep imaging of the living mouse whole gut and reveal formation of new enteric neurons promoted by 5-HT4-receptor activation.	[Goto, Kei; Kawahara, Isao; Obata, Koji; Misawa, Hiromi; Takaki, Miyako] Nara Med Univ, Sch Med, Dept Physiol 2, Kashihara, Nara 634, Japan; [Goto, Kei; Kawahara, Isao; Luo, Yi; Kuniyasu, Hiroki; Takaki, Miyako] Nara Med Univ, Sch Med, Dept Mol Pathol, Kashihara, Nara 634, Japan; [Kato, Go; Ishikawa, Tatsuya; Nabekura, Junich] Natl Inst Physiol Sci, Div Homeostat Dev, Dept Dev Physiol, Okazaki, Aichi 444, Japan	Nara Medical University; Nara Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Takaki, M (corresponding author), Nara Med Univ, Sch Med, Dept Physiol 2, Kashihara, Nara 634, Japan.	mtakaki@naramed-u.ac.jp		Kato, Go/0000-0002-3098-9759	Cooperative Study Program of National Institute for Physiological Sciences; Ministry of Education, Science, Sports and Culture of Japan [20659210, 23390330, 24650325, 23591969]; Grants-in-Aid for Scientific Research [24650325] Funding Source: KAKEN	Cooperative Study Program of National Institute for Physiological Sciences; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Cooperative Study Program of National Institute for Physiological Sciences. This work was supported by Grants-in-aid for Scientific Research (20659210, 23390330, 24650325 for M.T. and 23591969 for H.M.) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharucha AE, 2000, GUT, V47, P667, DOI 10.1136/gut.47.5.667; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gershon MD, 2011, J CLIN INVEST, V121, P3386, DOI 10.1172/JCI59573; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Hofstra RMW, 1997, EUR J HUM GENET, V5, P180, DOI 10.1159/000484760; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Katsui R, 2008, AM J PHYSIOL-GASTR L, V294, pG1084, DOI 10.1152/ajpgi.00345.2007; Kawahara I, 2012, AM J PHYSIOL-GASTR L, V302, pG588, DOI 10.1152/ajpgi.00284.2011; Kurosaki R, 2004, PHARMACOL BIOCHEM BE, V78, P143, DOI 10.1016/j.pbb.2004.03.006; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Liu M, 2006, NEUROGASTROENT MOTIL, V18, P780; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Matsuyoshi H, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2010.01474.x; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohya TR, 2012, GASTROINTEST ENDOSC, V75, P405, DOI 10.1016/j.gie.2011.09.045; Surendran S, 2005, BIOCHEM BIOPH RES CO, V338, P919, DOI 10.1016/j.bbrc.2005.10.039; Takaki M, 2011, BIOCHEM BIOPH RES CO, V406, P529, DOI 10.1016/j.bbrc.2011.02.072; Thacker M, 2011, NEUROGASTROENT MOTIL, V23, pE500, DOI 10.1111/j.1365-2982.2011.01696.x; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Yamanouchi M, 2002, AM J PHYSIOL-GASTR L, V283, pG148, DOI 10.1152/ajpgi.00497.2001; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	21	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54814	10.1371/journal.pone.0054814	http://dx.doi.org/10.1371/journal.pone.0054814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23382976	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600044
J	Smith, ME; Henkel, TW; Uehling, JK; Fremier, AK; Clarke, HD; Vilgalys, R				Smith, Matthew E.; Henkel, Terry W.; Uehling, Jessie K.; Fremier, Alexander K.; Clarke, H. David; Vilgalys, Rytas			The Ectomycorrhizal Fungal Community in a Neotropical Forest Dominated by the Endemic Dipterocarp Pakaraimaea dipterocarpacea	PLOS ONE			English	Article							SPATIAL STRUCTURE; CANOPY TREES; RAIN-FOREST; HOST; DIVERSITY; CAESALPINIACEAE; PHYLOGENY; PATTERNS; CLADES	Ectomycorrhizal (ECM) plants and fungi can be diverse and abundant in certain tropical ecosystems. For example, the primarily paleotropical ECM plant family Dipterocarpaceae is one of the most speciose and ecologically important tree families in Southeast Asia. Pakaraimaea dipterocarpacea is one of two species of dipterocarp known from the Neotropics, and is also the only known member of the monotypic Dipterocarpaceae subfamily Pakaraimoideae. This Guiana Shield endemic is only known from the sandstone highlands of Guyana and Venezuela. Despite its unique phylogenetic position and unusual geographical distribution, the ECM fungal associations of P. dipterocarpacea are understudied throughout the tree's range. In December 2010 we sampled ECM fungi on roots of P. dipterocarpacea and the co-occurring ECM tree Dicymbe jenmanii (Fabaceae subfamily Caesalpinioideae) in the Upper Mazaruni River Basin of Guyana. Based on ITS rDNA sequencing we documented 52 ECM species from 11 independent fungal lineages. Due to the phylogenetic distance between the two host tree species, we hypothesized that P. dipterocarpacea would harbor unique ECM fungi not found on the roots of D. jenmanii. Although statistical tests suggested that several ECM fungal species did exhibit host preferences for either P. dipterocarpacea or D. jenmanii, most of the ECM fungi were multi-host generalists. We also detected several ECM fungi that have never been found in long-term studies of nearby rainforests dominated by other Dicymbe species. One particular mushroom-forming fungus appears to be unique and may represent a new ECM lineage of Agaricales that is endemic to the Neotropics.	[Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Henkel, Terry W.; Uehling, Jessie K.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Fremier, Alexander K.] Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID USA; [Clarke, H. David] Univ N Carolina, Dept Biol, Asheville, NC 28804 USA; [Vilgalys, Rytas] Duke Univ, Dept Biol, Durham, NC USA	State University System of Florida; University of Florida; California State University System; California State Polytechnic University, Humboldt; Idaho; University of Idaho; University of North Carolina; University of North Carolina - Asheville; Duke University	Smith, ME (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	trufflesmith@ufl.edu	Smith, Matthew E./ABC-3015-2020; Fremier, Alexander/AAC-7706-2019; Uehling, Jessie/HGV-1602-2022; Smith, Matthew E/A-8115-2012	Smith, Matthew E./0000-0002-0878-0932; Uehling, Jessie/0000-0002-8705-5893; Smith, Matthew E/0000-0002-0878-0932; Vilgalys, Rytas/0000-0001-8299-3605; Fremier, Alexander/0000-0002-4104-6633	National Science Foundation [DEB-0918591, DEB-3331108]; University of Florida's Institute for Food and Agricultural Sciences (IFAS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; Direct For Biological Sciences [0918591] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Florida's Institute for Food and Agricultural Sciences (IFAS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation grants DEB-0918591 to TWH and DEB-3331108 to RV. Participation by MES was also possible in part due to support from University of Florida's Institute for Food and Agricultural Sciences (IFAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; Alexander IJ, 2006, NEW PHYTOL, V172, P589, DOI 10.1111/j.1469-8137.2006.01930.x; [Anonymous], 2015, PC ORD MULTIVARIATE; ASHTON PS, 1988, ANNU REV ECOL SYST, V19, P347, DOI 10.1146/annurev.es.19.110188.002023; Ashton PS, 1977, TAXON, V26, P343; Bandou E, 2006, MYCORRHIZA, V16, P559, DOI 10.1007/s00572-006-0073-6; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Brearley FQ, 2006, SOIL BIOL BIOCHEM, V38, P3407, DOI 10.1016/j.soilbio.2006.05.012; Brearley FQ, 2012, BIOTROPICA, V44, P637, DOI 10.1111/j.1744-7429.2012.00862.x; Bruns TD, 1998, MOL ECOL, V7, P257, DOI 10.1046/j.1365-294X.1998.00337.x; Co-David D, 2009, PERSOONIA, V23, P147, DOI 10.3767/003158509X480944; Curtet L., 1998, REV DIPTEROCARPS TAX, P5; Dayanandan S, 1999, AM J BOT, V86, P1182, DOI 10.2307/2656982; Diedhiou AG, 2010, ENVIRON MICROBIOL, V12, P2219, DOI 10.1111/j.1462-2920.2010.02183.x; Fanshawe D.B., 1952, 29 IMP FOR I; FASSI BRUNO, 1962, ALLIONIA [TURIN], V8, P121; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gibbs AK, 1993, GEOLGOY GUIANA SHIEL; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Hammond DS, 1998, CONSERV BIOL, V12, P944, DOI 10.1046/j.1523-1739.1998.012005944.x; Henkel TW, 2012, BIODIVERS CONSERV, V21, P2195, DOI 10.1007/s10531-011-0166-1; Henkel TW, 2003, J TROP ECOL, V19, P417, DOI 10.1017/S0266467403003468; Henkel TW, 2002, MYCOL RES, V106, P515, DOI 10.1017/S0953756202005919; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Kennedy PG, 2003, J ECOL, V91, P1071, DOI 10.1046/j.1365-2745.2003.00829.x; Lilleskov EA, 2004, FEMS MICROBIOL ECOL, V49, P319, DOI 10.1016/j.femsec.2004.04.004; LONDONO AC, 1995, BRITTONIA, V47, P225, DOI 10.2307/2807116; Lopez-Quintero CA, 2012, BIODIVERS CONSERV, V21, P2221, DOI 10.1007/s10531-012-0280-8; MAGUIRE B, 1980, TAXON, V29, P225, DOI 10.2307/1220284; Maguire B, 1981, MEM NY BOT GARD, V32, P306; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; Morris MH, 2009, FEMS MICROBIOL ECOL, V69, P274, DOI 10.1111/j.1574-6941.2009.00704.x; Morton CM, 1999, PLANT SYST EVOL, V216, P197, DOI 10.1007/BF01084398; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Moyersoen B, 2012, TROPICAL FORESTS, P93; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; SINGER R, 1979, Acta Amazonica, V9, P25; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Smith ME, 2009, NEW PHYTOL, V182, P295, DOI 10.1111/j.1469-8137.2009.02801.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tedersoo L, 2007, NEW PHYTOL, V175, P321, DOI 10.1111/j.1469-8137.2007.02104.x; Tedersoo L, 2011, MOL ECOL, V20, P3071, DOI 10.1111/j.1365-294X.2011.05145.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tedersoo L, 2010, NEW PHYTOL, V185, P351, DOI 10.1111/j.1469-8137.2009.03134.x; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zwickl D. J, 2006, GENETIC ALGORITHM AP	52	64	66	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55160	10.1371/journal.pone.0055160	http://dx.doi.org/10.1371/journal.pone.0055160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383090	Green Published, gold			2022-12-27	WOS:000314610600068
J	Alvarez, YD; Belingheri, AV; Bay, AEP; Javis, SE; Tedford, HW; Zamponi, G; Marengo, FD				Alvarez, Yanina D.; Veronica Belingheri, Ana; Perez Bay, Andres E.; Javis, Scott E.; Tedford, H. William; Zamponi, Gerald; Marengo, Fernando D.			The Immediately Releasable Pool of Mouse Chromaffin Cell Vesicles Is Coupled to P/Q-Type Calcium Channels via the Synaptic Protein Interaction Site	PLOS ONE			English	Article							BUFFERED CA2+ DIFFUSION; N-TYPE; NEUROTRANSMITTER RELEASE; SYNTAXIN 1A; EXOCYTOSIS; SECRETION; RIM; CA(V)2.2; MICRODOMAINS; CAPACITANCE	It is generally accepted that the immediately releasable pool is a group of readily releasable vesicles that are closely associated with voltage dependent Ca2+ channels. We have previously shown that exocytosis of this pool is specifically coupled to P/Q Ca2+ current. Accordingly, in the present work we found that the Ca2+ current flowing through P/Q-type Ca2+ channels is 8 times more effective at inducing exocytosis in response to short stimuli than the current carried by L-type channels. To investigate the mechanism that underlies the coupling between the immediately releasable pool and P/Q-type channels we transiently expressed in mouse chromaffin cells peptides corresponding to the synaptic protein interaction site of Cav2.2 to competitively uncouple P/Q-type channels from the secretory vesicle release complex. This treatment reduced the efficiency of Ca2+ current to induce exocytosis to similar values as direct inhibition of P/Q-type channels via v omega-agatoxin-IVA. In addition, the same treatment markedly reduced immediately releasable pool exocytosis, but did not affect the exocytosis provoked by sustained electric or high K+ stimulation. Together, our results indicate that the synaptic protein interaction site is a crucial factor for the establishment of the functional coupling between immediately releasable pool vesicles and P/Q-type Ca2+ channels.	[Alvarez, Yanina D.; Veronica Belingheri, Ana; Perez Bay, Andres E.; Marengo, Fernando D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias CONICET, Lab Fisiol & Biol Mol,Dept Fisiol & Biol Mol & Ce, Buenos Aires, DF, Argentina; [Javis, Scott E.; Tedford, H. William; Zamponi, Gerald] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Calgary	Marengo, FD (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias CONICET, Lab Fisiol & Biol Mol,Dept Fisiol & Biol Mol & Ce, Buenos Aires, DF, Argentina.	fernando@fbmc.fcen.uba.ar	Marengo, Fernando Diego/HHN-6611-2022	Marengo, Fernando D./0000-0002-4372-2092; Zamponi, Gerald W./0000-0002-0644-9066	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT 05-11661-2002, PICT 01002-2007, PICT 0029-2010]; Universidad de Buenos Aires (Argentina) [UBACyT X082 2004-2006, UBACyT X461 2008-2010, UBACyT 2011-2014]; CONICET (Argentina) [PIP 5847]; Canadian Institutes of Health Research; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina; Alberta Heritage Foundation for Medical Research (AHFMR)	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Universidad de Buenos Aires (Argentina)(University of Buenos Aires); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported by grants PICT 05-11661-2002, PICT 01002-2007 and PICT 0029-2010 from Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina), UBACyT X082 2004-2006, UBACyT X461 2008-2010, and UBACyT 2011-2014 from Universidad de Buenos Aires (Argentina), PIP 5847 from CONICET (Argentina); and an operating grant to GZ from the Canadian Institutes of Health Research. YDA, AVB and AEPB held a Fellowship from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina. FDM is a CONICET researcher. HWT held a Fellowship from the Alberta Heritage Foundation for Medical Research (AHFMR) and SEJ held an AHFMR Studentship. GZ is an AHFMR Scientist and a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER EM, 1991, J NEUROSCI, V11, P1496; Albillos A, 2000, J NEUROSCI, V20, P8323, DOI 10.1523/JNEUROSCI.20-22-08323.2000; Aldea M, 2002, J NEUROCHEM, V81, P911, DOI 10.1046/j.1471-4159.2002.00845.x; Alvarez YD, 2008, CELL CALCIUM, V43, P155, DOI 10.1016/j.ceca.2007.04.014; Alvarez YD, 2011, J NEUROCHEM, V116, P155, DOI 10.1111/j.1471-4159.2010.07108.x; Andres-Mateos E, 2005, EUR J NEUROSCI, V22, P2187, DOI 10.1111/j.1460-9568.2005.04385.x; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Bay AEP, 2007, AM J PHYSIOL-CELL PH, V293, pC1509, DOI 10.1152/ajpcell.00632.2006; Beedle AM, 2004, NAT NEUROSCI, V7, P118, DOI 10.1038/nn1180; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; Davies JN, 2011, BIOCHEM BIOPH RES CO, V411, P562, DOI 10.1016/j.bbrc.2011.06.185; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Elhamdani A, 1998, J NEUROSCI, V18, P6230; Engisch KL, 1996, J NEUROSCI, V16, P1359; FIDLER N, 1989, BIOPHYS J, V56, P1153, DOI 10.1016/S0006-3495(89)82762-6; GANDIA L, 1995, PFLUG ARCH EUR J PHY, V430, P55, DOI 10.1007/BF00373839; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Giancippoli A, 2006, BIOPHYS J, V90, P1830, DOI 10.1529/biophysj.105.071647; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Graham ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017999; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Harkins AB, 2004, P NATL ACAD SCI USA, V101, P15219, DOI 10.1073/pnas.0401001101; Hernandez-Guijo JM, 1998, PFLUG ARCH EUR J PHY, V436, P75, DOI 10.1007/s004240050606; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jarvis SE, 2005, CELL CALCIUM, V37, P483, DOI 10.1016/j.ceca.2005.01.017; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Lara B, 1998, PFLUG ARCH EUR J PHY, V435, P472, DOI 10.1007/s004240050541; Lomax RB, 1997, AM J PHYSIOL-CELL PH, V272, pC476, DOI 10.1152/ajpcell.1997.272.2.C476; Marengo FD, 2000, BIOPHYS J, V79, P1800, DOI 10.1016/S0006-3495(00)76431-9; Marengo FD, 2005, CELL CALCIUM, V38, P87, DOI 10.1016/j.ceca.2005.06.006; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; Moser T, 1997, J NEUROSCI, V17, P2314; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Prakriya M, 1999, J NEUROPHYSIOL, V81, P2267, DOI 10.1152/jn.1999.81.5.2267; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; Santana F, 1999, N-S ARCH PHARMACOL, V360, P33, DOI 10.1007/s002109900041; Segura J, 2000, BIOPHYS J, V79, P1771, DOI 10.1016/S0006-3495(00)76429-0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SMITH PD, 1984, ANAL BIOCHEM, V143, P188, DOI 10.1016/0003-2697(84)90575-X; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Sun L, 2003, J BIOL CHEM, V278, P38301, DOI 10.1074/jbc.M212801200; Sun L, 2002, ANN NY ACAD SCI, V971, P244, DOI 10.1111/j.1749-6632.2002.tb04468.x; Szabo Z, 2006, EUR J NEUROSCI, V24, P709, DOI 10.1111/j.1460-9568.2006.04947.x; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Wykes RCE, 2007, J NEUROSCI, V27, P5236, DOI 10.1523/JNEUROSCI.3545-06.2007; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	61	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54846	10.1371/journal.pone.0054846	http://dx.doi.org/10.1371/journal.pone.0054846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382986	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800081
J	Crowder, DW; Dykstra, EA; Brauner, JM; Duffy, A; Reed, C; Martin, E; Peterson, W; Carriere, Y; Dutilleul, P; Owen, JP				Crowder, David W.; Dykstra, Elizabeth A.; Brauner, Jo Marie; Duffy, Anne; Reed, Caitlin; Martin, Emily; Peterson, Wade; Carriere, Yves; Dutilleul, Pierre; Owen, Jeb P.			West Nile Virus Prevalence across Landscapes Is Mediated by Local Effects of Agriculture on Vector and Host Communities	PLOS ONE			English	Article							CULEX-TARSALIS DIPTERA; COREGIONALIZATION ANALYSIS; MULTISCALE ASSESSMENT; SPATIAL RELATIONSHIPS; LARGE-SCALE; CULICIDAE; RISK; EPIDEMIOLOGY; DIVERSITY; OUTBREAKS	Arthropod-borne viruses (arboviruses) threaten the health of humans, livestock, and wildlife. West Nile virus (WNV), the world's most widespread arbovirus, invaded the United States in 1999 and rapidly spread across the county. Although the ecology of vectors and hosts are key determinants of WNV prevalence across landscapes, the factors shaping local vector and host populations remain unclear. Here, we used spatially-explicit models to evaluate how three land-use types (orchards, vegetable/forage crops, natural) and two climatic variables (temperature, precipitation) influence the prevalence of WNV infections and vector/host distributions at landscape and local spatial scales. Across landscapes, we show that orchard habitats were associated with greater prevalence of WNV infections in reservoirs (birds) and incidental hosts (horses), while increased precipitation was associated with fewer infections. At local scales, orchard habitats increased the prevalence of WNV infections in vectors (mosquitoes) and the abundance of mosquitoes and two key reservoir species, the American robin and the house sparrow. Thus, orchard habitats benefitted WNV vectors and reservoir hosts locally, creating focal points for the transmission of WNV at landscape scales in the presence of suitable climatic conditions.	[Crowder, David W.; Martin, Emily; Peterson, Wade; Owen, Jeb P.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Dykstra, Elizabeth A.; Brauner, Jo Marie; Duffy, Anne; Reed, Caitlin] Washington State Dept Hlth, Olympia, WA USA; [Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Dutilleul, Pierre] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada	Washington State University; University of Arizona; McGill University	Crowder, DW (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	dcrowder@wsu.edu		Crowder, David/0000-0002-3720-1581; Scott, Emily/0000-0001-9295-9320; Owen, Jeb/0000-0002-2042-0526	United States Department of Agriculture (USDA) Agriculture and Food Research Initiative [2011-67012-30718]; USDA Risk Avoidance and Mitigation Program [2006-0207436]	United States Department of Agriculture (USDA) Agriculture and Food Research Initiative; USDA Risk Avoidance and Mitigation Program	This study was supported by United States Department of Agriculture (USDA) Agriculture and Food Research Initiative Project 2011-67012-30718 and USDA Risk Avoidance and Mitigation Program Project 2006-0207436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Benton, Yakima, Franklin, Columbia and Grant #1 Mosquito Control Districts, and the Kittitas County Local Health Department, for sharing their mosquito surveillance data. * Disclaimer. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views or policies of the Washington State Department of Health.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Carriere Y, 2004, ECOL APPL, V14, P1615, DOI 10.1890/03-5268; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Center for Disease Control, ARBONET; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Clements AN, 2010, BIOL MOSQUITOES; Darsie RF, 2004, IDENTIFICATION GEOGR; Dutilleul P, 2011, SPAT TEMP HET CONC A; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; ESRI, 2010, ARCGIS DESKT REL 10; FLUETSCH KM, 1994, ENVIRON TOXICOL CHEM, V13, P1651, DOI [10.1897/1552-8618(1994)13[1651:ANSADI]2.0.CO;2, 10.1002/etc.5620131015]; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Jones CE, 2012, J MED ENTOMOL, V49, P467, DOI 10.1603/ME11191; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kesavaraju B, 2012, AM J TROP MED HYG, V87, P359, DOI 10.4269/ajtmh.2012.11-0662; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lothrop HD, 2001, J MED ENTOMOL, V38, P325, DOI 10.1603/0022-2585-38.2.325; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Pelletier B, 2009, ENVIRON ECOL STAT, V16, P467, DOI 10.1007/s10651-008-0096-6; Pelletier B, 2009, ENVIRON ECOL STAT, V16, P439, DOI 10.1007/s10651-008-0090-z; Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Rochlin I, 2009, AM J TROP MED HYG, V80, P661, DOI 10.4269/ajtmh.2009.80.661; SAS Institute, 2010, JMP 10 0; Service MW, 1997, J MED ENTOMOL, V34, P578; Shaman J, 2002, EMERG INFECT DIS, V8, P575, DOI 10.3201/eid0806.010417; The Mathworks Inc, 2008, MATLAB VERS R2008A; US Department of Agriculture National Agriculture Statistics Service Spatial Analysis Research Section, CROPL DAT LAYER; US Geological Survey Patuxent Wildlife Research Center, N AM BREED BIRD SURV; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38; Ward MP, 2009, VET RES COMMUN, V33, P461, DOI 10.1007/s11259-008-9192-1; Washington State Department of Health, W NIL VIR SURV MAPS; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Western Regional Climate Center, COOP CLIM DAT SUMM; Wimberly MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003744	44	36	37	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55006	10.1371/journal.pone.0055006	http://dx.doi.org/10.1371/journal.pone.0055006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383032	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800102
J	Hirai, H; Kamio, N; Huang, G; Matsusue, A; Ogino, S; Kimura, N; Satake, S; Ashihara, E; Imanishi, J; Tenen, DG; Maekawa, T				Hirai, Hideyo; Kamio, Naoka; Huang, Gang; Matsusue, Akiko; Ogino, Shinpei; Kimura, Nobuhiko; Satake, Sakiko; Ashihara, Eishi; Imanishi, Jiro; Tenen, Daniel G.; Maekawa, Taira			Cyclic AMP Responsive Element Binding Proteins Are Involved in 'Emergency' Granulopoiesis through the Upregulation of CCAAT/Enhancer Binding Protein beta	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; FACTOR-C/EBP-ALPHA; G-CSF; HEMATOPOIETIC-CELLS; GENE-TRANSCRIPTION; DEFICIENT MICE; NF-IL6 GENE; CREB; DIFFERENTIATION; EXPRESSION	In contrast to the definitive role of the transcription factor, CCAAT/Enhancer binding protein alpha (C/EBP alpha), in steady-state granulopoiesis, previous findings have suggested that granulopoiesis during emergency situations, such as infection, is dependent on C/EBP beta. In this study, a novel lentivirus-based reporter system was developed to elucidate the molecular switch required for C/EBP beta-dependency. The results demonstrated that two cyclic AMP responsive elements (CREs) in the proximal promoter region of C/EBP beta were involved in the positive regulation of C/EBP beta transcription during granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced differentiation of bone marrow cells. In addition, the transcripts of CRE binding (CREB) family proteins were readily detected in hematopoietic stem/progenitor cells. CREB was upregulated, phosphorylated and bound to the CREs in response to GM-CSF stimulation. Retroviral transduction of a dominant negative CREB mutant reduced C/EBP beta mRNA levels and significantly impaired the proliferation/differentiation of granulocyte precursors, while a constitutively active form of CREB facilitated C/EBP beta transcription. These data suggest that CREB proteins are involved in the regulation of granulopoiesis via C/EBP beta upregulation.	[Hirai, Hideyo; Kamio, Naoka; Matsusue, Akiko; Ogino, Shinpei; Kimura, Nobuhiko; Satake, Sakiko; Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan; [Huang, Gang] Div Expt Hematol, Cincinnati, OH USA; [Huang, Gang] Div Pathol, Cincinnati, OH USA; [Ashihara, Eishi] Kyoto Pharmaceut Univ, Dept Clin & Translat Physiol, Kyoto 607, Japan; [Imanishi, Jiro] Meiji Univ Integrat Med, Kyoto, Japan; [Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA USA; [Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore	Kyoto University; University System of Ohio; University of Cincinnati; Kyoto Pharmaceutical University; Harvard University; Harvard Medical School; National University of Singapore	Hirai, H (corresponding author), Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan.	hhirai@kuhp.kyoto-u.ac.jp		Tenen, Daniel/0000-0002-6423-3888	Mitsubishi Foundation; Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Yasuda Medical Foundation; Fujiwara Foundation; Takeda Science Foundation; Kobayashi Foundation for Cancer Research; Senshin Medical Research Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; National Cancer Center Research and Development Fund [23-A-23]; Grants-in-Aid for Scientific Research [23592678] Funding Source: KAKEN	Mitsubishi Foundation; Mitsubishi Pharma Research Foundation; Kanae Foundation for the Promotion of Medical Science; Yasuda Medical Foundation; Fujiwara Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Mitsubishi Foundation, Mitsubishi Pharma Research Foundation, the Kanae Foundation for the Promotion of Medical Science, the Yasuda Medical Foundation, the Fujiwara Foundation, Takeda Science Foundation (to HH), the Kobayashi Foundation for Cancer Research, and Senshin Medical Research Foundation (to TM), and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to HH, EA and TM), the Global COE Program 'Center for Frontier Medicine' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to TM) and the National Cancer Center Research and Development Fund (23-A-23) (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; Akasaka K, 1999, CELL MOL BIOL, V45, P555; Basu S, 2000, BLOOD, V95, P3725; Berrier A, 1998, J IMMUNOL, V161, P2267; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Foka P, 2001, BIOCHEM BIOPH RES CO, V285, P430, DOI 10.1006/bbrc.2001.5203; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Hirai H, 2005, BLOOD, V106, P1948, DOI 10.1182/blood-2004-12-4872; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Kamio N, 2010, BIOCHEM BIOPH RES CO, V393, P498, DOI 10.1016/j.bbrc.2010.02.033; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Lin WC, 2002, DNA CELL BIOL, V21, P551, DOI 10.1089/104454902320308924; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Nerlov C, 2010, BIOESSAYS, V32, P680, DOI 10.1002/bies.201000004; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Parker D, 1996, MOL CELL BIOL, V16, P694; Pigazzi M, 2008, LEUKEMIA, V22, P2217, DOI 10.1038/leu.2008.244; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang YM, 2002, BBA-GENE STRUCT EXPR, V1577, P102, DOI 10.1016/S0167-4781(02)00401-3; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54862	10.1371/journal.pone.0054862	http://dx.doi.org/10.1371/journal.pone.0054862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382991	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800084
J	Juraschek, SP; Shantha, GPS; Chu, AY; Miller, ER; Guallar, E; Hoogeveen, RC; Ballantyne, CM; Brancati, FL; Schmidt, MI; Pankow, JS; Young, JH				Juraschek, Stephen P.; Shantha, Ghanshyam Palamaner Subash; Chu, Audrey Y.; Miller, Edgar R., III; Guallar, Eliseo; Hoogeveen, Ron C.; Ballantyne, Christie M.; Brancati, Frederick L.; Schmidt, Maria Ines; Pankow, James S.; Young, J. Hunter			Lactate and Risk of Incident Diabetes in a Case-Cohort of the Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							SKELETAL-MUSCLE; 1ST-DEGREE RELATIVES; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MITOCHONDRIAL DYSFUNCTION; GLUCOSE; MELLITUS; RELEASE; OBESITY; INFLAMMATION	Background: Oxidative capacity is decreased in type 2 diabetes. Whether decreased oxidative capacity is a cause or consequence of diabetes is unknown. Our purpose is to evaluate whether lactate, a marker of oxidative capacity, is associated with incident diabetes. Methods and Findings: We conducted a case-cohort study in the Atherosclerosis Risk in Communities (ARIC) study at year 9 of follow-up. We evaluated lactate's association with diabetes risk factors at baseline and estimated the hazard ratio for incident diabetes by quartiles of plasma lactate in 544 incident diabetic cases and 533 non-cases. Plasma lactate showed a graded positive relationship with fasting glucose and insulin (P < 0.001). The relative hazard for incident diabetes increased across lactate quartiles (P-trend <= 0.001). Following adjustment for demographic factors, medical history, physical activity, adiposity, and serum lipids, the hazard ratio in the highest quartile was 2.05 times the hazard in the lowest quartile (95% CI: 1.28, 3.28). After including fasting glucose and insulin the association became non-significant. Conclusions: Lactate, an indicator of oxidative capacity, predicts incident diabetes independent of many other risk factors and is strongly related to markers of insulin resistance. Future studies should evaluate the temporal relationship between elevated lactate and impaired fasting glucose and insulin resistance.	[Juraschek, Stephen P.; Guallar, Eliseo; Brancati, Frederick L.; Young, J. Hunter] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Juraschek, Stephen P.; Shantha, Ghanshyam Palamaner Subash; Miller, Edgar R., III; Guallar, Eliseo; Brancati, Frederick L.; Young, J. Hunter] Johns Hopkins Med Inst, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Juraschek, Stephen P.; Shantha, Ghanshyam Palamaner Subash; Miller, Edgar R., III; Guallar, Eliseo; Brancati, Frederick L.; Young, J. Hunter] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Chu, Audrey Y.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Miller, Edgar R., III; Guallar, Eliseo; Brancati, Frederick L.; Young, J. Hunter] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Sect Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Methodist DeBakey Heart Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX USA; [Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Grad Studies Program Epidemiol, Sch Med, Porto Alegre, RS, Brazil; [Schmidt, Maria Ines] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Pankow, James S.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Brigham & Women's Hospital; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities	Young, JH (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	jhyoung@jhmi.edu	Guallar, Eliseo/D-3807-2014; Schmidt, Maria Inês/AGT-5691-2022; Schmidt, Maria/V-3196-2019; Schmidt, Maria Inês/AGP-6441-2022; Ballantyne, Christie/A-6599-2008	Guallar, Eliseo/0000-0002-4471-9565; Schmidt, Maria Inês/0000-0002-3837-0731; Ballantyne, Christie/0000-0002-6432-1730; Juraschek, Stephen/0000-0003-4168-2696; Pankow, James/0000-0001-7076-483X; Hoogeveen, Ron/0000-0003-2399-4653	National Institutes of Health/National Heart, Lung, and Blood Institute [T32HL007024]; P60 Diabetes P & C Core of the Diabetes Research Training Center [5P60DK079637-04]; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055022, N01HC055021, N01HC055020, N01HC055018, N01HC055015, N01HC055019, N01HC055016] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024, T32HL007575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); P60 Diabetes P & C Core of the Diabetes Research Training Center; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SPJ is supported in part by a National Institutes of Health/National Heart, Lung, and Blood Institute T32HL007024 Cardiovascular Epidemiology Training Grant. This work was supported by P60 Diabetes P & C Core of the Diabetes Research Training Center (5P60DK079637-04). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021 and N01-HC-55022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieff A. I., 1987, AM J PHYSIOL-ENDOC M, V253, P271; Avogaro A, 1996, J CLIN INVEST, V98, P108, DOI 10.1172/JCI118754; BARHAM D, 1972, ANALYST, V97, P142, DOI 10.1039/an9729700142; Bernal-Mizrachi C, 2006, NAT MED, V12, P46, DOI 10.1038/nm0106-46; Bjorntorp P, 1967, Diabetologia, V3, P346, DOI 10.1007/BF00429867; Brecher AS, 1996, ALCOHOL, V13, P553, DOI 10.1016/S0741-8329(96)00067-5; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; CHEN YDI, 1993, DIABETES METAB, V19, P348; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Choi CS, 2002, AM J PHYSIOL-ENDOC M, V283, pE233, DOI 10.1152/ajpendo.00557.2001; CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; CRANDALL DL, 1983, HORM METAB RES, V15, P326, DOI 10.1055/s-2007-1018710; Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126; Dela F, 2010, AM J PHYSIOL-ENDOC M, V299, pE80, DOI 10.1152/ajpendo.00765.2009; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Gladden LB, 2008, MED SCI SPORT EXER, V40, P477, DOI [10.1249/mss.0b013e31815fa580, 10.1249/MSS.0b013e31815fa580]; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; HOWELL R. RODNEY, 1965, ARTHRITIS RHEUM, V8, P780, DOI 10.1002/art.1780080441; Iossa S, 2004, DIABETES, V53, P2861, DOI 10.2337/diabetes.53.11.2861; Irving BA, 2011, J CLIN ENDOCR METAB, V96, pE1137, DOI 10.1210/jc.2010-2863; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; KREISBERG RA, 1980, ANN INTERN MED, V92, P227, DOI 10.7326/0003-4819-92-2-227; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; OHLSON LO, 1988, DIABETOLOGIA, V31, P798; Ostergard T, 2006, AM J PHYSIOL-ENDOC M, V290, pE998, DOI 10.1152/ajpendo.00012.2005; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207; Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, pE709, DOI 10.1152/ajpendo.00104.2006; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Sandqvist MM, 2001, DIABETES, V50, P2344, DOI 10.2337/diabetes.50.10.2344; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Skov V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002466; Stefanovski D, 2012, DIABETES CARE, V35, P1015, DOI 10.2337/dc11-1540; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468; Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Woerle HJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE67, DOI 10.1152/ajpendo.00529.2004; Ye JP, 2011, CURR DIABETES REP, V11, P203, DOI 10.1007/s11892-011-0183-1; YKIJARVINEN H, 1990, METABOLISM, V39, P859, DOI 10.1016/0026-0495(90)90133-W; Zhu N, 2010, J CLIN ENDOCR METAB, V95, P5097, DOI 10.1210/jc.2010-0716	54	41	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55113	10.1371/journal.pone.0055113	http://dx.doi.org/10.1371/journal.pone.0055113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383072	Green Published, gold			2022-12-27	WOS:000315563800111
J	Lovy, M; Skliba, J; Sumbera, R				Loevy, Matej; Skliba, Jan; Sumbera, Radim			Spatial and Temporal Activity Patterns of the Free-Living Giant Mole-Rat (Fukomys mechowii), the Largest Social Bathyergid	PLOS ONE			English	Article							CRYPTOMYS-HOTTENTOTUS-HOTTENTOTUS; CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; COLONY; DAMARENSIS; RODENTIA; SOLITARY; EUSOCIALITY; ORGANIZATION; DISPERSAL	Despite the considerable attention devoted to the biology of social species of African mole-rats (Bathyergidae, Rodentia), knowledge is lacking about their behaviour under natural conditions. We studied activity of the largest social bathyergid, the giant mole-rat Fukomys mechowii, in its natural habitat in Zambia using radio-telemetry. We radio-tracked six individuals during three continuous 72-h sessions. Five of these individuals, including a breeding male, belonged to a single family group; the remaining female was probably a solitary disperser. The non-breeders of the family were active (i.e. outside the nest) 5.8 hours per 24h-day with the activity split into 6.5 short bouts. The activity was more concentrated in the night hours, when the animals also travelled longer distances from the nest. The breeding male spent only 3.2 hours per day outside the nest, utilizing less than 20% of the whole family home range. The dispersing female displayed a much different activity pattern than the family members. Her 8.0 hours of outside-nest activity per day were split into 4.6 bouts which were twice as long as in the family non-breeders. Her activity peak in the late afternoon coincided with the temperature maximum in the depth of 10 cm (roughly the depth of the foraging tunnels). Our results suggest that the breeding individuals (at least males) contribute very little to the work of the family group. Nevertheless, the amount of an individual's activity and its daily pattern are probably flexible in this species and can be modified in response to actual environmental and social conditions.	[Loevy, Matej; Skliba, Jan; Sumbera, Radim] Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Lovy, M (corresponding author), Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic.	mates.lovy@gmail.com	Lövy, Matěj/AGN-3116-2022; Šumbera, Radim/D-9072-2016	Lövy, Matěj/0000-0002-6451-2393; Šumbera, Radim/0000-0001-8658-9378; Skliba, Jan/0000-0002-0567-9302	Grant Agency of the University of South Bohemia [04-136/2010/P]; Czech Science Foundation [P506/11/1512]; Grant Agency of the Academy of Sciences of the Czech Republic [KJB601410826]	Grant Agency of the University of South Bohemia; Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	This work was supported by the Grant Agency of the University of South Bohemia (04-136/2010/P, to ML), the Czech Science Foundation (P506/11/1512, to RS, gacr.cz) and the Grant Agency of the Academy of Sciences of the Czech Republic (KJB601410826, to JS, gaav.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENEDIX JH, 1994, ANIM BEHAV, V48, P501, DOI 10.1006/anbe.1994.1271; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BENNETT NC, 1988, J MAMMAL, V69, P293, DOI 10.2307/1381379; BENNETT NC, 1992, J ZOOL, V228, P435, DOI 10.1111/j.1469-7998.1992.tb04446.x; BENNETT NC, 1990, J ZOOL, V220, P225, DOI 10.1111/j.1469-7998.1990.tb04305.x; BENNETT NC, 1994, OECOLOGIA, V97, P222, DOI 10.1007/BF00323153; Braude S, 2000, BEHAV ECOL, V11, P7, DOI 10.1093/beheco/11.1.7; Brett R.A., 1991, P137; BURDA H, 1993, NATURWISSENSCHAFTEN, V80, P235, DOI 10.1007/BF01175742; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Dammann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018757; de Vries JL, 2008, J ZOOL, V276, P343, DOI 10.1111/j.1469-7998.2008.00496.x; Favreau A, 2009, ANIM BEHAV, V77, P983, DOI 10.1016/j.anbehav.2009.01.004; Gaylard A, 1998, J ZOOL, V244, P313, DOI 10.1017/S095283699800301X; Hazell RWA, 2000, J ZOOL, V252, P19; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; Jarvis JUM, 1998, OECOLOGIA, V113, P290, DOI 10.1007/s004420050380; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; Kawalika M, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P205, DOI 10.1007/978-3-540-69276-8_15; Kronfeld-Schor N, 2008, BIOL RHYTHM RES, V39, P193, DOI 10.1080/09291010701683268; Lacey E.A., 1991, P275; LAVER P. N., 2005, ABODE KERNEL HOME RA; Lovegrove B.G., 1987, Koedoe, V30, P149; LOVEGROVE BG, 1995, PHYSIOL BEHAV, V58, P679, DOI 10.1016/0031-9384(95)00106-S; LOVEGROVE BG, 1988, J ZOOL, V216, P391, DOI 10.1111/j.1469-7998.1988.tb02437.x; Lovy M, 2012, J ZOOL, V286, P145, DOI 10.1111/j.1469-7998.2011.00860.x; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Nemec P, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P129, DOI 10.1007/978-3-540-69276-8_11; Nevo, 1999, MOSAIC EVOLUTION SUB; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; ORiain MJ, 1996, NATURE, V380, P619, DOI 10.1038/380619a0; RADO R, 1993, CAN J ZOOL, V71, P1733, DOI 10.1139/z93-245; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Rezende EL, 2003, J ARID ENVIRON, V55, P63, DOI 10.1016/S0140-1963(02)00259-8; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Valentinuzzi VS, 2009, CHRONOBIOL INT, V26, P14, DOI 10.1080/07420520802686331; Scantlebury M, 2006, NATURE, V440, P795, DOI 10.1038/nature04578; Scharff A, 2001, J MAMMAL, V82, P1003, DOI 10.1644/1545-1542(2001)082<1003:NHOTGM>2.0.CO;2; Schielke CKM, 2012, MAMM BIOL, V77, P1, DOI 10.1016/j.mambio.2011.09.004; Sichilima AM, 2008, J ZOOL, V275, P276, DOI 10.1111/j.1469-7998.2008.00439.x; Skliba J, 2007, J MAMMAL, V88, P1009, DOI 10.1644/06-MAMM-A-235R1.1; Skliba J, 2009, ETHOLOGY, V115, P217, DOI 10.1111/j.1439-0310.2008.01604.x; Spinks AC, 1999, OIKOS, V85, P435, DOI 10.2307/3546693; StatSoft Inc, 2010, STATISTICA DAT AN SO; Sumbera R, 2007, PHYSIOL BEHAV, V92, P526, DOI 10.1016/j.physbeh.2007.04.029; Sumbera R, 2012, ACTA THERIOL, V57, P121, DOI 10.1007/s13364-011-0059-4; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Wallace ED, 1998, J ZOOL, V244, P51, DOI 10.1111/j.1469-7998.1998.tb00006.x	48	38	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55357	10.1371/journal.pone.0055357	http://dx.doi.org/10.1371/journal.pone.0055357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383166	Green Published, Green Submitted, gold			2022-12-27	WOS:000315563800145
J	Rosenberg, RS; Baughman, SL; Bailenson, JN				Rosenberg, Robin S.; Baughman, Shawnee L.; Bailenson, Jeremy N.			Virtual Superheroes: Using Superpowers in Virtual Reality to Encourage Prosocial Behavior	PLOS ONE			English	Article							VIDEO GAMES INCREASES; SELF; EMPATHY; IMPACT	Background: Recent studies have shown that playing prosocial video games leads to greater subsequent prosocial behavior in the real world. However, immersive virtual reality allows people to occupy avatars that are different from them in a perceptually realistic manner. We examine how occupying an avatar with the superhero ability to fly increases helping behavior. Principal Findings: Using a two-by-two design, participants were either given the power of flight (their arm movements were tracked to control their flight akin to Superman's flying ability) or rode as a passenger in a helicopter, and were assigned one of two tasks, either to help find a missing diabetic child in need of insulin or to tour a virtual city. Participants in the "super-flight" conditions helped the experimenter pick up spilled pens after their virtual experience significantly more than those who were virtual passengers in a helicopter. Conclusion: The results indicate that having the "superpower" of flight leads to greater helping behavior in the real world, regardless of how participants used that power. A possible mechanism for this result is that having the power of flight primed concepts and prototypes associated with superheroes (e.g., Superman). This research illustrates the potential of using experiences in virtual reality technology to increase prosocial behavior in the physical world.	[Baughman, Shawnee L.; Bailenson, Jeremy N.] Stanford Univ, Dept Commun, Palo Alto, CA 94304 USA	Stanford University		Robin@DrRobinRosenberg.com						Anderson CA, 2004, J ADOLESCENCE, V27, P113, DOI 10.1016/j.adolescence.2003.10.009; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Bailenson J, 2004, P 7 ANN INT WORKSH P; Bailenson JN, 2005, PRESENCE-VIRTUAL AUG, V14, P379, DOI 10.1162/105474605774785235; Blascovich J., 2011, INFINITE REALITY AVA, DOI DOI 10.1162/PRES_R_00068; CALVERT SL, 1994, J APPL DEV PSYCHOL, V15, P125, DOI DOI 10.1016/0193-3973(94)90009-4; Cheung PC, 1998, J ADOLESCENCE, V21, P31, DOI 10.1006/jado.1997.0127; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Fox J, 2009, PRESENCE-TELEOP VIRT, V18, P294, DOI 10.1162/pres.18.4.294; Fox J, 2009, MEDIA PSYCHOL, V12, P1, DOI 10.1080/15213260802669474; Gabriel S, 2011, PSYCHOL SCI, V22, P990, DOI 10.1177/0956797611415541; Gentile DA, 2009, PERS SOC PSYCHOL B, V35, P752, DOI 10.1177/0146167209333045; Gillath O, 2008, MEDIA PSYCHOL, V11, P259, DOI 10.1080/15213260801906489; Greitemeyer T, 2011, J SOC PSYCHOL, V151, P121, DOI 10.1080/00224540903365588; Greitemeyer T, 2010, EMOTION, V10, P796, DOI 10.1037/a0020194; Greitemeyer T, 2010, J PERS SOC PSYCHOL, V98, P211, DOI 10.1037/a0016997; Hershfield HE, 2011, J MARKETING RES, V48, pS23, DOI 10.1509/jmkr.48.SPL.S23; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Lanier J, 2001, SCI AM, V284, P66, DOI 10.1038/scientificamerican0401-66; Nelson LD, 2005, J EXP SOC PSYCHOL, V41, P423, DOI 10.1016/j.jesp.2004.08.003; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Rothbaum BO, 2000, J CONSULT CLIN PSYCH, V68, P1020, DOI 10.1037/0022-006X.68.6.1020; Slater M, 2004, PRESENCE-VIRTUAL AUG, V13, P484, DOI 10.1162/1054746041944849; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2009, IEEE COMPUT GRAPH, V29, P76, DOI 10.1109/MCG.2009.55; Wheeler SC, 2007, PERS SOC PSYCHOL REV, V11, P234, DOI 10.1177/1088868307302223; Wheeler SC, 2001, J EXP SOC PSYCHOL, V37, P173, DOI 10.1006/jesp.2000.1448; Wyer NA, 2011, J EXP SOC PSYCHOL, V47, P1300, DOI 10.1016/j.jesp.2011.05.008	29	173	177	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55003	10.1371/journal.pone.0055003	http://dx.doi.org/10.1371/journal.pone.0055003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383029	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800099
J	Yokochi, N; Tanaka, S; Matsumoto, K; Oishi, H; Tashiro, Y; Yoshikane, Y; Nakashima, M; Kanda, K; Kobayashi, G				Yokochi, Nana; Tanaka, Shigemitsu; Matsumoto, Kouichi; Oishi, Hirotaka; Tashiro, Yukihiro; Yoshikane, Yu; Nakashima, Mikio; Kanda, Kohzo; Kobayashi, Genta			Distribution of Virulence Markers among Vibrio vulnificus Isolates of Clinical and Environmental Origin and Regional Characteristics in Japan	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CAPSULAR POLYSACCHARIDE OPERON; OLIGONUCLEOTIDE PROBES; PHENOTYPIC METHODS; PCR; EPIDEMIOLOGY; IDENTIFICATION; SEPTICEMIA; INFECTION; STRAINS	Background: Vibrio vulnificus is an opportunistic human pathogen that is widely distributed in estuarine environments and is capable of causing necrotizing fasciitis and sepsis. In Japan, based on epidemiological research, the incidences of V. vulnificus were concentrated in Kyusyu, mainly in coastal areas of the Ariake Sea. To examine the virulence potential, various genotyping methods have recently been developed. This study aimed to investigate the distribution of virulence markers among V. vulnificus isolates of clinical and environmental origin in three coastal areas with different infection incidences and to determine whether these isolates have the siderophore encoding gene viuB. Methodology/Principal Findings: We examined the distribution of genotypes of the 16S ribosomal ribonucleic acid (rRNA) gene, vvhA, vcg, and capsular polysaccharide (CPS), and the presence of viuB in 156 isolates collected from patients and environmental samples in Japan. The environmental samples were collected from three coastal areas: the Ariake Sea, Ise & Mikawa Bay, and Karatsu Bay. The results showed disparity in the ratios of genotypes depending on the sample origins. V. vulnificus isolates obtained from patients were classified into the clinical type for all genotypes. In the environmental isolates, the ratios of the clinical type for genotypes of the 16S rRNA gene, vvhA, and vcg were in the order of the Ariake Sea>Ise & Mikawa Bay>Karatsu Bay. Meanwhile, CPS analysis showed no significant difference. Most isolates possessed viuB. Conclusions: Many V. vulnificus belonging to the clinical type existed in the Ariake Sea. Three coastal areas with different infection incidences showed distinct ratios of genotypes. This may indicate that the distribution of clinical isolates correlates with the incidence of V. vulnificus infection.	[Yokochi, Nana; Kanda, Kohzo; Kobayashi, Genta] Saga Univ, Fac Agr, Dept Appl Biochem & Food Sci, Saga 840, Japan; [Tanaka, Shigemitsu] Osaka Municipal Tech Res Inst, Biomat & Commod Chem Res Div, Osaka 536, Japan; [Matsumoto, Kouichi; Oishi, Hirotaka; Nakashima, Mikio] Saga Univ, Fac Med, Dept Anesthesiol & Crit Care Med, Saga 840, Japan; [Tashiro, Yukihiro] Kyushu Univ, Inst Adv Study, Higashi Ku, Fukuoka, Japan; [Yoshikane, Yu] Kochi Univ, Tosa Food Business Creator Project Team, Nankoku, Kochi, Japan	Saga University; Saga University; Kyushu University; Kochi University	Kobayashi, G (corresponding author), Saga Univ, Fac Agr, Dept Appl Biochem & Food Sci, Saga 840, Japan.	gentak@cc.saga-u.ac.jp		Matsumoto, Kouichi/0000-0002-5743-3822; Tashiro, Yukihiro/0000-0003-3245-7227	Ariake Sea Research Project, Saga University, Japan	Ariake Sea Research Project, Saga University, Japan	This study was supported by the Ariake Sea Research Project, Saga University, Japan (http://www.ariake.civil.saga-u.ac.jp/index_e.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acinas SG, 1999, APPL ENVIRON MICROB, V65, P514; AZNAR R, 1994, INT J SYST BACTERIOL, V44, P330, DOI 10.1099/00207713-44-2-330; Bertilsson S, 2002, APPL ENVIRON MICROB, V68, P6077, DOI 10.1128/AEM.68.12.6077-6086.2002; Biosca EG, 1997, APPL ENVIRON MICROB, V63, P1460, DOI 10.1128/AEM.63.4.1460-1466.1997; Bisharat N, 1999, LANCET, V354, P1421, DOI 10.1016/S0140-6736(99)02471-X; Bisharat N, 1996, LANCET, V348, P1585, DOI 10.1016/S0140-6736(05)66199-5; BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; Bogard RW, 2007, APPL ENVIRON MICROB, V73, P7501, DOI 10.1128/AEM.01551-07; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Colodner R, 2004, J CLIN MICROBIOL, V42, P4137, DOI 10.1128/JCM.42.9.4137-4140.2004; Dalsgaard A, 1996, EUR J CLIN MICROBIOL, V15, P227, DOI 10.1007/BF01591359; DePaola A, 2003, APPL ENVIRON MICROB, V69, P4006, DOI 10.1128/AEM.69.7.4006-4011.2003; Han FF, 2009, FOODBORNE PATHOG DIS, V6, P1251, DOI 10.1089/fpd.2009.0343; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; Hsueh PR, 2004, EMERG INFECT DIS, V10, P1363, DOI 10.3201/eid1008.040047; Inoue Y, 2008, J DERMATOL, V35, P129, DOI 10.1111/j.1346-8138.2008.00432.x; Inoue Y, 2007, BIOSCI TRENDS, V1, P134; Jones MK, 2008, APPL ENVIRON MICROB, V74, P182, DOI 10.1128/AEM.02436-07; Kim MS, 2001, AQUACULTURE, V193, P199, DOI 10.1016/S0044-8486(00)00495-6; Mahmud ZH, 2008, FEMS MICROBIOL ECOL, V64, P209, DOI 10.1111/j.1574-6941.2008.00460.x; Matsumoto K, 2010, J INFECT CHEMOTHER, V16, P272, DOI 10.1007/s10156-010-0050-z; MAXWELL EL, 1991, MED J AUSTRALIA, V154, P214, DOI 10.5694/j.1326-5377.1991.tb121039.x; MELHUS A, 1995, SCAND J INFECT DIS, V27, P81, DOI 10.3109/00365549509018980; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Oishi Hirotaka, 2006, Kansenshogaku Zasshi, V80, P680; Panicker G, 2004, CAN J MICROBIOL, V50, P911, DOI 10.1139/W04-085; PARK SD, 1991, J AM ACAD DERMATOL, V24, P397, DOI 10.1016/0190-9622(91)70059-B; Powell JL, 1997, INFECT IMMUN, V65, P3713, DOI 10.1128/IAI.65.9.3713-3718.1997; Randa MA, 2004, APPL ENVIRON MICROB, V70, P5469, DOI 10.1128/AEM.70.9.5469-5476.2004; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Sanjuan E, 2009, APPL ENVIRON MICROB, V75, P1604, DOI 10.1128/AEM.01594-08; Senoh M, 2005, MICROBIOL IMMUNOL, V49, P513, DOI 10.1111/j.1348-0421.2005.tb03756.x; SIMPSON LM, 1987, INFECT IMMUN, V55, P269, DOI 10.1128/IAI.55.1.269-272.1987; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; Warner E, 2008, APPL ENVIRON MICROB, V74, P80, DOI 10.1128/AEM.01434-07; Wright AC, 2001, INFECT IMMUN, V69, P6893, DOI 10.1128/IAI.69.11.6893-6901.2001; Yahiro S, 2008, KUMAMOTO PREFECTURAL, V38, P27	38	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55219	10.1371/journal.pone.0055219	http://dx.doi.org/10.1371/journal.pone.0055219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383115	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800133
J	Qiu, QC; Lu, PC; Xiang, YZ; Shyr, Y; Chen, X; Lehmann, BD; Viox, DJ; George, AL; Yi, YJ				Qiu, Qingchao; Lu, Pengcheng; Xiang, Yuzhu; Shyr, Yu; Chen, Xi; Lehmann, Brian David; Viox, Daniel Joseph; George, Alfred L., Jr.; Yi, Yajun			A Data Similarity-Based Strategy for Meta-analysis of Transcriptional Profiles in Cancer	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; 70-GENE PROGNOSIS-SIGNATURE; SAMPLE-SIZE CALCULATIONS; BREAST-CANCER; RISK STRATIFICATION; DISTANT METASTASIS; HISTOLOGIC GRADE; DNA MICROARRAYS; VALIDATION; PREDICT	Background: Robust transcriptional signatures in cancer can be identified by data similarity-driven meta-analysis of gene expression profiles. An unbiased data integration and interrogation strategy has not previously been available. Methods and Findings: We implemented and performed a large meta-analysis of breast cancer gene expression profiles from 223 datasets containing 10,581 human breast cancer samples using a novel data similarity-based approach (iterative EXALT). Cancer gene expression signatures extracted from individual datasets were clustered by data similarity and consolidated into a meta-signature with a recurrent and concordant gene expression pattern. A retrospective survival analysis was performed to evaluate the predictive power of a novel meta-signature deduced from transcriptional profiling studies of human breast cancer. Validation cohorts consisting of 6,011 breast cancer patients from 21 different breast cancer datasets and 1,110 patients with other malignancies (lung and prostate cancer) were used to test the robustness of our findings. During the iterative EXALT analysis, 633 signatures were grouped by their data similarity and formed 121 signature clusters. From the 121 signature clusters, we identified a unique meta-signature (BRmet50) based on a cluster of 11 signatures sharing a phenotype related to highly aggressive breast cancer. In patients with breast cancer, there was a significant association between BRmet50 and disease outcome, and the prognostic power of BRmet50 was independent of common clinical and pathologic covariates. Furthermore, the prognostic value of BRmet50 was not specific to breast cancer, as it also predicted survival in prostate and lung cancers. Conclusions: We have established and implemented a novel data similarity-driven meta-analysis strategy. Using this approach, we identified a transcriptional meta-signature (BRmet50) in breast cancer, and the prognostic performance of BRmet50 was robust and applicable across a wide range of cancer-patient populations.	[Qiu, Qingchao; Xiang, Yuzhu; George, Alfred L., Jr.; Yi, Yajun] Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA; [Qiu, Qingchao] S China Univ Technol, Canc Res Inst, Hengyang, Hunan, Peoples R China; [Qiu, Qingchao] S China Univ Technol, Human Morphol Ctr, Hengyang, Hunan, Peoples R China; [Lu, Pengcheng; Shyr, Yu; Chen, Xi] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Xiang, Yuzhu] Shandong Univ, Prov Hosp, Minimally Invas Urol Ctr, Jinan 250100, Shandong, Peoples R China; [Lehmann, Brian David] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Viox, Daniel Joseph] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [George, Alfred L., Jr.; Yi, Yajun] Vanderbilt Univ, Inst Integrat Genom, Nashville, TN USA	Vanderbilt University; South China University of Technology; South China University of Technology; Vanderbilt University; Shandong University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Vanderbilt University	Yi, YJ (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA.	yajun.yi@vanderbilt.edu	Lehmann, Brian D./H-8464-2019	Lehmann, Brian D./0000-0003-0407-5248	National Cancer Institute at the National Institutes of Health [CA114033]; American Cancer Society [IRG-58-009-51]; National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH) [UL1 RR024975, CRC1838]; NATIONAL CANCER INSTITUTE [K01CA114033, P50CA095103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a Howard Temin Award from the National Cancer Institute at the National Institutes of Health (CA114033 to YY), American Cancer Society-Institutional Research Grant (#IRG-58-009-51 to YY), and the Vanderbilt Clinical and Translational Science Awards (CTSA) UL1 RR024975 from National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), (CRC1838 to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Alles MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004710; Anders CK, 2011, J CLIN ONCOL, V29, pE18, DOI 10.1200/JCO.2010.28.9199; [Anonymous], 2007, LANCET ONCOL, V8, P1079, DOI 10.1016/S1470-2045(07)70346-7; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bisognin A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-201; Borozan I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-305; Bueno-de-Mesquita JM, 2009, BREAST CANCER RES TR, V117, P483, DOI 10.1007/s10549-008-0191-2; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cahan P, 2005, GENE, V360, P78, DOI 10.1016/j.gene.2005.07.008; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; CANTOR AB, 1992, J CLIN EPIDEMIOL, V45, P1131, DOI 10.1016/0895-4356(92)90153-E; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Clark TG, 2003, BRIT J CANCER, V89, P781, DOI 10.1038/sj.bjc.6601117; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeConde R, 2006, STAT APPL GENET MOL, V5; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Flanagan MB, 2008, MODERN PATHOL, V21, P1255, DOI 10.1038/modpathol.2008.54; Foekens JA, 2006, J CLIN ONCOL, V24, P1665, DOI 10.1200/JCO.2005.03.9115; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Geradts J, 2010, CANCER INVEST, V28, P969, DOI 10.3109/07357907.2010.512600; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Haibe-Kains B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r18; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Lukes L, 2009, CANCER RES, V69, P310, DOI 10.1158/0008-5472.CAN-08-3520; Ma SG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-1; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Mehta R, 2011, CLIN BREAST CANCER, V11, P20, DOI 10.3816/CBC.2011.n.004; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mook S, 2009, BREAST CANCER RES TR, V116, P295, DOI 10.1007/s10549-008-0130-2; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Nedumpara T, 2011, BREAST, V20, P437, DOI 10.1016/j.breast.2011.04.006; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Reis JS, 2006, J CLIN PATHOL, V59, P225, DOI 10.1136/jcp.2005.028324; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2002, CANCER RES, V62, P4427; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shih JH, 1995, CONTROL CLIN TRIALS, V16, P395, DOI 10.1016/S0197-2456(95)00132-8; Smith DD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-63; Sontrop HMJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021681; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stevens JR, 2009, BIOINFORMATICS, V25, P2619, DOI 10.1093/bioinformatics/btp468; Straver ME, 2010, BREAST CANCER RES TR, V119, P551, DOI 10.1007/s10549-009-0333-1; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Szabo PM, 2010, ONCOGENE, V29, P3163, DOI 10.1038/onc.2010.80; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Wren JD, 2009, BIOINFORMATICS, V25, P1694, DOI 10.1093/bioinformatics/btp290; Wu J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-420; Yi YJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r133	92	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54979	10.1371/journal.pone.0054979	http://dx.doi.org/10.1371/journal.pone.0054979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383020	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200001
J	Reen, FJ; Haynes, JM; Mooij, MJ; O'Gara, F				Reen, F. Jerry; Haynes, Jill M.; Mooij, Marlies J.; O'Gara, Fergal			A Non-Classical LysR-Type Transcriptional Regulator PA2206 Is Required for an Effective Oxidative Stress Response in Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SALMONELLA-TYPHIMURIUM; SINORHIZOBIUM-MELILOTI; OPPORTUNISTIC PATHOGEN; HUMAN NEUTROPHILS; GENE-EXPRESSION; FULL VIRULENCE; OXYR	LysR-type transcriptional regulators (LTTRs) are emerging as key circuit components in regulating microbial stress responses and are implicated in modulating oxidative stress in the human opportunistic pathogen Pseudomonas aeruginosa. The oxidative stress response encapsulates several strategies to overcome the deleterious effects of reactive oxygen species. However, many of the regulatory components and associated molecular mechanisms underpinning this key adaptive response remain to be characterised. Comparative analysis of publically available transcriptomic datasets led to the identification of a novel LTTR, PA2206, whose expression was altered in response to a range of host signals in addition to oxidative stress. PA2206 was found to be required for tolerance to H2O2 in vitro and lethality in vivo in the Zebrafish embryo model of infection. Transcriptomic analysis in the presence of H2O2 showed that PA2206 altered the expression of 58 genes, including a large repertoire of oxidative stress and iron responsive genes, independent of the master regulator of oxidative stress, OxyR. Contrary to the classic mechanism of LysR regulation, PA2206 did not autoregulate its own expression and did not influence expression of adjacent or divergently transcribed genes. The PA2214-15 operon was identified as a direct target of PA2206 with truncated promoter fragments revealing binding to the 5'-ATTGCCTGGGGTTAT-3' LysR box adjacent to the predicted -35 region. PA2206 also interacted with the pvdS promoter suggesting a global dimension to the PA2206 regulon, and suggests PA2206 is an important regulatory component of P. aeruginosa adaptation during oxidative stress.	[Reen, F. Jerry; Haynes, Jill M.; Mooij, Marlies J.; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	University College Cork	O'Gara, F (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland.	f.ogara@ucc.ie	Reen, Jerry/AAG-7155-2019	O'Gara, Fergal/0000-0002-2659-0673; Reen, F. Jerry/0000-0002-7717-9892	European Commission [MTKD-CT-2006-042062, O36314, FP7-PEOPLE-2009-RG, EU 256596]; Science Foundation Ireland [SFI 04/BR/B0597, 07/IN.1/B948, 08/RFP/GEN1295, 08/RFP/GEN1319, 09/RFP/BMT2350]; Department of Agriculture and Food [DAF RSF 06 321, DAF RSF 06 377, FIRM 08/RDC/629]; Irish Research Council for Science, Engineering and Technology [05/EDIV/FP107, PD/2011/2414]; Health Research Board [RP/2006/271, RP/2007/290, HRA/2009/146]; Environmental Protection Agency [EPA2006-PhD-S-21, EPA2008-PhD-S-2]; Marine Institute [C2CRA 2007/082]; Higher Education Authority of Ireland [PRTLI3]; Health Service Executive (HSE) surveillance fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture and Food(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board; Environmental Protection Agency(United States Environmental Protection Agency); Marine Institute; Higher Education Authority of Ireland; Health Service Executive (HSE) surveillance fund	This research was supported in part by grants awarded by the European Commission (MTKD-CT-2006-042062; O36314; FP7-PEOPLE-2009-RG, EU 256596, 2010-2013), Science Foundation Ireland (SFI 04/BR/B0597; 07/IN.1/B948; 08/RFP/GEN1295; 08/RFP/GEN1319; 09/RFP/BMT2350), the Department of Agriculture and Food (DAF RSF 06 321; DAF RSF 06 377; FIRM 08/RDC/629), the Irish Research Council for Science, Engineering and Technology (05/EDIV/FP107; PD/2011/2414), the Health Research Board (RP/2006/271; RP/2007/290; HRA/2009/146), the Environmental Protection Agency (EPA2006-PhD-S-21; EPA2008-PhD-S-2), the Marine Institute (Beaufort award C2CRA 2007/082), the Higher Education Authority of Ireland (PRTLI3) and the Health Service Executive (HSE) surveillance fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braz VS, 2010, J BACTERIOL, V192, P5480, DOI 10.1128/JB.00496-10; Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115; Cheung DOY, 2000, INFECT IMMUN, V68, P4585, DOI 10.1128/IAI.68.8.4585-4592.2000; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Chugani S, 2007, MICROB PATHOGENESIS, V42, P29, DOI 10.1016/j.micpath.2006.10.004; CORNELIS P, 1992, J GEN MICROBIOL, V138, P1337, DOI 10.1099/00221287-138-7-1337; Fargier E, 2012, J BACTERIOL, V194, P3502, DOI 10.1128/JB.06632-11; Flores-Cruz Z, 2011, APPL ENVIRON MICROB, V77, P6426, DOI 10.1128/AEM.05813-11; Fradrich C, 2012, J BACTERIOL, V194, P1100, DOI 10.1128/JB.06425-11; Frisk A, 2004, INFECT IMMUN, V72, P5433, DOI 10.1128/IAI.72.9.5433-5438.2004; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Gonzalez-Flecha B, 1999, J BACTERIOL, V181, P3833; Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009; Harris AG, 2002, MICROBIOL-SGM, V148, P3813, DOI 10.1099/00221287-148-12-3813; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; HOIBY N, 1990, THORAX, V45, P881, DOI 10.1136/thx.45.11.881; HRYNIEWICZ MM, 1994, J BACTERIOL, V176, P3673, DOI 10.1128/JB.176.12.3673-3682.1994; Imperi F, 2010, ENVIRON MICROBIOL, V12, P1630, DOI 10.1111/j.1462-2920.2010.02210.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Johnson JR, 2006, INFECT IMMUN, V74, P461, DOI 10.1128/IAI.74.1.461-468.2006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lahiri A, 2008, MICROBIOL-SGM, V154, P2837, DOI 10.1099/mic.0.2008/017574-0; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Lau GW, 2005, INFECT IMMUN, V73, P2550, DOI 10.1128/IAI.73.4.2550-2553.2005; Lee JS, 2005, INFECT IMMUN, V73, P4399, DOI 10.1128/IAI.73.7.4399-4403.2005; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; MacLean AM, 2008, J BACTERIOL, V190, P1237, DOI 10.1128/JB.01456-07; MacLean AM, 2011, MICROBIOL-SGM, V157, P2522, DOI 10.1099/mic.0.050542-0; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mailloux RJ, 2011, ANTON LEEUW INT J G, V99, P433, DOI 10.1007/s10482-010-9538-x; Mark GL, 2005, P NATL ACAD SCI USA, V102, P17454, DOI 10.1073/pnas.0506407102; Melstrom KA, 2007, J SURG RES, V143, P50, DOI 10.1016/j.jss.2007.02.046; NEU HC, 1983, J ANTIMICROB CHEMOTH, V11, P1; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; PAPPSZABO E, 1994, INFECT IMMUN, V62, P2662; PARSEK MR, 1994, P NATL ACAD SCI USA, V91, P12393, DOI 10.1073/pnas.91.26.12393; ROWLEY DL, 1991, J BACTERIOL, V173, P968, DOI 10.1128/jb.173.3.968-977.1991; Salunkhe P, 2005, J BACTERIOL, V187, P2565, DOI 10.1128/JB.187.8.2565-2572.2005; Salva PS, 1996, PEDIATR PULM, V21, P11, DOI 10.1002/(SICI)1099-0496(199601)21:1<11::AID-PPUL2>3.0.CO;2-T; Sambrook J., 2002, MOL CLONING LAB MANU; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Taylor PD, 1998, INFECT IMMUN, V66, P3208, DOI 10.1128/IAI.66.7.3208-3217.1998; Tian ZX, 2009, NUCLEIC ACIDS RES, V37, P7546, DOI 10.1093/nar/gkp828; Tkachenko AG, 2012, RES MICROBIOL, V163, P83, DOI 10.1016/j.resmic.2011.10.009; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Turlin E, 2005, RES MICROBIOL, V156, P312, DOI 10.1016/j.resmic.2004.10.012; Verneuil N, 2005, MICROBIOL-SGM, V151, P3997, DOI 10.1099/mic.0.28325-0; Vinckx T, 2010, MICROBIOL-SGM, V156, P678, DOI 10.1099/mic.0.031971-0; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Wilson R, 1996, EUR RESPIR J, V9, P1523, DOI 10.1183/09031936.96.09071523; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861	62	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54479	10.1371/journal.pone.0054479	http://dx.doi.org/10.1371/journal.pone.0054479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382903	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500013
J	van Nierop, BJ; van Assen, HC; van Deel, ED; Niesen, LBP; Duncker, DJ; Strijkers, GJ; Nicolay, K				van Nierop, Bastiaan J.; van Assen, Hans C.; van Deel, Elza D.; Niesen, Leonie B. P.; Duncker, Dirk J.; Strijkers, Gustav J.; Nicolay, Klaas			Phenotyping of Left and Right Ventricular Function in Mouse Models of Compensated Hypertrophy and Heart Failure with Cardiac MRI	PLOS ONE			English	Article							MURINE MODEL; MECHANISMS; MICE; SEGMENTATION; TRANSITION; DISEASE	Background: Left ventricular (LV) and right ventricular (RV) function have an important impact on symptom occurrence, disease progression and exercise tolerance in pressure overload-induced heart failure, but particularly RV functional changes are not well described in the relevant aortic banding mouse model. Therefore, we quantified time-dependent alterations in the ventricular morphology and function in two models of hypertrophy and heart failure and we studied the relationship between RV and LV function during the transition from hypertrophy to heart failure. Methods: MRI was used to quantify RV and LV function and morphology in healthy (n = 4) and sham operated (n = 3) C57BL/6 mice, and animals with a mild (n = 5) and a severe aortic constriction (n = 10). Results: Mice subjected to a mild constriction showed increased LV mass (P < 0.01) and depressed LV ejection fraction (EF) (P < 0.05) as compared to controls, but had similar RVEF (P > 0.05). Animals with a severe constriction progressively developed LV hypertrophy (P < 0.001), depressed LVEF (P < 0.001), followed by a declining RVEF (P < 0.001) and the development of pulmonary remodeling, as compared to controls during a 10-week follow-up. Myocardial strain, as a measure for local cardiac function, decreased in mice with a severe constriction compared to controls (P < 0.05). Conclusions: Relevant changes in mouse RV and LV function following an aortic constriction could be quantified using MRI. The well-controlled models described here open opportunities to assess the added value of new MRI techniques for the diagnosis of heart failure and to study the impact of new therapeutic strategies on disease progression and symptom occurrence.	[van Nierop, Bastiaan J.; Niesen, Leonie B. P.; Strijkers, Gustav J.; Nicolay, Klaas] Eindhoven Univ Technol, Biomed NMR, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [van Assen, Hans C.] Eindhoven Univ Technol, Dept Elect Engn, NL-5600 MB Eindhoven, Netherlands; [van Deel, Elza D.; Duncker, Dirk J.] Univ Med Ctr Rotterdam, Erasmus MC, Thoraxctr, Rotterdam, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Erasmus University Rotterdam; Erasmus MC	van Nierop, BJ (corresponding author), Eindhoven Univ Technol, Biomed NMR, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	b.j.v.nierop@tue.nl	van Assen, Hans C./F-4593-2016	van Assen, Hans C./0000-0003-4907-904X; Strijkers, Gustav/0000-0001-6700-5058; Nicolay, Klaas/0000-0002-4179-616X	Center for Translational Molecular Medicine; project TRIUMPH [01C-103]; Netherlands Heart Foundation	Center for Translational Molecular Medicine; project TRIUMPH; Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by the Center for Translational Molecular Medicine (www.ctmm.nl), project TRIUMPH (grant 01C-103), and by the Netherlands Heart Foundation (http://www.hartstichting.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee Dipanjan, 2010, Curr Heart Fail Rep, V7, P202, DOI 10.1007/s11897-010-0031-7; Berry JM, 2007, DRUG DISCOV TODAY DI, V4, P197, DOI [DOI 10.1016/J.DDM0D.2007.06.003, 10.1016/j.ddmod.2007.06.003]; Bottomley PA., 2007, ENCY MAGNETIC RESONA; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chen YJ, 2012, HYPERTENSION, V59, P1170, DOI 10.1161/HYPERTENSIONAHA.111.186072; Cokkinos DV, 2011, HEART FAIL REV, V16, P1, DOI 10.1007/s10741-010-9192-4; Coolen BF, 2011, NMR BIOMED, V24, P154, DOI 10.1002/nbm.1566; Costandi PN, 2006, AM J PHYSIOL-HEART C, V291, pH2971, DOI 10.1152/ajpheart.00571.2006; de Couto G, 2010, NAT REV CARDIOL, V7, P334, DOI 10.1038/nrcardio.2010.51; DENOLIN H, 1983, EUR HEART J, V4, P445, DOI 10.1093/oxfordjournals.eurheartj.a061500; FISCHER SE, 1993, MAGNET RESON MED, V30, P191, DOI 10.1002/mrm.1910300207; Florack L., 2007, 2007 IEEE 11 INT C C, P1; Florack L, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/341242; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Garot J, 2000, CIRCULATION, V101, P981, DOI 10.1161/01.CIR.101.9.981; Gupta A, 2009, AM J PHYSIOL-HEART C, V297, pH59, DOI 10.1152/ajpheart.00178.2009; Hankiewicz JH, 2008, AM J PHYSIOL-HEART C, V294, pH330, DOI 10.1152/ajpheart.01109.2007; Heijman E, 2008, J MAGN RESON IMAGING, V27, P86, DOI 10.1002/jmri.21236; Iles L, 2008, J AM COLL CARDIOL, V52, P1574, DOI 10.1016/j.jacc.2008.06.049; Jacoby C, 2006, BASIC RES CARDIOL, V101, P87, DOI 10.1007/s00395-005-0542-7; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Kee K, 2010, CIRC J, V74, P2507, DOI 10.1253/circj.CJ-10-0869; Le Tourneau T, 2011, MINERVA CARDIOANGIOL, V59, P349; Lemon DD, 2011, J MOL CELL CARDIOL, V51, P41, DOI 10.1016/j.yjmcc.2011.04.005; Lindqvist P, 2008, EUR J ECHOCARDIOGR, V9, P225, DOI 10.1016/j.euje.2007.04.002; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lygate C, 2006, DRUG DISCOV TODAY DI, V3, P283, DOI 10.1016/j.ddmod.2006.10.002; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; MANNING WJ, 1994, AM J PHYSIOL, V266, pH1672, DOI 10.1152/ajpheart.1994.266.4.H1672; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Qu JX, 2009, CIRC RES, V104, P365, DOI 10.1161/CIRCRESAHA.108.184044; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rothermel BA, 2005, PHYSIOL GENOMICS, V23, P18, DOI 10.1152/physiolgenomics.00061.2005; van Deel ED, 2011, J MOL CELL CARDIOL, V50, P1017, DOI 10.1016/j.yjmcc.2011.01.016; van Nierop BJ, 2013, MAGN RESON MED, V69, P1735, DOI 10.1002/mrm.24424; Vandsburger MH, 2010, MAGN RESON MED, V63, P648, DOI 10.1002/mrm.22280; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wiesmann F, 2002, AM J PHYSIOL-HEART C, V283, pH1065, DOI 10.1152/ajpheart.00802.2001	42	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55424	10.1371/journal.pone.0055424	http://dx.doi.org/10.1371/journal.pone.0055424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383329	Green Published, Green Submitted, gold			2022-12-27	WOS:000314597900036
J	Codolo, G; Plotegher, N; Pozzobon, T; Brucale, M; Tessari, I; Bubacco, L; de Bernard, M				Codolo, Gaia; Plotegher, Nicoletta; Pozzobon, Tommaso; Brucale, Marco; Tessari, Isabella; Bubacco, Luigi; de Bernard, Marina			Triggering of Inflammasome by Aggregated alpha-Synuclein, an Inflammatory Response in Synucleinopathies	PLOS ONE			English	Article							STATISTICAL-MECHANICAL THEORY; PARKINSONS-DISEASE; NALP3 INFLAMMASOME; ESCHERICHIA-COLI; MICROGLIAL ACTIVATION; CEREBROSPINAL-FLUID; NLRP3 INFLAMMASOME; FUTURE-DIRECTIONS; SUBSTANTIA-NIGRA; IMMUNE-RESPONSE	Parkinson's disease (PD) is one of the most common neurodegenerative diseases. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of the brain. Another feature is represented by the formation in these cells of inclusions called Lewy bodies (LB), principally constituted by fibrillar a-synuclein (alpha Syn). This protein is considered a key element in the aetiology of a group of neurodegenerative disorders termed synucleinopathies, which include PD, but the cellular and molecular mechanisms involved are not completely clear. It is established that the inflammatory process plays a crucial role in the pathogenesis and/or progression of PD; moreover, it is known that aggregated alpha Syn, released by neurons, activates microglia cells to produce pro-inflammatory mediators, such as IL-1 beta. IL-1b is one of the strongest pro-inflammatory cytokines; it is produced as an inactive mediator, and its maturation and activation requires inflammasome activation. In particular, the NLRP3 inflammasome is activated by a wide variety of stimuli, among which are crystallized and particulate material. In this work, we investigated the possibility that IL-1 beta production, induced by fibrillar alpha Syn, is involved the inflammasome activation. We demonstrated the competence of monomeric and fibrillar alpha Syn to induce synthesis of IL-1 beta, through TLR2 interaction; we found that the secretion of the mature cytokine was a peculiarity of the fibrillated protein. Moreover, we observed that the secretion of IL-1 beta involves NLRP3 inflammasome activation. The latter relies on the phagocytosis of fibrillar alpha Syn, followed by increased ROS production and cathepsin B release into the cytosol. Taken together, our data support the notion that fibrillar alpha Syn, likely released by neuronal degeneration, acts as an endogenous trigger inducing a strong inflammatory response in PD.	[Codolo, Gaia; Plotegher, Nicoletta; Tessari, Isabella; Bubacco, Luigi; de Bernard, Marina] Univ Padua, Dept Biol, Padua, Italy; [Codolo, Gaia; Pozzobon, Tommaso; de Bernard, Marina] Venetian Inst Mol Med, Padua, Italy; [Brucale, Marco] Natl Res Council CNR, Inst Nanostruct Mat ISMN, Rome, Italy	University of Padua; Veneto Institute Molecular Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR)	de Bernard, M (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	luigi.bubacco@unipd.it; marina.debernard@unipd.it	Bubacco, Luigi/B-5602-2012; Brucale, Marco/G-2455-2018; Tessari, Isabella/K-7847-2016	Bubacco, Luigi/0000-0001-7927-9208; Tessari, Isabella/0000-0002-5823-645X; CODOLO, GAIA/0000-0002-7793-2549; BRUCALE, MARCO/0000-0001-7244-4389; de Bernard, Marina/0000-0002-0091-4502; Plotegher, Nicoletta/0000-0001-7421-8705	Italian Ministry of University and Research; Fondazione Cariplo [2011-0485]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by Italian Ministry of University and Research, Prin projects (to MdB and LB) and Fondazione Cariplo, grant No 2011-0485 (to MdB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NEUROSCI RES, V69, P337, DOI 10.1016/j.neures.2010.12.020; Beraud D, J NEUROIMMUNE PHARM; Beraud Dawn, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS17, DOI 10.1016/S1353-8020(11)70008-6; Beraud D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00080; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Litteljohn D, 2010, PARKINSONS DIS, V2011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maguire-Zeiss KA, 2010, J NEURAL TRANSM, V117, P1019, DOI 10.1007/s00702-010-0431-6; Mankan AK, 2012, CLIN EXP IMMUNOL, V167, P369, DOI 10.1111/j.1365-2249.2011.04534.x; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; PALOKANGAS H, 1994, J BIOL CHEM, V269, P17577; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ren GP, 2007, J BACTERIOL, V189, P2777, DOI 10.1128/JB.01406-06; Reynolds AD, 2008, J NEUROIMMUNE PHARM, V3, P59, DOI 10.1007/s11481-008-9100-z; Roodveldt C, 2008, J CELL MOL MED, V12, P1820, DOI 10.1111/j.1582-4934.2008.00450.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Su E, DEV NEUROSCI, V32, P385; Su XM, 2009, NEUROTOX RES, V16, P238, DOI 10.1007/s12640-009-9053-x; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; van Gestel J, 2006, BIOPHYS J, V90, P3134, DOI 10.1529/biophysj.105.076000; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	66	349	369	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55375	10.1371/journal.pone.0055375	http://dx.doi.org/10.1371/journal.pone.0055375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383169	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600093
J	He, F; Kiener, TK; Lim, XF; Tan, YR; Raj, KVA; Tang, ML; Chow, VTK; Chen, QF; Kwang, J				He, Fang; Kiener, Tanja K.; Lim, Xiao Fang; Tan, Yunrui; Raj, Kattur Venkatachalam Ashok; Tang, Manli; Chow, Vincent T. K.; Chen, Qingfeng; Kwang, Jimmy			Development of A Sensitive and Specific Epitope-Blocking ELISA for Universal Detection of Antibodies to Human Enterovirus 71 Strains	PLOS ONE			English	Article							MOUTH-DISEASE; CAPSID PROTEIN; FOOT; OUTBREAK; HAND; INFECTION; EPIDEMIC; INFLUENZA; EVOLUTION; POLIOVIRUS	Background: Human Enterovirus 71 (EV71) is a common cause of hand, foot and mouth disease (HFMD) in young children. It is often associated with severe neurological diseases and mortalities in recent outbreaks across the Asia Pacific region. Currently, there is no efficient universal antibody test available to detect EV71 infections. Methodology/Principal Finding: In the present study, an epitope-blocking ELISA was developed to detect specific antibodies to human EV71 viruses in human or animal sera. The assay relies on a novel monoclonal antibody (Mab 1C6) that specifically binds to capsid proteins in whole EV71 viruses without any cross reaction to any EV71 capsid protein expressed alone. The sensitivity and specificity of the epitope-blocking ELISA for EV71 was evaluated and compared to microneutralization using immunized animal sera to multiple virus genotypes of EV71 and coxsackieviruses. Further, 200 serum sample from human individuals who were potentially infected with EV71 viruses were tested in both the blocking ELISA and microneutralization. Results indicated that antibodies to EV71 were readily detected in immunized animals or human sera by the epitope blocking ELISA whereas specimens with antibodies to other enteroviruses yielded negative results. This assay is not only simpler to perform but also shows higher sensitivity and specificity as compared to microneutralization. Conclusion: The epitope-blocking ELISA based on a unique Mab 1C6 provided highly sensitive and 100% specific detection of antibodies to human EV71 viruses in human sera.	[He, Fang; Kiener, Tanja K.; Lim, Xiao Fang; Tan, Yunrui; Raj, Kattur Venkatachalam Ashok; Tang, Manli; Kwang, Jimmy] Temasek Life Sci Lab, Singapore, Singapore; [Chow, Vincent T. K.; Kwang, Jimmy] Natl Univ Singapore, Dept Microbiol, Fac Med, Singapore 117548, Singapore; [Chen, Qingfeng] Natl Univ Singapore, Inst Mol & Cell Biol, Humanized Mouse Unit, Singapore 117548, Singapore; [Chen, Qingfeng] Singapore Massachusetts Inst Technol Alliance Res, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Kwang, J (corresponding author), Temasek Life Sci Lab, Singapore, Singapore.	kwang@tll.org.sg		Chow, Vincent/0000-0003-2634-6213; Kattur Venkatachalam, Ashok Raj/0000-0002-2628-3032	Temasek Life Science Laboratory	Temasek Life Science Laboratory	The authors are grateful for the financial support from Temasek Life Science Laboratory. (www.tll.org.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2007, J CLIN MICROBIOL, V45, P2037, DOI 10.1128/JCM.02432-06; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Alho A, 2003, J CLIN MICROBIOL, V41, P2294, DOI 10.1128/JCM.41.6.2294-2299.2003; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; BLOMBERG J, 1974, LANCET, V2, P112; Buttinelli G, 2003, VIROLOGY, V312, P74, DOI 10.1016/S0042-6822(03)00182-X; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Fiore L, 1997, J VIROL, V71, P6905, DOI 10.1128/JVI.71.9.6905-6912.1997; Frimann TH, 2007, VACCINE, V25, P6191, DOI 10.1016/j.vaccine.2007.06.002; Gallagher S, 2004, CURR PROTOC NEUROSCI; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Joki-Korpela P, 2000, J GEN VIROL, V81, P1709, DOI 10.1099/0022-1317-81-7-1709; KENNETT ML, 1974, B WORLD HEALTH ORGAN, V51, P609; Kuck D, 2007, J VIROL METHODS, V140, P17, DOI 10.1016/j.jviromet.2006.10.005; Lim XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029751; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Meng T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021757; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Olcese VA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-29; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Ranganathan Shoba, 2002, Appl Bioinformatics, V1, P43; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Singh BK, 2004, VET RES COMMUN, V28, P437, DOI 10.1023/B:VERC.0000034996.18533.90; Singh S, 2002, J CLIN MICROBIOL, V40, P2823, DOI 10.1128/JCM.40.8.2823-2827.2002; Stelzer-Braid S, 2008, J CLIN VIROL, V43, P241, DOI 10.1016/j.jcv.2008.06.012; TAKEDA N, 1994, J VIROL, V68, P854, DOI 10.1128/JVI.68.2.854-862.1994; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tran Chau Bich Nguyen, 2011, PLoS One, V6, pe21116, DOI 10.1371/journal.pone.0021116; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yamaguchi T, 1996, ARCH VIROL, V141, P1493, DOI 10.1007/BF01718250; Yokoyama Wayne M, 2006, Curr Protoc Immunol, VChapter 2, DOI 10.1002/0471142735.im0205s74	45	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55517	10.1371/journal.pone.0055517	http://dx.doi.org/10.1371/journal.pone.0055517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383215	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600119
J	Mack, B; Eggert, C; Eder, K; Imrich, S; Baumeister, P; Harreus, U; Gires, O				Mack, Brigitte; Eggert, Carola; Eder, Katharina; Imrich, Sannia; Baumeister, Philipp; Harreus, Ulrich; Gires, Olivier			Rapid and Non-Enzymatic In Vitro Retrieval of Tumour Cells from Surgical Specimens	PLOS ONE			English	Article							MOUSE MODELS; CANCER; LYMPHOCYTES; LINES; NECK; HEAD	The study of tumourigenesis commonly involves the use of established cell lines or single cell suspensions of primary tumours. Standard methods for the generation of short-term tumour cell cultures include the disintegration of tissue based on enzymatic and mechanical stress. Here, we describe a simple and rapid method for the preparation of single cells from primary carcinomas, which is independent of enzymatic treatment and feeder cells. Tumour biopsies are processed to 1 mm 3 cubes termed explants, which are cultured 1-3 days on agarose-coated well plates in specified medium. Through incisions generated in the explants, single cells are retrieved and collected from the culture supernatant and can be used for further analysis including in vitro and in vivo studies. Collected cells retain tumour-forming capacity in xenotransplantation assays, mimic the phenotype of the primary tumour, and facilitate the generation of cell lines.	[Mack, Brigitte; Eggert, Carola; Eder, Katharina; Imrich, Sannia; Baumeister, Philipp; Harreus, Ulrich; Gires, Olivier] Univ Munich, Grosshadern Clin, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany	University of Munich	Harreus, U (corresponding author), Univ Munich, Grosshadern Clin, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.	Uli.harreus@med.uni-muenchen.de; Olivier.gires@med.uni-muenchen.de	Gires, Olivier/V-2689-2017	Gires, Olivier/0000-0002-2292-7064				Borrell B, 2010, NATURE, V463, P858, DOI 10.1038/463858a; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Comer DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032924; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Dairkee SH, 1997, CANCER RES, V57, P1590; Denzel S, 2012, INT J EXP PATHOL, V93, P341, DOI 10.1111/j.1365-2613.2012.00826.x; Dieudonne A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041952; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; KEDAR E, 1982, EUR J CANCER CLIN ON, V18, P991, DOI 10.1016/0277-5379(82)90248-6; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Paget C, 2012, J BIOL CHEM, V287, P8816, DOI 10.1074/jbc.M111.304758; Sacks PG, 1996, CANCER METAST REV, V15, P27, DOI 10.1007/BF00049486; Silasi Dan-Arin, 2008, V414, P35; Valente MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019337; WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G; Zender L, 2007, CELL, V129, P838, DOI 10.1016/j.cell.2007.05.013	17	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55540	10.1371/journal.pone.0055540	http://dx.doi.org/10.1371/journal.pone.0055540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383219	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600123
J	Shen, Y; Wu, LJ; Xi, B; Liu, X; Zhao, XY; Cheng, H; Hou, DQ; Wang, XY; Mi, J				Shen, Yue; Wu, Lijun; Xi, Bo; Liu, Xin; Zhao, Xiaoyuan; Cheng, Hong; Hou, Dongqing; Wang, Xingyu; Mi, Jie			GCKR Variants Increase Triglycerides While Protecting from Insulin Resistance in Chinese Children	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TYPE-2 DIABETES RISK; FASTING GLUCOSE; POPULATION; OBESITY; GENES; ADOLESCENTS; LOCI; POLYMORPHISMS; ASSOCIATIONS	Background: Variants in gene encoding glucokinase regulator protein (GCKR) were found to have converse effects on triglycerides and glucose metabolic traits. We aimed to investigate the influence of GCKR variants for triglycerides and glucose metabolic traits in Chinese children and adults. Methods and Results: We genotyped two GCKR variants rs1260326 and rs1260333 in children and adults, and analyzed the association between two variants and triglycerides, glucose, insulin and HOMA-IR using linear regression model, and estimated the effect on insulin resistance using logistic regression model. Rs1260326 and rs1260333 associated with increased triglycerides in children and adults (p<0.05). In children, both variants significantly reduced insulin (p<0.05. for rs1260326, beta = -0.07; for rs1260333, beta = -0.07) and HOMA-IR (p<0.05. for rs1260326, beta = -0.03; for rs1260333, beta = -0.03). There were significant associations between two variants and insulin resistance for children. Under co-dominant model, for CT vs. CC, OR is 0.83 (95% CI 0.69-1.00) for rs1260326, and 0.83 (95% CI 0.68-1.00) for rs1260333; for TT vs. CC, OR is 0.72 (95% CI 0.58-0.88) for rs1260326, and 0.72 (95% CI 0.58-0.89) for rs1260333. Under allele model, for allele T vs. C, the ORs are 0.85 (95% CI 0.76-0.94) and 0.85 (95% CI 0.76-0.94) for rs1260326 and rs1260333, respectively). Conclusions: Our study confirmed the associations between GCKR variants and triglycerides in Chinese children and adults. Triglycerides-increasing alleles of GCKR variants reduce insulin and HOMA-IR index, and protect from insulin resistance in children. Our results suggested GCKR has an effect on development of insulin resistance in Chinese children.	[Shen, Yue] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Shen, Yue; Wu, Lijun; Zhao, Xiaoyuan; Cheng, Hong; Hou, Dongqing; Mi, Jie] Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China; [Xi, Bo] Shandong Univ, Sch Publ Hlth, Inst Maternal & Child Hlth Care, Jinan, Shandong, Peoples R China; [Liu, Xin; Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Institute of Pediatrics (CIP); Shandong University; Chinese Hypertension League	Wang, XY (corresponding author), Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China.	xingyuw@yahoo.com; jiemi2010@foxmail.com			National Nature Science Foundation of China [81172746]; Beijing Key Science and Technology Program [D111100000611002]; Beijing Health System Leading Talent [2009-1-08]; Beijing Training Project for the Leading Talents in S T [2011LJ07]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Key Science and Technology Program; Beijing Health System Leading Talent; Beijing Training Project for the Leading Talents in S T	This work was supported by National Nature Science Foundation of China (81172746), Beijing Key Science and Technology Program (D111100000611002), Beijing Health System Leading Talent Grant (2009-1-08), and the Beijing Training Project for the Leading Talents in S & T (2011LJ07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Hishida A, 2012, ENDOCR J; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Ling Y, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-66; Marshall WA, 1986, HUMAN GROWTH; Mi Jie, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P469; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Perez-Martinez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020555; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Roemmich JN, 2002, INT J OBESITY, V26, P701, DOI 10.1038/sj.ijo.0801975; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Windholz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022101; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55350	10.1371/journal.pone.0055350	http://dx.doi.org/10.1371/journal.pone.0055350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383164	gold, Green Published, Green Submitted			2022-12-27	WOS:000314610600091
J	Sohn, JC; Regier, JC; Mitter, C; Davis, D; Landry, JF; Zwick, A; Cummings, MP				Sohn, Jae-Cheon; Regier, Jerome C.; Mitter, Charles; Davis, Donald; Landry, Jean-Francois; Zwick, Andreas; Cummings, Michael P.			A Molecular Phylogeny for Yponomeutoidea (Insecta, Lepidoptera, Ditrysia) and Its Implications for Classification, Biogeography and the Evolution of Host Plant Use	PLOS ONE			English	Article							CONSENSUS TREES; ADVANCED MOTHS; ERMINE MOTH; GENE; BUTTERFLIES; SUPPORT; DISTRIBUTIONS; HISTORY; BIOLOGY	Background: Yponomeutoidea, one of the early-diverging lineages of ditrysian Lepidoptera, comprise about 1,800 species worldwide, including notable pests and insect-plant interaction models. Yponomeutoids were one of the earliest lepidopteran clades to evolve external feeding and to extensively colonize herbaceous angiosperms. Despite the group's economic importance, and its value for tracing early lepidopteran evolution, the biodiversity and phylogeny of Yponomeutoidea have been relatively little studied. Methodology/Principal Findings: Eight nuclear genes (8 kb) were initially sequenced for 86 putative yponomeutoid species, spanning all previously recognized suprageneric groups, and 53 outgroups representing 22 families and 12 superfamilies. Eleven to 19 additional genes, yielding a total of 14.8 to 18.9 kb, were then sampled for a subset of taxa, including 28 yponomeutoids and 43 outgroups. Maximum likelihood analyses were conducted on data sets differing in numbers of genes, matrix completeness, inclusion/weighting of synonymous substitutions, and inclusion/exclusion of "rogue" taxa. Monophyly for Yponomeutoidea was supported very strongly when the 18 "rogue" taxa were excluded, and moderately otherwise. Results from different analyses are highly congruent and relationships within Yponomeutoidea are well supported overall. There is strong support overall for monophyly of families previously recognized on morphological grounds, including Yponomeutidae, Ypsolophidae, Plutellidae, Glyphipterigidae, Argyresthiidae, Attevidae, Praydidae, Heliodinidae, and Bedelliidae. We also assign family rank to Scythropiinae (Scythropiidae stat. rev.), which in our trees are strongly grouped with Bedelliidae, in contrast to all previous proposals. We present a working hypothesis of among-family relationships, and an informal higher classification. Host plant family associations of yponomeutoid subfamilies and families are non-random, but show no trends suggesting parallel phylogenesis. Our analyses suggest that previous characterizations of yponomeutoids as predominantly Holarctic were based on insufficient sampling. Conclusions/Significance: We provide the first robust molecular phylogeny for Yponomeutoidea, together with a revised classification and new insights into their life history evolution and biogeography.	[Sohn, Jae-Cheon; Regier, Jerome C.; Mitter, Charles] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Davis, Donald] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Landry, Jean-Francois] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, CEF, Ottawa, ON, Canada; [Zwick, Andreas] State Museum Nat Hist, Dept Entomol, Stuttgart, Germany; [Cummings, Michael P.] Univ Maryland, Lab Mol Evolut, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Museum of Natural History; Agriculture & Agri Food Canada; University System of Maryland; University of Maryland College Park	Sohn, JC (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	jsohn@umd.edu	Yakovlev, Roman/J-7243-2013; Zwick, Andreas/A-5735-2015	Zwick, Andreas/0000-0002-7532-1752	U.S. National Science Foundation's Assembling the Tree of Life program [0531769]; Maryland Agricultural Experiment Station; Direct For Biological Sciences [1042845] Funding Source: National Science Foundation	U.S. National Science Foundation's Assembling the Tree of Life program; Maryland Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the U.S. National Science Foundation's Assembling the Tree of Life program, award number 0531769, and the Maryland Agricultural Experiment Station. This is contribution 244 of the Evolution of Terrestrial Ecosystems consortium of the National Museum of Natural History, in Washington, D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer A.J., 2011, ROGUENAROK EFFICIENT; Aberer AJ, 2011, ROGUENAROK; Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Alonso C, 2000, ANN ZOOL FENN, V37, P179; Bazinet A. L., 2011, 2011 IEEE International Symposium on Parallel & Distributed Processing, Workshops and Phd Forum, P1896, DOI 10.1109/IPDPS.2011.344; Bazinet AL, 2009, SCI MADE TRANSPARENT, P2; Borner C., 1939, Verhandlungen 7 Internat Kong Ent Berlin, V2, P1372; BROCK JP, 1971, J NAT HIST, V5, P29, DOI 10.1080/00222937100770031; Brown W.M., 1985, MOL EVOLUTIONARY GEN, P399; Bruand CT, 1851, TINEIDES MEM SOC EMU, V3, P23; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Common I.F.B., 1970, INSECTS AUSTR, P765; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; Davis D. R., 1998, HDB ZOOLOGY 5, P91, DOI [10.1515/9783110804744, DOI 10.1515/9783110804744]; Dugdale John S., 1999, Handbuch der Zoologie (Berlin), V4, P119; DUGDALE JS, 1998, HDB ZOOLOGY, V4, P217, DOI DOI 10.1515/9783110804744.217; Edwards E.D., 1996, Monographs on Australian Lepidoptera, V4, P50; Fracker S. B., 1915, Illinois Biological Monographs, V2; FRIESE GERRIT, 1960, BEITR ENT, V10, P1; Fu DeZhi, 2004, Kew Bulletin, V59, P111, DOI 10.2307/4111081; Gaedike R, 1997, LEPIDOPTERORUM CATAT; Gerasimov AM, 1952, INSECTS LEPIDOPTERA, V1, P1; Gershenson ZS, 1998, K NED AKAD WET VERH, V99, P1; Griffiths CS, 1999, P 22 INT ORN C DURB, P754; Grimaldi David, 2005, pi; Handlirsch A, 1925, HDB ENTOMOLOGIE, V3, P377; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heppner J.B., 2011, Lepidoptera Novae, V4, P61; Heppner J. B., 1998, Holarctic Lepidoptera, V5, P1; Heppner J.B., 1995, Tropical Lepidoptera, V6, P146; HEPPNER J. B, 1984, ATLAS NEOTROPICAL LE; Heppner JB, 2005, LEPID NEWS, V2003, P31; Heppner JB, 1977, J LEPID SOC, V31, P124; HEPPNER JB, 1983, CHECK LIST LEPIDOPTE, P26; HOEBEKE ER, 1987, ANN ENTOMOL SOC AM, V80, P462, DOI 10.1093/aesa/80.4.462; Holder MT, 2008, PHILOS T R SOC B, V363, P4013, DOI 10.1098/rstb.2008.0162; HSU Y.-F., 2005, UNIVERSITY OF CAL IF, V124, P1, DOI DOI 10.1525/CALIF0RNIA/9780520098473.003.0001; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; Karoko H., 1964, Esakia Hikosan, Vno. 4, P1; Karsholt O., 1996, The Lepidoptera of Europe : a distributional checklist.; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; Kloet GS, 1945, CHEKC LIST BRIT INSE; KUZNETSOV V I, 1977, Entomologicheskoe Obozrenie, V56, P19; Kuznetzov V.I., 1988, T ZOOLOGICHESKOGO I, V176, P52; Kyrki J., 1988, Nota Lepidopterologica, V11, P45; Kyrki J., 1990, Nota Lepidopterologica, V13, P28; KYRKI J, 1984, ENTOMOL SCAND, V15, P71, DOI 10.1163/187631284X00064; KYRKI J, 1986, SYST ENTOMOL, V11, P93, DOI 10.1111/j.1365-3113.1986.tb00168.x; LEATHER S R, 1986, Entomologist's Gazette, V37, P209; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Mason PG, 2010, CAN ENTOMOL, V142, P393, DOI 10.4039/n10-026; MENKEN SBJ, 1992, ANNU REV ENTOMOL, V37, P41, DOI 10.1146/annurev.en.37.010192.000353; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Mey W, 2006, DEUT ENTOMOL Z, V53, P114, DOI 10.1002/mmnd.200600012; Mey Wolfram, 2011, Esperiana Memoir, V6, P7; Mey Wolfram, 2007, Esperiana Memoir, V4, P9; Meyrick E, 1914, LEPIDOPTERORUM CATAL, V19; Meyrick E, 1928, REV HDB BRIT LEPIDOP; MINET J, 1986, Alexanor, V14, P291; MINET J, 1983, ANN SOC ENTOMOL FR, V19, P175; Moriuti S, 1977, FAUNA JAPONICA YPONO; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nielsen ES, 1996, MONOGRAPHS AUST LEPI, V4, P56; Pierce F. N., 1935, GENITALIA TINEID FAM; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Rambaut A, 2010, FIGTREE V131; Regier JC, 2008, PROTOCOLS CONCEPTS R; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Regier JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035574; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Ren FR, 2005, SYST BIOL, V54, P808, DOI 10.1080/10635150500354688; Robinson G.S., 2010, HOSTS A DATABASE WOR; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Seksyaeva S. V., 1994, Entomologicheskoe Obozrenie, V73, P716; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simmons MP, 2012, MOL PHYLOGENET EVOL, V62, P472, DOI 10.1016/j.ympev.2011.10.017; Stainton HT, 1854, INSECTA BRITANNICA L, V3; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Staudinger O, 1901, CATALOG LEPIDOPTEREN, V3; Stephens JF, 1829, SYSTEMETIC CATALOGUE; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Turner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009933; Ulenberg Sandrine A., 2009, Tijdschrift voor Entomologie, V152, P187; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; WILKINSON M, 1995, SYST BIOL, V44, P435, DOI 10.2307/2413604; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Zeller P. C., 1839, ISIS OKEN, V3, P168; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zwick A., 2010, DEGENERACY CODING WE; Zwick A, 2011, SYST ENTOMOL, V36, P31, DOI 10.1111/j.1365-3113.2010.00543.x; Zwickl DJ, 2011, GARLI 2 0	101	55	63	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55066	10.1371/journal.pone.0055066	http://dx.doi.org/10.1371/journal.pone.0055066			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383061	gold, Green Published			2022-12-27	WOS:000314610600063
J	Wong, MH; Johnson, MD				Wong, Mandi H.; Johnson, Meshell D.			Differential Response of Primary Alveolar Type I and Type II Cells to LPS Stimulation	PLOS ONE			English	Article							SURFACTANT-PROTEIN-D; NF-KAPPA-B; ACUTE LUNG INJURY; EPITHELIAL-CELLS; PULMONARY SURFACTANT; PNEUMOCOCCAL PNEUMONIA; GENE-EXPRESSION; PRIMARY CULTURE; HOST-DEFENSE; TNF-ALPHA	The alveolar epithelium serves as a barrier between organism and environment and functions as the first line of protection against potential respiratory pathogens. Alveolar type II (TII) cells have traditionally been considered the immune cells of the alveolar epithelium, as they possess immunomodulatory functions; however, the precise role of alveolar type I (TI) cells, which comprise similar to 95% of the alveolar epithelial surface area, in lung immunity is not clear. We sought to determine if there was a difference in the response of TI and TII cells to lung injury and if TI cells could actively participate in the alveolar immune response. TI cells isolated via fluorescence activated cell sorting (FACS) from LPS-injured rats demonstrated greater fold-induction of multiple inflammatory mediators than TII cells isolated in the same manner from the same animals. Levels of the cytokines TNF-alpha, IL-6 and IL-1 beta from cultured primary rat TI cells after LPS stimulation were significantly increased compared to similarly studied primary rat TII cells. We found that contrary to published reports, cultured TII cells produce relatively small amounts of TNF-alpha, IL-6 and IL-1 beta after LPS treatment; the higher levels of cytokine expression from cultured TII cells reported in the literature were likely from macrophage contamination due to traditional non-FACS TII cell isolation methods. Co-culture of TII cells with macrophages prior to LPS stimulation increased TNF-alpha and IL-6 production to levels reported by other investigators for TII cells, however, co-culture of TI cells and macrophages prior to LPS treatment resulted in marked increases in TNF-alpha and IL-6 production. Finally, exogenous surfactant blunted the IL-6 response to LPS in cultured TI cells. Taken together, these findings advocate a role for TI cells in the innate immune response and suggest that both TI and TII cells are active players in host defense mechanisms in the lung.	[Wong, Mandi H.; Johnson, Meshell D.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Wong, Mandi H.; Johnson, Meshell D.] No Calif Inst Res & Educ, San Francisco, CA USA; [Johnson, Meshell D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Northern California Institute for Research & Education; University of California System; University of California San Francisco	Johnson, MD (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	meshell.johnson@ucsf.edu			Department of Veterans Affairs [CDA2]; Northern California Institute for Research and Education	Department of Veterans Affairs(US Department of Veterans Affairs); Northern California Institute for Research and Education	This work was supported by grants from the Department of Veterans Affairs (CDA2) and the Northern California Institute for Research and Education (www.ncire.org). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate W, 2010, J LIPID RES, V51, P334, DOI 10.1194/jlr.M000513; Baloglu E, 2011, AM J RESP CELL MOL, V45, P1059, DOI 10.1165/rcmb.2010-0273OC; Barbarin V, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-112; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Carter JM, 2006, J OCCUP ENVIRON MED, V48, P1265, DOI 10.1097/01.jom.0000230489.06025.14; Chen JT, 2006, AM J RESP CELL MOL, V34, P264, DOI 10.1165/rcmb.2005-0117OC; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; CRESTANI B, 1994, J CLIN INVEST, V94, P731, DOI 10.1172/JCI117392; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Driscoll KE, 1998, ENVIRON HEALTH PERSP, V106, P1171, DOI 10.2307/3433981; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Gonzalez RF, 1998, BBA-PROTEIN STRUCT M, V1429, P208, DOI 10.1016/S0167-4838(98)00231-3; Gonzalez RF, 2009, AM J PHYSIOL-LUNG C, V297, pL1045, DOI 10.1152/ajplung.90389.2008; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gutierrez JA, 1998, AM J PHYSIOL-LUNG C, V274, pL196, DOI 10.1152/ajplung.1998.274.2.L196; Haddad JJ, 2009, MOL IMMUNOL, V47, P205, DOI 10.1016/j.molimm.2009.09.034; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hortobagyi L, 2008, J ALLERGY CLIN IMMUN, V122, P521, DOI 10.1016/j.jaci.2008.05.002; Ikegami M, 2007, CHEST, V132, P1447, DOI 10.1378/chest.07-0864; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Johnson MD, 2002, P NATL ACAD SCI USA, V99, P1966, DOI 10.1073/pnas.042689399; Kanj RS, 2005, J TOXICOL ENV HEAL A, V68, P185, DOI 10.1080/15287390590890509; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Ledeboer A, 2002, AM J PHYSIOL-REG I, V282, pR1762, DOI 10.1152/ajpregu.00766.2001; Manzer R, 2006, AM J RESP CELL MOL, V34, P158, DOI 10.1165/rcmb.2005-0205OC; MASON RJ, 1977, AM REV RESPIR DIS, V115, P81; Matthaei KI, 2007, J PHYSIOL-LONDON, V582, P481, DOI 10.1113/jphysiol.2007.134908; McRitchie DI, 2000, CYTOKINE, V12, P644, DOI 10.1006/cyto.1999.0656; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miura TA, 2006, ADV EXP MED BIOL, V581, P351; Moxley MA, 2000, AM J PHYSIOL-LUNG C, V279, pL985, DOI 10.1152/ajplung.2000.279.5.L985; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; PAINE R, 1993, J IMMUNOL, V150, P4561; Rosenberg GA, 2007, BRAIN RES, V1133, P186, DOI 10.1016/j.brainres.2006.11.041; Rubins JB, 2003, AM J RESP CRIT CARE, V167, P103, DOI 10.1164/rccm.2210007; Schroeter M, 2003, MOL BRAIN RES, V117, P1, DOI 10.1016/S0169-328X(03)00255-9; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; STONE KC, 1992, AM REV RESPIR DIS, V146, P454, DOI 10.1164/ajrccm/146.2.454; Takahashi F, 2004, LUNG, V182, P173; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; THOMASSEN MJ, 1992, AM J RESP CELL MOL, V7, P257, DOI 10.1165/ajrcmb/7.3.257; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; van der Windt GJW, 2011, J INFECT DIS, V203, P1850, DOI 10.1093/infdis/jir185; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Walker MG, 2009, EXP LUNG RES, V35, P591, DOI 10.1080/01902140902780460; Wang SH, 2011, AM J RESP CELL MOL, V44, P692, DOI 10.1165/rcmb.2009-0359OC; Wong MH, 2012, AM J RESP CELL MOL, V46, P641, DOI 10.1165/rcmb.2011-0289OC; Wright JR, 2004, BIOL NEONATE, V85, P326, DOI 10.1159/000078172; Yamamoto K, 2012, J IMMUNOL, V189, P2450, DOI 10.4049/jimmunol.1200634; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zhang F, 2008, INFLAMMATION, V31, P344, DOI 10.1007/s10753-008-9084-0	58	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55545	10.1371/journal.pone.0055545	http://dx.doi.org/10.1371/journal.pone.0055545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383221	Green Submitted, gold, Green Published			2022-12-27	WOS:000314610600124
J	Kurosawa, N; Fujimoto, R; Ozawa, T; Itoyama, T; Sadamori, N; Isobe, M				Kurosawa, Nobuyuki; Fujimoto, Rika; Ozawa, Tatsuhiko; Itoyama, Takahiro; Sadamori, Naoki; Isobe, Masaharu			Reduced Level of the BCL11B Protein Is Associated with Adult T-Cell Leukemia/Lymphoma	PLOS ONE			English	Article							VIRUS TYPE-1 HTLV-1; NF-KAPPA-B; TUMOR-SUPPRESSOR; THYMIC LYMPHOMAS; LEUKEMIA-VIRUS; GENE; PROMOTER; EXPRESSION; IDENTIFICATION; TRANSCRIPTION	Background: Adult T-cell leukemia/lymphoma (ATLL) develops in a small proportion of human T-cell leukemia virus type I (HTLV-I)-infected individuals. However, the mechanism by which HTLV-I causes ATLL has not been fully elucidated. To provide fundamental insights into the multistep process of leukemogenesis, we have mapped the chromosomal abnormalities in 50 ATLL cases to identify potential key regulators of ATLL. Results: The analysis of breakpoints in one ATLL case with the translocations t(14;17)(q32;q22-23) resulted in the identification of a Kruppel zinc finger gene, BCL11B, which plays a crucial role in T-cell development. Among the 7 ATLL cases that we examined by immunofluorescence analysis, 4 displayed low and one displayed moderate BCL11B signal intensities. A dramatically reduced level of the BCL11B protein was also found in HTLV-I-positive T-cell lines. The ectopic expression of BCL11B resulted in significant growth suppression in ATLL-derived cell lines but not in Jurkat cells. Conclusions: Our genetic and functional data provide the first evidence that a reduction in the level of the BCL11B protein is a key event in the multistep progression of ATLL leukemogenesis.	[Kurosawa, Nobuyuki; Isobe, Masaharu] Toyama Univ, Grad Sch, Fac Sci & Engn, Toyama 930, Japan; [Fujimoto, Rika] Kochi Med Sch, Dept Immunol, Kochi, Japan; [Ozawa, Tatsuhiko] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Immunol, Toyama 930, Japan; [Itoyama, Takahiro] Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan; [Sadamori, Naoki] Nagasaki Univ, Dept Nursing, Fac Nursing & Nutr, Nagasaki 852, Japan	University of Toyama; Kochi University; University of Toyama; Nagasaki University	Isobe, M (corresponding author), Toyama Univ, Grad Sch, Fac Sci & Engn, Toyama 930, Japan.	isobe@eng.u-toyama.ac.jp		Kurosawa, Nobuyuki/0000-0002-1548-4541; Ozawa, Tatsuhiko/0000-0002-3112-452X	Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan; Hokuriku Innovation Cluster for Health Science; Grants-in-Aid for Scientific Research [23650607] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokuriku Innovation Cluster for Health Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by funds from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan and the Hokuriku Innovation Cluster for Health Science to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya N, 2011, VIRUSES-BASEL, V3, P1532, DOI 10.3390/v3091532; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Fujimoto R, 2012, CANCER GENET-NY, V205, P356, DOI 10.1016/j.cancergen.2012.04.006; Ganguli-Indra G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005367; Gesk S, 2003, LEUKEMIA, V17, P738, DOI 10.1038/sj.leu.2402884; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; Grabarczyk P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012532; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Hidaka T, 2008, BLOOD, V112, P383, DOI 10.1182/blood-2008-01-131185; Itoyama A, 2001, BLOOD, V97, P3612, DOI 10.1182/blood.V97.11.3612; Kamimura K, 2007, ONCOGENE, V26, P5840, DOI 10.1038/sj.onc.1210388; Karlsson A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-195; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Liu PT, 2010, IMMUNOL REV, V238, P138, DOI 10.1111/j.1600-065X.2010.00953.x; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagamachi A, 2009, CANCER SCI, V100, P1219, DOI 10.1111/j.1349-7006.2009.01172.x; NARDUCCI MG, 1995, BLOOD, V86, P2358, DOI 10.1182/blood.V86.6.2358.bloodjournal8662358; Nicot C, 2005, AM J HEMATOL, V78, P232, DOI 10.1002/ajh.20307; Ohi H, 2007, ONCOGENE, V26, P5280, DOI 10.1038/sj.onc.1210325; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Saitou M, 2000, ONCOGENE, V19, P2796, DOI 10.1038/sj.onc.1203604; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Sugimoto J, 1999, CANCER RES, V59, P2313; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; VanValkenburgh J, 2011, J EXP MED, V208, P2069, DOI 10.1084/jem.20102683; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534	40	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55147	10.1371/journal.pone.0055147	http://dx.doi.org/10.1371/journal.pone.0055147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383087	gold, Green Submitted, Green Published			2022-12-27	WOS:000315563800121
J	Xu, ZX; Sun, X; Sun, JB				Xu, Zixiang; Sun, Xiao; Sun, Jibin			Construction and Analysis of the Model of Energy Metabolism in E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; THERMODYNAMIC ANALYSIS; RECONSTRUCTION; NETWORKS; CONSTRAINTS; PREDICTION; GSM/GPR	Genome-scale models of metabolism have only been analyzed with the constraint-based modelling philosophy and there have been several genome-scale gene-protein-reaction models. But research on the modelling for energy metabolism of organisms just began in recent years and research on metabolic weighted complex network are rare in literature. We have made three research based on the complete model of E. coli's energy metabolism. We first constructed a metabolic weighted network using the rates of free energy consumption within metabolic reactions as the weights. We then analyzed some structural characters of the metabolic weighted network that we constructed. We found that the distribution of the weight values was uneven, that most of the weight values were zero while reactions with abstract large weight values were rare and that the relationship between w (weight values) and v (flux values) was not of linear correlation. At last, we have done some research on the equilibrium of free energy for the energy metabolism system of E. coli. We found that E-out (free energy rate input from the environment) can meet the demand of E-in(ch) (free energy rate dissipated by chemical process) and that chemical process plays a great role in the dissipation of free energy in cells. By these research and to a certain extend, we can understand more about the energy metabolism of E. coli.	[Xu, Zixiang; Sun, Jibin] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Xu, Zixiang; Sun, Xiao] Southeast Univ, State Key Lab Bioelect, Nanjing, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Southeast University - China	Sun, X (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China.	xzx21c@163.com		Sun, Jibin/0000-0002-0208-504X	National Basic Research Program of China [2011CBA00804]; State Key Laboratory of Bioelectronics [2011E12]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Bioelectronics	Support for this work was provided by "National Basic Research Program of China (2011CBA00804)" and the Open Research Fund of State Key Laboratory of Bioelectronics (2011E12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard DA, 2004, J THEOR BIOL, V228, P327, DOI 10.1016/j.jtbi.2004.01.008; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bork P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100016; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Scott AB, 2005, BMC MICROBIOL, V5; Segura D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040036; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Yang F, 2005, METAB ENG, V7, P251, DOI 10.1016/j.ymben.2005.03.002; Zhu Y, 2013, BIOTECHNOL BIOENG, V110, P914, DOI 10.1002/bit.24739	24	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55137	10.1371/journal.pone.0055137	http://dx.doi.org/10.1371/journal.pone.0055137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383083	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800118
J	Ye, XM; Guo, Y; Zhang, Q; Chen, WJ; Hua, XF; Liu, W; Yang, Y; Chen, GH				Ye, Xiaoming; Guo, Yu; Zhang, Qi; Chen, Wenjie; Hua, Xuefeng; Liu, Wei; Yang, Yang; Chen, Guihua			beta Klotho Suppresses Tumor Growth in Hepatocellular Carcinoma by Regulating Akt/GSK-3 beta/Cyclin D1 Signaling Pathway	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; CYCLIN D1; CELL-CYCLE; RECEPTOR; EXPRESSION; CANCER; OVEREXPRESSION; APOPTOSIS; FAMILY; TARGET	beta Klotho is a regulator in multiple metabolic processes, while its role in cancer remains unclear. We found the expression of beta Klotho was down-regulated in human hepatocellular carcinoma tissues compared with that in paired adjacent non-tumourous liver tissues. Hepatoma cells also showed decreased expression of beta Klotho compared with normal hepatocyte cells. Reintroduction of beta Klotho into hepatoma cells inhibited their proliferation. The anti-proliferative effect of beta Klotho might be linked with G1 to S phase arrest, which was mediated by Akt/GSK-3 beta/cyclin D1 signaling, since forced expression beta Klotho reduced the phosphorylation level of Akt and GSK-3 beta and induced down-regulation of cyclin D1. Furthermore, beta Klotho overexpression could inhibit tumorgenesis, while constitutively activated Akt could override the suppressive effects of beta Klotho in vivo. These data suggest beta Klotho suppresses tumor growth in hepatocellular carcinoma.	[Ye, Xiaoming; Guo, Yu; Yang, Yang; Chen, Guihua] Sun Yat Sen Univ, Dept Gen Surg, Lingnan Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Xiaoming; Guo, Yu; Zhang, Qi; Chen, Wenjie; Hua, Xuefeng; Yang, Yang; Chen, Guihua] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China; [Ye, Xiaoming; Guo, Yu; Zhang, Qi; Chen, Wenjie; Liu, Wei; Yang, Yang; Chen, Guihua] Sun Yat Sen Univ, Hepatol Lab, Hosp Liver Dis, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yang, Y (corresponding author), Sun Yat Sen Univ, Dept Gen Surg, Lingnan Hosp, Guangzhou 510275, Guangdong, Peoples R China.	yysysu@163.com; chgh1955@263.net	yang, yang/GVT-5210-2022; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; Liu, Wei/AAH-5037-2020	Liu, Wei/0000-0002-4935-7591; Guo, Yu/0000-0002-8886-0106	National Basic Research Program of China (973 Program) [2009CB522404]; National Natural Science Foundation of China [30972915, 81170451, U0932006]; Science and Technology Planning Project of Guangdong Province [2011B031300016]; Specialized Research Fund for the Doctoral Program of Higher Education [20110171120091]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from National Basic Research Program of China (973 Program, 2009CB522404, http://www.973.gov.cn/), National Natural Science Foundation of China (30972915, 81170451 and U0932006, http://www.nsfc.gov.cn), Science and Technology Planning Project of Guangdong Province (2011B031300016, http://pro.gdstc.gov.cn) and Specialized Research Fund for the Doctoral Program of Higher Education (20110171120091, http://www.cutech.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese Marco, 2006, Hepatology, V43, P191, DOI 10.1002/hep.21022; Chen W, 2011, CANCER LETT, V307, P93, DOI 10.1016/j.canlet.2011.03.021; Deane NG, 2001, CANCER RES, V61, P5389; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Huang XQ, 2009, MOL CARCINOGEN, V48, P553, DOI 10.1002/mc.20494; Hui AM, 1998, HEPATO-GASTROENTEROL, V45, P1635; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Kim ND, 2006, CURR CANCER DRUG TAR, V6, P681; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Luo YD, 2010, J BIOL CHEM, V285, P30069, DOI 10.1074/jbc.M110.148288; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; NISHIDA N, 1994, CANCER RES, V54, P3107; Poh WJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-14; Sato Y, 1999, J GASTROENTEROL, V34, P486, DOI 10.1007/s005350050301; Scharf JG, 2003, HORM METAB RES, V35, P685; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Weinstein IB, 1996, J CELL BIOCHEM, P23; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482; Zhao HC, 2007, WORLD J GASTROENTERO, V13, P683, DOI 10.3748/wjg.v13.i5.683	32	43	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55615	10.1371/journal.pone.0055615	http://dx.doi.org/10.1371/journal.pone.0055615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383245	Green Submitted, Green Published, gold			2022-12-27	WOS:000315563800175
J	Kumar, V; Chichili, VPR; Tang, XH; Sivaraman, J				Kumar, Veerendra; Chichili, Vishnu Priyanka Reddy; Tang, Xuhua; Sivaraman, J.			A Novel Trans Conformation of Ligand-Free Calmodulin	PLOS ONE			English	Article							AMPHIPHILIC ALPHA-HELIX; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CALCIUM-BINDING; ION-BINDING; PROTEIN; COMPLEX; ACTIVATION; REVEALS	Calmodulin (CaM) is a highly conserved eukaryotic protein that binds specifically to more than 100 target proteins in response to calcium (Ca2+) signal. CaM adopts a considerable degree of structural plasticity to accomplish this physiological role; however, the nature and extent of this plasticity remain to be fully understood. Here, we report the crystal structure of a novel trans conformation of ligand-free CaM where the relative disposition of two lobes of CaM is different, a conformation to-date not reported. While no major structural changes were observed in the independent N- and C-lobes as compared with previously reported structures of Ca2+/CaM, the central helix was tilted by similar to 90 degrees at Arg75. This is the first crystal structure of CaM to show a drastic conformational change in the central helix, and reveals one of several possible conformations of CaM to engage with its binding partner.	[Kumar, Veerendra; Chichili, Vishnu Priyanka Reddy; Tang, Xuhua; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsjayar@nus.edu.sg		Kumar, Veerendra/0000-0002-9241-1303; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of Singapore (BMRC), A*STAR [R154000461305]; National University of Singapore (NUS)	Biomedical Research Council of Singapore (BMRC), A*STAR(Agency for Science Technology & Research (A*STAR)); National University of Singapore (NUS)(National University of Singapore)	The authors are grateful to the Biomedical Research Council of Singapore (BMRC), A*STAR, for the partial support of this study (R154000461305). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; X-ray diffraction data for this study were measured at beamline X8C at BNL, New York, USA. Veerendra Kumar is a graduate scholar in receipt of a research scholarship from the National University of Singapore (NUS).	ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAUDIER J, 1983, BIOCHEM BIOPH RES CO, V114, P1138, DOI 10.1016/0006-291X(83)90681-2; Black DJ, 2005, AM J PHYSIOL-CELL PH, V288, pC669, DOI 10.1152/ajpcell.00191.2004; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dash S, 1997, BIOCHEMISTRY-US, V36, P2025, DOI 10.1021/bi9621674; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fok AK, 2008, J EUKARYOT MICROBIOL, V55, P481, DOI 10.1111/j.1550-7408.2008.00347.x; Fujiwara T, 2005, J BACTERIOL, V187, P480, DOI 10.1128/JB.187.2.480-487.2005; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; HABERMANN E, 1983, ARCH TOXICOL, V54, P61, DOI 10.1007/BF00277816; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Hui OY, 1998, BIOMETALS, V11, P213, DOI 10.1023/A:1009226215543; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kursula P, 2007, ACTA CRYSTALLOGR F, V63, P653, DOI 10.1107/S1744309107034525; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINSE S, 1991, J BIOL CHEM, V266, P8050; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Medvedeva MV, 1999, FEBS LETT, V450, P139, DOI 10.1016/S0014-5793(99)00483-4; MURTAUGH TJ, 1983, METHOD ENZYMOL, V102, P158; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagnozzi D, 2010, BIOCHEMISTRY-US, V49, P7542, DOI 10.1021/bi100447t; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen Y, 2004, BIOCHEM BIOPH RES CO, V317, P309, DOI 10.1016/j.bbrc.2004.03.046; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; VanderSpoel D, 1996, PROTEIN SCI, V5, P2044; Warren JT, 2007, J MOL BIOL, V374, P517, DOI 10.1016/j.jmb.2007.09.048; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Wilson MA, 2003, ACTA CRYSTALLOGR D, V59, P1782, DOI 10.1107/S0907444903016846; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y	45	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54834	10.1371/journal.pone.0054834	http://dx.doi.org/10.1371/journal.pone.0054834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382982	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200002
J	McCormack, JE; Harvey, MG; Faircloth, BC; Crawford, NG; Glenn, TC; Brumfield, RT				McCormack, John E.; Harvey, Michael G.; Faircloth, Brant C.; Crawford, Nicholas G.; Glenn, Travis C.; Brumfield, Robb T.			A Phylogeny of Birds Based on Over 1,500 Loci Collected by Target Enrichment and High-Throughput Sequencing	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; MITOCHONDRIAL-DNA; SPECIES TREES; SISTER GROUP; AVIAN TREE; EVOLUTION; ALGORITHMS; UTILITY; INCONSISTENCY; PROBABILITIES	Evolutionary relationships among birds in Neoaves, the clade comprising the vast majority of avian diversity, have vexed systematists due to the ancient, rapid radiation of numerous lineages. We applied a new phylogenomic approach to resolve relationships in Neoaves using target enrichment (sequence capture) and high-throughput sequencing of ultraconserved elements (UCEs) in avian genomes. We collected sequence data from UCE loci for 32 members of Neoaves and one outgroup (chicken) and analyzed data sets that differed in their amount of missing data. An alignment of 1,541 loci that allowed missing data was 87% complete and resulted in a highly resolved phylogeny with broad agreement between the Bayesian and maximum-likelihood (ML) trees. Although results from the 100% complete matrix of 416 UCE loci were similar, the Bayesian and ML trees differed to a greater extent in this analysis, suggesting that increasing from 416 to 1,541 loci led to increased stability and resolution of the tree. Novel results of our study include surprisingly close relationships between phenotypically divergent bird families, such as tropicbirds (Phaethontidae) and the sunbittern (Eurypygidae) as well as between bustards (Otididae) and turacos (Musophagidae). This phylogeny bolsters support for monophyletic waterbird and landbird clades and also strongly supports controversial results from previous studies, including the sister relationship between passerines and parrots and the non-monophyly of raptorial birds in the hawk and falcon families. Although significant challenges remain to fully resolving some of the deep relationships in Neoaves, especially among lineages outside the waterbirds and landbirds, this study suggests that increased data will yield an increasingly resolved avian phylogeny.	[McCormack, John E.; Harvey, Michael G.; Brumfield, Robb T.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Harvey, Michael G.; Brumfield, Robb T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Faircloth, Brant C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Crawford, Nicholas G.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; University of California System; University of California Los Angeles; Boston University; University System of Georgia; University of Georgia	McCormack, JE (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	mccormack@oxy.edu	Brumfield, Robb T/K-6108-2015; Glenn, Travis C/A-2390-2008; Faircloth, Brant C/Y-3978-2019	Brumfield, Robb T/0000-0003-2307-0688; Glenn, Travis C/0000-0001-7725-3637; Faircloth, Brant/0000-0002-1943-0217	NSF [DEB-0841729, DEB-1242260]; Amazon; Direct For Biological Sciences [0841729] Funding Source: National Science Foundation; Division Of Environmental Biology [1242260] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Amazon; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by NSF grant DEB-0841729 to RTB. DEB-1242260 to BCF and TCG and an Amazon Web Services grant to BCF, NGC, JEM, and TCG provided partial support for computational analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2008, SYST BIOL, V57, P503, DOI 10.1080/10635150802164587; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Braun EL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-141; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Chubb AL, 2004, MOL PHYLOGENET EVOL, V30, P140, DOI 10.1016/S1055-7903(03)00159-3; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Degnan JH, 2005, EVOLUTION, V59, P24; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Fain MG, 2004, EVOLUTION, V58, P2558; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Gibb GC, 2010, MOL PHYLOGENET EVOL, V56, P698, DOI 10.1016/j.ympev.2010.04.016; Glenn TC, 2008, INTEGR COMP BIOL, V48, P463, DOI 10.1093/icb/icn061; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haddrath O, 2012, PROC ROY SOC B IN PR; Han KL, 2011, SYST BIOL, V60, P375, DOI 10.1093/sysbio/syq100; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Janes DE, 2011, GENOME BIOL EVOL, V3, P102, DOI 10.1093/gbe/evq087; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Kolaczkowski B, 2006, MOL BIOL EVOL, V23, P1819, DOI 10.1093/molbev/msl059; Kolaczkowski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007891; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Matzke A, 2012, MOL BIOL EVOL, V29, P1497, DOI 10.1093/molbev/msr319; Mayr G, 2011, J ZOOL SYST EVOL RES, V49, P58, DOI 10.1111/j.1439-0469.2010.00586.x; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Nabholz B, 2011, MOL BIOL EVOL, V28, P2197, DOI 10.1093/molbev/msr047; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Pasko L, 2011, MOL PHYLOGENET EVOL, V61, P760, DOI 10.1016/j.ympev.2011.07.021; Poe S, 2004, EVOLUTION, V58, P404, DOI 10.1111/j.0014-3820.2004.tb01655.x; Pratt RC, 2009, MOL BIOL EVOL, V26, P313, DOI 10.1093/molbev/msn248; Prychitko TM, 2003, MOL BIOL EVOL, V20, P762, DOI 10.1093/molbev/msg080; Rambaut A., 2007, TRACE 1 4; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J., 2001, MOL CLONING LAB MANU; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; Sibley CG, 1990, DISTRIBUTION TAXONOM; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Thomas B. T., 1996, HDB BIRDS WORLD, V3, P24; Van Tuinen M, 2001, P ROY SOC B-BIOL SCI, V268, P1345; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	73	241	247	8	167	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e54848	10.1371/journal.pone.0054848	http://dx.doi.org/10.1371/journal.pone.0054848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23382987	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200003
J	Abdulsid, A; Hanretty, K; Lyall, F				Abdulsid, Akrem; Hanretty, Kevin; Lyall, Fiona			Heat Shock Protein 70 Expression Is Spatially Distributed in Human Placenta and Selectively Upregulated during Labor and Preeclampsia	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; BLOOD-FLOW; NITRIC-OXIDE; PREGNANCY; MECHANISMS; INVASION; TISSUE; TERM	Placental oxidative stress is a feature of both human labor and the pregnancy syndrome preeclampsia. Heat shock proteins (HSPs) can be induced in cells as a protective mechanism to cope with cellular stress. We hypothesized that HSP 70 would increase during labor and preeclampsia and that expression would vary in different placental zones. Samples were obtained from 12 sites within each placenta: 4 equally spaced apart pieces were sampled from the inner, middle and outer placental regions. Non-labor, labor and preeclampsia were studied. HSP 70 expression was investigated by Western blot analysis. HSP 70 protein expression was increased in the middle compared with the outer area (p = 0.03) in non-labor and in both the inner and middle areas compared with the outer area (p = 0.01 and p = 0.02 respectively) in labor. HSP 70 was increased in the preeclampsia non-labor group compared to the control non-labor group in the inner region (p = 0.003) and in the control labor group compared with the preeclampsia labor group at the middle area (p = 0.001). In conclusion HSP 70 is expressed in a spatial manner in the placenta. Changes in HSP 70 expression occur during labor and preeclampsia but at different zones within the placenta. The physiological and pathological significance of these remains to be elucidated but the results have important implications for how data obtained from studies in placental disease (and other organs) can be influenced by sampling methods.	[Abdulsid, Akrem; Lyall, Fiona] Univ Glasgow, Yorkhill Hosp, Inst Med Genet, Glasgow, Lanark, Scotland; [Hanretty, Kevin] So Gen Hosp, Matern Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow; University of Glasgow	Lyall, F (corresponding author), Univ Glasgow, Yorkhill Hosp, Inst Med Genet, Glasgow, Lanark, Scotland.	fiona.lyall@glasgow.ac.uk			Libyan Ministry of Higher Education and Scientific Research	Libyan Ministry of Higher Education and Scientific Research	The authors are grateful to the Libyan Ministry of Higher Education and Scientific Research for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Barut F, 2010, PATHOL RES PRACT, V206, P651, DOI 10.1016/j.prp.2010.04.001; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; BRAR HS, 1988, AM J OBSTET GYNECOL, V158, P952, DOI 10.1016/0002-9378(88)90100-7; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P449, DOI 10.1080/14767050802054550; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; DIVERS MJ, 1995, GYNECOL OBSTET INVES, V40, P236, DOI 10.1159/000292344; Ekambaram P, 2011, EUR J OBSTET GYN R B, V156, P158, DOI 10.1016/j.ejogrb.2011.01.026; Fukushima A, 2005, J OBSTET GYNAECOL RE, V31, P72, DOI 10.1111/j.1447-0756.2005.00244.x; Gibb W, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2925; Hempstock J, 2003, HUM PATHOL, V34, P1265, DOI 10.1016/j.humpath.2003.08.006; Hnat MD, 2005, AM J OBSTET GYNECOL, V193, P836, DOI 10.1016/j.ajog.2005.01.059; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kim YJ, 2010, J MATERN-FETAL NEO M, V23, P153, DOI 10.3109/14767050903156676; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Li DG, 1996, SHOCK, V5, P320, DOI 10.1097/00024382-199605000-00002; Lyall F, 2000, FASEB J, V14, P208, DOI 10.1096/fasebj.14.1.208; Lyall F, 2006, AUST NZ J OBSTET GYN, V46, P266, DOI 10.1111/j.1479-828X.2006.00589.x; MALYSHEV IY, 1995, FEBS LETT, V370, P159, DOI 10.1016/0014-5793(95)00801-F; Myatt L, 1997, HUM REPROD, V12, P167, DOI 10.1093/humrep/12.1.167; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Myatt L, 1996, HYPERTENSION, V28, P488, DOI 10.1161/01.HYP.28.3.488; Nollen EAA, 2002, J CELL SCI, V115, P2809; Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Shah M, 1998, HISTOCHEM J, V30, P509, DOI 10.1023/A:1003259907014; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Ziegert M, 1999, Infect Dis Obstet Gynecol, V7, P180	36	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54540	10.1371/journal.pone.0054540	http://dx.doi.org/10.1371/journal.pone.0054540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23382911	Green Published, gold			2022-12-27	WOS:000315211500015
J	Boch, S; Muller, J; Pratil, D; Blaserl, S; Fischer, M				Boch, Steffen; Mueller, Joerg; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus			Up in the Tree - The Overlooked Richness of Bryophytes and Lichens in Tree Crowns	PLOS ONE			English	Article							EPIPHYTIC BRYOPHYTES; VERTICAL-DISTRIBUTION; STAND STRUCTURE; SPECIES COMPOSITION; BEECH FORESTS; DIVERSITY; BIODIVERSITY; ECOLOGY	Assessing diversity is among the major tasks in ecology and conservation science. In ecological and conservation studies, epiphytic cryptogams are usually sampled up to accessible heights in forests. Thus, their diversity, especially of canopy specialists, likely is underestimated. If the proportion of those species differs among forest types, plot-based diversity assessments are biased and may result in misleading conservation recommendations. We sampled bryophytes and lichens in 30 forest plots of 20 m x 20 m in three German regions, considering all substrates, and including epiphytic litter fall. First, the sampling of epiphytic species was restricted to the lower 2 m of trees and shrubs. Then, on one representative tree per plot, we additionally recorded epiphytic species in the crown, using tree climbing techniques. Per tree, on average 54% of lichen and 20% of bryophyte species were overlooked if the crown was not been included. After sampling all substrates per plot, including the bark of all shrubs and trees, still 38% of the lichen and 4% of the bryophyte species were overlooked if the tree crown of the sampled tree was not included. The number of overlooked lichen species varied strongly among regions. Furthermore, the number of overlooked bryophyte and lichen species per plot was higher in European beech than in coniferous stands and increased with increasing diameter at breast height of the sampled tree. Thus, our results indicate a bias of comparative studies which might have led to misleading conservation recommendations of plot-based diversity assessments.	[Boch, Steffen; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Pratil, Daniel; Blaserl, Stefan; Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	University of Bern; University of Bern; University of Potsdam	Boch, S (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Boch, Steffen/L-5436-2016; Schulze, Ernst-Detlef/K-9627-2014; Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	DFG (German Research Foundation); Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories" [FI 1246/6-1, FI 1246/9-1]	DFG (German Research Foundation)(German Research Foundation (DFG)); Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories"	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories"(FI 1246/6-1, FI 1246/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptroot A., 1997, V68, P203; Barkman J.J., 1958, BRYOLOGIST; Boch S, 2013, BASIC APPL ECOL, V14, P496, DOI 10.1016/j.baae.2013.06.001; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Bohn U., 2000, KARTE NATURLICHEN VE; CORNELISSEN JHC, 1989, J TROP ECOL, V5, P131, DOI 10.1017/S0266467400003400; Diaz IA, 2010, FOREST ECOL MANAG, V259, P1490, DOI 10.1016/j.foreco.2010.01.025; EVERSMAN S, 1987, BRYOLOGIST, V90, P212, DOI 10.2307/3242928; Fengel D., 1984, Wood: chemistry, ultrastructure, reactions.; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2009, BIODIVERS CONSERV, V18, P289, DOI 10.1007/s10531-008-9483-4; Fritz O, 2010, BIOL CONSERV, V143, P1008, DOI 10.1016/j.biocon.2010.01.016; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; HARRIS GP, 1971, J ECOL, V59, P431, DOI 10.2307/2258323; Holz I, 2002, BRYOLOGIST, V105, P334, DOI 10.1639/0007-2745(2002)105[0334:BDMDAD]2.0.CO;2; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; JARMAN SJ, 1995, NEW ZEAL J BOT, V33, P65, DOI 10.1080/0028825X.1995.10412944; Jonsson MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045701; Kiraly I, 2010, BIOL CONSERV, V143, P2063, DOI 10.1016/j.biocon.2010.05.014; Lutzoni F, 2009, CURR BIOL, V19, pR502, DOI 10.1016/j.cub.2009.04.034; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marialigeti S, 2009, BIODIVERS CONSERV, V18, P2223, DOI 10.1007/s10531-009-9586-6; Marmor L, 2013, LICHENOLOGIST, V45, P51, DOI 10.1017/S0024282912000564; MAZIMPAKA V, 1995, NOVA HEDWIGIA, V61, P431; McCune B, 1997, NORTHWEST SCI, V71, P145; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Milne J, 1999, OERST HIKOBIA, V13, P23; Moning C, 2009, FOREST ECOL MANAG, V258, P745, DOI 10.1016/j.foreco.2009.05.015; Nascimbene J, 2013, FOREST ECOL MANAG, V298, P27, DOI 10.1016/j.foreco.2013.03.008; Nascimbene J, 2009, BIODIVERS CONSERV, V18, P1509, DOI 10.1007/s10531-008-9537-7; Nebel, 2000, MOOSE BADEN WURTTEMB; Nebel M, 2005, MOOSE BADEN WURTTEMB, V3; Nebel M, 2001, MOOSE BADEN WURTTEMB, V2; Nimis PL, 2002, EARTH ENV SCI, V7; Normann F, 2010, ECOL INDIC, V10, P1111, DOI 10.1016/j.ecolind.2010.03.008; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Porley R., 2005, MOSSES LIVERWORTS; R Core Team, 2016, R FDN STAT COMP; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Redei K, 2001, LESNICKY CASOPIS, V47, P135; Romanski J, 2011, BRYOLOGIST, V114, P720, DOI 10.1639/0007-2745-114.4.720; Sillett SC, 2000, NORTHWEST SCI, V74, P44; SILLETT SC, 1995, BRYOLOGIST, V98, P251, DOI 10.2307/3243312; Sillett SC, 2004, FOREST CANOPIES, P151, DOI [DOI 10.1016/B978-012457553-0/50013-7, 10.1016/B978-012457553-0/50013-7]; Sporn SG, 2010, BIODIVERS CONSERV, V19, P745, DOI 10.1007/s10531-009-9731-2; Svensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062825; Tinya F, 2009, PLANT ECOL, V204, P69, DOI 10.1007/s11258-008-9566-z; Will-Wolf S, 2002, NATO SCI S SS IV EAR, V7, P203; WIRTH V., 2013, FLECHTEN DTSCH; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; [No title captured]	53	62	69	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e84913	10.1371/journal.pone.0084913	http://dx.doi.org/10.1371/journal.pone.0084913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358373	Green Published, Green Submitted, gold			2022-12-27	WOS:000328737700107
J	Yang, WK; Kang, CK; Chang, CH; Hsu, AD; Lee, TH; Hwang, PP				Yang, Wen-Kai; Kang, Chao-Kai; Chang, Chia-Hao; Hsu, An-Di; Lee, Tsung-Han; Hwang, Pung-Pung			Expression Profiles of Branchial FXYD Proteins in the Brackish Medaka Oryzias dancena: A Potential Saltwater Fish Model for Studies of Osmoregulation	PLOS ONE			English	Article							PHOSPHOLEMMAN-LIKE PROTEIN; NA+/K+-ATPASE EXPRESSION; SHARK RECTAL GLANDS; FUNCTIONAL INTERACTION; ION REGULATION; GENUS ORYZIAS; SODIUM-PUMP; FRESH-WATER; K+-ATPASE; NA,K-ATPASE	FXYD proteins are novel regulators of Na+-K+-ATPase (NKA). In fish subjected to salinity challenges, NKA activity in osmoregulatory organs (e. g., gills) is a primary driving force for the many ion transport systems that act in concert to maintain a stable internal environment. Although teleostean FXYD proteins have been identified and investigated, previous studies focused on only a limited group of species. The purposes of the present study were to establish the brackish medaka (Oryzias dancena) as a potential saltwater fish model for osmoregulatory studies and to investigate the diversity of teleostean FXYD expression profiles by comparing two closely related euryhaline model teleosts, brackish medaka and Japanese medaka (O. latipes), upon exposure to salinity changes. Seven members of the FXYD protein family were identified in each medaka species, and the expression of most branchial fxyd genes was salinity-dependent. Among the cloned genes, fxyd11 was expressed specifically in the gills and at a significantly higher level than the other fxyd genes. In the brackish medaka, branchial fxyd11 expression was localized to the NKA-immunoreactive cells in gill epithelia. Furthermore, the FXYD11 protein interacted with the NKA a-subunit and was expressed at a higher level in freshwater-acclimated individuals relative to fish in other salinity groups. The protein sequences and tissue distributions of the FXYD proteins were very similar between the two medaka species, but different expression profiles were observed upon salinity challenge for most branchial fxyd genes. Salinity changes produced different effects on the FXYD11 and NKA a-subunit expression patterns in the gills of the brackish medaka. To our knowledge, this report is the first to focus on FXYD expression in the gills of closely related euryhaline teleosts. Given the advantages conferred by the well-developed Japanese medaka system, we propose the brackish medaka as a saltwater fish model for osmoregulatory studies.	[Yang, Wen-Kai; Kang, Chao-Kai; Chang, Chia-Hao; Hsu, An-Di; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yang, Wen-Kai] MingDao Univ, Dept Biotechnol, Changhua, Taiwan; [Lee, Tsung-Han] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Chung Hsing University; Mingdao University; China Medical University Taiwan; Academia Sinica - Taiwan	Lee, TH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	thlee@email.nchu.edu.tw	Zheng, Yong/AAN-8928-2021; Gao 高程, Cheng/J-9586-2012; Hwang, Pung-Pung/AEQ-4633-2022; GUO, Liang-dong/C-1407-2015; Zheng, Yong/E-3947-2012; hwang, pp/A-3641-2011; Chang, Chia-Hao/AAW-2598-2020; Hwang, Pung-Pung/AAH-1538-2022; He, Xinhua/B-8047-2015	Zheng, Yong/0000-0001-5239-9824; Gao 高程, Cheng/0000-0003-2522-7909; Zheng, Yong/0000-0001-5239-9824; Chang, Chia-Hao/0000-0002-7583-4291; He, Xinhua/0000-0002-5570-3454; Lee, Tsung-Han/0000-0002-3542-4335; Yang, Wen-Kai/0000-0001-8095-2420	Academia Sinica of Taiwan [AS-98-TP-B08]; ATU plan of the Ministry of Education, Taiwan [CC-97118]; NICHD, USA [N01-HD-6-2915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER	Academia Sinica of Taiwan(Academia Sinica - Taiwan); ATU plan of the Ministry of Education, Taiwan; NICHD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the Academia Sinica of Taiwan to PPH and THL (AS-98-TP-B08). The work was also supported in part by a grant from the ATU plan of the Ministry of Education, Taiwan, to THL (CC-97118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The monoclonal antibody against the Na<SUP>+</SUP>-K<SUP>+</SUP>-ATPase alpha-subunit (alpha 5) was purchased from the Developmental Studies Hybridoma Bank maintained by the Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, and the Department of Biological Sciences, University of Iowa, Iowa City, IA 52242, under Contract N01-HD-6-2915, NICHD, USA.	Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bystriansky JS, 2011, J EXP BIOL, V214, P2435, DOI 10.1242/jeb.050633; Chen XP, 2009, COMP BIOCHEM PHYS C, V149, P647, DOI 10.1016/j.cbpc.2009.01.009; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; Crambert Gilles, 2003, Sci STKE, V2003, pRE1, DOI 10.1126/stke.2003.166.re1; Cutler CP, 2000, AM J PHYSIOL-REG I, V279, pR222, DOI 10.1152/ajpregu.2000.279.1.R222; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Freire CA, 2008, COMP BIOCHEM PHYS A, V149, P435, DOI 10.1016/j.cbpa.2008.02.003; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2005, J BIOENERG BIOMEMBR, V37, P387, DOI 10.1007/s10863-005-9476-x; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirose S, 2003, COMP BIOCHEM PHYS B, V136, P593, DOI 10.1016/S1096-4959(03)00287-2; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Inoue K, 2003, COMP BIOCHEM PHYS B, V136, P635, DOI 10.1016/S1096-4959(03)00204-5; Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727; Inoue K, 2012, ENVIRON BIOL FISH, V94, P559, DOI 10.1007/s10641-011-9852-9; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kang CK, 2013, COMP BIOCHEM PHYS A, V164, P181, DOI 10.1016/j.cbpa.2012.08.010; Kang CK, 2010, COMP BIOCHEM PHYS A, V157, P7, DOI 10.1016/j.cbpa.2010.05.013; Kang CK, 2008, COMP BIOCHEM PHYS A, V151, P566, DOI 10.1016/j.cbpa.2008.07.020; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; Lin YM, 2003, COMP BIOCHEM PHYS A, V135, P489, DOI 10.1016/S1095-6433(03)00136-3; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Mahmmoud YA, 2005, J BIOL CHEM, V280, P27776, DOI 10.1074/jbc.M503150200; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494, DOI 10.1111/j.1096-3642.2008.00417.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roberts TR, 1998, ICHTHYOL RES, V45, P213, DOI 10.1007/BF02673919; Saito K, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00129; Sakamoto T, 2001, AQUACULTURE, V193, P347, DOI 10.1016/S0044-8486(00)00471-3; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CH, 2012, COMP BIOCHEM PHYS A, V163, P302, DOI 10.1016/j.cbpa.2012.07.017; Tipsmark CK, 2011, J ENDOCRINOL, V209, P237, DOI 10.1530/JOE-10-0495; Tipsmark CK, 2010, AM J PHYSIOL-REG I, V299, pR1212, DOI 10.1152/ajpregu.00015.2010; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1367, DOI 10.1152/ajpregu.00454.2007; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Wang PJ, 2008, J EXP BIOL, V211, P3750, DOI 10.1242/jeb.018440; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yang WK, 2011, J COMP PHYSIOL B, V181, P953, DOI 10.1007/s00360-011-0568-0; Yang WK, 2009, J EXP MAR BIOL ECOL, V375, P41, DOI 10.1016/j.jembe.2009.05.004; Yusof S, 2012, ENVIRON BIOL FISH, V93, P43, DOI 10.1007/s10641-011-9888-x	55	118	135	10	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55470	10.1371/journal.pone.0055470	http://dx.doi.org/10.1371/journal.pone.0055470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	24086741	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600108
J	Petersen, JL; Mickelson, JR; Cothran, EG; Andersson, LS; Axelsson, J; Bailey, E; Bannasch, D; Binns, MM; Borges, AS; Brama, P; Machado, AD; Distl, O; Felicetti, M; Fox-Clipsham, L; Graves, KT; Guerin, G; Haase, B; Hasegawa, T; Hemmann, K; Hill, EW; Leeb, T; Lindgren, G; Lohi, H; Lopes, MS; McGivney, BA; Mikko, S; Orr, N; Penedo, MCT; Piercy, RJ; Raekallio, M; Rieder, S; Roed, KH; Silvestrelli, M; Swinburne, J; Tozaki, T; Vaudin, M; Wade, CM; McCue, ME				Petersen, Jessica L.; Mickelson, James R.; Cothran, E. Gus; Andersson, Lisa S.; Axelsson, Jeanette; Bailey, Ernie; Bannasch, Danika; Binns, Matthew M.; Borges, Alexandre S.; Brama, Pieter; Machado, Artur da Camara; Distl, Ottmar; Felicetti, Michela; Fox-Clipsham, Laura; Graves, Kathryn T.; Guerin, Gerard; Haase, Bianca; Hasegawa, Telhisa; Hemmann, Karin; Hill, Emmeline W.; Leeb, Tosso; Lindgren, Gabriella; Lohi, Hannes; Lopes, Maria Susana; McGivney, Beatrice A.; Mikko, Sofia; Orr, Nicholas; Penedo, M. Cecilia T.; Piercy, Richard J.; Raekallio, Marja; Rieder, Stefan; Roed, Knut H.; Silvestrelli, Maurizio; Swinburne, June; Tozaki, Teruaki; Vaudin, Mark; Wade, Claire M.; McCue, Molly E.			Genetic Diversity in the Modern Horse Illustrated from Genome-Wide SNP Data	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GENETICS; MICROSATELLITE DIVERSITY; LINKAGE DISEQUILIBRIUM; DOMESTICATION; PROGRAM; ORIGINS; INFERENCE; LINEAGES; NUMBER	Horses were domesticated from the Eurasian steppes 5,000-6,000 years ago. Since then, the use of horses for transportation, warfare, and agriculture, as well as selection for desired traits and fitness, has resulted in diverse populations distributed across the world, many of which have become or are in the process of becoming formally organized into closed, breeding populations (breeds). This report describes the use of a genome-wide set of autosomal SNPs and 814 horses from 36 breeds to provide the first detailed description of equine breed diversity. FST calculations, parsimony, and distance analysis demonstrated relationships among the breeds that largely reflect geographic origins and known breed histories. Low levels of population divergence were observed between breeds that are relatively early on in the process of breed development, and between those with high levels of within-breed diversity, whether due to large population size, ongoing outcrossing, or large within-breed phenotypic diversity. Populations with low within-breed diversity included those which have experienced population bottlenecks, have been under intense selective pressure, or are closed populations with long breed histories. These results provide new insights into the relationships among and the diversity within breeds of horses. In addition these results will facilitate future genome-wide association studies and investigations into genomic targets of selection.	[Petersen, Jessica L.; Mickelson, James R.; McCue, Molly E.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Cothran, E. Gus] Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Andersson, Lisa S.; Axelsson, Jeanette; Lindgren, Gabriella; Mikko, Sofia] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Bailey, Ernie; Graves, Kathryn T.] Univ Kentucky, Dept Vet Sci, Lexington, KY USA; [Bannasch, Danika; Penedo, M. Cecilia T.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Binns, Matthew M.] Equine Anal, Midway, KY USA; [Borges, Alexandre S.] Univ Estadual Paulista, Dept Vet Clin Sci, Botucatu, SP, Brazil; [Brama, Pieter] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Machado, Artur da Camara; Lopes, Maria Susana] Univ Azores, Inst Biotechnol & Bioengn, Biotechnol Ctr Azores, Angra Do Heroismo, Portugal; [Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Felicetti, Michela; Silvestrelli, Maurizio] Univ Perugia, Fac Vet Med, I-06100 Perugia, Italy; [Fox-Clipsham, Laura; Swinburne, June; Vaudin, Mark] Anim Hlth Trust, Newmarket, Suffolk, England; [Guerin, Gerard] French Natl Inst Agr Res, Anim Genet & Integrat Biol Unit, Jouy En Josas, France; [Haase, Bianca; Wade, Claire M.] Univ Sydney, Sydney, NSW 2006, Australia; [Hasegawa, Telhisa] Nihon Bioresource Coll, Koga, Ibaraki, Japan; [Hemmann, Karin; Lohi, Hannes; Raekallio, Marja] Univ Helsinki, Fac Vet Med, Helsinki, Finland; [Hill, Emmeline W.; McGivney, Beatrice A.] Univ Coll Dublin, Coll Agr Food Sci & Vet Med, Dublin 2, Ireland; [Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Orr, Nicholas] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Piercy, Richard J.] Univ London Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England; [Rieder, Stefan] Swiss Natl Stud Farm, Agroscope Liebefeld Posieux Res Stn, Avenches, Switzerland; [Roed, Knut H.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Swinburne, June] Anim DNA Diagnost Ltd, Cambridge, England; [Tozaki, Teruaki] Lab Racing Chem, Dept Mol Genet, Utsunomiya, Tochigi, Japan	University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Swedish University of Agricultural Sciences; University of Kentucky; University of California System; University of California Davis; Universidade Estadual Paulista; University College Dublin; Universidade dos Acores; University of Veterinary Medicine Hannover, Foundation; University of Perugia; Animal Health Trust; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Sydney; University of Helsinki; University College Dublin; University of Bern; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University of London Royal Veterinary College; Swiss Federal Research Station Agroscope; Norwegian University of Life Sciences	Petersen, JL (corresponding author), Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA.	jlpeters@umn.edu	da Câmara Machado, Artur/J-8668-2013; Raekallio, Marja/I-1606-2019; Lopes, Maria Susana/AAH-6614-2021; Bailey, Ernest/M-1859-2018; Borges, Alexandre S/B-5506-2013; Bannasch, Danika/GZL-8044-2022; Lopes, Maria/J-5379-2013; Mikko, Sofia/F-1347-2017; Leeb, Tosso/G-3187-2014; Tozaki, Teruaki/ABD-9286-2021; Petersen, Jessica/ABF-2462-2020; Lohi, Hannes/F-4596-2011	da Câmara Machado, Artur/0000-0002-6098-502X; Raekallio, Marja/0000-0002-2653-003X; Bailey, Ernest/0000-0001-8246-9117; Lopes, Maria/0000-0003-1170-9771; Mikko, Sofia/0000-0002-6375-1376; Leeb, Tosso/0000-0003-0553-4880; Tozaki, Teruaki/0000-0001-8797-6644; Petersen, Jessica/0000-0001-5438-8555; Lohi, Hannes/0000-0003-1087-5532; Waud, Bianca/0000-0001-6493-9808; Bannasch, Danika/0000-0002-7614-7207; Hill, Emmeline/0000-0002-1805-2250; McCue, Molly/0000-0002-6807-0318; Hemmann, Karin/0000-0003-3981-4231; Lindgren, Gabriella/0000-0001-6046-9669; Mickelson, James/0000-0001-6951-0234; Secorun Borges, Alexandre/0000-0001-6256-8089; Wade, Claire/0000-0003-3413-4771	National Research Initiative from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2008-35205-18766, 2009-55205-05254, 2012-67015-19432]; Foundation for the Advancement of the Tennessee Walking Show Horse; Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS) [1K08AR055713-01A2, 2T32AR007612]; American Quarter Horse Foundation; Morris Animal Foundation [D07EQ-500]; Swedish Research Council FORMAS [221-2009-1631, 2008-617]; Swedish-Norwegian Foundation for Equine Research [H0847211, H0947256]; Carl Tryggers Stiftelse [CTS 08: 29]; FCT; DRCT; Science Foundation Ireland [04/Y11/B539]; Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany [VWZN2012];  [FRCT/2011/317/005]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055713, T32AR007612] Funding Source: NIH RePORTER	National Research Initiative from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); Foundation for the Advancement of the Tennessee Walking Show Horse; Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS); American Quarter Horse Foundation; Morris Animal Foundation; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish-Norwegian Foundation for Equine Research; Carl Tryggers Stiftelse; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); DRCT; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Research Initiative Competitive Grants 2008-35205-18766, 2009-55205-05254, and 2012-67015-19432 from the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA); Foundation for the Advancement of the Tennessee Walking Show Horse and Tennessee Walking Horse Foundation; National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIHNAIMS) grant 1K08AR055713-01A2 (MEM salary support), and 2T32AR007612 (JLP salary support), American Quarter Horse Foundation grant "Selective Breeding Practices in the American Quarter Horse: Impact on Health and Disease 2011-2012''; Morris Animal Foundation Grant D07EQ-500; The Swedish Research Council FORMAS (Contract 221-2009-1631 and 2008-617); The Swedish-Norwegian Foundation for Equine Research (Contract H0847211 and H0947256); The Carl Tryggers Stiftelse (Contract CTS 08: 29); IBB-CBA-UAc, was supported by FCT and DRCT and MSL by FRCT/2011/317/005; Science Foundation Ireland Award (04/Y11/B539) to EWH; Volkswagen Stiftung und Niedersa chsisches Ministerium fur Wissenschaft und Kultur, Germany (VWZN2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle KS, 2004, ANIM GENET, V35, P270, DOI 10.1111/j.1365-2052.2004.01166.x; Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Achmann R, 2004, ANIM GENET, V35, P285, DOI 10.1111/j.1365-2052.2004.01157.x; Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Belkhir KP, 2001, GENTETIX LOGICIEL WI; Binns MM, 2012, ANIM GENET, V43, P340, DOI 10.1111/j.1365-2052.2011.02259.x; Bjornstad G, 2000, J ANIM BREED GENET, V117, P307, DOI 10.1046/j.1439-0388.2000.00264.x; Bjornstad G, 2003, ANIM GENET, V34, P55, DOI 10.1046/j.1365-2052.2003.00922.x; Bomcke E, 2011, GENET MOL BIOL, V34, P68, DOI 10.1590/S1415-47572010005000113; Bower MA, 2012, ARCHAEOMETRY, V54, P916, DOI 10.1111/j.1475-4754.2012.00666.x; Bower MA, 2011, BIOL LETTERS, V7, P316, DOI 10.1098/rsbl.2010.0800; Bowling AT, 2000, GENETICS HORSE, Vviii; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Conant EK, 2012, ANIM GENET, V43, P53, DOI 10.1111/j.1365-2052.2011.02210.x; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Corbin LJ, 2010, ANIM GENET, V41, P8, DOI 10.1111/j.1365-2052.2010.02092.x; Cothran EG, 2011, GENET MOL RES, V10, P2394, DOI 10.4238/2011.October.7.1; COTHRAN EG, 1987, ANIM GENET, V18, P285, DOI 10.1111/j.1365-2052.1987.tb00772.x; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Felicetti M, 2010, ANIM GENET, V41, P53, DOI 10.1111/j.1365-2052.2010.02102.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Firouz L, 1969, BIOL CONSERV, V1, P1; FLETCHER JL, 1946, J HERED, V37, P369, DOI 10.1093/oxfordjournals.jhered.a105563; GATES S, 1979, MAMMAL REV, V9, P3, DOI 10.1111/j.1365-2907.1979.tb00228.x; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Goloboff P., 2003, SYST BIOL, V54, P176; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Hendricks B., 2007, INT ENCY HORSE BREED; Hund A., 2008, PARASITE IMMUNOL, V20, P73; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Keyser-Tracqui C, 2005, ANIM GENET, V36, P203, DOI 10.1111/j.1365-2052.2005.01316.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lei CZ, 2009, ANIM GENET, V40, P933, DOI 10.1111/j.1365-2052.2009.01950.x; Leroy G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-5; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindgren G, 2004, NAT GENET, V36, P335, DOI 10.1038/ng1326; Ling YH, 2010, J HERED, V101, P639, DOI 10.1093/jhered/esq047; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Lopes MS, 2011, MOL TOOLS CHARACTERI; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; Luis C, 2007, ANIM GENET, V38, P20, DOI 10.1111/j.1365-2052.2006.01545.x; Lynghaug F, 2009, OFFICIAL HORSE BREED; MACCLUER JW, 1983, J HERED, V74, P394, DOI 10.1093/oxfordjournals.jhered.a109824; Mackay-Smith A, 2000, SPEED THOROUGHBRED C, Vxxvii; Marletta D, 2006, J ANIM BREED GENET, V123, P315, DOI 10.1111/j.1439-0388.2006.00603.x; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peilieu C, 1984, FAO ANIMAL PRODUCTIO, V46, P1; Petersen JL, 2012, PLOS GENET IN PRESS; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Shasavarani H, 2010, AFR J BIOTECHNOL, V9, P293; Silvestrelli M, 1991, ANIMAL GENETIC RESOU, V8, P74; Solis A, 2005, J HERED, V96, P670, DOI 10.1093/jhered/esi123; Ticklen M, 2006, GET KNOW FINNHORSE; Tozaki T, 2003, J HERED, V94, P374, DOI 10.1093/jhered/esg079; Tryon RC, 2009, JAVMA-J AM VET MED A, V234, P120, DOI 10.2460/javma.234.1.120; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Warmuth V, 2013, ANIM GENET, V44, P53, DOI 10.1111/j.1365-2052.2012.02371.x; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Weatherby and Sons, 1791, INTR GEN STUD BOOK; Weatherley L, 1978, GREAT HORSES BRITAIN, Vviii; WEIR BS, 1980, GENETICS, V95, P477; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245	81	165	176	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54997	10.1371/journal.pone.0054997	http://dx.doi.org/10.1371/journal.pone.0054997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383025	Green Published, gold, Green Accepted			2022-12-27	WOS:000315563800095
J	Wang, LZ; Ramirez, J; Yeo, W; Chan, MYM; Thuya, WL; Lau, JYA; Wan, SC; Wong, ALA; Zee, YK; Lim, R; Lee, SC; Ho, PC; Lee, HS; Chan, A; Ansher, S; Ratain, MJ; Goh, BC				Wang, Ling-Zhi; Ramirez, Jacqueline; Yeo, Winnie; Chan, Mei-Yi Michelle; Thuya, Win-Lwin; Lau, Jie-Ying Amelia; Wan, Seow-Ching; Wong, Andrea Li-Ann; Zee, Ying-Kiat; Lim, Robert; Lee, Soo-Chin; Ho, Paul C.; Lee, How-Sung; Chan, Anthony; Ansher, Sherry; Ratain, Mark J.; Goh, Boon-Cher			Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; PHASE-II; IN-VITRO; UGT1A1-ASTERISK-28 GENOTYPE; GENE-EXPRESSION; OVARIAN-CANCER; IDENTIFICATION; VORINOSTAT; NEUTROPENIA; ASSOCIATION	Belinostat is a hydroxamate class HDAC inhibitor that has demonstrated activity in peripheral T-cell lymphoma and is undergoing clinical trials for non-hematologic malignancies. We studied the pharmacokinetics of belinostat in hepatocellular carcinoma patients to determine the main pathway of metabolism of belinostat. The pharmacokinetics of belinostat in liver cancer patients were characterized by rapid plasma clearance of belinostat with extensive metabolism with more than 4-fold greater relative systemic exposure of major metabolite, belinostat glucuronide than that of belinostat. There was significant interindividual variability of belinostat glucuronidation. The major pathway of metabolism involves UGT1A1-mediated glucuronidation and a good correlation has been identified between belinostat glucuronide formation and glucuronidation of known UGT1A1 substrates. In addition, liver microsomes harboring UGT1A1*28 alleles have lower glucuronidation activity for belinostat compared to those with wildtype UGT1A1. The main metabolic pathway of belinostat is through glucuronidation mediated primarily by UGT1A1, a highly polymorphic enzyme. The clinical significance of this finding remains to be determined. Trial Registration: ClinicalTrials.gov NCT00321594 http://clinicaltrials.gov/ct2/show/NCT00321594	[Wang, Ling-Zhi; Thuya, Win-Lwin; Lau, Jie-Ying Amelia; Wan, Seow-Ching; Lee, Soo-Chin; Goh, Boon-Cher] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Wang, Ling-Zhi; Lee, How-Sung; Goh, Boon-Cher] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; [Ramirez, Jacqueline; Ratain, Mark J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Yeo, Winnie; Chan, Anthony] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chan, Mei-Yi Michelle; Ho, Paul C.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Wong, Andrea Li-Ann; Zee, Ying-Kiat; Lim, Robert; Lee, Soo-Chin; Goh, Boon-Cher] Natl Univ Hlth Syst, Dept Hematol & Oncol, Singapore, Singapore; [Ansher, Sherry] NCI, Div Canc Treatment, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Ratain, Mark J.] Univ Chicago, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA; [Ratain, Mark J.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA	National University of Singapore; National University of Singapore; University of Chicago; Chinese University of Hong Kong; National University of Singapore; National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Goh, BC (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	phcgbc@nus.edu.sg	Lee, Soo Chin/S-9111-2016; Ho, Paul C/O-9652-2014; Yeo, Winnie/R-4792-2018; Chan, Anthony/U-7768-2019; Wang, Lingzhi/AAF-1851-2020; Chau, Pak Chun Janita/A-4571-2015	Lee, Soo Chin/0000-0002-5835-6419; Ho, Paul C/0000-0001-9213-7116; Yeo, Winnie/0000-0002-0863-8469; Chan, Anthony/0000-0002-1771-163X; Wang, Lingzhi/0000-0001-5585-5426; Chau, Pak Chun Janita/0000-0002-3750-7396	National Research Foundation of Singapore (Experimental Therapeutics Program); National Medical Research Council of Singapore [NMRC/CSA/021/2010]	National Research Foundation of Singapore (Experimental Therapeutics Program)(National Research Foundation, Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	The study was sponsored by the National Research Foundation of Singapore (Experimental Therapeutics Program) and the National Medical Research Council of Singapore (NMRC/CSA/021/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu SR, 1995, CARCINOGENESIS, V16, P3069, DOI 10.1093/carcin/16.12.3069; Balliet RM, 2009, CANCER RES, V69, P2981, DOI 10.1158/0008-5472.CAN-08-4143; Bapat SA, 2010, EPIGENOMICS-UK, V2, P39, DOI 10.2217/EPI.09.38; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Cashen A, 2012, ANN HEMATOL, V91, P33, DOI 10.1007/s00277-011-1240-1; Ciotti M, 1999, CARCINOGENESIS, V20, P1963, DOI 10.1093/carcin/20.10.1963; Clive S, 2009, J CLIN ONCOL, V27, p15s; Dai Y, 2011, BRIT J HAEMATOL, V153, P222, DOI 10.1111/j.1365-2141.2011.08591.x; Du LH, 2005, RAPID COMMUN MASS SP, V19, P1779, DOI 10.1002/rcm.1984; Giaccone G, 2011, J CLIN ONCOL, V29, P2052, DOI 10.1200/JCO.2010.32.4467; Graber ALY, 2007, PHARMACOGENET GENOM, V17, P619, DOI 10.1097/FPC.0b013e3280121fe9; Gray SG, 2004, INT J ONCOL, V24, P773; Hoskins JM, 2007, J NATL CANCER I, V99, P1290, DOI 10.1093/jnci/djm115; Howman RA, 2011, EXPERT REV ANTICANC, V11, P457, DOI [10.1586/era.11.4, 10.1586/ERA.11.4]; Innocenti F, 2005, PHARMACOGENET GENOM, V15, P295, DOI 10.1097/01213011-200505000-00004; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; Iyer L, 1999, CLIN PHARMACOL THER, V65, P576, DOI 10.1016/S0009-9236(99)70078-0; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; Kang SP, 2010, PHARMACOGENET GENOM, V20, P638, DOI 10.1097/FPC.0b013e32833e1b37; Mackay HJ, 2010, EUR J CANCER, V46, P1573, DOI 10.1016/j.ejca.2010.02.047; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Na YS, 2011, CANCER CHEMOTH PHARM, V68, P389, DOI 10.1007/s00280-010-1495-6; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Piekarz RL, 2009, CLIN CANCER RES, V15, P3918, DOI 10.1158/1078-0432.CCR-08-2788; Ramalingam SS, 2009, J THORAC ONCOL, V4, P97, DOI 10.1097/JTO.0b013e318191520c; Shiraga T, 2005, BIOL PHARM BULL, V28, P124, DOI 10.1248/bpb.28.124; Steele NL, 2008, CLIN CANCER RES, V14, P804, DOI 10.1158/1078-0432.CCR-07-1786; Strassburg CP, 1998, J BIOL CHEM, V273, P8719, DOI 10.1074/jbc.273.15.8719; Tanji N, 2011, EXPERT REV ANTICANC, V11, P959, DOI [10.1586/era.10.230, 10.1586/ERA.10.230]; Tumber A, 2007, CANCER CHEMOTH PHARM, V60, P275, DOI 10.1007/s00280-006-0374-7; Wang LZ, 2010, J CHROMATOGR B, V878, P2409, DOI 10.1016/j.jchromb.2010.07.015; Wong NS, 2011, PHARMACOGENET GENOM, V21, P760, DOI 10.1097/FPC.0b013e32834a8639; Yeo W, 2012, J CLIN ONCOL, V30, P3361, DOI 10.1200/JCO.2011.41.2395	37	77	85	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e54522	10.1371/journal.pone.0054522	http://dx.doi.org/10.1371/journal.pone.0054522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23382909	Green Published, gold, Green Submitted			2022-12-27	WOS:000315563800052
J	Xu, JY; Yu, Y; Wu, X; Wu, YF; Jiang, C; Wang, SZ; Huang, QH; Liu, JM				Xu, Jinyu; Yu, Ying; Wu, Xi; Wu, Yongfa; Jiang, Che; Wang, Shengzhang; Huang, Qinghai; Liu, Jianmin			Morphological and Hemodynamic Analysis of Mirror Posterior Communicating Artery Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; WALL SHEAR-STRESS; COMPUTATIONAL FLUID-DYNAMICS; INTERNAL CAROTID-ARTERY; ASPECT RATIO; CEREBRAL ANEURYSMS; SACCULAR ANEURYSM; FLOW DYNAMICS; RUPTURE RISK; SIZE	Background and Purpose: Hemodynamic factors are commonly believed to play an important role in the pathogenesis, progression, and rupture of cerebral aneurysms. In this study, we aimed to identify significant hemodynamic and morphological parameters that discriminate intracranial aneurysm rupture status using 3-dimensional-angiography and computational fluid dynamics technology. Materials and Methods: 3D-DSA was performed in 8 patients with mirror posterior communicating artery aneurysms (Pcom-MANs). Each pair was divided into ruptured and unruptured groups. Five morphological and three hemodynamic parameters were evaluated for significance with respect to rupture. Results: The normalized mean wall shear stress (WSS) of the aneurysm sac in the ruptured group was significantly lower than that in the unruptured group (0.52 +/- 0.20 versus 0.81 +/- 0.21, P = .012). The percentage of the low WSS area in the ruptured group was higher than that in the unruptured group (4.11 +/- 4.66% versus 0.02 +/- 0.06%, P = .018). The AR was 1.04 +/- 0.21 in the ruptured group, which was significantly higher than 0.70 +/- 0.17 in the unruptured group (P = .012). By contrast, parameters that had no significant differences between the two groups were OSI (P = .674), aneurysm size (P = .327), size ratio (P = .779), vessel angle (P = 1.000) and aneurysm inclination angle (P = 1.000). Conclusions: Pcom-MANs may be a useful disease model to investigate possible causes of aneurysm rupture. The ruptured aneurysms manifested lower WSS, higher percentage of low WSS area, and higher AR, compared with the unruptured one. And hemodynamics is as important as morphology in discriminating aneurysm rupture status.	[Xu, Jinyu; Yu, Ying; Wu, Xi; Wu, Yongfa; Jiang, Che; Huang, Qinghai; Liu, Jianmin] Second Mil Med Univ, Dept Neurosurg, Changhai Hosp, Shanghai, Peoples R China; [Wang, Shengzhang] Fudan Univ, Dept Mech & Engn Sci, Shanghai 200433, Peoples R China	Naval Medical University; Fudan University	Huang, QH (corresponding author), Second Mil Med Univ, Dept Neurosurg, Changhai Hosp, Shanghai, Peoples R China.	ocinhqh@163.com; chstroke@163.com		Smith, M. Kumi/0000-0001-5861-8100; xu, junjie/0000-0003-4303-7295	National Natural Science Foundation of China [81171092, 81171093]; Shanghai Science and Technology Committee [11QA1408400, 11JC1415800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research was supported by the National Natural Science Foundation of China (Grant No. 81171092 and 81171093), Rising-star Plan and Key Project of Shanghai Science and Technology Committee (Grant No. 11QA1408400 and 11JC1415800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus M, 2009, ACTA NEUROCHIR, V151, P1569, DOI 10.1007/s00701-009-0316-3; Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; Beck J, 2006, SURG NEUROL, V65, P18, DOI 10.1016/j.surneu.2005.05.019; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Castro MA, 2009, AM J NEURORADIOL, V30, P297, DOI 10.3174/ajnr.A1323; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Goubergrits L, 2012, J R SOC INTERFACE, V9, P677, DOI 10.1098/rsif.2011.0490; Hassan T, 2005, J NEUROSURG, V103, P662, DOI 10.3171/jns.2005.103.4.0662; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; Jou LD, 2008, AM J NEURORADIOL, V29, P1761, DOI 10.3174/ajnr.A1180; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Lu G, 2011, AM J NEURORADIOL, V32, P1255, DOI 10.3174/ajnr.A2461; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; NISHIOKA H, 1984, ARCH NEUROL-CHICAGO, V41, P1142, DOI 10.1001/archneur.1984.04050220036011; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Tremmel M, 2009, NEUROSURGERY, V64, P622, DOI 10.1227/01.NEU.0000341529.11231.69; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Valencia A, 2006, INT J NUMER METH FL, V50, P751, DOI 10.1002/fld.1078; Weir B, 2003, J NEUROSURG, V99, P447, DOI 10.3171/jns.2003.99.3.0447; White PM, 2003, J NEURORADIOLOGY, V30, P336; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Zeng Z, 2011, AM J NEURORADIOL, V32, P595, DOI 10.3174/ajnr.A2324; Zeng ZJ, 2011, J BIOMECH, V44, P2809, DOI 10.1016/j.jbiomech.2011.08.002	30	82	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55413	10.1371/journal.pone.0055413	http://dx.doi.org/10.1371/journal.pone.0055413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383184	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600100
J	Chen, YY; Chen, F; Gunnell, D; Yip, PSF				Chen, Ying-Yeh; Chen, Feng; Gunnell, David; Yip, Paul S. F.			The Impact of Media Reporting on the Emergence of Charcoal Burning Suicide in Taiwan	PLOS ONE			English	Article							PROCESS INTENSITY FUNCTION; ESTIMATORS	We investigated the association of the intensity of newspaper reporting of charcoal burning suicide with the incidence of such deaths in Taiwan during 1998-2002. A counting process approach was used to estimate the incidence of suicides and intensity of news reporting. Conditional Poisson generalized linear autoregressive models were performed to assess the association of the intensity of newspaper reporting of charcoal burning and non-charcoal burning suicides with the actual number of charcoal burning and non-charcoal burning suicides the following day. We found that increases in the reporting of charcoal burning suicide were associated with increases in the incidence of charcoal burning suicide on the following day, with each reported charcoal burning news item being associated with a 16% increase in next day charcoal burning suicide (p<.0001). However, the reporting of other methods of suicide was not related to their incidence. We conclude that extensive media reporting of charcoal burning suicides appears to have contributed to the rapid rise in the incidence of the novel method in Taiwan during the initial stage of the suicide epidemic. Regulating media reporting of novel suicide methods may prevent an epidemic spread of such new methods.	[Chen, Ying-Yeh] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Chen, Feng] Univ New S Wales, Dept Stat, Sydney, NSW, Australia; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Yip, Paul S. F.] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of New South Wales Sydney; University of Bristol; University of Hong Kong; University of Hong Kong	Yip, PSF (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk	Chen, Ying-Yeh/AAY-1478-2021; Gunnell, David/ABE-6653-2020; Chen, Feng/B-5366-2009	Gunnell, David/0000-0002-0829-6470; Chen, Feng/0000-0002-9646-3338; Chen, Ying-Yeh/0000-0001-5543-5704	National Science Council, Taiwan [101-2314-B-532-005-MY2]; Department of Health, Taipei City Government [96001-61-001-043]; National Health Research Institute, Taiwan [NHRI-EX100-10024PC]; University of Hong Kong [HKU7030-PPR-12, HKU784210]; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taipei City Government; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); University of Hong Kong(University of Hong Kong); National Institute for Health Research(National Institute for Health Research (NIHR))	Y-YC was supported by the National Science Council, Taiwan (grant number 101-2314-B-532-005-MY2), Department of Health, Taipei City Government (grant number 96001-61-001-043) and the National Health Research Institute, Taiwan (grant number NHRI-EX100-10024PC). DG is a National Institute for Health Research senior investigator. PSFY was supported by General Research Fund grants of the University of Hong Kong (grant number HKU7030-PPR-12 and HKU784210). The funding agency has no role in the design, analysis, interpretation and the presentation of the data.	Chang SS, 2010, SOC PSYCH PSYCH EPID, V45, P143, DOI 10.1007/s00127-009-0049-x; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; Chen F, 2008, COMMUN STAT-THEOR M, V37, P294, DOI 10.1080/03610920701649035; Chen F, 2011, SCAND J STAT, V38, P631, DOI 10.1111/j.1467-9469.2011.00733.x; Chen F, 2011, STAT SINICA, V21, P107; Chen YY, 2011, J EPIDEMIOL COMMUN H, V65, P934, DOI 10.1136/jech.2010.117903; Chen YY, 2010, SOC SCI MED, V71, P2083, DOI 10.1016/j.socscimed.2010.09.043; Guan RJ, 2010, PC HOME PERSONAL NEW; Lin JJ, 2008, J EPIDEMIOL COMMUN H, V62, P566, DOI 10.1136/jech.2007.065771; Lin LY, 2008, MASS COMMUNICATION R, V95, P183; Liu KY, 2007, J EPIDEMIOL COMMUN H, V61, P248, DOI 10.1136/jech.2006.048553; Niederkrotenthaler T., 2009, SOC SCI MED, V69, P1085, DOI DOI 10.1016/j.socscimed.2009.07.041; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; Pirkis JE, 2006, SOC SCI MED, V62, P2874, DOI 10.1016/j.socscimed.2005.11.033; Sisask M, 2012, INT J ENV RES PUB HE, V9, P123, DOI 10.3390/ijerph9010123; Taiwan Suicide Prevention Center, 2009, SURV RES; Tsai CW, 2011, J AFFECT DISORDERS, V131, P402, DOI 10.1016/j.jad.2010.12.013; Wu KCC, 2012, INT J ENV RES PUB HE, V9, P1135, DOI 10.3390/ijerph9041135; Yip PSF, 2007, CRISIS, V28, P21, DOI 10.1027/0227-5910.28.S1.21	19	112	117	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55000	10.1371/journal.pone.0055000	http://dx.doi.org/10.1371/journal.pone.0055000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23555643	Green Published, gold			2022-12-27	WOS:000315563800097
J	Boch, S; Prati, D; Hessenmoller, D; Schulze, ED; Fischer, M				Boch, Steffen; Prati, Daniel; Hessenmoeller, Dominik; Schulze, Ernst-Detlef; Fischer, Markus			Richness of Lichen Species, Especially of Threatened Ones, Is Promoted by Management Methods Furthering Stand Continuity	PLOS ONE			English	Article							EPIPHYTIC LICHENS; OLD-GROWTH; BRYOPHYTE COMMUNITIES; BEECH FORESTS; DIVERSITY; CONSERVATION; BIODIVERSITY; DISPERSAL; INDICATOR; QUALITY	Lichens are a key component of forest biodiversity. However, a comprehensive study analyzing lichen species richness in relation to several management types, extending over different regions and forest stages and including information on site conditions is missing for temperate European forests. In three German regions (Schwabische Alb, Hainich-Dun, Schorfheide-Chorin), the so-called Biodiversity Exploratories, we studied lichen species richness in 631 forest plots of 400 m(2) comprising different management types (unmanaged, selection cutting, deciduous and coniferous age-class forests resulting from clear cutting or shelterwood logging), various stand ages, and site conditions, typical for large parts of temperate Europe. We analyzed how lichen species richness responds to management and habitat variables (standing biomass, cover of deadwood, cover of rocks). We found strong regional differences with highest lichen species richness in the Schwabische Alb, probably driven by regional differences in former air pollution, and in precipitation and habitat variables. Overall, unmanaged forests harbored 22% more threatened lichen species than managed age-class forests. In general, total, corticolous, and threatened lichen species richness did not differ among management types of deciduous forests. However, in the Schwabische-Alb region, deciduous forests had 61% more lichen species than coniferous forests and they had 279% more threatened and 76% more corticolous lichen species. Old deciduous age classes were richer in corticolous lichen species than young ones, while old coniferous age-classes were poorer than young ones. Overall, our findings highlight the importance of stand continuity for conservation. To increase total and threatened lichen species richness we suggest (1) conserving unmanaged forests, (2) promoting silvicultural methods assuring stand continuity, (3) conserving old trees in managed forests, (4) promoting stands of native deciduous tree species instead of coniferous plantations, and (5) increasing the amount of deadwood in forests.	[Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Bot Gardens, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Oeschger Ctr, Bern, Switzerland; [Hessenmoeller, Dominik; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, D-07745 Jena, Germany	University of Bern; University of Bern; University of Bern; Max Planck Society	Boch, S (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Boch, Steffen/L-5436-2016; Schulze, Ernst-Detlef/K-9627-2014; Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900	DFG (German Research Foundation) in the framework of the Biodiversity Exploratories "Infrastructure-Biodiversity-Exploratories" [SSP 1374, FI 1246/6-1, FI 1246/9-1]	DFG (German Research Foundation) in the framework of the Biodiversity Exploratories "Infrastructure-Biodiversity-Exploratories"(German Research Foundation (DFG))	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 "Infrastructure-Biodiversity-Exploratories" (FI 1246/6-1, FI 1246/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamini A, 2005, CONSERV BIOL, V19, P1051, DOI 10.1111/j.1523-1739.2005.00086.x; Berge E, 1998, TELLUS B, V50, P205, DOI 10.1034/j.1600-0889.1998.t01-2-00001.x; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; Edman M, 2008, J APPL ECOL, V45, P26, DOI 10.1111/j.1365-2664.2007.01354.x; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Fedrowitz K, 2012, J APPL ECOL, V49, P493, DOI 10.1111/j.1365-2664.2012.02113.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Fritz O, 2008, BIOL CONSERV, V141, P655, DOI 10.1016/j.biocon.2007.12.006; Fritz O, 2010, BIOL CONSERV, V143, P1008, DOI 10.1016/j.biocon.2010.01.016; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; Gilbert Oliver L., 1992, P159; Graae BJ, 1997, FOREST ECOL MANAG, V96, P111, DOI 10.1016/S0378-1127(97)00046-7; Gustafsson L, 2004, BASIC APPL ECOL, V5, P123, DOI 10.1078/1439-1791-00223; Hessenmoller D., 2011, Forstarchiv, V82, P171; Horstkotte T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028779; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; Jairus K, 2009, J APPL ECOL, V46, P930, DOI 10.1111/j.1365-2664.2009.01672.x; Juriado I, 2009, BIODIVERS CONSERV, V18, P105, DOI 10.1007/s10531-008-9460-y; Kirschbaum U, 2006, GEFAHRST REINHALT L, V66, P272; LESICA P, 1991, CAN J BOT, V69, P1745, DOI 10.1139/b91-222; Lohmus A, 2007, BIOL CONSERV, V135, P405, DOI 10.1016/j.biocon.2006.10.015; Lohmus A, 2010, BIOL CONSERV, V143, P891, DOI 10.1016/j.biocon.2009.12.036; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Moning C, 2009, ECOL INDIC, V9, P922, DOI 10.1016/j.ecolind.2008.11.002; Moning C, 2009, FOREST ECOL MANAG, V258, P745, DOI 10.1016/j.foreco.2009.05.015; Muir PS, 2006, ECOL APPL, V16, P1207, DOI 10.1890/1051-0761(2006)016[1207:IOOROG]2.0.CO;2; Nascimbene J, 2007, FOREST ECOL MANAG, V247, P43, DOI 10.1016/j.foreco.2007.04.011; Nascimbene J, 2010, FOREST ECOL MANAG, V260, P603, DOI 10.1016/j.foreco.2010.05.016; Neitlich PN, 1997, CONSERV BIOL, V11, P172, DOI 10.1046/j.1523-1739.1997.95492.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Parviainen J, 2003, J ENVIRON MANAGE, V67, P27, DOI 10.1016/S0301-4797(02)00185-8; Parviainen J, 2000, FORESTRY, V73, P107, DOI 10.1093/forestry/73.2.107; Perhans K, 2009, BIOL CONSERV, V142, P1125, DOI 10.1016/j.biocon.2008.12.033; Peterson EB, 2001, J VEG SCI, V12, P511, DOI 10.2307/3237003; Purvis OW, 2010, SYST BIODIVERS, V8, P193, DOI 10.1080/14772001003782088; PYKALA J, 2006, BASIC APPL ECOL, V223, P84, DOI DOI 10.1016/J.FORECO.2005.10.059; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Rolstad J, 2001, ECOL APPL, V11, P421, DOI 10.1890/1051-0761(2001)011[0421:ELINCS]2.0.CO;2; Rose Francis, 1992, P211; Rudolphi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018639; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Seaward MRD, 2008, LICHEN BIOLOGY, 2ND EDITION, P274, DOI 10.1017/CBO9780511790478.015; Sillett SC, 2000, ECOL APPL, V10, P789, DOI 10.1890/1051-0761(2000)010[0789:DLOELR]2.0.CO;2; Svoboda D, 2010, ENVIRON POLLUT, V158, P812, DOI 10.1016/j.envpol.2009.10.001; Thor Goran, 1995, Mitteilungen der Eidgenoessischen Forschungsanstalt fuer Wald Schnee und Landschaft, V70, P29; Uliczka H, 2000, BIOL CONSERV, V95, P343, DOI 10.1016/S0006-3207(00)00022-7; Umweltbundesamt, 2005, DAT UMW ZUST UMW DEU; Werth S, 2006, ECOLOGY, V87, P2037, DOI 10.1890/0012-9658(2006)87[2037:QDAELI]2.0.CO;2; Wirth V., 1996, SCHRIFTENREIHE VEGET, V28, P307; Wolseley PA, 2006, LICHENOLOGIST, V38, P307, DOI 10.1017/S0024282906006190	53	62	69	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55461	10.1371/journal.pone.0055461	http://dx.doi.org/10.1371/journal.pone.0055461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	24358373	Green Published, gold, Green Submitted			2022-12-27	WOS:000315483200052
J	Yang, W; Zheng, Y; Gao, C; He, XH; Ding, Q; Kim, Y; Rui, YC; Wang, SP; Guo, LD				Yang, Wei; Zheng, Yong; Gao, Cheng; He, Xinhua; Ding, Qiong; Kim, Yongchan; Rui, Yichao; Wang, Shiping; Guo, Liang-Dong			The Arbuscular Mycorrhizal Fungal Community Response to Warming and Grazing Differs between Soil and Roots on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SPECIES COMPOSITION; ATMOSPHERIC CO2; CARBON ALLOCATION; ELEVATED CO2; PLANT; DIVERSITY; GRASSLAND; TEMPERATURE; SPORE; COLONIZATION	Arbuscular mycorrhizal (AM) fungi form symbiotic associations with most plant species in terrestrial ecosystems, and are affected by environmental variations. To reveal the impact of disturbance on an AM fungal community under future global warming, we examined the abundance and community composition of AM fungi in both soil and mixed roots in an alpine meadow on the Qinghai-Tibetan Plateau, China. Warming and grazing had no significant effect on AM root colonization, spore density and extraradical hyphal density. A total of 65 operational taxonomic units (OTUs) of AM fungi were identified from soil and roots using molecular techniques. AM fungal OTU richness was higher in soil (54 OTUs) than in roots (34 OTUs), and some AM fungi that differed between soil and roots, showed significantly biased occurrence to warming or grazing. Warming and grazing did not significantly affect AM fungal OTU richness in soil, but warming with grazing significantly increased AM fungal OTU richness in roots compared to the grazing-only treatment. Non-metric multidimensional scaling analysis showed that the AM fungal community composition was significantly different between soil and roots, and was significantly affected by grazing in roots, whereas in soil it was significantly affected by warming and plant species richness. The results suggest that the AM fungal community responds differently to warming and grazing in soil compared with roots. This study provides insights into the role of AM fungi under global environmental change scenarios in alpine meadows of the Qinghai-Tibetan Plateau.	[Yang, Wei; Zheng, Yong; Gao, Cheng; Ding, Qiong; Kim, Yongchan; Guo, Liang-Dong] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Yang, Wei; Kim, Yongchan; Rui, Yichao] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Wang, Shiping] Chinese Acad Sci, Inst Tibetan Plateau Res, Lab Alpine Ecol & Biodivers, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Western Australia; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Guo, LD (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	guold@sun.im.ac.cn	Zheng, Yong/AAN-8928-2021; Gao 高程, Cheng/J-9586-2012; Hwang, Pung-Pung/AEQ-4633-2022; GUO, Liang-dong/C-1407-2015; Zheng, Yong/E-3947-2012; hwang, pp/A-3641-2011; Chang, Chia-Hao/AAW-2598-2020; Hwang, Pung-Pung/AAH-1538-2022; He, Xinhua/B-8047-2015	Zheng, Yong/0000-0001-5239-9824; Gao 高程, Cheng/0000-0003-2522-7909; Zheng, Yong/0000-0001-5239-9824; Chang, Chia-Hao/0000-0002-7583-4291; He, Xinhua/0000-0002-5570-3454; Lee, Tsung-Han/0000-0002-3542-4335; Yang, Wen-Kai/0000-0001-8095-2420	National Natural Science Foundation of China [31070434]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Natural Science Foundation of China (No. 31070434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ba L, 2012, PLANT SOIL, V352, P143, DOI 10.1007/s11104-011-0985-6; Bai G, 2013, MYCORRHIZA, V23, P289, DOI 10.1007/s00572-012-0468-5; Barto EK, 2010, J ECOL, V98, P745, DOI 10.1111/j.1365-2745.2010.01658.x; Beauregard MS, 2013, MYCORRHIZA, V23, P143, DOI 10.1007/s00572-012-0459-6; Borstler B, 2006, BIOL FERT SOILS, V42, P286, DOI 10.1007/s00374-005-0026-9; Bunn R, 2009, ECOLOGY, V90, P1378, DOI 10.1890/07-2080.1; Clark NM, 2009, J ARID ENVIRON, V73, P834, DOI 10.1016/j.jaridenv.2009.03.004; Colwell RK, 2013, ESTIMATES STAT ESTIM; Daniels B. A., 1982, Methods and principles of mycorrhizal research., P29; Davison J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041938; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Eom AH, 2001, MYCOLOGIA, V93, P233, DOI 10.2307/3761643; Frank DA, 2003, OECOLOGIA, V137, P603, DOI 10.1007/s00442-003-1385-2; Gange AC, 2002, OECOLOGIA, V131, P103, DOI 10.1007/s00442-001-0863-7; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; Heinemeyer A, 2004, GLOBAL CHANGE BIOL, V10, P52, DOI 10.1111/j.1365-2486.2003.00713.x; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Holland JN, 1996, OECOLOGIA, V107, P87, DOI 10.1007/BF00582238; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Johnson NC, 2005, GLOBAL CHANGE BIOL, V11, P1156, DOI 10.1111/j.1365-2486.2005.00967.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Klironomos JN, 2005, NATURE, V433, P621, DOI 10.1038/nature03268; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kula AAR, 2005, ECOL LETT, V8, P61, DOI 10.1111/j.1461-0248.2004.00690.x; Lekberg Y, 2008, BOTANY, V86, P1117, DOI 10.1139/B08-077; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Liu YJ, 2012, MYCORRHIZA, V22, P31, DOI 10.1007/s00572-011-0378-y; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Lugo MA, 2002, MYCOLOGIA, V94, P579, DOI 10.2307/3761709; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Miller SP, 1999, OECOLOGIA, V119, P586, DOI 10.1007/s004420050823; MONZ CA, 1994, PLANT SOIL, V165, P75, DOI 10.1007/BF00009964; Murray TR, 2010, ECOLOGY, V91, P815, DOI 10.1890/09-0209.1; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Pringle A, 2002, AM J BOT, V89, P1439, DOI 10.3732/ajb.89.9.1439; R Development Core Team, 2010, R LANG ENV STAT COMP; Renker C, 2005, ENVIRON POLLUT, V135, P255, DOI 10.1016/j.envpol.2004.11.002; Rillig MC, 1999, OECOLOGIA, V119, P572, DOI 10.1007/s004420050821; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Sanders IR, 2004, NEW PHYTOL, V164, P415, DOI 10.1111/j.1469-8137.2004.01208.x; Schwarzott D, 2001, MOL PHYLOGENET EVOL, V21, P190, DOI 10.1006/mpev.2001.1007; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Staddon PL, 2004, GLOBAL CHANGE BIOL, V10, P1909, DOI 10.1111/j.1365-2486.2004.00861.x; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Su YY, 2007, MYCORRHIZA, V17, P689, DOI 10.1007/s00572-007-0151-4; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2004, NEW PHYTOL, V164, P201, DOI 10.1111/j.1469-8137.2004.01205.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van Diepen LTA, 2011, MOL ECOL, V20, P799, DOI 10.1111/j.1365-294X.2010.04969.x; Wagner H, 2009, VEGAN COMMUNITY ECOL; Wang SP, 2012, ECOLOGY, V93, P2365, DOI 10.1890/11-1408.1; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Wolf J, 2003, NEW PHYTOL, V157, P579, DOI 10.1046/j.1469-8137.2003.00696.x; Zarei M, 2010, ENVIRON POLLUT, V158, P2757, DOI 10.1016/j.envpol.2010.04.017; Zavalloni C, 2012, PLANT SOIL, V359, P121, DOI 10.1007/s11104-012-1190-y; Zheng Y, 2012, APPL MICROBIOL BIOT, V93, P2193, DOI 10.1007/s00253-011-3535-5	74	118	135	10	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76447	10.1371/journal.pone.0076447	http://dx.doi.org/10.1371/journal.pone.0076447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086741	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000067
J	Liu, ZY; Li, W; Wang, J; Pan, J; Sun, SP; Yu, YH; Zhao, B; Ma, YZ; Zhang, TJ; Qi, J; Liu, GJ; Lu, FM				Liu, Zhiyuan; Li, Wei; Wang, Jie; Pan, Jian; Sun, Shipeng; Yu, Yanhua; Zhao, Bing; Ma, Yuzhi; Zhang, Tingju; Qi, Jie; Liu, Guijian; Lu, Fengmin			Identification and Characterization of the First Escherichia coli Strain Carrying NDM-1 Gene in China	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ACINETOBACTER-BAUMANNII; EMERGENCE; ENTEROBACTERIACEAE; RESISTANCE; CARBAPENEMASES; DISSEMINATION; WORLDWIDE; INFECTION; SPREAD	New Delhi metallo-beta-lactamase-1 (NDM-1), an acquired class B carbapenemase, is a significant clinical threat due to its extended hydrolysis of beta-lactams including carbapenems. In this study, we identified the first confirmed clinical isolate of Escherichia coli BJ01 harboring bla(NDM-1) in China. The isolate is highly resistant to all tested antimicrobials except polymyxin. bla(NDM-1), bla(CTX-M-57), and bla(TEM-1) were identified in the isolate. bla(NDM-1) was transferable to E. coli EC600 and DH5 alpha in both plasmid conjugation experiments and plasmid transformation tests. BJ01 was identified as a new sequence type, ST224, by multilocus sequence typing. Analysis of genetic environment shows complex transposon-like structures surrounding the blaNDM-1 gene. Genetic analysis revealed that the region flanking blaNDM-1 was very similar to previously identified NDM-positive Acinetobacter spp. isolated in China. The findings of this study raise attention to the emergence and spread of NDM-1-carrying Enterobacteriaceae in China.	[Liu, Zhiyuan; Wang, Jie; Pan, Jian; Sun, Shipeng; Zhao, Bing; Ma, Yuzhi; Zhang, Tingju; Qi, Jie; Liu, Guijian] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Liu, Zhiyuan; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Ctr Infect Dis, Beijing 100871, Peoples R China; [Li, Wei] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Yu, Yanhua] Capital Med Univ, Beijing Youan Hosp, Dept Clin Lab, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Peking University; Capital Medical University; Capital Medical University	Liu, GJ (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China.	GuijianLiu234@gmail.com; Fengmingqqq@gmail.com	Li, Wei/I-8060-2014; Yang, Jian/H-3169-2011; Liu, ZH/H-7536-2012	Yang, Jian/0000-0002-2170-589X; Liu, ZH/0000-0002-0086-5659; He, Hong S./0000-0002-3983-2512; Liu, Zhiyuan/0000-0002-4253-1753; Li, Wei/0000-0002-9991-7892	Guang'anmen Hospital [2011S242]; Beijing You'an Project for Liver diseases and AIDS [JYAN-2011-064]	Guang'anmen Hospital; Beijing You'an Project for Liver diseases and AIDS	This work was supported by Internal Funding of Guang'anmen Hospital (Grant# 2011S242) and Beijing You'an Project for Liver diseases and AIDS ( Grant# JYAN-2011-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birgy A, 2012, J CLIN MICROBIOL, V50, P1295, DOI 10.1128/JCM.06131-11; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Chen SD, 2011, AM J INFECT CONTROL, V39, pE55, DOI 10.1016/j.ajic.2011.02.009; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Chen Y, 2012, J BACTERIOL, V194, P204, DOI 10.1128/JB.06202-11; Clinical and Laboratory Standards Institute (CLSI), 1999, M26A CLSI, V19, P1; CLSI, 2012, M100S22 CLSI; D'Andrea MM, 2011, J CLIN MICROBIOL, V49, P2755, DOI 10.1128/JCM.00016-11; Espinal P, 2011, ANTIMICROB AGENTS CH, V55, P5396, DOI 10.1128/AAC.00679-11; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Fu Y, 2012, J ANTIMICROB CHEMOTH; Gaibani P, 2011, EUROSURVEILLANCE, V16, P2; Ho PL, 2012, J ANTIMICROB CHEMOTH, DOI [10.1093/jac/dks095, DOI 10.1093/JAC/DKS095.EPUB]; Hopkins TA, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2903479; Hu FP, 2012, J MED MICROBIOL, V61, P132, DOI 10.1099/jmm.0.036483-0; Hu HY, 2012, ANTIMICROB AGENTS CH, V56, P1698, DOI 10.1128/AAC.06199-11; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lascols C, 2011, J ANTIMICROB CHEMOTH, V66, P1992, DOI 10.1093/jac/dkr240; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Nielsen J, 2012, FEMS YEAST RES, V12, P1, DOI [10.1111/j.1567-1364.2011.00764.x, 10.1111/j.1574-6941.2011.01260.x]; OBRIEN TF, 1985, SCIENCE, V230, P87, DOI 10.1126/science.2994226; Pfeifer Y, 2011, ANTIMICROB AGENTS CH, V55, P1318, DOI 10.1128/AAC.01585-10; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Shakil S, 2011, J CHEMOTHERAPY, V23, P263, DOI 10.1179/joc.2011.23.5.263; Shi DS, 2012, EUR J CLIN MICROBIOL, V31, P797, DOI 10.1007/s10096-011-1377-9; Shibata N, 2003, J CLIN MICROBIOL, V41, P5407, DOI 10.1128/JCM.41.12.5407-5413.2003; Sowmiya M, 2012, INVEST OPHTH VIS SCI, V53, P5251, DOI 10.1167/iovs.12-10467; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; Wang XS, 2013, CLIN INFECT DIS, V56, P161, DOI 10.1093/cid/cis782; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037152; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Wilson ME, 2012, CURR INFECT DIS REP, V14, P213, DOI 10.1007/s11908-012-0252-x; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang R, 2011, J MED MICROBIOL, V60, P977, DOI 10.1099/jmm.0.015826-0; Zhou ZW, 2012, CAN J MICROBIOL, V58, P112, DOI [10.1139/W11-112, 10.1139/w11-112]	41	246	257	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66666	10.1371/journal.pone.0066666	http://dx.doi.org/10.1371/journal.pone.0066666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23383247	Green Submitted, gold, Green Published			2022-12-27	WOS:000320440500069
J	Sugihara, M; Odagiri, F; Suzuki, T; Murayama, T; Nakazato, Y; Unuma, K; Yoshida, K; Daida, H; Sakurai, T; Morimoto, S; Kurebayashi, N				Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Murayama, Takashi; Nakazato, Yuji; Unuma, Kana; Yoshida, Ken-ichi; Daida, Hiroyuki; Sakurai, Takashi; Morimoto, Sachio; Kurebayashi, Nagomi			Usefulness of Running Wheel for Detection of Congestive Heart Failure in Dilated Cardiomyopathy Mouse Model	PLOS ONE			English	Article							CHAIN ISOFORM EXPRESSION; KNOCKOUT MICE; TROPONIN MUTATION; NATURAL-HISTORY; EXERCISE; HYPERACTIVITY; DYSFUNCTION; PHENOTYPE	Background: Inherited dilated cardiomyopathy (DCM) is a progressive disease that often results in death from congestive heart failure (CHF) or sudden cardiac death (SCD). Mouse models with human DCM mutation are useful to investigate the developmental mechanisms of CHF and SCD, but knowledge of the severity of CHF in live mice is necessary. We aimed to diagnose CHF in live DCM model mice by measuring voluntary exercise using a running wheel and to determine causes of death in these mice. Methodology/Principal Findings: A knock-in mouse with a mutation in cardiac troponin T (Delta K210) (DCM mouse), which results in frequent death with a t(1/2) of 70 to 90 days, was used as a DCM model. Until 2 months of age, average wheel-running activity was similar between wild-type and DCM mice (approximately 7 km/day). At approximately 3 months, some DCM mice demonstrated low running activity (LO: <1 km/day) while others maintained high running activity (HI: >5 km/day). In the LO group, the lung weight/body weight ratio was much higher than that in the other groups, and the lungs were infiltrated with hemosiderin-loaded alveolar macrophages. Furthermore, echocardiography showed more severe ventricular dilation and a lower ejection fraction, whereas Electrocardiography (ECG) revealed QRS widening. There were two patterns in the time courses of running activity before death in DCM mice: deaths with maintained activity and deaths with decreased activity. Conclusions/Significance: Our results indicate that DCM mice with low running activity developed severe CHF and that running wheels are useful for detection of CHF in mouse models. We found that approximately half of Delta K210 DCM mice die suddenly before onset of CHF, whereas others develop CHF, deteriorate within 10 to 20 days, and die.	[Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Murayama, Takashi; Sakurai, Takashi; Kurebayashi, Nagomi] Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Tokyo, Japan; [Sugihara, Masami; Odagiri, Fuminori; Suzuki, Takeshi; Nakazato, Yuji; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Unuma, Kana] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Forens Med, Tokyo, Japan; [Unuma, Kana; Yoshida, Ken-ichi] Univ Tokyo, Dept Forens Med, Grad Sch Med, Tokyo, Japan; [Morimoto, Sachio] Kyushu Univ, Dept Clin Pharmacol, Fac Med Sci, Fukuoka 812, Japan	Juntendo University; Juntendo University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Kyushu University	Kurebayashi, N (corresponding author), Juntendo Univ, Dept Cellular & Mol Pharmacol, Grad Sch Med, Tokyo, Japan.	nagomik@juntendo.ac.jp		Morimoto, Sachio/0000-0001-9171-3636	Ministry of Education, Culture, Sports, Science and Technology of Japan [23136514]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences	This work was supported by a Grant-in Aid (# 23136514), a "High Technology Research Center'' Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2011-2015. The authors also thank the Vehicle Racing Commemorative Foundation and the Institute of Seizon and Life Sciences for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Goehringer C, 2009, CARDIOVASC RES, V82, P404, DOI 10.1093/cvr/cvp061; Hayek S, 2011, CARDIOVASC THER, V29, P362, DOI 10.1111/j.1755-5922.2010.00152.x; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Jing XF, 1998, ARCH PATHOL LAB MED, V122, P94; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Libby P., 2011, BRAUNWALDS HEART DIS, V8th; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; Luedde M, 2010, CARDIOVASC RES, V86, P452, DOI 10.1093/cvr/cvq009; Lygate CA, 2009, J MOL CELL CARDIOL, V46, P93, DOI 10.1016/j.yjmcc.2008.09.710; Medeiros A, 2008, J APPL PHYSIOL, V104, P103, DOI 10.1152/japplphysiol.00493.2007; Millane T, 2000, BRIT MED J, V320, P559, DOI 10.1136/bmj.320.7234.559; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Ojaimi C, 2005, AM J PHYSIOL-HEART C, V289, pH1399, DOI 10.1152/ajpheart.00170.2005; Okutucu S, 2010, CARDIOL J, V17, P219; Rundell VLM, 2004, AM J PHYSIOL-HEART C, V287, pH408, DOI 10.1152/ajpheart.00049.2004; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035353; Unuma K, 2010, CIRC J, V74, P2693, DOI 10.1253/circj.CJ-10-0529; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Watanabe T, 2008, J AM COLL CARDIOL, V52, P779, DOI 10.1016/j.jacc.2008.06.003; Watson PA, 2007, AM J PHYSIOL-HEART C, V293, pH246, DOI 10.1152/ajpheart.00734.2006; Zhan DY, 2009, CARDIOVASC RES, V84, P64, DOI 10.1093/cvr/cvp168	32	70	73	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55514	10.1371/journal.pone.0055514	http://dx.doi.org/10.1371/journal.pone.0055514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23585901	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600117
J	Xie, F; Yan, L; Li, JJ; Zheng, T; Shi, CY; Ying, J; Shen, RX; Yang, JM				Xie, Feng; Yan, Long; Li, Jiongjiong; Zheng, Tao; Shi, Changying; Ying, Jun; Shen, Rongxi; Yang, Jiamei			Effects of Nucleoside Analogue on Patients with Chronic Hepatitis B-Associated Liver Failure: Meta-Analysis	PLOS ONE			English	Article							ADEFOVIR DIPIVOXIL; ACUTE EXACERBATION; LAMIVUDINE; ENTECAVIR; THERAPY; TRANSPLANTATION; DECOMPENSATION; EFFICACY	Purpose: The effectiveness of nucleoside analogue on patients with chronic hepatitis B-associated liver failure is still controversial. To address this issue, we did a review of the literatures and analyzed the data with emphasis on the survival and reduction in serum HBV DNA level. Methods: We searched 11 randomized controlled trials that included 654 patients with chronic hepatitis B-associated liver failure. 340 patients adopted nucleoside analogue, such as lamivudine (LAM), entecavir (ETV), telbivudine (LdT), or tenofovir disoproxil fumarate (TDF), and the remaining 314 patients adopted no nucleoside analogue or placebo. A meta-analysis was carried out to examine the survival, HBV e antigen serologic conversion, and reduction in serum HBV DNA level. The pooled odds ratio (OR) was used to reflect the treatment effects. Results: The overall analysis revealed nucleoside analogue significantly improved 1-month(OR = 2.10; 95% CI, [1.29, 3.41]; p = 0.003), 3-month (OR = 2.15; 95% CI, [1.26, 3.65]; p = 0.005), 12-month survival (OR = 4.62; 95% CI, [1.96, 10.89]; p = 0.0005). Comparison of 3-month HBV DNA showed significant reduction for adoptive nucleoside analogue patients (OR = 54.47; 95% CI, [16.37, 201.74]; p < 0.00001). Comparison of 3-month HBV e antigen serologic conversion showed a highly significant improvement of HBV e antigen lost for patients received adoptive antiviral therapy (OR = 6.57; 95% CI, [1.64, 26.31]; p = 0.008). Conclusions: The benefits of nucleoside analogue on patients with chronic hepatitis B-associated liver failure is significant for improving patient survival, HBV e antigen serologic conversion, and rapid reduction of HBV DNA levels.	[Xie, Feng; Yan, Long; Li, Jiongjiong; Zheng, Tao; Shi, Changying; Ying, Jun; Shen, Rongxi; Yang, Jiamei] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Special Treatment & Liver Transplantat, Shanghai, Peoples R China	Naval Medical University	Yang, JM (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Special Treatment & Liver Transplantat, Shanghai, Peoples R China.	jiameiyang@gmail.com		Everbach, E. Carr/0000-0002-7125-939X	China Postdoctoral Science Fund [20100470107]; China Postdoctoral Science Special Fund [201104750]; CSCO Fund [Y-B2011-006]; Fund of the Ministry of Science and Technology of China [2008ZX10002-018]	China Postdoctoral Science Fund(China Postdoctoral Science Foundation); China Postdoctoral Science Special Fund; CSCO Fund; Fund of the Ministry of Science and Technology of China	This work was supported in part by grants from the China Postdoctoral Science Fund (20100470107), China Postdoctoral Science Special Fund (201104750), CSCO Fund (Y-B2011-006) and the Fund of the Ministry of Science and Technology of China (2008ZX10002-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Board of liver diseases infectious diseases and parasitic diseases of Chinese Medical Association, 2000, CHIN J HEPATOL, V6, P324; Chan HLY, 2012, J VIRAL HEPATITIS, V19, P732, DOI 10.1111/j.1365-2893.2012.01600.x; Chen J, 2009, HEPATOB PANCREAT DIS, V8, P261; Chien RN, 2003, J HEPATOL, V38, P322, DOI 10.1016/S0168-8278(02)00419-1; Cui YL, 2010, DIGEST DIS SCI, V55, P2373, DOI 10.1007/s10620-010-1257-7; EVERHART JE, 1992, GASTROENTEROLOGY, V103, P1692, DOI 10.1016/0016-5085(92)91198-D; Fontana RJ, 2004, AM J GASTROENTEROL, V99, P64, DOI 10.1111/j.1572-0241.2004.04032.x; Fontana RJ, 2002, GASTROENTEROLOGY, V123, P719, DOI 10.1053/gast.2002.35352; Garg H, 2011, HEPATOLOGY, V53, P774, DOI 10.1002/hep.24109; [过建春 Guo Jianchun], 2003, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V20, P313; Guo Y, 2008, CHIN J PREV CONTR CH, V16, P289; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Han Z, 2009, CHIN J CLIN HEPATOL, V25, P188; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2011, HEPATOLOGY, V54, P91, DOI 10.1002/hep.24361; Liaw YF, 2011, HEPATOLOGY, V53, P62, DOI 10.1002/hep.23952; Liver Failure and Artificial Liver Group Chinese Society of Infectious Diseases Chinese Medical Association, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P643; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marrero J, 2003, AM J RESP CRIT CARE, V168, P1421, DOI 10.1164/rccm.200303-361UP; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Qin R, 2012, MOD HOSP, V12, P55; Qiu S, 2009, CHIN J CLIN HEPATOL, V25, P190; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Schiff ER, 2003, HEPATOLOGY, V38, P1419, DOI 10.1016/j.hep.2003.09.040; Shim JH, 2010, J HEPATOL, V52, P176, DOI 10.1016/j.jhep.2009.11.007; Sun LJ, 2010, J GASTROEN HEPATOL, V25, P583, DOI 10.1111/j.1440-1746.2009.06089.x; Sun Qing-feng, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P410; Tsubota A, 2005, J GASTROEN HEPATOL, V20, P426, DOI 10.1111/j.1440-1746.2004.03534.x; Uemoto S, 2000, TRANSPLANTATION, V70, P152; VICKERS C, 1988, J HEPATOL, V7, P143, DOI 10.1016/S0168-8278(88)80475-6; World Health Organisation, 2012, HEP B FACT SHEET 204; Xun J, 2004, J CLIN HEPATOL, V7, P214; Yang H, 2008, JPMT, V15, P1100; Zhao R, 2009, CHIN J PUBLIC HLTH, V25, P758; Zhong X, 2009, CHIN J CLIN HEPATOL, V25, P331	38	39	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54773	10.1371/journal.pone.0054773	http://dx.doi.org/10.1371/journal.pone.0054773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23922797	Green Published, gold, Green Submitted			2022-12-27	WOS:000315211500026
J	Liu, ZH; Yang, J; He, HS				Liu, Zhihua; Yang, Jian; He, Hong S.			Identifying the Threshold of Dominant Controls on Fire Spread in a Boreal Forest Landscape of Northeast China	PLOS ONE			English	Article							ENVIRONMENTAL CONTROLS; CLIMATE-CHANGE; WILDFIRE; MIXEDWOOD; AREA; FREQUENCY; PATTERNS; BEHAVIOR; WEATHER; REGIMES	The relative importance of fuel, topography, and weather on fire spread varies at different spatial scales, but how the relative importance of these controls respond to changing spatial scales is poorly understood. We designed a "moving window'' resampling technique that allowed us to quantify the relative importance of controls on fire spread at continuous spatial scales using boosted regression trees methods. This quantification allowed us to identify the threshold value for fire size at which the dominant control switches from fuel at small sizes to weather at large sizes. Topography had a fluctuating effect on fire spread across the spatial scales, explaining 20-30% of relative importance. With increasing fire size, the dominant control switched from bottom-up controls (fuel and topography) to top-down controls (weather). Our analysis suggested that there is a threshold for fire size, above which fires are driven primarily by weather and more likely lead to larger fire size. We suggest that this threshold, which may be ecosystem-specific, can be identified using our "moving window'' resampling technique. Although the threshold derived from this analytical method may rely heavily on the sampling technique, our study introduced an easily implemented approach to identify scale thresholds in wildfire regimes.	[Liu, Zhihua; Yang, Jian; He, Hong S.] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [He, Hong S.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Missouri System; University of Missouri Columbia	Yang, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	yangjian@iae.ac.cn	Li, Wei/I-8060-2014; Yang, Jian/H-3169-2011; Liu, ZH/H-7536-2012	Yang, Jian/0000-0002-2170-589X; Liu, ZH/0000-0002-0086-5659; He, Hong S./0000-0002-3983-2512; Liu, Zhiyuan/0000-0002-4253-1753; Li, Wei/0000-0002-9991-7892	National Natural Science Foundation of China [31100345, 41071121]; Hundred Talent Program of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by National Natural Science Foundation of China (31100345 & 41071121) and the Hundred Talent Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Arienti MC, 2009, INT J WILDLAND FIRE, V18, P970, DOI 10.1071/WF08011; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Bergeron Y, 2002, SILVA FENN, V36, P81, DOI 10.14214/sf.553; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Cumming SG, 2001, ECOL APPL, V11, P97, DOI 10.1890/1051-0761(2001)011[0097:FTAWIT]2.0.CO;2; Cyr D, 2007, LANDSCAPE ECOL, V22, P1325, DOI 10.1007/s10980-007-9109-3; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Franklin J., 2000, TERRAIN ANAL PRINCIP; Hargrove WW, 2000, ECOL MODEL, V135, P243, DOI 10.1016/S0304-3800(00)00368-9; Hely C, 2000, J VEG SCI, V11, P813, DOI 10.2307/3236551; Hely C, 2010, INT J WILDLAND FIRE, V19, P1099, DOI 10.1071/WF09112; Johnson E.A., 1996, FIRE VEGETATION DYNA; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Larsen CPS, 1997, J BIOGEOGR, V24, P663, DOI 10.1111/j.1365-2699.1997.tb00076.x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Liu Zhi-hua, 2008, Yingyong Shengtai Xuebao, V19, P487; Liu ZH, 2012, J VEG SCI, V23, P782, DOI 10.1111/j.1654-1103.2012.01397.x; Liu ZH, 2012, GLOBAL CHANGE BIOL, V18, P2041, DOI 10.1111/j.1365-2486.2012.02649.x; Liu ZH, 2010, FOREST ECOL MANAG, V259, P1255, DOI 10.1016/j.foreco.2009.12.022; McKenzie D, 2011, NATURE PRECED; Parisien MA, 2011, ECOL APPL, V21, P789, DOI 10.1890/10-0326.1; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Parks SA, 2011, INT J WILDLAND FIRE, V20, P815, DOI 10.1071/WF10051; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Peterson GD, 2002, ECOSYSTEMS, V5, P329, DOI 10.1007/s10021-001-0077-1; Podur JJ, 2009, ECOL APPL, V19, P1246, DOI 10.1890/08-0790.1; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Ridgeway G., 2006, GEN BOOSTED REGRESSI, P5; Rollins MG, 2002, LANDSCAPE ECOL, V17, P539, DOI 10.1023/A:1021584519109; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Slocum MG, 2010, ECOSYSTEMS, V13, P828, DOI 10.1007/s10021-010-9357-y; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Van Wagner CE, 1987, FTR35 PET NAT FOR I; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; Wu ZW, 2011, ENVIRON MANAGE, V48, P1148, DOI 10.1007/s00267-011-9707-3; Xu C. H., 1997, ACTA ECOLOGICA SINIC, V17, P3; Xu HC, 1998, FOREST GREAT XING MO, P1; Yang J, 2008, ECOL APPL, V18, P1212, DOI 10.1890/07-0825.1; Zhou YL, 1991, VEGETATION GREAT XIN, P1	48	246	257	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55618	10.1371/journal.pone.0055618	http://dx.doi.org/10.1371/journal.pone.0055618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383247	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600137
J	Yuan, J; Tang, ZL; Yang, SL; Li, K				Yuan, Jing; Tang, Zhonglin; Yang, Shulin; Li, Kui			CRABP2 Promotes Myoblast Differentiation and Is Modulated by the Transcription Factors MyoD and Sp1 in C2C12 Cells	PLOS ONE			English	Article							LIPID-BINDING PROTEINS; GENE-EXPRESSION; MOUSE EMBRYOGENESIS; MUSCLE; ACID; PHOSPHORYLATION; ACTIVATION; MYOGENESIS; HOMOLOGY; PATTERN	Cellular retinoic acid binding protein 2 (CRABP2), a member of a family of specific carrier proteins for Vitamin A, belongs to a family of small cytosolic lipid binding proteins. Our previous study suggested that CRABP2 was involved in skeletal muscle development; however, the molecular function and regulatory mechanism of CRABP2 in myogenesis remained unclear. In this study, we found that the expression of the CRABP2 gene was upregulated during C2C12 differentiation. An overexpression assay revealed that CRABP2 promotes myogenic transformation by regulating the cell cycle during C2C12 differentiation. The region from -459 to -4 bp was identified as the core promoter and contains a TATA box, a GC box and binding sites for the transcription factors MyoD and Sp1. Over-expression, site-directed mutagenesis and EMSA assays indicated that the transcription factors MyoD and Sp1 regulate CRABP2 expression and promote myoblast differentiation in C2C12 cells.	[Yuan, Jing; Tang, Zhonglin; Yang, Shulin; Li, Kui] Chinese Acad Agr Sci, State Key Lab Anim Nutr, Inst Anim Sci, Beijing 100193, Peoples R China; [Yuan, Jing] Yangtze Univ, Coll Anim Sci, Jinzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Yangtze University	Tang, ZL (corresponding author), Chinese Acad Agr Sci, State Key Lab Anim Nutr, Inst Anim Sci, Beijing 100193, Peoples R China.	zhonglinqy_99@sina.com; kuili@iascaas.net.cn	Lin, Rongcheng/I-8105-2014	Lin, Rongcheng/0000-0001-8346-3390	National Key Project [2012CB124706-6, 2011ZX08006-002, 2009CB941604]; National Natural Science Foundation of China [31171192, 31172182]	National Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key Project (2012CB124706-6, 2011ZX08006-002, 2009CB941604) and the National Natural Science Foundation of China (31171192, 31172182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McGrane MM, 2007, J NUTR BIOCHEM, V18, P497, DOI 10.1016/j.jnutbio.2006.10.006; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Qin RF, 2000, J 4 MIL MED U, V21, P921; RUBERTE E, 1991, DEVELOPMENT, V111, P45; RUBERTE E, 1992, DEVELOPMENT, V115, P973; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Xu JW, 2007, GENE, V392, P221, DOI 10.1016/j.gene.2006.12.032; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284	26	18	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55479	10.1371/journal.pone.0055479	http://dx.doi.org/10.1371/journal.pone.0055479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383201	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600110
J	Wu, DM; Kraut, JA; Abraham, WM				Wu, Dongmei; Kraut, Jeffrey A.; Abraham, William M.			Sabiporide Improves Cardiovascular Function, Decreases the Inflammatory Response and Reduces Mortality in Acute Metabolic Acidosis in Pigs	PLOS ONE			English	Article							EXTRACELLULAR ACIDOSIS; EXCHANGE INHIBITION; SODIUM-BICARBONATE; LACTIC-ACIDOSIS; MECHANISMS; CONTRACTILITY; MYOCARDIUM; ACTIVATION; MANAGEMENT; DIAGNOSIS	Introduction: Acute metabolic acidosis impairs cardiovascular function and increases the mortality of critically ill patients. However, the precise mechanism(s) underlying these effects remain unclear. We hypothesized that targeting pH-regulatory protein, Na+/H+ exchanger (NHE1) could be a novel approach for the treatment of acute metabolic acidosis. The aim of the present study was to examine the impact of a novel NHE1 inhibitor, sabiporide, on cardiovascular function, blood oxygen transportation, and inflammatory response in an experimental model of metabolic acidosis produced by hemorrhage-induced hypovolemia followed by an infusion of lactic acid. Methods and Results: Anesthetized pigs were subjected to hypovolemia for 30 minutes. The animals then received a bolus infusion of sabiporide (3 mg/kg) or vehicle, followed by an infusion of lactic acid for 2 hours. The animals were continuously monitored for additional 3 hours. Hypovolemia followed by a lactic acid infusion resulted in a severe metabolic acidosis with blood pH falling to 6.8. In association with production of the acidemia, there was an excessive increase in pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). Treatment with sabiporide significantly attenuated the increase in PAP by 38% and PVR by 67%, as well as significantly improved cardiac output by 51%. Sabiporide treatment also improved mixed venous blood oxygen saturation (55% in sabiporide group vs. 28% in control group), and improved systemic blood oxygen delivery by 36%. In addition, sabiporide treatment reduced plasma levels of TNF-alpha (by 33%), IL-6 (by 63%), troponin-I (by 54%), ALT (by 34%), AST (by 35%), and urea (by 40%). Conclusion: These findings support the possible beneficial effects of sabiporide in the treatment of acute metabolic acidosis and could have implications for the treatment of metabolic acidosis in man.	[Wu, Dongmei] Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA; [Abraham, William M.] Mt Sinai Med Ctr, Div Pulm & Crit Care Med, Miami Beach, FL 33140 USA; [Wu, Dongmei] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju, South Korea; [Kraut, Jeffrey A.] Vet Adm Greater Angeles Healthcare Syst, Div Nephrol Med & Res Serv, Los Angeles, CA USA; [Kraut, Jeffrey A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Mount Sinai Medical Center; Mount Sinai Medical Center; Jeonbuk National University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, DM (corresponding author), Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA.	dongmeiwu@bellsouth.net	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	USAMRMC [W81XWH-06-1-0719]; Ministry of Education, Science and Technology [R31-20029, 2012007331]; National Research Foundation of Korea (NRF); honbuk National University, Korea	USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); honbuk National University, Korea	This work was supported by a USAMRMC grant W81XWH-06-1-0719 (to DW); and in part by the World Class University Program (R31-20029) funded by the Ministry of Education, Science and Technology; by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012007331); and by New Faculty funding from Chonbuk National University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 1998, NEW ENGL J MED, V338, P107, DOI 10.1056/NEJM199801083380207; ANDERSON SE, 1990, AM J PHYSIOL, V259, pC940, DOI 10.1152/ajpcell.1990.259.6.C940; BRIMIOULLE S, 1990, AM J PHYSIOL, V258, pH347, DOI 10.1152/ajpheart.1990.258.2.H347; CINGOLANI HE, 1975, SURGERY, V77, P427; COOPER DJ, 1993, AM REV RESPIR DIS, V148, P317, DOI 10.1164/ajrccm/148.2.317; Doods H, 2013, J BIOMEDICI IN PRESS; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; HUSEBY JS, 1981, CHEST, V79, P552, DOI 10.1378/chest.79.5.552; Karmazyn M, 1999, J THROMB THROMBOLYS, V8, P33, DOI 10.1023/A:1008990530176; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Lin X, 2012, RESUSCITATION; MARSIGLIA JC, 1973, CARDIOVASC RES, V7, P336, DOI 10.1093/cvr/7.3.336; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; Nemeth ZH, 2002, AM J PHYSIOL-CELL PH, V283, pC396, DOI 10.1152/ajpcell.00491.2001; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Siesjo BK, 1996, ACT NEUR S, V66, P8; Sikes PJ, 2005, CRIT CARE MED, V33, P605, DOI 10.1097/01.ccm.0000155910.89252.FE; Vaughan-Jones Richard D, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS134, DOI 10.1111/j.1540-8167.2006.00394.x; Webster KA, 1999, J CLIN INVEST, V104, P239; WIKLUND L, 1985, CRIT CARE MED, V13, P109, DOI 10.1097/00003246-198502000-00012; Wu DM, 2000, BASIC RES CARDIOL, V95, P449, DOI 10.1007/s003950070020; Wu DM, 2008, SHOCK, V29, P519, DOI 10.1097/SHK.0b013e318150757a; Wu DM, 2012, RESUSCITATION, V83, P774, DOI 10.1016/j.resuscitation.2011.11.025; Wu DM, 2009, CRIT CARE MED, V37, P1994, DOI 10.1097/CCM.0b013e3181a0052e	32	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53932	10.1371/journal.pone.0053932	http://dx.doi.org/10.1371/journal.pone.0053932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23437188	Green Submitted, Green Published, gold			2022-12-27	WOS:000313552400061
J	Li, FZ; Li, LB; Zhong, Y; Xie, QD; Huang, JH; Kang, XJ; Wang, D; Xu, L; Huang, TH				Li, FangZheng; Li, LianBing; Zhong, Ying; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua			Relationship between LTR Methylation and gag Expression of HIV-1 in Human Spermatozoa and SpermDerived Embryos	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GERM-CELL DEVELOPMENT; PATERNAL GENOME; ACTIVE DEMETHYLATION; DNA METHYLATION; HUMAN-SPERM; VERTICAL TRANSMISSION; PARENTAL ALLELES; MOUSE EMBRYO; GENE	Objective: Studying the methylation status of long terminal repeats (LTR) and its relationship to gag expression of HIV-1 in order to explore regulation mechanism of HIV-1 gene expression in vertical transmission from sperm to embryo. Methods/Principal Findings: Sperm samples were collected from a healthy donor and seven patients with HIV/AIDS. Zona-free hamster ova were fertilized by donor's spermatozoa transfected with pIRES2-EGFP-LTR-gag and patient's spermatozoa to obtain zygotes and 2-cell embryos, respectively. Interspecific in vitro fertilization, bisulfite sequencing PCR (BSP), RT-PCR, nested RT-PCR, nested real-time qRT-PCR and 2(-Delta Delta Ct) method, indirect immunofluoresence (IF) assay were performed. For donor's samples, the methylation rates of HIV-1 LTR were 0.56%, 1.67%, 0.56%, 0.56% in plasmid, spermatozoa, zygotes and 2-cell embryos, respectively while spermatozoa were transfected with unmethylated plasmid, and were 95.0%, 84.44%, 3.3%, 1.67% while transfected with methylated plasmid. The positive bands for HIV-1 gag cDNA were detected in spermatozoa and 2-cell embryos. The positive signals for HIV-1 p24 Gag protein were detected in 2-cell embryos but not in spermatozoa. For patient's samples, methylation rates of HIV-1 LTR were different in spermatozoa among patients. After fertilization, CpG sites in HIV-1 LTR were highly demethylated in zygotes and 2-cell embryos. The gag transcription levels increased with decreasing of methylation rates of HIV-1 LTR, which showed a strong negative correlations between gag transcription levels and methylation rates of HIV-LTR ether in the spermatozoa (r = -0.9877, P < 0.0001) or in the sperm-derived 2-cell embryos (r = 20.9092, P = 0.0045). Conclusion: LTR methylation regulates expression of HIV-1 gag in vertical transmission from sperm to embryo.	[Li, FangZheng; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua] Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Li, LianBing] Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China; [Zhong, Ying] Chengdu Jinjiang Hosp Maternal & Child Hlth Care, Ctr Reprod Med, Chengdu, Sichuan, Peoples R China	Shantou University	Huang, TH (corresponding author), Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China.	thhuang@stu.edu.cn	; Scott, Maxwell/J-1935-2015	li, feng/0000-0003-2227-9893; Scott, Maxwell/0000-0001-6536-4735	National Natural Science Foundation of China; Li Ka Shing Shantou University Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Shantou University Foundation	This work was financially supported by the National Natural Science Foundation of China and the Li Ka Shing Shantou University Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Ali BA, 2006, ASIAN J ANDROL, V8, P273, DOI 10.1111/j.1745-7262.2006.00141.x; BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903; BACHILLER D, 1991, MOL REPROD DEV, V30, P194, DOI 10.1002/mrd.1080300305; BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005; BAGASRA O, 1988, J ACQ IMMUN DEF SYND, V1, P431; Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gao YS, 2009, CURR HIV RES, V7, P562, DOI 10.2174/157016209789346237; GOEDERT JJ, 1986, SCIENCE, V231, P992, DOI 10.1126/science.3003917; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Huang JM, 2002, ASIAN J ANDROL, V4, P209; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KOHLER M, 1995, INFUSIONSTHERAPIE, V22, P46; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; McGowan JP, 2000, J ANTIMICROB CHEMOTH, V46, P657, DOI 10.1093/jac/46.5.657; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; MONK M, 1990, PHILOS T R SOC B, V326, P299, DOI 10.1098/rstb.1990.0013; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; RAHE B, 1983, NUCLEIC ACIDS RES, V11, P7947, DOI 10.1093/nar/11.22.7947; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028586; Wang DA, 2011, J MED VIROL, V83, P16, DOI 10.1002/jmv.21767; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	37	122	130	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54801	10.1371/journal.pone.0054801	http://dx.doi.org/10.1371/journal.pone.0054801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23409170	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500028
J	Yang, YL; Ji, C; Bi, ZG; Lu, CC; Wang, R; Gu, B; Cheng, L				Yang, Yan-li; Ji, Chao; Bi, Zhi-gang; Lu, Chun-cheng; Wang, Rong; Gu, Bing; Cheng, Lei			Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER CHEMOPREVENTIVE ACTIVITY; AMPK ACTIVATION; DOWN-REGULATION; AKT INHIBITOR; IN-VITRO; CERAMIDE; GROWTH; HSP90; CONTRIBUTES	Head and neck squamous cell carcinoma (HNSCC) represents more than 5% of all cancers diagnosed annually in United States and around the world. Despite advances in the management of patients with this disease, the survival has not been significantly improved, and the search for potential alternative therapies is encouraging. Here we demonstrate that deguelin administration causes a significant HNSCC cell death. Deguelin induces both cell apoptosis and autophagy by modulating multiple signaling pathways in cultured HNSCC cells. Deguelin inhibits Akt signaling, and down-regulates survivin and cyclin-dependent kinase 4 (Cdk4) expressions, by disrupting their association with heat shock protein-90 (Hsp-90). Deguelin induces ceramide production through de novo synthase pathway to promote HNSCC cell death. Importantly, increased ceramide level activates AMP-activated protein kinase (AMPK), which then directly phosphorylates Ulk1 and eventually leads to cell autophagy. We found that a low dose of deguelin sensitized HNSCC cells to 5-FU. Finally, using a nude mice Hep-2 xenograft model, we also showed a significant anti-tumor ability of deguelin in vivo. Together, we suggest that deguelin may represent a novel and effective chemo-agent against HNSCC.	[Yang, Yan-li; Cheng, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Ji, Chao] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Bi, Zhi-gang] Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China; [Lu, Chun-cheng] Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Rong] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Gu, Bing] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Bi, ZG (corresponding author), Nanjing Med Univ, BenQ Med Ctr, Dept Dermatol, Nanjing, Jiangsu, Peoples R China.	eltonbibenqhospital@yahoo.com.cn; jspent@126.com	Cheng, Lei/AAT-2690-2021; yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022	Cheng, Lei/0000-0001-6541-7702; Liu, Rong/0000-0001-7477-6520	National Natural Science Foundation [810701297, 81101188, 30671894, 30972822, 30801016]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province [XK200719, XK200731, RC2007065, RC2011071]; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China [2010NJMUZ19]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Health Promotion Project of Jiangsu Province; Science & Technology Development Foundation of Nanjing Medical University, the People's Republic of China	This research was supported by grants from the National Natural Science Foundation (810701297, 81101188, 30671894, 30972822 and 30801016), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the Health Promotion Project of Jiangsu Province (XK200719, XK200731, RC2007065 and RC2011071), and the Science & Technology Development Foundation of Nanjing Medical University (2010NJMUZ19), the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2004, INT J CANCER, V111, P679, DOI 10.1002/ijc.20333; Bortul R, 2005, BRIT J HAEMATOL, V129, P677, DOI 10.1111/j.1365-2141.2005.05504.x; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Bozec A, 2009, EXPERT OPIN EMERG DR, V14, P299, DOI 10.1517/14728210902997947; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Bruzzese F, 2006, CLIN CANCER RES, V12, P617, DOI 10.1158/1078-0432.CCR-05-1671; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Freudlsperger C, 2011, EXPERT OPIN THER TAR, V15, P63, DOI 10.1517/14728222.2011.541440; GERHAUSER C, 1995, NAT MED, V1, P260, DOI 10.1038/nm0395-260; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8; Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jang K.Y., 2012, CANC LETT; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Ji C, 2012, BIOCH BIOPHYS RES CO; Ji C, 2012, CELL SIGNAL, V24, P1781, DOI 10.1016/j.cellsig.2012.05.003; Ji C, 2012, BIOCHEM BIOPH RES CO, V421, P462, DOI 10.1016/j.bbrc.2012.04.012; Ji C, 2010, INT J MOL MED, V26, P257, DOI 10.3892/ijmm_00000460; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Lee YK, 2010, CANCER LETT, V292, P228, DOI 10.1016/j.canlet.2009.12.005; Lippert BM, 2007, INT J CANCER, V121, P1169, DOI 10.1002/ijc.22941; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; LoTempio MM, 2005, CLIN CANCER RES, V11, P6994, DOI 10.1158/1078-0432.CCR-05-0301; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moral M, 2008, HISTOL HISTOPATHOL, V23, P1269, DOI 10.14670/HH-23.1269; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Sano D, 2011, HEAD NECK-J SCI SPEC, V33, P349, DOI 10.1002/hed.21455; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Simmonds MA, 2003, CA-CANCER J CLIN, V53, P4, DOI 10.3322/canjclin.53.1.4; Sommer K, 2001, INT J ONCOL, V18, P1145; STELL PM, 1989, EUR J SURG ONCOL, V15, P407; STELL PM, 1991, HEAD NECK-J SCI SPEC, V13, P277, DOI 10.1002/hed.2880130403; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tripathi A, 2003, J CANCER RES CLIN, V129, P642, DOI 10.1007/s00432-003-0485-z; Udeani GO, 1997, CANCER RES, V57, P3424; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Veldman RJ, 1998, BIOCHEM J, V331, P563, DOI 10.1042/bj3310563; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Yao C, 2012, CELL BIOCH BIOPHYS; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zheng QY, 2012, BIOCHEM BIOPH RES CO, V419, P741, DOI 10.1016/j.bbrc.2012.02.093; Zhu QY, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.96	66	286	295	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54736	10.1371/journal.pone.0054736	http://dx.doi.org/10.1371/journal.pone.0054736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23383172	Green Published, Green Submitted, gold			2022-12-27	WOS:000314021500119
J	Wu, DZ; Cai, SG; Chen, MX; Ye, LZ; Chen, ZH; Zhang, HT; Dai, F; Wu, FB; Zhang, GP				Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Chen, Zhonghua; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping			Tissue Metabolic Responses to Salt Stress in Wild and Cultivated Barley	PLOS ONE			English	Article							PROLINE ACCUMULATION; GAS-CHROMATOGRAPHY; SODIUM-TRANSPORT; ABIOTIC STRESS; DROUGHT STRESS; TOLERANCE; PLANTS; ARABIDOPSIS; HOMEOSTASIS; MANNITOL	A thorough understanding of the mechanisms underlying barley salt tolerance and exploitation of elite genetic resource are essential for utilizing wild barley germplasm in developing barley varieties with salt tolerance. In order to reveal the physiological and molecular difference in salt tolerance between Tibetan wild barley (Hordeum spontaneum) and cultivated barley (Hordeum vulgare), profiles of 82 key metabolites were studies in wild and cultivated barley in response to salinity. According to shoot dry biomass under salt stress, XZ16 is a fast growing and salt tolerant wild barley. The results of metabolite profiling analysis suggested osmotic adjustment was a basic mechanism, and polyols played important roles in developing salt tolerance only in roots, and high level of sugars and energy in roots and active photosynthesis in leaves were important for barley to develop salt tolerance. The metabolites involved in tolerance enhancement differed between roots and shoots, and also between genotypes. Tibetan wild barley, XZ16 had higher chlorophyll content and higher contents of compatible solutes than CM72, while the cultivated barley, CM72 probably enhanced its salt tolerance mainly through increasing glycolysis and energy consumption, when the plants were exposed to high salinity. The current research extends our understanding of the mechanisms involved in barley salt tolerance and provides possible utilization of Tibetan wild barley in developing barley cultivars with salt tolerance.	[Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping] Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhonghua] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia	Zhejiang University; Western Sydney University	Zhang, GP (corresponding author), Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	Natural Science Foundation of China [31129005, 31171544]; Natural Science Foundation of Zhejiang Province, China [Z3110054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by Natural Science Foundation of China (31129005 and 31171544), Natural Science Foundation of Zhejiang Province, China (Z3110054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2003, PLANT PHYSIOL, V131, P1748, DOI 10.1104/pp.102.003616; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Cuin TA, 2007, PLANTA, V225, P753, DOI 10.1007/s00425-006-0386-x; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dai HX, 2011, J PLANT NUTR SOIL SC, V174, P952, DOI 10.1002/jpln.201100148; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Du J, 2008, PLANT J, V56, P653, DOI 10.1111/j.1365-313X.2008.03602.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kim HK, 2010, PHYTOCHEM ANALYSIS, V21, P4, DOI 10.1002/pca.1188; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; PHARR DM, 1995, HORTSCIENCE, V30, P1182, DOI 10.21273/HORTSCI.30.6.1182; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Renberg L, 2010, PLANT PHYSIOL, V154, P187, DOI 10.1104/pp.110.157651; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2006, PLANT PHYSIOL, V142, P1087, DOI 10.1104/pp.106.084053; Sakamoto A, 1998, PLANT MOL BIOL, V38, P1011, DOI 10.1023/A:1006095015717; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Shabala S, 2005, J EXP BOT, V56, P1369, DOI 10.1093/jxb/eri138; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Wang X, 2008, PLANTA, V227, P611, DOI 10.1007/s00425-007-0643-7; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; XU T, 1982, Acta Genetica Sinica, V9, P440; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	54	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55431	10.1371/journal.pone.0055431	http://dx.doi.org/10.1371/journal.pone.0055431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23437188	Green Published, Green Submitted, gold			2022-12-27	WOS:000314610600104
J	Zhang, ZZ; Wang, W; Li, WL				Zhang, Zhengzhi; Wang, Wei; Li, Wanlong			Genetic Interactions Underlying the Biosynthesis and Inhibition of beta-Diketones in Wheat and Their Impact on Glaucousness and Cuticle Permeability	PLOS ONE			English	Article							CUTICULAR WAX BIOSYNTHESIS; FATTY-ACID ELONGASE; DROUGHT TOLERANCE; EPICUTICULAR WAXES; CONDENSING ENZYME; ABC TRANSPORTER; CELL EXPANSION; COA REDUCTASE; PISUM-SATIVUM; SURFACE WAXES	Cuticular wax composition greatly impacts plant responses to dehydration. Two parallel pathways exist in Triticeae for manipulating wax composition: the acyl elongation, reduction, and decarbonylation pathway that is active at the vegetative stage and yields primary alcohols and alkanes, and the beta-diketone pathway that predominates at the reproductive stage and synthesizes beta-diketones. Variation in glaucousness during the reproductive stage of wheat is mainly controlled by the wax production genes, W1 and W2, and wax inhibitor genes, Iw1 and Iw2. Little is known about the metabolic and physiological effects of the genetic interactions among these genes and their roles in shifting wax composition during plant development. We characterized the effect of W1, W2, Iw1, and Iw2 and analyzed their interaction using a set of six near-isogenic lines (NILs) by metabolic, molecular and physiological approaches. Loss of functional alleles of both W genes or the presence of either Iw gene depletes beta-diketones and results in the nonglaucous phenotype. Elimination of beta-diketones is compensated for by an increase in aldehydes and primary alcohols in the Iw NILs. Accordingly, transcription of CER4-6, which encodes an alcohol-forming fatty acyl-CoA reductase, was elevated 120-fold in Iw1/Iw2. CER4-6 was transcribed at much higher levels in seedlings than in adult plants, and showed little difference between the glaucous and nonglaucous NILs, suggesting that Iw2 counteracts the developmental repression of CER4-6 at the reproductive stage. While W1 and W2 redundantly function in beta-diketone biosynthesis, a combination of both functional alleles led to the beta-diketone hydroxylation. Consistent with this, transcription of MAH1-9, which encodes a mid-chain alkane hydroxylase, increased seven-fold only in W1W2. In parallel with the hydroxyl-beta-diketone production patterns, glaucousness was intensified and cuticle permeability was reduced significantly in W1W2 compared to the other NILs. This suggests that both W1 and W2 are required for enhancing drought tolerance.	[Zhang, Zhengzhi; Wang, Wei; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this research was provided by South Dakota Agricultural Experiment Station and South Dakota Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1984, CEREAL CHEM, V61, P45; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dudnikov AJ, 2012, MOL BIOL REP, V39, P2355, DOI 10.1007/s11033-011-0986-9; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JENKS M. A., 2010, HORTICULTURAL REV, V23, P1, DOI [10.1002/9780470650752.ch1, DOI 10.1002/9780470650752.CH1]; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Richards R.A., 1984, P 6 INT WHEAT GEN S, P447; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Richardson A, 2007, PLANTA, V226, P1459, DOI 10.1007/s00425-007-0585-0; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; VONWETTSTEINKNOWLES P, 1980, CARLSBERG RES COMMUN, V45, P125, DOI 10.1007/BF02906514; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	75	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54129	10.1371/journal.pone.0054129	http://dx.doi.org/10.1371/journal.pone.0054129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349804	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900042
J	Zhang, ZH; Liu, ZH; Cui, ZT; Hu, YM; Wang, B; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua			Genetic Analysis of Grain Filling Rate Using Conditional QTL Mapping in Maize	PLOS ONE			English	Article							KERNEL WATER RELATIONS; WEIGHT RESPONSE; SINK; GROWTH; EXPRESSION; ENDOSPERM; TEMPERATURE; DISSECTION; DURATION; ENCODES	The grain filling rate (GFR) is an important dynamic trait that determines the final grain yield and is controlled by a network of genes and environment factors. To determine the genetic basis of the GFR, a conditional quantitative trait locus (QTL) analysis method was conducted using time-related phenotypic values of the GFR collected from a set of 243 immortalized F-2 (IF2) population, which were evaluated at two locations over 2 years. The GFR gradually rose in the 0-15 days after pollination (DAP) and 16-22 DAP, reaching a maximum at 23-29 DAP, and then gradually decreasing. The variation of kernel weight (KW) was mainly decided by the GFR, and not by the grain filling duration (GFD). Thirty-three different unconditional QTLs were identified for the GFR at the six sampling stages over 2 years. Among them, QTLs qGFR7b, qGFR9 and qGFR6d were identified at the same stages at two locations over 2 years. In addition, 14 conditional QTLs for GFR were detected at five stages. The conditional QTL qGFR7c was identified at stage V|IV (37-43 DAP) at two locations over 2 years, and qGFR7b was detected at the sixth stage (44-50 DAP) in all four environments, except at Anyang location in 2009. QTLs qQTL7b and qQTL6f were identified by unconditional and conditional QTL mapping at the same stages, and might represent major QTLs for regulating the GFR in maize in the IF2 population. Moreover, most of the QTLs identified were co-located with QTLs from previous studies that were associated with GFR, enzyme activities of starch synthesis, soluble carbohydrates, and grain filling related genes. These results indicated that the GFR is regulated by many genes, which are specifically expressed at different grain filling stages, and the specific expression of the genes between 16-35 DAP might be very important for deciding the final kernel weight.	[Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blewley JD, 1985, SEEDS PHYSL DEV GERM, P41; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; CAVALIERI AJ, 1985, CROP SCI, V25, P856, DOI 10.2135/cropsci1985.0011183X002500050031x; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Li ShaoChang, 2003, Acta Agronomica Sinica, V29, P775; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; SAS Institute, 2009, SAS STAT 9 2 US GUID; SEKA D, 1995, CROP SCI, V35, P74, DOI 10.2135/cropsci1995.0011183X003500010013x; SEKA D, 1995, CROP SCI, V35, P80, DOI 10.2135/cropsci1995.0011183X003500010014x; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Stewart DW, 1998, AGRON J, V90, P73, DOI 10.2134/agronj1998.00021962009000010014x; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Wu WR, 1999, GENETICS, V151, P297; Yan HB, 2009, THEOR APPL GENET, V119, P815, DOI 10.1007/s00122-009-1091-5; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng H, 2001, J MAIZE SCI, V9, P69; ZHU J, 1995, GENETICS, V141, P1633	44	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56344	10.1371/journal.pone.0056344	http://dx.doi.org/10.1371/journal.pone.0056344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23349804	Green Submitted, Green Published, gold			2022-12-27	WOS:000315159200037
J	Kim, SO; Sakchaisri, K; Thimmegowda, NR; Soung, NK; Jang, JH; Kim, YS; Lee, KS; Kwon, YT; Asami, Y; Ahn, JS; Erikson, RL; Kim, BY				Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Kim, Young Sang; Lee, Kyung Sang; Kwon, Yong Tae; Asami, Yukihiro; Ahn, Jong Seog; Erikson, Raymond Leo; Kim, Bo Yeon			STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage	PLOS ONE			English	Article							CDC25 PHOSPHATASES; CELL-CYCLE; I INHIBITORS; G2/M TRANSITION; CANCER-THERAPY; HISTONE H3; PHOSPHORYLATION; CHECKPOINT; CAMPTOTHECIN; MECHANISM	STK295900, a small synthetic molecule belonging to a class of symmetric bibenzimidazoles, exhibits antiproliferative activity against various human cancer cell lines from different origins. Examining the effect of STK295900 in HeLa cells indicates that it induces G(2) phase arrest without invoking DNA damage. Further analysis shows that STK295900 inhibits DNA relaxation that is mediated by topoisomerase 1 (Top 1) and topoisomerase 2 (Top 2) in vitro. In addition, STK295900 also exhibits protective effect against DNA damage induced by camptothecin. However, STK295900 does not affect etoposide-induced DNA damage. Moreover, STK295900 preferentially exerts cytotoxic effect on cancer cell lines while camptothecin, etoposide, and Hoechst 33342 affected both cancer and normal cells. Therefore, STK295900 has a potential to be developed as an anticancer chemotherapeutic agent.	[Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea; [Kim, Sun-Ok; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Taejon, South Korea; [Lee, Kyung Sang] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kwon, Yong Tae] Seoul Natl Univ, World Class Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Asami, Yukihiro] RIKEN Adv Sci Inst, Dept Biol Chem, Wako, Saitama, Japan; [Erikson, Raymond Leo] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RIKEN; Harvard University	Ahn, JS (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea.	jsahn@kribb.re.kr; bykim@kribb.re.kr	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	World Class Institute [2009-002]; Global RD Center (GRDC); World Class University [R31-2008-000-10103-0]; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea	World Class Institute; Global RD Center (GRDC); World Class University; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the World Class Institute (2009-002), Global R&D Center (GRDC), World Class University (R31-2008-000-10103-0) programs and a grant from KRIBB Research Initiative program funded by the Ministry of Education, Science and Technology (MEST) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiu CC, 2005, CANCER LETT, V223, P249, DOI 10.1016/j.canlet.2004.10.049; Clifford B, 2003, CANCER RES, V63, P4074; Dale AG, 2012, BIOCHEMISTRY; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; He L, 2007, CELL SIGNAL, V19, P1713, DOI 10.1016/j.cellsig.2007.03.006; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin S, 2000, BIOORG MED CHEM LETT, V10, P719, DOI 10.1016/S0960-894X(00)00087-1; JORDAN MA, 1992, J CELL SCI, V102, P401; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Mann J, 2001, J MED CHEM, V44, P138, DOI 10.1021/jm000297b; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narasimhan B, 2012, MED CHEM RES, V21, P269, DOI 10.1007/s00044-010-9533-9; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903; TSAO YP, 1992, CANCER RES, V52, P1823; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	46	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53908	10.1371/journal.pone.0053908	http://dx.doi.org/10.1371/journal.pone.0053908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349762	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000314019100036
J	Zhang, ZG; Vu, GP; Gong, H; Xia, C; Chen, YC; Liu, FY; Wu, JG; Lu, SW				Zhang, Zhigang; Vu, Gia-Phong; Gong, Hao; Xia, Chuan; Chen, Yuan-Chuan; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells	PLOS ONE			English	Article							P-MEDIATED INHIBITION; RNASE-P; ATTENUATED SALMONELLA; MESSENGER-RNA; CLEAVAGE; TYPHIMURIUM; STABILITY; SELECTION; DELIVERY; VECTORS	External guide sequences (EGSs) are RNA molecules that consist of a sequence complementary to a target mRNA and recruit intracellular ribonuclease P (RNase P), a tRNA processing enzyme, for specific degradation of the target mRNA. We have previously used an in vitro selection procedure to generate EGS variants that efficiently induce human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the S mRNA, pre-S/L mRNA, and pregenomic RNA (pgRNA) of hepatitis B virus (HBV), which are essential for viral replication and infection. The EGS variant was about 50-fold more efficient in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Following Salmonella-mediated gene delivery, the EGSs were expressed in cultured HBV-carrying cells. A reduction of about 97% and 75% in the level of HBV RNAs and proteins and an inhibition of about 6,000- and 130-fold in the levels of capsid-associated HBV DNA were observed in cells treated with Salmonella vectors carrying the expression cassette for the variant and the tRNA-derived EGS, respectively. Our study provides direct evidence that the EGS variant is more effective in blocking HBV gene expression and DNA replication than the tRNA-derived EGS. Furthermore, these results demonstrate the feasibility of developing Salmonella-mediated gene delivery of highly active EGS RNA variants as a novel approach for gene-targeting applications such as anti-HBV therapy.	[Zhang, Zhigang; Xia, Chuan; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Vu, Gia-Phong; Chen, Yuan-Chuan; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146) and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). G. V. and Y. C. were partially supported by a predoctoral Block grant from University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S., 1999, RNA WORLD, P351; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOPALAN V, 2006, RNA WORLD; Grillot-Courvalin C, 1999, CURR OPIN BIOTECH, V10, P477, DOI 10.1016/S0958-1669(99)00013-0; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hnatyszyn HJ, 2001, GENE THER, V8, P1863, DOI 10.1038/sj.gt.3301606; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werner M, 1998, RNA, V4, P847, DOI 10.1017/S1355838298980323; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Nan, 2008, Cancer Biol Ther, V7, P145; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	51	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65268	10.1371/journal.pone.0065268	http://dx.doi.org/10.1371/journal.pone.0065268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23349804	Green Submitted, gold, Green Published			2022-12-27	WOS:000320322400011
J	Kim, SYH; Kim, HM; Ryan, KA; Appelbaum, PS; Knopman, DS; Damschroder, L; De Vries, R				Kim, Scott Y. H.; Kim, H. Myra; Ryan, Kerry A.; Appelbaum, Paul S.; Knopman, David S.; Damschroder, Laura; De Vries, Raymond			How Important Is 'Accuracy' of Surrogate Decision-Making for Research Participation?	PLOS ONE			English	Article							DEMENTIA-RESEARCH; ADVANCE DIRECTIVES; CARE RESEARCH; CONSENT; DELIBERATION; BIOETHICS; CAPACITY; DISEASE; MAKERS; FAMILY	Background: There is a longstanding concern about the accuracy of surrogate consent in representing the health care and research preferences of those who lose their ability to decide for themselves. We sought informed, deliberative views of the older general public (>= 50 years old) regarding their willingness to participate in dementia research and to grant leeway to future surrogates to choose an option contrary to their stated wishes. Methodology/Principal Findings: 503 persons aged 50+ recruited by random digit dialing were randomly assigned to one of three groups: deliberation, education, or control. The deliberation group attended an all-day education/peer deliberation session; the education group received written information only. Participants were surveyed at baseline, after the deliberation session (or equivalent time), and one month after the session, regarding their willingness to participate in dementia research and to give leeway to surrogates, regarding studies of varying risk-benefit profiles (a lumbar puncture study, a drug randomized controlled trial, a vaccine randomized controlled trial, and an early phase gene transfer trial). At baseline, 48% (gene transfer scenario) to 92% (drug RCT) were willing to participate in future dementia research. A majority of respondents (57-71% depending on scenario) were willing to give leeway to future surrogate decision-makers. Democratic deliberation increased willingness to participate in all scenarios, to grant leeway in 3 of 4 scenarios (lumbar puncture, vaccine, and gene transfer), and to enroll loved ones in research in all scenarios. On average, respondents were more willing to volunteer themselves for research than to enroll their loved ones. Conclusions/Significance: Most people were willing to grant leeway to their surrogates, and this willingness was either sustained or increased after democratic deliberation, suggesting that the attitude toward leeway is a reliable opinion. Eliciting a person's current preferences about future research participation should also involve eliciting his or her leeway preferences.	[Kim, Scott Y. H.; Ryan, Kerry A.; De Vries, Raymond] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, H. Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Damschroder, Laura] Ann Arbor VA Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; New York State Psychiatry Institute; Mayo Clinic	Kim, SYH (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	scottkim@med.umich.edu	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	National Institute of Health [R01AG029550]; Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by National Institute of Health R01AG029550 and the Greenwall Foundation Faculty Scholars Award in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Scott Kim, H. Myra Kim, Kerry Ryan, Paul Appelbaum, Laura Damschroder, and Raymond De Vries have declared that they have no competing interests. David Knopman has read the journal's policy and has the following conflicts: he serves as Deputy Editor for Neurology (R); serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals, and receives research support from the National Institute of Health. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ciroldi M, 2007, INTENS CARE MED, V33, P807, DOI 10.1007/s00134-007-0582-6; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; De Vries R, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.3.3; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Karlawish J, 2009, AM J PSYCHIAT, V166, P182, DOI 10.1176/appi.ajp.2008.08050645; Kim SYH, 2011, NEUROLOGY, V77, P2097, DOI 10.1212/WNL.0b013e31823648cb; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2011, ARCH GEN PSYCHIAT, V68, P214, DOI 10.1001/archgenpsychiatry.2010.191; Kim SYH, 2010, ALZHEIMERS DEMENT, V6, P342, DOI 10.1016/j.jalz.2009.06.001; Kim SYH, 2009, J EMPIR RES HUM RES, V4, P3, DOI 10.1525/jer.2009.4.4.3; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kirchhoff KT, 2010, J AM GERIATR SOC, V58, P1233, DOI 10.1111/j.1532-5415.2010.02760.x; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Wendler D, 2002, AM J PSYCHIAT, V159, P585, DOI 10.1176/appi.ajp.159.4.585	19	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54790	10.1371/journal.pone.0054790	http://dx.doi.org/10.1371/journal.pone.0054790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23349762	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600042
